Citrus Sinensis ID: 005278
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 704 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.991 | 0.691 | 0.382 | 1e-128 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.985 | 0.677 | 0.376 | 1e-117 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.961 | 0.656 | 0.355 | 1e-111 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.960 | 0.576 | 0.327 | 1e-100 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.973 | 0.698 | 0.326 | 1e-100 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.955 | 0.538 | 0.331 | 2e-95 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.947 | 0.532 | 0.329 | 3e-92 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.948 | 0.585 | 0.320 | 4e-88 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.941 | 0.556 | 0.311 | 4e-86 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.951 | 0.686 | 0.322 | 6e-86 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 460 bits (1184), Expect = e-128, Method: Compositional matrix adjust.
Identities = 291/760 (38%), Positives = 430/760 (56%), Gaps = 62/760 (8%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+G +LPNL + N +G+IP +++N S L L ++ N+ +G IP TFGN+ +L++L
Sbjct: 254 LGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLF 312
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
L N L ++SS FL+SLTNC L LG+ N L G LP I N SA L G
Sbjct: 313 LHTNSLGSDSSR-DLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGT 371
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
+ G+IP +IGNL + L+ L+G +PT++G+L L+ L L N+L G IP + +
Sbjct: 372 LISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGN 431
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
+ L L+L+ N G VP L + + L L +G NKL T+P ++ +L +++S N
Sbjct: 432 MTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGN 491
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIG-----------------------GL 277
SL GSLP +I L+ L L L N+LSG +P T+G GL
Sbjct: 492 SLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGL 551
Query: 278 ENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIP-----KNFSAQSFLSNYA 332
++ + L++N G +P+ F S LE L+LS NNL G++P +N + S + N
Sbjct: 552 VGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNND 611
Query: 333 LCG--------PARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHR 384
LCG P Q PS K +S KKV + V I + ++ +A V + ++R R
Sbjct: 612 LCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGI--TLLLLLFMASVTLIWLRKR 669
Query: 385 NRSTKDGDQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVA 443
++ + + + SY D++ ATNGF+ N++G+GSFG+VYK L + VA
Sbjct: 670 KKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVA 729
Query: 444 IKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID-----FKALVLEFMPNGSL 498
+KV N+Q A +SF +ECE L+ IRHRNL+K+++ C +ID F+AL+ EFMPNGSL
Sbjct: 730 VKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSL 789
Query: 499 EKWLYSHNY--------FLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE 550
+ WL+ L +LERLNI IDV L+YLH P+ HCDLKP+N+LLD+
Sbjct: 790 DMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDD 849
Query: 551 NMTAHVSDFGISKLLGEGD-DSVIQTMTIA----TIGYMAPEYGSEGIISPKSDVYSYGI 605
++TAHVSDFG+++LL + D +S ++ A TIGY APEYG G S DVYS+GI
Sbjct: 850 DLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGI 909
Query: 606 LLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL--VREEQAFSVKIDCLLS 663
LL+E FT K+PTNE+F G +L + K +LP+ + ++VD ++ + F V ++CL
Sbjct: 910 LLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPV-VECLTM 968
Query: 664 IMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDVATT 703
+ + L CC ESP R++ +L I+E+F TT
Sbjct: 969 VFEVGLRCCEESPMNRLATSIVVKELISIRERFFKASRTT 1008
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1090), Expect = e-117, Method: Compositional matrix adjust.
Identities = 288/765 (37%), Positives = 418/765 (54%), Gaps = 71/765 (9%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
G +LPNL+ L + N +GTIP +++N S L LD+ SN +G IP +FG L +L +L
Sbjct: 269 FGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLG 328
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
L N L SS +FL +LTNC L L + N L G LP I N S L E G
Sbjct: 329 LNNNSLGNYSSG-DLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGN 387
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
+ G+IP IGNL + DL L G +P ++G L L+ + L+ N L G IP L +
Sbjct: 388 LISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGN 447
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
+ GL+ L L N G +P L S + L L+LG+NKL ++P L ++ +N+S N
Sbjct: 448 ISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFN 507
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
L G L +I LK L LD+S N+LSG IP T+ +LE L L N F GP+P G
Sbjct: 508 LLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG- 566
Query: 301 LISLESLDLSRNNLSGEIP-----------------------------KNFSAQSFLSNY 331
L L LDLS+NNLSG IP +N SA S N
Sbjct: 567 LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNI 626
Query: 332 ALCG--------PARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVLIAIVIIFFIRH 383
LCG P +++P R+++S +K+ + + ++ + + L + + ++ +
Sbjct: 627 NLCGGIPSLQLQPCSVELP--RRHSS--VRKIITICVSAVMAALLLLCLCVVYLCWY-KL 681
Query: 384 RNRSTKDGDQEDLLSLAT----WRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDG 439
R +S + + E+ S + + + SY ++ + T GF+ NL+G+G+FG+V+KG L
Sbjct: 682 RVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSK 741
Query: 440 TN-VAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNI-----DFKALVLEFM 493
VAIKV NL A++SF +ECE L IRHRNL+K+++ C + DF+ALV EFM
Sbjct: 742 NKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFM 801
Query: 494 PNGSLEKWLYSH--------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNN 545
PNG+L+ WL+ + LG+ RLNI IDV AL YLH P+ HCD+KP+N
Sbjct: 802 PNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSN 861
Query: 546 ILLDENMTAHVSDFGISKLLGEGDDSVIQTM-----TIATIGYMAPEYGSEGIISPKSDV 600
ILLD+++TAHVSDFG+++LL + D TIGY APEYG G S DV
Sbjct: 862 ILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDV 921
Query: 601 YSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT-EVVDANLVR--EEQAFSVK 657
YS+GI+L+E FT K+PTN++F+ ++L + K +L ++ D ++R Q F++
Sbjct: 922 YSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNM- 980
Query: 658 IDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDVAT 702
++CL + + + C ESP R+SM +A +KL I+E F D T
Sbjct: 981 VECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRDEET 1025
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 402 bits (1034), Expect = e-111, Method: Compositional matrix adjust.
Identities = 265/745 (35%), Positives = 392/745 (52%), Gaps = 68/745 (9%)
Query: 16 NKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKW 75
N+ +G IP ++ N S L D+SSN SG IP +FG L +L L + N L SS+
Sbjct: 276 NQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGL- 334
Query: 76 NFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSG 135
F+ ++ NC L L + N L G LP I N S +L + + G IP +IGNL
Sbjct: 335 EFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVS 394
Query: 136 MIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLC 195
+ L L+G +P + G+L LQ + L+ N + G IP ++ L +L+LN N
Sbjct: 395 LQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFH 454
Query: 196 GHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKV 255
G +P L L L + +N+L T+P + + YI+LS N L G P + L++
Sbjct: 455 GRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLEL 514
Query: 256 LTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
L L S N+LSG +P IGG ++E L + N F G +P L+SL+++D S NNLS
Sbjct: 515 LVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLS 573
Query: 316 GEIP-----------------------------KNFSAQSFLSNYALCGPAR-LQVPSC- 344
G IP +N +A S N +CG R +Q+ C
Sbjct: 574 GRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCI 633
Query: 345 -----RKYNSRGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHRNRSTKDGDQEDLLSL 399
RK +K + + + + I+++A + F R + + DG+ D +L
Sbjct: 634 VQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTL 693
Query: 400 ATW-RRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRS 457
+ + SY ++ AT+ F+ NL+G+G+FG+V+KG L + VA+KV NL A++S
Sbjct: 694 GMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKS 753
Query: 458 FDSECEILRSIRHRNLIKIISNCCNI-----DFKALVLEFMPNGSLEKWLY--------S 504
F +ECE + IRHRNL+K+I+ C ++ DF+ALV EFMP GSL+ WL
Sbjct: 754 FMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVND 813
Query: 505 HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564
H+ L E+LNI IDV ALEYLH P+ HCD+KP+NILLD+++TAHVSDFG+++L
Sbjct: 814 HSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQL 873
Query: 565 LGEGD-DSVIQTMTIA----TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNE 619
L + D +S + + A TIGY APEYG G S + DVYS+GILL+E F+ KKPT+E
Sbjct: 874 LYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDE 933
Query: 620 IFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQR 679
F G+ +L + K S+ G T +N + E L ++ + + C E P R
Sbjct: 934 SFAGDYNLHSYTK-SILSGCTSSGGSNAIDE---------GLRLVLQVGIKCSEEYPRDR 983
Query: 680 VSMKDAAAKLKKIKEKFLDDVATTS 704
+ +A +L I+ KF T +
Sbjct: 984 MRTDEAVRELISIRSKFFSSKTTIT 1008
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (943), Expect = e-100, Method: Compositional matrix adjust.
Identities = 260/794 (32%), Positives = 399/794 (50%), Gaps = 118/794 (14%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
+L NL+ L+ DN L+G IP+SI+N + L +LDLS N +G IP FG + +L +S+
Sbjct: 382 LLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGR 440
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N+ E + NC NL L +A N L G L PLIG L+ L
Sbjct: 441 NHFTGE-------IPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQK-LRILQVSYNSLT 492
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
G IP+EIGNL + + L+ G IP + L LQGL ++ N L+G IP ++ ++
Sbjct: 493 GPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKL 552
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNK-------------------------- 217
LS L+L+ NK G +P + L SL L L NK
Sbjct: 553 LSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLT 612
Query: 218 ------------------------LTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNL 253
LT T+P G LE V I+LS N +GS+P ++Q
Sbjct: 613 GTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQAC 672
Query: 254 KVLTNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312
K + LD S+N LSG IP + G++ + +L+L+ N F G +P+SFG++ L SLDLS N
Sbjct: 673 KNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSN 732
Query: 313 NLSGEIP-----------------------------KNFSAQSFLSNYALCGPARLQVPS 343
NL+GEIP KN +A + N LCG + P
Sbjct: 733 NLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPC 792
Query: 344 CRKYNSRGFKK---VALLVL-KYILPPITSIVLIAIVIIFFIRHRNRSTKDGDQEDLLSL 399
K S F K V L++L + ++++ + + ++ + DL S
Sbjct: 793 TIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSA 852
Query: 400 ATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRS 457
+R ++++AT+ FN N++G+ S +VYKG L DGT +A+KV NL+ + +
Sbjct: 853 LKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKW 912
Query: 458 FDSECEILRSIRHRNLIKIISNCCNI-DFKALVLEFMPNGSLEKWLYSHNYFLG-ILERL 515
F +E + L ++HRNL+KI+ KALVL FM NG+LE ++ +G +LE++
Sbjct: 913 FYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKI 972
Query: 516 NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575
++ + + ++YLH G+ P+VHCDLKP NILLD + AHVSDFG +++LG +D
Sbjct: 973 DLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTA 1032
Query: 576 MTIA---TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPT--NEIFIGEMSLKHW 630
T A TIGY+APE+ ++ K+DV+S+GI++ME T+++PT N+ +M+L+
Sbjct: 1033 STSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQL 1092
Query: 631 VKESLPD---GLTEVVDANL------VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS 681
V++S+ + G+ V+D L +++E+A + L L C PE R
Sbjct: 1093 VEKSIGNGRKGMVRVLDMELGDSIVSLKQEEAIE-------DFLKLCLFCTSSRPEDRPD 1145
Query: 682 MKDAAAKLKKIKEK 695
M + L K++ K
Sbjct: 1146 MNEILTHLMKLRGK 1159
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (941), Expect = e-100, Method: Compositional matrix adjust.
Identities = 253/774 (32%), Positives = 397/774 (51%), Gaps = 89/774 (11%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPN-TFGNLGSLQVLSLAY 63
L L++L L+ NKL+GT+P+S++N++ L +DL SN SG +P+ + LQ L L+Y
Sbjct: 190 LKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSY 249
Query: 64 NYLMTESSAAKWN-FLSSLTNCRNLTVLGLASNPL------------------------- 97
N+ ++ ++ F +SL N +L L LA N L
Sbjct: 250 NHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRI 309
Query: 98 RGILPPLIGNFS-----------------------ASLQEFYAYGCKLRGNIPQEIGNLS 134
G +PP I N + L+ Y L G IP E+G++
Sbjct: 310 HGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIP 369
Query: 135 GMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKL 194
+ + D++ +L+G+IP + G L +L+ L L+GN L G++P L L L+L+ N L
Sbjct: 370 RLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNL 429
Query: 195 CGHVP-PCLASLTSLR-RLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQN 252
G +P +++L +L+ L+L SN L+ +P ++ VL ++LS+N L+G +P + +
Sbjct: 430 TGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGS 489
Query: 253 LKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312
L +L+LSRN S +P+++G L L+ L ++ N+ G +P SF +L+ L+ S N
Sbjct: 490 CIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFN 549
Query: 313 NLSGEIP-----KNFSAQSFLSNYALCGPARLQVPSCRKYNS-------RGFKKVALLVL 360
LSG + + +SFL + LCG + + +C+K + +A VL
Sbjct: 550 LLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKKKHKYPSVLLPVLLSLIATPVL 608
Query: 361 KYILPPITSIVLIAIVIIFFIRHRNRSTKDGDQEDLLSLATWRRTSYLDIQRATNGFNEC 420
P+ + + + + +Q D + R SY + AT GFN
Sbjct: 609 CVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQND----PKYPRISYQQLIAATGGFNAS 664
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISN 479
+L+G+G FG VYKG L + T VA+KV + + S SF EC+IL+ RHRNLI+II+
Sbjct: 665 SLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITT 724
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYF---LGILERLNIMIDVGLALEYLHHGHSTPM 536
C F ALVL MPNGSLE+ LY Y L +++ +NI DV + YLHH +
Sbjct: 725 CSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKV 784
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLG------EGDDSV----IQTMTIATIGYMAP 586
VHCDLKP+NILLD+ MTA V+DFGIS+L+ DDSV + ++GY+AP
Sbjct: 785 VHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAP 844
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646
EYG S DVYS+G+LL+E + ++PT+ + SL ++K PD L +++
Sbjct: 845 EYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQA 904
Query: 647 LVR------EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
L R E+ + + +L ++ L L C +P R M D A ++ ++KE
Sbjct: 905 LSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKE 958
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (899), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 255/769 (33%), Positives = 369/769 (47%), Gaps = 96/769 (12%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L L L N+L G +P S+ N +L +LDL+ N SG IP++FG L L+ L L N
Sbjct: 479 LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNN 538
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L + N SL + RNLT + L+ N L G + PL G S+S F
Sbjct: 539 SL-------QGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG--SSSYLSFDVTNNGFED 589
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
IP E+GN + L L G IP +G++R L L + N L G+IP L + L
Sbjct: 590 EIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKL 649
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
+ ++LN N L G +PP L L+ L L L SN+ ++P+ + +L ++L NSLNG
Sbjct: 650 THIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNG 709
Query: 245 SLPSNIQNLKVLTNLDLSRNQLS------------------------------------- 267
S+P I NL L L+L +NQ S
Sbjct: 710 SIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDL 769
Query: 268 ------------GDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
GDIP+TIG L LETL L+ NQ G VP S G + SL L++S NNL
Sbjct: 770 QSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLG 829
Query: 316 GEIPKNFS---AQSFLSNYALCGPARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVL 372
G++ K FS A SFL N LCG + R N + +V+ + +T+I L
Sbjct: 830 GKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGL 889
Query: 373 IAIVIIFFIRHRN---RSTKDGDQEDLLSLATWRRT--------------SYLDIQRATN 415
+ +VI F + R+ + G S ++ + T + DI AT+
Sbjct: 890 MILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATH 949
Query: 416 GFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERAS-RSFDSECEILRSIRHRNLI 474
+E ++G+G G VYK L +G VA+K + + S +SF E + L IRHR+L+
Sbjct: 950 NLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLV 1009
Query: 475 KIISNCCNID--FKALVLEFMPNGSLEKWLYS-------HNYFLGILERLNIMIDVGLAL 525
K++ C + L+ E+M NGS+ WL+ L RL I + + +
Sbjct: 1010 KLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGV 1069
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGY 583
EYLHH P+VH D+K +N+LLD NM AH+ DFG++K+L E D+ + T + GY
Sbjct: 1070 EYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGY 1129
Query: 584 MAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP---DGLT 640
+APEY + KSDVYS GI+LME T K PT+ +F EM + WV+ L
Sbjct: 1130 IAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARD 1189
Query: 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689
+++D L + + D ++ +AL C SP++R S + A L
Sbjct: 1190 KLIDPKL---KPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 254/771 (32%), Positives = 383/771 (49%), Gaps = 104/771 (13%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L +L L L +N+L G IP S+ N ++ ++DL+ N SG IP++FG L +L++ + N
Sbjct: 480 LKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNN 539
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L + N SL N +NLT + +SN G + PL G S+S F G
Sbjct: 540 SL-------QGNLPDSLINLKNLTRINFSSNKFNGSISPLCG--SSSYLSFDVTENGFEG 590
Query: 125 NIPQEIG-------------------------------------NLSGMIVFDLNGC--- 144
+IP E+G +LSG+I +L C
Sbjct: 591 DIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKL 650
Query: 145 ---DLN-----GTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCG 196
DLN G IPT +G+L L L L NK GS+P ++ L + L L+GN L G
Sbjct: 651 THIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNG 710
Query: 197 HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVL 256
+P + +L +L L+L N+L+ +PS+ G L + + LS N+L G +P I L+ L
Sbjct: 711 SIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDL 770
Query: 257 TN-LDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
+ LDLS N +G IP+TI L LE+L L+ NQ G VP G + SL L+LS NNL
Sbjct: 771 QSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLE 830
Query: 316 GEIPKNFS---AQSFLSNYALCGPARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVL 372
G++ K FS A +F+ N LCG N R ++++ I + +I L
Sbjct: 831 GKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAI-SSLAAIAL 889
Query: 373 IAIVIIFFIRHRN---RSTKDG----------DQEDLLSLATWRR-TSYLDIQRATNGFN 418
+ +VII F + + + + G Q L S + + DI AT+ N
Sbjct: 890 MVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLN 949
Query: 419 ECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERAS-RSFDSECEILRSIRHRNLIKII 477
E ++G+G G VYK L +G +A+K + + S +SF+ E + L +IRHR+L+K++
Sbjct: 950 EEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLM 1009
Query: 478 SNCCNI--DFKALVLEFMPNGSLEKWLYSH-----NYFLGILERLNIMIDVGLALEYLHH 530
C + L+ E+M NGS+ WL+++ LG RL I + + +EYLH+
Sbjct: 1010 GYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHY 1069
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ--TMTIATIGYMAPEY 588
P+VH D+K +N+LLD N+ AH+ DFG++K+L D+ + TM + GY+APEY
Sbjct: 1070 DCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEY 1129
Query: 589 GSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL--PDG---LTEVV 643
+ KSDVYS GI+LME T K PT +F E + WV+ L P G +++
Sbjct: 1130 AYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLI 1189
Query: 644 DANL-----VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689
D+ L EE A+ V + +AL C P++R S + A+ L
Sbjct: 1190 DSELKSLLPCEEEAAYQV--------LEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (835), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 238/742 (32%), Positives = 371/742 (50%), Gaps = 74/742 (9%)
Query: 8 LKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNL-------------- 53
L+ + DNK SG+IP +I+N S L+ L L N SGLIP+ G L
Sbjct: 348 LEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLE 407
Query: 54 GS----------LQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPP 103
GS LQ L L+ N L S L RNLT L L SN L G +P
Sbjct: 408 GSIPPGLADCTDLQALDLSRNSLTG-------TIPSGLFMLRNLTKLLLISNSLSGFIPQ 460
Query: 104 LIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163
IGN S+ ++ + ++ G IP IG+L + D + L+G +P +G LQ +
Sbjct: 461 EIGNCSSLVRLRLGFN-RITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMI 519
Query: 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMP 223
L N L+GS+P + L GL L+++ N+ G +P L L SL +L L N + ++P
Sbjct: 520 DLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIP 579
Query: 224 SSFGSLEYVLYINLSANSLNGSLPS---NIQNLKVLTNLDLSRNQLSGDIPTTIGGLENL 280
+S G + ++L +N L+G +PS +I+NL++ L+LS N+L+G IP+ I L L
Sbjct: 580 TSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIA--LNLSSNRLTGKIPSKIASLNKL 637
Query: 281 ETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKN-----FSAQSFLSNYALCG 335
L L+ N +G + ++ +L SL++S N+ SG +P N S Q N LC
Sbjct: 638 SILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCS 696
Query: 336 PARLQVPSC----RKYNSRGFKKVALLVLKYILPPITS----IVLIAIVIIFFIRHRNRS 387
+ SC RK N G A K L +VL+ + + IR R
Sbjct: 697 STQ---DSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNI 753
Query: 388 TKDGDQEDLLSLATWRRTSYLDIQRATNGFNEC----NLLGTGSFGSVYKGTLFDGTNVA 443
+ D E L W+ T + + + + C N++G G G VY+ + +G +A
Sbjct: 754 DNERDSE-LGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIA 812
Query: 444 IKVF---------NLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494
+K + + + SF +E + L +IRH+N+++ + C N + + L+ ++MP
Sbjct: 813 VKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMP 872
Query: 495 NGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT 553
NGSL L+ L R I++ L YLHH P+VH D+K NNIL+ +
Sbjct: 873 NGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFE 932
Query: 554 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTR 613
+++DFG++KL+ EGD + GY+APEYG I+ KSDVYSYG++++E T
Sbjct: 933 PYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTG 992
Query: 614 KKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCM 673
K+P + + L WV+++ G EV+D+ L +A + D ++ ++ AL C
Sbjct: 993 KQPIDPTVPEGIHLVDWVRQN--RGSLEVLDSTLRSRTEA---EADEMMQVLGTALLCVN 1047
Query: 674 ESPEQRVSMKDAAAKLKKIKEK 695
SP++R +MKD AA LK+IK++
Sbjct: 1048 SSPDERPTMKDVAAMLKEIKQE 1069
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (819), Expect = 4e-86, Method: Compositional matrix adjust.
Identities = 239/767 (31%), Positives = 374/767 (48%), Gaps = 104/767 (13%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYL 66
NL T N+L G +P I NA+ L L LS N +G IP G L SL VL+L N
Sbjct: 449 NLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMF 508
Query: 67 MTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLI-------------GNFSAS-- 111
+ L +C +LT L L SN L+G +P I N S S
Sbjct: 509 QGKIPV-------ELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIP 561
Query: 112 -----------------LQEFYAYGC---KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIP 151
LQ + +L G IP+E+G ++ L+ L+G IP
Sbjct: 562 SKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIP 621
Query: 152 TAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRL 211
++ RL L L L GN L GSIP ++ + L LNL N+L GH+P L SL +L
Sbjct: 622 ASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKL 681
Query: 212 HLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIP 271
+L NKL +P+S G+L+ + +++LS N+L+G L S + ++ L L + +N+ +G+IP
Sbjct: 682 NLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIP 741
Query: 272 TTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQ----SF 327
+ +G L LE L +++N G +P L +LE L+L++NNL GE+P + Q +
Sbjct: 742 SELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKAL 801
Query: 328 LS-NYALCGPARLQVPSCRKYNS--RGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHR 384
LS N LCG R+ C+ + R +A L+L + +I V +F +R
Sbjct: 802 LSGNKELCG--RVVGSDCKIEGTKLRSAWGIAGLMLGF--------TIIVFVFVFSLRRW 851
Query: 385 NRSTKDGDQEDLLSLATWRRTSYL---------------------------------DIQ 411
+ + ++D + R ++ DI
Sbjct: 852 AMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIV 911
Query: 412 RATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHR 471
AT+ F++ N++G G FG+VYK L VA+K + + +R F +E E L ++H
Sbjct: 912 EATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHP 971
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILE---RLNIMIDVGLALEYL 528
NL+ ++ C + K LV E+M NGSL+ WL + L +L+ RL I + L +L
Sbjct: 972 NLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFL 1031
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY 588
HHG ++H D+K +NILLD + V+DFG+++L+ +S + T+ T GY+ PEY
Sbjct: 1032 HHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLI-SACESHVSTVIAGTFGYIPPEY 1090
Query: 589 GSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM--SLKHWVKESLPDG-LTEVVDA 645
G + K DVYS+G++L+E T K+PT F +L W + + G +V+D
Sbjct: 1091 GQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDP 1150
Query: 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
LV + ++K + L ++ +A+ C E+P +R +M D LK+I
Sbjct: 1151 LLV----SVALK-NSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (817), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 247/767 (32%), Positives = 378/767 (49%), Gaps = 97/767 (12%)
Query: 5 LPNLKYLTLFDNKLSGTIP-----------------NSITNASK-------LIMLDLSSN 40
+PNLK L L NKLSG IP N + N S L D+ +N
Sbjct: 163 IPNLKILDLAQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNN 222
Query: 41 SFSGLIPNTFGNLGSLQVLSLAYN-----------YLMTESSAAKWNFLSS-----LTNC 84
S +G IP T GN + QVL L+YN +L + + + N LS +
Sbjct: 223 SLTGSIPETIGNCTAFQVLDLSYNQLTGEIPFDIGFLQVATLSLQGNQLSGKIPSVIGLM 282
Query: 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGC 144
+ L VL L+ N L G +PP++GN + + ++ Y + KL G+IP E+GN+S + +LN
Sbjct: 283 QALAVLDLSGNLLSGSIPPILGNLTFT-EKLYLHSNKLTGSIPPELGNMSKLHYLELNDN 341
Query: 145 DLNGTIPTAVGRL------------------------RRLQGLYLHGNKLQGSIPYDLCH 180
L G IP +G+L L L +HGNK G+IP
Sbjct: 342 HLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQK 401
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
LE ++ LNL+ N + G +P L+ + +L L L +NK+ +PSS G LE++L +NLS N
Sbjct: 402 LESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRN 461
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
+ G +P + NL+ + +DLS N +SG IP + L+N+ L L +N G V S +
Sbjct: 462 HITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNV-GSLAN 520
Query: 301 LISLESLDLSRNNLSGEIPKN-----FSAQSFLSNYALCGPARLQVPSCRKYNSRGFKKV 355
+SL L++S NNL G+IPKN FS SF+ N LCG + L P ++SR +V
Sbjct: 521 CLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCG-SWLNSPC---HDSRRTVRV 576
Query: 356 ALLVLKYILPPITSIVLIAIVIIFFIR-HRNRSTKDGDQEDLLSLATWRRT--------- 405
++ + I +V++ +V+I R H DG + ++ +T +
Sbjct: 577 SISRAAILGIAIGGLVILLMVLIAACRPHNPPPFLDGSLDKPVTYSTPKLVILHMNMALH 636
Query: 406 SYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEIL 465
Y DI R T +E ++G G+ +VYK L + VAIK ++ + F++E E+L
Sbjct: 637 VYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNPQSMKQFETELEML 696
Query: 466 RSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLY--SHNYFLGILERLNIMIDVGL 523
SI+HRNL+ + + + L +++ NGSL L+ + L RL I
Sbjct: 697 SSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLDWDTRLKIAYGAAQ 756
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
L YLHH S ++H D+K +NILLD+++ A ++DFGI+K L S T + TIGY
Sbjct: 757 GLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVS-KSHTSTYVMGTIGY 815
Query: 584 MAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG-LTEV 642
+ PEY ++ KSDVYSYGI+L+E TR+K ++ E +L H + + + E+
Sbjct: 816 IDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDD----ESNLHHLIMSKTGNNEVMEM 871
Query: 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689
D ++ + V + + LAL C P R +M L
Sbjct: 872 ADPDITSTCKDLGV----VKKVFQLALLCTKRQPNDRPTMHQVTRVL 914
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 704 | ||||||
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.987 | 0.655 | 0.584 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.998 | 0.645 | 0.534 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.981 | 0.635 | 0.564 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.984 | 0.680 | 0.537 | 0.0 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.985 | 0.564 | 0.518 | 0.0 | |
| 359497186 | 1140 | PREDICTED: LRR receptor-like serine/thre | 0.985 | 0.608 | 0.519 | 0.0 | |
| 147776333 | 1205 | hypothetical protein VITISV_000078 [Viti | 0.985 | 0.575 | 0.518 | 0.0 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.984 | 0.664 | 0.532 | 0.0 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.985 | 0.477 | 0.513 | 0.0 | |
| 147852480 | 1229 | hypothetical protein VITISV_039533 [Viti | 0.985 | 0.564 | 0.511 | 0.0 |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 804 bits (2076), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/730 (58%), Positives = 535/730 (73%), Gaps = 35/730 (4%)
Query: 2 GYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSL 61
G LPNL+ L L N+LSG IP+SI NASKLI+LDLS NSFSG IP+ GNL +LQ L+L
Sbjct: 328 GLGLPNLEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNL 387
Query: 62 AYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCK 121
A N L ++S ++ +FLSSL+NCR+L L NPLRG LP IGN SASL+E YA+ C+
Sbjct: 388 AENILTSKSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCR 447
Query: 122 LRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL 181
+ GNIP+ IGNLS +I L +L G IP+ +GRL+ LQ L NKLQG IP ++CHL
Sbjct: 448 IIGNIPRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHL 507
Query: 182 EGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241
E LS L L N G +P CL+++TSLR L+LGSN+ TS +P++F SL+ +L INLS NS
Sbjct: 508 ERLSYLYLLENGFSGSLPACLSNITSLRELYLGSNRFTS-IPTTFWSLKDLLQINLSFNS 566
Query: 242 LNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSL 301
L G+LP I NLKV+T +D S NQLSGDIPT+I L+NL SL+DN+ QGP+P SFG L
Sbjct: 567 LTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDL 626
Query: 302 ISLESLDLSRNNLSGEIPK-----------------------------NFSAQSFLSNYA 332
+SLE LDLSRN+LSG IPK NFS +SF+ N A
Sbjct: 627 VSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEA 686
Query: 333 LCGPARLQVPSCRKYNS-RGFKKVALLVLKYILPPITSIVLI-AIVIIFFIRHRNRSTKD 390
LCGP R+QVP C+ ++ R K+ V++YI+P I I+L+ A+ +I F R R K
Sbjct: 687 LCGPIRMQVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKR--KL 744
Query: 391 GDQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQ 450
QED L ATWR+ SY ++ RAT GFNE NLLGTGS GSVYKGTL DG +A+KVF+LQ
Sbjct: 745 STQEDPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQ 804
Query: 451 LERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLG 510
LE FDSECE+LR +RHRNL+KIIS+CCN+DFKAL+LEF+P+GSLEKWLYSHNY+L
Sbjct: 805 LEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLD 864
Query: 511 ILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570
IL+RLNIMIDV ALEYLHHG + P+VHCDLKP+N+L++E+M AHVSDFGIS+LLGEG D
Sbjct: 865 ILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEG-D 923
Query: 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHW 630
+V QT+T+ATIGYMAPEYG EGI+S K DVYSYGI LMETFTRKKPT+++F GEMSLK+W
Sbjct: 924 AVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNW 983
Query: 631 VKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
VK+SLP +TEV+DANL+ EE+ F K DC+ SI++LAL+C + P +R+ M+D L+
Sbjct: 984 VKQSLPKAITEVIDANLLIEEEHFVAKKDCITSILNLALECSADLPGERICMRDVLPALE 1043
Query: 691 KIKEKFLDDV 700
KIK K+ DV
Sbjct: 1044 KIKLKYKKDV 1053
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1968), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/735 (53%), Positives = 514/735 (69%), Gaps = 32/735 (4%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+G LPNL +L L NKLSG IP+ I+NASKL +L+L SNSF+G IP++ G+L +LQ L
Sbjct: 356 LGLHLPNLIWLYLGINKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLK 415
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
L N L ++ ++ + SSL NC+NL L L+ NPL G LP +GN S SL+ F A
Sbjct: 416 LGANLLSSKKTSQELTIFSSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDG 475
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
++G++ + IGNLS + +L DL G IPT +G L+ LQGLYLHGN L GSIP +LC
Sbjct: 476 LIKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCD 535
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
L L L L GNKL G +P C ++LTSLR L L SN+ ST+ S+ +L+ +L +NL++N
Sbjct: 536 LRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASN 595
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
L GSLPS I+NL+ + +++S+NQLSG+IP +IGGL++L L L+ N+ QGP+P+S G
Sbjct: 596 YLTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGD 655
Query: 301 LISLESLDLSRNNLSGEIPK-----------------------------NFSAQSFLSNY 331
+ SLE LDLS NNLSG IPK NFSAQSF+ N
Sbjct: 656 IKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNE 715
Query: 332 ALCGPARLQVPSCRKYNSRGFKKV-ALLVLKYILPPITSIVLIAIVIIFFIRHRNRSTKD 390
ALCG ARLQV C+ NSR + + +VL+Y+LP I V + +I R+ R K
Sbjct: 716 ALCGSARLQVSPCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKF 775
Query: 391 GDQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQ 450
++D L+L T RR SY ++Q ATNGF E N LG GSFGSVYKGTL DGT +A KVFNLQ
Sbjct: 776 SIEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQ 835
Query: 451 LERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLG 510
LERA +SFD+ECE+LR++RHRNL+KII++C +FKALVLEFMPN SLEKWLYS +YFL
Sbjct: 836 LERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLN 895
Query: 511 ILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570
L+RLNIM+DV LEYLHHG++ PM HCD+KP+N+LL+E+M A ++DFGISKLLGE +
Sbjct: 896 NLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLLGE-EG 954
Query: 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHW 630
SV+QTMT+ATIGYMAPEYGSEGI+S + DVYSYG+LLMETFT+KKPT+++F ++SLK W
Sbjct: 955 SVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSW 1014
Query: 631 VKESLPDGLTEVVDANLVR-EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689
V++SL +T+V+DANL+ EE + K DC++SI+ LAL C + P R+ MK L
Sbjct: 1015 VEQSLSCEVTQVIDANLLGIEEDHLAAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTL 1074
Query: 690 KKIKEKFLDDVATTS 704
+KIK KFL D+ S
Sbjct: 1075 QKIKTKFLRDIRQLS 1089
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/725 (56%), Positives = 512/725 (70%), Gaps = 34/725 (4%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
G LPNL+ L L N LSG IP+SI NASKL LD N +G IP+ G+L L+ L+
Sbjct: 360 FGSYLPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLN 419
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
L N L ES + +FL+SLTNC+ L +L L+ NPL GILP IGN S SLQ F A C
Sbjct: 420 LGVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTC 479
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
KL+GNIP EIGNLS + + LN DL GTIP ++G+L++LQGLYL NKLQGSIP D+C
Sbjct: 480 KLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQ 539
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
L L EL L N+L G +P CL LT LR L+LGSNKL ST+PS+ SL ++L +++S+N
Sbjct: 540 LRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSN 599
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
L G LPS++ NLKVL +DLSRNQLSG+IP+ IGGL++L +LSLA N+F+GP+ SF +
Sbjct: 600 FLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSN 659
Query: 301 LISLESLDLSRNNLSGEIPK-----------------------------NFSAQSFLSNY 331
L SLE +DLS N L GEIPK NFSA+SF+ N
Sbjct: 660 LKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNK 719
Query: 332 ALCGPARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHRNRSTKDG 391
ALCG RL++P CR +R ++ L+LKYILP I S +L +I + R R R+
Sbjct: 720 ALCGSPRLKLPPCRT-GTRWSTTISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLP 778
Query: 392 DQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL 451
Q + L ATWRR SY +I +ATNGF+ NLLG GS GSVY+GTL DG N AIKVFNLQ
Sbjct: 779 TQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQE 838
Query: 452 ERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKALVLEFMPNGSLEKWLYSHNYFL 509
E A +SFD+ECE++ IRHRNLIKI+S+C N IDFKALVLE++PNGSLE+WLYSHNY L
Sbjct: 839 EAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCL 898
Query: 510 GILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569
IL+RLNIMIDV LA+EYLHHG STP+VHCDLKP+NILLDE+ HV DFGI+KLL E +
Sbjct: 899 DILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLRE-E 957
Query: 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH 629
+S+ +T T+ATIGYMAP+Y S GI++ DVYSYGI+LMETFTR++PT+EIF EMS+K+
Sbjct: 958 ESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKN 1017
Query: 630 WVKESLPDGLTEVVDANLVR-EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688
WV + L +TEVVDANL+R E++ F K C+ I+ LA+DC +SPE+R+ MKD
Sbjct: 1018 WVWDWLCGSITEVVDANLLRGEDEQFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTT 1077
Query: 689 LKKIK 693
LKKIK
Sbjct: 1078 LKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/725 (53%), Positives = 501/725 (69%), Gaps = 32/725 (4%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
LPNL+ L L N ++G++P + N S+L +LDLS N +G + FGNL +LQVLSL N
Sbjct: 291 LPNLEELQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSN 350
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
S+ NF++SLTN R L L + NPL G+LP +GN S+ L +FY Y KL+G
Sbjct: 351 SFTNHPSSQTLNFITSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKG 410
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
NIP EIGNLS +IV L L G IPT VG LR++Q LYLH N L GSIP D+C L
Sbjct: 411 NIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRL 470
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
++ LN N L G +P C+ +LTSLR L+L N L+ST+P + SL+ +L +NL +N L G
Sbjct: 471 VDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYG 530
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
SLPS + ++ + LS NQLSG+IP+TIG L+NL SL+ N FQG +P++FG L+SL
Sbjct: 531 SLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSL 590
Query: 305 ESLDLSRNNLSGEIPK-----------------------------NFSAQSFLSNYALCG 335
E LDLS+NNLSGEIPK NF+A+SF+ N LCG
Sbjct: 591 ELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCG 650
Query: 336 PARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHRNRSTKDGDQED 395
P+RLQVP C SR K +L++ LP + SI+L+ I + R R KD E
Sbjct: 651 PSRLQVPPC-SIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEA 709
Query: 396 LLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERAS 455
L A RR SYL++ ATN F+E NLLG GSFGSVY+G L DG NVA+K+FNLQL+RA
Sbjct: 710 LPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAF 769
Query: 456 RSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL 515
RSFD+ECEI+R+IRHRNL+KII +C N+DFKALVLE+MP GSLEKWLYSHNY L I++R+
Sbjct: 770 RSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRV 829
Query: 516 NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575
NIMIDV ALEYLHHG+ +P+VHCDLKP+N+LLDE+M AHV DFGI+KLLGE ++S QT
Sbjct: 830 NIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLLGE-NESFAQT 888
Query: 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635
T+ATIGYMAPEYG +G++S K DVYS+GI+LME TRK+PT+E+F GEMSLK VKESL
Sbjct: 889 RTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESL 948
Query: 636 PDGLTEVVDANLVREEQAFSVKID-CLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
PD + ++VD+N++ +SVK + C+ SIM LAL C ESP +R++M + A+LK IK
Sbjct: 949 PDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKA 1008
Query: 695 KFLDD 699
+FL D
Sbjct: 1009 EFLRD 1013
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/727 (51%), Positives = 497/727 (68%), Gaps = 33/727 (4%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+G L +L+ L + N+ SG IP SI+N SKL +L LS+NSF+G +P GNL L+VL
Sbjct: 505 IGTWLSDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLD 564
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
LA N L E A++ FL+SLTNC+ L L + +NP +G LP +GN +L+ F A C
Sbjct: 565 LAGNQLTDEHVASEVGFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASAC 624
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
+ RG IP IGNL+ +I DL DL G+IPT +GRL++LQ L++ GN+L+GSIP DLCH
Sbjct: 625 QFRGTIPTRIGNLTNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCH 684
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
L+ L L+L+ NKL G +P C L +L+ L L SN L +P+S SL +L +NLS+N
Sbjct: 685 LKNLGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSN 744
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
L G+LP + N+K +T LDLS+N +SG IP +G +NL LSL+ N+ QGP+P FG
Sbjct: 745 FLTGNLPPEVGNMKSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGD 804
Query: 301 LISLESLDLSRNNLSGEIPK-----------------------------NFSAQSFLSNY 331
L+SLESLDLS+NNLSG IPK NF+A+SF+ N
Sbjct: 805 LVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNE 864
Query: 332 ALCGPARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHRNRSTKDG 391
ALCG QV +C K N K +LKYIL P+ SIV + + I+ +IR R+
Sbjct: 865 ALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPT 924
Query: 392 DQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL 451
+ L T + S+ + ATN F E NL+G GS G VYKG L +G VAIKVFNL+
Sbjct: 925 PIDSWLP-GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEF 983
Query: 452 ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGI 511
+ A RSFDSECE+++ IRHRNL++II+ C N+DFKALVLE+MPNGSLEKWLYSHNYFL +
Sbjct: 984 QGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDL 1043
Query: 512 LERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571
++RLNIMIDV ALEYLHH S+ +VHCDLKPNN+LLD++M AHV+DFGI+KLL + +S
Sbjct: 1044 IQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTK-TES 1102
Query: 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV 631
+ QT T+ TIGYMAPE+GS+GI+S KSDVYSYGILLME F+RKKP +E+F G+++LK WV
Sbjct: 1103 MQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWV 1162
Query: 632 KESLPDGLTEVVDANLV-REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
ESL + + +VVDANL+ RE++ + K+ CL SIM LAL C +SPE+R++MKDA +LK
Sbjct: 1163 -ESLSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTDSPEERLNMKDAVVELK 1221
Query: 691 KIKEKFL 697
K + K L
Sbjct: 1222 KSRMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1847), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/727 (51%), Positives = 497/727 (68%), Gaps = 33/727 (4%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+G LP+L+ L + N+ SG IP SI+N SKL +L LS+NSF+G +P GNL L+VL
Sbjct: 416 IGTWLPDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLD 475
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
LA N L E A++ FL+SLTNC+ L L + + P +G LP +GN +L+ F A C
Sbjct: 476 LAGNQLTDEHVASEVGFLTSLTNCKFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASAC 535
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
+ RG IP IGNL+ +I DL DL G+IPT +G+L++LQ LY+ GN+++GSIP DLCH
Sbjct: 536 QFRGTIPTGIGNLTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCH 595
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
L+ L L L+ NKL G +P C L +L+ L L SN L +P+S SL +L +NLS+N
Sbjct: 596 LKDLGYLFLSSNKLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSN 655
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
L G+LP + N+K +T LDLS+N +SG IP+ +G L++L TLSL+ N+ QGP+P FG
Sbjct: 656 FLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGD 715
Query: 301 LISLESLDLSRNNLSGEIPK-----------------------------NFSAQSFLSNY 331
L+SLESLDLS+NNLSG IPK NF+A+SF+ N
Sbjct: 716 LVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNE 775
Query: 332 ALCGPARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHRNRSTKDG 391
ALCG QV +C K N K +LKYIL P+ SIV + + I+ +IR R+
Sbjct: 776 ALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPT 835
Query: 392 DQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL 451
+ L T + S+ + ATN F E NL+G GS G VYKG L +G VAIKVFNL+
Sbjct: 836 PIDSWLP-GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEF 894
Query: 452 ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGI 511
+ A RSFDSECE+++ IRHRNL++II+ C N+DFKALVLE+MPNGSLEKWLYSHNYFL +
Sbjct: 895 QGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDL 954
Query: 512 LERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571
++RLNIMIDV ALEYLHH S+ +VHCDLKPNN+LLD++M AHV+DFGI+KLL + +S
Sbjct: 955 IQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTK-TES 1013
Query: 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV 631
+ QT T+ TIGYMAPE+GS+GI+S KSDVYSYGILLME F+RKKP +E+F G ++LK WV
Sbjct: 1014 MQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWV 1073
Query: 632 KESLPDGLTEVVDANLV-REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
ESL + + +VVDANL+ RE++ + K+ CL SIM LAL C SPE+R++MKDA +LK
Sbjct: 1074 -ESLSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTNSPEKRLNMKDAVVELK 1132
Query: 691 KIKEKFL 697
K K K L
Sbjct: 1133 KSKMKLL 1139
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1842), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/727 (51%), Positives = 493/727 (67%), Gaps = 33/727 (4%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+G LP+L+ L + N+ SGTIP SI+N SKL +L LS NSF+G +P NL L+ L+
Sbjct: 481 IGTWLPDLEGLYIGANEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLKFLN 540
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
LA+N L E A+ FL+SLTNC+ L L + NPL+G LP +GN +L+ F AY C
Sbjct: 541 LAHNQLTDEHLASGVGFLTSLTNCKFLRYLWIGYNPLKGTLPNSLGNLPIALESFTAYAC 600
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
+ RG IP IGNL+ +I DL DL G+IPT +GRL++LQ L++ GN+++GSIP DLCH
Sbjct: 601 QFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCH 660
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
L+ L L L+ NKL G P C L +LR L L SN L +P+S SL +L +NLS+N
Sbjct: 661 LKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSN 720
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
L G+LP + N+K +T LDLS+N +SG IP+ +G L+ L TLSL+ N+ QGP+ FG
Sbjct: 721 FLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGD 780
Query: 301 LISLESLDLSRNNLSGEIPKN-----------------------------FSAQSFLSNY 331
L+SLESLDLS NNLSG IPK+ F+A+SF+ N
Sbjct: 781 LVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNE 840
Query: 332 ALCGPARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHRNRSTKDG 391
ALCG QV +C K N K +LKYIL P+ S V + + I+ +IR R+
Sbjct: 841 ALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPT 900
Query: 392 DQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL 451
+ L L T + S+ + ATN F E NL+G GS G VYKG L +G NVAIKVFNL+
Sbjct: 901 PIDSWL-LGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEF 959
Query: 452 ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGI 511
+ A RSFDSECE+++ IRHRNL++II+ C N+DFKALVLE+MPNGSLEKWLYSHNYFL +
Sbjct: 960 QGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDL 1019
Query: 512 LERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571
++RLNIMIDV ALEYLHH S+ +VHCDLKP+N+LLD++M AHV+DFGI+KLL E +S
Sbjct: 1020 IQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLTE-TES 1078
Query: 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV 631
+ QT T+ TIGYMAPE+GS GI+S KSDVYSYGILLME F RKKP +E+F G+++LK WV
Sbjct: 1079 MQQTKTLGTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV 1138
Query: 632 KESLPDGLTEVVDANLV-REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
ESL + + +VVD NL+ RE++ + K+ CL SIM LAL C +SP++R+ MKDA +LK
Sbjct: 1139 -ESLSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALACTTDSPKERIDMKDAVVELK 1197
Query: 691 KIKEKFL 697
K + K L
Sbjct: 1198 KSRIKLL 1204
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1829), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/729 (53%), Positives = 510/729 (69%), Gaps = 36/729 (4%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
LPNL++ + DN +G IP S+ NASKL +DL NSF G IP+ GNL SL+V S N
Sbjct: 317 LPNLEFFIIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEVFSFWVN 376
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+L +SS++ + SSLT C++L L++NPL G LP +GN S+SL+ + C + G
Sbjct: 377 HLTVKSSSSGLSLFSSLTKCKHLRRFDLSNNPLNGNLPISVGNLSSSLEVVEIFDCGITG 436
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
IP+EIGNLS + DL DL GTIPT + +L +LQ L LH N+L+GS PY+LC L+ L
Sbjct: 437 TIPKEIGNLSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYELCDLQSL 496
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
+ L L N L G +P CL ++ SLR L +G NK +ST+PS+ L +L +NLS+NSL+G
Sbjct: 497 AYLYLEVNALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNLSSNSLSG 556
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
SL +I NLK +T +DLS NQLSG IP++IGGL+ L LSLA N+ +G +P+ FG ISL
Sbjct: 557 SLAVDIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISL 616
Query: 305 ESLDLSRNNLSGEIPK-----------------------------NFSAQSFLSNYALCG 335
+ LDLS NNLSGEIPK N SA+SF+ N LCG
Sbjct: 617 QLLDLSNNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCG 676
Query: 336 PARLQVPSCRKYNSRGFKKVALLVLKY-ILPPITSIVLIAIVIIFFIRHRNRSTKDGDQE 394
A+LQV C +G K + L L+Y ++ +I+ +A V I FIR R R+ + E
Sbjct: 677 AAKLQVQPCETSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKRNMRI--TE 734
Query: 395 DLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERA 454
LL LAT +R SY ++++AT+ FNE NLLG GSFGSVYKGT DG++VA+KVFNLQ+E A
Sbjct: 735 GLLPLATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGA 794
Query: 455 SRSFDSECEILRSIRHRNLIKIISNCC--NIDFKALVLEFMPNGSLEKWLYSHNYFLGIL 512
+SFD ECE+LR IRHRNL+KII++C NIDFKALVLEFMPN SLEKWL S +FL +L
Sbjct: 795 FKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELL 854
Query: 513 ERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572
ERLNIM+DV A+EYLHHG++ P+VHCDLKP+NILLDENM AHV+DFGI+KLLG+ + S
Sbjct: 855 ERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGIAKLLGD-EHSF 913
Query: 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK 632
IQT+T+AT+GYMAPEYGSEG++S D+YS+GILLMETFTRKKPT+++F E+S+K WV+
Sbjct: 914 IQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQ 973
Query: 633 ESLPDGLTEVVDANLVR-EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691
ES+P G+T++ D +L+R EEQ FS K DC+LS+M +AL C + PE+R +++D L
Sbjct: 974 ESVPGGVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTLNH 1033
Query: 692 IKEKFLDDV 700
K KFL D+
Sbjct: 1034 TKVKFLKDI 1042
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 708 bits (1827), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/727 (51%), Positives = 488/727 (67%), Gaps = 33/727 (4%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+G LP+L+ L + N+ SG IP SI+N S+L LD+ N F+G +P GNL L+ L+
Sbjct: 730 LGTQLPDLEGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLN 789
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
L N L E SA++ FL+SLTNC L L + NPL+GILP +GN S SL+ F A C
Sbjct: 790 LGSNQLTDEHSASEVGFLTSLTNCNFLRTLWIEDNPLKGILPNSLGNLSISLESFDASAC 849
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
+ RG IP IGNL+ +I +L DL G IPT +G+L++LQ L + GN+L+GSIP DLC
Sbjct: 850 QFRGTIPTGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCR 909
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
L+ L L L+ N+L G +P CL L LR L+L SN L S +P S +L +L +NLS+N
Sbjct: 910 LKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSN 969
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
L G LP + N+K + LDLS+NQ+SG IP T+G L+NLE LSL+ N+ QGP+P FG
Sbjct: 970 FLTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGD 1029
Query: 301 LISLESLDLSRNNLSGEIPK-----------------------------NFSAQSFLSNY 331
L+SL+ LDLS+NNLSG IPK NF+A+SF+ N
Sbjct: 1030 LLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNE 1089
Query: 332 ALCGPARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHRNRSTKDG 391
ALCG QV +C K + L +LKYILPP+ SI+ + + ++ +IR R
Sbjct: 1090 ALCGAPHFQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRKNLEVPT 1149
Query: 392 DQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL 451
+ L + + S+ + ATN F E NL+G GS VYKG L +G VA+KVFNL+
Sbjct: 1150 PIDSWLP-GSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEF 1208
Query: 452 ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGI 511
+ A RSFDSECE+++SIRHRNL+KII+ C N+DFKALVLE+MP GSL+KWLYSHNYFL +
Sbjct: 1209 QGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDL 1268
Query: 512 LERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571
++RLNIMIDV ALEYLHH + +VHCDLKPNNILLD++M AHV DFGI++LL E +S
Sbjct: 1269 IQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLLTE-TES 1327
Query: 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV 631
+ QT T+ TIGYMAPEYGS+GI+S K DV+SYGI+LME F RKKP +E+F G+++LK WV
Sbjct: 1328 MQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWV 1387
Query: 632 KESLPDGLTEVVDANLV-REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
ESL D + EVVDANL+ RE++ F+ K+ CL SIM LAL C +SPE+R+ MKD LK
Sbjct: 1388 -ESLADSMIEVVDANLLRREDEDFATKLSCLSSIMALALACTTDSPEERIDMKDVVVGLK 1446
Query: 691 KIKEKFL 697
KIK + L
Sbjct: 1447 KIKIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852480|emb|CAN78527.1| hypothetical protein VITISV_039533 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1820), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/727 (51%), Positives = 493/727 (67%), Gaps = 33/727 (4%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+G LP+L+ L + N+ SG IP SI+N SKL LD+S NSF G +P GNL L+VL+
Sbjct: 505 IGTWLPDLEGLFIGGNEFSGIIPVSISNMSKLTQLDVSRNSFIGNVPKDLGNLTKLEVLN 564
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
LA N E A++ +FL+SLTNC+ L L + +NP +G LP +GN +L+ F A C
Sbjct: 565 LAGNQFTNEHLASEVSFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASAC 624
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
+ RG IP IGNL+ +I DL DL G+IPT +GRL++LQ L++ GN+L+GSIP DLCH
Sbjct: 625 QFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTILGRLKKLQRLHIAGNRLRGSIPNDLCH 684
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
L+ L L+L+ NKL G +P C L +L+ L L SN L +P+S SL +L +NLS+N
Sbjct: 685 LKNLGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSN 744
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
L G+LP + N+K +T LDLS+N +SG IP +G +NL LSL+ N+ QGP+P FG
Sbjct: 745 FLTGNLPPEVGNMKSITTLDLSKNLVSGYIPRRMGEQQNLAKLSLSQNRLQGPIPVEFGD 804
Query: 301 LISLESLDLSRNNLSGEIPK-----------------------------NFSAQSFLSNY 331
L+SLESLDLS+NNLSG IPK NF+A+SF+ N
Sbjct: 805 LVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGPFVNFTAESFMFNE 864
Query: 332 ALCGPARLQVPSCRKYNSRGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHRNRSTKDG 391
ALCG QV +C K N K +LKYIL P+ S + + + I+ +IR R+
Sbjct: 865 ALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTITLVVFIVLWIRRRDNMEIPT 924
Query: 392 DQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL 451
+ L T + S+ + ATN F E NL+G GS G VYKG L +G VAIKVFNL+
Sbjct: 925 PIDSWLP-GTHEKISHQRLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEF 983
Query: 452 ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGI 511
+ A RSFDSECE+++ IRHRNL++II+ C N+DFKALVL++MPNGSLEKWLYSHNYFL +
Sbjct: 984 QGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDL 1043
Query: 512 LERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571
++RLNIMIDV ALEYLHH S+ +VHCDLKP+N+LLD++M AHV+DFGI+KLL + +S
Sbjct: 1044 IQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGITKLLTK-TES 1102
Query: 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV 631
+ QT T+ TIGYMAPE+GS+GI+S KSDVYSYGILLME F RKKP +E+F G+++LK WV
Sbjct: 1103 MQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV 1162
Query: 632 KESLPDGLTEVVDANLV-REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
ESL + + +VVD NL+ RE++ + K+ CL SIM LAL C +SPE+R+ MKDA +LK
Sbjct: 1163 -ESLSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALACTNDSPEERLDMKDAVVELK 1221
Query: 691 KIKEKFL 697
K + K L
Sbjct: 1222 KSRMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 704 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.958 | 0.668 | 0.355 | 1.3e-98 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.943 | 0.658 | 0.356 | 4.5e-98 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.951 | 0.662 | 0.335 | 3.4e-93 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.897 | 0.616 | 0.352 | 1.1e-92 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.957 | 0.657 | 0.348 | 1.5e-90 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.933 | 0.637 | 0.337 | 1.8e-87 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.963 | 0.578 | 0.317 | 6e-87 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.474 | 0.292 | 0.341 | 2.9e-82 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.454 | 0.256 | 0.360 | 8.1e-82 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.946 | 0.664 | 0.315 | 8.7e-79 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 1.3e-98, P = 1.3e-98
Identities = 259/728 (35%), Positives = 379/728 (52%)
Query: 5 LPNLKYLTLFDNKLSGTIPN------SITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQV 58
+PNLK L L N L S+TN ++L L + N G +P + NL S ++
Sbjct: 305 VPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANL-SAKL 363
Query: 59 LSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAY 118
++L + S + N NL L L N L G LP +G +L+ +
Sbjct: 364 VTLDLGGTLISGSIPY-----DIGNLINLQKLILDQNMLSGPLPTSLGKL-LNLRYLSLF 417
Query: 119 GCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL 178
+L G IP IGN++ + DL+ G +PT++G L L++ NKL G+IP ++
Sbjct: 418 SNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEI 477
Query: 179 CHXXXXXXXXXXXXXXCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
G +P + +L +L L LG NKL+ +P + G+ + + L
Sbjct: 478 MKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLE 537
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSF 298
N G +P +++ L + +DLS N LSG IP LE L+L+ N +G VP
Sbjct: 538 GNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVK- 595
Query: 299 GSLISLESLDLSRNN-LSGEIPKNFSAQSFLSNYALCGPARLQVPSCRKYNSRGFKKVAL 357
G + ++ + NN L G I F + LS Q PS K +S KKV +
Sbjct: 596 GIFENATTVSIVGNNDLCGGI-MGFQLKPCLS----------QAPSVVKKHSSRLKKVVI 644
Query: 358 LVLKYILPPXXXXXXXXXXXXXXXRHRNRSTKDGDQEDLLSLATWRRTSYLDIQRATNGF 417
V I R +N+ T + L L + SY D++ ATNGF
Sbjct: 645 GVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLH--EKISYGDLRNATNGF 702
Query: 418 NECNLLGTGSFGSVYKGTLFDGTNV-AIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
+ N++G+GSFG+VYK L V A+KV N+Q A +SF +ECE L+ IRHRNL+K+
Sbjct: 703 SSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKL 762
Query: 477 ISNCCNIDF-----KALVLEFMPNGSLEKWLYS------H--NYFLGILERLNIMIDVGL 523
++ C +IDF +AL+ EFMPNGSL+ WL+ H + L +LERLNI IDV
Sbjct: 763 LTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVAS 822
Query: 524 ALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD-SVIQTMTIA-- 579
L+YLH H H P+ HCDLKP+N+LLD+++TAHVSDFG+++LL + D+ S ++ A
Sbjct: 823 VLDYLHVHCHE-PIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGV 881
Query: 580 --TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD 637
TIGY APEYG G S DVYS+GILL+E FT K+PTNE+F G +L + K +LP+
Sbjct: 882 RGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPE 941
Query: 638 GLTEVVDANLVRE--EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695
+ ++VD +++ F V ++CL + + L CC ESP R++ +L I+E+
Sbjct: 942 RILDIVDESILHIGLRVGFPV-VECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRER 1000
Query: 696 FLDDVATT 703
F TT
Sbjct: 1001 FFKASRTT 1008
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 974 (347.9 bits), Expect = 4.5e-98, P = 4.5e-98
Identities = 258/723 (35%), Positives = 385/723 (53%)
Query: 5 LPNLKYLTLFDNKLS----GTIP--NSITNASKLIMLDLSSNSFSGLIPNTFGNLGS-LQ 57
L NL YL L +N L G + +++TN S L L +S N G +P + N+ + L
Sbjct: 306 LENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELT 365
Query: 58 VLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYA 117
VL+L N + + + N L L LA N L G LP +GN L E
Sbjct: 366 VLNLKGNLIYG-------SIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNL-VGLGELIL 417
Query: 118 YGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD 177
+ + G IP IGNL+ ++ L+ G +P ++G + L + NKL G+IP +
Sbjct: 418 FSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKE 477
Query: 178 LCHXXXXXXXXXXXXXXCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINL 237
+ G +P + L +L L LG+N L+ +P + G + I L
Sbjct: 478 IMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYL 537
Query: 238 SANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP-K 296
N +G++P +I+ L + N+DLS N LSG I LE L+L+DN F+G VP +
Sbjct: 538 QENHFDGTIP-DIKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTE 596
Query: 297 SFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQVPSCRKYNSRGFKK-V 355
+L S+ NL G I K + + A P + PS K + G +
Sbjct: 597 GIFQNATLVSV-FGNKNLCGSI-KELKLKPCI---AQAPPVETRHPSLLKKVAIGVSVGI 651
Query: 356 ALLVLKYILPPXXXXXXXXXXXXXXXRHRNRSTKDGDQEDLLSLATWRRTSYLDIQRATN 415
ALL+L +I+ + R + K + + SY D++ AT+
Sbjct: 652 ALLLLLFIV------------SLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATD 699
Query: 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLI 474
GF+ N++G+GSFG+V+K L + VA+KV N+Q A +SF +ECE L+ IRHRNL+
Sbjct: 700 GFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLV 759
Query: 475 KIISNCCNIDF-----KALVLEFMPNGSLEKWLYS------H--NYFLGILERLNIMIDV 521
K+++ C +IDF +AL+ EFMPNGSL+KWL+ H + L +LERLNI IDV
Sbjct: 760 KLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDV 819
Query: 522 GLALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD-DSVIQTMTIA 579
L+YLH H H P+ HCDLKP+NILLD+++TAHVSDFG+++LL + D +S ++ A
Sbjct: 820 ASVLDYLHVHCHE-PIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSA 878
Query: 580 ----TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635
TIGY APEYG G S DVYS+G+L++E FT K+PTNE+F G +L + K +L
Sbjct: 879 GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAAL 938
Query: 636 PDGLTEVVDANLVRE--EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693
P+ + ++ D +++ F V ++CL I+ + L CC ESP R++ +AA +L I+
Sbjct: 939 PERVLDIADKSILHSGLRVGFPV-LECLKGILDVGLRCCEESPLNRLATSEAAKELISIR 997
Query: 694 EKF 696
E+F
Sbjct: 998 ERF 1000
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 928 (331.7 bits), Expect = 3.4e-93, P = 3.4e-93
Identities = 241/719 (33%), Positives = 373/719 (51%)
Query: 5 LPNLKYLTLFDNKLS----GTIP--NSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQV 58
+P+L+YL L +N L G + +S+TN + L +L + G +P + N+ S ++
Sbjct: 306 VPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANM-STEL 364
Query: 59 LSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAY 118
+SL N + + + N L L L N L G LP +G L Y
Sbjct: 365 ISL--NLIGNHFFGS---IPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKL-LRLGLLSLY 418
Query: 119 GCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL 178
++ G IP IGNL+ + + L+ G +P ++G+ + L + NKL G+IP ++
Sbjct: 419 SNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEI 478
Query: 179 CHXXXXXXXXXXXXXXCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
G +P + SL +L +L L +NK + +P + G+ + + L
Sbjct: 479 MQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQ 538
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSF 298
NS +G++P NI+ L + +DLS N LSG IP LE L+L+ N F G VP
Sbjct: 539 GNSFDGAIP-NIRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKG 597
Query: 299 GSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQVPSCRKYNSRGFKKVALL 358
S NL G I K+ + P Q P +S KKVA+L
Sbjct: 598 NFQNSTIVFVFGNKNLCGGI-KDLKLK----------PCLAQEPPVETKHSSHLKKVAIL 646
Query: 359 VLKYILPPXXXXXXXXXXXXXXXRHRNRSTKDGDQEDLLSLATWRRTSYLDIQRATNGFN 418
V I R +N+ T + L + SY D++ ATNGF+
Sbjct: 647 VSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFH--EKISYGDLRNATNGFS 704
Query: 419 ECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKII 477
N++G+GSFG+V+K L + VA+KV N+Q A +SF +ECE L+ RHRNL+K++
Sbjct: 705 SSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLL 764
Query: 478 SNCCNIDF-----KALVLEFMPNGSLEKWLYSHNY--------FLGILERLNIMIDVGLA 524
+ C + DF +AL+ E++PNGS++ WL+ L +LERLNI+IDV
Sbjct: 765 TACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASV 824
Query: 525 LEYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD-DSVIQTMTIA--- 579
L+YLH H H P+ HCDLKP+N+LL++++TAHVSDFG+++LL + D +S + ++ A
Sbjct: 825 LDYLHVHCHE-PIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVR 883
Query: 580 -TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG 638
TIGY APEYG G S DVYS+G+LL+E FT K+PT+E+F G ++L + K +LP+
Sbjct: 884 GTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEK 943
Query: 639 LTEVVDANLVREEQAFSVKI-DCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696
+ E+ D ++ + +CL ++ + L CC E P R++ + A +L I+E+F
Sbjct: 944 VFEIADKAILHIGLRVGFRTAECLTLVLEVGLRCCEEYPTNRLATSEVAKELISIRERF 1002
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 923 (330.0 bits), Expect = 1.1e-92, P = 1.1e-92
Identities = 238/675 (35%), Positives = 351/675 (52%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFG------NLGSLQVLS 60
+L + ++ N SG I + L L L N F + +G N LQ L+
Sbjct: 298 HLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLN 357
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
L N L N S+L+ +L+ L L N + G +P IGN LQ Y
Sbjct: 358 LGENNL----GGVLPNSFSNLST--SLSFLALELNKITGSIPKDIGNL-IGLQHLYLCNN 410
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
RG++P +G L + + +L+G+IP A+G L L L L NK G IPY L +
Sbjct: 411 NFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSN 470
Query: 181 XXXXXXXXXXXXXXCGHVPPCLASLTSLR-RLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239
G +P L ++ +L +++ N L ++P G L+ ++ + +
Sbjct: 471 LTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAES 530
Query: 240 NSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFG 299
N L+G +P+ + + ++L L L N LSG IP+ +G L+ LETL L+ N G +P S
Sbjct: 531 NRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLA 590
Query: 300 SLISLESLDLSRNNLSGEIPK--NFSAQSFLS---NYALCGPAR-LQVPSCRKYNSRGFK 353
+ L SL+LS N+ GE+P F+A S +S N LCG L +P C K
Sbjct: 591 DITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENR-K 649
Query: 354 KVALLVLKYILPPXXXXXXXXXXXXXXXRHRNRSTKDGDQEDLLSLATWRRTSYLDIQRA 413
+L + L H+ TK G S+ SY + +A
Sbjct: 650 HFPVLPISVSL--AAALAILSSLYLLITWHKR--TKKG-APSRTSMKGHPLVSYSQLVKA 704
Query: 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNL 473
T+GF NLLG+GSFGSVYKG L +VA+KV L+ +A +SF +ECE LR++RHRNL
Sbjct: 705 TDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNL 764
Query: 474 IKIISNCCNID-----FKALVLEFMPNGSLEKWLY------SHNYFLGILERLNIMIDVG 522
+KI++ C +ID FKA+V +FMPNGSLE W++ + L + R+ I++DV
Sbjct: 765 VKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVA 824
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT----- 577
AL+YLH P+VHCD+K +N+LLD +M AHV DFG++++L +G S+IQ T
Sbjct: 825 CALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGT-SLIQQSTSSMGF 883
Query: 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD 637
I TIGY APEYG I S D+YSYGIL++E T K+PT+ F ++ L+ +V+ L
Sbjct: 884 IGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHG 943
Query: 638 GLTEVVDANLVREEQ 652
+T+VVD L+ + +
Sbjct: 944 RVTDVVDTKLILDSE 958
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 903 (322.9 bits), Expect = 1.5e-90, P = 1.5e-90
Identities = 254/729 (34%), Positives = 379/729 (51%)
Query: 5 LPNLKYLTLFDNKL----SGTIP--NSITNASKLIMLDLSSNSFSGLIPNTFGNLGS-LQ 57
L NL L L +N L SG + ++TN S+L L++ N G +P NL + L
Sbjct: 321 LQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLT 380
Query: 58 VLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYA 117
LSL N L++ S + N +L L L N L G LPP +G S L++
Sbjct: 381 ELSLGGN-LISGSIP------HGIGNLVSLQTLDLGENLLTGKLPPSLGELS-ELRKVLL 432
Query: 118 YGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD 177
Y L G IP +GN+SG+ L G+IP+++G L L L NKL GSIP++
Sbjct: 433 YSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHE 492
Query: 178 LCHXXXXXXXXXXXXXXCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINL 237
L G + + L L L + NKL+ +P + + + ++ L
Sbjct: 493 LMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLL 552
Query: 238 SANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKS 297
NS G +P +I+ L L LDLS+N LSG IP + L+ L+L+ N F G VP
Sbjct: 553 QGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTE 611
Query: 298 FGSLISLESLDLSRN-NLSGEIPKNFSAQSFLSNYALCGPARLQVPSCRKYNS-RGFKKV 355
G + ++ + N NL G IP S Q P +++P R+++S R +
Sbjct: 612 -GVFRNTSAMSVFGNINLCGGIP---SLQ--------LQPCSVELP--RRHSSVRKIITI 657
Query: 356 ALLVLKYILPPXXXXXXXXXXXXXXXRHRNRSTKDGDQEDLLSLATWRRTSYLDIQRATN 415
+ + L + + + D+ + + + SY ++ + T
Sbjct: 658 CVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTG 717
Query: 416 GFNECNLLGTGSFGSVYKGTLFDGTN-VAIKVFNLQLERASRSFDSECEILRSIRHRNLI 474
GF+ NL+G+G+FG+V+KG L VAIKV NL A++SF +ECE L IRHRNL+
Sbjct: 718 GFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLV 777
Query: 475 KIISNCCNIDF-----KALVLEFMPNGSLEKWLY--------SHNYFLGILERLNIMIDV 521
K+++ C + DF +ALV EFMPNG+L+ WL+ + + LG+ RLNI IDV
Sbjct: 778 KLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDV 837
Query: 522 GLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD-DSV-IQTMTIA 579
AL YLH P+ HCD+KP+NILLD+++TAHVSDFG+++LL + D D+ IQ +
Sbjct: 838 ASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAG 897
Query: 580 ---TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP 636
TIGY APEYG G S DVYS+GI+L+E FT K+PTN++F+ ++L + K +L
Sbjct: 898 VRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQ 957
Query: 637 DGLT-EVVDANLVREEQA--FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693
++ D ++R A F++ ++CL + + + C ESP R+SM +A +KL I+
Sbjct: 958 KRQALDITDETILRGAYAQHFNM-VECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016
Query: 694 EKFLDDVAT 702
E F D T
Sbjct: 1017 ESFFRDEET 1025
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 1.8e-87, P = 1.8e-87
Identities = 242/716 (33%), Positives = 365/716 (50%)
Query: 12 TLFDNKLSGT-IPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGS-LQVLSLAYNYLMTE 69
+L +N SG ++ N ++L LD+ N G +P + NL + L L L N +
Sbjct: 325 SLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLI--- 381
Query: 70 SSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQE 129
+ N +L L L +N L G LP G +LQ Y + G IP
Sbjct: 382 ----SGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKL-LNLQVVDLYSNAISGEIPSY 436
Query: 130 IGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHXXXXXXXXX 189
GN++ + LN +G IP ++GR R L L++ N+L G+IP ++
Sbjct: 437 FGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDL 496
Query: 190 XXXXXCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSN 249
GH P + L L L NKL+ MP + G + ++ + NS +G++P +
Sbjct: 497 SNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-D 555
Query: 250 IQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDL 309
I L L N+D S N LSG IP + L +L L+L+ N+F+G VP + G + ++ +
Sbjct: 556 ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTT-GVFRNATAVSV 614
Query: 310 SRN-NLSGEIPKNFSAQSFLSNYALCGPARLQVPSCRKYNSRGFK-KVALLVLKYILPPX 367
N N+ G + + + + P + + S RK G +A L+L I+
Sbjct: 615 FGNTNICGGV-REMQLKPCIVQ---ASPRKRKPLSVRKKVVSGICIGIASLLLIIIV--- 667
Query: 368 XXXXXXXXXXXXXXRHRNRSTKDGDQEDLLSLATWR-RTSYLDIQRATNGFNECNLLGTG 426
R + + DG+ D +L + + SY ++ AT+ F+ NL+G+G
Sbjct: 668 ------ASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSG 721
Query: 427 SFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID- 484
+FG+V+KG L + VA+KV NL A++SF +ECE + IRHRNL+K+I+ C ++D
Sbjct: 722 NFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDS 781
Query: 485 ----FKALVLEFMPNGSLEKWLY--------SHNYFLGILERLNIMIDVGLALEYLH-HG 531
F+ALV EFMP GSL+ WL H+ L E+LNI IDV ALEYLH H
Sbjct: 782 EGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHC 841
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD-DSVIQTMTIA----TIGYMAP 586
H P+ HCD+KP+NILLD+++TAHVSDFG+++LL + D +S + + A TIGY AP
Sbjct: 842 HD-PVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAP 900
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646
EYG G S + DVYS+GILL+E F+ KKPT+E F G+ +L + K S+ G T +N
Sbjct: 901 EYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK-SILSGCTSSGGSN 959
Query: 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDVAT 702
+ E L ++ + + C E P R+ +A +L I+ KF T
Sbjct: 960 AIDEG---------LRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSKTT 1006
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 869 (311.0 bits), Expect = 6.0e-87, P = 6.0e-87
Identities = 227/715 (31%), Positives = 365/715 (51%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYL 66
NL+ L++ DN L+GT+ I KL +L +S NS +G IP GNL L +L YL
Sbjct: 456 NLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLNIL-----YL 510
Query: 67 MTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNI 126
S+ ++N L L + SN L G +P + + L K G I
Sbjct: 511 --HSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKL-LSVLDLSNNKFSGQI 567
Query: 127 PQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHXXXXXX 186
P L + L G NG+IP ++ L L + N L G+IP +L
Sbjct: 568 PALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQ 627
Query: 187 XXXXXXXXC--GHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
G +P L L ++ + L +N + ++P S + + V ++ S N+L+G
Sbjct: 628 LYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSG 687
Query: 245 SLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303
+P + Q + ++ +L+LSRN SG+IP + G + +L +L L+ N G +P+S +L +
Sbjct: 688 HIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLST 747
Query: 304 LESLDLSRNNLSGEIP-----KNFSAQSFLSNYALCGPARLQVPSCRKYNSRGFKK---V 355
L+ L L+ NNL G +P KN +A + N LCG + P K S F K V
Sbjct: 748 LKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRV 807
Query: 356 ALLVLKYILPPXXXXXXXXXXXXXXXRHRN-RSTKDGDQEDLLSLATWRRTSYLDIQRAT 414
L++L + + ++ + DL S +R ++++AT
Sbjct: 808 ILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQAT 867
Query: 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRS---FDSECEILRSIRHR 471
+ FN N++G+ S +VYKG L DGT +A+KV NL+ E ++ S F +E + L ++HR
Sbjct: 868 DSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLK-EFSAESDKWFYTEAKTLSQLKHR 926
Query: 472 NLIKIISNCCNID-FKALVLEFMPNGSLEKWLYSHNYFLG-ILERLNIMIDVGLALEYLH 529
NL+KI+ KALVL FM NG+LE ++ +G +LE++++ + + ++YLH
Sbjct: 927 NLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLH 986
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA---TIGYMAP 586
G+ P+VHCDLKP NILLD + AHVSDFG +++LG +D T A TIGY+AP
Sbjct: 987 SGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAP 1046
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKPT--NEIFIGEMSLKHWVKESLPDG---LTE 641
E+ ++ K+DV+S+GI++ME T+++PT N+ +M+L+ V++S+ +G +
Sbjct: 1047 EFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVR 1106
Query: 642 VVDANLVREEQAFSVKID-CLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695
V+D L + S+K + + + L L C PE R M + L K++ K
Sbjct: 1107 VLDMEL--GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGK 1159
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 466 (169.1 bits), Expect = 2.9e-82, Sum P(2) = 2.9e-82
Identities = 119/348 (34%), Positives = 178/348 (51%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L+ L L+ N L G IP I N S L M+DLS N SG IP++ G L L+
Sbjct: 297 LTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLE------E 350
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
++++++ + + ++++NC +L L L N + G++P +G + L F+A+ +L G
Sbjct: 351 FMISDNKFSG-SIPTTISNCSSLVQLQLDKNQISGLIPSELGTLT-KLTLFFAWSNQLEG 408
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHXXXX 184
+IP + + + + DL+ L GTIP+ + LR L L L N L G IP ++ +
Sbjct: 409 SIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSL 468
Query: 185 XXXXXXXXXXCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
G +P + SL + L SN+L +P GS + I+LS NSL G
Sbjct: 469 VRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEG 528
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
SLP+ + +L L LD+S NQ SG IP ++G L +L L L+ N F G +P S G L
Sbjct: 529 SLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGL 588
Query: 305 ESLDLSRNNLSGEIP------KNFSAQSFLSNYALCGPARLQVPSCRK 346
+ LDL N LSGEIP +N LS+ L G ++ S K
Sbjct: 589 QLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNK 636
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 8.1e-82, Sum P(2) = 8.1e-82
Identities = 119/330 (36%), Positives = 163/330 (49%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L L L N+L G +P S+ N +L +LDL+ N SG IP++FG L L+ L L YN
Sbjct: 479 LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLML-YN 537
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
++ + N SL + RNLT + L+ N L G + PL G S+S F
Sbjct: 538 ------NSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG--SSSYLSFDVTNNGFED 589
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHXXXX 184
IP E+GN + L L G IP +G++R L L + N L G+IP L
Sbjct: 590 EIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKL 649
Query: 185 XXXXXXXXXXCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
G +PP L L+ L L L SN+ ++P+ + +L ++L NSLNG
Sbjct: 650 THIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNG 709
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
S+P I NL L L+L +NQ SG +P +G L L L L+ N G +P G L L
Sbjct: 710 SIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDL 769
Query: 305 ES-LDLSRNNLSGEIPKNFSAQSFLSNYAL 333
+S LDLS NN +G+IP S L L
Sbjct: 770 QSALDLSYNNFTGDIPSTIGTLSKLETLDL 799
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 792 (283.9 bits), Expect = 8.7e-79, P = 8.7e-79
Identities = 222/703 (31%), Positives = 338/703 (48%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
++ +LK + L +N +G IP S + L +L+L N G IP G + L+VL L
Sbjct: 285 LISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWE 344
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLI--GNFSASLQEFYAYGCK 121
N T S K N R L +L L+SN L G LPP + GN L G
Sbjct: 345 NNF-TGSIPQKLG-----ENGR-LVILDLSSNKLTGTLPPNMCSGN---RLMTLITLGNF 394
Query: 122 LRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHX 181
L G+IP +G + + LNG+IP + L +L + L N L G +P
Sbjct: 395 LFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGV 454
Query: 182 XXXXXXXXXXXXXC-GHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
G +P + +L+ +++L L NK + ++P G L+ + ++ S N
Sbjct: 455 SGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHN 514
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
+G + I K+LT +DLSRN+LSGDIP + G++ L L+L+ N G +P + S
Sbjct: 515 LFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIAS 574
Query: 301 LISLESLDLSRNNLSGEIPKN-----FSAQSFLSNYALCGPARLQVPSCRKYNSRGFKKV 355
+ SL S+D S NNLSG +P F+ SF+ N LCGP + C K + K
Sbjct: 575 MQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGP---YLGPCGKGTHQSHVKP 631
Query: 356 ALLVLKYILPPXXXXXXXXXXXXXXXRHRNRSTKDGDQEDLLSLATWRRTSYLDIQRATN 415
K +L + R S ++ + L ++R + +
Sbjct: 632 LSATTKLLLVLGLLFCSMVFAIVAIIKAR--SLRNASEAKAWRLTAFQRLDFT-CDDVLD 688
Query: 416 GFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRS--FDSECEILRSIRHRNL 473
E N++G G G VYKGT+ G VA+K +S F++E + L IRHR++
Sbjct: 689 SLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHI 748
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNY-FLGILERLNIMIDVGLALEYLHHGH 532
++++ C N + LV E+MPNGSL + L+ L R I ++ L YLHH
Sbjct: 749 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDC 808
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG 592
S +VH D+K NNILLD N AHV+DFG++K L + S + + GY+APEY
Sbjct: 809 SPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 868
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK---ESLPDGLTEVVDANLVR 649
+ KSDVYS+G++L+E T KKP E G + + WV+ +S D + +V+D L
Sbjct: 869 KVDEKSDVYSFGVVLLELITGKKPVGEFGDG-VDIVQWVRSMTDSNKDCVLKVIDLRLS- 926
Query: 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
SV + + + ++AL C E +R +M++ L +I
Sbjct: 927 -----SVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEI 964
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 704 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-63 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-52 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 6e-63
Identities = 191/696 (27%), Positives = 312/696 (44%), Gaps = 63/696 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L NL+ L LF N +G IP ++T+ +L +L L SN FSG IP G +L VL L+ N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L E L + NL L L SN L G +P +G SL+ G
Sbjct: 367 NLTGE-------IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR-SLRRVRLQDNSFSG 418
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
+P E L + D++ +L G I + + LQ L L NK G +P D + L
Sbjct: 419 ELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRL 477
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
L+L+ N+ G VP L SL+ L +L L NKL+ +P S + ++ ++LS N L+G
Sbjct: 478 ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG 537
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
+P++ + VL+ LDLS+NQLSG+IP +G +E+L ++++ N G +P S G+ +++
Sbjct: 538 QIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP-STGAFLAI 596
Query: 305 ESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQ-VPSCRKYNSRGFKKVALLVLKYI 363
+ ++ N LCG +P C++ +
Sbjct: 597 NASAVAGNID------------------LCGGDTTSGLPPCKRVRK---TPSWWFYITCT 635
Query: 364 LPPITSIVLIAIVIIFFIRHRNRSTKDGDQEDLLSLATW-------RRTSYLDIQRATNG 416
L + L+A +F N K + ED TW + + + I +
Sbjct: 636 LGAFLVLALVAFGFVFIRGRNNLELKRVENED----GTWELQFFDSKVSKSITINDILSS 691
Query: 417 FNECNLLGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
E N++ G G+ YKG ++ +G +K N + S ++ + ++H N++K
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVK 747
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+I C + L+ E++ +L + L + L R I I + AL +LH S
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
+V +L P I++D H+ + LL T + Y+APE I+
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFISSAYVAPETRETKDIT 856
Query: 596 PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD-GLTEVVDANLVREEQAF 654
KSD+Y +G++L+E T K P + F S+ W + D L +D ++ +
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD---V 913
Query: 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
SV + ++ +M+LAL C P R D L+
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 2e-52
Identities = 124/317 (39%), Positives = 173/317 (54%), Gaps = 10/317 (3%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYL 66
+L+YL L +N +G+IP + L LDLS+N SG IPN G+ SL+VL L N L
Sbjct: 119 SLRYLNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176
Query: 67 MTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNI 126
+ + SLTN +L L LASN L G +P +G SL+ Y L G I
Sbjct: 177 VGKIPN-------SLTNLTSLEFLTLASNQLVGQIPRELGQMK-SLKWIYLGYNNLSGEI 228
Query: 127 PQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSE 186
P EIG L+ + DL +L G IP+++G L+ LQ L+L+ NKL G IP + L+ L
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 187 LNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSL 246
L+L+ N L G +P + L +L LHL SN T +P + SL + + L +N +G +
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348
Query: 247 PSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLES 306
P N+ LT LDLS N L+G+IP + NL L L N +G +PKS G+ SL
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR 408
Query: 307 LDLSRNNLSGEIPKNFS 323
+ L N+ SGE+P F+
Sbjct: 409 VRLQDNSFSGELPSEFT 425
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 1e-45
Identities = 133/369 (36%), Positives = 174/369 (47%), Gaps = 38/369 (10%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSF------------------------ 42
+LK L L N L G IPNS+TN + L L L+SN
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
Query: 43 SGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILP 102
SG IP G L SL L L YN L SSL N +NL L L N L G +P
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGP-------IPSSLGNLKNLQYLFLYQNKLSGPIP 277
Query: 103 PLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQG 162
P I + L L G IP+ + L + + L + G IP A+ L RLQ
Sbjct: 278 PSIFSLQ-KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV 336
Query: 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTM 222
L L NK G IP +L L+ L+L+ N L G +P L S +L +L L SN L +
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI 396
Query: 223 PSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLET 282
P S G+ + + L NS +G LPS L ++ LD+S N L G I + + +L+
Sbjct: 397 PKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQM 456
Query: 283 LSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSA-----QSFLSNYALCGPA 337
LSLA N+F G +P SFGS LE+LDLSRN SG +P+ + Q LS L G
Sbjct: 457 LSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEI 515
Query: 338 RLQVPSCRK 346
++ SC+K
Sbjct: 516 PDELSSCKK 524
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-44
Identities = 69/191 (36%), Positives = 98/191 (51%), Gaps = 9/191 (4%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNC 480
LG G FG+VY G VAIK+ + E EIL+ + H N++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+ + LV+E+ GSL+ L + L E L I++ + LEYL HS ++H D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRD 117
Query: 541 LKPNNILLDE-NMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-YGSEGIISPKS 598
LKP NILLD N ++DFG+SKLL + + T YMAPE +G S KS
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 599 DVYSYGILLME 609
D++S G++L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 7e-44
Identities = 114/338 (33%), Positives = 166/338 (49%), Gaps = 18/338 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
+PNL+ L L +N LSG IPN I + S L +LDL N G IPN+ NL SL+ L+LA N
Sbjct: 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198
Query: 65 YLMTESSAA-------KWNFLS----------SLTNCRNLTVLGLASNPLRGILPPLIGN 107
L+ + KW +L + +L L L N L G +P +GN
Sbjct: 199 QLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258
Query: 108 FSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHG 167
+LQ + Y KL G IP I +L +I DL+ L+G IP V +L+ L+ L+L
Sbjct: 259 LK-NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS 317
Query: 168 NKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFG 227
N G IP L L L L L NK G +P L +L L L +N LT +P
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377
Query: 228 SLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLAD 287
S + + L +NSL G +P ++ + L + L N SG++P+ L + L +++
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 288 NQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQ 325
N QG + + SL+ L L+RN G +P +F ++
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSK 475
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 9e-44
Identities = 85/274 (31%), Positives = 127/274 (46%), Gaps = 30/274 (10%)
Query: 423 LGTGSFGSVYKGTLFD-----GTNVAIKVFNL-QLERASRSFDSECEILRSIRHRNLIKI 476
LG G+FG VYKG L VA+K E+ F E I+R + H N++K+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ C + +V+E+M G L +L + L + + L+ + + +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
+H DL N L+ EN+ +SDFG+S+ L + DD + I +MAPE EG +
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 597 KSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655
KSDV+S+G+LL E FT ++P MS + V E L +G R Q +
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPY-----PGMSNEE-VLEYLKNGY---------RLPQPPN 227
Query: 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689
C + L L C E PE R + + L
Sbjct: 228 ----CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-43
Identities = 109/303 (35%), Positives = 159/303 (52%), Gaps = 9/303 (2%)
Query: 27 TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86
N+S+++ +DLS + SG I + L +Q ++L+ N L + T +
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIF------TTSSS 119
Query: 87 LTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDL 146
L L L++N G +P +L+ L G IP +IG+ S + V DL G L
Sbjct: 120 LRYLNLSNNNFTGSIP---RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176
Query: 147 NGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLT 206
G IP ++ L L+ L L N+L G IP +L ++ L + L N L G +P + LT
Sbjct: 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236
Query: 207 SLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQL 266
SL L L N LT +PSS G+L+ + Y+ L N L+G +P +I +L+ L +LDLS N L
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296
Query: 267 SGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQS 326
SG+IP + L+NLE L L N F G +P + SL L+ L L N SGEIPKN +
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356
Query: 327 FLS 329
L+
Sbjct: 357 NLT 359
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 5e-43
Identities = 87/275 (31%), Positives = 126/275 (45%), Gaps = 31/275 (11%)
Query: 423 LGTGSFGSVYKGTLFD-----GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKI 476
LG G+FG VYKGTL T VA+K E F E I++ + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 477 ISNCCNIDFKA-LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ C +V E+MP G L +L H L + + L + + + +EYL S
Sbjct: 67 LG-VCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKN 122
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
VH DL N L+ EN+ +SDFG+S+ + E D + I +MAPE +G +
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 596 PKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654
KSDV+S+G+LL E FT ++P MS + V E L DG L R E
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEE-VLELLEDGYR------LPRPE--- 227
Query: 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689
+C + L L C PE R + + L
Sbjct: 228 ----NCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 6e-43
Identities = 115/320 (35%), Positives = 150/320 (46%), Gaps = 57/320 (17%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L NL+YL L+ NKLSG IP SI + KLI LDLS NS SG IP L +L++L L N
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ A L+SL L VL L SN K G
Sbjct: 319 NFTGKIPVA----LTSLP---RLQVLQLWSN-------------------------KFSG 346
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
IP+ +G + + V DL+ N L G IP LC L
Sbjct: 347 EIPKNLGKHNNLTVLDLS------------------------TNNLTGEIPEGLCSSGNL 382
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
+L L N L G +P L + SLRR+ L N + +PS F L V ++++S N+L G
Sbjct: 383 FKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
+ S ++ L L L+RN+ G +P + G + LE L L+ NQF G VP+ GSL L
Sbjct: 443 RINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSEL 501
Query: 305 ESLDLSRNNLSGEIPKNFSA 324
L LS N LSGEIP S+
Sbjct: 502 MQLKLSENKLSGEIPDELSS 521
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 86/275 (31%), Positives = 126/275 (45%), Gaps = 31/275 (11%)
Query: 423 LGTGSFGSVYKGTLFDG-----TNVAIKVFNL-QLERASRSFDSECEILRSIRHRNLIKI 476
LG G+FG VYKGTL VA+K E+ F E I+R + H N++K+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWL-YSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ C + +V+E+MP G L +L + L + + L+ + + +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
+H DL N L+ EN+ +SDFG+S+ L + DD I +MAPE EG +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 596 PKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654
KSDV+S+G+LL E FT ++P MS V E L G R +
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPY-----PGMSNAE-VLEYLKKGY---------RLPK-- 225
Query: 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689
+C + L L C E PE R + + L
Sbjct: 226 --PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERAS--RSFDSECEILRSIRHRNLIKIISN 479
LG+GSFG+VYK G VA+K+ + E++ ++ E ILR + H N++++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539
+ D LV+E+ G L +L E I + + LEYLH S ++H
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH---SNGIIHR 122
Query: 540 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---YGSEGIISP 596
DLKP NILLDEN ++DFG++K L + S T + T YMAPE G+ P
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNG--YGP 178
Query: 597 KSDVYSYGILLMETFTRKKP 616
K DV+S G++L E T K P
Sbjct: 179 KVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASR-SFDSECEILRSIRHRNLIKIIS 478
LG GSFG VY G VAIKV + + R E +IL+ ++H N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHSTPMV 537
+ D LV+E+ G L L E + + ALEYLH G +V
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLHSKG----IV 119
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII--- 594
H DLKP NILLDE+ ++DFG+++ L G+ T + T YMAPE ++
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPE-----VLLGK 171
Query: 595 --SPKSDVYSYGILLMETFTRKKP 616
D++S G++L E T K P
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 81/285 (28%), Positives = 123/285 (43%), Gaps = 38/285 (13%)
Query: 421 NLLGTGSFGSVYKGTLFDGTN----VAIKVFNLQLERASRS-FDSECEILRSIRHRNLIK 475
LG G+FG VYKG L VA+K R F E +++ + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 476 IISNCCNIDFK-ALVLEFMPNGSLEKWLYSH--------NYFLGILERLNIMIDVGLALE 526
++ C + LVLE+M G L +L L + + L+ I + +E
Sbjct: 61 LLG-VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 586
YL S VH DL N L+ E++ +SDFG+S+ + + D +T I +MAP
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645
E +GI + KSDV+S+G+LL E FT P +S V E L G
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP-----YPGLSN-EEVLEYLRKGY------ 224
Query: 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
R + + L +M L C PE R + + +L+
Sbjct: 225 ---RLPKPEYCPDE-LYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 69/246 (28%), Positives = 109/246 (44%), Gaps = 23/246 (9%)
Query: 421 NLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQ--LERASRSFDSECEILRSIRHRNLIKII 477
LLG GSFGSVY D G +A+K L E + + E IL S++H N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 478 SNCCNIDFKAL--VLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLH-HGH 532
+ + + L LE++ GSL L F + E + + L YLH +G
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG- 121
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG 592
+VH D+K NIL+D + ++DFG +K LG+ + T +MAPE
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEI--------FIGEMSLKHWVKESLPDGLTEVVD 644
+D++S G ++E T K P +E+ IG + E L + + +
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 645 ANLVRE 650
L R+
Sbjct: 239 KCLRRD 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
F LG+G FG V++G + VAIK+ + F E + L+ +RH++LI +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYS-HNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ C + ++ E M GSL +L S L + +++ V + YL +S
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS-- 125
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
+H DL NIL+ E++ V+DFG+++L+ +D + + + APE S G S
Sbjct: 126 -IHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 596 PKSDVYSYGILLMETFTR 613
KSDV+S+GILL E FT
Sbjct: 183 TKSDVWSFGILLYEMFTY 200
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 78/281 (27%), Positives = 124/281 (44%), Gaps = 16/281 (5%)
Query: 421 NLLGTGSFGSVYKGT---LFDGTN--VAIKVFNLQLERASRS-FDSECEILRSIRHRNLI 474
LG G FG V L D T VA+K N E RS F+ E EILR++ H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 475 KIISNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
K C ++ L++E++P+GSL +L H + + L + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD-SVIQTMTIATIGYMAPEYGSE 591
+H DL NIL++ +SDFG++K+L E D ++ + I + APE
Sbjct: 130 ---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 592 GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651
S SDV+S+G+ L E FT P+ E L+ +T ++ L++E
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSP-PAE-FLRMIGIAQGQMIVTRLL--ELLKEG 242
Query: 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+ C + L C P+ R S D + ++
Sbjct: 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G G FG VYK G VAIKV L+ + +E +IL+ +H N++K
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY---G 64
Query: 482 NIDFKA---LVLEFMPNGSLEKWLYSHNYFLGILERLN------IMIDVGLALEYLHHGH 532
+ K +V+EF GSL+ L S N + L + ++ LEYLH
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG 592
++H D+K NILL + + DFG+S L + TM + T +MAPE +
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTM-VGTPYWMAPEVINGK 172
Query: 593 IISPKSDVYSYGILLMETFTRKKP 616
K+D++S GI +E K P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 62/192 (32%), Positives = 100/192 (52%), Gaps = 11/192 (5%)
Query: 422 LLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G G FG V G + G VA+K A+++F +E ++ ++RH NL++++
Sbjct: 13 TIGKGEFGDVMLGD-YRGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 482 NIDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+ +V E+M GSL +L S + + ++L +DV +EYL VH D
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDV 600
L N+L+ E++ A VSDFG++K + S Q + + APE E S KSDV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 601 YSYGILLMETFT 612
+S+GILL E ++
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 79/290 (27%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 423 LGTGSFGSVYKGTLF------DGTNVAIKVF-NLQLERASRSFDSECEILRSIRHRNLIK 475
LG G+FG V+ G + D VA+K A + F+ E E+L + +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHN-------------YFLGILERLNIMIDVG 522
C D +V E+M +G L K+L SH L + + L I + +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG 582
+ YL H VH DL N L+ ++ + DFG+S+ + D + T+ I
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 583 YMAPEYGSEGIISPKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGLTE 641
+M PE + +SDV+S+G++L E FT K+P + E V E + G
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VIECITQGRL- 242
Query: 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691
L R C + + L C P+QR+++KD +L+K
Sbjct: 243 -----LQRPR-------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 33/213 (15%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFNL-QLERASRSF-DSECEILRSIRHRNLIK-- 475
+G GSFG VY DG +K +L + R +E +IL+ + H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 476 ---IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGIL---ERLNIMIDVGLALEYLH 529
I V+E+ G L + + + L+ + + LAL+YLH
Sbjct: 66 ESFEEKGKLCI-----VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-- 587
++H D+KP NI L N + DFGISK+L + +T+ + T Y++PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTV-VGTPYYLSPELC 175
Query: 588 ----YGSEGIISPKSDVYSYGILLMETFTRKKP 616
Y KSD++S G +L E T K P
Sbjct: 176 QNKPYNY------KSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 82/301 (27%), Positives = 119/301 (39%), Gaps = 32/301 (10%)
Query: 416 GFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERAS---RSFDSECEILRSIRHRN 472
+ LG GSFG VY D VA+KV +LE S F E +IL S+ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 473 LIKIISNCCNID-FKALVLEFMPNGSLEKWLYSHNYFLGILERLN--IMIDVGLALEYLH 529
I + + + LV+E++ GSLE L + E I+ + ALEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 530 HGHSTPMVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVIQTMT----IATIGYM 584
S ++H D+KP NILLD + + DFG++KLL + + + T GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 585 APEY---GSEGIISPKSDVYSYGILLMETFTRKKP---TNEIFIGEMSLKHWVKESLPDG 638
APE S S SD++S GI L E T P +LK ++ P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698
+ + S + L + P+ R+S + K +
Sbjct: 236 ASPLSP----------SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285
Query: 699 D 699
Sbjct: 286 S 286
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 70/192 (36%), Positives = 99/192 (51%), Gaps = 4/192 (2%)
Query: 422 LLGTGSFGSVYKGTLFDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNC 480
+G G+FG VYKG L T VA+K L R F E EIL+ H N++K+I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+V+E +P GSL +L L + + L + +D +EYL S +H D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDV 600
L N L+ EN +SDFG+S+ G +V + I + APE + G + +SDV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 601 YSYGILLMETFT 612
+SYGILL ETF+
Sbjct: 179 WSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 33/209 (15%)
Query: 423 LGTGSFGSVYKGTLFDGTN--VAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKIISN 479
LG GS G VYK T A+K ++ + R E + LRS ++K
Sbjct: 9 LGQGSSGVVYKV-RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK---- 63
Query: 480 CCNIDFK----ALVLEFMPNGSLEKWLYSHNYFL-GILERLNIMIDVGLALEYLHHGHST 534
C +K ++VLE+M GSL L +L + I GL YLH
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLD--YLHTKRH- 120
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPE------ 587
++H D+KP+N+L++ ++DFGISK+L D Q T + T+ YM+PE
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD---QCNTFVGTVTYMSPERIQGES 176
Query: 588 YGSEGIISPKSDVYSYGILLMETFTRKKP 616
Y +D++S G+ L+E K P
Sbjct: 177 YSY------AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 69/194 (35%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 422 LLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASR-SFDSECEILRSIRHRNLIKIISNC 480
LLG G+FG V+KGTL D T VA+K L + + F SE IL+ H N++K+I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+V+E +P G +L L + + +D + YL S +H D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRD 118
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEYGSEGIISPKS 598
L N L+ EN +SDFG+S+ + DD + + + I + APE + G S +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 599 DVYSYGILLMETFT 612
DV+SYGILL ETF+
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 87/289 (30%), Positives = 139/289 (48%), Gaps = 43/289 (14%)
Query: 408 LDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRS 467
L++Q+ T G ++G G FG+V +G + G VA+K N++ + +++F E ++
Sbjct: 3 LNLQKLTLG----EIIGEGEFGAVLQGE-YTGQKVAVK--NIKCDVTAQAFLEETAVMTK 55
Query: 468 IRHRNLIK----IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFL-GILERLNIMIDVG 522
+ H+NL++ I+ N I V+E M G+L +L + L +++ L +DV
Sbjct: 56 LHHKNLVRLLGVILHNGLYI-----VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVA 110
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG 582
+EYL S +VH DL NIL+ E+ A VSDFG++++ G D+ + +
Sbjct: 111 EGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVK 162
Query: 583 YMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642
+ APE S KSDV+SYG+LL E F+ + +MSLK VKE + G
Sbjct: 163 WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP----KMSLKE-VKECVEKGY--- 214
Query: 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691
R E C + L C P++R S KL+K
Sbjct: 215 ------RMEPP----EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 76/295 (25%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 423 LGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERASRS-FDSECEILRSIRHRNLIK 475
LG G+FG VYKG L T+VAIK E + F E E++ ++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMID 520
++ C ++ E++ +G L ++L ++ L + L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
+ +EYL H VH DL N L+ E +T +SDFG+S+ + D +Q+ ++
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLMETFTRK-KP----TNEIFIGEMSLKHWVKESL 635
+ +M PE G + +SD++S+G++L E F+ +P +N+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---------------- 233
Query: 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
EV+ ++R Q DC + L ++C E P +R KD +L+
Sbjct: 234 -----EVI--EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 24/200 (12%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRS---FDSECEILRSIRHRNLIKIISN 479
LG G FG V+ GT T VA+K L+ + S F E +I++ +RH L+++ +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT----LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDV------GLA-LEYLHHGH 532
C + +V E+M GSL +L S G RL ++D+ G+A LE ++
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRNY-- 124
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG 592
+H DL NIL+ EN+ ++DFG+++L+ E D+ + I + APE + G
Sbjct: 125 ----IHRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYG 179
Query: 593 IISPKSDVYSYGILLMETFT 612
+ KSDV+S+GILL E T
Sbjct: 180 RFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 30/276 (10%)
Query: 423 LGTGSFGSVYKGT-LFDGTN----VAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKI 476
LG+G+FG+VYKG + +G VAIKV + A++ E ++ S+ H +++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ C + L+ + MP G L ++ +H +G LN + + + YL +
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---L 130
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
VH DL N+L+ ++DFG++KLL + I +MA E I +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 597 KSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655
KSDV+SYG+ + E T KP E +P E+ D L+ + +
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPY---------------EGIP--AVEIPD--LLEKGERLP 231
Query: 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691
C + + + + C M E R + K+ + K
Sbjct: 232 QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 70/241 (29%), Positives = 98/241 (40%), Gaps = 45/241 (18%)
Query: 423 LGTGSFGSVYK------GTLFDGTNVAIKVFNLQLERASRSFD---SECEILRSIRHRNL 473
LG GSFG V G L+ A+KV + + + +E IL I H +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 474 IKII------SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
+K+ LVLE+ P G L L F R ++ LALEY
Sbjct: 56 VKLHYAFQTEEKLY------LVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEY 108
Query: 528 LH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMA 585
LH G +++ DLKP NILLD + ++DFG++K L +T T T Y+A
Sbjct: 109 LHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLA 161
Query: 586 PEYGSEGIISPKSDVYSYGILLMETFTRKKP-----TNEIFIGEMSLKHWVKESLPDGLT 640
PE D +S G+LL E T K P EI+ + P+ L+
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY---EKILKD-PLRFPEFLS 217
Query: 641 E 641
Sbjct: 218 P 218
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 422 LLGTGSFGSVYKGTLF--DGTNVAIKVFNLQLERASRS----FDSECEILRSIRHRNLIK 475
+LG G FGSV +G L DG+ + + V ++L+ + S F SE ++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 476 IISNCCNIDFKA------LVLEFMPNGSLEKWLYSHN-----YFLGILERLNIMIDVGLA 524
+I C ++L FM +G L +L L + L M+D+ L
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD---DSVIQTMTIATI 581
+EYL + +H DL N +L E+MT V+DFG+SK + GD I M +
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 582 GYMAPEYGSEGIISPKSDVYSYGILLMETFTR 613
++A E ++ + + KSDV+++G+ + E TR
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 421 NLLGTGSFGSVYKG-TLFDGTNVAIKVFNLQ--LERASRSFDSECEILRSIRHRNLIKII 477
+L+G G+FG VYKG L G VAIK +L+ E A +S E ++L++++H N++K I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNI--MIDVGLALEYLHHGHSTP 535
+ D ++LE+ NGSL + + F E L + V L YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFP---ESLVAVYVYQVLQGLAYLH---EQG 119
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEYGSEGII 594
++H D+K NIL ++ ++DFG++ + +D ++ T +MAPE
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 595 SPKSDVYSYGILLMETFTRKKP 616
S SD++S G ++E T P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 73/228 (32%), Positives = 116/228 (50%), Gaps = 20/228 (8%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
+G G FG V G + G VA+K ++ + +++F +E ++ +RH NL++++
Sbjct: 14 IGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLG--VI 68
Query: 483 IDFKA---LVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
++ K +V E+M GSL +L S LG L +DV A+EYL + VH
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
DL N+L+ E+ A VSDFG++K + S Q + + APE E S KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 599 DVYSYGILLMETFTRKK-PTNEIFIGEM--SLKHWVKESLPDGLTEVV 643
DV+S+GILL E ++ + P I + ++ ++ K PDG VV
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV 228
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 26/286 (9%)
Query: 422 LLGTGSFGSVYK---GTLFDGTNVAIKVFNLQLERAS--RSFDSECEILRSIRHRNLIKI 476
LG G+FGSV L D T + V LQ A R F+ E EIL+S++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 477 ISNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
C + + LV+E++P GSL +L H L + L + +EYL S
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SK 127
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEYGSEGI 593
VH DL NIL++ + DFG++K+L + + ++ + I + APE +E
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 594 ISPKSDVYSYGILLMETFT---RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD---ANL 647
S SDV+S+G++L E FT + F+ M D +++ L
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG---------NDKQGQMIVYHLIEL 238
Query: 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693
++ C I + +C P QR S + A +++ I+
Sbjct: 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 37/228 (16%)
Query: 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFN---LQLERASRSFDSECEIL-RSIRHR 471
F ++G GSF +V AIK+ + L E+ + E E+L R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 472 NLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALE 526
+IK+ F+ VLE+ PNG L +++ L ++ LALE
Sbjct: 63 GIIKLYYT-----FQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALE 116
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD------------DSVIQ 574
YLH S ++H DLKP NILLD++M ++DFG +K+L DS I+
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 575 TMTIA------TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP 616
T Y++PE +E SD+++ G ++ + T K P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 70/267 (26%), Positives = 102/267 (38%), Gaps = 32/267 (11%)
Query: 422 LLGTGSFGSVYKGT----LFDGTNVAIKVF-NLQLERASRSFDSECEILRSIRHRNLIKI 476
LG GSFG V +G VA+K + +L F E I+ S+ H NLI++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHN---YFLGILERLNIMIDVGLALEYLHHGHS 533
+V E P GSL L + + L + I G+ YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR--YLESKR- 117
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT-IGYMAPEYGSEG 592
+H DL NILL + + DFG+ + L + +D + + + APE
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652
S SDV+ +G+ L E FT GE W S L + +D R E+
Sbjct: 176 TFSHASDVWMFGVTLWEMFT---------YGEEP---WAGLSGSQIL-KKIDKEGERLER 222
Query: 653 AFSVKIDCLLSIMHLALDCCMESPEQR 679
C I ++ L C +P R
Sbjct: 223 P----EACPQDIYNVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 42/283 (14%)
Query: 423 LGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
LG G+FG V+ + D VA+K A + F E E+L +++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSH---------------NYFLGILERLNIMIDV 521
C + D +V E+M +G L K+L +H LG+ + L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 522 GLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI 581
+ YL H VH DL N L+ N+ + DFG+S+ + D + T+ I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 582 GYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641
+M PE + +SDV+S+G++L E FT K + W + S + E
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLS-NTEVIE 236
Query: 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKD 684
+ V E C + + L C P+QR+++K+
Sbjct: 237 CITQGRVLERPRV-----CPKEVYDIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 5/193 (2%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
+G+G FG V+ G + VAIK + + F E +++ + H L+++ C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLK 542
LV EFM +G L +L + L + +DV + YL S+ ++H DL
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLA 127
Query: 543 PNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYS 602
N L+ EN VSDFG+++ + + D T T + + +PE S S KSDV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 603 YGILLMETFTRKK 615
+G+L+ E F+ K
Sbjct: 187 FGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 59/192 (30%), Positives = 95/192 (49%), Gaps = 5/192 (2%)
Query: 423 LGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKIISNC 480
+G G+FG V+ G L D T VA+K L ++ F E IL+ H N++++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+V+E + G +L + L + E + ++ + +EYL H +H D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHRD 119
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDV 600
L N L+ E +SDFG+S+ +G + M + + APE + G S +SDV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 601 YSYGILLMETFT 612
+S+GILL E F+
Sbjct: 180 WSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 67/209 (32%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 423 LGTGSFGSVYKGTLF--DGT--NVAIKVF-NLQLERASRSFDSECEILRSIRHRNLIKII 477
LG G+FGSV KG G VA+K + + F E ++ + H ++++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
C LV+E P G L K+L + + + V + + YL H V
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREI-PVSDLKELAHQVAMGMAYLESKH---FV 117
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG-----YMAPEYGSEG 592
H DL N+LL A +SDFG+S+ LG G D T G + APE + G
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY----YRATTAGRWPLKWYAPECINYG 173
Query: 593 IISPKSDVYSYGILLMETFTR-KKPTNEI 620
S KSDV+SYG+ L E F+ KP E+
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-21
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 31/279 (11%)
Query: 422 LLGTGSFGSVYKGTL----FDGTNVAIKVFNL-QLERASRSFDSECEILRSIRHRNLIKI 476
++G G FG V++G L VAIK E+ + F SE I+ H N+I++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
++ E+M NG+L+K+L H+ + + ++ + ++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNY 128
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG--YMAPEYGSEGII 594
VH DL NIL++ N+ VSDFG+S++L E D T + I + APE +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 595 SPKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653
+ SDV+S+GI++ E + ++P +MS H V +++ DG
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERP-----YWDMS-NHEVMKAINDGFR------------- 228
Query: 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+DC ++ L L C + +R D L K+
Sbjct: 229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 421 NLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIK 475
++G G FG V +G L +VAIK ++ F +E I+ H N+I+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYL-HHGHST 534
+ ++ E+M NGSL+K+L ++ + + + ++ + ++YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII 594
VH DL NIL++ N+ VSDFG+S+ L + + + I + APE +
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 595 SPKSDVYSYGILLMETFT 612
+ SDV+S+GI++ E +
Sbjct: 186 TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 41/289 (14%)
Query: 423 LGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
LG G+FG V+ D VA+K E A + F E E+L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--------------LNIMIDVG 522
C +V E+M +G L ++L SH IL L I +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG 582
+ YL H VH DL N L+ + + + DFG+S+ + D + T+ I
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 583 YMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642
+M PE + +SD++S+G++L E FT K + W + S TE
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK------------QPWYQLS----NTEA 233
Query: 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691
++ + + + C + + C P+QR+ +KD ++L+
Sbjct: 234 IEC--ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 423 LGTGSFGSVYKGTLFD------GTNVAIKVFNLQLERAS----RSFDSECEILRSIRHRN 472
LG GSFG VY+G T VAIK N E AS F +E +++ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH------NYFLGILERLNIM-----IDV 521
+++++ +V+E M G L+ +L S N LG + I
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 522 GLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI 581
G+A YL + VH DL N ++ E++T + DFG+++ + E D + +
Sbjct: 131 GMA--YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 582 GYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+MAPE +G+ + KSDV+S+G++L E T
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNV-AIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKI 476
++G G+FG V D + A+K N Q + + R+ +E IL+ + H L+ +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLN------IMIDVGLALEYLHH 530
+ + + LV++ + G L Y L + + + ++ LALEYLH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIVLALEYLH- 117
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
S ++H D+KP+NILLDE H++DF I+ + + T T T GYMAPE
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLC 172
Query: 591 EGIISPKSDVYSYGILLMETFTRKKP 616
S D +S G+ E K+P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRS---FDSECEILRSIRHRNLIKIISN 479
LGTG FG V G +VAIK+ ++ S S F E +++ + H L+++
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKM----IKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539
C +V E+M NG L +L H + L + DV + YL S +H
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 540 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM-TIATIGYMAPEYGSEGIISPKS 598
DL N L+D+ VSDFG+S+ + DD ++ + + + PE S KS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 599 DVYSYGILLMETFTRKKPTNEIF 621
DV+++G+L+ E ++ K E F
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 423 LGTGSFGSVYKGTL---FDGTNVAIKVFNLQLERASR-SFDSECEILRSIRHRNLIKIIS 478
LG+G+FG V KG +VAIKV + E++ R E EI+ + + ++++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
C + LV+E G L K+L + + + +M V + ++YL + VH
Sbjct: 63 -VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEYGSEGIISP 596
DL N+LL A +SDFG+SK LG DDS + + + + APE + S
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 597 KSDVYSYGILLMETFTR-KKP 616
+SDV+SYGI + E F+ +KP
Sbjct: 178 RSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIK-VFNLQLERAS----RSFDSECEILRSIRHRNLI 474
LG G++ VYK G VAIK + + + A + E ++L+ ++H N+I
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
++ + LV EFM LEK + + L + + M+ LEYLH S
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SN 121
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--YGSEG 592
++H DLKPNN+L+ + ++DFG+++ G + T + T Y APE +G+
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVVTRWYRAPELLFGAR- 178
Query: 593 IISPKSDVYSYGILLMETFTRK 614
D++S G + E R
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 30/215 (13%)
Query: 422 LLGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDS-------------ECEILRS 467
L+G+GSFGSVY G G +A+K Q+E S S S E +L+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVK----QVELPSVSASSKDRKRSMLDALAREIALLKE 62
Query: 468 IRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
++H N+++ + + + D + LE++P GS+ L ++ F L R N + + L Y
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNY 121
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA------TI 581
LH + ++H D+K NIL+D +SDFGISK L +S+ A ++
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA--NSLSTKTNGARPSLQGSV 176
Query: 582 GYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP 616
+MAPE + + K+D++S G L++E T K P
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 12/194 (6%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRS---FDSECEILRSIRHRNLIKIISN 479
LG G FG V++G + T VA+K L+ + F +E +I++ +RH LI++ +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKT----LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 480 CCNIDFKALVLEFMPNGSLEKWLY-SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
C + +V E M GSL ++L L + + +++ V + YL + +H
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
DL N+L+ EN V+DFG+++++ E D + I + APE S KS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 599 DVYSYGILLMETFT 612
DV+S+GILL E T
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 25/258 (9%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
LG G FG V+ GT T VAIK + +F E ++++ +RH L+++ + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 483 IDFKALVLEFMPNGSLEKWLY-SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
+ +V E+M GSL +L +L + + +++ + + Y+ + VH DL
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVY 601
+ NIL+ EN+ V+DFG+++L+ + + + Q I + APE G + KSDV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 602 SYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCL 661
S+GILL E T+ G + V EV+D V +C
Sbjct: 188 SFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ--VERGYRMPCPPECP 229
Query: 662 LSIMHLALDCCMESPEQR 679
S+ L C + PE+R
Sbjct: 230 ESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 77/282 (27%), Positives = 126/282 (44%), Gaps = 37/282 (13%)
Query: 422 LLGTGSFGSVYKGTL-FDGTN---VAIKVFNL-QLERASRSFDSECEILRSIRHRNLIK- 475
++G G FG V G L G VAIK E+ R F SE I+ H N+I
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 476 --IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+++ + +V E+M NGSL+ +L H+ +++ + ++ + ++YL
Sbjct: 71 EGVVTKSKPV---MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---D 124
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG--YMAPEYGSE 591
VH DL NIL++ N+ VSDFG+S++L E D T I + APE +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 592 GIISPKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650
+ SDV+SYGI++ E + ++P EMS + +K + E
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERP-----YWEMSNQDVIKA--------------IEE 224
Query: 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+DC ++ L LDC + +R + + L K+
Sbjct: 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNL-QLERASRS-FDSECEILRSIRHRNLIKIISN 479
+G GSFG+V K DG + K + + + SE ILR ++H N+++
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 480 CCNIDFKA----LVLEFMPNGSLEKWL---YSHNYFLGILERLNIMIDVGLALEYLHHGH 532
ID +V+E+ G L + + ++ I+ + LAL H+
Sbjct: 68 --IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 533 --STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
++H DLKP NI LD N + DFG++K+L G DS + T YM+PE +
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPEQLN 183
Query: 591 EGIISPKSDVYSYGILLMETFTRKKP 616
KSD++S G L+ E P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 60/193 (31%), Positives = 94/193 (48%), Gaps = 5/193 (2%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
LG+G FG V+ G +VAIK+ + + F E +++ + H NL+++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLK 542
+V E+M NG L +L LG L++ DV A+EYL S +H DL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127
Query: 543 PNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYS 602
N L+ E+ VSDFG+++ + + D T + + PE S KSDV+S
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 603 YGILLMETFTRKK 615
+G+L+ E F+ K
Sbjct: 187 FGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 35/282 (12%)
Query: 422 LLGTGSFGSVYKGTL----FDGTNVAIKVFNL-QLERASRSFDSECEILRSIRHRNLIK- 475
++G G FG V +G L VAIK E+ R F SE I+ H N+I
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 476 --IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+++ + ++ EFM NG+L+ +L ++ +++ + ++ + ++YL
Sbjct: 71 EGVVTKSRPV---MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---E 124
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA---TIGYMAPEYGS 590
VH DL NIL++ N+ VSDFG+S+ L + T ++ I + APE +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 591 EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650
+ SDV+SYGI++ E + GE +W + +V++A + +
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMS---------YGERP--YWDMSN-----QDVINA--IEQ 226
Query: 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+ +DC ++ L LDC + R + L K+
Sbjct: 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 30/287 (10%)
Query: 423 LGTGSFGSVYKGTLF------DGTN--VAIKVFNLQLERASRS-FDSECEILRSIRHRNL 473
LG G FG V +L+ DGT VA+K + + + S + E IL+++ H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 474 IKIISNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG 531
+K C K L++E++P GSL +L H L + + L + + YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQ 126
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-IQTMTIATIGYMAPEYGS 590
H +H DL N+LLD + + DFG++K + EG + ++ + + + A E
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 591 EGIISPKSDVYSYGILLMETFTRKKPTN---EIFIGEMSLKHWVKESLPDGLTEVVDANL 647
E S SDV+S+G+ L E T + F + K + L E L
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR--LIE-----L 236
Query: 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
+ +C + L +C + R + + LK++
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 423 LGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
LG G+FG V+ + D VA+K + A + F E E+L +++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGIL------------ERLNIMIDVGLA 524
C D +V E+M +G L K+L +H ++ + L+I +
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
+ YL H VH DL N L+ EN+ + DFG+S+ + D + T+ I +M
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 585 APEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644
PE + +SDV+S G++L E FT K + W + S + + +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQLSNNEVIECITQ 237
Query: 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMK 683
+++ + C + L L C P R+++K
Sbjct: 238 GRVLQRPRT------CPKEVYDLMLGCWQREPHMRLNIK 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 74/305 (24%), Positives = 123/305 (40%), Gaps = 72/305 (23%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNLIK 475
+G G++G VYK G VA+K ++ E+ A R E ++L+ +RH N+++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 476 II----SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG 531
+ S + +V E+M + L L S + M + L+YLH
Sbjct: 63 LKEIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---- 587
++H D+K +NIL++ + ++DFG+++ +S T + T+ Y PE
Sbjct: 120 G---ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELLLG 175
Query: 588 ---YGSEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEIFIGE 624
YG P+ D++S G +L E F K PT+E + G
Sbjct: 176 ATRYG------PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229
Query: 625 MSLKHWVKESLPDGLTEVVDANLVREEQAFSVKID----CLLSIMHLALDCCMESPEQRV 680
L + +RE F ID LL + L LD P++R+
Sbjct: 230 SKLPWFENLKPKK-----PYKRRLREF--FKHLIDPSALDLLDKL-LTLD-----PKKRI 276
Query: 681 SMKDA 685
S A
Sbjct: 277 SADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 69/222 (31%), Positives = 95/222 (42%), Gaps = 19/222 (8%)
Query: 416 GFNECNLLGTGSFGSVYK-GTLFDGTNVAIKVFNLQLERASRSFDS--ECEILRSIRHRN 472
F LG GS+GSVYK L D A+K +L D+ E IL S+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER---LNIMIDVGLALEYLH 529
+I + + +V+E+ P G L K + ++ I I + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG---YMAP 586
++H DLK NILL N + D GISK+L + M IG YMAP
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK-------KNMAKTQIGTPHYMAP 170
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK 628
E S KSD++S G LL E T P + ++ K
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G G+ G VYK T G VAIK L+ + + E I++ +H N++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYD--S 83
Query: 482 NIDFKAL--VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539
+ L V+E+M GSL + + + + + +V LEYLH S ++H
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHR 140
Query: 540 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE------YGSEGI 593
D+K +NILL ++ + ++DFG + L + + + T +MAPE YG
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYG---- 194
Query: 594 ISPKSDVYSYGILLME 609
PK D++S GI+ +E
Sbjct: 195 --PKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 426 GSFGSVY----KGTLFDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIKIIS 478
G++G V+ K T G AIKV + + +E +IL + ++K+
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHSTPMV 537
+ LV+E++P G L L + + R + ++ LALEYLH +G ++
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHSNG----II 115
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKL------LGEGDDSVIQTMTIATIGYMAPEYGSE 591
H DLKP+NIL+D N ++DFG+SK+ + DD + T Y+APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE---- 171
Query: 592 GII-----SPKSDVYSYGILLMETFT 612
+I S D +S G +L E
Sbjct: 172 -VILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 421 NLLGTGSFGSVYKGTLFD-GTNVAIKVF---NLQLERASRSFDSECEILRSIRHRNLIKI 476
+ LG G +G VY+G VA+K +++E F E +++ I+H NL+++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHPNLVQL 67
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ C ++ EFM G+L +L N + + L + + A+EYL +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
+H DL N L+ EN V+DFG+S+L+ GD I + APE + S
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 596 PKSDVYSYGILLMETFT 612
KSDV+++G+LL E T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 423 LGTGSFGSVYKGTLFDGTN--VAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKIISN 479
LG G+ G V K L T +A+K L++ A + E +IL ++
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLHHGHSTPMV 537
N ++ +E+M GSL+K L I ER+ I + V L YLH H ++
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKE--VQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPK 597
H D+KP+NIL++ + DFG+S G+ +S+ +T + T YMAPE S K
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS---GQLVNSLAKTF-VGTSSYMAPERIQGNDYSVK 179
Query: 598 SDVYSYGILLMETFTRKKP 616
SD++S G+ L+E T + P
Sbjct: 180 SDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 40/218 (18%)
Query: 421 NLLGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERAS--RSFDSECEILRSIRHRNLIK-- 475
N +G G+FG VY L G +A+K +Q + E ++L ++H NL+K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 476 ----------IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL 525
I C+ +LE +G + Y L +LE L
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLE----------GL 112
Query: 526 EYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV---IQTMTIATI 581
YLH HG +VH D+KP NI LD N + DFG + L ++ +Q++ T
Sbjct: 113 AYLHSHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTP 167
Query: 582 GYMAPEYGSEGIISPK---SDVYSYGILLMETFTRKKP 616
YMAPE + G +D++S G +++E T K+P
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 66/208 (31%), Positives = 94/208 (45%), Gaps = 47/208 (22%)
Query: 423 LGTGSFGSV----YKGTLFDGTNVAIKVFNLQLERASRSFD---SECEILRSIRHRNLIK 475
LGTGSFG V +KG+ G A+K+ + + + +E IL+SIRH L+
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 476 IISNCCNIDFKAL--VLEFMPNGSLEKWLYSHNYFLGILERLNIMI------DVGLALEY 527
+ D L V+E++P G L L R + V LALEY
Sbjct: 66 LYG--SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLALEY 116
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAP 586
LH +V+ DLKP N+LLD + ++DFG +K + T T+ T Y+AP
Sbjct: 117 LHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTPEYLAP 167
Query: 587 EYGSEGIISPK-----SDVYSYGILLME 609
E II K D ++ GIL+ E
Sbjct: 168 E-----IILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 422 LLGTGSFGSVYKG-TLFDGTNVAIKVFNL-----QLERASRSFDSECEILRSIRHRNLIK 475
LLG+GSFGSVY+G L DG A+K +L + A + + E +L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL---NIMIDVGLALEYLHHGH 532
+ D + LE +P GSL K L + F + RL I+ L LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN 122
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG---YMAPEYG 589
VH D+K NIL+D N ++DFG++K + E + + G +MAPE
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE------FSFAKSFKGSPYWMAPE-- 171
Query: 590 SEGIISPK------SDVYSYGILLMETFTRKKPTNEIF 621
+I+ + +D++S G ++E T K P +++
Sbjct: 172 ---VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-18
Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 30/283 (10%)
Query: 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-----RASRSFDSECEILRSIRH 470
F + +LG+G+FG+VYKG +G V I V +L +A++ E ++ S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH 530
++ +++ C + L+ + MP G L ++ H +G LN + + + YL
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
+VH DL N+L+ ++DFG++KLLG + I +MA E
Sbjct: 128 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 591 EGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649
I + +SDV+SYG+ + E T KP + I E+S E LP
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI--------- 235
Query: 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
C + + + + C M + R ++ + K+
Sbjct: 236 ----------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 57/194 (29%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
LG G FG V+ GT T VAIK +F E +I++ +RH L+ + + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 483 IDFKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
+ +V EFM GSL +L + +L + + +++ + + Y+ + +H DL
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDL 128
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVY 601
+ NIL+ +N+ ++DFG+++L+ + + + Q I + APE G + KSDV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 602 SYGILLMETFTRKK 615
S+GILL E T+ +
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 421 NLLGTGSFGSVYKGTLFD----GTN---VAIKVFNLQLERAS-----RSFDSECEILRSI 468
N LG+G+FG VY+GT D G+ VA+K L + + + F E ++ +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKT----LRKGATDQEKKEFLKEAHLMSNF 56
Query: 469 RHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYS------HNYFLGILERLNIMIDVG 522
H N++K++ C + + +++E M G L +L L + E L+I +DV
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDE-----NMTAHVSDFGISKLLGEGDDSVIQTMT 577
YL H +H DL N L+ E + + DFG+++ + + D +
Sbjct: 117 KGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ + +MAPE +G + +SDV+S+G+L+ E T
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 63/202 (31%), Positives = 108/202 (53%), Gaps = 17/202 (8%)
Query: 422 LLGTGSFGSVY--KGTLFDGTNVAIKVFNL-QLERASR-SFDSECEILRSIRHRNLIKII 477
++G G+FG V+ + D V IK + Q+ + R + +EC++L+ + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 478 SNCCNIDFKAL--VLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHST 534
N ++ KAL V+E+ P G+L +++ N L L+ + + LAL HH H+
Sbjct: 66 ENF--LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL---HHVHTK 120
Query: 535 PMVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGI 593
++H DLK NILLD++ M + DFGISK+L + + T Y++PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKP 177
Query: 594 ISPKSDVYSYGILLMETFTRKK 615
+ KSD+++ G +L E + K+
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 75/279 (26%), Positives = 130/279 (46%), Gaps = 32/279 (11%)
Query: 422 LLGTGSFGSVYKGTLF-DGTNV----AIKVFNLQL-ERASRSFDSECEILRSIRHRNLIK 475
+LG+G+FG+VYKG +G V AIK+ N +A+ F E I+ S+ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
++ C + + LV + MP+G L +++ H +G LN + + + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT-MTIATIGYMAPEYGSEGII 594
+VH DL N+L+ ++DFG+++LL EGD+ I +MA E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 595 SPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653
+ +SDV+SYG+ + E T KP + I E +PD L+ + +
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTRE----------IPD---------LLEKGER 229
Query: 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
C + + + + C M + R K+ AA+ ++
Sbjct: 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 421 NLLGTGSFGSVYKGTLFDG----TNVAIKVFN--LQLERASRSFDSECEILRSIRHRNLI 474
++G G FG VY GTL D + A+K N LE + F E I++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 475 KIISNCCNIDFKALV-LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
++ C + LV L +M +G L ++ S + + + + + V +EYL S
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---S 116
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEYGSE 591
VH DL N +LDE+ T V+DFG+++ + + + + T A + +MA E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 592 GIISPKSDVYSYGILLMETFTRKKP 616
+ KSDV+S+G+LL E TR P
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 57/194 (29%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
LG G FG V+ G T VAIK Q + +F +E +++ ++H L+++ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMID----VGLALEYLHHGHSTPMVH 538
+ ++ E+M NGSL +L + GI +N +ID + + ++ + +H
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKNY---IH 125
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
DL+ NIL+ E + ++DFG+++L+ E ++ + I + APE + G + KS
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 599 DVYSYGILLMETFT 612
DV+S+GILL E T
Sbjct: 185 DVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 17/224 (7%)
Query: 410 IQRATNGFNECNLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQLERASRS-FDSECEI 464
IQR C +G G FG VY+G VA+K + R F E I
Sbjct: 3 IQREDITLGRC--IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 465 LRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLA 524
+R H +++K+I + +V+E P G L +L + Y L + + + A
Sbjct: 61 MRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
L YL S VH D+ N+L+ + DFG+S+ L E + + I +M
Sbjct: 120 LAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWM 175
Query: 585 APEYGSEGIISPKSDVYSYGILLMETFTR-KKP----TNEIFIG 623
APE + + SDV+ +G+ + E KP N IG
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
LG G FG V+ GT T VA+K + SF E +I++ +RH L+++ + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 483 IDFKALVLEFMPNGSLEKWLYS-HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
+ +V E+M GSL +L L + +++ V + Y+ + +H DL
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDL 128
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVY 601
+ NIL+ + + ++DFG+++L+ + + + Q I + APE G + KSDV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 602 SYGILLMETFTRKK 615
S+GILL E T+ +
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQ------LERASRSFDSECEILRSIRHRNLI 474
+LG G++G+VY G G +A+K L E+ E ++L+S++H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGI-LERLNIMIDVGLALEYLHHGHS 533
+ + C + + ++ +EF+P GS+ L + I G+A YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--YLHNNC- 122
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLG----EGDDSVIQTMTIATIGYMAPEYG 589
+VH D+K NN++L N + DFG ++ L G S + T +MAPE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 590 SEGIISPKSDVYSYGILLMETFTRKKP 616
+E KSD++S G + E T K P
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 421 NLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSEC----EILRSIRHRNLIK 475
N +G GSFG V+K D A+K +L + +R E +L + +I+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 476 IISNCCNIDFKAL--VLEFMPNGSLEKWLYSHNYFLG------ILERLNIMIDVGLALEY 527
+D L V+E+ NG L K L G + R I I +GLA
Sbjct: 64 YYE--SFLDKGKLNIVMEYAENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLA--- 115
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 587
H HS ++H D+K N+ LD + D G++KLL D++ + T Y++PE
Sbjct: 116 --HLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPE 171
Query: 588 YGSEGIISPKSDVYSYGILLMETFTRKKP 616
+ + KSDV++ G++L E T K P
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 41/220 (18%)
Query: 422 LLGTGSFGSVYKGTLFD-GTNVAIKVFNL-----QLERASRSFDSECEILRSIRHRNLIK 475
LLG G+FG VY D G +A+K + ++ + + E ++L++++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 476 IISNCCNIDFK-ALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDVGLAL 525
C D ++ +E+MP GS++ L ++ Y ILE +
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----------GV 117
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL------GEGDDSVIQTMTIA 579
EYLH +VH D+K NIL D + DFG SK L G G SV
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV-----TG 169
Query: 580 TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNE 619
T +M+PE S K+DV+S G ++E T K P E
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 37/286 (12%)
Query: 423 LGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRS----FDSECEILRSIRHRNLIKII 477
LG G FGSV +G L D + + + V +++ +RS F SE ++ H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 478 SNCC----NIDFKA--LVLEFMPNGSLEKWL-YSH----NYFLGILERLNIMIDVGLALE 526
C + + + ++L FM +G L +L YS +L + M D+ +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 586
YL S +H DL N +L+ENM V+DFG+SK + GD + + ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646
E ++ + + KSDV+S+G+ + E TR + + G V+ S E+ D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP---YPG-------VENS------EIYD-- 225
Query: 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+R+ DCL + L C + +P+ R S + +L+K
Sbjct: 226 YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 71/296 (23%), Positives = 119/296 (40%), Gaps = 55/296 (18%)
Query: 423 LGTGSFGSVYKGTLF-----DGTNVAIKVF-NLQLERASRSFDSECEILRSIRHRNLIKI 476
LG +FG +YKG L+ VAIK ++ + F E ++ + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWL----------------------YSHNYFLGILER 514
+ ++ E++ G L ++L H F
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF------ 126
Query: 515 LNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574
L+I I + +EYL S VH DL NIL+ E + +SD G+S+ + D +Q
Sbjct: 127 LHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES 634
++ I +M PE G S SD++S+G++L E F+ L+ +
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------------FGLQPYY--- 228
Query: 635 LPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
G + +VR+ Q DC + L +C E P +R KD +L+
Sbjct: 229 ---GFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 63/184 (34%), Positives = 92/184 (50%), Gaps = 42/184 (22%)
Query: 421 NLLGTGSFGSVYK------GTLFDGTNVAIKVFNLQLERA-SRSFDSECEILRSIRHRNL 473
N +G+G+ G+VYK G L+ A+KV E R E EILR + H N+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLY-----ALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 474 IKIISNCCNIDFK-----ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYL 528
+K C+ F ++LEFM GSLE + FL + R I G+A YL
Sbjct: 135 VK-----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR---QILSGIA--YL 184
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM-----TIATIGY 583
H H +VH D+KP+N+L++ ++DFG+S++L QTM ++ TI Y
Sbjct: 185 HRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA-------QTMDPCNSSVGTIAY 234
Query: 584 MAPE 587
M+PE
Sbjct: 235 MSPE 238
|
Length = 353 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 63/228 (27%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLE------RASRSFDSECEILRSIRHRNL 473
+G+G++G V G VAIK + + R R E ++LR +RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 474 IKIISNCCNI-------DFKAL--VLEFMPNGSLEKWLYS--------HNYFL-GILERL 515
I ++ +I DF + V E M L K + S YFL IL
Sbjct: 62 IGLL----DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL--- 113
Query: 516 NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575
L+YLH + ++H DLKP+NIL++ N + DFG+++ + D+
Sbjct: 114 -------RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP-DEDEKGF 162
Query: 576 MT--IATIGYMAPE-------YGSEGIISPKSDVYSYGILLMETFTRK 614
+T + T Y APE Y ++ I D++S G + E TRK
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRY-TKAI-----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 75/312 (24%), Positives = 126/312 (40%), Gaps = 79/312 (25%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSEC--EI--LRSIRHR 471
+ + LG G++G VYK G VA+K ++L+ S EI L+ ++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK--IRLDNEEEGIPSTALREISLLKELKHP 58
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLH 529
N++K++ LV E+ L+K+L + L +IM + L Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE 587
++H DLKP NIL++ + ++DFG+++ G ++T T + T+ Y APE
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG----IPLRTYTHEVVTLWYRAPE 168
Query: 588 -------YGSEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEI 620
Y + + D++S G + E T K PT E
Sbjct: 169 ILLGSKHYST-AV-----DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 621 FIGEMSLKHWVKESLP-------DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCM 673
+ G L + K + P + + +D + LLS M L +
Sbjct: 223 WPGVTKLPDY-KPTFPKFPPKDLEKVLPRLDPEGI-----------DLLSKM-LQYN--- 266
Query: 674 ESPEQRVSMKDA 685
P +R+S K+A
Sbjct: 267 --PAKRISAKEA 276
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDS---ECEILRSIRHRNLIKIIS 478
+G G+ VY L + VAIK +L E+ S D E + + H N++K +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNI---MIDVGLALEYLH-HGHST 534
+ D LV+ ++ GSL + +Y G L+ I + +V LEYLH +G
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPEYGSEG 592
+H D+K NILL E+ + ++DFG+S L +G D + + T +MAPE +
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 593 I-ISPKSDVYSYGILLMETFTRKKP 616
K+D++S+GI +E T P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 421 NLLGTGSFGSVYKGTL--FDGTN----VAIKVFNLQLERASRS-FDSECEILRSIRHRNL 473
LG G+FG VY+G DG VA+K S F E I+ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLY------SHNYFLGILERLNIMIDVGLALEY 527
+++I + ++LE M G L+ +L L + + L DV +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 528 LHHGHSTPMVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
L H +H D+ N LL A ++DFG+++ + + I +M
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 585 APEYGSEGIISPKSDVYSYGILLMETFT 612
PE +GI + K+DV+S+G+LL E F+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 422 LLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASR----------SFDSECEILRSIRH 470
L+G G++G VY G +A+K L A R + SE E L+ + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER-LNIMIDVGLALEYLH 529
N+++ + ++ ++ LE++P GS+ L ++ F L R + GLA YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA--YLH 125
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-- 587
S ++H DLK +N+L+D + +SDFGISK + D+ ++ +MAPE
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 588 YGSEGIISPKSDVYSYGILLMETFTRKKP-TNEIFIGEM 625
+ S K D++S G +++E F ++P ++E I M
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 46/295 (15%)
Query: 421 NLLGTGSFGSVYKGTLF-DGT--NVAIKVFN-LQLERASRSFDSECEILRSI-RHRNLIK 475
+++G G+FG V + + DG N AIK+ E R F E E+L + H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF---------------LGILERLNIMID 520
++ C N + + +E+ P G+L +L L + L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
V ++YL +H DL N+L+ EN+ + ++DFG+S+ GE + V +TM
Sbjct: 128 VATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR--GE-EVYVKKTMGRLP 181
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGL 639
+ +MA E + + + KSDV+S+G+LL E + P + E+ E LP G
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------EKLPQGY 235
Query: 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
R E+ +C + L C + P +R + +L ++ E
Sbjct: 236 ---------RMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 68/224 (30%), Positives = 109/224 (48%), Gaps = 31/224 (13%)
Query: 411 QRATNGFNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDS--ECEILRS 467
+R + F+ +G G++G VYK D G VA+K L E+ + E +ILR
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 468 IRHRNLIK----IISNCCNIDFKA------LVLEFMPN---GSLEKWL--YSHNYFLGIL 512
+ HRN++ + +DFK LV E+M + G LE L +S ++ +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 513 ERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572
++L LE L++ H +H D+K +NILL+ ++DFG+++L ++S
Sbjct: 123 KQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-NSEESR 172
Query: 573 IQTMTIATIGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRK 614
T + T+ Y PE G E P DV+S G +L E FT+K
Sbjct: 173 PYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 67/209 (32%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
LG GS+GSVYK G VAIKV + E + E IL+ ++K +
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 481 CNIDFKA----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
FK +V+E+ GS+ + N L E I+ LEYLH S
Sbjct: 68 ----FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKK 120
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
+H D+K NILL+E A ++DFG+S L + T+ I T +MAPE +I
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-RNTV-IGTPFWMAPE-----VIQE 173
Query: 597 -----KSDVYSYGILLMETFTRKKPTNEI 620
K+D++S GI +E K P ++I
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 77/303 (25%), Positives = 124/303 (40%), Gaps = 57/303 (18%)
Query: 423 LGTGSFGSVYKGTLFD------GTNVAIKVFNLQLERAS----RSFDSECEILRSIRHRN 472
LG G FG V K T F T VA+K+ E AS R SE +L+ + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK---ENASSSELRDLLSEFNLLKQVNHPH 64
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWL-----------------YSHNYFLGILERL 515
+IK+ C L++E+ GSL +L S L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 516 NIMIDVGLA------LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569
+ + A ++YL +VH DL N+L+ E +SDFG+S+ + E D
Sbjct: 125 TMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH 629
V ++ + +MA E + I + +SDV+S+G+LL E T +G
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LGGNPYPG 232
Query: 630 WVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689
E L NL++ +C + +L L C + P++R + D + +L
Sbjct: 233 IAPERL---------FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
Query: 690 KKI 692
+K+
Sbjct: 284 EKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 68/290 (23%), Positives = 122/290 (42%), Gaps = 43/290 (14%)
Query: 423 LGTGSFGSVYKGTLFDGT------NVAIKVFNLQLERASRS-FDSECEILRSIRHRNLIK 475
LG FG VYKG LF VAIK + E R F E + ++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMID 520
++ +++ + + L ++L + L + ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
+ +E+L H +VH DL N+L+ + + +SD G+ + + D + ++
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT 640
I +M+PE G S SD++SYG++L E F+ L+ + S D
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YGLQPYCGYSNQD--- 234
Query: 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
V++ ++R Q DC + L L+C E P +R KD ++L+
Sbjct: 235 -VIE--MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 31/229 (13%)
Query: 408 LDIQRATNGFNECNLLGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDSECEILR 466
L+ + + E +LG G++G VY L +AIK + R + E +
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 467 SIRHRNLIKIISNCCNIDFKALVLEFMPNGSLE-----KW--LYSHN-----YFLGILER 514
++HRN+++ + + F + +E +P GSL KW L + Y ILE
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE- 119
Query: 515 LNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-NMTAHVSDFGISKLLGEGDDSVI 573
L+YL H +VH D+K +N+L++ + +SDFG SK L G +
Sbjct: 120 ---------GLKYL---HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCT 166
Query: 574 QTMTIATIGYMAPEYGSEGI--ISPKSDVYSYGILLMETFTRKKPTNEI 620
+T T T+ YMAPE +G +D++S G ++E T K P E+
Sbjct: 167 ETFT-GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 54/194 (27%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
LG G FG V+ G + T VA+K + ++F E ++++++H L+++ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL-EYLHHGHSTPMVHCDL 541
+ ++ E+M GSL +L S +L +L ID + E + + +H DL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHRDL 129
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVY 601
+ N+L+ E++ ++DFG+++++ E ++ + I + APE + G + KSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 602 SYGILLMETFTRKK 615
S+GILL E T K
Sbjct: 189 SFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 27/238 (11%)
Query: 422 LLGTGSFGSVYK--GTLFDGTNVAIK---VFNLQLERASRSFD-------SECEILR-SI 468
LG+G+FG VYK +A+K V N + R D SE I++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 469 RHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYS----HNYFLGILERL-NIMIDVGL 523
RH N+++ D +V++ + L + S F ER+ NI + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
AL YLH +VH DL PNNI+L E+ ++DFG++K T + TI Y
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILY 179
Query: 584 MAPEYGSEGIISPKSDVYSYGILLMETFTRKKP--TNEIFIGEMSLKHWVKESLPDGL 639
PE K+DV+++G +L + T + P + + + V E LP+G+
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-16
Identities = 39/108 (36%), Positives = 62/108 (57%), Gaps = 7/108 (6%)
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
+ L L G +P++I L+ L +++LS N + G+IP ++G + +LE L L+ N F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 295 PKSFGSLISLESLDLSRNNLSGEIPKNFSAQ-------SFLSNYALCG 335
P+S G L SL L+L+ N+LSG +P + +F N LCG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530
|
Length = 623 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 423 LGTGSFGSVY-------------KGTLFDGTN--VAIKVFNLQLERASRS-FDSECEILR 466
LG G FG V+ FDG VA+K+ + + +R+ F E +I+
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 467 SIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWL--------YSHNYFLGILERLNIM 518
+++ N+I+++ C + D ++ E+M NG L ++L ++H + + N++
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 519 ---IDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575
+ + ++YL S VH DL N L+ + T ++DFG+S+ L GD IQ
Sbjct: 133 YMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ I +MA E G + SDV+++G+ L E FT
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 422 LLGTGSFGSVYKGTLF-DGTN----VAIKVFNLQLERASRSFDSECE---ILRSIRHRNL 473
LLG+G FG+V+KG +G + VAIK +Q ++F + + S+ H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGH 532
++++ C + LV + P GSL + H L LN + + + YL H
Sbjct: 72 VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR- 129
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG 592
MVH +L NILL + ++DFG++ LL D + I +MA E G
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 593 IISPKSDVYSYGILLMETFT 612
+ +SDV+SYG+ + E +
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 5/193 (2%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
LG+G FG V+ G VAIK N + + F E +++ + H L+++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLK 542
+V EFM NG L +L L L++ DV +EYL +H DL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLA 127
Query: 543 PNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYS 602
N L+ VSDFG+++ + + D+ + + + PE + S KSDV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 603 YGILLMETFTRKK 615
+G+L+ E FT K
Sbjct: 187 FGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDS---------ECEILRSIRHRN 472
+G G++G VYK G VAIK + F+S E ++L+ + H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIK-------KIKLRFESEGIPKTALREIKLLKELNHPN 59
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HG 531
+IK++ + LV EFM + L K + L + + + L + H HG
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--YG 589
++H DLKP N+L++ ++DFG+++ G T + T Y APE G
Sbjct: 119 ----ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLG 172
Query: 590 SEGIISPKSDVYSYGILLMETFTRK 614
+G S D++S G + E +R+
Sbjct: 173 DKG-YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 422 LLGTGSFGSVYKGTLF--DGT--NVAIKVFNLQLERAS--RSFDSECEILRSIRHRNLIK 475
+LG G FGSV + L DG+ VA+K+ + +S F E ++ H N+IK
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 476 IISNCCNIDFKA------LVLEFMPNGSLEKWLYSHN-----YFLGILERLNIMIDVGLA 524
+I K ++L FM +G L +L + L + + MID+
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
+EYL S +H DL N +L+ENMT V+DFG+SK + GD + + ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 585 APEYGSEGIISPKSDVYSYGILLMETFTR 613
A E ++ + + SDV+++G+ + E TR
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 58/199 (29%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G+G++G VYK + G VAIKV L+ E +L+ RH N++ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMI---DVGLALEYLHHGHSTPMVH 538
D +V+E+ GSL+ +Y G L L I + L YLH +H
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IY--QVTRGPLSELQIAYVCRETLKGLAYLHETG---KIH 124
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-----IATIGYMAPEYGSEGI 593
D+K NILL E+ ++DFG+S L T+ I T +MAPE +
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQLT-------ATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 594 ISP---KSDVYSYGILLME 609
K D+++ GI +E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 27/247 (10%)
Query: 419 ECNLLGTGSFGSVY----KGTLFDGTN--VAIKVFNLQLERASRS-FDSECEILRSIRHR 471
E LG G FG V+ KG +G V +K + +S F E ++ R + H+
Sbjct: 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWL--------YSHNYFLGILERLNIMIDVGL 523
N+++++ C + ++LE+ G L+++L L +++ + + L
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
+++L + VH DL N L+ VS +SK + + + + +
Sbjct: 129 GMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDV-YNSEYYKLRNALIPLRW 184
Query: 584 MAPEYGSEGIISPKSDVYSYGILLMETFTR-----KKPTNEIF---IGEMSLKHWVKESL 635
+APE E S KSDV+S+G+L+ E FT+ ++E + L+ V E
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGC 244
Query: 636 PDGLTEV 642
P L ++
Sbjct: 245 PSRLYKL 251
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 81/305 (26%), Positives = 133/305 (43%), Gaps = 48/305 (15%)
Query: 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERAS----RSFDSECEIL-RSIRHRNLI 474
+++G G+FG V K + DG + + ++ E AS R F E E+L + H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF---------------LGILERLNIMI 519
++ C + + L +E+ P+G+L +L L + L+
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 520 DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA 579
DV ++YL +H DL NIL+ EN A ++DFG+S+ G+ + V +TM
Sbjct: 132 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRL 185
Query: 580 TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDG 638
+ +MA E + + + SDV+SYG+LL E + P + E+ E LP G
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQG 239
Query: 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698
R E+ ++C + L C E P +R S L ++ E+
Sbjct: 240 Y---------RLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286
Query: 699 DVATT 703
V TT
Sbjct: 287 YVNTT 291
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 69/300 (23%), Positives = 120/300 (40%), Gaps = 56/300 (18%)
Query: 422 LLGTGSFGSVYKGTLFD------GTNVAIKVFNLQ-LERASRSFDSECEILRSI-RHRNL 473
LG G+FG V K + VA+K+ E+ SE E+++ I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSH-------NYFLGILERLNIMI------- 519
I ++ C +V+E+ +G+L +L + + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 520 -DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI 578
V +E+L S +H DL N+L+ E+ ++DFG+++ + D T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKK------PTNEIFIGEMSLKHWVK 632
+ +MAPE + + + +SDV+S+G+LL E FT P E+F
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF----------- 244
Query: 633 ESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
L++E +C + HL DC E P QR + K L ++
Sbjct: 245 -------------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 29/226 (12%)
Query: 423 LGTGSFGSVY------------KGTLFDGTN-----VAIKVFNLQLERASR-SFDSECEI 464
LG G FG V+ K + VA+KV +R F E +I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 465 LRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLA 524
L + N+ +++ C +++E+M NG L ++L H L + +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS-T 131
Query: 525 LEY--------LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576
L Y + + S VH DL N L+ +N T ++DFG+S+ L D +Q
Sbjct: 132 LLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGR 191
Query: 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT--RKKPTNEI 620
I +MA E G + KSDV+++G+ L E T R++P +
Sbjct: 192 APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 46/295 (15%)
Query: 421 NLLGTGSFGSVYKGTLF-DG--TNVAIKVFN-LQLERASRSFDSECEILRSI-RHRNLIK 475
+++G G+FG V K + DG + AIK + R F E E+L + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF---------------LGILERLNIMID 520
++ C + + L +E+ P+G+L +L L + L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
V ++YL +H DL NIL+ EN A ++DFG+S+ G+ + V +TM
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRLP 174
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGL 639
+ +MA E + + + SDV+SYG+LL E + P + E+ E LP G
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQGY 228
Query: 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
R E+ +C + L C E P +R S L ++ E
Sbjct: 229 ---------RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 423 LGTGSFGSVY------------KGTLFDGTN-----VAIKVFNLQLERASRS-FDSECEI 464
LG G FG V+ K D + VA+K+ + +R+ F E +I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 465 LRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNY----------FLGILER 514
+ ++ N+I++++ C D ++ E+M NG L ++L H +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 515 LNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574
+ + + ++YL S VH DL N L+ +N T ++DFG+S+ L GD IQ
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ I +M+ E G + SDV+++G+ L E T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 7/191 (3%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
LG G FG V+ T T VA+K +F +E ++++++H L+K+
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL-HAVVT 71
Query: 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL-EYLHHGHSTPMVHCDL 541
+ ++ EFM GSL +L S G + L +ID + E + +H DL
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVY 601
+ NIL+ ++ ++DFG+++++ E ++ + I + APE + G + KSDV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 602 SYGILLMETFT 612
S+GILLME T
Sbjct: 188 SFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 64/217 (29%), Positives = 91/217 (41%), Gaps = 44/217 (20%)
Query: 415 NGFNECNLLGTGSFGSVYK------GTLFDGTNVAIKVFNL--------QLERASRSFDS 460
E + LG G+ GSV K G +F A+K Q+ R
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIF-----ALKTITTDPNPDLQKQILR------- 48
Query: 461 ECEILRSIRHRNLIKIISNC-----CNIDFKALVLEFMPNGSLE---KWLYSHNYFLGIL 512
E EI +S + ++K +I + +E+ GSL+ K + +G
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSI---GIAMEYCEGGSLDSIYKKVKKRGGRIGEK 105
Query: 513 ERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572
I V L YLH S ++H D+KP+NILL + DFG+S GE +S+
Sbjct: 106 VLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSL 159
Query: 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLME 609
T T T YMAPE S SDV+S G+ L+E
Sbjct: 160 AGTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 63/212 (29%), Positives = 89/212 (41%), Gaps = 33/212 (15%)
Query: 423 LGTGSFGSVYKGTL-FDGTNVAIK------VFNLQLERASRSFDSECEILRSIRHRNLIK 475
LG G FG V + A+K + + S E EIL H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNI--MIDVGLALEYLHHGHS 533
+ + + +++E+ G L L F R I ++ LA EYLH+
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHNRG- 113
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEYGSEG 592
+++ DLKP N+LLD N + DFG +K L G +T T T Y+APE
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPE----- 162
Query: 593 IISPK-----SDVYSYGILLMETFTRKKPTNE 619
II K D +S GILL E T + P E
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 55/186 (29%), Positives = 87/186 (46%), Gaps = 16/186 (8%)
Query: 439 GTNVAIKVF---NLQLERASRSFDSECEILRSIRHRNLIKII-SNCCNIDFKALVLEFMP 494
G VAIK+ + E F E + + H N++ ++ S V E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL---DEN 551
+L + L + L E +M+ V L+ L H+ +VH DLKP NI++
Sbjct: 63 GRTLREVLAADGA-LPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 552 MTAHVSDFGISKLLGEGDDSVIQTMTIAT--IG---YMAPEYGSEGIISPKSDVYSYGIL 606
A V DFGI LL D+ + T+T T +G Y APE ++P SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 607 LMETFT 612
+E T
Sbjct: 179 FLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 423 LGTGSFGSVYKGTLF--DGTNVAIKVFNLQLERASRSFD-----SECEILRSI-RHRNLI 474
LG G+FG V + T + ++ +KV L+ + S + SE +I+ + H N++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNY-FLGILERLNIMIDVGLALEYLHHGHS 533
++ C ++ E+ G L +L FL + + L+ V + +L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---S 159
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGI 593
+H DL N+LL + DFG+++ + + V++ + +MAPE +
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 594 ISPKSDVYSYGILLMETFT 612
+ +SDV+SYGILL E F+
Sbjct: 220 YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 45/229 (19%)
Query: 419 ECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIIS 478
+ +G G+FG+V K L + + V + RS E E R + +++ S
Sbjct: 8 DLGEIGRGAFGTVNK-MLHKPSGTIMAV------KRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 479 NCCNI-DFKALV---------LEFMPNGSLEK-WLYSHNYFLGILERLNIMIDVGL---- 523
+C I F + +E M + SL+K + Y + ++ I+ + +
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-EILGKIAVATVK 118
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
AL YL ++H D+KP+NILLD N + DFGIS G+ DS+ +T Y
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCRPY 173
Query: 584 MAPEYGSEGIISP--------KSDVYSYGILLMETFTRKKPT---NEIF 621
MAPE I P +SDV+S GI L E T K P N +F
Sbjct: 174 MAPER-----IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF 217
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 53/224 (23%)
Query: 417 FNECNLLGTGSFGSVYKGTLFD-GTN--VAIKVFNLQLERASRSFDSECEILRSIRHRNL 473
F +G GSFG VYK D TN VAIKV +L+ ++E EI +
Sbjct: 3 FTLLECIGKGSFGEVYKA--IDKRTNQVVAIKVIDLE--------EAEDEIEDIQQE--- 49
Query: 474 IKIISNC--CNI---------DFK-ALVLEFMPNGSLEKWLYSHNYFLGILE--RLN--- 516
I+ +S C I K +++E+ GS L +L+ +L+
Sbjct: 50 IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC----------LDLLKPGKLDETY 99
Query: 517 ---IMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573
I+ +V L LEYLH +H D+K NILL E ++DFG+S G+ ++
Sbjct: 100 IAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS---GQLTSTMS 153
Query: 574 QTMT-IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP 616
+ T + T +MAPE + K+D++S GI +E + P
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 420 CNLLGTGSFGSVY----KGTLFDG--TNVAIKVFNLQLERASR-SFDSECEILRSIRHRN 472
LG GSFG VY KG + D T VAIK N R F +E +++ +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYS-----HNYFLGILERLNIMI----DVGL 523
+++++ +++E M G L+ +L S N + L MI ++
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
+ YL+ + VH DL N ++ E+ T + DFG+++ + E D + + +
Sbjct: 131 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 584 MAPEYGSEGIISPKSDVYSYGILLMETFT 612
M+PE +G+ + SDV+S+G++L E T
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 423 LGTGSFGSVYKGTLFDGTNVA-IKVFNLQLERA---SRSFDSECEILRSIRHRNLIKIIS 478
+G G FG V G + G A + V L++ + F E + RS++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYF------LGILERLNIMIDVGLALEYLHHGH 532
C + LV+EF P G L+ +L S L+R+ I +GL H H
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL-----HLH 117
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE----- 587
+H DL N LL ++T + D+G+S + D V + ++APE
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 588 YGSEGII--SPKSDVYSYGILLMETF 611
+G+ ++ + +S+V+S G+ + E F
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 30/278 (10%)
Query: 422 LLGTGSFGSVYKGTLF-DGTN----VAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIK 475
+LG+G+FG+VYKG DG N VAIKV +A++ E ++ + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
++ C + LV + MP G L ++ + +G + LN + + + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
+VH DL N+L+ ++DFG+++LL + I +MA E +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 596 PKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654
+SDV+SYG+ + E T KP + I E +PD L+ + +
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPARE----------IPD---------LLEKGERL 230
Query: 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
C + + + + C M E R ++ + ++
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 37/217 (17%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
LG G+FG VYK + G A K+ ++ E F E +IL +H N++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILER-LN------IMIDVGLALEYLHHGHST 534
+ +++EF G+L+ + LER L + + AL +LH S
Sbjct: 73 YENKLWILIEFCDGGALDSIMLE-------LERGLTEPQIRYVCRQMLEALNFLH---SH 122
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE------- 587
++H DLK NILL + ++DFG+S + I T +MAPE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETF 180
Query: 588 ----YGSEGIISPKSDVYSYGILLMETFTRKKPTNEI 620
Y K+D++S GI L+E + P +E+
Sbjct: 181 KDNPYDY------KADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 422 LLGTGSFGSV-YKGTLFDGTNVAIKVFNLQ------LERASRSFDS--ECEILRSIR-HR 471
+LG+G+ G+V + DG A+KV +++ RA C+ ++ H
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 472 NLIKI-ISNCCNIDFKALVLEFMPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEY 527
+ K N N+ ALVL++ G L + + S N E + I V LA+
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV-- 156
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVIQTMTIATIGYMAP 586
HH HS M+H D+K NILL N + DFG SK+ D V +T T Y+AP
Sbjct: 157 -HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTPYYVAP 214
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKP 616
E S K+D++S G+LL E T K+P
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 37/221 (16%)
Query: 423 LGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERAS----RSFDSECEILRSIRHRN 472
+G G+FG V++ T VA+K+ E AS F E ++ H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWL--------------------YSHNYF-LGI 511
++K++ C L+ E+M G L ++L N L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 512 LERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571
E+L I V + YL VH DL N L+ ENM ++DFG+S+ + D
Sbjct: 130 TEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
I +M PE + +SDV++YG++L E F+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFD------SECEILRSIRHRNLI 474
LGTG+F S Y+ + GT +A+K +S + E ++ + H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFL-GILERLNIMIDVGLALEYLHHGHS 533
+++ C L +E+M GS+ L + F ++ + GL+ YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLS--YLHENQ- 123
Query: 534 TPMVHCDLKPNNILLDENMTAH---VSDFGI-----SKLLGEGDDSVIQTMTIATIGYMA 585
++H D+K N+L+D T ++DFG +K G G+ Q + TI +MA
Sbjct: 124 --IIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGE---FQGQLLGTIAFMA 176
Query: 586 PE------YGSEGIISPKSDVYSYGILLMETFTRKKPTN 618
PE YG DV+S G +++E T K P N
Sbjct: 177 PEVLRGEQYGRS------CDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRS-FDSECEILRSIRH---R 471
+ L+G G++G+VY+G + G VA+K+ NL S E +L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLN--IMIDVGLALEYLH 529
N+ K + +++E+ GS+ + + I E+ I+ +V +AL+Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISVIIREVLVALKYIH 118
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYG 589
++H D+K NIL+ + DFG++ LL + S ++ + T +MAPE
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMAPEVI 173
Query: 590 SEGII-SPKSDVYSYGILLMETFTRKKP 616
+EG K+D++S GI + E T P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 442 VAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEK 500
VA+K+ + +R+ F E +IL ++ N+I+++ C + D ++ E+M NG L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 501 WLYSHNYFLGILER------------------LNIMIDVGLALEYLHHGHSTPMVHCDLK 542
+L SH+ L++ + + ++YL S VH DL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 543 PNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYS 602
N L+ EN+T ++DFG+S+ L GD IQ + I +MA E G + SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 603 YGILLMETFT--RKKPTNEI 620
+G+ L E +++P E+
Sbjct: 226 FGVTLWEILMLCKEQPYGEL 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 72/301 (23%), Positives = 121/301 (40%), Gaps = 58/301 (19%)
Query: 423 LGTGSFGSVY--------KGTLFDGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRN 472
LG G FG V K T VA+K+ E+ SE E+++ I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWL---------YSHN------YFLGILERLNI 517
+I ++ C +++E+ G+L ++L Y +N L + ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
V +EYL S +H DL N+L+ E+ ++DFG+++ + D T
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKK------PTNEIFIGEMSLKHWV 631
+ +MAPE + I + +SDV+S+G+LL E FT P E+F
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---------- 252
Query: 632 KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691
L++E +C + + DC P QR + K L +
Sbjct: 253 --------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298
Query: 692 I 692
I
Sbjct: 299 I 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G G+ G+VY + G VAIK NLQ + +E ++R +H N++ + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
D +V+E++ GSL + G + + + ALE+LH ++H D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA--VCRECLQALEFLHSNQ---VIHRDI 141
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVY 601
K +NILL + + ++DFG + + S TM + T +MAPE + PK D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 602 SYGILLMETFTRKKP 616
S GI+ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 72/241 (29%), Positives = 112/241 (46%), Gaps = 34/241 (14%)
Query: 422 LLGTGSFGSVYKGTLFD-GTNVAIKV--FNLQLERASRSFDS-ECEI--LRSIRHRNLIK 475
LLG G+FG VY D G +A+K F+ + S+ ++ ECEI L+++RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 476 IISNCCNIDFKALVL--EFMPNGSLEKWLYSHNYFL-GILERLNIMIDVGLALEYLHHGH 532
+ + K L + E+MP GS++ L ++ + R I G++ YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS--YLH--- 123
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG---------Y 583
S +VH D+K NIL D + DFG SK IQT+ ++ G +
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKR--------IQTICMSGTGIKSVTGTPYW 175
Query: 584 MAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK---HWVKESLPDGLT 640
M+PE S K+DV+S ++E T K P E K K LPDG++
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235
Query: 641 E 641
+
Sbjct: 236 D 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 64/210 (30%), Positives = 90/210 (42%), Gaps = 35/210 (16%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFD---SECEILRSIRHRNLIKIIS 478
+G GSFG+VY + VAIK + ++++ + E L+ +RH N I
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI---- 78
Query: 479 NCCNIDFKA---------LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529
++K LV+E+ GS L H L +E I L YLH
Sbjct: 79 -----EYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY- 588
S +H D+K NILL E T ++DFG + L+ + V T +MAPE
Sbjct: 133 ---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVI 183
Query: 589 --GSEGIISPKSDVYSYGILLMETFTRKKP 616
EG K DV+S GI +E RK P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 6/198 (3%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK---VFNLQLERASRSFDSECEILRSIRHRNLIKIIS 478
+G G F VY+ T L DG VA+K +F+L +A E ++L+ + H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
+ + +VLE G L + + ++ + L H HS ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
D+KP N+ + + D G+ + + + T YM+PE E + KS
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKS 187
Query: 599 DVYSYGILLMETFTRKKP 616
D++S G LL E + P
Sbjct: 188 DIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-13
Identities = 34/90 (37%), Positives = 50/90 (55%)
Query: 140 DLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVP 199
L+ L G IP + +LR LQ + L GN ++G+IP L + L L+L+ N G +P
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 200 PCLASLTSLRRLHLGSNKLTSTMPSSFGSL 229
L LTSLR L+L N L+ +P++ G
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQ---LERASRSFDSECEILRSIRHRNLIKII 477
+GTG+FG V+ A+KV + + + +E +L+ + H +I++
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
+ F +++E++P G L +L + F ++ ALEYLH S +V
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SKEIV 123
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEYGSEGIISP 596
+ DLKP NILLD+ ++DFG +K L +T T+ T Y+APE +I
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYLAPE-----VIQS 172
Query: 597 KS-----DVYSYGILLMETFTRKKP 616
K D ++ GIL+ E P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 423 LGTGSFGSVY----KGTLFDGTNVAIKVFN----LQLERASRSFDSECEILRSIRHRNLI 474
LGTG++G V+ G G A+KV +Q + + +E ++L ++R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 475 KIISNCCNIDFKA-LVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-DVGLALEYLHHGH 532
+ D K L+L+++ G L LY +F + + I ++ LAL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF--TESEVRVYIAEIVLALDHLHQ-- 123
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY--GS 590
+++ D+K NILLD ++DFG+SK ++ + TI YMAPE G
Sbjct: 124 -LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRGG 181
Query: 591 EGIISPKSDVYSYGILLMETFTRKKP 616
G D +S G+L E T P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 21/228 (9%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
LG G+FG VYK + G A KV + E + E EIL + H ++K++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
+++EF P G+++ + + G+ E I + LE L + HS ++H DL
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDR--GLTEP-QIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 542 KPNNILLDENMTAHVSDFGIS----KLLGEGDDSVIQTMTIATIGYMAPEY-----GSEG 592
K N+LL + ++DFG+S K L D I T +MAPE +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS------FIGTPYWMAPEVVMCETMKDT 190
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT 640
K+D++S GI L+E + P +E+ + LK + +S P L+
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IAKSEPPTLS 236
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 44/293 (15%)
Query: 423 LGTGSFGSVY------KGTLFDGTNVAIKVFNLQLE-RASRSFD--SECEILRSIRHRNL 473
LG G FG V +G D T + V +L+ E + D E EILR++ H N+
Sbjct: 12 LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 474 IKIISNCCNIDFKA---LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH 530
+K C D L++EF+P+GSL+++L + + + ++L + + ++YL
Sbjct: 69 VKY-KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL-- 125
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD-SVIQTMTIATIGYMAPEYG 589
S VH DL N+L++ + DFG++K + + ++ + + + APE
Sbjct: 126 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 590 SEGIISPKSDVYSYGILLMETFT----RKKPTNEIFI------GEMSLKHWVKESLPDGL 639
+ SDV+S+G+ L E T P G+M++ V+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR------- 237
Query: 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
++ E + +C + L C P +R + ++ + I
Sbjct: 238 -------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 423 LGTGSFGSVYKGTLF----DGTNVAIKVFNLQ--LERASRSFDSECEILRSIRHRNLIKI 476
+G GS+G V +L DG IK NL+ R ++ + E ++L ++H N++
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 477 ISNCCNID-FKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLHHGHS 533
+ D +V+ F G L L L + E + + + +AL+YLH H
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH- 122
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGI 593
++H DLK N+ L V D GI+++L D + + I T YM+PE S
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKP 178
Query: 594 ISPKSDVYSYGILLMETFTRKKPTN 618
+ KSDV++ G + E T K N
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 422 LLGTGSFGSVYKGTLFD-GTNVAIKV--FNLQLERASRSFDS-ECEI--LRSIRHRNLIK 475
LLG G+FG VY D G +A+K F+ + S+ ++ ECEI L+++ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 476 IISNCCNIDFKAL--VLEFMPNGSLEKWLYSHNYFL-GILERLNIMIDVGLALEYLHHGH 532
+ + L +E MP GS++ L S+ + + I LE + + H
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLL------GEGDDSVIQTMTIATIGYMAP 586
S +VH D+K NIL D + DFG SK L G G SV T +M+P
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-----TGTPYWMSP 178
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKPTNE 619
E S K+D++S G ++E T K P E
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 28/209 (13%)
Query: 422 LLGTGSFGSVY---KGTLFD-GTNVAIKVF---NLQLERASRSFDSECEILRSIRHRNLI 474
+LG GSFG V+ K T D G A+KV L++ R+ E +IL + H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 475 KIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNI-MIDVGLALEYL 528
K+ + F+ L+L+F+ G L L F E + + ++ LAL++L
Sbjct: 62 KL-----HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHL 114
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPE 587
H S +++ DLKP NILLDE ++DFG+SK E D + + T+ YMAPE
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPE 168
Query: 588 YGSEGIISPKSDVYSYGILLMETFTRKKP 616
+ + +D +S+G+L+ E T P
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 423 LGTGSFGSVYKGTLFD------GTNVAIKVFNLQLERASR-SFDSECEILRSIRHRNLIK 475
LG GSFG VY+G D T VA+K N R F +E +++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYS-----HNYFLGILERLNIMI----DVGLALE 526
++ +V+E M +G L+ +L S N L MI ++ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 586
YL+ + VH DL N ++ + T + DFG+++ + E D + + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 587 EYGSEGIISPKSDVYSYGILLMETFT 612
E +G+ + SD++S+G++L E +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 423 LGTGSFGSVYKG---TLFDGTNVAIKVFNLQLERASRSFD--SECEILRSIRHRNLIKII 477
LG+G+FG+V KG VA+K+ + + E +++ + + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
C + LV+E G L K+L N + ++ V + ++YL T V
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEE---TNFV 117
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEYGSEGIIS 595
H DL N+LL A +SDFG+SK LG D++ + T + + APE + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 596 PKSDVYSYGILLMETFTR-KKP 616
KSDV+S+G+L+ E F+ +KP
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-12
Identities = 32/91 (35%), Positives = 50/91 (54%)
Query: 211 LHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDI 270
L L + L +P+ L ++ INLS NS+ G++P ++ ++ L LDLS N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 271 PTTIGGLENLETLSLADNQFQGPVPKSFGSL 301
P ++G L +L L+L N G VP + G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 67/301 (22%), Positives = 121/301 (40%), Gaps = 58/301 (19%)
Query: 423 LGTGSFGSVYKGTLF--------DGTNVAIKVF-NLQLERASRSFDSECEILRSI-RHRN 472
LG G FG V + VA+K+ + E+ SE E+++ I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWL---------YSHNYF------LGILERLNI 517
+I ++ C +++E+ G+L ++L YS++ + + ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
V +EYL S +H DL N+L+ EN ++DFG+++ + D T
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKK------PTNEIFIGEMSLKHWV 631
+ +MAPE + + + +SDV+S+G+L+ E FT P E+F
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF---------- 249
Query: 632 KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691
L++E +C + + DC P R + K L +
Sbjct: 250 --------------KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295
Query: 692 I 692
I
Sbjct: 296 I 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 35/204 (17%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDS-------ECEILRSIRHRNLI 474
+G G+ G V+K G VA+K L+ R E + L++ +H ++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALR-----RLEGGIPNQALREIKALQACQHPYVV 62
Query: 475 KIIS-----NCCNIDFKALVLEFMPNGSLEKWL--YSHNYFLGILERLNIMIDVGLALEY 527
K++ + LV+E+MP L + L ++ M+ L+
Sbjct: 63 KLLDVFPHGSGF-----VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML-----LKG 111
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 587
+ + H+ ++H DLKP N+L+ + ++DFG+++L E + + + +AT Y APE
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQVATRWYRAPE 170
Query: 588 --YGSEGIISPKSDVYSYGILLME 609
YG+ P D+++ G + E
Sbjct: 171 LLYGARK-YDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 45/218 (20%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKV---FNLQL--ERASRSFDSECEILRSIRHRNLI 474
+ +G G++G V T G VAIK F Q +R R E +ILR +H N+I
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66
Query: 475 KIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHN-------YFLGILERLNIMIDVG 522
I+ F++ +V E M L K + + + YFL + R
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------- 117
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVIQTMTIATI 581
L+Y+H S ++H DLKP+N+LL+ N + DFG++++ E D + T +AT
Sbjct: 118 -GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 582 GYMAPEYGSEGIISPKS-----DVYSYGILLMETFTRK 614
Y APE +++ K D++S G +L E + +
Sbjct: 174 WYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVA---IKVFNLQLERASRSFDSECEILRSIRHRNLIK--- 475
+G G F VYK L DG VA +++F + +A + E ++L+ + H N+IK
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 476 --IISNCCNIDFKALVLEFMPNGSLEKWL-YSHNYFLGILERL--NIMIDVGLALEYLHH 530
I +N NI VLE G L + + + I ER + + ALE++H
Sbjct: 70 SFIENNELNI-----VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH- 123
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT----IATIGYMAP 586
S ++H D+KP N+ + + D G+ + +T + T YM+P
Sbjct: 124 --SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS------KTTAAHSLVGTPYYMSP 175
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE-MSL 627
E E + KSD++S G LL E + P F G+ M+L
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNC 480
LG G+ G+VYK L +A+KV L + + SE EIL +I
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+ ++ EFM GSL+ + + LG I + V L YL S ++H D
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLW---SLKILHRD 120
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDV 600
+KP+N+L++ + DFG+S L I + T YMAPE S SDV
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 601 YSYGILLMETFTRKKPTNEIFIGEMSL 627
+S GI ME + P +I + SL
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSL 203
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 55/161 (34%), Positives = 81/161 (50%), Gaps = 27/161 (16%)
Query: 490 LEFMPNGSLEKW---LYSHNYFLG--ILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPN 544
+E M + SL+K+ +Y + IL + I + + ALEYLH S ++H D+KP+
Sbjct: 79 MEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHSKLS--VIHRDVKPS 133
Query: 545 NILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP-------- 596
N+L++ N + DFGIS G DSV +T+ YMAPE I+P
Sbjct: 134 NVLINRNGQVKLCDFGIS---GYLVDSVAKTIDAGCKPYMAPER-----INPELNQKGYD 185
Query: 597 -KSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP 636
KSDV+S GI ++E T + P + LK V+E P
Sbjct: 186 VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 77/281 (27%), Positives = 127/281 (45%), Gaps = 20/281 (7%)
Query: 11 LTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTES 70
L L N+L I + + + L LDL +N+ + + P +L+ L L+ N + +
Sbjct: 98 LDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLP 156
Query: 71 SAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEI 130
S L N NL L L+ N L LP L+ N ++L G K+ ++P EI
Sbjct: 157 --------SPLRNLPNLKNLDLSFNDLS-DLPKLLSN-LSNLNNLDLSGNKIS-DLPPEI 205
Query: 131 GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLN 190
LS + DL+ + + +++ L+ L GL L NKL+ +P + +L L L+L+
Sbjct: 206 ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLS 263
Query: 191 GNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI 250
N++ L SLT+LR L L N L++ +P L +L + L+ +L +
Sbjct: 264 NNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIA-LLLLLLELLLNLLLTLKALELKL 320
Query: 251 QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
+L N ++ N P + LE+L L DN
Sbjct: 321 --NSILLNNNILSNGE-TSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 422 LLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDS---ECEI--LRSIRHRNLIK 475
LLG G+FG VY D G +A K E S + ECEI L++++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 476 IISNCCNIDFKALV--LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+ K L +E+MP GS++ L ++ G L LE + + HS
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHS 124
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLL------GEGDDSVIQTMTIATIGYMAPE 587
+VH D+K NIL D + DFG SK L G G SV T +M+PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV-----TGTPYWMSPE 179
Query: 588 YGSEGIISPKSDVYSYGILLMETFTRKKPTNE 619
S K+DV+S G ++E T K P E
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 49/226 (21%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDS---------ECEILRSIRHRN 472
+G+G++G V G VAIK + +FD E +ILR +H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 473 LIKI--ISNCCNIDFKA--LVLEFMPNGSLEKWLYSH--------NYFLGILERLNIMID 520
+I I I DFK +V++ M + L ++S YFL L R
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR------ 118
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--I 578
L+Y+H S ++H DLKP+N+L++E+ + DFG+++ L MT +
Sbjct: 119 ---GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 579 ATIGYMAPEYG-SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIG 623
AT Y APE S + D++S G + E R+ ++F G
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 73/258 (28%), Positives = 117/258 (45%), Gaps = 45/258 (17%)
Query: 423 LGTGSFGSVYK-GTLFDGTNVAIKVFNLQLERASR-SFDSECEILRSIRHRNLIKIISNC 480
LG G+ GSV K + GT +A KV ++ + + R E +I+ R ++
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL---------NIMIDVGLALEYLHHG 531
N + + +EFM GSL+ I ++ I + V L YL++
Sbjct: 73 LNENNICMCMEFMDCGSLD----------RIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE 591
H ++H D+KP+NIL++ + DFG+S GE +S+ T + T YM+PE
Sbjct: 123 HR--IMHRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTYMSPERIQG 176
Query: 592 GIISPKSDVYSYGILLMETFTRKKP---TNEIFIGEMS-------LKHWVKE---SLPDG 638
G + KSDV+S GI ++E K P +N G+ L+ V+E LP
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236
Query: 639 -----LTEVVDANLVREE 651
L + VDA L+++
Sbjct: 237 DFPEDLRDFVDACLLKDP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G G+ G+VY + G VAIK NLQ + +E ++R ++ N++ + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
D +V+E++ GSL + ++ I L+ L HS ++H D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQVIHRDI 141
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVY 601
K +NILL + + ++DFG + + S TM + T +MAPE + PK D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 602 SYGILLMETFTRKKP 616
S GI+ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK---VFNLQLERASRSFDSECEILRSIRHRNLIKIIS 478
+G G F VY+ T L D VA+K +F + +A + E ++L+ + H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 479 NCCNIDFKALVLEFMPNGSLEKWL-YSHNYFLGILERL--NIMIDVGLALEYLHHGHSTP 535
+ + +VLE G L + + Y I ER + + A+E H HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE---HMHSRR 126
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
++H D+KP N+ + + D G+ + + + T YM+PE E +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 596 PKSDVYSYGILLMETFTRKKP 616
KSD++S G LL E + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 36/87 (41%), Positives = 52/87 (59%)
Query: 162 GLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTST 221
GL L L+G IP D+ L L +NL+GN + G++PP L S+TSL L L N +
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 222 MPSSFGSLEYVLYINLSANSLNGSLPS 248
+P S G L + +NL+ NSL+G +P+
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRS------FDSECEILRSIRHRNLIKI 476
+G G FG V G G + A +V +L RAS + F E + R + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKA-RVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLG------ILERLNIMIDVGLALEYLHH 530
+ C LVLEF P G L+ +L S+ + +L+R+ + GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL--WLHQ 118
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
+H DL N L +++ + D+G++ D + + + ++APE
Sbjct: 119 AD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 591 E-------GIISPKSDVYSYGILLMETFT 612
+ KS+++S G+ + E FT
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 422 LLGTGSFGSVYKGTLFD-GTNVAIKVF--NLQLERASRSFDSECEILRSIRHRNLIKIIS 478
++G G++G V K G VAIK F + E ++ E ++LR +RH N++ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
LV E++ LE L + L + + + A+ Y H S ++H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-------YGSE 591
D+KP NIL+ E+ + DFG ++ L S + T +AT Y APE YG
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLVGDTNYG-- 180
Query: 592 GIISPKSDVYSYGILLMETFT 612
DV++ G ++ E
Sbjct: 181 ----KPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 29/217 (13%)
Query: 417 FNECNLLGTGSFGSVY---KGTLFD-GTNVAIKVFN----LQLERASRSFDSECEILRSI 468
F +LGTG++G V+ K T D G A+KV +Q + +E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 469 RHRNLIKIISNCCNIDFKA-LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
R + + + K L+L+++ G + LY + F + G +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNF----SEDEVRFYSGEIILA 117
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK-LLGEGDDSVIQTMTI-ATIGYMA 585
L H H +V+ D+K NILLD ++DFG+SK L E + +T + TI YMA
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE---RTYSFCGTIEYMA 174
Query: 586 PEYGSEGIISPKS------DVYSYGILLMETFTRKKP 616
PE II K D +S GIL+ E T P
Sbjct: 175 PE-----IIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 40/239 (16%)
Query: 421 NLLGTGSFGSV----YKGTLFDGTNVAIKVFNLQLERASRSFD---SECEILRSIRHRNL 473
LGTGSFG V +KGT G AIK + + E IL + H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+ ++ + + + +LEF+ G L L F + + ++ LA EYLH S
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLH---S 136
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEYGSEG 592
+++ DLKP N+LLD V+DFG +K + + +T T+ T Y+APE
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPE----- 185
Query: 593 IISPKS-----DVYSYGILLMETFTRKKP---------TNEIFIGEMSLKHWVKESLPD 637
+I K D ++ G+LL E P +I G + +W D
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 49/195 (25%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G G+ G+V+ + G VAIK NLQ + +E +++ +++ N++ + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
D +V+E++ GSL + ++ I L+ L H+ ++H D+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQVIHRDI 141
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVY 601
K +N+LL + + ++DFG + + S TM + T +MAPE + PK D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 602 SYGILLMETFTRKKP 616
S GI+ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 69/311 (22%), Positives = 125/311 (40%), Gaps = 62/311 (19%)
Query: 423 LGTGSFGSVYKGTLF--------DGTNVAIKVF-NLQLERASRSFDSECEILRSI-RHRN 472
LG G FG V + + VA+K+ + ++ SE E+++ I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLY---------------SHNYFLGILERLNI 517
+I ++ C +++E+ G+L ++L L + ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
V +EYL S +H DL N+L+ E+ ++DFG+++ + + D +
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKK------PTNEIFIGEMSLKHWV 631
+ +MAPE + + + +SDV+S+GIL+ E FT P E+F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF---------- 246
Query: 632 KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691
L+RE +C + L +C P QR + K L K
Sbjct: 247 --------------KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292
Query: 692 ----IKEKFLD 698
+ E++LD
Sbjct: 293 VLAAVSEEYLD 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G G+ G+VY + G VAI+ NLQ + +E ++R ++ N++ + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
D +V+E++ GSL + G + + + ALE+LH S ++H D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA--VCRECLQALEFLH---SNQVIHRDI 142
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVY 601
K +NILL + + ++DFG + ++ + T +MAPE + PK D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 602 SYGILLMETFTRKKP 616
S GI+ +E + P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 65/213 (30%), Positives = 92/213 (43%), Gaps = 40/213 (18%)
Query: 422 LLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIK---- 475
++G G++G VYK G VAIK+ ++ + E ILR H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 476 -IISNCCNIDFKA-LVLEFMPNGS---LEKWLYSHNYFLGILERLN------IMIDVGLA 524
I N D + LV+E GS L K L +RL I+ +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG------KRLKEEWIAYILRETLRG 125
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVS--DFGISKLLGEGDDSVIQTMT-IATI 581
L YLH ++H D+K NILL +N A V DFG+S L D ++ + T I T
Sbjct: 126 LAYLHENK---VIHRDIKGQNILLTKN--AEVKLVDFGVSAQL---DSTLGRRNTFIGTP 177
Query: 582 GYMAPE-----YGSEGIISPKSDVYSYGILLME 609
+MAPE + +SDV+S GI +E
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 6e-11
Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 32/157 (20%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILR---SIR----HRNLI 474
LG G+FGSVY G VAIK ++++ S++ EC LR S+R H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 475 KI-----ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEY 527
K+ ++ V E+M G+L + L E + +I+ + L +
Sbjct: 62 KLKEVFRENDELY-----FVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 528 LH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563
+H HG H DLKP N+L+ ++DFG+++
Sbjct: 115 IHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 57/237 (24%)
Query: 415 NGFNECNLLGTGSFGSVYKGTLFDGTNV-AIKVFN--LQLERA-SRSFDSECEILRSIRH 470
+ F ++G G+FG V+ D V A+KV ++R +E +IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNI--MIDVGLALEYL 528
++K+ + + + LV+E+MP G L L + F R I ++ LAL+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV---LALDSV 117
Query: 529 HH-GHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDS-------------- 571
H G +H D+KP+NIL+D H+ +DFG+ K + + D
Sbjct: 118 HKLGF----IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 572 -------------VIQTMTIATIGYMAPE------YGSEGIISPKSDVYSYGILLME 609
V T+ T Y+APE YG + D +S G++L E
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG------LECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTN---VAIKVFNLQ-LERASRSFDSECEILRSIRHRN 472
F + +G GSFG V+KG D VAIK+ +L+ E E +L
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
+ K + +++E++ GS L + G + I + L+ L + H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLH 118
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEYGSE 591
S +H D+K N+LL E ++DFG++ G+ D+ I+ T + T +MAPE +
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 592 GIISPKSDVYSYGILLMETFTRKKPTNEI 620
K+D++S GI +E + P +++
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 417 FNECNLLGTGSFGSVY---KGTLFD-GTNVAIKVFN----LQLERASRSFDSECEILRSI 468
F +LGTG++G V+ K + D G A+KV +Q + + +E ++L I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 469 RHRNLIKIISNCCNIDFKA-LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
R + + D K L+L+++ G L L F + + I G +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF----KEQEVQIYSGEIVLA 117
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAP 586
L H H +++ D+K NILLD N ++DFG+SK E D V + + TI YMAP
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE--DEVERAYSFCGTIEYMAP 175
Query: 587 EY--GSEGIISPKSDVYSYGILLMETFTRKKP 616
+ G +G D +S G+L+ E T P
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-11
Identities = 34/86 (39%), Positives = 50/86 (58%), Gaps = 1/86 (1%)
Query: 90 LGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGT 149
LGL + LRG +P I LQ G +RGNIP +G+++ + V DL+ NG+
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 150 IPTAVGRLRRLQGLYLHGNKLQGSIP 175
IP ++G+L L+ L L+GN L G +P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 49/196 (25%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 422 LLGTGSFGSVYKGTLFDGTN----VAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKI 476
+LGTG FG + +G L + VAI ++ R F +E L H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ +V E+M NG+L+ +L H L + + ++ + ++YL + M
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL-----SEM 126
Query: 537 --VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG-YMAPEYGSEGI 593
VH L + +L++ ++ +S F +L + +++ TM+ + + APE
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 594 ISPKSDVYSYGILLME 609
S SDV+S+GI++ E
Sbjct: 185 FSSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 422 LLGTGSFGSVYKGTLFDGTNVAIKVFNLQ-LERAS--RS------FDSECEILRSIRHRN 472
+LG G +G V++ G + K+F ++ L++A+ R+ +E IL +++H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTG-KIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMID---------VGL 523
++ +I L+LE++ G L + H LER I ++ + L
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGEL----FMH------LEREGIFMEDTACFYLSEISL 111
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
ALE+LH +++ DLKP NILLD ++DFG+ K + +V T TI Y
Sbjct: 112 ALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFC-GTIEY 166
Query: 584 MAPEYGSEGIISPKSDVYSYGILLMETFT---------RKKPTNEIFIGEMSL 627
MAPE D +S G L+ + T RKK ++I G+++L
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTN---VAIKVFNLQ-LERASRSFDSECEILRSIRHRN 472
F + +G GSFG V+KG D VAIK+ +L+ E E +L
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
+ K + +++E++ GS L G L+ I + L+ L + H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH 118
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG 592
S +H D+K N+LL E+ ++DFG++ L D + + + T +MAPE +
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEI 620
K+D++S GI +E + P +E+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 423 LGTGSFGSVYK----GTLFDGTNVAIKVFNLQLERASRSFD-----SECEILRSI-RHRN 472
LG G FG V G D N + V L+ + D SE E+++ I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWL---------YSH------NYFLGILERLNI 517
+I ++ C +++E+ G+L ++L YS L + ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
V +EYL S +H DL N+L+ E+ ++DFG+++ + D T
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ +MAPE + + + +SDV+S+G+LL E FT
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNV-AIKVFNLQ-LERASRSFDSECEILRSIRHRNLI 474
F + +G GSFG VYKG V AIK+ +L+ E E +L +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
+ + +++E++ GS L G LE I + L+ L + HS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE 120
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEYGSEGI 593
+H D+K N+LL E ++DFG++ G+ D+ I+ T + T +MAPE +
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 594 ISPKSDVYSYGILLMETFTRKKPTNEI 620
K+D++S GI +E + P +++
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 39/97 (40%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
AL YL H ++H D+KP+NILLD + + DFGIS G DS +T + Y
Sbjct: 126 ALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCAAY 180
Query: 584 MAPEYGSEGIISPK----SDVYSYGILLMETFTRKKP 616
MAPE +PK +DV+S GI L+E T + P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 40/210 (19%)
Query: 422 LLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLER---------ASRSFDSECEILRSIRHR 471
L+G GS+G V K + G VAIK F LE A R E +L+ +RH
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMR----EIRMLKQLRHE 60
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLH 529
NL+ +I LV EF+ + L+ Y G+ E + + +E+ H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-- 587
S ++H D+KP NIL+ ++ + DFG ++ L + + T +AT Y APE
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELL 172
Query: 588 -----YGSEGIISPKSDVYSYGILLMETFT 612
YG D+++ G L+ E T
Sbjct: 173 VGDTKYGR------AVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 430 SVYKGTLFDGTNVAIKVF---NLQLERASRSFDSECEILRSIRHRNLIKI----ISNCCN 482
S+YKG +F+ V I+ F + + ++E + LR I N++KI I +
Sbjct: 35 SIYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLK 542
+ +L+LE+ G L + L L +L++ ID L L+ + P + +L
Sbjct: 94 LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 543 PNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP---KSD 599
+ L+ EN + G+ K+L S + + Y + + ++ I S K D
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLND-IFSEYTIKDD 204
Query: 600 VYSYGILLMETFTRKKP-----TNEIFIGEMSLKHWVKESLP 636
+YS G++L E FT K P T EI+ ++ + LP
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIY--DLIINKNNSLKLP 244
|
Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 71/303 (23%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNLIK 475
+G G++G VYKG G VA+K L+ E A R E +L+ ++H N++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH----- 530
+ L+ EF+ + L+K+L S +D L YL+
Sbjct: 64 LQDVLMQESRLYLIFEFL-SMDLKKYLDS--------LPKGQYMDAELVKSYLYQILQGI 114
Query: 531 --GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE- 587
HS ++H DLKP N+L+D ++DFG+++ G + T + T+ Y APE
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVRVYTHEVVTLWYRAPEV 172
Query: 588 -YGSEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEIFIGEMS 626
GS +P D++S G + E T+K PT +++ G S
Sbjct: 173 LLGSPRYSTP-VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231
Query: 627 LKHWVKESLP----DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682
L + K + P L V NL +E LL M L D P +R+S
Sbjct: 232 LPDY-KNTFPKWKKGSLRSAV-KNL--DEDGLD-----LLEKM-LIYD-----PAKRISA 276
Query: 683 KDA 685
K A
Sbjct: 277 KKA 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 59/225 (26%), Positives = 111/225 (49%), Gaps = 24/225 (10%)
Query: 423 LGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G GS G V T+ G VA+K +L+ ++ +E I+R +H N++++ ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLN------IMIDVGLALEYLHHGHSTP 535
D +V+EF+ G+L + +H R+N + + V AL LH +
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIAAVCLAVLKALSVLH---AQG 136
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
++H D+K ++ILL + +SDFG + + + + + T +MAPE S
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 596 PKSDVYSYGILLMETFTRKKPT-NEIFIGEMSLKHWVKESLPDGL 639
P+ D++S GI+++E + P NE + M + ++++LP L
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IRDNLPPKL 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
LG G+FG VYK + G A KV + + E + E +IL S H N++K++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL----NIMIDVGLALEYLHHGHSTPMV 537
+ +++EF G+++ + LER I + LE L++ H ++
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLE-------LERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPEY-----GS 590
H DLK NIL + ++DFG+S + IQ I T +MAPE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 591 EGIISPKSDVYSYGILLMETFTRKKPTNEI 620
+ K+DV+S GI L+E + P +E+
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 417 FNECNLLGTGSFGSVYKG-TLFDGTNVAIKVFNLQLER------ASRSFDSECEILRSIR 469
F + +G G++G VYK G VA+K L E A R E +L+ +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529
H N++K++ + LV EF+ + L+K++ + I + L YL
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASP---------LSGIPLPLIKSYLF 107
Query: 530 ---HG----HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IAT 580
G HS ++H DLKP N+L++ ++DFG+++ G ++T T + T
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVT 163
Query: 581 IGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRK 614
+ Y APE G + S D++S G + E TR+
Sbjct: 164 LWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 46/221 (20%)
Query: 414 TNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER---ASRSFDSECEILRSIR 469
TN + + +G G+FG V G NVAIK A R++ E ++L+ +R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLR 67
Query: 470 HRNLIKI----ISNCCNIDFKALVL-----EFMPNGSLEKWLYSHNYFLGILERLNIMID 520
H N+I + IS +I F +L + + LEK YFL + R
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILR------ 119
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
L+Y+H S +VH DLKP+NIL++EN + DFG++++ D + T ++T
Sbjct: 120 ---GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQM-TGYVST 168
Query: 581 IGYMAPE-------YGSEGIISPKSDVYSYGILLMETFTRK 614
Y APE Y E D++S G + E K
Sbjct: 169 RYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 25/229 (10%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRS------IRHRNLIKI 476
+G G FG V ++ T VA V ++ +A+ S + E L+ ++H N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVV--VKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLG-----ILERLNIMIDVGLALEYLHHG 531
+ C LV E+ G L+ +L + +L+R+ I G+ + H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE 591
+H DL N L ++T V D+GI + D + + ++APE E
Sbjct: 120 ----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 592 ---GIISPK----SDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE 633
G+I+ + S+V++ G+ L E F L H +K+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 423 LGTGSFGS--VYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIIS 478
LG G+FG +Y+ T D + V K NL E+ R +E IL ++H N+I +
Sbjct: 8 LGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 479 NCCNIDFKALV--LEFMPNGSLEKWLYSHNYFLGILERLNI--MIDVGLALEYLHHGHST 534
+ +D L+ +E+ G+L + E + + + + A+ Y+H
Sbjct: 67 HF--MDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KA 120
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII 594
++H D+K NI L + + DFGISK+LG + S+ +T+ + T YM+PE
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETV-VGTPYYMSPELCQGVKY 178
Query: 595 SPKSDVYSYGILLMETFTRKK 615
+ KSD+++ G +L E T K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 65/203 (32%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 423 LGTGSFGSVYKGTLFDGTN--VAIKVFNL---QLERASRSFDSECEILRSIRHRNLIKII 477
+G GSFG+VY T TN VA+K + Q + E + L+ ++H N I+
Sbjct: 29 IGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY- 86
Query: 478 SNCCNIDFKA-LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
C + A LV+E+ GS L H L+ + I AL+ L + HS M
Sbjct: 87 KGCYLKEHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY---GSEGI 593
+H D+K NILL E ++DFG + + V T +MAPE EG
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQ 196
Query: 594 ISPKSDVYSYGILLMETFTRKKP 616
K DV+S GI +E RK P
Sbjct: 197 YDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 20/194 (10%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G GS G V T G VA+K +L+ ++ +E I+R +H N++++ S+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLN------IMIDVGLALEYLHHGHSTP 535
D +V+EF+ G+L + +H R+N + + V AL +LH +
Sbjct: 87 VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIATVCLAVLKALSFLH---AQG 135
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
++H D+K ++ILL + +SDFG + + + + + T +MAPE S
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPEVISRLPYG 193
Query: 596 PKSDVYSYGILLME 609
+ D++S GI+++E
Sbjct: 194 TEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-10
Identities = 27/65 (41%), Positives = 39/65 (60%)
Query: 255 VLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
+ L L L G IP I L +L++++L+ N +G +P S GS+ SLE LDLS N+
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 315 SGEIP 319
+G IP
Sbjct: 479 NGSIP 483
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 29/69 (42%), Positives = 42/69 (60%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L +L+ + L N + G IP S+ + + L +LDLS NSF+G IP + G L SL++L+L N
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
Query: 65 YLMTESSAA 73
L AA
Sbjct: 501 SLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 4e-10
Identities = 61/188 (32%), Positives = 96/188 (51%), Gaps = 43/188 (22%)
Query: 423 LGTGSFGSVYKGTLFD---GTNVAIK-VF----NLQLERASRSFDSECEILRSIR-HRNL 473
LG G++G V+K D VA+K +F N A R+F E L+ + H N+
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNAT--DAQRTF-REIMFLQELGDHPNI 69
Query: 474 IKIISNCCNIDFKA-------LVLEFMPNGSLEKWLYSHNYF-LGILERLN---IMIDVG 522
+K++ N+ KA LV E+M E L H ILE ++ IM +
Sbjct: 70 VKLL----NV-IKAENDKDIYLVFEYM-----ETDL--HAVIRANILEDVHKRYIMYQLL 117
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV---IQTMTIA 579
AL+Y+H G+ ++H DLKP+NILL+ + ++DFG+++ L E +++ + T +A
Sbjct: 118 KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 580 TIGYMAPE 587
T Y APE
Sbjct: 175 TRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 423 LGTGSFGSVY--KGTLFDGTNVAIKVFNLQLERASRSFDSECEI--LRSIRHRNLIKIIS 478
+G GSFG +Y K D + IK +L S+ E+ L ++H N++ +
Sbjct: 8 IGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 479 NCCNIDFKALVLEFMPNGSLEKW-------LYSHNYFLGILERLNIMIDVGLALEYLHHG 531
+ +V+E+ G L K L+S + L + I +GL H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF----VQISLGL-----KHI 117
Query: 532 HSTPMVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
H ++H D+K NI L +N M A + DFGI++ L D + + T Y++PE
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQ 175
Query: 591 EGIISPKSDVYSYGILLMETFTRKKP 616
+ K+D++S G +L E T K P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 417 FNECNLLGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFD---SECEILRSIRHRN 472
F++ +G GSFG+VY + + VAIK + ++++ + E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 473 LIKIISNCCNIDFKA-LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG 531
I+ C + A LV+E+ GS L H L+ + I AL+ L +
Sbjct: 77 TIQY-RGCYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYL 131
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY--- 588
HS M+H D+K NILL E + DFG + ++ + V T +MAPE
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILA 185
Query: 589 GSEGIISPKSDVYSYGILLMETFTRKKP 616
EG K DV+S GI +E RK P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 61/228 (26%)
Query: 417 FNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDS---------ECEILR 466
+ + +G+G++G V G VAIK + SR F S E +L+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIK-------KLSRPFQSAIHAKRTYRELRLLK 69
Query: 467 SIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKW--LYSHNYFLG-----IL--ERLN- 516
+ H N+I +D F P SLE + +Y + +G I+ ++L+
Sbjct: 70 HMDHENVI------GLLDV------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD 117
Query: 517 --IMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574
I V L L + HS ++H DLKP+NI ++E+ + DFG+++ +
Sbjct: 118 DHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD------- 170
Query: 575 TMT--IATIGYMAPEYGSEGII------SPKSDVYSYGILLMETFTRK 614
MT +AT Y APE I+ + D++S G ++ E T K
Sbjct: 171 EMTGYVATRWYRAPE-----IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 62/247 (25%), Positives = 114/247 (46%), Gaps = 36/247 (14%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G GS G V T G VA+K +L+ ++ +E I+R H N++ + ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLN------IMIDVGLALEYLHHGHSTP 535
D +V+EF+ G+L + +H R+N + + V AL YL H+
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIATVCLSVLRALSYL---HNQG 138
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
++H D+K ++ILL + +SDFG + + + + + T +MAPE S
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 596 PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK--HWVKESLPDGLTEV----------V 643
+ D++S GI+++E + P + E L+ ++++LP + + +
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252
Query: 644 DANLVRE 650
D LVRE
Sbjct: 253 DLMLVRE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 40/98 (40%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 122 LRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL 181
LRG IP +I L + +L+G + G IP ++G + L+ L L N GSIP L L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 182 EGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLT 219
L LNLNGN L G VP L R LH S T
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGG----RLLHRASFNFT 523
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 59/183 (32%), Positives = 86/183 (46%), Gaps = 11/183 (6%)
Query: 173 SIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYV 232
+L +L L L+LN N+L ++ L LT+L L L +N +T P +
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELLE-LTNLTSLDLDNNNITDIPPLIGLLKSNL 142
Query: 233 LYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292
++LS N + SLPS ++NL L NLDLS N LS D+P + L NL L L+ N+
Sbjct: 143 KELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS- 199
Query: 293 PVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLS------NYALCGPARLQVPSCRK 346
+P L +LE LDLS N++ E+ + S LS N P + S +
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLE 258
Query: 347 YNS 349
Sbjct: 259 TLD 261
|
Length = 394 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 42/210 (20%)
Query: 423 LGTGSFGSVYKGTLFDGTNV--AIKVFNLQLERAS-RSFDSECEILRSIRHRNLIKIISN 479
LG G++GSVYK L T V A+K L+L+ + E +IL H+ + I
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI-- 61
Query: 480 CCNIDFKA---------LVLEFMPNGSLEKWLYSHNYFLGI-----LERLNIMIDVGLAL 525
+DF + +E+M GSL+K LY+ L R+ + GL
Sbjct: 62 ---VDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGL-- 115
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 585
++L H+ ++H D+KP N+L++ N + DFG+S G S+ +T I YMA
Sbjct: 116 KFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKT-NIGCQSYMA 169
Query: 586 PEYGSEG------IISPKSDVYSYGILLME 609
PE G + +SDV+S G+ ++E
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 417 FNECNLLGTGSFGSVY-KGTLFDGTNVAIKVFNLQLERASRSFD---SECEILRSIRHRN 472
F + +G GSFG+VY + VAIK + ++++ + E + L+ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 473 LIKIISNCCNIDFKA-LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG 531
I+ C + A LV+E+ GS L H L+ + I AL+ L +
Sbjct: 87 SIEY-KGCYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYL 141
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY--- 588
HS M+H D+K NILL E ++DFG + + + V T +MAPE
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILA 195
Query: 589 GSEGIISPKSDVYSYGILLMETFTRKKP 616
EG K DV+S GI +E RK P
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 36/285 (12%)
Query: 417 FNECNLLGTGSFGSV------YKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRH 470
F + +LG G FG V G ++ + K ++ + +E +IL +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKK--RIKKRKGESMALNEKQILEKVNS 59
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGI--LERLNIMIDVGLALEYL 528
+ ++ + D LVL M G L+ H Y +G E + L L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLK----FHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY 588
H V+ DLKP NILLD+ +SD G++ + EG+ I+ + T+GYMAPE
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRG-RVGTVGYMAPEV 172
Query: 589 GSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648
+ + D + G L+ E + P F G K VK E VD ++
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP----FRGR---KEKVKR-------EEVDRRVL 218
Query: 649 REEQAFSVKI-DCLLSIMHLALDCCMESPEQRVSMKD-AAAKLKK 691
E+ +S K + SI + L + P+QR+ ++ A ++K+
Sbjct: 219 ETEEVYSAKFSEEAKSICKMLL---TKDPKQRLGCQEEGAGEVKR 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G+G++G VYK + G AIKV L+ E +++ +H N++ +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
D + +EF GSL+ +Y + G L I L+ L++ HS +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IY---HVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS---EGIISPKS 598
K NILL +N ++DFG+S + + I T +MAPE + +G +
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190
Query: 599 DVYSYGILLMETFTRKKP 616
D+++ GI +E + P
Sbjct: 191 DIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGT--NVAIKVFN----LQLERASRSFDSECEILRSIRH 470
FN LGTGSFG V T + VAIK F ++ ++ F SE +IL I H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINH 90
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF---LGILERLNIMIDVGLALEY 527
+ + + + + LVLEF+ G +L + F +G I+ L EY
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV----LIFEY 146
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG---YM 584
L S +V+ DLKP N+LLD++ ++DFG +K V+ T T G Y+
Sbjct: 147 LQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRTYTLCGTPEYI 195
Query: 585 APEYGSEGIISPKSDVYSYGILLMETFTRKKP 616
APE +D ++ GI + E P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 38/227 (16%)
Query: 415 NGFNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFN---LQLERASRSFDSECEILRS 467
F+ +L+G G FG V K T G A+KV L + F+ E +IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 468 IRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
+ ++ + D LV+E+ P G L L +L R D +A Y
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL----------LSLLNRYEDQFDEDMAQFY 107
Query: 528 L-------HHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTI 578
L H H VH D+KP N+L+D T H+ +DFG + L + V + +
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDR--TGHIKLADFGSAARL-TANKMVNSKLPV 164
Query: 579 ATIGYMAPEY------GSEGIISPKSDVYSYGILLMETFTRKKPTNE 619
T Y+APE +G + D +S G++ E + P +E
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 417 FNECNLLGTGSFGSV------YKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRH 470
F + +LG G FG V G ++ + K ++ + +E +IL +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK--RIKKRKGESMALNEKQILEKVNS 59
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIM--IDVGLALEYL 528
R ++ + D LVL M G L+ +Y H G E + ++ LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAP 586
H +V+ DLKP NILLD++ +SD G++ + EG QT+ + T+GYMAP
Sbjct: 119 HQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTIKGRVGTVGYMAP 170
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKP 616
E + D ++ G LL E + P
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 51/226 (22%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERAS--RSFDSECEILRSIR---H 470
+ E +G G++G+VYK L G VA+K + L S E +L+ + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 471 RNLIKIISNCCNIDFK-----ALVLEFM-----------PNGSLEKWLYSHNYFLGILER 514
N+++++ C LV E + P L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI----------- 109
Query: 515 LNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574
++M + +++LH S +VH DLKP NIL+ + ++DFG++++ +
Sbjct: 110 KDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMAL 163
Query: 575 TMTIATIGYMAPE------YGSEGIISPKSDVYSYGILLMETFTRK 614
T + T+ Y APE Y + D++S G + E F R+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYAT------PVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 62/248 (25%), Positives = 97/248 (39%), Gaps = 33/248 (13%)
Query: 385 NRSTKDGDQEDLLSLATWRR-----TSYLDIQRATN-GFNECNLLGTGSFGSVYKGTLFD 438
+ + D D+E L + TS D +N + L GS G V+ T
Sbjct: 56 HATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHG 115
Query: 439 G---TNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495
V +K ++ E +IL++I HR +I +I K+ V MP
Sbjct: 116 DEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPK 167
Query: 496 GSLEKWLYSHNYFLGI-------LERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548
Y + F + LE+ I I L LE L + H ++H D+K NI L
Sbjct: 168 -------YKCDLFTYVDRSGPLPLEQA-ITIQRRL-LEALAYLHGRGIIHRDVKTENIFL 218
Query: 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLM 608
DE A + DFG + L D+ T+ +PE + K+D++S G++L
Sbjct: 219 DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLF 278
Query: 609 ETFTRKKP 616
E +
Sbjct: 279 EMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 53/198 (26%), Positives = 81/198 (40%), Gaps = 9/198 (4%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIKIIS 478
LG G FG V + G A K + L+ + + +E +IL + R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
D LV+ M G L+ +Y+ G E I + L H H +V+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICG-LEHLHQRRIVY 118
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
DLKP N+LLD++ +SD G++ L G T GYMAPE +
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 599 DVYSYGILLMETFTRKKP 616
D ++ G L E + P
Sbjct: 176 DWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 67/213 (31%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSI------- 468
F L+G G++G VYKG + G AIKV ++ + D E EI + I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TGDEEEEIKQEINMLKKYS 60
Query: 469 RHRNLIK-----IISNCCNIDFKA-LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVG 522
HRN+ I N +D + LV+EF GS+ + N L+ I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICR 118
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATI 581
L L H H ++H D+K N+LL EN + DFG+S L D +V + T I T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTP 175
Query: 582 GYMAPEY-----GSEGIISPKSDVYSYGILLME 609
+MAPE + KSD++S GI +E
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 38/232 (16%)
Query: 421 NLLGTGSFGSVYKG-TLFDGTNVAIK-VFNLQLE---RASRSFDSEC----------EIL 465
LG G++G V K G VAIK V +++ R C +I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 466 RSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL 525
I+H N++ ++ DF LV++ M L+K + L + I++ + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE-------GDDSVIQ---- 574
LH +H DL P NI ++ ++DFG+++ G D +Q
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 575 -TMTIATIGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRKK---PTNEI 620
T + T+ Y APE G+E D++S G + E T K NEI
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHF-AVDMWSVGCIFAELLTGKPLFPGENEI 240
|
Length = 335 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 45/223 (20%)
Query: 405 TSYLDIQRATNGFNECNLLGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDS--E 461
TSYL++++ LG GS+ +VYKG + +G VA+KV +++ E F + E
Sbjct: 5 TSYLNLEK----------LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIRE 53
Query: 462 CEILRSIRHRNLI---KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNI- 517
+L+ ++H N++ II + F V E+M + L +++ H G L N+
Sbjct: 54 ASLLKGLKHANIVLLHDIIHTKETLTF---VFEYM-HTDLAQYMIQHP---GGLHPYNVR 106
Query: 518 --MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575
M + L Y+H H ++H DLKP N+L+ ++DFG+++ + S +
Sbjct: 107 LFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYS 161
Query: 576 MTIATIGYMAP-------EYGSEGIISPKSDVYSYGILLMETF 611
+ T+ Y P +Y S D++ G + +E
Sbjct: 162 SEVVTLWYRPPDVLLGATDYSSA------LDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 73/308 (23%), Positives = 122/308 (39%), Gaps = 68/308 (22%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFD----SECEILRSIRHRNLIKII 477
+G G+FG V+K VA+K + +E F E +IL+ ++H N++ +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 478 SNCCNI-----DFKA---LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529
C +K LV EF + L L + N + E +M + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK--LLGEGDDSVIQTMTIATIGYMAPE 587
++H D+K NIL+ ++ ++DFG+++ L + T + T+ Y PE
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 588 -------YGSEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEI 620
YG P D++ G ++ E +TR T E+
Sbjct: 194 LLLGERDYG------PPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247
Query: 621 FIGEMSLKHWVKESLPDGLTEVVDANL---VREEQAFSVKIDCLLSIMHLALDCCMESPE 677
+ G L+ + K LP G V L V++ A + ID LL + P
Sbjct: 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDL-IDKLLVL----------DPA 296
Query: 678 QRVSMKDA 685
+R+ A
Sbjct: 297 KRIDADTA 304
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 42/217 (19%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFD--SECEILRSIRHRNLIKIIS 478
++G GS+G V G VAIK N E S + E ++LR +RH ++++I
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK- 65
Query: 479 NCCNI-------DFKAL--VLEFM---------PNGSLEKWLYSHNYFLGILERLNIMID 520
+I +FK + V E M N L H +FL L R
Sbjct: 66 ---HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP--EHHQFFLYQLLR------ 114
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVIQTMTIA 579
AL+Y+H + + H DLKP NIL + + + DFG++++ + ++ T +A
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 580 TIGYMAPEY-GS-EGIISPKSDVYSYGILLMETFTRK 614
T Y APE GS +P D++S G + E T K
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 72/244 (29%), Positives = 117/244 (47%), Gaps = 39/244 (15%)
Query: 383 HRNRSTKDGDQEDLLSLATWRRTSYLDIQRATN-GFNECNLLGTGSFGSVYKGTLFDGT- 440
H N + +D D+E + DI R+ N + N++G GSFG VY+ D +
Sbjct: 42 HNNNAGEDEDEE---------KMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSE 92
Query: 441 NVAIKVFNLQLERASRSFDSECEILRSIRHRNLI---------KIISNCCNIDFKALVLE 491
VAIK ++ + + + E I++++ H N+I N NI F +V+E
Sbjct: 93 KVAIK----KVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI-FLNVVME 147
Query: 492 FMPNGSLEKWL--YS-HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548
F+P ++ K++ Y+ +N+ L + + AL Y+H S + H DLKP N+L+
Sbjct: 148 FIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLI 203
Query: 549 DENM-TAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--YGSEGIISPKSDVYSYGI 605
D N T + DFG +K L G SV I + Y APE G+ + D++S G
Sbjct: 204 DPNTHTLKLCDFGSAKNLLAGQRSV---SYICSRFYRAPELMLGATNYTT-HIDLWSLGC 259
Query: 606 LLME 609
++ E
Sbjct: 260 IIAE 263
|
Length = 440 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 47/214 (21%)
Query: 426 GSFGSVY----KGTLFDGTNVAIKVF------------NLQLERASRSFDSECEILRSIR 469
G+FGSVY + T G AIKV N++ ERA I+
Sbjct: 7 GAFGSVYLAKKRST---GDYFAIKVLKKSDMIAKNQVTNVKAERA---------IMMIQG 54
Query: 470 HR-NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER---LNIMIDVGLAL 525
+ K+ + + D+ LV+E++ G + + LG L + +V L +
Sbjct: 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGV 110
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 585
E LH ++H D+KP N+L+D+ ++DFG+S+ + + T Y+A
Sbjct: 111 EDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLA 161
Query: 586 PEYGSEGIISPK-SDVYSYGILLMETFTRKKPTN 618
PE G+ K SD +S G ++ E P +
Sbjct: 162 PET-ILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 53/197 (26%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFD-SECEILRSIRHRNLIKIISNC 480
LG G++ +VYKG G VA+K +L E + S E +++ ++H N++++ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 481 CNIDFK-ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539
+ + K LV E+M + L+K++ +H G L+ + L+ + H ++H
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENRVLHR 124
Query: 540 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE--YGSEGIIS 595
DLKP N+L+++ ++DFG+++ G + T + + T+ Y AP+ GS S
Sbjct: 125 DLKPQNLLINKRGELKLADFGLARAFG----IPVNTFSNEVVTLWYRAPDVLLGSR-TYS 179
Query: 596 PKSDVYSYGILLMETFT 612
D++S G ++ E T
Sbjct: 180 TSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 62/207 (29%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLI 474
F ++G G++G VYKG + G AIKV ++ E E +L+ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76
Query: 475 KII------SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYL 528
S + D LV+EF GS+ + N L+ I L L
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGL 134
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPE 587
H H+ ++H D+K N+LL EN + DFG+S L D +V + T I T +MAPE
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPE 191
Query: 588 Y-----GSEGIISPKSDVYSYGILLME 609
+ +SD++S GI +E
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
V +E+L S +H DL NILL EN + DFG+++ + + D V +
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ +MAPE + + + +SDV+S+G+LL E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 64/238 (26%), Positives = 100/238 (42%), Gaps = 34/238 (14%)
Query: 422 LLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISN-- 479
++G G FG VY D K++ ++ R + E L ++ R ++ ++S
Sbjct: 1 IIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETL-ALNERIMLSLVSTGD 55
Query: 480 -----CCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529
C F +L+ M G L L H F R ++ L LE
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLE--- 111
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYG 589
H H+ +V+ DLKP NILLDE+ +SD G++ + ++ T GYMAPE
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVL 167
Query: 590 SEGIISPKS-DVYSYGILLME------TFTRKKPTNEIFIGEMSLKHWVKESLPDGLT 640
+G S D +S G +L + F + K ++ I M+L V LPD +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELPDSFS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 423 LGTGSFGSV-YKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G GS G V G VA+K+ +L+ ++ +E I+R +H+N++++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLN---IMIDVGLALEYLHHGHSTPMVH 538
+ +++EF+ G+L + RLN I L+ L + HS ++H
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQ--------TRLNEEQIATVCESVLQALCYLHSQGVIH 140
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
D+K ++ILL + +SDFG + + D + + T +MAPE S +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 599 DVYSYGILLMETFTRKKP 616
D++S GI+++E + P
Sbjct: 199 DIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 423 LGTGSFGSVYKGTLF----DGTNVAIKVFNLQLERASRSFDS--ECEILRSIRHRNLIKI 476
+G GSFG K L DG IK N+ +S E +L +++H N+++
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGIL----ERLNIMIDVGLALEYLHHGH 532
+ +V+++ G L K + N G+L + L+ + + LAL+ H H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVLFPEDQILDWFVQICLALK---HVH 118
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEYGSE 591
++H D+K NI L ++ T + DFGI+++L + +V T I T Y++PE
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICEN 175
Query: 592 GIISPKSDVYSYGILLMETFTRK 614
+ KSD+++ G +L E T K
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 509 LGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568
L L+ L+ V +E+L S VH DL N+LL + + DFG+++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ V + T + +MAPE + + + SDV+SYGILL E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 70/302 (23%), Positives = 126/302 (41%), Gaps = 72/302 (23%)
Query: 426 GSFGSVYKG----TLFDGTNVAIKVFNLQLERASRSFD----SECEILRSIRHRNLIKI- 476
G++G VY+ T G VA+K L++E+ F E IL ++H N++ +
Sbjct: 16 GTYGVVYRARDKKT---GEIVALK--KLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 477 -ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ N+D +V+E++ + L+ + + E +M+ + + +LH
Sbjct: 71 EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--- 126
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE--YGSE 591
++H DLK +N+LL+ + DFG+++ G S ++ T + T+ Y APE G
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLAREYG----SPLKPYTQLVVTLWYRAPELLLG-A 181
Query: 592 GIISPKSDVYSYGILLMETFTRKK--------------------PTNEIFIGEMSLKHWV 631
S D++S G + E T+K PT +I+ G L
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 632 KESLPDGLTEVVDANLVRE--------EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMK 683
K++ N +R+ + F LL+ + L D P +R+S +
Sbjct: 242 KKTFTK-----YPYNQLRKKFPALSLSDNGFD-----LLNRL-LTYD-----PAKRISAE 285
Query: 684 DA 685
DA
Sbjct: 286 DA 287
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 58/225 (25%)
Query: 423 LGTGSFGSV----YKGTLFDGTNVAIK----VFN--LQLERASRSFDSECEILRSIR-HR 471
LG G++G V T + VAIK VF+ + +RA R E ++LR R H+
Sbjct: 8 LGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHK 62
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSL-EKWLYSHNYFLGILE-RLNIMIDVGLALEYLH 529
N+ C D ++ + G+ E +LY ++E L+ +I G L H
Sbjct: 63 NIT------CLYD-----MDIVFPGNFNELYLYEE-----LMEADLHQIIRSGQPLTDAH 106
Query: 530 -------------HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576
+ HS ++H DLKP N+L++ + + DFG+++ E M
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 577 T--IATIGYMAPEYGSEGIISPKS-----DVYSYGILLMETFTRK 614
T +AT Y APE ++S +S DV+S G +L E RK
Sbjct: 167 TEYVATRWYRAPEI----MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 62/216 (28%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 417 FNECNLLGTGSFGSV----YKGTLFDGTNVAIKVFNLQLERASRSFD-----SECEILRS 467
F +LG G FG V + T G A K L+ +R + +E +IL
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT---GKMYACK--KLEKKRIKKRKGEAMALNEKQILEK 56
Query: 468 IRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
+ R ++ + D LVL M G L+ H Y +G N D A+ Y
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLK----FHIYNMG-----NPGFDEERAVFY 107
Query: 528 -------LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
L H +V+ DLKP NILLD+ +SD G++ + EG+ I+ + T
Sbjct: 108 AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRG-RVGT 164
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP 616
+GYMAPE + D + G L+ E K P
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 54/186 (29%), Positives = 81/186 (43%), Gaps = 22/186 (11%)
Query: 442 VAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKW 501
V K L ER + SE L + H ++K + + D L++E+ G L K
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155
Query: 502 LYS--------HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT 553
+ Y +G+L + LAL+ +H S M+H DLK NI L
Sbjct: 156 IKQRLKEHLPFQEYEVGLL-----FYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGI 207
Query: 554 AHVSDFGISKLLGEGDDSV---IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMET 610
+ DFG SK + DSV + + T Y+APE S K+D++S G++L E
Sbjct: 208 IKLGDFGFSK---QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264
Query: 611 FTRKKP 616
T +P
Sbjct: 265 LTLHRP 270
|
Length = 478 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
V +E+L S +H DL NILL EN + DFG+++ + + D V +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ +MAPE + + + +SDV+S+G+LL E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNC 480
+G G++G VYK T DG+ A+K+ + + ++E IL+S+ H N++K
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 481 CNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLN-IMIDVGL--ALEYLHHGH 532
D LVLE GS+ + + L +RL+ MI L AL L H H
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE----- 587
+ ++H D+K NNILL + DFG+S L + + ++ T +MAPE
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACE 203
Query: 588 --YGSEGIISPKSDVYSYGILLME 609
Y + DV+S GI +E
Sbjct: 204 QQYDYS--YDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 42/131 (32%), Positives = 70/131 (53%), Gaps = 9/131 (6%)
Query: 487 ALVLEFMPNGSLEKWLYSHNYF-LGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNN 545
++ +E M GSL++ L IL +++I + GLA YL H ++H D+KP+N
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREKHQ--IMHRDVKPSN 134
Query: 546 ILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGI 605
IL++ + DFG+S G+ DS+ + + T YM+PE S +SD++S G+
Sbjct: 135 ILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGL 190
Query: 606 LLMETFTRKKP 616
L+E + P
Sbjct: 191 SLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 412 RATNGFNECNLLGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDS--ECEILRSI 468
R+ F + N +G G++G VY+ G VA+K + ER S E +L ++
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 469 RHRNLIK----IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLA 524
RH N+++ ++ + F LV+E+ L L + + +M+ +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
L+YLH ++H DLK +N+LL + ++DFG+++ G + T + T+ Y
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYR 175
Query: 585 APE--YGSEGIISPKSDVYSYGILLMETFTRK 614
APE G + D+++ G +L E K
Sbjct: 176 APELLLGCTTYTT-AIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 46/176 (26%), Positives = 89/176 (50%), Gaps = 10/176 (5%)
Query: 415 NGFNECNLLGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDS--ECEILRSIRHR 471
+ + + LG GS+ +VYKG + +G VA+KV LQ E + F + E +L+ ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHA 63
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG 531
N++ + + LV E++ + L +++ H G L N+ + + L L +
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYI 119
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 587
H ++H DLKP N+L+ + ++DFG+++ + S + + T+ Y P+
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 422 LLGTGSFGSVYKGTLFDGTN--VAIKVFNLQLERASRSFDSECEILR------SIRHRNL 473
+LG GSFG V L GT+ AIKV L+ + + D +C + + +H L
Sbjct: 2 VLGKGSFGKVMLAEL-KGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGH 532
+ D V+E++ G L + F R +V LAL +LH HG
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHG- 116
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEYGSE 591
+++ DLK +NILLD ++DFG+ K EG + + T T T Y+APE E
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 592 GIISPKSDVYSYGILLMETFTRKKP 616
P D ++ G+L+ E + P
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 48/217 (22%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIK----VFNLQLERASRSFDSECEILRSIRHRNLIK-- 475
+G G++G V + VAIK F+ +++ A R+ E ++LR + H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTL-REIKLLRHLDHENVIAIK 70
Query: 476 -IISNCCNIDFKA--LVLEFMPNGSLEKWLYS-------H-NYFLGILERLNIMIDVGLA 524
I+ F +V E M + L + + S H YFL L R
Sbjct: 71 DIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR---------G 120
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
L+Y+H S ++H DLKP+N+LL+ N + DFG+++ E D T + T Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYR 175
Query: 585 APE-------YGSEGIISPKSDVYSYGILLMETFTRK 614
APE Y + DV+S G + E RK
Sbjct: 176 APELLLNCSEYTT------AIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 37/96 (38%), Positives = 51/96 (53%), Gaps = 14/96 (14%)
Query: 15 DNK-LSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYL---MTES 70
DN+ L G IPN I+ L ++LS NS G IP + G++ SL+VL L+YN + ES
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 71 SAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIG 106
L LT +L +L L N L G +P +G
Sbjct: 486 -------LGQLT---SLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 25/198 (12%)
Query: 448 NLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNY 507
N+ +++ SR F ++ R+ R L+K +++ + +L+ F P SLE+ + Y
Sbjct: 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH---KNIISLLNVFTPQKSLEE--FQDVY 98
Query: 508 FLGILERLNIMIDVGLALEY-------------LHHGHSTPMVHCDLKPNNILLDENMTA 554
+ L N+ + + L++ + H HS ++H DLKP+NI++ + T
Sbjct: 99 LVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158
Query: 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRK 614
+ DFG+++ G S + T + T Y APE D++S G ++ E K
Sbjct: 159 KILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
Query: 615 KPTNEIFIGEMSLKHWVK 632
+F G + W K
Sbjct: 216 I----LFPGRDYIDQWNK 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 26/205 (12%)
Query: 423 LGTGSFGSVYKGTLFDG-TNVAIKVFNLQLERASRSFDS----ECEILRSIRHRNLIKII 477
+G G++G VYK D TN I + ++LE+ S E +L+ ++H N++++
Sbjct: 10 IGEGTYGVVYKAR--DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYF---LGILERLNIMIDVGLALEYLHHGHST 534
+ LV E++ + L+K + S F +++ I G+A + HS
Sbjct: 68 DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA-----YCHSH 121
Query: 535 PMVHCDLKPNNILLDENMTA-HVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE--YG 589
++H DLKP N+L+D A ++DFG+++ G ++T T + T+ Y APE G
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG----IPVRTFTHEVVTLWYRAPEILLG 177
Query: 590 SEGIISPKSDVYSYGILLMETFTRK 614
S +P D++S G + E +K
Sbjct: 178 SRHYSTP-VDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 42/215 (19%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNV-AIKVFNLQLERASRS----FDSECEILRSIRHR 471
F+ ++G G+FG V V A+K+ + + E RS F E +I+ H
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERDIMA---HA 100
Query: 472 NLIKIISNCCNI-DFKAL--VLEFMPNGSL----------EKWLYSHNYFLGILERLNIM 518
N I+ D K L V+E+MP G L EKW R
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW-----------ARFYTA 149
Query: 519 IDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI 578
+V LAL+ +H S +H D+KP+N+LLD++ ++DFG + + V +
Sbjct: 150 -EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-NGMVRCDTAV 204
Query: 579 ATIGYMAPEY----GSEGIISPKSDVYSYGILLME 609
T Y++PE G +G + D +S G+ L E
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 415 NGFNECNLLGTGSFGSVYKGTLFDGTN-VAIKVF--NLQLERASRSFDSECEILRSIRHR 471
N F ++G G++G V K + VAIK F + + E + E ++LR+++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 472 NLIKIISNCCNIDFKALVLEF-----------MPNGSLEKWLYSHNYFLGILERLNIMID 520
N++++ LV E+ MPNG + + S+ Y L
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
++ +H H +VH D+KP N+L+ N + DFG ++ L EG ++ T +AT
Sbjct: 110 ----IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVAT 164
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLME 609
Y +PE D++S G +L E
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 423 LGTGSFGSVYK-GTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNC 480
+G G++G V+K +G+ A+K+ + + ++E IL+++ H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 481 CNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGL---ALEYLHHGH 532
D K LVLE GS+ + FL ER+ I + AL L H H
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS-- 590
+H D+K NNILL + DFG+S L + + ++ T +MAPE +
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 591 ---EGIISPKSDVYSYGILLME 609
+ + DV+S GI +E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 55/177 (31%), Positives = 81/177 (45%), Gaps = 34/177 (19%)
Query: 417 FNECNLLGTGSFGSVY----KGT--LFDGTNVAIKVFNLQ-------LERASRSFDSECE 463
F + LLG G G V+ KGT LF A+KV + + ++R +E E
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLF-----ALKVLDKKEMIKRNKVKRVL----TEQE 53
Query: 464 ILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWL--YSHNYFLGILERLNIMIDV 521
IL ++ H L + ++ + LV+++ P G L + L + R +V
Sbjct: 54 ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EV 112
Query: 522 GLALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQT 575
LALEYLH G +V+ DLKP NILL E+ H+ SDF +SK V +
Sbjct: 113 LLALEYLHLLG----IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKA 163
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 72/315 (22%), Positives = 124/315 (39%), Gaps = 87/315 (27%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNLIK 475
+G G++G VYK G VA+K L+++ A R E +L+ + I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQMLSESIYIV 64
Query: 476 IISNCCNIDFKA------LVLEFMPNGSLEKWLYSHNYFLG------ILERLNIMIDVGL 523
+ + +++ K LV E++ + L+K++ S+ G ++ + G+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG 582
A H H ++H DLKP N+L+D + ++D G+ + S T I T+
Sbjct: 124 A-----HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLW 176
Query: 583 YMAPE--YGSEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEI 620
Y APE GS +P D++S G + E ++ PT ++
Sbjct: 177 YRAPEVLLGSTHYSTP-VDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235
Query: 621 FIGEMSLKHW----------VKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALD 670
+ G L+ W + ++PD E +D LL M L D
Sbjct: 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD----------------LLQKM-LRYD 278
Query: 671 CCMESPEQRVSMKDA 685
P +R+S K A
Sbjct: 279 -----PAKRISAKAA 288
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 409 DIQRAT--NGFNECNLLGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDSECEIL 465
DI R + + +G+G++G VYK L G A+K+ L+ E ++
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60
Query: 466 RSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL 525
+ +H N++ + + + + +E+ GSL+ +Y + G L L I L
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IY---HVTGPLSELQIAYVCRETL 116
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-----IAT 580
+ L + HS +H D+K NILL +N ++DFG++ + T+ I T
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA-------KITATIAKRKSFIGT 169
Query: 581 IGYMAPEYGS---EGIISPKSDVYSYGILLMETFTRKKP 616
+MAPE + G + D+++ GI +E + P
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 41/131 (31%), Positives = 61/131 (46%), Gaps = 9/131 (6%)
Query: 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNI 546
+ +L+ M G L L H F R ++ L LE H H+ +V+ DLKP NI
Sbjct: 73 SFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLE---HMHNRFVVYRDLKPANI 128
Query: 547 LLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS-DVYSYGI 605
LLDE+ +SD G++ + ++ T GYMAPE +G+ S D +S G
Sbjct: 129 LLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWFSLGC 184
Query: 606 LLMETFTRKKP 616
+L + P
Sbjct: 185 MLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 40/209 (19%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVF-----NLQLER-ASRSFDSECEILRSIRHRNLIK 475
+G GS+G V+K + G VAIK F + +++ A R E +L+ ++H NL+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 476 IISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH 530
+I F+ LV E+ + L + L + + I+ A+ +
Sbjct: 65 LIEV-----FRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFC-- 116
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--- 587
H +H D+KP NIL+ + + DFG +++L D T +AT Y APE
Sbjct: 117 -HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLV 173
Query: 588 ----YGSEGIISPKSDVYSYGILLMETFT 612
YG P DV++ G + E T
Sbjct: 174 GDTQYG------PPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
V +E+L S +H DL NILL EN + DFG+++ + + D V +
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ +MAPE + + + +SDV+S+G+LL E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 24/223 (10%)
Query: 421 NLLGTGSFGSVYKGTLFDGTN-----VAIKVFNLQLERASRS----FDSECEILRSIRHR 471
+LL G+FG ++ G L D V +K + AS E +L + H+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 472 NLIKIISNCCNIDFKALVLE-FMPNGSLEKWLYSHNYF-------LGILERLNIMIDVGL 523
N++ I+ C VL +M G+L+ +L L + +++ I +
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
+ YLH ++H D+ N ++DE + ++D +S+ L D + + +
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW 185
Query: 584 MAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEM 625
MA E S SDV+S+G+LL E T + P EI EM
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDSECEI-----LRSIRHRNLIKI 476
+G G++G+VYK G VA+K +Q + E+ L + H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 477 ISNCCNIDFK-----ALVLEFMPNGSLEKWLYSHNYFLGILERL-NIMIDVGLALEYLHH 530
+ C LV E + + L +L E + ++M L++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
+ +VH DLKP NIL+ ++DFG++++ + T + T+ Y APE
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPEVLL 180
Query: 591 EGIISPKSDVYSYGILLMETFTRK 614
+ + D++S G + E F RK
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 423 LGTGSFGSVYKGTLFD--GTNVAIKVFNLQLERASRSFDS--ECEILR---SIRHRNLIK 475
+G G++G V+K G VA+K +Q + E +LR + H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 476 IISNCC--NIDFKA---LVLEFMPNGSLEKWLYSHNYFLGILERL-NIMIDVGLALEYLH 529
+ C D + LV E + + L +L E + ++M + L++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYG 589
S +VH DLKP NIL+ + ++DFG++++ + T + T+ Y APE
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVL 181
Query: 590 SEGIISPKSDVYSYGILLMETFTRK 614
+ + D++S G + E F RK
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRS-FDSECEILRSIRHRNLI 474
F + + LG G+ G V+K + G +A K+ +L+++ A R+ E ++L ++
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF-LGILERLNIMIDVGLALEYLHHGHS 533
+ ++ +E M GSL++ L IL +++I + GL YL H
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREKHK 124
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGI 593
++H D+KP+NIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 125 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTH 178
Query: 594 ISPKSDVYSYGILLMETFTRKKP 616
S +SD++S G+ L+E + P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 18/192 (9%)
Query: 426 GSFGSVYKGTLFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCN 482
+ K T VA+K NL E E R ++H N++ +++
Sbjct: 13 LMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQ-EIITSRQLQHPNILPYVTSFIV 70
Query: 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLHHGHSTPMVHCD 540
+V M GS E L +H + G+ E I+ DV AL+Y+H +H
Sbjct: 71 DSELYVVSPLMAYGSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRS 126
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDD--SVIQTMTIATIG---YMAPEYGSEGII- 594
+K ++ILL + +S S + + V+ +++ +++PE + +
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186
Query: 595 -SPKSDVYSYGI 605
+ KSD+YS GI
Sbjct: 187 YNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
+G+G+ G V +D AI N+ +++ SR F ++ R+ R L+K + N N
Sbjct: 32 IGSGAQGIVCAA--YD----AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKN 84
Query: 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY-------------LH 529
I L+ F P SLE+ + Y + L N+ + + L++ +
Sbjct: 85 I--IGLLNVFTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYG 589
H HS ++H DLKP+NI++ + T + DFG+++ G S + T + T Y APE
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVI 197
Query: 590 SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK 632
D++S G ++ E +F G + W K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 52/195 (26%), Positives = 79/195 (40%), Gaps = 49/195 (25%)
Query: 424 GTGSFGSVYKG---TLFDGTNVAIKVF---NLQLERASRSFDSECEILRSIRHRNLIKII 477
G G++G VYK DG AIK F Q S+S E +LR ++H N++
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS-- 66
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWL---YSHNYFLGIL----ERLNIMIDVGLA------ 524
LV F+ + +L Y+ + I+ + + I +
Sbjct: 67 ----------LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 525 -LEYLHHGHSTPMVHCDLKPNNILL----DENMTAHVSDFGIS-------KLLGEGDDSV 572
L +H+ HS ++H DLKP NIL+ E + D G++ K L + D V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 573 IQTMTIATIGYMAPE 587
+ TI Y APE
Sbjct: 177 V------TIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
L+YLH ++H D+KP N+L++ N + DFG+++ + E D+S T + T Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYR 171
Query: 585 APE--YGSEGIISPKSDVYSYGILLMETFTRK 614
APE GS S D++S G + E R+
Sbjct: 172 APEILMGSRHYTS-AVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 9/134 (6%)
Query: 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT 553
P + L + + L ++ + V +E+L S VH DL N+L+ E
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277
Query: 554 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT- 612
+ DFG+++ + + + + T + +MAPE + + SDV+S+GILL E FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337
Query: 613 -----RKKPTNEIF 621
+ P NE F
Sbjct: 338 GGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 3e-07
Identities = 27/59 (45%), Positives = 34/59 (57%)
Query: 256 LTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
L +LDLS N+L+ GL NL+ L L+ N P++F L SL SLDLS NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 25/231 (10%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
+G GSFG V + D +++ L+ R + S E+ ++ R ++ ++
Sbjct: 1 IGKGSFGKVMQVRKRD----TQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFI 55
Query: 483 IDFK---------ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+ K LVL F+ G L L F R ++ ALE LH
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH---K 111
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEYGSEG 592
+++ DLKP NILLD + DFG+ KL + DD +T T T Y+APE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGH 168
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL--PDGLTE 641
+ D ++ G+LL E T P + + EM + ++E L PDG
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRKILQEPLRFPDGFDR 218
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 41/130 (31%), Positives = 62/130 (47%), Gaps = 7/130 (5%)
Query: 488 LVLEFMPNGSLEKWLYSHNYFLGI-LERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNI 546
LV+ M G L+ +Y + G+ +ER+ I + LH HS +V+ D+KP N+
Sbjct: 70 LVMSLMNGGDLKYHIY-NVGERGLEMERV-IHYSAQITCGILHL-HSMDIVYRDMKPENV 126
Query: 547 LLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGIL 606
LLD+ +SD G++ L +G T T GYMAPE E S D ++ G
Sbjct: 127 LLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCS 183
Query: 607 LMETFTRKKP 616
+ E + P
Sbjct: 184 IYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 40/231 (17%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVFNLQ-LERAS--RSFDSECEILRSIRHRNLIKIIS 478
+G G +G V+ D G VA+K L + + R +E +IL + + L+K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILE----RLNIMIDVGLALEYLHH-GHS 533
+ ++ L +E++P G L + LG+L R M ++ A++ LH G+
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARF-YMAEMFEAVDALHELGY- 122
Query: 534 TPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTIATIGYMAPE--YG 589
+H DLKP N L+D + H+ +DFG+SK + +SV + + YMAPE G
Sbjct: 123 ---IHRDLKPENFLIDA--SGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRG 172
Query: 590 SEGIISPKSDVYSYGILLMETFTRKKP-----TNEIFIGEMSLKHWVKESL 635
D +S G +L E P NE + +LK+W KE+L
Sbjct: 173 KG--YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 36/207 (17%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFD-----SECEILRSIR-HRNLIK 475
+G G+F V K + G AIK +++ +S + E + LR + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 476 IISNCCNIDFK----ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-H 530
+I D K ALV E M + +L + + L + M + +L+++H +
Sbjct: 63 LIE--VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ----TMTIATIGYMAP 586
G + H D+KP NIL+ ++ ++DFG + + T I+T Y AP
Sbjct: 120 G----IFHRDIKPENILIKDD-ILKLADFGSCR-------GIYSKPPYTEYISTRWYRAP 167
Query: 587 E-YGSEGIISPKSDVYSYGILLMETFT 612
E ++G PK D+++ G + E +
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 26/76 (34%), Positives = 42/76 (55%)
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
+H DL NILL + DFG+++ + + V++ + +MAPE + +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 597 KSDVYSYGILLMETFT 612
+SDV+SYGILL E F+
Sbjct: 296 ESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 13/172 (7%)
Query: 422 LLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEIL-RSIRHRNLIKI 476
++G GSFG V DG A+KV ++ + + +E +L ++++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ + VL+F+ G L L F R ++ AL YLH S +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPE 587
V+ DLKP NILLD ++DFG+ K EG T T T Y+APE
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 62/234 (26%), Positives = 93/234 (39%), Gaps = 67/234 (28%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNLIK 475
LG G+FG VYK + G VA+K + E+ A R E +IL+ ++H N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71
Query: 476 II----SNCCNIDFKA----LVLEFMP---NGSLE----KWLYSH--NYFLGILERLNIM 518
+I K +V +M +G LE K S Y L +LE +N
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN-- 129
Query: 519 IDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL-----------GE 567
YLH H ++H D+K NIL+D ++DFG+++ G
Sbjct: 130 --------YLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 568 GDDSVIQTMTIATIGYMAPE-------YGSEGIISPKSDVYSYGILLMETFTRK 614
G T + T Y PE Y D++ G + E FTR+
Sbjct: 179 GTRKY--TNLVVTRWYRPPELLLGERRYT------TAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 5e-07
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 42/245 (17%)
Query: 407 YLDIQRATNGFNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSEC 462
Y D + N + +G G FG V+ K T AI L+ ER E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEV 63
Query: 463 EILRSIRHRNLIKIISNCCNIDFKAL--VLEFMPNGSLEKWLYSHNYFLGILER---LNI 517
++R ++H+N+++ I N + L ++EF G L + + G +E ++I
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 518 MIDVGLALEYLHHGHSTP----MVHCDLKPNNILLDENM-----------------TAHV 556
+ AL Y H+ P ++H DLKP NI L + A +
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 557 SDFGISKLLGEGDDSVIQTMTIATIG---YMAPEYGSEGIIS--PKSDVYSYGILLMETF 611
DFG+SK +G I++M + +G Y +PE S KSD+++ G ++ E
Sbjct: 184 GDFGLSKNIG------IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 612 TRKKP 616
+ K P
Sbjct: 238 SGKTP 242
|
Length = 1021 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 41/126 (32%), Positives = 63/126 (50%), Gaps = 19/126 (15%)
Query: 490 LEFMPNGSLEKWLYSHNY----FLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNN 545
+E M GSL++ L LG I I V L YL H ++H D+KP+N
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREKHK--IMHRDVKPSN 130
Query: 546 ILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--YGSEGIISPKSDVYSY 603
IL++ + DFG+S G+ DS+ + + T YM+PE G+ + SD++S
Sbjct: 131 ILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQGTHYTVQ--SDIWSL 184
Query: 604 GILLME 609
G+ L+E
Sbjct: 185 GLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 57/235 (24%), Positives = 103/235 (43%), Gaps = 43/235 (18%)
Query: 417 FNECNLLGTGSFGSVYKGTLFD---GTNVAIKVFNLQLE---RASRSFDSECEILRSIRH 470
+ + +G+G+ G V FD G NVA+K + + A R++ E +L+ + H
Sbjct: 23 YQQLKPIGSGAQGIVCAA--FDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNH 79
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY--- 527
+N+I ++ N+ F P SLE+ + Y + L N+ + + L++
Sbjct: 80 KNIISLL----NV--------FTPQKSLEE--FQDVYLVMELMDANLCQVIHMELDHERM 125
Query: 528 ----------LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
+ H HS ++H DLKP+NI++ + T + DFG+++ + + T
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPY 182
Query: 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK 632
+ T Y APE D++S G ++ E + IF G + W K
Sbjct: 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK----GSVIFQGTDHIDQWNK 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 422 LLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFD---SECEILRSIRHRNLI 474
LLG G+FG V K + G A+K+ ++ A +E +L++ RH L
Sbjct: 2 LLGKGTFGKVILVREKAS---GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
+ + D V+E++ G L L F R ++ AL+YLH G
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK-- 115
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII 594
+V+ DLK N++LD++ ++DFG+ K G D + ++T T Y+APE +
Sbjct: 116 -IVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 595 SPKSDVYSYGILLMETFTRKKP 616
D + G+++ E + P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 417 FNECNLLGTGSFGSV-YKGTLFDGTNVAIKVF------NLQLERASRSFDSECEILRSIR 469
+ + +G+G++G+V G VAIK L +RA R E +L+ ++
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMK 72
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKW--LYSHNYFLGI-------LERLN---I 517
H N+I L+ F P+ SL+++ Y F+G E+L+ I
Sbjct: 73 HENVI------------GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRI 120
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
V L+ L + H+ ++H DLKP N+ ++E+ + DFG+++ + D + T
Sbjct: 121 QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM--TGY 175
Query: 578 IATIGYMAPEYGSEGIIS-----PKSDVYSYGILLMETFTRK 614
+ T Y APE I++ D++S G ++ E T K
Sbjct: 176 VVTRWYRAPEV----ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 59/216 (27%), Positives = 87/216 (40%), Gaps = 42/216 (19%)
Query: 423 LGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDS---ECEILRSIRHRNLIK 475
LG G FG V + T G A K N + + + ++ E IL + R
Sbjct: 1 LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF--- 54
Query: 476 IISNCCNIDFKA---LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY----- 527
I+S K LV+ M G L +Y+ ++ N A Y
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYN-------VDEENPGFPEPRACFYTAQII 107
Query: 528 --LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT---IATIG 582
L H H +++ DLKP N+LLD + +SD G++ L +G Q+ T T G
Sbjct: 108 SGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-----QSKTKGYAGTPG 162
Query: 583 YMAPEY--GSEGIISPKSDVYSYGILLMETFTRKKP 616
+MAPE G E S D ++ G+ L E + P
Sbjct: 163 FMAPELLQGEEYDFS--VDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 13/171 (7%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFN----LQLERASRSFDSECEILRSIRHRNLIKII 477
+G GSFG V DG A+KV L+ + +L++++H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
+ D VL+++ G L L F R ++ AL YLH S ++
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLNII 118
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPE 587
+ DLKP NILLD ++DFG+ K EG + T T T Y+APE
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 422 LLGTGSFGSVYKGTLFDGTNV-AIKVFNLQLERASRSFDSEC-----EILRSIR-HRNLI 474
+LG GSFG V L + + A+KV L+ + + D EC IL R H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 475 KIISNCC--NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
++ CC D V+EF+ G L + F R ++ AL +LH
Sbjct: 60 QLY--CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH--- 113
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEYGSE 591
+++ DLK +N+LLD ++DFG+ K EG + T T T Y+APE E
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 592 GIISPKSDVYSYGILLMETFTRKKP 616
+ P D ++ G+LL E P
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 422 LLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILR------SIRHRNLIK 475
+LG GSFG V+ GTN + L+ + D EC ++ + H L
Sbjct: 2 MLGKGSFGKVFLAE-LKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNI-MIDVGLALEYLHHGHST 534
+ + V+E++ G L + S + F L R ++ L++LH S
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF--DLPRATFYAAEIICGLQFLH---SK 115
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISK--LLGEGDDSVIQTMTIATIGYMAPEYGSEG 592
+V+ DLK +NILLD + ++DFG+ K +LG+ T Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEILLGQ 171
Query: 593 IISPKSDVYSYGILLMETFTRKKP 616
+ D +S+G+LL E + P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNV-AIKVFNL--QLERASRS-FDSECEILRSIRHRN 472
F ++G G+FG V L + V A+K+ N L+RA + F E ++L + ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
+ + + + LV+++ G L L L + ++ +A++ +H H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY---- 588
VH D+KP+NIL+D N ++DFG L E D +V ++ + T Y++PE
Sbjct: 123 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEILQAM 178
Query: 589 -GSEGIISPKSDVYSYGILLMETFTRKKP 616
+G P+ D +S G+ + E + P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 423 LGTGSFGSVYKGT---LFDG-----TNVAIKVFNLQLERASRSFDSECEILRSIRHRNLI 474
LG G+F ++KG + D T V +KV + S SF ++ + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
C D +V E++ GSL+ +L + + I +L + + AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDK 119
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEYGSEG 592
+ H ++ N+LL + KL G + I I ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENP 179
Query: 593 -IISPKSDVYSYGILLMETFT 612
+S +D +S+G L E F+
Sbjct: 180 QNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 9e-07
Identities = 21/60 (35%), Positives = 31/60 (51%)
Query: 207 SLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQL 266
+L+ L L +N+LT +F L + ++LS N+L P L L +LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 30/224 (13%)
Query: 409 DIQRATNGFNECNLLGTGSFGSV----YKGTLFDGTNVAIKVFNLQL----ERASRS--- 457
D++ + ++G G+FG V +K T KV+ ++L E RS
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR--------KVYAMKLLSKFEMIKRSDSA 88
Query: 458 -FDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLN 516
F E +I+ ++++ + + +V+E+MP G L L S+ R
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF- 146
Query: 517 IMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576
+V LAL+ +H S +H D+KP+N+LLD++ ++DFG + + + V
Sbjct: 147 YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDT 202
Query: 577 TIATIGYMAPEY----GSEGIISPKSDVYSYGILLMETFTRKKP 616
+ T Y++PE G +G + D +S G+ L E P
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 59/270 (21%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI----- 476
LG GS G V+ D VA+K L ++ + E +I+R + H N++K+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 477 ---------ISNCCNIDFKALVLEFMPNG---SLEKWLYSHNYFLGILERLNIMIDVGLA 524
+ + ++ +V E+M LE+ S + RL M +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLRG 126
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLG-EGDDSVIQTMTIATIG 582
L+Y+ HS ++H DLKP N+ ++ E++ + DFG+++++ + + T
Sbjct: 127 LKYI---HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 583 YMAPEYGSEGIISPKS-----DVYSYGILLMETFTRKKPTNEIFIG--EMSLKHWVKESL 635
Y +P ++SP + D+++ G + E T K +F G E+ + ES+
Sbjct: 184 YRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLILESV 235
Query: 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIM 665
P +VREE + LL+++
Sbjct: 236 P----------VVREEDR-----NELLNVI 250
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 39/211 (18%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNLIK 475
+G G++G VYK G VA+K L+ E A R E +L+ + H N+++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 476 IISNCCNIDFKA-LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH---HG 531
++ + + + K LV EF+ + L+K++ S +D L YL+ G
Sbjct: 63 LL-DVVHSENKLYLVFEFL-DLDLKKYMDSSP---------LTGLDPPLIKSYLYQLLQG 111
Query: 532 ----HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMA 585
HS ++H DLKP N+L+D ++DFG+++ G ++T T + T+ Y A
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG----VPVRTYTHEVVTLWYRA 167
Query: 586 PE--YGSEGIISPKSDVYSYGILLMETFTRK 614
PE GS +P D++S G + E R+
Sbjct: 168 PEILLGSRQYSTP-VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 45/212 (21%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDS---------ECEILRSIRHRNL 473
+G+G++GSV FD T ++V +++ SR F S E +L+ ++H N+
Sbjct: 25 VGSGAYGSVCAA--FD-TKTGLRV---AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKW--LYSHNYFLGI----------LERLNIMIDV 521
I L+ F P SLE++ +Y + +G L ++ +
Sbjct: 79 I------------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 126
Query: 522 GLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI 581
L L + HS ++H DLKP+N+ ++E+ + DFG+++ DD + T +AT
Sbjct: 127 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATR 181
Query: 582 GYMAPEYGSEGI-ISPKSDVYSYGILLMETFT 612
Y APE + + D++S G ++ E T
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 40/143 (27%), Positives = 64/143 (44%), Gaps = 30/143 (20%)
Query: 488 LVLEFMPNGSL----------EKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
+V+E+MP G L EKW + +V LAL+ +H S ++
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYT------------AEVVLALDAIH---SMGLI 164
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY----GSEGI 593
H D+KP+N+LLD++ ++DFG + E T + T Y++PE G +G
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGDGY 223
Query: 594 ISPKSDVYSYGILLMETFTRKKP 616
+ D +S G+ L E P
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 19/198 (9%)
Query: 423 LGTGSFGSVY-----KGTLFDGTNV--AIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
LG GSFG+VY K + V I V L ++ + E ++L + H ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNI---MIDVGLALEYLHHGH 532
++ D ++ E+ L+ L + L + I + L + Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLL-GEGDDSVIQTMTIATIGYMAPEYGSE 591
++H DLK NI L N+ + DFG+S+LL G D + T T YM+PE
Sbjct: 127 ---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD---LATTFTGTPYYMSPEALKH 179
Query: 592 GIISPKSDVYSYGILLME 609
KSD++S G +L E
Sbjct: 180 QGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 37/218 (16%)
Query: 417 FNECNLLGTGSFGSV----YKGTLFDGTNVAIKVFNLQLER-ASRSFDS----ECEILRS 467
F +LG G FG V + T G A K L+ +R R ++ E IL
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT---GKMYACK--KLEKKRIKKRKGEAMALNEKRILEK 56
Query: 468 IRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
+ R ++ + D LVL M G L+ H Y +G N D A+ Y
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTIMNGGDLK----FHIYNMG-----NPGFDEQRAIFY 107
Query: 528 -------LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM--TI 578
L +V+ DLKP NILLD+ +SD G++ + EG +T+ +
Sbjct: 108 AAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-----ETVRGRV 162
Query: 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP 616
T+GYMAPE + + D + G L+ E + P
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 38/149 (25%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDS----ECEILRSIRHRNLIKII 477
+G G++G+V+K + VA+K ++L+ S E +L+ ++H+N++++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALK--RVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
+ LV E+ + L+K+ S N G ++ + + L+ L HS ++
Sbjct: 66 DVLHSDKKLTLVFEYC-DQDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHNVL 121
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLG 566
H DLKP N+L+++N ++DFG+++ G
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 520 DVGLALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI 578
++ L L++LH G +++ DLK +N+LLD ++DFG+ K EG + T T
Sbjct: 104 EIVLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTF 156
Query: 579 -ATIGYMAPEYGSEGIISPKSDVYSYGILLME 609
T Y+APE S P D ++ G+LL E
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 29/78 (37%), Positives = 48/78 (61%), Gaps = 6/78 (7%)
Query: 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHSTPMVHCDLKPNNI 546
LV+E++ G ++ L+ + YF + I +V LAL+YLH HG ++H DLKP+N+
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHRHG----IIHRDLKPDNM 135
Query: 547 LLDENMTAHVSDFGISKL 564
L+ ++DFG+SK+
Sbjct: 136 LISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-06
Identities = 22/60 (36%), Positives = 32/60 (53%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYL 66
NLK L L +N+L+ + L +LDLS N+ + + P F L SL+ L L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 13/172 (7%)
Query: 422 LLGTGSFGSVYKGTL-FDGTNVAIKVFN----LQLERASRSFDSECEILRSIRHRNLIKI 476
++G GSFG V DG+ A+KV L+ + + +L++++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ + VL+++ G L L FL R +V A+ YLH S +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNI 117
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPE 587
++ DLKP NILLD ++DFG+ K EG + T T T Y+APE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 26/201 (12%)
Query: 423 LGTGSFGSVYKGTLFDGTNV-AIKVFNLQLERASRSFDSECEILRSIRHRNLI--KIISN 479
+G G+FG VY+ D + A+KV + + A + E+ +I RN++ ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54
Query: 480 CCNI-----DFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529
I F+ LV ++M G L L F + I ++ LALE+LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-Y 588
+V+ DLKP NILLD + DFG+SK D+ T T Y+APE
Sbjct: 114 KYD---IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTEYLAPEVL 168
Query: 589 GSEGIISPKSDVYSYGILLME 609
E + D +S G+L+ E
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG 582
LA+ +H H VH D+KP+N+LLD N ++DFG S L D +V ++ + T
Sbjct: 113 LAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPD 168
Query: 583 YMAPEY-----GSEGIISPKSDVYSYGILLMETFTRKKP 616
Y++PE G P+ D +S G+ + E + P
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 25/76 (32%), Positives = 45/76 (59%)
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
+H D+ N+LL + A + DFG+++ + + V++ + +MAPE + + +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 597 KSDVYSYGILLMETFT 612
+SDV+SYGILL E F+
Sbjct: 294 QSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG 582
LA++ +H VH D+KP+N+LLD+N ++DFG S L D +V + + T
Sbjct: 113 LAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPD 168
Query: 583 YMAPEY-----GSEGIISPKSDVYSYGILLMETFTRKKP 616
Y++PE +G P+ D +S G+ + E + P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 46/165 (27%), Positives = 69/165 (41%), Gaps = 36/165 (21%)
Query: 422 LLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKII 477
L+G G FG VY K+ NL+ E + E + +I + I +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDIDKIALW 74
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL--------------------NI 517
N NID + + GS ++ + + L LE+L NI
Sbjct: 75 KNIHNIDHLGIPK-YYGCGSFKRCRMYYRFIL--LEKLVENTKEIFKRIKCKNKKLIKNI 131
Query: 518 MIDVGLALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561
M D+ LEY+H HG S H D+KP NI++D N ++ D+GI
Sbjct: 132 MKDMLTTLEYIHEHGIS----HGDIKPENIMVDGNNRGYIIDYGI 172
|
Length = 294 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 422 LLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFD---SECEILRSIRHRNLI 474
LLG G+FG V K T G A+K+ ++ A +E +L++ RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
+ D V+E+ G L L F R ++ ALEYLH S
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SR 114
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII 594
+V+ D+K N++LD++ ++DFG+ K G D + ++T T Y+APE +
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 595 SPKSDVYSYGILLMETFTRKKP 616
D + G+++ E + P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 56/235 (23%), Positives = 102/235 (43%), Gaps = 32/235 (13%)
Query: 423 LGTGSFGSVYKGTLF---DGTN--------VAIKVFNLQLERASRSFDSECEILRSIRHR 471
LG G+F ++YKG L D V +KV R S +F ++ + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG 531
+L+K+ C D +V E++ G L+ +L+ + + +L++ + AL YL
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL--- 117
Query: 532 HSTPMVHCDLKPNNILL-----DENMT--AHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
+VH ++ NIL+ +E +SD GI + ++ V + I ++
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPWI 171
Query: 585 APEYGSEGIISPKS--DVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLP 636
APE G S D +S+G L+E + ++P + + E + + LP
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 38/152 (25%), Positives = 58/152 (38%), Gaps = 38/152 (25%)
Query: 35 LDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLAS 94
L L + G IPN L LQ ++L+ N + SL + +L VL L+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPP-------SLGSITSLEVLDLSY 475
Query: 95 NPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAV 154
N G+IP+ +G L+ + + +LNG L+G +P A+
Sbjct: 476 N-------------------------SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
Query: 155 GRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSE 186
G G LH + LC + GL
Sbjct: 511 G------GRLLHRASFNFTDNAGLCGIPGLRA 536
|
Length = 623 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 41/228 (17%)
Query: 417 FNECNLLGTGSFGSV----YKGTLFDGTNVAIKVFNLQ--LERAS-RSFDSECEIL---R 466
F +LG G FG V YK T G AIK + R S E I
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 467 SIRHRNLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDV 521
S RH L+ + C F+ V+E+ G L ++ H + V
Sbjct: 58 SERHPFLVNL--FAC---FQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACV 110
Query: 522 GLALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVIQTMTI- 578
L L+YLH + +V+ DLK +N+LLD ++DFG+ K +G GD +T T
Sbjct: 111 VLGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD----RTSTFC 162
Query: 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP-----TNEIF 621
T ++APE +E + D + G+L+ E + P E+F
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 57/215 (26%)
Query: 423 LGTGSFGSV---YKGTLFDGTNVAIKVFNLQLER-------ASRSFDSECEILRSIRHRN 472
+G+G+ G V Y G NVAIK +L R A R++ E +++ + H+N
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIK----KLSRPFQNVTHAKRAY-RELVLMKLVNHKN 76
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNI--MIDVGL---ALEY 527
+I ++ N F P SLE+ + Y + L N+ +I + L + Y
Sbjct: 77 IIGLL-NV-----------FTPQKSLEE--FQDVYLVMELMDANLCQVIQMDLDHERMSY 122
Query: 528 L--------HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA 579
L H HS ++H DLKP+NI++ + T + DFG+++ G S + T +
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVV 179
Query: 580 TIGYMAPEYGSEGII-----SPKSDVYSYGILLME 609
T Y APE +I D++S G ++ E
Sbjct: 180 TRYYRAPE-----VILGMGYKENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 30/155 (19%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLER-----ASRSFDSECEILRSIRHRNLI-- 474
LG GS+ +VYKG + G VA+K L+ E A R E +L+ ++H N++
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVTL 68
Query: 475 -KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDV-----GLALEYL 528
II + LV E++ + L++++ G L N+ + + GLA Y
Sbjct: 69 HDIIHTKKTL---TLVFEYL-DTDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLA--YC 119
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563
H ++H DLKP N+L+ E ++DFG+++
Sbjct: 120 HQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 49/186 (26%), Positives = 87/186 (46%), Gaps = 44/186 (23%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDS---------ECEILRSIRHRNL 473
+G+G++GSV + +D T + KV +++ SR F S E +L+ ++H N+
Sbjct: 23 VGSGAYGSV--CSAYD-TRLRQKV---AVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKW--LYSHNYFLGI----------LERLNIMIDV 521
I L+ F P S+E + +Y +G L ++ +
Sbjct: 77 I------------GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI 124
Query: 522 GLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI 581
L L + HS ++H DLKP+N+ ++E+ + DFG+++ + DD + T +AT
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--TGYVATR 179
Query: 582 GYMAPE 587
Y APE
Sbjct: 180 WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 37/227 (16%)
Query: 422 LLGTGSFGSVYKGTLFD---GTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIK 475
L+G G G VY +D VA+K L + F E +I + H ++
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYS----------HNYFLGILERLNIMIDVGLAL 525
+ S C + D + ++ +L+ L S + L+I + +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFG--ISKLLGEGDDSVIQ--------- 574
EY+H S ++H DLKP+NILL + D+G I K L E D I
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 575 TMTI-----ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP 616
+MTI T YMAPE S +D+Y+ G++L + T P
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 4/84 (4%)
Query: 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNIL 547
L++EF+P G L L ++ F + R M + LA+E +H +H D+KP+NIL
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVH---KLGFIHRDIKPDNIL 133
Query: 548 LDENMTAHVSDFGISKLLGEGDDS 571
+D +SDFG+S + DS
Sbjct: 134 IDRGGHIKLSDFGLSTGFHKQHDS 157
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 47/194 (24%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNC 480
LG G++ +V+KG + VA+K L+ E A + E +L++++H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
LV E++ + L+++L + + + M + L Y H ++H D
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRD 128
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--YGSEGIISPKS 598
LKP N+L++E ++DFG+++ + + + + T+ Y P+ GS +P
Sbjct: 129 LKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP-I 185
Query: 599 DVYSYGILLMETFT 612
D++ G +L E T
Sbjct: 186 DMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 8/144 (5%)
Query: 423 LGTGSFGSVYKGTLFDGTN-VAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNC 480
LG G++ +V+KG N VA+K L+ E A + E +L+ ++H N++ + +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL-HDI 72
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLG-ILERLNIMIDVGLALEYLHHGHSTPMVHC 539
+ D K+L L F L+K L + G I+ N+ I + L L + H ++H
Sbjct: 73 VHTD-KSLTLVFE---YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 540 DLKPNNILLDENMTAHVSDFGISK 563
DLKP N+L++E ++DFG+++
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSECEIL--RSIRH 470
FN +LG GSFG V KGT AIK+ L+ + + D EC ++ R +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT---DELYAIKI--LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 471 RN----LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMI---DVGL 523
++ L ++ S +D V+E++ G L +Y H +G + + ++ +
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MY-HIQQVGKFKEPQAVFYAAEISV 112
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI-- 581
L +LH +++ DLK +N++LD ++DFG+ K + ++ +T T
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK------EHMVDGVTTRTFCG 163
Query: 582 --GYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE 624
Y+APE + D ++YG+LL E + P F GE
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP----FDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 422 LLGTGSFGSVYKGTLFDGTN--VAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISN 479
+LG GSFG V L GTN AIK L+ + D EC ++ R ++ +
Sbjct: 2 VLGKGSFGKVMLAEL-KGTNEFFAIKA--LKKDVVLEDDDVECTMVE----RRVLALAWE 54
Query: 480 C-------CNIDFKA---LVLEFMPNGSLEKWLYSHNYFLGILERLNIM-IDVGLALEYL 528
C K V+E++ G L + S F R ++ L++L
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRF--DEARARFYAAEIICGLQFL 112
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK--LLGEGDDSVIQTMTIATIGYMAP 586
H +++ DLK +N+LLD++ ++DFG+ K + GEG S T Y+AP
Sbjct: 113 H---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF----CGTPDYIAP 165
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKP 616
E + D +S+G+LL E + P
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 38/143 (26%), Positives = 73/143 (51%), Gaps = 6/143 (4%)
Query: 423 LGTGSFGSVYKGTLFDGTN-VAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNC 480
LG G++ +VYKG N VA+K L+ E A + E +L+ ++H N++ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
LV E++ + L+++L + N+ + + L L++ H ++H D
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129
Query: 541 LKPNNILLDENMTAHVSDFGISK 563
LKP N+L++E ++DFG+++
Sbjct: 130 LKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 5e-05
Identities = 21/67 (31%), Positives = 31/67 (46%), Gaps = 7/67 (10%)
Query: 31 KLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVL 90
L LDLS+N + + F L +L+VL L+ N L + S A + +L L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEA-------FSGLPSLRSL 53
Query: 91 GLASNPL 97
L+ N L
Sbjct: 54 DLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 422 LLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFD---SECEILRSIRHRNLI 474
LLG G+FG V K T G A+K+ ++ A +E +L++ RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
+ + D V+E+ G L L F R ++ AL+YLH +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHSEKN- 116
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII 594
+V+ DLK N++LD++ ++DFG+ K G D + ++T T Y+APE +
Sbjct: 117 -VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAPEVLEDNDY 173
Query: 595 SPKSDVYSYGILLMETFTRKKP 616
D + G+++ E + P
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 29/119 (24%), Positives = 50/119 (42%), Gaps = 19/119 (15%)
Query: 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548
V++++P G + L F L R I ++ A+E +H +H D+KP+NIL+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILI 134
Query: 549 DENMTAHVSDFGI---------SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
D + ++DFG+ SK +GD +M + E+ K
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME------PSEEWSEIDRCRLKP 187
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 422 LLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILR----SIRHRN--LIK 475
+LG GSFG V L G V L+ + D EC ++ ++ N L
Sbjct: 2 VLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIM-IDVGLALEYLHHGHST 534
+ + V+EF+ G L + F L R ++ L++LH S
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF--DLYRATFYAAEIVCGLQFLH---SK 115
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII 594
+++ DLK +N++LD + ++DFG+ K GD+ + T Y+APE
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKY 173
Query: 595 SPKSDVYSYGILLMETFTRKKP 616
+ D +S+G+LL E + P
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 48/216 (22%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSEC---------EILRSIRHR 471
+G+G++GSV G VAIK + SR F SE +L+ ++H
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIK-------KLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 472 NLIKII----SNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL 525
N+I ++ S +F+ LV+ +M L+K + L + V L
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP------LSEDKVQYLVYQML 127
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGY 583
L + HS ++H DLKP N+ ++E+ + DFG+++ MT + T Y
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWY 180
Query: 584 MAPEYGSEGIIS-----PKSDVYSYGILLMETFTRK 614
APE I++ D++S G ++ E T K
Sbjct: 181 RAPEV----ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 35/106 (33%), Positives = 49/106 (46%), Gaps = 28/106 (26%)
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL--------LGEGDDSV-- 572
LALEYLH + +VH DLKP+N+L+ ++DFG+SK+ L EG
Sbjct: 112 LALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 573 ---IQTMTIATIGYMAPE------YGSEGIISPKSDVYSYGILLME 609
+ T Y+APE YG D ++ GI+L E
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGK------PVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 59/229 (25%), Positives = 83/229 (36%), Gaps = 50/229 (21%)
Query: 78 LSSLTNCRNLTVLGLASNPLRGILPPLIGNF--SASLQEFYAYGCKLRGNIPQEIGNLSG 135
L LT L L L+ N L ++ + S+SLQE KL N +G+
Sbjct: 74 LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQEL-----KLNNN---GLGDRGL 125
Query: 136 MIV-------------FDLNGCDLNGTIPTAVGRL----RRLQGLYLHGNKLQGS-IPY- 176
++ L L G A+ + R L+ L L N + + I
Sbjct: 126 RLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRAL 185
Query: 177 --DLCHLEGLSELNLNGNKL----CGHVPPCLASLTSLRRLHLGSNKLTST--------M 222
L L L+LN N L + LASL SL L+LG N LT +
Sbjct: 186 AEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASAL 245
Query: 223 PSSFGSLEYVLYINLSANSLN----GSLPSNIQNLKVLTNLDLSRNQLS 267
S SL L ++LS N + L + + L LDL N+
Sbjct: 246 LSPNISL---LTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 2/89 (2%)
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 587
+ H H ++H D+K NI L +N + DFG ++LL + T Y+ PE
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPE 170
Query: 588 YGSEGIISPKSDVYSYGILLMETFTRKKP 616
+ KSD++S G +L E T K P
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 43/227 (18%)
Query: 417 FNECNLLGTGSFGSVY----KGT--LFDGTNVAIKVFNLQLERASRSFDSECEILR---- 466
FN +LG GSFG V KGT L+ AIK+ L+ + + D EC ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELY-----AIKI--LKKDVVIQDDDVECTMVEKRVL 54
Query: 467 --SIRHRNLIKIISNCCNIDFKALVLEFMPNGSLE-------KWLYSHNYFLGILERLNI 517
S + L ++ S +D V+E++ G L ++ H F
Sbjct: 55 ALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAA------ 108
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
++ + L +LH S +++ DLK +N++LD ++DFG+ K D V
Sbjct: 109 --EIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTF 161
Query: 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE 624
T Y+APE + D +++G+LL E + P F GE
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 48/171 (28%), Positives = 74/171 (43%), Gaps = 11/171 (6%)
Query: 422 LLGTGSFGSVY-----KGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
++G GSFG V F V K L+ + +L++++H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ D VL+++ G L L FL R ++ AL YLH S +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 117
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 587
V+ DLKP NILLD ++DFG+ K E + + + T Y+APE
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT--STFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 29/147 (19%), Positives = 59/147 (40%), Gaps = 19/147 (12%)
Query: 419 ECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLI--KI 476
LL G VY + +K+ + + E IL+ + + L K+
Sbjct: 2 SIKLLKGGLTNRVYLLGT-KDEDYVLKINPSR--EKGADREREVAILQLLARKGLPVPKV 58
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+++ + + L++E++ +L++ + E+ +I + E L H P+
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLA---ELLAKLHQLPL 107
Query: 537 ---VHCDLKPNNILLDENMTAHVSDFG 560
H DL P NIL+D+ + D+
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 26/163 (15%)
Query: 460 SECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLY-SHNYFLGILERLNIM 518
+E ILR+I H ++I++ F L+L P + + Y + + I + L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 519 IDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS---------KLLGEGD 569
V A++YLH ++H D+K NI ++ + DFG + K G
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA- 244
Query: 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
TI APE + P D++S GI+L E T
Sbjct: 245 ---------GTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 59/235 (25%)
Query: 417 FNECNLLGTGSFGSVY----KGT--LFDGTNVAIKVFNLQLERASRSFDSECEILR---- 466
FN +LG GSFG V KGT L+ AIK+ L+ + + D EC ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELY-----AIKI--LKKDVIIQDDDVECTMVEKRVL 54
Query: 467 --SIRHRNLIKIISNCCNIDFKALVLEFMPNGSLE-------KWLYSHNYFLGILERLNI 517
+ L ++ S +D V+E++ G L K+ H F
Sbjct: 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAA------ 108
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
++ + L +LH S +++ DLK +N++LD ++DFG+ K G + T T
Sbjct: 109 --EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRT 160
Query: 578 I-ATIGYMAPE------YGSEGIISPKS-DVYSYGILLMETFTRKKPTNEIFIGE 624
T Y+APE YG KS D +++G+LL E + P F GE
Sbjct: 161 FCGTPDYIAPEIIAYQPYG-------KSVDWWAFGVLLYEMLAGQPP----FDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 20/175 (11%)
Query: 422 LLGTGSFGSVY----KGTLFDGTNVAIKVFN----LQLERASRSFDSECEILRSIRHRNL 473
LLG G+FG V K T G A+K+ + + + + +E +L++ RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFL 57
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+ + D V+E+ G L L F R ++ AL YLH S
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---S 113
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPE 587
+V+ DLK N++LD++ ++DFG+ K EG T T Y+APE
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 8/149 (5%)
Query: 417 FNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQ--LERASRS-FDSECEILRSIRHRN 472
F + LG G+FG V D A+K + L R + +E +IL +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
++K+ + + D V++++P G + L F +L R I ++ LA+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGI 561
+H D+KP+NIL+D + ++DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 6/77 (7%)
Query: 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHSTPMVHCDLKPNNI 546
L++E++P G + L + F R I + LA++ +H G+ +H D+KP+N+
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-LAIDSIHKLGY----IHRDIKPDNL 132
Query: 547 LLDENMTAHVSDFGISK 563
LLD +SDFG+
Sbjct: 133 LLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
LPNLK L L N LS +P ++N S L LDLS N S +P L +L+ L L+ N
Sbjct: 162 LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN 219
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97
++ LSSL+N +NL+ L L++N L
Sbjct: 220 SII--------ELLSSLSNLKNLSGLELSNNKL 244
|
Length = 394 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 58/222 (26%), Positives = 86/222 (38%), Gaps = 38/222 (17%)
Query: 128 QEIGNLSGMIVFDLNGCDLNGT----IPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
+ + L + V L G L + +A+ L+ L L N+ L+G
Sbjct: 17 ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQG 76
Query: 184 ------LSELNLNGNKLCGHVPPCLASLT---SLRRLHLGSNKLTST-----------MP 223
L EL+L+ N L L SL SL+ L L +N L +P
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136
Query: 224 SSFGS--LEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGD-IPTTIGGL--- 277
+ L S +L +L +N ++LK L +L+ N + I GL
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRAN-RDLKEL---NLANNGIGDAGIRALAEGLKAN 192
Query: 278 ENLETLSLADNQF--QGPVPKS--FGSLISLESLDLSRNNLS 315
NLE L L +N +G + SL SLE L+L NNL+
Sbjct: 193 CNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 35/153 (22%), Positives = 68/153 (44%), Gaps = 13/153 (8%)
Query: 461 ECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMID 520
E +L+++ H ++I++ + +VL + L +L + L I + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-- 578
+ L YLH ++H D+K NI +++ + D G ++ V+ +
Sbjct: 166 ILEGLRYLH-AQR--IIHRDVKTENIFINDVDQVCIGDLGAAQF------PVVAPAFLGL 216
Query: 579 -ATIGYMAPEYGSEGIISPKSDVYSYGILLMET 610
T+ APE + + K+D++S GI+L E
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 8/149 (5%)
Query: 417 FNECNLLGTGSFGSVYKGTLFD-GTNVAIKVF---NLQLERASRSFDSECEILRSIRHRN 472
F + LG G+FG V D A+K ++ L +E +IL +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
++++ + + D V++++P G + L F L R I ++ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGI 561
+H D+KP+NIL+D + ++DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 37/144 (25%), Positives = 67/144 (46%), Gaps = 12/144 (8%)
Query: 520 DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVIQTMTI 578
++ LAL YLH +++ DLK +N+LLD ++D+G+ K L GD + +
Sbjct: 104 EISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFC 157
Query: 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG 638
T Y+APE D ++ G+L+ E + P + + + ++ D
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----DQNTEDY 212
Query: 639 LTEVVDANLVREEQAFSVKIDCLL 662
L +V+ +R ++ SVK +L
Sbjct: 213 LFQVILEKQIRIPRSLSVKAASVL 236
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 37/162 (22%)
Query: 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNIL 547
L++EF+P G + L + + I V LA++ +H +H D+KP+N+L
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LAIDSIHQ---LGFIHRDIKPDNLL 133
Query: 548 LDENMTAHVSDFGISKLLGEG--------------DDSVIQTM----------------- 576
LD +SDFG+ L + D Q M
Sbjct: 134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLA 193
Query: 577 --TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP 616
T+ T Y+APE + + D +S G+++ E P
Sbjct: 194 FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 19/57 (33%), Positives = 23/57 (40%)
Query: 138 VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKL 194
DL+ L A L L+ L L GN L P L L L+L+GN L
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 55/226 (24%)
Query: 423 LGTGSFGSVYKGTLFDGTN---VAIKVFNLQLERASRSFDS--ECEILRSIRHRNLIKII 477
+G G++G VYK DG + A+K Q+E S + E +LR ++H N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKHPNVI--- 61
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWL---YSHNYFLGILE--------RLNIMIDVGLA-- 524
+L F+ + + WL Y+ + I++ + + + G+
Sbjct: 62 ---------SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 112
Query: 525 -----LEYLHHGHSTPMVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVIQT 575
L+ +H+ H+ ++H DLKP NIL+ E ++D G ++L +S ++
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKP 168
Query: 576 MT-----IATIGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRK 614
+ + T Y APE G+ + D+++ G + E T +
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 11/100 (11%)
Query: 520 DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVIQTMTI 578
++ +AL +LH +++ DLK +N+LLD + ++D+G+ K LG GD + +
Sbjct: 104 EICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFC 157
Query: 579 ATIGYMAPEY--GSEGIISPKSDVYSYGILLMETFTRKKP 616
T Y+APE G E S D ++ G+L+ E + P
Sbjct: 158 GTPNYIAPEILRGEEYGFS--VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.003
Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 183 GLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241
L L+L+ N+L +P L +L+ L L N LTS P +F L + ++LS N+
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 242 L 242
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 18/147 (12%)
Query: 520 DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVIQTMTI 578
++ LAL +LH +++ DLK +N+LLD ++D+G+ K + GD T T
Sbjct: 104 EISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTF 156
Query: 579 -ATIGYMAPEY--GSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635
T Y+APE G + S D ++ G+L+ E + P + + + + ++
Sbjct: 157 CGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGMSDNP-----DQNT 209
Query: 636 PDGLTEVVDANLVREEQAFSVKIDCLL 662
D L +V+ +R ++ SVK +L
Sbjct: 210 EDYLFQVILEKQIRIPRSLSVKASSVL 236
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 704 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.88 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.82 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.52 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.5 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.49 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.4 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.38 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.26 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.24 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.22 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.16 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.06 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.95 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.92 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.88 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.86 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.67 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.65 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.58 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-81 Score=744.65 Aligned_cols=667 Identities=30% Similarity=0.488 Sum_probs=465.5
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccch----------
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAA---------- 73 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~---------- 73 (704)
.+++|+.|+|++|.+++.+|..+.++++|++|+|++|.+++..|..|.++++|++|++++|.+.......
T Consensus 258 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L 337 (968)
T PLN00113 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVL 337 (968)
T ss_pred CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEE
Confidence 3555666666666666556666666666666666666666555555566666666666655554332221
Q ss_pred -------hhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcC
Q 005278 74 -------KWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDL 146 (704)
Q Consensus 74 -------~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 146 (704)
.-.++..+..+++|+.|+|++|++.+..|..+..+ .+|+.|++.+|.+.+.+|..++++++|+.|++++|.+
T Consensus 338 ~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~-~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l 416 (968)
T PLN00113 338 QLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS-GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF 416 (968)
T ss_pred ECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCc-CCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEe
Confidence 00012224444455555555555554444444443 2455555555555555555666666666666666666
Q ss_pred ccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcc
Q 005278 147 NGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSF 226 (704)
Q Consensus 147 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 226 (704)
++..|..|..+++|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|++++..|..+
T Consensus 417 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~ 495 (968)
T PLN00113 417 SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKL 495 (968)
T ss_pred eeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhh
Confidence 66666666666666666666666666666666666777777777777766666544 34778888888888888888888
Q ss_pred cCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccce
Q 005278 227 GSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLES 306 (704)
Q Consensus 227 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 306 (704)
..+++|+.|++++|.+.+.+|..+.++++|+.|++++|++++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.
T Consensus 496 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 575 (968)
T PLN00113 496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ 575 (968)
T ss_pred hhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEecccCCCCCCCCC-----cccccccCcccccCCCc-cCCCcccCCCcccccceeeEEEEeecchhhHHHHHHHHH--h
Q 005278 307 LDLSRNNLSGEIPKN-----FSAQSFLSNYALCGPAR-LQVPSCRKYNSRGFKKVALLVLKYILPPITSIVLIAIVI--I 378 (704)
Q Consensus 307 L~l~~N~l~~~~p~~-----~~~~~~l~~~~l~g~~~-~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~--~ 378 (704)
|++++|++.|.+|.. +...++.+|..+||.+. ...+.|..... . ... ..+++.++++++++++++ +
T Consensus 576 l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~---~--~~~-~~~~~~~~~~~~~~~~~~~~~ 649 (968)
T PLN00113 576 VNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK---T--PSW-WFYITCTLGAFLVLALVAFGF 649 (968)
T ss_pred EeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc---c--cee-eeehhHHHHHHHHHHHHHHHH
Confidence 999999999999863 34455778888898653 33456643211 1 111 112221222222222222 2
Q ss_pred hhhhhccCC-CCCCCchh-hhhhccc--cccchHHHHHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchh
Q 005278 379 FFIRHRNRS-TKDGDQED-LLSLATW--RRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLER 453 (704)
Q Consensus 379 ~~~~~r~~~-~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~ 453 (704)
+++|+|++. .+..+.++ ....... ..............|...+.||+|+||.||+|+. .++..||||++.....
T Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~- 728 (968)
T PLN00113 650 VFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS- 728 (968)
T ss_pred HHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-
Confidence 222322211 11111100 0000000 0001122333445677888999999999999986 5789999998864321
Q ss_pred hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCC
Q 005278 454 ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533 (704)
Q Consensus 454 ~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~ 533 (704)
....|++.+++++||||++++|++.+.+..++||||+++|+|.++++. ++|..+.+++.|+++|++|||+.++
T Consensus 729 ---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~ 801 (968)
T PLN00113 729 ---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCS 801 (968)
T ss_pred ---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCC
Confidence 223568899999999999999999999999999999999999999963 7899999999999999999987668
Q ss_pred CCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhC
Q 005278 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTR 613 (704)
Q Consensus 534 ~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg 613 (704)
++|+||||||+||+++.++.+++. ||.+..... .....+|++|+|||++.+..++.++|||||||++|||+||
T Consensus 802 ~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred CCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC
Confidence 999999999999999999988875 665543321 1123578999999999999999999999999999999999
Q ss_pred CCCCCccccccccHHHHHHhhcCCC-cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 614 KKPTNEIFIGEMSLKHWVKESLPDG-LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 614 ~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
+.||+...........|.+...... ....+|+.+... .........++.+++.+||+.||++||+|+||+++|+++
T Consensus 875 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 875 KSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 9999766666677888877554433 334445444221 112234566788999999999999999999999999998
Q ss_pred HHHh
Q 005278 693 KEKF 696 (704)
Q Consensus 693 ~~~~ 696 (704)
.+..
T Consensus 952 ~~~~ 955 (968)
T PLN00113 952 SRSS 955 (968)
T ss_pred hccc
Confidence 6643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-53 Score=436.46 Aligned_cols=289 Identities=42% Similarity=0.692 Sum_probs=249.7
Q ss_pred cccccchHHHHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeee
Q 005278 401 TWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480 (704)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 480 (704)
....|++.++..+|++|...+.||+|+||.||+|.+.+|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988654332145699999999999999999999999
Q ss_pred eeCC-eEEEEEeccCCCCHHHHHhhCCC-ccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEee
Q 005278 481 CNID-FKALVLEFMPNGSLEKWLYSHNY-FLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSD 558 (704)
Q Consensus 481 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~D 558 (704)
.+.+ ..+||||||++|+|.++++.... .++|..|++||.++|+||+|||+...++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999997665 789999999999999999999998888999999999999999999999999
Q ss_pred eccceecCCCCCcceeccc-cccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccc-cccccHHHHHHhhcC
Q 005278 559 FGISKLLGEGDDSVIQTMT-IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIF-IGEMSLKHWVKESLP 636 (704)
Q Consensus 559 fgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~ 636 (704)
||+|+........ .... .||.+|+|||+...+..+.|+|||||||+++|++||+.|.+... .++..+..|+.....
T Consensus 221 FGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999655331111 1112 79999999999999999999999999999999999999887643 445669999988777
Q ss_pred CC-cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 637 DG-LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 637 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
.+ +.+++|+.+...... ......++..++..|++.+|++||+|.||+++|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~---~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYP---DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCC---hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 75 889999988631111 11456779999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=391.41 Aligned_cols=259 Identities=30% Similarity=0.457 Sum_probs=215.3
Q ss_pred CccccccccCceEEEEEEECCCCEEEEEEeeccchh--hhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-eEEEEEeccC
Q 005278 418 NECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLER--ASRSFDSECEILRSIRHRNLIKIISNCCNID-FKALVLEFMP 494 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 494 (704)
...+.+|+|+||+||+|.+.....||||++...... ..+.|.+|+.++.+++|||||+++|+|.++. ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 334569999999999999875555999999765322 2568999999999999999999999999987 7899999999
Q ss_pred CCCHHHHHhh-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCCCCCeeeCCCC-cEEEeeeccceecCCCCCc
Q 005278 495 NGSLEKWLYS-HNYFLGILERLNIMIDVGLALEYLHHGHSTP-MVHCDLKPNNILLDENM-TAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 495 ~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~-ivH~dlk~~Nil~~~~~-~~kl~Dfgla~~~~~~~~~ 571 (704)
+|+|.++++. .+..+++..++.++.+||+||+|||. .+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 9999999998 47789999999999999999999954 55 99999999999999998 99999999998765432
Q ss_pred ceeccccccccccCCcccC--CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 572 VIQTMTIATIGYMAPEYGS--EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
...+...||+.|||||++. ...++.|+|||||||++|||+||+.||.+..... ....+ ..
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--~~~~v----------------~~ 260 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--VASAV----------------VV 260 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--HHHHH----------------Hh
Confidence 2334468999999999999 6699999999999999999999999998854411 11111 00
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhh
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDD 699 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 699 (704)
...+...+..|+..+..++..||+.||++||++.|++..|+.+...+...
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 11122233347788999999999999999999999999999998877653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=366.81 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=208.0
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-eEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNID-FKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 492 (704)
+.+..+.||+|..|+|||++++ +++-+|+|++.... ....+++.+|+++++..+||+||.++|+|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4455679999999999999965 78999999996554 345678999999999999999999999999988 49999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
|++|+|++++...+ .+++...-+|+.+|.+||.|||+ +++||||||||+|||++..|++||||||.+..+...
T Consensus 160 MDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred cCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 99999999998664 38999999999999999999974 477999999999999999999999999999877543
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
.....+||..|||||.+.+..|+.++||||||++++|+.+|+.||............... .+++ ...+
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~--------~Iv~----~ppP 300 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC--------AIVD----EPPP 300 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH--------HHhc----CCCC
Confidence 234568999999999999999999999999999999999999999764221111111111 1111 1111
Q ss_pred hhhhhH-HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 653 AFSVKI-DCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 653 ~~~~~~-~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+. .+++++.+++..|+++||.+||+++|+++.
T Consensus 301 --~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 --RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222 478889999999999999999999999753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=387.97 Aligned_cols=255 Identities=29% Similarity=0.489 Sum_probs=219.2
Q ss_pred CCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCC
Q 005278 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 496 (704)
+..++.||+|.||+||.|.++....||+|.++.. ....+.|.+|+++|++++|++||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456789999999999999998889999998764 344578999999999999999999999999988999999999999
Q ss_pred CHHHHHhh-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 497 SLEKWLYS-HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 497 sL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
+|.+||+. .+..+...+...++.|||+||+|| .++++|||||.++||||+++..+||+|||+|+...+.. .....
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASE 362 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccCceEEEcccccccccCCCc-eeecC
Confidence 99999996 667799999999999999999999 67889999999999999999999999999999654433 33344
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (704)
...-+..|.|||.+..+.++.|||||||||+||||+| |+.||..... .+.+. ....+.+.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----~ev~~--------------~le~GyRl 423 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----EEVLE--------------LLERGYRL 423 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----HHHHH--------------HHhccCcC
Confidence 4456889999999999999999999999999999999 8888876432 22111 12234456
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 655 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
+.|..|+..+.++|..||+.+|++|||++.+...++++...
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 77788999999999999999999999999988888877654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=357.64 Aligned_cols=201 Identities=30% Similarity=0.497 Sum_probs=180.4
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeecc--chhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQ--LERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
...+|...+.||+|+||+||+|++. ++..||||.+... ..+..+.+..|+.+++.++|||||++++++..++..++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3468888889999999999999964 6899999999766 345567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC------CcEEEeeeccce
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN------MTAHVSDFGISK 563 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~------~~~kl~Dfgla~ 563 (704)
||||.+|+|.+|+++.+. +++.....++.|+|.|+++| |+++||||||||+|||++.. -.+||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999998764 89999999999999999999 56889999999999999864 458999999999
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcc
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEI 620 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~ 620 (704)
.+..+. .....+|++-|||||++..++|+.|+|+||.|+++|+|++|+.||+..
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 986432 344568999999999999999999999999999999999999999863
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=357.92 Aligned_cols=253 Identities=27% Similarity=0.352 Sum_probs=204.8
Q ss_pred HhCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchh-------hhHHHHHHHHHHHhcCCCCCceEEeeeeeCC
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER-------ASRSFDSECEILRSIRHRNLIKIISNCCNID 484 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 484 (704)
..+.|.+.+.+|+|+||.|-+|. ..+|+.||||+++++... ......+|+++|++++|||||++.+++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567788999999999999997 458999999999765421 1223579999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEeeecc
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN---MTAHVSDFGI 561 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~---~~~kl~Dfgl 561 (704)
..|+||||++||+|.+++-.++. +.+..-..++.|++.|+.|| |++||+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999987654 66777788999999999999 67999999999999999755 7799999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCC---CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGI---ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG 638 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (704)
|+..+.. ..+...+|||.|.|||++.++. +..++|+||+||++|-+++|.+||.+.... .++.+.+.
T Consensus 326 AK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-~sl~eQI~------ 395 (475)
T KOG0615|consen 326 AKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-PSLKEQIL------ 395 (475)
T ss_pred hhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-ccHHHHHh------
Confidence 9987643 3456679999999999987654 334789999999999999999999874332 22222111
Q ss_pred cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+.. ....+...+.+..++|.+|+..||++||++.|+++
T Consensus 396 -----~G~y~f---~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 -----KGRYAF---GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -----cCcccc---cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111111 11234456778899999999999999999999965
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=393.74 Aligned_cols=259 Identities=30% Similarity=0.497 Sum_probs=222.5
Q ss_pred CCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
.+....+.||+|+||+||+|+.. +...||||.++...+. ...+|++|++.++.++|||||+++|.|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455678999999999999843 3567999999877655 7789999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 488 LVLEFMPNGSLEKWLYSH-------------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
+|+|||..|||.+||..+ +..++..+.+.||.|||.||+||. ++.+|||||.++|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 999999999999999832 123788999999999999999995 4559999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 633 (704)
||+|||+++.+...+++.......-+.+|||||.+..+++|.++|||||||+|||+++ |+.||.+..+.+.- +
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI--e---- 716 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI--E---- 716 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH--H----
Confidence 9999999998877766665556667899999999999999999999999999999999 99999885443210 1
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
....+...+.++.|+.+++.||..||+..|++||+++||-..|+++.+.
T Consensus 717 -------------~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 717 -------------CIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -------------HHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 1122334567789999999999999999999999999999999987543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=371.86 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=210.8
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.+|...+.||+|||+.+|+++. .+|+.||+|++.+.. ....+.+.+||++.+.|+|||||+++++|++...+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999996 789999999997643 445678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
|+|++|+|.++++ .+..+++..+..+++||+.|+.|| |+.+|+|||||..|++++++.++||+|||+|..+.....
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999988 555699999999999999999999 567899999999999999999999999999998864432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....+|||-|+|||++.....+..+||||+||+||-|++|++||+...-. ..+... .
T Consensus 174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-ety~~I-------------------k 231 (592)
T KOG0575|consen 174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-ETYNKI-------------------K 231 (592)
T ss_pred --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-HHHHHH-------------------H
Confidence 234568999999999999999999999999999999999999999862110 011110 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......|...+.+..++|.++++.+|.+|||+++|+.
T Consensus 232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112233455677889999999999999999999953
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=339.60 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=206.6
Q ss_pred CCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEee-eeeCC-eEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISN-CCNID-FKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~-~~~lv 489 (704)
.+|.+.++||+|.||+||++. ..+|..+|.|.+.... .........|+.++++++|||||+++++ +.+.. ..++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 467888999999999999998 6789999999987543 3445678899999999999999999983 44444 48899
Q ss_pred EeccCCCCHHHHHh---hCCCccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 490 LEFMPNGSLEKWLY---SHNYFLGILERLNIMIDVGLALEYLHHGHST-PMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 490 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~-~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
|||+.+|+|.+.++ +.++.+++..+|+++.|++.||.++|..-.+ -|+||||||.||+++.+|.+|++|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999987 4567799999999999999999999763322 2899999999999999999999999999988
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
... .......+|||.||+||.+.+..|++|+||||+||++|||+.-+.||.+. .+.+..+....-..
T Consensus 179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qgd~------ 245 (375)
T KOG0591|consen 179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQGDY------ 245 (375)
T ss_pred cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcCCC------
Confidence 543 23345568999999999999999999999999999999999999999873 33333222111111
Q ss_pred cchhhhhhhhhh-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 646 NLVREEQAFSVK-IDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 646 ~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.+.+ ..++..+.+++..|+.+||+.||+.-.+++.+.
T Consensus 246 --------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 --------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1122 466788999999999999999998655544443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=381.91 Aligned_cols=269 Identities=26% Similarity=0.468 Sum_probs=227.2
Q ss_pred ccchHHHHHHhCCC---------CccccccccCceEEEEEEEC----CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcC
Q 005278 404 RTSYLDIQRATNGF---------NECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERASRSFDSECEILRSIR 469 (704)
Q Consensus 404 ~~~~~~~~~~~~~~---------~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~ 469 (704)
.++|+|.-++...| .+.++||.|.||.||+|+++ ....||||.++... ++...+|..|+.+|.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 45666665555444 45689999999999999865 24679999998654 556778999999999999
Q ss_pred CCCCceEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 005278 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD 549 (704)
Q Consensus 470 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~ 549 (704)
||||+++.|+.......++|+|||++|+|+.||+.+..++.+.+...++++||.|++|| .++++|||||.++|||++
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNILVN 765 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNILVN 765 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhheeec
Confidence 99999999999999999999999999999999999888899999999999999999999 678999999999999999
Q ss_pred CCCcEEEeeeccceecCCCCCcc-eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 550 ENMTAHVSDFGISKLLGEGDDSV-IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 550 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
.+-.+|++|||+++.+.+..... ....-.-+.+|.|||.+...++|.++|||||||+|||.++ |..||=+..+.+.
T Consensus 766 snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-- 843 (996)
T KOG0196|consen 766 SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-- 843 (996)
T ss_pred cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH--
Confidence 99999999999999886544222 1122233689999999999999999999999999999988 8899855332211
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
++ -..++.+.+.+.+|+..+.+||..||++|-.+||.+.||+.+|+++.+
T Consensus 844 ---Ik--------------aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 844 ---IK--------------AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ---HH--------------HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 11 122345677888999999999999999999999999999999999754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.71 Aligned_cols=270 Identities=23% Similarity=0.395 Sum_probs=217.8
Q ss_pred HHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 410 IQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 410 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
..+..+.+...+.||+|.||+||+|+|. ..||||++.... ....+.|+.|+.++++-+|.||+-++|||..+.. .
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 3344456677889999999999999986 369999997654 3355789999999999999999999999999887 9
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+|+.||+|.+|+.+++..+..++..+.+.|++|||+|+.|| |.++|||||+|..||++.+++.|||+|||++..-..
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 99999999999999998778899999999999999999999 779999999999999999999999999999976543
Q ss_pred CCCcceeccccccccccCCcccCC---CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSE---GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
-..........|...|||||++.. .+|++++||||||+|+|||+||..||.. ...+. +--++-
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dq-------------IifmVG 606 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQ-------------IIFMVG 606 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhh-------------eEEEec
Confidence 222222233457888999998764 4699999999999999999999999973 22111 111111
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhh
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDV 700 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 700 (704)
.++.. ........+|++++.+|+..||..+|++||.+.+|+.+|+++..+..+..
T Consensus 607 rG~l~-pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~ 661 (678)
T KOG0193|consen 607 RGYLM-PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN 661 (678)
T ss_pred ccccC-ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence 11111 11223345778899999999999999999999999999999877654433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.80 Aligned_cols=267 Identities=25% Similarity=0.309 Sum_probs=212.8
Q ss_pred hCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI--DFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 488 (704)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|+++... .....-..+||.+|+++.||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3567778899999999999998 5689999999998765 33445678999999999999999999999876 68999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
|+|||++ ||..++......++..++..++.|++.||+|+ |.++|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999988 99999998888899999999999999999999 6799999999999999999999999999999988654
Q ss_pred CCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCcccccc-----------ccHHHHHHhhcC
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGE-----------MSLKHWVKESLP 636 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~-----------~~~~~~~~~~~~ 636 (704)
.. ...+..+.|..|.|||++.+. .|+.++|+||.|||+.||++|++.|++..+-+ .+...|....+|
T Consensus 272 ~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 GS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 33 235667899999999988764 69999999999999999999999998732211 122223222222
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ...+.+.-.............+...++++..+|..||++|.||.++++
T Consensus 351 ~--~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 H--ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred c--ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 111111111111111223455677889999999999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.87 Aligned_cols=265 Identities=21% Similarity=0.242 Sum_probs=206.1
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
+.|+...++|+|+||+|||++.+ +|+.||||++.... ....+-..+|++++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999965 69999999996543 2334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|++. ++.+-+.+.....+...+.++++|++.|+.|+ |+.++|||||||+|||++.+|.+|+||||+|+.+.....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence 9988 55555666666689999999999999999999 667899999999999999999999999999999864222
Q ss_pred ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc---CCCcchhcc---
Q 005278 572 VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL---PDGLTEVVD--- 644 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--- 644 (704)
..+..+.|.+|.|||.+.+ ..|+..+||||.||++.||++|.+-|.+. ++.+...-+...+ ......++.
T Consensus 157 -~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~--SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 157 -NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR--SDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc--chHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2345578999999998876 78999999999999999999999987662 2222222222111 111111211
Q ss_pred -------ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 -------ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 -------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
|......+........+.-+.+++..|++.||++|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111112222344556889999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=337.78 Aligned_cols=244 Identities=28% Similarity=0.309 Sum_probs=202.7
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
..++|+..++||+|+||+||.++. ++++.+|+|+++++. ..+.+....|..++.+++||.||+++-.|++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 356899999999999999999985 468999999998764 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
|+||+.||.|.-+|++++. +++..+.-++..|+.||.|| |+++|||||+||+|||+|++|+++|+|||+++.....
T Consensus 103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999997765 77887778889999999999 6789999999999999999999999999999864332
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
. ..+...+||+.|||||++.+..++..+|-||+|+++|||++|.+||.... ...+.+......
T Consensus 179 ~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k---------- 241 (357)
T KOG0598|consen 179 G--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGK---------- 241 (357)
T ss_pred C--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCc----------
Confidence 2 23445799999999999999999999999999999999999999997632 222222221111
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVS 681 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 681 (704)
....+...+.+..+++...+..||++|..
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 01111123456788999999999999963
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=384.08 Aligned_cols=264 Identities=29% Similarity=0.462 Sum_probs=223.5
Q ss_pred CCCCccccccccCceEEEEEEECC--CC----EEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD--GT----NVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
..-+....||+|+||.||.|...+ |. .||||.+++.. .+...+|.+|..+|++++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344556789999999999998653 43 48999887654 456778999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 488 LVLEFMPNGSLEKWLYSH------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
+++|||++|+|..||++. ...+...+.+.++.|||+|++|| +++.+|||||.++|+|+++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL---e~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL---ESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH---HhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999976 67789999999999999999999 556799999999999999999999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcc
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLT 640 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (704)
|+.+.+.+.+.......-+..|||||.+..+.++.|+|||||||++||++| |..||.+..+.+. +..|
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~---------- 917 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDV---------- 917 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHH----------
Confidence 997766655554444455789999999999999999999999999999999 8889977432211 1111
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhh
Q 005278 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDV 700 (704)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 700 (704)
..+.+.+.+..|+..++++|..||+.+|++||++..+++.+.++...+....
T Consensus 918 --------~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 918 --------LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred --------HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 1122566778999999999999999999999999999999999887766543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.49 Aligned_cols=261 Identities=24% Similarity=0.290 Sum_probs=212.0
Q ss_pred hCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|+..+.||.|..++||+|+ ...++.||||++...... +-+.+.+|+..|+.++||||++++..|..+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4689999999999999999998 567899999999876533 34789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 492 FMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 492 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||.+|++.+.++.. ...+++..+..|++++++||.|| |++|.||||||+.|||++.+|.|||+|||.+..+.+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999853 44589999999999999999999 568999999999999999999999999998876654432
Q ss_pred cc-ee-ccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 571 SV-IQ-TMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 571 ~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.. .. ....||+.|||||++.. ..|+.|+||||||++..|+.+|..||....+.++-+... ....|.-.....+
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t~~~~-- 258 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLTSGLD-- 258 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcccccCC--
Confidence 22 11 44589999999999543 459999999999999999999999998865544433322 1111110111111
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......+...+.+++..|+++||++|||++++++
T Consensus 259 -------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 259 -------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1223345668899999999999999999999964
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=338.79 Aligned_cols=256 Identities=28% Similarity=0.385 Sum_probs=204.3
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC--eEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID--FKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 491 (704)
.+|...+.||+|+||+||++... +|+..|||..........+.+++|++++++++|||||+++|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35677789999999999999854 59999999987653333567899999999999999999999854444 6889999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeeeccceecCC-CC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-NMTAHVSDFGISKLLGE-GD 569 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-~~~~kl~Dfgla~~~~~-~~ 569 (704)
|+++|+|.+++...+..+++..+..+.+||++||+|| |+++||||||||+|||++. ++.+||+|||++..... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999999998765799999999999999999999 6789999999999999999 79999999999987653 11
Q ss_pred CcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.........||+.|||||++..+ ...+++||||+||++.||+||+.||... . ....+.-......
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~---~~~~~~~~ig~~~---------- 239 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F---EEAEALLLIGRED---------- 239 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c---chHHHHHHHhccC----------
Confidence 12223346799999999999854 3445999999999999999999999874 1 1111111110000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.....+...+.+..+++.+|++.+|++||||.++++.--
T Consensus 240 ---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 ---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 011233345677889999999999999999999977643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=347.00 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=207.7
Q ss_pred hCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchhhh-HHHHHHHHHHHhcC-CCCCceEEeeeeeCC-eEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERAS-RSFDSECEILRSIR-HRNLIKIISNCCNID-FKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lv 489 (704)
.++|...++||.|.||.||+|+ ..+|..||||+++.+..... ..-.+|+..+++++ ||||+++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4678889999999999999998 45799999999976653333 23468999999998 999999999999988 99999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
||||+. +|.+.++.+++.+++..+..|+.||.+||+|+ |+.|+.|||+||+|||+.....+||+|||+|+.+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEecccceeEecccccccccccCC
Confidence 999976 99999998899999999999999999999999 66899999999999999999999999999999875433
Q ss_pred CcceeccccccccccCCccc-CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh-------cCCC--c
Q 005278 570 DSVIQTMTIATIGYMAPEYG-SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES-------LPDG--L 639 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------~~~~--~ 639 (704)
..+..+.|..|+|||++ ..+.|+.+.|||++|||++|+.+-++-|.+..+-+. +-+.+.-. .+.+ +
T Consensus 165 ---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 165 ---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHHhCCCccccchhHHHH
Confidence 23455789999999975 577899999999999999999999888876332211 11111100 0000 0
Q ss_pred chhcc---ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 640 TEVVD---ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 640 ~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
...+. +...+. +.......++.+..+++..|+++||.+||||.|+++.
T Consensus 241 a~~mnf~~P~~~~~-~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPS-PLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCC-ChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00011 000000 0111122367889999999999999999999999764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=309.46 Aligned_cols=264 Identities=24% Similarity=0.352 Sum_probs=208.0
Q ss_pred CCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchh--hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER--ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.+|...+++|+|.||.||+|+ ..+|+.||||+++..... -.....+|+..++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467788999999999999998 568999999999765322 24567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
||+. +|...++.....++..++..++.++.+|++|| |++.|+|||+||.|+|++++|.+||+|||+|+.++.....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9975 99999998888899999999999999999999 5688999999999999999999999999999998765443
Q ss_pred ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHH---Hhhc---CCCcch---
Q 005278 572 VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV---KESL---PDGLTE--- 641 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~---~~~~~~--- 641 (704)
.. ..+.|..|.|||.+.+ ..|+..+||||.||++.||+-|.+-|.+ +.++.+.. +..- ++.|.+
T Consensus 158 ~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 158 QT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred cc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHHHHHcCCCCcccCccccc
Confidence 32 2378999999998776 4699999999999999999998876655 22233322 1110 111111
Q ss_pred hccccchhhh---hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 642 VVDANLVREE---QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 642 ~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+.|-...... ........++....+++..++..||.+|+++.|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111100000 0111223456677999999999999999999999653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=353.29 Aligned_cols=261 Identities=25% Similarity=0.426 Sum_probs=205.3
Q ss_pred HhCCCCccccccccCceEEEEEEE------CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCC
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNID 484 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 484 (704)
..++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346889999999999999999974 235689999987543 23346789999999999 8999999999887644
Q ss_pred -eEEEEEeccCCCCHHHHHhhCC---------------------------------------------------------
Q 005278 485 -FKALVLEFMPNGSLEKWLYSHN--------------------------------------------------------- 506 (704)
Q Consensus 485 -~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 506 (704)
..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 5789999999999999997431
Q ss_pred ----CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecccccccc
Q 005278 507 ----YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG 582 (704)
Q Consensus 507 ----~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 582 (704)
..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+.............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23677888999999999999995 57899999999999999999999999999987643322222233456788
Q ss_pred ccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHH
Q 005278 583 YMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCL 661 (704)
Q Consensus 583 y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (704)
|+|||++.+..++.++|||||||++|||++ |..||.+....+ .+..... .+ . ....+..++
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~----~~-------~------~~~~~~~~~ 303 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLK----DG-------T------RMRAPENAT 303 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHh----cC-------C------CCCCCCCCC
Confidence 999999999999999999999999999997 999997632211 1111110 00 0 001122345
Q ss_pred HHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 662 LSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 662 ~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
..+.+++..||+.||++||++.|+++.|+++.+
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 678899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=344.54 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=210.4
Q ss_pred CCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
..|..-.+||+|+.|.||.|+ ..+++.||||++.......++-+.+|+.+|+..+|+|||.+++.|...+..++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 466777899999999999997 5678999999998876666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++|+|.+.+.... +++.++..|++.+++||+|| |.++|+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K 425 (550)
T ss_pred CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence 9999999987655 89999999999999999999 678999999999999999999999999999987755432 3
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
.+..+|||.|||||++....|++|+||||||++++||+-|.+||-. +..+..... +.+ ...+.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyL---------Ia~----ng~P~ 488 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYL---------IAT----NGTPK 488 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHH---------Hhh----cCCCC
Confidence 4456799999999999999999999999999999999999999853 111111100 000 00122
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+...+..+.+++.+|++.||++||+|.|+++
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 3344456788999999999999999999999976
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=339.42 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=209.0
Q ss_pred HHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
+...++|.-.+.||+|+|++|++|+. .+++.+|||++.+.. +...+-+..|-.+|.+| .||.|++++-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34456888889999999999999984 579999999987543 22334577899999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.|+|+||+++|+|.+++++.+. +++....-++.+|..|++|| |+.|||||||||+|||+|++++++|+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999998754 88888888999999999999 7799999999999999999999999999999988
Q ss_pred CCCCCc---------cee--ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh
Q 005278 566 GEGDDS---------VIQ--TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES 634 (704)
Q Consensus 566 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 634 (704)
.+.... ... ...+||..|.+||++..+..++.+|+|+|||++|+|+.|++||.+..+ -..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yli-------- 295 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLI-------- 295 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHH--------
Confidence 653221 111 346899999999999999999999999999999999999999976321 011
Q ss_pred cCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 635 LPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+..+++-. ...++++++.+.+|+.+.+..||++|+|..||.+
T Consensus 296 ----FqkI~~l~-------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 296 ----FQKIQALD-------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ----HHHHHHhc-------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11111111 1223355677889999999999999999988754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.82 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=212.0
Q ss_pred CCCCccccccccCceEEEEEEECC--C--CE-EEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD--G--TN-VAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~--~--~~-vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
++-...++||+|+||.||+|++.. + .. ||||..+... .....+|.+|+++|++++|||||+++|++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344455899999999999998642 2 23 8999987522 45667899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++|||+|.||+|.++|++.+..++..++..++.+.|.||+|| |+++++||||.++|+|++.++.+||+|||+++.-.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 999999999999999998877899999999999999999999 67889999999999999999999999999987543
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
. .........-+..|+|||.+..+.+++++|||||||++||+++ |..||.+.... ....++.
T Consensus 314 ~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~------------- 376 (474)
T KOG0194|consen 314 Q--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIV------------- 376 (474)
T ss_pred c--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHH-------------
Confidence 1 1111112246789999999999999999999999999999999 88899874322 2222221
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
..+.....+...+..+..++.+||..+|++||+|.++.+.++.+.....
T Consensus 377 ---~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 377 ---KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1111122233456778889999999999999999999999999876544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=342.80 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=206.6
Q ss_pred CccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCC
Q 005278 418 NECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGS 497 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 497 (704)
..++-+|.|+-|.||+|++. ++.||||+++. .-+.+|..|++|+||||+.+.|+|.....+++|||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 44678999999999999975 78899998643 22458899999999999999999999999999999999999
Q ss_pred HHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccc
Q 005278 498 LEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577 (704)
Q Consensus 498 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 577 (704)
|...|+..+. +.......+..+||.|+.||| ...|||||||.-||||..+..+||+|||.++...+.. ..-.+
T Consensus 199 L~~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSF 271 (904)
T KOG4721|consen 199 LYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSF 271 (904)
T ss_pred HHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhh
Confidence 9999986654 677788899999999999995 4679999999999999999999999999999875432 23346
Q ss_pred cccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhh
Q 005278 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVK 657 (704)
Q Consensus 578 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (704)
+||..|||||++...+++.|+||||||||||||+||..||.+...... +..+-. ..-..+.+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------------IwGVGs-----NsL~LpvP 333 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------------IWGVGS-----NSLHLPVP 333 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------------EEeccC-----CcccccCc
Confidence 899999999999999999999999999999999999999976422110 000000 11124567
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 658 IDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 658 ~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
..|++.+.-++.+||+..|..||++++++..|+-...+.+
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 7899999999999999999999999999999987655544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=330.34 Aligned_cols=277 Identities=24% Similarity=0.338 Sum_probs=207.8
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhc--CCCCCceEEeeeeeCC----eEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSI--RHRNLIKIISNCCNID----FKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~~~l 488 (704)
......++||+|.||.||||++. ++.||||++.. +....|.+|-++++.. +|+||++++++-.... .+.|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 44556679999999999999976 59999999974 3566788888887765 8999999999886665 7889
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHh------cCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH------GHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~------~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
|+||.+.|+|.+||..+. ++|....+++..+++||+|||+ +|+++|+|||||++|||+.+|+++.|+|||+|
T Consensus 286 Vt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999999876 7999999999999999999996 47889999999999999999999999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCC-CC-----cccceeeHHHHHHHHhhCCCCCC--ccccccccHHHHHHhh
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGI-IS-----PKSDVYSYGILLMETFTRKKPTN--EIFIGEMSLKHWVKES 634 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~s~Gv~l~el~tg~~p~~--~~~~~~~~~~~~~~~~ 634 (704)
..+..+.........+||.+|||||++.+.. +. .+.||||+|.|+|||+++...++ ...+=...+..-+...
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 9987766655566689999999999987653 22 36899999999999999764432 1111011111111100
Q ss_pred cCC-Ccchh-ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 635 LPD-GLTEV-VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 635 ~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
..- ...+. +....+...+........+..+.+.+..||..||+.|.|+.=|-+.+.++.....
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 000 01111 1111111111111222335668889999999999999999999998888765543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=341.16 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=205.2
Q ss_pred HHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc----h-hhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCC
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL----E-RASRSFDSECEILRSIR-HRNLIKIISNCCNID 484 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~----~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 484 (704)
...++|...+.||+|+||+|+.|.. .+++.||+|++.... . ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999974 578999999776531 1 23456778999999999 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEeeeccce
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-MTAHVSDFGISK 563 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-~~~kl~Dfgla~ 563 (704)
..++||||+.+|+|.+++.. ...+.+.....+++|++.|++|+ |+++|+||||||+|++++.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999998 55588899999999999999999 67899999999999999999 999999999999
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCC-CC-cccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcch
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGI-IS-PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (704)
... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++.. .....+...
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~~~l~~ki~------ 236 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----VPNLYRKIR------ 236 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----HHHHHHHHh------
Confidence 874 1222345568999999999999876 65 78999999999999999999998721 111111100
Q ss_pred hccccchhhhhhhhhhHHH-HHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005278 642 VVDANLVREEQAFSVKIDC-LLSIMHLALDCCMESPEQRVSMKDAA 686 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~P~~Rpt~~ev~ 686 (704)
......+..+ +.++..++.+|+..+|.+|+++.||.
T Consensus 237 ---------~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 237 ---------KGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---------cCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0111222233 66788999999999999999999997
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.11 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=200.4
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeeccchhh---hHHHHHHHHHHHhcCCCCCceEEeeeee----CCeEEEEEec
Q 005278 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERA---SRSFDSECEILRSIRHRNLIKIISNCCN----IDFKALVLEF 492 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 492 (704)
...||+|++|.||+|.. +|+.||||+++...... .+.+.+|+.++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46899999999999987 68999999987543222 4678899999999999999999999876 3467899999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++|+|.+++.... .+++.....++.+++.|++|||. ..+++||||||+||++++++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 99999999998654 48899999999999999999964 2367899999999999999999999999998654321
Q ss_pred eeccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 573 IQTMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+........
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~~~~------------ 238 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLIINKN------------ 238 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcC------------
Confidence 23457899999999876 6789999999999999999999999976421 11111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
.....+..++..+.+++.+||+.||++||+++|+++.|+.++.
T Consensus 239 -~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 239 -NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0111122456778999999999999999999999999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.95 Aligned_cols=246 Identities=29% Similarity=0.419 Sum_probs=207.6
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|-+.+.||+|.||.||||+. .+.+.||+|.+.+.. +++.+.+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5678888999999999999985 468999999997654 3445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+.+ +|..++...+. +++..+..++.++..||.|| |+.+|.|||+||+||+++..+++|+||||+|+.+.. ..
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT 154 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence 9977 99999986544 89999999999999999999 678899999999999999999999999999998765 33
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
...+...|||-|||||+..++.|+..+|+||+||++||+++|++||... +..+.++....+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~------------- 216 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDP------------- 216 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCC-------------
Confidence 4455668999999999999999999999999999999999999999652 1222222221111
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+...+..+..++...+.+||.+|.+..+++.
T Consensus 217 --v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 --VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1112244667888999999999999999999865
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=335.06 Aligned_cols=263 Identities=27% Similarity=0.417 Sum_probs=221.2
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
......++||+|-||.|..++...+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++..++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 445667899999999999999988899999999877644 4478999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCc-cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSHNYF-LGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+|+.++... .......+|+.|||.|++|| .+.++||||+.++|+|+|.++++||+|||+++.+..++...
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHH---HhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999977433 36677788999999999999 67889999999999999999999999999999888888777
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh--CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT--RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....+-+.+|||||.+.-++++.++|||+||+++||+++ ...||....++.. ++ ...++.+.. ..
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-----ve-----n~~~~~~~~--~~ 762 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-----VE-----NAGEFFRDQ--GR 762 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-----HH-----hhhhhcCCC--Cc
Confidence 7777788999999999999999999999999999999876 7789877543211 11 111111110 11
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
......+.-|+.++.+++..||+.+-++||+++++...|.+.
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122445667889999999999999999999999998887653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=317.89 Aligned_cols=271 Identities=25% Similarity=0.397 Sum_probs=216.7
Q ss_pred HHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhc--CCCCCceEEeeeeeC----
Q 005278 410 IQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSI--RHRNLIKIISNCCNI---- 483 (704)
Q Consensus 410 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~---- 483 (704)
.+....+....+.||+|.||+||+|.|. |+.||||++.. .+++.+.+|.++++.+ +|+||+.+++.=..+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3445567788899999999999999986 89999999964 3556777888888875 999999999864332
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEecCCCCCCeeeCCCCcEEEee
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH-----GHSTPMVHCDLKPNNILLDENMTAHVSD 558 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-----~h~~~ivH~dlk~~Nil~~~~~~~kl~D 558 (704)
...+||++|+++|||.|||.+.. ++....++++..+|.||++||. +.++.|.|||||+.|||+..++.+.|+|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 25789999999999999998743 7889999999999999999994 4678899999999999999999999999
Q ss_pred eccceecCCCCC--cceeccccccccccCCcccCCCC----CC--cccceeeHHHHHHHHhhC----------CCCCCcc
Q 005278 559 FGISKLLGEGDD--SVIQTMTIATIGYMAPEYGSEGI----IS--PKSDVYSYGILLMETFTR----------KKPTNEI 620 (704)
Q Consensus 559 fgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~Dv~s~Gv~l~el~tg----------~~p~~~~ 620 (704)
+|+|-......+ .......+||.+|||||++.... +. ..+||||||.|+||+..+ +.||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 999987755422 33445668999999999976542 11 258999999999998864 3688888
Q ss_pred ccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 621 FIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
.+.+.++.+..+-...+.+...+. .......+...+.++|+.||..+|..|.|+-.+.+.|.++.+
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ip--------nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIP--------NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCC--------cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 888887777644333332222222 222333567789999999999999999999999999998864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.78 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=204.3
Q ss_pred hCCCCccccccccCceEEEEEEE------CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
.++|+..+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999973 235689999986443 23445788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-----------------------------------------------------------
Q 005278 486 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 506 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 506 (704)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986422
Q ss_pred ---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 507 ---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 507 ---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 14678889999999999999995 578999999999999999999999999999876543322
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...... ....++.......
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~------------- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRM------------- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccC-------------
Confidence 22223345678999999999999999999999999999998 88888663221 1122222111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
..+...+.++.+++..||+.||++||++.||++.|++.
T Consensus 337 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 ----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01112245688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.19 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=204.4
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
.++|+..+.||+|+||.||+|+.. ++..||+|+++... ......+.+|+++++.+ +|+||+++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888999999999999998742 24579999987543 23345688999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-----------------------------------------------------------
Q 005278 486 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 506 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 506 (704)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986321
Q ss_pred ----------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecc
Q 005278 507 ----------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576 (704)
Q Consensus 507 ----------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 576 (704)
..+++..+.+++.|++.|++|| |+.+|+||||||+||++++++.+||+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 2367888999999999999999 557899999999999999999999999999987644322222223
Q ss_pred ccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ........... ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~-----------------~~ 335 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQ-----------------MS 335 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccC-----------------cc
Confidence 345678999999988899999999999999999997 999997643221 11111110000 00
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
.+...+.++.+++..||+.||++||++.||++.|+++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 01122467889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=333.11 Aligned_cols=261 Identities=28% Similarity=0.414 Sum_probs=202.5
Q ss_pred CCCCccccccccCceEEEEEEECC-----------------CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD-----------------GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKI 476 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 476 (704)
++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999997532 3469999987543 2334578999999999999999999
Q ss_pred EeeeeeCCeEEEEEeccCCCCHHHHHhhCC------------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 005278 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHN------------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538 (704)
Q Consensus 477 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH 538 (704)
++++.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999986421 24678889999999999999995 578999
Q ss_pred cCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh--CCCC
Q 005278 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT--RKKP 616 (704)
Q Consensus 539 ~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t--g~~p 616 (704)
|||||+||+++.++.+||+|||+++.+.............++..|+|||++.++.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987644333222333456889999999988889999999999999999987 5567
Q ss_pred CCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 617 TNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
|...... .....+........... ....+..++..+.+++.+||+.+|++||++.||.+.|+
T Consensus 242 ~~~~~~~--~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE--QVIENAGEFFRDQGRQV----------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH--HHHHHHHHHhhhccccc----------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7653221 11111111111100000 00111234567899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=328.81 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=199.6
Q ss_pred HHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
...++|+.+.+||+|+||.||.|+. .+|..+|+|++++.. ....+.+..|-.+|....+|.||+++-.|.+.+..|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3568999999999999999999985 469999999998764 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
|||||++||++..+|...+. +++..+.-++.+++.|++-+ |+.|+|||||||+|+|||..|++||+|||++.-+..
T Consensus 218 LiMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999986654 77778888888899999999 668999999999999999999999999999854321
Q ss_pred C----------------------CCc----ce-------------------eccccccccccCCcccCCCCCCcccceee
Q 005278 568 G----------------------DDS----VI-------------------QTMTIATIGYMAPEYGSEGIISPKSDVYS 602 (704)
Q Consensus 568 ~----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 602 (704)
. ... .. .-..+|||-|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 000 00 01236999999999999999999999999
Q ss_pred HHHHHHHHhhCCCCCCcccccc--ccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC
Q 005278 603 YGILLMETFTRKKPTNEIFIGE--MSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV 680 (704)
Q Consensus 603 ~Gv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp 680 (704)
+|||+|||+.|.+||.+....+ ..+..|.... ..+....++.+..++|.+|+. ||++|.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l------------------~fP~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL------------------KFPEEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc------------------cCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence 9999999999999997733221 1122221111 112222345678899999999 999998
Q ss_pred C
Q 005278 681 S 681 (704)
Q Consensus 681 t 681 (704)
.
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 6
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=326.95 Aligned_cols=248 Identities=26% Similarity=0.333 Sum_probs=206.4
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..|...+.||+|.||.||+|.. .+++.||+|++.... ..+.+.+++|+.++.+++++||.++++.+..+....++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4677778999999999999985 468999999998664 34557899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
|.+|++.+.++.... +++.....|++++..|+.|| |..+.+|||||+.||++..+|.+|++|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-- 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-- 166 (467)
T ss_pred hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhh---hhcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence 999999999976543 47777888999999999999 567899999999999999999999999999987754332
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
.....+|||.|||||++....|+.|+||||+|++.+||.+|.+|+........ ...+. +..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--lflIp-----------------k~~ 227 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--LFLIP-----------------KSA 227 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--EEecc-----------------CCC
Confidence 23556899999999999988999999999999999999999999987543111 00000 011
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......++++.+.+++..|+++||+.||+|.++++
T Consensus 228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 11122266778899999999999999999999964
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=330.27 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=220.0
Q ss_pred hCCCCccccccccCceEEEEEEEC---CC--CEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF---DG--TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
.+.....++||+|-||.||+|.+- .| -.||||.-+.+. ....+.|.+|..+|++++||||++++|.|.+.. ..
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-ee
Confidence 344455679999999999999853 23 358888877643 345678999999999999999999999998764 58
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+|||.++-|.|..|++.++..++......++.||+.||+|| ++..+|||||..+|||+.....+|++|||+++.+.+
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999999999998899999999999999999999 678999999999999999999999999999999977
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
...... +...-+..|||||.+.-..++.++|||.|||++||++. |..||.+..+.+.- -
T Consensus 544 ~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----------------~-- 603 (974)
T KOG4257|consen 544 DAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----------------G-- 603 (974)
T ss_pred cchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------------E--
Confidence 655433 34456889999999999999999999999999999998 99999886554321 1
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
-...+.+.+.+..|++.++.++.+||.++|.+||++.|+...|.++..
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 122344567788999999999999999999999999999999998865
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=297.28 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=211.7
Q ss_pred HHhCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-----e
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID-----F 485 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 485 (704)
...++|.+.+.+|+|||+-||.++ ..+++.+|+|++.-...++.+...+|++..++++|||+++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 445789999999999999999998 6789999999998776677788999999999999999999999875433 4
Q ss_pred EEEEEeccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 486 KALVLEFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
.|++++|...|+|.+.+.. .+..+++.+...++.++++||++||. -.++++||||||.||++.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999983 34578999999999999999999976 3456999999999999999999999999998
Q ss_pred eecCCCCCcc-------eeccccccccccCCcccC---CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHH
Q 005278 563 KLLGEGDDSV-------IQTMTIATIGYMAPEYGS---EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK 632 (704)
Q Consensus 563 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~ 632 (704)
+...-.-... .......|..|.|||.+. +...+.++|||||||++|+|+.|..||+.....+.++.-
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL--- 253 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL--- 253 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE---
Confidence 7653221110 112235799999999763 566889999999999999999999999875443322111
Q ss_pred hhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 633 ESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
.+....+. .+....++..+.+++.+|++.||.+||++.+++..++.+
T Consensus 254 --------Av~n~q~s-----~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 --------AVQNAQIS-----IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------eeeccccc-----cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111111 111112577899999999999999999999999998865
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=332.84 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=217.1
Q ss_pred CCCCccccccccCceEEEEEEECC-CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.+....++||-|.||.||.|.|+. .-.||||.++.+ ....++|..|..+|+.++|||+|+++|+|......|+|+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 355567899999999999999874 667999999765 345688999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
..|+|.+||++.. ...+....+.++.||+.|++|| .++.+|||||.++|+|+.++..+||+|||+++.+... .+.
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYL---EkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHH---HHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC-cee
Confidence 9999999999653 4467777888999999999999 6688999999999999999999999999999998543 333
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
.+....-+..|.|||-+....++.|+|||+|||+|||+.| |..||.+.. +.+. ..+...+
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lSqV--------------Y~LLEkg 482 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQV--------------YGLLEKG 482 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HHHH--------------HHHHhcc
Confidence 4444556889999999999999999999999999999999 888987642 2221 1123334
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
.+...++.|++.++++|+.||+++|++||+++|+-+.++.+-
T Consensus 483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 455677899999999999999999999999999999998763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=378.31 Aligned_cols=326 Identities=33% Similarity=0.510 Sum_probs=253.2
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCC
Q 005278 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLT 82 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~ 82 (704)
..+++|++|+|++|.+++.+|..|+++++|++|+|++|.+.+..|..|.++++|++|+|++|.+....+ ..+.
T Consensus 233 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p-------~~~~ 305 (968)
T PLN00113 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP-------ELVI 305 (968)
T ss_pred hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCC-------hhHc
Confidence 468899999999999999999999999999999999999999999999999999999999999876543 3377
Q ss_pred CCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCe
Q 005278 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQG 162 (704)
Q Consensus 83 ~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 162 (704)
++++|++|++++|.+.+..|..+..++ +|++|++++|.+.+.+|..++.+++|+.|++++|.+.+..|..+..+++|+.
T Consensus 306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~ 384 (968)
T PLN00113 306 QLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384 (968)
T ss_pred CCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCE
Confidence 788888888888888777777777664 5777888777777777777777777777777777776666666665555555
Q ss_pred eeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEec------------------------CccC
Q 005278 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLG------------------------SNKL 218 (704)
Q Consensus 163 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~------------------------~n~l 218 (704)
|++++|++.+.+|..+..+++|+.|++++|.+++..|..+..+++|+.|+++ +|.+
T Consensus 385 L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~ 464 (968)
T PLN00113 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464 (968)
T ss_pred EECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCcee
Confidence 5555555555555555555555555555555555555445555555555554 4444
Q ss_pred CCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCccc
Q 005278 219 TSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSF 298 (704)
Q Consensus 219 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~ 298 (704)
.+..|..+ ..++|+.|++++|++.+..|..+.++++|+.|++++|++.+.+|..+..+++|+.|+|++|.+++.+|..+
T Consensus 465 ~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 543 (968)
T PLN00113 465 FGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASF 543 (968)
T ss_pred eeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhH
Confidence 44444433 23567777777888878888888889999999999999999999999999999999999999999999999
Q ss_pred ccccccceEEecccCCCCCCCCCcccccccCcccccCCC
Q 005278 299 GSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 299 ~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~ 337 (704)
..+++|+.|++++|+++|.+|..+...+.+....+.+++
T Consensus 544 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~ 582 (968)
T PLN00113 544 SEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582 (968)
T ss_pred hCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc
Confidence 999999999999999999999888777767666666554
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=325.09 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=205.2
Q ss_pred CCCCccccccccCceEEEEEEEC----CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
++|+..+.||+|+||.||+|.+. .+..||+|.++.... ...+.+.+|+..+++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999753 366899999876532 3345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++......+++..++.++.|++.|++||| +.+++||||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999876667899999999999999999995 5789999999999999999999999999876542211
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
. .......++..|+|||++.+..++.++|||||||++||+++ |..||...... ...+.+.. .
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~----~---------- 224 (266)
T cd05064 162 I-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVED----G---------- 224 (266)
T ss_pred h-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHC----C----------
Confidence 1 11112235678999999999999999999999999999775 99999763211 11111110 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
...+.+..++..+.+++..||+.+|++||++.|+.+.|+++
T Consensus 225 ---~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ---FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00112234567788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=300.59 Aligned_cols=237 Identities=24% Similarity=0.301 Sum_probs=200.1
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|+....+|.|+||.|..++.+ +|..+|+|++.++. -+..+...+|..+++.+.||+++++++.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357888899999999999999865 68999999998664 23456688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||++||.|.+++++.++ +++....-++.+|+.|++|| |+.+|++||+||+|||+|.+|.+||+|||.|+.+...
T Consensus 123 meyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999999987655 88888888999999999999 5678999999999999999999999999999986432
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
+...+|||.|+|||++.++.+..++|-|||||++|||+.|..||..... ...+.+.+. .
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~------------~---- 256 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILE------------G---- 256 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHh------------C----
Confidence 4456899999999999999999999999999999999999999976332 111111111 1
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCC
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQR 679 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 679 (704)
....|..+..++.+++...++.|-.+|
T Consensus 257 ---~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 ---KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 122333556678889999999999888
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=327.16 Aligned_cols=256 Identities=28% Similarity=0.512 Sum_probs=207.6
Q ss_pred CCCCccccccccCceEEEEEEECC------CCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD------GTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
++|+..+.||+|+||.||+|.... ...||+|.+..... .....+.+|++.+++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998543 25799999865432 33456899999999999999999999999988999
Q ss_pred EEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 005278 488 LVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM 552 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~ 552 (704)
++|||+++|+|.+++.... ..+++..++.++.|++.|++|| |+.+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccccceEEEcCCC
Confidence 9999999999999997532 4478889999999999999999 457899999999999999999
Q ss_pred cEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHH
Q 005278 553 TAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWV 631 (704)
Q Consensus 553 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~ 631 (704)
.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... .....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEMI 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 999999999987644333333334467889999999988889999999999999999998 99998763321 111111
Q ss_pred HhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 632 KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
... .....+..++.++.+++..||+.||.+||++.||++.|+++
T Consensus 240 ~~~-----------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 RSR-----------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HcC-----------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 110 00112335678899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=305.71 Aligned_cols=267 Identities=22% Similarity=0.274 Sum_probs=203.5
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchh--hhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLER--ASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKA 487 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 487 (704)
..+.|+.++.|++|.||.||+|+. .+++.||+|+++...+. -.-...+||.++.+.+|||||.+-.++.. -+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 446788999999999999999985 47899999999765432 22345789999999999999999988765 45799
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+|||||++ +|...+..-+..+...++..++.|++.|++|| |...|+|||+||+|+|+.+.|.+||+|||+|+.++.
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~l---H~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHL---HDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---hhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99999988 99999998777899999999999999999999 557799999999999999999999999999999876
Q ss_pred CCCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh------hcCCCcc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE------SLPDGLT 640 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~------~~~~~~~ 640 (704)
.. ...+..+.|..|.|||.+.+. .|+...|+||+|||+.|++++++-|.+..+-+ ++...+.. ....++.
T Consensus 230 p~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 230 PL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred Cc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCCccccCCCcc
Confidence 53 234566789999999987764 59999999999999999999998887632211 11111111 0111111
Q ss_pred hhccc---cchhhh-----hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 641 EVVDA---NLVREE-----QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 641 ~~~~~---~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..-.. .+.... ..+... .....-.+++...+.+||.+|.||.|.++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11100 000000 000000 13356678999999999999999999853
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=332.62 Aligned_cols=259 Identities=25% Similarity=0.451 Sum_probs=207.2
Q ss_pred CCCCccccccccCceEEEEEEEC-CCC----EEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGT----NVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.+|+..+.||+|+||.||+|++. +++ .||+|.+.... ......+.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999853 344 38999986443 33456788999999999999999999998765 4679
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
|+||+++|+|.+++......+++..++.++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 9999999999999997766789999999999999999999 5678999999999999999999999999999877543
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||++.... .+..+....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~------------- 227 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKG------------- 227 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCC-------------
Confidence 33222223345778999999999999999999999999999998 99998763211 111111110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
...+.+..++..+.+++..||+.+|++||++.+++..+.++.++.
T Consensus 228 ----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 001111234556889999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.21 Aligned_cols=249 Identities=33% Similarity=0.541 Sum_probs=196.4
Q ss_pred ccccccccCceEEEEEEEC-----CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 419 ECNLLGTGSFGSVYKGTLF-----DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 419 ~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..+.||+|.||.||+|.+. .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999976 36789999996543 33467899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++... ...+++..++.++.|++.||+|||. .+++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999976 6679999999999999999999964 67999999999999999999999999999887433333
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
...........|+|||.+.+..++.++||||||+++||+++ |+.||..... ..+..... +
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~~-~------------- 220 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKLK-Q------------- 220 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHHH-T-------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccc-c-------------
Confidence 33344567889999999998889999999999999999999 6788866411 11111110 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
......+..++..+.+++..||+.+|++||++.|+++.|
T Consensus 221 ~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011122234567788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.96 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=205.5
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIR-HRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 485 (704)
.++|.+.++||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 468888999999999999999853 13469999986543 234467899999999996 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-----------------------------------------------------------
Q 005278 486 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 506 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 506 (704)
.++||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999986421
Q ss_pred ------------------------------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 005278 507 ------------------------------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE 550 (704)
Q Consensus 507 ------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~ 550 (704)
..+++..+..++.|++.|++||| +.+|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 23677888999999999999994 578999999999999999
Q ss_pred CCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHH
Q 005278 551 NMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKH 629 (704)
Q Consensus 551 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~ 629 (704)
++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||........ ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HHH
Confidence 99999999999987643322222233457788999999988899999999999999999997 9999875322111 111
Q ss_pred HHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 630 WVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
.+. ... ....+..++..+.+++.+||+.+|++||++.+|.++|+++.
T Consensus 352 ~~~----~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 KIK----SGY-------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHh----cCC-------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111 000 01112244667889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.54 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=199.4
Q ss_pred CCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 417 FNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
|+..+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|++++++++|++|+++.+++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999985 579999999986543 12234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++... ...+++..+..++.|++.|++|| |+.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence 9999999888643 34589999999999999999999 567899999999999999999999999999987643221
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... .......
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~-~~~~~~~------------- 220 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEV-DRRVKED------------- 220 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHH-HHHhhcc-------------
Confidence 2334689999999999999999999999999999999999999976322110 1111 1000000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
....+...+..+.+++.+||+.||++||+ ++|+++
T Consensus 221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00112234567889999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.54 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=207.6
Q ss_pred CCCCccccccccCceEEEEEEECC----CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
++|+..+.||+|+||+||+|.+.. ...||||.++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999998642 4579999986543 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++......+++..+..++.|++.|++|| |+.+|+||||||+||++++++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999987666789999999999999999999 55789999999999999999999999999998775222
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.........++..|+|||...+..++.++||||||+++||+++ |..||...... ...+.+....
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~------------- 225 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGY------------- 225 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC-------------
Confidence 2222222345678999999998899999999999999999998 99998653211 1111111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
..+.+..++..+.+++..|++.+|++||++.||++.|+++
T Consensus 226 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.73 Aligned_cols=248 Identities=23% Similarity=0.278 Sum_probs=209.0
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
+.++|++.+.+|+|.||.||.|+. +++--||+|++.+.. .....++.+|+++-+.++||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 346899999999999999999985 467889999986543 3456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 489 VLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
++||.++|++...|... ...+++.....+..|+|.|+.|+ |.++|+||||||+|+|++.++..|++|||.+..-.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999999843 34588889999999999999999 77899999999999999999999999999987643
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.......+||..|.+||...+...+..+|+|++|+..||++.|.+||.... .+..+....+.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~-------------- 237 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV-------------- 237 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc--------------
Confidence 223445689999999999999999999999999999999999999998744 22222222111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+...+....++|..|+..+|.+|.+..|++.
T Consensus 238 -----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 -----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -----cccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 11122345667889999999999999999999865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=329.24 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=208.3
Q ss_pred hCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
...|...+-||.|+.|.|..|+ ..+|+.+|||++.+.. ......+++|+-+|+-+.|||+++++++|++..+.|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 3567788899999999999998 4689999999997653 22345789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
.||+++|.|.+++-+.+. +++....++++||..|+.|+|. .+|+|||+||+|+|+|..+++||+|||+|..-..+.
T Consensus 91 lEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999999987765 7888899999999999999955 569999999999999999999999999998753332
Q ss_pred CcceeccccccccccCCcccCCCCCC-cccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIIS-PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.....+|.|.|.|||++++.+|. .++||||.|||+|.++||+.||++. .+.....+.
T Consensus 167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlKV-------------- 224 (786)
T KOG0588|consen 167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLKV-------------- 224 (786)
T ss_pred ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHHH--------------
Confidence 23455899999999999998765 5899999999999999999999852 222222111
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+.+.++...+.++++++.+|+..||++|.|++||.+.
T Consensus 225 -~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 225 -QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 122344555677889999999999999999999999653
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.88 Aligned_cols=261 Identities=27% Similarity=0.446 Sum_probs=209.8
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
.++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457888899999999999999742 34668999987655555677999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEE
Q 005278 488 LVLEFMPNGSLEKWLYSHN------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAH 555 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~k 555 (704)
+||||+++++|.+++.... ..+++..++.++.|++.|++|| |+.+++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999997432 2489999999999999999999 457899999999999999999999
Q ss_pred EeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhh
Q 005278 556 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKES 634 (704)
Q Consensus 556 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 634 (704)
|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ....+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~- 237 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQ- 237 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc-
Confidence 999999986643322222233346788999999998899999999999999999998 899986542211 1111110
Q ss_pred cCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 635 LPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
... ...+..++.++.+++.+||+.+|.+||++.|+.+.|+++.++.
T Consensus 238 --~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 238 --GRV--------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred --CCc--------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 000 0011123456889999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=327.35 Aligned_cols=266 Identities=22% Similarity=0.270 Sum_probs=204.5
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|+..+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999865 68899999987543 2344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++|+|.+++.... .+++..+..++.|++.|++|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 999999999997654 47889999999999999999964 2369999999999999999999999999997653321
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC---cch-h-----
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG---LTE-V----- 642 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~-~----- 642 (704)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+........... ... .
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCcccc
Confidence 22346899999999999989999999999999999999999999653211 1111111000000 000 0
Q ss_pred ------------ccccc---------hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 643 ------------VDANL---------VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 643 ------------~~~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+.. ............++.++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 00000000011245678999999999999999999999765
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.24 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=202.5
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
++|+..+.||+|+||.||+|++.++..+|+|.+... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788899999999999999888889999987643 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|+|.+++......+++..+..++.|++.|++||| +.+|+||||+|+||+++.++.+|++|||.++........ ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-cc
Confidence 99999999865556899999999999999999995 578999999999999999999999999999865432211 11
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+..... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~-----~----------- 220 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFR-----L----------- 220 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC-----C-----------
Confidence 22345678999999988889999999999999999999 8999865321 111111111000 0
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
..+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus 221 -~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 -YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00112245688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=321.54 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=203.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCC----EEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGT----NVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|+..+.||+|+||+||+|.+. +++ .+++|.+..... .....+..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999864 454 477787754322 233567888889999999999999998754 45678
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
++||+++|+|.+++......+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999877667899999999999999999995 578999999999999999999999999999876543
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
..........++..|+|||+..++.++.++|||||||++||+++ |..||.+.... ...++.....
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~------------ 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGE------------ 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC------------
Confidence 33222334457789999999988899999999999999999998 99998763221 1122221110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
....+..++..+.+++..||+.+|++||++.|+.+.|..+.++
T Consensus 229 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 229 -----RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0011112345677899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.00 Aligned_cols=241 Identities=22% Similarity=0.252 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCC
Q 005278 421 NLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 496 (704)
+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 478999999987543 223356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecc
Q 005278 497 SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576 (704)
Q Consensus 497 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 576 (704)
+|.+++...+ .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence 9999987654 478999999999999999999 56789999999999999999999999999987542211 12234
Q ss_pred ccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhh
Q 005278 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSV 656 (704)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (704)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........... ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~---------------~~~ 214 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE---------------IRF 214 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCC---------------CCC
Confidence 5699999999999999999999999999999999999999965211 11111100000 011
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 657 KIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 657 ~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
+...+.++.+++.+|++.||++|| ++.|+++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 123456788999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=326.05 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=212.5
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe-EEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF-KALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 490 (704)
++|..++++|+|+||.++..+.+ ++..+++|.+.... ....+...+|+.++++++|||||.+.+.|.+.+. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998754 68899999987654 3345578999999999999999999999998887 99999
Q ss_pred eccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 491 EFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
+|++||++.+.+.+.+ ..+++..+.+++.|++.|+.||| +..|+|||||+.||+++.++.|||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998654 77999999999999999999995 5779999999999999999999999999999886543
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.......||+.||+||.+.+.+|..|+||||+||++|||++-+.+|.+... ...+.... ..
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----~~Li~ki~------------~~ 221 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----SELILKIN------------RG 221 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----HHHHHHHh------------hc
Confidence 234556899999999999999999999999999999999999999987322 11111111 11
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
...+.+..++.++..++..|++.+|+.||++.+++.+
T Consensus 222 --~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 --LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1233455667889999999999999999999999877
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.45 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=218.6
Q ss_pred CccccccccCceEEEEEEE-CCC----CEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 418 NECNLLGTGSFGSVYKGTL-FDG----TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
...++||+|+||+||+|.+ .+| -+||+|++.... .+...++.+|+-+|.+++|||+++++|+|..+. ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457899999999999985 344 468889886543 345678999999999999999999999998766 789999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
||+.|+|.+|++.++..+.....+.+..|||+||.|| |++++|||||.++|||+.+-..+||.|||+|+........
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999999999999999999999999999 5688999999999999999999999999999998776655
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......-.+.|||-|.+....++.++|||||||++||++| |..||++....+. +.+.+.
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------------------~dlle~ 915 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------------------PDLLEK 915 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------------------hHHHhc
Confidence 55555566888999999999999999999999999999999 9999987533211 222333
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
+.+.+.++-|+.+++.++.+||..|++.||+++++...+.++.++
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 445677778999999999999999999999999999998886543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.16 Aligned_cols=244 Identities=24% Similarity=0.266 Sum_probs=198.4
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999965 68999999987542 123456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++.... .+++.....++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999999998654 478888899999999999999 45789999999999999999999999999998764322
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... . ..........
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~-~~~~~i~~~~------------ 231 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----F-RIYEKILAGR------------ 231 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----H-HHHHHHhcCC------------
Confidence 234689999999999999999999999999999999999999965211 1 1111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++||+ ++|+++
T Consensus 232 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 232 ---LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0011123456788999999999999997 566653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=322.24 Aligned_cols=265 Identities=19% Similarity=0.266 Sum_probs=200.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|...+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57889999999999999999864 68999999986543 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++ |+|.+++......+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 97 499999987666688999999999999999999 567899999999999999999999999999976533221
Q ss_pred eeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh-c-CCC-cch-------
Q 005278 573 IQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES-L-PDG-LTE------- 641 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~-~~~-~~~------- 641 (704)
......+++.|+|||++.+ ..++.++||||+||++|||+||+.||.+....+. +....... . +.. +..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhh
Confidence 1233468999999998765 5689999999999999999999999975322111 11110000 0 000 000
Q ss_pred --hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 642 --VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 642 --~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..... ...........+..+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQ-PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCC-chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000110000 000111123456789999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=324.46 Aligned_cols=268 Identities=21% Similarity=0.266 Sum_probs=200.7
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999965 689999999875432 223467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|++ +++.+++......+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 995 689888887666688999999999999999999 45789999999999999999999999999997653222
Q ss_pred ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC---cchh-----
Q 005278 572 VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG---LTEV----- 642 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~----- 642 (704)
.......+|+.|+|||++.+ ..++.++||||+||++|||++|..||.+.......+........... +...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12234568999999998765 45788999999999999999999999764322111111111000000 0000
Q ss_pred cccc-ch----hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDAN-LV----REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~-~~----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.++. +. ............+..+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00 000000001112356788999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=315.61 Aligned_cols=248 Identities=27% Similarity=0.433 Sum_probs=199.0
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999864 78999999876443 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecccc
Q 005278 499 EKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI 578 (704)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 578 (704)
.+++......+++..++.++.|++.|++|| |+.+|+||||||+||+++.++.+|++|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 999987666689999999999999999999 56789999999999999999999999999998654322111112223
Q ss_pred ccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhh
Q 005278 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVK 657 (704)
Q Consensus 579 gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (704)
.+..|+|||.+.++.++.++||||||+++|||++ |..||...... .......... ....+
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~-----------------~~~~~ 218 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGV-----------------RLPCP 218 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCC-----------------CCCCc
Confidence 4567999999998889999999999999999998 88888653221 1111111000 00112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 658 IDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 658 ~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
..++..+.+++.+|++.+|++||++.|+.++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=317.83 Aligned_cols=255 Identities=22% Similarity=0.397 Sum_probs=207.1
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|+..++||+|+||.||+|...++..||+|.+... ....+.+.+|+.+++.++|+||+++++.+.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3578889999999999999999888889999987643 223567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 999999999753 455888999999999999999995 578999999999999999999999999999876543221
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......++..|+|||+..+..++.++|||||||++|||+| |..||...... ....++.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~--------------- 222 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR--------------- 222 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC---------------
Confidence 1222346778999999988889999999999999999998 99998653211 11111111100
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
.+....++.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 --MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011113456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=322.95 Aligned_cols=261 Identities=27% Similarity=0.436 Sum_probs=209.7
Q ss_pred CCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++.+++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999742 355689999876555555679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 005278 489 VLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT 553 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~ 553 (704)
||||+++++|.+++..+. ..+++..++.++.|++.|++|| |+.+|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCc
Confidence 999999999999997532 3478999999999999999999 5678999999999999999999
Q ss_pred EEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHH
Q 005278 554 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVK 632 (704)
Q Consensus 554 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 632 (704)
++|+|||++................++..|+|||++.+..++.++|||||||++|||+| |+.||......+ ......
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~ 239 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECIT 239 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh
Confidence 99999999986644332222333456788999999998999999999999999999999 999986532211 111111
Q ss_pred hhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 633 ESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
. .... ..+..++..+.+++.+||+.+|++||++.+|+++|+++.+..+
T Consensus 240 ~---~~~~--------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 240 Q---GRVL--------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred C---CCCC--------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 0 0000 0111235678899999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=328.06 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=202.2
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+..|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 58999999997543 123456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999997654 4788899999999999999995 57899999999999999999999999999986533
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......||+.|+|||++.+..++.++|||||||++|||++|..||......+ .... +... ..... .+...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~-i~~~-~~~~~---~~~~~-- 223 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWEN-LKYW-KETLQ---RPVYD-- 223 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHH-HHhc-ccccc---CCCCC--
Confidence 1234468999999999999999999999999999999999999997532111 0011 0000 00000 00000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.....++.++.+++.+|++.+|++||++.|+++.
T Consensus 224 ----~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 ----DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0001345678899999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.87 Aligned_cols=244 Identities=24% Similarity=0.301 Sum_probs=198.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999865 68999999986542 123456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++...+ .+++.....++.|++.|++|| |+.+|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 9999999999997654 478889999999999999999 5678999999999999999999999999999865432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~------------ 214 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKILAGK------------ 214 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC------------
Confidence 1234689999999999988899999999999999999999999975321 11111100000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
...+......+.+++.+|++.||.+||+ +.|+++
T Consensus 215 ---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 215 ---LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ---cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 0011123456788999999999999995 777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=321.66 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=204.9
Q ss_pred CCCCccccccccCceEEEEEEECC------CCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD------GTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
++|...+.||+|+||.||+|...+ ++.||||.+...... ....+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467788999999999999998633 478999998765433 4568999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC-------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 488 LVLEFMPNGSLEKWLYSHN-------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
+||||+++|+|.+++...+ ..+++..+..++.|++.|+.|| |+.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeeccccccceEEEcCCCeE
Confidence 9999999999999997542 3478889999999999999999 56789999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 633 (704)
+|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....+..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~~~ 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECITQ 239 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc
Confidence 9999999986543322222233456789999999999999999999999999999999 99998653221 11111110
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
+. ....+..++..+.+++.+||+.+|++||++.||++.|+
T Consensus 240 ----~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 ----GR-------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----CC-------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 00111234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=328.02 Aligned_cols=260 Identities=26% Similarity=0.429 Sum_probs=204.5
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccch-hhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC-C
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLE-RASRSFDSECEILRSI-RHRNLIKIISNCCNI-D 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 484 (704)
.++|++.+.||+|+||.||+|... +++.||+|+++.... .....+..|+.+++++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357889999999999999999632 357899999875432 2345678899999999 899999999988654 5
Q ss_pred eEEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 005278 485 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 506 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 506 (704)
..++++||+++|+|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999999986321
Q ss_pred --CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecccccccccc
Q 005278 507 --YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584 (704)
Q Consensus 507 --~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 584 (704)
..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25789999999999999999995 5789999999999999999999999999998764433222233345678899
Q ss_pred CCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHH
Q 005278 585 APEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLS 663 (704)
Q Consensus 585 aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (704)
|||++.+..++.++|||||||++|||++ |..||.+....+ .+..... .+.. ...+..++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~----~~~~-------------~~~~~~~~~~ 304 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLK----EGTR-------------MRAPEYATPE 304 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHh----ccCC-------------CCCCccCCHH
Confidence 9999999999999999999999999998 999987532211 1111111 1000 0011233457
Q ss_pred HHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 664 IMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 664 l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
+.+++.+||+.+|++||++.|++++|+++.+
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=316.65 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=206.2
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|+..+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778899999986542 23567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++++|.+++.... ..+++..+..++.+++.|+.||| +.+|+||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999997543 56899999999999999999995 578999999999999999999999999999877532211
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
.......+..|+|||+..+..++.++||||||+++|||+| |+.||.+.... .....+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~---------------- 221 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGY---------------- 221 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC----------------
Confidence 1112223568999999998899999999999999999999 99998763211 1111111000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
..+.+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 -RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0011123456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=320.91 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=203.8
Q ss_pred CCCCccccccccCceEEEEEEE-----CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-----FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677888999999999999974 246789999987433 2334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC----------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 005278 489 VLEFMPNGSLEKWLYSH----------------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM 552 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~----------------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~ 552 (704)
||||+++|+|.+++... ...+++.....++.|++.|++||| +.+|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 99999999999998632 124788889999999999999995 57899999999999999999
Q ss_pred cEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHH
Q 005278 553 TAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWV 631 (704)
Q Consensus 553 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~ 631 (704)
.+||+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||.+... ....+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 999999999987644332222333446778999999988889999999999999999998 8889865321 1111111
Q ss_pred HhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 632 KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
.... ....+..++..+.+++..||+.+|++||++.+|.+.|+++
T Consensus 240 ~~~~-----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 240 RKRQ-----------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HcCC-----------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 1100 0111223456788899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=318.63 Aligned_cols=256 Identities=29% Similarity=0.472 Sum_probs=210.5
Q ss_pred HhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
...+|+..+.||+|+||.||+|...+++.+|+|.+..........+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34578888999999999999999888999999998766555567799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++... ...+++..+..++.+++.|++||| +.+|+||||+|+||++++++.+||+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999853 445899999999999999999995 578999999999999999999999999999876432211
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....++..|+|||+..+..++.++||||||+++|+|++ |+.||...... ..........
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~--------------- 221 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITAGY--------------- 221 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHhCC---------------
Confidence 123346778999999988889999999999999999998 89998653211 1111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
..+.+..++..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 --RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0111224456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=342.21 Aligned_cols=250 Identities=23% Similarity=0.239 Sum_probs=202.7
Q ss_pred CCCccccccccCceEEEEEEEC-C-CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-D-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.|...+.||+|+||.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999743 4 6788999876554555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 494 PNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 494 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
++|+|.+++.. ....+++.....++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998863 234578899999999999999999 557899999999999999999999999999987654332
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
........||++|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~----------- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGKY----------- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCC-----------
Confidence 2223445699999999999999999999999999999999999999965221 111111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+.+..++..+.+++..||+.+|++||++.+++.
T Consensus 289 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 ---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0111234567889999999999999999999875
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.77 Aligned_cols=259 Identities=24% Similarity=0.310 Sum_probs=210.3
Q ss_pred hCCCCccccccccCceEEEEEEECCC-CEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEee-eee------CC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDG-TNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISN-CCN------ID 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~------~~ 484 (704)
..++++.+.|.+|||+.||.|+...+ ..+|+|++-...+..-+...+|+++|++|+ |+|||.+++. ... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34667788999999999999997655 999999987776677788999999999996 9999999993 211 23
Q ss_pred eEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 485 FKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
+++|.||||.+|.|.+++... ...+.+.++++|+.++++|+++||. .+.+|||||||-+|||++.+++.||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 678999999999999999843 2339999999999999999999998 67899999999999999999999999999987
Q ss_pred ecCCCCCcce-------eccccccccccCCccc---CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh
Q 005278 564 LLGEGDDSVI-------QTMTIATIGYMAPEYG---SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 564 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 633 (704)
-......... .-....|+.|+|||.+ .+...++|+|||++||+||-|+....||++..
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 5433221100 0112479999999964 67789999999999999999999999998721
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+++..+ .++....++..+.+||..||++||.+||++.||+..+.++..+
T Consensus 263 -----~laIlng~Y-----~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 -----KLAILNGNY-----SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -----ceeEEeccc-----cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 122333322 2233346678899999999999999999999999999887653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=324.96 Aligned_cols=238 Identities=22% Similarity=0.241 Sum_probs=191.9
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 423 LGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 423 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
||+|+||.||+|+.. +++.||+|++.... ......+..|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 58899999987532 23345678899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecccc
Q 005278 499 EKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI 578 (704)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 578 (704)
.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 99997654 4889999999999999999994 5789999999999999999999999999997543221 1223456
Q ss_pred ccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhH
Q 005278 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKI 658 (704)
Q Consensus 579 gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (704)
||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ ...+.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~---------------~~~~~ 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEP---------------LRFPD 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCC---------------CCCCC
Confidence 8999999999999999999999999999999999999997521 122222111110 01112
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCC---HHHHH
Q 005278 659 DCLLSIMHLALDCCMESPEQRVS---MKDAA 686 (704)
Q Consensus 659 ~~~~~l~~l~~~cl~~~P~~Rpt---~~ev~ 686 (704)
..+..+.+++.+||+.||++||+ +.|++
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 34566789999999999999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.99 Aligned_cols=246 Identities=26% Similarity=0.331 Sum_probs=204.1
Q ss_pred hCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
..+|++.+.+|+|.||.|-+|. ...|+.||||.+++... ++.-.+.+|+++|..++||||+.++++|...+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3578888999999999999998 46899999999986643 3344688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||..+|.|++|+.+.+. +++.....+++||..|+.|+ |+.+++|||+|.+|||+|.++++||+|||++-.+.+..
T Consensus 132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999999987654 88999999999999999999 67889999999999999999999999999998875433
Q ss_pred CcceeccccccccccCCcccCCCCCC-cccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIIS-PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
..+.++|+|-|.+||++.+.+|. +.+|-||+||++|-++.|..||++.. ....+++.. .
T Consensus 208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs------------~ 267 (668)
T KOG0611|consen 208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQIS------------R 267 (668)
T ss_pred ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhh------------c
Confidence 35667999999999999988764 57999999999999999999998832 111111111 1
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.+..... +....-+|++|+..+|++|.|+.||..
T Consensus 268 GaYrEP~~----PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 268 GAYREPET----PSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ccccCCCC----CchHHHHHHHHHhcCcccchhHHHHhh
Confidence 11111111 233445899999999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.87 Aligned_cols=270 Identities=28% Similarity=0.414 Sum_probs=205.7
Q ss_pred CCCCccccccccCceEEEEEEE-----CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-----FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 487 (704)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 2578999999876555556788999999999999999999998754 34678
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+|+||+++|+|.+++......+++..+..++.|++.|++|| |+.+|+||||||+||++++++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 99999999999999987666689999999999999999999 567899999999999999999999999999987654
Q ss_pred CCCcce-eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 568 GDDSVI-QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 568 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
...... .....++..|+|||+..+..++.++|||||||++|||++|..|+..... .+................
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhhcccccccccchHH
Confidence 322111 1112344569999999888899999999999999999998877543211 111100000000000000
Q ss_pred ---chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 647 ---LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 647 ---~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
........+.+..++..+.+++.+||+.+|++||||.||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00001111223345677999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=320.55 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=202.5
Q ss_pred HhCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF 485 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 485 (704)
..++|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998743 35679999986432 2344568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC---------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 005278 486 KALVLEFMPNGSLEKWLYSHN---------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV 556 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl 556 (704)
.++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999997432 23577888999999999999995 578999999999999999999999
Q ss_pred eeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhc
Q 005278 557 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 557 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.+... ........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~~~~~~ 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLRFVM 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH
Confidence 99999986543322222223345788999999998899999999999999999999 7888865321 11111111
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
..... ..+..++..+.+++.+|++.+|++||++.|+++.|+
T Consensus 236 ~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 EGGLL--------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCcC--------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11000 011234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=312.72 Aligned_cols=256 Identities=27% Similarity=0.385 Sum_probs=198.3
Q ss_pred HHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch---------h-----hhHHHHHHHHHHHhcCCCCCce
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE---------R-----ASRSFDSECEILRSIRHRNLIK 475 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~-----~~~~~~~e~~~l~~l~h~niv~ 475 (704)
....++|+....||+|.||.|-+|+. .+++.||||++.+... . ..+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34567899999999999999999984 4799999999965321 0 1247889999999999999999
Q ss_pred EEeeeee--CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 005278 476 IISNCCN--IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT 553 (704)
Q Consensus 476 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~ 553 (704)
++++..+ .+..|||+|||..|.+.. ....+..++..+.+++++++..||+|| |.++||||||||+|+|++++|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYL---H~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYL---HYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEEcCCCc
Confidence 9999976 457899999999888754 222333388999999999999999999 5688999999999999999999
Q ss_pred EEEeeeccceecCCCC---CcceeccccccccccCCcccCCC----CCCcccceeeHHHHHHHHhhCCCCCCcccccccc
Q 005278 554 AHVSDFGISKLLGEGD---DSVIQTMTIATIGYMAPEYGSEG----IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMS 626 (704)
Q Consensus 554 ~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~ 626 (704)
+||+|||.+.....+. ........+|||.|+|||...++ ..+.+.||||+||+||.++.|+.||-+...
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---- 324 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---- 324 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----
Confidence 9999999998763332 12223446899999999987663 255689999999999999999999966221
Q ss_pred HHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 627 LKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+.-+ ..++...+ .++...+....+.+++.+++.+||++|.+..||...
T Consensus 325 ~~l~---------~KIvn~pL-----~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 325 LELF---------DKIVNDPL-----EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HHHH---------HHHhcCcc-----cCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 1111 11111111 111222345678899999999999999999998644
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.71 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=196.9
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-----eEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID-----FKALV 489 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 489 (704)
.|...+++|.|+||.||+|... +++.||||+.-.+ .+--.+|.++|+.+.|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5667789999999999999965 5799999987433 223356999999999999999999886532 23489
Q ss_pred EeccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEeeeccceec
Q 005278 490 LEFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-MTAHVSDFGISKLL 565 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-~~~kl~Dfgla~~~ 565 (704)
||||+. +|.++++. .+..++...+.-+.+|+.+|+.|| |+.+|+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 99999983 356688888999999999999999 55899999999999999965 89999999999998
Q ss_pred CCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh--
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV-- 642 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 642 (704)
..+..+. ....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+. .+..++...++-.-...-+++
T Consensus 177 ~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHHHHhh
Confidence 7665442 3357889999998776 46999999999999999999999988772 223334444432222211111
Q ss_pred cc--------ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VD--------ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~--------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+. +.+.............+++..+++.++++++|.+|.++.|+++
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11 1111111000122344677899999999999999999999954
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=327.28 Aligned_cols=245 Identities=25% Similarity=0.284 Sum_probs=198.0
Q ss_pred hCCCCccccccccCceEEEEEEECC--CCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD--GTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.++|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578899999999999999998543 3689999986542 2234568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++.... .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999998654 488899999999999999999 5678999999999999999999999999999876432
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+ . ...... .
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~-~-~i~~~~-------~- 245 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIY-Q-KILEGI-------I- 245 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHH-H-HHhcCC-------C-
Confidence 1234689999999999888899999999999999999999999975311 1100 1 000100 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
..+...+..+.+++.+|++.||++|+ +++|+++
T Consensus 246 ------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 ------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 01112344577899999999999995 7888754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.94 Aligned_cols=267 Identities=21% Similarity=0.209 Sum_probs=200.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 68899999987543 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|++++.+..+. .....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 99987665544 33445889999999999999999995 57899999999999999999999999999987643221
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHH--hhcCCC----------c
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK--ESLPDG----------L 639 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~----------~ 639 (704)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||......+. +..... ...+.. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchh
Confidence 122334689999999999888899999999999999999999999976322110 000000 000000 0
Q ss_pred chhccccchh-hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 640 TEVVDANLVR-EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 640 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.....+.... ..........++..+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 00000111234567999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=320.91 Aligned_cols=260 Identities=27% Similarity=0.452 Sum_probs=206.8
Q ss_pred HHhCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNI 483 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 483 (704)
...++|+..+.||+|+||.||+|... +...+|+|.+.... ......+.+|+++++++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34567888999999999999999853 23679999987543 23445688999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhC---------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 484 DFKALVLEFMPNGSLEKWLYSH---------------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
+..+++|||+++|+|.+++... ...+++..++.++.|++.|++||| +.+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence 9999999999999999999642 345889999999999999999994 5789999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
+.++.+|++|||+++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||......+ .
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~ 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--L 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--H
Confidence 9999999999999987654332222223345678999999988899999999999999999998 889986532111 1
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
..... .. .....+..++..+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 244 ~~~~~----~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLK----EG-------------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHH----cC-------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11100 00 000112234567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=324.71 Aligned_cols=241 Identities=22% Similarity=0.255 Sum_probs=193.9
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCC
Q 005278 421 NLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 496 (704)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999985 468999999987543 223456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecc
Q 005278 497 SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576 (704)
Q Consensus 497 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 576 (704)
+|..++.... .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence 9999887654 488999999999999999999 45789999999999999999999999999987532211 11233
Q ss_pred ccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhh
Q 005278 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSV 656 (704)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (704)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .... ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~----~~~~---------------~~~ 214 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELI----LMEE---------------IRF 214 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHH----hcCC---------------CCC
Confidence 468999999999999999999999999999999999999996532110 00110 0000 001
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 657 KIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 657 ~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
+..++..+.+++.+|++.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 123456788999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=314.98 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=203.2
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
++|...+.||+|+||.||+|+..++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577888999999999999998777789999886432 234678999999999999999999999998888999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|+|.+++......+++..++.++.|++.|++|| |+.+++|+||||+||+++.++.+||+|||.++....... ...
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 9999999987655689999999999999999999 567899999999999999999999999999987644321 112
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....++..|+|||+..+..++.++|||||||++|||++ |..||......+ ....+.....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~----------------- 219 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLR----------------- 219 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCC-----------------
Confidence 22346678999999988889999999999999999999 999986532211 1111110000
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
...+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0001123467889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.35 Aligned_cols=199 Identities=25% Similarity=0.331 Sum_probs=174.1
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|+..+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999865 68899999887543 2344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++|+|.+++.... .+++.....++.+++.|++|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 999999999997654 37888999999999999999964 3469999999999999999999999999987653221
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCc
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNE 619 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~ 619 (704)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1234689999999999988899999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.18 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=210.7
Q ss_pred CccccccccCceEEEEEEEC--CC--CEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 418 NECNLLGTGSFGSVYKGTLF--DG--TNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
...++||+|.||.|++|.|. +| ..||||.++..... ....|.+|+.+|-+|+|+|+++++|.+.+ ....+|||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 44578999999999999975 23 46899999866533 66889999999999999999999999988 567899999
Q ss_pred cCCCCHHHHHhh-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYS-HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
++.|+|.+.|++ ....+.....-.++.|||.|+.|| ..++.||||+.++|+++-....+||+|||+.+-++.....
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YL---eskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999997 566688888999999999999999 7788999999999999999999999999999999776654
Q ss_pred ceec-cccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 572 VIQT-MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 572 ~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
..++ ...-...|+|||.+....++.++|||+|||++|||+| |..||-+.... .+-+.+|
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------------qIL~~iD----- 329 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------------QILKNID----- 329 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------------HHHHhcc-----
Confidence 4333 3456888999999999999999999999999999999 77898763211 0111222
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
++.....+..|+.++++++..||...|++||++..+.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3345667789999999999999999999999999997554
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.16 Aligned_cols=260 Identities=23% Similarity=0.414 Sum_probs=207.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCC----EEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGT----NVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
.++|+..+.||+|+||+||+|++ .+++ .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 35788889999999999999985 3454 48999986543 33456788999999999999999999998754 467
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+++||+++|+|.+++......+++..+..++.|++.|++|| |+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999999987666689999999999999999999 567899999999999999999999999999987754
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
...........+++.|+|||...+..++.++|||||||++||+++ |..||+.... .....++.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~---------- 229 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGER---------- 229 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCc----------
Confidence 322222222345678999999988889999999999999999998 8899865321 112222221100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
...+..++..+.+++..||+.||++||++.|+++.|+++..+.
T Consensus 230 -------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 -------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0111234567889999999999999999999999998886554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.68 Aligned_cols=242 Identities=21% Similarity=0.267 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 496 (704)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999854 68999999997543 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecc
Q 005278 497 SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576 (704)
Q Consensus 497 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 576 (704)
+|.+++.... .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 9999887553 488999999999999999999 56789999999999999999999999999987542211 12233
Q ss_pred ccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhh
Q 005278 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSV 656 (704)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (704)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~---------------~~~ 214 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMED---------------IKF 214 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCC---------------ccC
Confidence 4689999999999988999999999999999999999999965211 11111110000 011
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 005278 657 KIDCLLSIMHLALDCCMESPEQRV-----SMKDAAAK 688 (704)
Q Consensus 657 ~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~~ 688 (704)
+...+.++.+++.+|++.||++|| ++.|+++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 123455678899999999999997 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=301.24 Aligned_cols=268 Identities=24% Similarity=0.287 Sum_probs=203.7
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCC-CceEEeeeeeCC-----
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRN-LIKIISNCCNID----- 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 484 (704)
...|+..++||+|+||+||+|+. .+|+.||+|+++.... .......+|+.+++.++|+| |+++.+++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566778899999999999984 5799999999986643 34556789999999999999 999999998877
Q ss_pred -eEEEEEeccCCCCHHHHHhhCC---CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeec
Q 005278 485 -FKALVLEFMPNGSLEKWLYSHN---YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFG 560 (704)
Q Consensus 485 -~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 560 (704)
..++|+||++. +|..++.... ..++...+..+++|+..|++|| |+.+|+||||||+||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEECCCCcEeeeccc
Confidence 78899999965 9999998654 4577788999999999999999 66889999999999999999999999999
Q ss_pred cceecCCCCCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh-cC--
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES-LP-- 636 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~-- 636 (704)
+|+...-.. ...+...+|..|.|||++.+. .|+...||||+||++.||++++.-|.+..+- .++....+.. .|
T Consensus 166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPNE 242 (323)
T ss_pred hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCCc
Confidence 999664222 224556789999999998876 7999999999999999999999888764331 1111111111 11
Q ss_pred CCcchhcc-ccchhhhhhh-------hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 637 DGLTEVVD-ANLVREEQAF-------SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 637 ~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+.|..+.. +......+.. ...........+++.+|++++|.+|.+++.++++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11211110 1111111111 1111112468899999999999999999999875
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=295.83 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=201.3
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.+.|++.+.||+|+|+.||++.. .+|+.+|+|++.... ....+.+++|+++.+.++||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46788889999999999999874 579999999886443 335678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---NMTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---~~~~kl~Dfgla~~~~~ 567 (704)
|+|+||+|..-+-.. ..+++..+-..++||++++.|+ |..+|||||+||+|+++.+ ...+|++|||+|..+..
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999986655433 3367788888999999999999 6789999999999999963 44699999999998873
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
+ ......+|||+|||||++...+|+..+|||+-||++|-++.|..||.+.. ...+-+-+. ...+
T Consensus 166 g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I~-----------~g~y 229 (355)
T KOG0033|consen 166 G---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQIK-----------AGAY 229 (355)
T ss_pred c---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHh-----------cccc
Confidence 2 33556789999999999999999999999999999999999999997621 111111111 0000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. ..+......++..+++++|+..||++|.|+.|.++
T Consensus 230 d~---~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 DY---PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CC---CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 00 11123344567788999999999999999988754
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.96 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=204.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.+|...+.||+|+||.||+|... .++.||+|.+... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999864 5889999998644 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++... ...+++..+..++.|+++|++|| |+.+++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 999999999754 34589999999999999999999 4578999999999999999999999999999876432211
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......++..|+|||+..+..++.++|||||||++|||++ |..||.+... ..+..... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~-~~~------------ 222 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLE-KGY------------ 222 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH-CCC------------
Confidence 1112234678999999998899999999999999999998 8899865211 11111110 000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
....+..++..+.+++.+||+.+|++||++.|+.++|+.+
T Consensus 223 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111223467789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=310.86 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=207.2
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999854 78999999875422 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
||+++|+|.+++.. ....+++..+..++.|++.|++|| |+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998863 234578899999999999999999 567899999999999999999999999999987643
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||..... ....+......... +
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~-----~-- 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKIEQCDY-----P-- 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHHhcCCC-----C--
Confidence 221 12234588899999999888899999999999999999999999864221 11222211110000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
......++..+.+++.+||+.+|++||++.+|++.++.++
T Consensus 227 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 ------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0011234567889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=319.87 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=202.8
Q ss_pred CCCccccccccCceEEEEEEEC------CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
+|...+.||+|+||.||+|... ++..||+|+++.... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666789999999999999853 257899999875543 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC---------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 005278 489 VLEFMPNGSLEKWLYSH---------------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT 553 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~ 553 (704)
++||+++++|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 99999999999998521 234788889999999999999994 578999999999999999999
Q ss_pred EEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHH
Q 005278 554 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVK 632 (704)
Q Consensus 554 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 632 (704)
+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||.+... ..+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~ 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVIE 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence 99999999887644333222334456789999999988889999999999999999998 8888865321 11211
Q ss_pred hhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 633 ESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
...... ....+.+++..+.+++..||+.+|++||++++|++.|+.
T Consensus 238 ~i~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQ--------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCC--------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111110 011123456778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.66 Aligned_cols=250 Identities=27% Similarity=0.388 Sum_probs=201.9
Q ss_pred CCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 416 GFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+|+..+.||+|+||.||+|...++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 577888999999999999998777889999986432 2345688899999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
++|.+++......+++..+..++.|++.|++|| |+.+++||||||+||++++++.+||+|||+++........ ...
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~ 159 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQ 159 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccC
Confidence 999999987656789999999999999999999 4578999999999999999999999999999876432211 111
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (704)
...++..|+|||...+..++.++||||||+++||+++ |+.||...... .....+.... ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~-----------------~~ 220 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGY-----------------RL 220 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCC-----------------cC
Confidence 2234567999999998899999999999999999999 88998653221 1111111000 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 655 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
..+..++.++.+++.+||+.+|++||++.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11123466789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.99 Aligned_cols=266 Identities=24% Similarity=0.383 Sum_probs=203.0
Q ss_pred CccccccccCceEEEEEEE-----CCCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeEEEE
Q 005278 418 NECNLLGTGSFGSVYKGTL-----FDGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNI--DFKALV 489 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 489 (704)
...+.||+|+||+||++.. .++..||+|.+..... ...+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988653 3578899999875432 3456788999999999999999999988653 357899
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++.... +++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 99999999999997653 899999999999999999995 5789999999999999999999999999998765432
Q ss_pred Ccc-eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC-CCcchhccccc
Q 005278 570 DSV-IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP-DGLTEVVDANL 647 (704)
Q Consensus 570 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 647 (704)
... ......++..|+|||......++.++||||||+++|||+||..|+............+...... ..+....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence 211 1122345677999999988889999999999999999999999986532211111111000000 00111111111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
..+.+..++..+.+++..||+.+|++||+++++++.|+++.
T Consensus 242 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 -----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred -----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11122345678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.46 Aligned_cols=241 Identities=24% Similarity=0.308 Sum_probs=192.6
Q ss_pred ccccccCceEEEEEEE----CCCCEEEEEEeeccc----hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 421 NLLGTGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+.||+|+||.||+++. .+++.||+|++.... ......+..|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 357899999987532 12334678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++|+|.+++...+ .+.+..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence 99999999997654 3678888889999999999995 57899999999999999999999999999875432221
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~~~-------------- 216 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILKGK-------------- 216 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC--------------
Confidence 12234689999999999988899999999999999999999999975321 11111111000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
...+..++..+.+++.+|++.+|++|| ++.++++
T Consensus 217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 011123345678999999999999999 7777755
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=325.18 Aligned_cols=245 Identities=24% Similarity=0.271 Sum_probs=203.2
Q ss_pred HHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
....++|....+||+|.||+|+++..+ +++.+|||++++.. ..+.+....|.+++... +||.+++++.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999965 68899999998765 34567788899888887 59999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.+.||||+.||++..+ .+...+++..+.-++..|+.||.|| |+.+||+||||.+|||+|.+|++||+|||+++.-
T Consensus 444 l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999994333 3334589999999999999999999 6689999999999999999999999999999864
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
--. ...++..+|||.|||||++.+..|+..+|-|||||+||||+.|..||.+..++ ++.|.
T Consensus 519 m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------e~Fds 579 (694)
T KOG0694|consen 519 MGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------EVFDS 579 (694)
T ss_pred CCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHH
Confidence 322 22466789999999999999999999999999999999999999999863221 11111
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
-+.. ....|..++.+.+.++.+++..+|++|..+
T Consensus 580 I~~d---~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVND---EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcC---CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111 122344667888999999999999999976
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.79 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=204.0
Q ss_pred CCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.+|...+.||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46677889999999999999632 356899998876655566789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC--------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 489 VLEFMPNGSLEKWLYSHN--------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
+|||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 999999999999997543 24788999999999999999995 5789999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 633 (704)
||+|||++................+++.|+|||+..+..++.++|||||||++|||++ |..||......+ .......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~ 239 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECITQ 239 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHHc
Confidence 9999999986643222222223345788999999998899999999999999999998 899986532211 1111000
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
+ .....+..++..+.+++.+||+.||.+||++.||.+.|++
T Consensus 240 ----~-------------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 240 ----G-------------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----C-------------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0 0001112345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.87 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=204.6
Q ss_pred CCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
+|.+.+.||+|+||.||+|+.. ....+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999743 23578899886543 2334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC-----------------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 005278 489 VLEFMPNGSLEKWLYSH-----------------------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNN 545 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~N 545 (704)
++||+++|+|.+++... ...+++..++.++.|++.|++||| +.+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 99999999999998642 124788999999999999999995 5789999999999
Q ss_pred eeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCcccccc
Q 005278 546 ILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGE 624 (704)
Q Consensus 546 il~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~ 624 (704)
|++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222233356778999999888889999999999999999999 99998653211
Q ss_pred ccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 625 MSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
.+..+.... . ....+..++.++.+++..|++.+|++||+++|+++.|+++-.+
T Consensus 237 -~~~~~~~~~------------~-----~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 -RLFNLLKTG------------Y-----RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -HHHHHHhCC------------C-----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 111111110 0 0011223456788999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.55 Aligned_cols=261 Identities=25% Similarity=0.423 Sum_probs=208.0
Q ss_pred HhCCCCccccccccCceEEEEEEEC--------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeee
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCN 482 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 482 (704)
..++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467888899999999999999741 24579999986543 33456789999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 005278 483 IDFKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNIL 547 (704)
Q Consensus 483 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil 547 (704)
....++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence 999999999999999999997532 34788889999999999999995 578999999999999
Q ss_pred eCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCcccccccc
Q 005278 548 LDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMS 626 (704)
Q Consensus 548 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~ 626 (704)
++.++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++||+++ |..||....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----- 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----
Confidence 99999999999999987754333222333456788999999988889999999999999999998 778876532
Q ss_pred HHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 627 LKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+..... .. .....+..++..+.+++..||+.+|++||++.|+++.|+++...
T Consensus 245 ~~~~~~~~~-~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 VEELFKLLK-EG-------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHH-cC-------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 222221110 00 00011224566788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=315.33 Aligned_cols=261 Identities=23% Similarity=0.372 Sum_probs=209.2
Q ss_pred HhCCCCccccccccCceEEEEEEECC-----CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeee-CCe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFD-----GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCN-IDF 485 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 485 (704)
..++|...+.||+|+||.||+|...+ +..|++|++.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999998755 6889999886543 3345678899999999999999999998766 567
Q ss_pred EEEEEeccCCCCHHHHHhhCC-------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEee
Q 005278 486 KALVLEFMPNGSLEKWLYSHN-------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSD 558 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~D 558 (704)
.++++||+++|+|.+++.... ..+++..+..++.+++.|++||| +.+++||||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999997532 45889999999999999999995 57899999999999999999999999
Q ss_pred eccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCC
Q 005278 559 FGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPD 637 (704)
Q Consensus 559 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 637 (704)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+..+......
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~- 237 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYR- 237 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCC-
Confidence 999986644332222223346778999999988889999999999999999999 9999976321 222222221110
Q ss_pred CcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 638 GLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
......++.++.+++.+||+.+|++||++.|+++.|+.+.++
T Consensus 238 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 ----------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ----------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 011123456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.60 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=203.9
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIR-HRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 485 (704)
.++|.+.+.||+|+||.||+|++. .+..||+|++.... ......+.+|++++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346778899999999999999853 34689999997543 223456889999999997 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-----------------------------------------------------------
Q 005278 486 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 506 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 506 (704)
.++|+||+++|+|.+++++.+
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999997432
Q ss_pred --------------------------------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 507 --------------------------------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 507 --------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
..+++.....++.|++.|++|| |+.+|+||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCcCcccCCcceEEE
Confidence 1356777889999999999999 56789999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
++++.+|++|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+. .
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-F 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-H
Confidence 9999999999999987543222112223457889999999988889999999999999999998 8899865321111 0
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
...+. .+ . ....+..++..+.+++.+||+.+|.+||+++|+++.|+++.
T Consensus 352 ~~~~~----~~--------~-----~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 YNAIK----RG--------Y-----RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHH----cC--------C-----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 01000 00 0 01112234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.73 Aligned_cols=256 Identities=25% Similarity=0.307 Sum_probs=204.4
Q ss_pred HHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC---
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID--- 484 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 484 (704)
....++|.+.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+..+..++|+||+++.+.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457999999999999999999984 479999999986542 334456889999999999999999988765432
Q ss_pred -----eEEEEEeccCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 005278 485 -----FKALVLEFMPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV 556 (704)
Q Consensus 485 -----~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl 556 (704)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEeCCCCEEE
Confidence 367999999999999999743 34588999999999999999999 5678999999999999999999999
Q ss_pred eeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC
Q 005278 557 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP 636 (704)
Q Consensus 557 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 636 (704)
+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~~ 259 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTLA 259 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhc
Confidence 99999987654322222334579999999999999999999999999999999999999996521 2222221111
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
... ...+..++.++.+++..||+.+|++||++.++++.
T Consensus 260 ~~~--------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRY--------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC--------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 100 01122345678899999999999999999999764
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.35 Aligned_cols=264 Identities=22% Similarity=0.369 Sum_probs=206.0
Q ss_pred HhCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF 485 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 485 (704)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999743 24579999876443 2234467889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC---------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 005278 486 KALVLEFMPNGSLEKWLYSHN---------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV 556 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl 556 (704)
.++||||+++|+|.+++.... ...++..+..++.|++.|+.|| |+++|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997421 2346678889999999999999 5678999999999999999999999
Q ss_pred eeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhc
Q 005278 557 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 557 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||..... ..+.....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence 99999986543332222223345778999999988899999999999999999999 7888865321 11111111
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
... . ...+..++..+.+++.+|++.+|++||++.|+++.|++....+.+
T Consensus 236 ~~~--------~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 236 DGG--------Y------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred cCC--------C------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 000 0 011123356788999999999999999999999999886544433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=314.53 Aligned_cols=265 Identities=23% Similarity=0.304 Sum_probs=194.8
Q ss_pred CCCCccccccccCceEEEEEEEC--CCCEEEEEEeeccch--hhhHHHHHHHHHHHhc---CCCCCceEEeeeee-----
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF--DGTNVAIKVFNLQLE--RASRSFDSECEILRSI---RHRNLIKIISNCCN----- 482 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 482 (704)
++|+..+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999853 468899999875432 2234566777777766 69999999998852
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 483 IDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 483 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
....++||||++ ++|.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 446889999996 6999998753 34588999999999999999999 557899999999999999999999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc---CCC
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL---PDG 638 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~ 638 (704)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+........ +..
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence 9876432 22334568999999999988889999999999999999999999997632211 1111111100 000
Q ss_pred cchhc---cccchhhh--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 LTEVV---DANLVREE--QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 ~~~~~---~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.... ...+.... .......+.+..+.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 00000000 000111234566789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=326.03 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=201.0
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|...+.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999854 689999999975432 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++......+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 99999999999987766789999999999999999999 557899999999999999999999999999987654322
Q ss_pred cceeccccccccccCCcccC------CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 571 SVIQTMTIATIGYMAPEYGS------EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...........
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~------ 225 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYNNIMNFQ------ 225 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHHHHHcCC------
Confidence 1 223346899999999876 45678899999999999999999999965221 11111110000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. ...+.....+..+.+++..|++ +|++||++.++++
T Consensus 226 -~~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 -RF----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -Cc----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 0001111234567889999998 9999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.10 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=192.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 35566789999999999999854 68999999986543 23446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++|+|.+.. ...+..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9999986532 2456778889999999999995 57899999999999999999999999999987643221
Q ss_pred eeccccccccccCCcccCC-----CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 573 IQTMTIATIGYMAPEYGSE-----GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..... ..+..........
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~---------- 291 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICMS---------- 291 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhcc----------
Confidence 1233468999999998743 3345689999999999999999999973211 1111111100000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.....+..++.++.+++.+||+.||++||++.|+++.
T Consensus 292 ----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 ----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122345678899999999999999999999763
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=311.44 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=201.3
Q ss_pred CCccccccccCceEEEEEEEC-C---CCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe-----
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-D---GTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF----- 485 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 485 (704)
|...+.||+|+||.||+|... + +..||+|.++... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999864 2 3679999987543 2334678999999999999999999998866544
Q ss_pred -EEEEEeccCCCCHHHHHhhC-----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 486 -KALVLEFMPNGSLEKWLYSH-----NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 486 -~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
.++++||+++|+|.+++... ...+++.....++.|++.|++||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999998632 235889999999999999999995 578999999999999999999999999
Q ss_pred ccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCC
Q 005278 560 GISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDG 638 (704)
Q Consensus 560 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (704)
|+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||.+.... ....+.....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~--- 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGN--- 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---
Confidence 99987654433222233345778999999988899999999999999999999 88888663221 1111111100
Q ss_pred cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
....+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus 233 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 --------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111224456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.88 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=207.9
Q ss_pred hCCCCccccccccCceEEEEEEEC--------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNI 483 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 483 (704)
.++|.+.+.||+|+||.||+|+.. ++..+|+|.+.... ......+..|+++++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999742 23569999987543 33445688899999999 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
+..++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 99999999999999999997532 24788999999999999999995 5789999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
+.++.+||+|||.++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----~ 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----V 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----H
Confidence 9999999999999986643222111222234578999999988889999999999999999998 888886532 1
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
........ .. .....+..++.++.+++.+|++.+|++||++.||++.|+++.+....
T Consensus 249 ~~~~~~~~-~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 249 EELFKLLK-EG-------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred HHHHHHHH-cC-------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 11111110 00 00111224456788999999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.53 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=203.0
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|...+.||+|+||+||+|+.. +++.||+|++.... ......+..|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47888999999999999999965 68999999987543 134457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC-
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD- 569 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~- 569 (704)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999876 45889999999999999999995 5889999999999999999999999999998764432
Q ss_pred --------------------------CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccc
Q 005278 570 --------------------------DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIG 623 (704)
Q Consensus 570 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~ 623 (704)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001123346899999999999999999999999999999999999999763211
Q ss_pred cccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHH
Q 005278 624 EMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS-MKDAAAK 688 (704)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-~~ev~~~ 688 (704)
..+.. ... .. ... ..+....++..+.+++..|++ +|++||+ ++|+++.
T Consensus 237 ----~~~~~-i~~-~~-----~~~-----~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ----ETYNK-IIN-WK-----ESL-----RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----HHHHH-Hhc-cC-----Ccc-----cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11110 000 00 000 000111135678889999997 9999999 9999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.67 Aligned_cols=259 Identities=26% Similarity=0.444 Sum_probs=204.2
Q ss_pred CCCCccccccccCceEEEEEEECC-CC--EEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD-GT--NVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 489 (704)
++|+..+.||+|+||.||+|...+ +. .+++|.++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998653 33 47888876432 33446788999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 490 LEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
+||+++|+|.+++.+.. ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999997532 24788999999999999999995 5789999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 633 (704)
||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||..... ..+...
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----AELYEK 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence 99999998643211 11112233567999999988889999999999999999998 9999865321 111111
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
. ..+. ....+..++..+.+++..||+.+|.+||++.++++.|+.+.+++..
T Consensus 231 ~-~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 231 L-PQGY-------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred H-hcCC-------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1 0100 0011123456788999999999999999999999999998876644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.55 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=195.0
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.|+..+.||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999985 468999999997542 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC-
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD- 570 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~- 570 (704)
|+++|+|.+++.... .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999997654 378888899999999999999 567899999999999999999999999999764321000
Q ss_pred --------------------------------------------cceeccccccccccCCcccCCCCCCcccceeeHHHH
Q 005278 571 --------------------------------------------SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGIL 606 (704)
Q Consensus 571 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~ 606 (704)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000112469999999999998889999999999999
Q ss_pred HHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhh--hcCCCCCCCCCHHH
Q 005278 607 LMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALD--CCMESPEQRVSMKD 684 (704)
Q Consensus 607 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P~~Rpt~~e 684 (704)
+|||+||+.||......+. ...... ... .. ..+....++.++.+++.+ |+..+|..||++.|
T Consensus 238 l~elltG~~Pf~~~~~~~~-~~~i~~---~~~-------~~-----~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET-QLKVIN---WEN-------TL-----HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH-HHHHHc---ccc-------cc-----CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 9999999999976322111 000000 000 00 000111234566778877 55667777999999
Q ss_pred HHHH
Q 005278 685 AAAK 688 (704)
Q Consensus 685 v~~~ 688 (704)
+++.
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=310.13 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=204.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CC---CEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DG---TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.+|...+.||+|+||.||+|... ++ ..||||.+.... ......+..|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35677889999999999999864 33 369999987543 33456799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++......+++..++.++.|++.|++||| +.+++||||||+||+++.++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999876667899999999999999999995 5789999999999999999999999999988664432
Q ss_pred Ccceecccc---ccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 570 DSVIQTMTI---ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 570 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
......... .+..|+|||+..+..++.++|||||||++||+++ |..||..... .....++....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~---------- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDY---------- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCC----------
Confidence 211111111 2457999999998899999999999999999887 9999865321 11222221100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
..+.+.+++..+.+++..||+.+|++||++.+|++.|+++
T Consensus 229 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111224566788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=309.30 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=203.5
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|+..++||+|+||.||+|+..++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 35688899999999999999998777789999987532 234578999999999999999999998754 5578999999
Q ss_pred CCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++.+. ...+++..+..++.+++.|++|| |+.+++||||||+||++++++.++|+|||.++.+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 999999999854 34578999999999999999999 5678999999999999999999999999999876543321
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......++..|+|||+..+..++.++||||||+++||++| |..||......+ ..... ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----~~~~~-~~~~------------ 220 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQV-ERGY------------ 220 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----HHHHH-hcCC------------
Confidence 1223346778999999988889999999999999999999 788886532111 00100 0000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
......+++..+.+++.+|++.+|++||++.++.+.|++.
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011224566788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=312.60 Aligned_cols=253 Identities=28% Similarity=0.484 Sum_probs=196.9
Q ss_pred CccccccccCceEEEEEEECC-CC--EEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC------CeE
Q 005278 418 NECNLLGTGSFGSVYKGTLFD-GT--NVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI------DFK 486 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 486 (704)
.+.+.||+|+||.||+|+..+ ++ .+|+|.++... ....+.+..|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999998654 33 68999886542 33456788999999999999999999987432 246
Q ss_pred EEEEeccCCCCHHHHHhh-----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 487 ALVLEFMPNGSLEKWLYS-----HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
++++||+++|+|.+++.. ....+++.....++.|++.|++||| +.+|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998852 2234789999999999999999995 57899999999999999999999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcc
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLT 640 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (704)
++.+.............+++.|+|||+..+..++.++||||||+++|||++ |+.||...... ....... .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~----~~-- 230 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLR----QG-- 230 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH----cC--
Confidence 987654332222233356778999999999899999999999999999999 78898653211 1111111 00
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
.....+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 231 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 -----------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011123456688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=299.33 Aligned_cols=268 Identities=24% Similarity=0.283 Sum_probs=202.8
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeec--cchhhhHHHHHHHHHHHhcCCCCCceEEeeeee-----CC
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNL--QLERASRSFDSECEILRSIRHRNLIKIISNCCN-----ID 484 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 484 (704)
....|...+.||+|+||.|+.|.. .+|+.||+|++.. ......++..+|+..++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345666678999999999999985 4799999999873 334556778899999999999999999998865 34
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..|+|+|+| +.+|.+.++.+.. +......-++.|+..|++|+ |+.+|+|||+||+|++++.+...||+|||+|+.
T Consensus 100 DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchh---hcccccccccchhheeeccCCCEEeccccceee
Confidence 689999999 4599999886643 78888899999999999999 778899999999999999999999999999998
Q ss_pred cCCCCCcceeccccccccccCCccc-CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC----c
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYG-SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG----L 639 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~ 639 (704)
..........+..+.|..|.|||++ ....|+...||||.||++.||++|+.-|.+... ...-..+....... +
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQLILELLGTPSEEDL 252 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHHHHHhcCCCCHHHH
Confidence 8654333344666789999999975 567899999999999999999999998876211 11111111111110 0
Q ss_pred chhcc-------ccchhhh--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 640 TEVVD-------ANLVREE--QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 640 ~~~~~-------~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+-. .++.... +-........+..++++.+|+..||.+|+|++|+++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11100 0000000 001111234567889999999999999999999964
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.44 Aligned_cols=256 Identities=25% Similarity=0.404 Sum_probs=202.0
Q ss_pred HhCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF 485 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 485 (704)
.+++|...+.||+|+||.||+|... .+..||+|.+.... ......+..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567888999999999999999864 35678999876443 2334568899999999999999999999999888
Q ss_pred EEEEEeccCCCCHHHHHhhCC------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEEE
Q 005278 486 KALVLEFMPNGSLEKWLYSHN------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM---TAHV 556 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~---~~kl 556 (704)
.++||||+++|+|.+++...+ ..+++..+..++.|++.|++||| +.+++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999997543 25889999999999999999995 57899999999999998654 5999
Q ss_pred eeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhc
Q 005278 557 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 557 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||......+ ....+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~-- 236 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTG-- 236 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHc--
Confidence 99999987643222211222334578999999998899999999999999999997 999987532211 1111110
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.. ....+..++..+.+++.+|++.+|++||++.+|++.|.
T Consensus 237 -~~--------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 -GG--------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -CC--------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 00112234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=318.94 Aligned_cols=265 Identities=24% Similarity=0.429 Sum_probs=208.0
Q ss_pred hCCCCccccccccCceEEEEEEEC--------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNI 483 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 483 (704)
.++|...+.||+|+||.||+|+.. .+..+|+|.+.... ......+..|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888899999999999999742 24579999987543 23345688999999999 699999999999998
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
+..++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 89999999999999999997532 34788999999999999999995 5789999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~ 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--EL 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987643322221222234568999999988889999999999999999999 88888653211 11
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhh
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDV 700 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 700 (704)
..... .. .....+..++.++.+++.+|++.+|++||++.|+++.|+++......+.
T Consensus 246 ~~~~~----~~-------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 301 (314)
T cd05099 246 FKLLR----EG-------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEY 301 (314)
T ss_pred HHHHH----cC-------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCc
Confidence 11111 00 0001122345678899999999999999999999999999987655543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=308.52 Aligned_cols=248 Identities=27% Similarity=0.460 Sum_probs=196.5
Q ss_pred cccccCceEEEEEEEC---CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCC
Q 005278 422 LLGTGSFGSVYKGTLF---DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGS 497 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 497 (704)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 355799999865532 33467899999999999999999999875 456789999999999
Q ss_pred HHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc-eecc
Q 005278 498 LEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-IQTM 576 (704)
Q Consensus 498 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~-~~~~ 576 (704)
|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++.......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999876667899999999999999999994 5789999999999999999999999999998654332211 1122
Q ss_pred ccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
..++..|+|||.+....++.++|||||||++||+++ |..||...... .....+.... ...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~-----------------~~~ 218 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGK-----------------RLD 218 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC-----------------CCC
Confidence 234678999999888889999999999999999996 99999764221 1111111100 011
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
.+..++.++.+++..||+.+|++||++.+|.+.|+.+
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1224467788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=307.06 Aligned_cols=247 Identities=32% Similarity=0.478 Sum_probs=199.4
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCHH
Q 005278 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLE 499 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 499 (704)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999875432 33456889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccc
Q 005278 500 KWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA 579 (704)
Q Consensus 500 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 579 (704)
+++......+++..+..++.+++.++.|+ |+.+++||||+|+||+++.++.+|++|||++......... ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence 99986666689999999999999999999 5678999999999999999999999999999765332211 1122245
Q ss_pred cccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhH
Q 005278 580 TIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKI 658 (704)
Q Consensus 580 t~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (704)
+..|+|||+..+..++.++||||||+++||+++ |..||....... ...... ... ....+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~----~~~-------------~~~~~~ 217 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVE----KGY-------------RMSCPQ 217 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHH----cCC-------------CCCCCC
Confidence 678999999998899999999999999999998 999986532111 111111 000 001111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 659 DCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 659 ~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.++..+.+++.+|++.+|++||++.|++++|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 34567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=316.40 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=205.0
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
.++|...+.||+|+||.||+|... ++..||||.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357888899999999999999742 35579999887543 33346789999999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 486 KALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
.++||||+++|+|.+++.... ..+++..+..++.+++.|++||| +.+|+|+||||+||+++.++.++++|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997543 34899999999999999999995 57899999999999999999999999999986
Q ss_pred cCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
..............++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ........ ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~----~~---- 261 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKE----GY---- 261 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHc----CC----
Confidence 644322222223346788999999998889999999999999999998 999987643211 11111110 00
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
. ...+...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 262 ----~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ----R-----MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----c-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 001112245688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=341.47 Aligned_cols=260 Identities=22% Similarity=0.295 Sum_probs=204.0
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|++.++||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999864 68999999987542 223457899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC----------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeec
Q 005278 491 EFMPNGSLEKWLYSH----------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFG 560 (704)
Q Consensus 491 e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 560 (704)
||+++|+|.+++... ....++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998631 123566778899999999999995 5789999999999999999999999999
Q ss_pred cceecCCCCC----------------cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccc
Q 005278 561 ISKLLGEGDD----------------SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE 624 (704)
Q Consensus 561 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~ 624 (704)
++........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001122468999999999999999999999999999999999999997622211
Q ss_pred ccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHhHH
Q 005278 625 MSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV-SMKDAAAKLKKIKE 694 (704)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-t~~ev~~~L~~~~~ 694 (704)
..... .. .++ .......+.+..+.+++.+|++.||++|| +++++.+.|+.+.+
T Consensus 239 i~~~~----~i-------~~P------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYRD----VI-------LSP------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh----hc-------cCh------hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11000 00 000 00011123456788999999999999996 57778888877654
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=314.32 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=204.8
Q ss_pred hCCCCccccccccCceEEEEEEECC-----------------CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCce
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD-----------------GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIK 475 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 475 (704)
..+|+..+.||+|+||.||+|+..+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999987542 2458999987554 234567899999999999999999
Q ss_pred EEeeeeeCCeEEEEEeccCCCCHHHHHhhCC----------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 005278 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHN----------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNN 545 (704)
Q Consensus 476 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~N 545 (704)
+++++...+..++++||+++++|.+++.... ..+++..++.++.|++.|++||| +.+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999997543 25899999999999999999995 5789999999999
Q ss_pred eeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh--CCCCCCccccc
Q 005278 546 ILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT--RKKPTNEIFIG 623 (704)
Q Consensus 546 il~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t--g~~p~~~~~~~ 623 (704)
|+++.++.++|+|||+++...............+++.|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999987644333233334456789999999988889999999999999999998 66777653211
Q ss_pred cccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 624 EMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
+ ............... .....+..++.++.+++.+|++.+|++||++.||++.|+
T Consensus 241 ~--~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q--VIENAGHFFRDDGRQ----------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H--HHHHHHhcccccccc----------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 111111100000000 000111234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.30 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=207.3
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||.||+|+. .+++.+|||.+.... ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 579999999876432 223457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
||+++++|.+++.. ....+++..++.++.+++.|++|| |+.+++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 234589999999999999999999 567899999999999999999999999999887643
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
... ......++..|+|||+..+..++.++||||||+++|||++|..||...... ...+.+.... ...+.
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~-----~~~~~- 227 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQ-----CDYPP- 227 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhhc-----CCCCC-
Confidence 322 122346889999999998888999999999999999999999998653221 1111111000 00000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
.....++..+.+++.+||+.+|++||||.+|+++++++.
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 -------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011234567889999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.02 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=197.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999864 68999999997542 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999997654 4889999999999999999995 57899999999999999999999999999876532211
Q ss_pred cc------------------------------------eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCC
Q 005278 571 SV------------------------------------IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRK 614 (704)
Q Consensus 571 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~ 614 (704)
.. ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011235899999999999999999999999999999999999
Q ss_pred CCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 005278 615 KPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS---MKDAAA 687 (704)
Q Consensus 615 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt---~~ev~~ 687 (704)
.||...... ........ .. ..+ ..+.....+..+.+++..|+. +|.+|++ +.|+++
T Consensus 237 ~Pf~~~~~~-----~~~~~i~~-~~-----~~~-----~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQ-----ETYRKIIN-WK-----ETL-----QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHH-----HHHHHHHc-CC-----Ccc-----CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999753211 11110000 00 000 000001234567788999986 9999998 888865
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.45 Aligned_cols=262 Identities=21% Similarity=0.231 Sum_probs=197.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..+|++.+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 36899999999999999999985 468999999743 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+. ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+....... .
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N 238 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence 95 68988887543 4789999999999999999995 57899999999999999999999999999975432211 1
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccc------cccHHHHHHhhc--CCCc----c
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIG------EMSLKHWVKESL--PDGL----T 640 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~--~~~~----~ 640 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||-..... ...+...+.... +..+ .
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 123356999999999999999999999999999999999999886432110 111111111100 0000 0
Q ss_pred hhccccc-------h---hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 641 EVVDANL-------V---REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 641 ~~~~~~~-------~---~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..+ . ...+........+.++.+++.+|++.||++|||++|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0 000001112234667889999999999999999999964
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=318.48 Aligned_cols=246 Identities=19% Similarity=0.264 Sum_probs=194.0
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..+++++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999864 68999999997543 22335678899999998 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++...+ .+++..+..++.|++.|++|| |+.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 99999887553 489999999999999999999 56789999999999999999999999999987532211 1123
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccc---cccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIG---EMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ......+.........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------------- 221 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------------- 221 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-------------
Confidence 356899999999999999999999999999999999999999743211 1112222221111110
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCC------HHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVS------MKDAA 686 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt------~~ev~ 686 (704)
...+..++..+.+++.+|++.||++||+ +.|++
T Consensus 222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 222 -IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 0111233556788999999999999997 55664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=308.83 Aligned_cols=247 Identities=25% Similarity=0.409 Sum_probs=196.2
Q ss_pred cccccCceEEEEEEE---CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCC
Q 005278 422 LLGTGSFGSVYKGTL---FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 496 (704)
.||+|+||.||+|.+ .++..+|+|+++... ....+.+..|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999975 357889999986443 2335678899999999999999999998754 5668999999999
Q ss_pred CHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc-eec
Q 005278 497 SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-IQT 575 (704)
Q Consensus 497 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~-~~~ 575 (704)
+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++..+....... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997554 4889999999999999999995 5789999999999999999999999999998765432211 112
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (704)
...++..|+|||.+....++.++|||||||++|||++ |+.||...... ...+.+.... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~-----------------~~ 217 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGE-----------------RM 217 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCC-----------------CC
Confidence 2234678999999888889999999999999999998 99999763221 1122211100 01
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 655 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
..+..++.++.+++.+||+.||++||++.+|++.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11223456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=320.08 Aligned_cols=244 Identities=23% Similarity=0.261 Sum_probs=192.0
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHH---HhcCCCCCceEEeeeeeCCeEEEE
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEIL---RSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999854 68999999987542 22334566676665 456799999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|..++... .+++..+..++.|++.|++|| |+.+|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999888653 489999999999999999999 56789999999999999999999999999987542221
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.+... ...........
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~~----------- 217 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFDSIVNDE----------- 217 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC-----------
Confidence 122345689999999999999999999999999999999999999975321 11111110000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
...+..++..+.+++.+|++.||++||+ +.++++
T Consensus 218 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 ----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0111234566788999999999999994 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=311.98 Aligned_cols=260 Identities=24% Similarity=0.412 Sum_probs=203.8
Q ss_pred CCCccccccccCceEEEEEEE-----CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-----FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNI--DFKA 487 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 487 (704)
-|.+.+.||+|+||.||+++. .++..||+|.++... ....+.+.+|++++++++||||+++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999974 357889999986543 33446789999999999999999999998775 5688
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++++|.+++.+....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999876556899999999999999999994 67899999999999999999999999999987644
Q ss_pred CCCc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccc----------ccccHHHHHHhhcC
Q 005278 568 GDDS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFI----------GEMSLKHWVKESLP 636 (704)
Q Consensus 568 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~----------~~~~~~~~~~~~~~ 636 (704)
.... .......++..|+|||+..+..++.++|||||||++||++|++.|+..... ++.....+....
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL-- 239 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH--
Confidence 3221 112234567789999998888899999999999999999998776533111 011111111100
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
. .....+.+..++..+.+++.+|++.+|++||++.|+++.++++
T Consensus 240 -------~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 -------E-----EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -------H-----cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 0001112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.41 Aligned_cols=243 Identities=21% Similarity=0.248 Sum_probs=194.2
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCC
Q 005278 421 NLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 496 (704)
+.||+|+||.||+++. .+|+.||+|++.... ......+..|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 478999999997543 223456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecc
Q 005278 497 SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576 (704)
Q Consensus 497 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 576 (704)
+|.+++.... .+++..+..++.|++.||+|||. ..+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT 155 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence 9999887554 48899999999999999999953 26899999999999999999999999999875432211 1223
Q ss_pred ccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhh
Q 005278 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSV 656 (704)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (704)
..||+.|+|||++.+..++.++|||||||++|||+||+.||..... ........... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~~---------------~~~ 215 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE---------------IRF 215 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcCC---------------CCC
Confidence 4699999999999998999999999999999999999999965321 11111100000 001
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 005278 657 KIDCLLSIMHLALDCCMESPEQRV-----SMKDAAAK 688 (704)
Q Consensus 657 ~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~~ 688 (704)
+...+.++.+++.+|++.||++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 112345678899999999999997 88888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=310.18 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=205.3
Q ss_pred CCCCccccccccCceEEEEEEEC-C---CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-D---GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.+|.+.+.||+|+||.||+|+.. + +..+|+|.++... ....+.+..|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999853 2 3479999886543 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++......+++..+..++.|++.|++|| |+.+++||||||+||+++.++.++++|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999987666689999999999999999999 56789999999999999999999999999998765432
Q ss_pred Ccce-eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 570 DSVI-QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 570 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.... .....++..|+|||++.+..++.++||||||+++||+++ |..||...... ....++....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~------------ 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGY------------ 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCC------------
Confidence 2111 112234568999999998889999999999999999887 99998653221 1112111100
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
..+....++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=317.68 Aligned_cols=242 Identities=19% Similarity=0.261 Sum_probs=190.5
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999864 68899999987542 22345577888888877 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 99999887553 4889999999999999999995 57899999999999999999999999999875422111 123
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccc---ccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE---MSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------------- 220 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------------- 220 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------------
Confidence 4568999999999999999999999999999999999999996422111 11112221111110
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
....+...+..+.+++.+|++.||++||++
T Consensus 221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 001122345567889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=322.95 Aligned_cols=266 Identities=22% Similarity=0.285 Sum_probs=194.9
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC-----CeEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI-----DFKA 487 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 487 (704)
+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999854 68999999986432 22345688999999999999999999987543 2479
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+. ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 68999887554 4889999999999999999995 57899999999999999999999999999986532
Q ss_pred CCC-cceeccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC----cc
Q 005278 568 GDD-SVIQTMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG----LT 640 (704)
Q Consensus 568 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~ 640 (704)
... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.... ....++....... ..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHHH
Confidence 221 112233468999999998765 67899999999999999999999999653211 1111111000000 00
Q ss_pred hhccc-------cchhhh--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 641 EVVDA-------NLVREE--QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 641 ~~~~~-------~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.+... .+.... .........+..+.+++.+||+.||++||+++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 000000 0000011234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=317.77 Aligned_cols=240 Identities=22% Similarity=0.263 Sum_probs=189.0
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 58899999987543 12234455666776654 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999987654 4888999999999999999995 5789999999999999999999999999998653222 1223
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .......... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~---------------~~~ 214 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILND---------------RPH 214 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC---------------CCC
Confidence 45689999999999998999999999999999999999999976321 1111110000 001
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMK-DAA 686 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~-ev~ 686 (704)
.+..++..+.+++.+||+.+|++||++. ++.
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1122345678899999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.32 Aligned_cols=251 Identities=24% Similarity=0.252 Sum_probs=196.1
Q ss_pred CCCccccccccCceEEEEEEE----CCCCEEEEEEeeccc----hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeE
Q 005278 416 GFNECNLLGTGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 486 (704)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|+.+++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999874 358899999986532 22345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++||||+++|+|.+++.... .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999997654 388999999999999999999 45789999999999999999999999999998654
Q ss_pred CCCCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||....... ............ ++
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~------~~ 228 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSRRILKC------DP 228 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHHHHhcC------CC
Confidence 32221 12234689999999998765 47889999999999999999999996532211 111111111000 00
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
..+...+..+.+++.+|++.||++|| +++|+++
T Consensus 229 ---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 ---------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11112345678899999999999999 6667754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=309.08 Aligned_cols=253 Identities=26% Similarity=0.459 Sum_probs=203.0
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 357888899999999999999988888999999865432 34678999999999999999999998754 5578999999
Q ss_pred CCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++++|.+++... ...+++..+..++.+++.|++||| +.+|+||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 999999999754 345899999999999999999995 567999999999999999999999999999876443221
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......++..|+|||+..+..++.++||||||+++|||++ |..||.+.... ..........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~---------------- 220 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGY---------------- 220 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC----------------
Confidence 1122345678999999988889999999999999999999 88898653211 1111111000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
..+.+.+.+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 -RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001122345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=310.37 Aligned_cols=257 Identities=26% Similarity=0.484 Sum_probs=205.5
Q ss_pred hCCCCccccccccCceEEEEEEEC-CC---CEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DG---TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.+.... ......+..|++++++++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346778899999999999999864 33 379999886543 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999876667899999999999999999995 578999999999999999999999999999876433
Q ss_pred CCcce-eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 569 DDSVI-QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 569 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
..... ......+..|+|||++....++.++|||||||++||+++ |+.||..... .++...... .
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i~~-~-------- 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAIND-G-------- 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHhc-C--------
Confidence 22111 111223567999999988889999999999999999998 9999865321 112111110 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
. ..+...+++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ~-----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 F-----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C-----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=312.45 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=199.7
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.|+..+.||+|+||+||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999854 689999999865321 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 492 FMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 492 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
|+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988754 345899999999999999999995 57899999999999999999999999999987643221
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....|++.|+|||++.+..++.++||||+||++||+++|+.||.+.... ..... +.......
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~-~~~~~~~~------------ 220 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREE-VERRVKED------------ 220 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHH-HHHHhhhc------------
Confidence 22346899999999999888999999999999999999999999763211 11111 11111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAAK 688 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~~ 688 (704)
....+..++..+.+++..||+.||++|| +++++++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0011123456788999999999999999 78888553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.91 Aligned_cols=238 Identities=26% Similarity=0.302 Sum_probs=191.7
Q ss_pred ccccccCceEEEEEEE----CCCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 421 NLLGTGSFGSVYKGTL----FDGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3589999999975432 233457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|+|.+++.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA 155 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence 999999997653 4899999999999999999995 57899999999999999999999999999986533211 12
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (704)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~~---------------~ 215 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKAK---------------L 215 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcCC---------------C
Confidence 335689999999999888899999999999999999999999975321 11111110000 0
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 005278 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKD 684 (704)
Q Consensus 655 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~e 684 (704)
..+...+..+.+++..||+.||++||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111233456788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=308.40 Aligned_cols=253 Identities=24% Similarity=0.415 Sum_probs=204.1
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46788899999999999999998889999999987543 33467899999999999999999999874 45689999999
Q ss_pred CCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++... +..+++..+..++.|++.|++|| |+.+++||||||+||+++.++.++++|||++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence 999999998753 44689999999999999999999 5678999999999999999999999999999876432211
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......++..|+|||++.+..++.++||||||+++||+++ |+.||.+.... ..........
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~---------------- 220 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGY---------------- 220 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCC----------------
Confidence 1223346778999999988889999999999999999999 99999753211 1111111000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
....+..++.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 -RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001112335678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=313.81 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=200.4
Q ss_pred CCCCccccccccCceEEEEEEECC---------------CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD---------------GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIIS 478 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~ 478 (704)
++|++.+.||+|+||.||+++..+ ...||+|.++... ......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987532 2358999987543 233457899999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCCHHHHHhhCC-----------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 005278 479 NCCNIDFKALVLEFMPNGSLEKWLYSHN-----------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNIL 547 (704)
Q Consensus 479 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil 547 (704)
++......++||||+++++|.+++.... ..+++..+..++.|++.|++|| |+.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH---HhcCeeccccChhhEE
Confidence 9999999999999999999999996432 2368889999999999999999 5678999999999999
Q ss_pred eCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh--CCCCCCccccccc
Q 005278 548 LDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT--RKKPTNEIFIGEM 625 (704)
Q Consensus 548 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t--g~~p~~~~~~~~~ 625 (704)
+++++.+||+|||++................++..|+|||+..++.++.++|||||||++|||++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999986643322222233445788999999988889999999999999999998 566776532211
Q ss_pred cHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 626 SLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
................. ...+..++..+.+++.+||+.+|++||++++|++.|+
T Consensus 241 -~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 -VIENTGEFFRNQGRQIY----------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHhhhhcccccc----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111100000000000 0011123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=323.77 Aligned_cols=201 Identities=24% Similarity=0.354 Sum_probs=173.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||+||+|+.. +++.||+|++.... ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999854 68999999997543 223356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++...+ .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999998654 488999999999999999999 568899999999999999999999999999876532110
Q ss_pred c---------------------------------ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCC
Q 005278 571 S---------------------------------VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPT 617 (704)
Q Consensus 571 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~ 617 (704)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012346999999999999999999999999999999999999999
Q ss_pred Cc
Q 005278 618 NE 619 (704)
Q Consensus 618 ~~ 619 (704)
.+
T Consensus 237 ~~ 238 (363)
T cd05628 237 CS 238 (363)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=320.75 Aligned_cols=260 Identities=26% Similarity=0.409 Sum_probs=201.2
Q ss_pred hCCCCccccccccCceEEEEEEE------CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC-C
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNI-D 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 484 (704)
.++|...+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999973 347889999987543 23345688999999999 689999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 005278 485 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 506 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 506 (704)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 5789999999999999986421
Q ss_pred --------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecccc
Q 005278 507 --------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI 578 (704)
Q Consensus 507 --------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 578 (704)
..+++..+..++.|++.|++|| |+.+|+||||||+||+++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1357788889999999999999 56799999999999999999999999999998754332222222334
Q ss_pred ccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhh
Q 005278 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVK 657 (704)
Q Consensus 579 gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (704)
++..|+|||...+..++.++||||||+++|||++ |..||........ ...... .+. ....+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~----~~~-------------~~~~~ 304 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLK----EGT-------------RMRAP 304 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHh----ccC-------------CCCCC
Confidence 5678999999988889999999999999999997 8899865322110 111000 000 00001
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 658 IDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 658 ~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
...+.++.+++..||+.+|++||++.|+++.|+.+.+
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1123467899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.04 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=203.8
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 46789999987543 23456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCC---------------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 005278 487 ALVLEFMPNGSLEKWLYSHN---------------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNN 545 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~N 545 (704)
++|+||+++|+|.+++.... ..+++..++.++.|++.|++||| +.+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999997421 24678889999999999999995 5789999999999
Q ss_pred eeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCcccccc
Q 005278 546 ILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGE 624 (704)
Q Consensus 546 il~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~ 624 (704)
|+++.++.++|+|||++..+..............+..|+|||+..+..++.++|||||||++|||++ |..||.+...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999886543322222222345678999999988899999999999999999998 8888865321
Q ss_pred ccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 625 MSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
.++......... ...+..++.++.+++.+|++.+|++||++.|+++.|++
T Consensus 239 ---~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ---EEVIYYVRDGNV--------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHHHHHHhcCCC--------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 112111111000 01112345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.23 Aligned_cols=257 Identities=23% Similarity=0.389 Sum_probs=205.7
Q ss_pred CCCCccccccccCceEEEEEEECC----CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
++|...+.||+|+||.||+|...+ ...||+|...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788899999999999998543 3468999887554 3455679999999999999999999998876 456899
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++......+++..+..++.+++.|++||| +.+++||||||+||+++.++.++++|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999876666899999999999999999994 5789999999999999999999999999998764432
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
. .......++..|+|||.+....++.++||||||+++||+++ |..||......+ ...+.....
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~------------- 225 (270)
T cd05056 162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENGE------------- 225 (270)
T ss_pred c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCC-------------
Confidence 1 11222335678999999888889999999999999999986 999997643211 111111000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
....+..++..+.+++.+|+..+|++||++.++++.|++++.+
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0111224456788999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=325.96 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=192.7
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.|+..+.||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999985 468899999987542 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC-
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD- 570 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~- 570 (704)
|+++|+|.+++.+.+ .+++.....++.|++.|++|| |+.+|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999997654 478888899999999999999 557899999999999999999999999999753311000
Q ss_pred --------------------------------------------cceeccccccccccCCcccCCCCCCcccceeeHHHH
Q 005278 571 --------------------------------------------SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGIL 606 (704)
Q Consensus 571 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~ 606 (704)
........||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112368999999999999999999999999999
Q ss_pred HHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC---HH
Q 005278 607 LMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS---MK 683 (704)
Q Consensus 607 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt---~~ 683 (704)
+|||++|+.||......+. ...... . .. .. ..+.....+.++.+++.+++ .+|++|++ +.
T Consensus 238 l~elltG~~Pf~~~~~~~~-~~~i~~-~-~~--------~~-----~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLET-QMKVIN-W-QT--------SL-----HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHhCCCCCCCCCHHHH-HHHHHc-c-CC--------Cc-----CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 9999999999976321110 001000 0 00 00 00011123445667777765 49999997 77
Q ss_pred HHHH
Q 005278 684 DAAA 687 (704)
Q Consensus 684 ev~~ 687 (704)
|+++
T Consensus 301 ei~~ 304 (382)
T cd05625 301 EIKA 304 (382)
T ss_pred HHhc
Confidence 7654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=305.14 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=208.5
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999966 79999999886432 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
||+++|+|.+++.. ....+++..+..++.+++.|+.|| |+.+|+||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999863 345588999999999999999999 567899999999999999999999999999886543
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.... .....+++.|+|||+..+..++.++|||||||++|+|++|+.||.... .....+..........
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~------- 226 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCDYP------- 226 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCCCC-------
Confidence 2211 223458889999999988889999999999999999999999985422 2222221111000000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
......++..+.+++.+||+.+|++||++.+|+++|+++.
T Consensus 227 ------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 ------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0011134567889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=325.89 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=195.2
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|...+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788899999999999999985 478999999986532 223456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++...+ .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999997653 478888899999999999999 567899999999999999999999999999964321100
Q ss_pred c-----------c----------------------------------eeccccccccccCCcccCCCCCCcccceeeHHH
Q 005278 571 S-----------V----------------------------------IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGI 605 (704)
Q Consensus 571 ~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv 605 (704)
. . ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001236999999999999989999999999999
Q ss_pred HHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCC---CCH
Q 005278 606 LLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQR---VSM 682 (704)
Q Consensus 606 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---pt~ 682 (704)
++|||++|..||......+ .+..... . ...+ ..+.....+..+.+++.+|+. +|.+| +++
T Consensus 237 il~elltG~~Pf~~~~~~~-~~~~i~~-~-~~~~-------------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE-TYRKIIN-W-RETL-------------YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH-HHHHHHc-c-CCcc-------------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 9999999999996532111 0111100 0 0000 000111234567789999997 77765 589
Q ss_pred HHHHHH
Q 005278 683 KDAAAK 688 (704)
Q Consensus 683 ~ev~~~ 688 (704)
.|+++.
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 988664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=318.21 Aligned_cols=237 Identities=23% Similarity=0.270 Sum_probs=189.8
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999865 68899999987542 22345667888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence 99999887654 4889999999999999999995 5789999999999999999999999999987542221 1223
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~---------------~~ 214 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDE---------------VV 214 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCC---------------CC
Confidence 45689999999999988999999999999999999999999975321 11111111100 00
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMK 683 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 683 (704)
.+...+.++.+++.+|++.||++||++.
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 1112345678899999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.03 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=193.8
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 423 LGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 423 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
||+|+||.||+++.. +|+.+|+|.+..... .....+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999854 699999999864321 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccc
Q 005278 499 EKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577 (704)
Q Consensus 499 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 577 (704)
.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 9988643 345889999999999999999994 5789999999999999999999999999998764322 12334
Q ss_pred cccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhh
Q 005278 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVK 657 (704)
Q Consensus 578 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (704)
.|++.|+|||++.+..++.++||||+||++|||++|+.||...... .............. ... ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--------~~~------~~ 219 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE--------VKF------EH 219 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc--------ccc------cc
Confidence 6899999999998888999999999999999999999999753221 11111111111100 000 00
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 658 IDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 658 ~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
..++.++.+++.+||+.||++||+++|+++..
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12355678999999999999999998776433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=317.49 Aligned_cols=241 Identities=24% Similarity=0.265 Sum_probs=191.5
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 58899999987543 22335577888888876 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT 154 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence 99999887654 4788999999999999999995 5789999999999999999999999999987643221 1123
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~~~---------------~~ 214 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDD---------------VL 214 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC---------------CC
Confidence 346899999999999889999999999999999999999999763211 1111111000 00
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCC-------CHHHHHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRV-------SMKDAAA 687 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rp-------t~~ev~~ 687 (704)
.+..++.++.+++..|++.||++|| ++.++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1112345678899999999999999 6677654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=310.68 Aligned_cols=260 Identities=26% Similarity=0.450 Sum_probs=207.9
Q ss_pred CCCCccccccccCceEEEEEEEC-CCC----EEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGT----NVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.+|...+.||+|+||.||+|... +|+ .+|+|.+..... .....+.+|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999854 333 589998765532 345678899999999999999999999887 67899
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
|+||+++|+|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999887667899999999999999999995 588999999999999999999999999999876543
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
..........++..|+|||......++.++|+||||+++||+++ |+.||...... .+.+.+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~------------ 228 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGE------------ 228 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCC------------
Confidence 32222222334678999999988889999999999999999999 99998763211 1122111100
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
....+..++..+.+++.+||..+|++||++.++++.|+++.++..
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 229 -----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 011112234567889999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=310.78 Aligned_cols=244 Identities=23% Similarity=0.260 Sum_probs=193.1
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 423 LGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 423 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
||+|+||+||++... +++.||+|.+..... ...+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 689999999865432 1234677899999999999999999999999999999999999999
Q ss_pred HHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 499 EKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 499 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
.+++.. ....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++..+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 988853 3345899999999999999999995 578999999999999999999999999999876443221 22
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............ ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~---------------~~~ 219 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILND---------------SVT 219 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhccc---------------CCC
Confidence 3468999999999999999999999999999999999999997532111 111111110000 001
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
.+..++..+.+++..|++.||++|| +++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1223456788999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=312.32 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=203.6
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888899999999999999854 24689999986543 23345788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCC---------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEe
Q 005278 487 ALVLEFMPNGSLEKWLYSHN---------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVS 557 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~ 557 (704)
++||||+++|+|.+++.... ..+++..++.++.|++.|+.|| |+.+|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999997432 2367889999999999999999 46789999999999999999999999
Q ss_pred eeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcC
Q 005278 558 DFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLP 636 (704)
Q Consensus 558 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 636 (704)
|||+++.+.............++..|+|||.+.++.++.++|||||||++||++| |..||..... .....+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~--- 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVID--- 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHhc---
Confidence 9999986644332222233456789999999988889999999999999999998 8889865221 111111110
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.. ....+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 237 ~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GG--------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CC--------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00 00111233567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=315.72 Aligned_cols=259 Identities=26% Similarity=0.455 Sum_probs=204.9
Q ss_pred CCCCccccccccCceEEEEEEEC-CCC----EEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGT----NVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|+..+.||+|+||.||+|... +|+ .||+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56778889999999999999853 444 478888764432 2334688999999999999999999998764 4679
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
++||+++|+|.+++..+...+++..+..++.|++.|++|| |+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---hhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 9999999999999987766789999999999999999999 5678999999999999999999999999999876433
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
..........++..|+|||++.+..++.++|||||||++||+++ |+.||.+... .....++....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~------------ 228 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGE------------ 228 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCC------------
Confidence 22222223346778999999988899999999999999999998 8999865321 11222222110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
..+.+..++..+.+++..||..+|++||+++|+++.|+++.++.
T Consensus 229 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 229 -----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 00111123456788999999999999999999999999986554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=314.43 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=201.3
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCC--EEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGT--NVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 488 (704)
.++|+..+.||+|+||.||+|... ++. .+|+|.+.... ......+.+|++++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888899999999999999864 454 45777765432 23446788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 005278 489 VLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT 553 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~ 553 (704)
||||+++|+|.+++.... ..+++..+..++.|++.|++|| |+.+|+||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEecCCCc
Confidence 999999999999997432 2478899999999999999999 5678999999999999999999
Q ss_pred EEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHH
Q 005278 554 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVK 632 (704)
Q Consensus 554 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 632 (704)
+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||...... ....
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE 234 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHH
Confidence 999999998643211 11122234678999999988889999999999999999998 99998653211 1111
Q ss_pred hhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 633 ESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
. .+... ....+..++..+.+++.+||+.+|++||++.++++.|+.+.+.
T Consensus 235 ~-~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 K-LPQGY-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred H-HhcCC-------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 11100 0001112345678999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.58 Aligned_cols=271 Identities=27% Similarity=0.386 Sum_probs=207.5
Q ss_pred CCCCccccccccCceEEEEEEEC-----CCCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-----DGTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCN--IDFK 486 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 486 (704)
.+|...+.||+|+||.||+|++. ++..+|||.+...... ..+.+.+|++.++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999853 3688999998755432 45689999999999999999999999877 5578
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++||||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999877667899999999999999999995 5789999999999999999999999999998775
Q ss_pred CCCCcc-eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 567 EGDDSV-IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 567 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
...... ......++..|+|||...+..++.++||||||+++|||+||+.|+......... +...............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE 237 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence 332211 111234566799999998888999999999999999999999998653221110 0000000000000000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
.+. .......+..++.++.+++.+||+.+|++||+|.||+++|+++
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHH-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000 0011112234557789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=317.76 Aligned_cols=241 Identities=22% Similarity=0.257 Sum_probs=192.0
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCC-CCceEEeeeeeCCeEEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHR-NLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 490 (704)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++..++|+ +|+++.+++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999865 57899999987543 23345678899999999765 5888999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 9999999999987654 3788999999999999999995 5789999999999999999999999999987532211
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+.. . .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~---~--------~---- 217 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIME---H--------N---- 217 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHc---C--------C----
Confidence 1223446899999999999999999999999999999999999999753211 11111110 0 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
...+...+.++.+++.+|++.||++|++.
T Consensus 218 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ---VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00111234567889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=327.37 Aligned_cols=253 Identities=20% Similarity=0.279 Sum_probs=194.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999854 68999999986532 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++...+ .+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999997654 4788888889999999999995 57899999999999999999999999999753310000
Q ss_pred -----------------------------------------cceeccccccccccCCcccCCCCCCcccceeeHHHHHHH
Q 005278 571 -----------------------------------------SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLME 609 (704)
Q Consensus 571 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~e 609 (704)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112469999999999999999999999999999999
Q ss_pred HhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC---CHHHHH
Q 005278 610 TFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV---SMKDAA 686 (704)
Q Consensus 610 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp---t~~ev~ 686 (704)
|++|+.||.+....+ +..... .. . ... ..+....++..+.+++.+|+ .+|++|+ ++.|++
T Consensus 237 ll~G~~Pf~~~~~~~-----~~~~i~-~~-~----~~~-----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 237 MLVGQPPFLADTPAE-----TQLKVI-NW-E----TTL-----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhhCCCCCCCCCHHH-----HHHHHh-cc-C----ccc-----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999997632211 111000 00 0 000 00001123445667777766 4999999 888886
Q ss_pred HH
Q 005278 687 AK 688 (704)
Q Consensus 687 ~~ 688 (704)
+.
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=309.26 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=200.7
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999985 57899999998755444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++|+|.+++.... .+++..+..++.|++.|++||| +.+|+|||++|+||+++.++.++|+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 99999999987543 4789999999999999999995 57899999999999999999999999999987643221
Q ss_pred eeccccccccccCCcccC---CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 573 IQTMTIATIGYMAPEYGS---EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
......+++.|+|||.+. ...++.++|||||||++|||++|+.||......+. ...+.. ..+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~------------~~~~~ 228 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSK------------SNFQP 228 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeec------------CCCCC
Confidence 122346889999999874 44578899999999999999999999864321110 000000 00000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.........+..+.+++.+||+.+|++||+++++++.
T Consensus 229 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 229 --PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred --CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0001111335678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.39 Aligned_cols=248 Identities=33% Similarity=0.501 Sum_probs=200.6
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCHH
Q 005278 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLE 499 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 499 (704)
++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999777999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred HHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccc
Q 005278 500 KWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA 579 (704)
Q Consensus 500 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 579 (704)
+++......+++..+..++.+++.|++|| |+.+++||||+|+||+++.++.++|+|||++................+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99986655688999999999999999999 567899999999999999999999999999986543222111122334
Q ss_pred cccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhH
Q 005278 580 TIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKI 658 (704)
Q Consensus 580 t~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (704)
+..|+|||.+.++.++.++|+|||||++|||+| |..||...... .......... ....+.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~-----------------~~~~~~ 218 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY-----------------RMPAPQ 218 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC-----------------CCCCCc
Confidence 677999999988899999999999999999999 78888653211 1111111000 011122
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 659 DCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 659 ~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.++..+.+++.+|++.+|++||++.|+++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 34567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=322.97 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=199.1
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999864 68999999986432 2233457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++.... ++...+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999987543 678888889999999999995 578999999999999999999999999999876432
Q ss_pred CCcceeccccccccccCCcccCCC----CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEG----IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..... .. ..
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~----~~-~~--- 265 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMD----HK-NS--- 265 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHc----CC-Cc---
Confidence 21 112345699999999987643 4788999999999999999999999753211 01111100 00 00
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQ--RVSMKDAAAK 688 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~ev~~~ 688 (704)
+ ..+....++.++.+++..|++.+|++ ||++.|+++.
T Consensus 266 --~-----~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 --L-----TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --C-----CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 00111123567888999999999988 9999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.66 Aligned_cols=248 Identities=31% Similarity=0.522 Sum_probs=203.9
Q ss_pred ccccccCceEEEEEEECC----CCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 889999998765433 357889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhC--------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 496 GSLEKWLYSH--------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 496 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
++|.+++... ...+++..++.++.|++.|++|| |+.+++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 46789999999999999999999 568899999999999999999999999999988755
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
...........+++.|+|||......++.++||||+|+++|||++ |..||..... ......... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~----~-------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK----G-------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc----C--------
Confidence 432222334567889999999988889999999999999999999 6999876421 111111110 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.....+..++.++.+++.+|++.+|++||++.|+++.|+
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 -----YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122244677889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.98 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=202.7
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..+|+..+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35888899999999999999985 46899999998765555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++++|.+++... .+++..+..++.|++.|++|| |+.+|+||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 9999999998754 378889999999999999999 567899999999999999999999999999876543221
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+.. ........
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~~-~~~~~~~~----------- 235 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYL-IATNGTPE----------- 235 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHHH-HhcCCCCC-----------
Confidence 122346889999999998888999999999999999999999999653221 11111 00000000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+...+..+.+++.+||..+|++||++.|+++
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0011233456788999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.84 Aligned_cols=240 Identities=24% Similarity=0.295 Sum_probs=189.9
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 57899999987643 22334566777888764 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++... ..+++.....++.|++.|++|| |+.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence 9999999764 3478889999999999999999 567899999999999999999999999999875422211 123
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+... .+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~---------~~---------~ 214 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMD---------NP---------C 214 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---------CC---------C
Confidence 346899999999999989999999999999999999999999753211 111111100 00 0
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMK-DAA 686 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~-ev~ 686 (704)
.+..+...+.+++.+|++.||++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1112345678899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.61 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=201.9
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
++|.+.+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4678889999999999999998777789999876432 234678899999999999999999998754 56789999999
Q ss_pred CCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 495 NGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 495 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
+|+|.+++... ...+++..+..++.+++.|++||| +.+++|+||+|+||++++++.++|+|||++......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 99999999754 345789999999999999999994 578999999999999999999999999999876433221 1
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
.....++..|+|||+..+..++.++||||||+++|||+| |..||.+.... ....+......
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~---------------- 221 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYR---------------- 221 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC----------------
Confidence 222346778999999988889999999999999999999 89998763221 11111111100
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
...+.+.+..+.+++.+||+.+|++||++++|++.|++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 -MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.12 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=199.6
Q ss_pred ccccccCceEEEEEEECC--C--CEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLFD--G--TNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 3689999876654 556789999999999999999999999988 888999999999
Q ss_pred CCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc-e
Q 005278 496 GSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-I 573 (704)
Q Consensus 496 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~-~ 573 (704)
|+|.+++.... ..+++...+.++.|++.|++|| |+.+++||||+|+||+++.++.+||+|||++..+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998654 5689999999999999999999 56789999999999999999999999999998775432211 1
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
.....++..|+|||++.+..++.++|||||||++|||++ |..||......+ ....... .. .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~---~~-------------~ 218 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDK---EG-------------E 218 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh---cC-------------C
Confidence 123457789999999998899999999999999999999 999986532211 1111110 00 0
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
....+..++..+.+++..|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00111234567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.86 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=201.5
Q ss_pred CCCCccccccccCceEEEEEEEC-----------------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-----------------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKI 476 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 476 (704)
++|+..+.||+|+||.||++... ++..+|+|++.... ......+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999998532 23468999987543 2344678999999999999999999
Q ss_pred EeeeeeCCeEEEEEeccCCCCHHHHHhhCC----------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCe
Q 005278 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHN----------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNI 546 (704)
Q Consensus 477 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Ni 546 (704)
++++...+..++||||+++|+|.+++.... ..+++.....++.|++.|++||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999997532 23677889999999999999995 57899999999999
Q ss_pred eeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh--CCCCCCcccccc
Q 005278 547 LLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT--RKKPTNEIFIGE 624 (704)
Q Consensus 547 l~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t--g~~p~~~~~~~~ 624 (704)
+++.++.++++|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986644322222223345678999998888889999999999999999998 678886532211
Q ss_pred ccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 625 MSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
. ............... ..+.+..++..+.+++.+||+.||++||++.||++.|++
T Consensus 242 ~--~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V--IENTGEFFRDQGRQV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H--HHHHHHHHhhccccc----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 000000000000000 001122345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.27 Aligned_cols=239 Identities=22% Similarity=0.334 Sum_probs=189.1
Q ss_pred ccccccCceEEEEEEECC-------------CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 421 NLLGTGSFGSVYKGTLFD-------------GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
+.||+|+||.||+|+..+ ...||+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2258899876654455567889999999999999999999999988999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc-------EEEeeec
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT-------AHVSDFG 560 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~-------~kl~Dfg 560 (704)
+||||+++|+|..++......+++..+..++.|+++|++|| |+.+|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999887666689999999999999999999 5688999999999999987664 8999999
Q ss_pred cceecCCCCCcceeccccccccccCCcccC-CCCCCcccceeeHHHHHHHHh-hCCCCCCccccccccHHHHHHhhcCCC
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYGS-EGIISPKSDVYSYGILLMETF-TRKKPTNEIFIGEMSLKHWVKESLPDG 638 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (704)
++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+......+ ...... .
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~-----~ 224 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYE-----G 224 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHh-----c
Confidence 98755321 2235788899999876 567899999999999999998 5888876522110 000000 0
Q ss_pred cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
.. ........++.+++.+||+.||++||++.|+++.+
T Consensus 225 -------~~-------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 -------QC-------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -------Cc-------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 00011235678899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.95 Aligned_cols=249 Identities=25% Similarity=0.323 Sum_probs=203.0
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|+..+.||+|++|.||+|... +++.|++|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999864 68999999986432 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++++|.+++... ...+++..++.++.+++.|+.||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999864 456899999999999999999995 57899999999999999999999999999987654322
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......|++.|+|||+..+..++.++|+||||+++|||++|+.||..... ........ ....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~---~~~~------------ 218 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKII---RGVF------------ 218 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH---cCCC------------
Confidence 12334688999999999998899999999999999999999999975321 11111111 0000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
...+..++..+.+++.+||+.+|++||++.|+++.
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 --PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01111345678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.84 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=201.9
Q ss_pred HHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 410 IQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 410 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++.+++.+.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445666777789999999999999854 678899999876655566789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCcc--CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeeeccceec
Q 005278 489 VLEFMPNGSLEKWLYSHNYFL--GILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-NMTAHVSDFGISKLL 565 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-~~~~kl~Dfgla~~~ 565 (704)
|+||+++++|.+++......+ ++..+..++.|++.|++||| +.+|+||||||+||+++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999998654434 78888899999999999994 578999999999999986 679999999999866
Q ss_pred CCCCCcceeccccccccccCCcccCCCC--CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGI--ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
..... ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...|....
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~--------- 226 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGM--------- 226 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhh---------
Confidence 43221 122345889999999876543 7889999999999999999999986532111 11110000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. .....+..+..++.+++.+||+.+|++||++.|+++
T Consensus 227 ----~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 ----FK--IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----hc--cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 000112234566889999999999999999999965
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.39 Aligned_cols=241 Identities=22% Similarity=0.249 Sum_probs=192.2
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 490 (704)
+|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+..|..++..+ +|++|+++.+++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 578999999875432 2234566788888877 5899999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 9999999999987654 3788999999999999999995 5789999999999999999999999999997543211
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.. . .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~---~--------~---- 217 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME---H--------N---- 217 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHh---C--------C----
Confidence 1223456899999999999999999999999999999999999999763211 11111110 0 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
...+...+.++.+++.+|++.+|++|++.
T Consensus 218 ---~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00112335567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.39 Aligned_cols=265 Identities=17% Similarity=0.269 Sum_probs=199.9
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57888999999999999999864 68889999987543 22334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++ ++.+++...+..+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 975 89998887666688999999999999999999 457899999999999999999999999999976533221
Q ss_pred eeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh--cCCC-cchhc-----
Q 005278 573 IQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES--LPDG-LTEVV----- 643 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~-~~~~~----- 643 (704)
......+++.|+|||++.+ ..++.++|||||||++|||+||+.||......+. +....+.. .... +....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223467899999998764 5688999999999999999999999975322110 00100000 0000 00000
Q ss_pred -c---ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 644 -D---ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 644 -~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+ +..... .........+.++.+++.+|++.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQ-PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCC-chhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 000000 000111234567789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=317.45 Aligned_cols=237 Identities=24% Similarity=0.290 Sum_probs=187.0
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHH-HHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECE-ILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||+||+|+.. +|+.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999964 689999999875421 22234444444 56789999999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 99999987654 4788899999999999999995 5789999999999999999999999999987542221 1223
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~---------------~~ 214 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNKP---------------LR 214 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCC---------------CC
Confidence 4468999999999999999999999999999999999999997531 111111111100 00
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMK 683 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 683 (704)
.....+..+.+++.+|++.||++||+++
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1112355678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.62 Aligned_cols=241 Identities=23% Similarity=0.273 Sum_probs=193.2
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. +++.||||++.... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 58899999997543 22345677888899888 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|..++.... .+++..+..++.|++.||+|| |+.+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 99999887653 489999999999999999999 567899999999999999999999999999875322211 122
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i~~~~---------------~~ 214 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSILEDE---------------VR 214 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCC---------------CC
Confidence 34689999999999999999999999999999999999999975321 11111100000 00
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSM-----KDAAA 687 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~-----~ev~~ 687 (704)
.+..++..+.+++.+||+.||++||++ .++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 112335668899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.37 Aligned_cols=249 Identities=24% Similarity=0.303 Sum_probs=198.6
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
|++.+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++|||++++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999865 5788899998765555566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|..++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.+|++|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 9999988765566899999999999999999995 5789999999999999999999999999987653321 1123
Q ss_pred cccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 576 MTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
...+++.|+|||++. +..++.++|||||||++|||++|+.||......+ ......... +.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~-~~------------- 226 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE-PP------------- 226 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC-CC-------------
Confidence 346899999999873 4457789999999999999999999987632111 111111000 00
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..++..+.+++..||+.+|++||++.++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 --TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111233457889999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=308.76 Aligned_cols=251 Identities=25% Similarity=0.282 Sum_probs=201.3
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
+.|++.+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999865 58999999987665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
+++++..++.+....+++..+..++.|++.+++|| |+.+++||||+|+||+++.++.++|+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence 99999998876666689999999999999999999 56789999999999999999999999999987543221 11
Q ss_pred eccccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 574 QTMTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.....+++.|+|||++. ...++.++|||||||++|||++|..||...... .....+ .....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~----~~~~~--------- 232 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKI----AKSEP--------- 232 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHH----hcCCC---------
Confidence 22345788999999874 345788999999999999999999998653211 011111 00000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+....+..++.++.+++.+||+.+|++||++.|+++
T Consensus 233 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 ---PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000111233456788999999999999999999965
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.17 Aligned_cols=256 Identities=20% Similarity=0.271 Sum_probs=198.0
Q ss_pred HHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
....++|+..+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334578999999999999999999965 68899999986432 22345678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++||||+++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+|....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999999754 3788889999999999999995 5789999999999999999999999999998764
Q ss_pred CCCCcceeccccccccccCCcccCCC----CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEG----IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
.... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+........
T Consensus 194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~~~~------- 264 (370)
T cd05621 194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMDHKN------- 264 (370)
T ss_pred cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCc-------
Confidence 3221 122345699999999987653 3788999999999999999999999753211 11111111000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQ--RVSMKDAAAK 688 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~ev~~~ 688 (704)
.+ ..+.....+..+.+++..|++.+|.+ ||++.|+++.
T Consensus 265 ---~~-----~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ---SL-----NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---cc-----CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 00111123456777888899755543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.06 Aligned_cols=254 Identities=27% Similarity=0.456 Sum_probs=205.6
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|.+.+.||+|+||.||+|..++++.+|||.+.... ...+.+.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788899999999999999998888899999987542 33467899999999999999999999999888999999999
Q ss_pred CCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++++|.+++.... ..+++..+..++.+++.|++||| +.+++|+||+|+||++++++.++++|||.+........ .
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence 9999999998643 46899999999999999999994 57899999999999999999999999999987643211 1
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......++..|+|||...+..++.++||||+|+++||+++ |+.||.+.... ..........
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~---------------- 221 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERGY---------------- 221 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC----------------
Confidence 1122235678999999998889999999999999999999 99998653211 1111111000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
....+..++..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 -RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001112235678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=303.82 Aligned_cols=249 Identities=28% Similarity=0.337 Sum_probs=204.5
Q ss_pred CCCCccccccccCceEEEEEEECC-CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
++|+..+.||+|+||.||+|...+ ++.+|+|.+..... .+.+.+|++++++++||||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999764 88999999865432 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++++|.+++......+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 999999999876777899999999999999999995 57899999999999999999999999999987644321 1
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||........... .. .. .. ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--~~----~~----~~-------~~ 218 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--IP----NK----PP-------PT 218 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--hc----cC----CC-------CC
Confidence 2234578899999999888999999999999999999999999875322111000 00 00 00 00
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..+...+.+++.+||+.+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1112234567889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.72 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=189.6
Q ss_pred cccccCceEEEEEEECC---CCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCC
Q 005278 422 LLGTGSFGSVYKGTLFD---GTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGS 497 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 497 (704)
.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 68999999999998653 45789998865432 334578889999999999999999999999889999999999999
Q ss_pred HHHHHhhCC----CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 498 LEKWLYSHN----YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 498 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999997432 24567778889999999999995 57899999999999999999999999999976543322222
Q ss_pred eccccccccccCCcccCCC-------CCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 574 QTMTIATIGYMAPEYGSEG-------IISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+. ..+.. ........++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~~---~~~~~~~~~~ 233 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTV---REQQLKLPKP 233 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHh---hcccCCCCCC
Confidence 2334578899999987532 35789999999999999996 9999975432211 11100 0000011111
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.. ....+..+.+++..|+ .+|++||+++||++.|+
T Consensus 234 ~~---------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RL---------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cc---------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 1122345777999998 58999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.52 Aligned_cols=250 Identities=30% Similarity=0.494 Sum_probs=204.4
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999864 88999999876543 4567899999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++++|.+++.... ..+++..+..++.|++.|+.|| |+.+++||||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999997554 3589999999999999999999 567899999999999999999999999999987632211
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
....+..|+|||++.+..++.++||||||+++||+++ |..||...... .+...... ..
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~----~~------------ 216 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEK----GY------------ 216 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhc----CC------------
Confidence 2235678999999988889999999999999999997 99998653211 11111110 00
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
....+..++..+.+++.+|++.+|++||++.|++++|+.+
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 -RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0011123456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=303.93 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=200.8
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc-----hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-----ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|...+.||+|++|.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788999999999999999985 468999999886432 1123568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
|+||+++++|.+++.... .+++.....++.+++.|+.|| |+.+|+||||+|+||++++++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999987654 378888999999999999999 5578999999999999999999999999999866432
Q ss_pred CCcce-eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVI-QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
..... .....++..|+|||+..+..++.++||||+|+++||+++|+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~--------- 224 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQPT--------- 224 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHHHhccCC---------
Confidence 21111 12345788999999999988999999999999999999999998653111 11100000000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
....+..++..+.+++.+||+.+|++||++.|+++.
T Consensus 225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001122345567889999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.73 Aligned_cols=240 Identities=21% Similarity=0.260 Sum_probs=189.6
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. +|+.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999865 68899999987543 22334566778887765 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||+++...... ....
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence 99999987653 4788899999999999999995 5789999999999999999999999999987532211 1223
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... .+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~~~------~~---------~ 214 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIRVD------TP---------H 214 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC------CC---------C
Confidence 45689999999999999999999999999999999999999975321 1111110000 00 0
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMK-DAA 686 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~-ev~ 686 (704)
.+..++.++.+++.+|++.||++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1112345678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.94 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=191.6
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--------C
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNI--------D 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~ 484 (704)
..+|...+.||+|+||.||+|... +++.||||++... .....+|+.+++.++||||+++.+++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999864 6899999987543 23345799999999999999999887432 2
Q ss_pred eEEEEEeccCCCCHHHHHh---hCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeeec
Q 005278 485 FKALVLEFMPNGSLEKWLY---SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-TAHVSDFG 560 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-~~kl~Dfg 560 (704)
..++||||+++ ++.+++. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46689999975 7877775 23456899999999999999999995 57899999999999999665 79999999
Q ss_pred cceecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC-
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG- 638 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 638 (704)
+|+.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+ .+...........
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence 9987643322 223468999999998765 468999999999999999999999997632211 1111111100000
Q ss_pred ---------cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 ---------LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+....-+......-....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000000000000011112234567899999999999999999999964
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=303.59 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=198.4
Q ss_pred ccccccCceEEEEEEECC----CCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|.... +..+|+|.+..... ...+.+.+|+++++++.||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999997532 26899999875543 345678999999999999999999998764 467999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce-e
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI-Q 574 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~-~ 574 (704)
|+|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||+++.......... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998655 5899999999999999999994 57899999999999999999999999999987654332211 1
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....++..|+|||...+..++.++||||||+++||+++ |..||..... .....++....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~----------------- 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER----------------- 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc-----------------
Confidence 12234568999999988899999999999999999998 9999976322 222222221110
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
...+..++..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0112234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.13 Aligned_cols=251 Identities=26% Similarity=0.435 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEEC----CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeee-eCCeEEEEEeccC
Q 005278 421 NLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCC-NIDFKALVLEFMP 494 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 494 (704)
+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. ..+..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 24579999875432 334567889999999999999999999775 4556789999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc--c
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS--V 572 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~--~ 572 (704)
+|+|.+++.......++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++.+...... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999876555788888999999999999994 578999999999999999999999999999865432111 1
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCC-CCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRK-KPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......++..|+|||+..+..++.++|||||||++|||++|+ .||..... ......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~---~-------------- 218 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQ---G-------------- 218 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhc---C--------------
Confidence 112234677899999998888999999999999999999954 55543211 111111110 0
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
.....+..++..+.+++..||+.+|++||++.|+++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001111233567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.29 Aligned_cols=238 Identities=22% Similarity=0.308 Sum_probs=187.6
Q ss_pred cccccCceEEEEEEECC-------------------------CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceE
Q 005278 422 LLGTGSFGSVYKGTLFD-------------------------GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 476 (704)
.||+|+||.||+|.... ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998865544445678889999999999999999
Q ss_pred EeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----
Q 005278 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM---- 552 (704)
Q Consensus 477 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~---- 552 (704)
++++.+....++||||+++|+|..++......+++..+..++.|++.|++|| |+++|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYL---EDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999987666789999999999999999999 567899999999999997643
Q ss_pred ---cEEEeeeccceecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHh-hCCCCCCccccccccH
Q 005278 553 ---TAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETF-TRKKPTNEIFIGEMSL 627 (704)
Q Consensus 553 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~-tg~~p~~~~~~~~~~~ 627 (704)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......+ .
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~ 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K 230 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence 3799999988643221 12357788999998765 56899999999999999985 6899987532211 1
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
..+..... ..+......+.+++.+||+.+|++||++.++++.|
T Consensus 231 ~~~~~~~~-------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERFYEKKH-------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHhcc-------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11111000 00011124578899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.72 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=205.2
Q ss_pred CCCCccccccccCceEEEEEEEC--------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNID 484 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 484 (704)
.+|.+.+.||+|+||.||+|+.. .+..||+|.+.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888899999999999999742 12368999887543 23456788999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 005278 485 FKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD 549 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~ 549 (704)
..++++||+++|+|.+++.+.. ..+++..+..++.|++.|++|| |+.+|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEc
Confidence 9999999999999999997532 3478889999999999999999 457899999999999999
Q ss_pred CCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHH
Q 005278 550 ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLK 628 (704)
Q Consensus 550 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~ 628 (704)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+.. ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----HH
Confidence 999999999999987654322222222345678999999999999999999999999999998 888886532 22
Q ss_pred HHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 629 HWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
.+........ ....+..++..+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 244 ~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 244 ELFKLLKEGH--------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHHHHcCC--------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 2221111000 0011223456788999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.36 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=201.3
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
+|+..+.||+|+||.||+++.. +++.+|+|.++... ....+.+..|+.+++.++|+||+++.+.+.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999854 68999999986432 334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++... ...+++.....++.|++.|+.|| |+.+|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999999998753 34578899999999999999999 567899999999999999999999999999987643221
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||.... ..............
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~------------ 218 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGSYK------------ 218 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCCCC------------
Confidence 1223468899999999998889999999999999999999999997521 11111111100000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+..++..+.+++.+||+.||++||++.|++..
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0112334567889999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=302.72 Aligned_cols=253 Identities=23% Similarity=0.405 Sum_probs=204.3
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|...+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++.+++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678889999999999999999877888999988643 2345678899999999999999999999887 6789999999
Q ss_pred CCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++.+. ....++..+..++.+++.|++||| +.+++|+||+|+||+++.++.+||+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 999999999754 445788899999999999999995 57899999999999999999999999999987643222 1
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......++..|+|||++.+..++.++|+|||||++|+++| |..||..... .....+......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~--------------- 221 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYR--------------- 221 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCC---------------
Confidence 1222345678999999998889999999999999999999 8999875321 112222211100
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
.+.....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 --MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00112334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.70 Aligned_cols=253 Identities=24% Similarity=0.312 Sum_probs=203.6
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|++.+.||+|+||.||+|... ++..+|+|.+........+.+..|++++++++||||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999864 6899999998766555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++++|.+++......+++..+..++.|++.|+.||| +.+|+|+||+|+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 9999999999876667899999999999999999994 5789999999999999999999999999987653321 1
Q ss_pred eeccccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 573 IQTMTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
......+++.|+|||++. +..++.++||||||+++|||++|+.||...... .....+.. ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~----~~~-------- 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILK----SEP-------- 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhc----CCC--------
Confidence 123346899999999864 345778999999999999999999999763211 11111100 000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.....+..++..+.+++..||+.+|++||++.++++.
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ----PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011122345578899999999999999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.31 Aligned_cols=252 Identities=24% Similarity=0.278 Sum_probs=209.3
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchh---hhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLER---ASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 487 (704)
....|+..+.||+|.||.||+++.. +|+.+|+|.+.+.... +.+.+.+|+++|+++. |||||.+.+++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3457888899999999999999965 5999999999766532 3468999999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC----CcEEEeeeccce
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN----MTAHVSDFGISK 563 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~----~~~kl~Dfgla~ 563 (704)
+|||++.||.|.+.+... . +++.....++.|++.+++|| |+.+|+|||+||+|+++... +.+|++|||++.
T Consensus 113 lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999999876 3 89999999999999999999 56899999999999999633 479999999999
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+....... .. +.
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-~~------------i~ 251 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-LA------------IL 251 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-HH------------HH
Confidence 8765 23455678999999999999999999999999999999999999999773321111 11 11
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
...+. ...+.....+..+.+++..++..||.+|+++.++++.
T Consensus 252 ~~~~~---f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 RGDFD---FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCCCC---CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11110 1112233456778899999999999999999999873
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.65 Aligned_cols=241 Identities=24% Similarity=0.272 Sum_probs=187.7
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHH-HHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSEC-EILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 678899999875421 1223334443 456788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++.... .+.......++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~ 154 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS 154 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence 99999997654 367788888999999999999 56789999999999999999999999999997543221 1223
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~---------------~~ 214 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKP---------------LQ 214 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCC---------------cC
Confidence 45699999999999999999999999999999999999999975321 11111110000 00
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.....+..+.+++.+|++.+|++||++.+.+.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 11133556788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=303.77 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=202.3
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
.+|+..+.||+|+||.||+|...+++.+|+|.+.... .....+.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677788999999999999988778899999886432 234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|+|.+++......+++..+..++.+++.|++||| +.+++||||+|+||+++.++.++|+|||.++........ ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc-cc
Confidence 99999999876666889999999999999999995 578999999999999999999999999999866432211 11
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....++.+|+|||+..++.++.++||||||+++||+++ |..||..... ....... .... ...
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~-~~~~-~~~---------- 221 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETI-NAGF-RLY---------- 221 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHH-hCCC-CCC----------
Confidence 22345678999999988889999999999999999998 8999865221 1111110 0000 000
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
.+...+..+.+++.+||+.+|++||++.|+++.|
T Consensus 222 --~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 --KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 0111345788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.93 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=203.2
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36889999999999999999985 47999999998765555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++++|.+++.+. .+++..+..++.+++.|+.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 9999999998754 3788899999999999999994 57899999999999999999999999999987643321
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......+++.|+|||...+..++.++|||||||++|++++|+.||............+ . .. .+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-~----~~------------~~ 233 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T----NG------------TP 233 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-c----CC------------CC
Confidence 1223468899999999998889999999999999999999999996532111100000 0 00 00
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+...+..+.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112234456788999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.29 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=188.8
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeeccch---hhhHHHHHHHH-HHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE---RASRSFDSECE-ILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+. .+|+.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999985 4689999999875421 22334555554 56778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|..++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence 99999887543 4889999999999999999995 57899999999999999999999999999875422211 223
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~~--------~~-------~ 214 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILHK--------PL-------V 214 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHcC--------Cc-------c
Confidence 45689999999999999999999999999999999999999965321 1111111100 00 0
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.....+..+.+++.+|++.+|.+||++++.++.
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 011234567789999999999999998644333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=305.49 Aligned_cols=249 Identities=25% Similarity=0.308 Sum_probs=197.5
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 578999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++|+|..+. .+++..+..++.|++.|++||| +.+|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9999997653 2678888999999999999995 5789999999999999999999999999998654321
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccccc--HHHHHHhhcCCCcchhccccchhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMS--LKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||......... ...+........ .+..
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--- 220 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL--- 220 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC---
Confidence 22346899999999999889999999999999999999999999764322211 111111000000 0000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.....+.++.+++.+|++.+|++||+++|+++.
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 -----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011234567899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.08 Aligned_cols=243 Identities=26% Similarity=0.412 Sum_probs=196.8
Q ss_pred cccccccCceEEEEEEEC-CCCEEE---EEEeec-cchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe--EEEEEec
Q 005278 420 CNLLGTGSFGSVYKGTLF-DGTNVA---IKVFNL-QLERASRSFDSECEILRSIRHRNLIKIISNCCNIDF--KALVLEF 492 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~-~~~~va---vK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 492 (704)
..+||+|+|-+||||... +|..|| ||.-.. +.....++|..|+.+|+.|+||||++++++|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 358999999999999854 577776 232111 113345789999999999999999999999988665 7789999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|..|+|..|+.+++. .+......+++||.+||.|||. |.++|||||||-+||+|+ ..|.|||+|.|+|..+....
T Consensus 125 ~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 999999999998765 7888999999999999999999 789999999999999998 56899999999999875432
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
.....|||.|||||... ..|+..+||||||++|+||+|+..||........-+.+-.....|..+..+-|
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d------- 270 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD------- 270 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC-------
Confidence 12368999999999866 78999999999999999999999999875544444444333333443433333
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+++.++|.+|+.. .++||++.|+++
T Consensus 271 ----------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 ----------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 3567899999999 999999999953
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.21 Aligned_cols=259 Identities=20% Similarity=0.271 Sum_probs=199.3
Q ss_pred HHHHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC
Q 005278 408 LDIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNI 483 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 483 (704)
.++....++|++.+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455689999999999999999999865 68899999986432 22345578899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
+..++||||+++|+|.+++.... ++...+..++.|++.|++|| |+.+|+||||||+||+++.++.+||+|||++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999999987543 78888889999999999999 56789999999999999999999999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCC----CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCc
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEG----IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL 639 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (704)
.+..... .......||+.|+|||++... .++.++|||||||++|||++|+.||...... ..+..+.... ...
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~--~~~ 266 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHK--NSL 266 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC--Ccc
Confidence 7643221 122345699999999987653 3788999999999999999999999752210 0111111000 000
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQ--RVSMKDAAAK 688 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~ev~~~ 688 (704)
..+.....+..+.+++..|++..|.+ ||++.|+++.
T Consensus 267 -------------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 -------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -------------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 01111234566788999999844433 6788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=311.94 Aligned_cols=243 Identities=19% Similarity=0.253 Sum_probs=191.6
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. +++.||+|++..... ...+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999864 688999999976432 2345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++...+ .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence 99999887554 4899999999999999999995 5789999999999999999999999999987532211 1123
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccc-cccHHHHHHhhcCCCcchhccccchhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIG-EMSLKHWVKESLPDGLTEVVDANLVREEQAF 654 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+........ ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~~ 220 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------------PI 220 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------------CC
Confidence 456899999999999999999999999999999999999999653221 111122211111110 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005278 655 SVKIDCLLSIMHLALDCCMESPEQRVSMK 683 (704)
Q Consensus 655 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 683 (704)
..+...+..+.+++.+|++.||++||++.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11223345678899999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=300.63 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=204.6
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
++|+..+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999864 67889999997665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++++|.+++......++...+..++.|++.|++||| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence 999999999876566899999999999999999994 57899999999999999999999999999876543211 1
Q ss_pred eccccccccccCCcccCCC---CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 574 QTMTIATIGYMAPEYGSEG---IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....++..|+|||...+. .++.++||||||+++|||+||+.||......... ..... .... ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~~~----~~~~---~~----- 224 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLISK----SNFP---PP----- 224 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHh----ccCC---Cc-----
Confidence 2234678899999998776 8889999999999999999999998763321111 00000 0000 00
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
........+.++.+++.+||+.+|.+||++.||+.
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 --KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00112234567889999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=304.06 Aligned_cols=248 Identities=29% Similarity=0.486 Sum_probs=194.2
Q ss_pred ccccccCceEEEEEEEC-CCC--EEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGT--NVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. ++. .+|+|.+.... ......+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999865 343 46888876432 33446788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeec
Q 005278 496 GSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFG 560 (704)
Q Consensus 496 gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 560 (704)
|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997432 24788999999999999999995 5789999999999999999999999999
Q ss_pred cceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCc
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGL 639 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (704)
++..... .........+..|+|||+.....++.++|||||||++|||++ |..||..... ....... +...
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~-~~~~ 228 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKL-PQGY 228 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHHH-hCCC
Confidence 9863221 111112234677999999988889999999999999999997 9999865321 1111111 1100
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
....+..++..+.+++.+||+.+|.+||++.|+++.|+++.
T Consensus 229 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 -------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00011123456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.14 Aligned_cols=264 Identities=22% Similarity=0.262 Sum_probs=202.5
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999854 68889999886543 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++++|.+++... ..+++..+..++.|+++|++|||+ ..+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999999865 347889999999999999999964 2579999999999999999999999999987653221
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcc------------
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT------------ 640 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 640 (704)
.....++..|+|||...+..++.++||||||+++|||++|+.||.... ......+..........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCC
Confidence 223468899999999888889999999999999999999999986432 11222221111000000
Q ss_pred ---------hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 641 ---------EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 641 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+..+..... .........++.++.+++.+|++.+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00000011245678899999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=299.25 Aligned_cols=248 Identities=30% Similarity=0.450 Sum_probs=199.2
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeee-eCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC-NIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 493 (704)
++|...+.||+|+||.||+|... |..||+|.+... ...+.+.+|+.++++++|+|++++++++. .....++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47888899999999999999754 788999988643 23457889999999999999999999764 456789999999
Q ss_pred CCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++.... ..+++..+..++.+++.|++|| |+.+++||||||+||++++++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999998643 3478999999999999999999 56789999999999999999999999999988653321
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
....++..|+|||+..+..++.++|||||||++|||++ |+.||... .......... ...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~-~~~------------ 216 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVE-KGY------------ 216 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHh-cCC------------
Confidence 12335678999999988889999999999999999998 99998642 1122211110 000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
....+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 -KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0011123456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=320.08 Aligned_cols=265 Identities=22% Similarity=0.220 Sum_probs=199.2
Q ss_pred hCCCCccccccccCceEEEEEEEC---CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF---DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
..+|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3678999987532 34568999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
|++. ++|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9995 689898843 345899999999999999999995 57899999999999999999999999999987654433
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccc--ccHHHHHHhhc--CCCcchhcccc
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE--MSLKHWVKESL--PDGLTEVVDAN 646 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~ 646 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ..+....+... +..+.......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 333334579999999999999999999999999999999999999986633221 11111111110 00000000000
Q ss_pred c-----------hh--hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 647 L-----------VR--EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 647 ~-----------~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+ .. ..+........+.++.+++.+|++.||++||++.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00 000000011234567889999999999999999999754
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=320.85 Aligned_cols=264 Identities=19% Similarity=0.224 Sum_probs=197.8
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..+|.+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999865 58899999632 23456899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+. ++|.+++......+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 799999887666799999999999999999999 55789999999999999999999999999998764322222
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccc---c---ccHHHHHHhhcC--CCcchhcc
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIG---E---MSLKHWVKESLP--DGLTEVVD 644 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~---~---~~~~~~~~~~~~--~~~~~~~~ 644 (704)
......||+.|+|||++.+..++.++|||||||++|||++|..|+-..... . ..+...+..... ..+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 223456999999999999999999999999999999999988764322111 0 111222221110 00000000
Q ss_pred ccchhhh--------------hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 ANLVREE--------------QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ~~~~~~~--------------~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+.... ............+.+++.+||+.||.+|||+.|+++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000000 000001122346788999999999999999999975
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=314.76 Aligned_cols=245 Identities=25% Similarity=0.362 Sum_probs=202.2
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCHH
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLE 499 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 499 (704)
-++|+|.||+||-|+.. +...+|||-+.....+....+.+|+..-++++|.|||+++|.+.+.+..-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999954 56679999998777777778999999999999999999999999999999999999999999
Q ss_pred HHHhhCCCcc--CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEeeeccceecCCCCCcceecc
Q 005278 500 KWLYSHNYFL--GILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVIQTM 576 (704)
Q Consensus 500 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~Dfgla~~~~~~~~~~~~~~ 576 (704)
+.++..-.++ .+.+.--+..||.+||.||| +..|||||||-+|||++ -.|.+||+|||.++.+.. .+..+..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence 9998664445 56677778899999999995 56699999999999997 578999999999987743 2333455
Q ss_pred ccccccccCCcccCCCC--CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhh
Q 005278 577 TIATIGYMAPEYGSEGI--ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654 (704)
Q Consensus 577 ~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (704)
..||..|||||++..+. |+.++|||||||++.||.||++||-.+....- .++..++-.. -.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMFkVGmyKv--HP 798 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMFKVGMYKV--HP 798 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhhhhcceec--CC
Confidence 67999999999998764 88999999999999999999999976432211 1111222111 12
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 655 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.+++.+.+...++.+|+.+||.+||+|+++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 456677888999999999999999999999964
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=302.62 Aligned_cols=252 Identities=24% Similarity=0.311 Sum_probs=199.1
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
++|...+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677888999999999999985 468999999987654444566889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++++|.+++...+ .+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 9999999987554 4889999999999999999995 5689999999999999999999999999997664322 11
Q ss_pred eccccccccccCCcccC---CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 574 QTMTIATIGYMAPEYGS---EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....|++.|+|||++. ...++.++|||||||++|||++|+.||........ ...... .... .+..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~----~~~~---~~~~--- 231 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTK----SNFQ---PPKL--- 231 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhc----cCCC---CCcc---
Confidence 23446899999999874 45688899999999999999999999865322111 000000 0000 0000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.....++..+.+++.+|++.+|++||+++++++
T Consensus 232 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 ----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 001123446788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=281.65 Aligned_cols=253 Identities=27% Similarity=0.359 Sum_probs=203.5
Q ss_pred HHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch--------hhhHHHHHHHHHHHhc-CCCCCceEEeeee
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE--------RASRSFDSECEILRSI-RHRNLIKIISNCC 481 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 481 (704)
...+.|+..+.+|.|..++|.++.. .+|...|+|++..... .-.+.-.+|+.+++++ .||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3456788888999999999998874 4789999999864321 1234567899999998 6999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 482 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
.+...++|+|.|+.|.|.+++.+.. .+++....+|++|+..|++|| |.+.|||||+||+|||+|++.++||+|||+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999998654 388999999999999999999 668899999999999999999999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccC------CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGS------EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
|+.+.++.. ....+|||+|+|||.+. ...|+..+|+|+.||+||.++.|.+||-... .+.+...+
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlMLR~I---- 240 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLMLRMI---- 240 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHHHHH----
Confidence 998866543 45568999999999763 3458889999999999999999999985411 11111100
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.++ .+. ...+.+.+.+....+++.+|++.||++|.|++|+++
T Consensus 241 meG-------kyq---F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 241 MEG-------KYQ---FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred Hhc-------ccc---cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 001 000 122344566777889999999999999999999975
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=299.92 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=208.9
Q ss_pred CCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.=|...+.||+|.|+.|-+|+ ..+|+.||||++.+.. .-....+.+|++.|+-++|||||+++++...+...|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 456777889999999999998 4689999999997654 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEeeeccceecCCCCC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~Dfgla~~~~~~~~ 570 (704)
.=.+|+|++|+-++...+.+....+++.||..|+.|+|+.| +||||+||+||.+- .-|-+|++|||++-.+.++..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999999998888999999999999999999997766 99999999999875 678899999999987755442
Q ss_pred cceeccccccccccCCcccCCCCCCc-ccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISP-KSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
....+|...|-|||++.+..|+. ++||||+||++|.+++|+.||+...+.+. +.-++|=.+
T Consensus 175 ---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDCKY-- 236 (864)
T KOG4717|consen 175 ---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDCKY-- 236 (864)
T ss_pred ---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhcccc--
Confidence 34568999999999999888775 68999999999999999999987543321 222223221
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+...+.+..++|..|+..||++|.+.+||+.
T Consensus 237 -----tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 -----TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 234566788899999999999999999999864
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=308.30 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=202.4
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.+|+..+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+..++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999985 578999999987655455677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++++|.+++... .+++..+..++.+++.|++|| |+.+++||||+|+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 171 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFL---HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K 171 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence 999999988754 378999999999999999999 557899999999999999999999999999886543221 1
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
.....++..|+|||.+.+..++.++|||||||++|++++|+.||........ . ......... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~-~~~~~~~~~---------------~ 234 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L-YLIATNGTP---------------E 234 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHhcCCc---------------c
Confidence 2234688999999999988899999999999999999999999966322111 1 111000000 0
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++..+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1112234556888999999999999999999953
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=312.07 Aligned_cols=255 Identities=21% Similarity=0.259 Sum_probs=195.6
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999854 68999999987532 223456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++.+....+++..+..++.|++.|++|| |+++|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999987666689999999999999999999 567899999999999999999999999999976643322
Q ss_pred cceeccccccccccCCcccCC-----CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 571 SVIQTMTIATIGYMAPEYGSE-----GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+......... .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~--~---- 225 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHK--E---- 225 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCC--C----
Confidence 11223468999999998763 4578899999999999999999999965211 11111110000 0
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCC--CCCCCCCHHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCME--SPEQRVSMKDAAAK 688 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--~P~~Rpt~~ev~~~ 688 (704)
... .......++..+.+++.+|+.. ++..||++.++++.
T Consensus 226 ~~~----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 HFQ----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccc----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 0001112345667788887654 33347889888654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.38 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=188.0
Q ss_pred cccccCceEEEEEEECC---CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCC
Q 005278 422 LLGTGSFGSVYKGTLFD---GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGS 497 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 497 (704)
.||+|+||.||+|+..+ ...+|+|.+.... ......+.+|++.++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 4568888775433 2334568899999999999999999999999999999999999999
Q ss_pred HHHHHhhCC----CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 498 LEKWLYSHN----YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 498 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
|.+++.... ...++.....++.|++.|++|| |+.+|+||||||+||++++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999997543 2246777889999999999999 557899999999999999999999999999876433222222
Q ss_pred eccccccccccCCcccC-------CCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 574 QTMTIATIGYMAPEYGS-------EGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.....+++.|+|||+.. ...++.++|||||||++|||++ |..||......+ .+..... ........+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~----~~~~~~~~~ 233 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVR----EQDIKLPKP 233 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhh----ccCccCCCC
Confidence 23345678899999863 3457889999999999999999 778886532211 1111111 111111111
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
. .+..++..+.+++..|| .||++||+++||++.|.
T Consensus 234 ~---------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 Q---------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred c---------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 11133456677888898 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.25 Aligned_cols=248 Identities=26% Similarity=0.469 Sum_probs=196.9
Q ss_pred ccccccCceEEEEEEECC-------CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 421 NLLGTGSFGSVYKGTLFD-------GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999876543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-----cEEEeeecc
Q 005278 493 MPNGSLEKWLYSH------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-----TAHVSDFGI 561 (704)
Q Consensus 493 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-----~~kl~Dfgl 561 (704)
+++|+|.+++... ...+++..+..++.|++.|++||| +.+++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999742 234788999999999999999995 57899999999999999877 899999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcc
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLT 640 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (704)
+................++..|+|||++.++.++.++|||||||++|||+| |..||...... .....+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~---~--- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTA---G--- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhc---C---
Confidence 986644332222233346788999999999999999999999999999998 99998653211 11111110 0
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.....+..++..+.+++.+||+.+|++||++++|.+.|+
T Consensus 230 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 -----------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -----------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 001112234567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.13 Aligned_cols=240 Identities=23% Similarity=0.367 Sum_probs=189.5
Q ss_pred ccccccCceEEEEEEECC--------CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 421 NLLGTGSFGSVYKGTLFD--------GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.+.||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997532 234888887655444556788999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc--------EEEeeecccee
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT--------AHVSDFGISKL 564 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~--------~kl~Dfgla~~ 564 (704)
+++|+|.+++......+++..+..++.|++.|++|| |+.+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999987766789999999999999999999 5678999999999999987765 69999998875
Q ss_pred cCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCC-CCCCccccccccHHHHHHhhcCCCcchh
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRK-KPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
... .....++..|+|||++.+ ..++.++|||||||++||+++|. .|+....... ...... .
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~----~----- 220 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYE----D----- 220 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHH----c-----
Confidence 432 123457889999999876 45789999999999999999985 5554321110 000000 0
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
....+.....++.+++.+||+.+|++||+++|+++.|+
T Consensus 221 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00011122356789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=312.92 Aligned_cols=237 Identities=23% Similarity=0.277 Sum_probs=185.7
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHH-HHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSEC-EILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 689999999875421 2233444454 467889999999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 99998887543 4788888899999999999995 5789999999999999999999999999987532221 1223
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~---------------~~ 214 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHKP---------------LQ 214 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcCC---------------CC
Confidence 4568999999999998899999999999999999999999997532 111111111000 00
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMK 683 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 683 (704)
.+...+..+.+++.+|++.||++||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1112345678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=307.57 Aligned_cols=265 Identities=19% Similarity=0.264 Sum_probs=200.4
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57888999999999999999864 68899999986543 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++ ++|.+++......+++..+..++.|+++|++|| |+.+|+||||||+||++++++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence 97 599999987666789999999999999999999 567899999999999999999999999999976533221
Q ss_pred eeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC----Ccchhccccc
Q 005278 573 IQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD----GLTEVVDANL 647 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 647 (704)
......+++.|+|||++.+ ..++.++|||||||++|||+||+.||......+ ....+...... .+........
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChhhchhhhcccc
Confidence 1223457889999998765 457889999999999999999999997532211 11111111110 0111111000
Q ss_pred hhhh--h------hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 648 VREE--Q------AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 648 ~~~~--~------~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.... + .......++..+.+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 0 00011234556789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=317.22 Aligned_cols=266 Identities=22% Similarity=0.257 Sum_probs=196.4
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-----eEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID-----FKA 487 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 487 (704)
+|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999985 479999999986432 233457889999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+|+||+. ++|.+++.... .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 58888876543 488999999999999999999 557899999999999999999999999999986543
Q ss_pred CCCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh----
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV---- 642 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 642 (704)
... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||.+..... .+...............
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhh
Confidence 221 122334678999999988764 47899999999999999999999997632211 01110000000000000
Q ss_pred ------cccc-ch--hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 643 ------VDAN-LV--REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 643 ------~~~~-~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+... .. ............+.++.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 00 0000000111235678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.33 Aligned_cols=262 Identities=20% Similarity=0.247 Sum_probs=195.1
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-----
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID----- 484 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 484 (704)
..++|+..+.||+|+||.||++.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999985 468999999986432 233456788999999999999999999986543
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 485 -FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 485 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 47899999975 66666643 277888999999999999999 56789999999999999999999999999997
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh--hcCCCcch
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE--SLPDGLTE 641 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 641 (704)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ...|... ........
T Consensus 172 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 172 TACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH----IDQWNKVIEQLGTPSAE 244 (359)
T ss_pred ccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCcHH
Confidence 64322 112334689999999999999999999999999999999999999975321 1111110 00000000
Q ss_pred hc-----------c--ccchhhh-----------hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 642 VV-----------D--ANLVREE-----------QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 642 ~~-----------~--~~~~~~~-----------~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.. . +...... ............+.+++.+|++.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0 0000000 0000011124567899999999999999999999763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.60 Aligned_cols=201 Identities=23% Similarity=0.359 Sum_probs=173.1
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||.||+++.. +++.||+|++.... ......+..|+.++..++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 68999999987532 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++.... .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999997654 488899999999999999999 568899999999999999999999999999875532110
Q ss_pred c---------------------------------ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCC
Q 005278 571 S---------------------------------VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPT 617 (704)
Q Consensus 571 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~ 617 (704)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011346999999999999999999999999999999999999999
Q ss_pred Cc
Q 005278 618 NE 619 (704)
Q Consensus 618 ~~ 619 (704)
..
T Consensus 237 ~~ 238 (360)
T cd05627 237 CS 238 (360)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=311.21 Aligned_cols=242 Identities=21% Similarity=0.250 Sum_probs=191.7
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 490 (704)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+..|..+++.+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677789999999999999854 68999999987543 223345778888888885 577888999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 9999999999987654 3889999999999999999995 5789999999999999999999999999987543221
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+. ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~---~~~------------ 217 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIM---EHN------------ 217 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH---hCC------------
Confidence 1123346899999999999889999999999999999999999999763211 1111111 000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMK 683 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 683 (704)
...+..++.++.+++.+|++.+|++|++..
T Consensus 218 ---~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 ---VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ---CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 011123345678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=301.22 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=199.6
Q ss_pred CCCccccccccCceEEEEEEECCCCEEEEEEeeccc------hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL------ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
+|...+.||+|+||+||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477888999999999999998889999999886432 12335688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
+||+++++|.+++.+.. .+++..+..++.|++.|++||| +.+|+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999997654 4788999999999999999995 5779999999999999999999999999987653211
Q ss_pred C----cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 570 D----SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 570 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
. ........++..|+|||+..+..++.++|||||||++||+++|+.||...... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~----- 227 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAMFYIGAHRGLM----- 227 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHHHHhhhccCCC-----
Confidence 1 11122345899999999999888999999999999999999999999653211 1110000000000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++..+.+++.+||+.+|++||++.|+++
T Consensus 228 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 --------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011234566788999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=306.18 Aligned_cols=255 Identities=24% Similarity=0.296 Sum_probs=203.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999854 68999999876543 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++|+|.+++.+.+ .+++.....++.+++.|+.|||+ ..+++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 99999999887643 47899999999999999999974 3479999999999999999999999999987543221
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccc------cHHHHHHhhcCCCcchhcccc
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM------SLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.....|+..|+|||++.+..++.++|||||||++|+++||+.||......+. ....+........
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 229 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-------- 229 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--------
Confidence 1234689999999999888899999999999999999999999986432210 1111111111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
........++..+.+++.+|++.||++||++.|++++.
T Consensus 230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00001112456788999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=303.99 Aligned_cols=249 Identities=23% Similarity=0.275 Sum_probs=197.2
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
|+..+.||+|+||+||+|... +++.+|+|.+..... .....+.+|+++++.++|+||+++.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999864 689999999865431 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++... ...+++..+..++.|++.|+.|| |+.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999988754 34589999999999999999999 567899999999999999999999999999976543221
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
.....|+..|+|||++.+..++.++|+|||||++||+++|..||....... ....+.. ......
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~-~~~~~~------------ 221 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDR-RVLETE------------ 221 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hhhccc------------
Confidence 223468999999999988899999999999999999999999997532111 1111111 111100
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
......++..+.+++..|++.||++||+ +.|+++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0011123456788999999999999999 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=302.43 Aligned_cols=248 Identities=26% Similarity=0.309 Sum_probs=201.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999865 68999999987553 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++++|.+++... .+++..+..++.|++.|+.|| |+.+++||||+|+||++++++.++++|||+++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-- 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--
Confidence 9999999999865 589999999999999999999 557899999999999999999999999999988754321
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......+++.|+|||+..+..++.++||||||+++|||+||+.||....... ... ...... .+...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~-~~~~~~----~~~~~---- 219 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLF-LIPKNN----PPSLE---- 219 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHH-HhhhcC----CCCCc----
Confidence 1233468889999999998889999999999999999999999997532111 000 000000 00000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...++..+.+++..||..+|++||+++++++
T Consensus 220 ----~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 ----GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ----ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0014556888999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.18 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=197.7
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
|+..+.||+|+||.||++... +++.||||.+.... ......+..|+.++++++|++++.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 666789999999999999854 68999999986542 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++... ...+++..+..++.|++.|+.|| |+.+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999998643 34588999999999999999999 467899999999999999999999999999976543221
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+ .... ....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~~~-~~~~----------- 221 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ERLV-KEVQ----------- 221 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH-Hhhh-hhhh-----------
Confidence 123468999999999999999999999999999999999999997632211 00010 0000 0000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
......++..+.+++..||+.||++||+ +.|+++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 --EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0011234556789999999999999999 788865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=335.67 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=198.7
Q ss_pred HHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCe
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN--IDF 485 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 485 (704)
....++|.+.+.||+|+||+||+|+.. ++..+|+|.+.... ......+..|+.++++++||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 445578999999999999999999864 57889999886432 3345678899999999999999999998855 456
Q ss_pred EEEEEeccCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcC----CCCcEecCCCCCCeeeCC--------
Q 005278 486 KALVLEFMPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGH----STPMVHCDLKPNNILLDE-------- 550 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h----~~~ivH~dlk~~Nil~~~-------- 550 (704)
.++||||+++|+|.+++... ...+++..++.|+.||+.||+|||... ..+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999742 345899999999999999999998632 256999999999999964
Q ss_pred ---------CCcEEEeeeccceecCCCCCcceeccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCCCCCc
Q 005278 551 ---------NMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKKPTNE 619 (704)
Q Consensus 551 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~ 619 (704)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23589999999987643221 233468999999998754 4588999999999999999999999965
Q ss_pred cccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 620 IFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. ....+....... +.+ .....+..+.+++..||+.+|.+||++.|+++
T Consensus 246 ~~----~~~qli~~lk~~-------p~l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 AN----NFSQLISELKRG-------PDL--------PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CC----cHHHHHHHHhcC-------CCC--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 122221111000 000 01123456889999999999999999999984
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=304.11 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=197.6
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC------
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNI------ 483 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 483 (704)
.+.+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35667888899999999999999854 68899999986542 3345788999999998 799999999998653
Q ss_pred CeEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 484 DFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
...++||||+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||+|+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4578999999999999999864 345889999999999999999995 578999999999999999999999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD 637 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (704)
....... .......|++.|+|||++. +..++.++|||||||++|||++|+.||...... ..+... ..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~~--~~ 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLI--PR 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHHH--hc
Confidence 8654321 1223346899999999875 345788999999999999999999998653211 111100 00
Q ss_pred CcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 638 GLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ..+. .....++..+.+++.+||+.+|.+||++.|+++
T Consensus 231 ~----~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 N----PAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C----CCCC--------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 0000 011123456889999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=305.39 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=201.5
Q ss_pred cchHHHHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeee-
Q 005278 405 TSYLDIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCC- 481 (704)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~- 481 (704)
..+.++..+.++|+..+.||+|+||.||+|... +++.+|+|++... ......+..|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344556678899999999999999999999854 6889999987543 22345688899999999 6999999999874
Q ss_pred ----eCCeEEEEEeccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 482 ----NIDFKALVLEFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 482 ----~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
..+..++||||+++|+|.+++.. ....+++..+..++.|++.|+.|| |+.+|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCCCHHhEEECCCCCE
Confidence 34568999999999999998863 334578889999999999999999 45789999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHH
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH 629 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~ 629 (704)
+++|||++..+..... ......|++.|+|||++. +..++.++||||+||++|||++|+.||...... ..
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~ 237 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RA 237 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HH
Confidence 9999999987643221 122346899999999875 345788999999999999999999998653211 11
Q ss_pred HHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 630 WVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+.. ......... ..+..++..+.+++.+||+.+|++||++.|+++.
T Consensus 238 ~~~-~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFK-IPRNPPPTL------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Hhh-ccccCCCcc------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 100 000000000 0111234568889999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.23 Aligned_cols=238 Identities=23% Similarity=0.393 Sum_probs=189.2
Q ss_pred ccccccCceEEEEEEECC-C----------CEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 421 NLLGTGSFGSVYKGTLFD-G----------TNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
+.||+|+||.||+|...+ + ..+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 368999999999998654 3 25778876544332 6788999999999999999999999887 778999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-------cEEEeeeccc
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-------TAHVSDFGIS 562 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-------~~kl~Dfgla 562 (704)
|||+++|+|.+++......+++..+..++.|++.|++|| |+.+|+||||||+||+++.++ .+|++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999987665689999999999999999999 568899999999999999887 7999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCC--CCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCc
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEG--IISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGL 639 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (704)
..... .....++..|+|||++.+. .++.++||||||+++||+++ |..||...... ....+... ..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~---~~- 223 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQD---QH- 223 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhc---CC-
Confidence 86543 1223467789999998776 78999999999999999999 57777653211 11111110 00
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.. +. .....+.+++.+||..+|++||++.|+++.|+
T Consensus 224 -------~~------~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -------RL------PM--PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------CC------CC--CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 00156788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=302.38 Aligned_cols=252 Identities=31% Similarity=0.418 Sum_probs=198.0
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhh--HHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERAS--RSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
|+..+.||+|+||+||+++.. +++.+|+|++........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999965 567899999987643322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++++|.+++... ..+++..+..++.|+++||++||+ .+|+|+||||+||++++++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred cccccccccccc-cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--ccccc
Confidence 999999999833 347999999999999999999964 689999999999999999999999999998652 22233
Q ss_pred eccccccccccCCcccC-CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 574 QTMTIATIGYMAPEYGS-EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
.....++..|+|||+.. +..++.++||||+|+++|+|++|..||..... ............. ... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~--------~~~---~ 221 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKR--------PLP---S 221 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHT--------HHH---H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcccc--------ccc---c
Confidence 44567899999999988 88899999999999999999999999986410 0011111100000 000 0
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...........+.+++..||+.||++||++.|+++
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000011367899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.11 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=196.6
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|...+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..++|++|+++.+++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999865 68899999986532 223445788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++......+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999987655688999999999999999999 568899999999999999999999999999987643221
Q ss_pred cceeccccccccccCCcccCC-----CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 571 SVIQTMTIATIGYMAPEYGSE-----GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.......||++|+|||++.+ +.++.++|||||||++|||++|+.||..... ........... .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~------~ 225 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHE------E 225 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCC------C
Confidence 12233569999999998765 5678899999999999999999999965211 11111110000 0
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQ--RVSMKDAAAK 688 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~ev~~~ 688 (704)
.. .......+.+.++.+++.+|+...|++ |++++++.+.
T Consensus 226 ~~----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RF----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cc----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 000011123566788999988865544 4578877653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=299.44 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=202.3
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677789999999999999864 58899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++|+|.+++... .+++.....++.+++.|++|| |+.+++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence 9999999998754 378889999999999999999 567899999999999999999999999999987643221
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......++..|+|||++.+..++.++|+|||||++|||+||..||....... .... .... .
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~-~~~~-------------~ 217 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLFL-IPKN-------------N 217 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hhhh-hhcC-------------C
Confidence 1223457889999999988889999999999999999999999987532211 0000 0000 0
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.......++..+.+++..||+.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 011223456778899999999999999999999766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=291.13 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=203.5
Q ss_pred CCCCccccccccCceEEEEEEECC-CCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
+.|+..+.||+|.-|+||+++..+ +..+|+|++.+.. .....+.+.|.++|+.+.||.+..+++.++.+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356677899999999999999764 5899999997654 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC-
Q 005278 491 EFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG- 568 (704)
Q Consensus 491 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~- 568 (704)
|||+||+|+..++++ +..+++..+.-++..+..||+|| |-.|||.|||||+|||+.++|++-|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999854 56689999999999999999999 6689999999999999999999999999997543110
Q ss_pred -------------------------------C-C---------------------cceeccccccccccCCcccCCCCCC
Q 005278 569 -------------------------------D-D---------------------SVIQTMTIATIGYMAPEYGSEGIIS 595 (704)
Q Consensus 569 -------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 595 (704)
. . .......+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0011223689999999999999999
Q ss_pred cccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCC
Q 005278 596 PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMES 675 (704)
Q Consensus 596 ~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~ 675 (704)
.++|-|+|||++|||+.|..||.+... +..+. .++.+.+ .++.....+..+.++|++.+.+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~-~~Tl~------------NIv~~~l-----~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNN-KETLR------------NIVGQPL-----KFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCc-hhhHH------------HHhcCCC-----cCCCCCcchhHHHHHHHHHhccC
Confidence 999999999999999999999987432 22222 2222221 12222245677889999999999
Q ss_pred CCCCCC----HHHHHH
Q 005278 676 PEQRVS----MKDAAA 687 (704)
Q Consensus 676 P~~Rpt----~~ev~~ 687 (704)
|++|.. |.||.+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999997 777754
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=296.98 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=202.7
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|+..+.||+|+||.||.++. .+++.+++|.+.... ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999984 468999999886543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++... ...+++..+..++.|++.|++|| |+.+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999865 45689999999999999999999 457899999999999999999999999999987644321
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......+++.|+|||+..+..++.++||||||+++|||++|..||..... .............
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~----------- 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQGNYT----------- 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCC-----------
Confidence 22334689999999999888889999999999999999999999865211 1111111111000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+..++..+.+++.+||+.+|++||++.|+++.
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0112345668889999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.80 Aligned_cols=255 Identities=21% Similarity=0.253 Sum_probs=196.4
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.++..++|++|+++.+++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47888999999999999999865 57889999986432 223345888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++.+....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999876566899999999999999999995 57899999999999999999999999999976533221
Q ss_pred cceeccccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 571 SVIQTMTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.......... .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~-~---- 226 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKE-R---- 226 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCCc-c----
Confidence 1223356999999999875 3468889999999999999999999997521 1111111110000 0
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQ--RVSMKDAAAK 688 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~ev~~~ 688 (704)
. ........++..+.+++.+|+..+|++ |+++.|+++.
T Consensus 227 -~----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 -F----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -c----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 000011234566778888887654444 6889988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.63 Aligned_cols=264 Identities=25% Similarity=0.309 Sum_probs=193.3
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchh--hhHHHHHHHHHHHhc---CCCCCceEEeeeee-----CC
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLER--ASRSFDSECEILRSI---RHRNLIKIISNCCN-----ID 484 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 484 (704)
+|+..+.||+|+||+||+|+.. +++.||+|.++..... ....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999864 6899999998754321 223556677777665 69999999998864 34
Q ss_pred eEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 485 FKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
..++||||++ ++|.+++... ...+++..+..++.|++.|++|| |+.+|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5789999997 4898888754 34589999999999999999999 55789999999999999999999999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh-cCC--Ccc
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES-LPD--GLT 640 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~--~~~ 640 (704)
...... ......||..|+|||++.+..++.++||||+||++|||++|+.||...... ..+....... .+. .+.
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence 764322 123346889999999998888999999999999999999999998653221 1111111110 000 000
Q ss_pred hhc---cccchhhh--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 641 EVV---DANLVREE--QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 641 ~~~---~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... ........ ........++..+.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000000 000111234566789999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.58 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=199.3
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46788899999999999999965 78999999887543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC--CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSH--NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
+++++|.+++... ...+++..+..++.+++.|+.|||+ +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999998764 3358999999999999999999963 3589999999999999999999999999997653221
Q ss_pred cceeccccccccccCCcccCCCC------CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGI------ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
.....+++.|+|||.+.+.. ++.++|+|||||++|||++|+.||....... .... .. ...+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~-~~--------~~~~ 224 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQ-LS--------AIVD 224 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHH-HH--------HHhh
Confidence 22345788999999875543 5789999999999999999999996532111 0000 00 0000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. .....+.+++.++.+++.+|++.+|++||++.++++
T Consensus 225 ~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 225 G------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred c------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0 001112235667889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=302.58 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=206.6
Q ss_pred HHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEE
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 487 (704)
......|++.++||+||.+.||++...+.+.+|+|++.... ......|.+|+..|.++ .|.+||++++|-..++..|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34456789999999999999999998888899998765432 34557799999999999 4999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||= ..+|..+|.+.....+...+..+..|+++|+.++ |+.||||.||||.|+++- .|.+||+|||+|..+..
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 999976 4599999997766565457888999999999999 557899999999999986 46899999999999887
Q ss_pred CCCcceeccccccccccCCcccCCC-----------CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEG-----------IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP 636 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 636 (704)
...+......+||+-||+||.+... +.+.++||||+||++|+|+.|+.||+.... .|.+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aK---- 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAK---- 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHH----
Confidence 7777777778999999999976432 266789999999999999999999987322 2222
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+..+.++.-.-..+..+.. .+++++|..|++.||++||+..|+++
T Consensus 582 --l~aI~~P~~~Iefp~~~~~----~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 --LHAITDPNHEIEFPDIPEN----DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHhhcCCCccccccCCCCc----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 3344454332222222221 23889999999999999999999976
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=279.78 Aligned_cols=251 Identities=22% Similarity=0.260 Sum_probs=198.1
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+.+.+..||.|..|.||+++.. +|..+|||.+.... .++.+++...++++..- .+|.||+.+|+|.....+.+.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3445667999999999999865 68999999997654 23445566667666655 499999999999998888999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
|.. .+...+.+-...+++.-.-++...+..||.||.+. .+|+|||+||+|||+|+.|++|+||||++-.+-+ +.
T Consensus 173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---Sk 246 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SK 246 (391)
T ss_pred HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeec---cc
Confidence 843 66666766666788888888999999999999864 5799999999999999999999999999977643 34
Q ss_pred eeccccccccccCCcccCCC---CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 573 IQTMTIATIGYMAPEYGSEG---IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
..+..+|.+.|||||.+... .|+-++||||||++++|+.||+.||.+...+...+..... ..|
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~eP------------- 312 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEP------------- 312 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCC-------------
Confidence 45667899999999987644 6888999999999999999999999875443333333222 111
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+..+....++..+.+++..|++.|+.+||...++++.
T Consensus 313 --P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 --PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1122222367788999999999999999999998753
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.37 Aligned_cols=195 Identities=23% Similarity=0.279 Sum_probs=159.3
Q ss_pred cccccccCceEEEEEEEC---CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeEEEEEeccC
Q 005278 420 CNLLGTGSFGSVYKGTLF---DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKALVLEFMP 494 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 494 (704)
..+||+|+||+||+|+.. +++.||+|.+... .....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999854 4678999988643 223457789999999999999999998854 456789999986
Q ss_pred CCCHHHHHhhC--------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----CCCCcEEEeeeccc
Q 005278 495 NGSLEKWLYSH--------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL----DENMTAHVSDFGIS 562 (704)
Q Consensus 495 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~----~~~~~~kl~Dfgla 562 (704)
++|.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4888887632 23478889999999999999999 56789999999999999 46678999999999
Q ss_pred eecCCCCCc-ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCcc
Q 005278 563 KLLGEGDDS-VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEI 620 (704)
Q Consensus 563 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~ 620 (704)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876432211 12234568999999998876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.32 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=194.6
Q ss_pred cccccccc--CceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 419 ECNLLGTG--SFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 419 ~~~~ig~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
..++||+| +|++||+++. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 7889999985 478999999987543 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++..+ ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999754 344899999999999999999994 5789999999999999999999999998754432211100
Q ss_pred -----eeccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcc-----
Q 005278 573 -----IQTMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT----- 640 (704)
Q Consensus 573 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 640 (704)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... .......+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhcCCccccccccchh
Confidence 1112346778999999875 458899999999999999999999997633221111 111111100000
Q ss_pred --h--------hccccchh------------hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 641 --E--------VVDANLVR------------EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 641 --~--------~~~~~~~~------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+ ..+..... .....+....+...+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 00000000 00001112234567889999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.01 Aligned_cols=252 Identities=24% Similarity=0.284 Sum_probs=203.9
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778889999999999999865 68999999987653 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS-TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~-~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++++|.+++......++......++.|++.|++|| |+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999999999987656689999999999999999999 56 8999999999999999999999999999876532211
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
....++..|+|||+..+..++.++||||||+++|++++|+.||.....................
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 220 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------------- 220 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-------------
Confidence 1156888999999999889999999999999999999999999764222122222211111000
Q ss_pred hhhhhhH-HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 652 QAFSVKI-DCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 652 ~~~~~~~-~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+. .++..+.+++..||..+|++||++.|++.
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 221 -PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 000111 14567889999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.74 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=201.9
Q ss_pred CCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
++|+....||+|+||.||+|+.. +.+.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999854 3567999988654333 4567899999999999999999999999988999
Q ss_pred EEEeccCCCCHHHHHhhCC--------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 488 LVLEFMPNGSLEKWLYSHN--------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
+||||+++|+|.+++.... ..+++..+..++.|++.|++|| |+.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997543 1589999999999999999999 5678999999999999999999999999
Q ss_pred ccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCC
Q 005278 560 GISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDG 638 (704)
Q Consensus 560 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (704)
|++....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||...... ........ ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~---~~ 235 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQA---GK 235 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHc---CC
Confidence 9987543221 112233356788999999888888999999999999999999 78888653221 11111110 00
Q ss_pred cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.. ......++..+.+++.+|++.+|++||++.|+++.|.
T Consensus 236 ~~-------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LE-------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cC-------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 0011134567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=291.30 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=209.2
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
-|.+++++|+|+||.||+|..+ +|+.+|+|.+.. ..+-.++..|+.+|++...|++|+++|.+......++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3566789999999999999854 699999998754 4556788999999999999999999999998889999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
.|++.+.++.++..+.+..+..+++..+.||+|||. ..-+|||||+.|||++.+|.+|++|||.|-.+.+. -...
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKR 186 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhh
Confidence 999999999888889999999999999999999964 56799999999999999999999999999766432 1223
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (704)
..+.|||.|||||++..-.|..++||||+|++..||.-|++||.+..+.... + +.+. ...+.+
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------------F---MIPT--~PPPTF 249 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------------F---MIPT--KPPPTF 249 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------------E---eccC--CCCCCC
Confidence 4568999999999999989999999999999999999999999875432110 0 0000 011233
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 655 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..++..+.++.+++++|+-+.|++|-|+-++++.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 4456778889999999999999999999888764
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=300.18 Aligned_cols=266 Identities=22% Similarity=0.247 Sum_probs=199.9
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|+....||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999865 689999999864422 233567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|++++++..+.... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 99998888776543 34899999999999999999994 57899999999999999999999999999987654322
Q ss_pred ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHH---hhcCC--------Cc
Q 005278 572 VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK---ESLPD--------GL 639 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~--------~~ 639 (704)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+. ...+.. ...+. ..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccccc
Confidence 1223457889999998765 5578899999999999999999999976432211 111110 00000 00
Q ss_pred -chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 640 -TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 640 -~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.....+...............+..+.+++.+||+.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000000111233567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=298.51 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=197.8
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---------hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---------RASRSFDSECEILRSIRHRNLIKIISNCCNIDF 485 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 485 (704)
+|.....||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999854 688999998864321 122568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++|+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999997653 4788899999999999999995 578999999999999999999999999999876
Q ss_pred CCCCCc----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcch
Q 005278 566 GEGDDS----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641 (704)
Q Consensus 566 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (704)
...... .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||...... ... ... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-~~~-~~~--- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAI-FKI-GEN--- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHH-HHH-hcc---
Confidence 422111 1111235788999999998888999999999999999999999999763211 110 000 000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. ...+...+..+.+++.+||+.+|.+||++.|+++
T Consensus 228 -~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -AS---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -CC---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 0111234567888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=295.82 Aligned_cols=249 Identities=31% Similarity=0.515 Sum_probs=200.6
Q ss_pred CccccccccCceEEEEEEECC-----CCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 418 NECNLLGTGSFGSVYKGTLFD-----GTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++.+.||+|+||.||+++..+ +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998653 388999998755433 56789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCc-cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 492 FMPNGSLEKWLYSHNYF-LGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
|+++++|.+++...... +++..++.++.|++.|++|| |+.+++||||+|+||+++.++.++++|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999865444 89999999999999999999 567899999999999999999999999999987754422
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
... ....+++.|+|||...+..++.++||||+|+++|+|++ |..||..... ....+......
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~-------------- 221 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGY-------------- 221 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC--------------
Confidence 211 12337789999999988889999999999999999998 7888765211 11111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
....+..++.++.+++.+|++.+|++|||+.|+++.|
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011112456788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=302.99 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=199.2
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566778999999999999854 58899999987443 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++++|.+++... .+++..+..++.|++.|+.|| |+.+++|+||+|+||++++++.++++|||++..+..... .
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06642 85 GGGSALDLLKPG--PLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEEeCCCCEEEccccccccccCcch--h
Confidence 999999988653 478899999999999999999 568899999999999999999999999999987643221 1
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
.....++..|+|||++.+..++.++|||||||++|||++|+.|+....... ...+.. ... .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~----~~~----~~-------- 219 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIP----KNS----PP-------- 219 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhh----cCC----CC--------
Confidence 223457889999999998889999999999999999999999987532211 111110 000 00
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.....++..+.+++.+||+.+|++||++.|+++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 -TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011234566889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.02 Aligned_cols=264 Identities=23% Similarity=0.296 Sum_probs=196.8
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|+..+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999864 689999999865432 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC--CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSH--NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
++ ++|.+++... ...+++..+..++.|++.||+|| |+.+|+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 6898888743 25689999999999999999999 56789999999999999999999999999998654321
Q ss_pred cceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC--CC-c---chhc
Q 005278 571 SVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP--DG-L---TEVV 643 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~-~---~~~~ 643 (704)
.......+++.|+|||++.+ ..++.++|||||||++|||+||+.||.+...... .......... .. + ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhH
Confidence 11223457889999998765 4578899999999999999999999975321110 0000000000 00 0 0000
Q ss_pred c-----ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 644 D-----ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 644 ~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+ +..... ........++.++.+++.+|++.||++|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKG-SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcc-hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 000000 000011124567789999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=295.89 Aligned_cols=251 Identities=20% Similarity=0.338 Sum_probs=185.9
Q ss_pred cccccCceEEEEEEECCC---CEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCC
Q 005278 422 LLGTGSFGSVYKGTLFDG---TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGS 497 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 497 (704)
.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+..++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975443 345667665432 2345678999999999999999999999999999999999999999
Q ss_pred HHHHHhhCC---CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 498 LEKWLYSHN---YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 498 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
|.+++.+.. ...++.....++.|++.|++||| +.+++||||||+||+++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999998542 33566778899999999999995 578999999999999999999999999998643221111122
Q ss_pred ccccccccccCCcccCC-------CCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 575 TMTIATIGYMAPEYGSE-------GIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
....++..|+|||+... ..++.++|||||||++|||++ |..||..... ................++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhhcccccCCCc
Confidence 34467889999998743 345789999999999999997 5667754321 1111111111111111111
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
+. ......+.+++..|| .+|++||+++||++.|.
T Consensus 234 ~~---------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LE---------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cC---------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11 123456778899999 67999999999988873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.69 Aligned_cols=192 Identities=23% Similarity=0.297 Sum_probs=165.6
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
...+|.+.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4468999999999999999999865 5788999975322 23568999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+. |+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 995 6999999877677999999999999999999995 5789999999999999999999999999997542211
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCC
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPT 617 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~ 617 (704)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 122346899999999999999999999999999999999965554
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.20 Aligned_cols=326 Identities=25% Similarity=0.282 Sum_probs=230.6
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCC
Q 005278 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLT 82 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~ 82 (704)
+.+++|++++|.+|.++ .+|.......+|+.|+|.+|.|+.+..+.++.++.|++||||.|.|+.++... |.
T Consensus 99 ~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~s-------fp 170 (873)
T KOG4194|consen 99 YNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPS-------FP 170 (873)
T ss_pred hcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCC-------CC
Confidence 56777777777777777 66776666666777777777777777777777777777777777777766544 55
Q ss_pred CCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCe
Q 005278 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQG 162 (704)
Q Consensus 83 ~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 162 (704)
.-.++++|+|++|.|+......|..+. +|.+|.|+.|+++...+..|.+|++|+.|+|..|+|.-.-.-.|.++++|+.
T Consensus 171 ~~~ni~~L~La~N~It~l~~~~F~~ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~n 249 (873)
T KOG4194|consen 171 AKVNIKKLNLASNRITTLETGHFDSLN-SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQN 249 (873)
T ss_pred CCCCceEEeeccccccccccccccccc-hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhh
Confidence 666777777777777777777777775 6777777777777777777777777777777777777443556777777777
Q ss_pred eeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCccc
Q 005278 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242 (704)
Q Consensus 163 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 242 (704)
|.|..|.|...-...|..+.++++|+|+.|+++..-.+.+-+++.|+.|+|++|.|..+.++.++.+++|++|+|++|.|
T Consensus 250 lklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i 329 (873)
T KOG4194|consen 250 LKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRI 329 (873)
T ss_pred hhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccc
Confidence 77777777765566677777777777777777755556677777777777777777777777777777777777777777
Q ss_pred CCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCC---cccccccccceEEecccCCCCCCC
Q 005278 243 NGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP---KSFGSLISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 243 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~~p 319 (704)
+...+..|..+..|+.|+|++|.+...-..+|.++.+|+.|||++|.++..+. ..|..+++|+.|++.+|++....-
T Consensus 330 ~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~k 409 (873)
T KOG4194|consen 330 TRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPK 409 (873)
T ss_pred ccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecch
Confidence 76667777777777777777777765555566677777777777777665443 235567777777777777653333
Q ss_pred CCcccccccCcccccCCC
Q 005278 320 KNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 320 ~~~~~~~~l~~~~l~g~~ 337 (704)
..|..+..+..+.+.+++
T Consensus 410 rAfsgl~~LE~LdL~~Na 427 (873)
T KOG4194|consen 410 RAFSGLEALEHLDLGDNA 427 (873)
T ss_pred hhhccCcccceecCCCCc
Confidence 456666666666655554
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=295.00 Aligned_cols=248 Identities=26% Similarity=0.354 Sum_probs=198.7
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee-CCeEEEEEe
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN-IDFKALVLE 491 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 491 (704)
+|+..+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|+|++++.+.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999854 57899999986543 2344568899999999999999999998764 446789999
Q ss_pred ccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 492 FMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 492 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
|+++++|.+++... ...+++..+..++.+++.|+++| |+.+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999864 34589999999999999999999 567899999999999999999999999999987643221
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......+++.|+|||+..+..++.++||||||+++||+++|+.||..... ..+.........
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~----------- 219 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGKL----------- 219 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCC-----------
Confidence 12334688999999999999999999999999999999999999865221 111111100000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+...+..+.+++.+|++.+|++||++.|+++
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.74 Aligned_cols=245 Identities=28% Similarity=0.333 Sum_probs=199.1
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
-|..++-||.|+||.||-|+. .+.+.||||++.... .....++..|++++++++|||++.+-|+|......++|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355567899999999999984 578899999987543 2334578899999999999999999999999989999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
||- |+-.+.+.-++.++.+..+..|+.+.+.||+|| |+.+.||||||+.|||+++.|.||++|||.|..+.+.
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 995 588999988888899999999999999999999 5677999999999999999999999999999887543
Q ss_pred ceeccccccccccCCccc---CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 572 VIQTMTIATIGYMAPEYG---SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
..++|||.|||||++ ..+.|+-|+||||+|++..|+.-+++|+-.+.. -..+-+.+.... |.+
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQNes---------PtL- 245 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNES---------PTL- 245 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHhcCC---------CCC-
Confidence 346899999999986 457899999999999999999999999643211 011111111110 001
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
...+.+..+..++..|+++-|.+|||..+++..
T Consensus 246 -------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 -------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 122456678899999999999999999888653
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=295.98 Aligned_cols=250 Identities=23% Similarity=0.294 Sum_probs=193.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-----hhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-----ERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFK 486 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 486 (704)
.+|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999854 68999999886432 1234568899999999999999999998865 3567
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++++||+++++|.+++..... +++.....++.|++.|++|| |+.+|+||||+|+||+++.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 899999999999999976543 78889999999999999999 46789999999999999999999999999997653
Q ss_pred CCCC-cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 567 EGDD-SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 567 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.... ........++..|+|||++.+..++.++|||||||++||+++|+.||..... ... ......... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~-~~~~~~~~~----~~ 228 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAA-IFKIATQPT----NP 228 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHH-HHHHhcCCC----CC
Confidence 2211 1111224588999999999988899999999999999999999999975321 111 111000000 01
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+......+.+++ .||..+|++||+++||++
T Consensus 229 ---------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 ---------QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11122334456666 788899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.51 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=212.8
Q ss_pred CCCCccccccccCceEEEEEEEC----C----CCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF----D----GTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNID 484 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 484 (704)
++....+.+|+|+||.||+|... . ...||||.++... ..+.+.+..|+++|+.+ +|+||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34445569999999999999743 1 4579999987654 34567899999999999 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 005278 485 FKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD 549 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~ 549 (704)
..++|+||+..|+|.++++..+ ..+...+.+.++.|||.|++|| .+.++||||+.++||++.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L---~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL---ASVPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH---hhCCccchhhhhhhEEec
Confidence 9999999999999999999766 3488999999999999999999 678899999999999999
Q ss_pred CCCcEEEeeeccceecCCCCCccee-ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 550 ENMTAHVSDFGISKLLGEGDDSVIQ-TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 550 ~~~~~kl~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
++..+||+|||+|+........... +...-+..|||||.+....++.|+|||||||++|||+| |..||.+.... ..+
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-EEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-HHH
Confidence 9999999999999976554443322 21114667999999999999999999999999999999 88999763211 111
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
.++ .+.+.+...|..|+.+++++|..||+.+|++||++.|+++.++...
T Consensus 532 ~~~-----------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 532 LEF-----------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHH-----------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 112 2233445566788899999999999999999999999999999853
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.97 Aligned_cols=265 Identities=18% Similarity=0.195 Sum_probs=195.5
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC------
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI------ 483 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 483 (704)
..++|...+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999854 68899999986532 23345678899999999999999999987543
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
...++||||+++ ++.+++.. .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999965 77777753 278888999999999999999 56799999999999999999999999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC--cch
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG--LTE 641 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 641 (704)
...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+........... ...
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 653321 2233468999999999999999999999999999999999999997532111 1111111000000 000
Q ss_pred hcccc----------chh---h--------hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 642 VVDAN----------LVR---E--------EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 642 ~~~~~----------~~~---~--------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.+.+. ... . .............+.+++.+|++.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000 0 00000011123567899999999999999999999763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.76 Aligned_cols=254 Identities=27% Similarity=0.453 Sum_probs=198.0
Q ss_pred CCccccccccCceEEEEEEEC----CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC------
Q 005278 417 FNECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID------ 484 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 484 (704)
|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999753 36889999986543 234567889999999999999999999886532
Q ss_pred eEEEEEeccCCCCHHHHHhhC-----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 485 FKALVLEFMPNGSLEKWLYSH-----NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
..++++||+++|+|.+++... ...+++.....++.|++.|++||| +.+|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999999887532 234788899999999999999995 578999999999999999999999999
Q ss_pred ccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCC
Q 005278 560 GISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDG 638 (704)
Q Consensus 560 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (704)
|+++...............+++.|++||......++.++||||||+++|||++ |+.||..... .....+.....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~--- 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGN--- 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCC---
Confidence 99987643322222223345678999999988889999999999999999999 8888865322 11111111100
Q ss_pred cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
....+..++..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 --------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 --------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0001113456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=296.70 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=204.0
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|+||+||+|... ++..+|+|++.... ......+.+|+..++.++|+||+++++.+......++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999854 68899999986543 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC--CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSH--NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
+++++|.+++... ...+++.....++.|++.|++|| |+.+++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999754 24689999999999999999999 567899999999999999999999999999887654332
Q ss_pred cc--eeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 571 SV--IQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 571 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.. ......|+..|+|||++... .++.++|+|||||++|||++|+.||....... .+..+.... +. .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~-~~--------~~ 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND-PP--------SL 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC-CC--------Cc
Confidence 21 12334688999999988776 78999999999999999999999997642211 111111110 00 00
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. ......++..+.+++.+|++.||++||++.|+++
T Consensus 228 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ET----GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CC----ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0001244567889999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=295.69 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=197.4
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch----------hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE----------RASRSFDSECEILRSIRHRNLIKIISNCCNID 484 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 484 (704)
+|...+.||+|+||.||+|.. .+++.||+|.++.... ...+.+..|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778999999999999985 4689999998864211 11246788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..++||||+++|+|.+++.... .+++..+..++.|++.|+.|| |+.+++||||+|+||+++.++.++++|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999998764 478889999999999999999 557899999999999999999999999999986
Q ss_pred cCCCCCcceeccccccccccCCcccCCCC--CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSEGI--ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
..............++..|+|||+..... ++.++|+||||+++||+++|..||..... ...+.. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~~~ 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFK-LGNKRSAPP 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHH-hhccccCCc
Confidence 54322222223345889999999877654 78999999999999999999999864211 111111 000000000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... ....+++..+.+++.+||+.+|++||++.||++
T Consensus 233 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 233 IPP---------DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCc---------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000 011134567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=300.51 Aligned_cols=269 Identities=22% Similarity=0.305 Sum_probs=197.9
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++++|...+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++.+++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999985 4689999999865432 22346778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+. +++.+++......+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 6888887765555788888999999999999995 56899999999999999999999999999976433221
Q ss_pred cceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHH-HHHhhcCC-----------
Q 005278 571 SVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH-WVKESLPD----------- 637 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~----------- 637 (704)
......+++.|+|||++.+. .++.++|||||||++|||++|+.||+........+.+ |.....+.
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12234578999999988654 5788999999999999999999999764321111111 10000000
Q ss_pred -CcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 638 -GLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 638 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..........................+.+++.+|++.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000000112456788999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.66 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=202.6
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36888899999999999999985 46889999998655444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++++|.+++.+.. +++..+..++.+++.|+.|| |+.+++||||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 99999999987543 78889999999999999999 567899999999999999999999999999876543322
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......+++.|+|||......++.++||||||+++|++++|+.||......... ..+.. ....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~~~----------------~~~~ 233 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIAT----------------NGTP 233 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eehhc----------------CCCC
Confidence 122346888999999998888999999999999999999999999753221110 00000 0000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122334568889999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=296.91 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=199.7
Q ss_pred CCCccccccccCceEEEEEEECC--CCEEEEEEeeccc----------hhhhHHHHHHHHHHHh-cCCCCCceEEeeeee
Q 005278 416 GFNECNLLGTGSFGSVYKGTLFD--GTNVAIKVFNLQL----------ERASRSFDSECEILRS-IRHRNLIKIISNCCN 482 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 482 (704)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... ......+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999654 7889999875321 1223456778888875 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 483 IDFKALVLEFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 483 ~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
.+..++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+ ..+++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998853 44568999999999999999999952 368999999999999999999999999
Q ss_pred ccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCc
Q 005278 560 GISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL 639 (704)
Q Consensus 560 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (704)
|.+....... ......|+..|+|||...+..++.++||||||+++|||++|+.||.... .............
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~~~~ 230 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----MLSLATKIVEAVY 230 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HHHHHHHHhhccC
Confidence 9998764432 2334568899999999998889999999999999999999999986521 1111111110000
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
.. .....++..+.+++.+||+.||++||++.|+.++++
T Consensus 231 ~~-------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EP-------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred Cc-------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 001123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.85 Aligned_cols=265 Identities=20% Similarity=0.222 Sum_probs=195.6
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC------
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI------ 483 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 483 (704)
..++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 68999999986542 23345677899999999999999999988643
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~L---H~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 356899999965 67776653 378888999999999999999 56789999999999999999999999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc--------
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL-------- 635 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------- 635 (704)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+. +...+....
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 653321 22334689999999999988999999999999999999999999975321110 000000000
Q ss_pred --CCCcchhcc----------ccchhhh---hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 636 --PDGLTEVVD----------ANLVREE---QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 636 --~~~~~~~~~----------~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
......... +...... ............+.+++.+|++.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 0000000 0000111224567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.56 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=197.1
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334467999999999999854 6899999998765555566789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
++|.+++... .+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++........ ...
T Consensus 104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 9999988643 3788999999999999999995 56899999999999999999999999999876533221 122
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...|+..|+|||+..+..++.++||||||+++||+++|+.||....... .... +.... .+.. .
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~-~~~~~--------~~~~-------~ 239 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRR-IRDNL--------PPRV-------K 239 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHhcC--------CCcc-------c
Confidence 3468899999999988889999999999999999999999986521100 0000 01000 0000 0
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.....+..+.+++..|++.||++||++.|+++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111234567789999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.86 Aligned_cols=267 Identities=21% Similarity=0.259 Sum_probs=192.5
Q ss_pred HHHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCC------CCCceEEeeee
Q 005278 409 DIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRH------RNLIKIISNCC 481 (704)
Q Consensus 409 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~ 481 (704)
++....++|.+.+.||+|+||+||+|... +++.||||+++.. ....+.+..|+++++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999854 6889999998643 2233456678888887755 45888989887
Q ss_pred eC-CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC--------
Q 005278 482 NI-DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-------- 552 (704)
Q Consensus 482 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-------- 552 (704)
.. ...++|||++ +++|.+++.+.+ .+++..+..++.|++.||+|||+ +.+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccc
Confidence 64 5788999988 678999887653 48899999999999999999963 25899999999999998765
Q ss_pred --------cEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccc
Q 005278 553 --------TAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE 624 (704)
Q Consensus 553 --------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~ 624 (704)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||++....
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~- 351 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL- 351 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-
Confidence 499999998764321 123457999999999999999999999999999999999999999763221
Q ss_pred ccHHHHHHhh---cCCCcc---------hhcc------ccchhhh------hhhhhhHHHHHHHHHHHhhhcCCCCCCCC
Q 005278 625 MSLKHWVKES---LPDGLT---------EVVD------ANLVREE------QAFSVKIDCLLSIMHLALDCCMESPEQRV 680 (704)
Q Consensus 625 ~~~~~~~~~~---~~~~~~---------~~~~------~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp 680 (704)
.....+... .+..+. ...+ +...... ............+.+++..||+.||++||
T Consensus 352 -~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 352 -EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred -HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 100101000 000000 0000 0000000 00000001134577999999999999999
Q ss_pred CHHHHHH
Q 005278 681 SMKDAAA 687 (704)
Q Consensus 681 t~~ev~~ 687 (704)
|++|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999975
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=303.01 Aligned_cols=256 Identities=21% Similarity=0.237 Sum_probs=199.1
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999864 58899999987543 223456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++++|.+++...+ .+++.....++.+++.|++||| +.+++||||||+||+++.++.++++|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997654 4788899999999999999995 57899999999999999999999999999864211000
Q ss_pred -------------cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC
Q 005278 571 -------------SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD 637 (704)
Q Consensus 571 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (704)
........++..|+|||++....++.++|+||||+++||+++|..||.+... ..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~~~~~~ 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQVISD 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhc
Confidence 0011123578899999999888899999999999999999999999865221 1111111110
Q ss_pred CcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 638 GLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
... .+ .....++..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 232 ~~~---~~---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 DIE---WP---------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccC---CC---------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000 00 0001245667899999999999999997666665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.13 Aligned_cols=266 Identities=20% Similarity=0.241 Sum_probs=195.5
Q ss_pred HHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeC----
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNI---- 483 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 483 (704)
....++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34567899999999999999999985 4688999999865422 2345677899999999999999999987543
Q ss_pred --CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 484 --DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 484 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
...++++|++ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 77998887643 3889999999999999999995 57899999999999999999999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC--
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG-- 638 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-- 638 (704)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+........
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 9865432 223468999999998876 56889999999999999999999999652211 11111111100000
Q ss_pred cchhcccc--------chhhh--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 639 LTEVVDAN--------LVREE--QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 639 ~~~~~~~~--------~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
....+... +.... ..........+.+.+++.+|++.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00000 0000001123457899999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=292.03 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=201.2
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|+..+.||+|+||.||+++. .+|+.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999985 468999999986432 23446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++++|.+++... ...+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999999754 345789999999999999999995 57899999999999999999999999999987643221
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......|++.|+|||+..+..++.++|||||||+++++++|+.||.... .............
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~~------------ 218 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIRGSY------------ 218 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhcCCC------------
Confidence 1123357889999999988889999999999999999999999986421 1111111111110
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++.++.+++.+||+.+|++||++.||++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0112234567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.36 Aligned_cols=259 Identities=25% Similarity=0.310 Sum_probs=200.9
Q ss_pred chHHHHHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC
Q 005278 406 SYLDIQRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNI 483 (704)
Q Consensus 406 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 483 (704)
...++..+.++|...+.||+|+||.||++.. .+++.+|+|.+... ......+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3345556788999999999999999999986 46889999998643 22345678899999999 899999999998654
Q ss_pred -----CeEEEEEeccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEE
Q 005278 484 -----DFKALVLEFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAH 555 (704)
Q Consensus 484 -----~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~k 555 (704)
+..++|+||+++|+|.++++. ....+++..++.++.|++.|++||| +.+++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence 357999999999999998863 3456899999999999999999995 57899999999999999999999
Q ss_pred EeeeccceecCCCCCcceeccccccccccCCcccCCC-----CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHH
Q 005278 556 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG-----IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHW 630 (704)
Q Consensus 556 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~ 630 (704)
|+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||...... .....+
T Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~ 245 (291)
T cd06639 169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKI 245 (291)
T ss_pred Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHH
Confidence 999999886543221 12234688999999987543 3688999999999999999999998753211 111111
Q ss_pred HHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 631 VKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+. .+ ... ..+......+.+++.+||+.+|++||++.|+++
T Consensus 246 ~~~-~~---~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 246 PRN-PP---PTL------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hcC-CC---CCC------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 00 000 011123456888999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.28 Aligned_cols=266 Identities=21% Similarity=0.264 Sum_probs=197.0
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|+..+.||+|+||.||+|+.. +|+.||+|.+..... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999864 689999999865422 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++ ++|.+++......+++..+..++.|+++|+.||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 97 5898888766566899999999999999999995 57899999999999999999999999999986543221
Q ss_pred eeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC---c---chhcc-
Q 005278 573 IQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG---L---TEVVD- 644 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~- 644 (704)
......+++.|+|||++.+. .++.++|||||||++|||+||+.|+.........+....+...... + ....+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234578899999987664 4789999999999999999999986432211111111100000000 0 00000
Q ss_pred ---ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 ---ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.......-.......+.++.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000111234567889999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=294.59 Aligned_cols=247 Identities=26% Similarity=0.341 Sum_probs=198.8
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-----hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-----ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
+|...+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999865 78999999986543 22446788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999997654 4788999999999999999995 5789999999999999999999999999988764332
Q ss_pred CcceeccccccccccCCcccCCCC-CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGI-ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
......++..|+|||...... ++.++|+||||+++|++++|+.||....... ....+... ..
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~---~~---------- 219 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRS---KE---------- 219 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhc---cc----------
Confidence 123446889999999887766 8999999999999999999999997642110 00010000 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..+...+.+++.+||+.+|++||++.|+++
T Consensus 220 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 ----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00111233466788999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=296.19 Aligned_cols=246 Identities=28% Similarity=0.502 Sum_probs=197.4
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
++|+..+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4678889999999999999974 67889999986542 345788999999999999999999998664 4689999999
Q ss_pred CCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 495 NGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 495 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
+|+|.+++... ...+++..+..++.|++.|+.|| |+.+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999854 34578999999999999999999 46789999999999999999999999999987643221
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
.....+..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+... ...+.
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~-~~~~~------------- 214 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKEC-VEKGY------------- 214 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHH-HhCCC-------------
Confidence 12234678999999988899999999999999999998 9999865321 111111 00100
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
....+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 001112345678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=294.25 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=201.9
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeEEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKALVL 490 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 490 (704)
+|+..+.||.|+||.||++.. .+++.+|+|.+.... ....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 468899999986432 3345678899999999999999999998754 45678999
Q ss_pred eccCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 491 EFMPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGH--STPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 491 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h--~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
||+++++|.+++... ...+++..++.++.+++.|++|||..+ +.+++|+||+|+||+++.++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999753 456899999999999999999996443 889999999999999999999999999999876
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
..... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||..... ....+.+....
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~---------- 226 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEGK---------- 226 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhcCC----------
Confidence 54321 12234689999999999988899999999999999999999999976321 11111111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
....+...+..+.+++.+|++.+|++||++.||++.
T Consensus 227 -------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 -------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 001122345678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=297.40 Aligned_cols=264 Identities=20% Similarity=0.238 Sum_probs=201.2
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999864 68999999987553 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+ +++|.+++......+++..+..++.|+++|++||| +.+++|+||+|+||+++.++.++++|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999999866667899999999999999999995 57899999999999999999999999999987654321 1
Q ss_pred eeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC-------------C
Q 005278 573 IQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD-------------G 638 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------~ 638 (704)
......++..|+|||.+.+. .++.++||||+|+++|||++|..||.+.... ....+....... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHHHHHHHcCCCChHHHhhccCcch
Confidence 12334689999999987654 4688999999999999999998887653211 111111111000 0
Q ss_pred cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.....+..... .......+....+.+++.+|++.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 234 YNKITFPESKPI-PLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhcccCCCCCcc-hHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 000111233577899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=299.04 Aligned_cols=258 Identities=23% Similarity=0.287 Sum_probs=200.5
Q ss_pred chHHHHHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeee-
Q 005278 406 SYLDIQRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCN- 482 (704)
Q Consensus 406 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 482 (704)
+..++....+.|+..+.||+|+||.||+|+. .+++.+|+|.+.... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4445556678899999999999999999986 468999999986542 3345688899999999 69999999999853
Q ss_pred -----CCeEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 005278 483 -----IDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV 556 (704)
Q Consensus 483 -----~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl 556 (704)
....+++|||+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+|+||+|+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999999753 345788888999999999999995 578999999999999999999999
Q ss_pred eeeccceecCCCCCcceeccccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHH
Q 005278 557 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV 631 (704)
Q Consensus 557 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~ 631 (704)
+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||..........
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---- 236 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---- 236 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----
Confidence 99999876532211 122346889999999875 3467889999999999999999999996532111000
Q ss_pred HhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 632 KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ......+ ......++..+.+++.+||+.||++||++.|+++
T Consensus 237 ~------~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 L------IPRNPPP--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h------HhhCCCC--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0000000 0111234567899999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=304.13 Aligned_cols=194 Identities=29% Similarity=0.362 Sum_probs=168.3
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-C-----CCCceEEeeeeeCCeEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIR-H-----RNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 488 (704)
+|++.+.||+|.||.|-+|.. .+++.||||+++.. .....+...|+.+|..++ | -|+|+++++|....+.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 889999999999999999984 57999999999755 333456678999999996 3 489999999999999999
Q ss_pred EEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC--CCcEEEeeeccceec
Q 005278 489 VLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE--NMTAHVSDFGISKLL 565 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~--~~~~kl~Dfgla~~~ 565 (704)
|+|.+.. +|.++++.+ ...++...+..++.||+.||..| |+.+|||+||||+|||+.+ ...+||+|||.|+..
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999855 999999955 45589999999999999999999 5688999999999999974 347999999999986
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNE 619 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~ 619 (704)
..... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.+
T Consensus 342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 54433 23467789999999999999999999999999999999877765
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.07 Aligned_cols=263 Identities=24% Similarity=0.271 Sum_probs=199.4
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999975 589999998765432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|++++++.++..... .+++..+..++.|++.|++||| +.+++|||++|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 999998888765443 3899999999999999999995 57899999999999999999999999999987643321
Q ss_pred ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh-----hcCCCcchh---
Q 005278 572 VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE-----SLPDGLTEV--- 642 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~--- 642 (704)
......++..|+|||+..+ ..++.++||||||+++|||++|+.||..... ...+.+. .........
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCCchhhHHHhcc
Confidence 1223457889999998765 4578899999999999999999999864221 1111110 000000000
Q ss_pred -------ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 -------VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 -------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+..............++..+.+++..||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000011112244677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.47 Aligned_cols=236 Identities=22% Similarity=0.211 Sum_probs=181.7
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhc---CCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 423 LGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSI---RHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 423 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
||+|+||+||+|+.. +++.||||++..... ........|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 689999999865321 1223445566666665 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence 99999987653 4889999999999999999995 5789999999999999999999999999987543221 1123
Q ss_pred cccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (704)
...||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ............ . +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~-~-----~------- 216 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGKV-R-----F------- 216 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCCC-C-----C-------
Confidence 45689999999988654 478999999999999999999999965211 111111100000 0 0
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005278 655 SVKIDCLLSIMHLALDCCMESPEQRVSMK 683 (704)
Q Consensus 655 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 683 (704)
.....+..+.+++.+|++.||++||++.
T Consensus 217 -~~~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 217 -PKNVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred -CCccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 0012345677899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.44 Aligned_cols=247 Identities=21% Similarity=0.290 Sum_probs=197.0
Q ss_pred CccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCC
Q 005278 418 NECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 496 (704)
+....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999854 68999999987654445567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecc
Q 005278 497 SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576 (704)
Q Consensus 497 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 576 (704)
+|.+++... .+++..+..++.|++.|++|| |+.+++||||+|+||+++.++.++|+|||++........ ....
T Consensus 104 ~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 176 (297)
T cd06659 104 ALTDIVSQT--RLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS 176 (297)
T ss_pred CHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence 999987653 378999999999999999999 567899999999999999999999999999876543221 1223
Q ss_pred ccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhh
Q 005278 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSV 656 (704)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (704)
..|+..|+|||++.+..++.++|||||||++|||++|+.||..... .............. ...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~---------------~~~ 239 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPK---------------LKN 239 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCCC---------------ccc
Confidence 4688999999999888899999999999999999999999864211 11111111100000 000
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 657 KIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 657 ~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
....+..+.+++.+|++.+|++||++.|+++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11224567889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=298.47 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=197.4
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999865 689999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++ +|.+++......+++.....++.|+++|++||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 974 999999876667899999999999999999994 57899999999999999999999999999875432111
Q ss_pred eeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc-C-CC-cchhcc----
Q 005278 573 IQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL-P-DG-LTEVVD---- 644 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~-~~-~~~~~~---- 644 (704)
......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.........+....+... + .. +.....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122346889999998765 45788999999999999999999999653311111111110000 0 00 000000
Q ss_pred -----ccchhhhh-hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 -----ANLVREEQ-AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 -----~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
........ ...........+.+++.+|++.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 00000011256788999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.37 Aligned_cols=255 Identities=25% Similarity=0.271 Sum_probs=200.0
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 490 (704)
++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+ .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999964 689999999875432 345678999999999999999999998865 34689999
Q ss_pred eccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
||+++++|.+++.. ....++......++.|++.|++|| |+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988763 344578899999999999999999 567899999999999999999999999999876532
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccc---ccccHHHHHHhhcCCCcchhcc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFI---GEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
.. .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... .......|............
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE-- 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccC--
Confidence 21 1234578899999999988999999999999999999999999976422 11122222221111000000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......+..+.+++.+||+.+|++|||+.|+++
T Consensus 232 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 ---------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ---------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000123567889999999999999999999977
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.92 Aligned_cols=249 Identities=28% Similarity=0.365 Sum_probs=204.2
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++.+++++|++++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777889999999999999965 689999999976655456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+++|.+++......+++..+..++.+++.|++|| |+.+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 9999999987656689999999999999999999 558899999999999999999999999999987654321 2
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (704)
....++..|+|||++.+..++.++||||||+++|+|++|+.||...... ..............
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~------------ 217 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFKIATNGPPGL------------ 217 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHhcCCCCc------------
Confidence 3446889999999998888999999999999999999999998753211 11100000000000
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 655 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.....++..+.+++..|++.||++||++.|+++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011112456889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.72 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=205.5
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
..++.|+..+.||+|++|.||+|... ++..+|+|++..... ..+.+..|++.++.++|+|++++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888899999999999999976 689999999876543 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++++|.+++......+++..+..++.+++.|++|| |+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 99999999999987655689999999999999999999 568999999999999999999999999999876543221
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......++..|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.. ....
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~----~~~~---------- 234 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITT----KGIP---------- 234 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh----cCCC----------
Confidence 112335788999999998888999999999999999999999998653211 11111110 0000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......++..+.+++.+|++.+|.+||++.++++
T Consensus 235 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 --PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01111224567889999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.64 Aligned_cols=193 Identities=23% Similarity=0.296 Sum_probs=158.0
Q ss_pred ccccccCceEEEEEEEC---CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF---DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 495 (704)
.+||+|+||.||+|+.. ++..||+|.+... .....+.+|++++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999864 4578999988643 223467889999999999999999998854 5577899999865
Q ss_pred CCHHHHHhhC--------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----CCCCcEEEeeeccce
Q 005278 496 GSLEKWLYSH--------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL----DENMTAHVSDFGISK 563 (704)
Q Consensus 496 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~----~~~~~~kl~Dfgla~ 563 (704)
++.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||++ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 787777521 23478889999999999999999 56789999999999999 566799999999998
Q ss_pred ecCCCCCc-ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCc
Q 005278 564 LLGEGDDS-VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNE 619 (704)
Q Consensus 564 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~ 619 (704)
........ .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76443221 12233468999999998876 4588999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=297.06 Aligned_cols=253 Identities=25% Similarity=0.320 Sum_probs=199.6
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCC-----
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNID----- 484 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 484 (704)
..+++|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999964 678999999875433 346789999999999 6999999999996644
Q ss_pred -eEEEEEeccCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeec
Q 005278 485 -FKALVLEFMPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFG 560 (704)
Q Consensus 485 -~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 560 (704)
..++||||+++++|.+++... ...+++..+..++.|++.|++|| |+.+++|+||+|+||++++++.++++|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999998742 35689999999999999999999 56889999999999999999999999999
Q ss_pred cceecCCCCCcceeccccccccccCCcccCC-----CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYGSE-----GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
++....... .......|+..|+|||++.. ..++.++|||||||++|++++|+.||...... ....+...
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~--- 232 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPR--- 232 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhc---
Confidence 998654322 12233468899999998653 34778999999999999999999999653211 11111100
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. .+ ....+..++..+.+++.+|++.||++|||+.|+++
T Consensus 233 -~~-----~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 -NP-----PP-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -cC-----CC-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00 01111234567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=290.14 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=199.5
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999985 468999999986542 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-~~~kl~Dfgla~~~~~~~~ 570 (704)
+++++|.+++... ...+++..+..++.+++.|++|| |+.+++|+||+|+||+++.+ +.+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999864 34589999999999999999999 55789999999999999855 4689999999987644321
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....++..|+|||...+..++.++||||||+++|+|++|+.||..... .............
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~---------- 219 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMSGTFA---------- 219 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHhcCCC----------
Confidence 2234588899999999988899999999999999999999999865321 1111111100000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+..++..+.+++..||+.+|++||++.|+++
T Consensus 220 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 ----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011124566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.72 Aligned_cols=249 Identities=25% Similarity=0.310 Sum_probs=192.2
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-hhhHHHHHHHHH-HHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RASRSFDSECEI-LRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... .....+..|+.. ++..+||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47888999999999999999865 699999999875432 223445555554 666789999999999999999999999
Q ss_pred ccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 492 FMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHST-PMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 492 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~-~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
|++ |+|.+++.. ....+++..++.++.|++.|++||| +. +++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 688888763 3346899999999999999999995 44 899999999999999999999999999986533
Q ss_pred CCCcceeccccccccccCCcccCC----CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSE----GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
.. ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.........+...... ..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~~---- 225 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE----PS---- 225 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc----CC----
Confidence 21 1223468889999998764 456889999999999999999999986532211111111100 00
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.. ....++.++.+++..||+.+|++||++.|+++
T Consensus 226 -~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 -PQL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01124567889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=292.64 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=200.8
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|...+.||+|+||.||+|... +++.||+|.+..... ...+.+..|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999854 789999999876543 3567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++++|.+++.... .+++..+..++.+++.|++||| +.+|+|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999998653 3788899999999999999995 5789999999999999999999999999998775433221
Q ss_pred e--eccccccccccCCcccCCCC---CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 573 I--QTMTIATIGYMAPEYGSEGI---ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 573 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
. .....+++.|+|||++.+.. .+.++||||||+++||+++|+.||...... ........... .
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~--------~--- 224 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGH--------K--- 224 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhcCC--------C---
Confidence 1 11245788999999987766 889999999999999999999999753211 11111111000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+....++..+.+++..||+.+|++||++.|+++
T Consensus 225 ----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 ----PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001111123556788999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.73 Aligned_cols=265 Identities=23% Similarity=0.271 Sum_probs=198.7
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchh-----hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLER-----ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
+|+..+.||+|+||.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999864 6899999998754322 234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+ +|+|.+++......+++..+..++.|+++||.|| |+.+|+|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 8999999986655689999999999999999999 56789999999999999999999999999998765432
Q ss_pred CcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC---Ccc-----
Q 005278 570 DSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD---GLT----- 640 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~----- 640 (704)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+.......... .+.
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccc
Confidence 2 1223356788999998754 46788999999999999999998777642211 1111111100000 000
Q ss_pred -hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 641 -EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 641 -~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....................+..+.+++.+||+.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000001111233567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=296.51 Aligned_cols=247 Identities=22% Similarity=0.272 Sum_probs=197.7
Q ss_pred CCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 417 FNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
|...+.||+|++|.||+|.. .+++.+|+|.+........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999985 47899999998755444556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
++|.+++.. ..+++..+..++.|++.|++|| |+.+++||||+|+||+++.++.++++|||.+........ ...
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~ 173 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK 173 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence 999999876 3478899999999999999999 557899999999999999999999999998875533211 122
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...|++.|+|||...+..++.++|||||||++|||++|+.||..... ........... .+.. .
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~~-----~~~~-------~ 236 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDNL-----PPKL-------K 236 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhcC-----CCCC-------c
Confidence 34689999999999888899999999999999999999999864211 11111110000 0000 0
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....++..+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11123457889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=297.97 Aligned_cols=247 Identities=28% Similarity=0.300 Sum_probs=197.0
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
...|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++.+++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999864 68999999886432 22335688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
+||++ |++.+++......+++..+..++.|++.|+.|| |+.+|+||||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99996 688888776555689999999999999999999 4578999999999999999999999999998765332
Q ss_pred CcceeccccccccccCCcccC---CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 570 DSVIQTMTIATIGYMAPEYGS---EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
....+++.|+|||++. ...++.++||||||+++|||+||+.||...... ........... +
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~-----~- 232 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNDS-----P- 232 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHHhcCCC-----C-
Confidence 2245788999999874 456888999999999999999999998653211 00000000000 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
......++..+.+++.+||+.+|++||++.++++.
T Consensus 233 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 -------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00112345678899999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.44 Aligned_cols=250 Identities=23% Similarity=0.247 Sum_probs=194.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-----hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-----ERASRSFDSECEILRSIRHRNLIKIISNCCNI--DFK 486 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 486 (704)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999864 58999999875322 12345788899999999999999999998764 467
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
+++|||+++|+|.+++.... .+++.....++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999997654 3788888999999999999994 5789999999999999999999999999998653
Q ss_pred CCCCc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 567 EGDDS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 567 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
..... .......++..|+|||...+..++.++|||||||++|||++|+.||...... ..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~-~~~~~------- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFK-IATQP------- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHH-HhcCC-------
Confidence 22111 1122345889999999998888999999999999999999999998653111 11110 00000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.....+......+.+++.+|+. +|++||+++|+++
T Consensus 226 ------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011122344567788899985 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.24 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=199.7
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc------hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL------ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
+|+..+.||+|++|.||+|.. .+++.||+|.+.... ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999985 578999999986433 1234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeeeccceecCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-TAHVSDFGISKLLGE 567 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-~~kl~Dfgla~~~~~ 567 (704)
|+||+++++|.+++...+ .+++..+..++.|++.|++|| |+.+++|+||+|+||+++.++ .++|+|||.+..+..
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997654 478899999999999999999 457899999999999998776 599999999987644
Q ss_pred CCC--cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 568 GDD--SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 568 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
... ........++..|+|||+..+..++.++||||+|+++|++++|..||...... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~------- 227 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASAT------- 227 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhccC-------
Confidence 311 11122345789999999998888999999999999999999999998642211 1111111100000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.....+...+..+.+++.+|++.+|++||++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001122234567889999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=309.80 Aligned_cols=330 Identities=23% Similarity=0.255 Sum_probs=300.5
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
..++.++|++++|++..+-+..|.++++|+++++.+|.++ .+|...+...+|+.|+|.+|.|+++.... +..
T Consensus 76 lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~-------L~~ 147 (873)
T KOG4194|consen 76 LPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEE-------LSA 147 (873)
T ss_pred CccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHH-------HHh
Confidence 3456678999999999888889999999999999999999 66776677777999999999999988776 899
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
++.|+.||||.|.|+...-..|..- .++++|+|++|.|+..-...|.++.+|.+|.|++|+++...+..|.++++|+.|
T Consensus 148 l~alrslDLSrN~is~i~~~sfp~~-~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~L 226 (873)
T KOG4194|consen 148 LPALRSLDLSRNLISEIPKPSFPAK-VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESL 226 (873)
T ss_pred HhhhhhhhhhhchhhcccCCCCCCC-CCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhh
Confidence 9999999999999997666666654 379999999999999999999999999999999999998888899999999999
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
+|..|+|.-.-.-+|.++++|+.|.|.+|.+.......|-.+.+++.|+|..|+++.+-..++.++++|+.|+||+|.|.
T Consensus 227 dLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~ 306 (873)
T KOG4194|consen 227 DLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQ 306 (873)
T ss_pred hccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhh
Confidence 99999998444668999999999999999999877889999999999999999999888889999999999999999999
Q ss_pred CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCC---
Q 005278 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPK--- 320 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--- 320 (704)
.+.++.+.-.++|+.|+|++|+|+...+..|..+..|+.|+|++|++...--..|..+.+|+.|||++|.++..+.+
T Consensus 307 rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~ 386 (873)
T KOG4194|consen 307 RIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAV 386 (873)
T ss_pred eeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchh
Confidence 99999999999999999999999988889999999999999999999987778899999999999999999987765
Q ss_pred CcccccccCcccccCCCccCCC
Q 005278 321 NFSAQSFLSNYALCGPARLQVP 342 (704)
Q Consensus 321 ~~~~~~~l~~~~l~g~~~~~~~ 342 (704)
.|..+.+++.+.+.|+...+++
T Consensus 387 ~f~gl~~LrkL~l~gNqlk~I~ 408 (873)
T KOG4194|consen 387 AFNGLPSLRKLRLTGNQLKSIP 408 (873)
T ss_pred hhccchhhhheeecCceeeecc
Confidence 5778889999999999765543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.07 Aligned_cols=243 Identities=27% Similarity=0.308 Sum_probs=197.6
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999865 68999999986532 223466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++++|.+++.... .++...+..++.|++.|++||| +.+++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999997663 4889999999999999999995 578999999999999999999999999999876433
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ...+ .... ..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~-~~------------ 213 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIY-EKIL-EG------------ 213 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHH-HHHh-cC------------
Confidence 2234688999999999888889999999999999999999999865321 0000 0000 00
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAA 686 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~ 686 (704)
....+...+..+.+++.+||+.+|++|| +++|++
T Consensus 214 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 214 --KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 0011112345678899999999999999 666664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=288.38 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=205.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|++|.||+|+.. +++.||+|++..... .....+..|++.+++++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999866 599999999876543 3457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS-TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~-~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++++|.+++... ..+++..+..++.|++.|++|| |+ .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999865 4589999999999999999999 66 89999999999999999999999999999876433221
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccc-ccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFI-GEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....++..|+|||...+..++.++|+||||+++|+|+||+.||..... .......+.. ....
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~----------- 220 (264)
T cd06623 157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGPP----------- 220 (264)
T ss_pred --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCCC-----------
Confidence 1234578899999999998999999999999999999999999976432 1111111111 0000
Q ss_pred hhhhhhhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 651 EQAFSVKID-CLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 651 ~~~~~~~~~-~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
...+.. ++..+.+++..|++.+|++||++.|+++.
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 001112 45678899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=293.39 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=199.7
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
-|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+..+++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999854 68899999876443 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++++|.+++... .+++.....++.+++.|+.|| |+.+++|+||+|+||+++.++.++++|||++........ .
T Consensus 85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06641 85 GGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence 999999998754 478999999999999999999 668999999999999999999999999999876643221 1
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
.....++..|+|||+..+..++.++|+|||||++|+|++|..||...... .+... ......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~------------- 218 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL-IPKNNP------------- 218 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH-HhcCCC-------------
Confidence 22345788999999998888999999999999999999999998653211 11111 000000
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
......++..+.+++..|++.+|++||++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00112345667889999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.50 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=197.8
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcC---CCCCceEEeeeeeCCeEEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIR---HRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 490 (704)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999995 478999999986543 234467889999999996 999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++++|.+++... .+++.....++.+++.|+.|| |+.+|+|+||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998754 588999999999999999999 567899999999999999999999999999987754331
Q ss_pred cceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 571 SVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
......|+..|+|||...+ ..++.++|||||||++|+|++|..||..... ..+....... ..+.+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~~~~~-----~~~~~~- 223 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMMLIPKS-----KPPRLE- 223 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhccccC-----CCCCCC-
Confidence 1233468899999998765 4468899999999999999999999975321 1111100000 001110
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+.++.+++..||+.||++||++.|+++
T Consensus 224 -------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 -------DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -------cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0113567889999999999999999999965
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.85 Aligned_cols=264 Identities=24% Similarity=0.301 Sum_probs=196.3
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|+..+.||+|++|.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 689999998865432 2335788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+. ++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+|++|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 6899988743 456899999999999999999995 57899999999999999999999999999876543221
Q ss_pred ceeccccccccccCCcccCCCC-CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc-CCC-cchhcc----
Q 005278 572 VIQTMTIATIGYMAPEYGSEGI-ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL-PDG-LTEVVD---- 644 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~---- 644 (704)
......+++.|+|||+..+.. ++.++||||||+++|||+||+.||....... ...+...... +.. ......
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHH
Confidence 122335688999999876544 6889999999999999999999986532111 1111111100 000 000000
Q ss_pred -----ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 -----ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 -----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+..... ............+.+++.+|++.||++||+++|+++
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQ-DFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhccccccc-CHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000 000011123456788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=304.20 Aligned_cols=274 Identities=27% Similarity=0.349 Sum_probs=207.0
Q ss_pred CCCccccccccCceEEEEEE-ECCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC------CeEE
Q 005278 416 GFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNI------DFKA 487 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 487 (704)
.|...+.||+|+||.||+|+ ..+|+.||||.++... ....+..-+|++++++++|+|||++++.-.+. +...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34556789999999999999 4579999999997644 23456778999999999999999999986553 3567
Q ss_pred EEEeccCCCCHHHHHhh--CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--CCC--cEEEeeecc
Q 005278 488 LVLEFMPNGSLEKWLYS--HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD--ENM--TAHVSDFGI 561 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~--~~~--~~kl~Dfgl 561 (704)
+|||||.+|||...+.+ +...+++...+.++.+++.||.||| +.+||||||||.||++- ++| -.||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999984 4567999999999999999999994 67899999999999983 434 479999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccC-CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccH-HHHH-HhhcCCC
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGS-EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSL-KHWV-KESLPDG 638 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~~~~-~~~~~~~ 638 (704)
|+.+.++. .....+||..|++||+.. .+.|+..+|.|||||++||++||..||.......... ..|. ....+.+
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99886543 456678999999999988 5889999999999999999999999998754432211 1221 1222333
Q ss_pred cchhccccchhh----h---hhhhhhHHHHHHHHHHHhhhcCCCCCCCC--CHHHHHHHHHHhHHH
Q 005278 639 LTEVVDANLVRE----E---QAFSVKIDCLLSIMHLALDCCMESPEQRV--SMKDAAAKLKKIKEK 695 (704)
Q Consensus 639 ~~~~~~~~~~~~----~---~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp--t~~ev~~~L~~~~~~ 695 (704)
......+...+. . ............+.+.+..++..+|.+|- ...+....+..+...
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 222222221111 0 01111223334566777788888999999 777777777776544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=321.80 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=192.0
Q ss_pred HHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC-----
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNI----- 483 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 483 (704)
.+...+|++.+.||+||||.||+++.+ ||+.+|||++.... ......+.+|+..+++++|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 356678999999999999999999955 89999999997664 33456788999999999999999997333100
Q ss_pred --------------------------------------------------------------------------------
Q 005278 484 -------------------------------------------------------------------------------- 483 (704)
Q Consensus 484 -------------------------------------------------------------------------------- 483 (704)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHH
Q 005278 484 ----------------------------------DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529 (704)
Q Consensus 484 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh 529 (704)
...|+-||||+..++.+++..+...-.....|+++++|++|++|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI- 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI- 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH-
Confidence 124688999998777777776543335778899999999999999
Q ss_pred hcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC----C------------CCCcceeccccccccccCCcccCCC-
Q 005278 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG----E------------GDDSVIQTMTIATIGYMAPEYGSEG- 592 (704)
Q Consensus 530 ~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~- 592 (704)
|++|||||||||.||++|++..|||+|||+|.... . +......+..+||.-|+|||++.+.
T Consensus 714 --H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 714 --HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred --HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 66889999999999999999999999999998832 0 1122245567899999999987654
Q ss_pred --CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhh
Q 005278 593 --IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALD 670 (704)
Q Consensus 593 --~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 670 (704)
.|+.|+|+||+|||++||+. ||+...+....+...-+..+|.. ....++ ..+.-.++|.+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~--------------~~~~e~slI~~ 853 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDP--------------EHPEEASLIRW 853 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccc--------------cchHHHHHHHH
Confidence 49999999999999999985 56553332222222211111111 111111 12233579999
Q ss_pred hcCCCCCCCCCHHHHHH
Q 005278 671 CCMESPEQRVSMKDAAA 687 (704)
Q Consensus 671 cl~~~P~~Rpt~~ev~~ 687 (704)
+++.||++||||.|+++
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999964
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=292.17 Aligned_cols=260 Identities=21% Similarity=0.231 Sum_probs=194.2
Q ss_pred CCccccccccCceEEEEEEE-CCCCEEEEEEeeccch-hhhHHHHHHHHHHHhcC-CCCCceEEeeeeeC--CeEEEEEe
Q 005278 417 FNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE-RASRSFDSECEILRSIR-HRNLIKIISNCCNI--DFKALVLE 491 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 491 (704)
|...+.||+|+||.||+|.. .+++.||+|+++.... ........|+.+++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678999999999999985 4689999999865422 22233457888899885 99999999999887 88999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|++ |++.+++......+++..+..++.|++.||+||| +.+++||||+|+||+++. +.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 5888888876567899999999999999999995 578999999999999999 9999999999987643221
Q ss_pred ceeccccccccccCCcccC-CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcc----------
Q 005278 572 VIQTMTIATIGYMAPEYGS-EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT---------- 640 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 640 (704)
.....++..|+|||+.. ++.++.++||||+||++|||++|..||..... .....+..........
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 12235788999999754 45678899999999999999999999965321 1111222111111000
Q ss_pred --hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 641 --EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 641 --~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..... ........++..+.+++.+||+.+|++||++.|+++
T Consensus 231 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGT-GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccc-cHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 000112245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=303.96 Aligned_cols=250 Identities=24% Similarity=0.288 Sum_probs=206.0
Q ss_pred CCCccccccccCceEEEEEEECC-CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 416 GFNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
-|+++.-+|.|+||.||+|..++ +-..|.|++.......-+.+.-|++++..+.||+||++++.|...+...++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45566789999999999998654 55567788877777777889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
||.....+-+-++.+.+.++.-+++|++.||.|| |+..|||||+|+.|||++-+|.++++|||.+..... .....
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKR 187 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCcEeeecccccccchh--HHhhh
Confidence 9999999887778899999999999999999999 678899999999999999999999999998764321 12233
Q ss_pred ccccccccccCCccc-----CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 575 TMTIATIGYMAPEYG-----SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
..+.|||.|||||+. ...+|+.++||||||+++.||..+.+|...+...... .+.. ..
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl-lKia----------------KS 250 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-LKIA----------------KS 250 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH-HHHh----------------hc
Confidence 456899999999974 5678999999999999999999999998764332111 1111 11
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+....+...+..+.+++..|+..+|..||+++++++
T Consensus 251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12223344566778899999999999999999999865
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=294.16 Aligned_cols=266 Identities=21% Similarity=0.246 Sum_probs=197.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchh--hhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLER--ASRSFDSECEILRSIRHRNLIKIISNCCNI--DFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 489 (704)
++|+..+.||+|+||.||+|... +++.+|+|.++..... ....+.+|+.++++++||||+++.+++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999965 6889999998754322 233567899999999999999999998877 889999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
+||++ ++|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99997 5999998876667899999999999999999995 5789999999999999999999999999998765432
Q ss_pred CcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHH------------HHHhhcC
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH------------WVKESLP 636 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~------------~~~~~~~ 636 (704)
. ......+++.|+|||.+.+. .++.++|+||+|+++|||++|..||....... .... |......
T Consensus 161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhcc
Confidence 1 12234578899999987654 46889999999999999999999997532111 0111 1000000
Q ss_pred CCcchhccccchhhhhhhhhhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 637 DGLTEVVDANLVREEQAFSVKID-CLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....................+.. .+..+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000000000000101 3566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=278.25 Aligned_cols=260 Identities=20% Similarity=0.279 Sum_probs=201.7
Q ss_pred ccccccCceEEEEEE-ECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
+.+|+|+||.|--+. +.+|.++|||++.+.......+.-+|++++.+.+ |+||++++++|++....|+|||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 589999999999887 7789999999998886667788899999999994 99999999999999999999999999999
Q ss_pred HHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEEEeeeccceecCCCCC-----
Q 005278 499 EKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM---TAHVSDFGISKLLGEGDD----- 570 (704)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~---~~kl~Dfgla~~~~~~~~----- 570 (704)
.++++++.. +.+....++..+|+.||.+| |.+||.|||+||+|||-.+.. -+||+||.++.-+.....
T Consensus 164 LshI~~~~~-F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 164 LSHIQKRKH-FNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHhhh-ccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 999998765 88899999999999999999 679999999999999986543 589999998865532211
Q ss_pred cceeccccccccccCCccc-----CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 571 SVIQTMTIATIGYMAPEYG-----SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.......+|+..|||||+. ....|+.++|.||+|||+|-|++|..||.+....+.. |-+.......++.+=.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG---WdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG---WDRGEVCRVCQNKLFE 316 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---ccCCCccHHHHHHHHH
Confidence 1222345789999999964 2346899999999999999999999999886554332 2111111110000000
Q ss_pred cchhhhh--hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 NLVREEQ--AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+..... ....+...+.+..+++...+..||.+|.++.++++
T Consensus 317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111111 11233456677888999999999999999998876
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=295.80 Aligned_cols=246 Identities=28% Similarity=0.328 Sum_probs=196.6
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.|...+.||+|+||.||+|+.. ++..+|+|.+.... ......+..|++++++++|||++++++++.+.+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667789999999999999854 68999999986432 2334568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|++ |++.+.+......+++..+..++.+++.|+.||| +.+|+||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 996 5888888766666899999999999999999994 578999999999999999999999999998764322
Q ss_pred ceeccccccccccCCcccC---CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 572 VIQTMTIATIGYMAPEYGS---EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
....+++.|+|||++. .+.++.++|||||||++|||++|+.||..... ......+.....+
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~------------ 242 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESP------------ 242 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhccCC------------
Confidence 2345888999999863 46688999999999999999999999865311 1111111111000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
......++..+.+++.+|++.+|++||++.|+++..
T Consensus 243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 011113345688999999999999999999998864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=289.77 Aligned_cols=247 Identities=26% Similarity=0.324 Sum_probs=200.8
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999865 68999999987543 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++++|.+++... ..+++..+..++.|+++|+.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999766 45889999999999999999995 5789999999999999999999999999988764332
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...... ...+.......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~-------------- 216 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET-------------- 216 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc--------------
Confidence 123346888999999998888999999999999999999999999763221 11111111110
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH--HHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSM--KDAA 686 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~--~ev~ 686 (704)
.....+...+..+.+++.+||+.||.+||++ +|+.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011122345678899999999999999999 6553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=293.45 Aligned_cols=268 Identities=22% Similarity=0.249 Sum_probs=200.1
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999865 58899999886532 2234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|++++.+..+... ...+++..+..++.+++.|++||| +.+++|+|++|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 9998766655543 344899999999999999999995 57899999999999999999999999999987654332
Q ss_pred ceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHH-HHHHhhcCCCcchhc--cccc
Q 005278 572 VIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK-HWVKESLPDGLTEVV--DANL 647 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~ 647 (704)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.... .......+....... ++..
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 122334678899999998887 889999999999999999999999875322110000 000000000000000 0000
Q ss_pred hh---------hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 648 VR---------EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 648 ~~---------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. .......+..++.++.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000111223677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.19 Aligned_cols=252 Identities=27% Similarity=0.330 Sum_probs=199.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|++|.||+|... +++.+|+|.+..... ...+.+..|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999865 589999999875432 24456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 491 EFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 491 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
||+.+++|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998754 356899999999999999999995 5789999999999999999999999999987653221
Q ss_pred Ccc---------------------------eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccc
Q 005278 570 DSV---------------------------IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFI 622 (704)
Q Consensus 570 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~ 622 (704)
... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 01123578899999999988899999999999999999999999975322
Q ss_pred ccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC----HHHHHH
Q 005278 623 GEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS----MKDAAA 687 (704)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt----~~ev~~ 687 (704)
. ..+.. +..... ........+..+.+++.+|++.+|++||+ +.|+++
T Consensus 238 ~----~~~~~---------~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 D----ETFSN---------ILKKEV-----TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H----HHHHH---------HhcCCc-----cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 11111 000000 00011114567899999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=286.78 Aligned_cols=251 Identities=25% Similarity=0.300 Sum_probs=204.1
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeEEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNI--DFKALVL 490 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 490 (704)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999965 689999999876542 4467789999999999999999999999888 8899999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++++|.+++.... .+++..++.++.+++.|++||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998665 6899999999999999999995 57899999999999999999999999999987755432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
........++..|+|||...+...+.++||||||+++|++++|..||..... .......... .
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-------------~ 219 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIGS-------------S 219 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhccc-------------c
Confidence 1112345688999999999888899999999999999999999999976431 1111010000 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......+...+..+.+++.+|++.+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0001122233567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.63 Aligned_cols=253 Identities=25% Similarity=0.297 Sum_probs=193.2
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+..|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999854 68999999986543 234567889999999996 99999999999998899999999
Q ss_pred cCCCCHHHHH---hh-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 493 MPNGSLEKWL---YS-HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 493 ~~~gsL~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
+.. ++.++. .. ....+++..+..++.+++.|++|||+ +.+++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 555543 22 23558999999999999999999973 358999999999999999999999999999765432
Q ss_pred CCcceeccccccccccCCcccCCC---CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEG---IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ....-......... +
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~-----~ 229 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDP-----P 229 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCC-----C
Confidence 21 1233578899999998766 68899999999999999999999986532 11111111110000 0
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.+.. .....++.++.+++..|++.+|++||++.||++.
T Consensus 230 ~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSN-----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCC-----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0112356678899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=281.18 Aligned_cols=267 Identities=21% Similarity=0.323 Sum_probs=221.0
Q ss_pred HHHHHHhCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeee
Q 005278 408 LDIQRATNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNC 480 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~ 480 (704)
.++.....+++...++.+|.||.||.|.|. +.+.|-||.++.... -....+..|.-.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344445567888888999999999999654 345566777665443 2345678888899999999999999988
Q ss_pred ee-CCeEEEEEeccCCCCHHHHHh-----h--CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 005278 481 CN-IDFKALVLEFMPNGSLEKWLY-----S--HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM 552 (704)
Q Consensus 481 ~~-~~~~~lv~e~~~~gsL~~~l~-----~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~ 552 (704)
.+ .+..++++.++.-|+|..|+. + ..+.....+...++.|++.|++|| |+.+|||.||.++|++||+.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhhhcceehhhe
Confidence 55 567889999999999999998 2 234567788889999999999999 568899999999999999999
Q ss_pred cEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHH
Q 005278 553 TAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWV 631 (704)
Q Consensus 553 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~ 631 (704)
.+||+|=.+++.+-+.+..........+..||+||.+....|+.++|||||||++|||+| |+.||.+..+-+ ..++.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--m~~yl 511 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--MEHYL 511 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--HHHHH
Confidence 999999999999988888888888888999999999999999999999999999999999 999997743322 12222
Q ss_pred HhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 632 KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
.++.+...|..|++++..+|.-||+.+|++||+++|++.-|.++....
T Consensus 512 -----------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 512 -----------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -----------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 223344566789999999999999999999999999999999886544
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.31 Aligned_cols=249 Identities=19% Similarity=0.234 Sum_probs=194.5
Q ss_pred HHHHHHhCCCCccccc--cccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC
Q 005278 408 LDIQRATNGFNECNLL--GTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNI 483 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~i--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 483 (704)
.+.....++|+..+.+ |+|+||.||++.. .++..+|+|.+....... . |+.....+ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444555677777776 9999999999985 468899999986432111 1 22222222 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeeeccc
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-TAHVSDFGIS 562 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-~~kl~Dfgla 562 (704)
+..++||||+++|+|.+++.... .+++..+..++.|+++|++|| |+.+++||||+|+||+++.++ .++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999999998664 689999999999999999999 557899999999999999988 9999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
...... ....++..|+|||++.+..++.++||||||+++|||++|+.||............|.... ..
T Consensus 158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~----- 225 (267)
T PHA03390 158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK----- 225 (267)
T ss_pred eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc-----
Confidence 866432 123588999999999988899999999999999999999999985444333334443221 00
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS-MKDAAA 687 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-~~ev~~ 687 (704)
........+..+.+++.+|++.+|.+||+ ++|+++
T Consensus 226 ----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 ----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00111134567889999999999999996 688863
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.07 Aligned_cols=268 Identities=20% Similarity=0.223 Sum_probs=196.2
Q ss_pred CCCccccccccCceEEEEEEEC---CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF---DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNI--DFKA 487 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 487 (704)
+|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999864 47999999987633 33345678899999999999999999999888 7899
Q ss_pred EEEeccCCCCHHHHHhhC----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC----CCcEEEeee
Q 005278 488 LVLEFMPNGSLEKWLYSH----NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE----NMTAHVSDF 559 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~----~~~~kl~Df 559 (704)
+||||+++ ++.+++... ...++...++.++.|++.|++|| |+.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777776532 23578899999999999999999 5678999999999999999 999999999
Q ss_pred ccceecCCCCC-cceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCcccccc--------ccHHH
Q 005278 560 GISKLLGEGDD-SVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGE--------MSLKH 629 (704)
Q Consensus 560 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~--------~~~~~ 629 (704)
|++........ ........+++.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 112233467899999998765 457889999999999999999999997643322 01111
Q ss_pred HHHhhcC------------CCcchh---c-cccchhhhhhhhhh--HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 630 WVKESLP------------DGLTEV---V-DANLVREEQAFSVK--IDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 630 ~~~~~~~------------~~~~~~---~-~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
++..... ...... . .............. .....++.+++.+|++.||++||++.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1110000 000000 0 00000000000000 133467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=292.64 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=195.5
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCHH
Q 005278 421 NLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLE 499 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 499 (704)
.+||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 478999999986554455667899999999999999999999999999999999999999999
Q ss_pred HHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccc
Q 005278 500 KWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA 579 (704)
Q Consensus 500 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 579 (704)
+++... .+++.....++.|++.|++||| +.+++||||+|+||++++++.++|+|||++........ ......+
T Consensus 106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~ 178 (292)
T cd06657 106 DIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVG 178 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccccc
Confidence 987543 3788999999999999999995 57899999999999999999999999999876543221 1233468
Q ss_pred cccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHH
Q 005278 580 TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKID 659 (704)
Q Consensus 580 t~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (704)
++.|+|||+..+..++.++|+||+||++|||++|..||..... ...........+..+. ....
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~---------------~~~~ 241 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLK---------------NLHK 241 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcccC---------------Cccc
Confidence 8999999999888899999999999999999999999865211 1111111111111110 0112
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 660 CLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 660 ~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+..+.+++.+|++.+|.+||++.|+++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 3456778999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=286.32 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=199.5
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|+..+.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999865 58899999986542 23445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-TAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-~~kl~Dfgla~~~~~~~~ 570 (704)
+++++|.+++... ...+++..+..++.++++|++||| +.+++|+||+|+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999754 335789999999999999999995 57899999999999999875 469999999987643221
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......|++.|+|||+..+..++.++||||||+++||+++|..||.... ..++............
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-------- 222 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAPI-------- 222 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCCC--------
Confidence 1223458899999999988889999999999999999999999986532 2233322221111110
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..+.+++.+|++.+|++||++.|+++
T Consensus 223 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 ------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1123456888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=290.99 Aligned_cols=264 Identities=23% Similarity=0.300 Sum_probs=196.6
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
|+..+.||.|++|.||+|... +|+.||+|++..... ...+.+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999864 799999999875432 23356888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+ ++|.+++.... ..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 69999987654 45899999999999999999995 57899999999999999999999999999976533211
Q ss_pred eeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc-CCC--cchh-ccccc
Q 005278 573 IQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL-PDG--LTEV-VDANL 647 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~-~~~~~ 647 (704)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+....+... +.. +... ..+..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 11223568899999987654 57889999999999999999999986532111 1111111100 000 0000 00000
Q ss_pred hhh------hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 648 VRE------EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 648 ~~~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... ..........+..+.+++.+|++.+|++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0000112233467889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=290.48 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=198.6
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeEEEEEe
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI--DFKALVLE 491 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 491 (704)
|+..+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999865 58999999997653 23345688899999999999999999999888 78999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++ +|.+++......+++..+..++.|++.|++||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9975 899988766556899999999999999999995 46899999999999999999999999999987754332
Q ss_pred ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc-C--CCcchhcc---
Q 005278 572 VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL-P--DGLTEVVD--- 644 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~--- 644 (704)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+........ + ..+....+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchh
Confidence 12233457888999997654 45789999999999999999999998753211 11111111000 0 00000000
Q ss_pred -----ccchhhhhhhhhhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 -----ANLVREEQAFSVKID-CLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 -----~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.............. ++..+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000001111 3678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=287.39 Aligned_cols=242 Identities=22% Similarity=0.282 Sum_probs=185.7
Q ss_pred cccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHh---cCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 422 LLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRS---IRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+||||+.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 689999998865321 122334445444433 479999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|+|.+++...+ .+++..+..++.|++.|++||| +.+|+||||||+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 999999987654 3899999999999999999995 5789999999999999999999999999987653322 1
Q ss_pred ccccccccccCCcccC-CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGS-EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....|+..|+|||... +..++.++||||+||++|||++|..||........ ......... ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~------~~--------- 215 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT------VN--------- 215 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhc------CC---------
Confidence 2346899999999876 45688999999999999999999999975422111 111110000 00
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAAK 688 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~~ 688 (704)
...+..++.++.+++.+|++.||++|| +++|+++.
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 011223456788999999999999999 58888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=293.92 Aligned_cols=270 Identities=21% Similarity=0.265 Sum_probs=194.8
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNID------ 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 484 (704)
.++|+..+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457899999999999999999864 689999998864432 22345678999999999999999999986654
Q ss_pred --eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 485 --FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 485 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
..++||||+. +++.+++......+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999996 4888888766656899999999999999999995 468999999999999999999999999999
Q ss_pred eecCCCCCc--ceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccc-cHHHHHHhhcCCC
Q 005278 563 KLLGEGDDS--VIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEM-SLKHWVKESLPDG 638 (704)
Q Consensus 563 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~ 638 (704)
......... .......++..|+|||.+.+. .++.++||||||+++|||++|..||........ ..........+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 866432211 112234578899999987654 478899999999999999999999865321100 0000011111110
Q ss_pred c-chh-----cc----cc-chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 L-TEV-----VD----AN-LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 ~-~~~-----~~----~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ... .+ +. ............-....+.+++.+||+.||++||+++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000 00 00 00000000000012345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.64 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=201.3
Q ss_pred HhCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.+-++.....||.|.||.||-|. ..+|+..|||-++.+.. .......+|+.++..++|||+|+++|+-...+..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34567778899999999999998 56799999998876543 3345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
||||++|+|.+.+... +..++.....+..|++.|++|| |+.|||||||||.||+++.+|.+|.+|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHH---HhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999988643 3367777778899999999999 55789999999999999999999999999999886542
Q ss_pred Ccc--eeccccccccccCCcccCCCC---CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 570 DSV--IQTMTIATIGYMAPEYGSEGI---ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 570 ~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
.+. .-....||+.|||||++.+.. ...++||||+|||+.||+||+.||...... | ..+..
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~---------aIMy~ 1453 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------W---------AIMYH 1453 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------h---------HHHhH
Confidence 221 122347999999999986543 556899999999999999999999774321 1 11111
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. +.+.....|+..+.+-.+++..|+..||++|.++.|+++
T Consensus 1454 V---~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1454 V---AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred H---hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1 111223334446677788999999999999998887754
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=293.21 Aligned_cols=270 Identities=24% Similarity=0.277 Sum_probs=199.9
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC----
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNID---- 484 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 484 (704)
...++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 589999999875432 23356788999999999999999999987654
Q ss_pred ------eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEee
Q 005278 485 ------FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSD 558 (704)
Q Consensus 485 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~D 558 (704)
..++|+||+++ ++.+.+......+++..+..++.|++.|++||| +.+|+||||+|+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 788888766556899999999999999999994 57899999999999999999999999
Q ss_pred eccceecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh---h
Q 005278 559 FGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE---S 634 (704)
Q Consensus 559 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~---~ 634 (704)
||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+...... .
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence 999987644322 11223346788999997754 4578899999999999999999999975221 1111111110 0
Q ss_pred cCCCcchhccc--------cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 635 LPDGLTEVVDA--------NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 635 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+..+..+... .-.............+..+.+++..||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00001111000 000000000111124567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=284.38 Aligned_cols=242 Identities=26% Similarity=0.304 Sum_probs=194.0
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 423 LGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 423 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
||.|++|.||+|+.. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 58999999987543 23446789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecccc
Q 005278 499 EKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI 578 (704)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 578 (704)
.+++.+.. .+++..+..++.|++.|++|| |+.+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99998653 378899999999999999999 56889999999999999999999999999998764432 122346
Q ss_pred ccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhH
Q 005278 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKI 658 (704)
Q Consensus 579 gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (704)
+++.|+|||.+.+..++.++|+||+|+++|++++|..||...... .......... .. .....+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~--------~~-----~~~~~~~ 217 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYNDILK--------GN-----GKLEFPN 217 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHHHHhc--------cC-----CCCCCCc
Confidence 788999999988888999999999999999999999999764321 1111111110 00 0001111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 659 DCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 659 ~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
..+..+.+++.+||+.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 22567889999999999999999 666644
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=297.59 Aligned_cols=267 Identities=22% Similarity=0.272 Sum_probs=195.9
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-----eE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNID-----FK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 486 (704)
+++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 478999999986432 234456788999999999999999999875543 57
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++|+||+++ ++.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 899999964 888877543 4889999999999999999995 5789999999999999999999999999998764
Q ss_pred CCCCcc-eeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC----Ccc
Q 005278 567 EGDDSV-IQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD----GLT 640 (704)
Q Consensus 567 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 640 (704)
...... ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.... ....+....... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHH
Confidence 332211 1223468899999998654 56889999999999999999999999652210 111111111110 011
Q ss_pred hhccccchh---------hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 641 EVVDANLVR---------EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 641 ~~~~~~~~~---------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.+.+..... ...........+.++.+++.+||+.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111100000 000000111235678899999999999999999999765
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.13 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=203.6
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|...+.||+|+||.||++... ++..+|+|++..... .....+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999965 689999999875432 4556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 493 MPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 493 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
+++++|.+++... ...+++..+..++.+++.|++||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999864 366899999999999999999995 5689999999999999999999999999998764432
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... ..............
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~--------- 221 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQYP--------- 221 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCCCC---------
Confidence 12233468899999999888889999999999999999999999986532 11221111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+..++..+.+++.+||..+|++||++.|+++
T Consensus 222 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 -----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011134567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.46 Aligned_cols=267 Identities=23% Similarity=0.277 Sum_probs=197.0
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchh--hhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLER--ASRSFDSECEILRSIRHRNLIKIISNCCNI--DFKA 487 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 487 (704)
..++|+..+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.++++++|+||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3468999999999999999999864 6899999998754322 223466899999999999999999998764 5689
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+. ++|.+++......+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||++.....
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999996 4899988866566899999999999999999995 57899999999999999999999999999987654
Q ss_pred CCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC---cc-hh
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG---LT-EV 642 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~-~~ 642 (704)
.... .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+.. +....... .. ..
T Consensus 161 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~-~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDL-IIQLLGTPNESIWPGF 236 (309)
T ss_pred ccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhcCCCChhhchhh
Confidence 3211 222345788999998765 457899999999999999999999997532111 1111 11110000 00 00
Q ss_pred ccc----c--chhhh--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDA----N--LVREE--QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~----~--~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+. . ..... .........++.+.+++.+|++.||++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0 00000 000001113566788999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=287.24 Aligned_cols=265 Identities=22% Similarity=0.312 Sum_probs=198.3
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
+|+..+.||+|++|.||+|+.. +|+.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999965 689999999875532 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 494 PNGSLEKWLYSHN--YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 494 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
++ +|.+++.... ..+++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8999887543 45899999999999999999995 57899999999999999999999999999976533211
Q ss_pred ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc-CC--Ccchhcc---
Q 005278 572 VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL-PD--GLTEVVD--- 644 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~--- 644 (704)
......++..|+|||.+.+ ..++.++|||||||++|++++|+.||.+....+ .......... +. .+....+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCch
Confidence 1223457889999998765 457889999999999999999999997532211 1111111000 00 0000000
Q ss_pred --ccchh--hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 --ANLVR--EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 --~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..... ..........++..+.+++..|++.||++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00001112234567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.06 Aligned_cols=265 Identities=21% Similarity=0.249 Sum_probs=194.1
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCe-----
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIR-HRNLIKIISNCCNIDF----- 485 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 485 (704)
++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999864 689999998765432 22356888999999995 6999999999877665
Q ss_pred EEEEEeccCCCCHHHHHhhC----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeeec
Q 005278 486 KALVLEFMPNGSLEKWLYSH----NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-NMTAHVSDFG 560 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-~~~~kl~Dfg 560 (704)
.++||||+++ ++.+++... ...+++..+..++.||+.||+|| |+++|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 898888643 23579999999999999999999 4578999999999999998 8999999999
Q ss_pred cceecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh-cCCC
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES-LPDG 638 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~ 638 (704)
++..+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||.+..... .+....... .+..
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence 9986533211 1122356889999998765 457899999999999999999999986522111 011111100 0000
Q ss_pred --cchhcc-------ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 --LTEVVD-------ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 --~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+..... +...... ........+.++.+++..|++.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQD-LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchh-HHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000000 00011234667889999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=287.67 Aligned_cols=263 Identities=23% Similarity=0.287 Sum_probs=200.4
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
|+..+.||+|++|.||+|... +++.+|+|.+..... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999864 689999999865432 24567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++ ++.+++......+++..+..++.+++.|++||| +.+|+|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 898888876567899999999999999999995 5789999999999999999999999999998775432 11
Q ss_pred eccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC----cchhcc----
Q 005278 574 QTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG----LTEVVD---- 644 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---- 644 (704)
.....++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||......+ .+.. ........ +.....
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFK-IFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHcCCCchHhcccchhhhhh
Confidence 2234578899999988766 78999999999999999999999986532111 0101 00000000 000000
Q ss_pred --ccchhh--hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 --ANLVRE--EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 --~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...... .........++.++.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 0001122345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=291.35 Aligned_cols=253 Identities=22% Similarity=0.265 Sum_probs=195.3
Q ss_pred hCCCCccccccccCceEEEEEEECC-CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQL-ERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 490 (704)
.++|+..+.||+|+||.||+|...+ ++.||||.++... ......+..|+.++.+.. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678889999999999999999764 8999999987543 223345666777776664 999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||++ +++.++.......+++..+..++.+++.|++|||. ..+|+||||+|+||++++++.+||+|||++..+.....
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9985 47888776655568999999999999999999963 25899999999999999999999999999876643221
Q ss_pred cceeccccccccccCCcccCCCC----CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGI----ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.........+..+.....+
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 237 (296)
T cd06618 171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP---------- 237 (296)
T ss_pred ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC----------
Confidence 12335788999999887553 7889999999999999999999986522111111111111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+....++.++.+++.+||+.||++||++.++++.
T Consensus 238 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 ------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000111245678899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=282.42 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=201.6
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|+..+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 688999999876543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++++|.+++... ..+++..+..++.|++.|+.|| |+.+|+||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999765 4589999999999999999999 5678999999999999999999999999999877543321
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ........ ....
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~~------------- 216 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-QDDH------------- 216 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-ccCC-------------
Confidence 2334688999999998888889999999999999999999999865321 11111100 0000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+...+..+.+++.+|++.+|++||++.|++.
T Consensus 217 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 -PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0011123456788999999999999999999964
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.34 Aligned_cols=259 Identities=19% Similarity=0.193 Sum_probs=184.2
Q ss_pred hCCCCccccccccCceEEEEEEECC----CCEEEEEEeeccchhh-----------hHHHHHHHHHHHhcCCCCCceEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQLERA-----------SRSFDSECEILRSIRHRNLIKIIS 478 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~ 478 (704)
.++|.+.+.||+|+||.||+|...+ +..+|+|+........ ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998654 4566677543221110 011223334455678999999999
Q ss_pred eeeeCC----eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 479 NCCNID----FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 479 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
++.... ..++++|++.. ++.+.+... ...++..+..++.|++.|++|| |+.+|+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCcE
Confidence 765543 34678887743 666666543 2357788899999999999999 45789999999999999999999
Q ss_pred EEeeeccceecCCCCCc-----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHH
Q 005278 555 HVSDFGISKLLGEGDDS-----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH 629 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~ 629 (704)
+|+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||....... ....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HHHH
Confidence 99999999876432211 11223469999999999999999999999999999999999999998742211 1111
Q ss_pred HHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 630 WVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
-..... +..+.... .....+++.+.+++..|++.+|++||++.++++.+
T Consensus 245 ~~~~~~---~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDF---IKRLHEGK--------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHH---HHHhhhhh--------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111000 00000000 01123456788999999999999999999999876
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=287.59 Aligned_cols=243 Identities=23% Similarity=0.291 Sum_probs=191.2
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 423 LGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 423 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
||+|+||+||++... +|+.+|+|.+.... ......+..|++++++++||||+++.+.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 68999999986532 12334567899999999999999999999999999999999999999
Q ss_pred HHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccc
Q 005278 499 EKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577 (704)
Q Consensus 499 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 577 (704)
.+++.... ..+++..+..++.|++.|+.|| |+.+++||||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99997654 3589999999999999999999 55789999999999999999999999999987654321 12234
Q ss_pred cccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhh
Q 005278 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVK 657 (704)
Q Consensus 578 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (704)
.++..|+|||+..+..++.++||||+||++|+|++|+.||...... ........... .. ....+
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~--------------~~~~~ 218 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTL-EM--------------AVEYP 218 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhccc-cc--------------cccCC
Confidence 5788999999998888999999999999999999999999653221 11111111000 00 00111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 658 IDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 658 ~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
...+..+.+++.+||+.+|++|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 23356788999999999999999 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=287.88 Aligned_cols=245 Identities=25% Similarity=0.308 Sum_probs=194.2
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 423 LGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 423 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
||+|+||.||+++.. +|+.+|+|.+..... ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 499999999865432 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC------cc
Q 005278 499 EKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD------SV 572 (704)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~------~~ 572 (704)
.+++...+ .+++..+..++.|+++||+||| +.+++||||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998655 5899999999999999999995 57899999999999999999999999999876533211 11
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......++..|+|||.......+.++||||||+++||+++|..||..... ............
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~------------- 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQNILNGKI------------- 218 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCc-------------
Confidence 22334678899999998888899999999999999999999999865321 111111100000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
..+.....+..+.+++.+|++.+|++||++.++.+.|
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0000001256788999999999999999996555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.18 Aligned_cols=263 Identities=21% Similarity=0.224 Sum_probs=195.5
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC------
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI------ 483 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 483 (704)
..++|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999985 478999999986432 23345677899999999999999999988643
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
...++||||+. ++|.+.+... ++...+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35699999996 5888887644 78888999999999999999 45789999999999999999999999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC--C---
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD--G--- 638 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~--- 638 (704)
....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+.......... .
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence 7643221 22345788999999999999999999999999999999999999653210 0000000000000 0
Q ss_pred --------------------cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 --------------------LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.......... ..........+..+.+++.+|++.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFP-PDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccC-cccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000000 0000001123556889999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.27 Aligned_cols=269 Identities=23% Similarity=0.268 Sum_probs=197.0
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC--CeE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSI-RHRNLIKIISNCCNI--DFK 486 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 486 (704)
..++|+..+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4568888999999999999999865 68899999885421 22345577899999999 999999999998653 367
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++||||++ ++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5999988765 5788999999999999999995 5789999999999999999999999999998764
Q ss_pred CCCCc---ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc--CC---
Q 005278 567 EGDDS---VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL--PD--- 637 (704)
Q Consensus 567 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~--- 637 (704)
..... .......|+..|+|||++.+ ..++.++||||||+++|+|+||+.||......+. ......... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence 43221 12223458899999997754 5678899999999999999999999965322111 000000000 00
Q ss_pred -----C-cchhccccchhh-hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 638 -----G-LTEVVDANLVRE-EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 638 -----~-~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
. .....+...... .........++..+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 000000000000 00001111246778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=284.74 Aligned_cols=246 Identities=29% Similarity=0.347 Sum_probs=201.0
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|++++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 68899999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 493 MPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 493 ~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
+++++|.+++.. .+..+++..++.++.+++.|++|| |+.+++|+||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999875 235589999999999999999999 5688999999999999999999999999999876543
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
......+++.|+|||...+..++.++|+||+|+++||+++|+.||...... .+...+.. ...
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~---~~~---------- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR---GKY---------- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc---CCC----------
Confidence 122345788999999999888999999999999999999999999753211 11111110 000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++.++.+++.+|++.+|++||++.|+++
T Consensus 219 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 ----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111244567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=290.32 Aligned_cols=261 Identities=22% Similarity=0.231 Sum_probs=191.3
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeecc--chhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQ--LERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++|++
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344555555555543 6999999998754 234456799999999999999999999999999999999999999999
Q ss_pred HHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC-----cc
Q 005278 499 EKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD-----SV 572 (704)
Q Consensus 499 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~-----~~ 572 (704)
.+++... ...+++.....++.|++.|++||| +.+|+||||||+||+++.++.+|++|||.+..+..... ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999854 345888999999999999999995 57899999999999999999999999999876532211 11
Q ss_pred eeccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcc---------h
Q 005278 573 IQTMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT---------E 641 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 641 (704)
......++..|+|||++.. ..++.++|||||||++|||++|+.||............ .....+..+. .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhcCC
Confidence 1123357788999998865 35788999999999999999999999764322211111 1111000000 0
Q ss_pred -------hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 642 -------VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 642 -------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..++. ...............++.+++..||+.||++||+++|+++
T Consensus 243 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 243 MSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 0011112223345567889999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.48 Aligned_cols=267 Identities=22% Similarity=0.287 Sum_probs=197.2
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeee----CCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCN----IDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 486 (704)
.++|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++||||+++.+++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368899999999999999999854 699999999875432 234567789999999999999999988753 3467
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++||||+. |+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 689998875543 899999999999999999995 5789999999999999999999999999998764
Q ss_pred CCCCc--ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC---C-c
Q 005278 567 EGDDS--VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD---G-L 639 (704)
Q Consensus 567 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~-~ 639 (704)
..... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... ............ . +
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHhh
Confidence 33221 11223468899999998755 46889999999999999999999999653211 011111100000 0 0
Q ss_pred chhccccch-------hhh--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 640 TEVVDANLV-------REE--QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 640 ~~~~~~~~~-------~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......... ... .........+.++.+++.+|++.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000 000 000011234677899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.51 Aligned_cols=270 Identities=17% Similarity=0.181 Sum_probs=187.5
Q ss_pred HhCCCCccccccccCceEEEEEEECC--CCEEEEEE--------------eec---cchhhhHHHHHHHHHHHhcCCCCC
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFD--GTNVAIKV--------------FNL---QLERASRSFDSECEILRSIRHRNL 473 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~e~~~l~~l~h~ni 473 (704)
..++|++.+.||+|+||+||++.... +..++.|. +.+ ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987532 22222221 111 112234568899999999999999
Q ss_pred ceEEeeeeeCCeEEEEEeccCCCCHHHHHhhCC----CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 005278 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHN----YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD 549 (704)
Q Consensus 474 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~ 549 (704)
+++++++...+..++|+|++. +++.+++.... ..........++.|++.||+||| +.+|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 999999999999999999985 58888776432 22345567789999999999995 57899999999999999
Q ss_pred CCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCC-CCccccc-cccH
Q 005278 550 ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP-TNEIFIG-EMSL 627 (704)
Q Consensus 550 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p-~~~~~~~-~~~~ 627 (704)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|..+ +...... ...+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999876543221 12235699999999999999999999999999999999998754 4321111 1111
Q ss_pred HHHHHh------hcCCCc---chhccc-cchhh---hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 628 KHWVKE------SLPDGL---TEVVDA-NLVRE---EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 628 ~~~~~~------~~~~~~---~~~~~~-~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+.+.. ..+... ...++. .+... ..........+..+.+++.+|++.||++||++.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111110 011100 000000 00000 0000011122345678899999999999999999976
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=289.24 Aligned_cols=247 Identities=27% Similarity=0.312 Sum_probs=195.3
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|+++++.++|+|++++.+++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667789999999999999864 68889999886421 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+. |++.+++......+++..+..++.+++.|+.||| +.+++||||+|+||+++.++.++++|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9996 6888888766666899999999999999999995 578999999999999999999999999998865432
Q ss_pred cceeccccccccccCCcccC---CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 571 SVIQTMTIATIGYMAPEYGS---EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
....+++.|+|||++. ...++.++|||||||++|||++|+.||...... .....+.....+
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~----------- 232 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP----------- 232 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCCC-----------
Confidence 2235788999999864 456788999999999999999999998652111 111111110000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
......++..+.+++.+||+.+|++||++.++++.-
T Consensus 233 ------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 ------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 001123456688999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=291.09 Aligned_cols=271 Identities=22% Similarity=0.287 Sum_probs=195.5
Q ss_pred cccccc--CceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTG--SFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
..||+| +||+||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356776 9999999986 479999999986543 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc--
Q 005278 496 GSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-- 572 (704)
Q Consensus 496 gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~-- 572 (704)
|++.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998754 33488899999999999999999 46789999999999999999999999998654332211110
Q ss_pred ---eeccccccccccCCcccCCC--CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh---------cCCC
Q 005278 573 ---IQTMTIATIGYMAPEYGSEG--IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES---------LPDG 638 (704)
Q Consensus 573 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~~~ 638 (704)
......++..|+|||++.+. .++.++|||||||++|||++|+.||........ ........ .+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchh
Confidence 01112356679999998763 478899999999999999999999976422111 11110000 0000
Q ss_pred cch---------------hccc----cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHHHhHHH
Q 005278 639 LTE---------------VVDA----NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA--KLKKIKEK 695 (704)
Q Consensus 639 ~~~---------------~~~~----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~--~L~~~~~~ 695 (704)
... .... ......-.......++..+.+++.+||+.||++|||+.|+++ .++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 000 0000 000000011223356778999999999999999999999964 34555444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=287.45 Aligned_cols=266 Identities=21% Similarity=0.284 Sum_probs=194.1
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|+..+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999865 689999999865422 233568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeeeccceecCCCC
Q 005278 492 FMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-NMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 492 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-~~~~kl~Dfgla~~~~~~~ 569 (704)
|++ +++.+++... ....++.....++.|++.|++||| +.+++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5888887643 333678888899999999999995 578999999999999985 5679999999997653321
Q ss_pred CcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh-hcC-CC-cchhcc-
Q 005278 570 DSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE-SLP-DG-LTEVVD- 644 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~-~~-~~~~~~- 644 (704)
. ......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||......+. ..+.... ..+ .. +....+
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhccccccc
Confidence 1 1223357889999998765 4578899999999999999999999965321111 1110000 000 00 000000
Q ss_pred ccchhh------hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 ANLVRE------EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.+... ..........+.++.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0000011223566889999999999999999999965
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=281.53 Aligned_cols=250 Identities=22% Similarity=0.227 Sum_probs=196.0
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc-----hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-----ERASRSFDSECEILRSIRHRNLIKIISNCCNI--DFK 486 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 486 (704)
.+|...+.||+|+||.||+|+. .++..||+|.+.... ......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788899999999999999985 468999999875321 23345788999999999999999999998764 457
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++++||+++++|.+++..... +++.....++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 899999999999999876543 788899999999999999994 6789999999999999999999999999998653
Q ss_pred CCCC-cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 567 EGDD-SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 567 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.... ........++..|+|||++.+..++.++|+|||||++||+++|+.||...... ... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~------- 225 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AAI-FKIATQP------- 225 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HHH-HHHHcCC-------
Confidence 2111 11112345889999999998888999999999999999999999999753111 111 1000000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.....+......+.+++.+|++ +|.+||++.+++.
T Consensus 226 ------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0011222445678899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=283.10 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=195.4
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhc---CCCCCceEEeeeeeCCe-----
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSI---RHRNLIKIISNCCNIDF----- 485 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 485 (704)
|++.+.||+|+||.||+|+.. +++.+|+|+++.... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999976 489999999875432 2234566788777766 59999999999988776
Q ss_pred EEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 486 KALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
.+++|||+. ++|.+++.... ..+++..+..++.|+++|++||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999997 48999887543 35899999999999999999995 56899999999999999999999999999987
Q ss_pred cCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC-cchhc
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG-LTEVV 643 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 643 (704)
...... .....++..|+|||++.+..++.++|+|||||++|||++|..||...... ..+..+........ .....
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence 643321 12234788999999999889999999999999999999999998753221 11222222111100 00000
Q ss_pred c-----ccchhhh--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 644 D-----ANLVREE--QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 644 ~-----~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ..+.... .......+....+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000 001111234567889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=282.11 Aligned_cols=243 Identities=23% Similarity=0.241 Sum_probs=186.9
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHH-HhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEIL-RSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|... +|+.||+|.+..... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999864 689999999865421 1222344454444 445899999999999999999999999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
++|.+++.... .+++..+..++.|++.||.|| |+.+++||||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999997653 478899999999999999999 457899999999999999999999999999876432 12
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
...+++.|+|||...+..++.++||||||+++|||++|..||...... ........... .. ...
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--------~~---~~~ 215 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AVFDNILSRRI--------NW---PEE 215 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhccc--------CC---CCc
Confidence 345788999999988888899999999999999999999999653211 11111000000 00 001
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
....++..+.+++.+||+.+|++||++.++.+.|
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 1113456788999999999999999887665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=283.12 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=204.0
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.+.|..-++||+||||.||-++.. +|+.+|.|.+.++. .........|..++++++.+.||.+--.|..++..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 467788889999999999999854 79999999886553 23344578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 490 LEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
+..|.||+|.-++...+ ..+++..+.-++.+|+.||++| |+.+||.||+||+|||+|+.|+++|+|.|+|..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999998653 4589999999999999999999 6688999999999999999999999999999998765
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.. ....+||.||||||++..+.|+...|-||+||++|||+.|+.||...... ++| +.+|+...
T Consensus 341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----vk~----------eEvdrr~~ 403 (591)
T KOG0986|consen 341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----VKR----------EEVDRRTL 403 (591)
T ss_pred Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----hhH----------HHHHHHHh
Confidence 43 34458999999999999999999999999999999999999999763221 111 11222221
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMK 683 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 683 (704)
... ...+..++++..++....+..||++|..-+
T Consensus 404 ~~~--~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 EDP--EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cch--hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 111 122345677788899999999999998543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=287.10 Aligned_cols=244 Identities=27% Similarity=0.310 Sum_probs=192.9
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
|...+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999854 68999999986432 22335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+. |++.+++......+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 5888888766667899999999999999999995 57899999999999999999999999999864322
Q ss_pred eeccccccccccCCcccC---CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 573 IQTMTIATIGYMAPEYGS---EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.....|+..|+|||++. ...++.++|||||||++|||++|..||..... ........ .......
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~~---~~~~~~~------- 240 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIA---QNDSPTL------- 240 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHH---hcCCCCC-------
Confidence 12346888999999874 46688899999999999999999999865321 11111111 0000000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
....++..+.+++.+||+.+|.+||++.++++.
T Consensus 241 ------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011223457889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=282.14 Aligned_cols=241 Identities=22% Similarity=0.293 Sum_probs=184.9
Q ss_pred cccccCceEEEEEEE-CCCCEEEEEEeeccch---hhhHHHHHHHH---HHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 422 LLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE---RASRSFDSECE---ILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
.||+|+||.||+|.. .+++.||+|.+..... .....+..|.. .++...||+|+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4689999999865421 11222334433 3444579999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|+|.+++...+ .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 999999887554 4899999999999999999995 5789999999999999999999999999987653221 1
Q ss_pred ccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....|+..|+|||++.++ .++.++||||+||++|||++|+.||........ ......... . .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~------~---------~ 215 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT------M---------A 215 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhc------c---------C
Confidence 234689999999998754 688999999999999999999999976322111 110000000 0 0
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
...+..++..+.+++.+|++.+|++|| ++.|+++
T Consensus 216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 011112356788899999999999999 8999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.34 Aligned_cols=271 Identities=23% Similarity=0.251 Sum_probs=199.4
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC-----Ce
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI-----DF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 485 (704)
.++|.+.+.||+|+||+||+|+. .+++.||||.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45789999999999999999985 468999999986532 22345677899999999999999999988654 34
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++|+||+. ++|.+++.... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 68999887553 4899999999999999999994 578999999999999999999999999999866
Q ss_pred CCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc---CCCcch
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL---PDGLTE 641 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 641 (704)
.... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.... ........... ++....
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhh
Confidence 4322 11223457889999998754 46889999999999999999999999653210 00110000000 000000
Q ss_pred hccccchh---------hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHh
Q 005278 642 VVDANLVR---------EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK--LKKI 692 (704)
Q Consensus 642 ~~~~~~~~---------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~--L~~~ 692 (704)
..+..... .........+++.++.+++.+|++.+|++||+++|+++. ++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000 000011122456778999999999999999999999876 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=285.03 Aligned_cols=255 Identities=23% Similarity=0.277 Sum_probs=198.2
Q ss_pred CCCccccccccCceEEEEEEE----CCCCEEEEEEeeccc----hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeE
Q 005278 416 GFNECNLLGTGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 486 (704)
+|+..+.||+|++|.||+++. .+++.||||+++... ....+.+..|+++++++ +||||+++.+.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999974 357889999986432 22345688999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++||||+++|+|.+++.... .+++..+..++.|+++|++||| +.+++||||+|+||+++.++.++++|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999987643 4788899999999999999995 5789999999999999999999999999987654
Q ss_pred CCCCcceeccccccccccCCcccCCCC--CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGI--ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
..... ......|+..|+|||...+.. .+.++||||||+++|||++|..||..... ......+.+.....
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~------- 227 (288)
T cd05583 157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKS------- 227 (288)
T ss_pred ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHcc-------
Confidence 33211 122345889999999887655 78899999999999999999999864211 11111211111100
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
....+..++..+.+++.+||+.+|++|||++++.+.|+.
T Consensus 228 --------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 001122344567889999999999999999988776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.67 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=203.0
Q ss_pred HHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.....|.+...||+|.|+.|..|+. .++..||+|.+++..- .....+.+|+++|..++|||||+++.+...+...|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3456788899999999999999985 4799999999976542 223458899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+.+|.+.+++.++++-.. .....++.|+..|++|| |++.|||||||++||+++.+.++||+|||++..+..+
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999998877444 88888999999999999 6789999999999999999999999999999988643
Q ss_pred CCcceeccccccccccCCcccCCCC-CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGI-ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
......+|++.|.|||++.+.. .++++|+||+|+++|-++.|..||++..-.+. -..++...+
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------r~rvl~gk~ 272 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------RPRVLRGKY 272 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------cchheeeee
Confidence 2345568999999999998865 56789999999999999999999987321110 011111111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. .+.-...+.-+++++++-.+|.+|++++++.+
T Consensus 273 r-------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 273 R-------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred c-------ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1 11122344567899999999999999999843
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=291.02 Aligned_cols=272 Identities=23% Similarity=0.286 Sum_probs=203.1
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-----eEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID-----FKA 487 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 487 (704)
+|.+.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999965 58999999987543 334567899999999999999999999988765 789
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||++ ++|.+++.... .+++..+..++.+++.|++|| |+.+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 58988887554 689999999999999999999 557899999999999999999999999999987654
Q ss_pred CCC-cceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC--------
Q 005278 568 GDD-SVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD-------- 637 (704)
Q Consensus 568 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------- 637 (704)
... ........++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+....+. +.. +......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNL-IVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHH-HHHhcCCCChhHhhh
Confidence 321 0112334578899999998877 789999999999999999999999976432110 000 0000000
Q ss_pred ----Ccchhccc-cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHhHH
Q 005278 638 ----GLTEVVDA-NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK--LKKIKE 694 (704)
Q Consensus 638 ----~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~--L~~~~~ 694 (704)
.....+.. ...............+..+.+++..||+.+|++||++.++++. ++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000 0000000001112245678899999999999999999999874 554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=289.18 Aligned_cols=267 Identities=24% Similarity=0.291 Sum_probs=196.9
Q ss_pred HHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee-CCe
Q 005278 410 IQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN-IDF 485 (704)
Q Consensus 410 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 485 (704)
+..++++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+..|++++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999854 79999999876432 2234668889999999999999999998865 557
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++|+||+ +++|.+++... .+++.....++.|++.|++|| |+.+|+||||+|+||++++++.++|+|||.+...
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 88999998 56898888643 367888889999999999999 5678999999999999999999999999998754
Q ss_pred CCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh--cCCCc-ch
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES--LPDGL-TE 641 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~-~~ 641 (704)
... .....++..|+|||++.+ ..++.++||||||+++|+|+||+.||...... .....+.... .+..+ ..
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 321 122357889999998765 56899999999999999999999998653210 0111111000 00000 00
Q ss_pred hcccc-------chhh--hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 642 VVDAN-------LVRE--EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 642 ~~~~~-------~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+.. .... .+.......++..+.+++.+|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000 00001111245678999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=281.72 Aligned_cols=251 Identities=24% Similarity=0.271 Sum_probs=194.5
Q ss_pred CCCccccccccCceEEEEEEE----CCCCEEEEEEeeccc----hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeE
Q 005278 416 GFNECNLLGTGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 486 (704)
+|+..+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++.+++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477788999999999999985 368999999987532 12346688899999999 599999999999998899
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++|+||+++++|.+++.... .+++.....++.|++.|+.|| |+.+++||||+|+||+++.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999997654 478888899999999999999 56889999999999999999999999999998764
Q ss_pred CCCCcceeccccccccccCCcccCCC--CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEG--IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
..... ......|+..|+|||..... .++.++||||||+++|+|++|..||..... ......+........
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~------ 228 (290)
T cd05613 157 EDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE------ 228 (290)
T ss_pred ccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC------
Confidence 32211 12234588999999987653 467899999999999999999999864211 112222221111000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
.+.+..+...+.+++.+|++.+|++|| ++.++..
T Consensus 229 ---------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ---------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001123445678899999999999997 5666644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=282.08 Aligned_cols=262 Identities=21% Similarity=0.245 Sum_probs=194.2
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEEecc
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
|...+.||+|++|+||+|+.. +++.||+|.+..... .......+|+..+++++ |+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999975 588999999865432 22334567899999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+|++.+++.... ..+++..+..++.|++.++.||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999887654 56899999999999999999995 57899999999999999999999999999987643221
Q ss_pred eeccccccccccCCcccC-CCCCCcccceeeHHHHHHHHhhCCCCCCccccccc-----------cHHHHHHhhcCC-Cc
Q 005278 573 IQTMTIATIGYMAPEYGS-EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM-----------SLKHWVKESLPD-GL 639 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~-----------~~~~~~~~~~~~-~~ 639 (704)
.....++..|+|||++. ...++.++|+||||+++|||++|+.||......+. .-..|....... ..
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 12345788999999774 45578999999999999999999999865321110 000111100000 00
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+...... . ........+..+.+++.+||+.+|++||+++|++.
T Consensus 234 ~~~~~~~~~~-~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPT-S-LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccc-c-HHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 0 00001112467889999999999999999999965
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=267.05 Aligned_cols=249 Identities=22% Similarity=0.244 Sum_probs=199.3
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
..++|+.++++|+|.||.|-.++- .+++.+|+|++++.+. .+...-..|-++++..+||.+..+--.|+..+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 347888899999999999999985 4799999999987653 333456779999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||..||.|.-++.+.+. +++....-+-..|..||.|| |+++||.||+|.+|.++|.+|++||+|||+++.--
T Consensus 246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence 9999999999988876543 66666666788899999999 56889999999999999999999999999998532
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.....+...+|||.|+|||++....|+..+|-|.+||+||||++|+.||.....+ .+ .+++-..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--kL------------FeLIl~e-- 383 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--KL------------FELILME-- 383 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--HH------------HHHHHhh--
Confidence 2233456679999999999999999999999999999999999999999763211 11 1111110
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC--HHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVS--MKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt--~~ev~~ 687 (704)
....+...+++...++...+..||.+|.. ..|+.+
T Consensus 384 ----d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakE 420 (516)
T KOG0690|consen 384 ----DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKE 420 (516)
T ss_pred ----hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHH
Confidence 11122244556777899999999999973 344433
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=289.43 Aligned_cols=267 Identities=20% Similarity=0.257 Sum_probs=194.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID------ 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 484 (704)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999985 468999999986532 223356789999999999999999999986542
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..++|+||+.. ++.++.. ..+++..+..++.|++.|++|| |+.+|+||||||+||+++.++.++|+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46899999964 7776653 3478899999999999999999 457899999999999999999999999999876
Q ss_pred cCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC--Ccch
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD--GLTE 641 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 641 (704)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+..... .+.......... .+..
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 4321 123457889999998766 468899999999999999999999997532111 011100000000 0000
Q ss_pred hccc-c---c------hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHhH
Q 005278 642 VVDA-N---L------VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK--LKKIK 693 (704)
Q Consensus 642 ~~~~-~---~------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~--L~~~~ 693 (704)
.... . . .............+..+.+++..|++.||++||+++|+++. ++.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 0 0 00000000011234568899999999999999999999854 55544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=285.36 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=200.4
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 489 (704)
++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999864 79999999986532 233467888999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++++|.+++.+.. .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999998664 4899999999999999999995 5789999999999999999999999999998764332
Q ss_pred Cc------------------ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHH
Q 005278 570 DS------------------VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV 631 (704)
Q Consensus 570 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~ 631 (704)
.. .......++..|+|||......++.++||||||++++++++|+.||...... ..+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~-~ 234 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQK-I 234 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHH-H
Confidence 11 1222345789999999988888999999999999999999999999763210 00000 0
Q ss_pred HhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH----HHHHH
Q 005278 632 KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSM----KDAAA 687 (704)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~----~ev~~ 687 (704)
. . .....+...+..+.+++.+||+.+|++||++ .|+++
T Consensus 235 ~-----------~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 L-----------K-------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H-----------h-------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 0 0001112235568899999999999999999 77653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=263.73 Aligned_cols=252 Identities=23% Similarity=0.264 Sum_probs=196.6
Q ss_pred HhCCCCcc-ccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeee----CCe
Q 005278 413 ATNGFNEC-NLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCN----IDF 485 (704)
Q Consensus 413 ~~~~~~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 485 (704)
.+++|.+. ++||-|-.|.|-.+.. .+++.+|+|++. +....++|++.--.. .|||||+++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666643 6899999999999875 479999999875 234456777754433 79999999999865 346
Q ss_pred EEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEeeecc
Q 005278 486 KALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD---ENMTAHVSDFGI 561 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~---~~~~~kl~Dfgl 561 (704)
..+|||.|+||.|.+.++.++ ..+.+..+..|+.||+.|+.|| |+..|.||||||+|+|.. .+..+|++|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 679999999999999998664 4589999999999999999999 668899999999999996 456799999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcch
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (704)
|+.-.. .......+-||.|.|||++...+|+..+|+||+||++|-|++|.+||.+.... .+..-.+..+..+..+
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKRRIRTGQYE 285 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCChhHHhHhhccCcc
Confidence 986432 23345567899999999999999999999999999999999999999875431 1111111111111101
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+++...+++..++|+.++..+|++|.|+.|+..
T Consensus 286 ----------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 286 ----------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ----------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 122345567788899999999999999999999853
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=268.31 Aligned_cols=251 Identities=25% Similarity=0.267 Sum_probs=190.5
Q ss_pred CccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHh-cCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 418 NECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRS-IRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
+....||.|+||+|+|-..+ .|+..|||+++... +.+..++..|.+...+ -+.||||+++|.+...+..++.||.|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 34568999999999999854 69999999998665 3556777777776554 479999999999988888899999995
Q ss_pred CCCHHHHHh----hCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 495 NGSLEKWLY----SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 495 ~gsL~~~l~----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
.|+..+-. ..+..+++.-.-.|......||.||.+. ..||||||||+|||+|..|.+|+||||++-.+. .
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~ 220 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---D 220 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH---H
Confidence 46654332 2345588888888889999999999864 569999999999999999999999999987553 3
Q ss_pred cceeccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 571 SVIQTMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
+...+..+|...|||||.+.. ..|+-++||||+|++|||+.||+.||.....--.++.+.+....|. +...
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~-----l~~~-- 293 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI-----LLFD-- 293 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe-----ecCc--
Confidence 445566689999999998754 3488899999999999999999999976322111111111111110 1100
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+++..+..++..|+.+|-+.||...++.+
T Consensus 294 ------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 ------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ------ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111245677889999999999999999998864
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=291.87 Aligned_cols=266 Identities=20% Similarity=0.241 Sum_probs=193.3
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC---------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNI--------- 483 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 483 (704)
..+|...+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36889999999999999999985 46899999998765555567788999999999999999999876543
Q ss_pred -----CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEe
Q 005278 484 -----DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVS 557 (704)
Q Consensus 484 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~ 557 (704)
...++|+||++ ++|.+++... .+++.....++.|++.|++||| +.+|+||||||+||+++ +++.+|++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5898888643 3789999999999999999995 57899999999999998 45678999
Q ss_pred eeccceecCCCCCc-ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc
Q 005278 558 DFGISKLLGEGDDS-VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 558 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
|||.++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+. ....... .
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~-~ 235 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILES-V 235 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-c
Confidence 99999866432111 11123357889999997644 5688899999999999999999999965322110 1111000 0
Q ss_pred CCC-------cchhccccch-----hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 636 PDG-------LTEVVDANLV-----REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 636 ~~~-------~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.. .......... ..............++.+++.+|++.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0000000000 000000011134567889999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=287.74 Aligned_cols=267 Identities=22% Similarity=0.250 Sum_probs=194.0
Q ss_pred CCCCc-cccccccCceEEEEEEEC-CCCEEEEEEeeccchhh--------------hHHHHHHHHHHHhcCCCCCceEEe
Q 005278 415 NGFNE-CNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERA--------------SRSFDSECEILRSIRHRNLIKIIS 478 (704)
Q Consensus 415 ~~~~~-~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~ 478 (704)
++|.. .+.||+|+||+||+|... +++.||||.+....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999854 68999999986432111 124778999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEee
Q 005278 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSD 558 (704)
Q Consensus 479 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~D 558 (704)
++...+..++||||++ |+|.+++.... .+++.....++.|++.|++|| |+.+|+||||+|+||+++.++.++++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999996 69999887543 488999999999999999999 457899999999999999999999999
Q ss_pred eccceecCCCC------------CcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccc
Q 005278 559 FGISKLLGEGD------------DSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEM 625 (704)
Q Consensus 559 fgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~ 625 (704)
||.+....... .........+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 99998764111 01111223468889999988764 46889999999999999999999997532211
Q ss_pred cHHHHHHhhc-C--CCcchhcc-ccc----hh-hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 626 SLKHWVKESL-P--DGLTEVVD-ANL----VR-EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 626 ~~~~~~~~~~-~--~~~~~~~~-~~~----~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+........ + ..+..... +.. .. ..........++.++.+++..|++.+|++||++.|++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111000 0 00000000 000 00 00000111233567889999999999999999999975
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=286.71 Aligned_cols=269 Identities=21% Similarity=0.248 Sum_probs=197.4
Q ss_pred HHHHHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC-
Q 005278 408 LDIQRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI- 483 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~- 483 (704)
.++...+++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45677889999999999999999999985 578999999986532 22345678899999999999999999988643
Q ss_pred -----CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEee
Q 005278 484 -----DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSD 558 (704)
Q Consensus 484 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~D 558 (704)
...+++++++ +++|.+++... .+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEec
Confidence 3467888876 78998887654 3889999999999999999995 57899999999999999999999999
Q ss_pred eccceecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc--
Q 005278 559 FGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL-- 635 (704)
Q Consensus 559 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-- 635 (704)
||++...... .....++..|+|||+..+ ..++.++|||||||++|||++|+.||...... ..+........
T Consensus 164 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~ 237 (345)
T cd07877 164 FGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTP 237 (345)
T ss_pred cccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence 9998864321 223457889999998765 56888999999999999999999998642211 11111111000
Q ss_pred CCCcchhccccchhhh----------hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 636 PDGLTEVVDANLVREE----------QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+......+........ .........+..+.+++..|++.||++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000000 0000001235568899999999999999999998653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=286.67 Aligned_cols=267 Identities=22% Similarity=0.243 Sum_probs=194.8
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchh--hhHHHHHHHHHHHhcCCCCCceEEeeeeeCC------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLER--ASRSFDSECEILRSIRHRNLIKIISNCCNID------ 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 484 (704)
.++|+..+.||+|+||.||+|+.. +++.+|+|++...... ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999865 6899999998654322 2345778999999999999999999875433
Q ss_pred --eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 485 --FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 485 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
..++|+||+.+ ++.+.+......+++..+..++.|+++|++|| |+.+|+||||||+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYL---HENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 46899999965 78887776666799999999999999999999 5678999999999999999999999999999
Q ss_pred eecCCCCCcc---------eeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHH
Q 005278 563 KLLGEGDDSV---------IQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK 632 (704)
Q Consensus 563 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~ 632 (704)
.......... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+..... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 8654322111 1122356888999998765 458899999999999999999999986532211 1111111
Q ss_pred hhcC--C-C------cch----hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 633 ESLP--D-G------LTE----VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 633 ~~~~--~-~------~~~----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.... . . ... ......... ...........+.+++.+|++.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRT--LEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCcc--HHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 0 0 000 000000000 00011123356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=281.59 Aligned_cols=262 Identities=25% Similarity=0.278 Sum_probs=197.7
Q ss_pred CCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
|+..+.||+|++|.||+|+.. +++.+|+|++.... ......+..|+.++++++|+|++++.+++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999965 59999999987653 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
+ ++|.+++......+++..+..++.+++.|++||| +.+|+||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 7 5999999876556899999999999999999995 56899999999999999999999999999987643221 1
Q ss_pred eccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC--CC--cchh-----c
Q 005278 574 QTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP--DG--LTEV-----V 643 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~--~~~~-----~ 643 (704)
.....++..|+|||.+.+. .++.++|||||||++||+++|+.||......+ .......... .. +... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHHHhCCCcHHHHHhhcccccc
Confidence 2233467789999988766 78999999999999999999999986532110 0000000000 00 0000 0
Q ss_pred c---ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 644 D---ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 644 ~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+ +....... ..........+.+++..||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 00000000 0011122567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=287.58 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=195.7
Q ss_pred HHHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC--
Q 005278 410 IQRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID-- 484 (704)
Q Consensus 410 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 484 (704)
+....++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344567899999999999999999984 479999999985432 223456889999999999999999999886543
Q ss_pred ----eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeec
Q 005278 485 ----FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFG 560 (704)
Q Consensus 485 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 560 (704)
..++||||+ +++|.+++... .+++..+..++.|++.|++|| |+.+|+||||||+||+++.++.++++|||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~L---H~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 67998888643 488999999999999999999 55789999999999999999999999999
Q ss_pred cceecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc--CC
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL--PD 637 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~ 637 (704)
++...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||....... .+........ +.
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCH
Confidence 99865322 123357889999998765 458889999999999999999999997532110 0111100000 00
Q ss_pred Ccchhcccc-----------chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005278 638 GLTEVVDAN-----------LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAA 686 (704)
Q Consensus 638 ~~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~ 686 (704)
.+...+... .... ........++..+.+++.+|++.||++||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKK-DFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcc-hHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000000000 0000 00011123456688999999999999999999997
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=307.92 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=203.5
Q ss_pred HHHHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC
Q 005278 408 LDIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNI 483 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 483 (704)
.+++-..++|+++++||+|+||.|..+++. +++.+|+|++.+-. ..+..-|..|-.+|..-+.+-|+.+.-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 344555689999999999999999999964 68999999987521 33456799999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
.+.|+|||||+||+|...+.+.. .+++..+.-++..|..||.-| |+.|+|||||||+|||+|..|++||+|||.+-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999999877 688888887888888888888 67899999999999999999999999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccC----C-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGS----E-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG 638 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (704)
.+...+ .......+|||.|++||++. + +.|++.+|-||+||++|||+.|..||..-.- ..++.+
T Consensus 224 km~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-veTY~K--------- 292 (1317)
T KOG0612|consen 224 KMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-VETYGK--------- 292 (1317)
T ss_pred hcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-HHHHHH---------
Confidence 776432 34455678999999999863 3 6799999999999999999999999975210 011111
Q ss_pred cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 005278 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS---MKDAAA 687 (704)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt---~~ev~~ 687 (704)
+++..- ...++...+.+....++|...+. +|+.|.. +.|+..
T Consensus 293 ---Im~hk~---~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 293 ---IMNHKE---SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ---Hhchhh---hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 111100 00111223456667778877664 7888887 777643
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=264.61 Aligned_cols=202 Identities=25% Similarity=0.321 Sum_probs=168.2
Q ss_pred hCCCCccccccccCceEEEEEEEC---C--CCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeee-CCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF---D--GTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCN-IDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 485 (704)
...|+.+..||+|.||.||+|.-. + ...+|+|+++.... ...-..-+|+..++.++|||++.++.++.. ...
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 357889999999999999999532 2 23789999875532 233457789999999999999999999877 778
Q ss_pred EEEEEeccCCCCHHHHHhhC----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC----CcEEEe
Q 005278 486 KALVLEFMPNGSLEKWLYSH----NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN----MTAHVS 557 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~----~~~kl~ 557 (704)
+++++||.+. +|.+.++.+ ...++...+..|+.||..|+.||| +.=|+|||+||.||++..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 8999999988 999988733 356899999999999999999995 4559999999999999876 899999
Q ss_pred eeccceecCCCCCcc-eeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCc
Q 005278 558 DFGISKLLGEGDDSV-IQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNE 619 (704)
Q Consensus 558 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~ 619 (704)
|||+|+.+...-... ....++.|..|.|||.+.+. .||++.|||+.||++.||+|-.+-|.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999886543332 33456789999999988765 599999999999999999998876654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=285.07 Aligned_cols=265 Identities=22% Similarity=0.256 Sum_probs=189.7
Q ss_pred CCCccccccccCceEEEEEEEC-C--CCEEEEEEeeccch--hhhHHHHHHHHHHHhc-CCCCCceEEeeeee----CCe
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-D--GTNVAIKVFNLQLE--RASRSFDSECEILRSI-RHRNLIKIISNCCN----IDF 485 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 485 (704)
+|+..+.||+|+||.||+++.. + +..||+|++..... .....+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999854 4 78899999864322 2245678899999999 59999999987543 245
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++++||+. ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899886 68999886543 4889999999999999999994 578999999999999999999999999999876
Q ss_pred CCCCCc--ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc-C-CC-c
Q 005278 566 GEGDDS--VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL-P-DG-L 639 (704)
Q Consensus 566 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~-~~-~ 639 (704)
...... .......|++.|+|||+..+ ..++.++|+||+||++|++++|+.||...... ..+.......- + .. +
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 432211 11223468999999998765 46889999999999999999999998652210 00000000000 0 00 0
Q ss_pred chhccccc---------hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005278 640 TEVVDANL---------VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAA 686 (704)
Q Consensus 640 ~~~~~~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~ 686 (704)
....++.. ................+.+++.+|++.+|++||++.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000000 000000001112346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=276.60 Aligned_cols=247 Identities=22% Similarity=0.254 Sum_probs=192.6
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-----hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-----ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
+|...+.||+|+||.||+++.. .+..+++|+++... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4777889999999999999854 34556666654311 12334577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 490 LEFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
+||+++++|.+++.. ....+++..++.++.|++.|+.|| |+.+++|+||+|+||+++. +.++++|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 345689999999999999999999 4578999999999999975 569999999998764
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.... ......|++.|+|||...+..++.++|+||||+++|++++|..||.... ............
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~-------- 221 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVEGP-------- 221 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcCC--------
Confidence 3222 1223457889999999888888999999999999999999999986421 111111111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..++.++.+++.+||+.+|++||++.|+++
T Consensus 222 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00112244567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=307.34 Aligned_cols=145 Identities=25% Similarity=0.415 Sum_probs=129.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|.+.++||+|+||.||+|... +++.||||+++... ......+..|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999965 68999999987542 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
||+++++|.+++...+ .+++..+..++.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997654 3788889999999999999995 4689999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=287.88 Aligned_cols=264 Identities=21% Similarity=0.261 Sum_probs=195.6
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe---
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF--- 485 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 485 (704)
...++|+..+.||+|++|.||+|+.. +++.||+|++.... ......+.+|+.++++++|||++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35678999999999999999999865 68899999986432 2234567789999999999999999988766554
Q ss_pred ---EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 486 ---KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 486 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
.++|+||+ +++|.+++... .+++..+..++.|++.|++|| |+.+|+||||+|+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYI---HSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 56999988753 489999999999999999999 5578999999999999999999999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh--------
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE-------- 633 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------- 633 (704)
...... .....++..|+|||...+ ..++.++|||||||++||+++|+.||...... ..+......
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHH
Confidence 865432 123357889999998755 36788999999999999999999999653211 011111100
Q ss_pred ---hcCCCcchhcccc-chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 634 ---SLPDGLTEVVDAN-LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 634 ---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
............. ..............+.++.+++.+|++.+|++|||+.||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000 00000000111123567899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-33 Score=271.67 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=197.6
Q ss_pred hCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccc--hh-----hhHHHHHHHHHHHhcCCCCCceEEeeeee-CC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ER-----ASRSFDSECEILRSIRHRNLIKIISNCCN-ID 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 484 (704)
.++|-.++++|+|||+.||+|. +...+.||||+-.... .. ..+...+|.++-+.+.||.||++++++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3577788999999999999998 4568899999865432 11 12346789999999999999999999954 56
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEeeecc
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD---ENMTAHVSDFGI 561 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~---~~~~~kl~Dfgl 561 (704)
..+-|.|||+|.+|+-|++.++. +++..+..|+.||+.||.||.+ -+.+|||-|+||.|||+- .-|.+||+|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 78899999999999999987754 8899999999999999999987 678999999999999994 567899999999
Q ss_pred ceecCCCCCcc-----eeccccccccccCCcccC----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHH
Q 005278 562 SKLLGEGDDSV-----IQTMTIATIGYMAPEYGS----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK 632 (704)
Q Consensus 562 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~ 632 (704)
++++.+..+.. .++..+||.+|++||.+. ..+.+.|+||||.||++|+++.|+.||+..... .+...
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ----QdILq 695 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ----QDILQ 695 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH----HHHHh
Confidence 99997654432 334558999999999643 346888999999999999999999999763211 11111
Q ss_pred hhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005278 633 ESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAA 686 (704)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~ 686 (704)
. ..++... .-.++..+..+.+...+|++|+++--++|....++.
T Consensus 696 e------NTIlkAt----EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 E------NTILKAT----EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h------hchhcce----eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 0 0111111 111222334456677899999999888888776663
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=271.36 Aligned_cols=236 Identities=28% Similarity=0.302 Sum_probs=191.8
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 423 LGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 423 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
||+|+||.||++... +++.+|+|.+..... .....+..|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 589999999875532 2445788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecccc
Q 005278 499 EKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI 578 (704)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 578 (704)
.+++.... .+++.....++.|+++|+.||| +.+++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 99998654 4899999999999999999995 5889999999999999999999999999998764332 1223446
Q ss_pred ccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhH
Q 005278 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKI 658 (704)
Q Consensus 579 gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (704)
++..|+|||...+...+.++|+||||+++||+++|..||..... .......... ....+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~---------------~~~~~~ 214 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKD---------------PLRFPE 214 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcC---------------CCCCCC
Confidence 78899999999888899999999999999999999999965321 1111111100 011112
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCHHH
Q 005278 659 DCLLSIMHLALDCCMESPEQRVSMKD 684 (704)
Q Consensus 659 ~~~~~l~~l~~~cl~~~P~~Rpt~~e 684 (704)
..+..+.+++.+|+..||++||++++
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 22466789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-33 Score=276.62 Aligned_cols=242 Identities=23% Similarity=0.356 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCC
Q 005278 420 CNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 496 (704)
.+.+|+|.||+||-|+. ++|+.||||++.+-. .....++++|+.+++++.||.||.+...|+.++.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 37899999999999985 579999999997654 34557899999999999999999999999999999999999955
Q ss_pred CHHHHH-hhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEEEeeeccceecCCCCCcc
Q 005278 497 SLEKWL-YSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM---TAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 497 sL~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~---~~kl~Dfgla~~~~~~~~~~ 572 (704)
+..+.+ ...+..+++....-++.||+.||.||| -++|+|+|+||+|||+.+.. .+||||||+|+++++...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 555554 566667888888889999999999995 58899999999999997443 699999999999876432
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
....+|||.|+|||++..+.|...-|+||.||++|--++|..||.+. .++.+-+ -+..+..
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQI-----------QNAaFMy--- 783 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQI-----------QNAAFMY--- 783 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHh-----------hcccccc---
Confidence 34568999999999999999999999999999999999999999762 1111111 1111111
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAA 686 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~ 686 (704)
....+.+.+...+++|...++..=.+|-+..+.+
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1223445667788999999999888898876654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=234.51 Aligned_cols=198 Identities=25% Similarity=0.359 Sum_probs=170.4
Q ss_pred CCCccccccccCceEEEEEE-ECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+|...++||+|.||+||+|+ ..+++-||+|..+... +.......+|+-+++.++|+|||++++.........+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 56677899999999999998 4568899999987654 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
|.. +|..+...-...++......++.|+.+|+.++ |+..+.|||+||.|.+++.+|+.|++|||+++-.+-.. .
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelkladfglarafgipv--r 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R 156 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence 965 89998887777799999999999999999999 56679999999999999999999999999999765322 2
Q ss_pred eeccccccccccCCcccCCCC-CCcccceeeHHHHHHHHhhCCCC-CCc
Q 005278 573 IQTMTIATIGYMAPEYGSEGI-ISPKSDVYSYGILLMETFTRKKP-TNE 619 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p-~~~ 619 (704)
-.+..+.|..|.+|.++.+.+ |+...|+||.||++.|+.....| |.+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 234557899999999987754 88999999999999999985544 544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=266.42 Aligned_cols=222 Identities=19% Similarity=0.137 Sum_probs=176.7
Q ss_pred cCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCHHHHHhh
Q 005278 426 GSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYS 504 (704)
Q Consensus 426 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 504 (704)
|.+|.||+++. .+++.+|+|.+.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999985 478999999986542 234455566666899999999999999999999999999999999876
Q ss_pred CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecccccccccc
Q 005278 505 HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584 (704)
Q Consensus 505 ~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 584 (704)
.. .+++.....++.|++.|++||| +.+|+||||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~ 149 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC 149 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence 54 3899999999999999999994 5789999999999999999999999999887654321 2234577899
Q ss_pred CCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHH
Q 005278 585 APEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSI 664 (704)
Q Consensus 585 aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 664 (704)
|||...+..++.++||||+|+++|||++|..|+...... ...... ...+..++..+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~~~~---------~~~~~~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INTHTT---------LNIPEWVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------cccccc---------cCCcccCCHHH
Confidence 999998888999999999999999999999886532110 000000 00111234567
Q ss_pred HHHHhhhcCCCCCCCCCHHHH
Q 005278 665 MHLALDCCMESPEQRVSMKDA 685 (704)
Q Consensus 665 ~~l~~~cl~~~P~~Rpt~~ev 685 (704)
.+++.+|++.||++||++.+.
T Consensus 206 ~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHccCCHHHhcCCCcc
Confidence 889999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=262.70 Aligned_cols=265 Identities=22% Similarity=0.257 Sum_probs=198.7
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcC--CC----CCceEEeeeeeCCe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIR--HR----NLIKIISNCCNIDF 485 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~l~~~~~~~~~ 485 (704)
.+++|.+...+|+|.||.|-++... .+..||||+++ .+....+...-|+++++++. .| -+|.+.+||.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik-~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK-NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHH-HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3789999999999999999998743 47899999985 33455667788999999993 22 37788888999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC--------------
Q 005278 486 KALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-------------- 550 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-------------- 550 (704)
.++|+|.+ |-|+.+++.+++ ..++...+..++.|+++++++| |+.+++|-|+||+||++.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999988 569999999754 5689999999999999999999 6688999999999999832
Q ss_pred ------CCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccc
Q 005278 551 ------NMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE 624 (704)
Q Consensus 551 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~ 624 (704)
+..+|++|||.|+.-... .+..+.|..|.|||++.+-.++.++||||+||||+|+.||..-|+...+.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 335899999999875433 245578999999999999999999999999999999999999887643221
Q ss_pred -ccHHHHHHhhcCCC-----------------cchhcccc--------chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCC
Q 005278 625 -MSLKHWVKESLPDG-----------------LTEVVDAN--------LVREEQAFSVKIDCLLSIMHLALDCCMESPEQ 678 (704)
Q Consensus 625 -~~~~~~~~~~~~~~-----------------~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~ 678 (704)
..+.+-+-.-.|.. +.+...++ .................+.+++..++..||++
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 01111111111111 00000000 00000001111233566999999999999999
Q ss_pred CCCHHHHHH
Q 005278 679 RVSMKDAAA 687 (704)
Q Consensus 679 Rpt~~ev~~ 687 (704)
|+|++|+++
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999964
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=280.22 Aligned_cols=240 Identities=23% Similarity=0.233 Sum_probs=192.6
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.++.|+....+|.|+|+.|-.+.. .+++..+||++... .....+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356777778899999999999874 46899999998755 33445677666665 7999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee-CCCCcEEEeeeccceecCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL-DENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~-~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|.+.+|-+.+.+..... +. ..+..|+.+++.|+.|| |++||||||+||+|||+ +..++++|+|||.++...+.
T Consensus 396 e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYL---HEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHH---HhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999988888875543 22 66778999999999999 55889999999999999 69999999999999876443
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
....+-|..|.|||+.....+++++|+||||++||+|++|+.||.....+ ... ...+..
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei-~~~i~~------------ 528 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEI-HTRIQM------------ 528 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHH-HHhhcC------------
Confidence 22335688999999999999999999999999999999999999874433 111 111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......+....+++.+|++.||.+||+|.++..
T Consensus 529 ----~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 529 ----PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 0011345667889999999999999999999853
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-33 Score=255.78 Aligned_cols=269 Identities=20% Similarity=0.284 Sum_probs=198.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee--------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN-------- 482 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 482 (704)
...|+...+||+|.||.||+|+. ++|+.||+|+.-... +.......+|+++++.++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 34667778999999999999985 468889998653321 2334567889999999999999999988843
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 483 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
....|+||++|++ +|...+......++..++.+++.++..||.|+ |...|+|||+||.|+||+.++.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i---Hr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI---HRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHH---HHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 2357899999987 99999987777799999999999999999999 5678999999999999999999999999999
Q ss_pred eecCCCCC--cceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh----c
Q 005278 563 KLLGEGDD--SVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES----L 635 (704)
Q Consensus 563 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~ 635 (704)
+.+..... ....+.++.|..|.+||.+.+ ..++++.|||..||++.||+||.+-+++..+ ....+.+... -
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLHLISQLCGSIT 249 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHHHHHHHhccCC
Confidence 76643322 223455677999999997765 5699999999999999999999988876322 1122222211 1
Q ss_pred CCCcchhccccchhhh-------hhhhhhHHH------HHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 636 PDGLTEVVDANLVREE-------QAFSVKIDC------LLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~-------~~~~~~~~~------~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
++.|.++..-.+...- .......+. .+...+++..++..||.+|+++++++..
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1112211111100000 000000111 1356789999999999999999998654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=238.48 Aligned_cols=213 Identities=27% Similarity=0.312 Sum_probs=173.6
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.++......||+|++|.|-+-++ ++|+..|+|.++... .+..++...|+.+..+. .+|.+|+++|...+.....+.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34455567899999999988874 689999999997655 34556677788776554 7999999999999989999999
Q ss_pred eccCCCCHHHHHh---hCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLY---SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
|.|. .||..+-. ..+..+++...-+|+..+.+||.|||+ +..++|||+||+|||++.+|++|+||||.+-.+.+
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9995 47766554 456678999999999999999999985 56799999999999999999999999999987743
Q ss_pred CCCcceeccccccccccCCcccCC----CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHH
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSE----GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK 632 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~ 632 (704)
+...+...|...|||||.+.. ..|+-|+||||+|+++.||.+++.||+........+.+.+.
T Consensus 202 ---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 202 ---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 344555678899999997653 46889999999999999999999999875554444444443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=261.60 Aligned_cols=243 Identities=21% Similarity=0.256 Sum_probs=196.0
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 487 (704)
...+|.-+.+||+|+||.|-+|..+ +.+.+|||++++.+. .+.+--..|-+++... +-|.++++..+|..-+..|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3457888899999999999999855 577899999987652 2233445677777766 5789999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+.||+|--.++.-+. +.+..+.-++..||-||-+| |+++|+.||+|.+||++|.+|++||+|||+++.---
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999888876544 66777788999999999999 789999999999999999999999999999975321
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
....+...+|||.|+|||++...+|+..+|-|||||++|||+.|+.||++..+ ..+-+ .+.+.
T Consensus 503 --~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--~elF~-----------aI~eh-- 565 (683)
T KOG0696|consen 503 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQ-----------AIMEH-- 565 (683)
T ss_pred --CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHH-----------HHHHc--
Confidence 12234557899999999999999999999999999999999999999987322 11111 11111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS 681 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 681 (704)
....+...+.+.+.+....+.+.|.+|..
T Consensus 566 -----nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 -----NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -----cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 22334456778888999999999999974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=277.44 Aligned_cols=258 Identities=23% Similarity=0.289 Sum_probs=207.3
Q ss_pred hHHHHHHhCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeee--
Q 005278 407 YLDIQRATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCN-- 482 (704)
Q Consensus 407 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-- 482 (704)
+..+...++-|++.+.||+|.+|.||+++ .++|+.+|+|+.... ....++++.|.++++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 33344566788999999999999999998 567999999998655 33456788899999988 69999999999854
Q ss_pred ---CCeEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEee
Q 005278 483 ---IDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSD 558 (704)
Q Consensus 483 ---~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~D 558 (704)
++...||||||.+||..+.++.- +..+.|..+.-|++.++.|+.+| |...++|||||-.|||++.++.||++|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCceEEEeccCcEEEee
Confidence 56889999999999999999832 56689999999999999999999 556699999999999999999999999
Q ss_pred eccceecCCCCCcceeccccccccccCCcccCC-----CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh
Q 005278 559 FGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE-----GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 559 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 633 (704)
||.+..+...- .......|||.|||||++.- ..|+..+|+||+|++..||.-|.+|+.++.+...
T Consensus 167 FGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------- 236 (953)
T KOG0587|consen 167 FGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------- 236 (953)
T ss_pred eeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------
Confidence 99998764322 22344579999999998753 3477899999999999999999999877543211
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.++. .....+....+.....++.++|..|+.+|.++||++.++++
T Consensus 237 LF~I---------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 LFLI---------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hccC---------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0000 00111223345566788999999999999999999998865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=258.70 Aligned_cols=238 Identities=30% Similarity=0.364 Sum_probs=191.9
Q ss_pred CceEEEEEEEC-CCCEEEEEEeeccchhh-hHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCHHHHHhh
Q 005278 427 SFGSVYKGTLF-DGTNVAIKVFNLQLERA-SRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYS 504 (704)
Q Consensus 427 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 504 (704)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999987654433 67899999999999999999999999999999999999999999999876
Q ss_pred CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceecccccccccc
Q 005278 505 HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584 (704)
Q Consensus 505 ~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 584 (704)
... +++..++.++.+++.++.||| +.+++|+||+|+||+++.++.++++|||.+....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 544 789999999999999999995 4689999999999999999999999999998775432 223446888999
Q ss_pred CCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHH
Q 005278 585 APEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSI 664 (704)
Q Consensus 585 aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 664 (704)
|||......++.++||||||++++++++|..||...... .....+....... .......++.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~---------------~~~~~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPP---------------FPPPEWKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCC---------------CccccccCCHHH
Confidence 999998888899999999999999999999998652111 1111111100000 000000145678
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHH
Q 005278 665 MHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 665 ~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=285.82 Aligned_cols=259 Identities=24% Similarity=0.250 Sum_probs=168.6
Q ss_pred HhCCCCccccccccCceEEEEEEEC-C----CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEee------ee
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-D----GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISN------CC 481 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 481 (704)
..++|+..+.||+|+||.||+|+.. + +..||||++...... +....| .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999864 4 789999987543211 111111 1112222222222211 23
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCcc-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 005278 482 NIDFKALVLEFMPNGSLEKWLYSHNYFL-------------------GILERLNIMIDVGLALEYLHHGHSTPMVHCDLK 542 (704)
Q Consensus 482 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk 542 (704)
.....++|+||+++++|.+++....... ....+..++.|++.||+||| +.+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 4567899999999999999987543211 12335579999999999995 5789999999
Q ss_pred CCCeeeCC-CCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCC----------------------CCCcccc
Q 005278 543 PNNILLDE-NMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG----------------------IISPKSD 599 (704)
Q Consensus 543 ~~Nil~~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 599 (704)
|+|||++. ++.+||+|||+|+.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 579999999999866433222 22345689999999954221 2345679
Q ss_pred eeeHHHHHHHHhhCCCCCCccc--------cccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhh
Q 005278 600 VYSYGILLMETFTRKKPTNEIF--------IGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDC 671 (704)
Q Consensus 600 v~s~Gv~l~el~tg~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 671 (704)
||||||++|||+++..|++... ..+.....|.....+.. .+.... .............+++.+|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-----~~~~~~---~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRA-----SPDLRR---GFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcccc-----chhhhh---hhhhccccchHHHHHHHHH
Confidence 9999999999999877754311 11122333322111110 000000 0000001123456899999
Q ss_pred cCCCCCCCCCHHHHHH
Q 005278 672 CMESPEQRVSMKDAAA 687 (704)
Q Consensus 672 l~~~P~~Rpt~~ev~~ 687 (704)
++.||++|||++|+++
T Consensus 434 L~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 434 MRFKGRQRISAKAALA 449 (566)
T ss_pred ccCCcccCCCHHHHhC
Confidence 9999999999999976
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=276.12 Aligned_cols=257 Identities=21% Similarity=0.232 Sum_probs=180.2
Q ss_pred HhCCCCccccccccCceEEEEEEE-----------------CCCCEEEEEEeeccchhh--------------hHHHHHH
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-----------------FDGTNVAIKVFNLQLERA--------------SRSFDSE 461 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~--------------~~~~~~e 461 (704)
..++|++.++||+|+||+||+|.. .+++.||||++....... .+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999963 235789999986443221 1234457
Q ss_pred HHHHHhcCCCCC-----ceEEeeeee--------CCeEEEEEeccCCCCHHHHHhhCC----------------------
Q 005278 462 CEILRSIRHRNL-----IKIISNCCN--------IDFKALVLEFMPNGSLEKWLYSHN---------------------- 506 (704)
Q Consensus 462 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------- 506 (704)
+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888876654 677777643 346799999999999999987421
Q ss_pred -CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccC
Q 005278 507 -YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 585 (704)
Q Consensus 507 -~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 585 (704)
..+++..+..++.|++.+++||| +.+|+||||||+||+++.++.+||+|||++..+..... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 12456778899999999999995 56899999999999999999999999999976543221 11122345889999
Q ss_pred CcccCCCCC----------------------CcccceeeHHHHHHHHhhCCC-CCCccccc-------cccHHHHHHhhc
Q 005278 586 PEYGSEGII----------------------SPKSDVYSYGILLMETFTRKK-PTNEIFIG-------EMSLKHWVKESL 635 (704)
Q Consensus 586 PE~~~~~~~----------------------~~~~Dv~s~Gv~l~el~tg~~-p~~~~~~~-------~~~~~~~~~~~~ 635 (704)
||.+..... ..+.||||+||++|||++|.. |+.....- ......|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 997653221 124799999999999999875 66542111 112222211100
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCC---CCCCCHHHHHH
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESP---EQRVSMKDAAA 687 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~Rpt~~ev~~ 687 (704)
. ...............+++.+++..+| .+|+|++|+++
T Consensus 459 ~--------------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 Q--------------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred c--------------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 00111112234567889999999766 68999999964
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=269.48 Aligned_cols=242 Identities=22% Similarity=0.305 Sum_probs=198.4
Q ss_pred CCCCccccccccCceEEEEEEECC-CCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.+++.+..+|-||||.|-+.+.+. ...+|+|++++.. ....+.+..|-.+|...+.|.||+++-.|.+...+|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 455666789999999999988654 3348888887553 345567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
|-|-||.+...++..+. ++..+..-++..+.+|++|| |+++||.||+||+|.++|.+|-+||.|||+|+.++.+..
T Consensus 500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999987655 77777777899999999999 668899999999999999999999999999998876543
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
+...+|||.|.|||++..+..+.++|.||+|+++||+++|.+||.+..... .+ ..+..++.
T Consensus 576 ---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk----tY--n~ILkGid---------- 636 (732)
T KOG0614|consen 576 ---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK----TY--NLILKGID---------- 636 (732)
T ss_pred ---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH----HH--HHHHhhhh----------
Confidence 456789999999999999999999999999999999999999998743211 11 11111111
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVS 681 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 681 (704)
....|....+...+++++.+..+|.+|..
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 12233445667788999999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=278.26 Aligned_cols=242 Identities=27% Similarity=0.378 Sum_probs=187.3
Q ss_pred ccccccccCce-EEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccCCC
Q 005278 419 ECNLLGTGSFG-SVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 419 ~~~~ig~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 496 (704)
..+++|.|+.| .||+|.. +|+.||||++-. ....-..+|+..++.- .|||||++++.-.+....|+..|.|..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 34678899888 5899986 589999998753 3345678999999998 699999999999999999999999966
Q ss_pred CHHHHHhhCC--Cc-cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---C--CcEEEeeeccceecCCC
Q 005278 497 SLEKWLYSHN--YF-LGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---N--MTAHVSDFGISKLLGEG 568 (704)
Q Consensus 497 sL~~~l~~~~--~~-~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---~--~~~kl~Dfgla~~~~~~ 568 (704)
+|+++++... .. ......+.++.|++.|+++| |+.+|||||+||.||||+. + ..++|+|||+++.+..+
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 9999998641 11 12245678999999999999 5578999999999999975 3 47999999999998665
Q ss_pred CCcc-eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhC-CCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 569 DDSV-IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 569 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.... ......||.||+|||.+....-+.++||||+||++|+.++| .+||++....+..... +.... ..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L--~~ 734 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTL--VH 734 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Cccce--ee
Confidence 4432 24456899999999999998888899999999999999995 8999874332221111 00000 00
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+ ....++ ...++|.+|++++|..||+|.+|+.
T Consensus 735 L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 L-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 011122 6778999999999999999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=265.34 Aligned_cols=215 Identities=23% Similarity=0.361 Sum_probs=176.0
Q ss_pred hHHHHHHh---CCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEee
Q 005278 407 YLDIQRAT---NGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISN 479 (704)
Q Consensus 407 ~~~~~~~~---~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~ 479 (704)
|..++++. .-|-.++.||-|+||+|.+++ .++...+|.|.+++.. .......+.|-++|..-..+-||+++-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44444443 456777899999999999997 4457789999987653 3345667889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 480 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
|.+.+..|+||||++||++-.+|-+-+- +++....-++..+..|+++. |++|+|||||||+|||||.+|++||+||
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEccCCceeeeec
Confidence 9999999999999999999999886654 56666666777899999999 7799999999999999999999999999
Q ss_pred ccceecC---------CCCC-------------------------------cceeccccccccccCCcccCCCCCCcccc
Q 005278 560 GISKLLG---------EGDD-------------------------------SVIQTMTIATIGYMAPEYGSEGIISPKSD 599 (704)
Q Consensus 560 gla~~~~---------~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 599 (704)
|++.-+. .++. .......+||+-|+|||++....++.-+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 9986431 1100 00012236999999999999999999999
Q ss_pred eeeHHHHHHHHhhCCCCCCccccccc
Q 005278 600 VYSYGILLMETFTRKKPTNEIFIGEM 625 (704)
Q Consensus 600 v~s~Gv~l~el~tg~~p~~~~~~~~~ 625 (704)
-||.|||||||+.|+.||.....++.
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 99999999999999999987555543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-32 Score=274.03 Aligned_cols=296 Identities=29% Similarity=0.408 Sum_probs=173.5
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccc-cCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSG-LIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
+.+|++|.+++|++. .+...+..++.|+.+.+..|+++. -+|..+-+|..|+.||||+|++...+. .+.+
T Consensus 54 lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~--------~LE~ 124 (1255)
T KOG0444|consen 54 LQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPT--------NLEY 124 (1255)
T ss_pred HhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcch--------hhhh
Confidence 456777777777777 455667777777777777777762 245556667777777777777766443 3666
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
-+++..|+||+|+|..+....|.++. .|-.|+|++|++. .+|..+..+.+|++|+|++|.+....-..+..|++|+.|
T Consensus 125 AKn~iVLNLS~N~IetIPn~lfinLt-DLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vL 202 (1255)
T KOG0444|consen 125 AKNSIVLNLSYNNIETIPNSLFINLT-DLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVL 202 (1255)
T ss_pred hcCcEEEEcccCccccCCchHHHhhH-hHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhh
Confidence 77777777777777744444444443 5777777777776 566667777777777777776654333444445555555
Q ss_pred eccCcccC-CCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCccc
Q 005278 164 YLHGNKLQ-GSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242 (704)
Q Consensus 164 ~L~~n~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 242 (704)
++++.+-+ .-+|.++..+.||..+|+|.|.+. .+|+.+-++++|+.|+|++|+|+ .+....+...+|+.|++|.|++
T Consensus 203 hms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQL 280 (1255)
T KOG0444|consen 203 HMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQL 280 (1255)
T ss_pred hcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchh
Confidence 55554433 234555555555555555555555 55555555555555555555555 2333344444555555555555
Q ss_pred CCCCCcccccCcCCcEEEeecCccCC-CCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCC
Q 005278 243 NGSLPSNIQNLKVLTNLDLSRNQLSG-DIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315 (704)
Q Consensus 243 ~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 315 (704)
+ .+|++++++++|+.|++.+|+++- -+|..++.+.+|+.+..++|.+. .+|+.+..+..|+.|.|+.|++.
T Consensus 281 t-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi 352 (1255)
T KOG0444|consen 281 T-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI 352 (1255)
T ss_pred c-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee
Confidence 5 455555555555555555555432 24444555555555555555544 45555555555555555555543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=244.60 Aligned_cols=248 Identities=19% Similarity=0.253 Sum_probs=198.6
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 488 (704)
.++|....+||+|+|+.|..+++ ++.+-+|+|++++.. .++....+.|..+..+- +||.+|.+..+|......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46889999999999999999985 468889999987654 23345567787777766 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
|.||+++|+|--++++++. ++++.+.-+...|..||.|| |++||+.||+|.+||++|..|++|++|+|+++.--..
T Consensus 329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999888876654 78888888888999999999 6799999999999999999999999999999754222
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccc--cccccHHHHHHhhcCCCcchhcccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIF--IGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
...++..+|||.|+|||++.+..|+..+|-|++||+|+||+.|+.||+-.. +.++.-.++.-+.+.+. .
T Consensus 405 --gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-------q 475 (593)
T KOG0695|consen 405 --GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-------Q 475 (593)
T ss_pred --CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-------c
Confidence 223566799999999999999999999999999999999999999998543 33444444433222111 1
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS 681 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 681 (704)
...+...+.+...++..-+.+||++|..
T Consensus 476 -------iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 476 -------IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -------ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1122233445667888899999999864
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-32 Score=276.70 Aligned_cols=302 Identities=28% Similarity=0.410 Sum_probs=264.5
Q ss_pred CCCCCCEEecCCCcCc-ccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCC
Q 005278 4 MLPNLKYLTLFDNKLS-GTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLT 82 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~ 82 (704)
.||.|+.+++..|++. .-+|..+-.+..|+.|||++|+++ ..|..+..-+++-+|+||+|+|.+++... |.
T Consensus 76 ~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~l-------fi 147 (1255)
T KOG0444|consen 76 DLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSL-------FI 147 (1255)
T ss_pred cchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchH-------HH
Confidence 4788999999999876 347888999999999999999999 67888999999999999999999998776 88
Q ss_pred CCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCc-cccChhhcCCCCcC
Q 005278 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLN-GTIPTAVGRLRRLQ 161 (704)
Q Consensus 83 ~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~ 161 (704)
++.-|-+||||+|++. .+|+.+..+. +|++|.|++|.+.-.--..+..+++|++|.+++.+=+ ..+|.++..+.+|.
T Consensus 148 nLtDLLfLDLS~NrLe-~LPPQ~RRL~-~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~ 225 (1255)
T KOG0444|consen 148 NLTDLLFLDLSNNRLE-MLPPQIRRLS-MLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLR 225 (1255)
T ss_pred hhHhHhhhccccchhh-hcCHHHHHHh-hhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhh
Confidence 9999999999999998 6777777775 7999999999987655556677788889999987643 36788999999999
Q ss_pred eeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcc
Q 005278 162 GLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241 (704)
Q Consensus 162 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 241 (704)
.+|||.|.+. ..|+.+.++++|+.|+||+|+|+ .+........+|+.|+++.|+++ .+|+.+..+++|+.|.+.+|+
T Consensus 226 dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~Nk 302 (1255)
T KOG0444|consen 226 DVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNK 302 (1255)
T ss_pred hccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCc
Confidence 9999999998 88999999999999999999998 44445666778999999999998 899999999999999999999
Q ss_pred cC-CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCC
Q 005278 242 LN-GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPK 320 (704)
Q Consensus 242 l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 320 (704)
++ .-+|+.++++.+|+.+..++|.+. ..|+.++.+..|+.|.|+.|++- .+|+.+.-++.|+.||+..|+---..|.
T Consensus 303 L~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 303 LTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred ccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 87 568999999999999999999998 89999999999999999999998 8999999999999999999986544444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=231.30 Aligned_cols=262 Identities=19% Similarity=0.310 Sum_probs=194.5
Q ss_pred HhCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCC--eEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCNID--FKAL 488 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~l 488 (704)
..++|++.+++|+|.+++||.|. ..+.+.++||+++. ...+.+.+|+.+++.++ ||||+++++...++. ...+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45789999999999999999998 56788999999864 34577899999999996 999999999997754 5679
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeeeccceecCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-NMTAHVSDFGISKLLGE 567 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-~~~~kl~Dfgla~~~~~ 567 (704)
|+||+.+.+....-.. ++...+.-.+.+++.||.|+ |++||+|||+||.|+++|. .-..+++|+|+|.++.+
T Consensus 113 iFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999999777664432 55667788899999999999 7899999999999999995 55799999999999877
Q ss_pred CCCcceeccccccccccCCcccC-CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh------------
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGS-EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES------------ 634 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~------------ 634 (704)
+... ..++.+..|--||.+- ...++..-|+|||||++..|+..+.||-.-.....+++..++-.
T Consensus 186 ~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Ccee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 6543 3345667788999764 45688899999999999999999999743222122222222211
Q ss_pred ---cCCCcchhccccchhhhhhh--hhhH-HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 635 ---LPDGLTEVVDANLVREEQAF--SVKI-DCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 635 ---~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+...+..++..........+ .... -..++.++++.+.+.+|-.+|||++|...
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11112222221111111111 0111 12367889999999999999999999854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=231.22 Aligned_cols=210 Identities=35% Similarity=0.504 Sum_probs=182.3
Q ss_pred ccccCceEEEEEEECC-CCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCHHH
Q 005278 423 LGTGSFGSVYKGTLFD-GTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEK 500 (704)
Q Consensus 423 ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 500 (704)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998755322 34679999999999999999999999999899999999999999999
Q ss_pred HHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeeeccceecCCCCCcceeccccc
Q 005278 501 WLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-NMTAHVSDFGISKLLGEGDDSVIQTMTIA 579 (704)
Q Consensus 501 ~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 579 (704)
++......+++..+..++.+++.++++|| +.+++|+||+|.||+++. ++.++++|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 99866445899999999999999999995 569999999999999999 89999999999987644321 1233457
Q ss_pred cccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhH
Q 005278 580 TIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKI 658 (704)
Q Consensus 580 t~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (704)
...|++||..... ..+.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999998877 888999999999999998
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 659 DCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 659 ~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246679999999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=249.99 Aligned_cols=197 Identities=23% Similarity=0.319 Sum_probs=168.0
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhh-----HHHHHHHHHHHhcC---CCCCceEEeeeee
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAS-----RSFDSECEILRSIR---HRNLIKIISNCCN 482 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~-----~~~~~e~~~l~~l~---h~niv~l~~~~~~ 482 (704)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.+..- .+. ...-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46889999999999999999865 467789998876531 111 13567999999997 9999999999999
Q ss_pred CCeEEEEEeccC-CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 483 IDFKALVLEFMP-NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 483 ~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
.+.+|++||-.. +-+|.+++..+.. +++.....|++||+.|+++| |+.+|||||||-+||.++.+|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhccccc---cccCceecccccccEEEecCCeEEEeeccc
Confidence 999999999864 4488999876543 89999999999999999999 789999999999999999999999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCCC-cccceeeHHHHHHHHhhCCCCCCc
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS-PKSDVYSYGILLMETFTRKKPTNE 619 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~tg~~p~~~ 619 (704)
|.....+. ....+||.+|.|||++.+.+|- ...|||++|+++|.++....||..
T Consensus 717 aa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 98765443 4456899999999999987754 468999999999999998888753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-29 Score=232.12 Aligned_cols=266 Identities=23% Similarity=0.287 Sum_probs=189.9
Q ss_pred CCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-----eEEE
Q 005278 417 FNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID-----FKAL 488 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l 488 (704)
.+..+.||-|+||.||..+. .+|+.||.|++..-. -...+.+-+|+.++..++|.|++..++...... +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999985 479999999875322 234567888999999999999999988775543 4567
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
++|.|. .+|+..+-.. ..++...+.-++.||.+||+|| |+.+|.||||||.|.+++++-..||||||+|+.....
T Consensus 135 ~TELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 888884 4777766544 3477788888999999999999 6789999999999999999999999999999976433
Q ss_pred CCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC-----------
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP----------- 636 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 636 (704)
....++..+.|..|.|||++++. .|+.+.||||.||++.|++.++.-|+.... ....+.+.+..-
T Consensus 210 -~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 210 -DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred -hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHHHHHh
Confidence 33445556789999999998875 599999999999999999999888765221 111111111110
Q ss_pred CC-cchhccccchhhh----hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 637 DG-LTEVVDANLVREE----QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 637 ~~-~~~~~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
++ ...++........ .....+.+.-.+...+...++..||++|.+..+.++.+.
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00 0111111000000 000111122234567888999999999999998876543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=227.33 Aligned_cols=199 Identities=29% Similarity=0.406 Sum_probs=172.2
Q ss_pred CCccccccccCceEEEEEEECC-CCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 417 FNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999999764 899999999765444 56788999999999999999999999999899999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+++|.+++......+++.....++.+++.++.+|| +.+++|+|++|+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 99999999865543789999999999999999995 468999999999999999999999999999877543211 12
Q ss_pred ccccccccccCCccc-CCCCCCcccceeeHHHHHHHHhhCCCCCCc
Q 005278 575 TMTIATIGYMAPEYG-SEGIISPKSDVYSYGILLMETFTRKKPTNE 619 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~ 619 (704)
....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334578889999988 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=230.72 Aligned_cols=270 Identities=24% Similarity=0.330 Sum_probs=199.4
Q ss_pred HHHHHhCCCCccccccccCceEEEEEEEC----CCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC
Q 005278 409 DIQRATNGFNECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNI 483 (704)
Q Consensus 409 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 483 (704)
++....+.|..+++||+|.|++||+|... ..+.||+|.+... .....+..|++++..+ .+.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34556678899999999999999999843 4688999988643 4456789999999999 599999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEeeeccc
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGIS 562 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~Dfgla 562 (704)
+.+.+|+||+++....++... ++...+..+++.+..||+++ |..|||||||||+|++.+ ..+.-.|.|||+|
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhh---hccCccccCCCccccccccccCCceEEechhH
Confidence 999999999999888887754 56778889999999999999 779999999999999998 4567899999999
Q ss_pred eecCCC------------------------------------------CCcceeccccccccccCCcccCC-CCCCcccc
Q 005278 563 KLLGEG------------------------------------------DDSVIQTMTIATIGYMAPEYGSE-GIISPKSD 599 (704)
Q Consensus 563 ~~~~~~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 599 (704)
...... .........+||+||.|||++.. ...++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 722100 00011223479999999998754 56888999
Q ss_pred eeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh----------cCCC--cch---------------hcc-ccchh-h
Q 005278 600 VYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES----------LPDG--LTE---------------VVD-ANLVR-E 650 (704)
Q Consensus 600 v~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----------~~~~--~~~---------------~~~-~~~~~-~ 650 (704)
|||.||+++-+++++.||-....+-..+.+.+.-. .+.. +.+ .++ ..+.. .
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999865444443333332100 0111 000 000 00000 0
Q ss_pred hh--hhhhhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQ--AFSVKID-CLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~--~~~~~~~-~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. ......+ .+..+++++.+|+..||.+|-|++|+++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00 0011112 2347899999999999999999999965
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=231.62 Aligned_cols=130 Identities=24% Similarity=0.345 Sum_probs=111.0
Q ss_pred CCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-----C---CCCceEEeeeee---
Q 005278 415 NGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIR-----H---RNLIKIISNCCN--- 482 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~--- 482 (704)
.+|-+.++||=|.|++||++. .++.+.||+|+.+.. ....+....||+++++++ | ..||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 678899999999999999997 567899999998654 444567788999999994 2 479999999954
Q ss_pred -CCeEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 483 -IDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 483 -~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
+.++++|+|++ |.+|..++... -+.++...+.+|++||+.||.|||.. -+|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 55899999999 55899988854 34589999999999999999999964 589999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-28 Score=240.47 Aligned_cols=265 Identities=22% Similarity=0.238 Sum_probs=198.3
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcC------CCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIR------HRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~ 486 (704)
-.+|.+....|+|-|++|.+|..+ .|..||||++.... ...+.=..|+++|++|+ --|+++++..|....+.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 468888899999999999999854 48899999997653 22344467999999995 34899999999999999
Q ss_pred EEEEeccCCCCHHHHHhhC--CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEeeeccce
Q 005278 487 ALVLEFMPNGSLEKWLYSH--NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-MTAHVSDFGISK 563 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-~~~kl~Dfgla~ 563 (704)
|||||.+. -+|.+.|++. ...+....+..++.|+..||..| -.-+|+|.||||.|||+++. ..+||||||.|.
T Consensus 510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 99999884 4999999854 34578889999999999999999 45689999999999999965 568999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHH---------------
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK--------------- 628 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~--------------- 628 (704)
..+.... +....+..|.|||++.+..|+...|+||.||+|||+.||+.-|.+..+..+.-.
T Consensus 586 ~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 8765442 223456689999999999999999999999999999999998876433221000
Q ss_pred -HHHHhhcCCC---cchh---------------ccc------cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005278 629 -HWVKESLPDG---LTEV---------------VDA------NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMK 683 (704)
Q Consensus 629 -~~~~~~~~~~---~~~~---------------~~~------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 683 (704)
++..+.+... +... +.| .+................+.+++..|+..||++|.|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 0001111000 0000 001 01111112233345567788999999999999999999
Q ss_pred HHHH
Q 005278 684 DAAA 687 (704)
Q Consensus 684 ev~~ 687 (704)
++++
T Consensus 742 qAL~ 745 (752)
T KOG0670|consen 742 QALK 745 (752)
T ss_pred HHhc
Confidence 9864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=224.40 Aligned_cols=258 Identities=21% Similarity=0.235 Sum_probs=191.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC------e
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID------F 485 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 485 (704)
.+|.....+|.|.- .|..|... .++.||+|+..... ....++..+|...+..++|+||++++.++.... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46667788898888 56666532 58999999875442 334567889999999999999999999986543 5
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.|+|||+|. ++|.+.+... ++-.+...+..|+..|++|| |+.+|+||||||+||++..+..+||.|||+|+.-
T Consensus 96 ~y~v~e~m~-~nl~~vi~~e---lDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILME---LDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhh-hHHHHHHHHh---cchHHHHHHHHHHHHHHHHH---HhcceeecccCcccceecchhheeeccchhhccc
Confidence 689999995 4898888732 56678889999999999999 6799999999999999999999999999999854
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC-cchhcc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG-LTEVVD 644 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 644 (704)
.. ....+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|. ++..+.+|.+-....+ .....-
T Consensus 169 ~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 169 DT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred Cc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHHHH
Confidence 32 234555678999999999988889999999999999999999998765 3445666644221111 000000
Q ss_pred --------------ccchh-----hh------hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 --------------ANLVR-----EE------QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 --------------~~~~~-----~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.... .. .......-....+.+++.+|+..+|++|-+++++++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00000 00 000000011244678999999999999999999964
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-30 Score=249.33 Aligned_cols=151 Identities=32% Similarity=0.500 Sum_probs=122.6
Q ss_pred cCeeeccCcccCCCCCccccCCCCCC-EEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEec
Q 005278 160 LQGLYLHGNKLQGSIPYDLCHLEGLS-ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238 (704)
Q Consensus 160 L~~L~L~~n~l~~~~~~~l~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 238 (704)
+..++++.|++. ++|..+..++.+. .+.+++|.++ .+|..++.+++|..|+|++|.+. .+|..++.+..|+.|+++
T Consensus 390 Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS 466 (565)
T KOG0472|consen 390 VTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLS 466 (565)
T ss_pred eEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccc
Confidence 455566666665 5566555554433 3455555555 78888889999999999999887 688888888889999999
Q ss_pred CcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCC
Q 005278 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315 (704)
Q Consensus 239 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 315 (704)
.|++. .+|..+-.+..|+.+-.++|++....+..+.+|.+|..|||.+|.+. .+|..+++|.+|++|++++|+|.
T Consensus 467 ~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 467 FNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 99888 78888887888888888889998666666999999999999999998 89999999999999999999997
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-30 Score=249.46 Aligned_cols=316 Identities=33% Similarity=0.460 Sum_probs=189.0
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
+++++.|++++|++. .+|++++.+-.|+.|+..+|+++ ..|..+..+.+|..|++.+|++...+.. .-++
T Consensus 113 ~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~--------~i~m 182 (565)
T KOG0472|consen 113 LISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPEN--------HIAM 182 (565)
T ss_pred hhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHH--------HHHH
Confidence 344445555555554 44444555555555555555555 2333444444445555555544443322 2234
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhc-CCCCcCee
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVG-RLRRLQGL 163 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L 163 (704)
+.|++||...|-+. .+|+.++.+. +|.-|||..|++. ..| .|.+|+.|++|.++.|.|. .+|+... ++++|..|
T Consensus 183 ~~L~~ld~~~N~L~-tlP~~lg~l~-~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vL 257 (565)
T KOG0472|consen 183 KRLKHLDCNSNLLE-TLPPELGGLE-SLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVL 257 (565)
T ss_pred HHHHhcccchhhhh-cCChhhcchh-hhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceee
Confidence 55555555555544 3444444442 3555555555554 333 4555555555555555555 3444333 66777777
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCC----------------------
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTST---------------------- 221 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---------------------- 221 (704)
||+.|+++ ..|+.++.+++|++||+|+|.|+ .+|..++++ .|+.|.+.+|.+..+
T Consensus 258 DLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~ 334 (565)
T KOG0472|consen 258 DLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKD 334 (565)
T ss_pred eccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhcc
Confidence 77777776 66777777777777777777777 556666666 666666666654300
Q ss_pred ----------------CCCcccC---Cc--------------------------cccEEEecCcccC-------------
Q 005278 222 ----------------MPSSFGS---LE--------------------------YVLYINLSANSLN------------- 243 (704)
Q Consensus 222 ----------------~~~~~~~---l~--------------------------~L~~L~l~~N~l~------------- 243 (704)
.+..|.. +- -....+++.|++.
T Consensus 335 dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelv 414 (565)
T KOG0472|consen 335 DGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELV 414 (565)
T ss_pred CCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHH
Confidence 0000000 00 0223444444433
Q ss_pred ----------CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee----------------------
Q 005278 244 ----------GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ---------------------- 291 (704)
Q Consensus 244 ----------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~---------------------- 291 (704)
+.+|..++.+++|..|+|++|.+. .+|..++.+..|+.||++.|+|.
T Consensus 415 T~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi 493 (565)
T KOG0472|consen 415 TDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQI 493 (565)
T ss_pred HHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccc
Confidence 245666778888999999999888 88888898888999999988875
Q ss_pred ccC-CcccccccccceEEecccCCCCCCCCCcccccccCcccccCCCccC
Q 005278 292 GPV-PKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQ 340 (704)
Q Consensus 292 ~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~~~~ 340 (704)
+.+ |+.+.+|.+|..|||.+|.+. .+|+.+.....+....+.|+|..+
T Consensus 494 ~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 494 GSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred cccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCC
Confidence 122 233778889999999999987 677788888888999999998653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=214.83 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=192.8
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEee-eeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISN-CCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 490 (704)
.+.|.+.+.+|+|.||.+-+++++ +.+.+++|.+.... ...++|.+|...--.+ .|.||+.-++. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 357888999999999999999865 57889999886553 3456788887765555 58999987764 67778888999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--CCCcEEEeeeccceecCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD--ENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~--~~~~~kl~Dfgla~~~~~~ 568 (704)
||++.|+|.+-+...+ +.+.....++.|++.|+.|+ |++.+||||||.+||||- +...+|+||||+.+..+..
T Consensus 102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999887644 67888899999999999999 778999999999999993 3458999999998865432
Q ss_pred CCcceeccccccccccCCcccCC-----CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSE-----GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
. ....-+..|.+||.... -...+.+|+|.||+++|.++||+.||+.....+..+..|..-..... .
T Consensus 177 V-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--~-- 247 (378)
T KOG1345|consen 177 V-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--P-- 247 (378)
T ss_pred e-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--c--
Confidence 1 12234567899996432 23667899999999999999999999976666666666654222111 1
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
...+.. .-+++.++.+..+-+..+|++|=-..++.++.+.
T Consensus 248 --~~P~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 248 --ALPKKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred --cCchhh------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 111111 1234567788999999999999666666665544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-28 Score=247.26 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=200.3
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|+....+|.|.||.||||+. .+++..|+|+++.....+...+++|+-+++..+||||+.++|.+...+...+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46889999999999999999984 57999999999887777778889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+.+|+|++.=+.. ..+++.++.-+++...+|++|| |+++-+|||||-.||++++.|.+|+.|||.+..+... -.
T Consensus 94 cgggslQdiy~~T-gplselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA 167 (829)
T ss_pred cCCCcccceeeec-ccchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence 9999999855543 3478888888999999999999 7788999999999999999999999999998765432 12
Q ss_pred eeccccccccccCCccc---CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 573 IQTMTIATIGYMAPEYG---SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
......||+.|||||+. ..+.|..++|||+.|++..|+---+.|.-+..... -.........+ +
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTkS~~q-------p---- 234 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTKSGFQ-------P---- 234 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhccCCC-------C----
Confidence 23346799999999964 56778999999999999999987777754332211 01111111100 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+...........+.++++.|+..+|++||++..+++
T Consensus 235 --p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 --PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111112233456788999999999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=209.45 Aligned_cols=170 Identities=22% Similarity=0.160 Sum_probs=130.4
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
|+|.+++...+..+++..++.++.|++.||+|||+. + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 789999987667799999999999999999999763 2 999999999999999 99998764321
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
..||+.|+|||++.+..++.++|||||||++|||+||+.||.........+..+.....+.... ...
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~ 130 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR------------DRS 130 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc------------ccc
Confidence 2588999999999999999999999999999999999999965432222222222211111000 000
Q ss_pred hhHHHHH--HHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 656 VKIDCLL--SIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 656 ~~~~~~~--~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
....... .+.+++..||+.+|++||++.|+++.+......
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 1112222 688999999999999999999999998877544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-26 Score=212.73 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=193.1
Q ss_pred CccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 418 NECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
....+|.+...|+.|+|+++ |..+++|++.... ....+.|.+|.-.++-+.||||..++|.|..+....++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34457889999999999987 5667778876543 33457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 496 GSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 496 gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
|+|+..+++. ....+..+..+++.++|+|++|||.. ++-|.---+.+..|++|++.+++|+- +-+++ +...
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf------sfqe 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQE 343 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee------eeec
Confidence 9999999965 34467788999999999999999874 44455667999999999999888752 11111 1111
Q ss_pred ccccccccccCCcccCCCCC---CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 575 TMTIATIGYMAPEYGSEGII---SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
....-.|.||+||.+..++- -..+|+|||++++||+.|+..||.+..+.+....--. ++
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-----eg------------- 405 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-----EG------------- 405 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----cc-------------
Confidence 22345789999998876653 3479999999999999999999988765544322211 11
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
-+...+...+..+.+++.-|+.+||.+||.++.|+-.|+++.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 122233345667788999999999999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=260.99 Aligned_cols=195 Identities=18% Similarity=0.223 Sum_probs=137.8
Q ss_pred cCC-CCCceEEeee-------eeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 005278 468 IRH-RNLIKIISNC-------CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539 (704)
Q Consensus 468 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~ 539 (704)
++| +||+++++++ ...+..+.++||+ +++|.+++......+++..+..++.||++||+|| |+++|+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAA---HSQGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHH---HhCCeeec
Confidence 445 5777888877 2234567788987 5699999987666699999999999999999999 56889999
Q ss_pred CCCCCCeeeCCC-------------------CcEEEeeeccceecCCCCC--------------cceeccccccccccCC
Q 005278 540 DLKPNNILLDEN-------------------MTAHVSDFGISKLLGEGDD--------------SVIQTMTIATIGYMAP 586 (704)
Q Consensus 540 dlk~~Nil~~~~-------------------~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y~aP 586 (704)
||||+|||++.. +.+|++|||+++....... ........||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999654 4455666666653211000 0011123578899999
Q ss_pred cccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHH
Q 005278 587 EYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMH 666 (704)
Q Consensus 587 E~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 666 (704)
|++.+..++.++|||||||++|||++|..|+.... .....+..... .+. ..........
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~--------~~~----------~~~~~~~~~~ 243 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVL--------PPQ----------ILLNWPKEAS 243 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhc--------Chh----------hhhcCHHHHH
Confidence 99999999999999999999999999988865311 01111111000 000 0011233457
Q ss_pred HHhhhcCCCCCCCCCHHHHHH
Q 005278 667 LALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 667 l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
++.+||+++|.+||+|.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=237.52 Aligned_cols=265 Identities=27% Similarity=0.383 Sum_probs=214.1
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCC
Q 005278 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86 (704)
Q Consensus 7 ~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~ 86 (704)
.-..|+|++|.++ .+|+.+. ++|+.|++.+|+++.+ |. .+++|++|+|++|+|+.++. ..++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~L-P~---lp~~Lk~LdLs~N~LtsLP~-----------lp~s 263 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLTSLPV-----------LPPG 263 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCC-CC---CCCCCcEEEecCCccCcccC-----------cccc
Confidence 4568999999999 7888776 4899999999999964 43 36899999999999997642 1368
Q ss_pred CcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeecc
Q 005278 87 LTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLH 166 (704)
Q Consensus 87 L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 166 (704)
|+.|+|++|++.. +|. ++.+|+.|++.+|+++. +|. .+++|+.|+|++|.+.+ +|.. ..+|+.|+++
T Consensus 264 L~~L~Ls~N~L~~-Lp~----lp~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls 330 (788)
T PRK15387 264 LLELSIFSNPLTH-LPA----LPSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAY 330 (788)
T ss_pred cceeeccCCchhh-hhh----chhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCC---cccccccccc
Confidence 9999999999984 333 33579999999999984 443 35789999999999994 4542 2468899999
Q ss_pred CcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCC
Q 005278 167 GNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSL 246 (704)
Q Consensus 167 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 246 (704)
+|+|+ .+|.. ..+|++|+|++|+|+ .+|.. .++|+.|++++|.|+. +|.. ..+|+.|++++|.+++ +
T Consensus 331 ~N~L~-~LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-L 397 (788)
T PRK15387 331 NNQLT-SLPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-L 397 (788)
T ss_pred cCccc-ccccc---ccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-C
Confidence 99998 45642 258999999999999 45653 3578899999999984 5543 3579999999999984 5
Q ss_pred CcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCCcc
Q 005278 247 PSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323 (704)
Q Consensus 247 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 323 (704)
|.. .++|+.|++++|+++ .+|.. ..+|+.|++++|+|+ .+|..+.++++|+.|+|++|+|++..|..+.
T Consensus 398 P~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~ 466 (788)
T PRK15387 398 PVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 466 (788)
T ss_pred CCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHH
Confidence 543 357999999999999 56754 356889999999999 7999999999999999999999998877553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=211.94 Aligned_cols=167 Identities=21% Similarity=0.239 Sum_probs=129.5
Q ss_pred HHHhCCCCccccccccCceEEEEEEEC--CCCEEEEEEeeccc-----hhhhHHHHHHHHHHHhcCCCCCce-EEeeeee
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLF--DGTNVAIKVFNLQL-----ERASRSFDSECEILRSIRHRNLIK-IISNCCN 482 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~ 482 (704)
....++|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 445678999999999999999999864 57788999865331 223456899999999999999985 4432
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCeeeCCCCcEEEeeecc
Q 005278 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL-KPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 483 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dl-k~~Nil~~~~~~~kl~Dfgl 561 (704)
+..++||||+++++|... ... . ...++.+++++++|| |+.+|+|||| ||+||+++.++.+||+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~l---H~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDL---HRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHH---HHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 457999999999999632 111 1 146788999999999 5689999999 99999999999999999999
Q ss_pred ceecCCCCCcce------eccccccccccCCcccCCC
Q 005278 562 SKLLGEGDDSVI------QTMTIATIGYMAPEYGSEG 592 (704)
Q Consensus 562 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 592 (704)
|+.+........ -....+++.|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 998755332111 1244688889999987543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=238.84 Aligned_cols=313 Identities=22% Similarity=0.283 Sum_probs=192.7
Q ss_pred CCCCCCCEEecCCCc------CcccCCccccCCC-CCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhh
Q 005278 3 YMLPNLKYLTLFDNK------LSGTIPNSITNAS-KLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKW 75 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~------i~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 75 (704)
..|++|+.|.+.++. +...+|..|..++ +|+.|++.++.++. .|..| ...+|++|++++|.+..+.
T Consensus 555 ~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~~L~----- 627 (1153)
T PLN03210 555 KGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLEKLW----- 627 (1153)
T ss_pred hcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCC-CCCcC-CccCCcEEECcCccccccc-----
Confidence 356677777775442 2234555566654 46777777666663 34444 3566777777776665532
Q ss_pred cccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhc
Q 005278 76 NFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVG 155 (704)
Q Consensus 76 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 155 (704)
..+..+++|++|+|++|.....+|. +..+ ++|++|+|.+|.....+|..+.++++|+.|++++|.....+|..+
T Consensus 628 ---~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l-~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i- 701 (1153)
T PLN03210 628 ---DGVHSLTGLRNIDLRGSKNLKEIPD-LSMA-TNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI- 701 (1153)
T ss_pred ---cccccCCCCCEEECCCCCCcCcCCc-cccC-CcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-
Confidence 2245666677777766544334443 3332 356777776666555666666667777777776654333455443
Q ss_pred CCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccc------------------------------cCc
Q 005278 156 RLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCL------------------------------ASL 205 (704)
Q Consensus 156 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~------------------------------~~l 205 (704)
++++|+.|+|++|.....+|.. .++|++|+|++|.++ .+|..+ ...
T Consensus 702 ~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~ 777 (1153)
T PLN03210 702 NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLS 777 (1153)
T ss_pred CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhcc
Confidence 5666666666666543344432 245666666666654 333221 123
Q ss_pred CCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeec
Q 005278 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSL 285 (704)
Q Consensus 206 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 285 (704)
++|+.|+|++|.....+|..++++++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|.. ..+|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 467777777776666677778888888888888776444666555 6777888888877554455543 357788888
Q ss_pred cCceeeccCCcccccccccceEEecccCCCCCCCCCcccccccCcccccCCC
Q 005278 286 ADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 286 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~ 337 (704)
++|.++ .+|..+..+++|+.|++++|+--..+|.....+..+....+.+++
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 888887 678888888888888888855444566655555556555555544
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-25 Score=215.88 Aligned_cols=296 Identities=22% Similarity=0.261 Sum_probs=226.6
Q ss_pred EEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcE
Q 005278 10 YLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTV 89 (704)
Q Consensus 10 ~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~ 89 (704)
..+.++-.++ ++|..+. ++-++++|..|.|+.+.+++|+.+++|+.||||+|.|+.+.+.+ |..+++|.+
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~A-------F~GL~~l~~ 119 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDA-------FKGLASLLS 119 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHh-------hhhhHhhhH
Confidence 4555666677 5665432 45788999999999999999999999999999999999988777 999999888
Q ss_pred EEccC-CCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCc
Q 005278 90 LGLAS-NPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGN 168 (704)
Q Consensus 90 L~L~~-n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 168 (704)
|-+.+ |+|+...-..|..+. +|+.|.+.-|++.-...+.|..+++|..|.+.+|.+..+--..|..+.+++.+++..|
T Consensus 120 Lvlyg~NkI~~l~k~~F~gL~-slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~n 198 (498)
T KOG4237|consen 120 LVLYGNNKITDLPKGAFGGLS-SLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQN 198 (498)
T ss_pred HHhhcCCchhhhhhhHhhhHH-HHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcC
Confidence 87777 899976667777764 6999999999999999999999999999999999999554558999999999999999
Q ss_pred ccC------------CCCCccccCCCCCCEEEcCCCcCCccCCccccCc-CCCCEEEecCccCCCCCC-CcccCCccccE
Q 005278 169 KLQ------------GSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASL-TSLRRLHLGSNKLTSTMP-SSFGSLEYVLY 234 (704)
Q Consensus 169 ~l~------------~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~ 234 (704)
.+- ...|..++.+.-..-..+.++++....+..|... .++..=..+.+...++.| ..|..+++|+.
T Consensus 199 p~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ 278 (498)
T KOG4237|consen 199 PFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRK 278 (498)
T ss_pred ccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceE
Confidence 832 1234444555555555566666654444333321 122211222333333333 46788888889
Q ss_pred EEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCC
Q 005278 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314 (704)
Q Consensus 235 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l 314 (704)
|+|++|+++.+-+.+|.....++.|.|..|+|...-...|.++..|+.|+|.+|+|+..-|..|..+.+|..|+|-.|++
T Consensus 279 lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 279 LNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred eccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 99999988888888888888889999999988866667788888899999999999888888888888899998888888
Q ss_pred CC
Q 005278 315 SG 316 (704)
Q Consensus 315 ~~ 316 (704)
.+
T Consensus 359 ~C 360 (498)
T KOG4237|consen 359 NC 360 (498)
T ss_pred cC
Confidence 64
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-22 Score=203.98 Aligned_cols=261 Identities=19% Similarity=0.205 Sum_probs=195.1
Q ss_pred CCCccccccccCceEEEEEEECCC--CEEEEEEeeccchhhhHHHHHHHHHHHhcCC----CCCceEEeee-eeCCeEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLFDG--TNVAIKVFNLQLERASRSFDSECEILRSIRH----RNLIKIISNC-CNIDFKAL 488 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 488 (704)
+|.+.+.||+|+||.||.+...+. ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986543 4788888665433322378889999999873 6899999998 47778899
Q ss_pred EEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-----CcEEEeeeccc
Q 005278 489 VLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-----MTAHVSDFGIS 562 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-----~~~kl~Dfgla 562 (704)
||+.+ |.+|.++..... ..++..+...|+.|+..+|+++ |+.|++||||||.|+.++.. ..+.+.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 779999886544 7799999999999999999999 67899999999999999854 46999999999
Q ss_pred e--ecCCCCC----cc-e-eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh
Q 005278 563 K--LLGEGDD----SV-I-QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES 634 (704)
Q Consensus 563 ~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 634 (704)
+ .+..... .. . .....||..|+++....+...+.+.|+||++.++.|+..|..||........ ........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence 8 3321111 11 1 2234599999999999999999999999999999999999999976433211 11110000
Q ss_pred cCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 635 LPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
... .... .....+..+.++...+-..+..++|....+...+++...+
T Consensus 254 ~~~----~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKL----LTDR----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhh----cccc----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000 0000 0112234555666666668999999999999998776554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=187.05 Aligned_cols=263 Identities=15% Similarity=0.184 Sum_probs=205.3
Q ss_pred CCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
-.|.+.++||+|.||+++.|+ +-+++.||||.-.. ..+..++..|.+..+.| ..++|...+-+..++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 378899999999999999998 66899999997432 33456788999999999 578999999888888888999998
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-----CcEEEeeeccceecCC
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-----MTAHVSDFGISKLLGE 567 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-----~~~kl~Dfgla~~~~~ 567 (704)
+ |.||.+...-.++.++..++..+|.|+..-++|+| ++..|.|||||+|+||... ..+.++|||+|+.+.+
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8 77999999888888999999999999999999995 5669999999999999743 3589999999998866
Q ss_pred CCCc-----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 568 GDDS-----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 568 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
.... .-.....||.+||+-....+...+.+.|+-|+|-++++.+-|..||+++..... -..+- .+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kYe---------KI 251 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-KEKYE---------KI 251 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-HHHHH---------Hh
Confidence 4431 122334699999999999999999999999999999999999999998654321 11111 11
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
-+. ....+....+..++.++...+...-+.+-.+-|..+=+...+..+.+.
T Consensus 252 Ge~--Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 252 GET--KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ccc--cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 110 011112233445566777777777777889999887777666665543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=234.27 Aligned_cols=285 Identities=22% Similarity=0.317 Sum_probs=210.4
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEeccccc-CCCcccchhhcccccCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY-LMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~~~~~~~l 84 (704)
++|+.|++.++.++ .+|..| ...+|++|+|.+|.+. ..+..+..+++|++|+|++|. +..++ .+..+
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip---------~ls~l 656 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP---------DLSMA 656 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC---------ccccC
Confidence 35777888777776 566666 4677888888887777 345566777788888887764 33322 26667
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeee
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLY 164 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 164 (704)
++|++|+|++|.....+|..+..+. +|+.|++++|...+.+|..+ ++++|+.|+|++|......|.. .++|++|+
T Consensus 657 ~~Le~L~L~~c~~L~~lp~si~~L~-~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~ 731 (1153)
T PLN03210 657 TNLETLKLSDCSSLVELPSSIQYLN-KLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLD 731 (1153)
T ss_pred CcccEEEecCCCCccccchhhhccC-CCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeee
Confidence 7777888877766666777776664 57777777776555666554 6777777777777544344432 34566667
Q ss_pred ccCcccCCCCCccc------------------------------cCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEec
Q 005278 165 LHGNKLQGSIPYDL------------------------------CHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLG 214 (704)
Q Consensus 165 L~~n~l~~~~~~~l------------------------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 214 (704)
+++|.++ .+|..+ ...++|+.|+|++|.....+|..+.++++|+.|+++
T Consensus 732 L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls 810 (1153)
T PLN03210 732 LDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIE 810 (1153)
T ss_pred cCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECC
Confidence 7776665 334321 123578899999998777899999999999999999
Q ss_pred CccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccC
Q 005278 215 SNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294 (704)
Q Consensus 215 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 294 (704)
+|...+.+|..+ .+++|+.|++++|.....+|.. .++|+.|+|++|.++ .+|..+..+++|+.|+|++|+-...+
T Consensus 811 ~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l 885 (1153)
T PLN03210 811 NCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRV 885 (1153)
T ss_pred CCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCcc
Confidence 986544677665 7899999999998765555543 367999999999998 78999999999999999996544478
Q ss_pred CcccccccccceEEecccC
Q 005278 295 PKSFGSLISLESLDLSRNN 313 (704)
Q Consensus 295 p~~~~~l~~L~~L~l~~N~ 313 (704)
|..+..+++|+.+++++|.
T Consensus 886 ~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 886 SLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CcccccccCCCeeecCCCc
Confidence 8888999999999999986
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-24 Score=230.93 Aligned_cols=304 Identities=31% Similarity=0.361 Sum_probs=201.2
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCC
Q 005278 8 LKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNL 87 (704)
Q Consensus 8 l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L 87 (704)
++.++|..|.+.+.++..+.++.+ .|+|.+|.+.. -.+..+.+|+.|...+|+++.... ..++|
T Consensus 158 ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l~~-----------~g~~l 221 (1081)
T KOG0618|consen 158 IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLSNLANLEVLHCERNQLSELEI-----------SGPSL 221 (1081)
T ss_pred chhhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhhhccchhhhhhhhcccceEEe-----------cCcch
Confidence 677888888888888887777777 78888888882 235677778888888888776542 33577
Q ss_pred cEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccC
Q 005278 88 TVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHG 167 (704)
Q Consensus 88 ~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 167 (704)
+.|+.++|.+....+. ..+.+|++++++.|+++ .+|+.++.+.+|+.|+..+|.+. .+|..+..+++|+.|.+..
T Consensus 222 ~~L~a~~n~l~~~~~~---p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~ 296 (1081)
T KOG0618|consen 222 TALYADHNPLTTLDVH---PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAY 296 (1081)
T ss_pred heeeeccCcceeeccc---cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhh
Confidence 7777777777633222 22346777777777777 44477777777777777777775 6666666677777777777
Q ss_pred cccCCCCCccccCCCCCCEEEcCCCcCCccCCcccc-------------------------CcCCCCEEEecCccCCCCC
Q 005278 168 NKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLA-------------------------SLTSLRRLHLGSNKLTSTM 222 (704)
Q Consensus 168 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-------------------------~l~~L~~L~l~~n~l~~~~ 222 (704)
|.+. -+|..+.+++.|+.|+|..|+|....+..+. .++.|+.|++.+|.++...
T Consensus 297 nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c 375 (1081)
T KOG0618|consen 297 NELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSC 375 (1081)
T ss_pred hhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccc
Confidence 7776 5566666667777777777766622111111 1234556666666666655
Q ss_pred CCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCccccccc
Q 005278 223 PSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302 (704)
Q Consensus 223 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 302 (704)
-..+.++.+|+.|+|++|++.......+.+++.|+.|+||+|+++ .+|..+..++.|++|...+|++. ..| .+..++
T Consensus 376 ~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~ 452 (1081)
T KOG0618|consen 376 FPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLP 452 (1081)
T ss_pred hhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcC
Confidence 556666777777777777777555555667777777777777777 66677777777777777777776 555 666777
Q ss_pred ccceEEecccCCCCC-CCCCcccccccCcccccCCC
Q 005278 303 SLESLDLSRNNLSGE-IPKNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 303 ~L~~L~l~~N~l~~~-~p~~~~~~~~l~~~~l~g~~ 337 (704)
.|+.+|+|.|+++.. +|.... .+.+..+.++|+.
T Consensus 453 qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 453 QLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred cceEEecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence 777777777777642 222221 1445555666665
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-22 Score=220.20 Aligned_cols=247 Identities=27% Similarity=0.320 Sum_probs=198.2
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
++|+.|++.+|+++ .+|. ..++|++|+|++|+++.+ |.. .++|++|+|++|.+..++. ...
T Consensus 222 ~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls~N~L~~Lp~-----------lp~ 282 (788)
T PRK15387 222 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIFSNPLTHLPA-----------LPS 282 (788)
T ss_pred cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCcc-cCc---ccccceeeccCCchhhhhh-----------chh
Confidence 47899999999999 5675 368999999999999965 432 4689999999999987542 125
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeec
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL 165 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 165 (704)
+|+.|+|++|+++. +|. .+++|+.|+|++|++++. |.. ..+|+.|++++|.++. +|.. ..+|+.|+|
T Consensus 283 ~L~~L~Ls~N~Lt~-LP~----~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdL 349 (788)
T PRK15387 283 GLCKLWIFGNQLTS-LPV----LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSV 349 (788)
T ss_pred hcCEEECcCCcccc-ccc----cccccceeECCCCccccC-CCC---cccccccccccCcccc-cccc---ccccceEec
Confidence 78999999999984 343 345799999999999963 432 3468889999999984 5532 258999999
Q ss_pred cCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCC
Q 005278 166 HGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245 (704)
Q Consensus 166 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 245 (704)
++|+|+ .+|.. .++|+.|++++|+|+ .+|.. ..+|+.|++++|.|++ +|.. .++|+.|++++|.++.
T Consensus 350 S~N~Ls-~LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss- 416 (788)
T PRK15387 350 SDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS- 416 (788)
T ss_pred CCCccC-CCCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-
Confidence 999999 45643 357889999999999 46653 3579999999999985 5543 3689999999999984
Q ss_pred CCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccc
Q 005278 246 LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSL 301 (704)
Q Consensus 246 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 301 (704)
+|..+ .+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..|..+..+
T Consensus 417 IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 417 LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 66543 46889999999999 789999999999999999999998887766443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-24 Score=210.52 Aligned_cols=278 Identities=24% Similarity=0.267 Sum_probs=234.8
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEeccc-ccCCCcccchhhcccccCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY-NYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~~~~~~~~l 84 (704)
+..+.++|..|.|+.+-+.+|+.+++|+.|||++|.|+.|.|++|.++++|.+|.+-+ |+|+.+...+ |.++
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~-------F~gL 139 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGA-------FGGL 139 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhH-------hhhH
Confidence 4567899999999988889999999999999999999999999999999998888866 9999999887 9999
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcC------------ccccCh
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDL------------NGTIPT 152 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l------------~~~~~~ 152 (704)
.+|+.|.+.-|++.......|..+. +|..|.+.+|.+...-...|..+..++++.+..|.+ ....|.
T Consensus 140 ~slqrLllNan~i~Cir~~al~dL~-~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~i 218 (498)
T KOG4237|consen 140 SSLQRLLLNANHINCIRQDALRDLP-SLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPI 218 (498)
T ss_pred HHHHHHhcChhhhcchhHHHHHHhh-hcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchh
Confidence 9999999999999988888888885 799999999999977777999999999999999983 234455
Q ss_pred hhcCCCCcCeeeccCcccCCCCCccccCC-CCCCEEEcCCCcCCccCC-ccccCcCCCCEEEecCccCCCCCCCcccCCc
Q 005278 153 AVGRLRRLQGLYLHGNKLQGSIPYDLCHL-EGLSELNLNGNKLCGHVP-PCLASLTSLRRLHLGSNKLTSTMPSSFGSLE 230 (704)
Q Consensus 153 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 230 (704)
.++...-..-..+.++++..+.+..|... ..+..=..+.+...+.-| ..|..+++|+.|+|++|.|+.+-+.+|.+..
T Consensus 219 etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a 298 (498)
T KOG4237|consen 219 ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA 298 (498)
T ss_pred hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchh
Confidence 66677777777778888775555554432 233222223333333444 4688999999999999999999999999999
Q ss_pred cccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 231 YVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 231 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
.+++|.|..|++.......|.++..|+.|+|.+|+|+..-|.+|..+..|..|+|-.|.+.
T Consensus 299 ~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 299 ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 9999999999998777788899999999999999999888999999999999999999876
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=177.72 Aligned_cols=261 Identities=18% Similarity=0.194 Sum_probs=199.0
Q ss_pred HhCCCCccccccccCceEEEEEE-ECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCC-CCCceEEeeeeeCCeEEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRH-RNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 490 (704)
....|..+++||.|+||.+|.|. ..+|+.||+|+-+... ...++..|..+.+.+++ ..|..+..+..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35689999999999999999998 6689999999854432 22467789999999974 67777788888888889999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD---ENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~---~~~~~kl~Dfgla~~~~~ 567 (704)
|.+ |.+|.+.+.-..+.++..++.-.+.|+..-++|+ |.++++||||||+|+|.+ ....+.++|||+|+.+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 988 7799999987777799999999999999999999 557799999999999997 345689999999988754
Q ss_pred CCCc-----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccc--cHHHHHHhhcCCCcc
Q 005278 568 GDDS-----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM--SLKHWVKESLPDGLT 640 (704)
Q Consensus 568 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 640 (704)
.... .......||.+|.+-....+...+.+.|+-|+|.++.+.-.|..||++...... -+.........
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s---- 242 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS---- 242 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC----
Confidence 3321 122334799999998888877888899999999999999999999998643211 11111111000
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
-+....+..+|.++.-.+..|-..--++-|...-+-+.++-+.
T Consensus 243 ----------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 243 ----------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred ----------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 0112233455666777788888888888888776666665543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-22 Score=221.41 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=120.7
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
.+.+.|+|+++.++ .+|..+. ++|+.|+|++|+++.+ |..+. ++|++|++++|.++.++.. + ..
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsL-P~~l~--~nL~~L~Ls~N~LtsLP~~--------l--~~ 241 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSL-PENLQ--GNIKTLYANSNQLTSIPAT--------L--PD 241 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcC-Chhhc--cCCCEEECCCCccccCChh--------h--hc
Confidence 34566666666666 4555443 4566666666666643 33332 3566666666666554321 1 13
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeec
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL 165 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 165 (704)
+|+.|+|++|++. .+|..+. .+|+.|++++|++. .+|..+. ++|+.|++++|+|+. +|..+. ++|+.|++
T Consensus 242 ~L~~L~Ls~N~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~L 311 (754)
T PRK15370 242 TIQEMELSINRIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNV 311 (754)
T ss_pred cccEEECcCCccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHh
Confidence 5666666666665 3344332 24555555555555 2333322 245555555555542 232221 24444555
Q ss_pred cCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCC
Q 005278 166 HGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245 (704)
Q Consensus 166 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 245 (704)
++|+++ .+|..+. + +|+.|++++|.++. +|..+. ++|+.|++++|.++ .
T Consensus 312 s~N~Lt-~LP~~l~--~------------------------sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~ 360 (754)
T PRK15370 312 QSNSLT-ALPETLP--P------------------------GLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-V 360 (754)
T ss_pred cCCccc-cCCcccc--c------------------------cceeccccCCcccc-CChhhc--CcccEEECCCCCCC-c
Confidence 555544 2332221 3 44444555554442 333322 34555555555544 2
Q ss_pred CCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCccc----ccccccceEEecccCCC
Q 005278 246 LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSF----GSLISLESLDLSRNNLS 315 (704)
Q Consensus 246 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~----~~l~~L~~L~l~~N~l~ 315 (704)
+|..+. ++|+.|++++|+++ .+|..+. ..|+.|++++|+++ .+|..+ ..++++..|++.+|+++
T Consensus 361 LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 361 LPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 333332 34555555555555 3443332 24555666666655 344332 23355566666666665
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-23 Score=225.11 Aligned_cols=282 Identities=31% Similarity=0.401 Sum_probs=188.2
Q ss_pred CCE-EecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCC
Q 005278 8 LKY-LTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86 (704)
Q Consensus 8 l~~-L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~ 86 (704)
++. |+|.+|++. .-.+.++.+|+.|..+.|.+.... ..-++|+.|+.++|.+..... -..-.+
T Consensus 179 l~~~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~---------~p~p~n 242 (1081)
T KOG0618|consen 179 LTHQLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV---------HPVPLN 242 (1081)
T ss_pred hheeeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecc---------cccccc
Confidence 444 888888876 223666777777777777766431 223445555555555442211 112234
Q ss_pred CcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcC-----
Q 005278 87 LTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQ----- 161 (704)
Q Consensus 87 L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----- 161 (704)
|+++++++|+++. .|.++..+ .+|+.+.+.+|.+. .+|..+...++|+.|++..|.+. -+|....+++.|+
T Consensus 243 l~~~dis~n~l~~-lp~wi~~~-~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 243 LQYLDISHNNLSN-LPEWIGAC-ANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred ceeeecchhhhhc-chHHHHhc-ccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 5555555555542 23444443 24555555555552 44444444444444444444444 3333444444444
Q ss_pred --------------------eeeccCcccCCCCC-ccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCC
Q 005278 162 --------------------GLYLHGNKLQGSIP-YDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTS 220 (704)
Q Consensus 162 --------------------~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 220 (704)
.|+.+.|.+. ..| -.=..++.|++|++.+|.+++..-+.+.++++|+.|+|++|+|..
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 4444444444 222 111123568899999999998777789999999999999999997
Q ss_pred CCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeec-cCCcccc
Q 005278 221 TMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG-PVPKSFG 299 (704)
Q Consensus 221 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~ 299 (704)
.....+.+++.|++|+||+|+++ .+|..+.+++.|++|...+|++. ..| .+..++.|+.+|++.|+++. .+|....
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC
Confidence 77778899999999999999999 88899999999999999999999 788 79999999999999999985 4455444
Q ss_pred cccccceEEecccCC
Q 005278 300 SLISLESLDLSRNNL 314 (704)
Q Consensus 300 ~l~~L~~L~l~~N~l 314 (704)
+ ++|++||++||.-
T Consensus 475 ~-p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 475 S-PNLKYLDLSGNTR 488 (1081)
T ss_pred C-cccceeeccCCcc
Confidence 4 8999999999984
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-22 Score=218.69 Aligned_cols=261 Identities=22% Similarity=0.247 Sum_probs=192.5
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeec----c-ch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 419 ECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNL----Q-LE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 419 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~----~-~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
..+++|.|++|.|+.... ......+.|.++. . .. .....+..|.-+-..+.|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998877763 2344444444331 1 11 111225667777788899999888888777666666699
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|++. +|..++.+. ..+....+-.++.|+..|++|+ |+.||.|||+|++|++++.++.+||+|||.+....-....
T Consensus 402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 999988765 3377888899999999999999 6789999999999999999999999999999876544333
Q ss_pred --ceeccccccccccCCcccCCCCCCc-ccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 572 --VIQTMTIATIGYMAPEYGSEGIISP-KSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 572 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.......|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+..+.. ........
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-----------~~~~~~~~ 545 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-----------NNYSDQRN 545 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-----------hccccccc
Confidence 4455678999999999999988877 489999999999999999999765444333200 00001111
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhhc
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDVA 701 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~~ 701 (704)
...+........+..-..++..+++++|.+|-|+.+| +.+.|.+.+.
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i------~~d~W~~~i~ 592 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQI------LNDEWIRSIE 592 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHH------hhChHhhhcc
Confidence 1112233444556777889999999999999999999 5556655554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-21 Score=215.82 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=180.4
Q ss_pred CCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcC
Q 005278 54 GSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNL 133 (704)
Q Consensus 54 ~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 133 (704)
.+.+.|+++++.++.++.. + .++|+.|+|++|+|+ .+|..+. .+|++|++++|+++ .+|..+.
T Consensus 178 ~~~~~L~L~~~~LtsLP~~--------I--p~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~-- 240 (754)
T PRK15370 178 NNKTELRLKILGLTTIPAC--------I--PEQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP-- 240 (754)
T ss_pred cCceEEEeCCCCcCcCCcc--------c--ccCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--
Confidence 3467777777777765432 1 246777777777777 3454443 36778888887777 3455443
Q ss_pred CCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEe
Q 005278 134 SGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHL 213 (704)
Q Consensus 134 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 213 (704)
.+|+.|+|++|.+. .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++
T Consensus 241 ~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~L 311 (754)
T PRK15370 241 DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNV 311 (754)
T ss_pred ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHh
Confidence 47889999999988 5666654 57999999999998 5677664 58999999999998 4565443 47999999
Q ss_pred cCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeecc
Q 005278 214 GSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGP 293 (704)
Q Consensus 214 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 293 (704)
++|.++. +|..+. ++|+.|++++|.++. +|..+. ++|+.|++++|+++ .+|..+. ++|+.|+|++|+++ .
T Consensus 312 s~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~ 381 (754)
T PRK15370 312 QSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-N 381 (754)
T ss_pred cCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-C
Confidence 9999984 555443 689999999999984 666554 68999999999998 6776553 68999999999999 6
Q ss_pred CCcccccccccceEEecccCCCCCCCCCccc----ccccCcccccCCCc
Q 005278 294 VPKSFGSLISLESLDLSRNNLSGEIPKNFSA----QSFLSNYALCGPAR 338 (704)
Q Consensus 294 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~----~~~l~~~~l~g~~~ 338 (704)
+|..+. .+|+.|++++|+++ .+|..+.. .+.+....+.+++.
T Consensus 382 LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npl 427 (754)
T PRK15370 382 LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPF 427 (754)
T ss_pred CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCc
Confidence 776654 37999999999998 55654322 23344455666653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-20 Score=193.37 Aligned_cols=258 Identities=31% Similarity=0.379 Sum_probs=196.8
Q ss_pred CCccccccccCceEEEEEEECCCCEEEEEEeeccchh---hhHHHHHHHHHHHhcCCC-CCceEEeeeeeCCeEEEEEec
Q 005278 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLER---ASRSFDSECEILRSIRHR-NLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 492 (704)
|.....||.|+||.||++... ..+++|.+...... ....+.+|+..++.+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999866 88899998765432 367799999999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhhCC--CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeeeccceecCCCC
Q 005278 493 MPNGSLEKWLYSHN--YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-TAHVSDFGISKLLGEGD 569 (704)
Q Consensus 493 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-~~kl~Dfgla~~~~~~~ 569 (704)
+.++++.+++.... ..+.......++.+++.+++|+ |+.+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776554 2588999999999999999999 557799999999999999988 79999999998665433
Q ss_pred Ccc----eeccccccccccCCcccCC---CCCCcccceeeHHHHHHHHhhCCCCCCccccc--cccHHHHHHhhcCCCcc
Q 005278 570 DSV----IQTMTIATIGYMAPEYGSE---GIISPKSDVYSYGILLMETFTRKKPTNEIFIG--EMSLKHWVKESLPDGLT 640 (704)
Q Consensus 570 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 640 (704)
... ......|+..|+|||...+ .......|+||+|++++++++|..||...... .......+.........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 2355679999999999887 57888999999999999999999997653321 11111111111111000
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
........ ......+.+++..|+..+|..|.++.+....
T Consensus 237 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNP---------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCcccc---------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 1223467789999999999999998887654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=195.86 Aligned_cols=217 Identities=27% Similarity=0.376 Sum_probs=166.8
Q ss_pred HHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 005278 465 LRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPN 544 (704)
Q Consensus 465 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~ 544 (704)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+......+++.....++++++.|++|+|+ ++...|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 356789999999999999999999999999999999999888889999999999999999999974 333399999999
Q ss_pred CeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCC-------CCCcccceeeHHHHHHHHhhCCCCC
Q 005278 545 NILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG-------IISPKSDVYSYGILLMETFTRKKPT 617 (704)
Q Consensus 545 Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~Gv~l~el~tg~~p~ 617 (704)
|+++|....+|++|||+.....+...........-..-|.|||.+... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998876432122222223345679999987653 1467899999999999999999999
Q ss_pred Cccccccc--cHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 618 NEIFIGEM--SLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 618 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
+....... ....+++. .......+.+.... +..+.+..++..||..+|.+||++++|-..++.+..
T Consensus 159 ~~~~~~~~~~eii~~~~~----~~~~~~rP~i~~~~-------e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK----GGSNPFRPSIELLN-------ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHh----cCCCCcCcchhhhh-------hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 87433332 22222222 11112222221111 334468889999999999999999999888887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=177.40 Aligned_cols=140 Identities=19% Similarity=0.176 Sum_probs=108.3
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeeccchh--h------------------------hHHHHHHHHHHHhcCCCCC
Q 005278 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLER--A------------------------SRSFDSECEILRSIRHRNL 473 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni 473 (704)
...||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999778999999998754211 0 1123459999999988776
Q ss_pred ceEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 005278 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT 553 (704)
Q Consensus 474 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~ 553 (704)
.....+.. ...++||||++++++....... ..++......++.|++.+++|+| |+.+|+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEEE-CCc
Confidence 44333222 2237999999988776553332 34788899999999999999996 356899999999999998 478
Q ss_pred EEEeeeccceec
Q 005278 554 AHVSDFGISKLL 565 (704)
Q Consensus 554 ~kl~Dfgla~~~ 565 (704)
++++|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.8e-21 Score=180.99 Aligned_cols=172 Identities=14% Similarity=0.144 Sum_probs=132.6
Q ss_pred HHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhH---------HHHHHHHHHHhcCCCCCceEEeeeee
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASR---------SFDSECEILRSIRHRNLIKIISNCCN 482 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~e~~~l~~l~h~niv~l~~~~~~ 482 (704)
...++|...+++|.|+||.||.+.. ++..+|+|.++........ .+++|+..+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468999999999999999999765 5778999999755432222 26899999999999999999988654
Q ss_pred C--------CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 483 I--------DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 483 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
. ...++||||++|.+|.++.. ++. ....+++.++..+ |+.+++|||++|+||++++++ +
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~l---H~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESL---HQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHH---HHcCCccCCCChHHEEEeCCC-E
Confidence 3 35789999999999988732 222 3456889999999 568999999999999999988 9
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETF 611 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~ 611 (704)
+++|||........... ..+.....+..++|+||||+++....
T Consensus 174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999987654211100 01334445667899999999987654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-22 Score=206.43 Aligned_cols=284 Identities=23% Similarity=0.243 Sum_probs=158.1
Q ss_pred EEecCCCcCc-ccCCccccCCCCCCEEeccCcccccc----CchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 10 YLTLFDNKLS-GTIPNSITNASKLIMLDLSSNSFSGL----IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 10 ~L~l~~~~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
.|+|.++.++ ......|..+.+|++|++++|.+++. ++..+...++|++|+++++.+...... ...++..+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~-~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRG-LQSLLQGLTKG 80 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchH-HHHHHHHHHhc
Confidence 5778888877 45556677788899999998888643 445566777888888888877631111 11134456678
Q ss_pred CCCcEEEccCCCCcccCChhhhhccc--ccceEEecCCcccc----cCChhhhcC-CCCCEEEccCCcCccc----cChh
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSA--SLQEFYAYGCKLRG----NIPQEIGNL-SGMIVFDLNGCDLNGT----IPTA 153 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~--~L~~L~l~~n~l~~----~~~~~~~~l-~~L~~L~L~~n~l~~~----~~~~ 153 (704)
++|++|+|++|.+....+..+..+.. +|++|++++|.+.+ .+...+..+ ++|++|++++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 88888888888887665555555432 26666666665542 222333444 5555555555555421 2223
Q ss_pred hcCCCCcCeeeccCcccCCC----CCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCC
Q 005278 154 VGRLRRLQGLYLHGNKLQGS----IPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSL 229 (704)
Q Consensus 154 ~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 229 (704)
+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++.... .....+..+
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------------------~l~~~~~~~ 220 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--------------------ALAETLASL 220 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH--------------------HHHHHhccc
Confidence 33444455555555554421 112223334444444444444321110 111223344
Q ss_pred ccccEEEecCcccCCCCCcccc-----cCcCCcEEEeecCccCC----CCCCCcCCCCCcceeeccCceeecc----CCc
Q 005278 230 EYVLYINLSANSLNGSLPSNIQ-----NLKVLTNLDLSRNQLSG----DIPTTIGGLENLETLSLADNQFQGP----VPK 296 (704)
Q Consensus 230 ~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~----~p~ 296 (704)
++|++|++++|.+++.....+. ..++|+.|++++|.++. .+...+..+++|+.+++++|.++.. ...
T Consensus 221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~ 300 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAE 300 (319)
T ss_pred CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHH
Confidence 5555555555555432222221 13567777777777752 2233455567788888888887743 333
Q ss_pred ccccc-cccceEEecccCC
Q 005278 297 SFGSL-ISLESLDLSRNNL 314 (704)
Q Consensus 297 ~~~~l-~~L~~L~l~~N~l 314 (704)
.+... +.|+.+++.+|++
T Consensus 301 ~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 301 SLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHhhcCCchhhcccCCCCC
Confidence 34444 6778888887764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-22 Score=204.39 Aligned_cols=236 Identities=22% Similarity=0.234 Sum_probs=167.4
Q ss_pred CCCCCCEEecCCCcCcc----cCCccccCCCCCCEEeccCccccc------cCchhhcCCCCCCEEecccccCCCcccch
Q 005278 4 MLPNLKYLTLFDNKLSG----TIPNSITNASKLIMLDLSSNSFSG------LIPNTFGNLGSLQVLSLAYNYLMTESSAA 73 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~----~~~~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 73 (704)
.+++|+.|++++|.++. .++..+...++|++|+++++.+.. ..+..|..+++|++|+|++|.+.......
T Consensus 21 ~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~ 100 (319)
T cd00116 21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGV 100 (319)
T ss_pred HHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHH
Confidence 35679999999999953 366677888999999999998872 34457888999999999999997644433
Q ss_pred hhcccccCCCCCCCcEEEccCCCCcccCC----hhhhhcccccceEEecCCcccc----cCChhhhcCCCCCEEEccCCc
Q 005278 74 KWNFLSSLTNCRNLTVLGLASNPLRGILP----PLIGNFSASLQEFYAYGCKLRG----NIPQEIGNLSGMIVFDLNGCD 145 (704)
Q Consensus 74 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~~~~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~n~ 145 (704)
+...... ++|++|++++|++.+... ..+..+.++|++|++++|.+++ .++..+..+.+|++|++++|.
T Consensus 101 ---~~~l~~~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~ 176 (319)
T cd00116 101 ---LESLLRS-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNG 176 (319)
T ss_pred ---HHHHhcc-CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCC
Confidence 1111222 569999999999984332 3334443689999999999984 345567788899999999999
Q ss_pred Cccc----cChhhcCCCCcCeeeccCcccCCCC----CccccCCCCCCEEEcCCCcCCccCCcccc-----CcCCCCEEE
Q 005278 146 LNGT----IPTAVGRLRRLQGLYLHGNKLQGSI----PYDLCHLEGLSELNLNGNKLCGHVPPCLA-----SLTSLRRLH 212 (704)
Q Consensus 146 l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~ 212 (704)
+++. ++..+..+++|+.|++++|.+++.. +..+..+++|++|++++|.+++.....+. ..++|+.|+
T Consensus 177 l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~ 256 (319)
T cd00116 177 IGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLS 256 (319)
T ss_pred CchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEE
Confidence 9842 3445666789999999999987432 34566778899999999988753222222 236777777
Q ss_pred ecCccCCCC----CCCcccCCccccEEEecCcccC
Q 005278 213 LGSNKLTST----MPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 213 l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
+++|.++.. +...+..+++|+++++++|.++
T Consensus 257 l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 257 LSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred ccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 777777521 1223334455555555555555
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-20 Score=205.20 Aligned_cols=250 Identities=22% Similarity=0.232 Sum_probs=175.8
Q ss_pred CCCccccccccCceEEEEEEECCCCEEEEEEeeccch-hhhHHHHHHHHH--HHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 416 GFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE-RASRSFDSECEI--LRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++...+.+|.+.|=.|.+|+..+|. |+||++-++.. -.-+.|.++++- ...++|||++.+.-+.......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566688999999999999988777 89999876542 223344433333 4555899999988776667777888899
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC-CCCCc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG-EGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~-~~~~~ 571 (704)
..+ +|+|.+..+ ..+...+.+.|+.|+..|+..+ |+.+|+|||||.+|||++.=..+.|+||..-+... +.++.
T Consensus 103 vkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 876 999988754 3477778888999999999999 67899999999999999999999999997643221 11111
Q ss_pred ----ceeccccccccccCCcccCCC----------C-CCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhc
Q 005278 572 ----VIQTMTIATIGYMAPEYGSEG----------I-ISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 572 ----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
........-..|+|||.+... . .+++-||||+||++.|+++ |++||.-. ++-.+-...
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~- 251 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN- 251 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC-
Confidence 112222334569999964331 1 5678899999999999999 67777531 111111110
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~ 690 (704)
..+++..- ..-....+.+++..|++.||++|.+|++.++.-+
T Consensus 252 ------~~~~e~~L-------e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 252 ------ADDPEQLL-------EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred ------ccCHHHHH-------HhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 00000000 0000125778999999999999999999998743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-19 Score=167.28 Aligned_cols=141 Identities=20% Similarity=0.175 Sum_probs=110.5
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeeccchh--------------------------hhHHHHHHHHHHHhcCCCCC
Q 005278 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLER--------------------------ASRSFDSECEILRSIRHRNL 473 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni 473 (704)
...||+|++|.||+|+..+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754210 01224678999999999987
Q ss_pred ceEEeeeeeCCeEEEEEeccCCCCHHHH-HhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 005278 474 IKIISNCCNIDFKALVLEFMPNGSLEKW-LYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM 552 (704)
Q Consensus 474 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~ 552 (704)
.....+.... .++||||++++++... +.. ..++......++.+++.++.++|+ ..+|+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CC
Confidence 5544443332 4799999998865443 332 336778889999999999999963 27899999999999999 88
Q ss_pred cEEEeeeccceecCC
Q 005278 553 TAHVSDFGISKLLGE 567 (704)
Q Consensus 553 ~~kl~Dfgla~~~~~ 567 (704)
.++|+|||++..+..
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.5e-19 Score=162.35 Aligned_cols=186 Identities=15% Similarity=0.090 Sum_probs=137.2
Q ss_pred CccccccccCceEEEEEEECCCCEEEEEEeeccchh----hhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEEec
Q 005278 418 NECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLER----ASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.+...+++|+||+||.+.- ++..++.+.+.....- ....+.+|+++++++. |+++.+++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997764 6788887776544221 1235889999999995 5889999886 346899999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL-KPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dl-k~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+.|.+|.+.... ....++.++..+++++ |+.||+|||| ||.||+++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998764321 1235778999999999 5678999999 799999999999999999999865432210
Q ss_pred ----c-------eeccccccccccCCcccC--CCCCCcccceeeHHHHHHHHhhCCCCCCc
Q 005278 572 ----V-------IQTMTIATIGYMAPEYGS--EGIISPKSDVYSYGILLMETFTRKKPTNE 619 (704)
Q Consensus 572 ----~-------~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~ 619 (704)
. .......++.|++|+-.. ...--...+-++-|.-+|.++||+.|+-+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 011224677788887422 12222456788899999999999988644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-19 Score=174.85 Aligned_cols=197 Identities=24% Similarity=0.250 Sum_probs=137.1
Q ss_pred CCCCCceEEeeeee---------------------------CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHH
Q 005278 469 RHRNLIKIISNCCN---------------------------IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDV 521 (704)
Q Consensus 469 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i 521 (704)
+|||||++.++|.+ +...|+||..+++ +|.+++..+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999987743 2356799998866 9999998654 3555666788999
Q ss_pred HHHHHHHHhcCCCCcEecCCCCCCeee--CCCC--cEEEeeeccceecCCCCC----cceeccccccccccCCcccCCCC
Q 005278 522 GLALEYLHHGHSTPMVHCDLKPNNILL--DENM--TAHVSDFGISKLLGEGDD----SVIQTMTIATIGYMAPEYGSEGI 593 (704)
Q Consensus 522 ~~~l~~Lh~~h~~~ivH~dlk~~Nil~--~~~~--~~kl~Dfgla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~ 593 (704)
.+|+.|| |++||.|||+|++||++ |+|+ ...|+|||.+---....- .......-|.-.-||||+....+
T Consensus 351 LEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999 56789999999999998 4444 467899997643211110 01111224677789999864322
Q ss_pred ------CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHH
Q 005278 594 ------ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHL 667 (704)
Q Consensus 594 ------~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 667 (704)
.-.|+|.|+.|.+.||+++...||....+...+...+- +.+....+..+++.+.++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq------------------e~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ------------------ESQLPALPSRVPPVARQL 489 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh------------------hhhCCCCcccCChHHHHH
Confidence 12389999999999999999999987322211111111 111223445667788999
Q ss_pred HhhhcCCCCCCCCCHHHHHHHH
Q 005278 668 ALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 668 ~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
+...++.||++|++..-....|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 9999999999999875544443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=193.76 Aligned_cols=198 Identities=22% Similarity=0.223 Sum_probs=160.7
Q ss_pred HHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC---CCCCceEEeeeeeCCeEE
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIR---HRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~ 487 (704)
+...+.|.+.+.||+|+||+||+|...+|+.||+|+=+..... +|.--.+++.+|+ -+.|+.+..++...+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3445678888999999999999999888999999986544321 1222234444444 344556666666677788
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-------CCCcEEEeeec
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-------ENMTAHVSDFG 560 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-------~~~~~kl~Dfg 560 (704)
+|+||.+.|+|.+++. ....++|.-++-+..|++..+++| |..+||||||||+|+++. ....++|+|||
T Consensus 771 lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~l---H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHL---HAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHH---HhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999998 444589999999999999999999 567899999999999994 24468999999
Q ss_pred cceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCC
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKK 615 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~ 615 (704)
.+..+.-..........++|-++-.+|...+..++.++|.|.++.+++-|+.|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9998866555556667789999999999999999999999999999999999875
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=171.15 Aligned_cols=229 Identities=22% Similarity=0.259 Sum_probs=145.5
Q ss_pred CccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcC----------CCCCceEEeeee--
Q 005278 418 NECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIR----------HRNLIKIISNCC-- 481 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~niv~l~~~~~-- 481 (704)
...+.||.|+++.||.++.. +++++|||++.... ....+.+++|.-....+. |-.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34578999999999999976 58999999986443 234456666665554432 212222222211
Q ss_pred -------eC---C-----eEEEEEeccCCCCHHHHHh---hCC---CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 005278 482 -------NI---D-----FKALVLEFMPNGSLEKWLY---SHN---YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540 (704)
Q Consensus 482 -------~~---~-----~~~lv~e~~~~gsL~~~l~---~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~d 540 (704)
.. . ..+++|+-+ .++|.+++. ... .......+..+..|+.+.+++|| ..|++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence 11 1 235778877 569988865 221 12344556677789999999995 57899999
Q ss_pred CCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCC--------CCCCcccceeeHHHHHHHHhh
Q 005278 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE--------GIISPKSDVYSYGILLMETFT 612 (704)
Q Consensus 541 lk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~Gv~l~el~t 612 (704)
|+|+|++++.+|.+.|+||+.....+.. ......+..|.+||.... -.++.+.|.|++|+++|.|++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999988764321 111345678999996533 257889999999999999999
Q ss_pred CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCC
Q 005278 613 RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQR 679 (704)
Q Consensus 613 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 679 (704)
|+.||+......... ..+..+.+.+..+..+|..+++.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~------------------------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE------------------------WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG------------------------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccc------------------------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999998632211100 0122333567788999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.6e-20 Score=190.92 Aligned_cols=225 Identities=24% Similarity=0.267 Sum_probs=176.2
Q ss_pred cccccCceEEEEEE----ECCCCEEEEEEeeccch--hhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEEeccC
Q 005278 422 LLGTGSFGSVYKGT----LFDGTNVAIKVFNLQLE--RASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 422 ~ig~G~~g~V~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
.+|+|+||.|+.++ ...|..+|+|+.++... ........|..++..++ ||.++++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36999999999764 23477889998865531 12225667888889887 9999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|++...+..... +...........++-+++++ |+.+|+|||+|++||+++.+|++++.|||+++..-+...
T Consensus 81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 9999988876544 45555566667778888888 789999999999999999999999999999987644322
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (704)
.+||..|||||++. .....+|-||||++++||+||..||... ...- +.. ...
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~------~~~~----------------Il~--~~~ 204 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD------TMKR----------------ILK--AEL 204 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH------HHHH----------------Hhh--hcc
Confidence 27999999999988 4567899999999999999999999760 0010 000 123
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 655 SVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 655 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
..+......+.+++..++..+|..|...
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 3444566677788888899999999865
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.8e-21 Score=163.76 Aligned_cols=165 Identities=27% Similarity=0.462 Sum_probs=106.2
Q ss_pred hhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCC
Q 005278 130 IGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLR 209 (704)
Q Consensus 130 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 209 (704)
+.++++++.|.||+|.++ .+|..+..+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.+|.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 344555666666777666 45556666666777777777766 56666666666677766666666 6666666666666
Q ss_pred EEEecCccCC-CCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCc
Q 005278 210 RLHLGSNKLT-STMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADN 288 (704)
Q Consensus 210 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 288 (704)
.|+|.+|++. ..+|..|..++.|+.|+|++|-+. .+|..++++++|+.|.+..|.+- ..|..++.+..|+.|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 6666666664 245566666666666666666665 56666666666666666666666 56666666666666666666
Q ss_pred eeeccCCccccc
Q 005278 289 QFQGPVPKSFGS 300 (704)
Q Consensus 289 ~l~~~~p~~~~~ 300 (704)
+++ .+|..+++
T Consensus 184 rl~-vlppel~~ 194 (264)
T KOG0617|consen 184 RLT-VLPPELAN 194 (264)
T ss_pred eee-ecChhhhh
Confidence 666 45554443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=158.00 Aligned_cols=137 Identities=18% Similarity=0.218 Sum_probs=104.8
Q ss_pred CCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-----CCCCCceEEeeeeeCC---eEE-
Q 005278 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSI-----RHRNLIKIISNCCNID---FKA- 487 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 487 (704)
+.....||+|+||.||. ..+....+||++........+.+.+|+.+++.+ .||||++++|++.+.. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 333333479988765444557799999999999 5799999999998863 333
Q ss_pred EEEec--cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHH-HHHHhcCCCCcEecCCCCCCeeeCC----CCcEEEeeec
Q 005278 488 LVLEF--MPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL-EYLHHGHSTPMVHCDLKPNNILLDE----NMTAHVSDFG 560 (704)
Q Consensus 488 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~Lh~~h~~~ivH~dlk~~Nil~~~----~~~~kl~Dfg 560 (704)
+|+|| +++|+|.+++.+.. +++. ..++.++..++ +|| |+.+|+||||||+||+++. ++.++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yL---h~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYL---LDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 55899999997642 4444 35577777777 999 4577999999999999974 3479999954
Q ss_pred cc
Q 005278 561 IS 562 (704)
Q Consensus 561 la 562 (704)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.8e-20 Score=159.21 Aligned_cols=162 Identities=35% Similarity=0.568 Sum_probs=151.1
Q ss_pred hcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCcccc
Q 005278 154 VGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVL 233 (704)
Q Consensus 154 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 233 (704)
+.+++++..|.|+.|+++ .+|..++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.+|.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 446788899999999999 78889999999999999999999 88899999999999999999998 8999999999999
Q ss_pred EEEecCcccC-CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEeccc
Q 005278 234 YINLSANSLN-GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312 (704)
Q Consensus 234 ~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N 312 (704)
.|||++|++. ..+|..|..+..|+.|+|++|.+. .+|..++.+++|+.|.+..|.+- .+|..++.+..|++|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 9999999987 578999999999999999999998 89999999999999999999998 89999999999999999999
Q ss_pred CCCCCCCC
Q 005278 313 NLSGEIPK 320 (704)
Q Consensus 313 ~l~~~~p~ 320 (704)
+++-..|+
T Consensus 184 rl~vlppe 191 (264)
T KOG0617|consen 184 RLTVLPPE 191 (264)
T ss_pred eeeecChh
Confidence 99854443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-17 Score=157.67 Aligned_cols=143 Identities=20% Similarity=0.139 Sum_probs=110.4
Q ss_pred CCCCccccccccCceEEEEEE--ECCCCEEEEEEeeccchh------------------------hhHHHHHHHHHHHhc
Q 005278 415 NGFNECNLLGTGSFGSVYKGT--LFDGTNVAIKVFNLQLER------------------------ASRSFDSECEILRSI 468 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 468 (704)
..|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|++.++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357778899999999999998 568999999998743210 112357899999999
Q ss_pred CCCC--CceEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCCCCC
Q 005278 469 RHRN--LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP-MVHCDLKPNN 545 (704)
Q Consensus 469 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~-ivH~dlk~~N 545 (704)
.+.. +.+++++ . ..++||||++++++..+.... ..........++.|++.++++| |+.+ |+|||+||+|
T Consensus 108 ~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~L---H~~g~iiH~Dikp~N 179 (237)
T smart00090 108 YEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKL---YKEGELVHGDLSEYN 179 (237)
T ss_pred HhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHH---HhcCCEEeCCCChhh
Confidence 7533 3444443 2 347999999998887655332 2355566788999999999999 5677 9999999999
Q ss_pred eeeCCCCcEEEeeeccceecC
Q 005278 546 ILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 546 il~~~~~~~kl~Dfgla~~~~ 566 (704)
|+++ ++.++++|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999988643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=154.86 Aligned_cols=134 Identities=21% Similarity=0.328 Sum_probs=112.6
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeeccch--------hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE--------RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
+.||+|++|.||+|.. +|..+++|+...... .....+.+|++.+..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 678899997653221 1234578899999999999988877777777788999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
+++++|.+++.... + .+..++.+++.++.++ |+.+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986542 2 7888999999999999 557899999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-16 Score=151.01 Aligned_cols=142 Identities=19% Similarity=0.170 Sum_probs=110.1
Q ss_pred HHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccch----------------------hhhHHHHHHHHHHHhc
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE----------------------RASRSFDSECEILRSI 468 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l 468 (704)
.....-|...+.||+|+||.||+|...+|+.||||++..... .....+..|...+..+
T Consensus 11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 333344777899999999999999988899999998764320 0112367789999999
Q ss_pred CCC--CCceEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCe
Q 005278 469 RHR--NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNI 546 (704)
Q Consensus 469 ~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Ni 546 (704)
.|+ .+...++. ...++||||+++++|.+.... .....++.+++.++.++| +.+|+||||+|.||
T Consensus 91 ~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Ni 156 (198)
T cd05144 91 YEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNI 156 (198)
T ss_pred HHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccE
Confidence 877 44555442 345899999999999775431 234578889999999995 47899999999999
Q ss_pred eeCCCCcEEEeeeccceecC
Q 005278 547 LLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 547 l~~~~~~~kl~Dfgla~~~~ 566 (704)
++++++.++|+|||.+....
T Consensus 157 ll~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEcCCCcEEEEECCccccCC
Confidence 99999999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-16 Score=173.02 Aligned_cols=137 Identities=20% Similarity=0.283 Sum_probs=110.7
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--------hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--------ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 485 (704)
...|...+.||+|+||+||+|.+.+. .+++|+..... ....+.+.+|+++++.++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556678999999999999986544 34444322111 1123568899999999999999988888777777
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
.++||||+++++|.+++. ....++.+++.++.|| |+.+++|||+||+||++ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999875 3467899999999999 55789999999999999 678999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.5e-16 Score=150.39 Aligned_cols=130 Identities=22% Similarity=0.341 Sum_probs=106.1
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeeccc--------hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 422 LLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--------ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.||+|+||.||+|.+ +|..|++|...... ....+.+.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999984 57889999864321 112356788999999999887665555555666778999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
++++|.+++..... .++.+++.++.++ |+.+++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKL---HKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHH---HHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998764321 7899999999999 568999999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.7e-17 Score=167.82 Aligned_cols=122 Identities=26% Similarity=0.475 Sum_probs=107.0
Q ss_pred eEEEEEeccCCCCHHHHHh--hCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 485 FKALVLEFMPNGSLEKWLY--SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
+.++.|+++.-.+|.+|+. ......++.....++.|++.|++| ++.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 5689999999999999996 334567888899999999999998 67999999999999999999999999999
Q ss_pred eecCCCC----CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh
Q 005278 563 KLLGEGD----DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612 (704)
Q Consensus 563 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t 612 (704)
....... ....++...||..||+||.+.+..|+.|+||||+|++++|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8775443 1224455689999999999999999999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-16 Score=173.41 Aligned_cols=212 Identities=24% Similarity=0.241 Sum_probs=142.1
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..+|+.++.|..|+||.||..++. ..+.+|+|+ .++ ..+.+- ++.....|.+ |
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq-----~lilRn--ilt~a~npfv---------------v--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQ-----NLILRN--ILTFAGNPFV---------------V--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-ccc-----chhhhc--cccccCCcce---------------e---
Confidence 368999999999999999999865 467788843 221 111110 1111222222 2
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC--
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD-- 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~-- 570 (704)
|+....++..+. ++.. .+.+++|| |+.+|+|||+||+|.+|+.-|++|++|||+++.......
T Consensus 136 ---gDc~tllk~~g~-lPvd--------mvla~Eyl---h~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP-LPVD--------MVLAVEYL---HSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccCCC-Ccch--------hhHHhHhh---ccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 455555543322 2222 27789999 779999999999999999999999999999876432110
Q ss_pred ----------cc-eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCc
Q 005278 571 ----------SV-IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL 639 (704)
Q Consensus 571 ----------~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (704)
.. .....+||+.|+|||++....|+..+|-|++|+++||.+.|+.||.+.... .-+.+.+.. .
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-elfg~visd----~- 274 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISD----D- 274 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-HHHhhhhhh----h-
Confidence 00 112347999999999999999999999999999999999999999773221 111111111 0
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMK 683 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 683 (704)
..+. ...+..+.++.+++.+.++.+|..|.-..
T Consensus 275 -------i~wp----E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 275 -------IEWP----EEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred -------cccc----ccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 0000 01112345678899999999999997444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.3e-15 Score=135.00 Aligned_cols=135 Identities=21% Similarity=0.264 Sum_probs=115.4
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCC--CCCceEEeeeeeCCeEEEEEeccCCC
Q 005278 419 ECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRH--RNLIKIISNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 419 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 496 (704)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..++.++| ..+.+++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999999754 7899999865432 4678999999999976 58999999888888899999999988
Q ss_pred CHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 497 SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 497 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
.+..+ +......++.+++++++++|..+..+++|+|++|.||+++..+.+++.|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4566778899999999999877667899999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.9e-17 Score=176.73 Aligned_cols=256 Identities=22% Similarity=0.249 Sum_probs=195.8
Q ss_pred hCCCCccccccccCceEEEEEEECC--CCEEEEEEeeccc--hhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD--GTNVAIKVFNLQL--ERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 488 (704)
...|...+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-+.+. |+|++++++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3467777789999999998876433 4455666554332 223344556777777776 9999999999999999999
Q ss_pred EEeccCCCCHHHHH-hhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeeeccceecC
Q 005278 489 VLEFMPNGSLEKWL-YSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-TAHVSDFGISKLLG 566 (704)
Q Consensus 489 v~e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-~~kl~Dfgla~~~~ 566 (704)
+++|..+|++.+.+ .......+......+..|+..++.|+|. ..+++|+|+||+|.+++..+ ..++.|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999988 5444356777788899999999999941 78899999999999999999 99999999999886
Q ss_pred C-CCCcceeccccc-cccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 567 E-GDDSVIQTMTIA-TIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 567 ~-~~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
. ...........| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++........+..|........
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT----- 251 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-----
Confidence 6 344444445578 999999998877 45677899999999999999999999887666666666654321100
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAA 686 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~ 686 (704)
............++..+++..+|+.|.+.+++.
T Consensus 252 ----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 ----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ----------cCccccCChhhhhcccccccCCchhcccccccc
Confidence 001112234456788889989999999988873
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=137.57 Aligned_cols=137 Identities=22% Similarity=0.237 Sum_probs=97.5
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeeccchh--hhHH----------------------HHHHHHHHHhcCCCC--C
Q 005278 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLER--ASRS----------------------FDSECEILRSIRHRN--L 473 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i 473 (704)
.+.||+|+||+||+|...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999778999999998653211 1111 135666666664433 4
Q ss_pred ceEEeeeeeCCeEEEEEeccCCCCHHHH-HhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 005278 474 IKIISNCCNIDFKALVLEFMPNGSLEKW-LYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM 552 (704)
Q Consensus 474 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~ 552 (704)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. +.+|+|||+||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 445543 235899999998543221 11111 01 5567899999999999953 27899999999999999 89
Q ss_pred cEEEeeeccceecC
Q 005278 553 TAHVSDFGISKLLG 566 (704)
Q Consensus 553 ~~kl~Dfgla~~~~ 566 (704)
.++++|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-13 Score=135.61 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=103.9
Q ss_pred cccc-ccCceEEEEEEECCCCEEEEEEeeccc-------------hhhhHHHHHHHHHHHhcCCCCC--ceEEeeeeeC-
Q 005278 421 NLLG-TGSFGSVYKGTLFDGTNVAIKVFNLQL-------------ERASRSFDSECEILRSIRHRNL--IKIISNCCNI- 483 (704)
Q Consensus 421 ~~ig-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~- 483 (704)
..|| .||.|+||.+... +..++||.+.... ......+.+|++++.+++|+++ ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999864 7789999885321 1123567889999999998875 6777764332
Q ss_pred C---eEEEEEeccCC-CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 484 D---FKALVLEFMPN-GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 484 ~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
. ..++||||+++ .+|.+++.... ++.. .+.+++.++.+| |+.||+||||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARF---HDAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 23599999997 69998886532 3433 356889999999 5689999999999999999999999999
Q ss_pred ccceec
Q 005278 560 GISKLL 565 (704)
Q Consensus 560 gla~~~ 565 (704)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 988753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.6e-16 Score=158.84 Aligned_cols=177 Identities=32% Similarity=0.541 Sum_probs=150.1
Q ss_pred cCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEE
Q 005278 132 NLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRL 211 (704)
Q Consensus 132 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 211 (704)
.+..-...||+.|++. .+|..+..+-.|+.+.|+.|.|. .+|..++.+..|.+|||+.|+++ .+|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3445566888889888 78888888888888999999988 78888999999999999999998 7777777766 8899
Q ss_pred EecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 212 HLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 212 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
.+++|+++ .+|..++.+..|..|+.+.|.+. .+|..++.+.+|+.|.+..|++. .+|..+..++ |..||++.|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee
Confidence 99999988 78888888888999999999988 78888888889999999999998 7777777554 888999999998
Q ss_pred ccCCcccccccccceEEecccCCCCC
Q 005278 292 GPVPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 292 ~~~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
.+|-.|..|..|++|-|.+||+..+
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCCCC
Confidence 8888999999999999999998743
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-15 Score=147.67 Aligned_cols=247 Identities=20% Similarity=0.238 Sum_probs=137.0
Q ss_pred cccCCCCCCEEeccCccccc----cCchhhcCCCCCCEEecccc---cCCCcccchhhcccccCCCCCCCcEEEccCCCC
Q 005278 25 SITNASKLIMLDLSSNSFSG----LIPNTFGNLGSLQVLSLAYN---YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97 (704)
Q Consensus 25 ~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~n---~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i 97 (704)
.+..+.++++|+|++|.+.. .+...+.+.++|+.-++|+= +.......+...+.+.+..+++|++||||.|-+
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 34557778888888888873 34445677778888877763 222222233333445566777888888888888
Q ss_pred cccCChhhhhccc---ccceEEecCCcccccCCh-------------hhhcCCCCCEEEccCCcCccc----cChhhcCC
Q 005278 98 RGILPPLIGNFSA---SLQEFYAYGCKLRGNIPQ-------------EIGNLSGMIVFDLNGCDLNGT----IPTAVGRL 157 (704)
Q Consensus 98 ~~~~~~~~~~~~~---~L~~L~l~~n~l~~~~~~-------------~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l 157 (704)
.-..+..|..+.+ +|++|+|.+|++...--. ..++-+.|+++..++|++... +...|...
T Consensus 105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~ 184 (382)
T KOG1909|consen 105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSH 184 (382)
T ss_pred CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhc
Confidence 7666666655433 466666666666521111 122334555555555555422 22234444
Q ss_pred CCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCC----CCCCcccCCcccc
Q 005278 158 RRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTS----TMPSSFGSLEYVL 233 (704)
Q Consensus 158 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~ 233 (704)
+.|+.+.+++|.|....- ..+...+..+++|+.|+|.+|.++. .+...++.+++|+
T Consensus 185 ~~leevr~~qN~I~~eG~--------------------~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~ 244 (382)
T KOG1909|consen 185 PTLEEVRLSQNGIRPEGV--------------------TALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLR 244 (382)
T ss_pred cccceEEEecccccCchh--------------------HHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchhe
Confidence 555555555555542111 0111233444444444444444442 1223444455555
Q ss_pred EEEecCcccCCCCCcccc-----cCcCCcEEEeecCccCC----CCCCCcCCCCCcceeeccCceee
Q 005278 234 YINLSANSLNGSLPSNIQ-----NLKVLTNLDLSRNQLSG----DIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 234 ~L~l~~N~l~~~~~~~~~-----~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
.|++++|.+......+|. ..|+|+.|.+.+|.++. .+...+...+.|..|+|++|.+.
T Consensus 245 El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 245 ELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred eecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 555555555544333331 35677788888887764 22334556788888888888884
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1e-15 Score=147.92 Aligned_cols=247 Identities=19% Similarity=0.232 Sum_probs=185.3
Q ss_pred hhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCC---CCcccCChhhhhcccccceEEecCCcccc
Q 005278 48 NTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASN---PLRGILPPLIGNFSASLQEFYAYGCKLRG 124 (704)
Q Consensus 48 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n---~i~~~~~~~~~~~~~~L~~L~l~~n~l~~ 124 (704)
..+..+..+++|+||+|.+......+ +...+.+.++|+..++|+- +....+|..+..+.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~---i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~--------------- 85 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARA---IAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLS--------------- 85 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHH---HHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHH---------------
Confidence 34667888999999999887766554 5666778888999888863 44445555555443
Q ss_pred cCChhhhcCCCCCEEEccCCcCccccCh----hhcCCCCcCeeeccCcccCCCC-------------CccccCCCCCCEE
Q 005278 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPT----AVGRLRRLQGLYLHGNKLQGSI-------------PYDLCHLEGLSEL 187 (704)
Q Consensus 125 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~L~~n~l~~~~-------------~~~l~~l~~L~~L 187 (704)
.++..+++|++||||+|.+....+. -+.+..+|++|+|.+|.+...- .+....-+.|+.+
T Consensus 86 ---~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~ 162 (382)
T KOG1909|consen 86 ---KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVF 162 (382)
T ss_pred ---HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEE
Confidence 4667778899999999988744433 3456788999999999886221 1223445789999
Q ss_pred EcCCCcCCccC----CccccCcCCCCEEEecCccCCCC----CCCcccCCccccEEEecCcccCC----CCCcccccCcC
Q 005278 188 NLNGNKLCGHV----PPCLASLTSLRRLHLGSNKLTST----MPSSFGSLEYVLYINLSANSLNG----SLPSNIQNLKV 255 (704)
Q Consensus 188 ~L~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~ 255 (704)
...+|++.... ...|...+.|+.+.+..|.|... +...|..+++|+.|||.+|.++. .+...++.+++
T Consensus 163 i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~ 242 (382)
T KOG1909|consen 163 ICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPH 242 (382)
T ss_pred EeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccch
Confidence 99999998432 34566778999999999998732 23457789999999999999984 34556778899
Q ss_pred CcEEEeecCccCCCCCCCc-----CCCCCcceeeccCceeec----cCCcccccccccceEEecccCCC
Q 005278 256 LTNLDLSRNQLSGDIPTTI-----GGLENLETLSLADNQFQG----PVPKSFGSLISLESLDLSRNNLS 315 (704)
Q Consensus 256 L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 315 (704)
|+.|++++|.+......+| ...++|+.|.|.+|.++. .+-..+...+.|..|+|++|.+.
T Consensus 243 L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 243 LRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred heeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9999999999986555444 347899999999999984 33344567899999999999995
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.2e-13 Score=154.26 Aligned_cols=112 Identities=36% Similarity=0.700 Sum_probs=80.9
Q ss_pred ccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecc
Q 005278 232 VLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSR 311 (704)
Q Consensus 232 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~ 311 (704)
++.|+|++|.+.+.+|..++.+++|+.|+|++|++.|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 66777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred cCCCCCCCCCccc-------ccccCcccccCCCccCCCccc
Q 005278 312 NNLSGEIPKNFSA-------QSFLSNYALCGPARLQVPSCR 345 (704)
Q Consensus 312 N~l~~~~p~~~~~-------~~~l~~~~l~g~~~~~~~~c~ 345 (704)
|+++|.+|..+.. ..+..|..+||.|. .+.|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence 7777777764432 22445666777653 34564
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.1e-13 Score=148.04 Aligned_cols=198 Identities=29% Similarity=0.432 Sum_probs=109.6
Q ss_pred EEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC-CCcEEEccCCCCcccCChhhhhccccc
Q 005278 34 MLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR-NLTVLGLASNPLRGILPPLIGNFSASL 112 (704)
Q Consensus 34 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~~~~~L 112 (704)
.|++..|.+. .....+..++.++.|++.+|.++.++.. ...+. +|++|++++|++... |..+..+ +.|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~--------~~~~~~nL~~L~l~~N~i~~l-~~~~~~l-~~L 165 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPL--------IGLLKSNLKELDLSDNKIESL-PSPLRNL-PNL 165 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccccCccc--------cccchhhcccccccccchhhh-hhhhhcc-ccc
Confidence 5777777774 2334456667788888888888776543 33443 778888888877732 2222222 245
Q ss_pred ceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCC
Q 005278 113 QEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGN 192 (704)
Q Consensus 113 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 192 (704)
+.|++++|++. .++...+.++.|+.|++++|.+. .+|........|++|++++|.+. ..+..+.++.++..|.+.+|
T Consensus 166 ~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n 242 (394)
T COG4886 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242 (394)
T ss_pred cccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCc
Confidence 55555555554 33333335555666666666655 44444444445666666666433 34445555555555555556
Q ss_pred cCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCc
Q 005278 193 KLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPS 248 (704)
Q Consensus 193 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 248 (704)
++. ..+..+..+++++.|++++|.++.... ++.+.+++.|++++|.+....+.
T Consensus 243 ~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 243 KLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred eee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 555 224445555556666666665553222 55555555555555555544333
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.2e-15 Score=153.93 Aligned_cols=200 Identities=29% Similarity=0.409 Sum_probs=110.7
Q ss_pred EEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCC
Q 005278 58 VLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMI 137 (704)
Q Consensus 58 ~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 137 (704)
.|.|++-++...+.++ .-..+.--...||+.|++. ++|..++.+ ..|+
T Consensus 54 ~l~Ls~rrlk~fpr~a------~~~~ltdt~~aDlsrNR~~-elp~~~~~f-------------------------~~Le 101 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGA------ASYDLTDTVFADLSRNRFS-ELPEEACAF-------------------------VSLE 101 (722)
T ss_pred ccccccchhhcCCCcc------ccccccchhhhhccccccc-cCchHHHHH-------------------------HHHH
Confidence 4556666665555443 1133444556677777776 445554444 3444
Q ss_pred EEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCcc
Q 005278 138 VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNK 217 (704)
Q Consensus 138 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 217 (704)
.+.|..|.+. .+|..+.++..|.+|||+.|+++ .+|..++.++ |+.|-+++|+++ .+|..++.++.|..|+.+.|.
T Consensus 102 ~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ne 177 (722)
T KOG0532|consen 102 SLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNE 177 (722)
T ss_pred HHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhh
Confidence 4445555554 45555555555555555555555 4555555544 555555555555 455555555555555555555
Q ss_pred CCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcc
Q 005278 218 LTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKS 297 (704)
Q Consensus 218 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 297 (704)
+. .+|..++.+.+|+.|++..|++. .+|..+..++ |..||+|.|+++ .+|..|..|..|++|-|.+|.+. ..|..
T Consensus 178 i~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAq 252 (722)
T KOG0532|consen 178 IQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQ 252 (722)
T ss_pred hh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHH
Confidence 55 45555555555555555555555 3444444444 666666666666 56666666666666666666665 44444
Q ss_pred c
Q 005278 298 F 298 (704)
Q Consensus 298 ~ 298 (704)
+
T Consensus 253 I 253 (722)
T KOG0532|consen 253 I 253 (722)
T ss_pred H
Confidence 4
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.2e-13 Score=141.84 Aligned_cols=145 Identities=21% Similarity=0.282 Sum_probs=100.7
Q ss_pred CCCccccccccCceEEEEEEECCCCEEEEEEeeccchhh----------------------------------------h
Q 005278 416 GFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERA----------------------------------------S 455 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~ 455 (704)
.|+ .+.||.|++|.||+|++.+|+.||||+.+...... +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 444 36899999999999999999999999986432110 0
Q ss_pred HHHHHHHHHHHhcC----CCCCceEEeeee-eCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHH-HHHHH
Q 005278 456 RSFDSECEILRSIR----HRNLIKIISNCC-NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLA-LEYLH 529 (704)
Q Consensus 456 ~~~~~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~Lh 529 (704)
-.|..|.+.+.+++ |.+-+.+-..+. .....++||||++|+++.++........ .+..++..++.+ +..+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql- 273 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV- 273 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH-
Confidence 02445666565552 333333333332 2345689999999999988765322112 234566665553 4555
Q ss_pred hcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 530 ~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
|..|++|+|++|.||+++.++.++++|||++..+.+
T Consensus 274 --~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 --LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 568899999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.2e-13 Score=129.48 Aligned_cols=202 Identities=20% Similarity=0.258 Sum_probs=139.4
Q ss_pred HHHHhcCCCCCceEEeeeeeCC-----eEEEEEeccCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 005278 463 EILRSIRHRNLIKIISNCCNID-----FKALVLEFMPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGHST 534 (704)
Q Consensus 463 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~ 534 (704)
.-+-++-|.|||++..||.+.. ...+++|||..|++.++|++. ...+......+++-||..||.|||. +++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3444557999999999986643 467899999999999999843 3447777888999999999999998 789
Q ss_pred CcEecCCCCCCeeeCCCCcEEEeeeccceecCC--CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh
Q 005278 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGE--GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612 (704)
Q Consensus 535 ~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t 612 (704)
+|+|+++.-+-|++..++-+|++--.-...... ...........+-++|.|||+-.....+.++|||+||+...||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999999888742211111000 000111223356789999999888888889999999999999988
Q ss_pred CCCC-CCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 613 RKKP-TNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 613 g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+..- ..+ +... ... ..+...+-..-.+ .-..++.+|++..|..||+|++++..
T Consensus 278 lEiq~tns----eS~~--~~e----e~ia~~i~~len~-------------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNS----ESKV--EVE----ENIANVIIGLENG-------------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCC----ccee--ehh----hhhhhheeeccCc-------------cccCcCcccccCCCCCCcchhhhhcC
Confidence 7642 211 0000 000 0011111000000 01236889999999999999998654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.4e-13 Score=144.23 Aligned_cols=194 Identities=33% Similarity=0.517 Sum_probs=95.2
Q ss_pred EEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCC-CCCEEEccCCcCccccChhhcCCCCcCeeeccC
Q 005278 89 VLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLS-GMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHG 167 (704)
Q Consensus 89 ~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 167 (704)
.|+++.|.+..... .+..+ ..++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~~-~~~~~-~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNIS-ELLEL-TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCch-hhhcc-cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 56666666632211 11221 23555555555555 3344444442 5666666666655 3444555566666666666
Q ss_pred cccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCC
Q 005278 168 NKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLP 247 (704)
Q Consensus 168 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 247 (704)
|+++ .+|......++|+.|++++|+++ .+|........|+.|.+++|.+. ..+..+..+.++..+.+.+|++. ..+
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 6665 34444445555666666666665 44443333344555555555322 23444445555555555555544 223
Q ss_pred cccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeec
Q 005278 248 SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292 (704)
Q Consensus 248 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 292 (704)
..+..+++|+.|++++|+++ .++. ++.+.+++.|++++|.+..
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred chhccccccceecccccccc-cccc-ccccCccCEEeccCccccc
Confidence 44444444445555555444 2222 4444444444444444443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.1e-14 Score=138.52 Aligned_cols=212 Identities=23% Similarity=0.228 Sum_probs=105.6
Q ss_pred CCCCCCEEeccCccccccCc-hhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhh
Q 005278 28 NASKLIMLDLSSNSFSGLIP-NTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIG 106 (704)
Q Consensus 28 ~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 106 (704)
+++.|++..|.++.+..... +....+++++.|||++|-+...... ......+++|+.|+|+.|++..-......
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v-----~~i~eqLp~Le~LNls~Nrl~~~~~s~~~ 193 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPV-----LKIAEQLPSLENLNLSSNRLSNFISSNTT 193 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHH-----HHHHHhcccchhcccccccccCCccccch
Confidence 35555555555555553221 2445555555555555555443321 12234455555555555555422211111
Q ss_pred hcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccc-cChhhcCCCCcCeeeccCcccCCCCCccccCCCCCC
Q 005278 107 NFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGT-IPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185 (704)
Q Consensus 107 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 185 (704)
. .+++|+.|.|+.|+++-. +-.....+|+|+.|+|..|...........-++.|+
T Consensus 194 ~------------------------~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~ 249 (505)
T KOG3207|consen 194 L------------------------LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQ 249 (505)
T ss_pred h------------------------hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHh
Confidence 1 344555555555555411 112233455555555555532212222233345566
Q ss_pred EEEcCCCcCCccC-CccccCcCCCCEEEecCccCCCCCCCc------ccCCccccEEEecCcccC-CCCCcccccCcCCc
Q 005278 186 ELNLNGNKLCGHV-PPCLASLTSLRRLHLGSNKLTSTMPSS------FGSLEYVLYINLSANSLN-GSLPSNIQNLKVLT 257 (704)
Q Consensus 186 ~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~------~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~ 257 (704)
+|||++|++.... -...+.++.|+.|+++.|.+..+--.. ...+++|++|+++.|++. ......+..+++|+
T Consensus 250 ~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk 329 (505)
T KOG3207|consen 250 ELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLK 329 (505)
T ss_pred hccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhh
Confidence 6666666554221 123455566666666666655322111 234567777777777764 22334455567778
Q ss_pred EEEeecCccCC
Q 005278 258 NLDLSRNQLSG 268 (704)
Q Consensus 258 ~L~l~~n~l~~ 268 (704)
.|.+..|.+..
T Consensus 330 ~l~~~~n~ln~ 340 (505)
T KOG3207|consen 330 HLRITLNYLNK 340 (505)
T ss_pred hhhcccccccc
Confidence 88888888864
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.6e-14 Score=138.34 Aligned_cols=185 Identities=22% Similarity=0.118 Sum_probs=122.0
Q ss_pred CCCCCCEEecCCCcCcccCC--ccccCCCCCCEEeccCccccc--cCchhhcCCCCCCEEecccccCCCcccchhhcccc
Q 005278 4 MLPNLKYLTLFDNKLSGTIP--NSITNASKLIMLDLSSNSFSG--LIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLS 79 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~--~~~~~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~ 79 (704)
++++|+...|.++.+. ..+ .....+++++.|||+.|-+.. .+......|++|+.|+|+.|++....... .
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~---~-- 192 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSN---T-- 192 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcccc---c--
Confidence 5788999999999988 344 478889999999999999884 34455789999999999999987644322 0
Q ss_pred cCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCcccc-ChhhcCCC
Q 005278 80 SLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTI-PTAVGRLR 158 (704)
Q Consensus 80 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~ 158 (704)
-..+++|+.|.|++|.++-..-..+....++|+.|+|+.|.....-......+..|++|||++|++-... ....+.++
T Consensus 193 -~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~ 271 (505)
T KOG3207|consen 193 -TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLP 271 (505)
T ss_pred -hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccccccccccc
Confidence 1256788888888888874433344444456777777777544444445555666777777777665222 13455666
Q ss_pred CcCeeeccCcccCCC-CCcc-----ccCCCCCCEEEcCCCcCC
Q 005278 159 RLQGLYLHGNKLQGS-IPYD-----LCHLEGLSELNLNGNKLC 195 (704)
Q Consensus 159 ~L~~L~L~~n~l~~~-~~~~-----l~~l~~L~~L~L~~n~l~ 195 (704)
.|..|+++.|.|... .|+. ...+++|++|+++.|++.
T Consensus 272 ~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 272 GLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred chhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 677777776666532 1211 223455555555555553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-11 Score=130.11 Aligned_cols=168 Identities=17% Similarity=0.165 Sum_probs=128.1
Q ss_pred ECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHH
Q 005278 436 LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL 515 (704)
Q Consensus 436 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 515 (704)
..++.+|.|..++...........+-++.++.++||||+++++.+...+..|+|+|.+. .|..++.+.+ .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 45788999998876544445667888999999999999999999999999999999974 6777776543 44556
Q ss_pred HHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCC
Q 005278 516 NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595 (704)
Q Consensus 516 ~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 595 (704)
..+.||+.||.+|| ++.+++|++|.-..|++++.|+.||++|.++........ ......--..|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 67899999999998 457799999999999999999999999998865432111 011111223456666544333
Q ss_pred cccceeeHHHHHHHHhhCCC
Q 005278 596 PKSDVYSYGILLMETFTRKK 615 (704)
Q Consensus 596 ~~~Dv~s~Gv~l~el~tg~~ 615 (704)
-..|.|.||++++|++.|..
T Consensus 182 ~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cchhhhhHHHHHHHHhCccc
Confidence 34699999999999999943
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.4e-12 Score=134.68 Aligned_cols=248 Identities=22% Similarity=0.228 Sum_probs=181.0
Q ss_pred CCCccccccc--cCceEEEEEEE---CCCCEEEEEEeeccch--hhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEE
Q 005278 416 GFNECNLLGT--GSFGSVYKGTL---FDGTNVAIKVFNLQLE--RASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 416 ~~~~~~~ig~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 487 (704)
.|.....+|. |.+|.||.+.. .++..+|+|.-+.... .....=.+|+..-.++ .|++.++....+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556678999 99999999986 3688899997443322 2233334566666666 4999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHH----HHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEeeeccc
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGL----ALEYLHHGHSTPMVHCDLKPNNILLDEN-MTAHVSDFGIS 562 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-~~~kl~Dfgla 562 (704)
+-+|++. .++.++.+.....++....+.+..+..+ |+.++ |...++|-|+||.||+...+ ...+++|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhheecccccceeecCCccee
Confidence 9999885 7999999877777888888989988888 98888 78889999999999999999 88999999999
Q ss_pred eecCCCCCcceec---cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCc
Q 005278 563 KLLGEGDDSVIQT---MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL 639 (704)
Q Consensus 563 ~~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (704)
..++++....... ...|...|++||...+ .++...|+|++|.+..+..++..+...-. ...|..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----~~~W~~------- 337 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK-----NSSWSQ------- 337 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC-----CCCccc-------
Confidence 9987765322111 2257888999998654 56889999999999999999876643210 111211
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.++.+.. ......-..++...+..+++.+|-.|++++.+..
T Consensus 338 ---~r~~~ip----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ---LRQGYIP----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---cccccCc----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000000 0011111234445788999999999998887643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.8e-12 Score=134.26 Aligned_cols=146 Identities=17% Similarity=0.211 Sum_probs=97.1
Q ss_pred hCCCCccccccccCceEEEEEEECC-CCEEEEEEeeccchh----------------------------------hhH--
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLER----------------------------------ASR-- 456 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~-- 456 (704)
-..|+. +.||.|++|.||+|++.+ |+.||||+.+..... ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 346776 799999999999999887 999999998744210 011
Q ss_pred ----HHHHHHHHHHhcC----CCCCceEEeeeee-CCeEEEEEeccCCCCHHHHH--hhCCCccCHHHHHHHHHHHHHHH
Q 005278 457 ----SFDSECEILRSIR----HRNLIKIISNCCN-IDFKALVLEFMPNGSLEKWL--YSHNYFLGILERLNIMIDVGLAL 525 (704)
Q Consensus 457 ----~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~i~~~i~~~l 525 (704)
.+.+|+..+.+++ +.+.+.+-.++.+ ....++||||++|+++.++- ...+ .+. ..++...+..
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~---~~la~~~v~~- 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDM---KLLAERGVEV- 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCH---HHHHHHHHHH-
Confidence 1344555555542 4444444444433 34568999999999998753 2222 221 1222222222
Q ss_pred HHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeeeccceecCC
Q 005278 526 EYLHHGHSTPMVHCDLKPNNILLDENM----TAHVSDFGISKLLGE 567 (704)
Q Consensus 526 ~~Lh~~h~~~ivH~dlk~~Nil~~~~~----~~kl~Dfgla~~~~~ 567 (704)
|+++-...|++|+|++|.||+++.++ .+++.|||++..+.+
T Consensus 272 -~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 -FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 22222457899999999999999888 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.1e-11 Score=113.85 Aligned_cols=131 Identities=18% Similarity=0.163 Sum_probs=95.9
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCc-eEEeeeeeCCeEEEEEeccCCCCH
Q 005278 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLI-KIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
.+.++.|.++.||+++.. +..+++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 457899999999999864 77899998754321 223567899999998665544 444443 2335799999999887
Q ss_pred HHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 499 EKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH--STPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h--~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
.+. . .....++.+++++++.||... ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~-~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE-D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 643 0 112345678999999996532 23469999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.4e-12 Score=114.39 Aligned_cols=139 Identities=25% Similarity=0.305 Sum_probs=42.2
Q ss_pred cCCCcCcccCCccccCCCCCCEEeccCccccccCchhhc-CCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEE
Q 005278 13 LFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFG-NLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLG 91 (704)
Q Consensus 13 l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~ 91 (704)
|..+.|. .++. +.+...+++|+|++|.|+.+ +.+. .+.+|++|+|++|.|+.++. +..++.|++|+
T Consensus 4 lt~~~i~-~~~~-~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~~---------l~~L~~L~~L~ 70 (175)
T PF14580_consen 4 LTANMIE-QIAQ-YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLEG---------LPGLPRLKTLD 70 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S--TT-------------TT--EEE
T ss_pred ccccccc-cccc-cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccccC---------ccChhhhhhcc
Confidence 3444455 3333 45556788899999999865 2354 57888999999998887652 77788888888
Q ss_pred ccCCCCcccCChhhhhcccccceEEecCCccccc-CChhhhcCCCCCEEEccCCcCcccc---ChhhcCCCCcCeeec
Q 005278 92 LASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN-IPQEIGNLSGMIVFDLNGCDLNGTI---PTAVGRLRRLQGLYL 165 (704)
Q Consensus 92 L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~---~~~~~~l~~L~~L~L 165 (704)
+++|.|+.. ++.+....++|++|++++|+|... .-..++.+++|+.|+|.+|.+.... ...+..+|+|+.||-
T Consensus 71 L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 71 LSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred cCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 888888844 333433234677777777777642 2244566677777777777665321 113445666666653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.7e-13 Score=124.39 Aligned_cols=131 Identities=32% Similarity=0.361 Sum_probs=84.1
Q ss_pred CCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEE
Q 005278 156 RLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYI 235 (704)
Q Consensus 156 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 235 (704)
....|++|||++|.|+ .+.++..-++.++.|+++.|.|. .+. .+..+++|+.|||++|.++ ....+-..+.+++.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3445666666666666 55555655666666666666666 222 2666666777777777665 333444456666777
Q ss_pred EecCcccCCCCCcccccCcCCcEEEeecCccCCC-CCCCcCCCCCcceeeccCceeec
Q 005278 236 NLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGD-IPTTIGGLENLETLSLADNQFQG 292 (704)
Q Consensus 236 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~ 292 (704)
.|+.|.|.+ ...+.++-+|..||+++|+|... -...++++|.|+.|.|.+|.+.+
T Consensus 358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 777776652 23455566677788888887642 23467888888888888888874
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8.7e-13 Score=141.16 Aligned_cols=248 Identities=26% Similarity=0.269 Sum_probs=113.8
Q ss_pred CCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhh
Q 005278 28 NASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGN 107 (704)
Q Consensus 28 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 107 (704)
.+..+..+.+..|.|.. .-..+..+++|+.|++.+|+|..+... +..+++|++|+|++|.|+...+ +..
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~--------l~~~~~L~~L~ls~N~I~~i~~--l~~ 138 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENL--------LSSLVNLQVLDLSFNKITKLEG--LST 138 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccc--------hhhhhcchheeccccccccccc--hhh
Confidence 44555555566666653 223355566666666666666554321 3455666666666666653321 111
Q ss_pred cccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccC-hhhcCCCCcCeeeccCcccCCCCCccccCCCCCCE
Q 005278 108 FSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIP-TAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSE 186 (704)
Q Consensus 108 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 186 (704)
+. .|+.|++.+|.|... ..+..+..|+.+++++|.+....+ . ...+.+++.+++.+|.+.. ...+..+..+..
T Consensus 139 l~-~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~ 212 (414)
T KOG0531|consen 139 LT-LLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVL 212 (414)
T ss_pred cc-chhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHH
Confidence 11 122333333332211 112224455555555555542222 1 3444455555555555441 122333333334
Q ss_pred EEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCcc
Q 005278 187 LNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQL 266 (704)
Q Consensus 187 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l 266 (704)
+++..|.++...+ +..+.. ..|+.+++++|.+. ..+..+..+..+..|++++|++
T Consensus 213 ~~l~~n~i~~~~~--l~~~~~----------------------~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~ 267 (414)
T KOG0531|consen 213 LSLLDNKISKLEG--LNELVM----------------------LHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRI 267 (414)
T ss_pred hhcccccceeccC--cccchh----------------------HHHHHHhcccCccc-cccccccccccccccchhhccc
Confidence 4444444442111 111111 02445555555544 2223444455566666666666
Q ss_pred CCCCCCCcCCCCCcceeeccCceeec---cCCcc-cccccccceEEecccCCCCCCC
Q 005278 267 SGDIPTTIGGLENLETLSLADNQFQG---PVPKS-FGSLISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 267 ~~~~~~~~~~l~~L~~L~L~~n~l~~---~~p~~-~~~l~~L~~L~l~~N~l~~~~p 319 (704)
... ..+.....+..+.+..|.+.. ..... ....+.++.+.+.+|++....+
T Consensus 268 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 268 SNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 522 123444555566666666542 11111 4566777777777777765544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.4e-12 Score=123.42 Aligned_cols=133 Identities=27% Similarity=0.402 Sum_probs=108.0
Q ss_pred CCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEE
Q 005278 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLD 260 (704)
Q Consensus 181 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 260 (704)
.+.|++|||++|.|+ .+.++..-.|.++.|++++|.|..+ +.+..+++|+.||||+|.++ .+..+--++-+.+.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 356899999999998 6666777789999999999999843 34888999999999999988 4555556778899999
Q ss_pred eecCccCCCCCCCcCCCCCcceeeccCceeecc-CCcccccccccceEEecccCCCCCCC
Q 005278 261 LSRNQLSGDIPTTIGGLENLETLSLADNQFQGP-VPKSFGSLISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 261 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p 319 (704)
|++|.|.. -..++.+.+|..||+++|+|... --..++++|-|+.+.|.+||+.+...
T Consensus 359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99999862 23477888999999999999742 23568899999999999999986543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=4e-10 Score=105.18 Aligned_cols=137 Identities=21% Similarity=0.175 Sum_probs=97.6
Q ss_pred ccccccCceEEEEEEECC-------CCEEEEEEeeccc----------------------hhhhHH----HHHHHHHHHh
Q 005278 421 NLLGTGSFGSVYKGTLFD-------GTNVAIKVFNLQL----------------------ERASRS----FDSECEILRS 467 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~----~~~e~~~l~~ 467 (704)
..||.|.-+.||.|.-.+ +..+|||+++... ....+. .++|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999997443 4799999875321 001112 3489999999
Q ss_pred cCC--CCCceEEeeeeeCCeEEEEEeccCCCCHHH-HHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 005278 468 IRH--RNLIKIISNCCNIDFKALVLEFMPNGSLEK-WLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPN 544 (704)
Q Consensus 468 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~ 544 (704)
+.. -++.+.+++ ...++||||+.++.+.. .+.. ..++......+..+++.++..++ |+.++||||+++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLY--KECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCCCHH
Confidence 953 456666664 34579999997654422 1221 12444556677889999999885 4568999999999
Q ss_pred CeeeCCCCcEEEeeeccceecC
Q 005278 545 NILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 545 Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
||+++ ++.++++|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4679999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-10 Score=101.70 Aligned_cols=131 Identities=23% Similarity=0.317 Sum_probs=101.0
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeeccc--------hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--------ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..+++|+-+.+|.+.+. |..+++|.=..+. .-..+...+|++++.+++--.|...+-+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999765 4446666432211 11234567899999999766666666666778888899999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
++|..|.+.+... ...++..+..-+.-| |..+|||+|+.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888765 255677777777888 668999999999999998766 99999999985
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-11 Score=112.19 Aligned_cols=121 Identities=31% Similarity=0.381 Sum_probs=34.1
Q ss_pred CCCEEEcCCCcCCccCCcccc-CcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCccc-ccCcCCcEEE
Q 005278 183 GLSELNLNGNKLCGHVPPCLA-SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLD 260 (704)
Q Consensus 183 ~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~ 260 (704)
++++|+|.+|+|+. +. .++ .+.+|+.|++++|.|+.. +.+..+++|+.|++++|.|+. +...+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 44555555555552 21 232 344555555555555522 234455555555555555552 22222 2455666666
Q ss_pred eecCccCCCC-CCCcCCCCCcceeeccCceeeccCC----cccccccccceEEe
Q 005278 261 LSRNQLSGDI-PTTIGGLENLETLSLADNQFQGPVP----KSFGSLISLESLDL 309 (704)
Q Consensus 261 l~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~l 309 (704)
+++|+|.... -..++.+++|+.|+|.+|+++.. + ..+..+|+|+.||-
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 6666665311 13455566666666666666532 2 12456677776543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.4e-11 Score=132.50 Aligned_cols=114 Identities=32% Similarity=0.531 Sum_probs=106.1
Q ss_pred CCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeecc
Q 005278 207 SLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLA 286 (704)
Q Consensus 207 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 286 (704)
.++.|+|++|.+.+.+|..+..+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeeccCCcccccc-cccceEEecccCCCCCCCC
Q 005278 287 DNQFQGPVPKSFGSL-ISLESLDLSRNNLSGEIPK 320 (704)
Q Consensus 287 ~n~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~ 320 (704)
+|+++|.+|..+..+ .++..+++.+|+..+..|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 999999999998764 5678999999997766554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3e-12 Score=137.02 Aligned_cols=243 Identities=26% Similarity=0.282 Sum_probs=175.9
Q ss_pred CCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhc
Q 005278 29 ASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNF 108 (704)
Q Consensus 29 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~ 108 (704)
-+.++.++...+.+...... ...+..++.+++..|.|..+.. .+..+++|+.|++..|+|.....
T Consensus 48 ~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~~~~--------~l~~~~~l~~l~l~~n~i~~i~~------ 112 (414)
T KOG0531|consen 48 PSDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAKILN--------HLSKLKSLEALDLYDNKIEKIEN------ 112 (414)
T ss_pred cchhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhhhhc--------ccccccceeeeeccccchhhccc------
Confidence 34566667766666643322 2567778888899999987322 27788999999999999984321
Q ss_pred ccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEE
Q 005278 109 SASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELN 188 (704)
Q Consensus 109 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 188 (704)
.+..+++|++|++++|.|+.+. .+..++.|+.|++++|.|+.. ..+..+++|+.++
T Consensus 113 --------------------~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~ 168 (414)
T KOG0531|consen 113 --------------------LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLD 168 (414)
T ss_pred --------------------chhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhccc
Confidence 1567788888888888888443 356667788899999998732 3566688899999
Q ss_pred cCCCcCCccCC-ccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccC
Q 005278 189 LNGNKLCGHVP-PCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLS 267 (704)
Q Consensus 189 L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 267 (704)
+++|+++..-+ . ...+.+|+.+++.+|.+. ....+..+..+..+++..|.+...-+........|+.+++++|++.
T Consensus 169 l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 169 LSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS 245 (414)
T ss_pred CCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccc
Confidence 99999884433 2 577888999999999887 3344555566666788888887432221111113899999999998
Q ss_pred CCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCC
Q 005278 268 GDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 268 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 316 (704)
..+..+..+.++..|++.+|++... ..+...+.+..++.+.|++..
T Consensus 246 -~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~ 291 (414)
T KOG0531|consen 246 -RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLAL 291 (414)
T ss_pred -cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcc
Confidence 5556788899999999999998742 345677788888999998874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-09 Score=97.30 Aligned_cols=142 Identities=20% Similarity=0.247 Sum_probs=105.2
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEe-eccc-------hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 419 ECNLLGTGSFGSVYKGTLFDGTNVAIKVF-NLQL-------ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 419 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
....+-||+-+.|+++.+. |+...||.- .+.. .-..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999864 777777742 2211 123456788999999987656655555666666678999
Q ss_pred eccCC-CCHHHHHhhCCCccC-HHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEEEeeecccee
Q 005278 491 EFMPN-GSLEKWLYSHNYFLG-ILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM---TAHVSDFGISKL 564 (704)
Q Consensus 491 e~~~~-gsL~~~l~~~~~~~~-~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~---~~kl~Dfgla~~ 564 (704)
||+++ .++.+++......-. .......+..|.+.+.-| |..+|+|+|+.++||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 478888875432222 233367899999999999 567799999999999997554 468999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.8e-11 Score=122.79 Aligned_cols=249 Identities=19% Similarity=0.139 Sum_probs=173.0
Q ss_pred HHHhCCCCccccccccCceEEEEEEEC--CCCEEEEEEeeccchhhhHH--HHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLF--DGTNVAIKVFNLQLERASRS--FDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
.....+|..+..||.|.|+.|++...+ ++..+++|...........+ -..|+.+...+ .|.++++....|..-+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344568889999999999999998643 57888988775443222221 23456565555 58999998888888888
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEeeecccee
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-MTAHVSDFGISKL 564 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-~~~kl~Dfgla~~ 564 (704)
.++--||+++++...... -..-++...++++..+++.++.++ |++.++|+|++|+||++..+ +..+++|||.+..
T Consensus 341 ~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccc---cchhhhcccccccceeeccchhhhhccccccccc
Confidence 889999999998877662 223356677888999999999999 68999999999999999886 8889999999874
Q ss_pred cCCCCCcceecccccccccc--CCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 565 LGEGDDSVIQTMTIATIGYM--APEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
+.-. .....+.-+++ +|+......+..+.|++|||..+.|..++..--.. ..+|.. +
T Consensus 417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~~~~~---------i 475 (524)
T KOG0601|consen 417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GVQSLT---------I 475 (524)
T ss_pred ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcc-------ccccee---------e
Confidence 3211 11112333344 56666677888999999999999999998643211 011100 0
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
. ....+........+..+...+...++..||.+.+.....+-
T Consensus 476 ~-------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 476 R-------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred e-------cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0 00011111222445667778888999999999887665443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.1e-11 Score=134.30 Aligned_cols=287 Identities=23% Similarity=0.239 Sum_probs=153.4
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCcc--ccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNS--FSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~--i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
...+...+-+|.+. .++.+.. .+.|++|-+.+|. +..+....|..|+.|++|||++|.--. .+|+.++.
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~-------~LP~~I~~ 593 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLS-------KLPSSIGE 593 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccC-------cCChHHhh
Confidence 34455566666655 3344322 3367777777775 555555567777777777777653211 24555677
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcC--ccccChhhcCCCCcC
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDL--NGTIPTAVGRLRRLQ 161 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l--~~~~~~~~~~l~~L~ 161 (704)
+-+|++|+|+++.+. .+|..+.++. .|.+|++..+.....+|.....+++|++|.+..-.. ....-..+..+.+|+
T Consensus 594 Li~LryL~L~~t~I~-~LP~~l~~Lk-~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~ 671 (889)
T KOG4658|consen 594 LVHLRYLDLSDTGIS-HLPSGLGNLK-KLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLE 671 (889)
T ss_pred hhhhhcccccCCCcc-ccchHHHHHH-hhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchh
Confidence 777777777777776 6677777764 577777777666655666666677777777765442 222233344455555
Q ss_pred eeeccCcccCCCCCccccCCCCCC----EEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccC------Ccc
Q 005278 162 GLYLHGNKLQGSIPYDLCHLEGLS----ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGS------LEY 231 (704)
Q Consensus 162 ~L~L~~n~l~~~~~~~l~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------l~~ 231 (704)
.+....... .+-..+..++.|. .+.+.++... ..+..+..+.+|+.|.+.++.+.......+.. +++
T Consensus 672 ~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~ 748 (889)
T KOG4658|consen 672 NLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPN 748 (889)
T ss_pred hheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHH
Confidence 555433332 1112222333332 3333333333 34455667777777777777765332222211 222
Q ss_pred ccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeecc-CCcccccccccceE
Q 005278 232 VLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGP-VPKSFGSLISLESL 307 (704)
Q Consensus 232 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L 307 (704)
+..+...++... ..+.+.--.++|+.|++..+.....+......+..++.+-+..+.+.+. .-...+.++++..+
T Consensus 749 l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~ 824 (889)
T KOG4658|consen 749 LSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWL 824 (889)
T ss_pred HHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEec
Confidence 222222222221 2222333446777777777776666655566666666655666655543 23333444444433
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-09 Score=107.00 Aligned_cols=143 Identities=20% Similarity=0.206 Sum_probs=109.4
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCC--CCceEEeeeeeCC---eEEEEEecc
Q 005278 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHR--NLIKIISNCCNID---FKALVLEFM 493 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~ 493 (704)
.+.++.|..+.||+++..+|+.+++|....... .....+..|.++++.+++. ++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 357899999999999877778999999754322 1345789999999999763 4577777776543 568999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG------------------------------------------ 531 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------------------------------------------ 531 (704)
++.++.+.+.. ..++......++.++++++..||..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888775432 2356667777888888888888742
Q ss_pred -----------CCCCcEecCCCCCCeeeCC--CCcEEEeeecccee
Q 005278 532 -----------HSTPMVHCDLKPNNILLDE--NMTAHVSDFGISKL 564 (704)
Q Consensus 532 -----------h~~~ivH~dlk~~Nil~~~--~~~~kl~Dfgla~~ 564 (704)
....++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245799999999999998 56789999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.9e-09 Score=104.08 Aligned_cols=265 Identities=12% Similarity=0.095 Sum_probs=167.0
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeee-------eeCCeEEEEE
Q 005278 419 ECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNC-------CNIDFKALVL 490 (704)
Q Consensus 419 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~-------~~~~~~~lv~ 490 (704)
....+|+|+.+.+|-.- +-...+.|++.....-.. .+.+..|... .||-+-.-+.|= ..+....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45679999999998642 223345687765432211 1223344444 455433212111 1122356777
Q ss_pred eccCCC-CHHHHHh-----hCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 491 EFMPNG-SLEKWLY-----SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 491 e~~~~g-sL~~~l~-----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..+++- .+..+.. .+-....|....++++.+|.+.+.|| ..|.+-+|+.++|+|+.+++.+.+.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 776654 2223222 12234789999999999999999995 56788899999999999999999998654443
Q ss_pred cCCCCCcceeccccccccccCCccc-----CCCCCCcccceeeHHHHHHHHhhC-CCCCCcccccc---ccHH-HHHHhh
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYG-----SEGIISPKSDVYSYGILLMETFTR-KKPTNEIFIGE---MSLK-HWVKES 634 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~Gv~l~el~tg-~~p~~~~~~~~---~~~~-~~~~~~ 634 (704)
. .........+|...|.+||.- .+...+...|.|.+||++++++.| ++||.+..... ..+. ......
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 3 233445667899999999963 344567789999999999999986 99998853221 1111 111100
Q ss_pred cCCCcchhcc--ccchhhhhhhhhhHHHHHHHHHHHhhhcCCC--CCCCCCHHHHHHHHHHhHHHhhhh
Q 005278 635 LPDGLTEVVD--ANLVREEQAFSVKIDCLLSIMHLALDCCMES--PEQRVSMKDAAAKLKKIKEKFLDD 699 (704)
Q Consensus 635 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~--P~~Rpt~~ev~~~L~~~~~~~~~~ 699 (704)
+ ...-+ +.+.. .+......-.++++.-+..+|+... |.-||+++-++..|.++.++...=
T Consensus 244 f----~ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 244 F----AYASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred e----eechhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 0 00001 01111 1112233345667788888998764 678999999999999998877653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.6e-10 Score=84.28 Aligned_cols=61 Identities=43% Similarity=0.646 Sum_probs=38.4
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYL 66 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i 66 (704)
|+|++|+|++|+++.+-++.|.++++|++|++++|.++.+.+++|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4566666666666655445666666666666666666666666666666666666666653
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.4e-10 Score=127.84 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=165.1
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeecc---chhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQ---LERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
...+++.+.+.+.+|.++.++.++-. .|...+.|+.... ...+.+....+-.+.-..++|-+++..--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 35567788888999999999887632 2433333332211 1112222222223333334566665555545566778
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
++++|..++++...++..+. .+..........+.++.+|| |...+.|+|++|.|.+...+++.+++|||.....+.
T Consensus 881 L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L---~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESL---HSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhcc---ccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999999886553 33334444556678889999 667799999999999999999999999985433211
Q ss_pred C---------------------C--------CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCC
Q 005278 568 G---------------------D--------DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTN 618 (704)
Q Consensus 568 ~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~ 618 (704)
. . .........||+.|.+||...+......+|.|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 0011223468999999999999999999999999999999999999997
Q ss_pred ccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005278 619 EIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMK 683 (704)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 683 (704)
....... +..+......+. ..+...+....+++...+..+|.+|-.|.
T Consensus 1037 a~tpq~~-------------f~ni~~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI-------------FENILNRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhh-------------hhccccCCCCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 7432211 111222111111 11223344566788888889999998765
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.5e-10 Score=82.83 Aligned_cols=61 Identities=38% Similarity=0.543 Sum_probs=56.2
Q ss_pred CCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCC
Q 005278 30 SKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97 (704)
Q Consensus 30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i 97 (704)
++|++|++++|+++.+.+++|.++++|++|++++|.++.++..+ |.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~-------f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDA-------FSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTT-------TTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHH-------HcCCCCCCEEeCcCCcC
Confidence 57899999999999998899999999999999999999887665 99999999999999985
|
... |
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.3e-10 Score=108.75 Aligned_cols=258 Identities=19% Similarity=0.249 Sum_probs=121.3
Q ss_pred cCCCCCCEEeccCcccccc----CchhhcCCCCCCEEecccccCCCccc---chhhcccccCCCCCCCcEEEccCCCCcc
Q 005278 27 TNASKLIMLDLSSNSFSGL----IPNTFGNLGSLQVLSLAYNYLMTESS---AAKWNFLSSLTNCRNLTVLGLASNPLRG 99 (704)
Q Consensus 27 ~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~---~~~~~~~~~~~~l~~L~~L~L~~n~i~~ 99 (704)
.-+..+++++|++|.|... ++..+.+-.+|+..+++.-.....-. ....-+...+.+|+.|+.++||.|.+..
T Consensus 27 ~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~ 106 (388)
T COG5238 27 EMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGS 106 (388)
T ss_pred HhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCc
Confidence 3366777777777777643 33345555666666665532221110 0011123335566677777777776665
Q ss_pred cCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCcccc
Q 005278 100 ILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179 (704)
Q Consensus 100 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 179 (704)
..|+.+..+ +++-+.|++|.|++|++..+-.+-++. .|. +|..|+ ..+
T Consensus 107 ~~~e~L~d~---------------------is~~t~l~HL~l~NnGlGp~aG~rigk--al~--~la~nK-------Kaa 154 (388)
T COG5238 107 EFPEELGDL---------------------ISSSTDLVHLKLNNNGLGPIAGGRIGK--ALF--HLAYNK-------KAA 154 (388)
T ss_pred ccchHHHHH---------------------HhcCCCceeEEeecCCCCccchhHHHH--HHH--HHHHHh-------hhc
Confidence 555544432 334445555555555544222222220 000 011111 111
Q ss_pred CCCCCCEEEcCCCcCCccCC----ccccCcCCCCEEEecCccCCCCCC-----CcccCCccccEEEecCcccCCC----C
Q 005278 180 HLEGLSELNLNGNKLCGHVP----PCLASLTSLRRLHLGSNKLTSTMP-----SSFGSLEYVLYINLSANSLNGS----L 246 (704)
Q Consensus 180 ~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~-----~~~~~l~~L~~L~l~~N~l~~~----~ 246 (704)
+-|.|+...+.+|++..... ..+..-.+|+.+.+..|.|....- ..+..+.+|+.|||.+|.++.. +
T Consensus 155 ~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~L 234 (388)
T COG5238 155 DKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYL 234 (388)
T ss_pred cCCCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHH
Confidence 22345555555555441110 111122345555555555432110 1122344555555555555421 2
Q ss_pred CcccccCcCCcEEEeecCccCCCCCCCc------CCCCCcceeeccCceeeccCCcc-----c--ccccccceEEecccC
Q 005278 247 PSNIQNLKVLTNLDLSRNQLSGDIPTTI------GGLENLETLSLADNQFQGPVPKS-----F--GSLISLESLDLSRNN 313 (704)
Q Consensus 247 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~------~~l~~L~~L~L~~n~l~~~~p~~-----~--~~l~~L~~L~l~~N~ 313 (704)
...++.++.|+.|.+..|-++......+ ...++|..|...+|...+.+... + .++|-|..|.+.+|+
T Consensus 235 a~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr 314 (388)
T COG5238 235 ADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNR 314 (388)
T ss_pred HHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCc
Confidence 2344455556666666666654333221 13466677777777655422211 1 367778888888888
Q ss_pred CCC
Q 005278 314 LSG 316 (704)
Q Consensus 314 l~~ 316 (704)
|..
T Consensus 315 ~~E 317 (388)
T COG5238 315 IKE 317 (388)
T ss_pred chh
Confidence 864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.5e-08 Score=94.40 Aligned_cols=127 Identities=21% Similarity=0.245 Sum_probs=82.5
Q ss_pred EEEEEEECCCCEEEEEEeeccc--------------------------hhhhHHHHHHHHHHHhcCCC--CCceEEeeee
Q 005278 430 SVYKGTLFDGTNVAIKVFNLQL--------------------------ERASRSFDSECEILRSIRHR--NLIKIISNCC 481 (704)
Q Consensus 430 ~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 481 (704)
.||.|...+|..+|||+.+... .......++|.+.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999875320 00123467899999999766 456666542
Q ss_pred eCCeEEEEEeccC--CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 482 NIDFKALVLEFMP--NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 482 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
...+||||++ +..+....... ++......++.++...+..++ |..||+|||+.+.||+++++ .+.++||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecc-eEEEEec
Confidence 2369999998 55554433322 112334556777777555543 56899999999999999988 9999999
Q ss_pred ccceecC
Q 005278 560 GISKLLG 566 (704)
Q Consensus 560 gla~~~~ 566 (704)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.2e-09 Score=122.72 Aligned_cols=277 Identities=22% Similarity=0.240 Sum_probs=186.9
Q ss_pred ccCCCCCCEEeccCccccccCchhhcCCCCCCEEeccccc--CCCcccchhhcccccCCCCCCCcEEEccCCCCcccCCh
Q 005278 26 ITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY--LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPP 103 (704)
Q Consensus 26 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~--i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 103 (704)
..+....+...+-+|.+..+ +.... .++|++|-+..|. +..++..- |..++.|+.|||++|.=.+.+|.
T Consensus 519 ~~~~~~~rr~s~~~~~~~~~-~~~~~-~~~L~tLll~~n~~~l~~is~~f-------f~~m~~LrVLDLs~~~~l~~LP~ 589 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIEHI-AGSSE-NPKLRTLLLQRNSDWLLEISGEF-------FRSLPLLRVLDLSGNSSLSKLPS 589 (889)
T ss_pred ccchhheeEEEEeccchhhc-cCCCC-CCccceEEEeecchhhhhcCHHH-------HhhCcceEEEECCCCCccCcCCh
Confidence 34557889999999999844 33333 4479999999996 55554433 88899999999999988889999
Q ss_pred hhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccC--CCCCccccCC
Q 005278 104 LIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQ--GSIPYDLCHL 181 (704)
Q Consensus 104 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~l~~l 181 (704)
.++.+. +|+.|+++++.+. .+|..+++|..|.+|++..+.-...+++....+++|++|.+..-... ...-..+..+
T Consensus 590 ~I~~Li-~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~L 667 (889)
T KOG4658|consen 590 SIGELV-HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENL 667 (889)
T ss_pred HHhhhh-hhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcc
Confidence 999986 7999999999999 89999999999999999999876677888888999999999876532 2223344555
Q ss_pred CCCCEEEcCCCcCCccCCccccCcCCCC----EEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCccccc-----
Q 005278 182 EGLSELNLNGNKLCGHVPPCLASLTSLR----RLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQN----- 252 (704)
Q Consensus 182 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~----- 252 (704)
.+|+.+....... .+...+..++.|. .+.+.++... ..+..+..+.+|+.|.+.++.+..........
T Consensus 668 e~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~ 744 (889)
T KOG4658|consen 668 EHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLL 744 (889)
T ss_pred cchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhh
Confidence 6666666544332 1111223333333 4444443333 45667788899999999999886433322211
Q ss_pred -CcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCC
Q 005278 253 -LKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 253 -l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
++++..+...++... ..+...-..++|+.|.+.++.....+......+..+..+-+..+.+.+.
T Consensus 745 ~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 745 CFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred hHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 223333333333222 2222233457788888888877666666666666666655555555543
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=8.7e-11 Score=109.90 Aligned_cols=180 Identities=19% Similarity=0.151 Sum_probs=112.7
Q ss_pred hhhcCCCCCEEEccCCcCccccCh----hhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccC
Q 005278 129 EIGNLSGMIVFDLNGCDLNGTIPT----AVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLAS 204 (704)
Q Consensus 129 ~~~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~ 204 (704)
++-.|++|+..+||+|.+....|. .+++-+.|+.|.|++|.+...--..+++ .|.+ |..| .-..+
T Consensus 87 aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigk--al~~--la~n-------KKaa~ 155 (388)
T COG5238 87 ALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGK--ALFH--LAYN-------KKAAD 155 (388)
T ss_pred HHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHH--HHHH--HHHH-------hhhcc
Confidence 455666666666666666544333 2334455666666666554111111110 0110 0111 12345
Q ss_pred cCCCCEEEecCccCCCCCC----CcccCCccccEEEecCcccCCCCC-----cccccCcCCcEEEeecCccCCC----CC
Q 005278 205 LTSLRRLHLGSNKLTSTMP----SSFGSLEYVLYINLSANSLNGSLP-----SNIQNLKVLTNLDLSRNQLSGD----IP 271 (704)
Q Consensus 205 l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~~~-----~~~~~l~~L~~L~l~~n~l~~~----~~ 271 (704)
-|.|+.+....|++..-.. ..|..-.+|+.+.+..|.|.-... ..+..+.+|+.|||..|-++-. +.
T Consensus 156 kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La 235 (388)
T COG5238 156 KPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLA 235 (388)
T ss_pred CCCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHH
Confidence 6899999999999973221 123333689999999999873321 2334678999999999999743 33
Q ss_pred CCcCCCCCcceeeccCceeeccCCccc------ccccccceEEecccCCCCCCC
Q 005278 272 TTIGGLENLETLSLADNQFQGPVPKSF------GSLISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 272 ~~~~~l~~L~~L~L~~n~l~~~~p~~~------~~l~~L~~L~l~~N~l~~~~p 319 (704)
..+..++.|+.|.+.+|-++.....++ ...|+|..|...+|...+.+-
T Consensus 236 ~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i 289 (388)
T COG5238 236 DALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGII 289 (388)
T ss_pred HHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCcee
Confidence 456778899999999999986555443 246888999999998876543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.7e-08 Score=98.20 Aligned_cols=166 Identities=20% Similarity=0.237 Sum_probs=126.1
Q ss_pred ceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee----CCeEEEEEeccCC-CCHHHH
Q 005278 428 FGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN----IDFKALVLEFMPN-GSLEKW 501 (704)
Q Consensus 428 ~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 501 (704)
..+.||+.. .||..+++|+++.........-..-+++++++.|+|+|++.+++.. ....++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899974 4899999999965443333333456889999999999999998863 4467899999885 467665
Q ss_pred Hhh--------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 502 LYS--------------HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 502 l~~--------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
-.. .+...++...|.++.|+..||.++ |+.|..-+-+.+++|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI---HssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI---HSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH---HhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 431 234468889999999999999999 567888899999999999999999999888776543
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCC
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKK 615 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~ 615 (704)
... |.+.+ -.+-|.=.||.+++.+.||..
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 220 11111 236788899999999999864
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4e-11 Score=126.33 Aligned_cols=127 Identities=28% Similarity=0.264 Sum_probs=72.7
Q ss_pred CCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEee
Q 005278 183 GLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLS 262 (704)
Q Consensus 183 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 262 (704)
.|...+.+.|.+. ....++.-++.|+.|+|++|+++.+. .+..+++|++|||++|.+....--....+. |+.|.++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 3555555666655 44444555566666666666665332 555666666666666666532222222333 6677777
Q ss_pred cCccCCCCCCCcCCCCCcceeeccCceeecc-CCcccccccccceEEecccCCC
Q 005278 263 RNQLSGDIPTTIGGLENLETLSLADNQFQGP-VPKSFGSLISLESLDLSRNNLS 315 (704)
Q Consensus 263 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~ 315 (704)
+|.++.. ..+.++.+|+.||+++|-|.+- --..+..+..|+.|+|.|||+.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7766522 2355666777777777766541 1233456667777777777775
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.2e-07 Score=94.07 Aligned_cols=139 Identities=12% Similarity=0.042 Sum_probs=98.1
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeeccchh-----------hhHHHHHHHHHHHhcCCCC--CceEEeeeee-----C
Q 005278 422 LLGTGSFGSVYKGTLFDGTNVAIKVFNLQLER-----------ASRSFDSECEILRSIRHRN--LIKIISNCCN-----I 483 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----~ 483 (704)
.+-+.....|++.++ +|+.+.||........ ....+.+|.+.+.++...+ ....+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 334344445667665 5788999977433211 1114778999998885333 3344555533 2
Q ss_pred CeEEEEEeccCCC-CHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-------CCcE
Q 005278 484 DFKALVLEFMPNG-SLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-------NMTA 554 (704)
Q Consensus 484 ~~~~lv~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-------~~~~ 554 (704)
...++|||++++. +|.+++... ....+......++.+++..+.-| |..||+|+|++++||+++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L---H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM---HAAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCccCCCChhhEEEeccccCCCCCceE
Confidence 3468999999886 898888532 22345567778999999999999 5689999999999999975 4689
Q ss_pred EEeeecccee
Q 005278 555 HVSDFGISKL 564 (704)
Q Consensus 555 kl~Dfgla~~ 564 (704)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998864
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.5e-09 Score=101.65 Aligned_cols=188 Identities=20% Similarity=0.205 Sum_probs=115.5
Q ss_pred cCCCCCEEEccCCcCcc--ccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccC-CccccCcCCC
Q 005278 132 NLSGMIVFDLNGCDLNG--TIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHV-PPCLASLTSL 208 (704)
Q Consensus 132 ~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L 208 (704)
.++.+++|||.+|.|+. .+...+.++|.|+.|+|+.|++...+-..-..+.+|+.|.|.+..+.... ...+..+|.+
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 34566677777777662 33445566777777777777776433211135667888888777766332 2356677788
Q ss_pred CEEEecCccCCCCC--CCcccCC-ccccEEEecCcccCC--CCCcccccCcCCcEEEeecCccCCCC-CCCcCCCCCcce
Q 005278 209 RRLHLGSNKLTSTM--PSSFGSL-EYVLYINLSANSLNG--SLPSNIQNLKVLTNLDLSRNQLSGDI-PTTIGGLENLET 282 (704)
Q Consensus 209 ~~L~l~~n~l~~~~--~~~~~~l-~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~ 282 (704)
+.|+++.|.+.... .+..... +.++.|++..|.... ..-.--.-+|++..+-+..|++...- -..+..++.+..
T Consensus 149 telHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~ 228 (418)
T KOG2982|consen 149 TELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSC 228 (418)
T ss_pred hhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchh
Confidence 88888888544221 2222222 245555555554320 11111123567888888888886433 234556777788
Q ss_pred eeccCceeec-cCCcccccccccceEEecccCCCCCCC
Q 005278 283 LSLADNQFQG-PVPKSFGSLISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 283 L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p 319 (704)
|+|+.|+|.. .-.+.+..++.|..|.+++||+.....
T Consensus 229 LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~ 266 (418)
T KOG2982|consen 229 LNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLR 266 (418)
T ss_pred hhhcccccccHHHHHHHcCCchhheeeccCCccccccc
Confidence 8999998874 223567788899999999999875544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-07 Score=90.38 Aligned_cols=132 Identities=23% Similarity=0.220 Sum_probs=94.2
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeeccc----------------------hhhhHHHHHHHHHHHhcCCC--CCc
Q 005278 419 ECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL----------------------ERASRSFDSECEILRSIRHR--NLI 474 (704)
Q Consensus 419 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--niv 474 (704)
+...||.|.-+.||.|..++|.++|||.=+... .......++|.++|+++... .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 457899999999999999999999999642210 01223467899999999655 666
Q ss_pred eEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 475 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
+.+++ +...+||||+++-.|...- ++....-.++..|..-+.-. -..||||+|+++-||+++++|.+
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~---~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKA---YRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHH---HHcCccccCCchheEEEecCCCE
Confidence 66665 3457999999886654422 12233334444454444444 23679999999999999999999
Q ss_pred EEeeeccce
Q 005278 555 HVSDFGISK 563 (704)
Q Consensus 555 kl~Dfgla~ 563 (704)
.++||--+.
T Consensus 242 ~vIDwPQ~v 250 (304)
T COG0478 242 VVIDWPQAV 250 (304)
T ss_pred EEEeCcccc
Confidence 999996554
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.4e-09 Score=98.93 Aligned_cols=81 Identities=17% Similarity=0.270 Sum_probs=39.7
Q ss_pred ccccEEEecCcccCCCC-CcccccCcCCcEEEeecCccCC-CCCCCcCCCCCcceeeccCceeeccCCc------ccccc
Q 005278 230 EYVLYINLSANSLNGSL-PSNIQNLKVLTNLDLSRNQLSG-DIPTTIGGLENLETLSLADNQFQGPVPK------SFGSL 301 (704)
Q Consensus 230 ~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~------~~~~l 301 (704)
|++..+-+..|.++... -..+..++.+..|+|+.|+|.. .-.+++.++++|..|.+++|.+.+.+.. -++.+
T Consensus 199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL 278 (418)
T KOG2982|consen 199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARL 278 (418)
T ss_pred ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeec
Confidence 34444444444443211 1122334444455555555542 1123455566666666666665543322 24678
Q ss_pred cccceEEec
Q 005278 302 ISLESLDLS 310 (704)
Q Consensus 302 ~~L~~L~l~ 310 (704)
++++.|+=+
T Consensus 279 ~~v~vLNGs 287 (418)
T KOG2982|consen 279 TKVQVLNGS 287 (418)
T ss_pred cceEEecCc
Confidence 888887654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.9e-10 Score=120.00 Aligned_cols=154 Identities=24% Similarity=0.248 Sum_probs=64.8
Q ss_pred CCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCccc---ccCChhhhcC------CCCCEEEccCCcCccccC
Q 005278 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR---GNIPQEIGNL------SGMIVFDLNGCDLNGTIP 151 (704)
Q Consensus 81 ~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~---~~~~~~~~~l------~~L~~L~L~~n~l~~~~~ 151 (704)
+..+++|+.|.|.++++... ..+-.+-.+|++|...+ .+. ..+....+.. ..|.+.+++.|.+. ..-
T Consensus 105 ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD 180 (1096)
T KOG1859|consen 105 IFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LMD 180 (1096)
T ss_pred eccccceeeEEecCcchhhh--hhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hHH
Confidence 45566777777777776642 22222222344443221 111 0011111111 12444444444444 333
Q ss_pred hhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCcc
Q 005278 152 TAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEY 231 (704)
Q Consensus 152 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 231 (704)
.++.-++.|+.|+|+.|+++.. +.+..+++|++|||+.|.+. .+|..-..--.|+.|.|++|.++. ...+.++.+
T Consensus 181 ~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~t--L~gie~Lks 255 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTT--LRGIENLKS 255 (1096)
T ss_pred HHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHh--hhhHHhhhh
Confidence 3444445555555555555422 24444455555555555554 333211111124555555554441 123334444
Q ss_pred ccEEEecCcccC
Q 005278 232 VLYINLSANSLN 243 (704)
Q Consensus 232 L~~L~l~~N~l~ 243 (704)
|+.||+++|-|.
T Consensus 256 L~~LDlsyNll~ 267 (1096)
T KOG1859|consen 256 LYGLDLSYNLLS 267 (1096)
T ss_pred hhccchhHhhhh
Confidence 444444444443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.5e-08 Score=107.95 Aligned_cols=152 Identities=19% Similarity=0.255 Sum_probs=102.4
Q ss_pred HHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc-------eeccccccccccCCcccC
Q 005278 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-------IQTMTIATIGYMAPEYGS 590 (704)
Q Consensus 518 ~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~ 590 (704)
+.+++.|+.|+|. +.++||++|.|++|.+++.+..||+.|+.+.......... ..........|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455689999984 5789999999999999999999999999887654321110 111123456799999999
Q ss_pred CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhh
Q 005278 591 EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALD 670 (704)
Q Consensus 591 ~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 670 (704)
+...+.++|+||+||.+|.+..|+.+--........+.. ... ..+ . .........+.++.+-+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~~--~~~------~------~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SRN--LLN------A------GAFGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hhc--ccc------c------ccccccccCcHHHHHHHHH
Confidence 999999999999999999999655543221111111111 000 000 0 0111113456677888889
Q ss_pred hcCCCCCCCCCHHHHH
Q 005278 671 CCMESPEQRVSMKDAA 686 (704)
Q Consensus 671 cl~~~P~~Rpt~~ev~ 686 (704)
.+..++.-||++.++.
T Consensus 248 ~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLL 263 (700)
T ss_pred HhcCCcccCcchhhhh
Confidence 9999999999776664
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.1e-09 Score=102.21 Aligned_cols=177 Identities=21% Similarity=0.216 Sum_probs=109.9
Q ss_pred CCCEEecCCCcCcc-cCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEeccccc-CCCcccchhhcccccCCCC
Q 005278 7 NLKYLTLFDNKLSG-TIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY-LMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 7 ~l~~L~l~~~~i~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~~~~~~~l 84 (704)
.|++|||++..|+. .+..-++.+..|+.|.|.++.+.+-+...+++-.+|+.|||+.+. ++.-.. --.+.+|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~------~ll~~sc 259 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENAL------QLLLSSC 259 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHH------HHHHHhh
Confidence 47788888888872 233345668888888888988888888888888888999988764 333221 1236788
Q ss_pred CCCcEEEccCCCCccc-CChhhhhcccccceEEecCCccc---ccCChhhhcCCCCCEEEccCCc-CccccChhhcCCCC
Q 005278 85 RNLTVLGLASNPLRGI-LPPLIGNFSASLQEFYAYGCKLR---GNIPQEIGNLSGMIVFDLNGCD-LNGTIPTAVGRLRR 159 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~-~~~~~~~~~~~L~~L~l~~n~l~---~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~ 159 (704)
+.|.+|+|++|.+... ....+++..++|+.|+|+++.-. ..+..-...+++|.+|||++|. ++......|..++.
T Consensus 260 s~L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~ 339 (419)
T KOG2120|consen 260 SRLDELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNY 339 (419)
T ss_pred hhHhhcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcch
Confidence 8888888888876533 34555666667777777765422 1222233456666677776654 33223334555566
Q ss_pred cCeeeccCcccCCCCCcc---ccCCCCCCEEEcCC
Q 005278 160 LQGLYLHGNKLQGSIPYD---LCHLEGLSELNLNG 191 (704)
Q Consensus 160 L~~L~L~~n~l~~~~~~~---l~~l~~L~~L~L~~ 191 (704)
|++|.++.|.. .+|.. +...++|.+|+.-+
T Consensus 340 L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g 372 (419)
T KOG2120|consen 340 LQHLSLSRCYD--IIPETLLELNSKPSLVYLDVFG 372 (419)
T ss_pred heeeehhhhcC--CChHHeeeeccCcceEEEEecc
Confidence 66666666553 23432 22334455555443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 704 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-36 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-32 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-30 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-30 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-04 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-07 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 8e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 9e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 5e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 7e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 4e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 4e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 5e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 5e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 5e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-05 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 7e-05 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-04 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 1e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-04 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 2e-04 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-04 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 4e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-04 | ||
| 2v70_A | 220 | Third Lrr Domain Of Human Slit2 Length = 220 | 4e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2V70|A Chain A, Third Lrr Domain Of Human Slit2 Length = 220 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 704 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-87 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-85 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-84 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-82 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-82 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-81 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-78 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-76 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-73 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-65 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-28 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-23 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-12 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 9e-85 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 7e-82 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-56 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-23 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-71 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-63 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-58 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-55 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-53 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-52 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-38 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-36 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-31 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-30 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-12 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-12 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-07 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-62 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-60 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-59 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-54 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-40 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-36 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-33 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-29 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-14 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 6e-57 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-56 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-56 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 8e-56 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-55 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 7e-55 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-53 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-52 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 9e-50 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-45 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-45 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-43 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-34 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-30 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-27 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-20 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-11 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-07 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-53 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-52 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-52 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-50 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-48 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-47 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-45 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-41 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-37 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-51 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-51 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-51 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-51 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-50 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-49 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-47 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-44 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-31 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-27 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-26 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-50 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-50 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-48 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 8e-48 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-46 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-43 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-18 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-16 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-44 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-35 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-43 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-40 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-40 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-39 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-39 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-29 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-28 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-23 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-41 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-36 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-35 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-41 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-25 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-12 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-11 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-11 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-41 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-40 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-29 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-10 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-40 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-28 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-19 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-19 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-38 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-38 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-38 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-30 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-29 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-24 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-23 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-20 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-38 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-37 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-32 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-29 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-18 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-11 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-35 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-27 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-37 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-37 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 8e-35 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-29 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-18 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-37 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-37 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 7e-33 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-27 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-18 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-36 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-36 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-36 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-36 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 6e-36 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 8e-36 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 8e-36 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-36 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-35 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-35 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-35 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-35 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-28 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-19 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-17 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-35 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-35 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-35 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-35 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-34 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-33 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-23 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-13 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 9e-35 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 9e-35 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-34 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-34 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-34 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-32 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-25 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-17 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-12 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-04 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-34 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-25 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-11 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-34 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-34 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-34 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-34 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-34 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-33 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-33 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-33 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-33 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-33 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-33 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-31 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-07 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-32 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-32 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-32 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-32 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-32 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-32 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-32 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-23 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-21 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-10 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-07 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-31 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-31 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-31 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-31 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-31 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-31 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-31 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 9e-12 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-31 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-31 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-30 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-30 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-24 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-19 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-30 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-30 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-30 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-30 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-30 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-30 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-30 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-30 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-29 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-29 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-29 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-12 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-10 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-29 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-29 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 6e-29 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 8e-29 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 9e-29 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-28 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-28 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-23 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-04 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-28 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-28 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-28 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-25 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-23 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-28 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-27 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-27 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-27 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-27 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 9e-27 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-26 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-26 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-26 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-24 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-24 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-11 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-26 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-26 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-24 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-24 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-20 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-14 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-09 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-26 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-26 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-26 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-23 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 8e-23 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-17 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-25 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 9e-25 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-24 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-24 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-24 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-24 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-24 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-24 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-24 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-24 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-23 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-23 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 7e-23 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 8e-23 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 9e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-22 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-22 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 6e-21 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 7e-18 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-22 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-22 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-22 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-22 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-18 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-22 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-22 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-05 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 5e-22 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-21 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-21 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-21 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-21 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-21 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-18 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-07 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-21 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-21 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-21 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-21 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-21 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-21 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-21 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-21 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-21 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-09 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-21 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 7e-21 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 8e-21 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-21 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-13 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-20 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-20 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-20 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-20 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-20 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-20 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-20 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-19 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-07 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-20 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-20 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-20 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-16 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-20 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-20 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-20 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 8e-20 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 9e-20 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 9e-20 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-19 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-19 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-19 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-19 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 4e-19 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-19 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 6e-19 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-18 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-09 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 8e-19 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 9e-19 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-18 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-18 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-18 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-18 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-18 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 7e-18 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-17 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-17 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-17 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-17 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-17 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-17 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 8e-17 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 9e-17 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-06 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 9e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-16 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 8e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-05 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-04 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-16 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-16 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-16 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-04 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 7e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-12 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-16 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-16 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-16 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-15 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 7e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-07 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-16 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 8e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 9e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-06 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 9e-16 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 9e-16 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 9e-14 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-15 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-15 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-07 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-15 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-15 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-15 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-15 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-15 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 5e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-09 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-14 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-14 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-14 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-14 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 7e-14 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-13 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-13 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-05 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-13 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-13 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-13 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-06 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 7e-13 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 8e-13 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 8e-13 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 9e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-12 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-12 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-12 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-12 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-12 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-12 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 7e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 8e-12 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-04 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-11 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-11 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-11 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-10 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-05 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-11 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-11 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 4e-11 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 4e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 5e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-05 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-10 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 7e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-05 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-09 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 7e-09 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 8e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 7e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 5e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 3e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 3e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 3e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 6e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 3e-04 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 1e-04 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 6e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 1e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 4e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 7e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 6e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 6e-87
Identities = 105/339 (30%), Positives = 157/339 (46%), Gaps = 19/339 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L L N LSGTIP+S+ + SKL L L N G IP + +L+ L L +N
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L S L+NC NL + L++N L G +P IG +L G
Sbjct: 477 DL-------TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE-NLAILKLSNNSFSG 528
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
NIP E+G+ +I DLN NGTIP A+ + + N + G + +
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMK 584
Query: 185 SELNL--NGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242
E + N + G L L++ ++ S +F + ++++++S N L
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
Query: 243 NGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302
+G +P I ++ L L+L N +SG IP +G L L L L+ N+ G +P++ +L
Sbjct: 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 704
Query: 303 SLESLDLSRNNLSGEIPK-----NFSAQSFLSNYALCGP 336
L +DLS NNLSG IP+ F FL+N LCG
Sbjct: 705 MLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 1e-85
Identities = 91/329 (27%), Positives = 152/329 (46%), Gaps = 14/329 (4%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
NL++L + N S IP + + S L LD+S N SG L++L+++ N
Sbjct: 199 CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ ++L L LA N G +P + +L G G
Sbjct: 258 QFVGPIPPL---------PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQGLYLHGNKLQGSIPYDLCHL-E 182
+P G+ S + L+ + +G +P ++R L+ L L N+ G +P L +L
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368
Query: 183 GLSELNLNGNKLCGHVPP--CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
L L+L+ N G + P C +L+ L+L +N T +P + + ++ ++LS N
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN 428
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
L+G++PS++ +L L +L L N L G+IP + ++ LETL L N G +P +
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 301 LISLESLDLSRNNLSGEIPKNFSAQSFLS 329
+L + LS N L+GEIPK L+
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLA 517
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 4e-84
Identities = 102/332 (30%), Positives = 145/332 (43%), Gaps = 13/332 (3%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSIT-NASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L +L+YL+L +NK +G IP+ ++ L LDLS N F G +P FG+ L+ L+L+
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N E +L R L VL L+ N G LP + N SASL
Sbjct: 328 NNFSGELPM------DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 124 GNIPQEIGN--LSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL 181
G I + + + L G IP + L L+L N L G+IP L L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 182 EGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241
L +L L N L G +P L + +L L L N LT +PS + + +I+LS N
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 242 LNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSL 301
L G +P I L+ L L LS N SG+IP +G +L L L N F G +P +
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 302 ISLESLDLSRNNLSGEIPKNFSAQSFLSNYAL 333
S ++ N ++G+
Sbjct: 562 ----SGKIAANFIAGKRYVYIKNDGMKKECHG 589
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 2e-82
Identities = 85/333 (25%), Positives = 130/333 (39%), Gaps = 16/333 (4%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASK--LIMLDLSSNSFSGLIPNTFGNLGSLQV 58
+ + +L L L N SG I ++ K L L L +N F+G IP T N L
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422
Query: 59 LSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAY 118
L L++NYL SSL + L L L N L G +P + +L+
Sbjct: 423 LHLSFNYL-------SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK-TLETLILD 474
Query: 119 GCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL 178
L G IP + N + + L+ L G IP +GRL L L L N G+IP +L
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
Query: 179 CHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
L L+LN N G +P + + + +N + + + +
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGA 590
Query: 239 AN--SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPK 296
N G + L +++ G T ++ L ++ N G +PK
Sbjct: 591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
Query: 297 SFGSLISLESLDLSRNNLSGEIPKNFSAQSFLS 329
GS+ L L+L N++SG IP L+
Sbjct: 651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN 683
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 4e-82
Identities = 103/325 (31%), Positives = 155/325 (47%), Gaps = 18/325 (5%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
LK+L + NK+SG + ++ L LD+SSN+FS IP G+ +LQ L ++
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISG 232
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N L +F +++ C L +L ++SN G +PP SLQ K
Sbjct: 233 NKL-------SGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLK-SLQYLSLAENKFT 282
Query: 124 GNIPQEI-GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHL 181
G IP + G + DL+G G +P G L+ L L N G +P D L +
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 342
Query: 182 EGLSELNLNGNKLCGHVPPCLASLT-SLRRLHLGSNKLTSTMPSSFG--SLEYVLYINLS 238
GL L+L+ N+ G +P L +L+ SL L L SN + + + + + L
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSF 298
N G +P + N L +L LS N LSG IP+++G L L L L N +G +P+
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
Query: 299 GSLISLESLDLSRNNLSGEIPKNFS 323
+ +LE+L L N+L+GEIP S
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLS 487
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 3e-81
Identities = 91/332 (27%), Positives = 133/332 (40%), Gaps = 21/332 (6%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSIT---NASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSL 61
L +L+ L L N +SG +L L +S N SG + +L+ L +
Sbjct: 150 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDV 207
Query: 62 AYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCK 121
+ N T + L +C L L ++ N L G I + L+ +
Sbjct: 208 SSNNFSTG--------IPFLGDCSALQHLDISGNKLSGDFSRAISTCT-ELKLLNISSNQ 258
Query: 122 LRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQGLYLHGNKLQGSIPYDLCH 180
G IP L + L G IP + G L GL L GN G++P
Sbjct: 259 FVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316
Query: 181 LEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVL-YINLS 238
L L L+ N G +P L + L+ L L N+ + +P S +L L ++LS
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376
Query: 239 ANSLNGSLPSNIQN--LKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPK 296
+N+ +G + N+ L L L N +G IP T+ L +L L+ N G +P
Sbjct: 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436
Query: 297 SFGSLISLESLDLSRNNLSGEIPKNFSAQSFL 328
S GSL L L L N L GEIP+ L
Sbjct: 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 3e-78
Identities = 102/334 (30%), Positives = 154/334 (46%), Gaps = 22/334 (6%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTF---GNLGSLQVLS 60
LK+L + N L S + L +LDLS+NS SG + G L+ L+
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLA 184
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
++ N + + ++ C NL L ++SN + P +G+ S +LQ G
Sbjct: 185 ISGNKI---------SGDVDVSRCVNLEFLDVSSNNFSTGI-PFLGDCS-ALQHLDISGN 233
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
KL G+ + I + + + +++ G IP L+ LQ L L NK G IP L
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSG 291
Query: 181 -LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMP-SSFGSLEYVLYINLS 238
+ L+ L+L+GN G VPP S + L L L SN + +P + + + ++LS
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 239 ANSLNGSLPSNIQNLKV-LTNLDLSRNQLSGDIPTTIGG--LENLETLSLADNQFQGPVP 295
N +G LP ++ NL L LDLS N SG I + L+ L L +N F G +P
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
Query: 296 KSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLS 329
+ + L SL LS N LSG IP + + S L
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 5e-76
Identities = 95/333 (28%), Positives = 151/333 (45%), Gaps = 18/333 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIP--NSITNASKLIMLDLSSNSFSGLIP-NTFGNLGSLQVLSL 61
+L L L N LSG + S+ + S L L++SSN+ + L SL+VL L
Sbjct: 99 SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 62 AYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCK 121
+ N + S A C L L ++ N + G + + +L+
Sbjct: 159 SANSI----SGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCV-NLEFLDVSSNN 211
Query: 122 LRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL 181
IP +G+ S + D++G L+G A+ L+ L + N+ G IP L
Sbjct: 212 FSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPL 268
Query: 182 EGLSELNLNGNKLCGHVPPCLA-SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
+ L L+L NK G +P L+ + +L L L N +P FGS + + LS+N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 241 SLNGSLP-SNIQNLKVLTNLDLSRNQLSGDIPTTIGGL-ENLETLSLADNQFQGPVPKSF 298
+ +G LP + ++ L LDLS N+ SG++P ++ L +L TL L+ N F GP+ +
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 299 G--SLISLESLDLSRNNLSGEIPKNFSAQSFLS 329
+L+ L L N +G+IP S S L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV 421
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 5e-73
Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 18/314 (5%)
Query: 16 NKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKW 75
N + +S+ + + L L LS++ +G + F SL L L+ N L +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTT--- 118
Query: 76 NFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEI---GN 132
L+SL +C L L ++SN L G SL+ + G
Sbjct: 119 --LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 133 LSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGN 192
+ ++G ++G + V R L+ L + N IP L L L+++GN
Sbjct: 177 CGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGN 233
Query: 193 KLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSS-FGSLEYVLYINLSANSLNGSLPSNIQ 251
KL G +++ T L+ L++ SN+ +P SL+ Y++L+ N G +P +
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQ---YLSLAENKFTGEIPDFLS 290
Query: 252 -NLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPK-SFGSLISLESLDL 309
LT LDLS N G +P G LE+L+L+ N F G +P + + L+ LDL
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350
Query: 310 SRNNLSGEIPKNFS 323
S N SGE+P++ +
Sbjct: 351 SFNEFSGELPESLT 364
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 6e-65
Identities = 82/305 (26%), Positives = 136/305 (44%), Gaps = 24/305 (7%)
Query: 28 NASKLIMLDLSSNSFS---GLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84
K+ +DLSS + + ++ +L L+ L L+ +++ +S
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGS--------VSGFKCS 99
Query: 85 RNLTVLGLASNPLRGILPPL--IGNFSASLQEFYAYGCKLRGNIPQEIG-NLSGMIVFDL 141
+LT L L+ N L G + L +G+ S L+ L G L+ + V DL
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCS-GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 142 NGCDLNGTIP---TAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHV 198
+ ++G L+ L + GNK+ G + + L L+++ N +
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI 216
Query: 199 PPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTN 258
P L ++L+ L + NKL+ + + + +N+S+N G +P LK L
Sbjct: 217 -PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQY 273
Query: 259 LDLSRNQLSGDIPTTIGG-LENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGE 317
L L+ N+ +G+IP + G + L L L+ N F G VP FGS LESL LS NN SGE
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333
Query: 318 IPKNF 322
+P +
Sbjct: 334 LPMDT 338
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-28
Identities = 37/150 (24%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 179 CHLEGLSELNLNGNKL---CGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYI 235
C + ++ ++L+ L V L SLT L L L ++ + ++ F + +
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSL 105
Query: 236 NLSANSLNGSLPS--NIQNLKVLTNLDLSRNQLSGDIPTTIG-GLENLETLSLADNQFQG 292
+LS NSL+G + + ++ + L L++S N L + G L +LE L L+ N G
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 293 PVPKSF---GSLISLESLDLSRNNLSGEIP 319
+ L+ L +S N +SG++
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD 195
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-23
Identities = 42/130 (32%), Positives = 62/130 (47%), Gaps = 4/130 (3%)
Query: 204 SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSR 263
+TS+ N S + SS SL + + LS + +NGS+ + LT+LDLSR
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSR 109
Query: 264 NQLSGDIPT--TIGGLENLETLSLADNQFQGPVPKS-FGSLISLESLDLSRNNLSGEIPK 320
N LSG + T ++G L+ L+++ N P S L SLE LDLS N++SG
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVV 169
Query: 321 NFSAQSFLSN 330
+
Sbjct: 170 GWVLSDGCGE 179
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-12
Identities = 24/63 (38%), Positives = 33/63 (52%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
+P L L L N +SG+IP+ + + L +LDLSSN G IP L L + L+
Sbjct: 654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 64 NYL 66
N L
Sbjct: 714 NNL 716
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 9e-85
Identities = 104/310 (33%), Positives = 156/310 (50%), Gaps = 13/310 (4%)
Query: 386 RSTKDGDQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIK 445
S D L R +D++ ATN F+ L+G G FG VYKG L DG VA+K
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 446 VFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH 505
+ + F++E E L RH +L+ +I C + L+ ++M NG+L++ LY
Sbjct: 70 RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 506 NYFLGIL---ERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562
+ + +RL I I L YLH ++H D+K NILLDEN ++DFGIS
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIF- 621
K E D + + T+ T+GY+ PEY +G ++ KSDVYS+G++L E + +
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 622 IGEMSLKHWVKESLPDG-LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV 680
++L W ES +G L ++VD NL + ++ + L A+ C S E R
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDRP 301
Query: 681 SMKDAAAKLK 690
SM D KL+
Sbjct: 302 SMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 7e-82
Identities = 101/312 (32%), Positives = 157/312 (50%), Gaps = 23/312 (7%)
Query: 392 DQEDL-LSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQ 450
+ED + L +R S ++Q A++ F+ N+LG G FG VYKG L DGT VA+K +
Sbjct: 6 AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK----R 61
Query: 451 LERAS-----RSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH 505
L+ F +E E++ HRNL+++ C + LV +M NGS+ L
Sbjct: 62 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
Query: 506 NYFLGILE---RLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562
L+ R I + L YLH ++H D+K NILLDE A V DFG++
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFI 622
KL+ D+ + T TIG++APEY S G S K+DV+ YG++L+E T ++ + +
Sbjct: 182 KLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 623 GE---MSLKHWVKESLPDG-LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQ 678
+ L WVK L + L +VD +L + + + + ++ +AL C SP +
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDL---QGNYKDE--EVEQLIQVALLCTQSSPME 295
Query: 679 RVSMKDAAAKLK 690
R M + L+
Sbjct: 296 RPKMSEVVRMLE 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 1e-76
Identities = 81/333 (24%), Positives = 142/333 (42%), Gaps = 44/333 (13%)
Query: 22 IPNSITNASKL----IMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNF 77
I + N + L D + ++ G++ +T + L L+ L +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL-----PKPYPI 68
Query: 78 LSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMI 137
SSL N L L + L G IP I L+ +
Sbjct: 69 PSSLANLPYLNFLYIGGIN------------------------NLVGPIPPAIAKLTQLH 104
Query: 138 VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGH 197
+ +++G IP + +++ L L N L G++P + L L + +GN++ G
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 198 VPPCLASLTSLRR-LHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVL 256
+P S + L + + N+LT +P +F +L + +++LS N L G + K
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 257 TNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSG 316
+ L++N L+ D+ +G +NL L L +N+ G +P+ L L SL++S NNL G
Sbjct: 224 QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 317 EIP-----KNFSAQSFLSNYALCGPARLQVPSC 344
EIP + F ++ +N LCG +P+C
Sbjct: 283 EIPQGGNLQRFDVSAYANNKCLCGS---PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-56
Identities = 66/285 (23%), Positives = 114/285 (40%), Gaps = 59/285 (20%)
Query: 5 LPNLKYLTLFD-NKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
LP L +L + N L G IP +I ++L L ++ + SG IP+ + +L L +Y
Sbjct: 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N L S+++ NL + N ++
Sbjct: 135 NALSG-------TLPPSISSLPNLVGITFDGN-------------------------RIS 162
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
G IP G+ S + + + N+L G IP +L
Sbjct: 163 GAIPDSYGSFSKL-----------------------FTSMTISRNRLTGKIPPTFANLN- 198
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L+ ++L+ N L G S + +++HL N L + G + + ++L N +
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIY 257
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADN 288
G+LP + LK L +L++S N L G+IP G L+ + + A+N
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 42/179 (23%), Positives = 66/179 (36%), Gaps = 35/179 (19%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
G +T+ N+L+G IP + N + L +DLS N G FG+ + Q +
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
LA N L + L + +NL L L +N
Sbjct: 228 LAKNSLAFD--------LGKVGLSKNLNGLDLRNN------------------------- 254
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
++ G +PQ + L + +++ +L G IP G L+R NK P C
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-71
Identities = 85/317 (26%), Positives = 147/317 (46%), Gaps = 29/317 (9%)
Query: 392 DQEDLLSLATWRRT-SYLDIQRATNGFNE------CNLLGTGSFGSVYKGTLFDGTNVAI 444
+ + L T + S+ +++ TN F+E N +G G FG VYKG + + T VA+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 445 KVFNLQLERAS----RSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEK 500
K ++ + + FD E +++ +H NL++++ + D LV +MPNGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 501 WLYSHNYFLGILE---RLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVS 557
L + L R I + +LH +H D+K NILLDE TA +S
Sbjct: 120 RLSCLDGTP-PLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKIS 175
Query: 558 DFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPT 617
DFG+++ + +V+ + + T YMAPE G I+PKSD+YS+G++L+E T
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 618 NEIFIGEMSLKHWVKESLPDG--LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMES 675
+E L +E + + + +D + + ++ +A C E
Sbjct: 235 DEHR-EPQLLLDIKEEIEDEEKTIEDYIDKKM----NDADST--SVEAMYSVASQCLHEK 287
Query: 676 PEQRVSMKDAAAKLKKI 692
+R +K L+++
Sbjct: 288 KNKRPDIKKVQQLLQEM 304
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-63
Identities = 57/363 (15%), Positives = 124/363 (34%), Gaps = 48/363 (13%)
Query: 5 LPNLKYLTLFDNKLSG-------------------TIPNSITNASKLIMLDLSSNSFSGL 45
L L+ + ++ T N L +++ +
Sbjct: 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 46 IPNTFGNLGSLQVLSLAYNYLMT-ESSAAKWNFLSSLTNCRNLTVLGLASNPLRGI-LPP 103
+P L +Q++++A N ++ E W L+ + ++ + N L+ +
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324
Query: 104 LIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163
+ L +L G +P G+ + +L + G +++ L
Sbjct: 325 SLQKMK-KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENL 382
Query: 164 YLHGNKLQG-SIPYDLCHLEGLSELNLNGNKL-------CGHVPPCLASLTSLRRLHLGS 215
NKL+ +D + +S ++ + N++ + P ++ ++L +
Sbjct: 383 SFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN 442
Query: 216 NKLTSTMPSSFGSLEYVLYINLSANSLNG-------SLPSNIQNLKVLTNLDLSRNQLSG 268
N+++ F + + INL N L N +N +LT++DL N+L+
Sbjct: 443 NQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
Query: 269 DIPTTI--GGLENLETLSLADNQFQGPVPKSFGSLISLESL------DLSRNNLSGEIPK 320
+ L L + L+ N F P + +L+ D N E P+
Sbjct: 503 -LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
Query: 321 NFS 323
+
Sbjct: 561 GIT 563
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 6e-58
Identities = 58/335 (17%), Positives = 115/335 (34%), Gaps = 35/335 (10%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
+L + + +I S K + SN+ + + L L+ +
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGN- 215
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ + C N L + Y C
Sbjct: 216 -----------SPFVAENICEAWENENSEYAQQYKTEDLKWDNLK-DLTDVEVYNCPNLT 263
Query: 125 NIPQEIGNLSGMIVFDLNGCDL--------NGTIPTAVGRLRRLQGLYLHGNKLQ-GSIP 175
+P + L M + ++ + ++Q +Y+ N L+ +
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 176 YDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYI 235
L ++ L L N+L G P S L L+L N++T + G E V +
Sbjct: 324 TSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENL 382
Query: 236 NLSANSLNGSLPSN--IQNLKVLTNLDLSRNQLSG-------DIPTTIGGLENLETLSLA 286
+ + N L +P+ +++ V++ +D S N++ + T N+ +++L+
Sbjct: 383 SFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441
Query: 287 DNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKN 321
+NQ + F + L S++L N L+ IPKN
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKN 475
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 9e-55
Identities = 55/335 (16%), Positives = 100/335 (29%), Gaps = 38/335 (11%)
Query: 5 LPNLKYLTLFDNKL-SGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
++ + + N L + + S+ KL ML+ N G +P FG+ L L+LAY
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPL-IGNFSASLQEFYAYGCKL 122
N + + + + L A N L+ I + S + ++
Sbjct: 363 NQITEIPA-------NFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS-VMSAIDFSYNEI 414
Query: 123 RG-------NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQG--- 172
+ + +L+ ++ L + L GN L
Sbjct: 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK 474
Query: 173 ----SIPYDLCHLEGLSELNLNGNKLCGHVPPCLA--SLTSLRRLHLGSNKLTSTMPSSF 226
+ + L+ ++L NKL + +L L + L N + P+
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQP 532
Query: 227 GSLE--YVLYI----NLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENL 280
+ I + N P I LT L + N + + I N+
Sbjct: 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNI 589
Query: 281 ETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
L + DN I L +
Sbjct: 590 SVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-53
Identities = 53/333 (15%), Positives = 107/333 (32%), Gaps = 27/333 (8%)
Query: 5 LPNLKYLTLFDNKLSG----TIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
L L+ L L + P I+ +
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV---DYDPREDFSD 160
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
L + + ++ + + S T +G SN + + + + L++FY
Sbjct: 161 LIKDCINSDPQ--QKSIKKSSRITLKDTQIGQLSNNITFV-SKAVMRLT-KLRQFYMGNS 216
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
E + T L+ L + ++ +P L
Sbjct: 217 PFVAENICEAWENE-----NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
Query: 181 LEGLSELNLNGNKL--------CGHVPPCLASLTSLRRLHLGSNKLTS-TMPSSFGSLEY 231
L + +N+ N+ ++ +++G N L + + +S ++
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
Query: 232 VLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
+ + N L G LP+ + L +L+L+ NQ++ G E +E LS A N+ +
Sbjct: 332 LGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK 390
Query: 292 G-PVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323
P S+ + ++D S N + KNF
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 8e-52
Identities = 51/312 (16%), Positives = 109/312 (34%), Gaps = 21/312 (6%)
Query: 25 SITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84
S+ + ++ L L SG +P+ G L L+VL+L + + ++
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE---KVNERLFGPKGISAN 132
Query: 85 RNLTVLGLASNPLRGILPPLIGNFSAS-LQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNG 143
+ + S L + + +I +
Sbjct: 133 MSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLS 192
Query: 144 CDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLA 203
++ + AV RL +L+ Y+ + + E
Sbjct: 193 NNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWD 246
Query: 204 SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL--------NGSLPSNIQNLKV 255
+L L + + + + +P+ +L + IN++ N + ++ +
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 256 LTNLDLSRNQL-SGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
+ + + N L + + T++ ++ L L NQ +G +P +FGS I L SL+L+ N +
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI 365
Query: 315 SGEIPKNFSAQS 326
+ IP NF +
Sbjct: 366 TE-IPANFCGFT 376
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-38
Identities = 39/299 (13%), Positives = 84/299 (28%), Gaps = 45/299 (15%)
Query: 36 DLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASN 95
+ + + + + G + LSL ++ L VL L S+
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP-------DAIGQLTELEVLALGSH 115
Query: 96 PLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVG 155
+ P+ I T
Sbjct: 116 GEKVNERL---------------------FGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154
Query: 156 RLR--RLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHL 213
R L ++ + Q SI +++ N + V + LT LR+ ++
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYM 213
Query: 214 GSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTT 273
G++ + E N + NLK LT++++ +PT
Sbjct: 214 GNSPFVAENICEAWENE-----NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268
Query: 274 IGGLENLETLSLADNQF--------QGPVPKSFGSLISLESLDLSRNNL-SGEIPKNFS 323
+ L ++ +++A N+ ++ + + NNL + + +
Sbjct: 269 LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-36
Identities = 37/266 (13%), Positives = 73/266 (27%), Gaps = 37/266 (13%)
Query: 5 LPNLKYLTLFDNKLSG-------TIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQ 57
+ + + N++ + + + ++LS+N S F L
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 58 VLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYA 117
++L N L + + + N LT + L N L + L
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDL 520
Query: 118 YGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD 177
P + N S + F + GN+ P
Sbjct: 521 SYNSFSK-FPTQPLNSSTLKGFGI------------------RNQRDAQGNRTLREWPEG 561
Query: 178 LCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINL 237
+ L++L + N + V + ++ L + N S S L
Sbjct: 562 ITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYML 618
Query: 238 SANSLNGSLPSNIQNLKVLTNLDLSR 263
+ Q+++ LD+ R
Sbjct: 619 FYD--------KTQDIRGCDALDIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 23/228 (10%), Positives = 62/228 (27%), Gaps = 14/228 (6%)
Query: 111 SLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNG----TIPTAVGRLRRLQGLYLH 166
+ G G +P IG L+ + V L P + +
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 167 GNKLQGSIPYDLCHLE--GLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPS 224
Q + + L + +N + + ++ SN +T +
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSK 200
Query: 225 SFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLS 284
+ L + + + + Q L++L +
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVE 255
Query: 285 LADNQFQGPVPKSFGSLISLESLDLSRNNLSG--EIPKNFSAQSFLSN 330
+ + +P +L ++ ++++ N ++ ++ A +
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPV 303
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-30
Identities = 27/229 (11%), Positives = 66/229 (28%), Gaps = 30/229 (13%)
Query: 120 CKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
+G Q N + F+ ++ R+ GL L G G +P +
Sbjct: 47 WSQQGFGTQPGANWN----FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIG 102
Query: 180 HLEGLSELNLNGNKLCG----HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEY--VL 233
L L L L + P +++ S + T ++ ++
Sbjct: 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI 162
Query: 234 YINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGP 293
++++ S+ + + T + N ++ + + L L + ++ F
Sbjct: 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAE 221
Query: 294 -------------------VPKSFGSLISLESLDLSRNNLSGEIPKNFS 323
+ +L L +++ ++P
Sbjct: 222 NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 21/103 (20%), Positives = 34/103 (33%), Gaps = 4/103 (3%)
Query: 236 NLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGP-- 293
N + ++ + +T L L SG +P IG L LE L+L + +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 294 --VPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALC 334
PK + +S E R + + F C
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDC 165
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 18/112 (16%), Positives = 31/112 (27%), Gaps = 6/112 (5%)
Query: 225 SFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGD----IPTTIGGLENL 280
S S V ++L +G +P I L L L L + + P I +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 281 ETLSLADNQFQGPVPKSFG--SLISLESLDLSRNNLSGEIPKNFSAQSFLSN 330
E +Q L ++ + I K+ +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 20/100 (20%), Positives = 28/100 (28%), Gaps = 4/100 (4%)
Query: 238 SANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKS 297
+ N N S N + + ++ + LSL G VP +
Sbjct: 41 ALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA 100
Query: 298 FGSLISLESLDLSRNNLSG----EIPKNFSAQSFLSNYAL 333
G L LE L L + PK SA
Sbjct: 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQK 140
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-62
Identities = 66/308 (21%), Positives = 115/308 (37%), Gaps = 23/308 (7%)
Query: 406 SYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEIL 465
++ + + G FG V+K VA+K+F +Q ++ S + E L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ-DKQSWQNEYEVYSL 72
Query: 466 RSIRHRNLIKIISNCCNIDFKA----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDV 521
++H N+++ I L+ F GSL +L + E +I +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETM 130
Query: 522 GLALEYLH------HGHSTP-MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574
L YLH P + H D+K N+LL N+TA ++DFG++ G +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 575 TMTIATIGYMAPEYGSEGII-----SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH 629
+ T YMAPE I + D+Y+ G++L E +R + M
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 630 WVKESLP--DGLTEVVDANLVREEQAFSV-KIDCLLSIMHLALDCCMESPEQRVSMKDAA 686
P + + EVV R K + + +C E R+S
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 687 AKLKKIKE 694
++ +++
Sbjct: 311 ERITQMQR 318
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-60
Identities = 79/340 (23%), Positives = 129/340 (37%), Gaps = 24/340 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
N+ L L N+L + T S+L LD+ N+ S L P L L+VL+L +N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L S + C NLT L L SN ++ I +L L
Sbjct: 84 ELSQLSD-------KTFAFCTNLTELHLMSNSIQKIKNNPFVKQK-NLITLDLSHNGLSS 135
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTA--VGRLRRLQGLYLHGNKLQGSIPYDLCHLE 182
L + L+ + + L+ L L N+++ P +
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 183 GLSELNLNGNKLCGHVPPCLA---SLTSLRRLHLGSNKLTSTMPSSFGSLEYV--LYINL 237
L L LN +L + L + TS+R L L +++L++T ++F L++ ++L
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 238 SANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADN--------- 288
S N+LN + L L L N + ++ GL N+ L+L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 289 QFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFL 328
SF L LE L++ N++ G F+ L
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-59
Identities = 76/342 (22%), Positives = 128/342 (37%), Gaps = 20/342 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
NL L L N L+ +S +L L N+ L ++ L +++ L+L +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 65 YLMTESSAAKWNFL--SSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKL 122
+ S A + S + L L + N + GI + +L+
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFT 365
Query: 123 RGNIPQEIGNLSGMI-----VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD 177
+ + +L ++ A L L+ L L N++ +
Sbjct: 366 SL-RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 178 -LCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTS--TMPSSFGSLEYVLY 234
LE + E+ L+ NK A + SL+RL L L + + PS F L +
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLS--------GDIPTTIGGLENLETLSLA 286
++LS N++ ++ L+ L LDL N L+ G + GL +L L+L
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 287 DNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFL 328
N F + F L L+ +DL NNL+ F+ Q L
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL 586
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-54
Identities = 65/329 (19%), Positives = 110/329 (33%), Gaps = 16/329 (4%)
Query: 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLA 62
+ + ++ L S L L++ N G+ N F L +L+ LSL+
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 63 YNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKL 122
++ SL + L +L L N + I L+ ++
Sbjct: 362 NSFT--SLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLG-HLEVLDLGLNEI 417
Query: 123 RGNIP-QEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQG--SIPYDLC 179
+ QE L + L+ + + LQ L L L+ S P
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 180 HLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTS--------TMPSSFGSLEY 231
L L+ L+L+ N + L L L L L N L L +
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 232 VLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
+ +NL +N + ++L L +DL N L+ + +L++L+L N
Sbjct: 538 LHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT 597
Query: 292 GPVPKSFG-SLISLESLDLSRNNLSGEIP 319
K FG + +L LD+ N
Sbjct: 598 SVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-40
Identities = 49/243 (20%), Positives = 83/243 (34%), Gaps = 9/243 (3%)
Query: 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCD 145
+ V + L + P + ++ +LR S + D+
Sbjct: 5 SHEVADCSHLKLTQV-PD---DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 146 LNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASL 205
++ P +L L+ L L N+L L+EL+L N +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLK--VLTNLDLSR 263
+L L L N L+ST + LE + + LS N + + L L+LS
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 264 NQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFG---SLISLESLDLSRNNLSGEIPK 320
NQ+ P + L L L + Q + + + S+ +L LS + LS
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 321 NFS 323
F
Sbjct: 241 TFL 243
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-36
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 4/207 (1%)
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185
+P ++ + + V +L L R +L L + N + P L L
Sbjct: 19 VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLK 76
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
LNL N+L A T+L LHL SN + + F + ++ ++LS N L+ +
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 246 LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLEN--LETLSLADNQFQGPVPKSFGSLIS 303
L+ L L LS N++ + N L+ L L+ NQ + P F ++
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196
Query: 304 LESLDLSRNNLSGEIPKNFSAQSFLSN 330
L L L+ L + + + ++
Sbjct: 197 LFGLFLNNVQLGPSLTEKLCLELANTS 223
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 5/193 (2%)
Query: 138 VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGH 197
V D + L +P + + L L N+L+ + L+ L++ N +
Sbjct: 8 VADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKL 64
Query: 198 VPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLT 257
P L L+ L+L N+L+ +F + ++L +NS+ + K L
Sbjct: 65 EPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLI 124
Query: 258 NLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSL--ISLESLDLSRNNLS 315
LDLS N LS T LENL+ L L++N+ Q + SL+ L+LS N +
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184
Query: 316 GEIPKNFSAQSFL 328
P F A L
Sbjct: 185 EFSPGCFHAIGRL 197
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 39/175 (22%), Positives = 61/175 (34%), Gaps = 6/175 (3%)
Query: 159 RLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKL 218
+ KL +P DL ++ LNL N+L + L L +G N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 219 TSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLE 278
+ P L + +NL N L+ LT L L N + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 279 NLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYAL 333
NL TL L+ N + L +L+ L LS N + + +N +L
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL---DIFANSSL 173
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-14
Identities = 33/144 (22%), Positives = 53/144 (36%), Gaps = 10/144 (6%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L +L L L N + +L ++DL N+ + L + F N SL+ L+L N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ + F + NLT L + NP I F + E + +L
Sbjct: 595 LITSVEKKV---FGPAFR---NLTELDMRFNPFDCT-CESIAWFVNWINETHTNIPELSS 647
Query: 125 NIP-QEIGNLSGMIV--FDLNGCD 145
+ + G V FD + C
Sbjct: 648 HYLCNTPPHYHGFPVRLFDTSSCK 671
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-57
Identities = 73/283 (25%), Positives = 112/283 (39%), Gaps = 42/283 (14%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
+G G+FG V K + +VAIK + ER ++F E L + H N++K+ C
Sbjct: 16 VGRGAFGVVCKAK-WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG-ACL 71
Query: 483 IDFKALVLEFMPNGSLEKWLYSHN--YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
LV+E+ GSL L+ + ++ + + YLH ++H D
Sbjct: 72 NPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 541 LKPNNILLDENMT-AHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPEYGSEGIISPK 597
LKP N+LL T + DFG + + MT + +MAPE S K
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQ-------THMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 598 SDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE----SLPDGLTEVVDANLVREEQA 653
DV+S+GI+L E TR+KP +EI + V L
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK---------------- 227
Query: 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696
+ I L C + P QR SM++ + + F
Sbjct: 228 -----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-56
Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQ--LERASRSFDSECEILRSIRHRNLIKIISNC 480
+G GSFG+V++ + G++VA+K+ Q F E I++ +RH N++ +
Sbjct: 45 IGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHN--YFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
++V E++ GSL + L+ L RL++ DV + YLH+ + P+VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII---- 594
+LK N+L+D+ T V DFG+S+L + + T +MAPE ++
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPE-----VLRDEP 215
Query: 595 -SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653
+ KSDVYS+G++L E T ++P + + + V R E
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNL-------------NPAQVVAAVGFKCK-RLE-- 259
Query: 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDD 699
+ + + + C P +R S L+ + + +
Sbjct: 260 --IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-56
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 53/292 (18%)
Query: 423 LGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERAS-------RSFDSECEILRSIRHRNLI 474
+G G FG V+KG L D + VAIK L + F E I+ ++ H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
K+ + +V+EF+P G L L + + +L +M+D+ L +EY+ + +
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNP 143
Query: 535 PMVHCDLKPNNILLDE-----NMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE 587
P+VH DL+ NI L + A V+DFG+S+ + +++ + +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSVSGLLGNFQWMAPE 196
Query: 588 --YGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE-----SLPDGLT 640
E + K+D YS+ ++L T + P +E G++ + ++E ++P+
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE--- 253
Query: 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
DC + ++ C P++R +L ++
Sbjct: 254 ------------------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 8e-56
Identities = 70/278 (25%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNC 480
+G+GSFG+VYKG + G VA+K+ N+ + ++F +E +LR RH N++ +
Sbjct: 32 IGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-Y 88
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
A+V ++ SL L++ + + ++I ++YLH + ++H D
Sbjct: 89 STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---YGSEGIISPK 597
LK NNI L E+ T + DFG++ S +I +MAPE S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 598 SDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVK 657
SDVY++GI+L E T + P + + D + E+V + + + V+
Sbjct: 206 SDVYAFGIVLYELMTGQLP-------------YSNINNRDQIIEMVGRGSLSPDLS-KVR 251
Query: 658 IDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695
+C + L +C + ++R S A+++++ +
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-55
Identities = 63/284 (22%), Positives = 114/284 (40%), Gaps = 41/284 (14%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNC 480
L G ++KG + G ++ +KV ++ R SR F+ EC LR H N++ ++
Sbjct: 18 LNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL-GA 75
Query: 481 CN---IDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
C L+ +MP GSL L+ N+ + + + +D+ + +LH +
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLI 134
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---YGSEGI 593
L ++++DE+MTA +S + S + ++APE E
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 594 ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653
+D++S+ +LL E TR+ P ++ E+ +K V L R
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-------------VALEGL-R---- 229
Query: 654 FSVKI--DCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695
I + L C E P +R L+K+++K
Sbjct: 230 --PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 197 bits (501), Expect = 2e-53
Identities = 59/350 (16%), Positives = 122/350 (34%), Gaps = 46/350 (13%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGL---------IPNTFGNLGS 55
L +L + L++ +P+ + + +L L+++ N + +
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 56 LQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEF 115
+Q+ + YN L ++A SL L +L N +R + G L +
Sbjct: 550 IQIFYMGYNNLEEFPASA------SLQKMVKLGLLDCVHNKVRHL--EAFGTNV-KLTDL 600
Query: 116 YAYGCKLRGNIPQEIG-NLSGMIVFDLNGCDLNGTIPTAV--GRLRRLQGLYLHGNKLQG 172
++ IP++ + + L IP + + + NK+
Sbjct: 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS 658
Query: 173 -----SIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTS------- 220
S D S + L+ N++ A+ + + + L +N +TS
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 221 TMPSSFGSLEYVLYINLSANSLNGSLPSNIQ--NLKVLTNLDLSRNQLSGDIPTTIGGLE 278
++ + + I+L N L SL + + L L+N+D+S N S PT
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSS 776
Query: 279 NLETLSL------ADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNF 322
L+ + N+ P + SL L + N++ ++ +
Sbjct: 777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 5e-52
Identities = 59/342 (17%), Positives = 109/342 (31%), Gaps = 46/342 (13%)
Query: 5 LPNLKYLTLFDNKLSG---------TIPNSITNASKLIMLDLSSNSFSGLIPN-TFGNLG 54
LP L+ L + N+ + + K+ + + N+ + + +
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573
Query: 55 SLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQE 114
L +L +N + L + LT L L N + I P F+ ++
Sbjct: 574 KLGLLDCVHNKV---------RHLEAFGTNVKLTDLKLDYNQIEEI-PEDFCAFTDQVEG 623
Query: 115 FYAYGCKLRGNIPQ--EIGNLSGMIVFDLNGCDLNGTIPTA-----VGRLRRLQGLYLHG 167
KL+ IP ++ M D + + + + L
Sbjct: 624 LGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682
Query: 168 NKLQGSIPYDLCHLEGLSELNLNGNKL-------CGHVPPCLASLTSLRRLHLGSNKLTS 220
N++Q +S + L+ N + + L + L NKLTS
Sbjct: 683 NEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
Query: 221 TMPS-SFGSLEYVLYINLSANSLNGSLPSNIQNLKVLT------NLDLSRNQLSGDIPTT 273
+L Y+ +++S N + S P+ N L D N++ PT
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801
Query: 274 IGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
I +L L + N + V + L LD++ N
Sbjct: 802 ITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNI 840
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 9e-50
Identities = 56/364 (15%), Positives = 118/364 (32%), Gaps = 52/364 (14%)
Query: 5 LPNLKYLTLFDNKLSG-------------------TIPNSITNASKLIMLDLSSNSFSGL 45
L L+ + ++ + S +N L ++L +
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 46 IPNTFGNLGSLQVLSLAYNYLMT--ESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPP 103
+P+ +L LQ L++A N ++ + A + + + N L
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPAS 566
Query: 104 L-IGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGR-LRRLQ 161
+ L K+R + G + L+ + IP +++
Sbjct: 567 ASLQKMV-KLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 162 GLYLHGNKLQGSIP--YDLCHLEGLSELNLNGNKLCGHVPPCLASL-----TSLRRLHLG 214
GL NKL+ IP ++ + + ++ + NK+ S+ + + L
Sbjct: 623 GLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681
Query: 215 SNKLTSTMPSSFGSLEYVLYINLSANSL-------NGSLPSNIQNLKVLTNLDLSRNQLS 267
N++ F + + I LS N + N +N +LT +DL N+L+
Sbjct: 682 YNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT 741
Query: 268 GDIPTTI--GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSR------NNLSGEIP 319
+ L L + ++ N F P + L++ + N + + P
Sbjct: 742 S-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799
Query: 320 KNFS 323
+
Sbjct: 800 TGIT 803
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-45
Identities = 52/337 (15%), Positives = 103/337 (30%), Gaps = 25/337 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFG-NLGSLQVLSLAY 63
L LK L+ + + + M + + F L + L
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
+ + S ++ T +G +N + I I + LQ Y
Sbjct: 406 DAINRNPEMKPIKKDSRIS--LKDTQIGNLTNRITFI-SKAIQRLT-KLQIIYFANSPFT 461
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
+ + + + + L+ L + L+ +P L L
Sbjct: 462 YDNIAVDWEDA-----NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516
Query: 184 LSELNLNGNKL---------CGHVPPCLASLTSLRRLHLGSNKLTSTMPS-SFGSLEYVL 233
L LN+ N+ + + ++ ++G N L S S + +
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLG 576
Query: 234 YINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIG-GLENLETLSLADNQFQG 292
++ N + L + LT+L L NQ+ IP + +E L + N+ +
Sbjct: 577 LLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY 633
Query: 293 -PVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFL 328
P + S+ + S+D S N + E +
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDY 670
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-45
Identities = 48/323 (14%), Positives = 99/323 (30%), Gaps = 33/323 (10%)
Query: 16 NKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKW 75
+ + N ++ L L+ G +P+ G L L+VLS +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR---- 364
Query: 76 NFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSG 135
+ + +R + ++ L + N E+ +
Sbjct: 365 ---LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKK 419
Query: 136 MIVFDLNGCDLNG------TIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNL 189
L + I A+ RL +LQ +Y + + N
Sbjct: 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANS 474
Query: 190 NGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG----- 244
+ K + ++L L + L + + +P L + +N++ N
Sbjct: 475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLK 534
Query: 245 ----SLPSNIQNLKVLTNLDLSRNQLSG-DIPTTIGGLENLETLSLADNQFQGPVPKSFG 299
L + + + N L ++ + L L N+ + ++FG
Sbjct: 535 ADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFG 592
Query: 300 SLISLESLDLSRNNLSGEIPKNF 322
+ + L L L N + EIP++F
Sbjct: 593 TNVKLTDLKLDYNQIE-EIPEDF 614
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 5e-43
Identities = 42/324 (12%), Positives = 88/324 (27%), Gaps = 44/324 (13%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
+ L L NK+ + KL L L N + + ++ L ++N
Sbjct: 572 MVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHN 629
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSA----SLQEFYAYGC 120
L + + + + + + N + + + +
Sbjct: 630 KLKYIPNIF------NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDL-------NGTIPTAVGRLRRLQGLYLHGNKLQGS 173
+++ + S + L+ + L + L NKL S
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-S 742
Query: 174 IPYDL--CHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEY 231
+ D L LS ++++ N P + + L+ + +
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQR-------------- 787
Query: 232 VLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
+ N + P+ I L L + N + + + L L +ADN
Sbjct: 788 ----DAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNI 840
Query: 292 GPVPKSFGSLISLESLDLSRNNLS 315
S I L +
Sbjct: 841 SIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 38/301 (12%), Positives = 85/301 (28%), Gaps = 31/301 (10%)
Query: 35 LDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLAS 94
+ + + N G + LSLA ++ L VL +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP-------DAIGQLTELKVLSFGT 356
Query: 95 NPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIG------NLSGMIVFDLNGCDLNG 148
+ L G+ + ++R + + NLS ++ +N
Sbjct: 357 HSETV-SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMK 415
Query: 149 TIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSL 208
I + + N++ I + L L + + +
Sbjct: 416 PIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTY-DNIAV----DW 469
Query: 209 RRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSG 268
+ K S+ +L+ + + L LP + +L L +L+++ N+
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 269 ---------DIPTTIGGLENLETLSLADNQFQG-PVPKSFGSLISLESLDLSRNNLSGEI 318
+ ++ + N + P S ++ L LD N + +
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HL 588
Query: 319 P 319
Sbjct: 589 E 589
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 34/255 (13%), Positives = 63/255 (24%), Gaps = 27/255 (10%)
Query: 5 LPNLKYLTLFDNKLSGTIPN-----SITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVL 59
+ + + NK+ N + LS N F + +
Sbjct: 643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTI 702
Query: 60 SLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYG 119
L+ N + + + + N LT + L N L + L
Sbjct: 703 ILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSY 762
Query: 120 CKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
P + N S + F + GN++ P +
Sbjct: 763 NCFSS-FPTQPLNSSQLKAFGI------------------RHQRDAEGNRILRQWPTGIT 803
Query: 180 HLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239
L +L + N + V L L L + N S +S L
Sbjct: 804 TCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLY 860
Query: 240 NSLNGSLPSNIQNLK 254
+ + ++
Sbjct: 861 DKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-27
Identities = 30/233 (12%), Positives = 63/233 (27%), Gaps = 28/233 (12%)
Query: 120 CKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
++ N + L G G +P A+G+L L+ L + S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 180 HLEGLSELNLNGNKLCGHVPPC-LASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
+++ H L L L + + ++ I+L
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLK 426
Query: 239 ANSLNG------SLPSNIQNLKVLTNLDLSRNQLSG-------------------DIPTT 273
+ + IQ L L + + + + + +
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS 486
Query: 274 IGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQS 326
L++L + L + +P L L+SL+++ N
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 5e-20
Identities = 24/170 (14%), Positives = 56/170 (32%), Gaps = 9/170 (5%)
Query: 168 NKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFG 227
+ DL + ++ L+L G G VP + LT L+ L G++ T +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 228 SLEYVLYINLSANSLNGSLPSN-IQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLA 286
+ + + + L DL ++ ++ + + ++ +SL
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLK 426
Query: 287 DNQFQG------PVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSN 330
D Q + K+ L L+ + + + + + +
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY 476
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 15/89 (16%), Positives = 30/89 (33%)
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
N + ++ N +T L L+ G +P IG L L+ LS +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 295 PKSFGSLISLESLDLSRNNLSGEIPKNFS 323
++ + + ++ + K F
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFL 392
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 13/99 (13%), Positives = 29/99 (29%), Gaps = 1/99 (1%)
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
++ +N + + N + + + + LSLA +G V
Sbjct: 281 LDGKNWRYYSGTINNTIHS-LNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339
Query: 295 PKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYAL 333
P + G L L+ L ++ + +
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-53
Identities = 68/284 (23%), Positives = 111/284 (39%), Gaps = 41/284 (14%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQ----LERASRSFDSECEILRSIRHRNLIKIIS 478
+G G FG VY+ + G VA+K + + + E ++ ++H N+I +
Sbjct: 15 IGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
C LV+EF G L + L + +N + + + YLH P++H
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 539 CDLKPNNILLDE--------NMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEYG 589
DLK +NIL+ + N ++DFG+++ M+ A +MAPE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVI 186
Query: 590 SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649
+ S SDV+SYG+LL E T + P + G+ + A V
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVP-------------F------RGIDGLAVAYGVA 227
Query: 650 EEQA-FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+ + C L DC P R S + +L I
Sbjct: 228 MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 77/320 (24%), Positives = 126/320 (39%), Gaps = 38/320 (11%)
Query: 405 TSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEI 464
+ + + L+G G +G+VYKG+L D VA+KVF+ + +F +E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 465 --LRSIRHRNLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNI 517
+ + H N+ + I + LV+E+ PNGSL K+L H + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116
Query: 518 MIDVGLALEYLH-----HGHSTP-MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571
V L YLH H P + H DL N+L+ + T +SDFG+S L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 572 VIQTMTIA------TIGYMAPEYGSEGI-------ISPKSDVYSYGILLMETFTRKKPTN 618
A TI YMAPE + + D+Y+ G++ E F R
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 619 EIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ------AFSVKIDCLLSIMHLALDCC 672
+ E E + + RE+Q A+ + S+ DC
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 673 MESPEQRVSMKDAAAKLKKI 692
+ E R++ + A ++ ++
Sbjct: 297 DQDAEARLTAQXAEERMAEL 316
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-52
Identities = 58/332 (17%), Positives = 107/332 (32%), Gaps = 29/332 (8%)
Query: 5 LPNLKYLTLFDNKLSGT------IPNSITNASKLIMLDLSSNS---FSGLIPNTFGNLGS 55
L L+ L + +++ L + + + I + F L +
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 56 LQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEF 115
+ SL + + + L L + + +
Sbjct: 284 VSSFSLVSVTI---------ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK------ 328
Query: 116 YAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLN--GTIPTAVGRLRRLQGLYLHGNKLQGS 173
+G +L + DL+ L+ G + L+ L L N +
Sbjct: 329 RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT- 387
Query: 174 IPYDLCHLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYV 232
+ + LE L L+ + L SL +L L + F L +
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 233 LYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
+ ++ NS + +I L+ LT LDLS+ QL PT L +L+ L+++ N F
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 292 GPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323
+ L SL+ LD S N++ +
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-50
Identities = 66/335 (19%), Positives = 109/335 (32%), Gaps = 24/335 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIP-NSITNASKLIMLDLSSNSFSG------LIPNTFGNLGSLQ 57
L LTL +N S + I + L + L F + L +L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 58 VLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYA 117
+ YL + + N++ L S + + +++ Q
Sbjct: 259 IEEFRLAYLDYYLD----DIIDLFNCLTNVSSFSLVSVTIERVKD---FSYNFGWQHLEL 311
Query: 118 YGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQ--GSIP 175
CK ++ +L L G + L L+ L L N L G
Sbjct: 312 VNCKFGQFPTLKLKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCS 366
Query: 176 YDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSS-FGSLEYVLY 234
L L+L+ N + + L L L + L S F SL ++Y
Sbjct: 367 QSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDI-PTTIGGLENLETLSLADNQFQGP 293
+++S + L L L ++ N + P L NL L L+ Q +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 294 VPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFL 328
P +F SL SL+ L++S NN + + L
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-48
Identities = 71/355 (20%), Positives = 119/355 (33%), Gaps = 48/355 (13%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
P L+ L L ++ + + S L L L+ N L F L SLQ L
Sbjct: 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGI-LPPLIGNFSASLQEFYAYGCKLR 123
L + + + + + L L +A N ++ LP N + +L+ K++
Sbjct: 111 NLASLEN-------FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQ 162
Query: 124 GNIPQEIGNLSGMIVF----DLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
++ L M + DL+ +N P A + RL L L N ++
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCI 221
Query: 180 H-LEGLSELNLNGNKLCGH---VPPCLASLTSLRRLHLGSNKLTS------TMPSSFGSL 229
L GL L + ++L L L + +L + F L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 230 EYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLS-------------------GDI 270
V +L + ++ +L+L + G
Sbjct: 282 TNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
Query: 271 PTTIGGLENLETLSLADNQ--FQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323
+ L +LE L L+ N F+G +S SL+ LDLS N + + NF
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFL 393
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-47
Identities = 55/318 (17%), Positives = 97/318 (30%), Gaps = 41/318 (12%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L N+ +L + S L+L + F +L L S
Sbjct: 281 LTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN--- 335
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
K S + +L L L+ N L G
Sbjct: 336 ---------KGGNAFSEVDLPSLEFLDLSRNGLSFK-----------------------G 363
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEG 183
Q + + DL+ + T+ + L +L+ L + L+ + L
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTM-PSSFGSLEYVLYINLSANSL 242
L L+++ L+SL L + N P F L + +++LS L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 243 NGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302
P+ +L L L++S N L +L+ L + N +
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542
Query: 303 -SLESLDLSRNNLSGEIP 319
SL L+L++N+ +
Sbjct: 543 SSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-45
Identities = 68/359 (18%), Positives = 116/359 (32%), Gaps = 47/359 (13%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
+ K L L N L S + +L +LDLS + + +L L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG- 124
+ + + + + +L L L + IG+ +L+E ++
Sbjct: 88 IQSLAL-------GAFSGLSSLQKLVAVETNLASLENFPIGHLK-TLKELNVAHNLIQSF 139
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQ----GLYLHGNKLQGSIPYDLCH 180
+P+ NL+ + DL+ + T + L ++ L L N + P
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 181 LEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHL------GSNKLTSTMPSSFGSLEYVL 233
+ L +L L N +V C+ L L L L S+ L +
Sbjct: 200 IR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 234 YINLSANSLNGS---LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQF 290
L+ + L +++ L + + L L + +F
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316
Query: 291 -------------------QGPVPKSFGSLISLESLDLSRNNLS--GEIPKNFSAQSFL 328
+G S L SLE LDLSRN LS G ++ + L
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-41
Identities = 63/334 (18%), Positives = 98/334 (29%), Gaps = 64/334 (19%)
Query: 2 GYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSN--SFSGLIPNTFGNLGSLQVL 59
L +LK LT G S + L LDLS N SF G + SL+ L
Sbjct: 321 TLKLKSLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 60 SLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYG 119
L++N ++T S+ L L + L+ +
Sbjct: 379 DLSFNGVIT--------MSSNFLGLEQLEHLDFQHSNLKQMSE----------------- 413
Query: 120 CKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
+ LR L L + + +
Sbjct: 414 -------------------------------FSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 180 HLEGLSELNLNGNKLCGHVPPC-LASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
L L L + GN + P L +L L L +L P++F SL + +N+S
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLE-NLETLSLADNQFQG--PVP 295
N+ + L L LD S N + + +L L+L N F
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
Query: 296 KSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLS 329
+ L + + P + LS
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS 596
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-37
Identities = 54/256 (21%), Positives = 91/256 (35%), Gaps = 12/256 (4%)
Query: 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFD 140
+ N+T + N + N S + LR + + V D
Sbjct: 4 VEVVPNITYQCMELN-----FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 141 LNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPP 200
L+ C++ A L L L L GN +Q L L +L L
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 201 CLASLTSLRRLHLGSNKLTST-MPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTN- 258
+ L +L+ L++ N + S +P F +L + +++LS+N + ++++ L +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 259 ---LDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPK-SFGSLISLESLDLSRNNL 314
LDLS N ++ P + L L+L +N V K L LE L
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 315 SGEIPKNFSAQSFLSN 330
E +S L
Sbjct: 238 RNEGNLEKFDKSALEG 253
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 37/288 (12%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
LG G FG K T + G + +K E R+F E +++R + H N++K I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
+ E++ G+L + S + +R++ D+ + YLH S ++H DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGD------------DSVIQTMTIATIGYMAPEYG 589
+N L+ EN V+DFG+++L+ + D + + +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 590 SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649
+ K DV+S+GI+L E R +
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNA-------------------DPDYLPRTMDFGLN 235
Query: 650 EEQAFSVKI--DCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695
+C S + + CC PE+R S L+ ++
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-51
Identities = 59/289 (20%), Positives = 111/289 (38%), Gaps = 38/289 (13%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIIS 478
L+G G FG VY G + G VAI++ +++ E ++F E R RH N++ +
Sbjct: 39 ELIGKGRFGQVYHGR-WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
C + A++ +L + L + + I ++ + YLH + ++H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT-MTIA--TIGYMAPE-------- 587
DLK N+ D N ++DFG+ + G + + I + ++APE
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 588 -YGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646
+ S SDV++ G + E R+ P F + + +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QP---------AEAIIWQMGTG 258
Query: 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695
+ +I I + L C E+R + L+K+ ++
Sbjct: 259 MKPNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-51
Identities = 61/326 (18%), Positives = 113/326 (34%), Gaps = 17/326 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L NL +L L ++ ++ + +L L L++N + +L+ L
Sbjct: 56 LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT 115
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ + L N + L L L SN + I P L+ +
Sbjct: 116 GISSIDFIP-------LHNQKTLESLYLGSNHISSIKLPKGFPTE-KLKVLDFQNNAIHY 167
Query: 125 NIPQEIGNLSG--MIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL--CH 180
+++ +L + +LNG D+ I Q L G + I L
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 181 LEGLSELNLNGNKLCGHVPPCLASL--TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
++ L P L S+ ++L + + ++F + ++L+
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV-PKS 297
A L+ LPS + L L L LS N+ + +L LS+ N + +
Sbjct: 287 ATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 298 FGSLISLESLDLSRNNLSGEIPKNFS 323
+L +L LDLS +++ N
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQ 371
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-51
Identities = 61/323 (18%), Positives = 107/323 (33%), Gaps = 14/323 (4%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
+ + L N L + + L LDL+ + +TF + L L L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L+ + ++L+ + L L + I + N +L+ Y +
Sbjct: 92 PLIFMAE-------TALSGPKALKHLFFIQTGISSIDFIPLHNQK-TLESLYLGSNHISS 143
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQ-GSIPYDLCHLEG 183
+ + V D ++ + L++ L L+ N I
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 184 LSELNLNGNKLCGHVPPCLA--SLTSLRRLHLGSNKLTSTMPSSFGSLE--YVLYINLSA 239
LN G + + L ++ SL P+ F L V INL
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 240 NSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFG 299
+ + L LDL+ LS ++P+ + GL L+ L L+ N+F+ S
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 300 SLISLESLDLSRNNLSGEIPKNF 322
+ SL L + N E+
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGC 345
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-50
Identities = 70/334 (20%), Positives = 114/334 (34%), Gaps = 19/334 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITN--ASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLA 62
+ +L T D P + ++L + F + NTF LQ L L
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 63 YNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKL 122
+L S L L L L++N + NF SL G
Sbjct: 287 ATHLSE--------LPSGLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTK 337
Query: 123 RGNI-PQEIGNLSGMIVFDLNGCDLN--GTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
R + + NL + DL+ D+ + L LQ L L N+
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 180 HLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
L L+L +L +L L+ L+L + L + F L + ++NL
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 239 ANSL---NGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP 295
N N +++Q L L L LS LS L+ + + L+ N+
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
Query: 296 KSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLS 329
++ L + L+L+ N++S +P S
Sbjct: 518 EALSHLKGIY-LNLASNHISIILPSLLPILSQQR 550
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 5e-49
Identities = 61/333 (18%), Positives = 120/333 (36%), Gaps = 14/333 (4%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKL--IMLDLSSNSFSGLIPNTFGNLGSLQVLSLA 62
LK L +N + +++ + + L+L+ N +G+ P F + Q L+
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF-DSAVFQSLNFG 210
Query: 63 YNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSA-SLQEFYAYGCK 121
+ + ++L + I P + S++
Sbjct: 211 GTQNLLVIFKG-----LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265
Query: 122 LRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL 181
SG+ DL L+ +P+ + L L+ L L NK + +
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 182 EGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTST--MPSSFGSLEYVLYINLS 238
L+ L++ GN + CL +L +LR L L + + ++ +L ++ +NLS
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSG-DIPTTIGGLENLETLSLADNQFQGPVPKS 297
N + L LDL+ +L D + L L+ L+L+ + +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444
Query: 298 FGSLISLESLDLSRNNLSGEIPKNFSAQSFLSN 330
F L +L+ L+L N+ + ++ L
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-47
Identities = 71/294 (24%), Positives = 108/294 (36%), Gaps = 15/294 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L+ L L LS +P+ + S L L LS+N F L + N SL LS+ N
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFS--ASLQEFYAYGCKL 122
E L N NL L L+ + + + LQ +
Sbjct: 336 TKRLELGT------GCLENLENLRELDLSHDDIETS-DCCNLQLRNLSHLQSLNLSYNEP 388
Query: 123 RGNIPQEIGNLSGMIVFDLNGCDLNGTIP-TAVGRLRRLQGLYLHGNKLQGSIPYDLCHL 181
+ + + DL L + L L+ L L + L S L
Sbjct: 389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448
Query: 182 EGLSELNLNGNKLCG---HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
L LNL GN L +L L L L L+S +F SL+ + +++LS
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292
N L S + +LK + L+L+ N +S +P+ + L T++L N
Sbjct: 509 HNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-44
Identities = 70/335 (20%), Positives = 117/335 (34%), Gaps = 19/335 (5%)
Query: 5 LPNLK--YLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPN--TFGNLGSLQVLS 60
L L L N ++ I +++ L+ +I + SL + +
Sbjct: 176 LQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
S L ++ + L + I FS LQE
Sbjct: 235 FEDMDDEDISP----AVFEGLCEM-SVESINLQKHYFFNISSNTFHCFS-GLQELDLTAT 288
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LC 179
L +P + LS + L+ + L L + GN + + L
Sbjct: 289 HLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
Query: 180 HLEGLSELNLNGNKL--CGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINL 237
+LE L EL+L+ + + L +L+ L+ L+L N+ S +F + ++L
Sbjct: 348 NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407
Query: 238 SANSLNGSLP-SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG---P 293
+ L S QNL +L L+LS + L GL L+ L+L N F
Sbjct: 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQ 467
Query: 294 VPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFL 328
S +L LE L LS +LS F++ +
Sbjct: 468 KTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 42/228 (18%), Positives = 74/228 (32%), Gaps = 5/228 (2%)
Query: 106 GNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL 165
G S + L L + DL C + RL L L
Sbjct: 29 GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVL 88
Query: 166 HGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSS 225
N L L + L L + L + +L L+LGSN ++S
Sbjct: 89 TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148
Query: 226 FGSLEYVLYINLSANSLNGSLPSNIQNLKVLTN--LDLSRNQLSGDIPTTIGGLENLETL 283
E + ++ N+++ ++ +L+ TN L+L+ N ++G I ++L
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSL 207
Query: 284 SLADNQFQGPVPK--SFGSLISLESLDLSRNNLSGEIPKNFSAQSFLS 329
+ Q + K ++ SL + P F +S
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 39/194 (20%), Positives = 68/194 (35%), Gaps = 5/194 (2%)
Query: 138 VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGH 197
++ LN IP + + L N L L L+ L+L ++
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 198 VPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLT 257
S L L L +N L ++ + + ++ ++ + N K L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 258 NLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLE--SLDLSRNNLS 315
+L L N +S E L+ L +N + SL SL+L+ N+++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 316 GEIPKNFSAQSFLS 329
G P F + F S
Sbjct: 193 GIEPGAFDSAVFQS 206
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-26
Identities = 33/171 (19%), Positives = 57/171 (33%), Gaps = 3/171 (1%)
Query: 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTM 222
L IP L L + N L + L +L L L ++
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 223 PSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLET 282
+F S + + L+AN L + + K L +L + +S + + LE+
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 283 LSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYAL 333
L L N L+ LD N + ++ S+ +N +L
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-50
Identities = 70/295 (23%), Positives = 110/295 (37%), Gaps = 27/295 (9%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEI--LRSIRHRNLIKIIS 478
+G G +G V+ G + G VA+KVF E S+ E EI +RH N++ I+
Sbjct: 43 KQIGKGRYGEVWMGK-WRGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98
Query: 479 NCCNIDFK----ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH----- 529
L+ ++ NGSL +L + L L + L +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE 587
+ H DLK NIL+ +N T ++D G++ + V T YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 588 --YGSEGIISP----KSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE--SLPDGL 639
S +D+YS+G++L E R + ++ V S D
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
V L +CL + L +C +P R++ L K+ E
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-50
Identities = 63/296 (21%), Positives = 121/296 (40%), Gaps = 33/296 (11%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEI--LRSIRHRNLIKIIS 478
+G G +G V++G+ + G NVA+K+F+ + E+ S+ E E+ +RH N++ I+
Sbjct: 14 ECVGKGRYGEVWRGS-WQGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69
Query: 479 NCCNIDFKA----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH----- 529
+ + L+ + GSL +L L + L I++ + L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE 587
+ H DLK NIL+ +N ++D G++ + + + + T YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 588 ------YGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641
+ D++++G++L E R + + + D E
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP---PFYDVVPNDPSFE 244
Query: 642 VVDANLVREEQ-----AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+ + ++Q L S+ L +C ++P R++ L KI
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 8e-48
Identities = 63/295 (21%), Positives = 119/295 (40%), Gaps = 27/295 (9%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEI--LRSIRHRNLIKIIS 478
+G G FG V++G + G VA+K+F+ + ER S+ E EI +RH N++ I+
Sbjct: 48 ESIGKGRFGEVWRGK-WRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103
Query: 479 NCCNIDFKA----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH----- 529
+ LV ++ +GSL +L + Y + + + + + L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE 587
+ H DLK NIL+ +N T ++D G++ D++ T YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 588 --YGSEGIISP----KSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE--SLPDGL 639
S + ++D+Y+ G++ E R ++ V S+ +
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
V + L + L + + +C + R++ L ++ +
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 5e-47
Identities = 79/311 (25%), Positives = 136/311 (43%), Gaps = 29/311 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L NL+YL L N+++ P ++N KL L + +N + + NL +L+ L L +
Sbjct: 65 LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNED 120
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ +S L N + L L +N L PL N + L K++
Sbjct: 121 NISD---------ISPLANLTKMYSLNLGANHNLSDLSPL-SNMT-GLNYLTVTESKVKD 169
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
P I NL+ + LN + P + L L + N++ P + ++ L
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
+ L + NK+ LA+L+ L L +G+N+++ ++ L + +N+ +N ++
Sbjct: 224 NSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD 279
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
S + NL L +L L+ NQL + IGGL NL TL L+ N P SL +
Sbjct: 280 --ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335
Query: 305 ESLDLSRNNLS 315
+S D + +
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-46
Identities = 70/315 (22%), Positives = 136/315 (43%), Gaps = 29/315 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L ++ L + K++ +I I + L L+L+ N + + P NL L L + N
Sbjct: 43 LESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTN 98
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ +S+L N NL L L + + I P + N + +
Sbjct: 99 KI---------TDISALQNLTNLRELYLNEDNISDISP--LANLT-KMYSLNLGANHNLS 146
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
++ + N++G+ + + P + L L L L+ N+++ P L L L
Sbjct: 147 DLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
N++ P +A++T L L +G+NK+T S +L + ++ + N ++
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD 257
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
+ +++L L L++ NQ+S + + L L +L L +NQ + G L +L
Sbjct: 258 --INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313
Query: 305 ESLDLSRNNLSGEIP 319
+L LS+N+++ P
Sbjct: 314 TTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-43
Identities = 67/319 (21%), Positives = 125/319 (39%), Gaps = 31/319 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L ++ + + L ++ + + L +L+ L+L N
Sbjct: 21 LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG--IEYLTNLEYLNLNGN 76
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ +S L+N LT L + +N + I + N + +L+E Y +
Sbjct: 77 QI---------TDISPLSNLVKLTNLYIGTNKITDI--SALQNLT-NLRELYLNEDNISD 124
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
P + NL+ M +L + + + + L L + +K++ P + +L L
Sbjct: 125 ISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDL 179
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
L+LN N++ LASLTSL N++T + ++ + + + N +
Sbjct: 180 YSLSLNYNQI--EDISPLASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD 235
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
S + NL LT L++ NQ+S + L L+ L++ NQ +L L
Sbjct: 236 L--SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQL 289
Query: 305 ESLDLSRNNLSGEIPKNFS 323
SL L+ N L E +
Sbjct: 290 NSLFLNNNQLGNEDMEVIG 308
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 32/160 (20%), Positives = 57/160 (35%), Gaps = 12/160 (7%)
Query: 160 LQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLT 219
L + P L L + L S+ +L + K+
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASV--TDVVTQEELESITKLVVAGEKVA 57
Query: 220 STMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLEN 279
S L + Y+NL+ N + S + NL LTNL + N+++ + + L N
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 280 LETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIP 319
L L L ++ +L + SL+L N+ ++
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 29/137 (21%), Positives = 53/137 (38%), Gaps = 10/137 (7%)
Query: 183 GLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242
G + L + + P A L R L +T + LE + + ++ +
Sbjct: 1 GAATLATLPAPI-NQIFP-DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV 56
Query: 243 NGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302
I+ L L L+L+ NQ++ P + L L L + N+ + +L
Sbjct: 57 AS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLT 110
Query: 303 SLESLDLSRNNLSGEIP 319
+L L L+ +N+S P
Sbjct: 111 NLRELYLNEDNISDISP 127
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-47
Identities = 54/331 (16%), Positives = 106/331 (32%), Gaps = 32/331 (9%)
Query: 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLA 62
+ + L + + ++ + D + + N + Q+ +
Sbjct: 9 HHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRT 64
Query: 63 YNYLMTESSAAKWNFLSSLTNCR--NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
L L + L L S PL P S LQ
Sbjct: 65 GRALKA--------TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAA 114
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC- 179
L +P + +G+ L L +P ++ L RL+ L + +P L
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 180 --------HLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEY 231
L L L L + +P +A+L +L+ L + ++ L++ + + L
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK 230
Query: 232 VLYINLSANSLNGSLPSNIQNLKVLTNLDLS-RNQLSGDIPTTIGGLENLETLSLADNQF 290
+ ++L + + P L L L + L +P I L LE L L
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVN 289
Query: 291 QGPVPKSFGSLISLESLDLSRNNLSGEIPKN 321
+P L + + + +L ++ ++
Sbjct: 290 LSRLPSLIAQLPANCIILVP-PHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-44
Identities = 58/337 (17%), Positives = 109/337 (32%), Gaps = 29/337 (8%)
Query: 20 GTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLS 79
G+ + ++S L ++ + +W+
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRN-----------RWHSAW 50
Query: 80 SLTNCRNLTVLGLASNPLRGILPPLIGNF-SASLQEFYAYGCKLRGNIPQEIGNLSGMIV 138
N N + L+ L+ + L P + LS +
Sbjct: 51 RQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQH 108
Query: 139 FDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG-NKL--- 194
++ L +P + + L+ L L N L+ ++P + L L EL++ +L
Sbjct: 109 MTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTEL 166
Query: 195 -----CGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSN 249
L +L+ L L + S +P+S +L+ + + + + L+ +L
Sbjct: 167 PEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPA 224
Query: 250 IQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLAD-NQFQGPVPKSFGSLISLESLD 308
I +L L LDL + P GG L+ L L D + +P L LE LD
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLD 283
Query: 309 LSRNNLSGEIPKNFSAQSFLSNYALCGPARLQVPSCR 345
L +P + + + Q+ R
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 10/230 (4%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L +L+++T+ L +P+++ + L L L+ N L P + +L L+ LS+
Sbjct: 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRAC 160
Query: 65 YLMTE--SSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKL 122
+TE A + NL L L +R LP I N +L+ L
Sbjct: 161 PELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQ-NLKSLKIRNSPL 218
Query: 123 RGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLE 182
+ I +L + DL GC P G L+ L L ++P D+ L
Sbjct: 219 SA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 183 GLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSN---KLTSTMPSSFGSL 229
L +L+L G +P +A L + + + + +L P + +
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-43
Identities = 62/338 (18%), Positives = 104/338 (30%), Gaps = 28/338 (8%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNAS--------KLIMLDLSSNSFSGLIPNTFGNLGSL 56
L L L + I S + L+ + F L ++
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV 287
Query: 57 QVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFY 116
+SLA + +L + L + L+ + L+
Sbjct: 288 SAMSLAGVSI---------KYLEDVPKHFKWQSLSIIRCQLKQFPT---LDLP-FLKSLT 334
Query: 117 AYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRL--RRLQGLYLHGNKLQGSI 174
K +I + L + DL+ L+ + + L L+ L L N +
Sbjct: 335 LTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IM 391
Query: 175 PYDLCHLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVL 233
+ LE L L+ + L SL L L + F L +
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451
Query: 234 YINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292
+ ++ NS + SN+ N LT LDLS+ QL L L+ L+++ N
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 293 PVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSN 330
+ L SL +LD S N + L+
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAF 549
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-40
Identities = 63/338 (18%), Positives = 106/338 (31%), Gaps = 29/338 (8%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L +L L L N + P S + + L L + L G L +L+ L++A+N
Sbjct: 79 LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN 138
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNF---SASLQEFYAYGCK 121
++ + A +N NL + L+ N ++ I +
Sbjct: 139 FIHSCKLPA------YFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192
Query: 122 LRGNIPQEIGNLSGMIVFDLNGCDLNGTIP-TAVGRLRRLQGLYLHGNKLQGSIP---YD 177
+ I + + L G + I T + L L L + + ++
Sbjct: 193 ID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 178 LCHLEGLS-----ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYV 232
+EGL E L L ++ + L +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQS 311
Query: 233 LYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292
L ++ L ++ LK L L+ N+ S I L +L L L+ N
Sbjct: 312 L--SIIRCQLKQFPTLDLPFLKS---LTLTMNKGS--ISFKKVALPSLSYLDLSRNALSF 364
Query: 293 PVPKSF--GSLISLESLDLSRNNLSGEIPKNFSAQSFL 328
S+ SL LDLS N + NF L
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEEL 401
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-40
Identities = 71/339 (20%), Positives = 116/339 (34%), Gaps = 30/339 (8%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L++L L ++ + L L L+ N P +F L SL+ L
Sbjct: 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGI-LPPLIGNFSASLQEFYAYGCKLR 123
L + S + L L +A N + LP N + +L ++
Sbjct: 115 KLASLES-------FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT-NLVHVDLSYNYIQ 166
Query: 124 GNIPQEIGNLSGM----IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
++ L + D++ ++ I + +L L L GN +I
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCL 225
Query: 180 H-LEGLSELNLNGNKLCGHV------PPCLASLTSLRR--LHLGSNKLTSTMPSSFGSLE 230
L GL L + P + L + L S F L
Sbjct: 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285
Query: 231 YVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQF 290
V ++L+ S+ L ++ K +L + R QL PT L L++L+L N+
Sbjct: 286 NVSAMSLAGVSIK-YLEDVPKHFK-WQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKG 340
Query: 291 QGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLS 329
+ +L SL LDLSRN LS ++S S
Sbjct: 341 S--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-39
Identities = 63/324 (19%), Positives = 105/324 (32%), Gaps = 28/324 (8%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
+ K + L N L S +N S+L LDLS + + L L L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG- 124
+ + S S + +L L L + IG +L++ +
Sbjct: 92 IQSFSP-------GSFSGLTSLENLVAVETKLASLESFPIGQLI-TLKKLNVAHNFIHSC 143
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQG----LYLHGNKLQGSIPYDLCH 180
+P NL+ ++ DL+ + + LR L + N + I
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQ 202
Query: 181 LEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHL------GSNKLTSTMPSSFGSLE--Y 231
L EL L GN ++ CL +L L L L PS L
Sbjct: 203 GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262
Query: 232 VLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
+ L+ + L ++ + L+ + + ++LS+ Q +
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK 320
Query: 292 GPVPKSFGSLISLESLDLSRNNLS 315
L L+SL L+ N S
Sbjct: 321 QF---PTLDLPFLKSLTLTMNKGS 341
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-39
Identities = 73/331 (22%), Positives = 112/331 (33%), Gaps = 20/331 (6%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIP-NTFGNLGSLQVL 59
+ L + N + I + KL L L N S I NL L V
Sbjct: 176 LRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234
Query: 60 SLAYNYLMTESSAAKW--NFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYA 117
L E + + + + L + L + ++
Sbjct: 235 RLILGEFKDERNLEIFEPSIMEGLCDVTIDE-FRLTYTNDFSDDIVKFHCLA-NVSAMSL 292
Query: 118 YGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD 177
G + +++ + C L PT L L+ L L NK SI +
Sbjct: 293 AGVSI--KYLEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMNKG--SISFK 345
Query: 178 LCHLEGLSELNLNGNKLCGHVPPC---LASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLY 234
L LS L+L+ N L C SLR L L N M ++F LE + +
Sbjct: 346 KVALPSLSYLDLSRNAL-SFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQH 403
Query: 235 INLSANSLNGSLP-SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG- 292
++ ++L S +L+ L LD+S D GL +L TL +A N F+
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463
Query: 293 PVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323
+ F + +L LDLS+ L F
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 53/259 (20%), Positives = 91/259 (35%), Gaps = 12/259 (4%)
Query: 79 SSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIV 138
+ N+T L + P + +S + L+ N S +
Sbjct: 6 PCIEVVPNITYQ-CMDQKLSKV-PD---DIPSSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 139 FDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHV 198
DL+ C++ A L L L L GN +Q P L L L KL
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120
Query: 199 PPCLASLTSLRRLHLGSNKLTS-TMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLT 257
+ L +L++L++ N + S +P+ F +L +++++LS N + +++Q L+
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180
Query: 258 N----LDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPK-SFGSLISLESLDLSRN 312
LD+S N + I L L+L N + K +L L L
Sbjct: 181 QVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239
Query: 313 NLSGEIPKNFSAQSFLSNY 331
E S +
Sbjct: 240 EFKDERNLEIFEPSIMEGL 258
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 50/220 (22%), Positives = 80/220 (36%), Gaps = 11/220 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITN--ASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLA 62
LP+L YL L N LS + S ++ + L LDLS N ++ F L LQ L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQ 407
Query: 63 YNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKL 122
++ L + S+ + L L ++ + + + SL G
Sbjct: 408 HSTLKRVTE------FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT-SLNTLKMAGNSF 460
Query: 123 RGNIPQEI-GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL 181
+ N + N + + DL+ C L L RLQ L + N L L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520
Query: 182 EGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTST 221
LS L+ + N++ SL +L +N +
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-23
Identities = 35/153 (22%), Positives = 65/153 (42%), Gaps = 5/153 (3%)
Query: 172 GSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEY 231
GS+ + + ++ KL VP + +S + + L N L SF +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKL-SKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 232 VLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
+ +++LS + L L+NL L+ N + P + GL +LE L + +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 292 GPVPKSFGSLISLESLDLSRNNLSG-EIPKNFS 323
G LI+L+ L+++ N + ++P FS
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-41
Identities = 84/326 (25%), Positives = 135/326 (41%), Gaps = 33/326 (10%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L NL LTLF+N+++ P + N + L L+LSSN+ S + L SLQ LS
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQ 166
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L L N L L ++SN + I ++ + +L+ A ++
Sbjct: 167 VT----------DLKPLANLTTLERLDISSNKVSDI--SVLAKLT-NLESLIATNNQISD 213
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
P +G L+ + LNG L + L L L L N++ P L L L
Sbjct: 214 ITP--LGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKL 267
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
+EL L N++ LA LT+L L L N+L S +L+ + Y+ L N+++
Sbjct: 268 TELKLGANQISN--ISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD 323
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
S + +L L L N++S +++ L N+ LS NQ P +L +
Sbjct: 324 I--SPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRI 377
Query: 305 ESLDLSRNNLSGEIPKNFSAQSFLSN 330
L L+ + + S +
Sbjct: 378 TQLGLNDQAWTNAPVNYKANVSIPNT 403
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-39
Identities = 72/315 (22%), Positives = 131/315 (41%), Gaps = 33/315 (10%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L ++ T+ T+ ++ L + L +L ++ + N
Sbjct: 23 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNN 78
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L ++ L N L + + +N + I P + N + +L + ++
Sbjct: 79 QLTD---------ITPLKNLTKLVDILMNNNQIADITP--LANLT-NLTGLTLFNNQITD 126
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
P + NL+ + +L+ ++ +A+ L LQ L GN++ P L +L L
Sbjct: 127 IDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTL 179
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
L+++ NK+ LA LT+L L +N+++ + G L + ++L+ N L
Sbjct: 180 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD 235
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
+ +L LT+LDL+ NQ+S P + GL L L L NQ P L +L
Sbjct: 236 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL 289
Query: 305 ESLDLSRNNLSGEIP 319
+L+L+ N L P
Sbjct: 290 TNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-36
Identities = 66/311 (21%), Positives = 126/311 (40%), Gaps = 31/311 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L +L+ L+ N+++ P + N + L LD+SSN S + L +L+ L N
Sbjct: 155 LTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNN 209
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ ++ L NL L L N L+ I + + + +L + ++
Sbjct: 210 QISD---------ITPLGILTNLDELSLNGNQLKDI--GTLASLT-NLTDLDLANNQISN 257
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
P + L+ + L ++ P + L L L L+ N+L+ P + +L+ L
Sbjct: 258 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNL 311
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
+ L L N + P ++SLT L+RL +NK++ SS +L + +++ N ++
Sbjct: 312 TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD 367
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
+ + NL +T L L+ + + T+ P + S
Sbjct: 368 --LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSY 423
Query: 305 ESLDLSRNNLS 315
D++ N S
Sbjct: 424 TEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-35
Identities = 67/307 (21%), Positives = 115/307 (37%), Gaps = 33/307 (10%)
Query: 13 LFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSA 72
D ++ T ++ + L + + + +L + L + +
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS---- 60
Query: 73 AKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGN 132
+ + NLT + ++N L I P + N + L + ++ P + N
Sbjct: 61 -----IDGVEYLNNLTQINFSNNQLTDITP--LKNLT-KLVDILMNNNQIADITP--LAN 110
Query: 133 LSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGN 192
L+ + L + P + L L L L N + L L L +L+ N
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-N 165
Query: 193 KLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQN 252
++ P LA+LT+L RL + SNK++ S L + + + N ++ + +
Sbjct: 166 QVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDI--TPLGI 219
Query: 253 LKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312
L L L L+ NQL T+ L NL L LA+NQ P L L L L N
Sbjct: 220 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 275
Query: 313 NLSGEIP 319
+S P
Sbjct: 276 QISNISP 282
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-41
Identities = 77/344 (22%), Positives = 129/344 (37%), Gaps = 20/344 (5%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
+ L L N++ + + L L+L+ N S + P F NL +L+ L L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN 125
L T NLT L ++ N + +L + + +L+ L
Sbjct: 92 LKLIPLGV-------FTGLSNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLV-Y 142
Query: 126 IPQEI-GNLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
I L+ + L C+L +IPT L L L L + Y L
Sbjct: 143 ISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L L ++ + P +L L + LT+ + L Y+ ++NLS N ++
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS 261
Query: 244 GSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302
++ ++ L L + L QL+ P GL L L+++ NQ F S+
Sbjct: 262 -TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVG 320
Query: 303 SLESLDLSRNNLS-----GEIPKNFSAQSFLSNYALC-GPARLQ 340
+LE+L L N L+ + + +F C P +Q
Sbjct: 321 NLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFVQ 364
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 42/201 (20%), Positives = 68/201 (33%), Gaps = 12/201 (5%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEG 183
IP E L DL + L+ L L+ N + ++ +L
Sbjct: 29 GIPTETRLL------DLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81
Query: 184 LSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242
L L L N+L +P L++L +L + NK+ + F L + + + N L
Sbjct: 82 LRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 243 NGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSL 301
+ L L L L + L+ + L L L L SF L
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 302 ISLESLDLSRNNLSGEIPKNF 322
L+ L++S + N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNC 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 40/216 (18%), Positives = 64/216 (29%), Gaps = 60/216 (27%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L L L ++ S +L +L++S + + +L LS+ +
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L A + + L L L+ NP+ I
Sbjct: 235 NLTAVPYLA-------VRHLVYLRFLNLSYNPISTIEG---SMLHE-------------- 270
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEG 183
L RLQ + L G +L + L
Sbjct: 271 --------------------------------LLRLQEIQLVGGQLA-VVEPYAFRGLNY 297
Query: 184 LSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKL 218
L LN++GN+L + S+ +L L L SN L
Sbjct: 298 LRVLNVSGNQL-TTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 25/94 (26%), Positives = 40/94 (42%), Gaps = 7/94 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L++L L N +S + + +L + L + + P F L L+VL+++ N
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLR 98
L T + + NL L L SNPL
Sbjct: 307 QLTTLEESV-------FHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 34/211 (16%), Positives = 62/211 (29%), Gaps = 39/211 (18%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L LK L + T+ + L L ++ + + + +L L+ L+L+YN
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYN 258
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ T + L L + L L + P F
Sbjct: 259 PISTIEGSM-------LHELLRLQEIQLVGGQLAVVEP---YAFR--------------- 293
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
L+ + V +++G L + + L+ L L N L C L +
Sbjct: 294 -------GLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD-----CRLLWV 341
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGS 215
P C A+ ++
Sbjct: 342 FR-RRWRLNFNRQQPTC-ATPEFVQGKEFKD 370
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-41
Identities = 75/276 (27%), Positives = 120/276 (43%), Gaps = 25/276 (9%)
Query: 423 LGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNC 480
+G G+FG V+ G L D T VA+K L F E IL+ H N++++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+V+E + G +L + L + L ++ D +EYL S +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDV 600
L N L+ E +SDFG+S+ +G + + + + APE + G S +SDV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 601 YSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKID 659
+S+GILL ETF+ P + +S + +E + G L E
Sbjct: 299 WSFGILLWETFSLGASP----YPN-LSNQQ-TREFVEKGGR------LPCPE-------L 339
Query: 660 CLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695
C ++ L C P QR S +L+ I+++
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 66/334 (19%), Positives = 120/334 (35%), Gaps = 30/334 (8%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
++ L L D ++ + A + L + N+ L P+ F N+ L VL L N
Sbjct: 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L + N LT L +++N L I + SLQ +L
Sbjct: 128 DLSSLPRGI-------FHNTPKLTTLSMSNNNLERI-EDDTFQATTSLQNLQLSSNRLT- 178
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
++ + + + +++ L + + ++ L N + + + L
Sbjct: 179 HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVEL 228
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
+ L L N L L + L + L N+L M F ++ + + +S N L
Sbjct: 229 TILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 285
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
+L Q + L LDLS N L + + LE L L N + + +L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 341
Query: 305 ESLDLSRNNLSG----EIPKNFSAQSFLSNYALC 334
++L LS N+ + +N + + C
Sbjct: 342 KNLTLSHNDWDCNSLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-29
Identities = 57/310 (18%), Positives = 110/310 (35%), Gaps = 26/310 (8%)
Query: 21 TIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSS 80
I +++ + + + L + ++++ + + +A
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL------- 64
Query: 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEI-GNLSGMIVF 139
L + R + +L L + I ++Q+ Y +R +P + N+ + V
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIR-YLPPHVFQNVPLLTVL 122
Query: 140 DLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEGLSELNLNGNKLCGHV 198
L DL+ +L L + N L+ I D L L L+ N+L HV
Sbjct: 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THV 180
Query: 199 PPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTN 258
+ + SL ++ N L+ + V ++ S NS+N + + LT
Sbjct: 181 DL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTI 230
Query: 259 LDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEI 318
L L N L+ D + L + L+ N+ + + F + LE L +S N L +
Sbjct: 231 LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 319 PKNFSAQSFL 328
L
Sbjct: 288 NLYGQPIPTL 297
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 41/225 (18%), Positives = 74/225 (32%), Gaps = 25/225 (11%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
++P+L + + N LS ++ + LD S NS + + L +L L +
Sbjct: 184 LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVE---LTILKLQH 235
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N L + L N L + L+ N L I+ L+ Y +L
Sbjct: 236 NNLTD---------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RLERLYISNNRLV 285
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
+ + + V DL+ L + + RL+ LYL N + ++
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHT 340
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGS 228
L L L+ N A ++ R + +
Sbjct: 341 LKNLTLSHNDW--DCNSLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 10/101 (9%), Positives = 30/101 (29%)
Query: 215 SNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTI 274
+ S+ +++ + + L + + + +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 275 GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
+E L+L D Q + +F +++ L + N +
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 59/333 (17%), Positives = 112/333 (33%), Gaps = 49/333 (14%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
K + D+ L + + +A + LDLS N S + L++L+L+ N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L L + L L L +N +
Sbjct: 69 VLYE---------TLDLESLSTLRTLDLNNNYV--------------------------- 92
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
QE+ + +++ + R + + +YL NK+ D +
Sbjct: 93 ---QELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 185 SELNLNGNKLCG-HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L+L N++ + AS +L L+L N + + ++LS+N L
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA 204
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ-GPVPKSFGSLI 302
+ Q+ +T + L N+L I + +NLE L N F G + F
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 303 SLESLDLSRN-NLSGEIPKNFSAQSFLSNYALC 334
++++ L+G+ + + + A C
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 39/206 (18%), Positives = 77/206 (37%), Gaps = 16/206 (7%)
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185
I + N + + + L + + ++ L L GN L DL L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
LNL+ N L + L SL++LR L L +N + + ++ + N+++
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 246 LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG-PVPKSFGSLISL 304
+ + + N+ L+ N+++ G ++ L L N+ + S +L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 305 ESLDLSRNNLSGEIPKNFSAQSFLSN 330
E L+L N + + Q +
Sbjct: 172 EHLNLQYNFIY-----DVKGQVVFAK 192
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 36/212 (16%), Positives = 68/212 (32%), Gaps = 16/212 (7%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGL-IPNTFGNLGSLQVLSLA 62
K + L +NK++ S++ LDL N + + +L+ L+L
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 63 YNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKL 122
YN++ + L L L+SN L + P + + + KL
Sbjct: 178 YNFIYD---------VKGQVVFAKLKTLDLSSNKLAFM-GPEFQSAA-GVTWISLRNNKL 226
Query: 123 RGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLE 182
I + + + FDL G + + + + ++ +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEEC 283
Query: 183 GLSELNLNGNKLCGHVP-PCLASLTSLRRLHL 213
+ L G C +P P L +L H
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 26/161 (16%), Positives = 55/161 (34%), Gaps = 22/161 (13%)
Query: 173 SIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYV 232
+I + + + L + S +++ L L N L+ + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 233 LYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLS------------------GDIPTTI 274
+NLS+N L ++++L L LDL+ N + + +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR 118
Query: 275 GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
+ + + LA+N+ G ++ LDL N +
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 73/285 (25%), Positives = 130/285 (45%), Gaps = 20/285 (7%)
Query: 423 LGTGSFGSVYKGTLF-----DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKII 477
LG G+FGSV G VA+K E R F+ E EIL+S++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 478 SNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
C + + L++E++P GSL +L H + ++ L + +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEYGSEGII 594
+H DL NIL++ + DFG++K+L + + ++ + I + APE +E
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 595 SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG---LTEVVDANLVREE 651
S SDV+S+G++L E FT + + M + + G + +++ L++
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG----NDKQGQMIVFHLIE--LLKNN 248
Query: 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696
C I + +C + QR S +D A ++ +I++
Sbjct: 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 18/284 (6%)
Query: 423 LGTGSFGSVYKGTLF-----DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKII 477
LG G+FGSV G VA+K E R F+ E EIL+S++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 478 SNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
C + + L++E++P GSL +L H + ++ L + +EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEYGSEGII 594
+H DL NIL++ + DFG++K+L + + ++ + I + APE +E
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 595 SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT--EVVDANLVREEQ 652
S SDV+S+G++L E FT + + M + K+ + +++ L++
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ---GQMIVFHLIE--LLKNNG 280
Query: 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696
C I + +C + QR S +D A ++ +I+++
Sbjct: 281 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-38
Identities = 65/345 (18%), Positives = 124/345 (35%), Gaps = 26/345 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
+K L L NK++ + + L +L L S+ + + + F +LGSL+ L L+ N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+L + SS+ +L L L NP + + + +LQ +
Sbjct: 85 HLSSLSSSW-------FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 125 NIPQE-IGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
I + L+ + ++ L ++ +R + L LH ++ + L
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFG----------SLEYVL 233
+ L L L L + + + + SF L V
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
Query: 234 YINLSANSLNGSLPSNIQNLK--------VLTNLDLSRNQLSGDIPTTIGGLENLETLSL 285
+ + + N L PS + + L + + L D+ T LE ++ +++
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 286 ADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSN 330
+++ L SLE LDLS N + E KN + + +
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 68/344 (19%), Positives = 124/344 (36%), Gaps = 34/344 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGL-IPNTFGNLGSLQVLSLAY 63
L +L++L L DN LS + S L L+L N + L + + F NL +LQ L +
Sbjct: 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
+E +L L + + LR + + + + +
Sbjct: 133 VETFSEIRR------IDFAGLTSLNELEIKALSLRNYQSQSLKSIR-DIHHLTLHLSESA 185
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQG----------S 173
+ LS + +L +L + + + +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 174 IPYDLCHLEGLSELNLNGNKLCG------HVPPCLASL--TSLRRLHLGSNKLTSTMPSS 225
+ + L + + N L V L + ++RRLH+ L + +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 226 FGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTT---IGGLENLE 281
+ LE V I + + + +P + Q+LK L LDLS N + + G +L+
Sbjct: 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 282 TLSLADNQFQ--GPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323
TL L+ N + + +L +L SLD+SRN +P +
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-32
Identities = 61/351 (17%), Positives = 121/351 (34%), Gaps = 38/351 (10%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L +L L + L S+ + + L L + + L+ L S++ L L
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 65 YLMT--ESSAAKWNFLSSL--TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYG- 119
L S S + R + + N L +L ++ + G
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 120 CKLRGNIPQEIGNLSGMIVFDLNGCDLNG-----TIPTAVGRLRRLQGLYLHGNKLQGSI 174
+ + L + + + + T L +++ + + +K+ +
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LV 325
Query: 175 PYDLC-HLEGLSELNLNGNKL---CGHVPPCLASLTSLRRLHLGSNKLTS--TMPSSFGS 228
P HL+ L L+L+ N + C + SL+ L L N L S +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 229 LEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLS---GDIPTTI----------- 274
L+ + +++S N+ + +P + Q + + L+LS + IP T+
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD 444
Query: 275 ---GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNF 322
L L+ L ++ N+ + S L + +SRN L +P
Sbjct: 445 SFSLFLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLK-SVPDGI 492
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-30
Identities = 56/342 (16%), Positives = 110/342 (32%), Gaps = 35/342 (10%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
+ ++ +LTL ++ + + S + L+L + + + +
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGIL---PPLIGNFSA-------SLQE 114
+ + L L L+ + L G+ P S +++
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290
Query: 115 FYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSI 174
+ L ++ L + + + + L+ L+ L L N +
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY 350
Query: 175 PYD---LCHLEGLSELNLNGNKL--CGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSL 229
+ L L L+ N L L +L +L L + N MP S
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWP 409
Query: 230 EYVLYINLSAN---SLNGSLPSNIQNLKV--------------LTNLDLSRNQLSGDIPT 272
E + ++NLS+ + +P ++ L V L L +SRN+L +P
Sbjct: 410 EKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPD 468
Query: 273 TIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
L + ++ NQ + F L SL+ + L N
Sbjct: 469 A-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 48/317 (15%), Positives = 101/317 (31%), Gaps = 21/317 (6%)
Query: 5 LPNLKYLTLFDNKLSGTIP-NSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L NL+ L + + + I + L L++ + S + ++ + L+L
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
+ + ++ L L L FS + + K
Sbjct: 182 SES-------AFLLEIFADILSSVRYLELRDTNLARF------QFSPLPVDEVSSPMKKL 228
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
+ + S + L L + ++
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILE-LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
+ L++ L + + L ++R+ + ++K+ S L+ + +++LS N +
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
Query: 244 GSLPSN---IQNLKVLTNLDLSRNQLS--GDIPTTIGGLENLETLSLADNQFQGPVPKSF 298
N L L LS+N L + L+NL +L ++ N F P+P S
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSC 406
Query: 299 GSLISLESLDLSRNNLS 315
+ L+LS +
Sbjct: 407 QWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 49/288 (17%), Positives = 93/288 (32%), Gaps = 42/288 (14%)
Query: 7 NLKYLTLFDNKLSGTIPNSIT-NASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
L L F+ S + + L + + + L ++ +++ +
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSA--SLQEFYAYGCKLR 123
+ + + ++L L L+ N + A SLQ L
Sbjct: 322 VFLVPCSF-------SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV-----LS 369
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
N + + +++ L+ L L + N +P E
Sbjct: 370 QNHLRSMQKTGEILL-----------------TLKNLTSLDISRNTFH-PMPDSCQWPEK 411
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
+ LNL+ + V C+ +L L + +N L S L+ + +S N L
Sbjct: 412 MRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNNNLDS-FSLFLPRLQE---LYISRNKLK 464
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
+LP VL + +SRNQL L +L+ + L N +
Sbjct: 465 -TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 45/241 (18%), Positives = 83/241 (34%), Gaps = 17/241 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
++ L + L + + K+ + + ++ + + +L SL+ L L+ N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFS--ASLQEFYAYGCKL 122
LM E + + L L L+ N LR + +L
Sbjct: 345 -LMVEEYLKNSACKGAWPS---LQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTF 399
Query: 123 RGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLE 182
+P M +L+ + + T + + L+ L + N L S L
Sbjct: 400 H-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLP 451
Query: 183 GLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242
L EL ++ NKL +P + L + + N+L S F L + I L N
Sbjct: 452 RLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
Query: 243 N 243
+
Sbjct: 510 D 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 42/235 (17%), Positives = 78/235 (33%), Gaps = 6/235 (2%)
Query: 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLN 142
+C V S I P +A+++ K+ ++ + + V L
Sbjct: 3 SCDASGVCDGRSRSFTSI-PS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58
Query: 143 GCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKL-CGHVPPC 201
+N A L L+ L L N L L L LNL GN V
Sbjct: 59 SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 202 LASLTSLRRLHLGS-NKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLD 260
+LT+L+ L +G+ + F L + + + A SL ++++++ + +L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 261 LSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
L ++ + + L ++ L L D + S
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-38
Identities = 58/320 (18%), Positives = 105/320 (32%), Gaps = 27/320 (8%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
K + D+ L + + +A + LDLS N S + L++L+L+ N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L L + L L L +N ++ + S++ +A +
Sbjct: 69 VLYE---------TLDLESLSTLRTLDLNNNYVQEL-LVG-----PSIETLHAANNNIS- 112
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQG-SIPYDLCHLEG 183
+ G L + G R+Q L L N++ + +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L LNL N + V L+ L L SNKL M F S V +I+L N L
Sbjct: 171 LEHLNLQYNFI-YDVKG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGD-IPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302
+ ++ + L + DL N + + ++T++ + ++
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECT 284
Query: 303 SLESLDLSRNNLSGEIPKNF 322
++P F
Sbjct: 285 VPTLGHYGAYCCE-DLPAPF 303
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-37
Identities = 59/316 (18%), Positives = 119/316 (37%), Gaps = 25/316 (7%)
Query: 22 IPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSL 81
I N ++ + ++ +S + + + +++ L L+ N L S+ + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA-------ADL 54
Query: 82 TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDL 141
L +L L+SN L L + + S +L+ L N QE+ +
Sbjct: 55 APFTKLELLNLSSNVLYETLD--LESLS-TLRTLD-----LNNNYVQELLVGPSIETLHA 106
Query: 142 NGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCG-HVPP 200
+++ + R + + +YL NK+ D + L+L N++ +
Sbjct: 107 ANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 201 CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLD 260
AS +L L+L N + + ++LS+N L + Q+ +T +
Sbjct: 164 LAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 261 LSRNQLSGDIPTTIGGLENLETLSLADNQFQ-GPVPKSFGSLISLESLDLSRN-NLSGEI 318
L N+L I + +NLE L N F G + F ++++ L+G+
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 319 PKNFSAQSFLSNYALC 334
+ + + A C
Sbjct: 280 EEECTVPTLGHYGAYC 295
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 50/315 (15%), Positives = 89/315 (28%), Gaps = 21/315 (6%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
P+++ L +N +S + + L++N + L G +Q L L N
Sbjct: 98 GPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ T NF + L L L N + + + A L+ KL
Sbjct: 155 EIDT------VNFAELAASSDTLEHLNLQYNFIYDV-KGQV--VFAKLKTLDLSSNKLA- 204
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQ-GSIPYDLCHLEG 183
+ E + +G+ L L I A+ + L+ L GN G++ +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
+ + K T H G+ L + + S
Sbjct: 264 VQTVAKQTVKKLTGQN--EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ 321
Query: 244 GSLPSNIQ----NLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFG 299
GS ++ N +D + Q I + TL V
Sbjct: 322 GSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381
Query: 300 SLISLESLDLSRNNL 314
+ L+
Sbjct: 382 AHAELDGTLQQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-29
Identities = 53/332 (15%), Positives = 100/332 (30%), Gaps = 30/332 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L+ L L N L + + S L LDL++N S++ L A N
Sbjct: 57 FTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANN 109
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ S + + + LA+N + + G S +Q ++
Sbjct: 110 NISRVSCSR----------GQGKKNIYLANNKITMLRDLDEGCRS-RVQYLDLKLNEIDT 158
Query: 125 -NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
N + + + +L + + V +L+ L L NKL + + G
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKL-TSTMPSSFGSLEYVLYINLSANSL 242
++ ++L NKL + L +L L N T+ F + V ++ ++
Sbjct: 216 VTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ--TVAKQTV 272
Query: 243 NGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG----PVPKSF 298
N + V T L L+ A QG +
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECER 332
Query: 299 GSLISLESLDLSRNNLSGEIPKNFSAQSFLSN 330
+ +D + I + +
Sbjct: 333 ENQARQREIDALKEQYRTVIDQVTLRKQAKIT 364
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 5e-18
Identities = 30/281 (10%), Positives = 68/281 (24%), Gaps = 16/281 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
LK L L NKL+ + +A+ + + L +N I +L+ L N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGN 247
Query: 65 YLMT---ESSAAKWNFLSSLTNCRNLTVLGLASNPLRGI-LPPLIGNFSASLQEFYAYGC 120
+K + ++ + G L L +A
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
+ + G + R + + + + I
Sbjct: 308 IALKRKEHALLSGQGS---------ETERLECERENQARQREIDALKEQYRTVIDQVTLR 358
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
+ L L V + L + ++ L +
Sbjct: 359 KQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKR 418
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLE 281
+ + + D+ +++ + + L+ L
Sbjct: 419 YEEMYVEQQSVQNNAIRDWDMYQHKET-QLAEENARLKKLN 458
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 14/72 (19%), Positives = 25/72 (34%)
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
++ QN ++ + L + + N++ L L+ N L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 305 ESLDLSRNNLSG 316
E L+LS N L
Sbjct: 61 ELLNLSSNVLYE 72
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 74/280 (26%), Positives = 117/280 (41%), Gaps = 19/280 (6%)
Query: 423 LGTGSFGSVYKGTLF-----DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKII 477
LG G+FGSV G VA+K R F E +IL+++ ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 478 SNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
++ LV+E++P+G L +L H L L + +EYL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEYGSEGII 594
VH DL NIL++ ++DFG++KLL D V++ + I + APE S+ I
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 595 SPKSDVYSYGILLMETFTR-KKPTNEIFIGEMSLKHWVKESLPD-GLTEVVDANLVREEQ 652
S +SDV+S+G++L E FT K + L+ +++ L+ E Q
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRLLE--LLEEGQ 261
Query: 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
C + L C SP+ R S +L +
Sbjct: 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-37
Identities = 59/313 (18%), Positives = 111/313 (35%), Gaps = 27/313 (8%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L N K +T ++ + + + ++ +L+L+ + F ++Q L + +N
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ N LTVL L N L LP I + + L L
Sbjct: 110 AIRYLPPHV-------FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE- 160
Query: 125 NIPQEI-GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
I + + + L+ L + + + L + N L L
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIA 212
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
+ EL+ + N + V L L L N LT + + ++ ++LS N L
Sbjct: 213 VEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE 267
Query: 244 GSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302
+ + ++ L L +S N+L + + L+ L L+ N V ++
Sbjct: 268 -KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFD 324
Query: 303 SLESLDLSRNNLS 315
LE+L L N++
Sbjct: 325 RLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-35
Identities = 60/311 (19%), Positives = 104/311 (33%), Gaps = 50/311 (16%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
++ L + N + P+ N L +L L N S L F N L LS++ N
Sbjct: 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN 157
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L +L L L+SN L +
Sbjct: 158 NLERIEDDT-------FQATTSLQNLQLSSNRLTHV------------------------ 186
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
++ + + +++ L + + ++ L N + + + L
Sbjct: 187 ----DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVN--VEL 234
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
+ L L N L L + L + L N+L M F ++ + + +S N L
Sbjct: 235 TILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 291
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
+L Q + L LDLS N L + + LE L L N + + +L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 347
Query: 305 ESLDLSRNNLS 315
++L LS N+
Sbjct: 348 KNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 57/310 (18%), Positives = 110/310 (35%), Gaps = 26/310 (8%)
Query: 21 TIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSS 80
I +++ + + + L + ++++ + + +A
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL------- 70
Query: 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEI-GNLSGMIVF 139
L + R + +L L + I ++Q+ Y +R +P + N+ + V
Sbjct: 71 LDSFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIR-YLPPHVFQNVPLLTVL 128
Query: 140 DLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEGLSELNLNGNKLCGHV 198
L DL+ +L L + N L+ I D L L L+ N+L HV
Sbjct: 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THV 186
Query: 199 PPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTN 258
+ + SL ++ N L+ + V ++ S NS+N + + LT
Sbjct: 187 DL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTI 236
Query: 259 LDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEI 318
L L N L+ D + L + L+ N+ + + F + LE L +S N L +
Sbjct: 237 LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 293
Query: 319 PKNFSAQSFL 328
L
Sbjct: 294 NLYGQPIPTL 303
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 20/128 (15%), Positives = 45/128 (35%), Gaps = 3/128 (2%)
Query: 195 CGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNL 253
+ L +H+ +L + +++ LP+ + +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 74
Query: 254 KVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNN 313
+ + L+L+ Q+ ++ L + N + P F ++ L L L RN+
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134
Query: 314 LSGEIPKN 321
LS +P+
Sbjct: 135 LS-SLPRG 141
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 60/279 (21%), Positives = 114/279 (40%), Gaps = 16/279 (5%)
Query: 423 LGTGSFGSVYKGTLF-----DGTNVAIKVF-NLQLERASRSFDSECEILRSIRHRNLIKI 476
LG G FG V G VA+K E EILR++ H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 477 ISNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
C L++EF+P+GSL+++L + + + ++L + + ++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ-- 146
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEYGSEGI 593
VH DL N+L++ + DFG++K + + ++ + + + APE +
Sbjct: 147 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 594 ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653
SDV+S+G+ L E T + + + + +T +V+ ++E +
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT--VTRLVN--TLKEGKR 261
Query: 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+C + L C P R S ++ + +
Sbjct: 262 LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 11/201 (5%)
Query: 423 LGTGSFGSVYKGTLFDG-----TNVAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKI 476
LG+G+FG+VYKG VAIK + E ++ S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ C L+ + MP G L ++ H +G LN + + + YL +
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
VH DL N+L+ ++DFG++KLLG + I +MA E I +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 597 KSDVYSYGILLMETFTR-KKP 616
+SDV+SYG+ + E T KP
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 58/205 (28%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 423 LGTGSFGSVYKGTL----FDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIK 475
LG GSFG V +G +VA+K L A F E + S+ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ K +V E P GSL L H + + V + YL
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--- 141
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT---IGYMAPEYGSEG 592
+H DL N+LL + DFG+ + L + DD M + APE
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPESLKTR 199
Query: 593 IISPKSDVYSYGILLMETFTR-KKP 616
S SD + +G+ L E FT ++P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-36
Identities = 70/330 (21%), Positives = 111/330 (33%), Gaps = 49/330 (14%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
++ L + DN L+ ++P L L++S N + L P L L + S
Sbjct: 60 PAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLTSL-PVLPPGLLELSIFSNPLT 114
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+L S L L + N L LP L LQE +L
Sbjct: 115 HLPALPS--------------GLCKLWIFGNQLTS-LPVLPPG----LQELSVSDNQLA- 154
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
++P L L ++P L+ L + N+L S+P L L
Sbjct: 155 SLPALPSELC---KLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKL 206
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
N L A + L+ L + N+LTS +P L+ + +S N L
Sbjct: 207 WAYNNRLTSL-------PALPSGLKELIVSGNRLTS-LPVLPSELKE---LMVSGNRLT- 254
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
SLP L +L + RNQL+ +P ++ L + T++L N ++ + S
Sbjct: 255 SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310
Query: 305 ESLDLSRNNLSGEIPKNFSAQSFLSNYALC 334
L A
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAAD 340
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-33
Identities = 67/314 (21%), Positives = 124/314 (39%), Gaps = 52/314 (16%)
Query: 30 SKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSA--------AKWNFLSSL 81
+ +L++ + + L P+ + L + N L + + N L+SL
Sbjct: 40 NGNAVLNVGESGLTTL-PDCLPA--HITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSL 96
Query: 82 ----TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMI 137
L++ LP L L + + +G +L ++P L
Sbjct: 97 PVLPPGLLELSIFSNPLTH----LPALPSG----LCKLWIFGNQLT-SLPVLPPGLQ--- 144
Query: 138 VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGH 197
++ L ++P L + L+ + N+L S+P L+ EL+++ N+L
Sbjct: 145 ELSVSDNQLA-SLPALPSELCK---LWAYNNQLT-SLPMLPSGLQ---ELSVSDNQLA-S 195
Query: 198 VPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLT 257
+P + L +L +N+LTS +P+ L+ + +S N L SLP L
Sbjct: 196 LPT---LPSELYKLWAYNNRLTS-LPALPSGLK---ELIVSGNRLT-SLPVLPSE---LK 244
Query: 258 NLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGE 317
L +S N+L+ +P L +LS+ NQ +P+S L S +++L N LS
Sbjct: 245 ELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSER 299
Query: 318 IPKNFSAQSFLSNY 331
+ + Y
Sbjct: 300 TLQALREITSAPGY 313
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-27
Identities = 50/232 (21%), Positives = 80/232 (34%), Gaps = 36/232 (15%)
Query: 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNG 143
VL + + L LP + + L ++P L +++G
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA---HITTLVIPDNNLT-SLPALPPELR---TLEVSG 90
Query: 144 CDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLA 203
L ++P L L L GL +L + GN+L +P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPV--- 138
Query: 204 SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSR 263
L+ L + N+L S +P+ L + N L SLP L L +S
Sbjct: 139 LPPGLQELSVSDNQLAS-LPALPSELC---KLWAYNNQLT-SLPMLPSG---LQELSVSD 190
Query: 264 NQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
NQL+ +PT L L +N+ +P L+ L +S N L+
Sbjct: 191 NQLA-SLPTLPSELYKLWAY---NNRLT-SLPALPS---GLKELIVSGNRLT 234
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 6e-18
Identities = 36/145 (24%), Positives = 53/145 (36%), Gaps = 20/145 (13%)
Query: 179 CHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
C G + LN+ + L +P CL + L + N LTS +P+ L + +S
Sbjct: 37 CLNNGNAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNLTS-LPALPPELR---TLEVS 89
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSF 298
N L SLP L L+ L L L + NQ +P
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLTS-LPVLP 140
Query: 299 GSLISLESLDLSRNNLSGEIPKNFS 323
L+ L +S N L+ +P S
Sbjct: 141 P---GLQELSVSDNQLA-SLPALPS 161
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 50/194 (25%), Positives = 97/194 (50%), Gaps = 7/194 (3%)
Query: 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISN 479
LG G FG V+ T T VA+K + +F +E ++++++H L+K+
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLH-A 250
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHNY-FLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
+ ++ EFM GSL +L S + + ++ + + ++ + +H
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
DL+ NIL+ ++ ++DFG+++++ + + + + I + APE + G + KS
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKS 366
Query: 599 DVYSYGILLMETFT 612
DV+S+GILLME T
Sbjct: 367 DVWSFGILLMEIVT 380
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 423 LGTGSFGSVYKGTLFDG---TNVAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKIIS 478
LG G+FGSV +G +VAIKV E+A E +I+ + + ++++I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
C LV+E G L K+L + + ++ V + ++YL + VH
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 133
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT---IGYMAPEYGSEGIIS 595
DL N+LL A +SDFG+SK LG D T A + + APE + S
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECINFRKFS 191
Query: 596 PKSDVYSYGILLMETFTR-KKP 616
+SDV+SYG+ + E + +KP
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 70/285 (24%), Positives = 123/285 (43%), Gaps = 22/285 (7%)
Query: 423 LGTGSFGSVYKGTL-----FDGTNVAIKVFNLQ---LERASRSFDSECEILRSIRHRNLI 474
LG G FG V G VA+K L+ + + E +ILR++ H ++I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 475 KIISNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
K C + + LV+E++P GSL +L H+ +G+ + L + + YLH H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH 154
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEYGSE 591
+H DL N+LLD + + DFG++K + EG + ++ + + + APE E
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 592 GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651
SDV+S+G+ L E T + + L + + + + + L+
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT--VLRLTE--LLERG 267
Query: 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696
+ C + HL +C R + ++ LK + EK+
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-36
Identities = 58/194 (29%), Positives = 100/194 (51%), Gaps = 7/194 (3%)
Query: 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISN 479
LG G FG V+ GT T VAIK + +F E ++++ +RH L+++ +
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA- 246
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
+ + +V E+M GSL +L +L + + +++ + + Y+ + VH
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
DL+ NIL+ EN+ V+DFG+++L+ + + + Q I + APE G + KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKS 362
Query: 599 DVYSYGILLMETFT 612
DV+S+GILL E T
Sbjct: 363 DVWSFGILLTELTT 376
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 17/233 (7%)
Query: 389 KDGDQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDG----TNVAI 444
+D D L + I + ++G G FG VY G D AI
Sbjct: 1 RDLDSALLAEVKDV------LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAI 54
Query: 445 KVFN-LQLERASRSFDSECEILRSIRHRNLIKIISNCCNID-FKALVLEFMPNGSLEKWL 502
K + + + +F E ++R + H N++ +I + ++L +M +G L +++
Sbjct: 55 KSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
Query: 503 YSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562
S + + ++ + V +EYL VH DL N +LDE+ T V+DFG++
Sbjct: 115 RSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 563 KLLGEGDDSVIQTMTIAT--IGYMAPEYGSEGIISPKSDVYSYGILLMETFTR 613
+ + + + +Q A + + A E + KSDV+S+G+LL E TR
Sbjct: 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-36
Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 39/292 (13%)
Query: 421 NLLGTGSFGSVYKGTLFDG----TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIK 475
++G G FG VY GTL D + A+K N F +E I++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 476 IISNCCNIDFKAL-VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
++ C + L VL +M +G L ++ + + + + + + V +++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-- 212
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEYGSEG 592
VH DL N +LDE T V+DFG+++ + + + + T A + +MA E
Sbjct: 213 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 593 IISPKSDVYSYGILLMETFTR-KKP----TNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647
+ KSDV+S+G+LL E TR P ++
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---------------------DIT--VY 308
Query: 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDD 699
+ + + C + + L C E R S + +++ I F+ +
Sbjct: 309 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 423 LGTGSFGSVYKGTLFDG-----TNVAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKI 476
LG+G FG+V+KG V IKV + R S + S+ H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ C LV +++P GSL + H LG LN + + + YL M
Sbjct: 81 LG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---M 136
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
VH +L N+LL V+DFG++ LL D ++ + I +MA E G +
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196
Query: 597 KSDVYSYGILLMETFTR-KKP 616
+SDV+SYG+ + E T +P
Sbjct: 197 QSDVWSYGVTVWELMTFGAEP 217
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 421 NLLGTGSFGSVYKGTLFDG----TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIK 475
++G G FG VY GTL D + A+K N F +E I++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 476 IISNCCNIDFKAL-VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
++ C + L VL +M +G L ++ + + + + + + V ++YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SK 147
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEYGSEG 592
VH DL N +LDE T V+DFG+++ + + + + T A + +MA E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 593 IISPKSDVYSYGILLMETFTR 613
+ KSDV+S+G+LL E TR
Sbjct: 208 KFTTKSDVWSFGVLLWELMTR 228
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 423 LGTGSFGSVYKGTLFDGTN----VAIKVFNL-QLERASRSFDSECEILRSIRHRNLIKII 477
+G+G G V G L VAIK ER R F SE I+ H N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
+V E+M NGSL+ +L +H+ I++ + ++ VG + YL V
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM-TIATIGYMAPEYGSEGIISP 596
H DL N+L+D N+ VSDFG+S++L + D+ T I + APE + S
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 597 KSDVYSYGILLMETFTR-KKP 616
SDV+S+G+++ E ++P
Sbjct: 234 ASDVWSFGVVMWEVLAYGERP 254
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 58/194 (29%), Positives = 100/194 (51%), Gaps = 7/194 (3%)
Query: 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISN 479
LG G FG V+ GT T VAIK + +F E ++++ +RH L+++ +
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA- 329
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
+ + +V E+M GSL +L +L + + +++ + + Y+ + VH
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
DL+ NIL+ EN+ V+DFG+++L+ + + + Q I + APE G + KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKS 445
Query: 599 DVYSYGILLMETFT 612
DV+S+GILL E T
Sbjct: 446 DVWSFGILLTELTT 459
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 11/201 (5%)
Query: 423 LGTGSFGSVYKGTLFDG-----TNVAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKI 476
LG+G+FG+VYKG VAIK + E ++ S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ C L+ + MP G L ++ H +G LN + + + YL +
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
VH DL N+L+ ++DFG++KLLG + I +MA E I +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 597 KSDVYSYGILLMETFTR-KKP 616
+SDV+SYG+ + E T KP
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP 219
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-35
Identities = 73/339 (21%), Positives = 124/339 (36%), Gaps = 35/339 (10%)
Query: 5 LPNLKYLTLFDNKLSGTIP-NSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L +L++L + I N+ S LI+L L N F L F L +L+VL+L
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQ 112
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
L + + NF LT +L +L L N ++ I P K++
Sbjct: 113 CNL--DGAVLSGNFFKPLT---SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
Query: 124 GNIPQEI-----------GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQG 172
+I +E LS + + D+N L + + L L GN +
Sbjct: 168 -SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226
Query: 173 SIPYDLCHLEGLSEL-----NLNGNKLCGHVPPCLASL----------TSLRRLHLGSNK 217
S+ +++ + + N + ++ L +K
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSK 286
Query: 218 LTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGG 276
+ + + S F + + L+ N +N + N L L L+LS+N L
Sbjct: 287 IFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345
Query: 277 LENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
L+ LE L L+ N + +SF L +L+ L L N L
Sbjct: 346 LDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-31
Identities = 71/319 (22%), Positives = 120/319 (37%), Gaps = 22/319 (6%)
Query: 5 LPNLKYLTLFDNKL-SGTIPNSI-TNASKLIMLDLSSNSFSGLIPNT-FGNLGSLQVLSL 61
L NL+ LTL L + + + L ML L N+ + P + F N+ VL L
Sbjct: 102 LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDL 161
Query: 62 AYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFS--ASLQEFYAYG 119
+N + + NF L+ + L + GN S+ G
Sbjct: 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSG 221
Query: 120 CKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
+ ++ + + + G + +
Sbjct: 222 NGFKESMAKRFFDAIAGTKIQSLILSNS-----------YNMGSSFGHTNFKDPDNFTFK 270
Query: 180 HLE--GLSELNLNGNKLCGHVPPCL-ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYIN 236
LE G+ +L+ +K+ + + + T L +L L N++ ++F L ++L +N
Sbjct: 271 GLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLN 329
Query: 237 LSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP 295
LS N L GS+ S + +NL L LDLS N + + GL NL+ L+L NQ +
Sbjct: 330 LSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPD 388
Query: 296 KSFGSLISLESLDLSRNNL 314
F L SL+ + L N
Sbjct: 389 GIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 75/346 (21%), Positives = 119/346 (34%), Gaps = 64/346 (18%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIP-NTFGNLGSLQVLSLAYN 64
++ Y+ L N ++ S + L L + + +I NTF L SL +L L YN
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRG-ILPPLIGNFS--ASLQEFYAYGCK 121
+ + A NL VL L L G +L F SL+
Sbjct: 90 QFLQLETGA-------FNGLANLEVLTLTQCNLDGAVLSG--NFFKPLTSLEMLV----- 135
Query: 122 LRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL 181
LR N I + F +RR L L NK++ DL +
Sbjct: 136 LRDN---NIKKIQPASFFL---------------NMRRFHVLDLTFNKVKSICEEDLLNF 177
Query: 182 EG--LSELNLNGNKL--------CGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLE- 230
+G + L L+ L TS+ L L N +M F
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIA 237
Query: 231 ----YVLYINLSANSLNGSLPSNIQNLKV----------LTNLDLSRNQLSGDIPTTI-G 275
L ++ S N + +N ++ + DLS++++ + ++
Sbjct: 238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFS 296
Query: 276 GLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKN 321
+LE L+LA N+ +F L L L+LS+N L I
Sbjct: 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSR 341
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 57/283 (20%), Positives = 91/283 (32%), Gaps = 46/283 (16%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTFGNLGS--LQVLSL 61
L +L+ L L DN + P S N + +LDL+ N + N +L L
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL 187
Query: 62 AYNYL-MTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGN-------FSASLQ 113
+ L W + ++T L L+ N + + + S L
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247
Query: 114 EFYAYGCKLRGNIPQEIGNLS--GMIVFDLNGCDLNG----------------------- 148
Y G ++ N + G+ + CDL+
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLA 307
Query: 149 -----TIPTAV-GRLRRLQGLYLHGNKLQGSIPYDLCH-LEGLSELNLNGNKLCGHVPPC 201
I L L L L N L SI + L+ L L+L+ N + +
Sbjct: 308 QNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQ 365
Query: 202 L-ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L +L+ L L +N+L S F L + I L N +
Sbjct: 366 SFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-17
Identities = 44/213 (20%), Positives = 70/213 (32%), Gaps = 16/213 (7%)
Query: 132 NLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQGLYLHGNKLQGSIPYD-LCHLEGLSELNL 189
L + + I L L L L N+ + L L L L
Sbjct: 52 RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTL 110
Query: 190 NGNKLCGHVPP--CLASLTSLRRLHLGSNKLTSTMPSS-FGSLEYVLYINLSANSLNGSL 246
L G V LTSL L L N + P+S F ++ ++L+ N +
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
Query: 247 PSNIQNL--KVLTNLDLSRNQL--------SGDIPTTIGGLENLETLSLADNQFQGPVPK 296
++ N K T L LS L + ++ TL L+ N F+ + K
Sbjct: 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 297 SFGSLISLESLDLSRNNLSGEIPKNFSAQSFLS 329
F I+ + + S + +F +F
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD 263
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 38/194 (19%), Positives = 64/194 (32%), Gaps = 60/194 (30%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVL 59
G +K L +K+ + S+ ++ + L L L+ N + + N F L L L
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328
Query: 60 SLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYG 119
+L+ N+L + S N L VL L+ N +R
Sbjct: 329 NLSQNFLGSIDSRM-------FENLDKLEVLDLSYNHIR--------------------- 360
Query: 120 CKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-L 178
+ + F L L+ L L N+L+ S+P
Sbjct: 361 -----ALGDQ--------SFL---------------GLPNLKELALDTNQLK-SVPDGIF 391
Query: 179 CHLEGLSELNLNGN 192
L L ++ L+ N
Sbjct: 392 DRLTSLQKIWLHTN 405
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 58/191 (30%), Positives = 91/191 (47%), Gaps = 7/191 (3%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKIISNCC 481
+G+G FG V+ G + VAIK ++ S F E E++ + H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541
LV EFM +G L +L + L + +DV + YL ++H DL
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 130
Query: 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVY 601
N L+ EN VSDFG+++ + D T T + + +PE S S KSDV+
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 602 SYGILLMETFT 612
S+G+L+ E F+
Sbjct: 190 SFGVLMWEVFS 200
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 423 LGTGSFGSVYKGTLFDGTN-----VAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKI 476
+G G FG VYKG L + VAIK E+ F E I+ H N+I++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
++ E+M NG+L+K+L + +L+ + ++ + ++YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 168
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM-TIATIGYMAPEYGSEGIIS 595
VH DL NIL++ N+ VSDFG+S++L + ++ T I + APE S +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 596 PKSDVYSYGILLMETFTR-KKP 616
SDV+S+GI++ E T ++P
Sbjct: 229 SASDVWSFGIVMWEVMTYGERP 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-35
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 423 LGTGSFGSVYKGTLFDG---TNVAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKIIS 478
LG G+FGSV +G +VAIKV E+A E +I+ + + ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
C + LV+E G L K+L + + ++ V + ++YL + VH
Sbjct: 404 -VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 459
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT---IGYMAPEYGSEGIIS 595
+L N+LL A +SDFG+SK LG D T A + + APE + S
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECINFRKFS 517
Query: 596 PKSDVYSYGILLMETFTR-KKP 616
+SDV+SYG+ + E + +KP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-35
Identities = 72/359 (20%), Positives = 119/359 (33%), Gaps = 46/359 (12%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
P L+ L L ++ + + S L L L+ N L F L SLQ L
Sbjct: 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L + + + + + L L +A N ++ P + +L+ K++
Sbjct: 111 NLASLENFP-------IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 125 NIPQEIGNLSGMIVF----DLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
++ L M + DL+ +N I + RL L L N ++
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 181 -LEGLSELNLNGNKLCGHV------PPCLASLTSLRRLHLGSNKLT---STMPSSFGSLE 230
L GL L + L L +L L + F L
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 231 YVLYINLSANSL----NGSLPSNIQNLKV---------------LTNLDLSRNQLSGDIP 271
V +L + ++ + S Q+L++ L L + N+
Sbjct: 283 NVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS 342
Query: 272 TTIGGLENLETLSLADNQ--FQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFL 328
L +LE L L+ N F+G +S SL+ LDLS N + + NF L
Sbjct: 343 EV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL 398
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-34
Identities = 66/341 (19%), Positives = 111/341 (32%), Gaps = 38/341 (11%)
Query: 5 LPNLKYLTLFDNKLSGTIP-NSITNASKLIMLDLSSNSFSG------LIPNTFGNLGSLQ 57
L LTL +N S + I + L + L F + L +L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 58 VLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYA 117
+ YL + + N++ L S + + +++ Q
Sbjct: 259 IEEFRLAYLDYYLD----DIIDLFNCLTNVSSFSLVSVTIERVKD---FSYNFGWQHLEL 311
Query: 118 YGCK----------------LRGNIPQEIGNLSGMI---VFDLNGCDLN--GTIPTAVGR 156
CK N + + DL+ L+ G +
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 157 LRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPC-LASLTSLRRLHLGS 215
L+ L L N + ++ + LE L L+ + L SL +L L +
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 216 NKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTI 274
F L + + ++ NS + +I L+ LT LDLS+ QL PT
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 275 GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
L +L+ L++A NQ + F L SL+ + L N
Sbjct: 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 68/327 (20%), Positives = 111/327 (33%), Gaps = 18/327 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIM----LDLSSNSFSGLIPNTFGNLGSLQVLS 60
L NL++L L NK+ + ++ + LDLS N + + P F + L L+
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLT 206
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSA-SLQEFYAYG 119
L N+ L+ L R + L + +++EF
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 120 CKLRGN-IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL 178
+ I L+ + F L + + Q L L K P
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFG-QFPTL- 322
Query: 179 CHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLT--STMPSSFGSLEYVLYIN 236
L+ L L NK L SL L L N L+ S + Y++
Sbjct: 323 -KLKSLKRLTFTSNKG--GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 237 LSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQGPVP 295
LS N + ++ SN L+ L +LD + L ++ L NL L ++ +
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 296 KSFGSLISLESLDLSRNNLSGEIPKNF 322
F L SLE L ++ N+ +
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 70/342 (20%), Positives = 114/342 (33%), Gaps = 41/342 (11%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
+ K L L N L S + +L +LDLS + + +L L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 66 LMTESSAA------------KWNFLSSL-----TNCRNLTVLGLASNPLRGILPPLIGNF 108
+ + + A L+SL + + L L +A N ++ P +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 109 SASLQEFYAYGCKLRGNIPQEIGNLSGMIVF----DLNGCDLNGTIPTAVGRLRRLQGLY 164
+L+ K++ ++ L M + DL+ +N I + RL L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206
Query: 165 LHGNKLQGSIPYDLCH-LEGLSELNLNGNKLCGHV------PPCLASLTSLRRLHLGSNK 217
L N ++ L GL L + L L +L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 218 LT---STMPSSFGSLEYVLYINLSANSLNGSLP-SNIQNLKVLTNLDLSRNQLSGDIPTT 273
L + F L V +L + ++ S + L ++ Q
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT----- 321
Query: 274 IGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
L++L+ L+ N+ S L SLE LDLSRN LS
Sbjct: 322 -LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLS 360
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 54/271 (19%), Positives = 87/271 (32%), Gaps = 20/271 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L N+ +L + S L+L + F L SL+ L+ N
Sbjct: 281 LTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQF---PTLKLKSLKRLTFTSN 335
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGI-LPPLIGNFSASLQEFYAYGCKLR 123
S + +L L L+ N L + SL+ +
Sbjct: 336 KG---------GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQGLYLHGNKLQGSIPYDLCHLE 182
+ L + D +L +V LR L L + + + L
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 183 GLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241
L L + GN + P L +L L L +L P++F SL + +N+++N
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505
Query: 242 LNGSLPSNI-QNLKVLTNLDLSRNQLSGDIP 271
L S+P I L L + L N P
Sbjct: 506 LK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 48/216 (22%), Positives = 79/216 (36%), Gaps = 7/216 (3%)
Query: 107 NFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLH 166
N S + LR + + V DL+ C++ A L L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 167 GNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTS-TMPSS 225
GN +Q L L +L L + L +L+ L++ N + S +P
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 226 FGSLEYVLYINLSANSLNGSLPSNIQNLKVLTN----LDLSRNQLSGDIPTTIGGLENLE 281
F +L + +++LS+N + ++++ L + LDLS N ++ I L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203
Query: 282 TLSLADNQFQGPVPK-SFGSLISLESLDLSRNNLSG 316
L+L +N V K L LE L
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 53/249 (21%), Positives = 90/249 (36%), Gaps = 14/249 (5%)
Query: 2 GYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSL 61
++L L + K + + L L +SN + +L SL+ L L
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKS---LKRLTFTSNKGGNA--FSEVDLPSLEFLDL 354
Query: 62 AYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCK 121
+ N L + + S +L L L+ N + + L+
Sbjct: 355 SRNGLSFKGCCS-----QSDFGTTSLKYLDLSFNGVITM-SSNFLGLE-QLEHLDFQHSN 407
Query: 122 LRGNIPQEI-GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LC 179
L+ + +L +I D++ L L+ L + GN Q + D
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 180 HLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239
L L+ L+L+ +L P SL+SL+ L++ SN+L S F L + I L
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHT 527
Query: 240 NSLNGSLPS 248
N + S P
Sbjct: 528 NPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-18
Identities = 31/147 (21%), Positives = 57/147 (38%), Gaps = 5/147 (3%)
Query: 178 LCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINL 237
+ + ++ +P L S + L L N L SF S + ++L
Sbjct: 4 VEVVPNIT-YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 238 SANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKS 297
S + Q+L L+ L L+ N + GL +L+ L +
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 298 FGSLISLESLDLSRNNL-SGEIPKNFS 323
G L +L+ L+++ N + S ++P+ FS
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFS 146
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 28/129 (21%), Positives = 44/129 (34%), Gaps = 4/129 (3%)
Query: 200 PCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNL 259
PC+ + ++ +P + ++LS N L + + L L
Sbjct: 2 PCVEVVPNIT-YQCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 260 DLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIP 319
DLSR ++ L +L TL L N Q +F L SL+ L NL+
Sbjct: 58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117
Query: 320 KNFSAQSFL 328
L
Sbjct: 118 FPIGHLKTL 126
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 423 LGTGSFGSVYKGTL----FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKII 477
+G G FG V G L +VAIK + E+ R F E I+ H N+I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
+V E+M NGSL+ +L H+ +++ + ++ + ++YL V
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YV 169
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM-TIATIGYMAPEYGSEGIISP 596
H DL NIL++ N+ VSDFG+ ++L + ++ T I + +PE + +
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 597 KSDVYSYGILLMETFTR-KKP 616
SDV+SYGI+L E + ++P
Sbjct: 230 ASDVWSYGIVLWEVMSYGERP 250
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-35
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 9/192 (4%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERAS--RSFDSECEILRSIRHRNLIKIISNC 480
LG+G FG V G +VA+K+ E + F E + + + H L+K C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+V E++ NG L +L SH L + L + DV + +L +H D
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRD 129
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDV 600
L N L+D ++ VSDFG+++ + + + + APE S KSDV
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-VKWSAPEVFHYFKYSSKSDV 188
Query: 601 YSYGILLMETFT 612
+++GIL+ E F+
Sbjct: 189 WAFGILMWEVFS 200
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 74/336 (22%), Positives = 123/336 (36%), Gaps = 30/336 (8%)
Query: 5 LPNLKYLTLFDNKLSGTI-PNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L L+ L L TI + N L +LDL S+ L P+ F L L L L +
Sbjct: 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYF 106
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGI-LPPLIGNFSASLQEFYAYGCKL 122
L + K + +L LT L L+ N +R + L P G + SL+ ++
Sbjct: 107 CGL--SDAVLKDGYFRNLK---ALTRLDLSKNQIRSLYLHPSFGKLN-SLKSIDFSSNQI 160
Query: 123 RGNIPQEIGNLSGM--IVFDLNGCDLNGTIPTAVG------RLRRLQGLYLHGNKLQGSI 174
E+ L G F L L + G R L+ L + GN I
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
Query: 175 PYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLE--YV 232
+ N + L + G + + ++F L V
Sbjct: 221 TGNFS------------NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
Query: 233 LYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292
+++LS + + LK L L+L+ N+++ GL+NL+ L+L+ N
Sbjct: 269 RHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328
Query: 293 PVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFL 328
+F L + +DL +N+++ + F L
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-34
Identities = 68/333 (20%), Positives = 119/333 (35%), Gaps = 36/333 (10%)
Query: 16 NKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKW 75
L+ +P + L LS N + ++F L LQ+L L Y
Sbjct: 14 CNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK--- 66
Query: 76 NFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQE--IGNL 133
+ N NL +L L S+ + + P L E Y C L + ++ NL
Sbjct: 67 ---EAFRNLPNLRILDLGSSKIYFLHPDAFQGLF-HLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 134 SGMIVFDLNGCDLNG-TIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG--LSELNLN 190
+ DL+ + + + G+L L+ + N++ ++L L+G LS +L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 191 GNKLCGHVPPCLASL------TSLRRLHLGSNKLTSTMPS------------SFGSLEYV 232
N L V L L + N T + S ++
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242
Query: 233 LYINLSANSLNGSLPSNIQNLKV--LTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQF 290
+ +++ + L + +LDLS + L++L+ L+LA N+
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI 302
Query: 291 QGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323
++F L +L+ L+LS N L NF
Sbjct: 303 NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFY 335
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-34
Identities = 66/322 (20%), Positives = 110/322 (34%), Gaps = 29/322 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFS--GLIPNTFGNLGSLQVLSLA 62
LPNL+ L L +K+ P++ L L L S L F NL +L L L+
Sbjct: 72 LPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 63 YNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSA-SLQEFYAYGCK 121
N + + S +L + +SN + + + +L F
Sbjct: 132 KNQIRSLYLH------PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS 185
Query: 122 LRGNIPQEIGNLSGMI------VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIP 175
L + + G + D++G I N + S
Sbjct: 186 LYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT------------GNFSNAISKSQA 233
Query: 176 YDLCHLEGLSELNLNGNKLCGHVPPCLASL--TSLRRLHLGSNKLTSTMPSSFGSLEYVL 233
+ L + + + A L +S+R L L + S F +L+ +
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293
Query: 234 YINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGP 293
+NL+ N +N L L L+LS N L + GL + + L N
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII 353
Query: 294 VPKSFGSLISLESLDLSRNNLS 315
++F L L++LDL N L+
Sbjct: 354 QDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 70/354 (19%), Positives = 127/354 (35%), Gaps = 39/354 (11%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITN--ASKLIMLDLSSNSFSGLIPNTFGNLG------SL 56
L +LK + N++ + + L L++NS + +G L
Sbjct: 147 LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206
Query: 57 QVLSLAYNYLMTESSAAKWNFLS-----SLTNCRNLTVLGLASNPLRGILPPLIGN-FSA 110
++L ++ N + + N +S SL ++ G + ++ +
Sbjct: 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARS 266
Query: 111 SLQEFYAYGCKLRGNIPQEI-GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNK 169
S++ + ++ + L + V +L +N A L LQ L L N
Sbjct: 267 SVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 170 LQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTS--TMPS--- 224
L + L ++ ++L N + L L+ L L N LT+ +PS
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPD 385
Query: 225 ---SFGSLEYVLYINLSANSLNGS--------LPSNIQNLKVLTNLDLSRNQLSG-DIPT 272
S L + INL+AN ++ S + + + L L L++N+ S
Sbjct: 386 IFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQ 445
Query: 273 TIGGLENLETLSLADNQFQGPV-----PKSFGSLISLESLDLSRNNLSGEIPKN 321
T +LE L L +N Q F L L+ L L+ N L+ +P
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPG 498
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 76/390 (19%), Positives = 133/390 (34%), Gaps = 68/390 (17%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L NL+ L L N L ++ K+ +DL N + + TF L LQ L L
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD- 371
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
N L+++ ++ + L+ N L + + + + L
Sbjct: 372 -----------NALTTIHFIPSIPDIFLSGNKLVT-----LPKINLTANLIH-----LSE 410
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH-LEG 183
N + + L + R+ LQ L L+ N+
Sbjct: 411 NRLENLDILYFL------------------LRVPHLQILILNQNRFSSCSGDQTPSENPS 452
Query: 184 LSELNLNGNKLCGHVPPCL-----ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
L +L L N L L L+ L+ L+L N L S P F L + ++L+
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLN 512
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP-KS 297
+N L L N L LD+SRNQL P +L L + N+F +
Sbjct: 513 SNRLT-VLSHND-LPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICECELST 567
Query: 298 FGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQVPSCRKYNSRGFK-KVA 356
F + ++ ++ ++ ++ P S ++ G +
Sbjct: 568 FINWLNHTNVTIAGP---------------PADIYCVYPDSFSGVSLFSLSTEGCDEEEV 612
Query: 357 LLVLKYILPPITSIVLIAIVIIFFIRHRNR 386
L LK+ L + ++ L ++ + R
Sbjct: 613 LKSLKFSLFIVCTVTLTLFLMTILTVTKFR 642
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 51/240 (21%), Positives = 81/240 (33%), Gaps = 39/240 (16%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L L+ L L DN L+ +I + + LS N L + ++ L+
Sbjct: 360 FLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSE 410
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N L L L +L +L L N + + SL++ + L+
Sbjct: 411 NRLENLDI------LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
E+ L LQ LYL+ N L P HL
Sbjct: 465 LAWETELC-------------------WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L L+LN N+L + +L L + N+L + P F SL ++++ N
Sbjct: 506 LRGLSLNSNRLT-VLSHN-DLPANLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 6e-12
Identities = 27/113 (23%), Positives = 38/113 (33%), Gaps = 5/113 (4%)
Query: 207 SLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQL 266
R LT +P + E + LS N + S+ L+ L L+L
Sbjct: 5 DGRIAFYRFCNLTQ-VPQVLNTTER---LLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 267 SGDI-PTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEI 318
I L NL L L ++ P +F L L L L LS +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 15/63 (23%), Positives = 21/63 (33%), Gaps = 4/63 (6%)
Query: 259 LDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEI 318
L+ +P L E L L+ N + SF L L+ L+L I
Sbjct: 9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 319 PKN 321
K
Sbjct: 65 DKE 67
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 65/318 (20%), Positives = 115/318 (36%), Gaps = 51/318 (16%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
P+ L L +NK++ N L L L +N S + P F L L+ L L+ N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN 125
L + L L + N + + F+
Sbjct: 112 LKELPEKM---P-------KTLQELRVHENEITKVRK---SVFN---------------- 142
Query: 126 IPQEIGNLSGMIVFDLNGCDL-NGTIPTAV-GRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
L+ MIV +L L + I +++L + + + +IP L
Sbjct: 143 ------GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPS 193
Query: 184 LSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242
L+EL+L+GNK+ V L L +L +L L N +++ S + ++ ++L+ N L
Sbjct: 194 LTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 243 NGSLPSNIQNLKVLTNLDLSRNQLSG------DIPTTIGGLENLETLSLADNQFQGPV-- 294
+P + + K + + L N +S P + +SL N Q
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311
Query: 295 PKSFGSLISLESLDLSRN 312
P +F + ++ L
Sbjct: 312 PSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 66/325 (20%), Positives = 116/325 (35%), Gaps = 53/325 (16%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYL 66
+L+ + D L +P + +LDL +N + + F NL +L L L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 67 MTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNI 126
S A L L L+ N L+ + + +LQE + N
Sbjct: 89 SKISPGA-------FAPLVKLERLYLSKNQLKELPEKM---PK-TLQELR-----VHEN- 131
Query: 127 PQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGS-IPYD-LCHLEGL 184
EI + + L ++ + L N L+ S I ++ L
Sbjct: 132 --EITKVR----------------KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 173
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
S + + + +P SL LHL NK+T +S L + + LS NS++
Sbjct: 174 SYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS- 229
Query: 245 SLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG------PVPKS 297
++ + N L L L+ N+L +P + + ++ + L +N P
Sbjct: 230 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 288
Query: 298 FGSLISLESLDLSRNNLS-GEIPKN 321
S + L N + EI +
Sbjct: 289 NTKKASYSGVSLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 52/287 (18%), Positives = 93/287 (32%), Gaps = 59/287 (20%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L+ L L N+L +P + L L + N + + + F L + V+ L N
Sbjct: 99 LVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 155
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L + + + L+ + +A + I G SL E + G K+
Sbjct: 156 PLKSSGIEN-----GAFQGMKKLSYIRIADTNITTIPQ---GLPP-SLTELHLDGNKIT- 205
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEG 183
+ L L L L N + ++ L +
Sbjct: 206 KVDAA--------SLK---------------GLNNLAKLGLSFNSIS-AVDNGSLANTPH 241
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L EL+LN NKL VP LA ++ ++L +N +++ + F
Sbjct: 242 LRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCP--------------- 285
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDI--PTTIGGLENLETLSLADN 288
P + + L N + P+T + + L +
Sbjct: 286 ---PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 132 NLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG 191
NL + L ++ P A L +L+ LYL N+L+ +P + + L EL ++
Sbjct: 74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHE 130
Query: 192 NKLCGHVPP-CLASLTSLRRLHLGSNKLTSTM--PSSFGSLEYVLYINLSANSLNGSLPS 248
N++ V L + + LG+N L S+ +F ++ + YI ++ ++ ++P
Sbjct: 131 NEI-TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 188
Query: 249 NIQNLKVLTNLDLSRNQLSGDIPT-TIGGLENLETLSLADNQFQGPVPKSFGSLISLESL 307
+ LT L L N+++ + ++ GL NL L L+ N S + L L
Sbjct: 189 GL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 245
Query: 308 DLSRNNLSGEIPKNFSAQSFL 328
L+ N L ++P + ++
Sbjct: 246 HLNNNKLV-KVPGGLADHKYI 265
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 34/192 (17%), Positives = 57/192 (29%), Gaps = 53/192 (27%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
+ P+L L L NK++ S+ + L L LS NS S + + N L+ L L
Sbjct: 190 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 249
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N L+ L + + + V+ L +N + I +F
Sbjct: 250 NKLVKVPGG--------LADHKYIQVVYLHNNNISAIGS---NDFCP------------- 285
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSI--PYDLCHL 181
P + G+ L N +Q P +
Sbjct: 286 ---------------------------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
Query: 182 EGLSELNLNGNK 193
+ + L K
Sbjct: 319 YVRAAVQLGNYK 330
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 420 CNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERAS--RSFDSECEILRSIRHRNLIKI 476
+ LG G +G VY+G VA+K E F E +++ I+H NL+++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ C ++ EFM G+L +L N + + L + + A+EYL +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 338
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
+H +L N L+ EN V+DFG+S+L+ GD I + APE + S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 596 PKSDVYSYGILLMETFT 612
KSDV+++G+LL E T
Sbjct: 398 IKSDVWAFGVLLWEIAT 414
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 51/192 (26%), Positives = 90/192 (46%), Gaps = 9/192 (4%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERAS--RSFDSECEILRSIRHRNLIKIISNC 480
LGTG FG V G +VAIK+ E + F E +++ ++ H L+++ C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
++ E+M NG L +L + + L + DV A+EYL +H D
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRD 145
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDV 600
L N L+++ VSDFG+S+ + + + + + + PE S KSD+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VRWSPPEVLMYSKFSSKSDI 204
Query: 601 YSYGILLMETFT 612
+++G+L+ E ++
Sbjct: 205 WAFGVLMWEIYS 216
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 11/200 (5%)
Query: 423 LGTGSFGSVYKGTLFDGTN----VAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKII 477
+G G FG V++G N VAIK + F E +R H +++K+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
+ +++E G L +L Y L + + + AL YL V
Sbjct: 83 G-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 138
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPK 597
H D+ N+L+ N + DFG+S+ + E + I +MAPE + +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 598 SDVYSYGILLMETFTR-KKP 616
SDV+ +G+ + E KP
Sbjct: 198 SDVWMFGVCMWEILMHGVKP 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 423 LGTGSFGSVYKGTL---FDGTNVAIKVF--NLQLERASRSFDSECEILRSIRHRNLIKII 477
LG+G+FG+V KG VA+K+ +E +++ + + ++++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
C + LV+E G L K+L + + + + ++ V + ++YL + V
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN---FV 139
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT---IGYMAPEYGSEGII 594
H DL N+LL A +SDFG+SK L ++ + + APE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYYKF 197
Query: 595 SPKSDVYSYGILLMETFTR-KKP 616
S KSDV+S+G+L+ E F+ +KP
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-34
Identities = 64/192 (33%), Positives = 99/192 (51%), Gaps = 13/192 (6%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC- 481
+G G FG V G + G VA+K ++ + +++F +E ++ +RH NL++++
Sbjct: 201 IGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+V E+M GSL +L S LG L +DV A+EYL + VH D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 314
Query: 541 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDV 600
L N+L+ E+ A VSDFG++K + S Q + + APE E S KSDV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 601 YSYGILLMETFT 612
+S+GILL E ++
Sbjct: 370 WSFGILLWEIYS 381
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 423 LGTGSFGSVYKGTLFDG----TNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKI 476
LG G FGSV +G L VA+K L +R F SE ++ H N+I++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 477 ISNCCNIDFKA-----LVLEFMPNGSLEKWLYSH-----NYFLGILERLNIMIDVGLALE 526
+ C + + ++L FM G L +L + + L M+D+ L +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 586
YL + + +H DL N +L ++MT V+DFG+SK + GD + + ++A
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTR 613
E ++ + + KSDV+++G+ + E TR
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATR 245
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 51/193 (26%), Positives = 103/193 (53%), Gaps = 11/193 (5%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERAS--RSFDSECEILRSIRHRNLIKIISNC 480
LG G FG V+ G T VA+K + + +F +E +++ ++H+ L+++ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYA-V 76
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539
+ ++ E+M NGSL +L + + L I + L++ + + ++ + +H
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 540 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSD 599
DL+ NIL+ + ++ ++DFG+++L+ + + + + I + APE + G + KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSD 192
Query: 600 VYSYGILLMETFT 612
V+S+GILL E T
Sbjct: 193 VWSFGILLTEIVT 205
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 423 LGTGSFGSVYKGTLFDG----TNVAIKVF--NLQLERASRSFDSECEILRSIRHRNLIKI 476
LG G FGSV + L VA+K+ ++ F E ++ H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 477 ISNCCNIDFKA------LVLEFMPNGSLEKWLYSH-----NYFLGILERLNIMIDVGLAL 525
+ K ++L FM +G L +L + + L + + M+D+ +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 585
EYL + +H DL N +L E+MT V+DFG+S+ + GD + + ++A
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 586 PEYGSEGIISPKSDVYSYGILLMETFTR 613
E ++ + + SDV+++G+ + E TR
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 423 LGTGSFGSVYKGTLFDG----TNVAIKVFNL-QLERASRSFDSECEILRSIRHRNLIKII 477
LG G FG VY+G + NVA+K F SE I++++ H +++K+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
+ +++E P G L +L + L +L + + + A+ YL + V
Sbjct: 80 GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CV 135
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPK 597
H D+ NIL+ + DFG+S+ + + D + I +M+PE + +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRFTTA 194
Query: 598 SDVYSYGILLMETFTR-KKP 616
SDV+ + + + E + K+P
Sbjct: 195 SDVWMFAVCMWEILSFGKQP 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNL--QLERASRSFDSECEILRSIRHRNLIKIIS 478
+G GSF +VYKG VA + + F E E+L+ ++H N+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 479 NCCNIDFKA----LVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLHHGH 532
+ + LV E M +G+L+ +L ++ + + L++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMK---IKVLRSWCRQILKGLQFLH-TR 148
Query: 533 STPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE 591
+ P++H DLK +NI + + + D G++ L S + + I T +MAPE E
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAV-IGTPEFMAPEMYEE 204
Query: 592 GIISPKSDVYSYGILLMETFTRKKPTNEI 620
DVY++G+ ++E T + P +E
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSEC 232
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-33
Identities = 69/324 (21%), Positives = 116/324 (35%), Gaps = 55/324 (16%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
P+L+++ +N+L +P + N L + +NS L SL+ + N
Sbjct: 172 PPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNN 225
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L L L N LT + +N L+ LP L + L+ L
Sbjct: 226 ILEE---------LPELQNLPFLTTIYADNNLLK-TLPDLPPS----LEALNVRDNYLT- 270
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIP-------------TAVGRLRRLQGLYLHGNKLQ 171
++P+ +L+ + V + L+ P + L+ L + NKL
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330
Query: 172 GSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEY 231
+P LE L + N L VP +L++LH+ N L P S+E
Sbjct: 331 -ELPALPPRLE---RLIASFNHLA-EVPE---LPQNLKQLHVEYNPLRE-FPDIPESVE- 380
Query: 232 VLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
+L NS +P QNLK L + N L + P +E+L + +
Sbjct: 381 ----DLRMNSHLAEVPELPQNLKQL---HVETNPLR-EFPDIPESVEDLR---MNSERVV 429
Query: 292 GPVPKSFGSLISLESLDLSRNNLS 315
P + + LE ++
Sbjct: 430 DPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-32
Identities = 65/331 (19%), Positives = 107/331 (32%), Gaps = 57/331 (17%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L+ + L+ +P N + + + P G + V L
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
R L L + L LP L + L+ A L
Sbjct: 69 ------------------LDRQAHELELNNLGLS-SLPELPPH----LESLVASCNSLT- 104
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPT---------------AVGRLRRLQGLYLHGNK 169
+P+ +L ++V + N L+ P + L+ + + N
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164
Query: 170 LQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSL 229
L+ +P LE + N+L P L +L L ++ +N L +P SL
Sbjct: 165 LK-KLPDLPPSLE---FIAAGNNQL--EELPELQNLPFLTAIYADNNSLKK-LPDLPLSL 217
Query: 230 EYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQ 289
E I N L +QNL LT + N L +P +LE L++ DN
Sbjct: 218 ES---IVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNY 268
Query: 290 FQGPVPKSFGSLISLESLDLSRNNLSGEIPK 320
+P+ SL L+ + + LS P
Sbjct: 269 LTD-LPELPQSLTFLDVSENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-32
Identities = 80/320 (25%), Positives = 121/320 (37%), Gaps = 51/320 (15%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
+ L L + LS ++P + L L S NS + L P +L SL V +
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTEL-PELPQSLKSLLVDNNNL 123
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
LS L L LG+++N L + P + N S L+ L+
Sbjct: 124 KA------------LSDLPP--LLEYLGVSNNQLEKL--PELQNSS-FLKIIDVDNNSLK 166
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
+P +L L +P + L L +Y N L+ +P LE
Sbjct: 167 -KLPDLPPSL---EFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLE- 218
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
+ N L P L +L L ++ +N L + +P SLE +N+ N L
Sbjct: 219 --SIVAGNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDLPPSLE---ALNVRDNYLT 270
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303
LP Q+ LT LD+S N SG + NL L+ + N+ + S
Sbjct: 271 -DLPELPQS---LTFLDVSENIFSG-LSELPP---NLYYLNASSNEIR----SLCDLPPS 318
Query: 304 LESLDLSRNNLSGEIPKNFS 323
LE L++S N L E+P
Sbjct: 319 LEELNVSNNKLI-ELPALPP 337
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 65/345 (18%), Positives = 107/345 (31%), Gaps = 65/345 (18%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
LK + + +N L +P+ + L + +N L NL L + N
Sbjct: 152 SSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEEL--PELQNLPFLTAIYADNN 205
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L +L + +N L P + N L YA L+
Sbjct: 206 SLKKLPD-----------LPLSLESIVAGNNILE--ELPELQNLP-FLTTIYADNNLLK- 250
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
+P +L ++ L +P L L + L P L
Sbjct: 251 TLPDLPPSLE---ALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NL 299
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
LN + N++ + SL L++ +NKL +P+ LE + S N L
Sbjct: 300 YYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIE-LPALPPRLER---LIASFNHLA- 350
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLE----------------NLETLSLADN 288
+P QNLK L + N L + P +E NL+ L + N
Sbjct: 351 EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETN 406
Query: 289 QFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYAL 333
+ P S+ E L ++ + L +
Sbjct: 407 PLRE-FPDIPESV---EDLRMNSERVVDPYEFAHETTDKLEDDVF 447
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 25/140 (17%), Positives = 42/140 (30%), Gaps = 43/140 (30%)
Query: 197 HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVL 256
+ P S T L+ S+ LT +P +N+K
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLTE-------------------------MPVEAENVKSK 36
Query: 257 TNLDLSRNQLSGDIPTTIGGL-------------ENLETLSLADNQFQGPVPKSFGSLIS 303
T + ++ + P G L L + +P+
Sbjct: 37 TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPP---H 92
Query: 304 LESLDLSRNNLSGEIPKNFS 323
LESL S N+L+ E+P+
Sbjct: 93 LESLVASCNSLT-ELPELPQ 111
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 59/266 (22%), Positives = 100/266 (37%), Gaps = 38/266 (14%)
Query: 412 RATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRH 470
R + F E +LG G+FG V K D AIK E + SE +L S+ H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61
Query: 471 RNLIKIISNCCNIDFKA-------------LVLEFMPNGSLEKWLYSHNYFLGILERLNI 517
+ +++ + + +E+ NG+L ++S N E +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
+ AL Y+H ++H DLKP NI +DE+ + DFG++K + D +
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 578 IAT---------IG---YMAPE-YGSEGIISPKSDVYSYGILLME-------TFTRKKPT 617
IG Y+A E G + K D+YS GI+ E R
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNIL 238
Query: 618 NEIFIGEMSLKHWVKESLPDGLTEVV 643
++ + ++ +++
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKII 264
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 65/195 (33%), Positives = 98/195 (50%), Gaps = 15/195 (7%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
+G G FG V G G VA+K ++ + +++F +E ++ +RH NL++++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLG-V 82
Query: 481 CNIDFKAL--VLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
+ L V E+M GSL +L S LG L +DV A+EYL V
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 139
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPK 597
H DL N+L+ E+ A VSDFG++K + S Q + + APE E S K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 598 SDVYSYGILLMETFT 612
SDV+S+GILL E ++
Sbjct: 195 SDVWSFGILLWEIYS 209
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-32
Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 10/195 (5%)
Query: 423 LGTGSFGSVYKGTLFDGTN----VAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKII 477
+G G FG V++G N VAIK + F E +R H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
+ +++E G L +L + L + + + AL YL S V
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPK 597
H D+ N+L+ N + DFG+S+ + E + I +MAPE + +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 598 SDVYSYGILLMETFT 612
SDV+ +G+ + E
Sbjct: 573 SDVWMFGVCMWEILM 587
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 31/214 (14%)
Query: 423 LGTGSFGSVYKGTL--------FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLI 474
LG G+F ++KG T V +KV + S SF ++ + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
C D LV EF+ GSL+ +L + + IL +L + + A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133
Query: 535 PMVHCDLKPNNILLD--------ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 586
++H ++ NILL +SD GIS + D + I ++ P
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPP 186
Query: 587 E---YGSEGIISPKSDVYSYGILLMETFTR-KKP 616
E ++ +D +S+G L E + KP
Sbjct: 187 ECIENP--KNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 423 LGTGSFGSVYKGTLFDG-TNVAIKVFNLQLERAS--RSFDSECEILRSIRHRNLIKIISN 479
LG G +G VY+G VA+K E F E +++ I+H NL++++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
C ++ EFM G+L +L N + + L + + A+EYL +H
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
DL N L+ EN V+DFG+S+L+ GD I + APE + S KS
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 599 DVYSYGILLMETFTR 613
DV+++G+LL E T
Sbjct: 194 DVWAFGVLLWEIATY 208
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQ-LERASRSFDSECEILR-SIRHRNLI 474
F ++LG G+ G++ +FD +VA+K + A R E ++LR S H N+I
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNVI 81
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
+ + F+ + +E +L++++ ++ LE + ++ L +L HS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSL 137
Query: 535 PMVHCDLKPNNILLDE-----NMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEY 588
+VH DLKP+NIL+ + A +SDFG+ K L G S + + T G++APE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 589 ---GSEGIISPKSDVYSYGILLMETFTRKKP 616
+ + D++S G + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 67/317 (21%), Positives = 112/317 (35%), Gaps = 50/317 (15%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
P+ L L +N +S + L L L +N S + F L LQ L ++ N+
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN 125
L+ +L L + N +R + G FS
Sbjct: 114 LVEIPPNL---P-------SSLVELRIHDNRIRKVPK---GVFS---------------- 144
Query: 126 IPQEIGNLSGMIVFDLNGCDL-NGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
L M ++ G L N +L L + KL IP DL E L
Sbjct: 145 ------GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETL 195
Query: 185 SELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
+EL+L+ NK+ + L + L RL LG N++ S L + ++L N L+
Sbjct: 196 NELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLE------NLETLSLADNQFQGPV--P 295
+P+ + +LK+L + L N ++ + +SL +N P
Sbjct: 255 -RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 296 KSFGSLISLESLDLSRN 312
+F + ++
Sbjct: 314 ATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 66/317 (20%), Positives = 105/317 (33%), Gaps = 51/317 (16%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYL 66
+L+ + D L +P I+ +LDL +N S L + F L L L L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 67 MTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNI 126
A + R L L ++ N L I P L S SL E + N
Sbjct: 91 SKIHEKA-------FSPLRKLQKLYISKNHLVEIPPNL---PS-SLVELR-----IHDN- 133
Query: 127 PQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQ-GSIPYDLCHLEGLS 185
I + LR + + + GN L+ L+
Sbjct: 134 --RIRKVP----------------KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLN 175
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
L ++ KL +P L +L LHL NK+ + + + L N +
Sbjct: 176 YLRISEAKL-TGIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-M 231
Query: 246 LPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSL--- 301
+ + L L L L N+LS +P + L+ L+ + L N F +
Sbjct: 232 IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFG 290
Query: 302 ---ISLESLDLSRNNLS 315
+ L N +
Sbjct: 291 VKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 56/288 (19%), Positives = 98/288 (34%), Gaps = 60/288 (20%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L+ L + N L IP ++ S L+ L + N + F L ++ + + N
Sbjct: 101 LRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN 157
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L E+S + L L L ++ L GI +L E + L
Sbjct: 158 PL--ENSGFEPGAFDGL----KLNYLRISEAKLTGIPK---DLPE-TLNELH-----LDH 202
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEG 183
N +I + + R +L L L N+++ I L L
Sbjct: 203 N---KIQAIE----------------LEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPT 242
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L EL+L+ NKL VP L L L+ ++L +N +T + F + + +
Sbjct: 243 LRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV---------- 291
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDI--PTTIGGLENLETLSLADNQ 289
+ L N + P T + + + + +
Sbjct: 292 --------KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 132 NLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG 191
L + L ++ A LR+LQ LY+ N L IP +L L EL ++
Sbjct: 76 GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHD 132
Query: 192 NKLCGHVPP-CLASLTSLRRLHLGSNKLTSTM--PSSFGSLEYVLYINLSANSLNGSLPS 248
N++ VP + L ++ + +G N L ++ P +F L+ + Y+ +S L +P
Sbjct: 133 NRI-RKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLT-GIPK 189
Query: 249 NIQNLKVLTNLDLSRNQLSGDIPT-TIGGLENLETLSLADNQFQGPVPKSFGSLISLESL 307
++ + L L L N++ I + L L L NQ + S L +L L
Sbjct: 190 DL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLREL 246
Query: 308 DLSRNNLSGEIPKNFSAQSFL 328
L N LS +P L
Sbjct: 247 HLDNNKLS-RVPAGLPDLKLL 266
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 49/198 (24%), Positives = 72/198 (36%), Gaps = 12/198 (6%)
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185
+P+EI + DL D++ L+ L L L NK+ L L
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL-NG 244
+L ++ N L +PP L +SL L + N++ F L + I + N L N
Sbjct: 106 KLYISKNHL-VEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162
Query: 245 SLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303
LK L L +S +L+ IP E L L L N+ Q +
Sbjct: 163 GFEPGAFDGLK-LNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSK 218
Query: 304 LESLDLSRNNLSGEIPKN 321
L L L N + I
Sbjct: 219 LYRLGLGHNQIR-MIENG 235
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 26/192 (13%), Positives = 49/192 (25%), Gaps = 53/192 (27%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
+ L L L NK+ + SKL L L N + + L +L+ L L
Sbjct: 191 LPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN 250
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N L + L + + L V+ L +N + +
Sbjct: 251 NKLSRVPAG--------LPDLKLLQVVYLHTNNITKV----------------------- 279
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQ-GSIPYDL-CHL 181
+ + + + G+ L N + + +
Sbjct: 280 -----GVNDFCPVGFGV---------------KRAYYNGISLFNNPVPYWEVQPATFRCV 319
Query: 182 EGLSELNLNGNK 193
+ K
Sbjct: 320 TDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 28/87 (32%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
+ S L ++P I T LDL N +S GL++L L L +N+
Sbjct: 38 VQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94
Query: 295 PKSFGSLISLESLDLSRNNLSGEIPKN 321
K+F L L+ L +S+N+L EIP N
Sbjct: 95 EKAFSPLRKLQKLYISKNHLV-EIPPN 120
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 28/224 (12%)
Query: 411 QRATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIR 469
+R F E L+G+G FG V+K DG IK E+A R E + L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 470 HRNLIK------------IISNCCNIDFKA----LVLEFMPNGSLEKWLYSHN-YFLGIL 512
H N++ S+ + K + +EF G+LE+W+ L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 513 ERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572
L + + ++Y+H S +++ DLKP+NI L + + DFG+ L
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-- 177
Query: 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP 616
+T + T+ YM+PE S + D+Y+ G++L E
Sbjct: 178 -RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIK--- 475
+G GSFG DG IK N+ + E +L +++H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 476 --IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLHHG 531
+ I V+++ G L K + + L E L+ + + LAL+++H
Sbjct: 91 SFEENGSLYI-----VMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDR 144
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---- 587
++H D+K NI L ++ T + DFGI+++L + + I T Y++PE
Sbjct: 145 K---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARAC-IGTPYYLSPEICEN 199
Query: 588 --YGSEGIISPKSDVYSYGILLMETFTRKKP 616
Y + KSD+++ G +L E T K
Sbjct: 200 KPYNN------KSDIWALGCVLYELCTLKHA 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 67/302 (22%), Positives = 125/302 (41%), Gaps = 53/302 (17%)
Query: 423 LGTGSFGSVYKGTLFDG------TNVAIKVFNLQLERASRS----FDSECEILRSIRHRN 472
LG GSFG VY+G T VAIK N E AS F +E +++ +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDVGL 523
+++++ +++E M G L+ +L S + + + + ++
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
+ YL+ + VH DL N ++ E+ T + DFG+++ + E D + + +
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 584 MAPEYGSEGIISPKSDVYSYGILLMETFTR-KKP----TNEIFIGEMSLKHWVKESLPDG 638
M+PE +G+ + SDV+S+G++L E T ++P +NE
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------------------- 247
Query: 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698
+V+ V E +C + L C +P+ R S + + +K+ E
Sbjct: 248 --QVLR--FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303
Query: 699 DV 700
+V
Sbjct: 304 EV 305
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 32/212 (15%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIK---VFNLQLERASRSFDSECEILRSIRHRNLIK-- 475
+G G F VY+ L DG VA+K +F+L +A E ++L+ + H N+IK
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 476 ---IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGIL-ER--LNIMIDVGLALEYLH 529
I N NI VLE G L + + ++ ER + + ALE++H
Sbjct: 99 ASFIEDNELNI-----VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYG 589
++H D+KP N+ + + D G+ + + ++ + T YM+PE
Sbjct: 154 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSL-VGTPYYMSPE-- 206
Query: 590 SEGII-----SPKSDVYSYGILLMETFTRKKP 616
I + KSD++S G LL E + P
Sbjct: 207 ---RIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 423 LGTGSFGSVYKGTLFDG------TNVAIKVFN-LQLERASRSFDSECEILRSIRHRNLIK 475
LG G+FG VY+G + VA+K + E+ F E I+ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSH------NYFLGILERLNIMIDVGLALEYLH 529
I + +++E M G L+ +L L +L+ L++ D+ +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 530 HGHSTPMVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 586
H +H D+ N LL A + DFG+++ + + + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 587 EYGSEGIISPKSDVYSYGILLMETFT 612
E EGI + K+D +S+G+LL E F+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 33/301 (10%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN-LQLERASRSFDSECEILRSIRHRNLIKI--I 477
+LG G+ +V++G G AIKVFN + R E E+L+ + H+N++K+ I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLHHGHSTP 535
K L++EF P GSL L + G+ E L ++ DV + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 536 MVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE 591
+VH ++KP NI+ D ++DFG ++ L DD ++ T Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYER 189
Query: 592 GII--------SPKSDVYSYGILLMETFTRKKPTNEIFIGEMS---LKHWVKESLPDGLT 640
++ D++S G+ T P + + + ++
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 641 EVVDANLVREEQAFSVKIDCLLS-----IMHLALDCCMES-PEQRVSMKDAAAKLKKIKE 694
V A + + + + C LS ++ L +E+ E+ A+ I
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
Query: 695 K 695
+
Sbjct: 310 R 310
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 61/303 (20%), Positives = 100/303 (33%), Gaps = 43/303 (14%)
Query: 21 TIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSS 80
+IP+ +T + LDLS+N + + + +LQ L L N + T + SS
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS----FSS 98
Query: 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFD 140
L + L L L+ N L + S SL L GN L +F
Sbjct: 99 LGS---LEHLDLSYNYLSNLSSSWFKPLS-SLTFLN-----LLGN---PYKTLGETSLFS 146
Query: 141 LNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEGLSELNLNGNKLCGHVP 199
L +LQ L + I L L EL ++ + L + P
Sbjct: 147 ---------------HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191
Query: 200 PCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQ-------- 251
L S+ ++ L L + + V + L L+ S +
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251
Query: 252 NLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSR 311
N+ ++ L + + + L L + NQ + F L SL+ + L
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHT 310
Query: 312 NNL 314
N
Sbjct: 311 NPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 42/209 (20%), Positives = 76/209 (36%), Gaps = 12/209 (5%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL-CHLEG 183
+ + + +L DL+ + + + R LQ L L N + +I D L
Sbjct: 49 GLTEAVKSL------DLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 184 LSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSS-FGSLEYVLYINLSANS 241
L L+L+ N L ++ L+SL L+L N + +S F L + + +
Sbjct: 102 LEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 242 LNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
+ L L L++ + L P ++ ++N+ L L Q +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDV 220
Query: 301 LISLESLDLSRNNLSGEIPKNFSAQSFLS 329
S+E L+L +L S S
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNS 249
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 32/168 (19%), Positives = 54/168 (32%), Gaps = 27/168 (16%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L+ L + + L P S+ + + L L L+ S++ L L
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232
Query: 65 YLMT-ESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
L T S +SL + + L ++ L + L E +L+
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQI--SGLLELEFSRNQLK 290
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQ 171
++P +FD RL LQ ++LH N
Sbjct: 291 -SVPDG--------IFD---------------RLTSLQKIWLHTNPWD 314
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIIS 478
+GTGS+G K DG + K + E + SE +LR ++H N+++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 479 NCCNIDFKAL--VLEFMPNGSLEKWLYSHNYFLGILER---LNIMIDVGLALEYLHHGHS 533
+ L V+E+ G L + L+ L +M + LAL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 534 TP--MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE 591
++H DLKP N+ LD + DFG++++L D S +T + T YM+PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTF-VGTPYYMSPEQMNR 190
Query: 592 GIISPKSDVYSYGILLMETFTRKKP 616
+ KSD++S G LL E P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-31
Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 35/307 (11%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN-LQLERASRSFDSECEILRSIRHRNLIKI--I 477
+LG G+ +V++G G AIKVFN + R E E+L+ + H+N++K+ I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLH-HGHST 534
K L++EF P GSL L + G+ E L ++ DV + +L +G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 535 PMVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
+VH ++KP NI+ D ++DFG ++ L DD ++ T Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYE 188
Query: 591 EGII--------SPKSDVYSYGILLMETFTRKKPTNEIFIGE---MSLKHWVKESLPDGL 639
++ D++S G+ T P + + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 640 TEVVDANLVREEQAFSVKIDCLLS-----IMHLALDCCMES-PEQRVSMKDAAAKLKKIK 693
+ V A + + + + C LS ++ L +E+ E+ A+ I
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308
Query: 694 EKFLDDV 700
+ + V
Sbjct: 309 HRMVIHV 315
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 11/201 (5%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
+LG G++G VY G L + +AIK + R S+ E + + ++H+N+++ + +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLHHGHSTPMVH 538
F + +E +P GSL L S L E+ + L+YLH +VH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 539 CDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--YGSEGIIS 595
D+K +N+L++ + +SDFG SK L G + +T T T+ YMAPE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFT-GTLQYMAPEIIDKGPRGYG 203
Query: 596 PKSDVYSYGILLMETFTRKKP 616
+D++S G ++E T K P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP 224
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 64/305 (20%), Positives = 105/305 (34%), Gaps = 41/305 (13%)
Query: 21 TIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSS 80
+I I N L + N+ SG + F + +L + +S
Sbjct: 2 SIMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGEN--------RNEAVSL 52
Query: 81 LTNC--RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIV 138
L C + L L L LP + + L ++P+ +L
Sbjct: 53 LKECLINQFSELQLNRLNLS-SLPDNLPP---QITVLEITQNALI-SLPELPASLE---Y 104
Query: 139 FDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHV 198
D L+ T+P L+ L + N+L +P LE +N + N+L +
Sbjct: 105 LDACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPALLE---YINADNNQL-TML 155
Query: 199 PPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTN 258
P TSL L + +N+LT +P SLE +++S N L SLP+
Sbjct: 156 P---ELPTSLEVLSVRNNQLTF-LPELPESLEA---LDVSTNLLE-SLPAVPVRNHHSEE 207
Query: 259 ----LDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
N+++ IP I L+ T+ L DN + +S + R
Sbjct: 208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
Query: 315 SGEIP 319
S
Sbjct: 267 SMSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-24
Identities = 51/325 (15%), Positives = 96/325 (29%), Gaps = 87/325 (26%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
++ L L LS ++P+++ ++ +L+++ N+ L P + L+ L
Sbjct: 57 LINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALISL-PELPAS---LEYLDACD 109
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N L T LP L + L+ +L
Sbjct: 110 NRLST--------------------------------LPELPAS----LKHLDVDNNQLT 133
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
+P+ L+ + N+L +P LE
Sbjct: 134 -MLPELPAL---------------------------LEYINADNNQLT-MLPELPTSLE- 163
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSL----EYVLYINLSA 239
L++ N+L +P SL L + +N L S +P+ E ++
Sbjct: 164 --VLSVRNNQL-TFLPE---LPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRE 216
Query: 240 NSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFG 299
N + +P NI +L + L N LS I ++ F +
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQ 273
Query: 300 SLISLESLDLSRNNLSGEIPKNFSA 324
+ + D + S
Sbjct: 274 NTLHRPLADAVTAWFPENKQSDVSQ 298
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 2e-19
Identities = 55/324 (16%), Positives = 94/324 (29%), Gaps = 35/324 (10%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
+ P + L + N L ++P + L LD N S L P + L+ L +
Sbjct: 78 LPPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLSTL-PELPAS---LKHLDVDN 129
Query: 64 NYLMT--------ESSAAKWNFLSSL-TNCRNLTVLGLASNPLRGILPPLIGNFSASLQE 114
N L E A N L+ L +L VL + +N L LP L + L+
Sbjct: 130 NQLTMLPELPALLEYINADNNQLTMLPELPTSLEVLSVRNNQLTF-LPELPES----LEA 184
Query: 115 FYAYGCKLRGNIPQEIGNLSGM----IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKL 170
L ++P I F + IP + L + L N L
Sbjct: 185 LDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242
Query: 171 QGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLE 230
I L + + + + + S +
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIW 300
Query: 231 YVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQF 290
+ AN+ + L + + N R Q++ + L L
Sbjct: 301 HAFEHEEHANTFSAFL-DRLSDTVSARNTSGFREQVAAWLEK----LSASAELRQQSFAV 355
Query: 291 QGPVPKSFGSLISLESLDLSRNNL 314
+S ++L +L + L
Sbjct: 356 AADATESCEDRVALTWNNLRKTLL 379
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 423 LGTGSFGSVYKGTLFDG------TNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
LG G+FG V+ + VA+K E A + F E E+L ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF--------------LGILERLNIMIDVG 522
C +V E+M +G L ++L SH LG+ + L + V
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG 582
+ YL H VH DL N L+ + + + DFG+S+ + D + T+ I
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 583 YMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+M PE + +SDV+S+G++L E FT
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 423 LGTGSFGSVYKGTLFDG------TNVAIKVFNLQLERASRS----FDSECEILRSIRHRN 472
LG G+FG VY+G + VA+K E S F E I+ H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH------NYFLGILERLNIMIDVGLALE 526
+++ I + ++LE M G L+ +L L +L+ L++ D+ +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 527 YLHHGHSTPMVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
YL H +H D+ N LL A + DFG+++ + + + +
Sbjct: 196 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 584 MAPEYGSEGIISPKSDVYSYGILLMETFT 612
M PE EGI + K+D +S+G+LL E F+
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNL--IKI 476
+G+G V++ AIK NL+ + S+ +E L ++ + I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHSTP 535
+ +V+E N L WL ER + ++ A+ +H HG
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-------- 587
+VH DLKP N L+ + M + DFGI+ + SV++ + T+ YM PE
Sbjct: 148 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 588 ---YGSEGIISPKSDVYSYGILLMETFTRKKP 616
S+ ISPKSDV+S G +L K P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 50/224 (22%), Positives = 85/224 (37%), Gaps = 29/224 (12%)
Query: 412 RATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNL-QLERASRSFDSECEILRSIR 469
R F LG G FG V++ D N AIK L E A E + L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 470 HRNLIK----IISNCCNIDFKA--------LVLEFMPNGSLEKWLYSHNYFLGILER--L 515
H +++ + + + ++ +L+ W+ L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 516 NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD----- 570
+I + + A+E+LH ++H DLKP+NI + V DFG+ + + ++
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 571 --SVIQTMTIATIG---YMAPEYGSEGIISPKSDVYSYGILLME 609
+G YM+PE S K D++S G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 423 LGTGSFGSVYKGTLFDG------TNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
LG G+FG V+ ++ VA+K A + F E E+L +++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSH---------------NYFLGILERLNIMIDV 521
C + D +V E+M +G L K+L +H LG+ + L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 522 GLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI 581
+ YL H VH DL N L+ N+ + DFG+S+ + D + T+ I
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 582 GYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+M PE + +SDV+S+G++L E FT
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNL--IKI 476
+G+G V++ AIK NL+ + S+ +E L ++ + I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHSTP 535
+ +V+E N L WL ER + ++ A+ +H HG
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 128
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-------- 587
+VH DLKP N L+ + M + DFGI+ + SV++ + T+ YM PE
Sbjct: 129 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 588 ---YGSEGIISPKSDVYSYGILLMETFTRKKP 616
S+ ISPKSDV+S G +L K P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNL--IKI 476
+G+G V++ AIK NL+ + S+ +E L ++ + I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHSTP 535
+ +V+E N L WL ER + ++ A+ +H HG
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 175
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-------- 587
+VH DLKP N L+ + M + DFGI+ + SV++ + + YM PE
Sbjct: 176 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 588 ---YGSEGIISPKSDVYSYGILLMETFTRKKP 616
S+ ISPKSDV+S G +L K P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-30
Identities = 71/323 (21%), Positives = 116/323 (35%), Gaps = 74/323 (22%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQ-LERASRSFDSECEILR-SIRHRNLIKIIS 478
+LG GS G+V F G VA+K + + A E ++L S H N+I+
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPNVIRYYC 76
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYF------LGILERLNIMIDVGLALEYLH-HG 531
+ F + LE N +L+ + S N ++++ + + +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 532 HSTPMVHCDLKPNNILLD-------------ENMTAHVSDFGISKLLGEGDDSVIQTMTI 578
++H DLKP NIL+ EN+ +SDFG+ K L G S +
Sbjct: 136 ----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 579 A--TIGYMAPE-------YGSEGIISPKSDVYSYGILLMETFTRKKP--------TNEIF 621
T G+ APE ++ ++ D++S G + ++ K + I
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 622 IGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS 681
G SL + E D L+S M + D P +R +
Sbjct: 252 RGIFSLDEMKCLHDRSLIAEATD----------------LISQM-IDHD-----PLKRPT 289
Query: 682 MKDAAA----KLKKIKEKFLDDV 700
K K +FL V
Sbjct: 290 AMKVLRHPLFWPKSKKLEFLLKV 312
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 20/231 (8%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKII 477
LG G +VY VAIK + E + F+ E + H+N++ +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 478 SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMV 537
D LV+E++ +L +++ SH L + +N + +++ H +V
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMR---IV 133
Query: 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT-MTIATIGYMAPEYGSEGIISP 596
H D+KP NIL+D N T + DFGI+K L + S+ QT + T+ Y +PE
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 597 KSDVYSYGILLMETFTRKKPTNEIFIGE----MSLKHWVKESLPDGLTEVV 643
+D+YS GI+L E + P F GE +++KH +++S+P+ T+V
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDVR 237
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 21/213 (9%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
LG G F V L DG A+K ++ E ++ R H N++++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 481 CNIDFKA----LVLEFMPNGSLEKWLYSHNYFLGIL---ERLNIMIDVGLALEYLHHGHS 533
L+L F G+L + L + L +++ + LE +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA-------TIGYMAP 586
H DLKP NILL + + D G + Q +T+ TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 587 E---YGSEGIISPKSDVYSYGILLMETFTRKKP 616
E S +I ++DV+S G +L + P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 62/273 (22%), Positives = 97/273 (35%), Gaps = 40/273 (14%)
Query: 22 IPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSL 81
IP+S T L+L SN L F L L LSL+ N L + ++ S
Sbjct: 26 IPSSAT------RLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ-----SD 74
Query: 82 TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDL 141
+L L L+ N + + +G L+ + + + +S VF
Sbjct: 75 FGTTSLKYLDLSFNGVITMSSNFLG--LEQLEHLD-----FQHS---NLKQMSEFSVFL- 123
Query: 142 NGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPP- 200
LR L L + + + L L L + GN + P
Sbjct: 124 --------------SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
Query: 201 CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNL 259
L +L L L +L P++F SL + +N+S N+ SL + + L L L
Sbjct: 170 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVL 228
Query: 260 DLSRNQLSGDIPTTIGGL-ENLETLSLADNQFQ 291
D S N + + +L L+L N F
Sbjct: 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 49/220 (22%), Positives = 83/220 (37%), Gaps = 8/220 (3%)
Query: 107 NFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLN--GTIPTAVGRLRRLQGLY 164
+S KL+ L+ + L+ L+ G + L+ L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 165 LHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPC--LASLTSLRRLHLGSNKLTSTM 222
L N + ++ + LE L L+ + L + SL +L L +
Sbjct: 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTRVAF 142
Query: 223 PSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLE 281
F L + + ++ NS + +I L+ LT LDLS+ QL PT L +L+
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202
Query: 282 TLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKN 321
L+++ N F + L SL+ LD S N++ K
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 48/202 (23%), Positives = 74/202 (36%), Gaps = 10/202 (4%)
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKL--QGSIPYDLCHLEG 183
+P I S +L L +L +L L L N L +G
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSS-FGSLEYVLYINLSANSL 242
L L+L+ N + + L L L + L S F SL ++Y+++S
Sbjct: 80 LKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 243 NGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGS 300
+ I L L L ++ N + I L NL L L+ Q + P +F S
Sbjct: 139 R-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 301 LISLESLDLSRNNLSGEIPKNF 322
L SL+ L++S NN +
Sbjct: 198 LSSLQVLNMSHNNFF-SLDTFP 218
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 30/122 (24%), Positives = 47/122 (38%), Gaps = 13/122 (10%)
Query: 5 LPNLKYLTLFDNKLSGTI-PNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L +L+ L + N P+ T L LDLS L P F +L SLQVL++++
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N + + +L VL + N + + +F +SL L
Sbjct: 209 NNFFSLDTFP-------YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN-----LT 256
Query: 124 GN 125
N
Sbjct: 257 QN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 6/94 (6%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L NL +L L +L P + + S L +L++S N+F L + L SLQVL + N
Sbjct: 174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLR 98
++MT +F S +L L L N
Sbjct: 234 HIMTSKKQELQHFPS------SLAFLNLTQNDFA 261
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 423 LGTGSFGSVYKGTLFDG------TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIK 475
LG FG VYKG LF VAIK + F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSH---------------NYFLGILERLNIMID 520
++ +++ + +G L ++L L + ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
+ +EYL H +VH DL N+L+ + + +SD G+ + + D + ++
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
I +MAPE G S SD++SYG++L E F+
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 50/244 (20%), Positives = 85/244 (34%), Gaps = 42/244 (17%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSI-RHRN 472
F + LG GS+G V+K DG A+K + +E + +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 473 LIKIIS-----NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
+++ + E SL++ + L + + D LAL +
Sbjct: 119 CVRLEQAWEEGGILYL-----QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 587
LH +VH D+KP NI L + DFG+ LG + YMAPE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQ-EGDPRYMAPE 226
Query: 588 YGSEGII----SPKSDVYSYGILLMETFTRKKP------TNEIFIGEMSLKHWVKESLPD 637
++ +DV+S G+ ++E + ++ G +
Sbjct: 227 -----LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL------PPEFTA 275
Query: 638 GLTE 641
GL+
Sbjct: 276 GLSS 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKI- 476
+LG G V+ L D +VA+KV L F E + ++ H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 477 -----ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG 531
+ + + +V+E++ +L +++ + + ++ D AL + H
Sbjct: 79 DTGEAETPAGPLPY--IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN 135
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT-MTIATIGYMAPEYGS 590
++H D+KP NI++ V DFGI++ + + +SV QT I T Y++PE
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 591 EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE----MSLKHWVKESLP 636
+ +SDVYS G +L E T + P F G+ ++ +H V+E
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQH-VREDPI 237
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 39/223 (17%)
Query: 423 LGTGSFGSVYKGTLFDG------TNVAIKVFNLQLERASRS----FDSECEILRSIRHRN 472
+G G+FG V++ T VA+K+ E AS F E ++ + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH-----------------------NYFL 509
++K++ C L+ E+M G L ++L S L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 510 GILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569
E+L I V + YL VH DL N L+ ENM ++DFG+S+ + D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
I +M PE + +SDV++YG++L E F+
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 423 LGTGSFGSVYKGTLFDG------TNVAIKVFNLQLERASRS----FDSECEILRSIRHRN 472
LG G FG V K T F T VA+K+ E AS S SE +L+ + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH-----------------------NYFL 509
+IK+ C L++E+ GSL +L L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 510 GILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569
+ + ++ + ++YL +VH DL NIL+ E +SDFG+S+ + E D
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
V ++ + +MA E + I + +SDV+S+G+LL E T
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 55/204 (26%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASR-SFDSECEILRSIRHRNLIKII--- 477
LGTG FG V + G VAIK +L +R + E +I++ + H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 478 ---SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLHHGH 532
D L +E+ G L K+L G+ E ++ D+ AL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 533 STPMVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-- 587
++H DLKP NI+L + + + D G +K L + + T+ Y+APE
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPELL 195
Query: 588 ----YGSEGIISPKSDVYSYGILL 607
Y D +S+G L
Sbjct: 196 EQKKYT------VTVDYWSFGTLA 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 45/240 (18%), Positives = 89/240 (37%), Gaps = 35/240 (14%)
Query: 422 LLGTGSFGSVYKG--TLFDGTNVAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKII- 477
+ G G +Y +G V +K + +++ +E + L + H ++++I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 478 ------SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-H 530
+ + + +V+E++ SL++ L + E + ++++ AL YLH
Sbjct: 147 FVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSI 201
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT-MTIATIGYMAPEYG 589
G +V+ DLKP NI+L E + D G + T G+ APE
Sbjct: 202 G----LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-------SFGYLYGTPGFQAPEI- 248
Query: 590 SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649
+ +D+Y+ G L G + ++ + L R
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLPT----RNGR-YVDGLPEDDPVLKTYDSYGRLLRR 303
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 423 LGTGSFGSVYKGTLFD------GTNVAIKVFNLQLERASRS----FDSECEILRSI-RHR 471
LG G+FG V + F VA+K+ E A+ S SE +IL I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 472 NLIKIISNCCNIDFKALV-LEFMPNGSLEKWLYSH---------------NYFLGILERL 515
N++ ++ C +V +EF G+L +L S FL + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 516 NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575
V +E+L +H DL NILL E + DFG+++ + + D V +
Sbjct: 152 CYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ +MAPE + + + +SDV+S+G+LL E F+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 63/312 (20%), Positives = 106/312 (33%), Gaps = 66/312 (21%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
+ L +P+ I ++ +L+L N + N+F +L L++L L+ N+
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN 125
+ T A NL L L N L I G F
Sbjct: 100 IRTIEIGA-------FNGLANLNTLELFDNRLTTIPN---GAFVY--------------- 134
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL-CHLEGL 184
L +L+ L+L N ++ SIP + L
Sbjct: 135 -------------------------------LSKLKELWLRNNPIE-SIPSYAFNRIPSL 162
Query: 185 SELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L+L K ++ L++LR L+L L + L + ++LS N L+
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLS 220
Query: 244 GSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302
++ Q L L L + ++Q+ L++L ++LA N F L
Sbjct: 221 -AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279
Query: 303 SLESLDLSRNNL 314
LE + L N
Sbjct: 280 HLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 9/213 (4%)
Query: 107 NFSASLQEFYAYGCKLRGNIPQEI-GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL 165
S + + + +++ I +L + + L+ + A L L L L
Sbjct: 61 GISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119
Query: 166 HGNKLQGSIPYD-LCHLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGS-NKLTSTM 222
N+L +IP +L L EL L N + +P + SLRRL LG +L+
Sbjct: 120 FDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYIS 177
Query: 223 PSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLET 282
+F L + Y+NL+ +L +P+ + L L LDLS N LS P + GL +L+
Sbjct: 178 EGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK 235
Query: 283 LSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
L + +Q Q +F +L SL ++L+ NNL+
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 54/288 (18%), Positives = 90/288 (31%), Gaps = 83/288 (28%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L +L+ L L N + + + L L+L N + + F L L+ L L N
Sbjct: 87 LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNN 146
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ + S A +L L L
Sbjct: 147 PIESIPSYA-------FNRIPSLRRLDLGELK---------------------------- 171
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
+ +S A L L+ L L L+ IP +L L L
Sbjct: 172 ----RLSYIS----------------EGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKL 209
Query: 185 SELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
EL+L+GN L + P L L++L + +++ ++F
Sbjct: 210 DELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF----------------- 251
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
NL+ L ++L+ N L+ L +LE + L N +
Sbjct: 252 -------DNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 20/60 (33%), Positives = 28/60 (46%), Gaps = 3/60 (5%)
Query: 256 LTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
+ + R L ++P I N L+L +NQ Q SF L LE L LSRN++
Sbjct: 45 FSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 45/242 (18%), Positives = 84/242 (34%), Gaps = 19/242 (7%)
Query: 382 RHRNRSTKDGDQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGT-LFDGT 440
+ + + D E +L + Y + + + +G GSFG V++ G
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 441 NVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEK 500
A+K L+ E + ++ + + + +E + GSL +
Sbjct: 85 QCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 501 WLYSHNYFLGILERL--NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-MTAHVS 557
+ E + LEYLH + ++H D+K +N+LL + A +
Sbjct: 140 LIKQMGCLP---EDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALC 193
Query: 558 DFGISKLLGEGDDSVIQTMTIATIG---YMAPEYGSEGIISPKSDVYSYGILLMETFTRK 614
DFG + L G +MAPE K D++S +++
Sbjct: 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
Query: 615 KP 616
P
Sbjct: 254 HP 255
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 35/231 (15%)
Query: 422 LLGTGSFGSVYKGTLFD---GTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIK 475
L+G G G VY+ D VA+K+ + L E ++ +++
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 476 IISNCCNIDFKA------LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529
I DF + + + L L L + I+ +G AL+ H
Sbjct: 99 IH------DFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH 151
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT-MTIATIGYMAPEY 588
H D+KP NIL+ + A++ DFGI+ D+ + Q T+ T+ YMAPE
Sbjct: 152 AAG---ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPER 206
Query: 589 GSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE---MSLKHWVKESLP 636
SE + ++D+Y+ +L E T P + G+ + H + +++P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP----YQGDQLSVMGAH-INQAIP 252
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 421 NLLGTGSFGSVYKGTLFD------GTNVAIKVFNLQLERASRS----FDSECEILRSI-R 469
LG G+FG V + T F VA+K+ A SE +I+ + +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQ 108
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH-------------NYFLGILERLN 516
H N++ ++ C + ++ E+ G L +L N + L+
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 517 IMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576
V + +L + +H D+ N+LL A + DFG+++ + + +++
Sbjct: 169 FSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ +MAPE + + + +SDV+SYGILL E F+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 423 LGTGSFGSVYKGTLFD------GTNVAIKVFNLQLERASRS----FDSECEILRSI-RHR 471
LG G+FG V + T + VA+K+ A + SE ++L + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH-----------------NYFLGILER 514
N++ ++ C ++ E+ G L +L L + +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 515 LNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574
L+ V + +L S +H DL NILL + DFG+++ + + V++
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ +MAPE + + +SDV+SYGI L E F+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 68/311 (21%), Positives = 91/311 (29%), Gaps = 64/311 (20%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
+ LS +P I S L+L N+ + +TF +L L+VL L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN 125
+ A +L L L N L I S L+E + + +
Sbjct: 111 IRQIEVGA-------FNGLASLNTLELFDNWLTVIPSGAFEYLS-KLRELWLRNNPIE-S 161
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL-HGNKLQGSIPYD-LCHLEG 183
IP A R+ L L L KL+ I L
Sbjct: 162 IP-----------------------SYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFN 197
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L LNL + P L L L L + N P SF
Sbjct: 198 LKYLNLGMCNI--KDMPNLTPLVGLEELEMSGNHFPEIRPGSF----------------- 238
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303
L L L + +Q+S GL +L L+LA N F L
Sbjct: 239 -------HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291
Query: 304 LESLDLSRNNL 314
L L L N
Sbjct: 292 LVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 10/219 (4%)
Query: 107 NFSASLQEFYAYGCKLRGNIPQEI-GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL 165
++ + ++ I + +L + V L + A L L L L
Sbjct: 72 GIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130
Query: 166 HGNKLQGSIPYD-LCHLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGS-NKLTSTM 222
N L IP +L L EL L N + +P + SL RL LG KL
Sbjct: 131 FDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYIS 188
Query: 223 PSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLET 282
+F L + Y+NL ++ +P+ + L L L++S N P + GL +L+
Sbjct: 189 EGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246
Query: 283 LSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKN 321
L + ++Q +F L SL L+L+ NNLS +P +
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHD 284
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 51/241 (21%), Positives = 83/241 (34%), Gaps = 37/241 (15%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L +L+ L L N + + + L L+L N + + F L L+ L L N
Sbjct: 98 LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLAS-NPLRGILPPLIGNFSASLQEFYAYGCKLR 123
+ + S A +L L L L I G F
Sbjct: 158 PIESIPSYA-------FNRVPSLMRLDLGELKKLEYISE---GAFE-------------- 193
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
L + +L C++ +P + L L+ L + GN P L
Sbjct: 194 --------GLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSS 243
Query: 184 LSELNLNGNKLCGHVPPC-LASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242
L +L + +++ + L SL L+L N L+S F L Y++ ++L N
Sbjct: 244 LKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
Query: 243 N 243
N
Sbjct: 303 N 303
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 423 LGTGSFGSVYKGTLFD--------GTNVAIKVFNLQLERASRS----FDSECEILRSI-R 469
LG G+FG V VA+K+ + A+ SE E+++ I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH---------------NYFLGILER 514
H+N+I ++ C +++E+ G+L ++L + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 515 LNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574
++ + +EYL +H DL N+L+ EN ++DFG+++ + D
Sbjct: 160 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
T + +MAPE + + + +SDV+S+G+L+ E FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 423 LGTGSFGSVYKGTLFD--------GTNVAIKVFNLQLERASRS----FDSECEILRSI-R 469
LG G FG V VA+K+ + A+ SE E+++ I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145
Query: 470 HRNLIKIISNCCNIDFKA-LVLEFMPNGSLEKWLYSH---------------NYFLGILE 513
H+N+I ++ C D +++E+ G+L ++L + + +
Sbjct: 146 HKNIINLL-GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 514 RLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573
++ + +EYL +H DL N+L+ EN ++DFG+++ + D
Sbjct: 205 LVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
T + +MAPE + + + +SDV+S+G+L+ E FT
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 423 LGTGSFGSVYKGTLFD--------GTNVAIKVFNLQLERASRS----FDSECEILRSI-R 469
LG G+FG V T VA+K+ A+ SE E+++ I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH---------------NYFLGILER 514
H+N+I ++ C +++E+ G+L ++L + L +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 515 LNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574
++ V +EYL +H DL N+L+ E+ ++DFG+++ + D
Sbjct: 194 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
T + +MAPE + I + +SDV+S+G+LL E FT
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 423 LGTGSFGSVYKGTLFDG------TNVAIKVFNLQLERASRS----FDSECEILRSI-RHR 471
LG+G+FG V T + VA+K+ E+A S SE +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH----------------------NYFL 509
N++ ++ C L+ E+ G L +L S L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 510 GILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569
+ L V +E+L VH DL N+L+ + DFG+++ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ V++ + +MAPE EGI + KSDV+SYGILL E F+
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 421 NLLGTGSFGSVYKGTLFDG---TNVAIKVFNLQLERASRS----FDSECEILRSI-RHRN 472
+++G G+FG V K + + AIK E AS+ F E E+L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF---------------LGILERLNI 517
+I ++ C + + L +E+ P+G+L +L L + L+
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
DV ++YL +H DL NIL+ EN A ++DFG+S+ + V +TM
Sbjct: 148 AADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 201
Query: 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ +MA E + + + SDV+SYG+LL E +
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 43/312 (13%), Positives = 94/312 (30%), Gaps = 70/312 (22%)
Query: 394 EDLLSLATWRRTSYLDIQRATNG----FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFN 448
+ L+S + W ++ +LG + + T G + + V
Sbjct: 53 DSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPY 112
Query: 449 LQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE------FMPNGSLE 499
A + E LR +R K F +++ + E
Sbjct: 113 FTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDE 172
Query: 500 KWLYSHNYF--------------------------LGILERLNIMIDVGLALEYLH-HGH 532
+ ++ + F L RL + + V L LH +G
Sbjct: 173 RDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY---- 588
+VH L+P +I+LD+ ++ F G ++ G+ PE
Sbjct: 232 ---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIGRGFAPPETTAER 282
Query: 589 ------GSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE--MSLKHWV---KESLPD 637
+++ D ++ G+ + + P + + W+ +++P
Sbjct: 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAALGGSEWIFRSCKNIPQ 338
Query: 638 GLTEVVDANLVR 649
+ +++ L
Sbjct: 339 PVRALLEGFLRY 350
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 63/267 (23%), Positives = 110/267 (41%), Gaps = 19/267 (7%)
Query: 417 FNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSF-DSECEILRSIRHRNLI 474
F + + LG G+ G V+K + G +A K+ +L+++ A R+ E ++L ++
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 475 K-----IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529
+I +E M GSL++ + + + I V L YL
Sbjct: 95 GFYGAFYSDGEISI-----CMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYG 589
H ++H D+KP+NIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 149 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERL 202
Query: 590 SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649
S +SD++S G+ L+E + P E+ L + T R
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 650 EEQAFSVKIDCLLSIMHLALDCCMESP 676
F + ++I L E P
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 51/232 (21%), Positives = 97/232 (41%), Gaps = 36/232 (15%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIK-- 475
LLG GSF VY+ + G VAIK+ + + + +E +I ++H ++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 476 -IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
+ + LVLE NG + ++L + E + M + + YLH
Sbjct: 78 NYFEDSNYV---YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII 594
++H DL +N+LL NM ++DFG++ L + T+ T Y++PE +
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLC-GTPNYISPEIATRSAH 189
Query: 595 SPKSDVYSYGILL---------------METFTRKKPTNEIFIGEMSLKHWV 631
+SDV+S G + T + + + + + ++
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------VVLADYEMPSFL 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 57/199 (28%), Positives = 82/199 (41%), Gaps = 10/199 (5%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
IP + L+G ++ + R L L+LH N L L L
Sbjct: 29 GIPAASQRI------FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 185 SELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
+L+L+ N V P L L LHL L P F L + Y+ L N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 244 GSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302
+LP + ++L LT+L L N++S GL +L+ L L N+ P +F L
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 303 SLESLDLSRNNLSGEIPKN 321
L +L L NNLS +P
Sbjct: 202 RLMTLYLFANNLS-ALPTE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 51/239 (21%), Positives = 83/239 (34%), Gaps = 33/239 (13%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
+ + L N++S S L +L L SN + + F L L+ L L+ N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN 125
+ ++ L L L L+ + P L + +LQ Y L+
Sbjct: 92 QLRSVDP------ATFHGLGRLHTLHLDRCGLQELGPGLFRGLA-ALQYLYLQDNALQ-A 143
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185
+P L L L+LHGN++ L L
Sbjct: 144 LP-----------------------DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 186 ELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L L+ N++ HV P L L L+L +N L++ + L + Y+ L+ N
Sbjct: 181 RLLLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 47/211 (22%), Positives = 81/211 (38%), Gaps = 5/211 (2%)
Query: 107 NFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLH 166
A+ Q + +G ++ + + L+ L A L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 167 GNKLQGSIPYD-LCHLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPS 224
N S+ L L L+L+ L + P L +L+ L+L N L +
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 225 SFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETL 283
+F L + ++ L N ++ S+P + L L L L +N+++ P L L TL
Sbjct: 148 TFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206
Query: 284 SLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
L N ++ L +L+ L L+ N
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 57/273 (20%), Positives = 84/273 (30%), Gaps = 67/273 (24%)
Query: 22 IPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSL 81
IP + + L N S + +F +L +L L N L +AA
Sbjct: 30 IPAASQR------IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA-------F 76
Query: 82 TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDL 141
T L L L+ N + P F
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDP--ATFH-------------------------------- 102
Query: 142 NGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEGLSELNLNGNKLCGHVPP 200
L RL L+L LQ + L L L L N L +P
Sbjct: 103 --------------GLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL-QALPD 146
Query: 201 -CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTN 258
L +L L L N+++S +F L + + L N + + + ++L L
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMT 205
Query: 259 LDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
L L N LS + L L+ L L DN +
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 28/94 (29%), Positives = 37/94 (39%), Gaps = 7/94 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L NL +L L N++S + L L L N + + P+ F +LG L L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLR 98
L + A L R L L L NP
Sbjct: 212 NLSALPTEA-------LAPLRALQYLRLNDNPWV 238
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 25/219 (11%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISN 479
+L G F VY+ + G A+K E +R+ E ++ + H N+++ S
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 480 CCNI-------DFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLHH 530
+ L+L + G L ++L + L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA----------T 580
P++H DLK N+LL T + DFG + + D A T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 581 IGYMAPE---YGSEGIISPKSDVYSYGILLMETFTRKKP 616
Y PE S I K D+++ G +L R+ P
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 62/359 (17%), Positives = 118/359 (32%), Gaps = 42/359 (11%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGL-IPNTFGNLGSLQVLSLAY 63
L+YL L NKL + N L LDLS N+F L I FGN+ L+ L L+
Sbjct: 68 NQELEYLDLSHNKLVKISCHPTVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLST 124
Query: 64 NYL------------------MTESSAAKWNFLSSLTNCRNLTV-LGLASNPLRGILPPL 104
+L + + + L + ++ + +N + +
Sbjct: 125 THLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDV 184
Query: 105 IGNFSASLQ------EFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLR 158
A+L+ C +I ++ + LN + + +L
Sbjct: 185 SVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV 244
Query: 159 R--------LQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRR 210
+ + L G Y L+ LS + + +++
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 211 LHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDI 270
+ + + L+++ S N L ++ N +L L L L NQL ++
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 271 PTTIG---GLENLETLSLADNQFQ-GPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQ 325
+++L+ L ++ N SL SL++S N L+ I + +
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR 422
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 59/339 (17%), Positives = 100/339 (29%), Gaps = 35/339 (10%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
L + N +S + I + SKL +L +S N L + F L+ L L++N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFS--ASLQEFYAYGCKLR 123
L+ S N L L L+ N + P+ F + L+ L
Sbjct: 81 LVKISC-------HPTVN---LKHLDLSFNAFDAL--PICKEFGNMSQLKFLGLSTTHLE 128
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQ-----------G 172
+ I +L+ V + G L+ LH
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 173 SIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEY- 231
+L L N + L + L L L + + T L +
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 232 --VLYINLSANSLNGSLPSNI-----QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLS 284
V Y ++S L G L +LK L+ + + N+ +
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 285 LADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323
+ + + LD S N L+ + +N
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 60/373 (16%), Positives = 120/373 (32%), Gaps = 69/373 (18%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITN---------------------------ASKLIMLDL 37
+ LK+L L L + I + L ++
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 38 SSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR----NLTVLGLA 93
++ F ++ + + +L++ ++ + S TN + L +
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 94 SNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGN--------------------- 132
N IL + + ++ F KL+G + +
Sbjct: 234 WNSFIRILQLV---WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 133 --------LSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
S M + + ++ L N L ++ + HL L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 185 SELNLNGNKL--CGHVPPCLASLTSLRRLHLGSNKLTST-MPSSFGSLEYVLYINLSANS 241
L L N+L + + SL++L + N ++ + +L +N+S+N
Sbjct: 351 ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410
Query: 242 LNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSL 301
L ++ + + LDL N++ IP + LE L+ L++A NQ + F L
Sbjct: 411 LTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467
Query: 302 ISLESLDLSRNNL 314
SL+ + L N
Sbjct: 468 TSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 8e-20
Identities = 55/292 (18%), Positives = 111/292 (38%), Gaps = 15/292 (5%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
+ + F + L+ N + L ++ + NSF + + V + +
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI----LQLVWHTTVWYFSIS 255
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ + +F S T+ + L++ + S+ I +++ R
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD---LCHL 181
+S + D + L T+ G L L+ L L N+L+ + +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQM 373
Query: 182 EGLSELNLNGNKLCGHVPPCL-ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
+ L +L+++ N + + SL L++ SN LT T+ VL L +N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLD--LHSN 431
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQ 291
+ S+P + L+ L L+++ NQL +P I L +L+ + L N +
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 47/285 (16%), Positives = 90/285 (31%), Gaps = 14/285 (4%)
Query: 165 LHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPS 224
N L +P DL + + LN++ N + + SL+ LR L + N++ S
Sbjct: 7 RSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 225 SFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQL-SGDIPTTIGGLENLETL 283
F + + Y++LS N L + L +LDLS N + I G + L+ L
Sbjct: 64 VFKFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120
Query: 284 SLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQVPS 343
L+ + L + L + + + + P +
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHF 180
Query: 344 CRKYNSRGFKKVALLVLKYILPPITSIVLIAIV-------IIFFIRHRNRSTKDGDQEDL 396
+ + + L +K +L ++I+ + + N T +
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240
Query: 397 LSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTN 441
L L Y I S S+ ++ +
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 29/210 (13%), Positives = 66/210 (31%), Gaps = 7/210 (3%)
Query: 107 NFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLH 166
+ S + +I +LS + + ++ + + + L+ L L
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77
Query: 167 GNKLQGSIPYDLCHLEGLSELNLNGNKL-CGHVPPCLASLTSLRRLHLGSNKLTSTMPSS 225
NKL I L L+L+ N + +++ L+ L L + L +
Sbjct: 78 HNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLP 134
Query: 226 FGSLEYV-LYINLSANSLNGSLPSNIQNLKVLTN--LDLSRNQLSGDIPTTIGGLENLET 282
L + + L P +Q+ + + + + + ++ + NLE
Sbjct: 135 IAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 283 LSLADNQFQGPVPKSFGSLISLESLDLSRN 312
++ L L++ N
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSN 224
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 24/83 (28%), Positives = 38/83 (45%), Gaps = 3/83 (3%)
Query: 233 LYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292
++ S N L +P ++ + T L++S+N +S + I L L L ++ N+ Q
Sbjct: 3 FLVDRSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 293 PVPKSFGSLISLESLDLSRNNLS 315
F LE LDLS N L
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV 82
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 43/235 (18%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFN-LQLERASRSFDS----------------ECEIL 465
L G F + D A+K + LE+ S E +I+
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 466 RSIRHRNLIK---IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF-------LGILERL 515
I++ + II+N + + ++ E+M N S+ K+ + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEV-Y--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 516 NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575
I+ V + Y+H+ + + H D+KP+NIL+D+N +SDFG S+ + D I+
Sbjct: 155 CIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG 209
Query: 576 MTIATIGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK 628
+ T +M PE K D++S GI L F P F ++SL
Sbjct: 210 -SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 45/202 (22%), Positives = 78/202 (38%), Gaps = 34/202 (16%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIK-- 475
LG G F ++ + A K+ L E I RS+ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 476 -IISNCCNIDFKALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDVGLAL 525
+ + +VLE SL + Y I+
Sbjct: 82 GFFEDNDFV---FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----------GC 128
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 585
+YLH ++H DLK N+ L+E++ + DFG++ + E D + + T Y+A
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLC-GTPNYIA 183
Query: 586 PEYGSEGIISPKSDVYSYGILL 607
PE S+ S + DV+S G ++
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIM 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 45/202 (22%), Positives = 78/202 (38%), Gaps = 34/202 (16%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIK-- 475
LG G F ++ + A K+ L E I RS+ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 476 -IISNCCNIDFKALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDVGLAL 525
+ + +VLE SL + Y I+
Sbjct: 108 GFFEDNDFV---FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----------GC 154
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 585
+YLH ++H DLK N+ L+E++ + DFG++ + E D + + T Y+A
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLC-GTPNYIA 209
Query: 586 PEYGSEGIISPKSDVYSYGILL 607
PE S+ S + DV+S G ++
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIM 231
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 18/196 (9%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIKI 476
LG G FG+VY +A+KV L+ E EI +RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 477 ---ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+ + L+LE+ P G++ + L + F + ++ AL Y H
Sbjct: 75 YGYFHDATRV---YLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKR- 129
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGI 593
++H D+KP N+LL ++DFG S S + T+ Y+ PE +
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLC-GTLDYLPPEMIEGRM 183
Query: 594 ISPKSDVYSYGILLME 609
K D++S G+L E
Sbjct: 184 HDEKVDLWSLGVLCYE 199
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 56/327 (17%), Positives = 102/327 (31%), Gaps = 53/327 (16%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L L N ++ T+ ++ + L L SN + L L L L+ N
Sbjct: 63 LTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTN 116
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L ++ LT L A N L I + + + L E + K
Sbjct: 117 KLTK----------LDVSQNPLLTYLNCARNTLTEID---VSHNT-QLTELDCHLNKK-- 160
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
++ + + D + + + V + + L L N + + DL L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KL--DLNQNIQL 214
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYV------------ 232
+ L+ + NKL + + LT L N LT S+ L +
Sbjct: 215 TFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDL 271
Query: 233 ----LYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADN 288
I A ++ + L LD ++ ++ + L L L +
Sbjct: 272 THNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNT 328
Query: 289 QFQGPVPKSFGSLISLESLDLSRNNLS 315
+ + L+SL ++
Sbjct: 329 ELTE-LD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 58/311 (18%), Positives = 96/311 (30%), Gaps = 41/311 (13%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L L ++ ++ + I + L L +SN+ + L +L L+ N
Sbjct: 41 LATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSN 95
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L +T LT L +N L + + N L L
Sbjct: 96 KLTN----------LDVTPLTKLTYLNCDTNKLTKL--DVSQN--PLLTYLNCARNTLT- 140
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
I + + + + D + V +L L NK+ D+ + L
Sbjct: 141 EID--VSHNTQLTELDCHLN--KKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLL 193
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
+ LN + N + + L L L SNKLT L + Y + S N L
Sbjct: 194 NRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT- 246
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
L + L LT L + L +I + L + + L
Sbjct: 247 ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQL 299
Query: 305 ESLDLSRNNLS 315
LD ++
Sbjct: 300 YLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 58/314 (18%), Positives = 98/314 (31%), Gaps = 39/314 (12%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
N ++ T S + L LD ++S + + L L L N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNN 75
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN 125
+ T L+ NLT L SN L + + L KL
Sbjct: 76 ITTL----------DLSQNTNLTYLACDSNKLTNL--DVTPL--TKLTYLNCDTNKLT-K 120
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185
+ + + + L I V +L L H NK + D+ L+
Sbjct: 121 LD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLT 173
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
L+ + NK+ + ++ L RL+ +N +T + L +++ S+N L
Sbjct: 174 TLDCSFNKI-TELD--VSQNKLLNRLNCDTNNITKLDLNQNIQLT---FLDCSSNKLT-E 226
Query: 246 LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLE 305
+ + L LT D S N L+ ++ + L L TL L
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLI 278
Query: 306 SLDLSRNNLSGEIP 319
E+
Sbjct: 279 YFQAEGCRKIKELD 292
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 57/341 (16%), Positives = 105/341 (30%), Gaps = 44/341 (12%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
NL YL NKL+ + +T +KL L+ +N + L L L+ A N
Sbjct: 84 NTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARN 137
Query: 65 YL----------MTESSAAKWNFLSS--LTNCRNLTVLGLASNPLRGILPPLIGNFSASL 112
L +TE ++ +T LT L + N + + + N L
Sbjct: 138 TLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL--DVSQN--KLL 193
Query: 113 QEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQG 172
+ + + + D + L I V L +L N L
Sbjct: 194 NRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT- 246
Query: 173 SIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYV 232
D+ L L+ L+ L + L T L + +
Sbjct: 247 --ELDVSTLSKLTTLHCIQTDL-LEID--LTHNTQLIYFQAEGCRKIKE--LDVTHNTQL 299
Query: 233 LYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292
++ A + L + L L L+ +L+ ++ + L++LS + Q
Sbjct: 300 YLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD 353
Query: 293 PVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYAL 333
S G + +L + + + + S +
Sbjct: 354 -FS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSP 392
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-23
Identities = 57/317 (17%), Positives = 103/317 (32%), Gaps = 49/317 (15%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
P L YL N L+ I +++ ++L LD N + L L ++N
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ ++ + L L +N + + L N L KL
Sbjct: 181 KITE----------LDVSQNKLLNRLNCDTNNITKL--DLNQN--IQLTFLDCSSNKLT- 225
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
I + L+ + FD + L + V L +L L+ L I DL H L
Sbjct: 226 EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EI--DLTHNTQL 277
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
G + + T L L + +T ++Y+ L+ L
Sbjct: 278 IYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGITE---LDLSQNPKLVYLYLNNTELT- 331
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
L + + L +L + D + +G + L A+ Q I++
Sbjct: 332 ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQ-----------TITM 376
Query: 305 ESLDLSRNNLSGEIPKN 321
L+ N+L+ + +
Sbjct: 377 PKETLTNNSLTIAVSPD 393
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 48/305 (15%), Positives = 95/305 (31%), Gaps = 41/305 (13%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L N ++ + + +L LD SSN + + L L + N
Sbjct: 190 NKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVN 243
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L ++ LT L L I L N L F A GC+
Sbjct: 244 PLTELD----------VSTLSKLTTLHCIQTDLLEI--DLTHN--TQLIYFQAEGCRKIK 289
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
+ ++ + + + + D + + + + +L LYL+ +L + D+ H L
Sbjct: 290 EL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL--DVSHNTKL 341
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
L+ + + + +L + + + + + ++ G
Sbjct: 342 KSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
Query: 245 ----SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS 300
P + TN ++ LS D P T + + G V F +
Sbjct: 400 NPMNIEPGDGGVYDQATN-TITWENLSTDNPAVTY------TFTSENGAIVGTVTTPFEA 452
Query: 301 LISLE 305
++
Sbjct: 453 PQPIK 457
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 3e-25
Identities = 25/232 (10%), Positives = 55/232 (23%), Gaps = 45/232 (19%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIKII 477
L G V+ + + A+KVF + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 478 SNCCNIDFKA--------------------------LVLEFM-----PNGSLEKWLYSHN 506
+ L++ S ++Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 507 YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566
GIL + + L +VH P+N+ + + + D +G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 567 EGDDSVIQTMTIATIGYMAPEY--GSEGIISPKSDVYSYGILLMETFTRKKP 616
+ + Y E+ S + + + G+ + + P
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 42/252 (16%), Positives = 77/252 (30%), Gaps = 34/252 (13%)
Query: 408 LDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTN------VAIKVFNLQLERASRSFDSE 461
+ Q + +LLG G+F VY+ T D + +KV
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 462 CEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL----EKWLYSHNYFLGILERLNI 517
E L+ +K S + LV E G+L + + + ++
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAH-----------VSDFGISKLLG 566
+ + +E +H ++H D+KP+N +L + D G S +
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKS-----DVYSYGILLMETFTRKKPTNEIF 621
I T T G+ E ++S K D + + +
Sbjct: 235 LFPKGTIFTAKCETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
Query: 622 IGEMSLKHWVKE 633
GE + +
Sbjct: 290 GGECKPEGLFRR 301
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 35/259 (13%), Positives = 83/259 (32%), Gaps = 59/259 (22%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRS----------------------- 457
+LG + + T G + + V S +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 458 -----FDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM----PNGSLEKWLYSH--- 505
F ++++ + + +I++ + ++ + + + + L SH
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 506 NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565
+ L RL + + V L LHH +VH L+P +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 566 GEGDDSVIQTMTIATIGYMAPEY-----------GSEGIISPKSDVYSYGILLMETFTRK 614
G + ++ + G+ PE +++ D ++ G+++ +
Sbjct: 257 GA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 615 KP---TNEIFIGEMSLKHW 630
P + E +
Sbjct: 311 LPITKDAALGGSEWIFRSC 329
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 36/229 (15%)
Query: 404 RTSYLDIQRATNGFNE----CNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSF 458
R + L +T+GF E +LG G V + A+K+ ++ + +
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 459 D---------SECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF 508
+ E +ILR + H N+I++ F LV + M G L +L
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 509 LGILER--LNIMIDVGLALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565
E+ IM + + LH +VH DLKP NILLD++M ++DFG S L
Sbjct: 122 S---EKETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 566 GEGDDSVIQTMTIA-TIGYMAPE------YGSEGIISPKSDVYSYGILL 607
G+ + + T Y+APE + + D++S G+++
Sbjct: 175 DPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRS-FDSECEI-LRSIRHRNLIK---- 475
+G G++GSV K G +A+K ++ + + ++ +RS +++
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 476 -IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFL---GILERL--NIMIDVGLALEYLH 529
C I +E M + S +K Y + Y + I E + I + AL +L
Sbjct: 90 LFREGDCWI-----CMELM-STSFDK-FYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-- 587
+H D+KP+NILLD + + DFGIS G+ DS+ +T YMAPE
Sbjct: 143 ENLKI--IHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERI 197
Query: 588 --YGSEGIISPKSDVYSYGILLME 609
S +SDV+S GI L E
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYE 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRS-FDSECEI-LRSIRHRNLIK---- 475
LG G++G V K + G +A+K + + + +I +R++ +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 476 -IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLG--ILERL--NIMIDVGLALEYLHH 530
I +E M + SL+K Y G I E + I + + ALE+LH
Sbjct: 75 LFREGDVWI-----CMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--- 587
S ++H D+KP+N+L++ + DFGIS G D V + + YMAPE
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPYMAPERIN 182
Query: 588 -YGSEGIISPKSDVYSYGILLME 609
++ S KSD++S GI ++E
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIE 205
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 38/240 (15%)
Query: 387 STKDGDQEDLLSLATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIK 445
S G Q L++ R + ++ +G+G+ G V+K G +A+K
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEIN------DLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 446 VFNLQLERASRSFDS---ECEIL-RSIRHRNLIK-----IISNCCNIDFKALVLEFMPNG 496
++ + +++ +S +++ I + I +E M
Sbjct: 57 Q--MRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI-----AMELM-GT 108
Query: 497 SLEKWLYSHNYFLGILERL--NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554
EK I ER+ + + + AL YL H ++H D+KP+NILLDE
Sbjct: 109 CAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQI 164
Query: 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-----YGSEGIISPKSDVYSYGILLME 609
+ DFGIS G D + + YMAPE ++ ++DV+S GI L+E
Sbjct: 165 KLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 34/203 (16%)
Query: 422 LLGTGSFGSVY----KGTLFDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLI 474
LG G FG+VY K +A+KV L+ E E EI +RH N++
Sbjct: 21 PLGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 475 KI---ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG 531
++ + I L+LEF P G L K L H F M ++ AL Y H
Sbjct: 78 RMYNYFHDRKRI---YLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHER 133
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE 591
++H D+KP N+L+ ++DFG S +TM T+ Y+ PE
Sbjct: 134 K---VIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMC-GTLDYLPPE---- 182
Query: 592 GIIS-----PKSDVYSYGILLME 609
+I K D++ G+L E
Sbjct: 183 -MIEGKTHDEKVDLWCAGVLCYE 204
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 42/231 (18%), Positives = 87/231 (37%), Gaps = 44/231 (19%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSI-RHRN 472
F+E +G+G FGSV+K DG AIK L ++ E + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 473 LIKIIS-----NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGIL---ERLNIMIDVGLA 524
+++ S + I E+ GSL + + + E ++++ VG
Sbjct: 73 VVRYFSAWAEDDHMLI-----QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ---------- 574
L Y+H +VH D+KP+NI + + + + + + +
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 575 TMTIATIG---YMAPEYGSEGII------SPKSDVYSYGILLMETFTRKKP 616
+ G ++A E ++ PK+D+++ + ++ +
Sbjct: 185 SSPQVEEGDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 34/203 (16%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
+LG+G+F V+ G A+K S ++E +L+ I+H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 481 CNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILERL--NIMIDVGLALEYLH-HGH 532
+ LV++ + G L E+ +Y+ E+ ++ V A++YLH +G
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYT--------EKDASLVIQQVLSAVKYLHENG- 126
Query: 533 STPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEY 588
+VH DLKP N+L +EN ++DFG+SK+ G T T GY+APE
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEV 178
Query: 589 GSEGIISPKSDVYSYG----ILL 607
++ S D +S G ILL
Sbjct: 179 LAQKPYSKAVDCWSIGVITYILL 201
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 61/252 (24%), Positives = 107/252 (42%), Gaps = 37/252 (14%)
Query: 382 RHRNRSTKDGDQEDLLSLAT----WRRTSYLDIQRATNGFNE----CNLLGTGSFGSVYK 433
+ + R + + L + + D + LG+G+ G V
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 434 GT-LFDGTNVAIKVFN--------LQLERASRSFDSECEILRSIRHRNLIKIISNCCNID 484
VAI++ + + + + ++E EIL+ + H +IKI N + +
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK-NFFDAE 212
Query: 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLH-HGHSTPMVHCDL 541
+VLE M G L + + E + LA++YLH +G ++H DL
Sbjct: 213 DYYIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLHENG----IIHRDL 265
Query: 542 KPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---YGSEGIIS 595
KP N+LL +E+ ++DFG SK+LGE S+++T+ T Y+APE +
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTL-CGTPTYLAPEVLVSVGTAGYN 322
Query: 596 PKSDVYSYGILL 607
D +S G++L
Sbjct: 323 RAVDCWSLGVIL 334
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 43/201 (21%), Positives = 80/201 (39%), Gaps = 22/201 (10%)
Query: 424 GTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDS----ECEILRSIRHRNLIKIIS 478
G +V G V ++ NL E S + E + + H N++ +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINL--EACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLH-HGHSTP 535
+ +V FM GS + L ++ G+ E I+ V AL+Y+H G+
Sbjct: 94 TFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHMGY--- 149
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD--SVIQTMTIATIG---YMAPEYGS 590
VH +K ++IL+ + ++S + + V+ ++ +++PE
Sbjct: 150 -VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 591 EGII--SPKSDVYSYGILLME 609
+ + KSD+YS GI E
Sbjct: 209 QNLQGYDAKSDIYSVGITACE 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-23
Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 45/214 (21%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNL--------QLERASRSFDSECEILRSIR-HRN 472
+G G V + G A+K+ + QLE + E ILR + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLAL 525
+I +I + + F LV + M G L EK S E+ +IM + A+
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS--------EKETRSIMRSLLEAV 213
Query: 526 EYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGY 583
+LH + +VH DLKP NILLD+NM +SDFG S L G+ + + T GY
Sbjct: 214 SFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGY 265
Query: 584 MAPE------YGSEGIISPKSDVYSYG----ILL 607
+APE + + D+++ G LL
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 32/201 (15%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
+G GS+G V A K F E EI++S+ H N+I++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLH-HGHSTPMVH 538
+ LV+E G L + + F E IM DV A+ Y H + H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFR---ESDAARIMKDVLSAVAYCHKLN----VAH 129
Query: 539 CDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-----YGS 590
DLKP N L + + DFG++ G +++T + T Y++P+ YG
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTK-VGTPYYVSPQVLEGLYG- 185
Query: 591 EGIISPKSDVYSYG----ILL 607
P+ D +S G +LL
Sbjct: 186 -----PECDEWSAGVMMYVLL 201
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 51/190 (26%), Positives = 80/190 (42%), Gaps = 14/190 (7%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
++P++ L L+ L + RL L L +L + D L L
Sbjct: 28 DLPKDTTIL------HLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDG-TLPVL 79
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
L+L+ N+L +P +L +L L + N+LTS + L + + L N L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137
Query: 245 SLPSNI-QNLKVLTNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLI 302
+LP + L L L+ N L+ ++P + GLENL+TL L +N +PK F
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSH 195
Query: 303 SLESLDLSRN 312
L L N
Sbjct: 196 LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 45/158 (28%), Positives = 67/158 (42%), Gaps = 7/158 (4%)
Query: 160 LQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLT 219
L+L N L L L++LNL+ +L +L L L L N+L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 220 STMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTI-GGL 277
S +P +L + +++S N L SLP + L L L L N+L +P +
Sbjct: 91 S-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 278 ENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
LE LSLA+N L +L++L L N+L
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 7/162 (4%)
Query: 160 LQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLT 219
+ L ++P DL + + L+L+ N L L T L +L+L +LT
Sbjct: 12 HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 220 STMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLEN 279
G+L + ++LS N L SLP Q L LT LD+S N+L+ + GL
Sbjct: 69 K--LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 280 LETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKN 321
L+ L L N+ + P LE L L+ NNL+ E+P
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAG 166
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 52/263 (19%), Positives = 77/263 (29%), Gaps = 69/263 (26%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
+ + + L+ +P + + + L LS N T L L+L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
L L L L L+ N L+
Sbjct: 65 AELTK---------LQVDGTLPVLGTLDLSHNQLQ------------------------- 90
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL-CHLE 182
++P L L L + N+L S+P L
Sbjct: 91 -------------------------SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 183 GLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241
L EL L GN+L +PP L L +L L +N LT LE + + L NS
Sbjct: 125 ELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 242 LNGSLPSNIQNLKVLTNLDLSRN 264
L ++P +L L N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 58/205 (28%), Positives = 83/205 (40%), Gaps = 38/205 (18%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFN--LQLERASRSFDSECEILRSIRHRNLIKIISN 479
LG GSFG V K A+KV N + + + E E+L+ + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLH-HGHSTPM 536
+ +V E G L + F E I+ V + Y+H H +
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFS---EHDAARIIKQVFSGITYMHKHN----I 142
Query: 537 VHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE---- 587
VH DLKP NILL +++ + DFG+S + M T Y+APE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-----TKMKDRIGTAYYIAPEVLRG 197
Query: 588 -YGSEGIISPKSDVYSYG----ILL 607
Y K DV+S G ILL
Sbjct: 198 TYD------EKCDVWSAGVILYILL 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 47/212 (22%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFN--------LQLERASRSFDSECEILRSIRHRNL 473
LG+G+ G V VAIK+ + + + + ++E EIL+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 474 IKIISNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLH 529
IKI + D + +VLE M G L + + E + LA++YLH
Sbjct: 78 IKIKNF---FDAEDYYIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLH 131
Query: 530 -HGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYM 584
+G ++H DLKP N+LL +E+ ++DFG SK+LGE T+ T Y+
Sbjct: 132 ENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYL 183
Query: 585 APE---------YGSEGIISPKSDVYSYGILL 607
APE Y D +S G++L
Sbjct: 184 APEVLVSVGTAGYN------RAVDCWSLGVIL 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 29/199 (14%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIKIIS 478
LG GSFG V G A+KV + ++ + S E ++L+ + H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLHHGHSTPM 536
+ + LV E G L + S F E I+ V + Y+H +
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFS---EVDAARIIRQVLSGITYMHKNK---I 147
Query: 537 VHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-----Y 588
VH DLKP N+LL ++ + DFG+S I T Y+APE Y
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGTY 204
Query: 589 GSEGIISPKSDVYSYGILL 607
K DV+S G++L
Sbjct: 205 D------EKCDVWSTGVIL 217
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 10/195 (5%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
+ +G G+ G+VY + G VAI+ NLQ + +E ++R ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ + D +V+E++ GSL + + ++ I L+ L HS
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTD-VVTE----TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEYGSEGII 594
++H D+K +NILL + + ++DFG + + T + T +MAPE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 595 SPKSDVYSYGILLME 609
PK D++S GI+ +E
Sbjct: 194 GPKVDIWSLGIMAIE 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 38/208 (18%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN----LQLERASRSFDSECEILRSIRHRNLIK- 475
LLG GS+G V + A+K+ ++ + E ++LR +RH+N+I+
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 476 --IISNCCNIDFKALVLEFMPNGSLEKWLY----------SHNYFLGILERLNIMIDVGL 523
++ N +V+E+ G E +H YF +++
Sbjct: 72 VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID---------- 120
Query: 524 ALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVIQTMTIATI 581
LEYLH G +VH D+KP N+LL T +S G+++ L D +T + +
Sbjct: 121 GLEYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSP 175
Query: 582 GYMAPE--YGSEGIISPKSDVYSYGILL 607
+ PE G + K D++S G+ L
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 4e-22
Identities = 56/323 (17%), Positives = 102/323 (31%), Gaps = 52/323 (16%)
Query: 8 LKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLM 67
+ + P+ ++ I +L S + + L S+ + + +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 68 TESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIP 127
+ + + N+T L L N L I P + N +L + K++
Sbjct: 57 S---------VQGIQYLPNVTKLFLNGNKLTDIKP--LTNLK-NLGWLFLDENKIK---- 100
Query: 128 QEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSEL 187
++ +L L++L+ L L N + I L HL L L
Sbjct: 101 -DLSSLKD---------------------LKKLKSLSLEHNGIS-DIN-GLVHLPQLESL 136
Query: 188 NLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLP 247
L NK+ L+ LT L L L N+++ L + + LS N + S
Sbjct: 137 YLGNNKI--TDITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI--SDL 190
Query: 248 SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESL 307
+ LK L L+L + L T+ D P S E
Sbjct: 191 RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDG--DYEKP 248
Query: 308 DLSRNNLSGEIPKNFSAQSFLSN 330
++ + +F ++
Sbjct: 249 NVKWHLPEFTNEVSFIFYQPVTI 271
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 1e-18
Identities = 56/296 (18%), Positives = 97/296 (32%), Gaps = 50/296 (16%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L ++ + ++ + ++ I + L L+ N + + P NL +L L L N
Sbjct: 42 LNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN 97
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ LSSL + + L L L N + I + + L+ Y K+
Sbjct: 98 KIKD---------LSSLKDLKKLKSLSLEHNGISDING--LVHLP-QLESLYLGNNKI-- 143
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
+I LS L +L L L N++ I L L L
Sbjct: 144 ---TDITVLSR---------------------LTKLDTLSLEDNQIS-DIV-PLAGLTKL 177
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
L L+ N + LA L +L L L S + + + +L + + SL
Sbjct: 178 QNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 235
Query: 245 ----SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPK 296
S + + V +L N++S + + Q V
Sbjct: 236 PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYT 291
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 47/210 (22%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISN 479
LG G+F V + G A K+ N + R + + E I R ++H N++++ +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 480 CCNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLALEYLH-HG 531
F LV + + G L + YS E + + + ++ Y H +G
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYS--------EADASHCIQQILESIAYCHSNG 125
Query: 532 HSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPE 587
+VH +LKP N+LL + ++DFG++ + + + A T GY++PE
Sbjct: 126 ----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPE 177
Query: 588 ------YGSEGIISPKSDVYSYG----ILL 607
Y D+++ G ILL
Sbjct: 178 VLKKDPYS------KPVDIWACGVILYILL 201
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-22
Identities = 35/180 (19%), Positives = 67/180 (37%), Gaps = 15/180 (8%)
Query: 452 ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGI 511
+ + + +N + + + + ++ +L+ W+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 512 LER--LNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569
L+I I + A+E+LH ++H DLKP+NI + V DFG+ + + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218
Query: 570 D----------SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNE 619
+ T + T YM+PE S K D++S G++L E E
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 18/76 (23%), Positives = 27/76 (35%), Gaps = 2/76 (2%)
Query: 412 RATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNL-QLERASRSFDSECEILRSIR 469
R F +G G FG V++ D N AIK L E A E + L +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 470 HRNLIKIISNCCNIDF 485
H +++ +
Sbjct: 63 HPGIVRYFNAWLETPP 78
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
+ +G GS G V G VA+K+ +L+ ++ +E I+R +H N+++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLHHGHS 533
+ + + +++EF+ G+L + S E + V AL YLH +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLN---EEQIATVCEAVLQALAYLH---A 159
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEYGSEG 592
++H D+K ++ILL + +SDFG + V + + + T +MAPE S
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRS 216
Query: 593 IISPKSDVYSYGILLME 609
+ + + D++S GI+++E
Sbjct: 217 LYATEVDIWSLGIMVIE 233
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-22
Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 28/198 (14%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQ--LERASRSFDSECEILRSIRHRNLIKIISN 479
LG+G++G V AIK+ ++ E +L+ + H N++K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLHHGHSTPMV 537
+ LV+E G L + F E I+ V + YLH + +V
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFN---EVDAAVIIKQVLSGVTYLHKHN---IV 158
Query: 538 HCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-----YG 589
H DLKP N+LL +++ + DFG+S + + T Y+APE Y
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRKKYD 215
Query: 590 SEGIISPKSDVYSYGILL 607
K DV+S G++L
Sbjct: 216 ------EKCDVWSIGVIL 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 61/308 (19%), Positives = 117/308 (37%), Gaps = 36/308 (11%)
Query: 23 PNSIT------NASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWN 76
P +I + I + ++ + + +L + LS + T
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-------- 55
Query: 77 FLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGM 136
+ + NL L L N + + P + N + + E G L+ N+ I L +
Sbjct: 56 -IEGVQYLNNLIGLELKDNQITDLAP--LKNLT-KITELELSGNPLK-NVS-AIAGLQSI 109
Query: 137 IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCG 196
DL + P + L LQ LYL N++ +I L L L L++ ++
Sbjct: 110 KTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS- 164
Query: 197 HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVL 256
+ P LA+L+ L L NK++ S SL ++ ++L N ++ S + N L
Sbjct: 165 DLTP-LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDV--SPLANTSNL 219
Query: 257 TNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV-PKSFGSLISLESLDLSRNNLS 315
+ L+ ++ + P NL ++ P+ P + + S +L+ N S
Sbjct: 220 FIVTLTNQTIT-NQPVFY--NNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
Query: 316 GEIPKNFS 323
+++
Sbjct: 277 FINNVSYT 284
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 54/263 (20%), Positives = 105/263 (39%), Gaps = 26/263 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L + L+ F ++ TI + + LI L+L N + L P NL + L L+ N
Sbjct: 40 LDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L +S++ +++ L L S + + P + S +LQ Y ++
Sbjct: 96 PLKN---------VSAIAGLQSIKTLDLTSTQITDVTP--LAGLS-NLQVLYLDLNQIT- 142
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
NI + L+ + + + + T + L +L L NK+ I L L L
Sbjct: 143 NIS-PLAGLTNLQYLSIGNAQV--SDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNL 197
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
E++L N++ LA+ ++L + L + +T+ +L + + +
Sbjct: 198 IEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP-- 253
Query: 245 SLPSNIQNLKVLTNLDLSRNQLS 267
P+ I + + +L+ N S
Sbjct: 254 IAPATISDNGTYASPNLTWNLTS 276
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 39/205 (19%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFN-LQLERASRSFDSECEILRSIRHRNLIKIISNC 480
LG+G+FG V+ G IK N + + ++E E+L+S+ H N+IKI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 481 CNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLALEYLH-HGH 532
+ +V+E G L E +M + AL Y H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL----SEGYVAELMKQMMNALAYFHSQH- 144
Query: 533 STPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE 587
+VH DLKP NIL + + DFG+++L + T A T YMAPE
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-----EHSTNAAGTALYMAPE 196
Query: 588 -----YGSEGIISPKSDVYSYGILL 607
K D++S G+++
Sbjct: 197 VFKRDVT------FKCDIWSAGVVM 215
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-21
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 39/211 (18%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKV-------------FNLQLERASRSFDSECEILR 466
LG+G++G V + AIKV N +E+ +E +L+
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 467 SIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLA 524
S+ H N+IK+ + + LV EF G L + + + + F E NIM +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD---ECDAANIMKQILSG 158
Query: 525 LEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATI 581
+ YLH + +VH D+KP NILL + + + DFG+S + + T
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTA 212
Query: 582 GYMAPE-----YGSEGIISPKSDVYSYGILL 607
Y+APE Y K DV+S G+++
Sbjct: 213 YYIAPEVLKKKYN------EKCDVWSCGVIM 237
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 58/165 (35%), Positives = 79/165 (47%), Gaps = 6/165 (3%)
Query: 151 PTAVGRLRRLQGLYLHGNKLQGSIPYDLCH-LEGLSELNLNGNKLCGHVPPCL-ASLTSL 208
A RL +L+ LYL+ NKLQ ++P + L+ L L + NKL +P + L +L
Sbjct: 54 SKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNL 111
Query: 209 RRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLS 267
L L N+L S P F SL + Y++L N L SLP + L L L L NQL
Sbjct: 112 AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170
Query: 268 GDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312
L L+TL L +NQ + +F SL L+ L L N
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 51/169 (30%), Positives = 71/169 (42%), Gaps = 12/169 (7%)
Query: 150 IPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCL-ASLTSL 208
IP + L L NKL L L L LN NKL +P + L +L
Sbjct: 35 IPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNL 87
Query: 209 RRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLS 267
L + NKL + F L + + L N L SLP + +L LT L L N+L
Sbjct: 88 ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 268 GDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
+P + L +L+ L L +NQ + +F L L++L L N L
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 64/221 (28%), Positives = 87/221 (39%), Gaps = 42/221 (19%)
Query: 22 IPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSL 81
IP LDL SN S L F L L++L L N L T + F L
Sbjct: 35 IPADTKK------LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI---F-KEL 84
Query: 82 TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDL 141
N L L + N L+ LP + + +L E +L+ ++P VFD
Sbjct: 85 KN---LETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLP------PR--VFD- 130
Query: 142 NGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC-HLEGLSELNLNGNKLCGHVPP 200
L +L L L N+LQ S+P + L L EL L N+L VP
Sbjct: 131 --------------SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPE 174
Query: 201 CL-ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
LT L+ L L +N+L +F SLE + + L N
Sbjct: 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 55/214 (25%), Positives = 74/214 (34%), Gaps = 60/214 (28%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L L+ L L DNKL T+P I L L ++ N L F L +L L L
Sbjct: 60 LTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDR 118
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N L + F SLT LT L L N L+
Sbjct: 119 NQLKSLPPRV---F-DSLT---KLTYLSLGYNELQ------------------------- 146
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH-LE 182
++P+ VFD +L L+ L L+ N+L+ +P L
Sbjct: 147 -SLPKG--------VFD---------------KLTSLKELRLYNNQLK-RVPEGAFDKLT 181
Query: 183 GLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSN 216
L L L+ N+L SL L+ L L N
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 26/81 (32%), Positives = 37/81 (45%), Gaps = 3/81 (3%)
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
++ S+ L ++PSNI LDL N+LS L L L L DN+ Q
Sbjct: 21 VDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77
Query: 295 PKSFGSLISLESLDLSRNNLS 315
F L +LE+L ++ N L
Sbjct: 78 AGIFKELKNLETLWVTDNKLQ 98
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 50/227 (22%), Positives = 91/227 (40%), Gaps = 43/227 (18%)
Query: 408 LDIQRATNGFNE----CNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFD--- 459
LD+ F + C ++G G F V + G A+K+ ++ +S
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 460 --SECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGIL 512
E I ++H ++++++ + +V EFM L ++ Y
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS---- 128
Query: 513 ERL--NIMIDVGLALEYLH-HGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLG 566
E + + M + AL Y H + ++H D+KP+ +LL + + + FG++ LG
Sbjct: 129 EAVASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
Query: 567 EGDDSVIQTMTIATIGYMAPE------YGSEGIISPKSDVYSYGILL 607
E V + T +MAPE YG DV+ G++L
Sbjct: 185 E-SGLVAGGR-VGTPHFMAPEVVKREPYG------KPVDVWGCGVIL 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
+ LG G+FG VYK G A KV + E + E EIL + H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
++ + +++EF P G+++ + + L + + + AL +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--- 137
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPE-----YG 589
++H DLK N+L+ ++DFG+S + ++ + + I T +MAPE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 590 SEGIISPKSDVYSYGILLME 609
+ K+D++S GI L+E
Sbjct: 195 KDTPYDYKADIWSLGITLIE 214
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 28/198 (14%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQ--LERASRSFDSECEILRSIRHRNLIKIISN 479
LG GSFG V K A+KV N + + + E E+L+ + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLHHGHSTPMV 537
+ +V E G L + F E I+ V + Y+H + +V
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFS---EHDAARIIKQVFSGITYMHKHN---IV 143
Query: 538 HCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-----YG 589
H DLKP NILL +++ + DFG+S + ++ I T Y+APE Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDR-IGTAYYIAPEVLRGTYD 200
Query: 590 SEGIISPKSDVYSYGILL 607
K DV+S G++L
Sbjct: 201 ------EKCDVWSAGVIL 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 54/237 (22%), Positives = 87/237 (36%), Gaps = 56/237 (23%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFD-----SECEILRSIRHRNLIKI 476
+G GS+G V AIK+ N R D +E +++ + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 477 ISNCCNIDFKALVLEFMPNGSL-------------------------------------E 499
+ + LV+E G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 500 KWLYSHNYFLGILERL--NIMIDVGLALEYLH-HGHSTPMVHCDLKPNNILL--DENMTA 554
+ + E+L NIM + AL YLH G + H D+KP N L +++
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNKSFEI 209
Query: 555 HVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE--YGSEGIISPKSDVYSYGILL 607
+ DFG+SK + ++ MT T ++APE + PK D +S G+LL
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 51/227 (22%)
Query: 410 IQRATNGFNE----CNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSEC 462
+ A+ F++ LG G+F V + G A K+ N + R + + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 463 EILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--L 515
I R ++H N++++ + F LV + + G L + YS E
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS--------EADAS 131
Query: 516 NIMIDVGLALEYLH-HGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDS 571
+ + + ++ Y H +G +VH +LKP N+LL + ++DFG++ + + +
Sbjct: 132 HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185
Query: 572 VIQTMTIA-TIGYMAPE------YGSEGIISPKSDVYSYG----ILL 607
A T GY++PE Y D+++ G ILL
Sbjct: 186 --AWHGFAGTPGYLSPEVLKKDPYS------KPVDIWACGVILYILL 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 40/212 (18%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDS---ECEILRSIRHRNLIKIIS 478
+G+G+ V VAIK NL E+ S D E + + H N++
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHHPNIVSYY- 79
Query: 479 NCCNIDFKAL--VLEFMPNGSL----EKWLYSHNYFLGILERLNIMI---DVGLALEYLH 529
+ L V++ + GS+ + + + G+L+ I +V LEYLH
Sbjct: 80 -TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 530 -HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ----TMTIATIGYM 584
+G +H D+K NILL E+ + ++DFG+S L G D T + T +M
Sbjct: 139 KNGQ----IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-VGTPCWM 193
Query: 585 APE-------YGSEGIISPKSDVYSYGILLME 609
APE Y K+D++S+GI +E
Sbjct: 194 APEVMEQVRGYD------FKADIWSFGITAIE 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 49/210 (23%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQ-----LERASRSFDSECEILRSIRHRNLIK 475
LG G++G V VA+K+ +++ E + E I + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 476 ---IISNCCNIDFKALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDVGL 523
L LE+ G L + +F ++
Sbjct: 70 FYGHRREGNIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------- 116
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
+ YLH + H D+KP N+LLDE +SDFG++ + + + T+ Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 584 MAPEYGSEGIIS------PKSDVYSYGILL 607
+APE ++ DV+S GI+L
Sbjct: 174 VAPE-----LLKRREFHAEPVDVWSCGIVL 198
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDS---ECEILRSIRHRN 472
F + +G GSFG V+KG VAIK+ +L E A + E +L
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL--EEAEDEIEDIQQEITVLSQCDSPY 81
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMI---DVGLALEYLH 529
+ K + +++E++ GS G L+ I ++ L+YLH
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSA-----LDLLEPGPLDETQIATILREILKGLDYLH 136
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEY 588
S +H D+K N+LL E+ ++DFG++ L D+ I+ T + T +MAPE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEV 190
Query: 589 GSEGIISPKSDVYSYGILLMETFTRKKP 616
+ K+D++S GI +E + P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 53/240 (22%), Positives = 83/240 (34%), Gaps = 38/240 (15%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
+ K L L N L S + +L +LDLS + + +L L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN 125
+ + + A + +L L L + IG+ +L+E + N
Sbjct: 88 IQSLALGA-------FSGLSSLQKLVAVETNLASLENFPIGHLK-TLKELN-----VAHN 134
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD----LCHL 181
I + F L L+ L L NK+Q SI L +
Sbjct: 135 ---LIQSFKLPEYFS---------------NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQM 175
Query: 182 EGLS-ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
L+ L+L+ N + + P L+ L L +N+L S F L + I L N
Sbjct: 176 PLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 12/189 (6%)
Query: 132 NLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQGLYLHGNKLQGSIPYDL-CHLEGLSELNL 189
+ + V DL+ C++ TI L L L L GN +Q S+ L L +L
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107
Query: 190 NGNKLCGHVPPCLASLTSLRRLHLGSNKLTS-TMPSSFGSLEYVLYINLSANSLNGSLPS 248
L + L +L+ L++ N + S +P F +L + +++LS+N + S+
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC 166
Query: 249 NI----QNLKVLT-NLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303
+ +L +LDLS N ++ I L+ L+L NQ + F L S
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTS 225
Query: 304 LESLDLSRN 312
L+ + L N
Sbjct: 226 LQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 14/174 (8%)
Query: 151 PTAVGRLRRLQGLYLHGNKLQGSIPYDLC-HLEGLSELNLNGNKLCGHVPP-CLASLTSL 208
+ LQ L L ++Q +I L LS L L GN + + + L+SL
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSL 102
Query: 209 RRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSN--IQNLKVLTNLDLSRNQL 266
++L L S G L+ + +N++ N + S NL L +LDLS N++
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 267 SGDIPT-TIGGLENLE----TLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
I + L + +L L+ N P +F + L+ L L N L
Sbjct: 162 Q-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 29/121 (23%), Positives = 53/121 (43%), Gaps = 5/121 (4%)
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRN 264
S + L L N L SF S + ++LS + ++ Q+L L+ L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 265 QLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL-SGEIPKNF 322
+ + GL +L+ L + G L +L+ L+++ N + S ++P+ F
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 323 S 323
S
Sbjct: 146 S 146
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 45/218 (20%), Positives = 74/218 (33%), Gaps = 64/218 (29%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L +L L L N + ++ + S L L + + L G+L +L+ L++A+
Sbjct: 75 LSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N + S + S+LT NL L L+SN ++
Sbjct: 134 NLI---QSFKLPEYFSNLT---NLEHLDLSSNKIQ------------------------- 162
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQG----LYLHGNKLQGSIPYDLC 179
+I L ++ L L N + I
Sbjct: 163 -SIYCT--------DLR---------------VLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 180 HLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSN 216
L EL L+ N+L VP LTSL+++ L +N
Sbjct: 198 KEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 28/161 (17%), Positives = 64/161 (39%), Gaps = 7/161 (4%)
Query: 157 LRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSN 216
+ L + L + + + + +L +N + P ++ L++L RL +
Sbjct: 43 MNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHA-TNYNP-ISGLSNLERLRIMGK 98
Query: 217 KLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGG 276
+TS + L + +++S ++ + S+ + I L + ++DLS N DI +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKT 157
Query: 277 LENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGE 317
L L++L++ + L L + G+
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 22/136 (16%), Positives = 52/136 (38%), Gaps = 5/136 (3%)
Query: 180 HLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239
+ L+ + L + + + +++ L + + T+ + L + + +
Sbjct: 42 QMNSLTYITLANINV-TDLTG-IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMG 97
Query: 240 NSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFG 299
+ N+ L LT LD+S + I T I L + ++ L+ N
Sbjct: 98 KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG-AITDIMPLK 156
Query: 300 SLISLESLDLSRNNLS 315
+L L+SL++ + +
Sbjct: 157 TLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 31/190 (16%), Positives = 68/190 (35%), Gaps = 18/190 (9%)
Query: 31 KLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVL 90
+ L +S + + T + SL ++LA + L+ + N+ L
Sbjct: 24 AYLNGLLGQSSTANI---TEAQMNSLTYITLANINVTD---------LTGIEYAHNIKDL 71
Query: 91 GLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTI 150
+ + P I S +L+ G + + + L+ + + D++ + +I
Sbjct: 72 TINNIHATNYNP--ISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 151 PTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRR 210
T + L ++ + L N I L L L LN+ + + + + L +
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQ 185
Query: 211 LHLGSNKLTS 220
L+ S +
Sbjct: 186 LYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 23/180 (12%), Positives = 51/180 (28%), Gaps = 31/180 (17%)
Query: 110 ASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNK 169
SL + ++ I + +N P + L L+ L + G
Sbjct: 44 NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 170 LQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSL 229
+ +L L L+ L+++ + + + +L + + L N +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-------- 151
Query: 230 EYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQ 289
++ L L +L++ + + D I L L
Sbjct: 152 -----------------IMPLKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 21/116 (18%), Positives = 44/116 (37%), Gaps = 4/116 (3%)
Query: 203 ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLS 262
A + SL + L + +T + + + ++ + I L L L +
Sbjct: 41 AQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIM 96
Query: 263 RNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEI 318
++ D + GL +L L ++ + + +L + S+DLS N +I
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 24/121 (19%), Positives = 46/121 (38%), Gaps = 7/121 (5%)
Query: 203 ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLS 262
++ + LG + + + SL Y I L+ ++ L + I+ + +L ++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTY---ITLANINVT-DL-TGIEYAHNIKDLTIN 74
Query: 263 RNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNF 322
+ + I GL NLE L + + L SL LD+S + I
Sbjct: 75 NIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 323 S 323
+
Sbjct: 133 N 133
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 22/118 (18%), Positives = 47/118 (39%), Gaps = 11/118 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L NL+ L + ++ +++ + L +LD+S ++ I L + + L+YN
Sbjct: 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKL 122
+T+ + L L L + + + I +F L + YA+ +
Sbjct: 147 GAITD--------IMPLKTLPELKSLNIQFDGVHDYRG--IEDFP-KLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 20/139 (14%), Positives = 42/139 (30%), Gaps = 13/139 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
N+K LT+ + + P I+ S L L + + L SL +L ++++
Sbjct: 65 AHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L+ + + + L+ N + PL L+ +
Sbjct: 123 AHDDSI-------LTKINTLPKVNSIDLSYNGAITDIMPLKTL--PELKSLNIQFDGVHD 173
Query: 125 NIPQEIGNLSGMIVFDLNG 143
I + +
Sbjct: 174 YRG--IEDFPKLNQLYAFS 190
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-21
Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 44/212 (20%)
Query: 420 CNLLGTGSFGSVYKGT-LFDGTNVAIKVFNL-QLERASR-SFDSECEILRSIRHRNLIKI 476
LG G+F V + + G A + N +L + E I R ++H N++++
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 477 ISNCCNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLALEYLH 529
+ L+ + + G L + YS E + + + A+ + H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--------EADASHCIQQILEAVLHCH 127
Query: 530 -HGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 585
G +VH +LKP N+LL + ++DFG++ + EG+ T GY++
Sbjct: 128 QMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGF-AGTPGYLS 181
Query: 586 PE------YGSEGIISPKSDVYSYG----ILL 607
PE YG D+++ G ILL
Sbjct: 182 PEVLRKDPYG------KPVDLWACGVILYILL 207
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
F+ LG GS+GSVYK G VAIK + E + E I++ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ +V+E+ GS+ + N L E I+ LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEYGSEGII 594
+H D+K NILL+ A ++DFG++ L D++ + T I T +MAPE E
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 595 SPKSDVYSYGILLME 609
+ +D++S GI +E
Sbjct: 203 NCVADIWSLGITAIE 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 51/211 (24%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQ-----LERASRSFDSECEILRSIRHRNLIK 475
LG G++G V VA+K+ +++ E + E I + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 476 ---IISNCCNIDFKALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDVGL 523
L LE+ G L + +F ++
Sbjct: 70 FYGHRREGNIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------- 116
Query: 524 ALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIG 582
+ YLH G + H D+KP N+LLDE +SDFG++ + + + T+
Sbjct: 117 GVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 583 YMAPEYGSEGIIS------PKSDVYSYGILL 607
Y+APE ++ DV+S GI+L
Sbjct: 173 YVAPE-----LLKRREFHAEPVDVWSCGIVL 198
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 8e-21
Identities = 48/253 (18%), Positives = 76/253 (30%), Gaps = 20/253 (7%)
Query: 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQ---EIGNLSGMI 137
R+L L + + S SL+ ++ I + +SG+
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 138 VFDLNGCDLNGTIPTAVGRL--RRLQGLYLHGNKLQGSIPYDL----CHLEGLSELNLNG 191
L ++ GT P + L L L + GL L++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 192 NKLCGHVPPCLASLTSLRRLHLGSNKLTSTM-------PSSFGSLEYVLYINLSANSLNG 244
+ +L L L N P F +L+ + N + +G
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLIS 303
+ L LDLS N L L +L+L+ + VPK +
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--K 275
Query: 304 LESLDLSRNNLSG 316
L LDLS N L
Sbjct: 276 LSVLDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 48/323 (14%), Positives = 92/323 (28%), Gaps = 38/323 (11%)
Query: 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLA 62
+ P + + F+ + + S +L SL+ L++
Sbjct: 17 FSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVR 76
Query: 63 YNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFS-ASLQEFYAYGCK 121
+ + + L L L + + G PP + + L
Sbjct: 77 AARIPSRILFG----ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132
Query: 122 LRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL 181
+ L + L+ L + +
Sbjct: 133 WATR-DAWLAELQQWL-------------------KPGLKVLSIAQAHSLNFSCEQVRVF 172
Query: 182 EGLSELNLNGNKLCGHVP----PCLASLTSLRRLHLGSNKLTS---TMPSSFGSLEYVLY 234
LS L+L+ N G C +L+ L L + + + + + +
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232
Query: 235 INLSANSLNGSLP-SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGP 293
++LS NSL + + L +L+LS L +P + L L L+ N+
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDR- 288
Query: 294 VPKSFGSLISLESLDLSRNNLSG 316
P S L + +L L N
Sbjct: 289 NP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 38/197 (19%), Positives = 59/197 (29%), Gaps = 37/197 (18%)
Query: 2 GYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNT----FGNLGSLQ 57
++ P LK L++ + L LDLS N G +LQ
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
Query: 58 VLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYA 117
VL+L + T S + L L L+ N LR ++ + L
Sbjct: 205 VLALRNAGMETPS----GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260
Query: 118 YGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD 177
L+ +P+ + +L L L N+L P
Sbjct: 261 SFTGLKQ-VPKGL--------------------------PAKLSVLDLSYNRLD-RNP-S 291
Query: 178 LCHLEGLSELNLNGNKL 194
L + L+L GN
Sbjct: 292 PDELPQVGNLSLKGNPF 308
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 42/204 (20%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNC 480
LG GSF K A+K+ + ++E ++ E L+ H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 481 CNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLALEYLH-HGH 532
+ LV+E + G L +K +S E IM + A+ ++H G
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFS--------ETEASYIMRKLVSAVSHMHDVG- 126
Query: 533 STPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-- 587
+VH DLKP N+L ++N+ + DFG ++L D+ ++T T+ Y APE
Sbjct: 127 ---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTP-CFTLHYAAPELL 181
Query: 588 ----YGSEGIISPKSDVYSYGILL 607
Y D++S G++L
Sbjct: 182 NQNGYD------ESCDLWSLGVIL 199
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 15/224 (6%)
Query: 392 DQEDLLSLATWRRTSYLDIQRATNGFNE----CNLLGTGSFGSVYKGT-LFDGTNVAIKV 446
+ D W++ ++ + LG+G+FG V++ G K
Sbjct: 24 NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 83
Query: 447 FNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHN 506
N + +E I+ + H LI + + L+LEF+ G L + + +
Sbjct: 84 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 143
Query: 507 YFLGILERLNIMIDVGLALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISK 563
Y + E +N M L+++H H +VH D+KP NI+ + + V DFG++
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLAT 199
Query: 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILL 607
L + I +T AT + APE + +D+++ G+L
Sbjct: 200 KLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 65/231 (28%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN-LQLERASRSFDS------------------- 460
+G GS+G V D T A+KV + +L R +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 461 ------ECEILRSIRHRNLIKII-----SNCCNIDFKALVLEFMPNGSL----------E 499
E IL+ + H N++K++ N ++ +V E + G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGPVMEVPTLKPLSE 136
Query: 500 KWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559
+ YF ++ +EYLH+ ++H D+KP+N+L+ E+ ++DF
Sbjct: 137 D--QARFYFQDLI----------KGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADF 181
Query: 560 GISKLLGEGDDSVIQTMTIATIGYMAPE---YGSEGIISPKSDVYSYGILL 607
G+S +G D+++ T+ T +MAPE + DV++ G+ L
Sbjct: 182 GVSNEF-KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISN 479
+LG G+ V L A+K+ Q E E+L + HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 480 CCNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLALEYLH-HG 531
D LV E M GS+ ++ ++ E ++ DV AL++LH G
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFN--------ELEASVVVQDVASALDFLHNKG 131
Query: 532 HSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDD-SVIQTMTIATI----GY 583
+ H DLKP NIL ++ + DF + + D S I T + T Y
Sbjct: 132 ----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 584 MAPE-----YGSEGIISPKSDVYSYGILL 607
MAPE I + D++S G++L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 54/212 (25%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQ-------LERASRSFDSECEILRSIRHRNL 473
LG G+FG V G G VA+K+ N Q + + R E + L+ RH ++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHI 73
Query: 474 IK---IISNCCNIDFKALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDV 521
IK +IS + +V+E++ G L ++ H F IL
Sbjct: 74 IKLYQVISTPTDF---FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-------- 122
Query: 522 GLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI 581
A++Y H +VH DLKP N+LLD +M A ++DFG+S + D ++T + +
Sbjct: 123 --AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRT-SCGSP 174
Query: 582 GYMAPEYGSEGIIS------PKSDVYSYGILL 607
Y APE +IS P+ D++S G++L
Sbjct: 175 NYAAPE-----VISGRLYAGPEVDIWSCGVIL 201
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 2e-20
Identities = 57/346 (16%), Positives = 107/346 (30%), Gaps = 41/346 (11%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITN------------------------ASKLIMLDLSSN 40
L L +L L K + + +L L +
Sbjct: 145 LTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204
Query: 41 SFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL--R 98
S ++ +L L L+ L E+ FLS LT L + L +
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 99 GILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGN-----LSGMIVFDLNGCDLNGTIPTA 153
+ + ++ Y + I +E L +++ + +
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 154 VGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHL 213
+ L + + LN N V ++L L+ L L
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 214 GSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-----QNLKVLTNLDLSRNQLSG 268
N L + + + + SLN SL S+ + + L+LS N L+G
Sbjct: 385 QRNGLKN-FFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTG 442
Query: 269 DIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
+ + ++ L L +N+ +PK L +L+ L+++ N L
Sbjct: 443 SVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 3e-20
Identities = 60/347 (17%), Positives = 102/347 (29%), Gaps = 29/347 (8%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
P K L+L N +S I+ S+L +L LS N L + F L+ L +++N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFS--ASLQEFYAYGCKLR 123
L S + + L L L+ N + P+ F L K R
Sbjct: 112 LQNISC-------CPMAS---LRHLDLSFNDFDVL--PVCKEFGNLTKLTFLGLSAAKFR 159
Query: 124 GNIPQEIGNLSGMIVF-DLNGCDLNGTIPTAVGRL-RRLQGLYLHGNKLQGSIPYD-LCH 180
+ +L + DL + G ++ + L H N L +
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 181 LEGLSELNLNGNKL----CGHVPPCLASLTSLRRLHLGSNKLTS---TMPSSFGSLEYVL 233
L L N+ N L +L + L + T F V
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 234 YINLSANSLNGSLPSNIQN-----LKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADN 288
Y+N+ ++ + LK L + + L+ +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 289 QFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCG 335
S S L+ ++N + + + S L L
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 52/319 (16%), Positives = 98/319 (30%), Gaps = 14/319 (4%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGL-IPNTFGNLGSLQVLSLAY 63
+L+YL + N+L I + L LDLS N F L + FGNL L L L+
Sbjct: 99 NQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSA 155
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
+ L +L + + P + ++
Sbjct: 156 AKF-RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN 214
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL-- 181
++ I + C T + + R L + L + L
Sbjct: 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274
Query: 182 -EGLSELNLNGNKLCGHVPP-----CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYI 235
+ LN+ + + +L SL H+ + + + + +
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 236 NLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP 295
LS + + T L+ ++N + + L+ L+TL L N +
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FF 393
Query: 296 KSFGSLISLESLDLSRNNL 314
K ++ SL+ +L
Sbjct: 394 KVALMTKNMSSLETLDVSL 412
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 22/83 (26%), Positives = 34/83 (40%), Gaps = 3/83 (3%)
Query: 233 LYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292
++ S +L +P ++ L LS+N +S I L L L L+ N+ +
Sbjct: 34 SMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS 90
Query: 293 PVPKSFGSLISLESLDLSRNNLS 315
F LE LD+S N L
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRLQ 113
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 45/208 (21%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
LG G+ VY+ A+KV +++ +E +L + H N+IK+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIF 117
Query: 481 CNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLALEYLH-HGH 532
+LVLE + G L EK YS ER + + + A+ YLH +G
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYS--------ERDAADAVKQILEAVAYLHENG- 168
Query: 533 STPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-- 587
+VH DLKP N+L + ++DFG+SK++ +++T+ T GY APE
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTV-CGTPGYCAPEIL 222
Query: 588 ----YGSEGIISPKSDVYSYG----ILL 607
YG P+ D++S G ILL
Sbjct: 223 RGCAYG------PEVDMWSVGIITYILL 244
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDS---ECEILRSIRHRN 472
F++ +G GSFG+VY + + VAIK + ++++ + E L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
I+ LV+E+ GS L H L +E + L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---YG 589
S M+H D+K NILL E + DFG + ++ + + + T +MAPE
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----SF-VGTPYWMAPEVILAM 225
Query: 590 SEGIISPKSDVYSYGILLME 609
EG K DV+S GI +E
Sbjct: 226 DEGQYDGKVDVWSLGITCIE 245
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 56/318 (17%), Positives = 99/318 (31%), Gaps = 50/318 (15%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
P + + ++ I +L S + + L S+ + +
Sbjct: 2 PLGSETITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 57
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN 125
+ + + + N+T L L N L I P + N +L + K++
Sbjct: 58 IKS---------VQGIQYLPNVTKLFLNGNKLTDIKP--LANLK-NLGWLFLDENKVK-- 103
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185
++ +L L++L+ L L N + I L HL L
Sbjct: 104 ---DLSSLKD---------------------LKKLKSLSLEHNGIS-DIN-GLVHLPQLE 137
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
L L NK+ L+ LT L L L N+++ L + + LS N + S
Sbjct: 138 SLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI--S 191
Query: 246 LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLE 305
+ LK L L+L + L T+ D P S
Sbjct: 192 DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 251
Query: 306 SLDLSRNNLSGEIPKNFS 323
++ + E+ F
Sbjct: 252 NVKWHLPEFTNEVSFIFY 269
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 57/290 (19%), Positives = 98/290 (33%), Gaps = 49/290 (16%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L ++ + ++ + ++ I + L L+ N + + P NL +L L L N
Sbjct: 45 LNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ LSSL + + L L L N + I + + L+ Y K+
Sbjct: 101 KVKD---------LSSLKDLKKLKSLSLEHNGISDING--LVHLP-QLESLYLGNNKI-- 146
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
+I LS L +L L L N++ I L L L
Sbjct: 147 ---TDITVLSR---------------------LTKLDTLSLEDNQIS-DIV-PLAGLTKL 180
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
L L+ N + + LA L +L L L S + + + +L + + SL
Sbjct: 181 QNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL-- 236
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
P I + ++ + L T+ A +F G V
Sbjct: 237 VTPEIISDDGDYEKPNVKWH-LPEFTNEVSFIFYQPVTIGKAKARFHGRV 285
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 48/253 (18%), Positives = 87/253 (34%), Gaps = 41/253 (16%)
Query: 78 LSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMI 137
+ S L + + + S+ + A + + + +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDI-----KSVQGIQY-- 66
Query: 138 VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGH 197
L + L+L+GNKL I L +L+ L L L+ NK+
Sbjct: 67 -------------------LPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKV--K 103
Query: 198 VPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLT 257
L L L+ L L N ++ + L + + L N + + + + L L
Sbjct: 104 DLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLD 159
Query: 258 NLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGE 317
L L NQ+S DI + GL L+ L L+ N ++ L +L+ L+L +
Sbjct: 160 TLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNK 215
Query: 318 IPKNFSAQSFLSN 330
+ S +
Sbjct: 216 PINHQSNLVVPNT 228
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 52/210 (24%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIK-- 475
+G+G+FG VA+K E R E RS+RH N+++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 476 -IISNCCNIDFKALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDVGLAL 525
+I ++ A+++E+ G L + + + +F +L +
Sbjct: 83 EVILTPTHL---AIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----------SGV 129
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAH--VSDFGISKLLGEGDDSVIQTMTIATIGY 583
Y H + H DLK N LLD + + DFG SK S ++ T+ T Y
Sbjct: 130 SYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKS-TVGTPAY 183
Query: 584 MAPEYGSEGIIS------PKSDVYSYGILL 607
+APE ++ +DV+S G+ L
Sbjct: 184 IAPE-----VLLRQEYDGKIADVWSCGVTL 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 44/205 (21%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEIL-RSIRHRNLIKIISNC 480
+G GS+ + A+K+ + + E EIL R +H N+I +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85
Query: 481 CNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLALEYLH-HGH 532
+ + +V E M G L + +S ER ++ + +EYLH G
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFS--------EREASAVLFTITKTVEYLHAQG- 136
Query: 533 STPMVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE- 587
+VH DLKP+NIL + + DFG +K L ++ ++ T T ++APE
Sbjct: 137 ---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTP-CYTANFVAPEV 191
Query: 588 -----YGSEGIISPKSDVYSYGILL 607
Y D++S G+LL
Sbjct: 192 LERQGYD------AACDIWSLGVLL 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 43/205 (20%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFN------LQLERASRSFDSECEILRSIRHRNLIK 475
+G G+F V + G VAIK+ + L++ R E I++ + H N++K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 476 ---IISNCCNIDFKALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDVGL 523
+I + L++E+ G + +L +H + F I+
Sbjct: 79 LFEVIETEKTL---YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS---------- 125
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
A++Y H +VH DLK N+LLD +M ++DFG S + Y
Sbjct: 126 AVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDA-FCGAPPY 179
Query: 584 MAPE-YGSEGIISPKSDVYSYGILL 607
APE + + P+ DV+S G++L
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVIL 204
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 8e-20
Identities = 50/234 (21%), Positives = 90/234 (38%), Gaps = 15/234 (6%)
Query: 382 RHRNRSTKDGDQEDLLSLATWRRTSYLDIQRATNGFNE----CNLLGTGSFGSVYKGT-L 436
+ D W++ ++ + + LGTG+FG V++ T
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179
Query: 437 FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNG 496
G N A K E + E + + +RH L+ + + + ++ EFM G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 497 SLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHSTPMVHCDLKPNNILLDENMTAH 555
L + + + + E + M V L ++H + VH DLKP NI+ +
Sbjct: 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNE 295
Query: 556 V--SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILL 607
+ DFG++ L +T T + APE + +D++S G+L
Sbjct: 296 LKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 9e-20
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 54/212 (25%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQ-------LERASRSFDSECEILRSIRHRNL 473
LG G+FG V G G VA+K+ N Q + + R E + L+ RH ++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHI 78
Query: 474 IK---IISNCCNIDFKALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDV 521
IK +IS +I +V+E++ G L ++ + F IL
Sbjct: 79 IKLYQVISTPSDI---FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-------- 127
Query: 522 GLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI 581
++Y H +VH DLKP N+LLD +M A ++DFG+S + D ++T + +
Sbjct: 128 --GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRT-SCGSP 179
Query: 582 GYMAPEYGSEGIIS------PKSDVYSYGILL 607
Y APE +IS P+ D++S G++L
Sbjct: 180 NYAAPE-----VISGRLYAGPEVDIWSSGVIL 206
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-20
Identities = 46/199 (23%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
++ +LG G FG V+K G +A K+ + + +E ++ + H NLI+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHST 534
+ + + LV+E++ G L + +Y L L+ + M + + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--- 207
Query: 535 PMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG 592
++H DLKP NIL + DFG+++ + ++ T ++APE +
Sbjct: 208 -ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN-FGTPEFLAPEVVNYD 263
Query: 593 IISPKSDVYSYG----ILL 607
+S +D++S G +LL
Sbjct: 264 FVSFPTDMWSVGVIAYMLL 282
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 33/234 (14%)
Query: 398 SLATWRRTSYLDIQRATN---GFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER 453
S + R +D+ + F L+G G++G VYKG + G AIKV ++ +
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 454 ASRSFDSECEILRSI-RHRNLIK-----IISNCCNIDFKA-LVLEFMPNGSLEKWLYSHN 506
E +L+ HRN+ I N +D + LV+EF GS+ + N
Sbjct: 64 EE-EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KN 120
Query: 507 YFLGILERLNIMI---DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563
L+ I ++ L +LH ++H D+K N+LL EN + DFG+S
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 564 LLGEGDDSVIQTMTIATIG---YMAPE-----YGSEGIISPKSDVYSYGILLME 609
L D +V + T IG +MAPE + KSD++S GI +E
Sbjct: 178 QL---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 54/214 (25%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFN------------LQLERASRSFDSECEILRSIR 469
LG+G+FG V+ V +K +L + + E IL +
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL----EIAILSRVE 87
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGS-LEKWLYSH---------NYFLGILERLNIMI 519
H N+IK++ N F LV+E +G L ++ H F ++
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV------- 140
Query: 520 DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA 579
A+ YL ++H D+K NI++ E+ T + DFG + L G + T
Sbjct: 141 ---SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYT-FCG 191
Query: 580 TIGYMAPEYGSEGIIS------PKSDVYSYGILL 607
TI Y APE ++ P+ +++S G+ L
Sbjct: 192 TIEYCAPE-----VLMGNPYRGPELEMWSLGVTL 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 56/208 (26%), Positives = 83/208 (39%), Gaps = 38/208 (18%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNL-QLERASRSFD-----SECEILRSIRHRNLIK 475
LG+G F V K G A K +L + R E ILR IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 476 IISNCCNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLALEYL 528
+ N L+LE + G L EK + E + + + YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLT--------EDEATQFLKQILDGVHYL 124
Query: 529 H-HGHSTPMVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGY 583
H + H DLKP NI+L N + DFGI+ + G+ + + T +
Sbjct: 125 HSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNI-FGTPEF 177
Query: 584 MAPEYGSEGIISPKSDVYSYG----ILL 607
+APE + + ++D++S G ILL
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILL 205
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 32/203 (15%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFD------SECEILRSIRHRNLIK 475
LG+G F V K G A K + RASR E ILR + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 476 IISNCCNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLALEYL 528
+ N L+LE + G L +K S E + + + + YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS--------EEEATSFIKQILDGVNYL 131
Query: 529 HHGHSTPMVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
H + + H DLKP NI+L + DFG++ + +G + + T ++
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNI-FGTPEFV 185
Query: 585 APEYGSEGIISPKSDVYSYGILL 607
APE + + ++D++S G++
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 50/200 (25%), Positives = 79/200 (39%), Gaps = 26/200 (13%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFD------SECEILRSIRHRNLIK 475
LG+G F V K G A K + RASR E ILR + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILER--LNIMIDVGLALEYLHHGHS 533
+ N L+LE + G L +L E + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS---EEEATSFIKQILDGVNYLHTKK- 135
Query: 534 TPMVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE 587
+ H DLKP NI+L + DFG++ + +G T ++APE
Sbjct: 136 --IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-----VEFKNIFGTPEFVAPE 188
Query: 588 YGSEGIISPKSDVYSYGILL 607
+ + ++D++S G++
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 48/213 (22%), Positives = 86/213 (40%), Gaps = 56/213 (26%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEIL-RSIRHRNLIKIISN 479
+LG G G V + G A+K+ +A + E + ++ +++ I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90
Query: 480 CCNIDFKA----LVLEFMPNGSLEKWLYSHNYFLGILERLN----------IMIDVGLAL 525
N+ +++E M G L F I ER + IM D+G A+
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 526 EYLH-HGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIA-T 580
++LH H + H D+KP N+L +++ ++DFG +K + T T
Sbjct: 142 QFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYT 192
Query: 581 IGYMAPE------YGSEGIISPKSDVYSYGILL 607
Y+APE Y D++S G+++
Sbjct: 193 PYYVAPEVLGPEKYD------KSCDMWSLGVIM 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 46/223 (20%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIR 469
F +G GSFG V T A+K N Q R+ E +I++ +
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 470 HRNLIKI------ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-DVG 522
H L+ + + +V++ + G L L + +F E + + I ++
Sbjct: 74 HPFLVNLWYSFQDEEDMF------MVVDLLLGGDLRYHLQQNVHFK--EETVKLFICELV 125
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TI 581
+AL+YL + ++H D+KP+NILLDE+ H++DF I+ +L Q T+A T
Sbjct: 126 MALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTK 178
Query: 582 GYMAPEYGSEGIISPKS--------DVYSYGILLMETFTRKKP 616
YMAPE + S + D +S G+ E ++P
Sbjct: 179 PYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFN----LQLERASRSFDSECEILRSI 468
F +LG GSF +V T AIK+ ++ + E +++ +
Sbjct: 32 FKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVT-RERDVMSRL 87
Query: 469 RHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYL 528
H +K+ + + L + NG L K++ F R ++ ALEYL
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYL 146
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPE 587
H ++H DLKP NILL+E+M ++DFG +K+L + + T Y++PE
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPE 202
Query: 588 YGSEGIISPK-----SDVYSYGILLME 609
+++ K SD+++ G ++ +
Sbjct: 203 -----LLTEKSACKSSDLWALGCIIYQ 224
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 6e-19
Identities = 41/176 (23%), Positives = 67/176 (38%), Gaps = 18/176 (10%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIP-TAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLE 182
++P L DL+ +L+ RL L L L N L I + +
Sbjct: 36 SLPSYTALL------DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 183 GLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241
L L+L+ N L + + L +L L L +N + ++F + + + LS N
Sbjct: 89 NLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 242 LNGSLP----SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENL--ETLSLADNQFQ 291
++ P + L L LDLS N+L T + L L L +N +
Sbjct: 148 IS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 42/204 (20%), Positives = 67/204 (32%), Gaps = 25/204 (12%)
Query: 158 RRLQGLYLHGNKLQGSIP--YDLCHLEGLSELNLNGNKLCGHVPPC-LASLTSLRRLHLG 214
L L N L + + L L L L+ N L + + +LR L L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLS 96
Query: 215 SNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIP-- 271
SN L + F L+ + + L N + + N +++ L L LS+NQ+S P
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154
Query: 272 --TTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNN------------LSGE 317
L L L L+ N+ + L + L +N S
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHW 214
Query: 318 IPKNFSAQSFLSNYALC-GPARLQ 340
+ S+ C +L
Sbjct: 215 QYRQLSSVMDFQEDLYCMHSKKLH 238
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 47/230 (20%), Positives = 71/230 (30%), Gaps = 72/230 (31%)
Query: 22 IPNSITNASKLIMLDLSSNSFSGLIPNT-FGNLGSLQVLSLAYNYLMTESSAAKWNFLSS 80
+P+ LDLS N+ S L L +L L L++N+L SS A
Sbjct: 37 LPSYTAL------LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEA------- 83
Query: 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFD 140
NL L L+SN L + + +F
Sbjct: 84 FVPVPNLRYLDLSSNHLH--------------------------TLDEF--------LFS 109
Query: 141 LNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEGLSELNLNGNKLCGHVP 199
L+ L+ L L+ N + + + + L +L L+ N++ P
Sbjct: 110 ---------------DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI-SRFP 152
Query: 200 P----CLASLTSLRRLHLGSNKLTSTMPSSFGSLE--YVLYINLSANSLN 243
L L L L SNKL + L + L N L
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 52/237 (21%), Positives = 79/237 (33%), Gaps = 47/237 (19%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L NL L L N L+ I + L LDLSSN L F +L +L+VL L
Sbjct: 63 LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN 121
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N+++ A + L L L+ N + LI + +
Sbjct: 122 NHIVVVDRNA-------FEDMAQLQKLYLSQNQISRFPVELIKDGN-------------- 160
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRL--QGLYLHGNKLQGSIPYDLCHL 181
L +++ DL+ L T + +L GLYLH N L+ C L
Sbjct: 161 --------KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD-----CKL 207
Query: 182 ----EGLSELNLNGNKLCGHVPPC-----LASLTSLRRLHLGSNKLTSTMPSSFGSL 229
L+ C L ++ SL + K ++ +L
Sbjct: 208 YQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKESAWEAHLGDTL 264
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 49/206 (23%), Positives = 79/206 (38%), Gaps = 38/206 (18%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFD------SECEILRSIRHRNLIK 475
LG+G F V K G A K + ++SR E IL+ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 476 IISNCCNIDFKALVLEFMPNGSL-----EKWLYSHNYFLGILER--LNIMIDVGLALEYL 528
+ N L+LE + G L EK + E + + + YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLT--------EEEATEFLKQILNGVYYL 130
Query: 529 H-HGHSTPMVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVIQTMTIA--TI 581
H + H DLKP NI+L + DFG++ + G T
Sbjct: 131 HSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-----NEFKNIFGTP 181
Query: 582 GYMAPEYGSEGIISPKSDVYSYGILL 607
++APE + + ++D++S G++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 44/189 (23%), Positives = 84/189 (44%), Gaps = 12/189 (6%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
LG G FG V++ K ++ E IL RHRN++ + +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESFE 71
Query: 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHSTPMVHCD 540
+++ ++ EF+ + + + + + L E ++ + V AL++LH H + H D
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN----IGHFD 127
Query: 541 LKPNNILL--DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
++P NI+ + T + +FG ++ L GD + Y APE ++S +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 599 DVYSYGILL 607
D++S G L+
Sbjct: 185 DMWSLGTLV 193
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 61/309 (19%)
Query: 411 QRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLER------ASRSFDSECEI 464
Q + + +G G++G VYK G VA+K L E A R E +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISL 72
Query: 465 LRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLA 524
L+ + H N++ +I + LV EFM L+K L + L + + +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIG 582
+ + H ++H DLKP N+L++ + ++DFG+++ G +++ T + T+
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG----IPVRSYTHEVVTLW 184
Query: 583 YMAPE--YGSEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEI 620
Y AP+ GS+ S D++S G + E T K P
Sbjct: 185 YRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243
Query: 621 FIGEMSLKHWVKESLP----DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESP 676
+ L W + + + ++ ++ LLS M L D P
Sbjct: 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGF---CQEGID-----LLSNM-LCFD-----P 289
Query: 677 EQRVSMKDA 685
+R+S +DA
Sbjct: 290 NKRISARDA 298
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK- 475
+ C ++G GSFG V++ L + VAIK +R E +I+R ++H N++
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDL 97
Query: 476 ---IISNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNI---MIDVGLALEY 527
SN D LVLE++P ++ + + + L I M + +L Y
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTA-HVSDFGISKLLGEGDDSVIQTMT--IATIGYM 584
+ HS + H D+KP N+LLD + DFG +K+L G + I + Y
Sbjct: 157 I---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-----EPNVSYICSRYYR 208
Query: 585 APEYGSEGII------SPKSDVYSYGILLMETFTRKKPTNEIFIGE 624
APE +I + D++S G ++ E +P +F GE
Sbjct: 209 APE-----LIFGATNYTTNIDIWSTGCVMAELMQG-QP---LFPGE 245
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 46/203 (22%), Positives = 77/203 (37%), Gaps = 34/203 (16%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERAS--RSFDSECEILRSIRHR-NLIKIIS 478
LG G F V + G A K + E +L + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERL----------NIMIDVGLALEYL 528
N L+LE+ G + F L L ++ + + YL
Sbjct: 97 VYENTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 529 H-HGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
H + +VH DLKP NILL + DFG+S+ +G ++ + + T Y+
Sbjct: 148 HQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREI-MGTPEYL 200
Query: 585 APEYGSEGIISPKSDVYSYGILL 607
APE + I+ +D+++ GI+
Sbjct: 201 APEILNYDPITTATDMWNIGIIA 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 49/212 (23%), Positives = 83/212 (39%), Gaps = 55/212 (25%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEIL-RSIRHRNLIKIISNC 480
LG G G V + A+K+ +A R E E+ R+ + ++++I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 481 CNIDFKA----LVLEFMPNGSLEKWLYSHNYFLGILERLN----------IMIDVGLALE 526
N+ +V+E + G L F I +R + IM +G A++
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 527 YLH-HGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TI 581
YLH + H D+KP N+L N ++DFG +K + T T
Sbjct: 176 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTP 227
Query: 582 GYMAPE------YGSEGIISPKSDVYSYGILL 607
Y+APE Y D++S G+++
Sbjct: 228 YYVAPEVLGPEKYD------KSCDMWSLGVIM 253
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 55/212 (25%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQ-------LERASRSFDSECEILRSIRHRNL 473
LG GSFG V T VA+K + Q R R E L+ +RH ++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHI 71
Query: 474 IK---IISNCCNIDFKALVLEFMPNGSLEKWLYSH---------NYFLGILERLNIMIDV 521
IK +I+ +I +V+E+ G L ++ +F I+
Sbjct: 72 IKLYDVITTPTDI---VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC-------- 119
Query: 522 GLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI 581
A+EY H +VH DLKP N+LLD+N+ ++DFG+S + D + ++T + +
Sbjct: 120 --AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKT-SCGSP 171
Query: 582 GYMAPEYGSEGIIS------PKSDVYSYGILL 607
Y APE +I+ P+ DV+S GI+L
Sbjct: 172 NYAAPE-----VINGKLYAGPEVDVWSCGIVL 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 41/227 (18%)
Query: 417 FNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
+ + ++G GSFG VY+ L D G VAIK +R E +I+R + H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 476 ----IISNCCNIDFKAL--VLEFMPNGSLEKWLYSHNYFLGILERLNI---MIDVGLALE 526
S+ D L VL+++P ++ + ++ L + + M + +L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTA-HVSDFGISKLLGEGDDSVIQTMT--IATIGY 583
Y+H S + H D+KP N+LLD + + DFG +K L G + I + Y
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-----EPNVSYICSRYY 222
Query: 584 MAPEYGSEGII------SPKSDVYSYGILLMETFTRKKPTNEIFIGE 624
APE +I + DV+S G +L E +P IF G+
Sbjct: 223 RAPE-----LIFGATDYTSSIDVWSAGCVLAELLLG-QP---IFPGD 260
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 61/254 (24%), Positives = 97/254 (38%), Gaps = 54/254 (21%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSEC--------EI 464
F+ ++G G FG VY T G A+K L +R +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADT---GKMYAMKC--LDKKRIKMKQGETLALNERIMLSL 245
Query: 465 LRSIRHRNLIKIISNCCNIDFKAL--VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVG 522
+ + ++ + + L +L+ M G L L H F R ++
Sbjct: 246 VSTGDCPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EII 302
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTIA- 579
L LE++ H+ +V+ DLKP NILLDE+ HV SD G++ + +
Sbjct: 303 LGLEHM---HNRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKK-----KPHASVG 352
Query: 580 TIGYMAPEYGSEGIISPKS------DVYSYGILLMET------FTRKKPTNEIFIGEMSL 627
T GYMAPE ++ D +S G +L + F + K ++ I M+L
Sbjct: 353 THGYMAPE-----VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407
Query: 628 KHWVKESLPDGLTE 641
LPD +
Sbjct: 408 TM--AVELPDSFSP 419
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 61/298 (20%), Positives = 117/298 (39%), Gaps = 62/298 (20%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNLIK 475
+G G++G+V+K VA+K L + A R E +L+ ++H+N+++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ + LV EF L+K+ S N L + + + L + H +
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE--YGSE 591
++H DLKP N+L++ N +++FG+++ G ++ + + T+ Y P+ +G++
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFG----IPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 592 GIISPKSDVYSYGILLMETFTRKK---------------------PTNEIFIGEMSLKHW 630
+ S D++S G + E + PT E + L +
Sbjct: 178 -LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 631 V---KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
L VV LL + L + P QR+S ++A
Sbjct: 237 KPYPMYPATTSLVNVVPKL---NATGRD-----LLQNL-LKCN-----PVQRISAEEA 280
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 57/217 (26%), Positives = 82/217 (37%), Gaps = 58/217 (26%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN----------LQLERASRSFDSECEILRSIRH 470
LLG+G FGSVY G + D VAIK R E +L+ +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVSS 105
Query: 471 R--NLIKIISNCCNIDFKALVLEF-MPNGSLEKWLYSH---------NYFLGILERLNIM 518
+I+++ D L+LE P L ++ ++F +LE
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE----- 160
Query: 519 IDVGLALEYLH-HGHSTPMVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVIQTM 576
A+ + H G ++H D+K NIL+D N + DFG LL D+V
Sbjct: 161 -----AVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD- 207
Query: 577 TIATIGYMAPEYGSEGIIS------PKSDVYSYGILL 607
T Y PE I + V+S GILL
Sbjct: 208 FDGTRVYSPPE-----WIRYHRYHGRSAAVWSLGILL 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-17
Identities = 60/252 (23%), Positives = 95/252 (37%), Gaps = 50/252 (19%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSEC-----EILRS 467
F + +LG G FG V + T G A K L+ +R + +IL
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKK--LEKKRIKKRKGEAMALNEKQILEK 240
Query: 468 IRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-DVGLALE 526
+ R ++ + D LVL M G L+ +Y R ++ LE
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTIA-TIGY 583
LH +V+ DLKP NILLD++ H+ SD G++ + EG T+GY
Sbjct: 301 DLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQ----TIKGRVGTVGY 351
Query: 584 MAPEYGSEGIISPKS-----DVYSYGILLMETFT---------RKKPTNEIFIGEMSLKH 629
MAPE ++ + D ++ G LL E +K E+ + +
Sbjct: 352 MAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--RLVKEV 404
Query: 630 WVKESLPDGLTE 641
E + +
Sbjct: 405 --PEEYSERFSP 414
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 64/317 (20%), Positives = 109/317 (34%), Gaps = 86/317 (27%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIK--VFNLQLERASRSFDS---------ECEILRSIRHR 471
+ +GS+G+V G +G VAIK + R E +L H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 472 NLIK---IISNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALE 526
N++ I + LV E M L + ++ + M + L L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYM 584
LH +VH DL P NILL +N + DF +++ + T + Y
Sbjct: 149 VLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-----KTHYVTHRWYR 200
Query: 585 APEYGSEGII------SPKSDVYSYGILLMETFTRK--------------------KPTN 618
APE ++ + D++S G ++ E F RK P
Sbjct: 201 APE-----LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 619 EI--FIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVK--------IDCLLSIMHLA 668
E S + +++ SL +A++ +D L++ M L
Sbjct: 256 EDVVMFSSPSARDYLRNSLS-----------NVPARAWTAVVPTADPVALD-LIAKM-LE 302
Query: 669 LDCCMESPEQRVSMKDA 685
+ P++R+S + A
Sbjct: 303 FN-----PQRRISTEQA 314
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 77/313 (24%), Positives = 123/313 (39%), Gaps = 61/313 (19%)
Query: 408 LDIQRATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASR-SFDS----E 461
LD++ + + + LG G F +VYK VAIK L ++ + E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 462 CEILRSIRHRNLIK---IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIM 518
++L+ + H N+I + NI +LV +FM LE + ++ L M
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNI---SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118
Query: 519 IDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT- 577
+ LEYLH ++H DLKPNN+LLDEN ++DFG++K G S + T
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG----SPNRAYTH 171
Query: 578 -IATIGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRK-------------------- 614
+ T Y APE +G+ + D+++ G +L E R
Sbjct: 172 QVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230
Query: 615 KPTNEIFIGEMSLKHWV--KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCC 672
PT E + SL +V K L + A + L+ + +
Sbjct: 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA---GDDLLD-----LIQGL-FLFN-- 279
Query: 673 MESPEQRVSMKDA 685
P R++ A
Sbjct: 280 ---PCARITATQA 289
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 8e-17
Identities = 67/307 (21%), Positives = 114/307 (37%), Gaps = 70/307 (22%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTN--VAIKVFNLQLER------ASRSFDSECEILRSI 468
++ +G G++G VYK + A+K L+ E R E IL+ +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57
Query: 469 RHRN---LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL 525
+H N L +I + LV E + L+K L L + + ++ + +
Sbjct: 58 KHSNIVKLYDVIHTKKRL---VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGY 583
Y H ++H DLKP N+L++ ++DFG+++ G ++ T I T+ Y
Sbjct: 114 AYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG----IPVRKYTHEIVTLWY 166
Query: 584 MAPE--YGSEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEIF 621
AP+ GS+ S D++S G + E P ++ +
Sbjct: 167 RAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 622 IGEMSLKHWVKE---SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQ 678
L + P + +E LLS M L LD P Q
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGL---DESGID-----LLSKM-LKLD-----PNQ 271
Query: 679 RVSMKDA 685
R++ K A
Sbjct: 272 RITAKQA 278
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-17
Identities = 34/128 (26%), Positives = 62/128 (48%), Gaps = 2/128 (1%)
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
E+ L N + P + LRR+ L +N+++ P +F L + + L N +
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 246 LPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
LP ++ + L L L L+ N+++ L NL LSL DN+ Q +F L ++
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154
Query: 305 ESLDLSRN 312
+++ L++N
Sbjct: 155 QTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 29/112 (25%), Positives = 54/112 (48%), Gaps = 4/112 (3%)
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRN 264
++ + L N + P +F + + I+LS N ++ L + Q L+ L +L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 265 QLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
+++ ++P ++ GL +L+ L L N+ +F L +L L L N L
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 36/142 (25%), Positives = 55/142 (38%), Gaps = 28/142 (19%)
Query: 151 PTAVGRLRRLQGLYLHGNKLQGSIPYDLC-HLEGLSELNLNGNKLCGHVPP-CLASLTSL 208
P A ++L+ + L N++ + D L L+ L L GNK+ +P L SL
Sbjct: 49 PGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSL 106
Query: 209 RRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSG 268
+ L L +NK+ +F Q+L L L L N+L
Sbjct: 107 QLLLLNANKINCLRVDAF------------------------QDLHNLNLLSLYDNKLQT 142
Query: 269 DIPTTIGGLENLETLSLADNQF 290
T L ++T+ LA N F
Sbjct: 143 IAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 37/188 (19%), Positives = 59/188 (31%), Gaps = 58/188 (30%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
+ + L N + P + + KL +DLS+N S L P+ F L SL L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN 125
+ + + L +L +L L +N +
Sbjct: 92 I----TELPKSLFEGLF---SLQLLLLNANKIN--------------------------C 118
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEGL 184
+ + F L L L L+ NKLQ +I L +
Sbjct: 119 LRVD--------AFQ---------------DLHNLNLLSLYDNKLQ-TIAKGTFSPLRAI 154
Query: 185 SELNLNGN 192
++L N
Sbjct: 155 QTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 9/94 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L +L L L+ NK++ +P S+ L +L L++N + L + F +L +L +LSL
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97
N L T + + R + + LA NP
Sbjct: 138 NKLQTIAKGT-------FSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 26/97 (26%), Positives = 39/97 (40%), Gaps = 9/97 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L+ + L +N++S + L L L N + L + F L SLQ+L L
Sbjct: 55 YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNA 113
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGI 100
N + + F L NL +L L N L+ I
Sbjct: 114 NKI---NCLRVDAF-QDLH---NLNLLSLYDNKLQTI 143
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 51/233 (21%), Positives = 99/233 (42%), Gaps = 35/233 (15%)
Query: 411 QRATNGFNECNLLGTGSFGSVYKGTLFD-GTNVAIK-VFNLQLERASRSFDSECEILRSI 468
++ + F + G G+FG+V G G +VAIK V +R + L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNREL-QIMQDLAVL 76
Query: 469 RHRNLIKII-------SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNI---M 518
H N++++ + +V+E++P+ +L + ++ + I +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 519 IDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVIQTMT 577
+ ++ LH S + H D+KP+N+L++ + T + DFG +K L + +
Sbjct: 136 FQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAY 191
Query: 578 IATIGYMAPEYGSEGII------SPKSDVYSYGILLMETFTRKKPTNEIFIGE 624
I + Y APE +I + D++S G + E +P IF G+
Sbjct: 192 ICSRYYRAPE-----LIFGNQHYTTAVDIWSVGCIFAEMMLG-EP---IFRGD 235
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 47/262 (17%), Positives = 85/262 (32%), Gaps = 38/262 (14%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIP-NTFGNLGSLQVLSLA-Y 63
N L KL + + L +++S N +I + F NL L + +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
N L+ + A N NL L +++ ++ LP + S ++
Sbjct: 90 NNLLYINPEA-------FQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLD-----IQ 136
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
NI I + F G L+L+ N +Q I +
Sbjct: 137 DNI--NIHTIERN-SFV--------------GLSFESVILWLNKNGIQ-EIHNSAFNGTQ 178
Query: 184 LSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242
L ELNL+ N +P + L + ++ S +L+ + +
Sbjct: 179 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK- 237
Query: 243 NGSLPSNIQNLKVLTNLDLSRN 264
LP+ ++ L L L+
Sbjct: 238 --KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 34/215 (15%), Positives = 67/215 (31%), Gaps = 9/215 (4%)
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEGL 184
IP ++ I L A L+ + + N + I D +L L
Sbjct: 24 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 185 SELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
E+ + ++ P +L +L+ L + + + + +++ N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141
Query: 244 GSLPSN-IQNLKV-LTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSL 301
++ N L L L++N + + G + E +N + F
Sbjct: 142 HTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGA 201
Query: 302 ISLESLDLSRNNLS---GEIPKNFSAQSFLSNYAL 333
LD+SR + +N S Y L
Sbjct: 202 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 34/194 (17%), Positives = 68/194 (35%), Gaps = 40/194 (20%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIP-NTFGNLGS-LQVLSL 61
LPNL+YL + + + +P+ ++ + ++LD+ N I N+F L +L L
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 62 AYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCK 121
N + ++A + + +N L + F
Sbjct: 162 NKNGIQEIHNSA-------FNGTQLDELNLSDNNNLEELPN---DVFH------------ 199
Query: 122 LRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL 181
SG ++ D++ ++ + L++L+ + K +P L L
Sbjct: 200 ----------GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKL 245
Query: 182 EGLSELNLNGNKLC 195
L E +L C
Sbjct: 246 VALMEASLTYPSHC 259
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 51/155 (32%), Positives = 68/155 (43%), Gaps = 6/155 (3%)
Query: 161 QGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLT 219
+ L L L L L+ LNL+ N+L + LT L L L +N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 220 STMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTI-GGL 277
S F L + + L N L SLPS + L L L L+ NQL IP L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 278 ENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312
NL+TLSL+ NQ Q +F L L+++ L N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 42/132 (31%), Positives = 60/132 (45%), Gaps = 6/132 (4%)
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
+L+L L LT L L+L N+L + F L + + L+ N L S
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 246 LPSNI-QNLKVLTNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQGPVPKS-FGSLI 302
LP + +L L L L NQL +P+ + L L+ L L NQ Q +P F L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLT 155
Query: 303 SLESLDLSRNNL 314
+L++L LS N L
Sbjct: 156 NLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 51/169 (30%), Positives = 71/169 (42%), Gaps = 12/169 (7%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL-CHLEG 183
IP + L DL L L +L L L N+LQ ++ + L
Sbjct: 32 GIPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 184 LSELNLNGNKLCGHVPPCL-ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242
L L L N+L +P + LT L +L+LG N+L S F L + + L+ N L
Sbjct: 85 LGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143
Query: 243 NGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQF 290
S+P+ L L L LS NQL L L+T++L NQF
Sbjct: 144 Q-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 4/112 (3%)
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRN 264
+L L S L + ++F L + ++NL N L +L + + +L L L L+ N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANN 93
Query: 265 QLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
QL+ +P + L L+ L L NQ + F L L+ L L+ N L
Sbjct: 94 QLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 52/211 (24%), Positives = 70/211 (33%), Gaps = 62/211 (29%)
Query: 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMT 68
+ L L L+ + +KL L+L N L F +L L L LA N L +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 69 ESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQ 128
LT L L L N L+ LP G
Sbjct: 98 LPLGV----FDHLT---QLDKLYLGGNQLKS-LPS--G---------------------- 125
Query: 129 EIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIP---YDLCHLEGLS 185
VFD RL +L+ L L+ N+LQ SIP +D L L
Sbjct: 126 ---------VFD---------------RLTKLKELRLNTNQLQ-SIPAGAFD--KLTNLQ 158
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSN 216
L+L+ N+L L L+ + L N
Sbjct: 159 TLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 24/71 (33%), Positives = 30/71 (42%), Gaps = 2/71 (2%)
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
S+PS I LDL L+ T GL L L+L NQ Q F L L
Sbjct: 28 SVPSGIPADT--EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 305 ESLDLSRNNLS 315
+L L+ N L+
Sbjct: 86 GTLGLANNQLA 96
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 25/93 (26%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L L L L N+L ++P+ + +KL L L++N + F L +LQ LSL+
Sbjct: 106 LTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLST 164
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNP 96
N L + A L + L N
Sbjct: 165 NQLQSVPHGA-------FDRLGKLQTITLFGNQ 190
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 68/317 (21%), Positives = 126/317 (39%), Gaps = 64/317 (20%)
Query: 412 RATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER------ASRSFDSECEI 464
+ + + +G G+FG V+K G VA+K ++ E+ A R E +I
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKI 69
Query: 465 LRSIRHRNLIKII------SNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLN 516
L+ ++H N++ +I ++ N + LV +F + L L + + E
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128
Query: 517 IMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576
+M + L Y+H ++H D+K N+L+ + ++DFG+++ +S
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 577 T--IATIGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRK------------------ 614
T + T+ Y PE G P D++ G ++ E +TR
Sbjct: 186 TNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 615 --KPTNEIFIGEMSLKHWVKESLPDG----LTEVVDANLVREEQAFSVKIDCLLSIMHLA 668
T E++ + + + K L G + + + VR+ A L+ + L
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL-KAYVRDPYALD-----LIDKL-LV 297
Query: 669 LDCCMESPEQRVSMKDA 685
LD P QR+ DA
Sbjct: 298 LD-----PAQRIDSDDA 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 65/306 (21%), Positives = 119/306 (38%), Gaps = 67/306 (21%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLE-----RASRSFDSECEILRSIRH 470
+ + + LG G++ +VYKG VA+K L+ E A R E +L+ ++H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKH 59
Query: 471 RN---LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
N L II ++ LV E++ L+++L + + + + L Y
Sbjct: 60 ANIVTLHDIIHTEKSL---TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMA 585
H ++H DLKP N+L++E ++DFG+++ +T + T+ Y
Sbjct: 116 CHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS----IPTKTYDNEVVTLWYRP 168
Query: 586 PE--YGSEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEIFIG 623
P+ GS S + D++ G + E T + PT E + G
Sbjct: 169 PDILLGST-DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227
Query: 624 EMSLKHWVKESLP----DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQR 679
+S + + + P + L + LL+ + L + R
Sbjct: 228 ILSNEEFKTYNYPKYRAEALLSHAPRL---DSDGAD-----LLTKL-LQFE-----GRNR 273
Query: 680 VSMKDA 685
+S +DA
Sbjct: 274 ISAEDA 279
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 5/130 (3%)
Query: 186 ELNLNGNKLCGHVPP--CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
EL LN N+ + L LR+++ +NK+T +F V I L++N L
Sbjct: 36 ELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 244 GSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302
++ + + L+ L L L N+++ + GL ++ LSL DNQ P +F +L
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153
Query: 303 SLESLDLSRN 312
SL +L+L N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 28/113 (24%), Positives = 48/113 (42%), Gaps = 5/113 (4%)
Query: 206 TSLRRLHLGSNKLTSTMPS-SFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSR 263
L L +N+ T + F L + IN S N + + + + + L+
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90
Query: 264 NQLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
N+L ++ + GLE+L+TL L N+ SF L S+ L L N ++
Sbjct: 91 NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 41/170 (24%), Positives = 62/170 (36%), Gaps = 35/170 (20%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQGLYLHGNKLQGSIPYD-LCHLE 182
+IPQ L LN + T + +L +L+ + NK+ I
Sbjct: 29 HIPQYTAEL------RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 183 GLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241
G++E+ L N+L +V L SL+ L L SN++T SF
Sbjct: 82 GVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSF--------------- 125
Query: 242 LNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291
L + L L NQ++ P L +L TL+L N F
Sbjct: 126 ---------IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 35/191 (18%), Positives = 61/191 (31%), Gaps = 59/191 (30%)
Query: 55 SLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQE 114
L L N + + L L + ++N + I
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLP------QLRKINFSNNKITDI-------------- 72
Query: 115 FYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSI 174
E G F+ + + L N+L+ ++
Sbjct: 73 --------------EEG------AFE---------------GASGVNEILLTSNRLE-NV 96
Query: 175 PYDLC-HLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYV 232
+ + LE L L L N++ V L+S+R L L N++T+ P +F +L +
Sbjct: 97 QHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSL 155
Query: 233 LYINLSANSLN 243
+NL AN N
Sbjct: 156 STLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 21/96 (21%), Positives = 41/96 (42%), Gaps = 7/96 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
LP L+ + +NK++ + AS + + L+SN + F L SL+ L L N
Sbjct: 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN 115
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGI 100
+ + + L+ ++ +L L N + +
Sbjct: 116 RITCVGNDS----FIGLS---SVRLLSLYDNQITTV 144
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 19/61 (31%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSI-TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
L +LK L L N+++ + N S + +L L N + + P F L SL L+L
Sbjct: 104 LESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLA 162
Query: 64 N 64
N
Sbjct: 163 N 163
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 58/300 (19%), Positives = 104/300 (34%), Gaps = 65/300 (21%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNLIK 475
+G GS+G V+K G VAIK F + A R E +L+ ++H NL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH-HGHST 534
++ LV E+ + ++ L + + +I A+ + H H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE----- 587
+H D+KP NIL+ ++ + DFG ++LL +AT Y +PE
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLLT----GPSDYYDDEVATRWYRSPELLVGD 177
Query: 588 --YGSEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEIFIGEM 625
YG + DV++ G + E +
Sbjct: 178 TQYGP-PV-----DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231
Query: 626 SLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
+ +++ +PD + LL L +D P +R++ +
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFP--NISYPALG-LLKGC-LHMD-----PTERLTCEQL 282
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 51/292 (17%), Positives = 92/292 (31%), Gaps = 54/292 (18%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L N L ++ + S + + +++ L +L+ L L++N
Sbjct: 18 LANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHN 73
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ LS L + L L + N L+ + SA L + +L
Sbjct: 74 QISD---------LSPLKDLTKLEELSVNRNRLKNLNGIP----SACLSRLFLDNNEL-- 118
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
++ +L L+ L+ L + NKL+ SI L L L
Sbjct: 119 ---RDTDSLIH---------------------LKNLEILSIRNNKLK-SIV-MLGFLSKL 152
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
L+L+GN++ + L L + + L K + LYI + +G
Sbjct: 153 EVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQ----PELYITNTVKDPDG 206
Query: 245 SL--PSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
P I N + + +L + + F G V
Sbjct: 207 RWISPYYISNGGSYVDGCVL-WELPVYTDEVSYKFSEYINVGETEAIFDGTV 257
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 42/194 (21%), Positives = 70/194 (36%), Gaps = 15/194 (7%)
Query: 130 IGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNL 189
L+ + +L + T + L +Q + +Q S+ + L EL+L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHL 70
Query: 190 NGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSN 249
+ N++ L LT L L + N+L + L + L N L +
Sbjct: 71 SHNQI--SDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLS---RLFLDNNEL--RDTDS 123
Query: 250 IQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDL 309
+ +LK L L + N+L I +G L LE L L N+ L + +DL
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT--NTGGLTRLKKVNWIDL 179
Query: 310 SRNNLSGEIPKNFS 323
+ E K
Sbjct: 180 TGQKCVNEPVKYQP 193
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 38/240 (15%), Positives = 84/240 (35%), Gaps = 22/240 (9%)
Query: 78 LSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMI 137
+ N L + ++ S +Q F ++ ++ + + +
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS--QKELS-GVQNFNGDNSNIQ-SL-AGMQFFTNLK 66
Query: 138 VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS--ELNLNGNKLC 195
L+ + + + + L +L+ L ++ N+L+ +L + L L+ N+L
Sbjct: 67 ELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELR 119
Query: 196 GHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKV 255
L L +L L + +NKL S G L + ++L N + + + LK
Sbjct: 120 D--TDSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEI--TNTGGLTRLKK 173
Query: 256 LTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
+ +DL+ + + L T+ D ++ P S + S +
Sbjct: 174 VNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS--NGGSYVDGCVLWELPV 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 59/218 (27%), Positives = 80/218 (36%), Gaps = 58/218 (26%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFN----------LQLERASRSFDSECEILRSIR- 469
LLG G FG+V+ G L D VAIKV E +L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL----EVALLWKVGA 93
Query: 470 ---HRNLIKIISNCCNIDFKA------LVLEF-MPNGSLEKWLYSHNYFLGIL-ERL--N 516
H +I+++ D+ LVLE +P L ++ G L E
Sbjct: 94 GGGHPGVIRLL------DWFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRC 143
Query: 517 IMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVIQT 575
V A+++ H +VH D+K NIL+D A + DFG LL D
Sbjct: 144 FFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD 197
Query: 576 MTIATIGYMAPEYGSEGIIS------PKSDVYSYGILL 607
T Y PE IS + V+S GILL
Sbjct: 198 -FDGTRVYSPPE-----WISRHQYHALPATVWSLGILL 229
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 49/163 (30%), Positives = 67/163 (41%), Gaps = 6/163 (3%)
Query: 153 AVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLH 212
L + + + + ++ +L + L L GNKL H L LT+L L
Sbjct: 36 TQNELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKL--HDISALKELTNLTYLI 91
Query: 213 LGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIP 271
L N+L S F L + + L N L SLP + L LT L+L+ NQL
Sbjct: 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPK 150
Query: 272 TTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
L NL L L+ NQ Q F L L+ L L +N L
Sbjct: 151 GVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 59/162 (36%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 156 RLRRLQGLYLHGNKLQGSIP-YDLCHLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHL 213
L ++ L L GNKL I L L+ L L GN+L +P LT+L+ L L
Sbjct: 61 YLPNVRYLALGGNKLH-DISALK--ELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVL 116
Query: 214 GSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPT 272
N+L S F L + Y+NL+ N L SLP + L LT LDLS NQL +P
Sbjct: 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPE 174
Query: 273 TI-GGLENLETLSLADNQFQGPVPK-SFGSLISLESLDLSRN 312
+ L L+ L L NQ + VP F L SL+ + L N
Sbjct: 175 GVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTM 222
L + ++ + L + ++ N + + + L ++R L LG NKL
Sbjct: 24 ANLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLHDI- 78
Query: 223 PSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPTTI-GGLENL 280
S+ L + Y+ L+ N L SLP+ + L L L L NQL +P + L NL
Sbjct: 79 -SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNL 135
Query: 281 ETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPK 320
L+LA NQ Q F L +L LDLS N L +P+
Sbjct: 136 TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPE 174
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 35/130 (26%), Positives = 57/130 (43%), Gaps = 8/130 (6%)
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
+ NL + L S+ ++ ++ + S L V Y+ L N L+
Sbjct: 23 KANLKKKSV-TDAVTQN-ELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH-D 77
Query: 246 LPSNIQNLKVLTNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLISL 304
+ + ++ L LT L L+ NQL +P + L NL+ L L +NQ Q F L +L
Sbjct: 78 ISA-LKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNL 135
Query: 305 ESLDLSRNNL 314
L+L+ N L
Sbjct: 136 TYLNLAHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 28/112 (25%), Positives = 41/112 (36%), Gaps = 12/112 (10%)
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQ 265
+ +L +T + L + I + + + S+ IQ L + L L N+
Sbjct: 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNK 74
Query: 266 LSGDIPTTIG---GLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
L I L NL L L NQ Q F L +L+ L L N L
Sbjct: 75 L-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL 121
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 64/218 (29%), Positives = 80/218 (36%), Gaps = 70/218 (32%)
Query: 5 LPNLKYLTLFDNKLSGTIP--NSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLA 62
LPN++YL L NKL I +TN L L L+ N L F L +L+ L L
Sbjct: 62 LPNVRYLALGGNKLH-DISALKELTN---LTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117
Query: 63 YNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKL 122
N L + LT NLT L LA N L+ LP G
Sbjct: 118 ENQLQSLPDGV----FDKLT---NLTYLNLAHNQLQS-LPK--G---------------- 151
Query: 123 RGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIP---YDLC 179
VFD +L L L L N+LQ S+P +D
Sbjct: 152 ---------------VFD---------------KLTNLTELDLSYNQLQ-SLPEGVFD-- 178
Query: 180 HLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSN 216
L L +L L N+L VP LTSL+ + L N
Sbjct: 179 KLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 46/236 (19%)
Query: 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMT 68
L ++ + + + +++ + L +++ L+L N L
Sbjct: 22 IKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKL-- 75
Query: 69 ESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQ 128
+ L LTN LT L L N L+ LP + + +L+E +L+ ++P
Sbjct: 76 ----HDISALKELTN---LTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLP- 125
Query: 129 EIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIP---YDLCHLEGLS 185
G VFD +L L L L N+LQ S+P +D L L+
Sbjct: 126 -----DG--VFD---------------KLTNLTYLNLAHNQLQ-SLPKGVFD--KLTNLT 160
Query: 186 ELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
EL+L+ N+L +P LT L+ L L N+L S F L + YI L N
Sbjct: 161 ELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 4e-16
Identities = 58/254 (22%), Positives = 97/254 (38%), Gaps = 51/254 (20%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSEC-----EILRS 467
F + +LG G FG V+ K T G A K L +R + + +IL
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKAT---GKLYACKK--LNKKRLKKRKGYQGAMVEKKILAK 241
Query: 468 IRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGIL--ERLNIMI-DVGLA 524
+ R ++ + LV+ M G + +Y+ + R +
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTIA-TI 581
LE+LH +++ DLKP N+LLD++ +V SD G++ L G T A T
Sbjct: 302 LEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTK---TKGYAGTP 353
Query: 582 GYMAPEYGSEGIISPKS-----DVYSYGILLMETFT---------RKKPTNEIFIGEMSL 627
G+MAPE ++ + D ++ G+ L E K E+ + L
Sbjct: 354 GFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--QRVL 406
Query: 628 KHWVKESLPDGLTE 641
+ + PD +
Sbjct: 407 EQ--AVTYPDKFSP 418
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 43/217 (19%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQ--LERASRS-FDSECEILRSIR 469
F ++G G+FG V K A+K+ N L+RA + F E ++L +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMID--------- 520
+ + + + + LV+++ G L + L + +
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDL----LTL------LSKFEDRLPEEMARFYLA 182
Query: 521 -VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMT 577
+ +A++ +H VH D+KP+NIL+D N H+ +DFG L E D +V ++
Sbjct: 183 EMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLME-DGTVQSSVA 236
Query: 578 IATIGYMAPE-----YGSEGIISPKSDVYSYGILLME 609
+ T Y++PE G +G P+ D +S G+ + E
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 8e-16
Identities = 40/196 (20%), Positives = 68/196 (34%), Gaps = 19/196 (9%)
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185
+ E+ + + + + + T + +R L L LQ L+ +
Sbjct: 364 LQSELESCKELQELEP---ENKWCLLTIILLMRALDPLLYEKETLQ-----YFSTLKAVD 415
Query: 186 ELNLNGNKLC-----GHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
+ +R LHL LT L V +++LS N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHN 473
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG-PVPKSFG 299
L +LP + L+ L L S N L ++ + L L+ L L +N+ Q +
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLV 530
Query: 300 SLISLESLDLSRNNLS 315
S L L+L N+L
Sbjct: 531 SCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 9e-14
Identities = 40/192 (20%), Positives = 75/192 (39%), Gaps = 15/192 (7%)
Query: 127 PQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL-- 184
++ + +L+ + + + + + + LQ L +I + L+ L
Sbjct: 342 CRDSATDEQLFRCELS-VEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 185 -SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
E + L P A L LR L N + + V ++L+ L
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYAD------VRVLHLAHKDL- 453
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303
++ +++ L ++T+LDLS N+L +P + L LE L +DN + +L
Sbjct: 454 -TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--NVDGVANLPR 509
Query: 304 LESLDLSRNNLS 315
L+ L L N L
Sbjct: 510 LQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 45/245 (18%), Positives = 74/245 (30%), Gaps = 40/245 (16%)
Query: 23 PNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLT 82
+L +LS LQ + L KW L+ +
Sbjct: 342 CRDSATDEQLFRCELSVE-----------KSTVLQSELESCKELQELEPENKWCLLTIIL 390
Query: 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLN 142
R L L L+ L K + + V L
Sbjct: 391 LMRALDPLLYEKETLQY-FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 143 GCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCL 202
DL T+ + +L + L L N+L+ ++P L L L L + N L +V +
Sbjct: 450 HKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-V 504
Query: 203 ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLS 262
A+L L+ L L +N+L +++ + + L L+L
Sbjct: 505 ANLPRLQELLLCNNRLQ-----QSAAIQP------------------LVSCPRLVLLNLQ 541
Query: 263 RNQLS 267
N L
Sbjct: 542 GNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 43/217 (19%), Positives = 73/217 (33%), Gaps = 18/217 (8%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L K + + + + + +L L+ + I L L
Sbjct: 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQ 406
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
Y T L ++ R + L S L ++ A ++ + L
Sbjct: 407 YFST---------LKAVDPMRAAYLDDLRSKFLLE--NSVLKMEYADVRVLHLAHKDLT- 454
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
+ + L + DL+ L +P A+ LR L+ L N L+ ++ + +L L
Sbjct: 455 VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRL 510
Query: 185 SELNLNGNKLCGH-VPPCLASLTSLRRLHLGSNKLTS 220
EL L N+L L S L L+L N L
Sbjct: 511 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 12/95 (12%)
Query: 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLA 62
+++ L L L+ + + + + LDLS N +P L L+VL +
Sbjct: 438 MEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQAS 494
Query: 63 YNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97
N L + + N L L L +N L
Sbjct: 495 DNALEN---------VDGVANLPRLQELLLCNNRL 520
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 9e-16
Identities = 47/215 (21%), Positives = 93/215 (43%), Gaps = 42/215 (19%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFN----LQLERASRSFDSECEILRSI 468
+ ++G G+FG V K T A+K+ + ++ ++ F E +I+
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFA 126
Query: 469 RHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVG------ 522
++++ + + +V+E+MP G L + ++ ++
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAE 176
Query: 523 --LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTI 578
LAL+ +H S +H D+KP+N+LLD++ H+ +DFG + + T +
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTA-V 230
Query: 579 ATIGYMAPE----YGSEGIISPKSDVYSYGILLME 609
T Y++PE G +G + D +S G+ L E
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-16
Identities = 32/194 (16%), Positives = 73/194 (37%), Gaps = 13/194 (6%)
Query: 151 PTAVGRLRRLQGLYLHGNKLQGSIPYDL-CHLEGLSELNLNGNKLCGHVPP-CLASLTSL 208
A L + +Y+ + + +L ++ + + + ++ P L L L
Sbjct: 48 SHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLL 107
Query: 209 RRLHLGSNKLTSTMP--SSFGSLEYVLYINLSANSLNGSLPSNI-QNL-KVLTNLDLSRN 264
+ L + + L P + S + + ++ N S+P N Q L L L N
Sbjct: 108 KFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166
Query: 265 QLSGDIPTTIGGLENLETLSLADNQFQGPVPK-SFGSLIS-LESLDLSRNNLS---GEIP 319
+ + L+ + L N++ + K +FG + S LD+S+ +++ +
Sbjct: 167 GFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGL 225
Query: 320 KNFSAQSFLSNYAL 333
++ + + L
Sbjct: 226 EHLKELIARNTWTL 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 45/271 (16%), Positives = 86/271 (31%), Gaps = 76/271 (28%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSN-SFSGLIPNTFGNLGSLQVLSLA 62
+ P+ + L L + L ++ +N + + +S + + L ++F NL + + +
Sbjct: 29 LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 63 YNYLMTESSAAKWNFLSSL-----TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYA 117
L+ + L LG+ + L+ + P L
Sbjct: 89 NT-----------RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL------------- 123
Query: 118 YGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYD 177
T V L + N SIP +
Sbjct: 124 ----------------------------------TKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 178 ----LCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPS-SFGSLEYV 232
LC+ L L N V + T L ++L NK + + +FG +
Sbjct: 150 AFQGLCNE--TLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 233 L-YINLSANSLNGSLPSNI-QNLKVLTNLDL 261
+++S S+ +LPS ++LK L +
Sbjct: 207 PSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 26/148 (17%), Positives = 53/148 (35%), Gaps = 7/148 (4%)
Query: 177 DLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYIN 236
C + + + +P + S + L L L + +F +L + I
Sbjct: 6 PPCECHQEEDFRVTCKDI-QRIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIY 61
Query: 237 LSANSLNGSLPSNI-QNLKVLTNLDLSRNQLSGDIPT-TIGGLENLETLSLADNQFQG-P 293
+S + L S+ NL +T++++ + I + L L+ L + + + P
Sbjct: 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFP 121
Query: 294 VPKSFGSLISLESLDLSRNNLSGEIPKN 321
S L+++ N IP N
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVN 149
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 31/206 (15%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFD---SECEILRSIR 469
F+ LGTGSFG V K + G + A+K+ + Q + + +E IL+++
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529
L+K+ + + +V+E++ G + L F R + L EYLH
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH 158
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEY 588
+++ DLKP N+L+D+ V+DFG +K + +T T+ T +APE
Sbjct: 159 SLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPE- 208
Query: 589 GSEGIISPKS-----DVYSYGILLME 609
II K D ++ G+L+ E
Sbjct: 209 ----IILSKGYNKAVDWWALGVLIYE 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 37/154 (24%), Positives = 62/154 (40%), Gaps = 3/154 (1%)
Query: 459 DSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIM 518
D I ++ R S E + FL + +
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199
Query: 519 IDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTI 578
V +E+L S +H DL NILL E + DFG+++ + + D V +
Sbjct: 200 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT 612
+ +MAPE + + + +SDV+S+G+LL E F+
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 33/150 (22%), Positives = 54/150 (36%), Gaps = 17/150 (11%)
Query: 423 LGTGSFGSVYKGTLFD------GTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLI 474
LG G+FG V + F VA+K+ R+ SE +IL I H N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 475 KIISNCCNIDFKALV-LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
++ C +V +EF G+L +L S R + +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--------RNEFVPYKTKGARFRQGKDY 141
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISK 563
+ DLK + + ++ S F K
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 63/296 (21%), Positives = 105/296 (35%), Gaps = 53/296 (17%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNL 473
L+G GS+G V K G VAIK F + A R E ++L+ +RH NL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENL 86
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+ ++ C LV EF+ + ++ L L + + + + H +
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN- 144
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE--YG 589
++H D+KP NIL+ ++ + DFG ++ L + + +AT Y APE G
Sbjct: 145 --IIHRDIKPENILVSQSGVVKLCDFGFARTLA----APGEVYDDEVATRWYRAPELLVG 198
Query: 590 SEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEIFIGEMSLKH 629
DV++ G L+ E F +
Sbjct: 199 DV-KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 630 WVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
+ LP+ + V ID L L +D P++R +
Sbjct: 258 FAGVRLPEIKEREPLERRYP--KLSEVVID-LAKKC-LHID-----PDKRPFCAEL 304
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 37/209 (17%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFN----LQLERASRSFDSECEILRSI 468
F LGTGSFG V+ + G A+KV ++L++ + E +L +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTN-DERLMLSIV 63
Query: 469 RHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYL 528
H +I++ + ++++++ G L L F + + +V LALEYL
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYL 122
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTI-ATIGYMA 585
H +++ DLKP NILLD+N H+ +DFG +K + + T T+ T Y+A
Sbjct: 123 HSKD---IIYRDLKPENILLDKN--GHIKITDFGFAKYVPD------VTYTLCGTPDYIA 171
Query: 586 PEYGSEGIISPKS-----DVYSYGILLME 609
PE ++S K D +S+GIL+ E
Sbjct: 172 PE-----VVSTKPYNKSIDWWSFGILIYE 195
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 74/314 (23%), Positives = 128/314 (40%), Gaps = 68/314 (21%)
Query: 412 RATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER------ASRSFDSECEI 464
+ + + LG G++G VYK VAIK L+ E A R E +
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86
Query: 465 LRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLA 524
L+ ++HRN+I++ S + L+ E+ N L+K++ + + + + + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK-SFLYQLING 144
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAH-----VSDFGISKLLGEGDDSVIQTMT-- 577
+ + H +H DLKP N+LL + + + DFG+++ G I+ T
Sbjct: 145 VNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG----IPIRQFTHE 197
Query: 578 IATIGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRK--------------------K 615
I T+ Y PE GS S D++S + E +
Sbjct: 198 IITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256
Query: 616 PTNEIFIGEMSLKHWVKESLP----DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDC 671
P + + G +L W K+S P L V+ A L +++ LL+ M L +D
Sbjct: 257 PDDTTWPGVTALPDW-KQSFPKFRGKTLKRVLGALL--DDEGLD-----LLTAM-LEMD- 306
Query: 672 CMESPEQRVSMKDA 685
P +R+S K+A
Sbjct: 307 ----PVKRISAKNA 316
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 25/208 (12%), Positives = 56/208 (26%), Gaps = 57/208 (27%)
Query: 422 LLGTGSFGSVYKGTLFD---GTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIK 475
G ++ D VA+ + Q + + S L I + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 476 IISNCCNIDFKA------LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529
++ D +V E++ GSL++ + + + M + A + H
Sbjct: 96 VL------DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH 146
Query: 530 -HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY 588
G + P+ + + + ++ M
Sbjct: 147 RAG----VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA- 179
Query: 589 GSEGIISPKSDVYSYGILLMETFTRKKP 616
+P+ D+ G L + P
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWP 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 71/308 (23%), Positives = 116/308 (37%), Gaps = 74/308 (24%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER-----ASRSFDSECEILRSIRHRN---L 473
LG G++ +VYKG G VA+K L E A R E +++ ++H N L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRL 68
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFL--GILERLNI---MIDVGLALEYL 528
+I + LV EFM N L+K++ S LE + + L +
Sbjct: 69 YDVIHTENKL---TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAP 586
H ++H DLKP N+L+++ + DFG+++ G + T + + T+ Y AP
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG----IPVNTFSSEVVTLWYRAP 177
Query: 587 E--YGSEGIISPKSDVYSYGILLMETFTRK--------------------KPTNEIFIG- 623
+ GS S D++S G +L E T K P ++
Sbjct: 178 DVLMGSR-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 624 ------EMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPE 677
+++ L L L + L + L L+ P+
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPL--DGNLMD-----FLHGL-LQLN-----PD 283
Query: 678 QRVSMKDA 685
R+S K A
Sbjct: 284 MRLSAKQA 291
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 43/213 (20%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RASRSFDSECEILRSIRHRNLIK 475
+G+G+ G V NVAIK F Q RA R E +++ + H+N+I
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88
Query: 476 I----ISNCCNIDFKA--LVLEFMPNGSLEKWLYS------HNYFLGILERLNIMIDVGL 523
+ +F+ +V+E M +L + + +Y L +
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC--------- 138
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATI 581
+++LH S ++H DLKP+NI++ + T + DFG+++ G MT + T
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-----MTPYVVTR 190
Query: 582 GYMAPEYGSEGIISPKSDVYSYGILLMETFTRK 614
Y APE D++S G ++ E
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 55/224 (24%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQ--LERA-SRSFDSECEILRSIR 469
F ++G G+F V K T G A+K+ N L+R F E ++L +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 470 HRNLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMID---- 520
R + ++ + F+ LV+E+ G L + L + I
Sbjct: 120 RRWITQL--HFA---FQDENYLYLVMEYYVGGDL----LTL------LSKFGERIPAEMA 164
Query: 521 ------VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSV 572
+ +A++ +H VH D+KP+NILLD H+ +DFG L D +V
Sbjct: 165 RFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRA-DGTV 218
Query: 573 IQTMTIATIGYMAPE-------YGSEGIISPKSDVYSYGILLME 609
+ + T Y++PE G P+ D ++ G+ E
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 70/358 (19%), Positives = 110/358 (30%), Gaps = 73/358 (20%)
Query: 5 LPNLKYLTLFDNKLSGT----IPNSITNASKLIMLDLSSNSFSG----------LIPNTF 50
L + + L D L+ I +++ L L+L SN P+
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC- 85
Query: 51 GNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSA 110
+Q LSL L S+L L L L+ N L L+
Sbjct: 86 ----KIQKLSLQNCCLTGAGCGV---LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL 138
Query: 111 SLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGT----IPTAVGRLRRLQGLYLH 166
Q C+L L C L+ + + + + L +
Sbjct: 139 DPQ------CRLE--------------KLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 167 GNKLQGSIPYDLC-----HLEGLSELNLNGNKL----CGHVPPCLASLTSLRRLHLGSNK 217
N + + LC L L L + C + +AS SLR L LGSNK
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 218 LTST-----MPSSFGSLEYVLYINLSANSLN----GSLPSNIQNLKVLTNLDLSRNQLSG 268
L P + + + + G L ++ + L L L+ N+L
Sbjct: 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 298
Query: 269 DIPTTIG-GLEN----LETLSLADNQFQGPVPKSFGSLI----SLESLDLSRNNLSGE 317
+ + L LE+L + F F S++ L L +S N L
Sbjct: 299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 64/325 (19%), Positives = 99/325 (30%), Gaps = 65/325 (20%)
Query: 30 SKLIMLDLSSNSFSGL-IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLT 88
+ LD+ S L QV+ L L TE+ + S+L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL-TEARCK--DISSALRVNPALA 59
Query: 89 VLGLASNPLRGILPPLIGNFSASL--QEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDL 146
L L SN +G+ Q CK++ L C L
Sbjct: 60 ELNLRSNE--------LGDVGVHCVLQGLQTPSCKIQ--------------KLSLQNCCL 97
Query: 147 NGT----IPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLE-----GLSELNLNGNKL--- 194
G + + + L LQ L+L N L + LC L +L L L
Sbjct: 98 TGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA 157
Query: 195 -CGHVPPCLASLTSLRRLHLGSNK--------LTSTMPSSFGSLEYVLYINLSANSLN-- 243
C + L + + L + +N L + S LE + L + +
Sbjct: 158 SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE---ALKLESCGVTSD 214
Query: 244 --GSLPSNIQNLKVLTNLDLSRNQLSGD-----IPTTIGGLENLETLSLADNQFQGPVPK 296
L + + L L L N+L P + L TL + +
Sbjct: 215 NCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG 274
Query: 297 SFGSLI----SLESLDLSRNNLSGE 317
++ SL+ L L+ N L E
Sbjct: 275 DLCRVLRAKESLKELSLAGNELGDE 299
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 57/332 (17%), Positives = 97/332 (29%), Gaps = 83/332 (25%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNA----SKLIMLDLSSNSFS---------GLIPNTFGNL 53
L+ L L LS + + L +S+N + GL +
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP---- 198
Query: 54 GSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASL- 112
L+ L L + +++ + + +L L L SN +G+ +
Sbjct: 199 CQLEALKLESCGVTSDNCRD---LCGIVASKASLRELALGSNK--------LGDVGMAEL 247
Query: 113 -QEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLN----GTIPTAVGRLRRLQGLYLHG 167
+LR + C + G + + L+ L L G
Sbjct: 248 CPGLLHPSSRLR--------------TLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293
Query: 168 NKLQGS--------IPYDLCHLEGLSELNLNGNKL----CGHVPPCLASLTSLRRLHLGS 215
N+L + C LE L + C H LA L L + +
Sbjct: 294 NELGDEGARLLCETLLEPGCQLE---SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISN 350
Query: 216 NKLTST--------MPSSFGSLEYVLYINLSANSLN----GSLPSNIQNLKVLTNLDLSR 263
N+L + L + L+ ++ SL + + L LDLS
Sbjct: 351 NRLEDAGVRELCQGLGQPGSVLR---VLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 407
Query: 264 NQLSGDIPTTIG-GLEN----LETLSLADNQF 290
N L + + LE L L D +
Sbjct: 408 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 54/247 (21%), Positives = 94/247 (38%), Gaps = 61/247 (24%)
Query: 423 LGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIIS--- 478
LGTGSFG V + + G A+K +R E +I++ + H N+IK++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY----------- 527
+ + K N K +N+ ++ + + + +EY
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 528 -----------------------LHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISK 563
+ HS + H D+KP N+L++ ++ T + DFG +K
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190
Query: 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGII------SPKSDVYSYGILLMETFTRKKPT 617
L + S I + Y APE ++ +P D++S G + E KP
Sbjct: 191 KLIPSEPS---VAYICSRFYRAPE-----LMLGATEYTPSIDLWSIGCVFGELILG-KP- 240
Query: 618 NEIFIGE 624
+F GE
Sbjct: 241 --LFSGE 245
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 46/214 (21%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RASRSFDSECEILRSIRHRNLIK 475
+G+G++GSV G VAIK F ++ RA R E +L+ ++H N+I
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 476 I----ISNCCNIDFKA--LVLEFMPNGSLEKWLYS------HNYFLGILERLNIMIDVGL 523
+ +F LV+ FM L+K + Y + + +
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK--------- 137
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATI 581
L+Y+H S +VH DLKP N+ ++E+ + DFG+++ MT + T
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTR 187
Query: 582 GYMAPE-YGSEGIISPKSDVYSYGILLMETFTRK 614
Y APE S + D++S G ++ E T K
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 49/218 (22%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK---VFNLQLE--RASRSFDSECEILRSIRHRNLIK- 475
+G G++G V + VAIK F Q R R E +IL RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 476 --IISNCCNIDFKA--LVLEFMPNGSLEKWLYS-------HNYFLGILERLNIMIDVGLA 524
II K +V + M L K L + YFL + R
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR---------G 140
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIG 582
L+Y+H S ++H DLKP+N+LL+ + DFG++++ + D +T +AT
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYVATRW 196
Query: 583 YMAPEYGSEGII------SPKSDVYSYGILLMETFTRK 614
Y APE I+ + D++S G +L E + +
Sbjct: 197 YRAPE-----IMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 53/218 (24%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RASRSFDSECEILRSIRHRNLIK 475
+G+G+ G V NVAIK F Q RA R E +++ + H+N+I
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIS 125
Query: 476 II----SNCCNIDFKA--LVLEFMPNGSLEKWLYS------HNYFLGILERLNIMIDVGL 523
++ +F+ LV+E M +L + + +Y L +
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLC--------- 175
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATI 581
+++LH ++H DLKP+NI++ + T + DFG+++ G MT + T
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-----MMTPYVVTR 227
Query: 582 GYMAPEYGSEGII-----SPKSDVYSYGILLMETFTRK 614
Y APE +I D++S G ++ E K
Sbjct: 228 YYRAPE-----VILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 54/224 (24%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK---VFNLQLE--RASRSFDSECEILRSIRHRNLIK- 475
LG G++G V T G VAIK F+ L R R E +IL+ +H N+I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 476 --IISNCCNIDFKA--LVLEFMPNGSLEKWLYS-------HNYFLGILERLNIMIDVGLA 524
I +F ++ E M L + + + YF+ R A
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLR---------A 124
Query: 525 LEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT------MT- 577
++ LH + ++H DLKP+N+L++ N V DFG+++++ E + M
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 578 -IATIGYMAPEYGSEGII------SPKSDVYSYGILLMETFTRK 614
+AT Y APE ++ S DV+S G +L E F R+
Sbjct: 182 FVATRWYRAPE-----VMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSEC-----EILRS 467
F LLG G+FG V K T G A+K+ L+ E + +L++
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKAT---GRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQN 204
Query: 468 IRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-DVGLALE 526
RH L + + D V+E+ G L L F +R ++ AL+
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS--EDRARFYGAEIVSALD 262
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 586
YLH + +V+ DLK N++LD++ ++DFG+ K G D + ++T T Y+AP
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTF-CGTPEYLAP 318
Query: 587 EYGSEGIISPKS-----DVYSYGILLME 609
E ++ D + G+++ E
Sbjct: 319 E-----VLEDNDYGRAVDWWGLGVVMYE 341
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 48/226 (21%), Positives = 85/226 (37%), Gaps = 56/226 (24%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK--VFNLQLE--RASRSFDSECEILRSIRHRNLIKII 477
LG G G V+ VAIK V A R E +I+R + H N++K+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 478 ------------SNCCNIDFKA--LVLEFMPNGSLEKWLYSHN-------YFLGILERLN 516
+ + +V E+M L L F+ L R
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR-- 131
Query: 517 IMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLG-EGDDSVIQ 574
L+Y+H S ++H DLKP N+ ++ E++ + DFG+++++
Sbjct: 132 -------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 575 TMTIATIGYMAPEYGSEGII------SPKSDVYSYGILLMETFTRK 614
+ + T Y +P ++ + D+++ G + E T K
Sbjct: 182 SEGLVTKWYRSPR-----LLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 57/220 (25%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RASRSFDSECEILRSIRHRNLIK 475
+G+G++GSV G VA+K F + R R E +L+ ++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 476 I----ISNCCNIDFKA--LVLEFMPNGSLEKWLYS-------HNYFLGILERLNIMIDVG 522
+ +F LV M L + + + + R
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR-------- 143
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IAT 580
L+Y+H S ++H DLKP+N+ ++E+ + DFG+++ MT +AT
Sbjct: 144 -GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVAT 192
Query: 581 IGYMAPEYGSEGII------SPKSDVYSYGILLMETFTRK 614
Y APE I+ + D++S G ++ E T +
Sbjct: 193 RWYRAPE-----IMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 3/128 (2%)
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
L L+ N++ P SL +L+ L+LGSN+L + F SL + ++L N L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 246 LPSNI-QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
LPS + L L L + N+L+ +P I L +L L+L NQ + +F L SL
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 305 ESLDLSRN 312
L N
Sbjct: 162 THAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 3/110 (2%)
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRN 264
T+ + L+L N++T P F SL + + L +N L +LP + +L LT LDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 265 QLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
QL+ L +L+ L + N+ +P+ L L L L +N L
Sbjct: 99 QLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 46/182 (25%), Positives = 61/182 (33%), Gaps = 57/182 (31%)
Query: 35 LDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLAS 94
L L N + L P F +L +L+ L L N L SLT LTVL L +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV----FDSLTQ---LTVLDLGT 97
Query: 95 NPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAV 154
N L LP VFD
Sbjct: 98 NQLTV-LPS-------------------------------A--VFD-------------- 109
Query: 155 GRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLG 214
RL L+ L++ NKL +P + L L+ L L+ N+L L+SL +L
Sbjct: 110 -RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLF 167
Query: 215 SN 216
N
Sbjct: 168 GN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 24/71 (33%), Positives = 30/71 (42%), Gaps = 2/71 (2%)
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
S+P+ I L L NQ++ P L NL+ L L NQ F SL L
Sbjct: 33 SVPAGIPTNA--QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 305 ESLDLSRNNLS 315
LDL N L+
Sbjct: 91 TVLDLGTNQLT 101
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 50/217 (23%)
Query: 417 FNECNLLGTGSFGSV----YKGTLFDGTNVAIKVFNLQLERASRSFDSEC-----EILRS 467
F+ LLG G+FG V K T G A+K+ L+ E + +L++
Sbjct: 7 FDYLKLLGKGTFGKVILVREKAT---GRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQN 61
Query: 468 IRHRNLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-DV 521
RH L + F+ V+E+ G L L F ER ++
Sbjct: 62 TRHPFLTAL--KYA---FQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGAEI 114
Query: 522 GLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKL-LGEGDDSVIQTMTI 578
ALEYLH S +V+ D+K N++LD++ H+ +DFG+ K + +G T
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGA----TMKTF 165
Query: 579 -ATIGYMAPEYGSEGIISPKS-----DVYSYGILLME 609
T Y+APE ++ D + G+++ E
Sbjct: 166 CGTPEYLAPE-----VLEDNDYGRAVDWWGLGVVMYE 197
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 47/215 (21%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RASRSFDSECEILRSIRHRNLIK 475
+G+G++G+V G VAIK F +L RA R E +L+ +RH N+I
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 476 II----SNCCNIDFKA--LVLEFMPNGSLEKWLYS-------HNYFLGILERLNIMIDVG 522
++ + DF LV+ FM L K + + + + +
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK-------- 139
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IAT 580
L Y+H + ++H DLKP N+ ++E+ + DFG+++ MT + T
Sbjct: 140 -GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMTGYVVT 188
Query: 581 IGYMAPEY-GSEGIISPKSDVYSYGILLMETFTRK 614
Y APE + + D++S G ++ E T K
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 65/318 (20%), Positives = 116/318 (36%), Gaps = 75/318 (23%)
Query: 412 RATNGFNECNLLGTGSFGSVYKGTLFDGTN--VAIKVFNLQLER------ASRSFDSECE 463
RA + +G G++G V+K VA+K +Q R E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61
Query: 464 I-----LRSIRHRNLIK----IISNCCNIDFKA-LVLEFMPNGSLEKWLYSH-NYFLGIL 512
+ L + H N+++ + + + K LV E + L +L +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 513 ERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572
++M + L++LH +VH DLKP NIL+ + ++DFG++++
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS-----F 172
Query: 573 IQTMT--IATIGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRK-------------- 614
+T + T+ Y APE S + D++S G + E F RK
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230
Query: 615 ------KPTNEIFIGEMSLKHWVKESLP-DGLTEVVDANLVREEQAFSVKIDCLLSIMHL 667
P E + +++L S + + V ++ +E LL L
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV-TDI--DELGKD-----LLLKC-L 281
Query: 668 ALDCCMESPEQRVSMKDA 685
+ P +R+S A
Sbjct: 282 TFN-----PAKRISAYSA 294
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 70/314 (22%), Positives = 117/314 (37%), Gaps = 65/314 (20%)
Query: 412 RATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLER-ASRSFDSEC--EI--- 464
AT+ + +G G++G+VYK G VA+K + E+
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 465 --LRSIRHRNLIK----IISNCCNIDFKA-LVLEFMPNGSLEKWLYSHN-YFLGILERLN 516
L + H N+++ ++ + + K LV E + L +L L +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 517 IMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576
+M L++LH +VH DLKP NIL+ T ++DFG++++ +
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS-----YQMAL 176
Query: 577 T--IATIGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRK------------------ 614
T + T+ Y APE S + D++S G + E F RK
Sbjct: 177 TPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
Query: 615 --KPTNEIFIGEMSLKHWV-KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDC 671
P + + ++SL P + VV + EE LL M L +
Sbjct: 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVV-PEM--EESGAQ-----LLLEM-LTFN- 284
Query: 672 CMESPEQRVSMKDA 685
P +R+S A
Sbjct: 285 ----PHKRISAFRA 294
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 4e-13
Identities = 80/574 (13%), Positives = 175/574 (30%), Gaps = 154/574 (26%)
Query: 149 TIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSL 208
+ A+ LR + + + G + GS G + +A
Sbjct: 139 KLRQALLELRPAKNVLIDG--VLGS---------GKT---------------WVALDV-C 171
Query: 209 RRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSG 268
S K+ M F + ++NL + ++ +Q L L +D + S
Sbjct: 172 L-----SYKVQCKMD--FK----IFWLNLKNCNSPETVLEMLQKL--LYQIDPNWTSRSD 218
Query: 269 DIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL-SGEIPKNFSAQS- 326
+ +++ L P L+ L N+ + + F+
Sbjct: 219 HSSNIKLRIHSIQA-ELRRLLKSKPYENCL--LV----LL----NVQNAKAWNAFNLSCK 267
Query: 327 --FLSNY-----ALCGPARLQVPSCRKYNSRGF--KKVALLVLKYI------LPP-ITSI 370
+ + L + ++S +V L+LKY+ LP + +
Sbjct: 268 ILLTTRFKQVTDFLSAATTTHISL--DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT 325
Query: 371 VLIAIVIIFFIRHRNRSTKDGDQEDLLSLATWRRTSYLDIQRATNGFNEC-NLLGTGSFG 429
+ II S +DG LATW +++ + T N+L +
Sbjct: 326 NPRRLSII------AESIRDG-------LATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 430 SVYKG-TLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487
++ ++F ++ + +L + D ++ + +L++ I +
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSL-IWFDVIKSDVM-VVVNKLHKYSLVEKQPKESTISIPS 430
Query: 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-----DVGLALE----YLHHGHSTPMVH 538
+ LE E L H I++ NI D+ Y H GH H
Sbjct: 431 IYLELKVKLENEYAL--HR---SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-----H 480
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPK- 597
L + ++ F + D ++ I + + + + G I
Sbjct: 481 --------LKNIEHPERMTLF--RMVF--LDFRFLE----QKIRHDSTAWNASGSILNTL 524
Query: 598 SDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVK 657
+ Y P E + ++ ++ + ++ NL+ +
Sbjct: 525 QQLKFYK----PYICDNDPKYERLVN--AILDFLPK---------IEENLICSKY----- 564
Query: 658 IDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691
++ +AL E ++A ++++
Sbjct: 565 ----TDLLRIAL-----MAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 79/500 (15%), Positives = 144/500 (28%), Gaps = 174/500 (34%)
Query: 78 LSSLTNCRNLTVLG--------LASNPLRGILPPLIGNFSASLQEFYAYG--------CK 121
L L +N+ + G +A + S +Q + C
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTWVALDVCL----------SYKVQCKMDFKIFWLNLKNCN 193
Query: 122 LRGNIPQEIGNLSGMIVFDLN-GCDLNGTIP----TAVGRLRRLQGLYLHGNKL------ 170
+ + + L I + D + I + LRRL + N L
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV 253
Query: 171 -QGSI--PYDL-C---------------------------HLEGLSE----------LNL 189
++L C H L+ L+
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 190 NGNKL----CGHVPPCLASLTSLRR---------LHLGSNKLTSTMPSSFGSLE----YV 232
L P L+ + R H+ +KLT+ + SS LE
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 233 LYINLSANSLNGSLPSNIQNLKVLTNLDLSR--NQLSGDIPTTIGGLENLETLSLADNQF 290
++ LS P + + T L LS + + + L SL + Q
Sbjct: 374 MFDRLSV------FPPSA---HIPTIL-LSLIWFDVIKSDVMVV--VNKLHKYSLVEKQ- 420
Query: 291 QGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSA-QSFLSNYALCGPARLQVPSCRKYNS 349
PK IS+ S+ L L ++ ++ +S + +Y + + ++S
Sbjct: 421 ----PKES--TISIPSIYLE---LKVKLENEYALHRSIVDHYNI----------PKTFDS 461
Query: 350 RGFKKVALLVLKYILPPITSIVLIAIVIIFFIRHRNRSTKDGDQEDLLSLATWRRTSYLD 409
L +Y I H ++ + ++ L R +LD
Sbjct: 462 DDLIPPYL--DQYFY--------------SHIGHHLKNIEHPERMTLF------RMVFLD 499
Query: 410 -------IQRATNGFNEC----NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSF 458
I+ + +N N L F YK + D +L A F
Sbjct: 500 FRFLEQKIRHDSTAWNASGSILNTLQQLKF---YKPYICDNDPK-----YERLVNAILDF 551
Query: 459 DSECE--ILRSIRHRNLIKI 476
+ E ++ S ++ +L++I
Sbjct: 552 LPKIEENLICS-KYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 6e-06
Identities = 66/459 (14%), Positives = 131/459 (28%), Gaps = 127/459 (27%)
Query: 246 LPSNIQNLKVLTNLDLSRNQLSG----DI---PTTIGGLENLETLSLADNQFQGPVPKSF 298
+ + N D+ ++ LS I + G L L Q + V K
Sbjct: 26 EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT-LLSKQEEM-VQKFV 83
Query: 299 GSLIS------LESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQVPSCRKYN-SRG 351
++ + + + S + L N KYN SR
Sbjct: 84 EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN---------DNQVFAKYNVSR- 133
Query: 352 FKKV-----ALLVLKYILPPITSI-----------VLIAIVI------------IFFIRH 383
+ ALL L+ P ++ + V IF++
Sbjct: 134 LQPYLKLRQALLELR----PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNL 189
Query: 384 RNRSTKDGDQEDLLSLATWRRTSYLDIQRATNGFN---ECNLLGTGS----FGSVYKGTL 436
+N ++ + E L L + R+ + N + + Y+ L
Sbjct: 190 KNCNSPETVLEMLQKL--LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 437 FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNG 496
NV +A +F+ C+IL + R + + +S + L+
Sbjct: 248 LVLLNVQNA-------KAWNAFNLSCKILLTTRFKQVTDFLS---AATTTHISLDHHSMT 297
Query: 497 SLEKWLYSHNYFLGILER-LNIMID-------------VGLALEYLHHGHST----PMVH 538
+ + +L + L+ + + E + G +T V+
Sbjct: 298 ------LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351
Query: 539 CDLKPNNIL------LDEN-MTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE 591
CD K I+ L+ + + I T+ ++ I + +
Sbjct: 352 CD-KLTTIIESSLNVLEPAEYRKMFDRLSVFP-----PSAHIPTILLSLIWFDVIKSDVM 405
Query: 592 GIIS-----------PKSDVYSYGILLMETFTRKKPTNE 619
+++ PK S + +E + K NE
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIYLE--LKVKLENE 442
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 40/167 (23%), Positives = 67/167 (40%), Gaps = 39/167 (23%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEIL-RSIRHRNLIKII--- 477
LG G G V + A+K+ +A R E E+ R+ + ++++I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 478 -SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLN----------IMIDVGLALE 526
+ +V+E + G L F I +R + IM +G A++
Sbjct: 81 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 527 YLH-HGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISK-LLGEG 568
YLH + H D+KP N+L N ++DFG +K GE
Sbjct: 132 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK 174
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 61/324 (18%), Positives = 117/324 (36%), Gaps = 82/324 (25%)
Query: 423 LGTGSFGSVYKGTLFDGTN---VAIKVFNLQLERASRSFDSECEI--LRSIRHRNLIKII 477
+G G++G VYK DG + A+K Q+E S + EI LR ++H N+I +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALK----QIEGTGISMSACREIALLRELKHPNVISLQ 84
Query: 478 SNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGL----------AL 525
+ + L+ ++ + L + H + + + G+ +
Sbjct: 85 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRA--SKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAH----VSDFGISKLLGEGDDSVIQTMT---- 577
YLH ++H DLKP NIL+ ++D G ++L S ++ +
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN----SPLKPLADLDP 194
Query: 578 -IATIGYMAPE--YGSEGIISPKSDVYSYGILLMETFTRK-------------------- 614
+ T Y APE G+ + D+++ G + E T +
Sbjct: 195 VVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253
Query: 615 ---------KPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKID----CL 661
P ++ + + + +L++ + VK D L
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313
Query: 662 LSIMHLALDCCMESPEQRVSMKDA 685
L + L +D P +R++ + A
Sbjct: 314 LQKL-LTMD-----PIKRITSEQA 331
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 8e-13
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 44/216 (20%)
Query: 417 FNECNLLGTGSFGSVY---KGTLFDGTNV-AIKVFN----LQLERASRSFDSECEILRSI 468
F +LG G +G V+ K T + + A+KV ++ + + +E IL +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 469 RHRNLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-DVG 522
+H ++ + F+ L+LE++ G L L F+ + + ++
Sbjct: 79 KHPFIVDL--IYA---FQTGGKLYLILEYLSGGELFMQLEREGIFM--EDTACFYLAEIS 131
Query: 523 LALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTIA 579
+AL +LH G +++ DLKP NI+L+ HV +DFG+ K T T
Sbjct: 132 MALGHLHQKG----IIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTFC 182
Query: 580 -TIGYMAPEYGSEGIISPKS-----DVYSYGILLME 609
TI YMAPE I+ D +S G L+ +
Sbjct: 183 GTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYD 213
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 9e-13
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 42/214 (19%)
Query: 417 FNECNLLGTGSFGSVY---KGTLFDGTNV-AIKVFN--LQLERASRSFDSECEILRSIRH 470
F +LG GSFG V+ K + D + A+KV R E +IL + H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 471 RNLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-DVGLA 524
++K+ + F+ L+L+F+ G L L F E + + ++ LA
Sbjct: 86 PFIVKL--HYA---FQTEGKLYLILDFLRGGDLFTRLSKEVMFT--EEDVKFYLAELALA 138
Query: 525 LEYLH-HGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTI-AT 580
L++LH G +++ DLKP NILLDE H+ +DFG+SK + + + T
Sbjct: 139 LDHLHSLG----IIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFCGT 189
Query: 581 IGYMAPEYGSEGIISPKS-----DVYSYGILLME 609
+ YMAPE +++ + D +S+G+L+ E
Sbjct: 190 VEYMAPE-----VVNRRGHTQSADWWSFGVLMFE 218
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (167), Expect = 1e-12
Identities = 49/321 (15%), Positives = 88/321 (27%), Gaps = 68/321 (21%)
Query: 413 ATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKV--------FNLQLERASRSFDSECEI 464
T C +G G FG V++ D T VAIK+ N ++ E I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 465 LRSI---------RHRNLIKIISNCCNI------------------------------DF 485
+ + R I + S C D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 486 KALVLEFMPNG-SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPN 544
+VLEF G LE+ + +I+ + +L H DL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191
Query: 545 NILLDENMTAHVSDFGISKLLG---------EGDDSVIQTMTIATIGYMAPEYGSE---G 592
N+LL + + K D ++ + + + + G
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251
Query: 593 IISPKSDVYSY-GILLMETFTRKKP-TNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650
+ D+Y + P +N +++ ++ K + + + R+
Sbjct: 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK 311
Query: 651 EQAFSVKIDCLLSIMHLALDC 671
Q F + S L
Sbjct: 312 IQEFHRTMLNFSSATDLLCQH 332
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 43/214 (20%)
Query: 417 FNECNLLGTGSFGSV----YKGTLFDGTNVAIKVFNLQLERASRSFDSEC-----EIL-R 466
F +LG GSFG V +K T AIK L+ + D EC +L
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSL 73
Query: 467 SIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-DVGLAL 525
+ H L + + V+E++ G L + S + F L R ++ L L
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD--LSRATFYAAEIILGL 131
Query: 526 EYLH-HGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKL-LGEGDDSVIQTMTI-AT 580
++LH G +V+ DLK +NILLD++ H+ +DFG+ K + +T T T
Sbjct: 132 QFLHSKG----IVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDA----KTNTFCGT 181
Query: 581 IGYMAPEYGSEGIISPKS-----DVYSYGILLME 609
Y+APE I+ + D +S+G+LL E
Sbjct: 182 PDYIAPE-----ILLGQKYNHSVDWWSFGVLLYE 210
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 41/179 (22%), Positives = 79/179 (44%), Gaps = 17/179 (9%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK----VFNLQLERASRSFDSECEILRSIRHRNLIK-- 475
+GTGS+G V + + VAIK VF ++ R E IL + H +++K
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID-CKRIL-REIAILNRLNHDHVVKVL 118
Query: 476 -IISNCCNIDFKA--LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
I+ F +VLE + +K + Y + + ++ ++ + ++Y+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH--- 173
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE 591
S ++H DLKP N L++++ + V DFG+++ + ++ Q M
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 50/232 (21%)
Query: 417 FNECNLLGTGSFGSV----YKGTLFDGTNVAIKVFNLQLERASRSFDSEC-----EIL-R 466
FN +LG GSFG V KGT A+K+ L+ + + D EC +L
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVLAL 397
Query: 467 SIRHRNLIKIISNCC--NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-DVGL 523
+ L ++ + C +D V+E++ G L + F ++ +
Sbjct: 398 PGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK--EPHAVFYAAEIAI 453
Query: 524 ALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKL-LGEGDDSVIQTMTIA- 579
L +L S +++ DLK +N++LD H+ +DFG+ K + +G T T
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV----TTKTFCG 504
Query: 580 TIGYMAPEYGSEGIISPKS-----DVYSYGILLMETFTRKKP-----TNEIF 621
T Y+APE II+ + D +++G+LL E + P +E+F
Sbjct: 505 TPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 50/221 (22%)
Query: 417 FNECNLLGTGSFGSVY---KGTLFDGTNV-AIKVFN----LQLERASRSFDSECEILRSI 468
F +LGTG++G V+ K + D + A+KV +Q + + +E ++L I
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 469 RHR----NLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMI 519
R L + F+ L+L+++ G L L F + I +
Sbjct: 116 RQSPFLVTL-----HYA---FQTETKLHLILDYINGGELFTHLSQRERFT--EHEVQIYV 165
Query: 520 -DVGLALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQT 575
++ LALE+LH G +++ D+K NILLD N HV +DFG+SK +
Sbjct: 166 GEIVLALEHLHKLG----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD 219
Query: 576 MTIATIGYMAPEYGSEGIISPKS-------DVYSYGILLME 609
TI YMAP+ I+ D +S G+L+ E
Sbjct: 220 F-CGTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYE 254
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 54/248 (21%), Positives = 91/248 (36%), Gaps = 70/248 (28%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RASRSFDSECEILRSIRHRNLIK 475
+G GS+G VY NVAIK +F ++ R R E IL ++ +I+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 476 ---IISNCCNIDFKA--LVLEFMPNGSLEKWLYSHN--------YFLGILERLNIMIDVG 522
+I + F +VLE + L+K + L L
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL-------- 140
Query: 523 LALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT------- 575
++H + ++H DLKP N LL+++ + V DFG+++ + D+ I
Sbjct: 141 -GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 576 -----------MT--IATIGYMAPE-------YGSEGIISPKSDVYSYGILLMETFTRKK 615
+T + T Y APE Y ++ I D++S G + E +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENY-TKSI-----DIWSTGCIFAELLNMLQ 250
Query: 616 PTNEIFIG 623
Sbjct: 251 SHINDPTN 258
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 59/214 (27%), Positives = 84/214 (39%), Gaps = 46/214 (21%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSF----DSECEILRSIRHR---NL 473
++G GSFG V K +VA+K+ R + F E IL +R + N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 474 IKIISNCCNIDFKA---LVLEFMPNGSLEKWLYS---HNYFLGILERL--NIMIDVGLAL 525
+ +I N F+ + E L LY N F G L + L
Sbjct: 159 MNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAH--VSDFGISKLLGEGDDSVIQTMTIATIGY 583
+ LH ++HCDLKP NILL + + V DFG S + + IQ+ Y
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----Y 265
Query: 584 MAPEYGSEGII-----SPKSDVYSYGILLMETFT 612
APE +I D++S G +L E T
Sbjct: 266 RAPE-----VILGARYGMPIDMWSLGCILAELLT 294
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 44/226 (19%), Positives = 87/226 (38%), Gaps = 52/226 (23%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSF----DSECEILRSIR------- 469
LG G F +V+ + + T+VA+K+ R + + + E ++L+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 470 -HRNLIKIISNCCNIDFKA-------LVLEFMPNGSLEKWLYSHNYFLGILERL--NIMI 519
I+ + + K +V E + +L + + GI I
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISK 138
Query: 520 DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAH------VSDFGISKLLGEGDDSVI 573
+ L L+Y+H ++H D+KP N+L++ + ++D G + E + I
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 574 QTMTIATIGYMAPEYGSEGII-----SPKSDVYSYGILLMETFTRK 614
QT Y +PE ++ +D++S L+ E T
Sbjct: 197 QTRE-----YRSPE-----VLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 66/235 (28%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RASRSFDSECEILRSIR-HRNLI 474
LG G++G V+K G VA+K F + R R E IL + H N++
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72
Query: 475 KIISNCCNIDFKA--LVLEFMPNGSLEKWLYS-------HNYFLGILERLNIMIDVGLAL 525
+++ + + LV ++M L + + Y + L + +
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIK---------VI 122
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFG-----------------ISKLLGEG 568
+YLH S ++H D+KP+NILL+ V+DFG E
Sbjct: 123 KYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 569 DDSVIQTMT--IATIGYMAPE-------YGSEGIISPKSDVYSYGILLMETFTRK 614
D +T +AT Y APE Y ++GI D++S G +L E K
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKY-TKGI-----DMWSLGCILGEILCGK 228
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 48/130 (36%), Positives = 62/130 (47%), Gaps = 6/130 (4%)
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
L+L N L LTSL +L+LG NKL S F L + Y+NLS N L S
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 246 LPSNI-QNLKVLTNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQGPVPK-SFGSLI 302
LP+ + L L L L+ NQL +P + L L+ L L NQ + VP F L
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLT 148
Query: 303 SLESLDLSRN 312
SL+ + L N
Sbjct: 149 SLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 36/110 (32%), Positives = 46/110 (41%), Gaps = 2/110 (1%)
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRN 264
L L +N L S F L + + L N L SLP+ + L LT L+LS N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 265 QLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
QL L L+ L+L NQ Q F L L+ L L +N L
Sbjct: 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 44/143 (30%), Positives = 58/143 (40%), Gaps = 10/143 (6%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC-HLEG 183
IP + L DL L L L LYL GNKLQ S+P + L
Sbjct: 25 GIPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L+ LNL+ N+L LT L+ L L +N+L S F L + + L N L
Sbjct: 78 LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137
Query: 244 GSLPSNI-QNLKVLTNLDLSRNQ 265
S+P + L L + L N
Sbjct: 138 -SVPDGVFDRLTSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 24/70 (34%), Positives = 29/70 (41%), Gaps = 2/70 (2%)
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
S+P+ I T LDL N L L +L L L N+ Q F L SL
Sbjct: 21 SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 305 ESLDLSRNNL 314
L+LS N L
Sbjct: 79 TYLNLSTNQL 88
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 46/187 (24%), Positives = 61/187 (32%), Gaps = 62/187 (33%)
Query: 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMT 68
YL L N L + L L L N L F L SL L+L+ N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL-- 88
Query: 69 ESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQ 128
S F LT L L L +N L+ LP G
Sbjct: 89 -QSLPNGVF-DKLT---QLKELALNTNQLQS-LPD--G---------------------- 118
Query: 129 EIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIP---YDLCHLEGLS 185
VFD +L +L+ L L+ N+L+ S+P +D L L
Sbjct: 119 ---------VFD---------------KLTQLKDLRLYQNQLK-SVPDGVFD--RLTSLQ 151
Query: 186 ELNLNGN 192
+ L+ N
Sbjct: 152 YIWLHDN 158
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 51/243 (20%), Positives = 94/243 (38%), Gaps = 59/243 (24%)
Query: 403 RRTSYLDIQRATNGFNE------CNLLGTGSFGSVYKGT-LFDGTNVAIKVFNL-QLERA 454
R Y D + + LG G + V++ + + V +K+ + ++
Sbjct: 18 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI 77
Query: 455 SRSFDSECEILRSIR-HRNLIKII----SNCCNIDFKALVLEFMPNGSLEKWLYSHN--- 506
R E +IL ++R N+I + ALV E + N ++ +
Sbjct: 78 KR----EIKILENLRGGPNIITLADIVKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYD 131
Query: 507 --YFL-GILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGIS 562
+++ IL+ AL+Y H S ++H D+KP+N+++D E+ + D+G
Sbjct: 132 IRFYMYEILK----------ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-- 176
Query: 563 KLLGEGDDSVIQTMT--IATIGYMAPE-------YGSEGIISPKSDVYSYGILLMETFTR 613
L E Q +A+ + PE Y D++S G +L R
Sbjct: 177 --LAEFYHPG-QEYNVRVASRYFKGPELLVDYQMY------DYSLDMWSLGCMLASMIFR 227
Query: 614 KKP 616
K+P
Sbjct: 228 KEP 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 49/217 (22%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSEC-----EIL-R 466
F+ ++G GSFG V K A+KV LQ + + + + +L +
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAE---EVFYAVKV--LQKKAILKKKEEKHIMSERNVLLK 94
Query: 467 SIRHRNLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-D 520
+++H L+ + + F+ VL+++ G L L FL R +
Sbjct: 95 NVKHPFLVGL--HFS---FQTADKLYFVLDYINGGELFYHLQRERCFL--EPRARFYAAE 147
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTI 578
+ AL YLH S +V+ DLKP NILLD H+ +DFG+ K E + + T T
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTF 199
Query: 579 -ATIGYMAPEYGSEGIISPKS-----DVYSYGILLME 609
T Y+APE ++ + D + G +L E
Sbjct: 200 CGTPEYLAPE-----VLHKQPYDRTVDWWCLGAVLYE 231
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 34/111 (30%), Positives = 50/111 (45%), Gaps = 7/111 (6%)
Query: 206 TSLRRLHLGSNKLTSTMPS-SFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSR 263
L L N+L FG L +++ + L N L + N + + L L
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGE 87
Query: 264 NQLSGDIPTTI-GGLENLETLSLADNQFQGPVPK-SFGSLISLESLDLSRN 312
N++ +I + GL L+TL+L DNQ V SF L SL SL+L+ N
Sbjct: 88 NKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 34/124 (27%), Positives = 52/124 (41%), Gaps = 15/124 (12%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQGLYLHGNKLQGSIP---YDLCH 180
+IP L LN +L + GRL L L L N+L I ++
Sbjct: 26 DIPLHTTEL------LLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFE--G 76
Query: 181 LEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239
+ EL L NK+ + L L+ L+L N+++ MP SF L + +NL++
Sbjct: 77 ASHIQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLAS 135
Query: 240 NSLN 243
N N
Sbjct: 136 NPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 31/93 (33%), Positives = 44/93 (47%), Gaps = 7/93 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
LP+L L L N+L+G PN+ AS + L L N + F L L+ L+L N
Sbjct: 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97
+ + + L+SLT+ L LASNP
Sbjct: 113 QISCVMPGS-FEHLNSLTS------LNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 20/65 (30%), Positives = 28/65 (43%), Gaps = 2/65 (3%)
Query: 257 TNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
T L L+ N+L + G L +L L L NQ G P +F ++ L L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 316 GEIPK 320
EI
Sbjct: 92 -EISN 95
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 51/218 (23%)
Query: 417 FNECNLLGTGSFGSV----YKGTLFDGTNVAIKVFNLQLERASRSFDSEC-----EIL-R 466
FN +LG GSFG V KGT A+K+ L+ + + D EC +L
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVLAL 76
Query: 467 SIRHRNLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-D 520
+ L ++ C F+ V+E++ G L + F +
Sbjct: 77 PGKPPFLTQLH--SC---FQTMDRLYFVMEYVNGGDLMYHIQQVGRFK--EPHAVFYAAE 129
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKL-LGEGDDSVIQTMT 577
+ + L +L S +++ DLK +N++LD H+ +DFG+ K + +G T T
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV----TTKT 180
Query: 578 I-ATIGYMAPEYGSEGIISPKS-----DVYSYGILLME 609
T Y+APE II+ + D +++G+LL E
Sbjct: 181 FCGTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYE 213
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 60/213 (28%), Positives = 87/213 (40%), Gaps = 41/213 (19%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSEC-----EIL-R 466
F +LG GSFG V K T G A+KV L+ + + D EC IL
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKET---GDLYAVKV--LKKDVILQDDDVECTMTEKRILSL 79
Query: 467 SIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMI-DVGLAL 525
+ H L ++ D V+EF+ G L + F R ++ AL
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAEIISAL 137
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKL-LGEGDDSVIQTMTI-ATI 581
+LH +++ DLK +N+LLD H +DFG+ K + G T T T
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGV----TTATFCGTP 188
Query: 582 GYMAPEYGSEGIISPKS-----DVYSYGILLME 609
Y+APE I+ D ++ G+LL E
Sbjct: 189 DYIAPE-----ILQEMLYGPAVDWWAMGVLLYE 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 55/220 (25%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRN 472
F+ ++G GS+ V K T A+KV ++ E + D + ++
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKV--VKKELVNDDEDIDW----VQTEKH 61
Query: 473 LIKIISN--------CCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMI 519
+ + SN C F+ V+E++ G L + E
Sbjct: 62 VFEQASNHPFLVGLHSC---FQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARFYS 116
Query: 520 -DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKL-LGEGDDSVIQT 575
++ LAL YLH +++ DLK +N+LLD H+ +D+G+ K L GD T
Sbjct: 117 AEISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGD----TT 167
Query: 576 MTI-ATIGYMAPEYGSEGIISPKS-----DVYSYGILLME 609
T T Y+APE I+ + D ++ G+L+ E
Sbjct: 168 STFCGTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFE 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 55/220 (25%)
Query: 417 FNECNLLGTGSFGSVY----KGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRN 472
F+ ++G GS+ V K T A++V ++ E + D + ++
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRV--VKKELVNDDEDIDW----VQTEKH 104
Query: 473 LIKIISN--------CCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMI 519
+ + SN C F+ V+E++ G L + E
Sbjct: 105 VFEQASNHPFLVGLHSC---FQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARFYS 159
Query: 520 -DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV--SDFGISKL-LGEGDDSVIQT 575
++ LAL YLH +++ DLK +N+LLD H+ +D+G+ K L GD T
Sbjct: 160 AEISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGD----TT 210
Query: 576 MTI-ATIGYMAPEYGSEGIISPKS-----DVYSYGILLME 609
T T Y+APE I+ + D ++ G+L+ E
Sbjct: 211 STFCGTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFE 245
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-11
Identities = 36/136 (26%), Positives = 61/136 (44%), Gaps = 19/136 (13%)
Query: 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGN---KLCGHVPPCLASLTSLRRLHLGSNKLT 219
L+ ++ + L L+ L L+ N K+ L+ + +LR L LG N +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLIK 83
Query: 220 --STMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLS--GDIPTTIG 275
+ + +LE + +S N + SL S I+ L L L +S N+++ G+I +
Sbjct: 84 KIENLDAVADTLEE---LWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLA 137
Query: 276 GLENLETLSLADNQFQ 291
L+ LE L LA N
Sbjct: 138 ALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 25/134 (18%), Positives = 47/134 (35%), Gaps = 38/134 (28%)
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
EL+ + + L++L + + L L +N +
Sbjct: 29 ELHGMIPPI-EKMDATLSTLKACKHLALSTNNIEKI------------------------ 63
Query: 246 LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLEN----LETLSLADNQFQGPVPKSFGSL 301
S++ ++ L L L RN + I L+ LE L ++ NQ L
Sbjct: 64 --SSLSGMENLRILSLGRNLI-----KKIENLDAVADTLEELWISYNQIA--SLSGIEKL 114
Query: 302 ISLESLDLSRNNLS 315
++L L +S N ++
Sbjct: 115 VNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 27/94 (28%), Positives = 40/94 (42%), Gaps = 9/94 (9%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
+ NL+ L+L N + I N A L L +S N + L + L +L+VL ++
Sbjct: 68 GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSN 124
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97
N + W + L L L LA NPL
Sbjct: 125 NKI------TNWGEIDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 40/193 (20%), Positives = 72/193 (37%), Gaps = 51/193 (26%)
Query: 31 KLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVL 90
+ + L + L + + L+L+ N + +SSL+ NL +L
Sbjct: 26 EKVELHGMIPPIEKMDAT-LSTLKACKHLALSTNNIEK---------ISSLSGMENLRIL 75
Query: 91 GLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTI 150
L N ++ I + + +L+E + + N +I +LSG+
Sbjct: 76 SLGRNLIKKIEN--LDAVADTLEELW-----ISYN---QIASLSGI-------------- 111
Query: 151 PTAVGRLRRLQGLYLHGNKLQ--GSIPYDLCHLEGLSELNLNGNKLCGHVPPC------- 201
+L L+ LY+ NK+ G I L L+ L +L L GN L
Sbjct: 112 ----EKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGNPLYNDYKENNATSEYR 166
Query: 202 ---LASLTSLRRL 211
+ L +L++L
Sbjct: 167 IEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 23/91 (25%), Positives = 39/91 (42%), Gaps = 12/91 (13%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L K+L L N + I + ++ L +L L N I N +L+ L ++YN
Sbjct: 47 LKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYN 103
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASN 95
+ + LS + NL VL +++N
Sbjct: 104 QIAS---------LSGIEKLVNLRVLYMSNN 125
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 37/109 (33%), Positives = 51/109 (46%), Gaps = 4/109 (3%)
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRN 264
+S RL L SNKL S F L + ++LS N + SLP + L LT L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 265 QLSGDIPTTI-GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312
+L +P + L L+ L+L NQ + F L SL+ + L N
Sbjct: 87 KLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 32/106 (30%), Positives = 43/106 (40%), Gaps = 2/106 (1%)
Query: 161 QGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTS 220
L L NKLQ L L++L+L+ N++ LT L L+L NKL S
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS 90
Query: 221 TMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRNQ 265
F L + + L N L S+P I L L + L N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 24/76 (31%), Positives = 31/76 (40%), Gaps = 3/76 (3%)
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
S+P+ I + T L+L N+L L L LSL+ NQ Q F L L
Sbjct: 21 SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78
Query: 305 ESLDLSRNNLSGEIPK 320
L L N L +P
Sbjct: 79 TILYLHENKLQ-SLPN 93
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 36/129 (27%), Positives = 54/129 (41%), Gaps = 29/129 (22%)
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
EL L+GN+ VP L++ L + L +N++++ SF
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSF------------------- 74
Query: 246 LPSNIQNLKVLTNLDLSRNQLSGDIPTTI-GGLENLETLSLADNQFQGPVPK-SFGSLIS 303
N+ L L LS N+L IP GL++L LSL N VP+ +F L +
Sbjct: 75 -----SNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSA 127
Query: 304 LESLDLSRN 312
L L + N
Sbjct: 128 LSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 2/84 (2%)
Query: 237 LSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPK 296
L N +P + N K LT +DLS N++S + + L TL L+ N+ + P+
Sbjct: 38 LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPR 96
Query: 297 SFGSLISLESLDLSRNNLSGEIPK 320
+F L SL L L N++S +P+
Sbjct: 97 TFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 27/118 (22%), Positives = 51/118 (43%), Gaps = 11/118 (9%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC-HLEG 183
IP+++ L L+G +P + + L + L N++ ++ ++
Sbjct: 28 GIPRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 184 LSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
L L L+ N+L +PP L SLR L L N ++ +F L + ++ + AN
Sbjct: 80 LLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 20/71 (28%), Positives = 35/71 (49%), Gaps = 3/71 (4%)
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
LP I + +T L L NQ + +P + ++L + L++N+ +SF ++ L
Sbjct: 24 VLPKGIP--RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 305 ESLDLSRNNLS 315
+L LS N L
Sbjct: 81 LTLILSYNRLR 91
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 25/92 (27%), Positives = 40/92 (43%), Gaps = 8/92 (8%)
Query: 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMT 68
L L N+ + +P ++N L ++DLS+N S L +F N+ L L L+YN L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 69 ESSAAKWNFLSSLTNCRNLTVLGLASNPLRGI 100
L +L +L L N + +
Sbjct: 93 IPPRT----FDGLK---SLRLLSLHGNDISVV 117
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
+L + L +N++S S +N ++L+ L LS N + P TF L SL++LSL N
Sbjct: 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGN 112
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97
+ S + F + L+ L + +NPL
Sbjct: 113 DI---SVVPEGAF----NDLSALSHLAIGANPL 138
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 40/213 (18%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVF--NLQLERASRSFDSECEILRSIRHR---NLI 474
+L+G GSFG V K + VAIK+ ++ E +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---EVRLLELMNKHDTEMKY 116
Query: 475 KIISNCCNIDFKA---LVLEFMPNGSLEKWLYS---HNYFLGILERL--NIMIDVGLALE 526
I+ + F+ LV E L LY + F G+ L + AL
Sbjct: 117 YIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAH--VSDFGISKLLGEGDDSVIQTMTIATIGYM 584
+L + ++HCDLKP NILL + + DFG S LG+ IQ+ Y
Sbjct: 172 FLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YR 225
Query: 585 APEYGSEGII-----SPKSDVYSYGILLMETFT 612
+PE ++ D++S G +L+E T
Sbjct: 226 SPE-----VLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 16/72 (22%), Positives = 28/72 (38%), Gaps = 1/72 (1%)
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPT-TIGGLENLETLSLADNQFQGPVPKSFGSLIS 303
++ + LT L + Q + + GL L L++ + + P +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 304 LESLDLSRNNLS 315
L L+LS N L
Sbjct: 82 LSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 1e-09
Identities = 27/95 (28%), Positives = 38/95 (40%), Gaps = 2/95 (2%)
Query: 173 SIPYDLCHLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEY 231
+ L E L+EL + + H+ L L LR L + + L P +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 232 VLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQL 266
+ +NLS N+L SL L L LS N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 21/95 (22%), Positives = 38/95 (40%), Gaps = 9/95 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPN-SITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
NL L + + + + + +L L + + + P+ F L L+L++
Sbjct: 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLR 98
N L + S W + L +L L L+ NPL
Sbjct: 90 NALESLS----WKTVQGL----SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 21/101 (20%), Positives = 35/101 (34%), Gaps = 2/101 (1%)
Query: 215 SNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSN-IQNLKVLTNLDLSRNQLSGDIPTT 273
+ E + + + L ++ L L NL + ++ L P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 274 IGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
L L+L+ N + K+ L SL+ L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 18/97 (18%), Positives = 32/97 (32%), Gaps = 4/97 (4%)
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPT-AVGRLRRLQGLYLHGNKLQGSIPYD-LCHLE 182
+ + + + + + L L+ L + + L+ + D
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 183 GLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLT 219
LS LNL+ N L + SL+ L L N L
Sbjct: 81 RLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 3e-05
Identities = 15/95 (15%), Positives = 30/95 (31%), Gaps = 8/95 (8%)
Query: 16 NKLSGTIPNSITNASKLIMLDLSSNSFSGLIPN-TFGNLGSLQVLSLAYNYLMTESSAAK 74
+ + + A L L + + + LG L+ L++ + L + A
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA- 75
Query: 75 WNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFS 109
L+ L L+ N L + + S
Sbjct: 76 ------FHFTPRLSRLNLSFNALESLSWKTVQGLS 104
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 25/119 (21%), Positives = 35/119 (29%), Gaps = 25/119 (21%)
Query: 76 NFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSG 135
+ L L NLT L + + L + L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLEL--RDLR----------------------GLGE 57
Query: 136 MIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKL 194
+ + L P A RL L L N L+ S+ + L EL L+GN L
Sbjct: 58 LRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 42/316 (13%), Positives = 94/316 (29%), Gaps = 61/316 (19%)
Query: 8 LKYLTLFDNKLSG----TIPNSITNASKLIMLDLSSNSFSG----LIPNTFGNLGSLQVL 59
++ +L + ++ ++ + + + LS N+ + + L++
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 60 SLAYNY---LMTESSAAKWNFLSSLTNCRNLTVLGLASNPL-----RGILPPLIGNFSAS 111
+ + + E A L +L C L + L+ N ++ L +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH--TP 123
Query: 112 LQEFYAYGCKL-------------RGNIPQEIGNLSGMIVFDLNGCDLNG----TIPTAV 154
L+ Y + L + ++ N + L
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 155 GRLRRLQGLYLHGNKL-----QGSIPYDLCHLEGLSELNLNGNKL----CGHVPPCLASL 205
R L + + N + + + L + + L L+L N + L S
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 206 TSLRRLHLGSNKLTST---------MPSSFGSLEYVLYINLSANSLNGSLPSNI-----Q 251
+LR L L L++ L+ + L N + + +
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ---TLRLQYNEIELDAVRTLKTVIDE 300
Query: 252 NLKVLTNLDLSRNQLS 267
+ L L+L+ N+ S
Sbjct: 301 KMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 48/304 (15%), Positives = 86/304 (28%), Gaps = 60/304 (19%)
Query: 55 SLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQE 114
S++ SL + + TE + + L ++ + L+ N IG +A
Sbjct: 5 SIEGKSLKLDAITTEDEKS---VFAVLLEDDSVKEIVLSGNT--------IGTEAAR--- 50
Query: 115 FYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNG--TIPTAVGRLRRLQGLYLHGNKLQG 172
+ EI S + + + A+ + +L + L N
Sbjct: 51 --WLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 108
Query: 173 SIPYDLCHL----EGLSELNLNGNKL-------------CGHVPPCLASLTSLRRLHLGS 215
+ L L L L+ N L V + LR + G
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 216 NKLT-------STMPSSFGSLEYVLYINLSANSLN-----GSLPSNIQNLKVLTNLDLSR 263
N+L + S L + + N + L + + L LDL
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHT---VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225
Query: 264 NQLSGD----IPTTIGGLENLETLSLADNQFQGPVPKSFGSLI------SLESLDLSRNN 313
N + + + NL L L D + L++L L N
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285
Query: 314 LSGE 317
+ +
Sbjct: 286 IELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 32/213 (15%), Positives = 66/213 (30%), Gaps = 39/213 (18%)
Query: 160 LQGLYLHGNKLQG----SIPYDLCHLEGLSELNLNGNKL----CGHVPPCLASLTSLRRL 211
++G L + + S+ L + + E+ L+GN + + +AS L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 212 HLGSN---KLTSTMPSSFGSLEYVL-------YINLSANSLNG----SLPSNIQNLKVLT 257
++ +P + L L + LS N+ L + L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 258 NLDLSRNQLS-------------GDIPTTIGGLENLETLSLADNQFQGP----VPKSFGS 300
+L L N L + L ++ N+ + K+F S
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 301 LISLESLDLSRNNLSGEIPKNFSAQSFLSNYAL 333
L ++ + +N + E ++ + L
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 48/225 (21%), Positives = 80/225 (35%), Gaps = 50/225 (22%)
Query: 422 LLGTGSFGSVYKG--TLFDGTNVAIKVF--NLQLERASRSFDSECEILRSIRHR---NLI 474
LG G+FG V + + VA+K+ + A+R E +L+ I+ + N
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENKF 82
Query: 475 KIISNCCNIDFKA---LVLEFMPNGSLEKWLYS---HNYFLGILERL--NIMIDVGLALE 526
+ +F + E L K + N F ++ + AL
Sbjct: 83 LCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI------------Q 574
+LH + H DLKP NIL + + + S ++ I +
Sbjct: 138 FLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194
Query: 575 TMT--IATIGYMAPEYGSEGII-----SPKSDVYSYGILLMETFT 612
T +AT Y PE +I + DV+S G +L E +
Sbjct: 195 HHTTIVATRHYRPPE-----VILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 62/233 (26%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVF--NLQLERASRSFDSECEILRSIRHRNLIKIIS 478
+G G+FG V + + A+KV + R+++ E +IL+ I++ ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINN--N 96
Query: 479 NCCNI----DFKA---LVLEFMPNGSLEKWLYSHNYFLGILERL--NIMIDVGLALEYLH 529
N + L+ E + SL + + +N + G I++ AL YL
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLR 154
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVS-------------------------DFGISKL 564
+ H DLKP NILLD+ DFG +
Sbjct: 155 KMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 565 LGEGDDSVIQTMTIATIGYMAPEYGSEGII-----SPKSDVYSYGILLMETFT 612
+ S+I T Y APE +I SD++S+G +L E +T
Sbjct: 212 KSDYHGSIINTRQ-----YRAPE-----VILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 15/149 (10%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLI-KIISNC 480
+G G+FG + G L+ VAIK+ ++ + E + + + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 481 CNIDFKALVLEFMPNG-SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539
+ A+VLE + G SLE + + L I I + +EY+H S +++
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129
Query: 540 DLKPNNILL-----DENMTAHVSDFGISK 563
D+KP N L+ H+ DF ++K
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 8/114 (7%)
Query: 202 LASLTSLRRLHLGSNKLTST--MPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNL 259
+ R L L K+ + ++ + I+ S N + L L+ L L
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGATLDQFDA---IDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 260 DLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP-KSFGSLISLESLDLSRN 312
++ N++ L +L L L +N SL SL L + RN
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 8/97 (8%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+G L + DN++ + +L L +++N + L L L
Sbjct: 37 LGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97
L N L + L L + ++LT L + NP+
Sbjct: 95 LTNNSL------VELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 36/144 (25%), Positives = 54/144 (37%), Gaps = 31/144 (21%)
Query: 79 SSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIV 138
+ TN L L + P+I N A+L +F A N +++
Sbjct: 13 AQYTNAVRDRELDLRGYKI-----PVIENLGATLDQFDA--IDFSDNEIRKLDGFP---- 61
Query: 139 FDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLC--G 196
LRRL+ L ++ N++ L L+EL L N L G
Sbjct: 62 -----------------LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104
Query: 197 HVPPCLASLTSLRRLHLGSNKLTS 220
+ P LASL SL L + N +T+
Sbjct: 105 DLDP-LASLKSLTYLCILRNPVTN 127
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 23/108 (21%), Positives = 38/108 (35%), Gaps = 25/108 (23%)
Query: 157 LRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSN 216
L + + N+++ + L L L +N N++C +L L L L +N
Sbjct: 41 LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
Query: 217 KLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRN 264
L G L+ + +LK LT L + RN
Sbjct: 99 SL-----VELGDLDP------------------LASLKSLTYLCILRN 123
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 49/230 (21%), Positives = 81/230 (35%), Gaps = 60/230 (26%)
Query: 422 LLGTGSFGSVYKG--TLFDGTNVAIKVF--NLQLERASRSFDSECEILRSIRHR---NLI 474
LG G+FG V + G +VA+K+ + A+RS E ++L + +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNSTF 77
Query: 475 KIISNCCNIDFKA---LVLEFMPNGSLEKWLYS---HNYFLGILERL--NIMIDVGLALE 526
+ + + +V E L Y N FL + + ++
Sbjct: 78 RCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132
Query: 527 YLHHGHSTPMVHCDLKPNNILLDENMTAHVS-------------------DFGISKLLGE 567
+LH + H DLKP NIL ++ DFG + E
Sbjct: 133 FLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189
Query: 568 GDDSVIQTMTIATIGYMAPEYGSEGII-----SPKSDVYSYGILLMETFT 612
+++ T Y APE +I S DV+S G +L+E +
Sbjct: 190 HHSTLVSTRH-----YRAPE-----VILALGWSQPCDVWSIGCILIEYYL 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLI-KIISNC 480
+G+GSFG +Y GT + G VAIK+ ++ + E +I + ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 481 CNIDFKALVLEFMPNG-SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539
D+ +V+E + G SLE + + L + + +EY+H S +H
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 540 DLKPNNILLDENMTAH---VSDFGISK 563
D+KP+N L+ + + DFG++K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 33/149 (22%), Positives = 59/149 (39%), Gaps = 15/149 (10%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLI-KIISNC 480
+G GSFG +++GT L + VAIK + + E + + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 481 CNIDFKALVLEFMPNG-SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539
LV++ + G SLE L + + ++ +H +V+
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130
Query: 540 DLKPNNILLDENMTA-----HVSDFGISK 563
D+KP+N L+ + +V DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 13/147 (8%)
Query: 423 LGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLI-KIISNC 480
+G+GSFG +Y GT + VAIK+ N++ + E +I R ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 481 CNIDFKALVLEFMPNG-SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539
D+ LV++ + G SLE + L + L + + +E++H S +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127
Query: 540 DLKPNNILLDENMTAH---VSDFGISK 563
D+KP+N L+ A+ + DFG++K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 29/135 (21%), Positives = 48/135 (35%), Gaps = 28/135 (20%)
Query: 180 HLEGLSELNLNGNKL-CGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
+ EL L+ ++ G + L L + LTS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI----------------- 57
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGP-VPKS 297
+N+ L L L+LS N++SG + NL L+L+ N+ + +
Sbjct: 58 ---------ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
Query: 298 FGSLISLESLDLSRN 312
L +L+SLDL
Sbjct: 109 LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-08
Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 8/93 (8%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L++L+ + L+ +I N + +KL L+LS N SG + +L L+L+ N
Sbjct: 41 FEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97
+ + + L NL L L + +
Sbjct: 99 KI------KDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-06
Identities = 26/128 (20%), Positives = 46/128 (35%), Gaps = 26/128 (20%)
Query: 137 IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCG 196
+V D + + G + L+ L L SI +L L L +L L+ N++ G
Sbjct: 22 LVLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSG 78
Query: 197 HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVL 256
+ +L L+L NK+ ++E ++ L+ L
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEP------------------LKKLENL 115
Query: 257 TNLDLSRN 264
+LDL
Sbjct: 116 KSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 21/85 (24%), Positives = 32/85 (37%), Gaps = 9/85 (10%)
Query: 235 INLSANSLN-GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLE---NLETLSLADNQF 290
+ L + N G L + L L L T+I L L+ L L+DN+
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKLELSDNRV 76
Query: 291 QGPVPKSFGSLISLESLDLSRNNLS 315
G + +L L+LS N +
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 31/170 (18%), Positives = 66/170 (38%), Gaps = 37/170 (21%)
Query: 422 LLGTGSFGSVYKGTLFDGTNVAIKVF---------NLQLERASRSF---DSECEILRSIR 469
+G G FG +Y + +V N L + + +I + IR
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 470 HRNLIKI---------ISNCCNIDFKALVLEFMPNG-SLEKWLYSHNYFLGILERLNI-- 517
R L + + + ++ ++++ G L+K ++ L +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 518 -MIDVGLALEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISK 563
++D+ LEY+H VH D+K +N+LL + + ++ D+G++
Sbjct: 160 RILDI---LEYIHEHE---YVHGDIKASNLLLNYKNPD-QVYLVDYGLAY 202
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-08
Identities = 32/134 (23%), Positives = 48/134 (35%), Gaps = 28/134 (20%)
Query: 181 LEGLSELNLNGNKLC-GHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239
+ EL L+ K G + A +L L L + L S
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV------------------ 64
Query: 240 NSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP-KSF 298
SN+ L L L+LS N++ G + L NL L+L+ N+ + +
Sbjct: 65 --------SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116
Query: 299 GSLISLESLDLSRN 312
L L+SLDL
Sbjct: 117 KKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-08
Identities = 24/94 (25%), Positives = 39/94 (41%), Gaps = 8/94 (8%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
NL++L+L + L ++ N + KL L+LS N G + L +L L+L+
Sbjct: 47 EFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSG 104
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL 97
N L + L L L L L + +
Sbjct: 105 NKL------KDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 9e-07
Identities = 30/132 (22%), Positives = 50/132 (37%), Gaps = 26/132 (19%)
Query: 136 MIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLC 195
+V D + G I L+ L L L S+ +L L L +L L+ N++
Sbjct: 28 ELVLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIF 84
Query: 196 GHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKV 255
G + L +L L+L NKL +LE ++ L+
Sbjct: 85 GGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEP------------------LKKLEC 121
Query: 256 LTNLDLSRNQLS 267
L +LDL +++
Sbjct: 122 LKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 20/85 (23%), Positives = 31/85 (36%), Gaps = 9/85 (10%)
Query: 235 INLSANSLN-GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLE---NLETLSLADNQF 290
+ L N G + L L L L ++ L L+ L L++N+
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKLELSENRI 83
Query: 291 QGPVPKSFGSLISLESLDLSRNNLS 315
G + L +L L+LS N L
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 3/67 (4%)
Query: 156 RLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLC--GHVPPCLASLTSLRRLHL 213
+L +L+ L L N++ G + L L+ LNL+GNKL + P L L L+ L L
Sbjct: 69 KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDL 127
Query: 214 GSNKLTS 220
+ ++T+
Sbjct: 128 FNCEVTN 134
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 36/170 (21%), Positives = 67/170 (39%), Gaps = 40/170 (23%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNL------QLERASRSF---DSECEILRSIRHR 471
+G+G FG +Y A V + L + + + I + I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 472 NLIKI---------ISNCCNIDFKALVLEFMPNG-SLEKWLYSHNYF-----LGILERLN 516
L + ++ ++ +V+E + G L+K + F L + R
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIR-- 159
Query: 517 IMIDVGLALEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISK 563
M+DV LEY+H VH D+K N+LL + + +++D+G+S
Sbjct: 160 -MLDV---LEYIHENE---YVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 46/283 (16%), Positives = 93/283 (32%), Gaps = 47/283 (16%)
Query: 81 LTNCRNLTVLGLASNPL-----RGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIG---- 131
+ +T L L+ N L ++ AS+ G L E+
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANT-PASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 132 -NLSGMIVFDLNGCDLNGTIPTAVGRL-----RRLQGLYLHGNKLQGSIPYDLCHL---- 181
+ + +L+G L+ + + + L L N +
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 182 -EGLSELNLNGNKL----CGHVPPCLASL-TSLRRLHLGSNKLTSTMPSSFGSL-----E 230
++ LNL GN L + LA++ ++ L+L N L S +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 231 YVLYINLSANSLNGSLPSNI-----QNLKVLTNLDLSRNQLSGD----IPTTIGGLENLE 281
V ++LSAN L + + + +L+L N L G + L++L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 282 TLSLADNQFQGPVPK-------SFGSLISLESLDLSRNNLSGE 317
T+ L + + + +F ++ + +D + +
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 54/335 (16%), Positives = 105/335 (31%), Gaps = 52/335 (15%)
Query: 30 SKLIMLDLSSNSFS-----GLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84
+ LDLS N+ LI S+ L+L+ N L ++S L++
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA--IP 79
Query: 85 RNLTVLGLASNPLRGI----LPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNL-----SG 135
N+T L L+ N L L + ++ E +
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 136 MIVFDLNGCDLNGTIPTAVGRL-----RRLQGLYLHGNKLQGSIPYDLCHL-----EGLS 185
+ +L G DL + ++ + L L GN L +L ++
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT 199
Query: 186 ELNLNGNKL----CGHVPPCLASL-TSLRRLHLGSNKLTST----MPSSFGSLEYVLYIN 236
L+L+ N L + +S+ + L+L N L + SL+++ +
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259
Query: 237 LSANSLNG-------SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGL-----ENLETLS 284
L + + +L + N++ + +D + ++ I L + S
Sbjct: 260 LDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPS 319
Query: 285 LADN-----QFQGPVPKSFGSLISLESLDLSRNNL 314
L + Q + L + L
Sbjct: 320 LLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 34/154 (22%), Positives = 48/154 (31%), Gaps = 26/154 (16%)
Query: 187 LNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSL-----EYVLYINLSANS 241
L + V + + L L N L S V +NLS NS
Sbjct: 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS 62
Query: 242 LNGS--------LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGL-----ENLETLSLADN 288
L L + N+ T+L+LS N LS + + L L N
Sbjct: 63 LGFKNSDELVQILAAIPANV---TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWN 119
Query: 289 QFQGPVPKSFGSLI-----SLESLDLSRNNLSGE 317
F F S+ SL+L N+L +
Sbjct: 120 DFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK 153
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 24/155 (15%), Positives = 51/155 (32%), Gaps = 18/155 (11%)
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGS-----LEYV-LY 234
L+ + LN K ++ +L+ L + S L ++ LE + LY
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 235 INLSANSLNGSLPS-----NIQNLKVLTNLDLSRNQLSGDIPTTIGG---LENLETLSLA 286
+ + +G + + L L + + + L LET+ ++
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 287 DNQFQG----PVPKSFGSLISLESLDLSRNNLSGE 317
+ + L+ +++ N LS E
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 4e-05
Identities = 28/150 (18%), Positives = 56/150 (37%), Gaps = 20/150 (13%)
Query: 140 DLNGCDLNGTIPTAVGRLR--RLQGLYLHGNKLQGSIPYDL--CHLEGLSELNL------ 189
LN + GT ++G+ L+ L + L S+ D+ L L +L L
Sbjct: 173 LLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVED 232
Query: 190 -NGNKLCGHVPPCLA--SLTSLRRLHLGSNKLTSTMPSSFGS---LEYVLYINLSANSLN 243
+ P + +L+ L + + + + F L + +++SA L
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 244 GS----LPSNIQNLKVLTNLDLSRNQLSGD 269
L ++ +K L +++ N LS +
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 4e-04
Identities = 11/75 (14%), Positives = 27/75 (36%), Gaps = 7/75 (9%)
Query: 155 GRLRRLQGLYLHGNKLQGSIPYDLCH---LEGLSELNLNGNKLCG----HVPPCLASLTS 207
R L+ L + + Q + L L ++++ L + + +
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 208 LRRLHLGSNKLTSTM 222
L+ +++ N L+ M
Sbjct: 309 LKFINMKYNYLSDEM 323
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 28/166 (16%), Positives = 57/166 (34%), Gaps = 31/166 (18%)
Query: 423 LGTGSFGSVYKGT---------LFDGTNVAIKV--FNLQLERASRSFDSECEI------- 464
+ G +Y+ ++K+ + +L F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 465 -LRSIRHRNLIKIISNCCNID-FKALVLEFMPNG-SLEK-WLYSHNYFLGILERLNIMID 520
L S + + + D ++ LVL + G SL+ S + L L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISK 563
+ ALE+LH VH ++ NI + D++ ++ +G +
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQS-QVTLAGYGFAF 209
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 52/255 (20%), Positives = 84/255 (32%), Gaps = 76/255 (29%)
Query: 423 LGTGSFGSVYKG-TLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC 481
LG G F +V+ + VA+KV E + + E +L+S+R+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 482 NI---DFK---------ALVLEFMPNG-SLEKWLYSHNYFLGILERL--NIMIDVGLALE 526
DFK +V E + G L KW+ NY G+ I+ V L+
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQ-GLPLPCVKKIIQQVLQGLD 160
Query: 527 YLHHGHSTPMVHCDLKPNNILL-------------------------------------- 548
YLH ++H D+KP NILL
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 549 -----------DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPK 597
E + ++D G + + + IQT Y + E +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273
Query: 598 SDVYSYGILLMETFT 612
+D++S + E T
Sbjct: 274 ADIWSTACMAFELAT 288
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 14/95 (14%)
Query: 150 IPTAVGRLRRLQGLYLHGNKLQGSIP---YDLCHLEGLSELNLNGNKLCGHVPP-CLASL 205
IPT Q LYL+ N++ + +D L L+ L+L+ N+L +P L
Sbjct: 28 IPT------TTQVLYLYDNQIT-KLEPGVFD--RLTQLTRLDLDNNQL-TVLPAGVFDKL 77
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
T L +L L N+L S +F +L+ + +I L N
Sbjct: 78 TQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRN 264
T+ + L+L N++T P F L + ++L N L LP+ + L LT L L+ N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
Query: 265 QLSGDIPTTI-GGLENLETLSLADN 288
QL IP L++L + L +N
Sbjct: 89 QLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 24/80 (30%), Positives = 32/80 (40%), Gaps = 3/80 (3%)
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
++ S SL S+P+ I L L NQ++ P L L L L +NQ
Sbjct: 14 VDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLP 70
Query: 295 PKSFGSLISLESLDLSRNNL 314
F L L L L+ N L
Sbjct: 71 AGVFDKLTQLTQLSLNDNQL 90
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 27/80 (33%), Positives = 38/80 (47%), Gaps = 2/80 (2%)
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
L L N++ P LT L RL L +N+LT F L + ++L+ N L S
Sbjct: 34 VLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK-S 92
Query: 246 LPSNI-QNLKVLTNLDLSRN 264
+P NLK LT++ L N
Sbjct: 93 IPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNI-QNLKVLTNLDLSRN 264
T +RL L +N++T P F L + + ++N L ++P+ + L LT LDL+ N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91
Query: 265 QLSGDIPTTI-GGLENLETLSLADN 288
L IP L++L + L +N
Sbjct: 92 HLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 14/95 (14%)
Query: 150 IPTAVGRLRRLQGLYLHGNKLQGSIP---YDLCHLEGLSELNLNGNKLCGHVPP-CLASL 205
IPT Q L+L+ N++ + +D HL L +L N NKL +P L
Sbjct: 31 IPT------DKQRLWLNNNQIT-KLEPGVFD--HLVNLQQLYFNSNKL-TAIPTGVFDKL 80
Query: 206 TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240
T L +L L N L S +F +L+ + +I L N
Sbjct: 81 TQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 23/80 (28%), Positives = 33/80 (41%), Gaps = 3/80 (3%)
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
+N L S+P+ I L L+ NQ++ P L NL+ L N+
Sbjct: 17 VNCQNIRLA-SVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIP 73
Query: 295 PKSFGSLISLESLDLSRNNL 314
F L L LDL+ N+L
Sbjct: 74 TGVFDKLTQLTQLDLNDNHL 93
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 27/80 (33%), Positives = 41/80 (51%), Gaps = 2/80 (2%)
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245
L LN N++ P L +L++L+ SNKLT+ F L + ++L+ N L S
Sbjct: 37 RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLK-S 95
Query: 246 LPSNI-QNLKVLTNLDLSRN 264
+P NLK LT++ L N
Sbjct: 96 IPRGAFDNLKSLTHIYLYNN 115
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 42/236 (17%), Positives = 86/236 (36%), Gaps = 22/236 (9%)
Query: 5 LPNLKYLTLFDNKLS-GTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
++++ L ++ + T+ ++ SKL L L S I NT +L L+L+
Sbjct: 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151
Query: 64 NYLMTESSAAKWNFLSSL-TNCRNLTVLGLASNPL---RGILPPLIGNFSASLQEFYAYG 119
+E + L +L ++C L L L+ + + + + S ++ + G
Sbjct: 152 CSGFSEFA------LQTLLSSCSRLDELNLSWCFDFTEKHVQ-VAVAHVSETITQLNLSG 204
Query: 120 CKLR---GNIPQEIGNLSGMIVFDLNGCD-LNGTIPTAVGRLRRLQGLYLHG-NKLQGSI 174
+ ++ + ++ DL+ L +L LQ L L +
Sbjct: 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET 264
Query: 175 PYDLCHLEGLSELNLNGNKLCGHVPPCLASL-TSLRRLHLGSNKLTSTMPSSFGSL 229
+L + L L + G G L L +L L + + T+ + G+
Sbjct: 265 LLELGEIPTLKTLQVFGIVPDG----TLQLLKEALPHLQINCSHFTTIARPTIGNK 316
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 43/191 (22%), Positives = 70/191 (36%), Gaps = 29/191 (15%)
Query: 140 DLNGCDLN-GTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG-----NK 193
DL+ + T+ + + +LQ L L G +L I L L LNL+G
Sbjct: 99 DLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF 158
Query: 194 LCGHVPPCLASLTSLRRLHLGS-NKLTSTMPSSFGSLEYVL--------YINLSANSLN- 243
+ L+S + L L+L T ++ + +NLS N
Sbjct: 159 ALQTL---LSSCSRLDELNLSWCFDFTEK------HVQVAVAHVSETITQLNLSGYRKNL 209
Query: 244 --GSLPSNIQNLKVLTNLDLSR-NQLSGDIPTTIGGLENLETLSLADNQFQGPV-PKSFG 299
L + ++ L +LDLS L D L L+ LSL+ P G
Sbjct: 210 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 269
Query: 300 SLISLESLDLS 310
+ +L++L +
Sbjct: 270 EIPTLKTLQVF 280
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 40/347 (11%), Positives = 95/347 (27%), Gaps = 46/347 (13%)
Query: 6 PNLKYLTLFDNKLSGTIPNSI----TNASKLIMLDLSSNSFSGLIPNTFGNLG----SLQ 57
+K L + ++ S + + + L +L+ F+ + P + SL
Sbjct: 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223
Query: 58 VLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYA 117
+ + ++ F + N L + P ++
Sbjct: 224 SVKVGDFEILELVG-----FFKAAANLEEFCGGSLNEDIGM----PEKYMNLVFPRKLCR 274
Query: 118 YGCKLRGN--IPQEIGNLSGMIVFDLNGCDLNG-TIPTAVGRLRRLQGLYLHGNKLQGSI 174
G G +P + + DL L T + + L+ L +
Sbjct: 275 LGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGL 334
Query: 175 PYDLCHLEGLSELNLNGNKLCGHVPPCLASLT------------SLRRLHLGSNKLT--- 219
+ + L L + + ++ L + + + +T
Sbjct: 335 EVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNES 394
Query: 220 -STMPSSFGSLEYVLYINLSANS------LNGSLPSNIQNLKVLTNLDLSRN--QLSGDI 270
++ + +L + L L+ + S + K L L+
Sbjct: 395 LESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454
Query: 271 PTTIG-GLENLETLSLADNQFQGP-VPKSFGSLISLESLDLSRNNLS 315
+ IG N+ + L + + +L+ L++ S
Sbjct: 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 36/243 (14%), Positives = 68/243 (27%), Gaps = 15/243 (6%)
Query: 83 NCRNLTVLGLASNPLR-GILPPLIGNFSASLQEFYAYGCKLRGN--IPQEIGNLSGMIVF 139
N R L + + L L + L+ C + + + +
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTL 169
Query: 140 DLNGCDLNGTIPTAVGRL----RRLQGLYLHGNKLQGSIPYDLCHL----EGLSELNLNG 191
+ + + L L+ L + + P DL + L + +
Sbjct: 170 LMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGD 229
Query: 192 NKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL--NGSLPSN 249
++ V + +L GS MP + +L + + S +P
Sbjct: 230 FEILELVG-FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPIL 288
Query: 250 IQNLKVLTNLDLSRNQLSGDIPTT-IGGLENLETLSLADNQFQGPVPKSFGSLISLESLD 308
+ LDL L + T I NLE L + + L+ L
Sbjct: 289 FPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLR 348
Query: 309 LSR 311
+ R
Sbjct: 349 IER 351
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 33/249 (13%), Positives = 63/249 (25%), Gaps = 30/249 (12%)
Query: 80 SLTNCRNLTVLGLASNPLRGILPPLIGNFSAS---LQEFYAYGCKLRGNIPQEI--GNLS 134
L + L G + P + S + L+ + + +
Sbjct: 79 KLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARAD 138
Query: 135 GMIVFDLNGCDL--NGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHL----EGLSELN 188
+ L+ C + + V R+++ L + + L L L LN
Sbjct: 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLN 198
Query: 189 LNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPS 248
+ + S L + L S + +
Sbjct: 199 FYMTE-FAKI-----SPKDLETIARNCRSLVS------------VKVGDFEILELVGFFK 240
Query: 249 NIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLD 308
NL+ L+ + + + L L L+ +P F + LD
Sbjct: 241 AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLD 299
Query: 309 LSRNNLSGE 317
L L E
Sbjct: 300 LLYALLETE 308
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 31/240 (12%), Positives = 69/240 (28%), Gaps = 36/240 (15%)
Query: 80 SLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGM--- 136
L++C + GLA+ I +L+E + + +
Sbjct: 136 VLSSCEGFSTDGLAA----------IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185
Query: 137 -IVFDLNGCDLNGT---IPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGN 192
+ +++ + + V R L+ L L+ + L L EL G
Sbjct: 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245
Query: 193 KLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQN 252
+ S + + + + ++ +++ LP+
Sbjct: 246 T------------------AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSV 287
Query: 253 LKVLTNLDLSRNQLSGD-IPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSR 311
LT L+LS + + + L+ L + D + + L L +
Sbjct: 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFP 347
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 43/252 (17%), Positives = 76/252 (30%), Gaps = 37/252 (14%)
Query: 80 SLTNCRNLTVLGLASNPLRGILPPLIGNFSA---SLQEFYAYGCKLRGNIPQEIG-NLSG 135
L + L + G + P I S+ L+E + + + I +
Sbjct: 72 ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKN 131
Query: 136 MIVFDLNGCDL--NGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLE----GLSELNL 189
V L+ C+ + R L+ L L + + + L H L LN+
Sbjct: 132 FKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI 191
Query: 190 NGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSN 249
+ L V S ++L RL L S + L+ L +
Sbjct: 192 SC--LASEV-----SFSALERLVTRCPNLKS--------------LKLNRAVPLEKLATL 230
Query: 250 IQNLKVLTNLDLSRNQLSGD------IPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303
+Q L L + + G + L LS + +P +
Sbjct: 231 LQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSR 290
Query: 304 LESLDLSRNNLS 315
L +L+LS +
Sbjct: 291 LTTLNLSYATVQ 302
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 704 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.87 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.75 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.74 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.72 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.4 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.07 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.84 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.36 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.36 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.18 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 98.14 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 98.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.07 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.87 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.62 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.59 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.34 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.13 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.07 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.9 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.89 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.82 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.8 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.78 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.76 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.13 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.79 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.68 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.37 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 85.72 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=437.43 Aligned_cols=264 Identities=26% Similarity=0.425 Sum_probs=208.3
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.+++...++||+|+||+||+|++. ..||||+++... ....+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 357778899999999999999865 369999986432 3445789999999999999999999998865 56799999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
||++|+|.++++.....+++..+..++.|||.||+|||+ ++||||||||+|||+++++.+||+|||+|+........
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999999998877779999999999999999999964 68999999999999999999999999999877554433
Q ss_pred ceeccccccccccCCcccCC---CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 572 VIQTMTIATIGYMAPEYGSE---GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.......||+.|||||++.+ +.++.++|||||||++|||+||+.||.+...... ....+..... .+..
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~~~~-------~p~~- 259 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGRGYA-------SPDL- 259 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHTTCC-------CCCS-
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCC-------CCCc-
Confidence 34455689999999998853 4689999999999999999999999976432111 1111111100 0100
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
...+.+++..+.+++.+||+.||++||||+||++.|+.++..+.
T Consensus 260 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 260 -----SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -----TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -----ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11223566788999999999999999999999999999887664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=443.35 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=216.4
Q ss_pred CCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|...+.||+|+||+||+|++. +++.||||+++.......+.|.+|++++++++|||||+++|+|.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777889999999999999863 478899999987666667889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 005278 489 VLEFMPNGSLEKWLYSHN------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHV 556 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl 556 (704)
|||||++|+|.++++..+ ..++|..+..++.|||.||+||| +++||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 46899999999999999999996 468999999999999999999999
Q ss_pred eeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhc
Q 005278 557 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 557 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+.... .....+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~-- 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQ-- 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHH--
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc--
Confidence 99999987754443333444579999999999999999999999999999999999 89999764321 11111111
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
+.....+..++.++.+++.+||+.||++||||+||.+.|+++.+..
T Consensus 246 ---------------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 246 ---------------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp ---------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ---------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 0111223456778999999999999999999999999999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=444.31 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=208.4
Q ss_pred CCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|...+.||+|+||+||+|++. +++.||||+++.......+.|.+|++++++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 478899999987666667789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC--------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 489 VLEFMPNGSLEKWLYSHN--------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
|||||++|+|.++++... ..++|..+..++.|||.||+||| +++||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 999999999999997542 35899999999999999999996 4679999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 633 (704)
||+|||+|+...........+...||+.|||||++.+..++.++|||||||++|||+| |+.||.+.... .....+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~ 275 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQ 275 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence 9999999997755444444455679999999999999999999999999999999999 89999764321 11111111
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
+.....+..+++++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 276 -----------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 -----------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -----------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 011122345677899999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=440.37 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=210.8
Q ss_pred CCCccccccccCceEEEEEEEC------CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
+++..+.||+|+||+||+|++. +++.||||+++.... ...+.|.+|+.++++++|||||+++|+|.+.+..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455678999999999999863 467899999975432 345789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC---------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 005278 489 VLEFMPNGSLEKWLYSH---------------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT 553 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~ 553 (704)
|||||++|+|.+++... ...++|..+..++.|||.||+||| +.+||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence 99999999999999743 235899999999999999999995 467999999999999999999
Q ss_pred EEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHH
Q 005278 554 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVK 632 (704)
Q Consensus 554 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 632 (704)
+||+|||+|+.+.........+...||++|||||++.++.++.++|||||||++|||+| |+.||.+.... .....+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~i~ 261 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMIR 261 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 99999999987754443334455679999999999999999999999999999999999 89999764321 1222211
Q ss_pred hhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 633 ESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
. +...+.+.+++..+.+++.+||+.||++||||+||++.|+++
T Consensus 262 ~-----------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 N-----------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp T-----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred c-----------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 011123346678899999999999999999999999999865
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=419.89 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=204.9
Q ss_pred CCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC----eEEEEEe
Q 005278 416 GFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID----FKALVLE 491 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e 491 (704)
+|...+.||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|++.+.+ ..++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 466778999999999999987 589999999865422 2233455777778899999999999997654 5799999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG-----HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
||++|+|.++++... ++|..+.+++.|++.||+|||+. |+++||||||||+|||++.++++||+|||+|+...
T Consensus 82 y~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 999999999998654 89999999999999999999864 46799999999999999999999999999998875
Q ss_pred CCCCcc--eeccccccccccCCcccCCC------CCCcccceeeHHHHHHHHhhCCCCCCcccc----------ccccHH
Q 005278 567 EGDDSV--IQTMTIATIGYMAPEYGSEG------IISPKSDVYSYGILLMETFTRKKPTNEIFI----------GEMSLK 628 (704)
Q Consensus 567 ~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~----------~~~~~~ 628 (704)
...... ......||+.|||||++.+. .++.++|||||||++|||+||+.||..... ......
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 543321 22345799999999998654 467899999999999999999877654322 112222
Q ss_pred HHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 629 HWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
.+......... ++.+ +......+++..+.+++.+||+.||++||||.||++.|+++.++
T Consensus 240 ~~~~~~~~~~~----rp~~----p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 240 EMRKVVCEQKL----RPNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHTTSCC----CCCC----CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcccC----CCCC----CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 22221111111 1111 11122335677899999999999999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=424.09 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=208.4
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56889999999999999999965 79999999997665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++|+|.+++... .+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 226 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence 999999999764 3899999999999999999995 57899999999999999999999999999998754322 2
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ......+....+. .
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~---------------~ 289 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP---------------R 289 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCC---------------C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC---------------C
Confidence 3456899999999999999999999999999999999999999976321 1111111111111 1
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++.++.+++.+||+.||++|||+.|+++
T Consensus 290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112244567889999999999999999999954
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=430.15 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=217.8
Q ss_pred HHhCCCCccccccccCceEEEEEEECC------CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCC-CCCceEEeeeeeC
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLFD------GTNVAIKVFNLQL-ERASRSFDSECEILRSIRH-RNLIKIISNCCNI 483 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~ 483 (704)
...++|+..+.||+|+||+||+|++.. ++.||||++.... ....+.|.+|++++++++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 345789999999999999999998542 3679999997654 3345679999999999965 8999999998764
Q ss_pred -CeEEEEEeccCCCCHHHHHhhC---------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 005278 484 -DFKALVLEFMPNGSLEKWLYSH---------------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNIL 547 (704)
Q Consensus 484 -~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil 547 (704)
+..++|||||++|+|.++++.. ...+++..+..++.|||.||+||| +++||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcccee
Confidence 5689999999999999999753 234899999999999999999995 578999999999999
Q ss_pred eCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCcccccccc
Q 005278 548 LDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMS 626 (704)
Q Consensus 548 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~ 626 (704)
+++++.+||+|||+|+.+.........+...||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~- 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999998765555555566789999999999999999999999999999999998 8999976432211
Q ss_pred HHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 627 LKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
+...+... .....+..+++++.+++.+||+.||++||||+||++.|+++.+...
T Consensus 297 ~~~~i~~g-----------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 297 FCRRLKEG-----------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp HHHHHHHT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHcC-----------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 11111111 1112233456788999999999999999999999999999876544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=420.14 Aligned_cols=256 Identities=20% Similarity=0.233 Sum_probs=208.0
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.+.|...++||+|+||+||+|+.. +|+.||||+++.... ..+|+.++++++|||||++++++.+.+..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356778889999999999999964 699999999975422 24699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-TAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++.+.+ .+++..+..++.||+.||+|| |+++||||||||+|||++.++ ++||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 99999999998654 489999999999999999999 567899999999999999987 6999999999987543221
Q ss_pred ---ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 572 ---VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 572 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
......+||+.|||||++.+..++.++|||||||++|||+||+.||.+...... +.......
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~-------------- 272 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP-------------- 272 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC--------------
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC--------------
Confidence 122335799999999999999999999999999999999999999976433222 11111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
.+....+..++..+.+++.+||+.||++|||+.|+++.|.+..+.
T Consensus 273 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 273 --PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp --CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 001112335567888999999999999999999999999887654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-52 Score=418.82 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=208.8
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999985 479999999997543 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++.+.+ .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999998654 4899999999999999999995 57899999999999999999999999999998865444
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......+||+.|||||++.+..++.++||||+||++|||+||+.||.+.... ..+.......
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~---------------- 250 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-LIFAKIIKLE---------------- 250 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTC----------------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC----------------
Confidence 44445668999999999999999999999999999999999999999763211 1111111100
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
...+..++.++.+++.+|++.||++|||++|+...
T Consensus 251 ---~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 251 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ---CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 01112345678899999999999999999997543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=422.65 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=201.1
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999986 479999999997543 3345679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 492 FMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 492 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
|+++|+|.+++... ...+++..+..++.||+.||+||| +++||||||||+|||+++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 99999999999854 345789999999999999999995 578999999999999999999999999999876321
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+... .+..........
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~~~~~----------- 242 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----KNLVLKIISGSF----------- 242 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTCC-----------
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHcCCC-----------
Confidence 1122345799999999999999999999999999999999999999976321 111111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++.++.+++.+||+.||++|||++|+++
T Consensus 243 ---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 ---PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112234567889999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=407.51 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=195.2
Q ss_pred CccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee----CCeEEEEE
Q 005278 418 NECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN----IDFKALVL 490 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 490 (704)
...+.||+|+||+||+|+.. +++.||+|++.... ....+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999864 68999999987543 3345679999999999999999999999865 34579999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEeeeccceecCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||++|+|.+++.+.. .+++..+..++.||+.||+|||. +..+||||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 9999999999998654 48999999999999999999975 334599999999999998 4799999999999864321
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.....+||+.|||||++.+ .++.++|||||||++|||+||+.||.+... ......... ....
T Consensus 186 ---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i~-~~~~--------- 247 (290)
T 3fpq_A 186 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVT-SGVK--------- 247 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHT-TTCC---------
T ss_pred ---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHHH-cCCC---------
Confidence 2334579999999998865 699999999999999999999999965321 111111111 1100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..+++++.+++.+||+.||++|||++|+++
T Consensus 248 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111223456889999999999999999999954
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=424.72 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=208.4
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999964 69999999998665555677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++|+|.+++.... +++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 303 (423)
T 4fie_A 231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 303 (423)
T ss_dssp TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence 9999999997643 899999999999999999995 57899999999999999999999999999998754322 2
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ......+....+..
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~~--------------- 366 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPR--------------- 366 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCCC---------------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCCC---------------
Confidence 3456799999999999999999999999999999999999999975321 11111111111111
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......++.++.+++.+||+.||++|||+.|+++
T Consensus 367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111234567889999999999999999999954
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=399.94 Aligned_cols=245 Identities=25% Similarity=0.416 Sum_probs=190.2
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999985 479999999997543 233467999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+ +|+|.+++.+.+ .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 689999998654 4899999999999999999995 5789999999999999999999999999998764332
Q ss_pred cceeccccccccccCCcccCCCCC-CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
......||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.. ...........
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i~~~------------ 227 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNISNG------------ 227 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHT------------
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcC------------
Confidence 2334679999999999988775 579999999999999999999997521 11211111000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..++.++.+++.+||+.||++|||++|+++
T Consensus 228 ---~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 ---VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00111234567889999999999999999999965
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=405.74 Aligned_cols=242 Identities=26% Similarity=0.298 Sum_probs=193.0
Q ss_pred CCCCccccccccCceEEEEEEEC----CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|++.+.||+|+||+||+|+.. +++.||||+++... ......+.+|++++++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999852 47889999997543 2234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++.+.+ .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999998654 4899999999999999999995 578999999999999999999999999999865432
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.. .....+||+.|||||++.+..++.++||||+||++|||+||+.||.+... .+........
T Consensus 180 ~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~~~----------- 241 (304)
T 3ubd_A 180 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETMTMILKA----------- 241 (304)
T ss_dssp -C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC-----------
T ss_pred Cc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHHHHHHcC-----------
Confidence 22 23346799999999999999999999999999999999999999976321 1111111000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
....+..+++++.+++.+||+.||++|||+
T Consensus 242 ----~~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 242 ----KLGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ----CCCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 011122345678899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=394.17 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=187.6
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC--------
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNID-------- 484 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 484 (704)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46889999999999999999864 79999999997543 334567899999999999999999999987544
Q ss_pred ----eEEEEEeccCCCCHHHHHhhCCC--ccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEee
Q 005278 485 ----FKALVLEFMPNGSLEKWLYSHNY--FLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSD 558 (704)
Q Consensus 485 ----~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~D 558 (704)
..++||||+++|+|.+++..... ..++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999986532 3466778899999999999995 57899999999999999999999999
Q ss_pred eccceecCCCCCc----------ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHH
Q 005278 559 FGISKLLGEGDDS----------VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK 628 (704)
Q Consensus 559 fgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~ 628 (704)
||+|+.+...... ...+..+||+.|||||++.+..++.++|||||||++|||++ ||...... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~----~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER----V 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH----H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH----H
Confidence 9999887543221 11233579999999999999999999999999999999996 77542110 0
Q ss_pred HHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 629 HWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...... ..... .+......+...+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~--------~~~~~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLTDV--------RNLKF------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHH--------HTTCC------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHH--------hcCCC------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 101100 00000 1112233455678999999999999999999965
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=386.75 Aligned_cols=268 Identities=23% Similarity=0.269 Sum_probs=200.2
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee------CC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN------ID 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 484 (704)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999986 479999999996543 2345678899999999999999999998764 35
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..|+|||||+ |+|.+++...+ .+++..+..++.||+.||+||| +.+||||||||+|||++.++.+||+|||+|+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 7899999996 68999997654 5899999999999999999995 57899999999999999999999999999987
Q ss_pred cCCCC--CcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC--c
Q 005278 565 LGEGD--DSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG--L 639 (704)
Q Consensus 565 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~ 639 (704)
+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.... ..+........... .
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHH
Confidence 64322 12233456899999999988765 5799999999999999999999999763211 11111111111100 0
Q ss_pred chhccccchhh--------h--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 640 TEVVDANLVRE--------E--QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 640 ~~~~~~~~~~~--------~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
........... . .........+.++.+++.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000 0 000011123567889999999999999999999854
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=383.82 Aligned_cols=200 Identities=21% Similarity=0.292 Sum_probs=170.2
Q ss_pred HHHhCCCCccccccccCceEEEEEEEC----CCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
....++|++.+.||+|+||+||+|+.+ +++.||||.+... .....+.+|+++++.+ +||||+++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999743 4678999988643 2345688999999998 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEeeecccee
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-MTAHVSDFGISKL 564 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-~~~kl~Dfgla~~ 564 (704)
.++||||+++|+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999999984 3889999999999999999995 5789999999999999876 7999999999987
Q ss_pred cCCCCCc--------------------------ceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCC
Q 005278 565 LGEGDDS--------------------------VIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPT 617 (704)
Q Consensus 565 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~ 617 (704)
....... ...+..+||+.|+|||++.+. .++.++||||+||++|||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 6432211 112334799999999998765 5899999999999999999999999
Q ss_pred Cc
Q 005278 618 NE 619 (704)
Q Consensus 618 ~~ 619 (704)
..
T Consensus 248 ~~ 249 (361)
T 4f9c_A 248 YK 249 (361)
T ss_dssp SC
T ss_pred CC
Confidence 54
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=373.86 Aligned_cols=283 Identities=35% Similarity=0.570 Sum_probs=233.6
Q ss_pred cchHHHHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC
Q 005278 405 TSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID 484 (704)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 484 (704)
+.+.++...+++|+..+.||+|+||.||+|+..+++.||||++........+.+.+|++++++++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34455666789999999999999999999998889999999987665556678999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC---CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 485 FKALVLEFMPNGSLEKWLYSHN---YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||. .+|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997543 358999999999999999999964 7899999999999999999999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccc-cccHHHHHHhhcCCC-c
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIG-EMSLKHWVKESLPDG-L 639 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~-~ 639 (704)
++...............||+.|+|||++.+..++.++||||||+++|||+||+.||...... ......|........ +
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98765433333334456899999999998889999999999999999999999999764333 234555544332222 3
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+++.... ....+++..+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 266 ~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLAD-----KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTT-----CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhcc-----ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 3444433322 22346778899999999999999999999999999988653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=373.85 Aligned_cols=286 Identities=34% Similarity=0.528 Sum_probs=238.9
Q ss_pred ccccccchHHHHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEe
Q 005278 400 ATWRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIIS 478 (704)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~ 478 (704)
.....+++.++....++|+..+.||+|+||.||+|+..+++.||||++..... .....+.+|+++++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 45667889999999999999999999999999999988899999999876532 23347899999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCCHHHHHhhCC---CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEE
Q 005278 479 NCCNIDFKALVLEFMPNGSLEKWLYSHN---YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAH 555 (704)
Q Consensus 479 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~k 555 (704)
++...+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||..+..+|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999998543 3489999999999999999999886666999999999999999999999
Q ss_pred EeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcc---ccccccHHHHHH
Q 005278 556 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEI---FIGEMSLKHWVK 632 (704)
Q Consensus 556 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~---~~~~~~~~~~~~ 632 (704)
|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||+.. .........|..
T Consensus 175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999987754332 2234456999999999998888999999999999999999999999742 234456677776
Q ss_pred hhcCCC-cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 633 ESLPDG-LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 633 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
...... .....+..... .....++..+.+++..||+.||++|||+.||+++|++
T Consensus 254 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQG-----NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSSCCSTTSSCTTCTT-----SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHhhchhhhhhcChhhcc-----ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 555443 33444433322 2334667889999999999999999999999999975
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=409.19 Aligned_cols=338 Identities=35% Similarity=0.581 Sum_probs=278.4
Q ss_pred CCCCCCEEecCCCcCcccCCcc-ccCCCCCCEEeccCccccccCchhhcC---------------------------CCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNS-ITNASKLIMLDLSSNSFSGLIPNTFGN---------------------------LGS 55 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~-~~~l~~L~~L~L~~n~i~~~~~~~~~~---------------------------l~~ 55 (704)
.+++|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..|..|.+ +++
T Consensus 316 ~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~ 395 (768)
T 3rgz_A 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395 (768)
T ss_dssp GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCC
T ss_pred cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCC
Confidence 3455555555555555444443 555555555555555555444544444 444
Q ss_pred CCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCC
Q 005278 56 LQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSG 135 (704)
Q Consensus 56 L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 135 (704)
|++|++++|.++.. .+..+.++++|++|+|++|++++..|..+..+. +|++|++++|.+.+.+|..+..+++
T Consensus 396 L~~L~L~~n~l~~~-------~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~ 467 (768)
T 3rgz_A 396 LQELYLQNNGFTGK-------IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKT 467 (768)
T ss_dssp CCEEECCSSEEEEE-------CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred ccEEECCCCccccc-------cCHHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCC
Confidence 55555555554432 344588899999999999999999999988875 7999999999999999999999999
Q ss_pred CCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecC
Q 005278 136 MIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGS 215 (704)
Q Consensus 136 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 215 (704)
|++|++++|.+.+.+|..+.++++|+.|+|++|++++.+|..+..+++|++|+|++|++++.+|..+..+++|+.|++++
T Consensus 468 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 547 (768)
T 3rgz_A 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547 (768)
T ss_dssp CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCS
T ss_pred ceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCc----------------------------------------------------------------------
Q 005278 216 NKLTSTMPSS---------------------------------------------------------------------- 225 (704)
Q Consensus 216 n~l~~~~~~~---------------------------------------------------------------------- 225 (704)
|.+++.+|..
T Consensus 548 N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~ 627 (768)
T 3rgz_A 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627 (768)
T ss_dssp SEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCS
T ss_pred CccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchh
Confidence 9988666643
Q ss_pred ccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccc
Q 005278 226 FGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLE 305 (704)
Q Consensus 226 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 305 (704)
+..+++|+.|+|++|++++.+|..++++++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|+
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 707 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence 34467899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEecccCCCCCCCC-----CcccccccCcccccCCCccCCCcccCCCcccc
Q 005278 306 SLDLSRNNLSGEIPK-----NFSAQSFLSNYALCGPARLQVPSCRKYNSRGF 352 (704)
Q Consensus 306 ~L~l~~N~l~~~~p~-----~~~~~~~l~~~~l~g~~~~~~~~c~~~~~~~~ 352 (704)
+|++++|+++|.+|. .|...++.+|..+||.|. +.|........
T Consensus 708 ~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~~~~~~ 756 (768)
T 3rgz_A 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPSNADGY 756 (768)
T ss_dssp EEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSCC----
T ss_pred EEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCCccCCC
Confidence 999999999999997 355667889999999873 36876555443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=396.05 Aligned_cols=252 Identities=22% Similarity=0.255 Sum_probs=209.3
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|++.+.||+|+||+||+|+.. +|+.||+|++........+.+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999864 7999999999876556667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC--CcEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN--MTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~--~~~kl~Dfgla~~~~~~~~ 570 (704)
|++|+|.+++......+++..+..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999999866667999999999999999999995 5789999999999999854 899999999999875432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....+||+.|||||++.+..++.++||||+||++|||++|..||.+.... .....+...... +
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~~~~~-~----------- 375 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSCDWN-M----------- 375 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCCC-C-----------
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHhCCCC-C-----------
Confidence 234457999999999999999999999999999999999999999763221 111111100000 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......++.++.+|+.+||+.||++||++.|+++
T Consensus 376 --~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 --DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111234567889999999999999999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=393.97 Aligned_cols=248 Identities=21% Similarity=0.287 Sum_probs=198.5
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHH---HHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSE---CEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ......+.+| +.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999965 69999999997543 1222333344 5666677999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
|+||||++||+|.+++.+.+ .+++..+..++.||+.||+|| |+.+||||||||+|||++.+|++||+|||+|+.+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yL---H~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999998654 489999999999999999999 56889999999999999999999999999999875
Q ss_pred CCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
... ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||.+....+ ...........
T Consensus 344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~i~~~-------- 409 (689)
T 3v5w_A 344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTM-------- 409 (689)
T ss_dssp SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHHHHHC--------
T ss_pred CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhcCC--------
Confidence 432 234589999999999864 579999999999999999999999997633221 11111110000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAA 686 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~ 686 (704)
....+..++.++.+++.+||+.||++|++ +.||.
T Consensus 410 -------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 410 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred -------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 01112234567889999999999999998 57764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=362.48 Aligned_cols=264 Identities=25% Similarity=0.377 Sum_probs=216.9
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
++|...+.||+|+||+||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888899999999999999965 68999999987655666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc-
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV- 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~- 572 (704)
++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999999987777999999999999999999995 4789999999999999999999999999998775432211
Q ss_pred -----------eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcch
Q 005278 573 -----------IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641 (704)
Q Consensus 573 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (704)
......||+.|+|||++.+..++.++||||||+++|||++|..|+............
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------------ 234 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------------ 234 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------------
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------------
Confidence 111346999999999999999999999999999999999999998653222110000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
..........+..++..+.+++.+||+.||++||++.|+++.|+++++....
T Consensus 235 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 235 -----NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp -----CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -----hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 0000001111234456788999999999999999999999999999877654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=365.92 Aligned_cols=270 Identities=24% Similarity=0.332 Sum_probs=212.0
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC----eEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID----FKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 489 (704)
.++|+..+.||+|+||+||+|+.. ++.||||++.... ........|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357889999999999999999865 7999999986542 33445677999999999999999999998754 36999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc-------CCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG-------HSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-------h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
|||+++|+|.+++.... +++..+..++.|++.||+|||.. |+.+|+||||||+||+++.++.+||+|||++
T Consensus 101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 99999999999998654 89999999999999999999542 2339999999999999999999999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCC-----CCCCcccceeeHHHHHHHHhhCCCCCCccccccc-----------c
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSE-----GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM-----------S 626 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~-----------~ 626 (704)
+...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+...... .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 88765444333444679999999999876 3566789999999999999999999976433211 1
Q ss_pred HHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 627 LKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+............ + ........++..+.+++.+||+.||++|||+.||++.|+++++.
T Consensus 259 ~~~~~~~~~~~~~~~~----~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPV----L----RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHTTSCCCCC----C----CGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCC----c----cccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1222111111111000 0 11112234567799999999999999999999999999999865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=370.68 Aligned_cols=262 Identities=25% Similarity=0.416 Sum_probs=215.2
Q ss_pred hCCCCccccccccCceEEEEEEEC--------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNI 483 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 483 (704)
.++|...+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999852 35679999997553 33456799999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 99999999999999999998643 34789999999999999999995 4789999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... ..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence 9999999999999997765443333344567899999999999999999999999999999999 99999764221 11
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
...+.... ....+..++..+.+++..||+.||++||++.|+++.|+++.....
T Consensus 315 ~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 315 FKLLKEGH-----------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HHHHHTTC-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHhcCC-----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11111110 011222456678899999999999999999999999999876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=356.94 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=207.8
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|+..+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999985 57999999999766555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++|+|.+++.... +++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (297)
T ss_dssp CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence 99999999998653 889999999999999999995 46899999999999999999999999999987654322
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........+
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~---------------- 234 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP---------------- 234 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSC----------------
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC----------------
Confidence 23345799999999999999999999999999999999999999975321111 1111010000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..++..+.+++.+||+.||++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01112244567889999999999999999999965
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=352.35 Aligned_cols=282 Identities=29% Similarity=0.472 Sum_probs=228.6
Q ss_pred cccccchHHHHHHhCCCCcc------ccccccCceEEEEEEECCCCEEEEEEeeccc----hhhhHHHHHHHHHHHhcCC
Q 005278 401 TWRRTSYLDIQRATNGFNEC------NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL----ERASRSFDSECEILRSIRH 470 (704)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h 470 (704)
....+++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678899999999999887 8899999999999985 68899999986532 2345679999999999999
Q ss_pred CCCceEEeeeeeCCeEEEEEeccCCCCHHHHHhhC--CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH--NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 471 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
|||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 99999999999999999999999999999999743 345899999999999999999995 4689999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK 628 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~ 628 (704)
+.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|..||....... ...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHH
Confidence 9999999999999987755443333445579999999998765 57899999999999999999999998643322 222
Q ss_pred HHHHhhc--CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 629 HWVKESL--PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 629 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
.+..... ...+...+++.+. ..+..++..+.+++..||+.||++||++.||++.|+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMN------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCS------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhcccccc------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222111 1123333333221 1234567789999999999999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=376.25 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=214.2
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888899999999999999976 78999999987543 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++|+|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999877667899999999999999999995 478999999999999999999999999999875432221
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......+++.|+|||++.++.++.++|||||||++|||+| |..||...... .....+...
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~---------------- 331 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKG---------------- 331 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTT----------------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC----------------
Confidence 11222346788999999998899999999999999999998 99999764221 111111110
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+.+..++..+.+++..||+.||++|||+.++++.|++++++
T Consensus 332 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 -GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 01112234566788999999999999999999999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=361.56 Aligned_cols=278 Identities=26% Similarity=0.408 Sum_probs=211.9
Q ss_pred hCCCCccccccccCceEEEEEEE-----CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-----FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 486 (704)
.++|+..+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36788899999999999999984 3688999999986655666789999999999999999999999855 3458
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999987777999999999999999999995 4789999999999999999999999999998775
Q ss_pred CCCCc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 567 EGDDS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 567 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
..... .......++..|+|||.+.+..++.++||||||+++|||+||..|+...... ...+...............
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence 43221 2223345788899999999999999999999999999999999998653211 0010000000000000000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
.........+.+..++..+.+++..||+.||++|||+.|+++.|+++++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 0000111122334567789999999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=362.42 Aligned_cols=262 Identities=28% Similarity=0.444 Sum_probs=212.3
Q ss_pred hCCCCccccccccCceEEEEEEEC----CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.++|.+.+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357888899999999999999974 34569999997643 3445679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999877667999999999999999999995 478999999999999999999999999999987543
Q ss_pred CCc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 569 DDS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 569 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+ ....+...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~------------ 270 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEG------------ 270 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT------------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcC------------
Confidence 322 22233456889999999998899999999999999999999 999996632211 11111100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
.....+..++..+.+++..||+.||++||++.||++.|+++.+...
T Consensus 271 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 271 -----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0111222456678899999999999999999999999999876544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=357.66 Aligned_cols=262 Identities=26% Similarity=0.380 Sum_probs=203.6
Q ss_pred HHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
...++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456888999999999999999986 58899999987543 23446789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC--CccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 490 LEFMPNGSLEKWLYSHN--YFLGILERLNIMIDVGLALEYLHHGHSTP--MVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~--ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||. .+ |+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999998654 248999999999999999999964 56 999999999999999999999999999865
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .........
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~---------- 255 (309)
T 3p86_A 190 ASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKC---------- 255 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHSC----------
T ss_pred cccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcC----------
Confidence 3321 12334579999999999999999999999999999999999999997632211 111110000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
.....+..++..+.+++.+||+.||++||++.|+++.|+.+.+...
T Consensus 256 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 256 ------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred ------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 0011122345678899999999999999999999999999876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=350.01 Aligned_cols=259 Identities=26% Similarity=0.349 Sum_probs=213.2
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|+..+.||+|+||.||+|+..++..||||++.... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46788899999999999999998888899999987543 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++|+|.+++......+++..++.++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS 161 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence 999999999877667999999999999999999995 47899999999999999999999999999987654322 22
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
.....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..........
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~-------------- 222 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLKVSQGH-------------- 222 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHTTC--------------
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHHHHcCC--------------
Confidence 334457788999999998889999999999999999999 99999753221 1111100000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
....+..++..+.+++..||+.||++||++.|+++.|++++++.
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 00111123456889999999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=354.23 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=211.8
Q ss_pred cccchHHHHHHhCC----------CCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCC
Q 005278 403 RRTSYLDIQRATNG----------FNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHR 471 (704)
Q Consensus 403 ~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ 471 (704)
..+++.+++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34666777666653 666779999999999999976 7999999999766555567789999999999999
Q ss_pred CCceEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC
Q 005278 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN 551 (704)
Q Consensus 472 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~ 551 (704)
||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||+|||. .+|+||||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999998754 48999999999999999999964 689999999999999999
Q ss_pred CcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHH
Q 005278 552 MTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV 631 (704)
Q Consensus 552 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~ 631 (704)
+.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~ 253 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRL 253 (321)
T ss_dssp CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH
T ss_pred CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 9999999999987654322 22345799999999999999999999999999999999999999975321 1111111
Q ss_pred HhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 632 KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+.. . .....++..+.+++.+||+.||++||++.|+++
T Consensus 254 ~~~~~~~--------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 254 RDSPPPK--------L-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHSSCCC--------C-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCCCC--------c-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111110 0 111233566889999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.59 Aligned_cols=261 Identities=26% Similarity=0.457 Sum_probs=202.2
Q ss_pred hCCCCccccccccCceEEEEEEEC----CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.++|+..+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999864 57789999987543 3445679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999987777999999999999999999996 468999999999999999999999999999876543
Q ss_pred CCc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 569 DDS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 569 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~~~------------ 266 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEG------------ 266 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHHTT------------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC------------
Confidence 221 11222345788999999999999999999999999999998 99999653221 111111100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
. ..+.+..++..+.+++..||+.||++||++.||++.|+++.+..
T Consensus 267 ~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 Y-----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp E-----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred C-----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0 01112245667899999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.31 Aligned_cols=265 Identities=25% Similarity=0.395 Sum_probs=208.4
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHh--cCCCCCceEEeeeee----CCeEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRS--IRHRNLIKIISNCCN----IDFKA 487 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~~ 487 (704)
.++|+..+.||+|+||+||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999987 6899999998643 34456667777776 799999999998754 34578
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG-----HSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
+||||+++|+|.++++.. .+++..++.++.|++.|++|||.. ++.+|+||||||+||+++.++.+||+|||++
T Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 999999999999999654 489999999999999999999731 2789999999999999999999999999999
Q ss_pred eecCCCCCcc--eeccccccccccCCcccCCC------CCCcccceeeHHHHHHHHhhC----------CCCCCcccccc
Q 005278 563 KLLGEGDDSV--IQTMTIATIGYMAPEYGSEG------IISPKSDVYSYGILLMETFTR----------KKPTNEIFIGE 624 (704)
Q Consensus 563 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~el~tg----------~~p~~~~~~~~ 624 (704)
+......... ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8765433221 12234799999999998776 455799999999999999999 88887655554
Q ss_pred ccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 625 MSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
................... +.......++..+.+++..||+.||++|||+.||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNI--------PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCC--------CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCCCCC--------ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 4444443322211111100 01112235678899999999999999999999999999876
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.82 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=212.8
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
++|+..+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5788889999999999999998889999999987543 234679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|+|.+++......+++..++.++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 164 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccc
Confidence 99999999877777999999999999999999995 5789999999999999999999999999998664321 1122
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+.....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~----------------- 225 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFR----------------- 225 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC-----------------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCcc-----------------
Confidence 33457888999999998899999999999999999999 99999763221 11111111000
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+..++..+.+++..||+.||++||+++|+++.|+++.++
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 011112345688999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=355.24 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=204.6
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
..++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999996 579999999997543 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++...+ .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999997654 3899999999999999999995 4689999999999999999999999999998764432
Q ss_pred CcceeccccccccccCCcccCCCCCC-cccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIIS-PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
......||+.|+|||++.+..+. .++||||+||++|||++|+.||.+... ..........
T Consensus 169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~----------- 229 (328)
T 3fe3_A 169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELRERVLRG----------- 229 (328)
T ss_dssp ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC-----------
T ss_pred ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC-----------
Confidence 23445799999999998887765 799999999999999999999976321 1111111000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..++..+.+++.+||+.||++|||+.|+++
T Consensus 230 ----~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 ----KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00111233566789999999999999999999965
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=365.39 Aligned_cols=268 Identities=25% Similarity=0.382 Sum_probs=215.8
Q ss_pred HHHHHHhCCCCccccccccCceEEEEEEE------CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEee
Q 005278 408 LDIQRATNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISN 479 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 479 (704)
.+.....++|...+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 34445668899999999999999999974 246889999997643 33456799999999999 79999999999
Q ss_pred eeeCC-eEEEEEeccCCCCHHHHHhhCCC---------------------------------------------------
Q 005278 480 CCNID-FKALVLEFMPNGSLEKWLYSHNY--------------------------------------------------- 507 (704)
Q Consensus 480 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------- 507 (704)
+.+.+ ..++||||+++|+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 88755 48999999999999999985432
Q ss_pred --------------ccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 508 --------------FLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 508 --------------~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
.+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 2889999999999999999995 46899999999999999999999999999987755444444
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+. ..........
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~---------------- 314 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTR---------------- 314 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCC----------------
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCC----------------
Confidence 455678999999999999999999999999999999998 9999976432221 1111111100
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
...+..++..+.+++..||+.||++||++.|+++.|+++.+..
T Consensus 315 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 315 -MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1111234567889999999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=355.74 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=205.4
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999865 799999999865432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+......
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999987553 4899999999999999999995 578999999999999999999999999999876433333
Q ss_pred ceeccccccccccCCcccCCCCC-CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||............|......
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 227 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 227 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------------
Confidence 33345579999999999877665 778999999999999999999998754433333333221110
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......++..+.+++.+||+.||++|||+.|+++
T Consensus 228 ---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0111234556788999999999999999999954
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=388.64 Aligned_cols=333 Identities=33% Similarity=0.499 Sum_probs=266.7
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchh-hcCCCCCCEEecccccCCCcccchhhc------
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNT-FGNLGSLQVLSLAYNYLMTESSAAKWN------ 76 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~n~i~~~~~~~~~~------ 76 (704)
.+++|++|+|++|.+++.+|..|+++++|++|+|++|.+++.+|.. |.++++|++|+|++|.++.........
T Consensus 292 ~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~ 371 (768)
T 3rgz_A 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLL 371 (768)
T ss_dssp TCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCS
T ss_pred hcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCc
Confidence 4599999999999999999999999999999999999999666655 999999999999999987432221100
Q ss_pred ------------ccccCCC--CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEcc
Q 005278 77 ------------FLSSLTN--CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLN 142 (704)
Q Consensus 77 ------------~~~~~~~--l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 142 (704)
.+..+.. +++|++|+|++|++.+..|..+..+. +|++|++++|.+++.+|..++++++|++|+++
T Consensus 372 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 450 (768)
T 3rgz_A 372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450 (768)
T ss_dssp EEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred EEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECC
Confidence 1222222 56677777777777777777777664 68888888888887888888888888888888
Q ss_pred CCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCC
Q 005278 143 GCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTM 222 (704)
Q Consensus 143 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 222 (704)
+|.+.+.+|..+..+++|++|++++|++++.+|..+..+++|++|+|++|++++.+|..+..+++|+.|++++|.+++.+
T Consensus 451 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 530 (768)
T 3rgz_A 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEEC
T ss_pred CCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcC
Confidence 88888778888888888888888888888778888888888888888888888888888888888888888888888888
Q ss_pred CCcccCCccccEEEecCcccCCCCCccc----------------------------------------------------
Q 005278 223 PSSFGSLEYVLYINLSANSLNGSLPSNI---------------------------------------------------- 250 (704)
Q Consensus 223 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~---------------------------------------------------- 250 (704)
|..+..+++|+.|++++|.+.+.+|..+
T Consensus 531 p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (768)
T 3rgz_A 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR 610 (768)
T ss_dssp CGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGT
T ss_pred CHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccc
Confidence 8888888888888888888776666433
Q ss_pred ------------------ccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEeccc
Q 005278 251 ------------------QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312 (704)
Q Consensus 251 ------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N 312 (704)
+.+++|+.|++++|+++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|||++|
T Consensus 611 ~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N 690 (768)
T 3rgz_A 611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690 (768)
T ss_dssp CCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCC
Confidence 33467888888888888888888888888888888888888888888888888888888888
Q ss_pred CCCCCCCCCcccccccCcccccCCC
Q 005278 313 NLSGEIPKNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 313 ~l~~~~p~~~~~~~~l~~~~l~g~~ 337 (704)
+++|.+|..+..++.+..+.+.+++
T Consensus 691 ~l~g~ip~~l~~l~~L~~L~ls~N~ 715 (768)
T 3rgz_A 691 KLDGRIPQAMSALTMLTEIDLSNNN 715 (768)
T ss_dssp CCEECCCGGGGGCCCCSEEECCSSE
T ss_pred cccCcCChHHhCCCCCCEEECcCCc
Confidence 8888888888877777776666654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=367.09 Aligned_cols=263 Identities=20% Similarity=0.240 Sum_probs=209.2
Q ss_pred chHHHHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeee
Q 005278 406 SYLDIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCC 481 (704)
Q Consensus 406 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 481 (704)
.+.+++...++|+..++||+|+||+||+|+.. +++.||+|++..... .....+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555666789999999999999999999976 588999999975321 22344889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 482 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
+.+..++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 999999999999999999999876667999999999999999999995 47899999999999999999999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP 636 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 636 (704)
|+....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.+....+ .+.........
T Consensus 222 a~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~ 299 (437)
T 4aw2_A 222 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKER 299 (437)
T ss_dssp CEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHHH
T ss_pred hhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhhcccc
Confidence 987654322 2233457999999999986 5678999999999999999999999997632111 11111100000
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQ--RVSMKDAAA 687 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~ev~~ 687 (704)
..+ ......++..+.+++.+|+..+|++ ||+++|+++
T Consensus 300 ~~~--------------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 300 FQF--------------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCC--------------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccC--------------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000 0001124567888999999988888 999999854
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=363.39 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=215.7
Q ss_pred hCCCCccccccccCceEEEEEEEC--------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNI 483 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 483 (704)
.++|...+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888999999999999999852 23579999987653 33456789999999999 999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 99999999999999999998643 35899999999999999999995 4689999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987765443334445568899999999999999999999999999999999 99999763211 11
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
...+..... ...+..++.++.+++..||+.||++||+++||++.|+++.+....
T Consensus 303 ~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 303 FKLLKEGHR-----------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHHTTCC-----------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHHcCCC-----------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 111111100 011123456788999999999999999999999999999765543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=358.31 Aligned_cols=258 Identities=25% Similarity=0.456 Sum_probs=204.5
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCE----EEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTN----VAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|+..+.||+|+||+||+|+.. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 57888999999999999999854 4443 5888775433 234567999999999999999999999998765 689
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
|+||+++|+|.+++......+++..++.++.|++.||+|||. .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 999999999999999877779999999999999999999964 68999999999999999999999999999887654
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
..........+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~------------ 236 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE------------ 236 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTC------------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCC------------
Confidence 44433444567889999999999999999999999999999999 99999764322 2222222111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
....+..++..+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 237 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0111223456788999999999999999999999999988653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=347.45 Aligned_cols=268 Identities=22% Similarity=0.286 Sum_probs=206.2
Q ss_pred HhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
..++|+..+.||+|+||+||+|+..+|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3478999999999999999999988899999999875432 23467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||++ |++.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9997 5899998877777999999999999999999995 47899999999999999999999999999987653322
Q ss_pred cceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc---CCCcchhcccc
Q 005278 571 SVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL---PDGLTEVVDAN 646 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 646 (704)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+........ +..+....+..
T Consensus 175 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 175 --SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred --cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhccc
Confidence 2334568999999998876 568999999999999999999999998643322 2222222111 11111110000
Q ss_pred ------c--hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 647 ------L--VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 647 ------~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ............++.++.+++.+|++.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0000011112234567889999999999999999999954
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=364.55 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=211.0
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|...+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357888999999999999999853 46789999986543 34456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCC------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEEEe
Q 005278 487 ALVLEFMPNGSLEKWLYSHN------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM---TAHVS 557 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~---~~kl~ 557 (704)
++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999998543 45899999999999999999995 47899999999999999555 59999
Q ss_pred eeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcC
Q 005278 558 DFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLP 636 (704)
Q Consensus 558 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 636 (704)
|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||...... .....+....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~~i~~~~- 303 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGG- 303 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTC-
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-
Confidence 9999986543333233344568999999999988999999999999999999998 99999763211 1111111110
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
....+..++..+.+++..||+.||++||++.||++.|+.+.+..
T Consensus 304 ----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 304 ----------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ----------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 01112234567889999999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=360.85 Aligned_cols=265 Identities=25% Similarity=0.392 Sum_probs=213.0
Q ss_pred HHhCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNID 484 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 484 (704)
...++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999864 34889999997543 334567999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC-----------------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 005278 485 FKALVLEFMPNGSLEKWLYSHN-----------------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dl 541 (704)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 9999999999999999998632 46899999999999999999995 468999999
Q ss_pred CCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCcc
Q 005278 542 KPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEI 620 (704)
Q Consensus 542 k~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~ 620 (704)
||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |..||.+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987644332223344568999999999988899999999999999999999 99999763
Q ss_pred ccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 621 FIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
... .....+.... . ...+..++..+.+++..||+.||++||++.|+++.|+++.+++..
T Consensus 281 ~~~--~~~~~~~~~~---~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 281 AHE--EVIYYVRDGN---I--------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp CHH--HHHHHHHTTC---C--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred ChH--HHHHHHhCCC---c--------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 221 1111111100 0 011223456788999999999999999999999999998876654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.10 Aligned_cols=264 Identities=22% Similarity=0.352 Sum_probs=216.9
Q ss_pred hCCCCccccccccCceEEEEEEE------CCCCEEEEEEeeccch-hhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQLE-RASRSFDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
.++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788899999999999999985 2468899999975432 3457799999999999 99999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCC-----------------ccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 486 KALVLEFMPNGSLEKWLYSHNY-----------------FLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
.++||||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 9999999999999999986532 4899999999999999999995 4689999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |+.||....... ..
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-HH
Confidence 9999999999999988765544334445568899999999988899999999999999999999 999997643221 11
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
.......... ..+..++..+.+++.+||+.||++||++.|+++.|+++.++...
T Consensus 258 ~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 258 YKMIKEGFRM-----------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HHHHHHTCCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred HHHhccCCCC-----------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 1111111100 11123456788999999999999999999999999998876544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=348.00 Aligned_cols=251 Identities=19% Similarity=0.285 Sum_probs=207.2
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|...+.||+|+||.||+|+.. +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999865 6889999998754 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC--CCcEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE--NMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~--~~~~kl~Dfgla~~~~~~~~ 570 (704)
+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999999877667999999999999999999995 468999999999999997 7899999999998875432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......||+.|+|||++.+..++.++||||+||++|||++|..||...... ............ .
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~------------~- 222 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYT------------F- 222 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC------------C-
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHcCCCC------------C-
Confidence 234457999999999999888999999999999999999999999763211 111111110000 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......++.++.+++.+|++.||++|||+.|+++
T Consensus 223 --~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 --DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111234567889999999999999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=347.49 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=210.3
Q ss_pred HhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..++|+..+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 346888899999999999999999888899999997543 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 176 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT 176 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence 9999999999876666999999999999999999995 4689999999999999999999999999998764321 11
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......+|+.|+|||++.+..++.++||||+|+++|||+| |+.||....... ....+.....
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~--------------- 239 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLR--------------- 239 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTCC---------------
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHHhcccC---------------
Confidence 1223456888999999998889999999999999999998 999997632211 1111111000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+..++..+.+++..||+.||++||+++|+++.|+++.++
T Consensus 240 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 --LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 001112345688999999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.07 Aligned_cols=266 Identities=23% Similarity=0.361 Sum_probs=212.2
Q ss_pred HhCCCCccccccccCceEEEEEEE------CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCC
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNID 484 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 484 (704)
..++|...+.||+|+||.||+|+. .++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457889999999999999999985 245689999997543 33456799999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCC----------------------ccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNY----------------------FLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLK 542 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk 542 (704)
..++||||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 99999999999999999986532 3789999999999999999995 4789999999
Q ss_pred CCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccc
Q 005278 543 PNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIF 621 (704)
Q Consensus 543 ~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~ 621 (704)
|+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||+| |..||.+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987755444444455678899999999988899999999999999999998 999997643
Q ss_pred cccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhh
Q 005278 622 IGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDD 699 (704)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 699 (704)
... ........... ...+..++..+.+++..||+.||++||++.|+++.|+.+.+.....
T Consensus 280 ~~~-~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 280 VDA-NFYKLIQNGFK-----------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp CSH-HHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred cHH-HHHHHHhcCCC-----------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 221 12222221110 0111234567889999999999999999999999999987665543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.73 Aligned_cols=272 Identities=14% Similarity=0.136 Sum_probs=209.6
Q ss_pred HhCCCCccccccccCceEEEEEEECC------CCEEEEEEeeccchh-----------hhHHHHHHHHHHHhcCCCCCce
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFD------GTNVAIKVFNLQLER-----------ASRSFDSECEILRSIRHRNLIK 475 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~ 475 (704)
..++|.+.+.||+|+||.||+|...+ ++.||||++...... ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 478999998654311 1122344566677778999999
Q ss_pred EEeeeeeC----CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--
Q 005278 476 IISNCCNI----DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-- 549 (704)
Q Consensus 476 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-- 549 (704)
+++++... ...++||||+ +|+|.+++......+++..+..++.|++.||+|||. .+|+||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 99998764 4579999999 999999998876779999999999999999999954 6899999999999999
Q ss_pred CCCcEEEeeeccceecCCCCCc-----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccc
Q 005278 550 ENMTAHVSDFGISKLLGEGDDS-----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE 624 (704)
Q Consensus 550 ~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~ 624 (704)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 8899999999999876432211 1113345999999999999999999999999999999999999999863322
Q ss_pred ccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 625 MSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
.....+........+....++.+. ...++.++.+++..||+.+|++||++.++++.|+++.++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFP--------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSC--------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcc--------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 222222222221222222221110 12346778999999999999999999999999999877643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.89 Aligned_cols=261 Identities=27% Similarity=0.435 Sum_probs=197.3
Q ss_pred HhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
..++|+..+.||+|+||+||+|+.. ..||||+++... ....+.+.+|++++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3568999999999999999999854 469999987543 33456799999999999999999999965 455679999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++++|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999999877777999999999999999999995 47899999999999999999999999999987654333
Q ss_pred cceeccccccccccCCcccC---CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh-hcCCCcchhcccc
Q 005278 571 SVIQTMTIATIGYMAPEYGS---EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE-SLPDGLTEVVDAN 646 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 646 (704)
........||+.|+|||++. +..++.++||||||+++|||++|+.||......+. ....... .......
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~------ 248 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVGRGSLSPDLS------ 248 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHHHHHTSCCCCTT------
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHHhcccccCcchh------
Confidence 33334457999999999886 66788899999999999999999999976432221 1111111 1111110
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
.....++..+.+++..||+.||++||++.|+++.|+++.+
T Consensus 249 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 --------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0112445678999999999999999999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=347.80 Aligned_cols=257 Identities=27% Similarity=0.393 Sum_probs=203.4
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
++|+..+.||+|+||.||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56888899999999999999874 788999998643 345678999999999999999999998874 4789999999
Q ss_pred CCCHHHHHhhCCC--ccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc-EEEeeeccceecCCCCCc
Q 005278 495 NGSLEKWLYSHNY--FLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT-AHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 495 ~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~-~kl~Dfgla~~~~~~~~~ 571 (704)
+|+|.+++..... .+++..++.++.|+++|++|||+.|..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986542 4788999999999999999998866689999999999999998886 799999999765322
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...................
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 222 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--------------- 222 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---------------
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---------------
Confidence 223468999999999999999999999999999999999999997643221111111111000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
......++..+.+++.+||+.||++||+++|+++.|+.+.+.+..
T Consensus 223 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 223 --PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp --CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred --CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 011123456688999999999999999999999999999876643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.05 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=214.2
Q ss_pred hCCCCccccccccCceEEEEEEE------CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788899999999999999985 245889999997543 33456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCC-----------------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 005278 487 ALVLEFMPNGSLEKWLYSHN-----------------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKP 543 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~ 543 (704)
++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 99999999999999998543 24889999999999999999995 46899999999
Q ss_pred CCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCcccc
Q 005278 544 NNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFI 622 (704)
Q Consensus 544 ~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~ 622 (704)
+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999988755443333344567899999999988889999999999999999999 9999976432
Q ss_pred ccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 623 GEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
. .....+..... ...+..++..+.+++.+||+.||++||++.|+++.|+++.++
T Consensus 259 ~--~~~~~~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 E--RLFNLLKTGHR-----------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp G--GHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H--HHHHHhhcCCc-----------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 1 12222211110 011123456788999999999999999999999999998654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=342.51 Aligned_cols=265 Identities=15% Similarity=0.144 Sum_probs=215.6
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|...+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.+++.+ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999985 57999999998643 2345688999999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc-----EEEeeeccceecC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT-----AHVSDFGISKLLG 566 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~-----~kl~Dfgla~~~~ 566 (704)
|+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999977667999999999999999999995 578999999999999987776 9999999998875
Q ss_pred CCCCc-----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccccc--HHHHHHhhcCCCc
Q 005278 567 EGDDS-----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMS--LKHWVKESLPDGL 639 (704)
Q Consensus 567 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~ 639 (704)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... +.........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 239 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS--- 239 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH---
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC---
Confidence 53321 1234457999999999999999999999999999999999999999874322110 0110000000
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
.........++..+.+++..||+.||++||++++|++.|+++.++...
T Consensus 240 -----------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 240 -----------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp -----------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -----------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 000111224567889999999999999999999999999999876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=345.47 Aligned_cols=274 Identities=25% Similarity=0.362 Sum_probs=210.8
Q ss_pred HHHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhc--CCCCCceEEeeeeeC---
Q 005278 409 DIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSI--RHRNLIKIISNCCNI--- 483 (704)
Q Consensus 409 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~--- 483 (704)
......++|+..+.||+|+||.||+|+.. ++.||||++... ....+..|.+++... +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445678999999999999999999875 899999998643 233445555555554 899999999999887
Q ss_pred -CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCeeeCCCCcEEEe
Q 005278 484 -DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG-----HSTPMVHCDLKPNNILLDENMTAHVS 557 (704)
Q Consensus 484 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----h~~~ivH~dlk~~Nil~~~~~~~kl~ 557 (704)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||.. +..+|+||||||+||+++.++.+||+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 6889999999999999999765 389999999999999999999753 24499999999999999999999999
Q ss_pred eeccceecCCCCCcc--eeccccccccccCCcccCCCCCCcc------cceeeHHHHHHHHhhC----------CCCCCc
Q 005278 558 DFGISKLLGEGDDSV--IQTMTIATIGYMAPEYGSEGIISPK------SDVYSYGILLMETFTR----------KKPTNE 619 (704)
Q Consensus 558 Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~Gv~l~el~tg----------~~p~~~ 619 (704)
|||++..+....... ......||+.|+|||++.+...+.+ +|||||||++|||+|| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998764432211 1224479999999999887766665 9999999999999999 666665
Q ss_pred cccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 620 IFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
..........+............. +.......++..+.+++.+||+.||++||++.||++.|+++.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSF--------PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCC--------CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hcCCCCchhhhHHHHhhhccCccc--------cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 544444444433322211111111 111123367888999999999999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=349.00 Aligned_cols=248 Identities=22% Similarity=0.259 Sum_probs=203.5
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|+..+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357889999999999999999865 69999999997643 23446788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999997654 4889999999999999999995 4689999999999999999999999999998643222
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...........
T Consensus 160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~----------- 221 (337)
T 1o6l_A 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEE----------- 221 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC-----------
T ss_pred --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC-----------
Confidence 123445799999999999999999999999999999999999999975321 11111100000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++|| ++.|+++
T Consensus 222 ----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 001123456788999999999999999 8888865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=348.32 Aligned_cols=264 Identities=17% Similarity=0.186 Sum_probs=212.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|...+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999985 579999999986542 234688999999999 99999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc-----EEEeeeccceecC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT-----AHVSDFGISKLLG 566 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~-----~kl~Dfgla~~~~ 566 (704)
|+ +|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 99999999876667999999999999999999996 468999999999999998887 9999999999765
Q ss_pred CCCCcc-----eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcch
Q 005278 567 EGDDSV-----IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641 (704)
Q Consensus 567 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (704)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~i------- 232 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQKI------- 232 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHHH-------
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHHH-------
Confidence 433211 1234579999999999999999999999999999999999999998743221 11111100
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
..... ..........++ ++.+++..||+.||.+||++.+|.+.|+++.++.
T Consensus 233 -~~~~~--~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 233 -GDTKR--ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -HHHHH--HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -Hhhhc--cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00000 000000111234 7899999999999999999999999999887664
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.04 Aligned_cols=251 Identities=20% Similarity=0.256 Sum_probs=204.8
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchh------hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|+..+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999865 6999999999765321 246789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeeeccc
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM----TAHVSDFGIS 562 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~----~~kl~Dfgla 562 (704)
++||||+++|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999997643 5899999999999999999995 46899999999999998777 7999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+... ..........
T Consensus 167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~~~~~~i~~~----- 233 (361)
T 2yab_A 167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANITAV----- 233 (361)
T ss_dssp EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTT-----
T ss_pred eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhc-----
Confidence 8875432 22345799999999999999999999999999999999999999976321 1111110000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.... .......++..+.+++.+||+.||++|||+.|+++
T Consensus 234 ---~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 ---SYDF---DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ---CCCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---CCCC---CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 00111234567889999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=365.20 Aligned_cols=252 Identities=28% Similarity=0.438 Sum_probs=208.4
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-eEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID-FKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 492 (704)
.++|...+.||+|+||.||+|+.. ++.||||+++... ..+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888899999999999999875 7899999987542 4578999999999999999999999987765 78999999
Q ss_pred cCCCCHHHHHhhCCC-ccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSHNY-FLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++...+. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999986543 4689999999999999999995 468999999999999999999999999999865322
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....+++.|+|||++.+..++.++|||||||++|||+| |+.||......+ ....+...
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~---------------- 402 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG---------------- 402 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTT----------------
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----------------
Confidence 122357889999999999999999999999999999998 999997643221 11111110
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
.....+..++..+.+++..||+.||++|||+.|+++.|+++...
T Consensus 403 -~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 -YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01122335667889999999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=344.96 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=206.1
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999854 68999999985432 23446789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++...+ .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999998654 4899999999999999999995 4789999999999999999999999999998764332
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
. .......||+.|+|||.+.+..++.++||||+|+++|||+||+.||.+.... ..............
T Consensus 166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~------- 232 (294)
T 4eqm_A 166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SIAIKHIQDSVPNV------- 232 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HHHHHHHSSCCCCH-------
T ss_pred c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhhccCCCc-------
Confidence 1 1223456999999999999999999999999999999999999999763221 11111111110000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHhHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRV-SMKDAAAKLKKIKE 694 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-t~~ev~~~L~~~~~ 694 (704)
......+++..+.+++.+|++.||++|| +++++.+.|+++..
T Consensus 233 ---~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 ---TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ---HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ---chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0111223466788999999999999999 89999999887643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=340.76 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=205.2
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchh-------hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLER-------ASRSFDSECEILRSIRHRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 485 (704)
.++|+..+.||+|+||.||+|+. .+++.||+|++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36888999999999999999996 47899999998654321 1167899999999999999999999987665
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc-----EEEeeec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT-----AHVSDFG 560 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~-----~kl~Dfg 560 (704)
++||||+++|+|.+++......+++..+..++.|++.|++|||. +..+|+||||||+||+++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 69999999999999998777779999999999999999999965 2233999999999999988776 9999999
Q ss_pred cceecCCCCCcceeccccccccccCCccc--CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYG--SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG 638 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (704)
+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||...................
T Consensus 175 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-- 247 (287)
T 4f0f_A 175 LSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL-- 247 (287)
T ss_dssp TCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC--
T ss_pred ccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC--
Confidence 9985432 23345799999999998 45568899999999999999999999997644332222222111100
Q ss_pred cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
....+..++..+.+++..||+.||++||++.|+++.|+++
T Consensus 248 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 --------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0111224456788999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=343.52 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=200.1
Q ss_pred hCCCCccccccccCceEEEEEEECC----CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.++|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678889999999999999998642 4579999986543 334567899999999999999999999985 456789
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999877767999999999999999999995 468999999999999999999999999999876543
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.. .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.... .....+.....
T Consensus 170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~~----------- 235 (281)
T 1mp8_A 170 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER----------- 235 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC-----------
T ss_pred cc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCCC-----------
Confidence 22 12233457889999999988899999999999999999997 99999764322 12222111100
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
...+..++..+.+++..||+.||++||++.|+++.|+++.+.-
T Consensus 236 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 236 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1112244567889999999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=350.75 Aligned_cols=262 Identities=25% Similarity=0.417 Sum_probs=213.1
Q ss_pred hCCCCccccccccCceEEEEEEEC--------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNI 483 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 483 (704)
.++|...+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468889999999999999999863 46789999997543 33456789999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 99999999999999999998543 24889999999999999999995 4689999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--HH
Confidence 9999999999999988765433333344567889999999988889999999999999999999 99999763211 11
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
...+..... ...+..++..+.+++..||+.||++||++.|+++.|+++.....
T Consensus 269 ~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 269 FKLLKEGHR-----------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHhcCCC-----------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111111100 01122345678899999999999999999999999999876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.56 Aligned_cols=262 Identities=25% Similarity=0.429 Sum_probs=195.7
Q ss_pred HHhCCCCccccccccCceEEEEEEECC-C---CEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLFD-G---TNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF 485 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 485 (704)
...++|+..+.||+|+||.||+|+... + ..||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999998543 3 279999987542 3445779999999999999999999999987665
Q ss_pred E------EEEEeccCCCCHHHHHhhC-----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 486 K------ALVLEFMPNGSLEKWLYSH-----NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 486 ~------~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
. ++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCE
Confidence 5 8999999999999999743 225899999999999999999995 4689999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 633 (704)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+ .......
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~ 254 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYNYLIG 254 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHHHHhc
Confidence 9999999987755443333444567889999999999999999999999999999999 899997643221 1111111
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
.. ....+..++..+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 255 ~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 255 GN-----------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp TC-----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC-----------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 0111223456788999999999999999999999999998653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.32 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=207.5
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999865 6899999999766555566899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC--CCcEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE--NMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~--~~~~kl~Dfgla~~~~~~~~ 570 (704)
+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 9999999999877667999999999999999999995 478999999999999974 5789999999999875432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ......+...... . +
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~-~----~------ 270 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWE-F----D------ 270 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCCC-C----C------
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC-C----C------
Confidence 22344799999999999999999999999999999999999999976321 1111111110000 0 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......++.++.+++.+||+.||++||++.|+++
T Consensus 271 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 271 ---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0011234567889999999999999999999976
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.98 Aligned_cols=272 Identities=22% Similarity=0.277 Sum_probs=211.2
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC--eEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNID--FKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 490 (704)
++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57888999999999999999965 58999999987543 234567889999999999999999999988755 779999
Q ss_pred eccCCCCHHHHHhhCC--CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----CCCCcEEEeeecccee
Q 005278 491 EFMPNGSLEKWLYSHN--YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL----DENMTAHVSDFGISKL 564 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~----~~~~~~kl~Dfgla~~ 564 (704)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999998543 33899999999999999999995 4689999999999999 7888899999999988
Q ss_pred cCCCCCcceeccccccccccCCcccC--------CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHH---HHHHh
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGS--------EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK---HWVKE 633 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~---~~~~~ 633 (704)
...... .....||+.|+|||++. +..++.++|||||||++|||+||+.||........... .....
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 754332 23456999999999875 57789999999999999999999999975433222221 22222
Q ss_pred hcCCCcchhc---cccchh---hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 634 SLPDGLTEVV---DANLVR---EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 634 ~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
..+..+.... ...+.. ...........+..+.+++..||+.||++||+++|+++...+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111111110 000000 0011123456678899999999999999999999999887654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=345.43 Aligned_cols=274 Identities=26% Similarity=0.414 Sum_probs=212.5
Q ss_pred CCccccccccCceEEEEEEEC-----CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeEEE
Q 005278 417 FNECNLLGTGSFGSVYKGTLF-----DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKAL 488 (704)
Q Consensus 417 ~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 488 (704)
|+..+.||+|+||+||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 388899999999999998653 58899999997653 3445679999999999999999999999987 467899
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++.... +++..++.++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 999999999999998654 899999999999999999995 478999999999999999999999999999987554
Q ss_pred CCc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC-cchhcccc
Q 005278 569 DDS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG-LTEVVDAN 646 (704)
Q Consensus 569 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 646 (704)
... .......+|+.|+|||++.+..++.++||||||+++|||+||+.||............ .... ........
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG-----IAQGQMTVLRLTE 262 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC-----SCCHHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhc-----ccccchhHHHHHH
Confidence 322 1233446888999999999888999999999999999999999998753221100000 0000 00000000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhh
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDV 700 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 700 (704)
..........+..++..+.+++..||+.||++||++.|+++.|+++.+++..+.
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 000011112233456789999999999999999999999999999999887653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=348.80 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=201.5
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999996 578999999987543 22345789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+ +|+|.+++...+ .+++..+..++.|++.|++|||. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 789999987654 48999999999999999999964 689999999999999999999999999998764432
Q ss_pred CcceeccccccccccCCcccCCCCC-CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
. .....||+.|+|||++.+..+ ++++||||+||++|+|++|+.||.+...... ...+...
T Consensus 163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~i~~~--- 223 (336)
T 3h4j_B 163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKKVNSC--- 223 (336)
T ss_dssp T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCCCCSS---
T ss_pred c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHHHHcC---
Confidence 2 234569999999999988775 7899999999999999999999976321110 0000000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..++..+.+++.+||+.||++|||++|+++
T Consensus 224 ----~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 ----VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ----CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ----CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00112234567889999999999999999999965
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=346.92 Aligned_cols=258 Identities=24% Similarity=0.419 Sum_probs=205.6
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCE----EEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTN----VAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|+..+.||+|+||+||+|+.. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999864 4554 7777765432 223356788999999999999999999986 456789
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999877667899999999999999999995 468999999999999999999999999999987655
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
..........+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... .....+.....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~----------- 235 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGER----------- 235 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCB-----------
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCC-----------
Confidence 44444455678889999999998999999999999999999999 99999764321 12222221110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+..++..+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 236 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 236 ------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011112344577899999999999999999999999988543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=340.06 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=195.2
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccch----hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE----RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|+..+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999964 88999999865432 2346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC--------CCcEEEeeecc
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE--------NMTAHVSDFGI 561 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~--------~~~~kl~Dfgl 561 (704)
|||+++|+|.+++... .+++..++.++.|++.|++|||.....+|+||||||+||+++. ++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999998643 4899999999999999999997743344999999999999986 77899999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcch
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (704)
+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .........
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~-- 231 (271)
T 3dtc_A 163 AREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-----AYGVAMNKL-- 231 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----HHHHHTSCC--
T ss_pred cccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHhhhcCCC--
Confidence 98664322 2234689999999999988999999999999999999999999976322111 000000000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
....+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus 232 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 -----------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0111223456788999999999999999999999999754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=347.35 Aligned_cols=269 Identities=25% Similarity=0.379 Sum_probs=216.6
Q ss_pred HHHHHHhCCCCccccccccCceEEEEEEE------CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEee
Q 005278 408 LDIQRATNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISN 479 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 479 (704)
.......++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33444567899999999999999999974 246889999997643 23446789999999999 79999999999
Q ss_pred eeeCC-eEEEEEeccCCCCHHHHHhhCCC---------------ccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 005278 480 CCNID-FKALVLEFMPNGSLEKWLYSHNY---------------FLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKP 543 (704)
Q Consensus 480 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~ 543 (704)
+...+ ..++||||+++|+|.+++..... .+++..++.++.|++.|++||| +.+|+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCcc
Confidence 87754 58999999999999999986543 2789999999999999999995 46899999999
Q ss_pred CCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCcccc
Q 005278 544 NNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFI 622 (704)
Q Consensus 544 ~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~ 622 (704)
+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |..||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999987755444444455678999999999998999999999999999999998 9999976432
Q ss_pred ccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 623 GEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
... .......... ...+..++..+.+++..||+.||++||++.|+++.|+++.+...
T Consensus 257 ~~~-~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DEE-FCRRLKEGTR-----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SHH-HHHHHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHH-HHHHhccCcc-----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 221 1111111100 01111234568899999999999999999999999999876654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.31 Aligned_cols=275 Identities=22% Similarity=0.353 Sum_probs=219.0
Q ss_pred HHHHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHh--cCCCCCceEEeeeeeCC-
Q 005278 408 LDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRS--IRHRNLIKIISNCCNID- 484 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~- 484 (704)
.......++|...+.||+|+||.||+|+. +++.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33345567899999999999999999987 5899999998643 34567788999888 78999999999998875
Q ss_pred ---eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCeeeCCCCcEEE
Q 005278 485 ---FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG-----HSTPMVHCDLKPNNILLDENMTAHV 556 (704)
Q Consensus 485 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----h~~~ivH~dlk~~Nil~~~~~~~kl 556 (704)
..++||||+++|+|.+++... .+++..++.++.|++.|++|||.. ++.+|+||||||+||+++.++.+||
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred ccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 789999999999999999764 389999999999999999999731 2688999999999999999999999
Q ss_pred eeeccceecCCCCCcc--eeccccccccccCCcccCCC------CCCcccceeeHHHHHHHHhhC----------CCCCC
Q 005278 557 SDFGISKLLGEGDDSV--IQTMTIATIGYMAPEYGSEG------IISPKSDVYSYGILLMETFTR----------KKPTN 618 (704)
Q Consensus 557 ~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~el~tg----------~~p~~ 618 (704)
+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||+|| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999998775443221 22345799999999998765 334689999999999999999 77887
Q ss_pred ccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 619 EIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
...........+............... .....+++..+.+++..||+.||++||++.||++.|+++.++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPN--------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCG--------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcc--------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 755555555555443322221111111 1122356778999999999999999999999999999997654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=346.07 Aligned_cols=269 Identities=23% Similarity=0.373 Sum_probs=209.0
Q ss_pred CCCCccccccccCceEEEEEEE-----CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-----FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNI--DFK 486 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 486 (704)
+.|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 368999999987543 23446789999999999999999999999876 668
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999876667999999999999999999995 4789999999999999999999999999998875
Q ss_pred CCCCc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcc---hh
Q 005278 567 EGDDS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT---EV 642 (704)
Q Consensus 567 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 642 (704)
..... .......||..|+|||++.+..++.++||||+|+++|||+||..|+.... ..+.....+.... ..
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHCSCCGGGHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccCCcccccCHHH
Confidence 54322 22334568889999999998899999999999999999999999865421 1111110010000 00
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
.... .........+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 252 ~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHH-HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH-HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000 0000111223345678899999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=340.79 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=212.0
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
++|...+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57888899999999999999988889999999975432 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 162 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-cccc
Confidence 99999999887777899999999999999999995 4789999999999999999999999999998664321 1112
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~----------------- 223 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFR----------------- 223 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC-----------------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCc-----------------
Confidence 23457889999999988889999999999999999999 89998763211 11111111000
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+..++..+.+++.+||+.||++||++.|+++.|+++.++
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 001112345688999999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=352.26 Aligned_cols=267 Identities=22% Similarity=0.380 Sum_probs=215.6
Q ss_pred HHHhCCCCccccccccCceEEEEEEECC-C-----CEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeee
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLFD-G-----TNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCN 482 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 482 (704)
....++|...+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445789999999999999999998642 2 479999987543 23456789999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 005278 483 IDFKALVLEFMPNGSLEKWLYSH-------------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD 549 (704)
Q Consensus 483 ~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~ 549 (704)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||. .+|+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEEC
Confidence 99999999999999999999743 2347899999999999999999964 6899999999999999
Q ss_pred CCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHH
Q 005278 550 ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLK 628 (704)
Q Consensus 550 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~ 628 (704)
.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |..||.+..... ...
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHH
Confidence 999999999999987654443333445567889999999988899999999999999999999 899997643221 111
Q ss_pred HHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 629 HWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
......... ..+..++..+.+++..||+.||++||++.|+++.|+++.++...
T Consensus 278 ~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 330 (333)
T 2i1m_A 278 KLVKDGYQM-----------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330 (333)
T ss_dssp HHHHHTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCC-----------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence 222211110 11112345788999999999999999999999999998766543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=355.32 Aligned_cols=253 Identities=19% Similarity=0.269 Sum_probs=203.5
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
..++|+..+.||+|+||+||+|.. .+|+.+|+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456899999999999999999985 478999999987543 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEeeeccceecC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD---ENMTAHVSDFGISKLLG 566 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~---~~~~~kl~Dfgla~~~~ 566 (704)
|||+++|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++ .++.+||+|||++....
T Consensus 89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999998654 4899999999999999999995 46899999999999998 56789999999998765
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+... ......+...... .
T Consensus 165 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~-~------- 232 (444)
T 3soa_A 165 GEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKAGAYD-F------- 232 (444)
T ss_dssp TTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCC-C-------
T ss_pred CCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCCC-C-------
Confidence 4322 22345799999999999999999999999999999999999999965221 1111111110000 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+....++..+.+++.+||+.||++|||+.|+++
T Consensus 233 ------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 ------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00111234567889999999999999999999976
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=341.73 Aligned_cols=266 Identities=23% Similarity=0.284 Sum_probs=201.9
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|+||+||+|+..+|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999988899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 975 999999877667899999999999999999995 46899999999999999999999999999987643221
Q ss_pred eeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC---CCcchh-----c
Q 005278 573 IQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP---DGLTEV-----V 643 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~-----~ 643 (704)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+......... ..+... .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhccccc
Confidence 2234468999999998865 458999999999999999999999997643211 11111111000 001000 0
Q ss_pred cccchhhh--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 644 DANLVREE--QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 644 ~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
++...... ........++..+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 000111234567889999999999999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.94 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=203.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchh------hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
++|...+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888999999999999999965 6899999998754321 3567999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeeeccce
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM----TAHVSDFGISK 563 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~----~~kl~Dfgla~ 563 (704)
+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999754 34899999999999999999995 47899999999999999887 89999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+....+ .+... ....
T Consensus 167 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~-~~~~-------- 233 (326)
T 2y0a_A 167 KIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANV-SAVN-------- 233 (326)
T ss_dssp ECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHH-HHTC--------
T ss_pred ECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHH-HhcC--------
Confidence 7753322 234569999999999999999999999999999999999999996532110 01111 0000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.... ......++..+.+++.+||+.||++|||+.|+++
T Consensus 234 -~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 -YEFE-----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CCCC-----HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCcC-----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0111234567889999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=368.88 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=211.2
Q ss_pred HhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..++|...+.||+|+||.||+|+..++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456788889999999999999999889999999997543 34678999999999999999999999986 5668999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-H
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-e
Confidence 9999999999854 235788999999999999999995 4689999999999999999999999999998764321 1
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......+|+.|+|||++....++.++|||||||++|||+| |+.||.+....+ ....+...
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~---------------- 401 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERG---------------- 401 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHT----------------
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----------------
Confidence 11223346789999999998899999999999999999999 999997632211 11111110
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
...+.+..++..+.+++.+||+.||++|||+.+|++.|+++....
T Consensus 402 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 011122345678899999999999999999999999999876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.01 Aligned_cols=274 Identities=26% Similarity=0.429 Sum_probs=214.6
Q ss_pred CCCCccccccccCceEEEEEEE-----CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC--eEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-----FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID--FKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~ 487 (704)
++|+..+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5688889999999999999984 368999999997665556678999999999999999999999986644 679
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999999987777999999999999999999995 47899999999999999999999999999988754
Q ss_pred CCCcc-eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc-
Q 005278 568 GDDSV-IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA- 645 (704)
Q Consensus 568 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 645 (704)
..... ......++..|+|||.+.+..++.++||||||+++|||+||..|+..... .+...............
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH------HHHHHHCTTCCTHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH------HHHHhhccccchhhhHHH
Confidence 43221 12234578889999999888899999999999999999999999764211 11100000000000000
Q ss_pred --cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 646 --NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 646 --~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
.........+.+..++..+.+++..||+.||++||++.|+++.|+++++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0000001112233456789999999999999999999999999999988764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.90 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=202.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-----hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-----RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 57889999999999999999864 689999999865321 135678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc---EEEeeeccc
Q 005278 489 VLEFMPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT---AHVSDFGIS 562 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~---~kl~Dfgla 562 (704)
||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999888643 345899999999999999999995 468999999999999986654 999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ............
T Consensus 181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~------ 250 (351)
T 3c0i_A 181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYK------ 250 (351)
T ss_dssp EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCC------
T ss_pred eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCC------
Confidence 8875432 123345799999999999999999999999999999999999999976311 111111110000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. .......++..+.+++.+||+.||++||++.|+++
T Consensus 251 ------~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 ------M---NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ------C---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------C---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00111234567889999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=348.89 Aligned_cols=271 Identities=27% Similarity=0.387 Sum_probs=213.0
Q ss_pred CCCCccccccccCceEEEEEEE-----CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeee--eCCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-----FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC--NIDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~ 487 (704)
++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999984 368899999998765666678999999999999999999999886 455689
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999876667999999999999999999995 47899999999999999999999999999998754
Q ss_pred CCCc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC----cchh
Q 005278 568 GDDS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG----LTEV 642 (704)
Q Consensus 568 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~ 642 (704)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +........ ....
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE------FLRMMGCERDVPALSRL 253 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HHHHCC----CCHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch------hhhhcccccccccHHHH
Confidence 3322 1223346888999999999888999999999999999999999998653211 000000000 0000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
.. ..........+..++..+.+++..||+.||++||++.|+++.|+++....
T Consensus 254 ~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 254 LE--LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HH--HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HH--HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 00 00001111223355678899999999999999999999999999886543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=350.70 Aligned_cols=244 Identities=23% Similarity=0.271 Sum_probs=195.6
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 487 (704)
..++|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|.++++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999865 68999999997643 23445688899999998 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus 101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999998654 3899999999999999999995 46899999999999999999999999999985432
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+..... . .
T Consensus 177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~----~--------~- 240 (353)
T 3txo_A 177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILN----D--------E- 240 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH----C--------C-
T ss_pred CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHc----C--------C-
Confidence 21 22344579999999999998889999999999999999999999997632111 1111111 0 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
...+...+..+.+++.+|++.||++||++
T Consensus 241 ------~~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 ------VVYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred ------CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 01111234567889999999999999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.23 Aligned_cols=267 Identities=21% Similarity=0.242 Sum_probs=203.3
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999965 68999999997543 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++ ++.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence 9975 777777766667999999999999999999995 4689999999999999999999999999998764322
Q ss_pred ceeccccccccccCCcccCCCC-CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC---cchhcc---
Q 005278 572 VIQTMTIATIGYMAPEYGSEGI-ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG---LTEVVD--- 644 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 644 (704)
.......||+.|+|||++.+.. ++.++||||+||++|||++|+.||.........+........... +.....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2234457899999999987765 899999999999999999998886432222222222222111110 100000
Q ss_pred c----cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 A----NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ~----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ..............++..+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 000000001111234567889999999999999999999954
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.56 Aligned_cols=259 Identities=25% Similarity=0.449 Sum_probs=202.6
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCE----EEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTN----VAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
.++|+..+.||+|+||.||+|+.. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367899999999999999999854 4554 4667664332 334577999999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+|+||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999987777999999999999999999995 46899999999999999999999999999988755
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
...........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~----------- 236 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE----------- 236 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTC-----------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence 443333444567889999999999999999999999999999999 99999764322 2222222111
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
....+..++..+.+++..||+.||++||++.|+++.|+++.+.
T Consensus 237 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 ------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111223456788999999999999999999999999998743
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=347.18 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=203.9
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999865 68999999997543 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN---MTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~---~~~kl~Dfgla~~~~~ 567 (704)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.+ +.+||+|||++.....
T Consensus 108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999999997654 4899999999999999999995 4689999999999999865 4599999999987653
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+... ......+...... .
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~-~-------- 249 (362)
T 2bdw_A 184 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYD-Y-------- 249 (362)
T ss_dssp CCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC-C--------
T ss_pred Ccc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCC-C--------
Confidence 322 2345799999999999998999999999999999999999999975321 1111111111000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.......++..+.+++.+||+.||++||++.|+++.
T Consensus 250 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001112345678899999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=368.93 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=211.5
Q ss_pred hCCCCccccccccCceEEEEEEECC-CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|...+.||+|+||.||+|++.. +..||||+++... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568888999999999999999764 8899999987543 3457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence 9999999999864 455899999999999999999995 4789999999999999999999999999998764322 2
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......+++.|+|||++.+..++.++|||||||++|||+| |..||.+.... .....+....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~--------------- 436 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDY--------------- 436 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTC---------------
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---------------
Confidence 22233456789999999998899999999999999999999 99999764322 1122111110
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
....+..++..+.+++..||+.||++||++.|+++.|+.+
T Consensus 437 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 437 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1112234567789999999999999999999999999886
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.61 Aligned_cols=244 Identities=23% Similarity=0.260 Sum_probs=194.0
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..++||+|+||+||+|+.. +++.||||++.... .........|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57899999999999999999976 79999999986532 22334455566666555 8999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+ +|+|.+++...+..+++..++.++.|++.||+|||. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 679999998777779999999999999999999964 689999999999999999999999999998764332
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......||++|+|||++.+ .++.++|||||||++|||++|..|+.... .|.. .... ..
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-------~~~~--~~~~-------~~--- 269 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-------GWQQ--LRQG-------YL--- 269 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-------HHHH--HTTT-------CC---
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHH--Hhcc-------CC---
Confidence 2334569999999998876 78999999999999999999977654311 1110 0000 00
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..++..+.+++.+||+.||++|||++|+++
T Consensus 270 --~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 --PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01112234677899999999999999999999964
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=353.94 Aligned_cols=271 Identities=23% Similarity=0.374 Sum_probs=216.7
Q ss_pred HHHHHHhCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeee
Q 005278 408 LDIQRATNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNC 480 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 480 (704)
.+.....++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344456678999999999999999999754 37889999987543 23445789999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCCHHHHHhhCC---------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC
Q 005278 481 CNIDFKALVLEFMPNGSLEKWLYSHN---------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN 551 (704)
Q Consensus 481 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~ 551 (704)
.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||. .+|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence 99999999999999999999997532 346899999999999999999954 689999999999999999
Q ss_pred CcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHH
Q 005278 552 MTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHW 630 (704)
Q Consensus 552 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~ 630 (704)
+.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||..... ...
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~ 249 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQV 249 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----HHH
Confidence 9999999999987644332222334467899999999998899999999999999999999 8899876322 111
Q ss_pred HHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhh
Q 005278 631 VKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDV 700 (704)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 700 (704)
......... ...+..++..+.+++..||+.||++||++.|+++.|++..+...+++
T Consensus 250 ~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 250 LRFVMEGGL--------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp HHHHHTTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HHHHHcCCc--------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 111111000 01112345678899999999999999999999999998766555443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.54 Aligned_cols=261 Identities=26% Similarity=0.454 Sum_probs=204.7
Q ss_pred CCCCccccccccCceEEEEEEECC-----CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFD-----GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
++|...+.||+|+||.||+|+... +..||||++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778999999999999998542 2359999987543 3345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++......+++..+..++.|++.||+|||. .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 999999999999998776779999999999999999999954 68999999999999999999999999999876543
Q ss_pred CCc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 569 DDS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 569 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~----------- 267 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGF----------- 267 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC-----------
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCC-----------
Confidence 221 12223356889999999998899999999999999999999 99999653221 1111111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
..+.+..++..+.+++.+||+.||++||++.|+++.|+++.+...
T Consensus 268 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 268 ------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp ------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 011122345678899999999999999999999999999876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.59 Aligned_cols=262 Identities=24% Similarity=0.410 Sum_probs=212.5
Q ss_pred CCCCccc-cccccCceEEEEEEEC---CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECN-LLGTGSFGSVYKGTLF---DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
++|.+.+ .||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4556665 8999999999999853 57889999997643 34556799999999999999999999999 45668999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999999877677999999999999999999995 4689999999999999999999999999998875433
Q ss_pred Cc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 570 DS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 570 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.. .......+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... .....+.....
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~~~----------- 231 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR----------- 231 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCC-----------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcCCc-----------
Confidence 21 12233457899999999988889999999999999999999 99999763221 11222111100
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhh
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDD 699 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 699 (704)
...+..++..+.+++..||+.||++||++.|+++.|+++..+....
T Consensus 232 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 232 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 1112244667889999999999999999999999999997765543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=338.43 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=204.7
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC--CeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI--DFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 489 (704)
.++|...+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999975 8899999987543 33456799999999999999999999999887 778999
Q ss_pred EeccCCCCHHHHHhhCCC-ccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 490 LEFMPNGSLEKWLYSHNY-FLGILERLNIMIDVGLALEYLHHGHSTP--MVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~h~~~--ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
|||+++|+|.+++..... .+++..++.++.|++.|++|| |+.+ |+||||||+||+++.++.++++|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH---TTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999986543 589999999999999999999 5556 9999999999999999999999999876432
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCc---ccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISP---KSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||......... .........
T Consensus 165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~------- 229 (271)
T 3kmu_A 165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-MKVALEGLR------- 229 (271)
T ss_dssp C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-HHHHHSCCC-------
T ss_pred c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-HHHHhcCCC-------
Confidence 2 2346899999999987765444 799999999999999999999763221110 011010000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
...+..++..+.+++..||+.||++|||++|+++.|+++++
T Consensus 230 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 ----------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01112345678899999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=354.84 Aligned_cols=262 Identities=24% Similarity=0.402 Sum_probs=200.5
Q ss_pred CCCccccccccCceEEEEEEEC--CC--CEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeee-CCeEEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF--DG--TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCN-IDFKALV 489 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 489 (704)
.|...+.||+|+||.||+|+.. ++ ..||||.+.... ....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999853 22 468999986533 3445779999999999999999999998754 5578999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999877777899999999999999999995 4689999999999999999999999999998764332
Q ss_pred Cc--ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 570 DS--VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 570 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.. .......+|+.|+|||++.+..++.++|||||||++|||+| |..||...... ..........
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~~----------- 313 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGR----------- 313 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTTC-----------
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcCC-----------
Confidence 21 12233467889999999999999999999999999999999 67777653222 2222221110
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhh
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDD 699 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 699 (704)
....+..++..+.+++.+||+.||++||++.|+++.|+++...+..+
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 01112234567889999999999999999999999999998877654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=347.54 Aligned_cols=249 Identities=25% Similarity=0.305 Sum_probs=201.6
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357889999999999999999865 68899999987543 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+....
T Consensus 94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999998653 4899999999999999999995 5789999999999999999999999999998765432
Q ss_pred CcceeccccccccccCCcccCC---CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 570 DSVIQTMTIATIGYMAPEYGSE---GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...........
T Consensus 170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~~---------- 234 (384)
T 4fr4_A 170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFET---------- 234 (384)
T ss_dssp ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHHHHHH----------
T ss_pred ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhh----------
Confidence 2344579999999999864 45899999999999999999999999753221 11111111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS-MKDAA 686 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-~~ev~ 686 (704)
.....+..++..+.+++.+||+.||++||+ +.++.
T Consensus 235 -----~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 235 -----TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred -----cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 001112234567889999999999999998 66654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.77 Aligned_cols=246 Identities=21% Similarity=0.292 Sum_probs=198.5
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 420 CNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
.+.||+|+||.||+|+. .+|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999986 46999999999876555667899999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee--CCCCcEEEeeeccceecCCCCCcceecc
Q 005278 499 EKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL--DENMTAHVSDFGISKLLGEGDDSVIQTM 576 (704)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~--~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 576 (704)
.+++......+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++.+..... ...
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~ 247 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV 247 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence 9999877667999999999999999999995 4789999999999999 6778999999999998754322 233
Q ss_pred ccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhh
Q 005278 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSV 656 (704)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (704)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+..+...... . . ...
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~--~--------~-----~~~ 311 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWD--L--------E-----DEE 311 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC--S--------C-----SGG
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC--C--------C-----hhh
Confidence 46999999999999999999999999999999999999999763211 111111111000 0 0 001
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 657 KIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 657 ~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...++..+.+++.+||+.||++||++.|+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1234567889999999999999999999987
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=348.46 Aligned_cols=249 Identities=18% Similarity=0.258 Sum_probs=198.7
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 488 (704)
.++|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..+++++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999965 58899999997653 22345688899999887 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus 131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999998654 4899999999999999999995 478999999999999999999999999999863322
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccc---cHHHHHHhhcCCCcchhccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM---SLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 645 (704)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ....+.... +..
T Consensus 207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~-------i~~- 276 (396)
T 4dc2_A 207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------ILE- 276 (396)
T ss_dssp T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH-------HHH-
T ss_pred C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH-------Hhc-
Confidence 2 223456799999999999999999999999999999999999999965321110 000111000 000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
.....+..++.++.+++.+||+.||++||++
T Consensus 277 ------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 277 ------KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0011122345678899999999999999996
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.92 Aligned_cols=245 Identities=26% Similarity=0.316 Sum_probs=202.4
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999865 69999999997543 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 99999999999998654 4889999999999999999994 578999999999999999999999999999876432
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ........ ....
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~--------~~~~-- 220 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKIL--------NAEL-- 220 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHH--------HCCC--
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHH--------hCCC--
Confidence 2345799999999999999999999999999999999999999975321 11111100 0000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
..+..++.++.+++.+|++.||++|| ++.|+++
T Consensus 221 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01112345688999999999999999 7888853
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.28 Aligned_cols=263 Identities=24% Similarity=0.398 Sum_probs=207.4
Q ss_pred hCCCCccccccccCceEEEEEEECC----CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeee-eCCeEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCC-NIDFKA 487 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~ 487 (704)
..+|...+.||+|+||.||+|+..+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568888999999999999998542 2358999886543 334567899999999999999999999864 456789
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999877777899999999999999999995 46899999999999999999999999999987644
Q ss_pred CCC--cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 568 GDD--SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 568 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
... ........+|+.|+|||.+.+..++.++||||+|+++|||++ |..||..... ............
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~~~~~~~~~~~-------- 250 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRR-------- 250 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--TTHHHHHHTTCC--------
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhcCCC--------
Confidence 321 112334467889999999998899999999999999999999 5555554222 111111111100
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
...+..++..+.+++.+||+.||++||++.|+++.|+++.+.+..
T Consensus 251 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 251 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 011123345788999999999999999999999999999887654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=349.75 Aligned_cols=273 Identities=25% Similarity=0.352 Sum_probs=200.1
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHH--HHHHHHhcCCCCCceEEeeeee-----CCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDS--ECEILRSIRHRNLIKIISNCCN-----IDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~l~~~~~~-----~~~~ 486 (704)
.++|+..+.||+|+||.||+|+. +++.||||++.... ...+.. |+..+..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46889999999999999999976 68999999986542 233333 4444556899999999985532 3356
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcC------CCCcEecCCCCCCeeeCCCCcEEEeeec
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH------STPMVHCDLKPNNILLDENMTAHVSDFG 560 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h------~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 560 (704)
++||||+++|+|.+++.... .++..+..++.|++.||+|||..+ ..+|+||||||+||+++.++.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 89999999999999997665 488899999999999999997531 2399999999999999999999999999
Q ss_pred cceecCCCCC------cceeccccccccccCCcccCC-------CCCCcccceeeHHHHHHHHhhCCCCCCccccc-cc-
Q 005278 561 ISKLLGEGDD------SVIQTMTIATIGYMAPEYGSE-------GIISPKSDVYSYGILLMETFTRKKPTNEIFIG-EM- 625 (704)
Q Consensus 561 la~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~-~~- 625 (704)
+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...... ..
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987753221 112234469999999999876 45677899999999999999997775432111 10
Q ss_pred -----------cHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 626 -----------SLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 626 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
....+......... .+.+ .........++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQ----RPKF---PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCC----CCCC---CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhccccc----CCCC---CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 01111000000000 0000 01111223466789999999999999999999999999999988
Q ss_pred Hhhhh
Q 005278 695 KFLDD 699 (704)
Q Consensus 695 ~~~~~ 699 (704)
.|.+.
T Consensus 319 ~~~~~ 323 (336)
T 3g2f_A 319 IWERN 323 (336)
T ss_dssp CCCC-
T ss_pred HHHhc
Confidence 77653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.64 Aligned_cols=266 Identities=26% Similarity=0.440 Sum_probs=201.4
Q ss_pred HHHhCCCCccccccccCceEEEEEEEC----CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID 484 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 484 (704)
....++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334568888999999999999999854 34589999987543 334567899999999999999999999997754
Q ss_pred -----eEEEEEeccCCCCHHHHHhh-----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 485 -----FKALVLEFMPNGSLEKWLYS-----HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 485 -----~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
..++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcE
Confidence 34899999999999999953 3356899999999999999999995 5789999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 633 (704)
||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ........
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~ 264 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYLLH 264 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHHc
Confidence 9999999987654433333344567889999999999999999999999999999999 88898763322 11111111
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
... ...+..++..+.+++.+||+.||++||++.|+++.|+++.+...+
T Consensus 265 ~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 265 GHR-----------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp TCC-----------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCC-----------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 100 111223456788999999999999999999999999999877653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=350.66 Aligned_cols=270 Identities=18% Similarity=0.244 Sum_probs=204.1
Q ss_pred hCCCCcccccccc--CceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTG--SFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.++|++.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999965 79999999997654 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 489 VLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999864 345899999999999999999995 46899999999999999999999999999876532
Q ss_pred CCC-----cceeccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCc-
Q 005278 568 GDD-----SVIQTMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL- 639 (704)
Q Consensus 568 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 639 (704)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.......... .....+...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-hcCCCCcccc
Confidence 211 111223468999999999887 67999999999999999999999999764332211111 100000000
Q ss_pred ----------------------chhccc----cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 640 ----------------------TEVVDA----NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 640 ----------------------~~~~~~----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...... ...........+..++..+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000000 000000111223345677999999999999999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.15 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=195.3
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCC--CCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRH--RNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 489 (704)
.++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45789999999999999999998889999999987543 3344678999999999986 9999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|| +.+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||+++......
T Consensus 88 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred Ee-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 99 56889999998754 4889999999999999999995 46899999999999997 6789999999998775443
Q ss_pred CcceeccccccccccCCcccCC-----------CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC
Q 005278 570 DSVIQTMTIATIGYMAPEYGSE-----------GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG 638 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (704)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+..........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~- 240 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI- 240 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC-
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc-
Confidence 3333445679999999998754 6789999999999999999999999976332111111111100000
Q ss_pred cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+...+..+.+++..||+.||++|||+.|+++.
T Consensus 241 ----------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 241 ----------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ----------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0111123467889999999999999999999753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=337.42 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=208.2
Q ss_pred HhCCCCccccccccCceEEEEEEECC----CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
..++|...+.||+|+||.||+|+..+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 34678889999999999999998542 3459999987653 34457799999999999999999999998754 468
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999999877777899999999999999999995 47899999999999999999999999999987644
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
... .......+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... ...........
T Consensus 166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~---------- 232 (281)
T 3cc6_A 166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDR---------- 232 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCC----------
T ss_pred ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCC----------
Confidence 321 12234457889999999988899999999999999999998 99999753222 11121111100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
...+..++..+.+++.+||+.||++||++.|+++.|+++.+.-.
T Consensus 233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 01112345678899999999999999999999999999876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.40 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=188.8
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467999999999999999999975 58899999987542 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEeeeccceecCCC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---NMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---~~~~kl~Dfgla~~~~~~ 568 (704)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 999999999997654 4899999999999999999995 468999999999999975 889999999999876432
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+......... ..
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-----~~----- 271 (349)
T 2w4o_A 205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-----FI----- 271 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-----CC-----
T ss_pred c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-----cC-----
Confidence 1 2234568999999999999999999999999999999999999996532221111111110000 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+....++..+.+++.+||+.||++||++.|+++
T Consensus 272 -----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 -----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011234567889999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=344.36 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=197.3
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC-------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNID------- 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 484 (704)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457889999999999999999975 79999999997543 335577999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEeccCCCCHHHHHhhCC--CccCHH
Q 005278 485 --------------------------------------------------FKALVLEFMPNGSLEKWLYSHN--YFLGIL 512 (704)
Q Consensus 485 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~--~~~~~~ 512 (704)
..++||||+++|+|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3789999999999999998643 335666
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc----------ceecccccccc
Q 005278 513 ERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS----------VIQTMTIATIG 582 (704)
Q Consensus 513 ~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~ 582 (704)
.++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999995 478999999999999999999999999999987654221 12234469999
Q ss_pred ccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHH
Q 005278 583 YMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLL 662 (704)
Q Consensus 583 y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (704)
|+|||++.+..++.++|||||||++|||++|..|+.... ........ . .........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------~~~~~~~~--------~------~~~~~~~~~~~ 300 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------RIITDVRN--------L------KFPLLFTQKYP 300 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------HHHHHHHT--------T------CCCHHHHHHCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------HHHHHhhc--------c------CCCcccccCCh
Confidence 999999999999999999999999999999877753311 00000000 0 00112224456
Q ss_pred HHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 663 SIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 663 ~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+.+++.+||+.||++||++.|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 6788999999999999999999965
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=365.32 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=205.3
Q ss_pred HhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..++|...+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346788889999999999999999888889999987543 235679999999999999999999999876 668999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence 9999999999753 345899999999999999999995 47899999999999999999999999999987654321
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......+++.|+|||++.+..++.++|||||||++|||+| |+.||.+....+ ....+...
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~---------------- 397 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERG---------------- 397 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT----------------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----------------
Confidence 12233457889999999998899999999999999999999 999997632211 11111100
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+.+..++..+.+++.+||+.||++|||++++++.|+++...
T Consensus 398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 01112234567789999999999999999999999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.32 Aligned_cols=249 Identities=24% Similarity=0.296 Sum_probs=195.0
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--------------------------hhhHHHHHHHHHHH
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--------------------------RASRSFDSECEILR 466 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 466 (704)
.++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999864 689999999865421 11356889999999
Q ss_pred hcCCCCCceEEeeeee--CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 005278 467 SIRHRNLIKIISNCCN--IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPN 544 (704)
Q Consensus 467 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~ 544 (704)
+++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||. .+|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 9999999999999986 5688999999999999886543 358999999999999999999954 68999999999
Q ss_pred CeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCC---CCcccceeeHHHHHHHHhhCCCCCCccc
Q 005278 545 NILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGI---ISPKSDVYSYGILLMETFTRKKPTNEIF 621 (704)
Q Consensus 545 Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~el~tg~~p~~~~~ 621 (704)
||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999998765432 2233457999999999987655 4788999999999999999999997531
Q ss_pred cccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 622 IGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+......... ..+....++..+.+++.+||+.||++||++.|+++
T Consensus 245 -----~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 -----IMCLHSKIKSQAL-------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----HHHHHHHHHHCCC-------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----HHHHHHHHhcccC-------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111111100000 00011133567889999999999999999999954
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.70 Aligned_cols=250 Identities=24% Similarity=0.287 Sum_probs=202.2
Q ss_pred HHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
....++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445679999999999999999999975 68999999997643 23345678899999887 99999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999998643 4899999999999999999995 468999999999999999999999999999864
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .....+....
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~---------- 234 (345)
T 1xjd_A 169 MLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDN---------- 234 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC----------
T ss_pred ccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHhCC----------
Confidence 32221 234457999999999999999999999999999999999999999763211 1111111000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMK-DAA 686 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~-ev~ 686 (704)
...+..++..+.+++.+||+.||++||++. |+.
T Consensus 235 --------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 --------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 001112356788999999999999999997 653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=334.25 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=207.0
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357889999999999999999965 78999999987543 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.........
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999998754 34899999999999999999995 478999999999999999999999999999876433222
Q ss_pred ceeccccccccccCCcccCCCCC-CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.........+..|......
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 227 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 227 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--------------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--------------
Confidence 22344578999999999887665 779999999999999999999998754433333443221100
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......++..+.+++.+||+.||++||++.|+++
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0011233556788999999999999999999964
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=340.13 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=208.9
Q ss_pred CCCccccccccCceEEEEEEEC-CC---CEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE-EEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DG---TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK-ALV 489 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 489 (704)
.|...+.||+|+||+||+|+.. ++ ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556689999999999999853 23 379999987543 33456789999999999999999999999876654 899
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+.+|+|.+++......+++..+..++.|++.|++|||. .+|+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999998877778999999999999999999954 689999999999999999999999999998664322
Q ss_pred C--cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 570 D--SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 570 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
. ........+|+.|+|||.+.+..++.++||||||+++|||++|+.|+..... .............
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~----------- 246 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRR----------- 246 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTCC-----------
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCCC-----------
Confidence 1 1122344678999999999999999999999999999999996665433211 1222222221111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhh
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDD 699 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 699 (704)
...+..++..+.+++..||+.||++|||+.|+++.|+++.+.+..+
T Consensus 247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 1112234567889999999999999999999999999998876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=343.32 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=203.5
Q ss_pred hCCCCccccccccCceEEEEEEEC-CC-------CEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DG-------TNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 485 (704)
.++|...+.||+|+||.||+|+.. ++ ..||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357888999999999999999854 33 4799999976656667789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc--------EEEe
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT--------AHVS 557 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~--------~kl~ 557 (704)
.++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999987767999999999999999999995 578999999999999998887 9999
Q ss_pred eeccceecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC
Q 005278 558 DFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP 636 (704)
Q Consensus 558 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 636 (704)
|||++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+........ ....... .
T Consensus 164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~--~ 234 (289)
T 4fvq_A 164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYED--R 234 (289)
T ss_dssp CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT--T
T ss_pred cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhc--c
Confidence 9999875422 223458899999999877 7799999999999999999996554432111111 1111110 0
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
.. .+...+..+.+++..||+.||++||++.|+++.|+++...
T Consensus 235 ~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 235 HQ-----------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp CC-----------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred CC-----------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 00 0011134567899999999999999999999999987543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=334.99 Aligned_cols=266 Identities=19% Similarity=0.215 Sum_probs=208.8
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeee-eeCCeEEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC-CNIDFKALVL 490 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 490 (704)
..++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+|+.+++.++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 578999999875432 234588899999999988877766665 6677889999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~---~~~~~~kl~Dfgla~~~~~ 567 (704)
||+ +|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 99999999876667999999999999999999995 4689999999999999 7889999999999988755
Q ss_pred CCCc-----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccc--cHHHHHHhhcCCCcc
Q 005278 568 GDDS-----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM--SLKHWVKESLPDGLT 640 (704)
Q Consensus 568 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 640 (704)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ............
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 237 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--- 237 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS---
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc---
Confidence 4321 122345799999999999999999999999999999999999999986432211 111111100000
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
+.......++..+.+++..||+.||++||++.|+++.|+++.++...
T Consensus 238 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 238 -----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -----------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred -----------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 00111123467889999999999999999999999999999876653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=372.95 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=206.1
Q ss_pred cccccCceEEEEEEEC---CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCCCC
Q 005278 422 LLGTGSFGSVYKGTLF---DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGS 497 (704)
Q Consensus 422 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 497 (704)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 46679999997653 2356789999999999999999999999976 56899999999999
Q ss_pred HHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc-ceecc
Q 005278 498 LEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VIQTM 576 (704)
Q Consensus 498 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~-~~~~~ 576 (704)
|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+...... .....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999877777999999999999999999995 468999999999999999999999999999876443221 11223
Q ss_pred ccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhh
Q 005278 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655 (704)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (704)
..+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... .....+.... ...
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~-----------------~~~ 559 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK-----------------RME 559 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTC-----------------CCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC-----------------CCC
Confidence 346789999999998999999999999999999998 99999764321 1112111110 111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhhc
Q 005278 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDVA 701 (704)
Q Consensus 656 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~~ 701 (704)
.+..++..+.+++..||+.||++||++.+|++.|+.+.........
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 2234567899999999999999999999999999998777665543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=341.32 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=214.1
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
..++|+..+.||+|+||.||+|... ++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4568889999999999999999975 4889999998754 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 492 FMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 492 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
|+++|+|.+++... ...+++..+..++.|++.|++|||. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 165 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence 99999999999864 4558999999999999999999964 679999999999999999999999999998765432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ...........
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~~------------- 230 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYR------------- 230 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCC-------------
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccCC-------------
Confidence 223344567889999999998899999999999999999999 99998763221 12222111110
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+..++..+.+++..|++.||++||++.|+++.|+++.++
T Consensus 231 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 111223456788999999999999999999999999987554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.21 Aligned_cols=262 Identities=21% Similarity=0.254 Sum_probs=207.1
Q ss_pred chHHHHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeee
Q 005278 406 SYLDIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCC 481 (704)
Q Consensus 406 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 481 (704)
.+.+.+...++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34445556789999999999999999999975 79999999997532 223345889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 482 NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 482 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
+.+..++||||+++|+|.+++.+.+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++++||+|||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999999876667999999999999999999995 47899999999999999999999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccC-------CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGS-------EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES 634 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 634 (704)
++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .+.......
T Consensus 209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~ 286 (412)
T 2vd5_A 209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHYK 286 (412)
T ss_dssp CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHH
T ss_pred heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhcc
Confidence 987654322 2233457999999999886 4578999999999999999999999997632111 111111000
Q ss_pred cCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCC---CCHHHHHH
Q 005278 635 LPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQR---VSMKDAAA 687 (704)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---pt~~ev~~ 687 (704)
.... .......++.++.+++.+|+. +|++| |+++|+++
T Consensus 287 ~~~~--------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 EHLS--------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHCC--------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cCcC--------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0000 000112345678899999999 99998 58888843
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.05 Aligned_cols=258 Identities=19% Similarity=0.245 Sum_probs=206.0
Q ss_pred HHHHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC
Q 005278 408 LDIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNI 483 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 483 (704)
.+++...++|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344556789999999999999999999965 68999999987532 12334588999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
+..++||||+++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999999764 3889999999999999999995 4789999999999999999999999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCC----CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCc
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGI----ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL 639 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (704)
...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.... ..+........
T Consensus 217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~---- 290 (410)
T 3v8s_A 217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKN---- 290 (410)
T ss_dssp ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHH----
T ss_pred eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHHHhccc----
Confidence 765432 12233567999999999987655 788999999999999999999999753211 11111111000
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQ--RVSMKDAAA 687 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~ev~~ 687 (704)
....+....++..+.+++.+|++.+|++ ||++.||++
T Consensus 291 -----------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 291 -----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -----------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -----------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0001111134567889999999999998 999999954
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=344.21 Aligned_cols=244 Identities=22% Similarity=0.232 Sum_probs=202.4
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999965 69999999997543 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 9999999999998654 3899999999999999999995 578999999999999999999999999999876432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~---------------- 254 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGK---------------- 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCC----------------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHcCC----------------
Confidence 23357999999999999999999999999999999999999999753211 0111111100
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++||+ ++|+++
T Consensus 255 ---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0111234567889999999999999998 777754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=339.27 Aligned_cols=267 Identities=24% Similarity=0.319 Sum_probs=190.2
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|+..+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468899999999999999999854 689999999875432 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 492 FMPNGSLEKWLYSH-----NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 492 ~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
|++ |+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999998743 245889999999999999999995 4789999999999999999999999999998764
Q ss_pred CCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc--CCC-cchh
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL--PDG-LTEV 642 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~-~~~~ 642 (704)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+........ ... +...
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhh
Confidence 3222 2234568999999999876 468999999999999999999999997633211 1111111100 000 0000
Q ss_pred c-----cccch-------hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 V-----DANLV-------REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~-----~~~~~-------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. .+... ...........++..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00000 000000111134567899999999999999999999954
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=346.83 Aligned_cols=253 Identities=21% Similarity=0.250 Sum_probs=193.9
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|...+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999965 78999999987542 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc--EEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT--AHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~--~kl~Dfgla~~~~~~~~ 570 (704)
+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 99999999997654 3899999999999999999995 578999999999999987765 999999999754322
Q ss_pred cceeccccccccccCCcccCCCCCCcc-cceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPK-SDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.......||+.|+|||++.+..++.+ +||||+||++|||++|+.||....... ..............
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~---------- 239 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVKY---------- 239 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTCC----------
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCCC----------
Confidence 12234569999999999888777655 899999999999999999997643322 22222221111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+....++..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 ---SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001111234567899999999999999999999763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=340.61 Aligned_cols=248 Identities=19% Similarity=0.259 Sum_probs=198.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 489 (704)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999965 68999999997643 23345688999999988 899999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999998654 4899999999999999999995 4689999999999999999999999999998643222
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccc---cHHHHHHhhcCCCcchhcccc
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM---SLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ......... +...
T Consensus 165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------i~~~- 234 (345)
T 3a8x_A 165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------ILEK- 234 (345)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH-------HHHC-
T ss_pred --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH-------HHcC-
Confidence 123445799999999999999999999999999999999999999975321110 000000000 0000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
....+..++..+.+++.+||+.||++||++
T Consensus 235 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 ------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 011122345678899999999999999996
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=348.21 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=195.8
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcC--CCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIR--HRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 490 (704)
.+|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4689999999999999999998789999999987543 334567899999999996 599999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
| +.+++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||+++.+.....
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 56889999998664 5788899999999999999995 57899999999999996 58999999999987754433
Q ss_pred cceeccccccccccCCcccCC-----------CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCc
Q 005278 571 SVIQTMTIATIGYMAPEYGSE-----------GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL 639 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (704)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~-------- 281 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII-------- 281 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH--------
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh--------
Confidence 333345579999999998754 4688999999999999999999999976322111111111
Q ss_pred chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
++.... ..+...+..+.+++..||+.||++||++.|+++.
T Consensus 282 ----~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 ----DPNHEI-----EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----CTTSCC-----CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----CccccC-----CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 110000 0011123467889999999999999999999753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.62 Aligned_cols=260 Identities=23% Similarity=0.397 Sum_probs=210.0
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|+..+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 46788899999999999999998888899999986542 345678999999999999999999999864 4578999999
Q ss_pred CCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++........ .
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence 9999999997542 35899999999999999999995 47899999999999999999999999999987754321 1
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.... ..........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~---------------- 227 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGY---------------- 227 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC----------------
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhccc----------------
Confidence 2233457889999999988889999999999999999999 89998763221 1111111100
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
....+..++..+.+++..|++.||++||++.++++.|+++......
T Consensus 228 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 228 -RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred -CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 0011123456788999999999999999999999999998765443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.73 Aligned_cols=265 Identities=19% Similarity=0.216 Sum_probs=211.7
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeee-eeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC-CNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 491 (704)
.++|...+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999996 579999999986542 335689999999999988877666655 56778899999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeeeccceecCCC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~---~~~~~~kl~Dfgla~~~~~~ 568 (704)
|+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 89999999866667999999999999999999995 4689999999999999 48889999999999887554
Q ss_pred CCcc-----eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccc--ccHHHHHHhhcCCCcch
Q 005278 569 DDSV-----IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE--MSLKHWVKESLPDGLTE 641 (704)
Q Consensus 569 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 641 (704)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 237 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---- 237 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS----
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC----
Confidence 3211 1234579999999999999999999999999999999999999998643221 1111111110000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
+.......++..+.+++..||+.||++||++.|+++.|+++..+...
T Consensus 238 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 238 ----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ----------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ----------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 00111224467789999999999999999999999999998776543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=345.10 Aligned_cols=254 Identities=18% Similarity=0.144 Sum_probs=207.6
Q ss_pred HhCCCCccccccccCceEEEEEE------ECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC---CCCCceEEeeeeeC
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGT------LFDGTNVAIKVFNLQLERASRSFDSECEILRSIR---HRNLIKIISNCCNI 483 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 483 (704)
..++|.+.+.||+|+||+||+|. ..+++.||||++... ....+..|+++++.++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45678999999999999999994 456899999998654 3456788888888887 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhh----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---------
Q 005278 484 DFKALVLEFMPNGSLEKWLYS----HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE--------- 550 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~--------- 550 (704)
+..++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +.+|+||||||+||+++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999974 3456999999999999999999995 578999999999999998
Q ss_pred --CCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHH
Q 005278 551 --NMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK 628 (704)
Q Consensus 551 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~ 628 (704)
++.+||+|||+|+.+.............||++|+|||++.+..++.++|||||||++|||+||+.||.....+...
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 8999999999998765444444455667999999999999999999999999999999999999998653221110
Q ss_pred HHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCC-CCHHHHHHHHHHhHHHh
Q 005278 629 HWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQR-VSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-pt~~ev~~~L~~~~~~~ 696 (704)
....+... .....+.+++..|++.+|.+| |+++++.+.|+++.+..
T Consensus 295 --------------~~~~~~~~--------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 295 --------------PEGLFRRL--------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp --------------ECSCCTTC--------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --------------echhcccc--------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00111100 113456678999999999999 57888898888876554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=333.95 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=184.7
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|.+.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788999999999999999986 4799999999875432 2236789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++++|.+++......+++..++.++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999877677999999999999999999995 4689999999999999999999999999998764322
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .........
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------~~~~~~~~~-- 229 (278)
T 3cok_A 167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------------LNKVVLADY-- 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCC--
T ss_pred C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------------HHHHhhccc--
Confidence 1 12234689999999999998999999999999999999999999975321110 000000000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+..++..+.+++.+||+.||++||+++|+++
T Consensus 230 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 -----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 011223557889999999999999999999965
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.07 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=201.3
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35788999999999999999986 479999999987432 33456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 490 LEFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
|||+++|+|.+++.. ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999974 3456899999999999999999995 4789999999999999999999999999998764
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.+.... ...+............
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~---- 258 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQCDYPPL---- 258 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHHHHTTCSCCC----
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHHhhcccCCCC----
Confidence 3221 123346899999999999999999999999999999999999999753222 1122111111100000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
....++..+.+++..||+.||++||++.||++.|+++++...
T Consensus 259 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 259 ---------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ---------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 011345678899999999999999999999999999987654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=341.40 Aligned_cols=264 Identities=22% Similarity=0.260 Sum_probs=209.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee----CCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN----IDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 488 (704)
.++|+..+.||+|+||.||+|+. .+++.||||++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46789999999999999999996 5799999999876555666789999999999999999999999863 347789
Q ss_pred EEeccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 489 VLEFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||. .+|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999985 35668999999999999999999964 68999999999999999999999999998765
Q ss_pred CCCCCcc-------eeccccccccccCCcccCCCC---CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc
Q 005278 566 GEGDDSV-------IQTMTIATIGYMAPEYGSEGI---ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 566 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 3211100 012235799999999987544 788999999999999999999999764333222222211100
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
..+....++..+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 265 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 265 -----------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred -----------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 001112345678899999999999999999999999998865443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.80 Aligned_cols=266 Identities=16% Similarity=0.159 Sum_probs=200.8
Q ss_pred hCCCCccccccccCceEEEEEEEC----CCCEEEEEEeeccchh-----------hhHHHHHHHHHHHhcCCCCCceEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQLER-----------ASRSFDSECEILRSIRHRNLIKIIS 478 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~ 478 (704)
.++|...+.||+|+||.||+|+.. ++..+|||++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367899999999999999999965 5788999998754211 1234667889999999999999999
Q ss_pred eeee----CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC--
Q 005278 479 NCCN----IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-- 552 (704)
Q Consensus 479 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-- 552 (704)
++.. ....++||||+ +++|.+++...+ .+++..++.++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence 9987 67889999999 999999998655 6899999999999999999996 46899999999999999877
Q ss_pred cEEEeeeccceecCCCCCc-----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccH
Q 005278 553 TAHVSDFGISKLLGEGDDS-----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSL 627 (704)
Q Consensus 553 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~ 627 (704)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999877432211 11234579999999999999999999999999999999999999996532222211
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
.......... .... . ........++..+.+++..||+.||++||++.+|++.|+++.
T Consensus 271 ~~~~~~~~~~-~~~~----~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLLDE-LPQS----V----LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHT-TTHH----H----HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhccc-ccHH----H----HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111000 0000 0 000001134567899999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=340.74 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=192.2
Q ss_pred hCCCCccccccccCceEEEEEEE----CCCCEEEEEEeeccc----hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 485 (704)
.++|+..+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999986 478999999987542 2234567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999999998654 3788999999999999999995 468999999999999999999999999999764
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~----------- 237 (327)
T 3a62_A 172 IHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKILKCK----------- 237 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTC-----------
T ss_pred ccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCC-----------
Confidence 3221 12234579999999999999999999999999999999999999997632111 011111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++|| ++.|+++
T Consensus 238 --------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 --------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011123356788999999999999999 6667754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=343.90 Aligned_cols=260 Identities=23% Similarity=0.377 Sum_probs=206.0
Q ss_pred hCCCCccccccccCceEEEEEEE------CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|...+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999983 257789999986443 34556789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCC------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEe
Q 005278 487 ALVLEFMPNGSLEKWLYSHN------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---NMTAHVS 557 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---~~~~kl~ 557 (704)
++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999998653 44889999999999999999995 468999999999999994 4469999
Q ss_pred eeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcC
Q 005278 558 DFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLP 636 (704)
Q Consensus 558 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 636 (704)
|||++................||+.|+|||++.+..++.++||||||+++|||+| |..||...... ....++.....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~ 263 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGGR 263 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHHhcCCC
Confidence 9999986644333333344568999999999988899999999999999999998 99998753211 11111111100
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+..++..+.+++..||+.||++||++.|+++.|+.+...
T Consensus 264 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 264 -----------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 011123456788999999999999999999999999988654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.34 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=203.7
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|...+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457889999999999999999865 5789999999776555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeeeccceecCCCC
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~---~~~~~~kl~Dfgla~~~~~~~ 569 (704)
+++++|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999999987654 3899999999999999999995 4789999999999999 788999999999998765432
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
......||+.|+|||++.+. ++.++||||||+++|||++|+.||......+ ........... .
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~----------~-- 226 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGTFT----------F-- 226 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC----------C--
T ss_pred ---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCC----------C--
Confidence 22345699999999987654 8999999999999999999999997632211 11111110000 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......++..+.+++.+|++.||++||++.|+++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 ---PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011134567889999999999999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=332.35 Aligned_cols=248 Identities=24% Similarity=0.308 Sum_probs=200.2
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
+.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467899999999999999999865 57899999986543 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999997653 3899999999999999999995 578999999999999999999999999998654322
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~------------ 221 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYKRISR------------ 221 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHH------------
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-----HHHHHHHh------------
Confidence 123456899999999999999999999999999999999999999753211 11110000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
.....+..++..+.+++.+||+.||++||++.|+++.
T Consensus 222 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 ---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0001112234567899999999999999999999763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=342.89 Aligned_cols=260 Identities=21% Similarity=0.253 Sum_probs=201.5
Q ss_pred HHHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-----hhhhHHHHHHHHHHHhcCCCCCceEEeeeee
Q 005278 409 DIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-----ERASRSFDSECEILRSIRHRNLIKIISNCCN 482 (704)
Q Consensus 409 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 482 (704)
++....++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34566778999999999999999999864 68899999986542 2345678999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC---------------------------------------CCccCHHHHHHHHHHHHH
Q 005278 483 IDFKALVLEFMPNGSLEKWLYSH---------------------------------------NYFLGILERLNIMIDVGL 523 (704)
Q Consensus 483 ~~~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~ 523 (704)
.+..++||||+++|+|.+++... ...+++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 122467778899999999
Q ss_pred HHHHHHhcCCCCcEecCCCCCCeeeCCCC--cEEEeeeccceecCCCCC--cceeccccccccccCCcccCC--CCCCcc
Q 005278 524 ALEYLHHGHSTPMVHCDLKPNNILLDENM--TAHVSDFGISKLLGEGDD--SVIQTMTIATIGYMAPEYGSE--GIISPK 597 (704)
Q Consensus 524 ~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~--~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 597 (704)
||+||| +.+|+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999995 46899999999999998776 899999999987643222 112345579999999998865 678999
Q ss_pred cceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCC
Q 005278 598 SDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPE 677 (704)
Q Consensus 598 ~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~ 677 (704)
+|||||||++|||++|+.||.+....+. ......... .. ..+....++..+.+++.+||+.||+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~------------~~---~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQVLNKKL------------CF---ENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC------------CT---TSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHhccc------------cc---CCcccccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999999976432211 111111000 00 0011123456788999999999999
Q ss_pred CCCCHHHHHH
Q 005278 678 QRVSMKDAAA 687 (704)
Q Consensus 678 ~Rpt~~ev~~ 687 (704)
+||++.|+++
T Consensus 321 ~Rps~~~~l~ 330 (345)
T 3hko_A 321 ERFDAMRALQ 330 (345)
T ss_dssp TSCCHHHHHH
T ss_pred HCCCHHHHhc
Confidence 9999999965
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=349.48 Aligned_cols=276 Identities=21% Similarity=0.270 Sum_probs=213.2
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC--eEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNID--FKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 489 (704)
.++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357888999999999999999965 58999999997543 234567889999999999999999999998755 77999
Q ss_pred EeccCCCCHHHHHhhCC--CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----CCCCcEEEeeeccce
Q 005278 490 LEFMPNGSLEKWLYSHN--YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL----DENMTAHVSDFGISK 563 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~----~~~~~~kl~Dfgla~ 563 (704)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998543 33899999999999999999995 4689999999999999 778889999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCC--------CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHH---HH
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSE--------GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHW---VK 632 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~---~~ 632 (704)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. ..
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 764432 2234569999999998764 567889999999999999999999997644333222222 11
Q ss_pred hhcCCCcchh---ccccchhh---hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 633 ESLPDGLTEV---VDANLVRE---EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 633 ~~~~~~~~~~---~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+..+... ....+... ..........+..+.+++..||+.||++||+++|+++.++++.++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1111111111 00000000 011123356778899999999999999999999999999887653
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=350.66 Aligned_cols=325 Identities=22% Similarity=0.248 Sum_probs=228.6
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCcccc-ccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFS-GLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.++|++|+|++|.+++..|..|.++++|++|+|++|.+. .+.+..|.++++|++|+|++|.++...... |.+
T Consensus 29 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~-------~~~ 101 (455)
T 3v47_A 29 PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGA-------FNG 101 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTT-------TTT
T ss_pred CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhh-------ccC
Confidence 478999999999999888999999999999999999997 456788999999999999999998765443 899
Q ss_pred CCCCcEEEccCCCCcccCChh--hhhcccccceEEecCCcccccCChh-hhcCCCCCEEEccCCcCccccChhhcCC--C
Q 005278 84 CRNLTVLGLASNPLRGILPPL--IGNFSASLQEFYAYGCKLRGNIPQE-IGNLSGMIVFDLNGCDLNGTIPTAVGRL--R 158 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~--~~~~~~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~ 158 (704)
+++|++|+|++|++.+..+.. +..+ ++|++|++++|.+.+..|.. +.++++|++|++++|.+.+..+..+..+ .
T Consensus 102 l~~L~~L~L~~n~l~~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~ 180 (455)
T 3v47_A 102 LANLEVLTLTQCNLDGAVLSGNFFKPL-TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGK 180 (455)
T ss_dssp CTTCCEEECTTSCCBTHHHHSSTTTTC-TTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTC
T ss_pred cccCCEEeCCCCCCCccccCcccccCc-ccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccc
Confidence 999999999999998755544 6665 47999999999999887876 8999999999999999998888877765 4
Q ss_pred CcCeeeccCcccCCCCCcc--------ccCCCCCCEEEcCCCcCCccCCccccC--------------------------
Q 005278 159 RLQGLYLHGNKLQGSIPYD--------LCHLEGLSELNLNGNKLCGHVPPCLAS-------------------------- 204 (704)
Q Consensus 159 ~L~~L~L~~n~l~~~~~~~--------l~~l~~L~~L~L~~n~l~~~~~~~~~~-------------------------- 204 (704)
+|+.|++++|.+++..+.. +..+++|++|++++|++++..|..+..
T Consensus 181 ~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~ 260 (455)
T 3v47_A 181 HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260 (455)
T ss_dssp EEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCS
T ss_pred cccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhh
Confidence 5566666666655433222 223455555555555554322221111
Q ss_pred -------------cCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCC
Q 005278 205 -------------LTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIP 271 (704)
Q Consensus 205 -------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 271 (704)
.++|+.|++++|.+++..+..+..+++|++|++++|.+.+..|..|..+++|+.|++++|++++..+
T Consensus 261 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 340 (455)
T 3v47_A 261 FKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS 340 (455)
T ss_dssp SCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECG
T ss_pred hccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcCh
Confidence 1456666666666665556666666666666666666665555566666666666666666665555
Q ss_pred CCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCCcccccccCcccccCCC
Q 005278 272 TTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 272 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~ 337 (704)
..+..+++|+.|+|++|++++..|..+..+++|++|++++|++++..+..|...+.+....+.+++
T Consensus 341 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 406 (455)
T 3v47_A 341 RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 406 (455)
T ss_dssp GGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred hHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCC
Confidence 566666666666666666665556666666666666666666665444455555555555555554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=353.70 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=203.6
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367889999999999999999965 799999999975432 2345789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++...+ .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999997653 4899999999999999999994 5789999999999999999999999999998875432
Q ss_pred CcceeccccccccccCCcccCCCCC-CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.... ......... .
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~~~i~~~--------~-- 232 (476)
T 2y94_A 171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLFKKICDG--------I-- 232 (476)
T ss_dssp ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHHHHHHTT--------C--
T ss_pred ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcC--------C--
Confidence 2234579999999999888765 68999999999999999999999763211 111111000 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++|||+.|+++
T Consensus 233 -----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 -----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0011123456889999999999999999999976
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=343.99 Aligned_cols=246 Identities=27% Similarity=0.323 Sum_probs=199.7
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
+.|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999985 579999999987542 233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||++ |++.+++......+++..+..++.|++.||+|||. .+|+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 68999887666679999999999999999999954 68999999999999999999999999999865432
Q ss_pred cceeccccccccccCCcccC---CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 571 SVIQTMTIATIGYMAPEYGS---EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
....||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+........+. .
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~---------~ 273 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA---------L 273 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC---------C
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCC---------C
Confidence 2346999999999873 5678999999999999999999999986532111 111111110000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
....++..+.+++..||+.||++|||+.|+++.
T Consensus 274 --------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 --------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 011234567889999999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=344.42 Aligned_cols=209 Identities=27% Similarity=0.318 Sum_probs=181.2
Q ss_pred ccccchHHHHHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-----CCCCce
Q 005278 402 WRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIR-----HRNLIK 475 (704)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~ 475 (704)
...+++.+.....++|.+.+.||+|+||+||+|+. .+++.||||++... ....+.+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44455555556678999999999999999999996 46899999998643 334566788999999996 999999
Q ss_pred EEeeeeeCCeEEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC----
Q 005278 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---- 550 (704)
Q Consensus 476 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---- 550 (704)
+++++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence 999999999999999999 899999998653 45899999999999999999995 578999999999999975
Q ss_pred ---------------------CCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHH
Q 005278 551 ---------------------NMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLME 609 (704)
Q Consensus 551 ---------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~e 609 (704)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999875432 234568999999999999999999999999999999
Q ss_pred HhhCCCCCCcc
Q 005278 610 TFTRKKPTNEI 620 (704)
Q Consensus 610 l~tg~~p~~~~ 620 (704)
|++|+.||...
T Consensus 252 ll~g~~pf~~~ 262 (360)
T 3llt_A 252 LYTGSLLFRTH 262 (360)
T ss_dssp HHHSSCSCCCS
T ss_pred HHHCCCCCCCC
Confidence 99999999763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=341.94 Aligned_cols=244 Identities=20% Similarity=0.240 Sum_probs=198.9
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 487 (704)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999975 48899999997643 23345688899999988 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999998654 3899999999999999999995 46899999999999999999999999999986432
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .......... .
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~--------~- 237 (353)
T 2i0e_A 174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEH--------N- 237 (353)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC--------C-
T ss_pred CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhC--------C-
Confidence 22 123445799999999999999999999999999999999999999976321 1111110000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
...+...+.++.+++.+||+.||++||++
T Consensus 238 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 238 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01112345678899999999999999964
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=337.19 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=200.4
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
..++|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999965 689999999875432 234678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++++|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999998653 4899999999999999999995 468999999999999999999999999999876443
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ..........+.
T Consensus 188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~----------- 253 (309)
T 2h34_A 188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR----------- 253 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC-----------
T ss_pred cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC-----------
Confidence 21 1223456899999999999999999999999999999999999999763221 111111110000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHhHHHhhh
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRV-SMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-t~~ev~~~L~~~~~~~~~ 698 (704)
....+..++..+.+++.+||+.||++|| +++++++.|+++.+....
T Consensus 254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0011223456788999999999999999 999999999987554433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=327.63 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=203.4
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999865 68999999987543 234467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc---EEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT---AHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~---~kl~Dfgla~~~~~ 567 (704)
||+++|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999999887653 4899999999999999999995 468999999999999986655 99999999987654
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... .............
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~--------- 226 (284)
T 3kk8_A 161 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDY--------- 226 (284)
T ss_dssp SCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCC---------
T ss_pred Ccc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHhccccC---------
Confidence 322 23456999999999999999999999999999999999999999653211 1111111100000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......++..+.+++.+|++.||++||++.|+++
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00011234567889999999999999999999965
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.11 Aligned_cols=265 Identities=21% Similarity=0.229 Sum_probs=198.3
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999975 58999999986543 2335668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++++|.+++... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 99999999887654 34899999999999999999995 46899999999999999999999999999987653322
Q ss_pred ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC------------
Q 005278 572 VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG------------ 638 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 638 (704)
......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.+....+. ...+.......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHTCG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhccccccccccccccc
Confidence 2234578999999998865 6789999999999999999999999976432211 11111110000
Q ss_pred -cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 -LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......+..............++..+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000000000111234667889999999999999999999965
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.22 Aligned_cols=259 Identities=21% Similarity=0.334 Sum_probs=195.4
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe----
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDF---- 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 485 (704)
.++|+..+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999995 5789999999976432 234578899999999999999999999876543
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||+++|+|.+++...+ .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 489999999999999998654 4899999999999999999995 468999999999999999999999999999876
Q ss_pred CCCCCc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 566 GEGDDS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 566 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+....... ..... ..
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~~----~~------ 235 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-YQHVR----ED------ 235 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHH----CC------
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhc----CC------
Confidence 543222 2223456899999999999999999999999999999999999999763221110 01100 00
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHH-HHHHHHh
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA-AAKLKKI 692 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev-~~~L~~~ 692 (704)
.. ........++..+.+++.+||+.||++||++.++ ...+.+.
T Consensus 236 --~~---~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 236 --PI---PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --CC---CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --CC---CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00 0011112345678899999999999999976655 4444443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.78 Aligned_cols=267 Identities=25% Similarity=0.318 Sum_probs=199.8
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch-----hhhHHHHHHHHHHHhcC---CCCCceEEeeeeeC
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE-----RASRSFDSECEILRSIR---HRNLIKIISNCCNI 483 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 483 (704)
..++|+..+.||+|+||+||+|+. .+++.||||++..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999995 5789999999874321 12346677888777764 99999999999775
Q ss_pred C-----eEEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEe
Q 005278 484 D-----FKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVS 557 (704)
Q Consensus 484 ~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~ 557 (704)
. ..++||||+. |+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5789999997 59999998654 34899999999999999999995 4679999999999999999999999
Q ss_pred eeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc-C
Q 005278 558 DFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL-P 636 (704)
Q Consensus 558 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~ 636 (704)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+........ +
T Consensus 163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 999998664322 2344578999999999999999999999999999999999999997632221 1112111110 0
Q ss_pred -C-Ccchhcc---ccchhh--hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 637 -D-GLTEVVD---ANLVRE--EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 637 -~-~~~~~~~---~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. .+..... ..+... ........+++..+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 0100000 000000 0001112234567889999999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=338.48 Aligned_cols=264 Identities=21% Similarity=0.247 Sum_probs=197.3
Q ss_pred hCCCCcc-ccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNEC-NLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.+.|.+. +.||+|+||.||+|+. .+++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 7899999999999985 47999999999766555567889999999995 7999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc---EEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT---AHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~---~kl~Dfgla~~~~~ 567 (704)
||+++|+|.+++.... .+++..+..++.|++.||+|||. .+|+||||||+||+++.++. +||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 9999999999998653 48999999999999999999964 68999999999999998776 99999999986542
Q ss_pred CCC-----cceeccccccccccCCcccCC-----CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC
Q 005278 568 GDD-----SVIQTMTIATIGYMAPEYGSE-----GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD 637 (704)
Q Consensus 568 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (704)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..+... ....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~ 243 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG---EACP 243 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc---ccch
Confidence 211 111223469999999998865 568899999999999999999999997643322110000 0000
Q ss_pred ----C-cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 638 ----G-LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 638 ----~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ...+....... .......++..+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEF---PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCCCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCccc---CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0 00000000000 00011234567889999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.23 Aligned_cols=266 Identities=20% Similarity=0.272 Sum_probs=197.6
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchh-hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLER-ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|...+.||+|+||+||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999965 7899999998654321 222456799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++ |+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence 97 5999999887777999999999999999999995 5789999999999999999999999999998654322 2
Q ss_pred eeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc---CCCcchhccccch
Q 005278 573 IQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL---PDGLTEVVDANLV 648 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 648 (704)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+........ +..+.........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcchhh
Confidence 2334568999999998876 568999999999999999999999997632211 1111111111 0111111110000
Q ss_pred --------hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 --------REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 --------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...........++..+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000001122234567889999999999999999999964
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=334.60 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=207.3
Q ss_pred hCCCCccc-cccccCceEEEEEEE---CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 414 TNGFNECN-LLGTGSFGSVYKGTL---FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 414 ~~~~~~~~-~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
.++|...+ .||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 999999999999964 246889999987543 22356799999999999999999999999 566789
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++|+|.+++.... .+++..++.++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 9999999999999998654 4899999999999999999995 46899999999999999999999999999988754
Q ss_pred CCCcc-eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 568 GDDSV-IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 568 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--------- 238 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER--------- 238 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC---------
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC---------
Confidence 43221 1223356789999999988889999999999999999999 99999763221 11111111100
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhh
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDD 699 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 699 (704)
...+..++..+.+++..||+.||++||++.|+++.|+++-..-...
T Consensus 239 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 239 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 0112244567889999999999999999999999999986655443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=345.94 Aligned_cols=266 Identities=12% Similarity=0.103 Sum_probs=208.2
Q ss_pred hCCCCccccccccCceEEEEEEECC---------CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCce---------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD---------GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK--------- 475 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 475 (704)
.++|...+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998653 789999998643 46889999999999999987
Q ss_pred ------EEeeeee-CCeEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 005278 476 ------IISNCCN-IDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNIL 547 (704)
Q Consensus 476 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil 547 (704)
+++++.. ....++||||+ +|+|.+++... ...+++..+..++.|++.||+|||. .+|+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 5677765 67889999999 99999999865 4569999999999999999999954 68999999999999
Q ss_pred eCCCC--cEEEeeeccceecCCCCCc-----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcc
Q 005278 548 LDENM--TAHVSDFGISKLLGEGDDS-----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEI 620 (704)
Q Consensus 548 ~~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~ 620 (704)
++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876432211 1123347999999999999999999999999999999999999999875
Q ss_pred ccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 621 FIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
................ ......+.. .....++..+.+++..||+.||++||++.|+++.|+++.++..
T Consensus 272 ~~~~~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVD-KPGPFVGPC--------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTCHHHHHHHHHHHHH-SCCCEECTT--------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcCHHHHHHHHHhccC-Chhhhhhhc--------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 4222222222211100 000000000 0011234678899999999999999999999999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.35 Aligned_cols=270 Identities=23% Similarity=0.281 Sum_probs=192.7
Q ss_pred HHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCC--e
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIR-HRNLIKIISNCCNID--F 485 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 485 (704)
...++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999985 479999999986432 344567889999999997 999999999997544 6
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 899999997 6999999764 4889999999999999999995 578999999999999999999999999999876
Q ss_pred CCCC-------------------CcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccc
Q 005278 566 GEGD-------------------DSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM 625 (704)
Q Consensus 566 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~ 625 (704)
.... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~ 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-N 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 4311 1112234579999999998876 67899999999999999999999999763221 1
Q ss_pred cHHHHHHhhcCCCcchh--ccccch--------------------------hhhhhhhhhHHHHHHHHHHHhhhcCCCCC
Q 005278 626 SLKHWVKESLPDGLTEV--VDANLV--------------------------REEQAFSVKIDCLLSIMHLALDCCMESPE 677 (704)
Q Consensus 626 ~~~~~~~~~~~~~~~~~--~~~~~~--------------------------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~ 677 (704)
.+.......-....... +..... ...........++..+.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 11111111000000000 000000 00000001113456789999999999999
Q ss_pred CCCCHHHHHHH
Q 005278 678 QRVSMKDAAAK 688 (704)
Q Consensus 678 ~Rpt~~ev~~~ 688 (704)
+|||++|+++.
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=341.65 Aligned_cols=243 Identities=24% Similarity=0.320 Sum_probs=201.8
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch--------hhhHHHHHHHHHHHhcCCCCCceEEeeeeeC
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE--------RASRSFDSECEILRSIRHRNLIKIISNCCNI 483 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 483 (704)
..++|+..+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456899999999999999999985 4789999999875431 1234577899999999999999999999999
Q ss_pred CeEEEEEeccCCC-CHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 484 DFKALVLEFMPNG-SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 484 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 9999997654 4899999999999999999995 468999999999999999999999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCCC-CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcch
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (704)
........ .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------ 236 (335)
T 3dls_A 178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------ 236 (335)
T ss_dssp EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence 88754332 234569999999999888776 88999999999999999999999753210
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..... ..+..++..+.+++..||+.||++||++.|+++.
T Consensus 237 -~~~~~-------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAAI-------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTCC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -Hhhcc-------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0111234568899999999999999999999763
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=335.63 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=204.3
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchh------hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLER------ASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|+..+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457889999999999999999965 6899999998754321 356799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeeeccc
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM----TAHVSDFGIS 562 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~----~~kl~Dfgla 562 (704)
++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 99999999999999997643 4899999999999999999995 46899999999999999888 7999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||.+... ............
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~--- 235 (321)
T 2a2a_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANITSVSY--- 235 (321)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTTCC---
T ss_pred eecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhccc---
Confidence 87754322 2344689999999999999999999999999999999999999975321 111111000000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. .......++..+.+++.+||+.||++||++.|+++
T Consensus 236 ---~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 ---DF-----DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ---CC-----CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ---cc-----ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00111234567889999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=333.41 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=204.9
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee---------
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN--------- 482 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 482 (704)
...+|+..+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467899999999999999999975 79999999987542 457789999999999999999998854
Q ss_pred -------CCeEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 483 -------IDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 483 -------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
....++||||+++|+|.+++... ...+++..++.++.|++.|++||| +.+|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence 44578999999999999999754 356899999999999999999996 4689999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES 634 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 634 (704)
||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..|+.... .+....
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~~~~~ 231 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KFFTDL 231 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HHHHHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HHHHHh
Confidence 9999999987754322 233468999999999999899999999999999999999998874311 111111
Q ss_pred cCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 635 LPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
....+ +..++..+.+++.+||+.||++||++.|+++.|+.+++....
T Consensus 232 ~~~~~-----------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 232 RDGII-----------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HTTCC-----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred hcccc-----------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 00000 112345677899999999999999999999999998765443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=333.52 Aligned_cols=247 Identities=21% Similarity=0.250 Sum_probs=179.3
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEEeccCCCC
Q 005278 420 CNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVLEFMPNGS 497 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 497 (704)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999965 6899999998643 3456788999999997 9999999999999999999999999999
Q ss_pred HHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEEEeeeccceecCCCCCccee
Q 005278 498 LEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM---TAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 498 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~---~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++....... ..
T Consensus 93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~ 166 (325)
T 3kn6_A 93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PL 166 (325)
T ss_dssp HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cc
Confidence 999998754 4899999999999999999995 47899999999999997665 899999999987644322 23
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccc--ccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE--MSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............. .. .
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~--------~~---~ 235 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--------FS---F 235 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC--------CC---C
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC--------CC---C
Confidence 34568999999999999999999999999999999999999997643211 11111111111100 00 0
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAA 686 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~ 686 (704)
.......++.++.+++..||+.||++||+++|++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 0111224567789999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=332.64 Aligned_cols=249 Identities=26% Similarity=0.301 Sum_probs=195.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|...+.||+|+||.||+|+.. ++..||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57888999999999999999864 689999999876542 3457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeeeccceecC
Q 005278 493 MPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLG 566 (704)
Q Consensus 493 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~---~~~~~~kl~Dfgla~~~~ 566 (704)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998642 456899999999999999999995 4789999999999999 456789999999998764
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
... ......||+.|+|||++. +.++.++||||||+++|||++|+.||.+....+ .........+.
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~--------- 243 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYKEPN--------- 243 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCC---------
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccCCcc---------
Confidence 322 223456899999999875 468899999999999999999999997632211 11111110000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... .....+..+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YAV------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC--------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccc------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00112456788999999999999999999964
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=340.62 Aligned_cols=259 Identities=28% Similarity=0.464 Sum_probs=206.1
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEE--EEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNV--AIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~v--avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 489 (704)
++|...+.||+|+||.||+|+.. ++..+ |+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999854 56644 999887533 33456789999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 490 LEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999998643 46899999999999999999995 5789999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 633 (704)
||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||+| |+.||.+... ......
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEK 253 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----HHHHHH
Confidence 9999999974322 112233457889999999988889999999999999999998 9999976321 111111
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~ 698 (704)
. .... ....+..++..+.+++.+||+.||++||++.|+++.|+++.++...
T Consensus 254 ~-~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 254 L-PQGY-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp G-GGTC-------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred h-hcCC-------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 1 1100 0011223456788999999999999999999999999998776543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=334.40 Aligned_cols=253 Identities=29% Similarity=0.431 Sum_probs=200.2
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC-CeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNI-DFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 492 (704)
.++|+..+.||+|+||.||+|+.. |+.||||++... ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467889999999999999999864 889999998654 2456789999999999999999999997554 478999999
Q ss_pred cCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 99999999998543 23788999999999999999995 468999999999999999999999999999865332
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~--------------- 231 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY--------------- 231 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTC---------------
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCC---------------
Confidence 123357889999999988899999999999999999998 99999763221 1111111000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
....+..++..+.+++.+||+.||++||++.|+++.|++++...
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 232 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 01112234567889999999999999999999999999998754
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.65 Aligned_cols=307 Identities=23% Similarity=0.252 Sum_probs=284.6
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
.++++.|+|++|++++..+..|.++++|++|+|++|.++++.|.+|.++++|++|+|++|.++.++... |.++
T Consensus 31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l 103 (477)
T 2id5_A 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGV-------FTGL 103 (477)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTS-------STTC
T ss_pred CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCccc-------ccCC
Confidence 468999999999999888899999999999999999999999999999999999999999999877554 8899
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeee
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLY 164 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 164 (704)
++|++|+|++|++....+..|..+. +|++|++++|.+.+..+..|.++++|++|+|++|.+++..+..|.++++|+.|+
T Consensus 104 ~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 182 (477)
T 2id5_A 104 SNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR 182 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCT-TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEE
T ss_pred CCCCEEECCCCccccCChhHccccc-cCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEe
Confidence 9999999999999988888888774 799999999999999999999999999999999999987778899999999999
Q ss_pred ccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCC
Q 005278 165 LHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244 (704)
Q Consensus 165 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 244 (704)
|++|.+++..+..+..+++|++|++++|.+.+.++.......+|+.|++++|.++...+..+..+++|+.|+|++|.+.+
T Consensus 183 l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 262 (477)
T 2id5_A 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIST 262 (477)
T ss_dssp EESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCc
Confidence 99999998888899999999999999999887887777777899999999999996655789999999999999999998
Q ss_pred CCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCC
Q 005278 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 245 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 319 (704)
..+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|++++|++.+..+
T Consensus 263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp ECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred cChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 888889999999999999999998889999999999999999999998777888999999999999999987544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.26 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=205.1
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999965 79999999997543 22345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 490 LEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||. .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999998643 358999999999999999999954 68999999999999999999999999999887543
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccc--cHHHHHHhhcCCCcchhcccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM--SLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+...+.. .+.
T Consensus 340 ~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~--------- 406 (576)
T 2acx_A 340 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPE--------- 406 (576)
T ss_dssp CC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCC---------
T ss_pred cc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccc---------
Confidence 22 2345799999999999998999999999999999999999999976432111 11111110 000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
..+..++..+.+++.+||+.||++|| +++||++
T Consensus 407 --------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 --------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01123456788999999999999999 6788854
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=367.04 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=200.9
Q ss_pred ccccccCceEEEEEEEC---CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF---DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||.||+|.+. .++.||||+++.... ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999976432 335789999999999999999999999865 457899999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc-cee
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VIQ 574 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~-~~~ 574 (704)
|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.+...... ...
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999997654 4899999999999999999995 468999999999999999999999999999877543321 222
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... .....+.... .
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~-----------------~ 590 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE-----------------R 590 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC-----------------C
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-----------------C
Confidence 33457889999999999999999999999999999998 99999764321 1111111110 1
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
...+..++.++.+++..||+.||++||++.+|++.|+++..+..
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 11223456788999999999999999999999999998876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=344.67 Aligned_cols=249 Identities=24% Similarity=0.287 Sum_probs=192.7
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHH-HHhcCCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEI-LRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.++|+..+.||+|+||.||+|+.. +++.||||++..... .....+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357899999999999999999965 588999999976532 233455666666 567899999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++++||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999998654 3788899999999999999995 578999999999999999999999999999864322
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
. .......||+.|+|||++.+..++.++|+|||||++|||++|..||.+....+ .+...... ..
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~------------~~- 256 (373)
T 2r5t_A 193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNK------------PL- 256 (373)
T ss_dssp C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHHS------------CC-
T ss_pred C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhc------------cc-
Confidence 2 12345579999999999999999999999999999999999999997632111 11111110 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+..++..+.+++.+||+.||++||++.+..+.
T Consensus 257 ------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 257 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp ------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 0111234567889999999999999998654433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=365.89 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=209.1
Q ss_pred HhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
..++|...+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456788889999999999999999888889999997543 235679999999999999999999999876 668999999
Q ss_pred cCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 493 MPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 493 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 418 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence 9999999999753 345899999999999999999995 4789999999999999999999999999998664321 1
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.......++..|+|||++.+..++.++|||||||++|||+| |+.||.+....+ ....+...
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~---------------- 480 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERG---------------- 480 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTT----------------
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----------------
Confidence 11223356789999999988899999999999999999999 999997632211 11111100
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
.....+..++..+.+++.+||+.||++||++.+|++.|+++..
T Consensus 481 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 481 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 0011123456778899999999999999999999999988743
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.66 Aligned_cols=258 Identities=22% Similarity=0.291 Sum_probs=204.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch------hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE------RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999975 699999999875431 13567999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeeeccce
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM----TAHVSDFGISK 563 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~----~~kl~Dfgla~ 563 (704)
+||||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999997543 4899999999999999999995 46899999999999999877 89999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
....... .....|++.|+|||++.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 161 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~----- 227 (283)
T 3bhy_A 161 KIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-----ETLTNISAVN----- 227 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTTC-----
T ss_pred eccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-----HHHHHhHhcc-----
Confidence 7644321 23446899999999999999999999999999999999999999763211 1111100000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHHHhHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA--KLKKIKEK 695 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~--~L~~~~~~ 695 (704)
... .......++..+.+++.+||+.||++||++.|+++ .+++++..
T Consensus 228 -~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 228 -YDF-----DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp -CCC-----CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred -cCC-----cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 000 00111234567889999999999999999999987 45555443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=355.87 Aligned_cols=249 Identities=22% Similarity=0.246 Sum_probs=194.5
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999854 68999999997542 22345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++.... .+++..+..++.|++.||+|||. ..+|+||||||+||+++.++.+||+|||+|+......
T Consensus 227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 99999999999997654 48999999999999999999964 2689999999999999999999999999998643222
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 304 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~----------- 365 (446)
T 4ejn_A 304 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE----------- 365 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC-----------
T ss_pred --cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCC-----------
Confidence 223446799999999999999999999999999999999999999965321 11111100000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++|| +++|+++
T Consensus 366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 001123456788999999999999999 9999865
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=340.57 Aligned_cols=249 Identities=20% Similarity=0.253 Sum_probs=191.1
Q ss_pred CCCCcc-ccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHh-cCCCCCceEEeeeee----CCeEE
Q 005278 415 NGFNEC-NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRS-IRHRNLIKIISNCCN----IDFKA 487 (704)
Q Consensus 415 ~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~ 487 (704)
++|... +.||+|+||+||+|... +++.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 466665 68999999999999865 689999999863 2456788888754 589999999999875 56789
Q ss_pred EEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEeeeccce
Q 005278 488 LVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---NMTAHVSDFGISK 563 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---~~~~kl~Dfgla~ 563 (704)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||. .+|+||||||+||+++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998653 458999999999999999999964 68999999999999997 7899999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccc--cHHHHHHhhcCCCcch
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM--SLKHWVKESLPDGLTE 641 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 641 (704)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+......
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~---- 285 (400)
T 1nxk_A 213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE---- 285 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC----
T ss_pred ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc----
Confidence 764322 23345789999999999999999999999999999999999999976432211 111111110000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
+ .......++.++.+++..||+.||++|||+.|+++.
T Consensus 286 -----~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 -----F-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----C-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----C-----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000112345678899999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=335.15 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=199.2
Q ss_pred hCCCCccccccccCceEEEEEEEC--CCC--EEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF--DGT--NVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|+..+.||+|+||+||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357889999999999999999853 333 68999986542 234567899999999999999999999998765 7
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++|+||+++|+|.+++......+++..+..++.|++.|++|||. .+|+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 89999999999999998766668999999999999999999964 689999999999999999999999999998875
Q ss_pred CCCCcc-eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 567 EGDDSV-IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 567 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ............
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~----- 242 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEGE----- 242 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSCC-----
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHHHHHHHccCC-----
Confidence 433221 2233467889999999988889999999999999999999 9999976322 111111111100
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
....+..++..+.+++..||+.||++||++.|+++.|+++...
T Consensus 243 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 --------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred --------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0111223456788999999999999999999999999987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=337.47 Aligned_cols=260 Identities=22% Similarity=0.253 Sum_probs=190.4
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeee--------eC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCC--------NI 483 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~ 483 (704)
..+|+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357889999999999999999964 78999999987665556678899999999996 999999999984 34
Q ss_pred CeEEEEEeccCCCCHHHHHhh--CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 484 DFKALVLEFMPNGSLEKWLYS--HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
...++||||+. |+|.+++.. ....+++..++.++.|++.||+|||. +..+|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45789999996 799999874 34568999999999999999999964 223399999999999999999999999999
Q ss_pred ceecCCCCCcc----------eeccccccccccCCccc---CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHH
Q 005278 562 SKLLGEGDDSV----------IQTMTIATIGYMAPEYG---SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK 628 (704)
Q Consensus 562 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~ 628 (704)
++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----- 259 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----- 259 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----
Confidence 98765432211 11134589999999988 5677899999999999999999999999652211
Q ss_pred HHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 629 HWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
......... .....++..+.+++..||+.||++||++.|+++.|+++.+...
T Consensus 260 ~~~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 RIVNGKYSI-----------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------CCC-----------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HhhcCcccC-----------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 111100000 0011122346789999999999999999999999999876543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=350.02 Aligned_cols=250 Identities=16% Similarity=0.169 Sum_probs=193.6
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeecc---chhhhHHHHHHH---HHHHhcCCCCCceEE-------ee
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQ---LERASRSFDSEC---EILRSIRHRNLIKII-------SN 479 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 479 (704)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999995 57999999999743 233457789999 555556899999998 55
Q ss_pred eeeCC-----------------eEEEEEeccCCCCHHHHHhhCC------CccCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005278 480 CCNID-----------------FKALVLEFMPNGSLEKWLYSHN------YFLGILERLNIMIDVGLALEYLHHGHSTPM 536 (704)
Q Consensus 480 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~i 536 (704)
+.+.+ ..++||||+ +|+|.+++...+ ..+++..++.++.|++.||+|||. .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 278999999 689999998542 224468888999999999999954 689
Q ss_pred EecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCC-----------CCCcccceeeHHH
Q 005278 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG-----------IISPKSDVYSYGI 605 (704)
Q Consensus 537 vH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gv 605 (704)
+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2334467 999999998877 8999999999999
Q ss_pred HHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 005278 606 LLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685 (704)
Q Consensus 606 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev 685 (704)
++|||++|+.||........ ...+.. ....++..+.+++.+||+.||++||++.|+
T Consensus 302 il~elltg~~Pf~~~~~~~~-------------~~~~~~-----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG-------------SEWIFR-----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHHSSCCC------CC-------------SGGGGS-----------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHHCCCCCcccccccc-------------hhhhhh-----------hccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 99999999999965321110 011100 011335678899999999999999999999
Q ss_pred HH--HHHHhHHHhh
Q 005278 686 AA--KLKKIKEKFL 697 (704)
Q Consensus 686 ~~--~L~~~~~~~~ 697 (704)
++ .++++.+...
T Consensus 358 l~hp~f~~~~~~~~ 371 (377)
T 3byv_A 358 METPEYEQLRTELS 371 (377)
T ss_dssp HTSHHHHHHHHHHH
T ss_pred hhChHHHHHHHHHH
Confidence 86 5555555443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=345.78 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=193.1
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--------hhhHHHHHHHHHHHhcCCCCCceEEeeeee
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--------RASRSFDSECEILRSIRHRNLIKIISNCCN 482 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 482 (704)
...++|...+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999864 689999999875421 112347899999999999999999999754
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEEEeee
Q 005278 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM---TAHVSDF 559 (704)
Q Consensus 483 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~---~~kl~Df 559 (704)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||. .+|+||||||+||+++.++ .+||+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeec
Confidence 45799999999999999887554 48999999999999999999964 6899999999999997544 5999999
Q ss_pred ccceecCCCCCcceeccccccccccCCcccCC---CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC
Q 005278 560 GISKLLGEGDDSVIQTMTIATIGYMAPEYGSE---GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP 636 (704)
Q Consensus 560 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 636 (704)
|+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+...+.....
T Consensus 287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i~~~~~ 362 (419)
T 3i6u_A 287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSGKY 362 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHHHTTCC
T ss_pred ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHHhcCCC
Confidence 9998764322 2334579999999998753 66888999999999999999999999763222 222222221111
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... ......++..+.+++.+||+.||++||++.|+++
T Consensus 363 ~~~--------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 NFI--------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC--------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 0111234567889999999999999999999976
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=336.29 Aligned_cols=267 Identities=23% Similarity=0.266 Sum_probs=199.7
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999965 58999999986543 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++++|.++..... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999988888765443 4899999999999999999995 46899999999999999999999999999987643221
Q ss_pred cceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcC------------C
Q 005278 571 SVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP------------D 637 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------~ 637 (704)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+......... .
T Consensus 180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhcc
Confidence 22345689999999988765 78999999999999999999999997632211 11111110000 0
Q ss_pred CcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 638 GLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......+..............++..+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000111111111111122245678999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.99 Aligned_cols=263 Identities=19% Similarity=0.221 Sum_probs=210.4
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCC-CCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRH-RNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|.+.++||+|+||.||+|+. .+++.||||++.... ....+..|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999995 579999999876542 23458899999999987 556666666777888999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeeeccceecCCC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~---~~~~~~kl~Dfgla~~~~~~ 568 (704)
|+ +++|.+++......+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 99999999876667999999999999999999995 4689999999999999 58899999999999887554
Q ss_pred CCcc-----eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccc--cHHHHHHhhcCCCcch
Q 005278 569 DDSV-----IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM--SLKHWVKESLPDGLTE 641 (704)
Q Consensus 569 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 641 (704)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... .+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~---- 235 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT---- 235 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS----
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc----
Confidence 3211 12245799999999999999999999999999999999999999987433211 111111111000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
........++.++.+++..||+.+|++||++.+|++.|+++....
T Consensus 236 ----------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 236 ----------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp ----------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 001112244678899999999999999999999999999986543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=329.52 Aligned_cols=248 Identities=21% Similarity=0.270 Sum_probs=203.6
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999965 58899999987543 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++++|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999887543 4899999999999999999995 4689999999999999999999999999998764322
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~----------- 231 (294)
T 2rku_A 170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIKKNE----------- 231 (294)
T ss_dssp C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTTC-----------
T ss_pred c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhhcc-----------
Confidence 2 223456899999999999989999999999999999999999999763211 1111000000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++||++.|+++
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0111123456788999999999999999999965
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=327.44 Aligned_cols=246 Identities=24% Similarity=0.294 Sum_probs=202.8
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357889999999999999999865 57899999986542 22346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 99999999999998654 4899999999999999999995 5789999999999999999999999999997654322
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~----------- 228 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRRIVNVD----------- 228 (284)
T ss_dssp ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTTC-----------
T ss_pred ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHHHhccc-----------
Confidence 23456899999999999999999999999999999999999999753211 1111100000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++..+.+++.+|++.||++||++.|+++
T Consensus 229 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 ----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0011123456789999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=338.01 Aligned_cols=271 Identities=24% Similarity=0.313 Sum_probs=199.3
Q ss_pred HHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-----hhhHHHHHHHHHHHhcCCCCCceEEeeeeeC
Q 005278 410 IQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-----RASRSFDSECEILRSIRHRNLIKIISNCCNI 483 (704)
Q Consensus 410 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 483 (704)
+....++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3455678999999999999999999964 689999999865321 1234688999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
+..++||||+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999999986 899999877777899999999999999999995 4689999999999999999999999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc-CC--Cc
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL-PD--GL 639 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~--~~ 639 (704)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+ .+........ +. .+
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTS
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhh
Confidence 7643321 2334578999999998865 458899999999999999999999987632211 1222221111 10 01
Q ss_pred chhcc-ccch-----hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 640 TEVVD-ANLV-----REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 640 ~~~~~-~~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..... +... ...+.......++..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 11000 0000 000000111234567899999999999999999999965
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=328.56 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=200.9
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|...+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888999999999999999965 7999999999865444556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeeeccceecCCCC
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~---~~~~~~kl~Dfgla~~~~~~~ 569 (704)
+++|+|.+++...+ .+++..+..++.|++.|++||| +.+|+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 99999999987654 4889999999999999999995 4689999999999999 78899999999999764322
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+...... .
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~-~---------- 226 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIKEGYYE-F---------- 226 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHCCCC-C----------
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCC-C----------
Confidence 123446899999999999999999999999999999999999999763211 111111110000 0
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......++..+.+++.+|++.||++||++.|+++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111234567889999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=349.90 Aligned_cols=248 Identities=22% Similarity=0.276 Sum_probs=202.4
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|...+.||+|+||.||+|+.. +|+.||+|++..... .....+..|++++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888999999999999999975 699999999975432 2345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 490 LEFMPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
|||+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999754 345899999999999999999995 4689999999999999999999999999998875
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~i~~~--------- 408 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQ--------- 408 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHHHHHC---------
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHHHhhc---------
Confidence 4322 123357999999999999999999999999999999999999999764221 1112221111100
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
....+..++..+.+++.+||+.||++||++
T Consensus 409 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 409 ------AVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ------ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 001112345678899999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.30 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=203.9
Q ss_pred HHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--------hhhHHHHHHHHHHHhc-CCCCCceEEee
Q 005278 410 IQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--------RASRSFDSECEILRSI-RHRNLIKIISN 479 (704)
Q Consensus 410 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~ 479 (704)
.....++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445578999999999999999999975 799999999865431 1245688999999999 79999999999
Q ss_pred eeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 480 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
+......++||||+++|+|.+++.... .+++..+..++.|++.||+|||. .+|+||||||+||+++.++.+||+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEec
Confidence 999999999999999999999997543 48999999999999999999964 68999999999999999999999999
Q ss_pred ccceecCCCCCcceeccccccccccCCcccCC------CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh
Q 005278 560 GISKLLGEGDDSVIQTMTIATIGYMAPEYGSE------GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 560 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 633 (704)
|++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+..
T Consensus 245 G~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i~~ 319 (365)
T 2y7j_A 245 GFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRMIME 319 (365)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred CcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh
Confidence 99987754322 234579999999998753 3588899999999999999999999965211 111111111
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.... . ..+....++..+.+++.+||+.||++||++.|+++
T Consensus 320 ~~~~-----------~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 GQYQ-----------F---SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp TCCC-----------C---CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-----------C---CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 0 00111234567889999999999999999999965
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.74 Aligned_cols=253 Identities=24% Similarity=0.294 Sum_probs=200.0
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3468899999999999999999975 589999999876655556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++...... .
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L 171 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence 99999999999876667999999999999999999995 468999999999999999999999999987543211 1
Q ss_pred ceeccccccccccCCccc-----CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 572 VIQTMTIATIGYMAPEYG-----SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ..........+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------- 240 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPP---------- 240 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC----------
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCc----------
Confidence 112234689999999987 46778999999999999999999999997632211 11111111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..++..+.+++..||+.||++||++.|+++
T Consensus 241 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 ------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00112234567889999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=330.80 Aligned_cols=252 Identities=26% Similarity=0.309 Sum_probs=201.0
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
...++|+..+.||+|+||.||+|... +|+.||||.+... .....+.+|+.++++++||||+++++++......++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999865 5899999998753 33567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++......+++..+..++.+++.|++||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999999866667899999999999999999995 47899999999999999999999999999987654321
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .........+..
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~------------ 244 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPPT------------ 244 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCC------------
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCcc------------
Confidence 2234568999999999999999999999999999999999999997532111 000111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++||++.|+++
T Consensus 245 ---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 ---FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0112234567889999999999999999999965
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.11 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=198.1
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ....+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467899999999999999999865 68999999987542 2345688888888 79999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC----CcEEEeeeccceecCC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN----MTAHVSDFGISKLLGE 567 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~----~~~kl~Dfgla~~~~~ 567 (704)
|+++|+|.+++...+ .+++..+..++.|++.|++||| +.+|+||||||+||++..+ +.+||+|||++.....
T Consensus 97 ~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999997654 4899999999999999999995 4689999999999998533 3599999999987654
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ................ +
T Consensus 173 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~~~~~~------~ 242 (342)
T 2qr7_A 173 ENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILARIGSGKFS------L 242 (342)
T ss_dssp TTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHHHHHCCCC------C
T ss_pred CCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHHHccCCcc------c
Confidence 322 22345789999999999888889999999999999999999999975321 1112221111000000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ......++..+.+++.+||+.||++||++.|+++
T Consensus 243 ~-----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 S-----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp C-----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C-----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0011234567889999999999999999999865
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=335.91 Aligned_cols=248 Identities=22% Similarity=0.288 Sum_probs=203.6
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|...+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457888999999999999999965 58899999987543 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 99999999999887543 4899999999999999999995 4689999999999999999999999999998764332
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+......
T Consensus 196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~---------------- 256 (335)
T 2owb_A 196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKN---------------- 256 (335)
T ss_dssp C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHT----------------
T ss_pred c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcC----------------
Confidence 2 2234568999999999998889999999999999999999999997532111 01110000
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..++..+.+++.+||+.||++||++.|+++
T Consensus 257 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 257 ---EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111123456788999999999999999999965
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=348.22 Aligned_cols=261 Identities=20% Similarity=0.220 Sum_probs=194.0
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC------C
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI------D 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 484 (704)
.++|+..+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999854 68999999997542 33456788999999999999999999999654 3
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 57999999976 57666653 3889999999999999999995 46899999999999999999999999999987
Q ss_pred cCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC------
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG------ 638 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 638 (704)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+...+.......
T Consensus 214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 214 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp ---CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHTT
T ss_pred cCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHH
Confidence 64322 2344579999999999999999999999999999999999999997632111 1111111000000
Q ss_pred -------------------cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 -------------------LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.......... .........+..+.+++.+||+.||++|||++|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFP--ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSC--CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccc--cccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 000111223567899999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.06 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=196.1
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee----CCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN----IDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 487 (704)
..|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677788999999999999864 68899999987543 3345678999999999999999999999865 35689
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEeeeccceecC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLG 566 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~Dfgla~~~~ 566 (704)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||. +..+|+||||||+||+++ .++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999998643 38899999999999999999965 223499999999999998 88999999999997643
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.. ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||...... .............
T Consensus 184 ~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~------ 248 (290)
T 1t4h_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSGVKP------ 248 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTTCCC------
T ss_pred cc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHHHHHhccCCc------
Confidence 32 1233468999999998764 5899999999999999999999999763221 1111111111000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+...+..+.+++..||+.||++||++.|+++
T Consensus 249 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0111123456889999999999999999999964
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.04 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=197.9
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
++|.....||+|+||.||+|+. .+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566999999999999995 468899999997665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeeeccceecCCCCC
Q 005278 494 PNGSLEKWLYSHN--YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-NMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 494 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-~~~~kl~Dfgla~~~~~~~~ 570 (704)
++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999998653 34578889999999999999996 468999999999999987 89999999999987643221
Q ss_pred cceeccccccccccCCcccCCCC--CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGI--ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...................
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 244 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH------------ 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC------------
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc------------
Confidence 223456899999999987643 7889999999999999999999997532211111110000000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++||++.|+++
T Consensus 245 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 -----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111234567889999999999999999999964
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=341.99 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=203.4
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367899999999999999999965 68999999987653 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++|+|.+++.... .+++..+..++.+++.|++|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 999999999998654 388999999999999999999752 27999999999999999999999999998755321
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHH----------------------
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH---------------------- 629 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~---------------------- 629 (704)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 123346899999999999999999999999999999999999999763221110000
Q ss_pred --HHHhhc-CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 630 --WVKESL-PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 630 --~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+..... +....+..+..... .........++..+.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNE-PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHS-CCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhcc-CCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000 00000000000000 0000111224567899999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=348.65 Aligned_cols=195 Identities=25% Similarity=0.375 Sum_probs=153.7
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee-----CCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN-----IDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 485 (704)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999854 78999999986532 3345678999999999999999999999844 356
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||+ +|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 89999998 57999998765 34899999999999999999995 468999999999999999999999999999876
Q ss_pred CCCCCc-------------------------ceeccccccccccCCccc-CCCCCCcccceeeHHHHHHHHhhC
Q 005278 566 GEGDDS-------------------------VIQTMTIATIGYMAPEYG-SEGIISPKSDVYSYGILLMETFTR 613 (704)
Q Consensus 566 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~el~tg 613 (704)
...... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 432211 122345789999999975 566799999999999999999993
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.28 Aligned_cols=262 Identities=11% Similarity=0.066 Sum_probs=186.7
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc--CCCCCceEE-------eee
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI--RHRNLIKII-------SNC 480 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~ 480 (704)
..+|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999965 78999999998643 23445678886555555 699988865 333
Q ss_pred eeC-----------------CeEEEEEeccCCCCHHHHHhhCCCccCHHHH------HHHHHHHHHHHHHHHhcCCCCcE
Q 005278 481 CNI-----------------DFKALVLEFMPNGSLEKWLYSHNYFLGILER------LNIMIDVGLALEYLHHGHSTPMV 537 (704)
Q Consensus 481 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~Lh~~h~~~iv 537 (704)
... ...++||||++ |+|.+++...+..+++..+ ..++.|++.||+||| +.+|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 322 33799999998 8999999865444566666 788899999999995 57899
Q ss_pred ecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCC
Q 005278 538 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKK 615 (704)
Q Consensus 538 H~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~ 615 (704)
||||||+||+++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+||+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876321 224457799999999987 679999999999999999999999
Q ss_pred CCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHHHhH
Q 005278 616 PTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA--KLKKIK 693 (704)
Q Consensus 616 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~--~L~~~~ 693 (704)
||......... .+...............+....++..+.+++.+||+.||++||++.|+++ .++++.
T Consensus 292 Pf~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 292 PFGLVTPGIKG-----------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp STTBCCTTCTT-----------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCCcCccccc-----------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 99874322110 00000000000000011112244677889999999999999999999975 344444
Q ss_pred HH
Q 005278 694 EK 695 (704)
Q Consensus 694 ~~ 695 (704)
..
T Consensus 361 ~~ 362 (371)
T 3q60_A 361 NE 362 (371)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=329.31 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=205.2
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.+.|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999854 68999999987553 3345779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++++|.+++... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 173 (303)
T ss_dssp CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence 99999999998753 4899999999999999999995 4689999999999999999999999999998765432
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+....+.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-------------- 237 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPP-------------- 237 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCC--------------
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCC--------------
Confidence 1223456899999999999999999999999999999999999999763221 111111111110
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+..++..+.+++..||+.||++||++.|+++.
T Consensus 238 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 ---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0111334568899999999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=335.92 Aligned_cols=268 Identities=22% Similarity=0.268 Sum_probs=194.7
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
...++|.+.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999854 789999999875432 234567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-----CCCcEEEeeeccce
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-----ENMTAHVSDFGISK 563 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-----~~~~~kl~Dfgla~ 563 (704)
||||++ |+|.+++..... +++..+..++.|++.||+|||. .+|+||||||+||+++ .++.+||+|||+++
T Consensus 111 v~e~~~-~~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEECCS-EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEecCC-CCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999997 599999986643 8999999999999999999954 6899999999999994 55569999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh-cCCC--c
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES-LPDG--L 639 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~--~ 639 (704)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+....... .+.. +
T Consensus 186 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 186 AFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTS
T ss_pred ccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhhh
Confidence 7643221 23345689999999998764 48999999999999999999999997632211 111111111 1110 0
Q ss_pred chhc--------cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 640 TEVV--------DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 640 ~~~~--------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.... .+..............++.++.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 00000000111112224567889999999999999999999954
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.71 Aligned_cols=251 Identities=24% Similarity=0.283 Sum_probs=201.3
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
..++|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3457999999999999999999965 78999999986543 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEeeeccceecC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD---ENMTAHVSDFGISKLLG 566 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~---~~~~~kl~Dfgla~~~~ 566 (704)
|||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+++...
T Consensus 100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999999987654 4899999999999999999995 46899999999999995 55679999999998764
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+ .+..........
T Consensus 176 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~--------- 241 (486)
T 3mwu_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAF--------- 241 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCS---------
T ss_pred CCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC---------
Confidence 332 2334579999999999875 58999999999999999999999997632111 111111100000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+....++..+.+++.+||+.||++|||+.|+++
T Consensus 242 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 ------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp ------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 01112234567889999999999999999999976
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.50 Aligned_cols=269 Identities=22% Similarity=0.278 Sum_probs=202.2
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeC-------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNI------- 483 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 483 (704)
.++|+..+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+++++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35789999999999999999996 4799999999865432 2345788999999999999999999999773
Q ss_pred -CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 484 -DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 484 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
+..++||||+++ ++.+.+......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 468999999975 888888876667999999999999999999995 468999999999999999999999999999
Q ss_pred eecCCCCC--cceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHH--hhcCC
Q 005278 563 KLLGEGDD--SVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK--ESLPD 637 (704)
Q Consensus 563 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~ 637 (704)
+.+..... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+..... ....... ...+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCh
Confidence 87753322 222344578999999998875 558999999999999999999999997632211 1111111 11111
Q ss_pred C-cchhccccch----------hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 638 G-LTEVVDANLV----------REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 638 ~-~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. +......... ............+..+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1 1111000000 000000011112456889999999999999999999965
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=337.08 Aligned_cols=274 Identities=21% Similarity=0.248 Sum_probs=201.3
Q ss_pred chHHHHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccch-----------hhhHHHHHHHHHHHhcCCCCCc
Q 005278 406 SYLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE-----------RASRSFDSECEILRSIRHRNLI 474 (704)
Q Consensus 406 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv 474 (704)
...++....++|...+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 34577888899999999999999999999988899999999864321 1236789999999999999999
Q ss_pred eEEeeeee-----CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 005278 475 KIISNCCN-----IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD 549 (704)
Q Consensus 475 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~ 549 (704)
++++++.. ....++||||++ |+|.+++......+++..+..++.|++.||+|||. .+|+||||||+||+++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLA 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEc
Confidence 99999844 336799999997 69999998777779999999999999999999964 6899999999999999
Q ss_pred CCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHH
Q 005278 550 ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK 628 (704)
Q Consensus 550 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~ 628 (704)
.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~ 244 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLN 244 (362)
T ss_dssp TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH
T ss_pred CCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 99999999999998543322 2334568999999998876 678999999999999999999999997632111 111
Q ss_pred HHHHhhcCCCcch-----------hccccchh--hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 629 HWVKESLPDGLTE-----------VVDANLVR--EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 629 ~~~~~~~~~~~~~-----------~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
............. ........ ..........++..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111110000000 00000000 00001112234567889999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=323.64 Aligned_cols=247 Identities=26% Similarity=0.432 Sum_probs=194.5
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|.+.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468899999999999999999975 799999999875431 2345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++++|.+++.... .+++..+..++.|++.|++|||. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999997654 38899999999999999999964 689999999999999999999999999998764432
Q ss_pred CcceeccccccccccCCcccCCCCC-CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... .....+....
T Consensus 166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~------------- 227 (276)
T 2h6d_A 166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGGV------------- 227 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-------------
T ss_pred ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCc-------------
Confidence 1234468999999999887765 68999999999999999999999753211 1111111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++..+.+++.+|++.||++||++.|+++
T Consensus 228 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 -----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0011123456888999999999999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=326.34 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=197.4
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 488 (704)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467899999999999999999975 79999999987543 33456788999999999 99999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC--------------
Q 005278 489 VLEFMPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-------------- 551 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-------------- 551 (704)
||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999854 245899999999999999999995 4689999999999999844
Q ss_pred -----CcEEEeeeccceecCCCCCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccc
Q 005278 552 -----MTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEM 625 (704)
Q Consensus 552 -----~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~ 625 (704)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|||++|..|+... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----D 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----H
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----h
Confidence 479999999998765422 23589999999998765 5668999999999999999998876431 1
Q ss_pred cHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 626 SLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..........+ ..+..++..+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 QWHEIRQGRLP------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHHTTCCC------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCC------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11111111000 011133567889999999999999999999964
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=332.47 Aligned_cols=260 Identities=18% Similarity=0.278 Sum_probs=199.0
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeee--CCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCN--IDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 490 (704)
++|+..+.||+|+||.||+|+. .+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6789999999999999999985 57899999998643 3467899999999997 9999999999988 66789999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeeeccceecCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-TAHVSDFGISKLLGEGD 569 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-~~kl~Dfgla~~~~~~~ 569 (704)
||+++++|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999998853 788899999999999999995 57899999999999999776 89999999998765433
Q ss_pred CcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHH------------HHhhcC
Q 005278 570 DSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHW------------VKESLP 636 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~------------~~~~~~ 636 (704)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+... ......
T Consensus 186 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 186 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2 234568999999998876 678999999999999999999999995422211111111 111000
Q ss_pred C---Ccchhccccchh---hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 637 D---GLTEVVDANLVR---EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 637 ~---~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ............ ..........++..+.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 000000000000 00001112234677899999999999999999999954
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=333.65 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=204.3
Q ss_pred cchHHHHHHhCCCCcc-ccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcC-CCCCceEEee
Q 005278 405 TSYLDIQRATNGFNEC-NLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIR-HRNLIKIISN 479 (704)
Q Consensus 405 ~~~~~~~~~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~ 479 (704)
..+.......+.|.+. +.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344455666777777 88999999999999865 699999999876442 23567899999999994 6999999999
Q ss_pred eeeCCeEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEE
Q 005278 480 CCNIDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---NMTAH 555 (704)
Q Consensus 480 ~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---~~~~k 555 (704)
+.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999998643 456899999999999999999995 468999999999999997 78999
Q ss_pred EeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc
Q 005278 556 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 556 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .... ....
T Consensus 175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i-~~~~ 249 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNI-SQVN 249 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-HHTC
T ss_pred EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHH-Hhcc
Confidence 99999998764332 12345799999999999999999999999999999999999999976322111 1111 1000
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. . .......++..+.+++.+||+.||++||+++|+++
T Consensus 250 ~~-~-------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 250 VD-Y-------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CC-C-------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc-c-------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00 0 00111234567889999999999999999999954
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=328.39 Aligned_cols=251 Identities=22% Similarity=0.254 Sum_probs=187.5
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46789999999999999999996 478999999987543 222334555566688889999999999999999999999
Q ss_pred eccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
||++ |+|.+++.. ....+++..+..++.|++.|++|||.. .+|+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 588888763 456699999999999999999999642 2899999999999999999999999999987643
Q ss_pred CCCcceeccccccccccCCccc----CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYG----SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
.. ......||+.|+|||++ .+..++.++||||+|+++|||++|+.||..................+.
T Consensus 163 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 233 (290)
T 3fme_A 163 DV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ------ 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC------
T ss_pred cc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC------
Confidence 22 22334699999999985 566789999999999999999999999975322222222222211110
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.....++..+.+++.+|++.||++|||+.|+++
T Consensus 234 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 -----------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 001133566889999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.98 Aligned_cols=264 Identities=22% Similarity=0.263 Sum_probs=205.0
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhh-----------------hHHHHHHHHHHHhcCCCCCceE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERA-----------------SRSFDSECEILRSIRHRNLIKI 476 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l 476 (704)
.++|...+.||+|+||.||+|+. +++.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 89999999987543211 1789999999999999999999
Q ss_pred EeeeeeCCeEEEEEeccCCCCHHHH------HhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 005278 477 ISNCCNIDFKALVLEFMPNGSLEKW------LYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD 549 (704)
Q Consensus 477 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~ 549 (704)
++++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.|++|||. +.+|+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999998 5542 4568999999999999999999964 27899999999999999
Q ss_pred CCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCC-CCCc-ccceeeHHHHHHHHhhCCCCCCccccccccH
Q 005278 550 ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG-IISP-KSDVYSYGILLMETFTRKKPTNEIFIGEMSL 627 (704)
Q Consensus 550 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~ 627 (704)
.++.+||+|||.+...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||....... ..
T Consensus 187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-EL 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-HH
T ss_pred CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HH
Confidence 9999999999999876432 23445799999999998877 6666 9999999999999999999997643211 11
Q ss_pred HHHHHhhcCCC---cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 628 KHWVKESLPDG---LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 628 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+....... ......+.... ........++..+.+++.+||+.||++||++.|+++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNK--KSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhccCcCCccchhhhhcccccc--ccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111110000 00000000000 000111234567899999999999999999999976
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=336.69 Aligned_cols=254 Identities=23% Similarity=0.257 Sum_probs=200.8
Q ss_pred hCCCCccccccccCceEEEEEEE----CCCCEEEEEEeeccc----hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERASRSFDSECEILRSI-RHRNLIKIISNCCNID 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 484 (704)
.++|+..+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35789999999999999999986 368999999986532 22345677899999999 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999998654 4899999999999999999995 46899999999999999999999999999987
Q ss_pred cCCCCCcceeccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~----- 281 (355)
T 1vzo_A 209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKS----- 281 (355)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHC-----
T ss_pred cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHHHHHHHHhcc-----
Confidence 643221 12234579999999999875 44788999999999999999999999753222 1222221111100
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAAK 688 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~~ 688 (704)
....+..++..+.+++.+||+.||++|| ++.|+++.
T Consensus 282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 0011223456678899999999999999 89998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.54 Aligned_cols=263 Identities=24% Similarity=0.314 Sum_probs=186.5
Q ss_pred HHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
....++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34467899999999999999999985 478999999986543 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhh-------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 489 VLEFMPNGSLEKWLYS-------HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
||||+++|+|.+++.. ....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999974 2445899999999999999999995 46899999999999999999999999999
Q ss_pred ceecCCCCC---cceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC
Q 005278 562 SKLLGEGDD---SVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD 637 (704)
Q Consensus 562 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (704)
+........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ........+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~ 245 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLTLQNDPP 245 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHTSSCC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHHhccCCC
Confidence 977643321 112234468999999998865 5689999999999999999999999976432221 1111111111
Q ss_pred Cc-chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 638 GL-TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 638 ~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. ....+. .....++..+.+++.+||+.||++||++.|+++
T Consensus 246 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDK---------EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC--------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccc---------hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 000011 111233457889999999999999999999976
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=328.14 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=201.0
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 488 (704)
.++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999865 68999999987543 3345678999999999999999999998754 568899
Q ss_pred EEeccCCCCHHHHHhhC---CCccCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 489 VLEFMPNGSLEKWLYSH---NYFLGILERLNIMIDVGLALEYLHHGH--STPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~h--~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
||||+++|+|.+++... ...+++..++.++.|++.|++|||... ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999743 345899999999999999999997632 1339999999999999999999999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+......
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~~~------ 234 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGKFR------ 234 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC------
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHHhhcccc------
Confidence 764322 1123346899999999999889999999999999999999999999764211 111111111000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKL 689 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L 689 (704)
..+..++..+.+++.+||+.||++||++.|+++.+
T Consensus 235 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 235 -----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred -----------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11123456788999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.97 Aligned_cols=200 Identities=26% Similarity=0.352 Sum_probs=166.8
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC-----Ce
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI-----DF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 485 (704)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999864 68899999997532 33456789999999999999999999999776 57
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||++ |+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999986 5999999764 34899999999999999999995 468999999999999999999999999999987
Q ss_pred CCCCCc--------------------ceeccccccccccCCccc-CCCCCCcccceeeHHHHHHHHhhCCCCCC
Q 005278 566 GEGDDS--------------------VIQTMTIATIGYMAPEYG-SEGIISPKSDVYSYGILLMETFTRKKPTN 618 (704)
Q Consensus 566 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~ 618 (704)
...... .......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 543211 123456799999999985 56679999999999999999998766654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=326.09 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=198.7
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc----hhhhHHHHHHHHHHHhcCCCCCceEEeeee--eCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL----ERASRSFDSECEILRSIRHRNLIKIISNCC--NIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 486 (704)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 68999999987543 234567899999999999999999999984 45678
Q ss_pred EEEEeccCCCCHHHHHhh-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 487 ALVLEFMPNGSLEKWLYS-HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
++||||+++| +.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 7777764 3456899999999999999999995 468999999999999999999999999999887
Q ss_pred CCCCCcceeccccccccccCCcccCCCC--CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGI--ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
.............||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~~~------ 228 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFENIGKG------ 228 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHC------
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHHhcC------
Confidence 5443333444557999999999887643 4779999999999999999999997521 11111110000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
....+..++..+.+++.+||+.||++||++.|+++.
T Consensus 229 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 ---------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001112345678899999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=360.98 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=207.0
Q ss_pred HhCCCCccccccccCceEEEEEEECC----CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
..++|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 34678888999999999999998642 4579999986543 3344679999999999999999999999854 5679
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++|+|.+++......+++..++.++.|++.||+|||. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 9999999999999998777679999999999999999999964 6899999999999999999999999999987644
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.... .....+....
T Consensus 544 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~----------- 609 (656)
T 2j0j_A 544 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGE----------- 609 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTC-----------
T ss_pred Ccc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence 322 22233457889999999988899999999999999999997 99999764221 1111111110
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
....+..++..+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 610 ------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 610 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0111224566788999999999999999999999999998654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=345.07 Aligned_cols=325 Identities=21% Similarity=0.256 Sum_probs=212.6
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCC
Q 005278 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLT 82 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~ 82 (704)
..+++|++|+|++|.++++.|..|.++++|++|+|++|.++++.|..|.++++|++|++++|.++.+.... +.
T Consensus 54 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~-------~~ 126 (606)
T 3t6q_A 54 SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP-------LH 126 (606)
T ss_dssp TTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSC-------CT
T ss_pred ccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcch-------hc
Confidence 45677777777777777666777777777777777777777777777777777777777777777654333 77
Q ss_pred CCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCC--EEEccCCcCccccChhhcCC---
Q 005278 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMI--VFDLNGCDLNGTIPTAVGRL--- 157 (704)
Q Consensus 83 ~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~--~L~L~~n~l~~~~~~~~~~l--- 157 (704)
++++|++|+|++|++.+..++.+.. .++|++|++++|.+++..+..++.+++|+ +|++++|.+.+..|..|...
T Consensus 127 ~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~ 205 (606)
T 3t6q_A 127 NQKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQ 205 (606)
T ss_dssp TCTTCCEEECCSSCCCCCCCCTTCC-CTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEE
T ss_pred cCCcccEEECCCCcccccCcccccC-CcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhcccc
Confidence 7777888888888777654444444 34688888888888777777777777777 77777777765555443221
Q ss_pred ------------------------------------------------CCcCeeeccCcccCCCCCccccCCCCCCEEEc
Q 005278 158 ------------------------------------------------RRLQGLYLHGNKLQGSIPYDLCHLEGLSELNL 189 (704)
Q Consensus 158 ------------------------------------------------~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 189 (704)
.+|+.|++++|.+++..+..|..+++|++|++
T Consensus 206 ~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 285 (606)
T 3t6q_A 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285 (606)
T ss_dssp EEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEEC
T ss_pred ccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEec
Confidence 04555555556665555555666667777777
Q ss_pred CCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCc-ccccCcCCcEEEeecCccCC
Q 005278 190 NGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPS-NIQNLKVLTNLDLSRNQLSG 268 (704)
Q Consensus 190 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~n~l~~ 268 (704)
++|+++ .+|..+..+++|+.|++++|.+++..+..+..+++|++|++++|.+.+.++. .+..+++|+.|++++|++++
T Consensus 286 ~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 364 (606)
T 3t6q_A 286 TATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364 (606)
T ss_dssp TTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCE
T ss_pred cCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCcccc
Confidence 777766 5566666667777777777776665566666666666666666666544433 36666666666666666664
Q ss_pred CC--CCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCC-cccccccCcccccCC
Q 005278 269 DI--PTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKN-FSAQSFLSNYALCGP 336 (704)
Q Consensus 269 ~~--~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~l~~~~l~g~ 336 (704)
.. +..+..+++|+.|++++|++++..|..+..+++|+.|++++|++.+..|.. +...+.+....+.++
T Consensus 365 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n 435 (606)
T 3t6q_A 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435 (606)
T ss_dssp EEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTC
T ss_pred ccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCC
Confidence 43 555666666666666666666666666666666666666666666554432 444554544444444
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.07 Aligned_cols=272 Identities=22% Similarity=0.250 Sum_probs=199.4
Q ss_pred HHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC------
Q 005278 411 QRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNI------ 483 (704)
Q Consensus 411 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 483 (704)
....++|...+.||+|+||+||+|+. .+|+.||||++.... ....+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999985 579999999986542 2234799999999999999999998443
Q ss_pred --------------------------------CeEEEEEeccCCCCHHHHHh---hCCCccCHHHHHHHHHHHHHHHHHH
Q 005278 484 --------------------------------DFKALVLEFMPNGSLEKWLY---SHNYFLGILERLNIMIDVGLALEYL 528 (704)
Q Consensus 484 --------------------------------~~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~L 528 (704)
...++||||++ |+|.+.+. .....+++..+..++.|++.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 58888776 3455689999999999999999999
Q ss_pred HhcCCCCcEecCCCCCCeeeC-CCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCC-CCCcccceeeHHHH
Q 005278 529 HHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGIL 606 (704)
Q Consensus 529 h~~h~~~ivH~dlk~~Nil~~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~ 606 (704)
| +.+|+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||+
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 4 67899999999999998 688999999999987644322 2344689999999988764 48999999999999
Q ss_pred HHHHhhCCCCCCccccccccHHHHHHhhcCCCc----------chhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCC
Q 005278 607 LMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL----------TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESP 676 (704)
Q Consensus 607 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P 676 (704)
+|||++|+.||.+.... ..+...+........ ....-+...........+..++..+.+++.+||+.||
T Consensus 232 l~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999999763221 112222211111100 0000000000001111222356678999999999999
Q ss_pred CCCCCHHHHHH--HHHHhHH
Q 005278 677 EQRVSMKDAAA--KLKKIKE 694 (704)
Q Consensus 677 ~~Rpt~~ev~~--~L~~~~~ 694 (704)
++|||+.|+++ .+++++.
T Consensus 311 ~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHHH
T ss_pred hhCCCHHHHhcCHHHHHHHh
Confidence 99999999974 3444433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=346.60 Aligned_cols=251 Identities=21% Similarity=0.266 Sum_probs=197.6
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.++|...+.||+|+||+||+|+.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357889999999999999999965 68999999987543 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEeeeccceecCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---NMTAHVSDFGISKLLGE 567 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---~~~~kl~Dfgla~~~~~ 567 (704)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++.....
T Consensus 116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999887553 3899999999999999999995 468999999999999976 45599999999987654
Q ss_pred CCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.. ......||+.|+|||++. +.++.++||||+||++|+|++|..||.+.... .....+...... .
T Consensus 192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~-~-------- 256 (494)
T 3lij_A 192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGKYT-F-------- 256 (494)
T ss_dssp TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC-C--------
T ss_pred Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC-C--------
Confidence 32 233457999999999876 46899999999999999999999999763221 111111110000 0
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~ 688 (704)
..+....++..+.+++.+||+.||++|||+.|+++.
T Consensus 257 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 -----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 001112345678899999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.60 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=193.9
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID------ 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 484 (704)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999986 479999999986432 234567889999999999999999999997653
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..++||||+ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 459999999 78999999864 4889999999999999999995 46899999999999999999999999999987
Q ss_pred cCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC--cch
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG--LTE 641 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 641 (704)
.... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+........... ...
T Consensus 178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 6432 234568999999998876 679999999999999999999999997632111 1111111100000 000
Q ss_pred hccccchh----------hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 642 VVDANLVR----------EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 642 ~~~~~~~~----------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+...... ...........+..+.+++.+|++.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000 00000111234567889999999999999999999976
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=346.11 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=199.9
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch-------------hhhHHHHHHHHHHHhcCCCCCceEEe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-------------RASRSFDSECEILRSIRHRNLIKIIS 478 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~ 478 (704)
..++|.+.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999965 688999999875421 23467899999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEE
Q 005278 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM---TAH 555 (704)
Q Consensus 479 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~---~~k 555 (704)
++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 9999999999999999999999997653 4899999999999999999995 46899999999999998775 699
Q ss_pred EeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc
Q 005278 556 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 556 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
|+|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++|..||.+.... .....+...
T Consensus 190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~- 262 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEKG- 262 (504)
T ss_dssp ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-
T ss_pred EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC-
Confidence 99999998775432 233457999999999877 46899999999999999999999999763221 111111100
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... ........++..+.+++..|++.||++|||+.|+++
T Consensus 263 ----------~~~---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 263 ----------KYY---FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp ----------CCC---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----------CCC---CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 001112234567889999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.07 Aligned_cols=250 Identities=25% Similarity=0.319 Sum_probs=203.3
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999965 79999999986543 23456799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeeeccceecC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL---DENMTAHVSDFGISKLLG 566 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~---~~~~~~kl~Dfgla~~~~ 566 (704)
|||+.+|+|.+++.... .+++..+..++.|++.||+|||. .+|+||||||+||++ +.++.+||+|||+++...
T Consensus 105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999999997654 48999999999999999999954 689999999999999 567899999999998765
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.... .....+......
T Consensus 181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~--------- 245 (484)
T 3nyv_A 181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEKGKYT--------- 245 (484)
T ss_dssp CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC---------
T ss_pred ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCC---------
Confidence 432 2334579999999998866 6899999999999999999999999763211 111111110000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+....++..+.+++.+||+.||++|||+.|+++
T Consensus 246 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 -----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 001112234567889999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.71 Aligned_cols=252 Identities=26% Similarity=0.320 Sum_probs=197.1
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--------hhhHHHHHHHHHHHhcCCCCCceEEeeeeeC
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--------RASRSFDSECEILRSIRHRNLIKIISNCCNI 483 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 483 (704)
..++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999865 689999999864321 1223588999999999999999999998766
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc---EEEeeec
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT---AHVSDFG 560 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~---~kl~Dfg 560 (704)
. .++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 5 799999999999999987543 4899999999999999999995 468999999999999987664 9999999
Q ss_pred cceecCCCCCcceeccccccccccCCccc---CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYG---SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD 637 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (704)
+++..... .......||+.|+|||++ ....++.++|||||||++|||++|..||....... .+...+......
T Consensus 163 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYN 238 (322)
T ss_dssp TCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCCC
T ss_pred cceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCccc
Confidence 99876432 122345689999999986 35678899999999999999999999997643222 222222211100
Q ss_pred CcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 638 GLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. ......++..+.+++.+||+.||++||++.|+++
T Consensus 239 ~~--------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 FI--------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cC--------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 0111234567889999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=329.87 Aligned_cols=256 Identities=24% Similarity=0.328 Sum_probs=196.6
Q ss_pred HHHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcC--CCCCceEEeeeeeCC
Q 005278 409 DIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIR--HRNLIKIISNCCNID 484 (704)
Q Consensus 409 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 484 (704)
.+....++|+..+.||+|+||.||+|+..+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 3344567899999999999999999998889999999986543 334567899999999997 599999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..++||| +.+++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++++ +.+||+|||++..
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 9999999 56889999998654 4889999999999999999995 468999999999999964 8999999999987
Q ss_pred cCCCCCcceeccccccccccCCcccCC-----------CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHh
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSE-----------GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 633 (704)
..............||+.|+|||++.+ ..++.++||||||+++|||++|+.||................
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence 754433333344579999999998765 468889999999999999999999997643221111111110
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... ...+..++..+.+++.+||+.||++||++.|+++
T Consensus 256 ~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 256 NHE-----------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp TSC-----------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccc-----------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 000 0001122456788999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=330.01 Aligned_cols=273 Identities=19% Similarity=0.213 Sum_probs=192.3
Q ss_pred HHHHHHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe-
Q 005278 408 LDIQRATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDF- 485 (704)
Q Consensus 408 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 485 (704)
.+.....++|.+.+.||+|+||.||+|+.. +|+.||||++... ........++++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345667789999999999999999999964 6899999998654 2334456778888999999999999999966433
Q ss_pred ------EEEEEeccCCCCHHHHHh---hCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEE
Q 005278 486 ------KALVLEFMPNGSLEKWLY---SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-NMTAH 555 (704)
Q Consensus 486 ------~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-~~~~k 555 (704)
.++||||+++ ++.+.+. .....+++..+..++.|++.|+.|||. |+.+|+||||||+||+++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence 7899999986 5555444 245568899999999999999999964 5899999999999999996 89999
Q ss_pred EeeeccceecCCCCCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh
Q 005278 556 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES 634 (704)
Q Consensus 556 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 634 (704)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... ..+....+..
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~ 248 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVL 248 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHc
Confidence 999999987654322 2345689999999988654 4899999999999999999999999763221 1122222111
Q ss_pred cCCC--cchhcc-----------ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 635 LPDG--LTEVVD-----------ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 635 ~~~~--~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.... .....+ ...............++..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1100 000000 0000000011111224678999999999999999999999953
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=339.58 Aligned_cols=198 Identities=25% Similarity=0.305 Sum_probs=172.0
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhc------CCCCCceEEeeeeeCCe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSI------RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~ 485 (704)
...+|++.+.||+|+||+||+|... +++.||||++... ....+.+.+|+++++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467999999999999999999865 5899999998754 33446678889888887 57799999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc--EEEeeeccc
Q 005278 486 KALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT--AHVSDFGIS 562 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~--~kl~Dfgla 562 (704)
.++||||+. ++|.+++.... ..+++..+..++.|++.||+|||. .+|+||||||+||+++.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999996 69999998654 458999999999999999999964 68999999999999999887 999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcc
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEI 620 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~ 620 (704)
...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 865432 22346899999999999999999999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=331.71 Aligned_cols=201 Identities=25% Similarity=0.301 Sum_probs=173.5
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CC-----CCceEEeeeeeCC
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIR-HR-----NLIKIISNCCNID 484 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~ 484 (704)
...++|++.+.||+|+||+||+|+.. +++.||||++... ......+..|+++++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34678999999999999999999865 6889999998743 233566788999998885 55 4999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--CCCcEEEeeecc
Q 005278 485 FKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD--ENMTAHVSDFGI 561 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~--~~~~~kl~Dfgl 561 (704)
..++||||++ |+|.+++.... ..+++..+..++.|++.||+|||. |+.+|+||||||+||+++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 59999998653 458999999999999999999975 578999999999999995 578899999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcc
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEI 620 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~ 620 (704)
++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9876432 22356899999999999999999999999999999999999999763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=333.22 Aligned_cols=259 Identities=24% Similarity=0.308 Sum_probs=198.4
Q ss_pred cchHHHHHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeee
Q 005278 405 TSYLDIQRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCN 482 (704)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 482 (704)
+.+.++....++|+..+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 33444555678999999999999999999996 478999999986542 3456789999999999 89999999999977
Q ss_pred ------CCeEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEE
Q 005278 483 ------IDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAH 555 (704)
Q Consensus 483 ------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~k 555 (704)
.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||. .+|+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence 46789999999999999999864 3468999999999999999999954 6899999999999999999999
Q ss_pred EeeeccceecCCCCCcceeccccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHH
Q 005278 556 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHW 630 (704)
Q Consensus 556 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~ 630 (704)
|+|||++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||....... ....
T Consensus 170 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~ 245 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--ALFL 245 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH
T ss_pred EeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHH
Confidence 999999987643211 123346899999999886 5678999999999999999999999996532211 0011
Q ss_pred HHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 631 VKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....... .. ....++..+.+++.+||+.||++||++.|+++
T Consensus 246 ~~~~~~~--------~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPRNPAP--------RL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHSCCC--------CC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhcCccc--------cC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1100000 00 01123457889999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=331.17 Aligned_cols=268 Identities=21% Similarity=0.242 Sum_probs=200.8
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC-----Ce
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNI-----DF 485 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 485 (704)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3468999999999999999999864 68899999987433 33446788999999999999999999998665 36
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||++ |+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 899999997 59999987643 899999999999999999995 478999999999999999999999999999876
Q ss_pred CCCCCcc-eeccccccccccCCcccC-CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCc---c
Q 005278 566 GEGDDSV-IQTMTIATIGYMAPEYGS-EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL---T 640 (704)
Q Consensus 566 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 640 (704)
....... ......||+.|+|||++. +..++.++||||+||++|||++|+.||.+....+ .+............ .
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence 5332211 123447999999999765 4558999999999999999999999997643221 11111111100000 0
Q ss_pred hhccccch---------hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 641 EVVDANLV---------REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 641 ~~~~~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+.... ...........++..+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 000000111234567889999999999999999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=330.27 Aligned_cols=260 Identities=19% Similarity=0.217 Sum_probs=191.3
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID------ 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 484 (704)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999854 68999999987542 334567889999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..++||||++ |+|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999997 478888863 3789999999999999999995 46899999999999999999999999999986
Q ss_pred cCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc--CCCcchh
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL--PDGLTEV 642 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 642 (704)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...|..... .....+.
T Consensus 177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHC-CCCCCHHH
T ss_pred ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHH
Confidence 64321 22345789999999999999999999999999999999999999976321 111111000 0000000
Q ss_pred c---c----------ccch-----h------hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 V---D----------ANLV-----R------EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~---~----------~~~~-----~------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. . +... . ...........+..+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 0 0000 0 00001112334678899999999999999999999965
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.11 Aligned_cols=262 Identities=22% Similarity=0.317 Sum_probs=200.6
Q ss_pred HHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
...++|+..+.||+|+||.||+|+..+ .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345789999999999999999998653 59999987543 22335678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++++|.+++...+..+++..++.++.|++.|++|||. .+|+||||||+||+++ ++.+||+|||+++......
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999998777679999999999999999999964 6899999999999998 6799999999987653221
Q ss_pred ---CcceeccccccccccCCcccCC---------CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC
Q 005278 570 ---DSVIQTMTIATIGYMAPEYGSE---------GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD 637 (704)
Q Consensus 570 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (704)
.........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .........
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~ 258 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIWQMGTG 258 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----HHHHHHHTT
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhccC
Confidence 1122233468999999998764 45788999999999999999999999763221 111111000
Q ss_pred CcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhh
Q 005278 638 GLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFL 697 (704)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~ 697 (704)
. .+.. ....++..+.+++..||+.||++||++.|+++.|+++.++..
T Consensus 259 ~-----~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 259 M-----KPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp C-----CCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred C-----CCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 0000 001233457889999999999999999999999999876643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=357.66 Aligned_cols=245 Identities=20% Similarity=0.237 Sum_probs=200.9
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeE
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 486 (704)
...++|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999965 68899999997542 23446688899999988 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++++||+|||+|+...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999998654 4899999999999999999995 4789999999999999999999999999998643
Q ss_pred CCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 567 EGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .......... .
T Consensus 494 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~--------~ 558 (674)
T 3pfq_A 494 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEH--------N 558 (674)
T ss_dssp CTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHSS--------C
T ss_pred cCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhC--------C
Confidence 322 223456799999999999999999999999999999999999999976321 1111111111 0
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSM 682 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 682 (704)
...+...+.++.+++..||+.||++||++
T Consensus 559 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 01112345678899999999999999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=319.89 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=202.5
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---------hhhhHHHHHHHHHHHhcC-CCCCceEEeee
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---------ERASRSFDSECEILRSIR-HRNLIKIISNC 480 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 480 (704)
...++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999965 68999999986432 123456889999999995 99999999999
Q ss_pred eeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeec
Q 005278 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFG 560 (704)
Q Consensus 481 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 560 (704)
......++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999998643 4899999999999999999995 4789999999999999999999999999
Q ss_pred cceecCCCCCcceeccccccccccCCcccC------CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYGS------EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES 634 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 634 (704)
++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||...... .....+...
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~ 244 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLRMIMSG 244 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--HHHHHHhcC
Confidence 9987654322 23456899999999874 456889999999999999999999999653211 111111110
Q ss_pred cCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 635 LPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... . ..+....++..+.+++.+||+.||++||++.|+++
T Consensus 245 ~~~-~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQ-F-------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCC-C-------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Ccc-c-------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 000 0 00111234567889999999999999999999964
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.97 Aligned_cols=321 Identities=22% Similarity=0.247 Sum_probs=280.2
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCC-cccchhhcccccCCCCCCC
Q 005278 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMT-ESSAAKWNFLSSLTNCRNL 87 (704)
Q Consensus 9 ~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~~~~~~~~l~~L 87 (704)
+.++.+++.++ .+|. + .++|++|+|++|.++++.+..|.++++|++|+|++|.+.. ++. ..|.++++|
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~-------~~~~~l~~L 81 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN-------NTFRGLSSL 81 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECT-------TTTTTCTTC
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECc-------ccccccccC
Confidence 46888899998 6676 3 3889999999999999999999999999999999999863 333 348999999
Q ss_pred cEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChh--hhcCCCCCEEEccCCcCccccChh-hcCCCCcCeee
Q 005278 88 TVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQE--IGNLSGMIVFDLNGCDLNGTIPTA-VGRLRRLQGLY 164 (704)
Q Consensus 88 ~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~ 164 (704)
++|+|++|++.+..|..|..+. +|++|++++|++++..+.. +.++++|++|+|++|.+.+..|.. +.++++|++|+
T Consensus 82 ~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~ 160 (455)
T 3v47_A 82 IILKLDYNQFLQLETGAFNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160 (455)
T ss_dssp CEEECTTCTTCEECTTTTTTCT-TCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEE
T ss_pred CEEeCCCCccCccChhhccCcc-cCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEe
Confidence 9999999999998899998874 7999999999999865555 999999999999999999887776 89999999999
Q ss_pred ccCcccCCCCCccccCC--CCCCEEEcCCCcCCccCCcc--------ccCcCCCCEEEecCccCCCCCCCcc--------
Q 005278 165 LHGNKLQGSIPYDLCHL--EGLSELNLNGNKLCGHVPPC--------LASLTSLRRLHLGSNKLTSTMPSSF-------- 226 (704)
Q Consensus 165 L~~n~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~--------~~~l~~L~~L~l~~n~l~~~~~~~~-------- 226 (704)
+++|++++..+..+..+ .+|+.|++++|.+.+..+.. +..+++|+.|++++|.+++..+..+
T Consensus 161 L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~ 240 (455)
T 3v47_A 161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK 240 (455)
T ss_dssp CTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCC
T ss_pred CCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccc
Confidence 99999998888888876 78999999999999655433 3366899999999998865333222
Q ss_pred -----------------------------c--CCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcC
Q 005278 227 -----------------------------G--SLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIG 275 (704)
Q Consensus 227 -----------------------------~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 275 (704)
. ..++|+.|++++|.+.+..|..+..+++|+.|++++|++++..|..|.
T Consensus 241 L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 320 (455)
T 3v47_A 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFW 320 (455)
T ss_dssp EEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred eeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhc
Confidence 1 126899999999999999999999999999999999999988899999
Q ss_pred CCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCCcccccccCcccccCCCccCC
Q 005278 276 GLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQV 341 (704)
Q Consensus 276 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~~~~~ 341 (704)
++++|+.|+|++|.+++..|..+..+++|+.|++++|++++..|..|...+.+....+.++....+
T Consensus 321 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 386 (455)
T 3v47_A 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSV 386 (455)
T ss_dssp TCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccC
Confidence 999999999999999988899999999999999999999999899898888888888887765443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.87 Aligned_cols=252 Identities=25% Similarity=0.302 Sum_probs=192.4
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee----------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN---------- 482 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------- 482 (704)
.++|+..+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457899999999999999999964 7999999998643 3445678999999999999999999998865
Q ss_pred ---CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 483 ---IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 483 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
....++||||+++|+|.+++......+++..++.++.|++.|++|||. .+|+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeC
Confidence 356789999999999999999777778899999999999999999954 68999999999999999999999999
Q ss_pred ccceecCCCCC------------cceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCcccccccc
Q 005278 560 GISKLLGEGDD------------SVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMS 626 (704)
Q Consensus 560 gla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~ 626 (704)
|++........ ........||+.|+|||++.+. .++.++|||||||++|||++ ||......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--- 234 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--- 234 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH---
Confidence 99987643211 1122344689999999998754 68999999999999999998 55431111
Q ss_pred HHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 627 LKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
............ ...+ .....++..+.+++..||+.||++||++.|+++
T Consensus 235 -~~~~~~~~~~~~--~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 -VNILKKLRSVSI--EFPP---------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHHSTTC--CCCT---------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHhcccccc--ccCc---------cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111100000 0000 011233456788999999999999999999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.13 Aligned_cols=264 Identities=21% Similarity=0.224 Sum_probs=200.4
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC--------CCCCceEEeeee---
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIR--------HRNLIKIISNCC--- 481 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 481 (704)
.++|.+.+.||+|+||+||+|+. .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36899999999999999999985 46899999998744 334567889999999995 788999999987
Q ss_pred -eCCeEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCeeeCCCC------
Q 005278 482 -NIDFKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHST-PMVHCDLKPNNILLDENM------ 552 (704)
Q Consensus 482 -~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~-~ivH~dlk~~Nil~~~~~------ 552 (704)
.....++||||+ +|++.+++... ...+++..+..++.|++.||+|||. . +|+||||||+||+++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence 456789999999 55666666543 4568999999999999999999964 5 899999999999999775
Q ss_pred -------------------------------------------cEEEeeeccceecCCCCCcceeccccccccccCCccc
Q 005278 553 -------------------------------------------TAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYG 589 (704)
Q Consensus 553 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 589 (704)
.+||+|||++...... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999999876432 2334689999999999
Q ss_pred CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccH----HHHHHhhcCCCcch----------hccc----------
Q 005278 590 SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSL----KHWVKESLPDGLTE----------VVDA---------- 645 (704)
Q Consensus 590 ~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~----------~~~~---------- 645 (704)
.+..++.++|||||||++|||+||+.||.......... ...+.......... ....
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999997643322110 00000000000000 0000
Q ss_pred ---cc-hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 ---NL-VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ---~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. .........+...+..+.+++.+||+.||++|||++|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 0000111223466788999999999999999999999964
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.64 Aligned_cols=263 Identities=21% Similarity=0.259 Sum_probs=201.4
Q ss_pred hCCCCccccccccCceEEEEEEE--CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCC------CCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL--FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHR------NLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~ 485 (704)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 36889999998643 33456788999999999765 49999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC--------------
Q 005278 486 KALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-------------- 550 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-------------- 550 (704)
.++||||+ +++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999998654 35889999999999999999995 468999999999999987
Q ss_pred -----CCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccc
Q 005278 551 -----NMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM 625 (704)
Q Consensus 551 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~ 625 (704)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 241 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE- 241 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence 668999999999875432 233468999999999999999999999999999999999999997632211
Q ss_pred cHHHHHHhh--cCCCcchhcc-----------------------ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC
Q 005278 626 SLKHWVKES--LPDGLTEVVD-----------------------ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV 680 (704)
Q Consensus 626 ~~~~~~~~~--~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp 680 (704)
......... .+........ ...............++..+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 111111100 0000000000 000000000112234567899999999999999999
Q ss_pred CHHHHHH
Q 005278 681 SMKDAAA 687 (704)
Q Consensus 681 t~~ev~~ 687 (704)
|+.|+++
T Consensus 322 t~~ell~ 328 (339)
T 1z57_A 322 TLREALK 328 (339)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999953
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=334.90 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=192.8
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC------eEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID------FKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l 488 (704)
.+|...+.||+|+||+||+|+...+..||+|++.... +...+|+++++.++||||+++++++.... ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4688899999999999999998777779999886432 22346999999999999999999985543 3789
Q ss_pred EEeccCCCCHHHHHh--hCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEeeeccceec
Q 005278 489 VLEFMPNGSLEKWLY--SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLL 565 (704)
Q Consensus 489 v~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~Dfgla~~~ 565 (704)
||||++++.+..... .....+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+|+..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998754433332 23456899999999999999999995 47899999999999999 7999999999999876
Q ss_pred CCCCCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcc--hh
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT--EV 642 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 642 (704)
..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ..+....+........ ..
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 44332 2345689999999988664 5899999999999999999999999763221 1122222211111000 00
Q ss_pred cccc--------chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDAN--------LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~--------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.++. .............++.++.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000 00000001111234567899999999999999999999964
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=345.54 Aligned_cols=181 Identities=24% Similarity=0.240 Sum_probs=104.2
Q ss_pred CCCCcCeeeccCcccCCC--CCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCC-CcccCCccc
Q 005278 156 RLRRLQGLYLHGNKLQGS--IPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMP-SSFGSLEYV 232 (704)
Q Consensus 156 ~l~~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L 232 (704)
.+++|++|++++|++++. .|..+..+++|++|++++|.++ .+|..+..+++|+.|++++|.+.+..+ ..+..+++|
T Consensus 348 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 426 (606)
T 3vq2_A 348 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426 (606)
T ss_dssp CCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC
T ss_pred cCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccC
Confidence 344555555555555533 2555556666666666666655 234555566666666666666655544 455556666
Q ss_pred cEEEecCcccCCCCCcccccCcCCcEEEeecCccCC-CCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecc
Q 005278 233 LYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSG-DIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSR 311 (704)
Q Consensus 233 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~ 311 (704)
++|++++|.+.+..|..+..+++|+.|++++|++++ .+|..++.+++|+.|+|++|++++..|..+..+++|+.|++++
T Consensus 427 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 506 (606)
T 3vq2_A 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506 (606)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCC
Confidence 666666666655555556666666666666666654 2455555666666666666666655555566666666666666
Q ss_pred cCCCCCCCCCcccccccCcccccCCC
Q 005278 312 NNLSGEIPKNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 312 N~l~~~~p~~~~~~~~l~~~~l~g~~ 337 (704)
|++++..|..|...+.+....+.++.
T Consensus 507 N~l~~~~~~~~~~l~~L~~L~l~~N~ 532 (606)
T 3vq2_A 507 NNLLFLDSSHYNQLYSLSTLDCSFNR 532 (606)
T ss_dssp SCCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred CcCCCcCHHHccCCCcCCEEECCCCc
Confidence 66665555555555555555555544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.15 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=182.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC------C
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI------D 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 484 (704)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999985 468999999986532 23456788999999999999999999998654 5
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..++|+||+ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 679999999 68999988753 4899999999999999999995 57899999999999999999999999999986
Q ss_pred cCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC---cc
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG---LT 640 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 640 (704)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+........... +.
T Consensus 182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHT
T ss_pred cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence 5432 234578999999998876 67899999999999999999999999763221 11111111110000 00
Q ss_pred hhccc-------cchh--hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 641 EVVDA-------NLVR--EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 641 ~~~~~-------~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+... .+.. ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000 0000 00000011133567889999999999999999999965
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=325.01 Aligned_cols=266 Identities=20% Similarity=0.265 Sum_probs=193.9
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeee-----------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCC----------- 481 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 481 (704)
.++|...+.||+|+||.||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468899999999999999999975 58999999987665556678999999999999999999999873
Q ss_pred ---eCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEe
Q 005278 482 ---NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVS 557 (704)
Q Consensus 482 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~ 557 (704)
+....++||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 6999998753 4889999999999999999995 46899999999999997 56799999
Q ss_pred eeccceecCCCCC-cceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc
Q 005278 558 DFGISKLLGEGDD-SVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 558 Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
|||+++....... ........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+ .... +....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~-~~~~~ 241 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQL-ILESI 241 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-HHHHS
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhc
Confidence 9999987643211 112233467999999998754 678999999999999999999999997632211 1111 11111
Q ss_pred CCCcc----hh-------ccccchh-hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 636 PDGLT----EV-------VDANLVR-EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 636 ~~~~~----~~-------~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+.... +. ....... ..........++.++.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11000 00 0000000 00001111235678899999999999999999999965
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.20 Aligned_cols=267 Identities=24% Similarity=0.302 Sum_probs=200.8
Q ss_pred HhCCCCccccccccCceEEEEEEE--CCCCEEEEEEeeccch--hhhHHHHHHHHHHHhc---CCCCCceEEeeee----
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL--FDGTNVAIKVFNLQLE--RASRSFDSECEILRSI---RHRNLIKIISNCC---- 481 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 481 (704)
+.++|+..+.||+|+||.||+|+. .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 4688999999875432 2234567788877776 8999999999987
Q ss_pred -eCCeEEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 482 -NIDFKALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 482 -~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence 4567899999997 69999998643 44899999999999999999995 468999999999999999999999999
Q ss_pred ccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC-
Q 005278 560 GISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG- 638 (704)
Q Consensus 560 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 638 (704)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+...........
T Consensus 165 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 165 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred cccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCc
Confidence 999865422 12334568999999999999899999999999999999999999997632211 1111111110000
Q ss_pred --cchhcc-c--cch--hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 --LTEVVD-A--NLV--REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 --~~~~~~-~--~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+..... + .+. ...........++..+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0 000 000001112244567889999999999999999999964
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=348.04 Aligned_cols=331 Identities=18% Similarity=0.258 Sum_probs=247.4
Q ss_pred CCCCCCCEEecCCCcCccc-----------------CCcccc--CCCCCCEEeccCccccccCchhhcCCCCCCEEeccc
Q 005278 3 YMLPNLKYLTLFDNKLSGT-----------------IPNSIT--NASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~-----------------~~~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 63 (704)
+.+++|++|+|++|.+++. +|..++ ++++|++|+|++|.+.+.+|..|.++++|++|+|++
T Consensus 203 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 282 (636)
T 4eco_A 203 MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282 (636)
T ss_dssp GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTT
T ss_pred hcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcC
Confidence 4688999999999999975 899988 999999999999999988999999999999999999
Q ss_pred cc-CCC-cccchhhcccccCCCCCCCcEEEccCCCCcccCCh--hhhhcccccceEEecCCcccccCChhhhcCCCCCEE
Q 005278 64 NY-LMT-ESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPP--LIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVF 139 (704)
Q Consensus 64 n~-i~~-~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~--~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 139 (704)
|+ ++. ..+.. +.-...+..+++|++|+|++|+++ .+|. .+..+. +|++|++++|.+++.+| .++++++|++|
T Consensus 283 n~~l~~~~lp~~-~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~-~L~~L~L~~N~l~g~ip-~~~~l~~L~~L 358 (636)
T 4eco_A 283 NRGISGEQLKDD-WQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMK-KLGMLECLYNQLEGKLP-AFGSEIKLASL 358 (636)
T ss_dssp CTTSCHHHHHHH-HHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCT-TCCEEECCSCCCEEECC-CCEEEEEESEE
T ss_pred CCCCccccchHH-HHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCC-CCCEEeCcCCcCccchh-hhCCCCCCCEE
Confidence 98 764 21111 000001223478888888888888 6676 677764 68888888888887777 78888888888
Q ss_pred EccCCcCccccChhhcCCCC-cCeeeccCcccCCCCCccccCCC--CCCEEEcCCCcCCccCCcccc-------CcCCCC
Q 005278 140 DLNGCDLNGTIPTAVGRLRR-LQGLYLHGNKLQGSIPYDLCHLE--GLSELNLNGNKLCGHVPPCLA-------SLTSLR 209 (704)
Q Consensus 140 ~L~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~l~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~ 209 (704)
+|++|.++ .+|..+..+++ |++|++++|+++ .+|..+..++ +|++|++++|++++..|..+. .+++|+
T Consensus 359 ~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~ 436 (636)
T 4eco_A 359 NLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436 (636)
T ss_dssp ECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEE
T ss_pred ECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCC
Confidence 88888888 67777888887 888888888887 6777766654 788888888888877777777 667888
Q ss_pred EEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcc-cccC-------cCCcEEEeecCccCCCCCCCcC--CCCC
Q 005278 210 RLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSN-IQNL-------KVLTNLDLSRNQLSGDIPTTIG--GLEN 279 (704)
Q Consensus 210 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l-------~~L~~L~l~~n~l~~~~~~~~~--~l~~ 279 (704)
.|++++|.++...+..+..+++|++|+|++|.++ .+|.. +... ++|+.|++++|+++ .+|..+. .+++
T Consensus 437 ~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~ 514 (636)
T 4eco_A 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPY 514 (636)
T ss_dssp EEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTT
T ss_pred EEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCC
Confidence 8888888887444444556778888888888877 44443 3222 27888888888887 6776665 7788
Q ss_pred cceeeccCceeeccCCcccccccccceEEe------cccCCCCCCCCCcccccccCcccccCCCccCCC
Q 005278 280 LETLSLADNQFQGPVPKSFGSLISLESLDL------SRNNLSGEIPKNFSAQSFLSNYALCGPARLQVP 342 (704)
Q Consensus 280 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l------~~N~l~~~~p~~~~~~~~l~~~~l~g~~~~~~~ 342 (704)
|+.|+|++|++++ +|..+..+++|+.|++ ++|++.+.+|..+...+.+....+.++....+|
T Consensus 515 L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ip 582 (636)
T 4eco_A 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVN 582 (636)
T ss_dssp CCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCC
T ss_pred cCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCCccC
Confidence 8888888888875 7777777888888887 456677777777777777777777766654443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=336.31 Aligned_cols=261 Identities=24% Similarity=0.281 Sum_probs=192.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC------CeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNI------DFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 487 (704)
.+|+..+.||+|+||.||+|+.. +|+.||||++.... +...+|+++++.++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36888899999999999999975 69999999986432 2234799999999999999999998542 2367
Q ss_pred EEEeccCCCCHHHHHh---hCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEeeeccce
Q 005278 488 LVLEFMPNGSLEKWLY---SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-MTAHVSDFGISK 563 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-~~~kl~Dfgla~ 563 (704)
+||||+++ ++.+.+. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 6766654 34566899999999999999999995 5789999999999999965 578999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC----
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG---- 638 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 638 (704)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... ..+...++..-...
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 7654322 2335689999999988664 7999999999999999999999999763221 12222222111110
Q ss_pred ------cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 639 ------LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 639 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+...+.+....-........+.++.+++.+||+.||++||++.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000000000000000011233567899999999999999999999964
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=345.84 Aligned_cols=320 Identities=19% Similarity=0.271 Sum_probs=282.6
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCcc-ccc-cCchhhcCC------CCCCEEecccccCCCcccchhh
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNS-FSG-LIPNTFGNL------GSLQVLSLAYNYLMTESSAAKW 75 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~-i~~-~~~~~~~~l------~~L~~L~L~~n~i~~~~~~~~~ 75 (704)
.+++|++|+|++|.+.+.+|..|.++++|++|+|++|. +++ .+|..+..+ ++|++|+|++|.++.++..
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~--- 323 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE--- 323 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCH---
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCch---
Confidence 78999999999999999999999999999999999998 998 789888887 9999999999999854430
Q ss_pred cccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCC-CCEEEccCCcCccccChhh
Q 005278 76 NFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSG-MIVFDLNGCDLNGTIPTAV 154 (704)
Q Consensus 76 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~ 154 (704)
..+.++++|++|+|++|++.+.+| .+..+. +|++|++++|+++ .+|..+.++++ |++|++++|.++ .+|..+
T Consensus 324 ---~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~ 396 (636)
T 4eco_A 324 ---TSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396 (636)
T ss_dssp ---HHHTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCC
T ss_pred ---hhhccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhh
Confidence 048999999999999999998888 777764 7999999999999 88888999999 999999999999 788888
Q ss_pred cCCC--CcCeeeccCcccCCCCCcccc-------CCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCc
Q 005278 155 GRLR--RLQGLYLHGNKLQGSIPYDLC-------HLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSS 225 (704)
Q Consensus 155 ~~l~--~L~~L~L~~n~l~~~~~~~l~-------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 225 (704)
..++ +|+.|++++|++++..|..+. .+++|++|+|++|+++...+..+..+++|+.|++++|.++...+..
T Consensus 397 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~ 476 (636)
T 4eco_A 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476 (636)
T ss_dssp CTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSS
T ss_pred hhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHH
Confidence 7765 999999999999999998888 8889999999999999544445667999999999999999444344
Q ss_pred ccCC-------ccccEEEecCcccCCCCCcccc--cCcCCcEEEeecCccCCCCCCCcCCCCCcceeec------cCcee
Q 005278 226 FGSL-------EYVLYINLSANSLNGSLPSNIQ--NLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSL------ADNQF 290 (704)
Q Consensus 226 ~~~l-------~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L------~~n~l 290 (704)
+... ++|+.|+|++|.++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++
T Consensus 477 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l 554 (636)
T 4eco_A 477 LKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554 (636)
T ss_dssp SEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBC
T ss_pred hccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcc
Confidence 4433 39999999999999 7888887 99999999999999996 8999999999999999 56888
Q ss_pred eccCCcccccccccceEEecccCCCCCCCCCcccccccCcccccCCCc
Q 005278 291 QGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPAR 338 (704)
Q Consensus 291 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~~ 338 (704)
.+.+|..+..+++|+.|++++|++ +.+|..+. +.+....+.+++.
T Consensus 555 ~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l 599 (636)
T 4eco_A 555 LREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPN 599 (636)
T ss_dssp CCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTT
T ss_pred cccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCC
Confidence 999999999999999999999999 77887655 5677777777763
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.10 Aligned_cols=320 Identities=22% Similarity=0.208 Sum_probs=291.5
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCC
Q 005278 8 LKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNL 87 (704)
Q Consensus 8 l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L 87 (704)
-+.++.+++.++ .+|..+. ++++.|+|++|.++++.+..|.++++|++|+|++|.++.+.... |.++++|
T Consensus 13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~-------~~~l~~L 82 (477)
T 2id5_A 13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA-------FNNLFNL 82 (477)
T ss_dssp TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT-------TTTCTTC
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhh-------hhCCccC
Confidence 367899999998 6787664 68999999999999999999999999999999999998876544 9999999
Q ss_pred cEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccC
Q 005278 88 TVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHG 167 (704)
Q Consensus 88 ~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 167 (704)
++|+|++|++....+..|..+ ++|++|+|++|.+.+..+..|.++++|++|+|++|.+.+..+..|.++++|++|+|++
T Consensus 83 ~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 161 (477)
T 2id5_A 83 RTLGLRSNRLKLIPLGVFTGL-SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEK 161 (477)
T ss_dssp CEEECCSSCCCSCCTTSSTTC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEES
T ss_pred CEEECCCCcCCccCcccccCC-CCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCC
Confidence 999999999997766667776 4799999999999999999999999999999999999988899999999999999999
Q ss_pred cccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCC
Q 005278 168 NKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLP 247 (704)
Q Consensus 168 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 247 (704)
|++++..+..+..+++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+..+.......+|+.|++++|.++...+
T Consensus 162 n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 241 (477)
T 2id5_A 162 CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241 (477)
T ss_dssp CCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCH
T ss_pred CcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCH
Confidence 99997666779999999999999999998888899999999999999998887777777777799999999999996655
Q ss_pred cccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCCcccccc
Q 005278 248 SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSF 327 (704)
Q Consensus 248 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ 327 (704)
..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|.+++..+..|...+.
T Consensus 242 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 321 (477)
T 2id5_A 242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN 321 (477)
T ss_dssp HHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGG
T ss_pred HHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcc
Confidence 78999999999999999999888888999999999999999999999999999999999999999999877777888888
Q ss_pred cCcccccCCCc
Q 005278 328 LSNYALCGPAR 338 (704)
Q Consensus 328 l~~~~l~g~~~ 338 (704)
+....+.+++.
T Consensus 322 L~~L~l~~N~l 332 (477)
T 2id5_A 322 LETLILDSNPL 332 (477)
T ss_dssp CCEEECCSSCE
T ss_pred cCEEEccCCCc
Confidence 88888888774
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.65 Aligned_cols=267 Identities=24% Similarity=0.251 Sum_probs=198.8
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC-----CeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNI-----DFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 486 (704)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999965 68999999986433 33456788999999999999999999988654 678
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecC
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLG 566 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~ 566 (704)
++||||+. |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 6999998764 4899999999999999999995 4689999999999999999999999999998775
Q ss_pred CCCCcc--------eeccccccccccCCcccC-CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh-cC
Q 005278 567 EGDDSV--------IQTMTIATIGYMAPEYGS-EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES-LP 636 (704)
Q Consensus 567 ~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~ 636 (704)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.+...... +....... .+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCC
Confidence 432111 112346899999999765 47789999999999999999999999976322111 11111100 00
Q ss_pred C--C-cchhccccchh---------hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 637 D--G-LTEVVDANLVR---------EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 637 ~--~-~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. . ........... ..........++..+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0 00000000000 00001111245677889999999999999999999965
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.30 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=201.4
Q ss_pred HHhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 412 RATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 412 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999965 78999999987543 2345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEeeeccceec
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN---MTAHVSDFGISKLL 565 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~---~~~kl~Dfgla~~~ 565 (704)
||||+++++|.+++.... .+++..++.++.|++.|++||| +.+|+||||||+||+++.+ +.+||+|||++...
T Consensus 99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 999999999999887554 4899999999999999999995 4689999999999999754 47999999999876
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
..... .....||+.|+|||.+.+. ++.++||||||+++|+|++|+.||...... .....+......
T Consensus 175 ~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-------- 240 (287)
T 2wei_A 175 QQNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYA-------- 240 (287)
T ss_dssp CCCSS---CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC--------
T ss_pred cCCCc---cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCC--------
Confidence 43321 2234589999999987754 889999999999999999999999763211 111111110000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+....++..+.+++.+|++.||++||++.|+++
T Consensus 241 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 ------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000111234567889999999999999999999976
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=339.85 Aligned_cols=323 Identities=20% Similarity=0.215 Sum_probs=290.3
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
+++++|+|++|.++++.|..|.++++|++|+|++|.++++.|.+|.++++|++|+|++|+++...... |.+++
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~-------~~~l~ 105 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETA-------LSGPK 105 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTT-------TSSCT
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhh-------hcccc
Confidence 57999999999999888999999999999999999999999999999999999999999998765544 99999
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcC--ee
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQ--GL 163 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L 163 (704)
+|++|+|++|++.+..+..+..+. +|++|++++|.+.+.....+..+++|++|++++|.+.+..+..|+.+++|+ .|
T Consensus 106 ~L~~L~L~~n~i~~l~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L 184 (606)
T 3t6q_A 106 ALKHLFFIQTGISSIDFIPLHNQK-TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184 (606)
T ss_dssp TCCEEECTTSCCSCGGGSCCTTCT-TCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEE
T ss_pred cccEeeccccCcccCCcchhccCC-cccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEE
Confidence 999999999999987777787764 799999999999986655666699999999999999988899999999999 89
Q ss_pred eccCcccCCCCCccccCC---------------------------------------------------CCCCEEEcCCC
Q 005278 164 YLHGNKLQGSIPYDLCHL---------------------------------------------------EGLSELNLNGN 192 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l---------------------------------------------------~~L~~L~L~~n 192 (704)
++++|++++..|..+... .+|+.|++++|
T Consensus 185 ~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n 264 (606)
T 3t6q_A 185 NLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264 (606)
T ss_dssp ECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTC
T ss_pred ecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecC
Confidence 999999997666554331 16888999999
Q ss_pred cCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCC
Q 005278 193 KLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPT 272 (704)
Q Consensus 193 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 272 (704)
.+++..+..|..+++|+.|++++|.++ .+|..+..+++|++|++++|.+.+..|..+..+++|+.|++++|.+.+.++.
T Consensus 265 ~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 343 (606)
T 3t6q_A 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343 (606)
T ss_dssp CCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCS
T ss_pred ccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccch
Confidence 999877888999999999999999998 6888899999999999999999988888999999999999999999877765
Q ss_pred -CcCCCCCcceeeccCceeeccC--CcccccccccceEEecccCCCCCCCCCcccccccCcccccCCC
Q 005278 273 -TIGGLENLETLSLADNQFQGPV--PKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 273 -~~~~l~~L~~L~L~~n~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~ 337 (704)
.+..+++|+.|++++|.+++.. |..+..+++|+.|++++|++.+..|..|...+.+....+.++.
T Consensus 344 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 411 (606)
T 3t6q_A 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411 (606)
T ss_dssp STTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCC
T ss_pred hhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCc
Confidence 5899999999999999999766 7889999999999999999999888888888877777776664
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=343.85 Aligned_cols=160 Identities=26% Similarity=0.258 Sum_probs=127.9
Q ss_pred ccCCCCCCEEEcCCCcCCcc--CCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCC-cccccCc
Q 005278 178 LCHLEGLSELNLNGNKLCGH--VPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLP-SNIQNLK 254 (704)
Q Consensus 178 l~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~ 254 (704)
+..+++|++|++++|++++. .+..+..+++|+.|++++|.+++ .+..+..+++|+.|++++|.+.+..+ ..+..++
T Consensus 346 ~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 424 (606)
T 3vq2_A 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424 (606)
T ss_dssp CCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCT
T ss_pred hccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccc
Confidence 34566777777777777754 36777888888888888888874 55778888888888888888887766 6788888
Q ss_pred CCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeec-cCCcccccccccceEEecccCCCCCCCCCcccccccCcccc
Q 005278 255 VLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG-PVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYAL 333 (704)
Q Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l 333 (704)
+|+.|++++|++++..|..+..+++|+.|++++|++++ .+|..+..+++|+.|++++|++++..|..|...+.+....+
T Consensus 425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 504 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504 (606)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEEC
Confidence 88888888888888788888888888888888888887 47888888888888888888888888877777777777766
Q ss_pred cCCCc
Q 005278 334 CGPAR 338 (704)
Q Consensus 334 ~g~~~ 338 (704)
.++..
T Consensus 505 s~N~l 509 (606)
T 3vq2_A 505 SHNNL 509 (606)
T ss_dssp CSSCC
T ss_pred CCCcC
Confidence 66643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=334.83 Aligned_cols=266 Identities=21% Similarity=0.232 Sum_probs=181.1
Q ss_pred CCCc-cccccccCceEEEEEEEC---CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeEEEE
Q 005278 416 GFNE-CNLLGTGSFGSVYKGTLF---DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKALV 489 (704)
Q Consensus 416 ~~~~-~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 489 (704)
.|+. .++||+|+||+||+|+.. +++.||||++... .....+.+|+.++++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4554 458999999999999965 5789999998643 234568899999999999999999999954 6788999
Q ss_pred EeccCCCCHHHHHhhC--------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----CCCCcEEEe
Q 005278 490 LEFMPNGSLEKWLYSH--------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL----DENMTAHVS 557 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~----~~~~~~kl~ 557 (704)
|||++ |+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 5888887632 124899999999999999999995 4689999999999999 678899999
Q ss_pred eeccceecCCCCCc-ceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCcccccc--------ccH
Q 005278 558 DFGISKLLGEGDDS-VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGE--------MSL 627 (704)
Q Consensus 558 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~--------~~~ 627 (704)
|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..... ..+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 99999876532211 22334578999999998877 458999999999999999999999997532210 111
Q ss_pred HHHHHhhc-CCC--cchhccc--------cchhhh-hhh-------hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 628 KHWVKESL-PDG--LTEVVDA--------NLVREE-QAF-------SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 628 ~~~~~~~~-~~~--~~~~~~~--------~~~~~~-~~~-------~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......- +.. +...... .+.... ... ......+..+.+++.+||+.||++|||++|+++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111110 000 1111000 000000 000 000011456789999999999999999999964
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.54 Aligned_cols=261 Identities=21% Similarity=0.256 Sum_probs=195.3
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE----
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK---- 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 486 (704)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468889999999999999999864 68999999987543 23356788999999999999999999999876654
Q ss_pred --EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 487 --ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 487 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
++||||+. |+|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 688887743 3899999999999999999995 46899999999999999999999999999986
Q ss_pred cCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC--cch
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG--LTE 641 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 641 (704)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+........... ...
T Consensus 194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHT
T ss_pred cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHHH
Confidence 5332 234568999999998877 779999999999999999999999997632111 1111111110000 000
Q ss_pred hccccchh----------hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 642 VVDANLVR----------EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 642 ~~~~~~~~----------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
........ ..........++..+.+++.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000000 00000111234677899999999999999999999964
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=322.36 Aligned_cols=252 Identities=19% Similarity=0.231 Sum_probs=172.8
Q ss_pred HhCCCCccc-cccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee----CCeE
Q 005278 413 ATNGFNECN-LLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN----IDFK 486 (704)
Q Consensus 413 ~~~~~~~~~-~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 486 (704)
..++|.+.+ .||+|+||.||+|+.. +++.||||++.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346788854 6999999999999965 69999999986431 222233344667799999999999876 4458
Q ss_pred EEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEeeeccc
Q 005278 487 ALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---NMTAHVSDFGIS 562 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---~~~~kl~Dfgla 562 (704)
++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999998653 46899999999999999999995 468999999999999986 455999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
+...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ........
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~---- 248 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLG---- 248 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhcc----
Confidence 8764322 2345689999999999888899999999999999999999999976432211000 00000000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... ........++..+.+++..||+.||++|||+.|+++
T Consensus 249 ---~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 ---QYG---FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----C---CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---ccc---cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 000111234567889999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.43 Aligned_cols=250 Identities=23% Similarity=0.296 Sum_probs=186.2
Q ss_pred CCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 416 GFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34456789999999998776678999999998653 235678899999987 89999999999999999999999995
Q ss_pred CCCHHHHHhhCCCc------cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-------------CcEE
Q 005278 495 NGSLEKWLYSHNYF------LGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDEN-------------MTAH 555 (704)
Q Consensus 495 ~gsL~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~-------------~~~k 555 (704)
|+|.+++...... .++..++.++.|++.||+||| +.+|+||||||+||+++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999855321 122345789999999999995 4689999999999999754 4899
Q ss_pred EeeeccceecCCCCCcc--eeccccccccccCCcccCC-------CCCCcccceeeHHHHHHHHhh-CCCCCCccccccc
Q 005278 556 VSDFGISKLLGEGDDSV--IQTMTIATIGYMAPEYGSE-------GIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEM 625 (704)
Q Consensus 556 l~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~ 625 (704)
|+|||+++......... ......||++|+|||++.+ ..++.++|||||||++|||+| |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 99999999875433211 1234579999999998865 678999999999999999999 999997532211
Q ss_pred cHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 626 SLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+........ . . .......++.++.+++.+||+.||++||++.||++
T Consensus 248 --~~i~~~~~~~~--~-----~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --SNIIRGIFSLD--E-----M-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHTCCCCC--C-----C-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHhcCCCCcc--c-----c-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 12222111100 0 0 01112345678899999999999999999999975
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=348.47 Aligned_cols=315 Identities=23% Similarity=0.201 Sum_probs=199.0
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchh--hcCCCCCCEEecccccCCCcccchhhccccc
Q 005278 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNT--FGNLGSLQVLSLAYNYLMTESSAAKWNFLSS 80 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~ 80 (704)
..+++|++|+|++|.+++..|+.|.++++|++|+|++|.+++..+.. |.++++|++|+|++|.++.... +..
T Consensus 70 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~------~~~ 143 (844)
T 3j0a_A 70 RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL------HPS 143 (844)
T ss_dssp SSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCC------CGG
T ss_pred cCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccccccc------chh
Confidence 45666777777777777666777777777777777777776544443 6667777777777776665432 123
Q ss_pred CCCCCCCcEEEccCCCCcccCChhhhhc----------------------------------------------------
Q 005278 81 LTNCRNLTVLGLASNPLRGILPPLIGNF---------------------------------------------------- 108 (704)
Q Consensus 81 ~~~l~~L~~L~L~~n~i~~~~~~~~~~~---------------------------------------------------- 108 (704)
|.++++|++|+|++|.+.+..+..+..+
T Consensus 144 ~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~ 223 (844)
T 3j0a_A 144 FGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGN 223 (844)
T ss_dssp GGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSG
T ss_pred HhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHH
Confidence 6677777777777777665555444332
Q ss_pred -----------------------------------------ccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCc
Q 005278 109 -----------------------------------------SASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLN 147 (704)
Q Consensus 109 -----------------------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 147 (704)
..+|++|++++|.+.+..+..+..+++|++|+|++|.+.
T Consensus 224 ~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 303 (844)
T 3j0a_A 224 FSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303 (844)
T ss_dssp GGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCC
T ss_pred HHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCC
Confidence 023445555555555555556666677777777777777
Q ss_pred cccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCC----
Q 005278 148 GTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMP---- 223 (704)
Q Consensus 148 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~---- 223 (704)
+..+..|.++++|++|+|++|++++..|..+..+++|++|++++|.+++..+..|..+++|+.|++++|.+++...
T Consensus 304 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L 383 (844)
T 3j0a_A 304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSI 383 (844)
T ss_dssp EECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSC
T ss_pred CCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCc
Confidence 6666677777777777777777776666777777777777777777776556667777777777777776653210
Q ss_pred --------------C----------------------cccCCccccEEEecCcccCCCC---------------------
Q 005278 224 --------------S----------------------SFGSLEYVLYINLSANSLNGSL--------------------- 246 (704)
Q Consensus 224 --------------~----------------------~~~~l~~L~~L~l~~N~l~~~~--------------------- 246 (704)
. .+..+++|+.|++++|.+++..
T Consensus 384 ~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l 463 (844)
T 3j0a_A 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463 (844)
T ss_dssp SEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCC
T ss_pred chhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcc
Confidence 0 0124555666666666555322
Q ss_pred ---------CcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCC
Q 005278 247 ---------PSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 247 ---------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+. ++|+.|++++|++++.
T Consensus 464 ~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~ 541 (844)
T 3j0a_A 464 QLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAP 541 (844)
T ss_dssp SSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCC
T ss_pred ccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCC
Confidence 22345556666666666666666666666777777777777777655555544 6677777777777777
Q ss_pred CCCCcccc
Q 005278 318 IPKNFSAQ 325 (704)
Q Consensus 318 ~p~~~~~~ 325 (704)
.|..|..+
T Consensus 542 ~~~~~~~L 549 (844)
T 3j0a_A 542 NPDVFVSL 549 (844)
T ss_dssp CSCCCSSC
T ss_pred ChhHhCCc
Confidence 76655433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.33 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=177.3
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHH-HHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECE-ILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.++|...+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368888999999999999999974 78999999997643 233345555555 677789999999999999999999999
Q ss_pred eccCCCCHHHHHhh----CCCccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 491 EFMPNGSLEKWLYS----HNYFLGILERLNIMIDVGLALEYLHHGHST-PMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 491 e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~-~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
||+++ +|.+++.. ....+++..+..++.|++.|++|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 88887763 24568999999999999999999965 5 8999999999999999999999999999876
Q ss_pred CCCCCcceeccccccccccCCccc----CCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcch
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYG----SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (704)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ..........
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~--- 246 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQVVKGD--- 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSC---
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHHHhcCC---
Confidence 4322 22334689999999998 46678999999999999999999999997532110 0000000000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+.+.. .....++..+.+++..||+.||++||++.|+++
T Consensus 247 --~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 --PPQLSN-----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCC-----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCC-----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000 011134567889999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.44 Aligned_cols=252 Identities=22% Similarity=0.255 Sum_probs=181.4
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch--hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
.++|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457888999999999999999975 799999999975432 22334555666788889999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+ ++.+..+.......+++..+..++.|++.||+|||.. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 999 5566666555456689999999999999999999642 289999999999999999999999999997664322
Q ss_pred cceeccccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 571 SVIQTMTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
......||+.|+|||++. ...++.++||||||+++|||++|+.||.........+....... +..
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~------- 249 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPL------- 249 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCC-------
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCC-------
Confidence 123446899999999984 55688999999999999999999999976322211111111110 000
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+....++..+.+++.+||+.||++||++.|+++
T Consensus 250 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 --------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0011123456889999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=320.86 Aligned_cols=262 Identities=21% Similarity=0.246 Sum_probs=198.9
Q ss_pred hCCCCccccccccCceEEEEEEEC-CC-CEEEEEEeeccchhhhHHHHHHHHHHHhcCCCC------CceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DG-TNVAIKVFNLQLERASRSFDSECEILRSIRHRN------LIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 485 (704)
.++|++.+.||+|+||+||+|... ++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999864 34 68999998643 334567889999999997665 9999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----------------
Q 005278 486 KALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL---------------- 548 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~---------------- 548 (704)
.++||||+ ++++.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 667777776543 56899999999999999999995 5789999999999999
Q ss_pred ---CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccc
Q 005278 549 ---DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEM 625 (704)
Q Consensus 549 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~ 625 (704)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE- 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 56789999999999875432 233568999999999999999999999999999999999999997632211
Q ss_pred cHHHHHHhhcCCCcchh----------------ccccc----------hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCC
Q 005278 626 SLKHWVKESLPDGLTEV----------------VDANL----------VREEQAFSVKIDCLLSIMHLALDCCMESPEQR 679 (704)
Q Consensus 626 ~~~~~~~~~~~~~~~~~----------------~~~~~----------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 679 (704)
....+........... .+... .............+..+.+++.+||+.||++|
T Consensus 247 -~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 -HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp -HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred -HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 1111111100000000 00000 00000011122345688999999999999999
Q ss_pred CCHHHHHH
Q 005278 680 VSMKDAAA 687 (704)
Q Consensus 680 pt~~ev~~ 687 (704)
||+.|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999963
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=323.59 Aligned_cols=241 Identities=23% Similarity=0.261 Sum_probs=197.8
Q ss_pred HhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchh------hhHHHHHHHHHHHhcC--CCCCceEEeeeeeC
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLER------ASRSFDSECEILRSIR--HRNLIKIISNCCNI 483 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~ 483 (704)
..++|...+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++++++ |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 457899999999999999999985 47899999998754321 2345778999999996 59999999999999
Q ss_pred CeEEEEEeccCC-CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEeeecc
Q 005278 484 DFKALVLEFMPN-GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGI 561 (704)
Q Consensus 484 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~Dfgl 561 (704)
+..++|+||+.+ ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999976 89999998643 4889999999999999999995 57899999999999999 789999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCC-CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcc
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT 640 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (704)
++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .......
T Consensus 197 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~----- 260 (320)
T 3a99_A 197 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV----- 260 (320)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC-----
T ss_pred cccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcccc-----
Confidence 98765322 233468999999998876665 678999999999999999999996521 1111000
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+..++.++.+++.+||+.||++||++.|+++
T Consensus 261 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 --------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001123456889999999999999999999965
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.52 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=186.9
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.+|...+.||+|+||+||.....+++.||||++.... ...+.+|+++++++ +||||+++++++.+....++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4688889999999999765556789999999986432 23356899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-----CCcEEEeeeccceecCCC
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-----NMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-----~~~~kl~Dfgla~~~~~~ 568 (704)
+ |+|.+++........+..+..++.|++.||+||| +.+|+||||||+||+++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6 6999999876655566667889999999999995 468999999999999953 336889999999877543
Q ss_pred CCc-ceeccccccccccCCcccC---CCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 569 DDS-VIQTMTIATIGYMAPEYGS---EGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 569 ~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
... .......||+.|+|||++. ...++.++|||||||++|||+| |..||...... ...... .......
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~~~~~~---~~~~~~~- 249 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---QANILL---GACSLDC- 249 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---HHHHHT---TCCCCTT-
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---HHHHHh---ccCCccc-
Confidence 221 2233457999999999987 4567889999999999999999 89998652211 111110 0000000
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..........+.+++.+||+.||++||++.||++
T Consensus 250 ----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 ----------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0011233456788999999999999999999984
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=336.44 Aligned_cols=136 Identities=22% Similarity=0.301 Sum_probs=88.1
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCC
Q 005278 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLT 82 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~ 82 (704)
..+++|++|+|++|.++++.+..|.++++|++|+|++|.++++.+.+|.++++|++|++++|.++.++... +.
T Consensus 49 ~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~-------~~ 121 (570)
T 2z63_A 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP-------IG 121 (570)
T ss_dssp TTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCS-------CT
T ss_pred hCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCcc-------cc
Confidence 45667777777777777666666777777777777777777666667777777777777777766654332 66
Q ss_pred CCCCCcEEEccCCCCccc-CChhhhhcccccceEEecCCcccccCChhhhcCCCC----CEEEccCCcC
Q 005278 83 NCRNLTVLGLASNPLRGI-LPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGM----IVFDLNGCDL 146 (704)
Q Consensus 83 ~l~~L~~L~L~~n~i~~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L----~~L~L~~n~l 146 (704)
++++|++|+|++|.+.+. .|..+..+. +|++|++++|++++..+..++.+.+| +.|++++|.+
T Consensus 122 ~l~~L~~L~L~~n~l~~~~lp~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l 189 (570)
T 2z63_A 122 HLKTLKELNVAHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189 (570)
T ss_dssp TCTTCCEEECCSSCCCCCCCCGGGGGCT-TCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCC
T ss_pred ccccccEEecCCCccceecChhhhcccC-CCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCc
Confidence 777777777777777653 466666653 57777777776665555555544444 4444444443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.02 Aligned_cols=244 Identities=25% Similarity=0.293 Sum_probs=190.1
Q ss_pred HHHHhCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch------hhhHHHHHHHHHHHhc----CCCCCceEEe
Q 005278 410 IQRATNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE------RASRSFDSECEILRSI----RHRNLIKIIS 478 (704)
Q Consensus 410 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~~ 478 (704)
.....++|...+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999985 4689999999865432 1223466799999999 8999999999
Q ss_pred eeeeCCeEEEEEec-cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEE
Q 005278 479 NCCNIDFKALVLEF-MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHV 556 (704)
Q Consensus 479 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl 556 (704)
++...+..++|+|| +.+++|.+++.... .+++..++.++.|++.||+|||. .+|+||||||+||+++ .++.+||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999999 78999999998654 48999999999999999999964 6899999999999999 8899999
Q ss_pred eeeccceecCCCCCcceeccccccccccCCcccCCCCCC-cccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhc
Q 005278 557 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS-PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635 (704)
Q Consensus 557 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 635 (704)
+|||++....... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||.... ......
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~- 249 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAE- 249 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHTC-
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhhc-
Confidence 9999998775432 2345689999999988766654 58999999999999999999997521 111100
Q ss_pred CCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++||++.|+++
T Consensus 250 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 250 ------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011133456889999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.98 Aligned_cols=264 Identities=18% Similarity=0.245 Sum_probs=198.6
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-----------CCCCceEEeeee
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIR-----------HRNLIKIISNCC 481 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 481 (704)
.++|...+.||+|+||+||+|+. .+++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35899999999999999999986 47899999998743 234567889999999886 899999999987
Q ss_pred eCC----eEEEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCeeeC------
Q 005278 482 NID----FKALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHST-PMVHCDLKPNNILLD------ 549 (704)
Q Consensus 482 ~~~----~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~-~ivH~dlk~~Nil~~------ 549 (704)
..+ ..++||||+ +++|.+++... ...+++..+..++.|++.||+|||+ . +|+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 654 789999999 88999999864 3458999999999999999999964 5 899999999999994
Q ss_pred CCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccc-----
Q 005278 550 ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE----- 624 (704)
Q Consensus 550 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~----- 624 (704)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876432 233468999999999999999999999999999999999999997643211
Q ss_pred ccHHHHHHhhc--CC----------------C-cchhccccc----hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC
Q 005278 625 MSLKHWVKESL--PD----------------G-LTEVVDANL----VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS 681 (704)
Q Consensus 625 ~~~~~~~~~~~--~~----------------~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 681 (704)
..+........ +. . +..+..... .........+..++..+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 01111111000 00 0 000000000 0001112234567888999999999999999999
Q ss_pred HHHHHH
Q 005278 682 MKDAAA 687 (704)
Q Consensus 682 ~~ev~~ 687 (704)
++|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999965
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=330.37 Aligned_cols=314 Identities=21% Similarity=0.235 Sum_probs=207.3
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
++|++|+|++|.+++..|..|.++++|++|+|++|.++++.|.+|.++++|++|+|++|+++.++ .. .++
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp--------~~--~l~ 90 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKIS--------CH--PTV 90 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEE--------CC--CCC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecC--------cc--ccC
Confidence 68899999999998777788999999999999999999888889999999999999999887643 22 788
Q ss_pred CCcEEEccCCCCcc-cCChhhhhcccccceEEecCCcccccCChhhhcCCCC--CEEEccCCcC--ccccChhhcCCC--
Q 005278 86 NLTVLGLASNPLRG-ILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGM--IVFDLNGCDL--NGTIPTAVGRLR-- 158 (704)
Q Consensus 86 ~L~~L~L~~n~i~~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-- 158 (704)
+|++|+|++|++.+ ..|..+..+. +|++|++++|.+.+ ..+..+++| ++|++++|.+ .+..|..+..+.
T Consensus 91 ~L~~L~L~~N~l~~~~~p~~~~~l~-~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~ 166 (520)
T 2z7x_B 91 NLKHLDLSFNAFDALPICKEFGNMS-QLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166 (520)
T ss_dssp CCSEEECCSSCCSSCCCCGGGGGCT-TCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEE
T ss_pred CccEEeccCCccccccchhhhccCC-cceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccc
Confidence 89999999999887 3677888774 78889988888875 356666677 8888888877 555555554422
Q ss_pred --------------------------------------------------------------------------------
Q 005278 159 -------------------------------------------------------------------------------- 158 (704)
Q Consensus 159 -------------------------------------------------------------------------------- 158 (704)
T Consensus 167 ~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~ 246 (520)
T 2z7x_B 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246 (520)
T ss_dssp EEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHT
T ss_pred eEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhh
Confidence
Q ss_pred -CcCeeeccCcccCCCCCccc-----cCCCCCCEEEcCCCcC--------------------------CccCCccccCcC
Q 005278 159 -RLQGLYLHGNKLQGSIPYDL-----CHLEGLSELNLNGNKL--------------------------CGHVPPCLASLT 206 (704)
Q Consensus 159 -~L~~L~L~~n~l~~~~~~~l-----~~l~~L~~L~L~~n~l--------------------------~~~~~~~~~~l~ 206 (704)
+|++|++++|++++.+|..+ ..+++|+.+++++|.+ .... .+..++
T Consensus 247 ~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~ 324 (520)
T 2z7x_B 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKIS 324 (520)
T ss_dssp SSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCC
T ss_pred CcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcccccc--chhhCC
Confidence 57777777777776667666 4444333333333333 1100 014556
Q ss_pred CCCEEEecCccCCCCCCCcccCCccccEEEecCcccCC--CCCcccccCcCCcEEEeecCccCCCCCC-CcCCCCCccee
Q 005278 207 SLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG--SLPSNIQNLKVLTNLDLSRNQLSGDIPT-TIGGLENLETL 283 (704)
Q Consensus 207 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L 283 (704)
+|+.|++++|.+++..|..+..+++|++|++++|.+++ .+|..+..+++|+.|++++|++++.+|. .+..+++|+.|
T Consensus 325 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L 404 (520)
T 2z7x_B 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404 (520)
T ss_dssp CCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEE
T ss_pred cccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEE
Confidence 66666666666665566666666666666666666654 3344556666666666666666653443 35555666666
Q ss_pred eccCceeeccCCcccccccccceEEecccCCCCCCCCCcccccccCcccccCCCc
Q 005278 284 SLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPAR 338 (704)
Q Consensus 284 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~~ 338 (704)
++++|++++..|..+. ++|+.|++++|+++ .+|..+...+.+....+.++..
T Consensus 405 ~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l 456 (520)
T 2z7x_B 405 NMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456 (520)
T ss_dssp ECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCC
T ss_pred ECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcC
Confidence 6666666555554443 45566666666655 4444443444444445544443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.48 Aligned_cols=315 Identities=22% Similarity=0.222 Sum_probs=238.5
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
.++++.|+|++|.+++..+..|.++++|++|+|++|.++++.|++|.++++|++|+|++|.++.++. . .+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~--------~--~l 120 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISC--------C--PM 120 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECS--------C--CC
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCc--------c--cc
Confidence 4689999999999997777889999999999999999998889999999999999999999886442 2 78
Q ss_pred CCCcEEEccCCCCccc-CChhhhhcccccceEEecCCcccccCChhhhcCCCC--CEEEccCCcC--ccccChhhcCCC-
Q 005278 85 RNLTVLGLASNPLRGI-LPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGM--IVFDLNGCDL--NGTIPTAVGRLR- 158 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~- 158 (704)
++|++|+|++|++.+. .|..|..+. +|++|++++|.+.+. .+..+++| ++|++++|.+ .+..|..+..+.
T Consensus 121 ~~L~~L~Ls~N~l~~l~~p~~~~~l~-~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~ 196 (562)
T 3a79_B 121 ASLRHLDLSFNDFDVLPVCKEFGNLT-KLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT 196 (562)
T ss_dssp TTCSEEECCSSCCSBCCCCGGGGGCT-TCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCE
T ss_pred ccCCEEECCCCCccccCchHhhcccC-cccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCc
Confidence 8999999999999874 357788774 799999999988764 34455555 8888888888 555565555433
Q ss_pred --------------------------------------------------------------------------------
Q 005278 159 -------------------------------------------------------------------------------- 158 (704)
Q Consensus 159 -------------------------------------------------------------------------------- 158 (704)
T Consensus 197 ~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~ 276 (562)
T 3a79_B 197 TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276 (562)
T ss_dssp EEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTS
T ss_pred ceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcc
Confidence
Q ss_pred CcCeeeccCcccCCCCCccc-----------------------------------------------------cCCCCCC
Q 005278 159 RLQGLYLHGNKLQGSIPYDL-----------------------------------------------------CHLEGLS 185 (704)
Q Consensus 159 ~L~~L~L~~n~l~~~~~~~l-----------------------------------------------------~~l~~L~ 185 (704)
+|++|++++|.+++.+|..+ ..+++|+
T Consensus 277 ~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~ 356 (562)
T 3a79_B 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356 (562)
T ss_dssp SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCC
T ss_pred cccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCce
Confidence 67778888888877777655 5567777
Q ss_pred EEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCC--CCcccCCccccEEEecCcccCCCCCc-ccccCcCCcEEEee
Q 005278 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTM--PSSFGSLEYVLYINLSANSLNGSLPS-NIQNLKVLTNLDLS 262 (704)
Q Consensus 186 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~ 262 (704)
+|++++|++++..|..+..+++|+.|++++|++++.. |..+..+++|++|++++|.+++.+|. .+..+++|+.|+++
T Consensus 357 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~ 436 (562)
T 3a79_B 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436 (562)
T ss_dssp EEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECC
T ss_pred EEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECC
Confidence 8888888877767777777778888888888777532 34577777888888888887763443 46677778888888
Q ss_pred cCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCC-cccccccCcccccCCC
Q 005278 263 RNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKN-FSAQSFLSNYALCGPA 337 (704)
Q Consensus 263 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~l~~~~l~g~~ 337 (704)
+|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|++++ +|.. +...+.+....+.+++
T Consensus 437 ~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~ 508 (562)
T 3a79_B 437 SNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNP 508 (562)
T ss_dssp SSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCC
T ss_pred CCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCC
Confidence 8887766665544 67888888888877 677666678888888888888874 4443 6666666666666665
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=322.04 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=194.6
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe-----
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF----- 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 485 (704)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367889999999999999999864 69999999986543 2335678899999999999999999999977653
Q ss_pred -EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 486 -KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 486 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
.++||||++ |+|.+++.. .+++..+..++.|++.||+|||. .+|+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 688887753 38999999999999999999964 6899999999999999999999999999986
Q ss_pred cCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC--cch
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG--LTE 641 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 641 (704)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+........... +..
T Consensus 176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHT
T ss_pred CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 5322 233468999999998876 678999999999999999999999997632211 1111111100000 000
Q ss_pred hcccc--------chh--hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 642 VVDAN--------LVR--EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 642 ~~~~~--------~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.+... +.. ..........++..+.+++.+|++.||++||+++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 000 00000111244677899999999999999999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=338.34 Aligned_cols=262 Identities=23% Similarity=0.288 Sum_probs=197.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeee------CCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCN------IDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 485 (704)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999986 468999999987543 3445678999999999999999999998765 667
Q ss_pred EEEEEeccCCCCHHHHHhhCC--CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc---EEEeeec
Q 005278 486 KALVLEFMPNGSLEKWLYSHN--YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMT---AHVSDFG 560 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~---~kl~Dfg 560 (704)
.++||||+++|+|.+++.... ..+++..++.++.+++.|++|||. .+|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998643 358889999999999999999964 78999999999999997665 9999999
Q ss_pred cceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCc-
Q 005278 561 ISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL- 639 (704)
Q Consensus 561 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 639 (704)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||.... ....|.........
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC-----
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhcccch
Confidence 9987654322 234579999999999999999999999999999999999999996521 11222111110000
Q ss_pred ----chhccccchhh---hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 005278 640 ----TEVVDANLVRE---EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685 (704)
Q Consensus 640 ----~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev 685 (704)
........... ..........+..+.+++..|++.||++|||+.|+
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000000000 00111223457789999999999999999999884
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=338.89 Aligned_cols=331 Identities=18% Similarity=0.211 Sum_probs=256.4
Q ss_pred CCCCCCCEEecCCCcCcc-----------------cCCcccc--CCCCCCEEeccCccccccCchhhcCCCCCCEEeccc
Q 005278 3 YMLPNLKYLTLFDNKLSG-----------------TIPNSIT--NASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~-----------------~~~~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 63 (704)
+.|++|+.|+|++|.+++ .+|..++ ++++|++|+|++|.+.+.+|..|.++++|++|+|++
T Consensus 445 ~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~ 524 (876)
T 4ecn_A 445 QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524 (876)
T ss_dssp GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTT
T ss_pred hcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcC
Confidence 468899999999999997 3899988 999999999999999999999999999999999999
Q ss_pred cc-CCC-cccchhhcccccCCCCCCCcEEEccCCCCcccCCh--hhhhcccccceEEecCCcccccCChhhhcCCCCCEE
Q 005278 64 NY-LMT-ESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPP--LIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVF 139 (704)
Q Consensus 64 n~-i~~-~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~--~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 139 (704)
|+ ++. ..+.....+...+..+++|++|+|++|++. .+|. .+..+. +|++|+|++|.++ .+| .++++++|++|
T Consensus 525 N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~-~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L 600 (876)
T 4ecn_A 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMV-KLGLLDCVHNKVR-HLE-AFGTNVKLTDL 600 (876)
T ss_dssp CTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCT-TCCEEECTTSCCC-BCC-CCCTTSEESEE
T ss_pred CCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCC-CCCEEECCCCCcc-cch-hhcCCCcceEE
Confidence 98 765 211110111124566779999999999999 7777 788775 7999999999998 777 88999999999
Q ss_pred EccCCcCccccChhhcCCCC-cCeeeccCcccCCCCCccccCCCC--CCEEEcCCCcCCccCCccc---c--CcCCCCEE
Q 005278 140 DLNGCDLNGTIPTAVGRLRR-LQGLYLHGNKLQGSIPYDLCHLEG--LSELNLNGNKLCGHVPPCL---A--SLTSLRRL 211 (704)
Q Consensus 140 ~L~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~l~~l~~--L~~L~L~~n~l~~~~~~~~---~--~l~~L~~L 211 (704)
+|++|.+. .+|..+..+++ |+.|+|++|+++ .+|..+..++. |+.|+|++|++++.+|... . .+++|+.|
T Consensus 601 ~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L 678 (876)
T 4ecn_A 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678 (876)
T ss_dssp ECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEE
T ss_pred ECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEE
Confidence 99999999 78888999988 999999999998 77877777654 8888888888886655322 2 33478888
Q ss_pred EecCccCCCCCCCcccCCccccEEEecCcccCCCCCccccc--------CcCCcEEEeecCccCCCCCCCcC--CCCCcc
Q 005278 212 HLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQN--------LKVLTNLDLSRNQLSGDIPTTIG--GLENLE 281 (704)
Q Consensus 212 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~--------l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~ 281 (704)
++++|.++...+..+..+++|+.|+|++|.+. .+|..+.. +++|+.|+|++|+++ .+|..+. .+++|+
T Consensus 679 ~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~ 756 (876)
T 4ecn_A 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLS 756 (876)
T ss_dssp ECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCC
T ss_pred EccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcC
Confidence 88888887433333447788888888888887 44444332 237888888888887 6777776 788888
Q ss_pred eeeccCceeeccCCcccccccccceEEecc------cCCCCCCCCCcccccccCcccccCCCccCCC
Q 005278 282 TLSLADNQFQGPVPKSFGSLISLESLDLSR------NNLSGEIPKNFSAQSFLSNYALCGPARLQVP 342 (704)
Q Consensus 282 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~------N~l~~~~p~~~~~~~~l~~~~l~g~~~~~~~ 342 (704)
.|+|++|++++ +|..+..+++|+.|+|++ |.+.+.+|..+...+.+..+.+.++....+|
T Consensus 757 ~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~Ip 822 (876)
T 4ecn_A 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVD 822 (876)
T ss_dssp EEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCC
T ss_pred EEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCCCccC
Confidence 88888888875 677777888888888865 6677778877777777777777776654433
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=333.67 Aligned_cols=329 Identities=20% Similarity=0.200 Sum_probs=233.2
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhccc----ccCCC
Q 005278 8 LKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFL----SSLTN 83 (704)
Q Consensus 8 l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~----~~~~~ 83 (704)
|+.|+|++|.+++..|..|.++++|++|+|++|.++++.+..|.++++|++|++++|......... .++ ..|..
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~--~lp~i~~~~~~~ 327 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA--SLPKIDDFSFQW 327 (680)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC--------CCEECTTTTTT
T ss_pred CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccc--cccccChhhccc
Confidence 666666666666555555666666666666666666555555555555555555443222100000 011 13556
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcc---------------------------cccceEEecCCcccccCChhhhcCCCC
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFS---------------------------ASLQEFYAYGCKLRGNIPQEIGNLSGM 136 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~---------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L 136 (704)
+++|++|++++|++.+..+..|..+. ++|++|++++|++++..|..+..+++|
T Consensus 328 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 407 (680)
T 1ziw_A 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407 (680)
T ss_dssp CTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCC
Confidence 66777777777776665555554432 245666666677777777788888888
Q ss_pred CEEEccCCcCccccC-hhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCC--ccCCccccCcCCCCEEEe
Q 005278 137 IVFDLNGCDLNGTIP-TAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLC--GHVPPCLASLTSLRRLHL 213 (704)
Q Consensus 137 ~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~l 213 (704)
++|+|++|.+.+.++ ..|.++++|++|++++|++++..+..+..+++|+.|++++|.++ +..|..+..+++|+.|++
T Consensus 408 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~L 487 (680)
T 1ziw_A 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487 (680)
T ss_dssp CEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEEC
T ss_pred CEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEEC
Confidence 888888888876554 57888888888888888888777778888888888888888876 466778888899999999
Q ss_pred cCccCCCCCCCcccCCccccEEEecCcccCCCC--------CcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeec
Q 005278 214 GSNKLTSTMPSSFGSLEYVLYINLSANSLNGSL--------PSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSL 285 (704)
Q Consensus 214 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 285 (704)
++|.+++..+..|..+++|++|++++|.+++.. +..+.++++|+.|++++|+++...+..|.++++|+.|+|
T Consensus 488 s~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 567 (680)
T 1ziw_A 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeEC
Confidence 999998877788888999999999999887432 223778888999999999998544457888999999999
Q ss_pred cCceeeccCCcccccccccceEEecccCCCCCCCCCcc-cccccCcccccCCCc
Q 005278 286 ADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS-AQSFLSNYALCGPAR 338 (704)
Q Consensus 286 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~~~l~~~~l~g~~~ 338 (704)
++|++++..+..|..+++|+.|++++|++++..|..|. ..+.+....+.|+|.
T Consensus 568 s~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~ 621 (680)
T 1ziw_A 568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCC
T ss_pred CCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCc
Confidence 99999876666778889999999999999887776665 555666667777764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=339.02 Aligned_cols=305 Identities=21% Similarity=0.223 Sum_probs=268.2
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCcccc-ccCchhhcCCCCCCEEecccccCCCcccchhhcccccCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFS-GLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLT 82 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~ 82 (704)
..++++.|+|++|.|+++.+..|.++++|+.|+|++|.+. .+.|.+|.++++|++|+|++|.+..+... .|.
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~-------~~~ 94 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD-------AFQ 94 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT-------SSC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh-------Hcc
Confidence 4588999999999999989999999999999999999544 55589999999999999999999886544 499
Q ss_pred CCCCCcEEEccCCCCcccCChh--hhhcccccceEEecCCcccccCC-hhhhcCCCCCEEEccCCcCccccChhhcCC--
Q 005278 83 NCRNLTVLGLASNPLRGILPPL--IGNFSASLQEFYAYGCKLRGNIP-QEIGNLSGMIVFDLNGCDLNGTIPTAVGRL-- 157 (704)
Q Consensus 83 ~l~~L~~L~L~~n~i~~~~~~~--~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-- 157 (704)
++++|++|+|++|.+.+..|.. +..+ ++|++|+|++|.+.+..+ ..|+++++|++|+|++|.+++..+..+..+
T Consensus 95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L-~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~ 173 (844)
T 3j0a_A 95 GLFHLFELRLYFCGLSDAVLKDGYFRNL-KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173 (844)
T ss_dssp SCSSCCCEECTTCCCSSCCSTTCCCSSC-SSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHH
T ss_pred CCcccCEeeCcCCCCCcccccCcccccc-CCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccC
Confidence 9999999999999999866654 6666 479999999999998755 679999999999999999998889888887
Q ss_pred CCcCeeeccCcccCCCCCccccCCCC------CCEEEcCCCcCCccCCccccC---------------------------
Q 005278 158 RRLQGLYLHGNKLQGSIPYDLCHLEG------LSELNLNGNKLCGHVPPCLAS--------------------------- 204 (704)
Q Consensus 158 ~~L~~L~L~~n~l~~~~~~~l~~l~~------L~~L~L~~n~l~~~~~~~~~~--------------------------- 204 (704)
++|+.|+++.|.+++..|..+..+++ |++|++++|.+++..+..+..
T Consensus 174 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~ 253 (844)
T 3j0a_A 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253 (844)
T ss_dssp CSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSST
T ss_pred CccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccC
Confidence 89999999999999888877777665 999999999877655443322
Q ss_pred -----------cCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCC
Q 005278 205 -----------LTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTT 273 (704)
Q Consensus 205 -----------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 273 (704)
.++|+.|++++|.+.+..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|++++..|..
T Consensus 254 ~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 333 (844)
T 3j0a_A 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333 (844)
T ss_dssp TGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCS
T ss_pred CCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHH
Confidence 268999999999999888889999999999999999999888889999999999999999999888889
Q ss_pred cCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCC
Q 005278 274 IGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 274 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 316 (704)
|.++++|+.|++++|++++..+..|..+++|+.|++++|.+++
T Consensus 334 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376 (844)
T ss_dssp CSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred hcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence 9999999999999999988778889999999999999999875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=338.48 Aligned_cols=318 Identities=19% Similarity=0.264 Sum_probs=273.2
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCcc-ccc-cCchhhcCCC-------CCCEEecccccCCCcccchh
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNS-FSG-LIPNTFGNLG-------SLQVLSLAYNYLMTESSAAK 74 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~-i~~-~~~~~~~~l~-------~L~~L~L~~n~i~~~~~~~~ 74 (704)
.+++|+.|+|++|.+.+.+|..|.++++|++|+|++|. +++ .+|..|.+++ +|++|+|++|.++.++..
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~-- 566 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPAS-- 566 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCH--
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCCh--
Confidence 78999999999999999999999999999999999998 987 7787776665 999999999999854320
Q ss_pred hcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCC-CCEEEccCCcCccccChh
Q 005278 75 WNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSG-MIVFDLNGCDLNGTIPTA 153 (704)
Q Consensus 75 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~ 153 (704)
..+.++++|++|+|++|++. .+| .+..+ ++|++|+|++|.+. .+|..+.++++ |++|+|++|.+. .+|..
T Consensus 567 ----~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L-~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~ 637 (876)
T 4ecn_A 567 ----ASLQKMVKLGLLDCVHNKVR-HLE-AFGTN-VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637 (876)
T ss_dssp ----HHHTTCTTCCEEECTTSCCC-BCC-CCCTT-SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSC
T ss_pred ----hhhhcCCCCCEEECCCCCcc-cch-hhcCC-CcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchh
Confidence 04899999999999999999 777 67666 47999999999999 88989999999 999999999999 77888
Q ss_pred hcCCCC--cCeeeccCcccCCCCCccc---c--CCCCCCEEEcCCCcCCccCCcc-ccCcCCCCEEEecCccCCCCCCCc
Q 005278 154 VGRLRR--LQGLYLHGNKLQGSIPYDL---C--HLEGLSELNLNGNKLCGHVPPC-LASLTSLRRLHLGSNKLTSTMPSS 225 (704)
Q Consensus 154 ~~~l~~--L~~L~L~~n~l~~~~~~~l---~--~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~ 225 (704)
+..++. |+.|+|++|++++.+|... . .+++|+.|+|++|+++ .+|.. +..+++|+.|+|++|.++...+..
T Consensus 638 ~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~ 716 (876)
T 4ecn_A 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENS 716 (876)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTS
T ss_pred hhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHH
Confidence 887755 9999999999997665322 2 3458999999999999 55654 458999999999999999433333
Q ss_pred ccC-------CccccEEEecCcccCCCCCcccc--cCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccC------cee
Q 005278 226 FGS-------LEYVLYINLSANSLNGSLPSNIQ--NLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLAD------NQF 290 (704)
Q Consensus 226 ~~~-------l~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~------n~l 290 (704)
+.. +++|+.|+|++|.++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++
T Consensus 717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l 794 (876)
T 4ecn_A 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRI 794 (876)
T ss_dssp SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBC
T ss_pred hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccc
Confidence 332 349999999999999 7888887 99999999999999996 899999999999999976 888
Q ss_pred eccCCcccccccccceEEecccCCCCCCCCCcccccccCcccccCCCc
Q 005278 291 QGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPAR 338 (704)
Q Consensus 291 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~~ 338 (704)
.+.+|..+..+++|+.|+|++|++ +.+|..+. +.+....+.+++.
T Consensus 795 ~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l 839 (876)
T 4ecn_A 795 LRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPN 839 (876)
T ss_dssp CCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTT
T ss_pred cccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCC
Confidence 899999999999999999999999 78888654 4677777777764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=302.92 Aligned_cols=232 Identities=12% Similarity=0.064 Sum_probs=183.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccch---hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+..+++++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999975 589999999975532 23467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++++|.+++... ........++.|++.||+||| +.+|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999999643 355678889999999999995 4689999999999999999999997443
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
|++| ++.++|||||||++|||+||+.||.+........ ...........
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~----------~~~~~~~~~~~-- 223 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA----------PAERDTAGQPI-- 223 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE----------ECCBCTTSCBC--
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH----------HHHHHhccCCC--
Confidence 3333 6789999999999999999999997632211000 00000000000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
.......+++..+.+++.+||+.||++| |+.|+++.|+++...
T Consensus 224 -~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 -EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp -CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred -ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0011222456778999999999999999 999999999997644
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=326.53 Aligned_cols=303 Identities=23% Similarity=0.275 Sum_probs=251.5
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCC
Q 005278 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLT 82 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~ 82 (704)
..+++|++|+|++|.+++..|+.|.++++|++|+|++|.++.+.+. .+++|++|+|++|.++.++. +..|.
T Consensus 73 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~Ls~N~l~~l~~------p~~~~ 143 (562)
T 3a79_B 73 SFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRHLDLSFNDFDVLPV------CKEFG 143 (562)
T ss_dssp TTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC---CCTTCSEEECCSSCCSBCCC------CGGGG
T ss_pred ccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc---ccccCCEEECCCCCccccCc------hHhhc
Confidence 5689999999999999988899999999999999999999965443 89999999999999987652 23488
Q ss_pred CCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcc--cccCChhhhcCC--------------------------
Q 005278 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKL--RGNIPQEIGNLS-------------------------- 134 (704)
Q Consensus 83 ~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l--~~~~~~~~~~l~-------------------------- 134 (704)
++++|++|+|++|++.......+..+ +|++|++++|.+ ++..|..+..+.
T Consensus 144 ~l~~L~~L~L~~n~l~~~~~~~l~~L--~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~ 221 (562)
T 3a79_B 144 NLTKLTFLGLSAAKFRQLDLLPVAHL--HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221 (562)
T ss_dssp GCTTCCEEEEECSBCCTTTTGGGTTS--CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEE
T ss_pred ccCcccEEecCCCccccCchhhhhhc--eeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccc
Confidence 99999999999999886443333333 348888888877 555555544432
Q ss_pred -------------------------------------------------------CCCEEEccCCcCccccChhh-----
Q 005278 135 -------------------------------------------------------GMIVFDLNGCDLNGTIPTAV----- 154 (704)
Q Consensus 135 -------------------------------------------------------~L~~L~L~~n~l~~~~~~~~----- 154 (704)
+|++|++++|.+.+.+|..+
T Consensus 222 ~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~ 301 (562)
T 3a79_B 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE 301 (562)
T ss_dssp EEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCS
T ss_pred eEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhccc
Confidence 56667777776665555443
Q ss_pred ------------------------------------------------cCCCCcCeeeccCcccCCCCCccccCCCCCCE
Q 005278 155 ------------------------------------------------GRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSE 186 (704)
Q Consensus 155 ------------------------------------------------~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 186 (704)
..+++|++|++++|++++..|..+..+++|++
T Consensus 302 ~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 381 (562)
T 3a79_B 302 TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT 381 (562)
T ss_dssp CSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCE
T ss_pred ccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCE
Confidence 67889999999999999889999999999999
Q ss_pred EEcCCCcCCcc--CCccccCcCCCCEEEecCccCCCCCC-CcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeec
Q 005278 187 LNLNGNKLCGH--VPPCLASLTSLRRLHLGSNKLTSTMP-SSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSR 263 (704)
Q Consensus 187 L~L~~n~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 263 (704)
|+|++|++++. .|..+..+++|+.|++++|.+++.+| ..+..+++|++|++++|.+++..|..+. ++|+.|++++
T Consensus 382 L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~ 459 (562)
T 3a79_B 382 LILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHN 459 (562)
T ss_dssp EECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCS
T ss_pred EECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCC
Confidence 99999999963 34678999999999999999998444 4688999999999999999876666554 6899999999
Q ss_pred CccCCCCCCCcCCCCCcceeeccCceeeccCCcc-cccccccceEEecccCCCCCCCC
Q 005278 264 NQLSGDIPTTIGGLENLETLSLADNQFQGPVPKS-FGSLISLESLDLSRNNLSGEIPK 320 (704)
Q Consensus 264 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~ 320 (704)
|+++ .+|..+..+++|+.|+|++|+++ .+|.. +..+++|+.|++++|++.|..|-
T Consensus 460 N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 460 NRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp SCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 9999 78887889999999999999999 56665 99999999999999999987653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=341.63 Aligned_cols=242 Identities=22% Similarity=0.287 Sum_probs=195.3
Q ss_pred hCCCCccccccccCceEEEEEEEC--CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCe-----
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF--DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDF----- 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 485 (704)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999875 68999999986443 3345678899999999999999999999987655
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||+++++|.+++.. .+++..++.++.|++.||+||| +.+|+||||||+||+++.+ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999988765 4899999999999999999995 4689999999999999985 8999999999876
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
... ....||++|+|||++.+.. +.++|||||||++|||++|..||.+...... .
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------~----- 285 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------P----- 285 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------C-----
T ss_pred ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------c-----
Confidence 432 3356999999999887654 8899999999999999999988765321110 0
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHHHHHhHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS-MKDAAAKLKKIKEK 695 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-~~ev~~~L~~~~~~ 695 (704)
. .......+..+.+++.+||+.||++||+ ++++...|..+.+.
T Consensus 286 ---~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 ---E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp ---T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred ---c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0 0011123456889999999999999994 67777777776543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=328.62 Aligned_cols=322 Identities=24% Similarity=0.252 Sum_probs=223.3
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
++++.|+|++|.++++.+..|.++++|++|+|++|.++++.+.+|.++++|++|+|++|.++.++... |.+++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l~ 100 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA-------FSGLS 100 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTT-------TTTCT
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhh-------hcCcc
Confidence 47999999999999888889999999999999999999999999999999999999999998876544 99999
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccc-cCChhhhcCCCCCEEEccCCcCccccChhhcCCCC-----
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG-NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRR----- 159 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~----- 159 (704)
+|++|+|++|++....+..+..+ ++|++|++++|.+.+ .+|..++++++|++|++++|.+++..+..++.+++
T Consensus 101 ~L~~L~L~~n~l~~l~~~~~~~l-~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~ 179 (570)
T 2z63_A 101 SLQKLVAVETNLASLENFPIGHL-KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179 (570)
T ss_dssp TCCEEECTTSCCCCSTTCSCTTC-TTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCC
T ss_pred ccccccccccccccCCCcccccc-ccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhh
Confidence 99999999999997766667776 479999999999997 47999999999999999999998765554444333
Q ss_pred --------------------------------------------------------------------------------
Q 005278 160 -------------------------------------------------------------------------------- 159 (704)
Q Consensus 160 -------------------------------------------------------------------------------- 159 (704)
T Consensus 180 ~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l 259 (570)
T 2z63_A 180 LSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259 (570)
T ss_dssp CEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEE
T ss_pred hhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccch
Confidence
Q ss_pred ------------------------cCeeeccCcccCCCCCcccc------------------------------------
Q 005278 160 ------------------------LQGLYLHGNKLQGSIPYDLC------------------------------------ 179 (704)
Q Consensus 160 ------------------------L~~L~L~~n~l~~~~~~~l~------------------------------------ 179 (704)
|+.|++++|.++ .+|..+.
T Consensus 260 ~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~ 338 (570)
T 2z63_A 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338 (570)
T ss_dssp EEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSC
T ss_pred hhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccc
Confidence 333444444333 2222222
Q ss_pred ------CCCCCCEEEcCCCcCCccC--CccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCC-ccc
Q 005278 180 ------HLEGLSELNLNGNKLCGHV--PPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLP-SNI 250 (704)
Q Consensus 180 ------~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~ 250 (704)
.+++|++|++++|++++.. +..+..+++|+.|++++|.+.+..+ .+..+++|++|++++|.+.+..+ ..+
T Consensus 339 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~ 417 (570)
T 2z63_A 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVF 417 (570)
T ss_dssp CBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTT
T ss_pred cccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhh
Confidence 2334444444444443221 2333444455555555554443222 25555666666666666654444 345
Q ss_pred ccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee-ccCCcccccccccceEEecccCCCCCCCCCcccccccC
Q 005278 251 QNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ-GPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLS 329 (704)
Q Consensus 251 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~ 329 (704)
..+++|+.|++++|++.+..|..+.++++|+.|++++|.++ +.+|..+..+++|+.|++++|++++..|..|...+.+.
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 497 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence 66666666666666666666666666666666666666665 45666666666666666666666666666665555555
Q ss_pred cccccCCC
Q 005278 330 NYALCGPA 337 (704)
Q Consensus 330 ~~~l~g~~ 337 (704)
...+.++.
T Consensus 498 ~L~l~~n~ 505 (570)
T 2z63_A 498 VLNMASNQ 505 (570)
T ss_dssp EEECCSSC
T ss_pred EEeCCCCc
Confidence 55555443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.09 Aligned_cols=310 Identities=21% Similarity=0.213 Sum_probs=257.4
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCc
Q 005278 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLT 88 (704)
Q Consensus 9 ~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~ 88 (704)
++|++++|+++ .+|..+. ++|++|+|++|.++++.+..|.++++|++|+|++|+++.+.... |.++++|+
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~-------~~~l~~L~ 72 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV-------FKFNQELE 72 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGG-------GTTCTTCC
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHH-------hhcccCCC
Confidence 68999999999 6788776 89999999999999999999999999999999999998865444 99999999
Q ss_pred EEEccCCCCcccCChhhhhcccccceEEecCCcccc-cCChhhhcCCCCCEEEccCCcCccccChhhcCCCCc--Ceeec
Q 005278 89 VLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG-NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRL--QGLYL 165 (704)
Q Consensus 89 ~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L 165 (704)
+|+|++|+++. +|.. . .++|++|++++|.+++ .+|..++++++|++|++++|.+.+ ..+..+++| +.|++
T Consensus 73 ~L~Ls~N~l~~-lp~~--~-l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l 145 (520)
T 2z7x_B 73 YLDLSHNKLVK-ISCH--P-TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLL 145 (520)
T ss_dssp EEECCSSCCCE-EECC--C-CCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEE
T ss_pred EEecCCCceee-cCcc--c-cCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEe
Confidence 99999999995 4544 3 4589999999999998 478999999999999999999985 467778888 99999
Q ss_pred cCccc--CCCCCccccCCC-------------------------------------------------------------
Q 005278 166 HGNKL--QGSIPYDLCHLE------------------------------------------------------------- 182 (704)
Q Consensus 166 ~~n~l--~~~~~~~l~~l~------------------------------------------------------------- 182 (704)
++|.+ ++..|..+..+.
T Consensus 146 ~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L 225 (520)
T 2z7x_B 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225 (520)
T ss_dssp EECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEE
T ss_pred ecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhc
Confidence 99999 666676666533
Q ss_pred ----------------------CCCEEEcCCCcCCccCCccc-----cCcCCCCEEEecCccC-----------------
Q 005278 183 ----------------------GLSELNLNGNKLCGHVPPCL-----ASLTSLRRLHLGSNKL----------------- 218 (704)
Q Consensus 183 ----------------------~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l----------------- 218 (704)
+|++|++++|++++.+|..+ ..+++|+.+++++|.+
T Consensus 226 ~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~ 305 (520)
T 2z7x_B 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305 (520)
T ss_dssp EEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCS
T ss_pred cccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCcee
Confidence 68888888888887777776 6666555555555554
Q ss_pred ---------CCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCC--CCCCCcCCCCCcceeeccC
Q 005278 219 ---------TSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSG--DIPTTIGGLENLETLSLAD 287 (704)
Q Consensus 219 ---------~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~ 287 (704)
.... .+..+++|++|++++|.+++..|..+..+++|+.|++++|++++ .+|..++.+++|+.|++++
T Consensus 306 ~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~ 383 (520)
T 2z7x_B 306 NFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQ 383 (520)
T ss_dssp EEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCS
T ss_pred EEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCC
Confidence 2111 12678999999999999999899999999999999999999996 5567799999999999999
Q ss_pred ceeeccCCc-ccccccccceEEecccCCCCCCCCCcccccccCcccccCCCcc
Q 005278 288 NQFQGPVPK-SFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARL 339 (704)
Q Consensus 288 n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~~~ 339 (704)
|++++.+|. .+..+++|+.|++++|++++..|..+. ..+....+.++...
T Consensus 384 N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp SCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred CcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence 999985665 488999999999999999987776553 34455555555433
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=326.90 Aligned_cols=154 Identities=24% Similarity=0.300 Sum_probs=83.4
Q ss_pred CCCCCCEEEcCCCcCCccCC---ccccCcCCCCEEEecCccCCCCCC--CcccCCccccEEEecCcccCCCCCcccccCc
Q 005278 180 HLEGLSELNLNGNKLCGHVP---PCLASLTSLRRLHLGSNKLTSTMP--SSFGSLEYVLYINLSANSLNGSLPSNIQNLK 254 (704)
Q Consensus 180 ~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 254 (704)
.+++|++|+|++|++++..| ..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.++ .+|..+..++
T Consensus 332 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~ 410 (549)
T 2z81_A 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410 (549)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCT
T ss_pred cCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccc
Confidence 35555666666666554332 224455555566665555553321 23555556666666666655 4555555555
Q ss_pred CCcEEEeecCccCCCCCCCc------------------CCCCCcceeeccCceeeccCCcccccccccceEEecccCCCC
Q 005278 255 VLTNLDLSRNQLSGDIPTTI------------------GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 255 ~L~~L~l~~n~l~~~~~~~~------------------~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 316 (704)
+|+.|++++|+++ .+|..+ ..+++|+.|+|++|+++ .+|. ...+++|+.|++++|++++
T Consensus 411 ~L~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~ 487 (549)
T 2z81_A 411 KMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKS 487 (549)
T ss_dssp TCCEEECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCC
T ss_pred cccEEECCCCCcc-cccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCC
Confidence 5555555555554 222211 24556666666666665 4444 3456666666666666666
Q ss_pred CCCCCcccccccCcccccCCC
Q 005278 317 EIPKNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 317 ~~p~~~~~~~~l~~~~l~g~~ 337 (704)
..|..+...+.+....+.+++
T Consensus 488 ~~~~~~~~l~~L~~L~l~~N~ 508 (549)
T 2z81_A 488 VPDGIFDRLTSLQKIWLHTNP 508 (549)
T ss_dssp CCTTGGGGCTTCCEEECCSSC
T ss_pred cCHHHHhcCcccCEEEecCCC
Confidence 555555555555555555554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=325.12 Aligned_cols=325 Identities=23% Similarity=0.224 Sum_probs=168.8
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
+++|++|+|++|.+++..+..|.++++|++|+|++|.++++.+..|.++++|++|+|++|.++..... .+.++
T Consensus 72 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-------~~~~l 144 (680)
T 1ziw_A 72 LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG-------TQVQL 144 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCC-------SSSCC
T ss_pred ccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCch-------hhccc
Confidence 34444445544444433333444555555555555555444444455555555555555544443322 24455
Q ss_pred CCCcEEEccCCCCcccCChhhhhc-ccccceEEecCCcccccCChhhhcC---------------------------CCC
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNF-SASLQEFYAYGCKLRGNIPQEIGNL---------------------------SGM 136 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~-~~~L~~L~l~~n~l~~~~~~~~~~l---------------------------~~L 136 (704)
++|++|+|++|++++..+..+..+ ..+|++|++++|.+++..|..+..+ ++|
T Consensus 145 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L 224 (680)
T 1ziw_A 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI 224 (680)
T ss_dssp TTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCC
T ss_pred ccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccc
Confidence 555555555555554444433321 1245555555555554444433322 233
Q ss_pred CEEEccCCcCccccChhhcCCCC--cCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCcccc-----------
Q 005278 137 IVFDLNGCDLNGTIPTAVGRLRR--LQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLA----------- 203 (704)
Q Consensus 137 ~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~----------- 203 (704)
++|++++|.+.+..+..|..++. |+.|++++|++++..|..+..+++|++|++++|.+++..|..+.
T Consensus 225 ~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (680)
T 1ziw_A 225 RNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304 (680)
T ss_dssp CEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECT
T ss_pred cEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEecc
Confidence 34444444444444444444432 55555555555555555555555566666665555544444343
Q ss_pred ----------------------CcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCC--CCCcccccC--cCCc
Q 005278 204 ----------------------SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG--SLPSNIQNL--KVLT 257 (704)
Q Consensus 204 ----------------------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l--~~L~ 257 (704)
.+++|+.|++++|.+++..+..|..+++|++|++++|.+.. .....|..+ ++|+
T Consensus 305 ~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~ 384 (680)
T 1ziw_A 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384 (680)
T ss_dssp TCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCC
T ss_pred chhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCc
Confidence 34444555555555554444445555555555554443221 111111111 2455
Q ss_pred EEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCC-cccccccccceEEecccCCCCCCCCCcccccccCcccccCC
Q 005278 258 NLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP-KSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGP 336 (704)
Q Consensus 258 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~ 336 (704)
.|++++|++++..|..+..+++|+.|++++|++++.+| ..+..+++|+.|++++|++.+..+..|...+.+....+.++
T Consensus 385 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n 464 (680)
T 1ziw_A 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464 (680)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTS
T ss_pred eEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccc
Confidence 55555566666666777778888888888888776555 56777777888888888777666666665555555544443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.09 Aligned_cols=289 Identities=23% Similarity=0.306 Sum_probs=253.6
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCC
Q 005278 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86 (704)
Q Consensus 7 ~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~ 86 (704)
+++.++++++.++ .+|..+. ++|+.|+|++|.++++.+..|.++++|++|+|++|.++.+.... |.++++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l~~ 101 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA-------FAPLVK 101 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT-------TTTCTT
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHH-------hcCCCC
Confidence 6899999999999 6777654 78999999999999998889999999999999999998875444 899999
Q ss_pred CcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCcc--ccChhhcCCCCcCeee
Q 005278 87 LTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNG--TIPTAVGRLRRLQGLY 164 (704)
Q Consensus 87 L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~ 164 (704)
|++|+|++|+++. +|..+. ++|++|++++|.+++..+..+.++++|++|++++|.+.. ..+..|..+++|++|+
T Consensus 102 L~~L~Ls~n~l~~-l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~ 177 (330)
T 1xku_A 102 LERLYLSKNQLKE-LPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177 (330)
T ss_dssp CCEEECCSSCCSB-CCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred CCEEECCCCcCCc-cChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEE
Confidence 9999999999984 454443 579999999999998888899999999999999999963 6788899999999999
Q ss_pred ccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCC
Q 005278 165 LHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244 (704)
Q Consensus 165 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 244 (704)
+++|+++ .+|..+. ++|++|++++|++++..+..+..+++|+.|++++|.+++..+..+..+++|++|++++|.++
T Consensus 178 l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~- 253 (330)
T 1xku_A 178 IADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253 (330)
T ss_dssp CCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-
T ss_pred CCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-
Confidence 9999999 5666554 89999999999999888889999999999999999999888889999999999999999999
Q ss_pred CCCcccccCcCCcEEEeecCccCCCCCCCcCC------CCCcceeeccCceeec--cCCcccccccccceEEecccC
Q 005278 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGG------LENLETLSLADNQFQG--PVPKSFGSLISLESLDLSRNN 313 (704)
Q Consensus 245 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~N~ 313 (704)
.+|..+..+++|+.|++++|++++..+..|.. .+.|+.|++++|.+.. ..|..|..+.+++.+++++|+
T Consensus 254 ~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 78888999999999999999999777777754 3788999999999864 567889999999999999985
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=305.90 Aligned_cols=308 Identities=19% Similarity=0.180 Sum_probs=261.0
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.+++++.|++++|.++...+..|.++++|++|+|++|.++++.+..|.++++|++|+|++|.++..+... |.+
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~ 115 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV-------FQN 115 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTT-------TTT
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHH-------hcC
Confidence 4689999999999999655556899999999999999999998899999999999999999998876544 899
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
+++|++|+|++|++....+..|..+ ++|++|++++|.+.+..+..+.++++|++|++++|.+++. .+..+++|+.|
T Consensus 116 l~~L~~L~L~~n~l~~l~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L 191 (390)
T 3o6n_A 116 VPLLTVLVLERNDLSSLPRGIFHNT-PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHA 191 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTC-TTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEE
T ss_pred CCCCCEEECCCCccCcCCHHHhcCC-CCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---cccccccccee
Confidence 9999999999999996555555665 4799999999999998899999999999999999999855 36678999999
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
++++|.+++ +...++|++|++++|.++.. |.. ..++|+.|++++|.+++. ..+..+++|++|++++|.+.
T Consensus 192 ~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~ 261 (390)
T 3o6n_A 192 NVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE 261 (390)
T ss_dssp ECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred ecccccccc-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCC
Confidence 999999873 23446899999999999854 332 247899999999999854 67888999999999999999
Q ss_pred CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCCcc
Q 005278 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 323 (704)
+..|..+..+++|+.|++++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++... +.
T Consensus 262 ~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~ 336 (390)
T 3o6n_A 262 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LS 336 (390)
T ss_dssp EEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CC
T ss_pred CcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---ch
Confidence 888899999999999999999998 56777788999999999999998 67778888999999999999998653 34
Q ss_pred cccccCcccccCCC
Q 005278 324 AQSFLSNYALCGPA 337 (704)
Q Consensus 324 ~~~~l~~~~l~g~~ 337 (704)
..+.+....+.|++
T Consensus 337 ~~~~L~~L~l~~N~ 350 (390)
T 3o6n_A 337 THHTLKNLTLSHND 350 (390)
T ss_dssp TTCCCSEEECCSSC
T ss_pred hhccCCEEEcCCCC
Confidence 44455666666665
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=298.01 Aligned_cols=303 Identities=23% Similarity=0.373 Sum_probs=262.1
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.+++|+.|++++|.++. ++ .+..+++|++|++++|.++++.+ |.++++|++|++++|.++.++ .+.+
T Consensus 42 ~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~~---------~~~~ 108 (347)
T 4fmz_A 42 ELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDIS---------ALQN 108 (347)
T ss_dssp HHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG---------GGTT
T ss_pred hcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCch---------HHcC
Confidence 57899999999999984 45 49999999999999999997655 999999999999999998753 2889
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
+++|++|+|++|++.+..+ +..+ ++|++|++++|.....++ .+..+++|++|++++|.+....+ +..+++|++|
T Consensus 109 l~~L~~L~l~~n~i~~~~~--~~~l-~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L 182 (347)
T 4fmz_A 109 LTNLRELYLNEDNISDISP--LANL-TKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182 (347)
T ss_dssp CTTCSEEECTTSCCCCCGG--GTTC-TTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEE
T ss_pred CCcCCEEECcCCcccCchh--hccC-CceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEE
Confidence 9999999999999996544 5555 479999999997765544 49999999999999999985544 8899999999
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
++++|++++. +. +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.++
T Consensus 183 ~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 256 (347)
T 4fmz_A 183 SLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256 (347)
T ss_dssp ECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccC
Confidence 9999999854 33 8889999999999999995544 8899999999999999986544 889999999999999998
Q ss_pred CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCCcc
Q 005278 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 323 (704)
+. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++..| +.
T Consensus 257 ~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~ 330 (347)
T 4fmz_A 257 DI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330 (347)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GG
T ss_pred CC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hh
Confidence 53 5788999999999999999854 458899999999999999999999999999999999999999998766 66
Q ss_pred cccccCcccccCCC
Q 005278 324 AQSFLSNYALCGPA 337 (704)
Q Consensus 324 ~~~~l~~~~l~g~~ 337 (704)
..+.+....+.+++
T Consensus 331 ~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 331 SLSKMDSADFANQV 344 (347)
T ss_dssp GCTTCSEESSSCC-
T ss_pred hhhccceeehhhhc
Confidence 66667777776664
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.20 Aligned_cols=288 Identities=26% Similarity=0.341 Sum_probs=250.3
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCC
Q 005278 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86 (704)
Q Consensus 7 ~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~ 86 (704)
+++.++++++.++ .+|..+. ++|+.|+|++|.++++.+..|.++++|++|+|++|.++.+.... |.++++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l~~ 103 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA-------FSPLRK 103 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG-------STTCTT
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhH-------hhCcCC
Confidence 6899999999998 6787664 79999999999999998999999999999999999998765444 899999
Q ss_pred CcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCc--cccChhhcCCCCcCeee
Q 005278 87 LTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLN--GTIPTAVGRLRRLQGLY 164 (704)
Q Consensus 87 L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~ 164 (704)
|++|+|++|++. .+|..+. ++|++|++++|.+++..+..+.++++|++|++++|.++ +..+..+..+ +|+.|+
T Consensus 104 L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~ 178 (332)
T 2ft3_A 104 LQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLR 178 (332)
T ss_dssp CCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCB
T ss_pred CCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEE
Confidence 999999999998 4454443 57999999999999888888999999999999999996 3677888888 999999
Q ss_pred ccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCC
Q 005278 165 LHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244 (704)
Q Consensus 165 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 244 (704)
+++|++++ +|..+. ++|++|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|++|++++|.++
T Consensus 179 l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~- 254 (332)
T 2ft3_A 179 ISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS- 254 (332)
T ss_dssp CCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-
Confidence 99999994 666654 78999999999999877788999999999999999999888888999999999999999998
Q ss_pred CCCcccccCcCCcEEEeecCccCCCCCCCcCC------CCCcceeeccCceee--ccCCcccccccccceEEecccC
Q 005278 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGG------LENLETLSLADNQFQ--GPVPKSFGSLISLESLDLSRNN 313 (704)
Q Consensus 245 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~l~~N~ 313 (704)
.+|..+..+++|+.|++++|++++..+..|.. ..+|+.|++++|++. +..|..|..+++|+.+++++|+
T Consensus 255 ~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 78888999999999999999999776666665 367899999999987 6778889999999999999885
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.17 Aligned_cols=240 Identities=18% Similarity=0.157 Sum_probs=179.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCC-CCCc--------------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRH-RNLI-------------- 474 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv-------------- 474 (704)
...|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+++.++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34567778999999999999995 479999999987432 2235779999999999987 2211
Q ss_pred -------eEEeeeee-----CCeEEEEEeccCCCCHHHHHh------hCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005278 475 -------KIISNCCN-----IDFKALVLEFMPNGSLEKWLY------SHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536 (704)
Q Consensus 475 -------~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~i 536 (704)
.++.++.. ....+++|+++ +++|.+++. .....+++..++.++.|++.||+||| +.+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 11111111 22356677765 679999985 23455788899999999999999995 5789
Q ss_pred EecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCccc----------CCCCCCcccceeeHHHH
Q 005278 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYG----------SEGIISPKSDVYSYGIL 606 (704)
Q Consensus 537 vH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~Gv~ 606 (704)
+||||||+||+++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999875322 334467 999999998 66678899999999999
Q ss_pred HHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005278 607 LMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAA 686 (704)
Q Consensus 607 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~ 686 (704)
+|||+||+.||......+. ...+.. ....++..+.+++.+||+.||++||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~~-------------~~~~~~-----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG-------------SEWIFR-----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC-------------SGGGGS-----------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhh-------------HHHHHh-----------hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999976322110 011100 0112346788999999999999999988885
Q ss_pred H
Q 005278 687 A 687 (704)
Q Consensus 687 ~ 687 (704)
+
T Consensus 363 ~ 363 (413)
T 3dzo_A 363 E 363 (413)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=320.62 Aligned_cols=325 Identities=24% Similarity=0.237 Sum_probs=259.2
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
+++++|||++|+|+++.+.+|.++++|++|+|++|.|+++.+++|.++++|++|+|++|+|+.++..+ |.+++
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~-------f~~L~ 124 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA-------FSGLS 124 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGG-------GTTCT
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHH-------hcCCC
Confidence 37999999999999877889999999999999999999999999999999999999999998877655 89999
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccc-cCChhhhcCCCCCEEEccCCcCccccChhhcCC-------
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG-NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRL------- 157 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l------- 157 (704)
+|++|+|++|++++..+..|..+. +|++|+|++|.+++ ..|..++.+++|++|+|++|.+++..+..|..+
T Consensus 125 ~L~~L~Ls~N~l~~l~~~~~~~L~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~ 203 (635)
T 4g8a_A 125 SLQKLVAVETNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 203 (635)
T ss_dssp TCCEEECTTSCCCCSTTCCCTTCT-TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCC
T ss_pred CCCEEECCCCcCCCCChhhhhcCc-ccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhh
Confidence 999999999999987777787774 79999999999976 467888999999999999998875544433211
Q ss_pred --------------------------------------------------------------------------------
Q 005278 158 -------------------------------------------------------------------------------- 157 (704)
Q Consensus 158 -------------------------------------------------------------------------------- 157 (704)
T Consensus 204 ~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~ 283 (635)
T 4g8a_A 204 LSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 283 (635)
T ss_dssp CEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEE
T ss_pred hhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhh
Confidence
Q ss_pred --------------------------------------------CCcCeeeccCcccCCCCC------------------
Q 005278 158 --------------------------------------------RRLQGLYLHGNKLQGSIP------------------ 175 (704)
Q Consensus 158 --------------------------------------------~~L~~L~L~~n~l~~~~~------------------ 175 (704)
..|+.|++.+|.+....+
T Consensus 284 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~ 363 (635)
T 4g8a_A 284 EEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 363 (635)
T ss_dssp EEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCC
T ss_pred hhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCC
Confidence 122333333333321111
Q ss_pred -ccccCCCCCCEEEcCCCcCCc-------------------------------------------------c-CCccccC
Q 005278 176 -YDLCHLEGLSELNLNGNKLCG-------------------------------------------------H-VPPCLAS 204 (704)
Q Consensus 176 -~~l~~l~~L~~L~L~~n~l~~-------------------------------------------------~-~~~~~~~ 204 (704)
.....+++|+.|++++|.+.. . .+..+..
T Consensus 364 ~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~ 443 (635)
T 4g8a_A 364 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 443 (635)
T ss_dssp BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTT
T ss_pred Ccccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccc
Confidence 011234566777777666531 1 1123556
Q ss_pred cCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC-CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCccee
Q 005278 205 LTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN-GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETL 283 (704)
Q Consensus 205 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 283 (704)
+++++.+++++|.+.+..+..+..+++|+.|++++|.+. ...|..|..+++|+.|+|++|++++..|..|.++++|+.|
T Consensus 444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 677778888888888777888888999999999999754 4678889999999999999999998889999999999999
Q ss_pred eccCceeeccCCcccccccccceEEecccCCCCCCCCCcccc-cccCcccccCCCc
Q 005278 284 SLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQ-SFLSNYALCGPAR 338 (704)
Q Consensus 284 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~l~~~~l~g~~~ 338 (704)
+|++|+|++..|..|..+++|+.|+|++|++++..|..+... +.+....+.|+|.
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~ 579 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 579 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence 999999998888899999999999999999999999888776 4677778888774
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=303.66 Aligned_cols=288 Identities=22% Similarity=0.231 Sum_probs=257.2
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.+++|++|+|++|.+++..+..|.++++|++|+|++|.++++.+..|.++++|++|+|++|.++.++... |.+
T Consensus 67 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~-------~~~ 139 (390)
T 3o6n_A 67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGI-------FHN 139 (390)
T ss_dssp HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-------TTT
T ss_pred ccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHH-------hcC
Confidence 5799999999999999888889999999999999999999999999999999999999999999876554 789
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
+++|++|+|++|++.+..+..+..+. +|++|++++|.+++. .+..+++|++|++++|.+.. +...++|++|
T Consensus 140 l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L 210 (390)
T 3o6n_A 140 TPKLTTLSMSNNNLERIEDDTFQATT-SLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEEL 210 (390)
T ss_dssp CTTCCEEECCSSCCCBCCTTTTSSCT-TCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEE
T ss_pred CCCCcEEECCCCccCccChhhccCCC-CCCEEECCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEE
Confidence 99999999999999988888888764 799999999999865 36788999999999999884 3445789999
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
++++|.++.. |... .++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+..|..+++|++|++++|.++
T Consensus 211 ~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 285 (390)
T 3o6n_A 211 DASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285 (390)
T ss_dssp ECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC
T ss_pred ECCCCeeeec-cccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc
Confidence 9999999844 4333 47999999999999954 57899999999999999999888999999999999999999998
Q ss_pred CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCC
Q 005278 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
+ ++..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|++++ ++ +..+++|+.|++++|++.+.
T Consensus 286 ~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 286 A-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp E-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHH
T ss_pred c-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccch
Confidence 4 5666788999999999999999 678788999999999999999985 43 77889999999999999863
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.09 Aligned_cols=230 Identities=20% Similarity=0.258 Sum_probs=178.4
Q ss_pred hCCCCcc-ccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHH-HhcCCCCCceEEeeeee----CCeE
Q 005278 414 TNGFNEC-NLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEIL-RSIRHRNLIKIISNCCN----IDFK 486 (704)
Q Consensus 414 ~~~~~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 486 (704)
.++|.+. +.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 7799999999999986 4789999999863 34567888888 55699999999999877 6678
Q ss_pred EEEEeccCCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEeeeccc
Q 005278 487 ALVLEFMPNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---NMTAHVSDFGIS 562 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---~~~~kl~Dfgla 562 (704)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998653 46899999999999999999995 478999999999999998 789999999998
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
.... +..++.++|||||||++|||++|+.||........ . .......
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------~---~~~~~~~ 214 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------S---PGMKTRI 214 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCSS
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------h---HHHHHHH
Confidence 7542 13456789999999999999999999975321110 0 0000000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...... ........++..+.+++.+||+.||++||++.|+++
T Consensus 215 ~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 215 RMGQYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CTTCCS---SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccc---CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 001111245677899999999999999999999976
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=318.68 Aligned_cols=308 Identities=19% Similarity=0.177 Sum_probs=244.1
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.+++++.|++++|.++...+..|.++++|+.|+|++|.++++.+..|..+++|++|+|++|.++.++... |.+
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~ 121 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV-------FQN 121 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTT-------TTT
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHH-------HcC
Confidence 4578899999999999766667888999999999999999988889999999999999999998876554 889
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
+++|++|+|++|.+....+..|..+ ++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.. ++.+++|+.|
T Consensus 122 l~~L~~L~L~~n~l~~l~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L 197 (597)
T 3oja_B 122 VPLLTVLVLERNDLSSLPRGIFHNT-PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHA 197 (597)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTC-TTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEE
T ss_pred CCCCCEEEeeCCCCCCCCHHHhccC-CCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhh
Confidence 9999999999999996666556666 47999999999999999989999999999999999998653 5667888888
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
++++|.+++ +...++|+.|++++|.++...+ .+ .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+.
T Consensus 198 ~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~-~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~ 267 (597)
T 3oja_B 198 NVSYNLLST-----LAIPIAVEELDASHNSINVVRG-PV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE 267 (597)
T ss_dssp ECCSSCCSE-----EECCTTCSEEECCSSCCCEEEC-SC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred hcccCcccc-----ccCCchhheeeccCCccccccc-cc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccC
Confidence 888888873 2344678888888888874332 22 2578888888888875 366778888888888888888
Q ss_pred CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCCcc
Q 005278 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 323 (704)
+..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++++.. +.
T Consensus 268 ~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~ 342 (597)
T 3oja_B 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LS 342 (597)
T ss_dssp EEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CC
T ss_pred CCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hh
Confidence 7778888888888888888888874 5666677888888888888887 57777778888888888888887553 23
Q ss_pred cccccCcccccCCC
Q 005278 324 AQSFLSNYALCGPA 337 (704)
Q Consensus 324 ~~~~l~~~~l~g~~ 337 (704)
..+.+....+.|++
T Consensus 343 ~~~~L~~L~l~~N~ 356 (597)
T 3oja_B 343 THHTLKNLTLSHND 356 (597)
T ss_dssp TTCCCSEEECCSSC
T ss_pred hcCCCCEEEeeCCC
Confidence 33344555555554
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=320.14 Aligned_cols=289 Identities=22% Similarity=0.216 Sum_probs=259.3
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.+++|+.|+|++|.+++..|..|.++++|++|+|++|.++++.+..|+++++|++|+|++|.++.++... |.+
T Consensus 73 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~-------~~~ 145 (597)
T 3oja_B 73 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGI-------FHN 145 (597)
T ss_dssp HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-------TTT
T ss_pred cCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHH-------hcc
Confidence 5789999999999999888889999999999999999999999999999999999999999999876554 799
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
+++|++|+|++|.+.+..|..|..+. +|++|++++|.+++.. ++.+++|+.|++++|.+.+ +...++|+.|
T Consensus 146 l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L 216 (597)
T 3oja_B 146 TPKLTTLSMSNNNLERIEDDTFQATT-SLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEEL 216 (597)
T ss_dssp CTTCCEEECCSSCCCBCCTTTTTTCT-TCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEE
T ss_pred CCCCCEEEeeCCcCCCCChhhhhcCC-cCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhhee
Confidence 99999999999999998888888874 7999999999999753 6778999999999999884 3456789999
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
++++|.++.. +..+ .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|+.+++|+.|+|++|.++
T Consensus 217 ~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 291 (597)
T 3oja_B 217 DASHNSINVV-RGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291 (597)
T ss_dssp ECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC
T ss_pred eccCCccccc-cccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC
Confidence 9999999843 3333 3689999999999996 367899999999999999999999999999999999999999998
Q ss_pred CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCC
Q 005278 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEI 318 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 318 (704)
+ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+++. | +..+++|+.|++++|++.+..
T Consensus 292 ~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 292 A-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp E-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHH
T ss_pred C-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChh
Confidence 5 5777788999999999999999 7888899999999999999999854 3 678899999999999998643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=293.23 Aligned_cols=284 Identities=27% Similarity=0.417 Sum_probs=247.9
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCC
Q 005278 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLT 82 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~ 82 (704)
..+++|++|++++|.+++. +. +.++++|++|+|++|.++++ ..|.++++|++|++++|.+...+. +.
T Consensus 63 ~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~~~---------~~ 129 (347)
T 4fmz_A 63 EYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP---------LA 129 (347)
T ss_dssp GGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCCGG---------GT
T ss_pred hhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCchh---------hc
Confidence 3589999999999999954 44 99999999999999999975 469999999999999999987542 78
Q ss_pred CCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCe
Q 005278 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQG 162 (704)
Q Consensus 83 ~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 162 (704)
.+++|++|++++|......+. +..+ ++|++|++++|.+.+..+ +..+++|++|++++|.+.+..+ +..+++|+.
T Consensus 130 ~l~~L~~L~l~~n~~~~~~~~-~~~l-~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 203 (347)
T 4fmz_A 130 NLTKMYSLNLGANHNLSDLSP-LSNM-TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHY 203 (347)
T ss_dssp TCTTCCEEECTTCTTCCCCGG-GTTC-TTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCE
T ss_pred cCCceeEEECCCCCCcccccc-hhhC-CCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccce
Confidence 999999999999976655443 6655 479999999999986554 8999999999999999985443 889999999
Q ss_pred eeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCccc
Q 005278 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242 (704)
Q Consensus 163 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 242 (704)
|++++|.+++..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.+++. ..+..+++|++|++++|.+
T Consensus 204 L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l 277 (347)
T 4fmz_A 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI 277 (347)
T ss_dssp EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred eecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCcc
Confidence 9999999995543 8889999999999999995433 88999999999999999864 5788999999999999999
Q ss_pred CCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCC
Q 005278 243 NGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315 (704)
Q Consensus 243 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 315 (704)
++. ..+..+++|+.|++++|++++..+..++.+++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 278 ~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 278 SDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 864 568899999999999999998888889999999999999999997666 889999999999999986
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=319.12 Aligned_cols=277 Identities=23% Similarity=0.271 Sum_probs=179.4
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
+++|++|+|++|.+++..|..|.++++|++|+|++|.++++.+.+|.++++|++|+|++|.++..+... |.++
T Consensus 25 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~-------~~~l 97 (549)
T 2z81_A 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSW-------FGPL 97 (549)
T ss_dssp CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHH-------HTTC
T ss_pred CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHH-------hccC
Confidence 356777777777777766777777777777777777777777777777777777777777777655443 6677
Q ss_pred CCCcEEEccCCCCccc-CChhhhhcccccceEEecCCc-ccccCChhhhcCCCCCEEEccCCcCccccChhhcC------
Q 005278 85 RNLTVLGLASNPLRGI-LPPLIGNFSASLQEFYAYGCK-LRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGR------ 156 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~-~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~------ 156 (704)
++|++|+|++|++.+. .|..+..+ ++|++|++++|. +....+..+.++++|++|++++|.+.+..|..++.
T Consensus 98 ~~L~~L~Ls~n~l~~~~~~~~~~~l-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 176 (549)
T 2z81_A 98 SSLKYLNLMGNPYQTLGVTSLFPNL-TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176 (549)
T ss_dssp TTCCEEECTTCCCSSSCSSCSCTTC-TTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEE
T ss_pred CCCcEEECCCCcccccchhhhhhcc-CCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCce
Confidence 7777777777777653 34455554 357777777776 33333456677777777777777776666655544
Q ss_pred ------------------CCCcCeeeccCcccCCCC--Ccc-ccCC----------------------------------
Q 005278 157 ------------------LRRLQGLYLHGNKLQGSI--PYD-LCHL---------------------------------- 181 (704)
Q Consensus 157 ------------------l~~L~~L~L~~n~l~~~~--~~~-l~~l---------------------------------- 181 (704)
+++|++|++++|++++.. |.. ...+
T Consensus 177 L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l 256 (549)
T 2z81_A 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256 (549)
T ss_dssp EEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEE
T ss_pred EecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccc
Confidence 566666667777666421 100 0011
Q ss_pred -----------------------------------------------------CCCCEEEcCCCcCCccCCccc-cCcCC
Q 005278 182 -----------------------------------------------------EGLSELNLNGNKLCGHVPPCL-ASLTS 207 (704)
Q Consensus 182 -----------------------------------------------------~~L~~L~L~~n~l~~~~~~~~-~~l~~ 207 (704)
++|+.|++++|+++ .+|..+ ..+++
T Consensus 257 ~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~ 335 (549)
T 2z81_A 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKS 335 (549)
T ss_dssp EEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTT
T ss_pred ccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCcc
Confidence 22333444444433 233333 35677
Q ss_pred CCEEEecCccCCCCCC---CcccCCccccEEEecCcccCCCCC--cccccCcCCcEEEeecCccCCCCCCCcCCCCCcce
Q 005278 208 LRRLHLGSNKLTSTMP---SSFGSLEYVLYINLSANSLNGSLP--SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLET 282 (704)
Q Consensus 208 L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 282 (704)
|+.|++++|.+++..+ ..++.+++|++|++++|.+++..+ ..+..+++|+.|++++|+++ .+|..+..+++|+.
T Consensus 336 L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~ 414 (549)
T 2z81_A 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414 (549)
T ss_dssp CCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCE
T ss_pred ccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccE
Confidence 7777777777765442 346667777777777777764322 34677777888888888877 67777777777777
Q ss_pred eeccCceee
Q 005278 283 LSLADNQFQ 291 (704)
Q Consensus 283 L~L~~n~l~ 291 (704)
|++++|+++
T Consensus 415 L~Ls~N~l~ 423 (549)
T 2z81_A 415 LNLSSTGIR 423 (549)
T ss_dssp EECTTSCCS
T ss_pred EECCCCCcc
Confidence 777777776
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=304.06 Aligned_cols=303 Identities=27% Similarity=0.420 Sum_probs=180.3
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.+++|++|+|++|.+++..+ +.++++|++|++++|.++++.+ |.++++|++|++++|.++..+. +.+
T Consensus 66 ~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~---------~~~ 132 (466)
T 1o6v_A 66 YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP---------LKN 132 (466)
T ss_dssp GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG---------GTT
T ss_pred hhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH---------HcC
Confidence 46677777777777774433 7777777777777777775544 6777777777777777665431 566
Q ss_pred CCCCcEEEccCCCCcccCC-------------------hhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCC
Q 005278 84 CRNLTVLGLASNPLRGILP-------------------PLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGC 144 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~-------------------~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 144 (704)
+++|++|+|++|++.+... ..+..+ ++|++|++++|.+.+. ..+..+++|++|++++|
T Consensus 133 l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n 209 (466)
T 1o6v_A 133 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANL-TTLERLDISSNKVSDI--SVLAKLTNLESLIATNN 209 (466)
T ss_dssp CTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred CCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccC-CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCC
Confidence 6777777777776654311 012222 2455555555555432 23555555555555555
Q ss_pred cCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCC
Q 005278 145 DLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPS 224 (704)
Q Consensus 145 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 224 (704)
.+.+..+ ++.+++|+.|++++|++++. ..+..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+
T Consensus 210 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~- 282 (466)
T 1o6v_A 210 QISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP- 282 (466)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-
T ss_pred ccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-
Confidence 5554333 45555666666666665532 245556666666666666664332 5566666666666666664332
Q ss_pred cccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCccccccccc
Q 005278 225 SFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304 (704)
Q Consensus 225 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 304 (704)
+..+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..| +..+++|+.|++++|++++. ..+..+++|
T Consensus 283 -~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L 355 (466)
T 1o6v_A 283 -LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNI 355 (466)
T ss_dssp -GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred -ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCC
Confidence 5666666666666666664332 5666666666666666665444 56666677777777766643 356666777
Q ss_pred ceEEecccCCCCCCCCCcccccccCcccccCCCc
Q 005278 305 ESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPAR 338 (704)
Q Consensus 305 ~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~~ 338 (704)
+.|++++|++++..| +...+.+....+.+++.
T Consensus 356 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~ 387 (466)
T 1o6v_A 356 NWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387 (466)
T ss_dssp CEEECCSSCCCBCGG--GTTCTTCCEEECCCEEE
T ss_pred CEEeCCCCccCccch--hhcCCCCCEEeccCCcc
Confidence 777777777766555 44445555555555443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.59 Aligned_cols=243 Identities=19% Similarity=0.225 Sum_probs=184.7
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccch--------hhhHHHHHHHHHHHhcC---------CCCCceE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE--------RASRSFDSECEILRSIR---------HRNLIKI 476 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~niv~l 476 (704)
.++|+..+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35788899999999999999987 789999999975421 22367899999999886 7777777
Q ss_pred Eeeee------------------------------eCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHH
Q 005278 477 ISNCC------------------------------NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALE 526 (704)
Q Consensus 477 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 526 (704)
.+.+. +.+..++||||+++|++.+.+.+ ..+++..+..++.|++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 77642 26789999999999977776644 34799999999999999999
Q ss_pred HHHhcCCCCcEecCCCCCCeeeCCCC--------------------cEEEeeeccceecCCCCCcceeccccccccccCC
Q 005278 527 YLHHGHSTPMVHCDLKPNNILLDENM--------------------TAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 586 (704)
Q Consensus 527 ~Lh~~h~~~ivH~dlk~~Nil~~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP 586 (704)
|||+ +.+|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+||
T Consensus 176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE 246 (336)
T ss_dssp HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence 9961 46799999999999999887 8999999999876432 34799999999
Q ss_pred cccCCCCCCcccceeeHHHH-HHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHH
Q 005278 587 EYGSEGIISPKSDVYSYGIL-LMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIM 665 (704)
Q Consensus 587 E~~~~~~~~~~~Dv~s~Gv~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 665 (704)
|++.+.. +.++||||+|++ .+++++|..||... .|...... .+.................++.++.
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLTD----KMLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHHH----HHHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHHH----hhhhhhccCcccchhhhhhcCHHHH
Confidence 9998766 889999998777 78899999998541 12110000 0000000000011123346788899
Q ss_pred HHHhhhcCCCCCCCCCHHHHH
Q 005278 666 HLALDCCMESPEQRVSMKDAA 686 (704)
Q Consensus 666 ~l~~~cl~~~P~~Rpt~~ev~ 686 (704)
+++.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 898886
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=291.76 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=182.3
Q ss_pred CCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccC-CCCcccCChhhhhcccccceEEecCCcccccCChhhhc
Q 005278 54 GSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLAS-NPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGN 132 (704)
Q Consensus 54 ~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 132 (704)
.++++|+|++|.+.... .++..+.++++|++|+|++ |.+.+.+|..+..+. +|++|++++|.+++.+|..+.+
T Consensus 50 ~~l~~L~L~~~~l~~~~-----~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~ 123 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPY-----PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT-QLHYLYITHTNVSGAIPDFLSQ 123 (313)
T ss_dssp CCEEEEEEECCCCSSCE-----ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCT-TCSEEEEEEECCEEECCGGGGG
T ss_pred ceEEEEECCCCCccCCc-----ccChhHhCCCCCCeeeCCCCCcccccCChhHhcCC-CCCEEECcCCeeCCcCCHHHhC
Confidence 45566666666655300 0122355666666666663 666666666665553 4666666666666666777777
Q ss_pred CCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCC-CCCEEEcCCCcCCccCCccccCcCCCCEE
Q 005278 133 LSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLE-GLSELNLNGNKLCGHVPPCLASLTSLRRL 211 (704)
Q Consensus 133 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 211 (704)
+++|++|+|++|.+.+.+|..|..+++|++|+|++|++++.+|..+..++ +|++|++++|++++..|..+..++ |+.|
T Consensus 124 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L 202 (313)
T 1ogq_A 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV 202 (313)
T ss_dssp CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred CCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence 77777777777777777777777777777777777777777777777776 777778877777777777777776 7888
Q ss_pred EecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 212 HLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 212 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
++++|.+++..+..|..+++|+.|++++|.+.+.++. +..+++|+.|++++|++++.+|..+..+++|+.|+|++|+++
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 281 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccc
Confidence 8888877777777777778888888888887755554 677788888888888888788888888888888888888888
Q ss_pred ccCCcccccccccceEEecccC
Q 005278 292 GPVPKSFGSLISLESLDLSRNN 313 (704)
Q Consensus 292 ~~~p~~~~~l~~L~~L~l~~N~ 313 (704)
+.+|.. ..+++|+.+++++|+
T Consensus 282 ~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 282 GEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp EECCCS-TTGGGSCGGGTCSSS
T ss_pred ccCCCC-ccccccChHHhcCCC
Confidence 888776 778888888888887
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=288.07 Aligned_cols=252 Identities=25% Similarity=0.442 Sum_probs=224.5
Q ss_pred CCCCEEeccCccccc--cCchhhcCCCCCCEEeccc-ccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhh
Q 005278 30 SKLIMLDLSSNSFSG--LIPNTFGNLGSLQVLSLAY-NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIG 106 (704)
Q Consensus 30 ~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 106 (704)
.++++|+|++|.+++ .+|..|.++++|++|+|++ |.+.... |..|.++++|++|+|++|++.+..|..+.
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~-------p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 122 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI-------PPAIAKLTQLHYLYITHTNVSGAIPDFLS 122 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCC-------CGGGGGCTTCSEEEEEEECCEEECCGGGG
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccC-------ChhHhcCCCCCEEECcCCeeCCcCCHHHh
Confidence 678888999998887 7888888899999999984 7776543 33488888999999999998888888888
Q ss_pred hcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCC-CcCeeeccCcccCCCCCccccCCCCCC
Q 005278 107 NFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLR-RLQGLYLHGNKLQGSIPYDLCHLEGLS 185 (704)
Q Consensus 107 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~ 185 (704)
.+. +|++|++++|.+.+.+|..+.++++|++|+|++|.+++.+|..+..++ +|+.|++++|++++.+|..+..++ |+
T Consensus 123 ~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~ 200 (313)
T 1ogq_A 123 QIK-TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LA 200 (313)
T ss_dssp GCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CS
T ss_pred CCC-CCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-cc
Confidence 774 699999999999888999999999999999999999988999999998 999999999999988999999887 99
Q ss_pred EEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCc
Q 005278 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQ 265 (704)
Q Consensus 186 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~ 265 (704)
+|++++|++++..|..+..+++|+.|++++|.+++..+. +..+++|++|++++|.+++.+|..+..+++|+.|++++|+
T Consensus 201 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 279 (313)
T 1ogq_A 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred EEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCc
Confidence 999999999988889999999999999999999866655 7889999999999999999999999999999999999999
Q ss_pred cCCCCCCCcCCCCCcceeeccCce-eec
Q 005278 266 LSGDIPTTIGGLENLETLSLADNQ-FQG 292 (704)
Q Consensus 266 l~~~~~~~~~~l~~L~~L~L~~n~-l~~ 292 (704)
+++.+|.. +.+++|+.|++++|+ +.|
T Consensus 280 l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 280 LCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp EEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred ccccCCCC-ccccccChHHhcCCCCccC
Confidence 99988886 889999999999998 444
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-32 Score=307.54 Aligned_cols=310 Identities=21% Similarity=0.252 Sum_probs=250.3
Q ss_pred CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccC
Q 005278 2 GYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSL 81 (704)
Q Consensus 2 ~~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~ 81 (704)
+..+++|++|+|++|.|+++.+++|.++++|++|+|++|+++++.+.+|.++++|++|+|++|+++.++..+ |
T Consensus 72 f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~-------~ 144 (635)
T 4g8a_A 72 FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP-------I 144 (635)
T ss_dssp TTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCC-------C
T ss_pred HhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhh-------h
Confidence 357899999999999999888889999999999999999999998899999999999999999999877554 8
Q ss_pred CCCCCCcEEEccCCCCccc-CChhhhhcccccceEEecCCcccccCChhhhcC---------------------------
Q 005278 82 TNCRNLTVLGLASNPLRGI-LPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNL--------------------------- 133 (704)
Q Consensus 82 ~~l~~L~~L~L~~n~i~~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l--------------------------- 133 (704)
.++++|++|+|++|.+... .|..+..+ ++|++|++++|++++..+..+..+
T Consensus 145 ~~L~~L~~L~Ls~N~l~~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~ 223 (635)
T 4g8a_A 145 GHLKTLKELNVAHNLIQSFKLPEYFSNL-TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 223 (635)
T ss_dssp TTCTTCCEEECCSSCCCCCCCCGGGGGC-TTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT
T ss_pred hcCcccCeeccccCccccCCCchhhccc-hhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccc
Confidence 8999999999999998764 45666665 469999999888766544433221
Q ss_pred --------------------------------------------------------------------------------
Q 005278 134 -------------------------------------------------------------------------------- 133 (704)
Q Consensus 134 -------------------------------------------------------------------------------- 133 (704)
T Consensus 224 ~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~ 303 (635)
T 4g8a_A 224 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFN 303 (635)
T ss_dssp CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTG
T ss_pred hhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhh
Confidence
Q ss_pred ------------------------CCCCEEEccCCcCccccCh-------------------hhcCCCCcCeeeccCccc
Q 005278 134 ------------------------SGMIVFDLNGCDLNGTIPT-------------------AVGRLRRLQGLYLHGNKL 170 (704)
Q Consensus 134 ------------------------~~L~~L~L~~n~l~~~~~~-------------------~~~~l~~L~~L~L~~n~l 170 (704)
..|+.|++.+|.+....+. ....+++|+.|+++.|.+
T Consensus 304 ~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l 383 (635)
T 4g8a_A 304 CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL 383 (635)
T ss_dssp GGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCC
T ss_pred hhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhcccc
Confidence 1233333333332211110 112345556666655544
Q ss_pred C-------------------------------------------------CC-CCccccCCCCCCEEEcCCCcCCccCCc
Q 005278 171 Q-------------------------------------------------GS-IPYDLCHLEGLSELNLNGNKLCGHVPP 200 (704)
Q Consensus 171 ~-------------------------------------------------~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~ 200 (704)
. .. .+..+..+++++.++++.|.+.+..+.
T Consensus 384 ~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~ 463 (635)
T 4g8a_A 384 SFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 463 (635)
T ss_dssp BEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTT
T ss_pred ccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccccccccccccccc
Confidence 2 11 123466778899999999999988888
Q ss_pred cccCcCCCCEEEecCccC-CCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCC
Q 005278 201 CLASLTSLRRLHLGSNKL-TSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLEN 279 (704)
Q Consensus 201 ~~~~l~~L~~L~l~~n~l-~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 279 (704)
.+..+++|+.|++++|.+ .+..|..|..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|.++++
T Consensus 464 ~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~ 543 (635)
T 4g8a_A 464 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 543 (635)
T ss_dssp TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTT
T ss_pred ccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCC
Confidence 999999999999999974 4567889999999999999999999999999999999999999999999888889999999
Q ss_pred cceeeccCceeeccCCcccccc-cccceEEecccCCCCCCC
Q 005278 280 LETLSLADNQFQGPVPKSFGSL-ISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 280 L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p 319 (704)
|+.|+|++|+|++..|..+..+ ++|+.|++++|++.+...
T Consensus 544 L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 544 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999999999999999988 689999999999997543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-32 Score=294.82 Aligned_cols=292 Identities=27% Similarity=0.411 Sum_probs=250.2
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhh-------
Q 005278 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKW------- 75 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~------- 75 (704)
..+++|++|++++|.+++..+ +.++++|++|+|++|.++++.+ |.++++|++|++++|.+...+.-...
T Consensus 87 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~ 162 (466)
T 1o6v_A 87 KNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLS 162 (466)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEE
T ss_pred hccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEee
Confidence 468899999999999996544 9999999999999999997644 89999999999999998875421100
Q ss_pred -----cccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCcccc
Q 005278 76 -----NFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTI 150 (704)
Q Consensus 76 -----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 150 (704)
.-...+.++++|++|++++|++... ..+..+ ++|++|++++|.+.+..+ ++.+++|++|++++|.+.+.
T Consensus 163 l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l-~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~- 236 (466)
T 1o6v_A 163 FGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKL-TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI- 236 (466)
T ss_dssp EEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGC-TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-
T ss_pred cCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccC-CCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-
Confidence 0012377889999999999999865 335555 479999999999997665 88899999999999999854
Q ss_pred ChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCc
Q 005278 151 PTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLE 230 (704)
Q Consensus 151 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 230 (704)
..+..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..++
T Consensus 237 -~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~ 309 (466)
T 1o6v_A 237 -GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLK 309 (466)
T ss_dssp -GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCT
T ss_pred -hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCC
Confidence 468899999999999999996544 8899999999999999996543 8899999999999999996544 88999
Q ss_pred cccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEec
Q 005278 231 YVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLS 310 (704)
Q Consensus 231 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~ 310 (704)
+|+.|++++|.+.+..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|+++
T Consensus 310 ~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~ 383 (466)
T 1o6v_A 310 NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 383 (466)
T ss_dssp TCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEecc
Confidence 99999999999997655 78999999999999999964 478999999999999999998777 8999999999999
Q ss_pred ccCCCCC
Q 005278 311 RNNLSGE 317 (704)
Q Consensus 311 ~N~l~~~ 317 (704)
+|++++.
T Consensus 384 ~n~~~~~ 390 (466)
T 1o6v_A 384 DQAWTNA 390 (466)
T ss_dssp CEEEECC
T ss_pred CCcccCC
Confidence 9999974
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-31 Score=279.07 Aligned_cols=270 Identities=21% Similarity=0.261 Sum_probs=239.0
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
.+.++.|+|++|++++..+..|.++++|++|+|++|.++++.|..|.++++|++|+|++|.++.++.. + .
T Consensus 51 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~--------~--~ 120 (330)
T 1xku_A 51 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK--------M--P 120 (330)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS--------C--C
T ss_pred CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChh--------h--c
Confidence 46899999999999988777999999999999999999999999999999999999999999876543 2 2
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccc--cCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCe
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG--NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQG 162 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 162 (704)
++|++|++++|++.+..+..+..+. +|++|++++|.+.. ..+..+.++++|++|++++|.++. +|..+. ++|++
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~ 196 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTE 196 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCT-TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSE
T ss_pred ccccEEECCCCcccccCHhHhcCCc-cccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCE
Confidence 7999999999999987777777764 79999999999964 788899999999999999999994 555443 89999
Q ss_pred eeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCccc
Q 005278 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242 (704)
Q Consensus 163 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 242 (704)
|++++|++++..|..+..+++|++|+|++|.+++..+..+..+++|+.|++++|.++ .+|..+..+++|++|++++|.+
T Consensus 197 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred EECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcC
Confidence 999999999888899999999999999999999887788999999999999999999 7888899999999999999999
Q ss_pred CCCCCccccc------CcCCcEEEeecCccCC--CCCCCcCCCCCcceeeccCce
Q 005278 243 NGSLPSNIQN------LKVLTNLDLSRNQLSG--DIPTTIGGLENLETLSLADNQ 289 (704)
Q Consensus 243 ~~~~~~~~~~------l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~n~ 289 (704)
++..+..|.. .+.|+.|++++|++.. ..|..|..+.+++.++|++|+
T Consensus 276 ~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 276 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 9877777754 3789999999999964 567789999999999999985
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-32 Score=280.07 Aligned_cols=269 Identities=22% Similarity=0.291 Sum_probs=238.6
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
.++++.|+|++|.+++..+..|.++++|++|+|++|.++++.|..|.++++|++|+|++|.++.++... .
T Consensus 53 ~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~--------~-- 122 (332)
T 2ft3_A 53 SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNL--------P-- 122 (332)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSC--------C--
T ss_pred CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCccc--------c--
Confidence 468999999999999888889999999999999999999999999999999999999999998765432 2
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCccc--ccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCe
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR--GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQG 162 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 162 (704)
++|++|++++|++....+..+..+ ++|++|++++|.++ +..+..+..+ +|++|++++|.+++ +|..+. ++|++
T Consensus 123 ~~L~~L~l~~n~i~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~ 197 (332)
T 2ft3_A 123 SSLVELRIHDNRIRKVPKGVFSGL-RNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNE 197 (332)
T ss_dssp TTCCEEECCSSCCCCCCSGGGSSC-SSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSC
T ss_pred ccCCEEECCCCccCccCHhHhCCC-ccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCE
Confidence 799999999999997777777776 47999999999996 4778888888 99999999999995 555444 79999
Q ss_pred eeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCccc
Q 005278 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242 (704)
Q Consensus 163 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 242 (704)
|++++|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|.++ .+|..+..+++|++|++++|.+
T Consensus 198 L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l 276 (332)
T 2ft3_A 198 LHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276 (332)
T ss_dssp CBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCC
T ss_pred EECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCC
Confidence 999999999888889999999999999999999887788999999999999999999 7888899999999999999999
Q ss_pred CCCCCccccc------CcCCcEEEeecCccC--CCCCCCcCCCCCcceeeccCce
Q 005278 243 NGSLPSNIQN------LKVLTNLDLSRNQLS--GDIPTTIGGLENLETLSLADNQ 289 (704)
Q Consensus 243 ~~~~~~~~~~------l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~L~~n~ 289 (704)
++..+..|.. .+.|+.|++++|++. +..|..|..+++|+.|++++|+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 277 TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 9777777765 467999999999997 5778889999999999999985
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-31 Score=287.56 Aligned_cols=296 Identities=20% Similarity=0.175 Sum_probs=223.3
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.+++|++|++++|.+++. | .|..+++|++|+|++|.++++ + |+.+++|++|++++|.++.++ +.+
T Consensus 40 ~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~~----------~~~ 104 (457)
T 3bz5_A 40 QLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNLD----------VTP 104 (457)
T ss_dssp HHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCC----------CTT
T ss_pred HcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCceee----------cCC
Confidence 478999999999999964 5 699999999999999999976 3 889999999999999998753 778
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
+++|++|+|++|++++. + +..+ ++|++|++++|++++. .++++++|++|++++|...+.+ .++.+++|+.|
T Consensus 105 l~~L~~L~L~~N~l~~l-~--~~~l-~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L 175 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTKL-D--VSQN-PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTL 175 (457)
T ss_dssp CTTCCEEECCSSCCSCC-C--CTTC-TTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEE
T ss_pred CCcCCEEECCCCcCCee-c--CCCC-CcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEE
Confidence 99999999999999874 3 5555 4799999999999874 3788899999999999655444 47788999999
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
++++|++++ +| +..+++|+.|++++|++++. .+..+++|+.|++++|++++ +| +..+++|+.|++++|.++
T Consensus 176 ~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~ 246 (457)
T 3bz5_A 176 DCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLT 246 (457)
T ss_dssp ECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCS
T ss_pred ECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCC
Confidence 999999985 44 78888999999999998854 37888899999999999986 44 778889999999999988
Q ss_pred CCCCcccccCc-------CCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcc--------cccccccceEE
Q 005278 244 GSLPSNIQNLK-------VLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKS--------FGSLISLESLD 308 (704)
Q Consensus 244 ~~~~~~~~~l~-------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~--------~~~l~~L~~L~ 308 (704)
+..+..+.++. +|+.|++++|++.+.+| ++.+++|+.|++++|.+.+.+|.. +..+++|+.|+
T Consensus 247 ~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~ 324 (457)
T 3bz5_A 247 ELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLY 324 (457)
T ss_dssp CCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred CcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEE
Confidence 76544444333 34445555555444444 356677777777777655554432 44556677777
Q ss_pred ecccCCCCCCCCCcccccccCcccccCCC
Q 005278 309 LSRNNLSGEIPKNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 309 l~~N~l~~~~p~~~~~~~~l~~~~l~g~~ 337 (704)
+++|++++. + +...+.+....+.++.
T Consensus 325 L~~N~l~~l-~--l~~l~~L~~L~l~~N~ 350 (457)
T 3bz5_A 325 LNNTELTEL-D--VSHNTKLKSLSCVNAH 350 (457)
T ss_dssp CTTCCCSCC-C--CTTCTTCSEEECCSSC
T ss_pred CCCCccccc-c--cccCCcCcEEECCCCC
Confidence 777777763 2 4444444444444443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=276.07 Aligned_cols=283 Identities=21% Similarity=0.232 Sum_probs=193.5
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCc
Q 005278 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLT 88 (704)
Q Consensus 9 ~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~ 88 (704)
+.++++++.++ .+|..+. ++|++|+|++|.++.+.+..|.++++|++|+|++|.++.... .+..+..+++|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~~~~~~L~ 81 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC-----CSQSDFGTTSLK 81 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE-----EEHHHHSCSCCC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC-----cccccccccccC
Confidence 46777777777 5565443 577777777777776666667777777777777777765431 012244566777
Q ss_pred EEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccC-hhhcCCCCcCeeeccC
Q 005278 89 VLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIP-TAVGRLRRLQGLYLHG 167 (704)
Q Consensus 89 ~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~ 167 (704)
+|+|++|.+.. +|..+..+++|++|++++|.+.+..+ ..+..+++|++|++++
T Consensus 82 ~L~Ls~n~i~~--------------------------l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~ 135 (306)
T 2z66_A 82 YLDLSFNGVIT--------------------------MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135 (306)
T ss_dssp EEECCSCSEEE--------------------------EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTT
T ss_pred EEECCCCcccc--------------------------ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCC
Confidence 77777766652 23345566777777777777765444 4677777777777777
Q ss_pred cccCCCCCccccCCCCCCEEEcCCCcCCc-cCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCC
Q 005278 168 NKLQGSIPYDLCHLEGLSELNLNGNKLCG-HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSL 246 (704)
Q Consensus 168 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 246 (704)
|.+++..+..+..+++|++|++++|.+++ ..|..+..+++|+.|++++|.+++..+..+..+++|++|++++|.+++..
T Consensus 136 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 215 (306)
T 2z66_A 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 215 (306)
T ss_dssp SCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred CcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence 77776666777777777777777777765 46667777777777777777777766777777777777777777777666
Q ss_pred CcccccCcCCcEEEeecCccCCCCCCCcCCCC-CcceeeccCceeeccCC--cccccccccceEEecccCCCCCCCCCcc
Q 005278 247 PSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLE-NLETLSLADNQFQGPVP--KSFGSLISLESLDLSRNNLSGEIPKNFS 323 (704)
Q Consensus 247 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 323 (704)
+..+..+++|+.|++++|++++..|..+..++ +|+.|+|++|++++.-+ .....+...+.+.+..+.+.+..|..+.
T Consensus 216 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~ 295 (306)
T 2z66_A 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 295 (306)
T ss_dssp SGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGT
T ss_pred hhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhC
Confidence 66777778888888888888877777777774 78888888888875322 1123344455555666666666665544
Q ss_pred cc
Q 005278 324 AQ 325 (704)
Q Consensus 324 ~~ 325 (704)
..
T Consensus 296 g~ 297 (306)
T 2z66_A 296 GM 297 (306)
T ss_dssp TC
T ss_pred Cc
Confidence 43
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=284.06 Aligned_cols=278 Identities=21% Similarity=0.203 Sum_probs=235.5
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCC
Q 005278 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLT 82 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~ 82 (704)
..+++|++|+|++|.+++. | ++.+++|++|+|++|.++++ + |.++++|++|++++|+++.++ +.
T Consensus 61 ~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l~----------~~ 124 (457)
T 3bz5_A 61 EKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKLD----------VS 124 (457)
T ss_dssp GGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCCC----------CT
T ss_pred cccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCeec----------CC
Confidence 4689999999999999964 4 99999999999999999986 3 899999999999999998753 78
Q ss_pred CCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCe
Q 005278 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQG 162 (704)
Q Consensus 83 ~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 162 (704)
.+++|++|++++|++++. + +..+ ++|++|++++|...+.+ .++.+++|++|++++|.+++ +| ++.+++|+.
T Consensus 125 ~l~~L~~L~l~~N~l~~l-~--l~~l-~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~ 195 (457)
T 3bz5_A 125 QNPLLTYLNCARNTLTEI-D--VSHN-TQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNR 195 (457)
T ss_dssp TCTTCCEEECTTSCCSCC-C--CTTC-TTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCE
T ss_pred CCCcCCEEECCCCcccee-c--cccC-CcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCE
Confidence 899999999999999975 2 5554 47999999999666555 48899999999999999996 44 889999999
Q ss_pred eeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCc-------cccEE
Q 005278 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLE-------YVLYI 235 (704)
Q Consensus 163 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-------~L~~L 235 (704)
|++++|++++. .+..+++|++|++++|++++ +| +..+++|+.|++++|.+++..+..+..+. +|+.|
T Consensus 196 L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L 269 (457)
T 3bz5_A 196 LNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEI 269 (457)
T ss_dssp EECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCC
T ss_pred EECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEE
Confidence 99999999964 48899999999999999996 55 88999999999999999987655554444 44556
Q ss_pred EecCcccCCCCCcccccCcCCcEEEeecCccCCCCCC--------CcCCCCCcceeeccCceeeccCCcccccccccceE
Q 005278 236 NLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPT--------TIGGLENLETLSLADNQFQGPVPKSFGSLISLESL 307 (704)
Q Consensus 236 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--------~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 307 (704)
++++|.+.+.+| ++.+++|+.|++++|+..+.+|. .+..+++|+.|++++|++++. + +..+++|+.|
T Consensus 270 ~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L 344 (457)
T 3bz5_A 270 DLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSL 344 (457)
T ss_dssp CCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEE
T ss_pred ECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEE
Confidence 666666554444 56789999999999987766554 366778999999999999973 3 8899999999
Q ss_pred EecccCCCC
Q 005278 308 DLSRNNLSG 316 (704)
Q Consensus 308 ~l~~N~l~~ 316 (704)
++++|++++
T Consensus 345 ~l~~N~l~~ 353 (457)
T 3bz5_A 345 SCVNAHIQD 353 (457)
T ss_dssp ECCSSCCCB
T ss_pred ECCCCCCCC
Confidence 999999997
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.58 Aligned_cols=281 Identities=19% Similarity=0.216 Sum_probs=163.8
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
+.....++++++++ .+|..+. ++|++|+|++|.++++.+..|.++++|++|+|++|.++.+.... |.+++
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l~ 100 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS-------FSSLG 100 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT-------TTTCT
T ss_pred CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhh-------cCCCC
Confidence 33455677777777 5566554 47788888888887776667777888888888877777654433 77777
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCC-hhhhcCCCCCEEEccCC-cCccccChhhcCCCCcCee
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIP-QEIGNLSGMIVFDLNGC-DLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L 163 (704)
+|++|+|++|++++..+..+..+ ++|++|++++|++++..+ ..+.++++|++|++++| .+....+..|.++++|++|
T Consensus 101 ~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L 179 (353)
T 2z80_A 101 SLEHLDLSYNYLSNLSSSWFKPL-SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179 (353)
T ss_dssp TCCEEECCSSCCSSCCHHHHTTC-TTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred CCCEEECCCCcCCcCCHhHhCCC-ccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEE
Confidence 77777777777775433334444 346666666666654333 35555666666666665 3444444555556666666
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
++++|++++..|..+..+++|++|++++|+++......+..+++|+.|++++|.+++..+..+..
T Consensus 180 ~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~--------------- 244 (353)
T 2z80_A 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST--------------- 244 (353)
T ss_dssp EEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-------------------
T ss_pred ECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc---------------
Confidence 66666665555555555566666666666554222222334555555555555555433332221
Q ss_pred CCCCcccccCcCCcEEEeecCccCC----CCCCCcCCCCCcceeeccCceeeccCCcc-cccccccceEEecccCCCCCC
Q 005278 244 GSLPSNIQNLKVLTNLDLSRNQLSG----DIPTTIGGLENLETLSLADNQFQGPVPKS-FGSLISLESLDLSRNNLSGEI 318 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~ 318 (704)
....+.++.+++++|.+++ .+|..+..+++|+.|++++|+++ .+|.. |..+++|+.|++++|++.+..
T Consensus 245 ------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 245 ------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp --------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 1123345555555555543 24455566666666666666666 34433 466666666666666666654
Q ss_pred C
Q 005278 319 P 319 (704)
Q Consensus 319 p 319 (704)
|
T Consensus 318 ~ 318 (353)
T 2z80_A 318 P 318 (353)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-29 Score=268.87 Aligned_cols=276 Identities=27% Similarity=0.376 Sum_probs=185.9
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
..++|+.|++++|.+++ +|.. .++|++|++++|.++++... .++|++|++++|.++.++ .+.+
T Consensus 89 ~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~----~~~L~~L~L~~n~l~~lp---------~~~~ 151 (454)
T 1jl5_A 89 LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYLGVSNNQLEKLP---------ELQN 151 (454)
T ss_dssp CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEEECCSSCCSSCC---------CCTT
T ss_pred CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCC----CCCCCEEECcCCCCCCCc---------ccCC
Confidence 34667788888887775 5543 36777777777777753221 257888888888877643 2788
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
+++|++|++++|++++ +|..+ .+|++|++++|++++ +| .++++++|++|++++|.+++ +|.. .++|++|
T Consensus 152 l~~L~~L~l~~N~l~~-lp~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L 220 (454)
T 1jl5_A 152 SSFLKIIDVDNNSLKK-LPDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESI 220 (454)
T ss_dssp CTTCCEEECCSSCCSC-CCCCC----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEE
T ss_pred CCCCCEEECCCCcCcc-cCCCc----ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEE
Confidence 8888888888888875 34322 368888888888886 45 58888888888888888874 3332 2477888
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
++++|+++ .+| .+..+++|++|++++|++++ +|.. +++|+.|++++|.+++ +|.. +++|++|++++|.++
T Consensus 221 ~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~ 290 (454)
T 1jl5_A 221 VAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFS 290 (454)
T ss_dssp ECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred ECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccC
Confidence 88888877 556 47777888888888887774 4432 2567777777776664 3322 245555555555554
Q ss_pred C--CCCcc-------------cccC-cCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceE
Q 005278 244 G--SLPSN-------------IQNL-KVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESL 307 (704)
Q Consensus 244 ~--~~~~~-------------~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 307 (704)
+ ..|.. +..+ ++|+.|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|+.|
T Consensus 291 ~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L 362 (454)
T 1jl5_A 291 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQL 362 (454)
T ss_dssp EESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEE
T ss_pred cccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEE
Confidence 3 22211 1122 477888888888874 5543 577888888888887 4665 46778888
Q ss_pred EecccCCCC--CCCCCcccc
Q 005278 308 DLSRNNLSG--EIPKNFSAQ 325 (704)
Q Consensus 308 ~l~~N~l~~--~~p~~~~~~ 325 (704)
++++|++++ .+|..+..+
T Consensus 363 ~L~~N~l~~l~~ip~~l~~L 382 (454)
T 1jl5_A 363 HVEYNPLREFPDIPESVEDL 382 (454)
T ss_dssp ECCSSCCSSCCCCCTTCCEE
T ss_pred ECCCCCCCcCCCChHHHHhh
Confidence 888888887 677666555
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=260.96 Aligned_cols=252 Identities=21% Similarity=0.232 Sum_probs=213.7
Q ss_pred CEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhccccc
Q 005278 33 IMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASL 112 (704)
Q Consensus 33 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L 112 (704)
+.++++++.++.+ |..+ .++|++|+|++|.++.++... |.++++|++|+|++|++...
T Consensus 10 ~~l~c~~~~l~~i-p~~~--~~~l~~L~L~~n~l~~i~~~~-------~~~l~~L~~L~L~~n~l~~~------------ 67 (306)
T 2z66_A 10 TEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGV-------FDKLTQLTKLSLSSNGLSFK------------ 67 (306)
T ss_dssp TEEECCSSCCSSC-CSCC--CTTCCEEECCSSCCCCCCTTT-------TTTCTTCSEEECCSSCCCEE------------
T ss_pred CEEEcCCCCcccC-CCCC--CCCCCEEECCCCccCccCHhH-------hhccccCCEEECCCCccCcc------------
Confidence 4677777777744 3322 256777777777777655443 66777777777777776522
Q ss_pred ceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCC-ccccCCCCCCEEEcCC
Q 005278 113 QEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIP-YDLCHLEGLSELNLNG 191 (704)
Q Consensus 113 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~ 191 (704)
+..+..+..+++|++|+|++|.+. .++..+..+++|++|++++|++++..+ ..+..+++|++|++++
T Consensus 68 -----------~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~ 135 (306)
T 2z66_A 68 -----------GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135 (306)
T ss_dssp -----------EEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTT
T ss_pred -----------cCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCC
Confidence 123456677899999999999998 567779999999999999999996554 5799999999999999
Q ss_pred CcCCccCCccccCcCCCCEEEecCccCCC-CCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCC
Q 005278 192 NKLCGHVPPCLASLTSLRRLHLGSNKLTS-TMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDI 270 (704)
Q Consensus 192 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 270 (704)
|.+++..+..+..+++|+.|++++|.+++ ..|..+..+++|++|++++|.+++..|..+..+++|+.|++++|++++..
T Consensus 136 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 215 (306)
T 2z66_A 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 215 (306)
T ss_dssp SCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred CcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence 99998888899999999999999999986 57889999999999999999999888999999999999999999999777
Q ss_pred CCCcCCCCCcceeeccCceeeccCCccccccc-ccceEEecccCCCCCC
Q 005278 271 PTTIGGLENLETLSLADNQFQGPVPKSFGSLI-SLESLDLSRNNLSGEI 318 (704)
Q Consensus 271 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~ 318 (704)
+..+..+++|+.|++++|++++..|..+..++ +|+.|++++|++++..
T Consensus 216 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp SGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred hhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 77899999999999999999999999999985 9999999999998754
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=271.76 Aligned_cols=253 Identities=19% Similarity=0.133 Sum_probs=193.8
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeec
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL 165 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 165 (704)
+|++|+|++|++++..+..+..+ ++|++|++++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|++
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRC-VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred cCcEEECCCCcCcccCHHHhccC-CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 44555555555544433344443 24555555555555566667888889999999999998666666889999999999
Q ss_pred cCcccCCCCC-ccccCCCCCCEEEcCCC-cCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 166 HGNKLQGSIP-YDLCHLEGLSELNLNGN-KLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 166 ~~n~l~~~~~-~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
++|++++..+ ..+..+++|++|++++| .+++..+..+..+++|+.|++++|.+++..+..+..+++|++|++++|.+.
T Consensus 132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 9999984433 37888999999999998 477666778999999999999999999888999999999999999999987
Q ss_pred CCCCcccccCcCCcEEEeecCccCCCCCCCcC---CCCCcceeeccCceeec----cCCcccccccccceEEecccCCCC
Q 005278 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIG---GLENLETLSLADNQFQG----PVPKSFGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~---~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~~ 316 (704)
......+..+++|+.|++++|++++..+..+. ....++.++|++|.+++ .+|..+..+++|+.|++++|+++.
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~ 291 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS 291 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc
Confidence 44444455689999999999999976555443 46778889999998876 577888999999999999999994
Q ss_pred CCCCCcccccccCcccccCCCcc
Q 005278 317 EIPKNFSAQSFLSNYALCGPARL 339 (704)
Q Consensus 317 ~~p~~~~~~~~l~~~~l~g~~~~ 339 (704)
..+..|...+.+....+.+++..
T Consensus 292 i~~~~~~~l~~L~~L~L~~N~~~ 314 (353)
T 2z80_A 292 VPDGIFDRLTSLQKIWLHTNPWD 314 (353)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCHHHHhcCCCCCEEEeeCCCcc
Confidence 43334678888888888888743
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=260.53 Aligned_cols=233 Identities=22% Similarity=0.296 Sum_probs=122.9
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
++++.|+|++|.++ .+|..+.++++|++|+|++|.++ .+|..|.++++|++|+|++|.++.+ +..+.+++
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~l--------p~~l~~l~ 150 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRAL--------PASIASLN 150 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCC--------CGGGGGCT
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccC--------cHHHhcCc
Confidence 45555555555555 44555555555555555555555 4455555555555555555555432 22255555
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeec
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL 165 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 165 (704)
+|++|+|++|++.+.+|..+... ..+..+.++++|++|+|++|.++ .+|..++.+++|++|+|
T Consensus 151 ~L~~L~L~~n~~~~~~p~~~~~~----------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L 213 (328)
T 4fcg_A 151 RLRELSIRACPELTELPEPLAST----------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213 (328)
T ss_dssp TCCEEEEEEETTCCCCCSCSEEE----------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEE
T ss_pred CCCEEECCCCCCccccChhHhhc----------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEc
Confidence 55555555555544444333221 11122344556666666666555 45555555555666666
Q ss_pred cCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCC
Q 005278 166 HGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245 (704)
Q Consensus 166 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 245 (704)
++|+++ .+|..+..+++|++|+|++|.+.+.+|..+..+++|+.|++++|.+.+.+|..+..+++|++|+|++|.+.+.
T Consensus 214 ~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 292 (328)
T 4fcg_A 214 RNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292 (328)
T ss_dssp ESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred cCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence 655555 3444555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred CCcccccCcCCcEEEeecCcc
Q 005278 246 LPSNIQNLKVLTNLDLSRNQL 266 (704)
Q Consensus 246 ~~~~~~~l~~L~~L~l~~n~l 266 (704)
+|..++++++|+.+++..|.+
T Consensus 293 iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 293 LPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp CCGGGGGSCTTCEEECCGGGS
T ss_pred ccHHHhhccCceEEeCCHHHH
Confidence 555555555555555444443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=267.82 Aligned_cols=247 Identities=24% Similarity=0.281 Sum_probs=138.1
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCC
Q 005278 8 LKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNL 87 (704)
Q Consensus 8 l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L 87 (704)
.+.++..++.++ .+|..+. ++++.|+|++|.++++.+..|.++++|++|+|++|.++.+.... |.++++|
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~-------~~~l~~L 114 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGA-------FNGLANL 114 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGG-------GTTCSSC
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhh-------ccCCccC
Confidence 345555555555 4454443 45666666666666555556666666666666666665544333 5555666
Q ss_pred cEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccC
Q 005278 88 TVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHG 167 (704)
Q Consensus 88 ~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 167 (704)
++|+|++|+++.. .+..|..+++|++|+|++|.+....+..|..+++|++|+|++
T Consensus 115 ~~L~L~~n~l~~~-------------------------~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~ 169 (440)
T 3zyj_A 115 NTLELFDNRLTTI-------------------------PNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGE 169 (440)
T ss_dssp CEEECCSSCCSSC-------------------------CTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCC
T ss_pred CEEECCCCcCCee-------------------------CHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCC
Confidence 6666666655543 334455555555555555555544444555555555555555
Q ss_pred c-ccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCC
Q 005278 168 N-KLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSL 246 (704)
Q Consensus 168 n-~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 246 (704)
| .+....+..|.++++|++|+|++|+++ .+| .+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|.+++..
T Consensus 170 ~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 247 (440)
T 3zyj_A 170 LKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIE 247 (440)
T ss_dssp CTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred CCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEC
Confidence 2 233222334555555555555555555 333 2455555666666666555555555555666666666666665555
Q ss_pred CcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 247 PSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 247 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 248 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred hhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 555666666666666666666555555566666666666666655
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=257.51 Aligned_cols=268 Identities=25% Similarity=0.303 Sum_probs=186.2
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCc
Q 005278 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLT 88 (704)
Q Consensus 9 ~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~ 88 (704)
+.++++++.++ .+|..+ .++|++|+|++|.++++.+..|.++++|++|+|++|.++.+.... |..+++|+
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~-------~~~l~~L~ 83 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA-------FTGLALLE 83 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT-------TTTCTTCC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhh-------cCCccCCC
Confidence 57788888887 556543 467888888888888777777888888888888888877654433 77778888
Q ss_pred EEEccCCC-CcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccC
Q 005278 89 VLGLASNP-LRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHG 167 (704)
Q Consensus 89 ~L~L~~n~-i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 167 (704)
+|+|++|+ +.... +..+..+++|++|++++|.+.+..+..|..+++|++|++++
T Consensus 84 ~L~l~~n~~l~~~~-------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 138 (285)
T 1ozn_A 84 QLDLSDNAQLRSVD-------------------------PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138 (285)
T ss_dssp EEECCSCTTCCCCC-------------------------TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EEeCCCCCCccccC-------------------------HHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCC
Confidence 88888876 55333 44555666777777777777766666777777777777777
Q ss_pred cccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCC
Q 005278 168 NKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLP 247 (704)
Q Consensus 168 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 247 (704)
|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|.+++..+..|..+++|+.|++++|.+++..+
T Consensus 139 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 218 (285)
T 1ozn_A 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (285)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred CcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCH
Confidence 77775555567777777777777777775555567777777777777777777667777777777777777777776655
Q ss_pred cccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCccccc--ccccceEEeccc
Q 005278 248 SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGS--LISLESLDLSRN 312 (704)
Q Consensus 248 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~--l~~L~~L~l~~N 312 (704)
..+..+++|+.|++++|++....+. ..-+..++.+..+.+.+.+..|..+.+ +..++..++.+|
T Consensus 219 ~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~C 284 (285)
T 1ozn_A 219 EALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC 284 (285)
T ss_dssp HHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCCC
T ss_pred HHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhCCcChhhcCHHHhccC
Confidence 6677777888888888877643221 112234556667777777777777654 344444444443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-33 Score=301.87 Aligned_cols=331 Identities=18% Similarity=0.177 Sum_probs=253.5
Q ss_pred CCCCCCEEecCCCcCcc----cCCccccCCCCCCEEeccCccccccCchhh-cCCC----CCCEEecccccCCCcccchh
Q 005278 4 MLPNLKYLTLFDNKLSG----TIPNSITNASKLIMLDLSSNSFSGLIPNTF-GNLG----SLQVLSLAYNYLMTESSAAK 74 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~----~L~~L~L~~n~i~~~~~~~~ 74 (704)
.+++|+.|+|++|.+++ .++..+..+++|++|+|++|.+++..+..+ ..++ +|++|+|++|.++..+...
T Consensus 26 ~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~- 104 (461)
T 1z7x_W 26 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV- 104 (461)
T ss_dssp HHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHH-
T ss_pred hcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHH-
Confidence 46889999999999884 356778888999999999999987655444 3466 6999999999988654322
Q ss_pred hcccccCCCCCCCcEEEccCCCCcccCChhhhhc----ccccceEEecCCccccc----CChhhhcCCCCCEEEccCCcC
Q 005278 75 WNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNF----SASLQEFYAYGCKLRGN----IPQEIGNLSGMIVFDLNGCDL 146 (704)
Q Consensus 75 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~----~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l 146 (704)
++..+..+++|++|+|++|++.+..+..++.. ..+|++|++++|++++. ++..+..+++|++|++++|.+
T Consensus 105 --l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i 182 (461)
T 1z7x_W 105 --LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182 (461)
T ss_dssp --HHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred --HHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCc
Confidence 45568899999999999999987766666553 23699999999999874 466677889999999999998
Q ss_pred ccccChhhc-----CCCCcCeeeccCcccCCC----CCccccCCCCCCEEEcCCCcCCccC-----CccccCcCCCCEEE
Q 005278 147 NGTIPTAVG-----RLRRLQGLYLHGNKLQGS----IPYDLCHLEGLSELNLNGNKLCGHV-----PPCLASLTSLRRLH 212 (704)
Q Consensus 147 ~~~~~~~~~-----~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~ 212 (704)
....+..+. ..++|++|++++|.+++. ++..+..+++|++|++++|.+++.. +..+..+++|+.|+
T Consensus 183 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~ 262 (461)
T 1z7x_W 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262 (461)
T ss_dssp HHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred chHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEE
Confidence 765554444 367999999999999854 4667778899999999999987532 22334578999999
Q ss_pred ecCccCCCC----CCCcccCCccccEEEecCcccCCCCCccccc-----CcCCcEEEeecCccCCC----CCCCcCCCCC
Q 005278 213 LGSNKLTST----MPSSFGSLEYVLYINLSANSLNGSLPSNIQN-----LKVLTNLDLSRNQLSGD----IPTTIGGLEN 279 (704)
Q Consensus 213 l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~n~l~~~----~~~~~~~l~~ 279 (704)
+++|.++.. ++..+..+++|++|++++|.+.+..+..+.. .++|+.|++++|.+++. ++..+..+++
T Consensus 263 L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~ 342 (461)
T 1z7x_W 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342 (461)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSS
T ss_pred CcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCC
Confidence 999998853 4566777899999999999887554444443 26899999999998865 4556677899
Q ss_pred cceeeccCceeeccCCccccc-----ccccceEEecccCCCC----CCCCCcccccccCcccccCCC
Q 005278 280 LETLSLADNQFQGPVPKSFGS-----LISLESLDLSRNNLSG----EIPKNFSAQSFLSNYALCGPA 337 (704)
Q Consensus 280 L~~L~L~~n~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~----~~p~~~~~~~~l~~~~l~g~~ 337 (704)
|+.|++++|.+++..+..+.. .++|+.|++++|++++ .+|..+...+.+....+.+++
T Consensus 343 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred ccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 999999999998766655543 6789999999999875 556555555666666666654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=267.64 Aligned_cols=247 Identities=24% Similarity=0.245 Sum_probs=139.6
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCC
Q 005278 8 LKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNL 87 (704)
Q Consensus 8 l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L 87 (704)
.+.++.+++.++ .+|..+. ++|+.|+|++|.++++.+..|.++++|++|+|++|.|+.+.... |.++++|
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~-------~~~l~~L 125 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGA-------FNGLASL 125 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT-------TTTCTTC
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhh-------ccCcccC
Confidence 345666666666 4555443 56666666666666666666666666666666666666554333 6666666
Q ss_pred cEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccC
Q 005278 88 TVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHG 167 (704)
Q Consensus 88 ~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 167 (704)
++|+|++|+++...+ ..|.++++|++|+|++|.++...+..|.++++|+.|++++
T Consensus 126 ~~L~L~~n~l~~~~~-------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 180 (452)
T 3zyi_A 126 NTLELFDNWLTVIPS-------------------------GAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE 180 (452)
T ss_dssp CEEECCSSCCSBCCT-------------------------TTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCC
T ss_pred CEEECCCCcCCccCh-------------------------hhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCC
Confidence 666666666664433 3444455555555555555544444555555555555555
Q ss_pred -cccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCC
Q 005278 168 -NKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSL 246 (704)
Q Consensus 168 -n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 246 (704)
|.++...+..|.++++|++|+|++|++++ +| .+..+++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+..
T Consensus 181 ~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 258 (452)
T 3zyi_A 181 LKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258 (452)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEEC
T ss_pred CCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceEC
Confidence 23332222345555555555555555552 22 2445555555555555555555555555555555555555555555
Q ss_pred CcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 247 PSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 247 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 259 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred HHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 555555666666666666666545555556666666666666655
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-31 Score=271.33 Aligned_cols=268 Identities=21% Similarity=0.222 Sum_probs=191.6
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCC
Q 005278 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86 (704)
Q Consensus 7 ~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~ 86 (704)
.++.++++.+.+.......+..+++|++|+|++|.++++.+..|.++++|++|+|++|.++.... +..+++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---------~~~l~~ 81 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---------LESLST 81 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE---------ETTCTT
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh---------hhhcCC
Confidence 35666777777776655666667788888888888888777888888888888888888765331 677788
Q ss_pred CcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeecc
Q 005278 87 LTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLH 166 (704)
Q Consensus 87 L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 166 (704)
|++|+|++|++++.. ..++|++|++++|.+++..+. .+++|++|+++
T Consensus 82 L~~L~Ls~n~l~~l~------------------------------~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~ 128 (317)
T 3o53_A 82 LRTLDLNNNYVQELL------------------------------VGPSIETLHAANNNISRVSCS---RGQGKKNIYLA 128 (317)
T ss_dssp CCEEECCSSEEEEEE------------------------------ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECC
T ss_pred CCEEECcCCcccccc------------------------------CCCCcCEEECCCCccCCcCcc---ccCCCCEEECC
Confidence 888888888776332 124566666666666544332 24566666777
Q ss_pred CcccCCCCCccccCCCCCCEEEcCCCcCCccCCccc-cCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCC
Q 005278 167 GNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCL-ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245 (704)
Q Consensus 167 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 245 (704)
+|++++..+..+..+++|++|+|++|.+++..+..+ ..+++|+.|++++|.+++. + ....+++|++|++++|.+++
T Consensus 129 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~- 205 (317)
T 3o53_A 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF- 205 (317)
T ss_dssp SSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-
T ss_pred CCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-
Confidence 777665555566666777777777777765555544 3567777777777777644 2 22247778888888888774
Q ss_pred CCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee-ccCCcccccccccceEEeccc-CCCCCCCC
Q 005278 246 LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ-GPVPKSFGSLISLESLDLSRN-NLSGEIPK 320 (704)
Q Consensus 246 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~ 320 (704)
+|..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|++. +.+|..+..+++|+.+++++| .+.|..|.
T Consensus 206 l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 4445788888999999999998 67788889999999999999998 778888899999999999844 45555443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-29 Score=252.32 Aligned_cols=237 Identities=21% Similarity=0.194 Sum_probs=157.5
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCc-CccccChhhcCCCCcCeee
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCD-LNGTIPTAVGRLRRLQGLY 164 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~ 164 (704)
+|++|+|++|+++...+..|..+. +|++|++++|.+++..+..+.++++|++|++++|. +....+..|..+++|++|+
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CceEEEeeCCcCCccCHHHcccCC-CCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 344444444444433333333321 34444444444444455666777778888888876 6656677777788888888
Q ss_pred ccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCC
Q 005278 165 LHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244 (704)
Q Consensus 165 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 244 (704)
+++|++++..|..+..+++|++|++++|++++..+..+..+++|+.|++++|.+++..+..|..+++|++|++++|.+.+
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 88888876667777777888888888888776555667777788888888887776666667777788888888887777
Q ss_pred CCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCCccc
Q 005278 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSA 324 (704)
Q Consensus 245 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 324 (704)
..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|++....+.. .-...++.+..+.|.+.+..|+.+..
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhCC
Confidence 77777777777888888888777655566777777778888877777433221 22234555566677777666665443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=268.20 Aligned_cols=270 Identities=23% Similarity=0.238 Sum_probs=176.4
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCC-------------CEEecccccCCCcc
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSL-------------QVLSLAYNYLMTES 70 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-------------~~L~L~~n~i~~~~ 70 (704)
+.++|+.|++++|++ +.+|.+|+++++|++|++++|.+++..|..++++++| ++|++++|.++.++
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp 87 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLP 87 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCC
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCC
Confidence 457899999999999 5899999999999999999999999999999888864 89999999887754
Q ss_pred cchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCcccc
Q 005278 71 SAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTI 150 (704)
Q Consensus 71 ~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 150 (704)
. -.++|++|++++|.+++ +|.. ..+|++|++++|++++. +.. .++|++|++++|.+++ +
T Consensus 88 ~-----------~~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-l 146 (454)
T 1jl5_A 88 E-----------LPPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-L 146 (454)
T ss_dssp S-----------CCTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-C
T ss_pred C-----------CcCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-C
Confidence 2 12678888888888886 4432 24688888888877742 211 1578888888888875 5
Q ss_pred ChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCc
Q 005278 151 PTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLE 230 (704)
Q Consensus 151 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 230 (704)
| .|+++++|++|++++|++++ +|..+ ++|++|++++|++++ +| .+..+++|+.|++++|.+++ +|... +
T Consensus 147 p-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~ 215 (454)
T 1jl5_A 147 P-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---L 215 (454)
T ss_dssp C-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---T
T ss_pred c-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---C
Confidence 5 47788888888888888874 55433 478888888888875 45 47778888888888888774 33322 4
Q ss_pred cccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEec
Q 005278 231 YVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLS 310 (704)
Q Consensus 231 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~ 310 (704)
+|++|++++|.+. .+| .++.+++|+.|++++|++++ +|.. +++|+.|++++|++++ +|.. .++|+.|+++
T Consensus 216 ~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls 285 (454)
T 1jl5_A 216 SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVS 285 (454)
T ss_dssp TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred cccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECc
Confidence 7777888888777 555 37777778888888887774 4432 3677777777777774 4443 3567777777
Q ss_pred ccCCCC
Q 005278 311 RNNLSG 316 (704)
Q Consensus 311 ~N~l~~ 316 (704)
+|++++
T Consensus 286 ~N~l~~ 291 (454)
T 1jl5_A 286 ENIFSG 291 (454)
T ss_dssp SSCCSE
T ss_pred CCccCc
Confidence 777766
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=265.87 Aligned_cols=252 Identities=20% Similarity=0.202 Sum_probs=218.1
Q ss_pred CCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCC
Q 005278 55 SLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLS 134 (704)
Q Consensus 55 ~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 134 (704)
....++.+++.++.++.. + .++|++|+|++|+|.+..+..|..+. +|++|+|++|.+++..+..|.+++
T Consensus 55 ~~~~v~c~~~~l~~iP~~--------~--~~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~ 123 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQG--------I--PSNTRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIRQIEVGAFNGLA 123 (452)
T ss_dssp SSCEEECCSSCCSSCCSC--------C--CTTCSEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCT
T ss_pred CCcEEEECCCCcCccCCC--------C--CCCccEEECcCCcCceECHHHcCCCC-CCCEEECCCCccCCcChhhccCcc
Confidence 356777777777765532 2 25778888888888877777777764 688888888888888888999999
Q ss_pred CCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCC-CcCCccCCccccCcCCCCEEEe
Q 005278 135 GMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG-NKLCGHVPPCLASLTSLRRLHL 213 (704)
Q Consensus 135 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l 213 (704)
+|++|+|++|.++...+..|..+++|++|+|++|+|+...+..|..+++|++|+|++ |.+....+..|..+++|+.|++
T Consensus 124 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L 203 (452)
T 3zyi_A 124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203 (452)
T ss_dssp TCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEEC
T ss_pred cCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEEC
Confidence 999999999999988888899999999999999999977777899999999999999 4565444567999999999999
Q ss_pred cCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeecc
Q 005278 214 GSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGP 293 (704)
Q Consensus 214 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 293 (704)
++|.+++. ..+..+++|+.|+|++|.+.+..|..|.++++|+.|++++|++++..+..|.++++|+.|+|++|++++.
T Consensus 204 ~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 281 (452)
T 3zyi_A 204 GMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSL 281 (452)
T ss_dssp TTSCCSSC--CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCccccc--ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCcc
Confidence 99999854 3588999999999999999988899999999999999999999988899999999999999999999987
Q ss_pred CCcccccccccceEEecccCCCCCCC
Q 005278 294 VPKSFGSLISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 294 ~p~~~~~l~~L~~L~l~~N~l~~~~p 319 (704)
.+..+..+++|+.|++++|++.+...
T Consensus 282 ~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 282 PHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred ChHHhccccCCCEEEccCCCcCCCCC
Confidence 77888999999999999999986543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=255.60 Aligned_cols=225 Identities=20% Similarity=0.258 Sum_probs=171.1
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeee
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLY 164 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 164 (704)
+++++|+|++|++. .+|..+..+ ++|++|+|++|.++ .+|..++++++|++|+|++|.+. .+|..++.+++|++|+
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l-~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRL-SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGG-TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred cceeEEEccCCCch-hcChhhhhC-CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 45555555555555 344444443 34555555555555 55666677777777777777777 5677777777777777
Q ss_pred ccCcccCCCCCccccC---------CCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEE
Q 005278 165 LHGNKLQGSIPYDLCH---------LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYI 235 (704)
Q Consensus 165 L~~n~l~~~~~~~l~~---------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 235 (704)
|++|++.+.+|..+.. +++|++|+|++|+++ .+|..+..+++|+.|++++|.+++ +|..+..+++|++|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE
Confidence 7777766667766554 888888888888888 777778888888888888888884 55678888888888
Q ss_pred EecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCC
Q 005278 236 NLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315 (704)
Q Consensus 236 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 315 (704)
++++|.+.+.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 88888888888888888888888888888888888888888888888888888888888888888888888888877665
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=264.00 Aligned_cols=250 Identities=20% Similarity=0.233 Sum_probs=208.2
Q ss_pred CCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCC
Q 005278 56 LQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSG 135 (704)
Q Consensus 56 L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 135 (704)
.+.++.+++.++.++.. + .++++.|+|++|++....+..|..+. +|++|+|++|.+++..+..|.++++
T Consensus 45 ~~~v~c~~~~l~~iP~~--------~--~~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~i~~~~~~~l~~ 113 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDG--------I--STNTRLLNLHENQIQIIKVNSFKHLR-HLEILQLSRNHIRTIEIGAFNGLAN 113 (440)
T ss_dssp SCEEECCSCCCSSCCSC--------C--CTTCSEEECCSCCCCEECTTTTSSCS-SCCEEECCSSCCCEECGGGGTTCSS
T ss_pred CCEEEeCCCCcCcCCCC--------C--CCCCcEEEccCCcCCeeCHHHhhCCC-CCCEEECCCCcCCccChhhccCCcc
Confidence 45566666666554432 1 14566666666666666556665553 5666666667666677788999999
Q ss_pred CCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCC-cCCccCCccccCcCCCCEEEec
Q 005278 136 MIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGN-KLCGHVPPCLASLTSLRRLHLG 214 (704)
Q Consensus 136 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~ 214 (704)
|++|+|++|.++...+..|..+++|++|+|++|+|+...+..|..+++|++|+|++| .+....+..|.++++|+.|+++
T Consensus 114 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~ 193 (440)
T 3zyj_A 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193 (440)
T ss_dssp CCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECT
T ss_pred CCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCC
Confidence 999999999999777778999999999999999999777778999999999999995 5554455679999999999999
Q ss_pred CccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccC
Q 005278 215 SNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294 (704)
Q Consensus 215 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 294 (704)
+|.++. +| .+..+++|+.|+|++|.+++..+..|.++++|+.|++++|++++..+..|.++++|+.|+|++|++++..
T Consensus 194 ~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 271 (440)
T 3zyj_A 194 MCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP 271 (440)
T ss_dssp TSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCC
T ss_pred CCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccC
Confidence 999984 44 5889999999999999999888999999999999999999999888999999999999999999999877
Q ss_pred CcccccccccceEEecccCCCCCC
Q 005278 295 PKSFGSLISLESLDLSRNNLSGEI 318 (704)
Q Consensus 295 p~~~~~l~~L~~L~l~~N~l~~~~ 318 (704)
+..|..+++|+.|+|++|++.+..
T Consensus 272 ~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 272 HDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp TTTTSSCTTCCEEECCSSCEECSS
T ss_pred hhHhccccCCCEEEcCCCCccCCC
Confidence 888899999999999999998643
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-28 Score=269.68 Aligned_cols=268 Identities=25% Similarity=0.349 Sum_probs=226.1
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCC
Q 005278 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86 (704)
Q Consensus 7 ~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~ 86 (704)
+++.|++++|+++ .+|..+. ++|++|+|++|.++.+.+ .+++|++|+|++|+++.++. .+++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~-----------~l~~ 102 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSLPV-----------LPPG 102 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSCCCC-----------CCTT
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCcCCC-----------CCCC
Confidence 5899999999999 7788776 899999999999996544 58999999999999987542 5789
Q ss_pred CcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeecc
Q 005278 87 LTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLH 166 (704)
Q Consensus 87 L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 166 (704)
|++|+|++|++++..+ ...+|+.|++++|++++ +|.. +++|++|+|++|.+++ +|. .+++|+.|+++
T Consensus 103 L~~L~Ls~N~l~~l~~-----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~ 169 (622)
T 3g06_A 103 LLELSIFSNPLTHLPA-----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAY 169 (622)
T ss_dssp CCEEEECSCCCCCCCC-----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCEEECcCCcCCCCCC-----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECC
Confidence 9999999999996433 34689999999999986 4443 5899999999999995 443 35789999999
Q ss_pred CcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCC
Q 005278 167 GNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSL 246 (704)
Q Consensus 167 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 246 (704)
+|+|++ +| ..+++|+.|+|++|.+++ +|.. +++|+.|++++|.++. +|.. +++|+.|++++|.+++ +
T Consensus 170 ~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-l 236 (622)
T 3g06_A 170 NNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-L 236 (622)
T ss_dssp SSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-C
T ss_pred CCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-C
Confidence 999994 56 456899999999999994 5543 4799999999999984 4433 4789999999999995 5
Q ss_pred CcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCCCccccc
Q 005278 247 PSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQS 326 (704)
Q Consensus 247 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 326 (704)
| ..+++|+.|++++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..+..+.
T Consensus 237 p---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 237 P---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp C---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred C---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 5 45688999999999999 5665 6789999999999999 7899999999999999999999988887655444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-31 Score=287.97 Aligned_cols=310 Identities=21% Similarity=0.192 Sum_probs=247.4
Q ss_pred CCCCCCEEecCCCcCcccCCcccc-CCC----CCCEEeccCccccc----cCchhhcCCCCCCEEecccccCCCcccchh
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSIT-NAS----KLIMLDLSSNSFSG----LIPNTFGNLGSLQVLSLAYNYLMTESSAAK 74 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~-~l~----~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 74 (704)
.+++|++|+|++|.+++..+..+. .++ +|++|+|++|.+++ ..+..|..+++|++|+|++|.++......
T Consensus 54 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~- 132 (461)
T 1z7x_W 54 VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL- 132 (461)
T ss_dssp TCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH-
T ss_pred hCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHH-
Confidence 468999999999999865444333 355 79999999999995 45888999999999999999987654332
Q ss_pred hccccc-CCCCCCCcEEEccCCCCcccCC----hhhhhcccccceEEecCCcccccCChhhhc-----CCCCCEEEccCC
Q 005278 75 WNFLSS-LTNCRNLTVLGLASNPLRGILP----PLIGNFSASLQEFYAYGCKLRGNIPQEIGN-----LSGMIVFDLNGC 144 (704)
Q Consensus 75 ~~~~~~-~~~l~~L~~L~L~~n~i~~~~~----~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~L~L~~n 144 (704)
+... +...++|++|+|++|++++... ..+..+ ++|++|++++|.++...+..+.. .++|++|++++|
T Consensus 133 --l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~-~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 209 (461)
T 1z7x_W 133 --LCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAK-PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESC 209 (461)
T ss_dssp --HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHC-TTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTS
T ss_pred --HHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhC-CCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCC
Confidence 2222 3346789999999999997654 333443 48999999999998765555543 679999999999
Q ss_pred cCccc----cChhhcCCCCcCeeeccCcccCCCC-----CccccCCCCCCEEEcCCCcCCcc----CCccccCcCCCCEE
Q 005278 145 DLNGT----IPTAVGRLRRLQGLYLHGNKLQGSI-----PYDLCHLEGLSELNLNGNKLCGH----VPPCLASLTSLRRL 211 (704)
Q Consensus 145 ~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~-----~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L 211 (704)
.++.. ++..+..+++|++|++++|++++.. +..+..+++|++|++++|.+++. ++..+..+++|+.|
T Consensus 210 ~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L 289 (461)
T 1z7x_W 210 GVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289 (461)
T ss_dssp CCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEE
T ss_pred CCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceE
Confidence 99864 5778888999999999999988532 22233589999999999999954 56677789999999
Q ss_pred EecCccCCCCCCCcccC-----CccccEEEecCcccCCC----CCcccccCcCCcEEEeecCccCCCCCCCcCC-----C
Q 005278 212 HLGSNKLTSTMPSSFGS-----LEYVLYINLSANSLNGS----LPSNIQNLKVLTNLDLSRNQLSGDIPTTIGG-----L 277 (704)
Q Consensus 212 ~l~~n~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-----l 277 (704)
++++|.+++..+..+.. .++|++|++++|.+++. ++..+..+++|+.|++++|++++..+..+.. .
T Consensus 290 ~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 369 (461)
T 1z7x_W 290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG 369 (461)
T ss_dssp ECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred ECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCC
Confidence 99999987544333332 36999999999999865 4566777899999999999998655544442 6
Q ss_pred CCcceeeccCceeec----cCCcccccccccceEEecccCCCCC
Q 005278 278 ENLETLSLADNQFQG----PVPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 278 ~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
++|+.|+|++|.+++ .+|..+..+++|++|++++|++++.
T Consensus 370 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 370 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred CceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 799999999999996 7888899999999999999999753
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-30 Score=261.91 Aligned_cols=251 Identities=20% Similarity=0.232 Sum_probs=186.4
Q ss_pred hhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCc-ccCChhhh-------hcccccceEEecCC
Q 005278 49 TFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLR-GILPPLIG-------NFSASLQEFYAYGC 120 (704)
Q Consensus 49 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~-------~~~~~L~~L~l~~n 120 (704)
.++..++|++|++++|.+ .++.. +... |++|+|++|++. ...|..+. .+ ++|++|++++|
T Consensus 38 ~~~~~~~L~~l~l~~n~l-~~p~~--------~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l-~~L~~L~L~~n 105 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE-ADLGQ--------FTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGI-SGLQELTLENL 105 (312)
T ss_dssp EEEEEEECTTHHHHCCTT-CCCHH--------HHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTT-SCCCEEEEEEE
T ss_pred EEccCCCceeEeeccccc-ccHHH--------HHHH--HhhcccccccccCCCcCHHHHHHHHHhcCc-CCccEEEccCC
Confidence 345566677777777766 33321 1111 666677777663 33444443 23 36777777777
Q ss_pred cccccCChhh--hcCCCCCEEEccCCcCccccChhhcCC-----CCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCc
Q 005278 121 KLRGNIPQEI--GNLSGMIVFDLNGCDLNGTIPTAVGRL-----RRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNK 193 (704)
Q Consensus 121 ~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 193 (704)
++++.+|..+ ..+++|++|+|++|.+++. |..++.+ ++|++|+|++|++++..|..+..+++|++|+|++|+
T Consensus 106 ~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 184 (312)
T 1wwl_A 106 EVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184 (312)
T ss_dssp BCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCT
T ss_pred cccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCC
Confidence 7777777765 7888888888888888866 7777776 888888888888887777888888888888888888
Q ss_pred CCcc--CCccc--cCcCCCCEEEecCccCCCC---CCCcccCCccccEEEecCcccCCCCC-cccccCcCCcEEEeecCc
Q 005278 194 LCGH--VPPCL--ASLTSLRRLHLGSNKLTST---MPSSFGSLEYVLYINLSANSLNGSLP-SNIQNLKVLTNLDLSRNQ 265 (704)
Q Consensus 194 l~~~--~~~~~--~~l~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~n~ 265 (704)
+.+. .+..+ ..+++|+.|++++|.+++. ....+..+++|++|++++|.+++..| ..+..+++|+.|++++|+
T Consensus 185 l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~ 264 (312)
T 1wwl_A 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264 (312)
T ss_dssp TCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSC
T ss_pred cCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCc
Confidence 7754 23333 7888899999999888732 12334567889999999999887664 456678899999999999
Q ss_pred cCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCC
Q 005278 266 LSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 266 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
++ .+|..+. ++|+.|+|++|++++. |. +..+++|+.|++++|++++.
T Consensus 265 l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 265 LK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred cC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 98 7777776 8899999999999865 66 88999999999999998853
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-29 Score=255.77 Aligned_cols=257 Identities=20% Similarity=0.187 Sum_probs=185.1
Q ss_pred cccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhh-cccccCCCCCCCcEEEccCCCCcccCCh
Q 005278 25 SITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKW-NFLSSLTNCRNLTVLGLASNPLRGILPP 103 (704)
Q Consensus 25 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 103 (704)
.+.+.++|++|++++|.+ .+|..+... |++|+|++|.+......... .-...+.++++|++|+|++|++++..|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 345566777777777777 345544443 77777777777543322100 0000011567777777777777776666
Q ss_pred hh--hhcccccceEEecCCcccccCChhhhcC-----CCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCC--C
Q 005278 104 LI--GNFSASLQEFYAYGCKLRGNIPQEIGNL-----SGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGS--I 174 (704)
Q Consensus 104 ~~--~~~~~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~ 174 (704)
.+ ..+ ++|++|++++|++++. |..++.+ ++|++|+|++|.+.+..+..|+.+++|++|+|++|++.+. .
T Consensus 114 ~~~~~~l-~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 191 (312)
T 1wwl_A 114 PLLEATG-PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191 (312)
T ss_dssp CSSSCCS-CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHH
T ss_pred HHHHhcC-CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHH
Confidence 55 333 4677777777777766 6777766 8888888888888877778888888888888888887643 2
Q ss_pred Cccc--cCCCCCCEEEcCCCcCCcc---CCccccCcCCCCEEEecCccCCCCCC-CcccCCccccEEEecCcccCCCCCc
Q 005278 175 PYDL--CHLEGLSELNLNGNKLCGH---VPPCLASLTSLRRLHLGSNKLTSTMP-SSFGSLEYVLYINLSANSLNGSLPS 248 (704)
Q Consensus 175 ~~~l--~~l~~L~~L~L~~n~l~~~---~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~ 248 (704)
+..+ ..+++|++|+|++|++++. ....+..+++|+.|++++|.+++..| ..+..+++|++|++++|.++ .+|.
T Consensus 192 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~ 270 (312)
T 1wwl_A 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK 270 (312)
T ss_dssp HHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCS
T ss_pred HHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhh
Confidence 3333 7788899999999988831 22344577889999999999887664 45667888999999999988 6777
Q ss_pred ccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeec
Q 005278 249 NIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292 (704)
Q Consensus 249 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 292 (704)
.+. ++|+.|++++|++++. |. +..+++|+.|+|++|++++
T Consensus 271 ~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 271 GLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp SCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 666 7899999999999855 65 8889999999999998875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-29 Score=258.19 Aligned_cols=246 Identities=21% Similarity=0.217 Sum_probs=156.9
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.+++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..+ |..+++|++|+|++|.++.++ .
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~------------~ 97 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL------------V 97 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE------------E
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc------------C
Confidence 46799999999999998888899999999999999999997765 999999999999999987643 3
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhh-cCCCCcCe
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQG 162 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~ 162 (704)
.++|++|++++|++.+..+..+ ++|++|++++|++++..+..++.+++|++|+|++|.+++..+..+ ..+++|++
T Consensus 98 ~~~L~~L~l~~n~l~~~~~~~~----~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 173 (317)
T 3o53_A 98 GPSIETLHAANNNISRVSCSRG----QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173 (317)
T ss_dssp CTTCCEEECCSSCCSEEEECCC----SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCE
T ss_pred CCCcCEEECCCCccCCcCcccc----CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCE
Confidence 4899999999999986544321 245666666666655555555555555555555555554444443 24555555
Q ss_pred eeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCccc
Q 005278 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242 (704)
Q Consensus 163 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 242 (704)
|+|++|+|++. + ....+++|++|+|++|++++ +|..+..+++|+.|++++|.++
T Consensus 174 L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~----------------------- 227 (317)
T 3o53_A 174 LNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV----------------------- 227 (317)
T ss_dssp EECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-----------------------
T ss_pred EECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-----------------------
Confidence 55555555532 1 12234555555555555552 2223444455555555555544
Q ss_pred CCCCCcccccCcCCcEEEeecCccC-CCCCCCcCCCCCcceeeccCc-eeeccCC
Q 005278 243 NGSLPSNIQNLKVLTNLDLSRNQLS-GDIPTTIGGLENLETLSLADN-QFQGPVP 295 (704)
Q Consensus 243 ~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n-~l~~~~p 295 (704)
.+|..+..+++|+.|++++|++. +.++..+..+++|+.|++++| .+++..|
T Consensus 228 --~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 228 --LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp --EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred --chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 33444455555555555555555 445555556666666666633 3444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=269.47 Aligned_cols=236 Identities=22% Similarity=0.223 Sum_probs=168.3
Q ss_pred CCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhc
Q 005278 29 ASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNF 108 (704)
Q Consensus 29 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~ 108 (704)
.++|++|+|++|.++++.|..|.++++|++|+|++|.++.... +..+++|++|+|++|.+++..+
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---------l~~l~~L~~L~Ls~N~l~~l~~------ 97 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---------LESLSTLRTLDLNNNYVQELLV------ 97 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE---------CTTCTTCCEEECCSSEEEEEEE------
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc---------cccCCCCCEEEecCCcCCCCCC------
Confidence 3478888888888888777888888888888888888765331 6777888888888887764321
Q ss_pred ccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEE
Q 005278 109 SASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELN 188 (704)
Q Consensus 109 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 188 (704)
.++|++|++++|.+.+..+. .+++|+.|+|++|.+++..|..+..+++|++|+
T Consensus 98 ------------------------~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 150 (487)
T 3oja_A 98 ------------------------GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150 (487)
T ss_dssp ------------------------CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEE
T ss_pred ------------------------CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEE
Confidence 14566666666666544432 245666666666666665566666666677777
Q ss_pred cCCCcCCccCCcccc-CcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccC
Q 005278 189 LNGNKLCGHVPPCLA-SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLS 267 (704)
Q Consensus 189 L~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 267 (704)
|++|.+++..|..+. .+++|+.|+|++|.+++.. .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|+++
T Consensus 151 Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred CCCCCCCCcChHHHhhhCCcccEEecCCCcccccc--ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc
Confidence 777776665555554 5667777777777776442 23346777777777777774 3444778888888888888888
Q ss_pred CCCCCCcCCCCCcceeeccCceee-ccCCcccccccccceEEec
Q 005278 268 GDIPTTIGGLENLETLSLADNQFQ-GPVPKSFGSLISLESLDLS 310 (704)
Q Consensus 268 ~~~~~~~~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~l~ 310 (704)
.+|..+..+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus 228 -~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp -EECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred -ccchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 46777888899999999999988 6777888888888888886
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=274.35 Aligned_cols=185 Identities=17% Similarity=0.112 Sum_probs=130.7
Q ss_pred cccccCceEEEEEE-ECCCCEEEEEEeeccc----------hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEE
Q 005278 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL----------ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 422 ~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 489 (704)
..+.|+.|.+..++ ..-|+.+|||++.... +...++|.+|+++|+++ .|+||+++++++.+....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666654 3468999999997542 22345799999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||++||+|.+++.+.+. ++.. +|+.||+.||+|+ |++|||||||||+|||+++++.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~yl---H~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAAL---EKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHH---HHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHH---HHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999999986543 5543 5899999999999 55889999999999999999999999999998764432
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCC
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP 616 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p 616 (704)
. .....+||++|||||++.+. +..++|+||+|++++++.++..|
T Consensus 394 ~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred c--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 2 23446799999999998754 56789999999999888776544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-28 Score=264.32 Aligned_cols=237 Identities=22% Similarity=0.211 Sum_probs=159.9
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.+++|+.|+|++|.+++..|..|.++++|+.|+|++|.+++..+ |..+++|++|+|++|.++.++ .
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~------------~ 97 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL------------V 97 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE------------E
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC------------C
Confidence 45689999999999998888999999999999999999998766 999999999999999988643 3
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhc-CCCCcCe
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVG-RLRRLQG 162 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~ 162 (704)
.++|++|+|++|.+.+..+..+ ++|++|+|++|.+++..|..++++++|++|+|++|.+++..|..+. .+++|+.
T Consensus 98 ~~~L~~L~L~~N~l~~~~~~~l----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~ 173 (487)
T 3oja_A 98 GPSIETLHAANNNISRVSCSRG----QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173 (487)
T ss_dssp CTTCCEEECCSSCCCCEEECCC----SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCE
T ss_pred CCCcCEEECcCCcCCCCCcccc----CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccE
Confidence 3899999999999997654322 3466666666666666666666666666666666666655555554 5666666
Q ss_pred eeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCccc
Q 005278 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242 (704)
Q Consensus 163 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 242 (704)
|+|++|.|++. | .+..+++|+.|+|++|.+++. |..+..+++|+.|+|++|.+++ +|..+.
T Consensus 174 L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~--------------- 234 (487)
T 3oja_A 174 LNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALR--------------- 234 (487)
T ss_dssp EECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCC---------------
T ss_pred EecCCCccccc-c-ccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhc---------------
Confidence 66666666533 1 222355566666666665532 2235555555555555555552 333444
Q ss_pred CCCCCcccccCcCCcEEEeecCccC-CCCCCCcCCCCCcceeecc
Q 005278 243 NGSLPSNIQNLKVLTNLDLSRNQLS-GDIPTTIGGLENLETLSLA 286 (704)
Q Consensus 243 ~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~ 286 (704)
.+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus 235 ---------~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 235 ---------FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp ---------CCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred ---------cCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 4445555555555554 3444455556666666654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-26 Score=252.39 Aligned_cols=250 Identities=26% Similarity=0.291 Sum_probs=211.7
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
.++|+.|+|++|+|+ .+|. .+++|++|+|++|.++++.. .+++|++|+|++|.++.++. .+
T Consensus 60 ~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~l~~-----------~l 120 (622)
T 3g06_A 60 PAHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTHLPA-----------LP 120 (622)
T ss_dssp CTTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC----CCTTCCEEEECSCCCCCCCC-----------CC
T ss_pred CCCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC----CCCCCCEEECcCCcCCCCCC-----------CC
Confidence 368999999999999 5666 67999999999999996543 78999999999999988542 46
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeee
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLY 164 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 164 (704)
++|++|+|++|+++. +|.. .++|++|++++|++++. |. .+++|+.|++++|.++. +| ..+++|+.|+
T Consensus 121 ~~L~~L~L~~N~l~~-lp~~----l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~ 187 (622)
T 3g06_A 121 SGLCKLWIFGNQLTS-LPVL----PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELS 187 (622)
T ss_dssp TTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEE
T ss_pred CCcCEEECCCCCCCc-CCCC----CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEE
Confidence 899999999999996 4433 26899999999999854 33 45789999999999995 55 5679999999
Q ss_pred ccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCC
Q 005278 165 LHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244 (704)
Q Consensus 165 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 244 (704)
+++|+|++ +|.. +++|+.|++++|.++ .+|.. +++|+.|++++|.|++ +| ..+++|+.|++++|.++
T Consensus 188 Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~- 254 (622)
T 3g06_A 188 VSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT- 254 (622)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-
T ss_pred CCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-
Confidence 99999994 5543 478999999999999 55543 4789999999999996 44 45689999999999999
Q ss_pred CCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccc
Q 005278 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303 (704)
Q Consensus 245 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 303 (704)
.+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..+..+++
T Consensus 255 ~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~~ 309 (622)
T 3g06_A 255 SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS 309 (622)
T ss_dssp CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHHH
T ss_pred cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhccc
Confidence 4555 6788999999999999 78999999999999999999999988888776653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-26 Score=230.55 Aligned_cols=209 Identities=23% Similarity=0.270 Sum_probs=163.3
Q ss_pred ccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcC
Q 005278 111 SLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLN 190 (704)
Q Consensus 111 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 190 (704)
+|++|++++|++++..+..+.++++|++|+|++|.+....+..|..+++|++|+|++|++++..+..+.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 56666666666666666677777888888888888876666778888888888888888886666778888888888888
Q ss_pred CCcCCccCCccccCcCCCCEEEecCccCCCC-CCCcccCCccccEEEecCcccCCCCCcccccCcCCc----EEEeecCc
Q 005278 191 GNKLCGHVPPCLASLTSLRRLHLGSNKLTST-MPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLT----NLDLSRNQ 265 (704)
Q Consensus 191 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~L~l~~n~ 265 (704)
+|.+++..+..+..+++|+.|++++|.+++. +|..+..+++|++|++++|.+++..+..+..+++|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 8888866665678888888888888888764 477888888888888888888877777777777777 88999999
Q ss_pred cCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCC
Q 005278 266 LSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPK 320 (704)
Q Consensus 266 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 320 (704)
+++..+..+. ..+|+.|++++|++++..+..+..+++|+.|++++|++.+..|.
T Consensus 189 l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 189 MNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred ccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 9855554444 45899999999999876666778899999999999999877653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=230.86 Aligned_cols=163 Identities=26% Similarity=0.267 Sum_probs=80.8
Q ss_pred hhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCC
Q 005278 130 IGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLR 209 (704)
Q Consensus 130 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 209 (704)
+..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..+..+++|++|++++|++++..+..+..+++|+
T Consensus 81 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 160 (272)
T 3rfs_A 81 LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT 160 (272)
T ss_dssp GTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCC
Confidence 34445555555555555544444455555555555555555544444444455555555555555443333444444455
Q ss_pred EEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCce
Q 005278 210 RLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQ 289 (704)
Q Consensus 210 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 289 (704)
.|++++|.+++..+.. +..+++|+.|++++|++++..+..+..+++|+.|++++|.
T Consensus 161 ~L~l~~n~l~~~~~~~------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (272)
T 3rfs_A 161 ELDLSYNQLQSLPEGV------------------------FDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216 (272)
T ss_dssp EEECCSSCCCCCCTTT------------------------TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCCcCccCHHH------------------------hcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence 5555554444433333 4444445555555555554444444555555555555555
Q ss_pred eeccCCcccccccccceEEecccCCCCCCCCCcc
Q 005278 290 FQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323 (704)
Q Consensus 290 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 323 (704)
+.+ .+++|+.++++.|.++|.+|..+.
T Consensus 217 ~~~-------~~~~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 217 WDC-------TCPGIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp BCC-------CTTTTHHHHHHHHHTGGGBBCTTS
T ss_pred ccc-------cCcHHHHHHHHHHhCCCcccCccc
Confidence 442 233455555555555555555443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=225.78 Aligned_cols=224 Identities=23% Similarity=0.256 Sum_probs=165.7
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCc
Q 005278 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLT 88 (704)
Q Consensus 9 ~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~ 88 (704)
...+..+.+++ .+|..+. ++|++|+|++|.++++.+..|.++++|++|+|++|.++.+.... |.++++|+
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-------~~~l~~L~ 79 (276)
T 2z62_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA-------YQSLSHLS 79 (276)
T ss_dssp TEEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTT-------TTTCTTCC
T ss_pred ceEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHH-------ccCCcCCC
Confidence 34666777777 5676554 57888888888888887778888888888888888887765443 77788888
Q ss_pred EEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCc
Q 005278 89 VLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGN 168 (704)
Q Consensus 89 ~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 168 (704)
+|+|++|++.+.. +..+.++++|++|++++|.+.+..+..+..+++|++|++++|
T Consensus 80 ~L~L~~n~l~~~~-------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 134 (276)
T 2z62_A 80 TLILTGNPIQSLA-------------------------LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134 (276)
T ss_dssp EEECTTCCCCEEC-------------------------TTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSS
T ss_pred EEECCCCccCccC-------------------------hhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCC
Confidence 8888888877443 345566677777777777777655556777777777777777
Q ss_pred ccCCC-CCccccCCCCCCEEEcCCCcCCccCCccccCcCCCC----EEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 169 KLQGS-IPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLR----RLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 169 ~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
++++. +|..+..+++|++|+|++|++++..+..+..+++|+ .|++++|.+++..+..+. ..+|+.|++++|.++
T Consensus 135 ~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~ 213 (276)
T 2z62_A 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLK 213 (276)
T ss_dssp CCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCS
T ss_pred ccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCcee
Confidence 77753 477777777888888888887766666666666666 788888888765554444 347888888888888
Q ss_pred CCCCcccccCcCCcEEEeecCccCC
Q 005278 244 GSLPSNIQNLKVLTNLDLSRNQLSG 268 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~~n~l~~ 268 (704)
+..+..+..+++|+.|++++|++.+
T Consensus 214 ~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 214 SVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred ecCHhHhcccccccEEEccCCcccc
Confidence 6666667888888888888888874
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-25 Score=220.63 Aligned_cols=184 Identities=30% Similarity=0.335 Sum_probs=110.9
Q ss_pred CCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEec
Q 005278 135 GMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLG 214 (704)
Q Consensus 135 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 214 (704)
+|++|+|++|.+....+..|.++++|++|+|++|+++...+..|..+++|++|+|++|++++..+..+..+++|+.|+++
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 45555555555554444455555555555555555553333344555555555555555554444455555666666666
Q ss_pred CccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccC
Q 005278 215 SNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294 (704)
Q Consensus 215 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 294 (704)
+|.+++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 66666555555666666666666666666555555666666677777777766555556666777777777777777555
Q ss_pred CcccccccccceEEecccCCCCCC
Q 005278 295 PKSFGSLISLESLDLSRNNLSGEI 318 (704)
Q Consensus 295 p~~~~~l~~L~~L~l~~N~l~~~~ 318 (704)
+..+..+++|+.|++++|++.+..
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 198 EGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCSS
T ss_pred HHHhccccCCCEEEecCCCeeCCC
Confidence 555667777777777777776543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-24 Score=217.98 Aligned_cols=203 Identities=28% Similarity=0.326 Sum_probs=143.3
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCC
Q 005278 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86 (704)
Q Consensus 7 ~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~ 86 (704)
+.+.+++++++++ .+|..+. ++|++|+|++|.++++.+..|.++++|++|+|++|.++.++... |.++++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~-------~~~l~~ 86 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI-------FKELKN 86 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTT-------TSSCTT
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhh-------hcCCCC
Confidence 4567777777777 4565444 56777777777777776667777777777777777777655443 666777
Q ss_pred CcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeecc
Q 005278 87 LTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLH 166 (704)
Q Consensus 87 L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 166 (704)
|++|+|++|++... .+..+.++++|++|+|++|.++...+..|..+++|++|+|+
T Consensus 87 L~~L~l~~n~l~~~-------------------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 141 (270)
T 2o6q_A 87 LETLWVTDNKLQAL-------------------------PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLG 141 (270)
T ss_dssp CCEEECCSSCCCCC-------------------------CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCcCCcC-------------------------CHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECC
Confidence 77777777776643 33445666677777777777776666667777777777777
Q ss_pred CcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCC
Q 005278 167 GNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244 (704)
Q Consensus 167 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 244 (704)
+|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+++..+..|..+++|+.|++++|.+..
T Consensus 142 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 142 YNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 777775555557777777777777777776555667777777777777777776666667777777888888777763
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=224.24 Aligned_cols=203 Identities=28% Similarity=0.288 Sum_probs=168.8
Q ss_pred cceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCC
Q 005278 112 LQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG 191 (704)
Q Consensus 112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 191 (704)
+..+.+..+.+... ..+..+++|+.|++++|.+.. + ..+..+++|++|++++|++++. ..+..+++|++|+|++
T Consensus 21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT
T ss_pred HHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC
Confidence 34445555554433 235667788888888888773 2 3477888888888888888742 4788888899999999
Q ss_pred CcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCC
Q 005278 192 NKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIP 271 (704)
Q Consensus 192 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 271 (704)
|.+++..+..+..+++|+.|++++|.+++..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|++++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 98887777778888999999999999988777788899999999999999987777778999999999999999998778
Q ss_pred CCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCC
Q 005278 272 TTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPK 320 (704)
Q Consensus 272 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 320 (704)
..++.+++|+.|++++|++++..|..+..+++|+.|++++|++.+..|.
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 8889999999999999999988888899999999999999999988774
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-24 Score=217.84 Aligned_cols=132 Identities=27% Similarity=0.253 Sum_probs=66.7
Q ss_pred CCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEe
Q 005278 134 SGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHL 213 (704)
Q Consensus 134 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 213 (704)
++|++|+|++|.+. .+|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 34444444444444 33334444444444555555544333344445555555555555555443444445555555555
Q ss_pred cCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccC
Q 005278 214 GSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLS 267 (704)
Q Consensus 214 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 267 (704)
++|++++..+..|..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++.
T Consensus 156 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 555555444444455555555555555555 44555555556666666666664
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-26 Score=240.72 Aligned_cols=231 Identities=19% Similarity=0.164 Sum_probs=152.5
Q ss_pred EEecCCCcCcccCCccccCCCCCCEEeccCccccccCc----hhhcCCC-CCCEEecccccCCCcccchhhcccccCCCC
Q 005278 10 YLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIP----NTFGNLG-SLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 10 ~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
.++|++|++++.+|..+...++|++|+|++|.+++..+ .+|.+++ +|++|+|++|.++...... +...+...
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~---l~~~l~~~ 78 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE---LVQILAAI 78 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHH---HHHHHHTS
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHH---HHHHHhcc
Confidence 46788899998888877777779999999999998777 7788888 8999999999888766544 22223333
Q ss_pred -CCCcEEEccCCCCcccCChhhhhc----ccccceEEecCCcccccCChhhhc-----CCCCCEEEccCCcCcccc----
Q 005278 85 -RNLTVLGLASNPLRGILPPLIGNF----SASLQEFYAYGCKLRGNIPQEIGN-----LSGMIVFDLNGCDLNGTI---- 150 (704)
Q Consensus 85 -~~L~~L~L~~n~i~~~~~~~~~~~----~~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~---- 150 (704)
++|++|+|++|++++..+..++.. +++|++|++++|.+++..+..+.. .++|++|+|++|.++...
T Consensus 79 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp CTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 889999999999887777665553 146777777777777665555433 257777777777776433
Q ss_pred ChhhcCCC-CcCeeeccCcccCCCCCcccc----CC-CCCCEEEcCCCcCCcc----CCccccC-cCCCCEEEecCccCC
Q 005278 151 PTAVGRLR-RLQGLYLHGNKLQGSIPYDLC----HL-EGLSELNLNGNKLCGH----VPPCLAS-LTSLRRLHLGSNKLT 219 (704)
Q Consensus 151 ~~~~~~l~-~L~~L~L~~n~l~~~~~~~l~----~l-~~L~~L~L~~n~l~~~----~~~~~~~-l~~L~~L~l~~n~l~ 219 (704)
+..+..++ +|++|+|++|++++..+..++ .+ ++|++|+|++|.+++. ++..+.. .++|+.|+|++|.++
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 33334444 777777777777655543333 33 4777777777777642 2333333 246777777777666
Q ss_pred CCCC----CcccCCccccEEEecCcccC
Q 005278 220 STMP----SSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 220 ~~~~----~~~~~l~~L~~L~l~~N~l~ 243 (704)
+..+ ..+..+++|+.|++++|.+.
T Consensus 239 ~~~~~~l~~~~~~l~~L~~L~L~~n~l~ 266 (362)
T 3goz_A 239 GPSLENLKLLKDSLKHLQTVYLDYDIVK 266 (362)
T ss_dssp CCCHHHHHHTTTTTTTCSEEEEEHHHHT
T ss_pred cHHHHHHHHHHhcCCCccEEEeccCCcc
Confidence 4433 22344455555555555533
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=218.86 Aligned_cols=203 Identities=22% Similarity=0.207 Sum_probs=120.6
Q ss_pred CCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCc
Q 005278 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRL 160 (704)
Q Consensus 81 ~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 160 (704)
+.++++|+++++++|+++. +|..+. +++++|+|++|.+++..+..+.++++|++|+|++|.+++..+. +.+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 3455566666666666652 232221 2455555555555555556666777777777777777644332 566677
Q ss_pred CeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCc
Q 005278 161 QGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240 (704)
Q Consensus 161 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 240 (704)
++|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 77777777776 55666666666777777777666555556666666666666666666555555566666666666666
Q ss_pred ccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 241 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
++++..+..|..+++|+.|++++|+++ .+|..+..+.+|+.|+|++|++.
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 665444444555555555555555555 44544555555555555555544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-26 Score=249.88 Aligned_cols=185 Identities=17% Similarity=0.217 Sum_probs=144.3
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeeccc--------hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 419 ECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--------ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 419 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
..+.||+|+||.||+|+ ..++.+++|+..... ....+.+.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 35689999999999995 457889999864322 112345899999999999999996555555777779999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++.. +..++.|++.|++||| +.+|+||||||+||+++. .+||+|||+++.......
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 99999999999876 4679999999999995 578999999999999999 999999999998754321
Q ss_pred cc-----eeccccccccccCCcccCC--CCCCcccceeeHHHHHHHHhhCCCCCC
Q 005278 571 SV-----IQTMTIATIGYMAPEYGSE--GIISPKSDVYSYGILLMETFTRKKPTN 618 (704)
Q Consensus 571 ~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~ 618 (704)
.. ......||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 11 1234579999999999876 567888999999999888888777764
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-27 Score=250.39 Aligned_cols=252 Identities=17% Similarity=0.190 Sum_probs=147.4
Q ss_pred chhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCC---cccCChhhhhcccccceEEecCCccc
Q 005278 47 PNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPL---RGILPPLIGNFSASLQEFYAYGCKLR 123 (704)
Q Consensus 47 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i---~~~~~~~~~~~~~~L~~L~l~~n~l~ 123 (704)
+..+..+++|++|+|++|.+....... ++..+..+++|++|+|++|.+ .+.+|..+..+
T Consensus 25 ~~~l~~~~~L~~L~L~~n~i~~~~~~~---l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l--------------- 86 (386)
T 2ca6_A 25 FAVLLEDDSVKEIVLSGNTIGTEAARW---LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL--------------- 86 (386)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHH---HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHH---------------
T ss_pred HHHHhcCCCccEEECCCCCCCHHHHHH---HHHHHHhCCCccEEeCcccccCccccchhHHHHHH---------------
Confidence 334445555555555555554433222 233344555555555555422 22333333221
Q ss_pred ccCChhhhcCCCCCEEEccCCcCcc----ccChhhcCCCCcCeeeccCcccCCCCCcccc----CC---------CCCCE
Q 005278 124 GNIPQEIGNLSGMIVFDLNGCDLNG----TIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC----HL---------EGLSE 186 (704)
Q Consensus 124 ~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~----~l---------~~L~~ 186 (704)
...+..+++|++|+|++|.+.. .++..+..+++|++|+|++|.+++..+..+. .+ ++|++
T Consensus 87 ---~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~ 163 (386)
T 2ca6_A 87 ---LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 163 (386)
T ss_dssp ---HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCE
T ss_pred ---HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcE
Confidence 1233444455555555555443 2344444455555555555554422222222 12 66777
Q ss_pred EEcCCCcCC-ccCC---ccccCcCCCCEEEecCccCCC-----CCCCcccCCccccEEEecCcccC----CCCCcccccC
Q 005278 187 LNLNGNKLC-GHVP---PCLASLTSLRRLHLGSNKLTS-----TMPSSFGSLEYVLYINLSANSLN----GSLPSNIQNL 253 (704)
Q Consensus 187 L~L~~n~l~-~~~~---~~~~~l~~L~~L~l~~n~l~~-----~~~~~~~~l~~L~~L~l~~N~l~----~~~~~~~~~l 253 (704)
|+|++|+++ ..++ ..+..+++|+.|++++|.++. ..+..+..+++|+.|+|++|.++ ..+|..+..+
T Consensus 164 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~ 243 (386)
T 2ca6_A 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243 (386)
T ss_dssp EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred EECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccC
Confidence 777777765 2233 345566677777777777652 23336667777777777777774 4566677788
Q ss_pred cCCcEEEeecCccCCC----CCCCc--CCCCCcceeeccCceeec----cCCccc-ccccccceEEecccCCCCCCC
Q 005278 254 KVLTNLDLSRNQLSGD----IPTTI--GGLENLETLSLADNQFQG----PVPKSF-GSLISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 254 ~~L~~L~l~~n~l~~~----~~~~~--~~l~~L~~L~L~~n~l~~----~~p~~~-~~l~~L~~L~l~~N~l~~~~p 319 (704)
++|+.|+|++|++++. ++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|+.|++++|++++..+
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 8888888888888754 45555 348889999999999987 477777 568999999999999886543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=235.72 Aligned_cols=256 Identities=21% Similarity=0.210 Sum_probs=164.2
Q ss_pred EEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC-CCcEEEccCCCCcccCChhhhhc----
Q 005278 34 MLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR-NLTVLGLASNPLRGILPPLIGNF---- 108 (704)
Q Consensus 34 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~~---- 108 (704)
.++|++|.+++.+|..+...++|++|+|++|.++..+... +...|..++ +|++|+|++|++++..+..++.+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~---l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~ 78 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVE---LIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHH---HHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTS
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHH---HHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhcc
Confidence 4688999999988888888888999999999998877522 334478888 89999999999998888877775
Q ss_pred ccccceEEecCCcccccCChhhhc----C-CCCCEEEccCCcCccccChhhc----C-CCCcCeeeccCcccCCCCCc--
Q 005278 109 SASLQEFYAYGCKLRGNIPQEIGN----L-SGMIVFDLNGCDLNGTIPTAVG----R-LRRLQGLYLHGNKLQGSIPY-- 176 (704)
Q Consensus 109 ~~~L~~L~l~~n~l~~~~~~~~~~----l-~~L~~L~L~~n~l~~~~~~~~~----~-l~~L~~L~L~~n~l~~~~~~-- 176 (704)
.++|++|+|++|.+++..+..+.. + ++|++|+|++|.++...+..+. . .++|++|+|++|++++..+.
T Consensus 79 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp CTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 246888888888887666664443 3 7788888888887765554443 3 25777777777777743332
Q ss_pred --cccCCC-CCCEEEcCCCcCCccCCcccc----Cc-CCCCEEEecCccCCCCC----CCcccC-CccccEEEecCcccC
Q 005278 177 --DLCHLE-GLSELNLNGNKLCGHVPPCLA----SL-TSLRRLHLGSNKLTSTM----PSSFGS-LEYVLYINLSANSLN 243 (704)
Q Consensus 177 --~l~~l~-~L~~L~L~~n~l~~~~~~~~~----~l-~~L~~L~l~~n~l~~~~----~~~~~~-l~~L~~L~l~~N~l~ 243 (704)
.+..++ +|++|+|++|++++..+..+. .+ ++|+.|+|++|.+++.. +..+.. .++|++|+|++|.++
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 234444 777777777777655443333 33 47777777777766422 222333 235666666666665
Q ss_pred CCCC----cccccCcCCcEEEeecCccCCCC-------CCCcCCCCCcceeeccCceeec
Q 005278 244 GSLP----SNIQNLKVLTNLDLSRNQLSGDI-------PTTIGGLENLETLSLADNQFQG 292 (704)
Q Consensus 244 ~~~~----~~~~~l~~L~~L~l~~n~l~~~~-------~~~~~~l~~L~~L~L~~n~l~~ 292 (704)
+..+ ..+..+++|+.|++++|.+.+.. +..+..+++|+.||+++|++.+
T Consensus 239 ~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp CCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred cHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 4333 22234455556666655543221 1233444444444444444443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=221.06 Aligned_cols=226 Identities=17% Similarity=0.174 Sum_probs=174.6
Q ss_pred CCCcEEEccCCCCcccCChhhhhc--ccccceEEecCCcccccCChhh--hcCCCCCEEEccCCcCccccC----hhhcC
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNF--SASLQEFYAYGCKLRGNIPQEI--GNLSGMIVFDLNGCDLNGTIP----TAVGR 156 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~--~~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~ 156 (704)
..++.|.+.++.+.......+... .++|++|++++|.+.+..|..+ ..+++|++|+|++|.+.+..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 356777777777654322211111 1358888888888888888877 888899999999999886544 34567
Q ss_pred CCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCcc--C--CccccCcCCCCEEEecCccCCCCCCC----cccC
Q 005278 157 LRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGH--V--PPCLASLTSLRRLHLGSNKLTSTMPS----SFGS 228 (704)
Q Consensus 157 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~l~~n~l~~~~~~----~~~~ 228 (704)
+++|++|+|++|++++..+..+..+++|++|+|++|++.+. + +..+..+++|+.|++++|.++. .+. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence 88999999999999877778888999999999999987642 2 2334678899999999999873 222 2467
Q ss_pred CccccEEEecCcccCCCCCcccccC---cCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccc
Q 005278 229 LEYVLYINLSANSLNGSLPSNIQNL---KVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLE 305 (704)
Q Consensus 229 l~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 305 (704)
+++|++|+|++|.+.+..|..+..+ ++|+.|++++|+++ .+|..+. ++|+.|+|++|++++. |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 7899999999999988778777776 68999999999999 6777664 7999999999999953 43 67889999
Q ss_pred eEEecccCCCC
Q 005278 306 SLDLSRNNLSG 316 (704)
Q Consensus 306 ~L~l~~N~l~~ 316 (704)
.|++++|+++.
T Consensus 298 ~L~L~~N~l~~ 308 (310)
T 4glp_A 298 NLTLDGNPFLV 308 (310)
T ss_dssp CEECSSTTTSC
T ss_pred EEECcCCCCCC
Confidence 99999999874
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-26 Score=241.06 Aligned_cols=268 Identities=16% Similarity=0.175 Sum_probs=154.7
Q ss_pred cCCccccCCCCCCEEeccCccccccCchh----hcCCCCCCEEecccccCCCcccc---hhhcccccCCCCCCCcEEEcc
Q 005278 21 TIPNSITNASKLIMLDLSSNSFSGLIPNT----FGNLGSLQVLSLAYNYLMTESSA---AKWNFLSSLTNCRNLTVLGLA 93 (704)
Q Consensus 21 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~----~~~l~~L~~L~L~~n~i~~~~~~---~~~~~~~~~~~l~~L~~L~L~ 93 (704)
.++..+..+++|++|+|++|.+++..+.. |..+++|++|+|++|.+..+... ....+...+..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 57788889999999999999999775544 77899999999999876644321 211233445789999999999
Q ss_pred CCCCccc----CChhhhhcccccceEEecCCcccccCChhhh----cC---------CCCCEEEccCCcCc-cccC---h
Q 005278 94 SNPLRGI----LPPLIGNFSASLQEFYAYGCKLRGNIPQEIG----NL---------SGMIVFDLNGCDLN-GTIP---T 152 (704)
Q Consensus 94 ~n~i~~~----~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~----~l---------~~L~~L~L~~n~l~-~~~~---~ 152 (704)
+|+++.. ++..+..+ ++|++|+|++|.++...+..+. .+ ++|++|+|++|.++ ...+ .
T Consensus 103 ~n~l~~~~~~~l~~~l~~~-~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 181 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKH-TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHC-TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhC-CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHH
Confidence 9999863 33344443 2466666666665433222222 22 55555555555554 2222 2
Q ss_pred hhcCCCCcCeeeccCcccCC-----CCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCccc
Q 005278 153 AVGRLRRLQGLYLHGNKLQG-----SIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFG 227 (704)
Q Consensus 153 ~~~~l~~L~~L~L~~n~l~~-----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 227 (704)
.+..+++|++|+|++|+|+. ..+..+..+++|++|+|++|.++... ...++..+.
T Consensus 182 ~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g--------------------~~~l~~~l~ 241 (386)
T 2ca6_A 182 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG--------------------SSALAIALK 241 (386)
T ss_dssp HHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH--------------------HHHHHHHGG
T ss_pred HHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH--------------------HHHHHHHHc
Confidence 34445555555555555441 12224444445555555555543000 023333444
Q ss_pred CCccccEEEecCcccCCC----CCccc--ccCcCCcEEEeecCccCC----CCCCCc-CCCCCcceeeccCceeeccCC-
Q 005278 228 SLEYVLYINLSANSLNGS----LPSNI--QNLKVLTNLDLSRNQLSG----DIPTTI-GGLENLETLSLADNQFQGPVP- 295 (704)
Q Consensus 228 ~l~~L~~L~l~~N~l~~~----~~~~~--~~l~~L~~L~l~~n~l~~----~~~~~~-~~l~~L~~L~L~~n~l~~~~p- 295 (704)
.+++|++|+|++|.+++. ++..+ +.+++|+.|+|++|++++ .+|..+ .++++|+.|++++|++++..+
T Consensus 242 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~ 321 (386)
T 2ca6_A 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 321 (386)
T ss_dssp GCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHH
T ss_pred cCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhH
Confidence 445555555555554432 23344 236667777777777775 356555 457778888888888776553
Q ss_pred -ccc-ccccccceEEe
Q 005278 296 -KSF-GSLISLESLDL 309 (704)
Q Consensus 296 -~~~-~~l~~L~~L~l 309 (704)
..+ ..+++++.+++
T Consensus 322 ~~~l~~~l~~~~~~~l 337 (386)
T 2ca6_A 322 VDEIREVFSTRGRGEL 337 (386)
T ss_dssp HHHHHHHHHHHTCCEE
T ss_pred HHHHHHHhhhcCcchh
Confidence 222 23445544444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.7e-24 Score=208.84 Aligned_cols=197 Identities=19% Similarity=0.161 Sum_probs=147.3
Q ss_pred cccceEEecCCcccccCChhhhcCCCCCEEEccCCc-CccccChhhcCCCCcCeeeccC-cccCCCCCccccCCCCCCEE
Q 005278 110 ASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCD-LNGTIPTAVGRLRRLQGLYLHG-NKLQGSIPYDLCHLEGLSEL 187 (704)
Q Consensus 110 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L 187 (704)
.+|++|++++|++++..+..|.++++|++|++++|. ++.+.+..|.++++|++|++++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 367777777777777777778888888888888886 7766666788888888888887 88876666677788888888
Q ss_pred EcCCCcCCccCCccccCcCCCC---EEEecCc-cCCCCCCCcccCCcccc-EEEecCcccCCCCCcccccCcCCcEEEee
Q 005278 188 NLNGNKLCGHVPPCLASLTSLR---RLHLGSN-KLTSTMPSSFGSLEYVL-YINLSANSLNGSLPSNIQNLKVLTNLDLS 262 (704)
Q Consensus 188 ~L~~n~l~~~~~~~~~~l~~L~---~L~l~~n-~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 262 (704)
++++|++++ +|. +..+++|+ .|++++| .+++..+..|..+++|+ .|++++|.++...+..+.. ++|+.|+++
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 888888874 555 77777777 8888888 78766666788888888 8888888887333334444 778888888
Q ss_pred cCc-cCCCCCCCcCCC-CCcceeeccCceeeccCCcccccccccceEEeccc
Q 005278 263 RNQ-LSGDIPTTIGGL-ENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312 (704)
Q Consensus 263 ~n~-l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N 312 (704)
+|+ +++..+..|.++ ++|+.|++++|+++ .+|.. .+++|+.|++++|
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence 884 775556677777 88888888888887 34443 5667777777765
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.1e-23 Score=204.45 Aligned_cols=179 Identities=27% Similarity=0.295 Sum_probs=109.0
Q ss_pred CCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecC
Q 005278 136 MIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGS 215 (704)
Q Consensus 136 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 215 (704)
.++++++++.++ .+|..+. ++++.|+|++|++++..+..+.++++|++|+|++|++++..+..|..+++|+.|++++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 445555555555 3343333 4556666666666655555566666666666666666655555556666666666666
Q ss_pred ccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCC
Q 005278 216 NKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP 295 (704)
Q Consensus 216 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 295 (704)
|.+++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 66665555556666666666666666665555555666666666666666665555556666666666666666665555
Q ss_pred cccccccccceEEecccCCCCC
Q 005278 296 KSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 296 ~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
..+..+++|+.|++++|++.+.
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHhCCCCCCEEEeeCCceeCC
Confidence 5666666677777777766654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.2e-24 Score=218.21 Aligned_cols=227 Identities=20% Similarity=0.203 Sum_probs=176.0
Q ss_pred CCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhh--hhcccccceEEecCCcccccCC----h
Q 005278 55 SLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLI--GNFSASLQEFYAYGCKLRGNIP----Q 128 (704)
Q Consensus 55 ~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~--~~~~~~L~~L~l~~n~l~~~~~----~ 128 (704)
.++.|.+.++.+....... +. .+..+++|++|+|++|++.+..|..+ ..+ ++|++|++++|.+++..+ .
T Consensus 65 ~l~~l~l~~~~~~~~~~~~---~~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~-~~L~~L~Ls~n~i~~~~~~~~~~ 139 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVG---AL-RVLAYSRLKELTLEDLKITGTMPPLPLEATG-LALSSLRLRNVSWATGRSWLAEL 139 (310)
T ss_dssp CCCEEEECSCCCBHHHHHH---HH-HHHHHSCCCEEEEESCCCBSCCCCCSSSCCC-BCCSSCEEESCCCSSTTSSHHHH
T ss_pred ceeEEEEeCCcCCHHHHHH---HH-HhcccCceeEEEeeCCEeccchhhhhhhccC-CCCCEEEeecccccchhhhhHHH
Confidence 4677777777665432111 11 12234668888888888888877776 444 478888888888886555 4
Q ss_pred hhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCC--C--CccccCCCCCCEEEcCCCcCCccCCc----
Q 005278 129 EIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGS--I--PYDLCHLEGLSELNLNGNKLCGHVPP---- 200 (704)
Q Consensus 129 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~--~~~l~~l~~L~~L~L~~n~l~~~~~~---- 200 (704)
.+..+++|++|+|++|.+.+..+..|+.+++|++|+|++|++.+. + +..+..+++|++|+|++|+++ .++.
T Consensus 140 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~ 218 (310)
T 4glp_A 140 QQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAA 218 (310)
T ss_dssp HTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHH
T ss_pred HhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHH
Confidence 456789999999999999988888999999999999999997642 2 233467899999999999997 3333
Q ss_pred cccCcCCCCEEEecCccCCCCCCCcccCC---ccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCC
Q 005278 201 CLASLTSLRRLHLGSNKLTSTMPSSFGSL---EYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGL 277 (704)
Q Consensus 201 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 277 (704)
.+..+++|+.|+|++|.+++..|..+..+ ++|++|++++|.++ .+|..+. ++|+.|++++|++++. |. +..+
T Consensus 219 l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l 293 (310)
T 4glp_A 219 LAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDEL 293 (310)
T ss_dssp HHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSC
T ss_pred HHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhC
Confidence 35678999999999999998878777776 69999999999999 6677664 7899999999999953 43 6788
Q ss_pred CCcceeeccCceeec
Q 005278 278 ENLETLSLADNQFQG 292 (704)
Q Consensus 278 ~~L~~L~L~~n~l~~ 292 (704)
++|+.|+|++|++++
T Consensus 294 ~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 294 PEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCSCEECSSTTTSC
T ss_pred CCccEEECcCCCCCC
Confidence 999999999999874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-23 Score=210.96 Aligned_cols=194 Identities=24% Similarity=0.368 Sum_probs=104.9
Q ss_pred ccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhh
Q 005278 26 ITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLI 105 (704)
Q Consensus 26 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 105 (704)
+..+++|++|++++|.++.+ + .+..+++|++|+|++|.++.++. +..+++|++|+|++|++.+.
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~---------~~~l~~L~~L~L~~n~l~~~----- 100 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP---------LKNLTKITELELSGNPLKNV----- 100 (308)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG---------GTTCCSCCEEECCSCCCSCC-----
T ss_pred HHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh---------HccCCCCCEEEccCCcCCCc-----
Confidence 34555566666666655543 2 35555556666666555554321 44555555555555555421
Q ss_pred hhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCC
Q 005278 106 GNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185 (704)
Q Consensus 106 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 185 (704)
..+..+++|++|++++|.+++. + .+..+++|++|++++|++++..+ +..+++|+
T Consensus 101 ----------------------~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~ 154 (308)
T 1h6u_A 101 ----------------------SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQ 154 (308)
T ss_dssp ----------------------GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCC
T ss_pred ----------------------hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCcc
Confidence 1345555666666666665532 2 25556666666666666653322 55556666
Q ss_pred EEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCc
Q 005278 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQ 265 (704)
Q Consensus 186 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~ 265 (704)
+|+|++|++++. +. +..+++|+.|++++|.+++..+ +..+++|++|++++|.+.+.. .+..+++|+.|++++|+
T Consensus 155 ~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~ 228 (308)
T 1h6u_A 155 YLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQT 228 (308)
T ss_dssp EEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEE
T ss_pred EEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCe
Confidence 666666666532 22 5555666666666666653322 555556666666666555332 25555666666666666
Q ss_pred cC
Q 005278 266 LS 267 (704)
Q Consensus 266 l~ 267 (704)
++
T Consensus 229 i~ 230 (308)
T 1h6u_A 229 IT 230 (308)
T ss_dssp EE
T ss_pred ee
Confidence 65
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=225.95 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=122.2
Q ss_pred CCEEecCCCcCcccCCccccCC--CCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 8 LKYLTLFDNKLSGTIPNSITNA--SKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 8 l~~L~l~~~~i~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
++.|+++++.+. +..+..+ ++++.|++++|.+++..+. +.++++|++|+|++|.+.... ++..+..++
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~------~~~~~~~~~ 118 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST------LHGILSQCS 118 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH------HHHHHTTBC
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH------HHHHHhhCC
Confidence 445555555444 2334444 4555555555555544333 234455555555555443221 111244445
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCC-cCccc-cChhhcCCCCcCee
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGC-DLNGT-IPTAVGRLRRLQGL 163 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L 163 (704)
+|++|+|++|++++ ..+..++.+++|++|+|++| .+++. ++..+..+++|++|
T Consensus 119 ~L~~L~L~~~~l~~-------------------------~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L 173 (336)
T 2ast_B 119 KLQNLSLEGLRLSD-------------------------PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 173 (336)
T ss_dssp CCSEEECTTCBCCH-------------------------HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEeCcCcccCH-------------------------HHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEE
Confidence 55555555555444 44444455555555555555 34431 33344455555555
Q ss_pred eccCc-ccCCC-CCccccCCC-CCCEEEcCCC--cCC-ccCCccccCcCCCCEEEecCcc-CCCCCCCcccCCccccEEE
Q 005278 164 YLHGN-KLQGS-IPYDLCHLE-GLSELNLNGN--KLC-GHVPPCLASLTSLRRLHLGSNK-LTSTMPSSFGSLEYVLYIN 236 (704)
Q Consensus 164 ~L~~n-~l~~~-~~~~l~~l~-~L~~L~L~~n--~l~-~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~ 236 (704)
++++| .+++. ++..+..++ +|++|++++| .++ +.++..+..+++|+.|++++|. +++..+..+..+++|++|+
T Consensus 174 ~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~ 253 (336)
T 2ast_B 174 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS 253 (336)
T ss_dssp ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred cCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEee
Confidence 55555 44432 233344455 5555555555 233 2333444455555555555555 4444444555555555555
Q ss_pred ecCcc-cCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCC-CCcceeeccCceeeccCCccccc
Q 005278 237 LSANS-LNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGL-ENLETLSLADNQFQGPVPKSFGS 300 (704)
Q Consensus 237 l~~N~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~ 300 (704)
+++|. +.......+.++++|+.|++++| ++. ..+..+ .++..|++++|++++..|..++.
T Consensus 254 l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 254 LSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 55553 22111124555666666666666 321 122222 23555556666666666655543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=204.47 Aligned_cols=187 Identities=17% Similarity=0.201 Sum_probs=115.4
Q ss_pred CcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEeccccc-CCCcccchhhcccccCCCCCCCcEEEccC-C
Q 005278 18 LSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY-LMTESSAAKWNFLSSLTNCRNLTVLGLAS-N 95 (704)
Q Consensus 18 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~~~~~~~l~~L~~L~L~~-n 95 (704)
++ .+|. +. ++|++|+|++|.++++.+..|.++++|++|++++|. ++.++..+ |.++++|++|+|++ |
T Consensus 23 l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~-------f~~l~~L~~L~l~~~n 91 (239)
T 2xwt_C 23 IQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS-------FYNLSKVTHIEIRNTR 91 (239)
T ss_dssp CS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTT-------EESCTTCCEEEEEEET
T ss_pred cc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhH-------cCCCcCCcEEECCCCC
Confidence 55 5666 43 389999999999998888889999999999999997 87766544 88889999999998 8
Q ss_pred CCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCC---EEEccCC-cCccccChhhcCCCCcC-eeeccCccc
Q 005278 96 PLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMI---VFDLNGC-DLNGTIPTAVGRLRRLQ-GLYLHGNKL 170 (704)
Q Consensus 96 ~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~L~~n~l 170 (704)
+++...+..|..+. +|++|++++|++++ +|. +..+++|+ +|++++| .++...+..|.++++|+ .|++++|++
T Consensus 92 ~l~~i~~~~f~~l~-~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 92 NLTYIDPDALKELP-LLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp TCCEECTTSEECCT-TCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred CeeEcCHHHhCCCC-CCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence 88865544444432 45555555555553 333 45555555 5555555 55544444455555555 555555555
Q ss_pred CCCCCccccCCCCCCEEEcCCCc-CCccCCccccCc-CCCCEEEecCccCC
Q 005278 171 QGSIPYDLCHLEGLSELNLNGNK-LCGHVPPCLASL-TSLRRLHLGSNKLT 219 (704)
Q Consensus 171 ~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l-~~L~~L~l~~n~l~ 219 (704)
+ .+|......++|++|+|++|+ +++..+..|..+ ++|+.|++++|+++
T Consensus 169 ~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 169 T-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp C-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred c-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 5 233222222455555555553 543334444454 55555555555554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-24 Score=226.23 Aligned_cols=234 Identities=17% Similarity=0.188 Sum_probs=181.9
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCccccc-CChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGN-IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
++++.|++++|.+.+..+.. ..+ ++|++|++++|.+.+. ++..+..+++|++|+|++|.+++..+..++.+++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~~-~~~-~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAEH-FSP-FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCSC-CCC-BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchhh-ccC-CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 45555555555555444332 222 3566666666665544 66778899999999999999998888999999999999
Q ss_pred eccCc-ccCCC-CCccccCCCCCCEEEcCCC-cCCcc-CCccccCcC-CCCEEEecCc--cCC-CCCCCcccCCccccEE
Q 005278 164 YLHGN-KLQGS-IPYDLCHLEGLSELNLNGN-KLCGH-VPPCLASLT-SLRRLHLGSN--KLT-STMPSSFGSLEYVLYI 235 (704)
Q Consensus 164 ~L~~n-~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~l~~n--~l~-~~~~~~~~~l~~L~~L 235 (704)
+|++| .+++. ++..+..+++|++|++++| .+++. ++..+..++ +|+.|++++| .++ +.++..+..+++|++|
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L 227 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE
Confidence 99999 67752 5666888999999999999 99854 567788899 9999999999 455 3456677789999999
Q ss_pred EecCcc-cCCCCCcccccCcCCcEEEeecCc-cCCCCCCCcCCCCCcceeeccCceeeccCCcccccc-cccceEEeccc
Q 005278 236 NLSANS-LNGSLPSNIQNLKVLTNLDLSRNQ-LSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSL-ISLESLDLSRN 312 (704)
Q Consensus 236 ~l~~N~-l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~l~~N 312 (704)
++++|. +++..+..+..+++|+.|++++|. +.......++.+++|+.|++++| ++. ..+..+ .+++.|++++|
T Consensus 228 ~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n 303 (336)
T 2ast_B 228 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCS 303 (336)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCC
T ss_pred eCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecc
Confidence 999999 777788899999999999999996 33222236888999999999999 442 234444 34788889999
Q ss_pred CCCCCCCCCccc
Q 005278 313 NLSGEIPKNFSA 324 (704)
Q Consensus 313 ~l~~~~p~~~~~ 324 (704)
++++..|..+..
T Consensus 304 ~l~~~~~~~~~~ 315 (336)
T 2ast_B 304 HFTTIARPTIGN 315 (336)
T ss_dssp CSCCTTCSSCSS
T ss_pred cCccccCCcccc
Confidence 999999876553
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=7.8e-23 Score=209.47 Aligned_cols=193 Identities=24% Similarity=0.380 Sum_probs=146.5
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCC
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTN 83 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~ 83 (704)
.|++|+.|++++|.++. ++ .+..+++|++|+|++|.++++.+ |.++++|++|+|++|.++..+ .+..
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~~---------~~~~ 105 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVS---------AIAG 105 (308)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCG---------GGTT
T ss_pred HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCch---------hhcC
Confidence 36789999999999994 55 69999999999999999997755 999999999999999998753 2888
Q ss_pred CCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCee
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGL 163 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 163 (704)
+++|++|+|++|++.+.. .+..+++|++|++++|.+++..+ +..+++|+.|
T Consensus 106 l~~L~~L~l~~n~l~~~~---------------------------~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L 156 (308)
T 1h6u_A 106 LQSIKTLDLTSTQITDVT---------------------------PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL 156 (308)
T ss_dssp CTTCCEEECTTSCCCCCG---------------------------GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred CCCCCEEECCCCCCCCch---------------------------hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEE
Confidence 999999999999987431 14556667777777777664433 6667777777
Q ss_pred eccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 164 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
+|++|++++. +. +..+++|++|++++|++++..+ +..+++|+.|++++|.+++.. .+..+++|+.|++++|.++
T Consensus 157 ~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 157 SIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp ECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred EccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 7777777643 22 6677777777777777774332 667777777777777777543 3677777777777777776
Q ss_pred C
Q 005278 244 G 244 (704)
Q Consensus 244 ~ 244 (704)
+
T Consensus 231 ~ 231 (308)
T 1h6u_A 231 N 231 (308)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-25 Score=251.01 Aligned_cols=311 Identities=14% Similarity=0.061 Sum_probs=156.5
Q ss_pred CCCCCEEecCCCcCccc----CCccccCCCCCCEEeccCccccc----cCchhhcCCCCCCEEecccccCCCcccch---
Q 005278 5 LPNLKYLTLFDNKLSGT----IPNSITNASKLIMLDLSSNSFSG----LIPNTFGNLGSLQVLSLAYNYLMTESSAA--- 73 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~----~~~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--- 73 (704)
+++|++|+|++|.+++. ++..+.++++|++|+|++|.+++ ..+..+.++++|++|+|++|.+..++...
T Consensus 163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~ 242 (592)
T 3ogk_B 163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAA 242 (592)
T ss_dssp CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHC
T ss_pred CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhh
Confidence 45566666666655433 22233445556666665555542 22333445555666666555543321000
Q ss_pred ----------------hhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCC-hhhhcCCCC
Q 005278 74 ----------------KWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIP-QEIGNLSGM 136 (704)
Q Consensus 74 ----------------~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L 136 (704)
.......+..+++|+.|+++++... ..|..+..+ ++|++|++++|.+++... ..+..+++|
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~-~~L~~L~Ls~~~l~~~~~~~~~~~~~~L 320 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFA-AQIRKLDLLYALLETEDHCTLIQKCPNL 320 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGG-GGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhc-CCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence 0001112233333333333332211 222222222 356666666666543322 234556666
Q ss_pred CEEEccCCcCccccChhhcCCCCcCeeecc-----------CcccCCCCCcc-ccCCCCCCEEEcCCCcCCccCCccccC
Q 005278 137 IVFDLNGCDLNGTIPTAVGRLRRLQGLYLH-----------GNKLQGSIPYD-LCHLEGLSELNLNGNKLCGHVPPCLAS 204 (704)
Q Consensus 137 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-----------~n~l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~~~~ 204 (704)
++|+++++-....++..+..+++|++|+++ .|.+++..... ...+++|++|+++.|.+++..+..+..
T Consensus 321 ~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~ 400 (592)
T 3ogk_B 321 EVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400 (592)
T ss_dssp CEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHH
T ss_pred CEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHh
Confidence 666666222222233333455666666666 24444221111 233566666666666666554444443
Q ss_pred -cCCCCEEEec----CccCCCC-----CCCcccCCccccEEEecCcc--cCCCCCcccc-cCcCCcEEEeecCccCC-CC
Q 005278 205 -LTSLRRLHLG----SNKLTST-----MPSSFGSLEYVLYINLSANS--LNGSLPSNIQ-NLKVLTNLDLSRNQLSG-DI 270 (704)
Q Consensus 205 -l~~L~~L~l~----~n~l~~~-----~~~~~~~l~~L~~L~l~~N~--l~~~~~~~~~-~l~~L~~L~l~~n~l~~-~~ 270 (704)
+++|+.|+++ .|.+++. .+..+.++++|++|++++|. +++..+..+. .+++|+.|++++|++++ .+
T Consensus 401 ~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~ 480 (592)
T 3ogk_B 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGL 480 (592)
T ss_dssp HCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHH
T ss_pred hCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHH
Confidence 6667777774 4555532 11224456677777776433 4433333333 36667777777777764 23
Q ss_pred CCCcCCCCCcceeeccCceeecc-CCcccccccccceEEecccCCCCC
Q 005278 271 PTTIGGLENLETLSLADNQFQGP-VPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 271 ~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
+..+.++++|+.|+|++|.+++. ++.....+++|+.|++++|+++..
T Consensus 481 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 481 MEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 33445667777777777776643 233345667777777777776643
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-22 Score=199.40 Aligned_cols=160 Identities=28% Similarity=0.299 Sum_probs=111.8
Q ss_pred CCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEe
Q 005278 134 SGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHL 213 (704)
Q Consensus 134 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 213 (704)
++|++|+|++|.+.+..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 35666666666666666666666666666666666666655556666667777777777776555556666777777777
Q ss_pred cCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeecc
Q 005278 214 GSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGP 293 (704)
Q Consensus 214 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 293 (704)
++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.+.
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 77777766556667777777777777777766666677777777788888877766666777788888888888887754
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-22 Score=210.08 Aligned_cols=240 Identities=16% Similarity=0.149 Sum_probs=135.2
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCC-cccchhhcccccCCCCCCC
Q 005278 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMT-ESSAAKWNFLSSLTNCRNL 87 (704)
Q Consensus 9 ~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~~~~~~~~l~~L 87 (704)
++++.++++++ .+|..+ .+++++|+|++|+|+.+.+++|.++++|++|+|++|++.. ++..+ |.++++|
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~-------f~~L~~l 81 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV-------FSNLPKL 81 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTS-------BCSCTTC
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhH-------hhcchhh
Confidence 45667777777 566655 2567777777777776666677777777777777777643 33222 5666665
Q ss_pred cE-EEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeecc
Q 005278 88 TV-LGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLH 166 (704)
Q Consensus 88 ~~-L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 166 (704)
.+ +.+++|++.. ..|..|.++++|++|++++|.+....+..+....++..|++.
T Consensus 82 ~~~l~~~~N~l~~-------------------------l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~ 136 (350)
T 4ay9_X 82 HEIRIEKANNLLY-------------------------INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 136 (350)
T ss_dssp CEEEEEEETTCCE-------------------------ECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEE
T ss_pred hhhhcccCCcccc-------------------------cCchhhhhccccccccccccccccCCchhhcccchhhhhhhc
Confidence 54 4444555554 444455555666666666666654444445555555555554
Q ss_pred C-cccCCCCCccccCCC-CCCEEEcCCCcCCccCCccccCcCCCCEEEecC-ccCCCCCCCcccCCccccEEEecCcccC
Q 005278 167 G-NKLQGSIPYDLCHLE-GLSELNLNGNKLCGHVPPCLASLTSLRRLHLGS-NKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 167 ~-n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
+ |+++...+..|..+. .++.|+|++|+|+. ++......++|+.|++.+ |.++.+.++.|..+++|++|++++|+|+
T Consensus 137 ~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp SCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred cccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence 3 445433334444443 45666666666663 333333445566666653 4555444445666666666666666666
Q ss_pred CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCc
Q 005278 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADN 288 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 288 (704)
...+.. +.+|+.|.+.++.--..+| .+..+++|+.+++.++
T Consensus 216 ~lp~~~---~~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 216 SLPSYG---LENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp CCCSSS---CTTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCH
T ss_pred ccChhh---hccchHhhhccCCCcCcCC-CchhCcChhhCcCCCC
Confidence 333322 3334444444443323455 3566677777776654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.4e-24 Score=238.57 Aligned_cols=308 Identities=11% Similarity=0.015 Sum_probs=227.0
Q ss_pred CCCCCCEEecCCCcCc----ccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCc--------c-
Q 005278 4 MLPNLKYLTLFDNKLS----GTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTE--------S- 70 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~----~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~--------~- 70 (704)
.+++|+.|+|++|.++ +.++..+.++++|++|+|++|.+.+ .+..+.++++|++|+++.+..... .
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 4789999999999987 3455566788999999999999886 567788888888888874322100 0
Q ss_pred ----------cchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEE
Q 005278 71 ----------SAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFD 140 (704)
Q Consensus 71 ----------~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 140 (704)
......++..+..+++|++|+|++|.+++.....+....++|++|++.++.....++..+..+++|++|+
T Consensus 269 ~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~ 348 (592)
T 3ogk_B 269 PRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLR 348 (592)
T ss_dssp CTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEE
T ss_pred cccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEE
Confidence 0001124555778999999999999987665544444456899999994444445555567899999999
Q ss_pred ccC-----------CcCcccc-ChhhcCCCCcCeeeccCcccCCCCCccccC-CCCCCEEEcC----CCcCCcc-----C
Q 005278 141 LNG-----------CDLNGTI-PTAVGRLRRLQGLYLHGNKLQGSIPYDLCH-LEGLSELNLN----GNKLCGH-----V 198 (704)
Q Consensus 141 L~~-----------n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~-l~~L~~L~L~----~n~l~~~-----~ 198 (704)
+++ |.++... +..+..+++|++|+++.|.+++..+..+.. +++|++|+++ .|.+++. +
T Consensus 349 L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~ 428 (592)
T 3ogk_B 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGV 428 (592)
T ss_dssp EECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHH
T ss_pred eecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHH
Confidence 993 5666432 333556899999999999998776666665 8999999996 7788853 3
Q ss_pred CccccCcCCCCEEEecCcc--CCCCCCCccc-CCccccEEEecCcccCC-CCCcccccCcCCcEEEeecCccCCC-CCCC
Q 005278 199 PPCLASLTSLRRLHLGSNK--LTSTMPSSFG-SLEYVLYINLSANSLNG-SLPSNIQNLKVLTNLDLSRNQLSGD-IPTT 273 (704)
Q Consensus 199 ~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~-~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~ 273 (704)
+..+..+++|+.|++++|. +++.....+. .+++|++|++++|.+++ .++..+..+++|+.|++++|++++. ++..
T Consensus 429 ~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 508 (592)
T 3ogk_B 429 RSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAA 508 (592)
T ss_dssp HHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHH
T ss_pred HHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHH
Confidence 3446778999999998543 6544444443 48899999999999875 3344567889999999999998754 3344
Q ss_pred cCCCCCcceeeccCceeeccCCccc-ccccccceEEeccc
Q 005278 274 IGGLENLETLSLADNQFQGPVPKSF-GSLISLESLDLSRN 312 (704)
Q Consensus 274 ~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~l~~N 312 (704)
+..+++|+.|+|++|++++.....+ ..+|.+....+..+
T Consensus 509 ~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 509 VTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 4678999999999999987655444 36777777666655
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-24 Score=241.81 Aligned_cols=186 Identities=15% Similarity=0.052 Sum_probs=111.1
Q ss_pred CCCCCCEEecCCCcCcccCCcccc-CCCCCCEEeccCc-ccccc-CchhhcCCCCCCEEecccccCCCcccchhhccccc
Q 005278 4 MLPNLKYLTLFDNKLSGTIPNSIT-NASKLIMLDLSSN-SFSGL-IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSS 80 (704)
Q Consensus 4 ~l~~l~~L~l~~~~i~~~~~~~~~-~l~~L~~L~L~~n-~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~ 80 (704)
.+++|+.|+|++|.+++..+..+. .+++|++|+|++| .+++. .+..+.++++|++|+|++|.++...... +...
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~---l~~~ 179 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHW---LSHF 179 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGG---GGGS
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHH---HHHH
Confidence 467888888888888766666665 6788888888888 55543 3344457888888888888876655433 3333
Q ss_pred CCCCCCCcEEEccCCC--CcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCc-------------
Q 005278 81 LTNCRNLTVLGLASNP--LRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCD------------- 145 (704)
Q Consensus 81 ~~~l~~L~~L~L~~n~--i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~------------- 145 (704)
...+++|++|+|++|. +.......+..-.++|++|++.+|...+.++..+..+++|++|+++++.
T Consensus 180 ~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~ 259 (594)
T 2p1m_B 180 PDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV 259 (594)
T ss_dssp CTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH
T ss_pred hhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHH
Confidence 4577788888888886 3222222222224578888888873222255555555666666544331
Q ss_pred -------------Cc----cccChhhcCCCCcCeeeccCcccCCCCC-ccccCCCCCCEEEcCCC
Q 005278 146 -------------LN----GTIPTAVGRLRRLQGLYLHGNKLQGSIP-YDLCHLEGLSELNLNGN 192 (704)
Q Consensus 146 -------------l~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n 192 (704)
+. ..++..+..+++|++|+|++|.+++... ..+..+++|++|++++|
T Consensus 260 ~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 324 (594)
T 2p1m_B 260 ALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324 (594)
T ss_dssp HHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred HHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc
Confidence 11 1122223345667777777766553221 12345566666666665
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.57 Aligned_cols=242 Identities=16% Similarity=0.120 Sum_probs=180.0
Q ss_pred CEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhccccc
Q 005278 33 IMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASL 112 (704)
Q Consensus 33 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L 112 (704)
+.++.++++++. +|..+ .++|++|+|++|+|+.++..+ |.++++|++|+|++|++.+.+|
T Consensus 12 ~~v~C~~~~Lt~-iP~~l--~~~l~~L~Ls~N~i~~i~~~~-------f~~l~~L~~L~Ls~N~i~~~i~---------- 71 (350)
T 4ay9_X 12 RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGA-------FSGFGDLEKIEISQNDVLEVIE---------- 71 (350)
T ss_dssp TEEEEESTTCCS-CCTTC--CTTCSEEEEESCCCSEECTTS-------STTCTTCCEEEEECCTTCCEEC----------
T ss_pred CEEEecCCCCCc-cCcCc--CCCCCEEEccCCcCCCcCHHH-------HcCCCCCCEEECcCCCCCCccC----------
Confidence 456777777774 34434 356777777777777766544 7777777777777777653322
Q ss_pred ceEEecCCcccccCChhhhcCCCCCE-EEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCC
Q 005278 113 QEFYAYGCKLRGNIPQEIGNLSGMIV-FDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG 191 (704)
Q Consensus 113 ~~L~l~~n~l~~~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 191 (704)
+.+|.+++++++ +.+++|++..+.++.|..+++|++|++++|+|+...+..+....++..|++.+
T Consensus 72 --------------~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~ 137 (350)
T 4ay9_X 72 --------------ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 137 (350)
T ss_dssp --------------TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES
T ss_pred --------------hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcc
Confidence 345677878775 66778999988899999999999999999999977676777888899999966
Q ss_pred -CcCCccCCccccCcC-CCCEEEecCccCCCCCCCcccCCccccEEEecC-cccCCCCCcccccCcCCcEEEeecCccCC
Q 005278 192 -NKLCGHVPPCLASLT-SLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA-NSLNGSLPSNIQNLKVLTNLDLSRNQLSG 268 (704)
Q Consensus 192 -n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 268 (704)
|++....+..|..+. .++.|++++|+|+.+.+. .....+|+.|++++ |.++...+..|..+++|+.|++++|+|+.
T Consensus 138 ~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~-~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~ 216 (350)
T 4ay9_X 138 NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNS-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216 (350)
T ss_dssp CTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTT-SSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC
T ss_pred ccccccccccchhhcchhhhhhccccccccCCChh-hccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCc
Confidence 677755566777764 689999999999954444 44567899999985 66775555678999999999999999995
Q ss_pred CCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccC
Q 005278 269 DIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNN 313 (704)
Q Consensus 269 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~ 313 (704)
..+..+.++++|+.++ +.-...+| .+.++++|+.++++++.
T Consensus 217 lp~~~~~~L~~L~~l~---~~~l~~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 217 LPSYGLENLKKLRARS---TYNLKKLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp CCSSSCTTCCEEECTT---CTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred cChhhhccchHhhhcc---CCCcCcCC-CchhCcChhhCcCCCCc
Confidence 4444555555554444 43233666 47899999999997653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.8e-21 Score=186.06 Aligned_cols=157 Identities=27% Similarity=0.262 Sum_probs=68.8
Q ss_pred CcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEec
Q 005278 159 RLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238 (704)
Q Consensus 159 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 238 (704)
+|++|++++|++++..+..+..+++|++|++++|++++..+..|..+++|+.|++++|.+++..+..|..+++|++|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 33444444444443323333344444444444444443323333444444444444444443333334444444444444
Q ss_pred CcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCC
Q 005278 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEI 318 (704)
Q Consensus 239 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 318 (704)
+|.+++..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|.+.+ .+++|+.|+++.|.++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCcee
Confidence 444443333334444445555555555543333344445555555555554432 2334555555555555555
Q ss_pred CCCc
Q 005278 319 PKNF 322 (704)
Q Consensus 319 p~~~ 322 (704)
|..+
T Consensus 182 p~~~ 185 (208)
T 2o6s_A 182 RNSA 185 (208)
T ss_dssp BCTT
T ss_pred eccC
Confidence 5443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-22 Score=204.39 Aligned_cols=151 Identities=16% Similarity=0.098 Sum_probs=118.8
Q ss_pred HHHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccch------------------hhhHHHHHHHHHHHhcCC
Q 005278 409 DIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE------------------RASRSFDSECEILRSIRH 470 (704)
Q Consensus 409 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h 470 (704)
.+......|...+.||+|+||.||+|+..+|+.||||+++.... .....+.+|++++++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 33444566777799999999999999987799999999864321 134568899999999994
Q ss_pred CCCceEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 005278 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE 550 (704)
Q Consensus 471 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~ 550 (704)
+++.+++.. +..++||||+++|+|.+ +.. .....++.|++.|++||| +.+|+||||||+||+++
T Consensus 164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp ---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred ---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence 455554433 45699999999999988 432 123469999999999995 57899999999999999
Q ss_pred CCcEEEeeeccceecCCCCCcceeccccccccccCCcccC
Q 005278 551 NMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590 (704)
Q Consensus 551 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 590 (704)
++.+||+|||+|+. +..|+|||++.
T Consensus 228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999999999974 33467888754
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.3e-21 Score=184.08 Aligned_cols=182 Identities=26% Similarity=0.247 Sum_probs=160.7
Q ss_pred cceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCC
Q 005278 112 LQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG 191 (704)
Q Consensus 112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 191 (704)
-+.+++.++.++.. |..+ .++|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|+|++
T Consensus 9 ~~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 9 GTTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TTEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 46788888888743 4333 46899999999999987777899999999999999999976666789999999999999
Q ss_pred CcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCC
Q 005278 192 NKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIP 271 (704)
Q Consensus 192 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 271 (704)
|++++..+..+..+++|+.|++++|.+++..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|++.+
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--- 162 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--- 162 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC---
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec---
Confidence 99997767778999999999999999998888889999999999999999998777779999999999999998874
Q ss_pred CCcCCCCCcceeeccCceeeccCCcccccccc
Q 005278 272 TTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303 (704)
Q Consensus 272 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 303 (704)
.+++|+.|+++.|+++|.+|..++.++.
T Consensus 163 ----~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ----TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 4568999999999999999999887765
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-23 Score=235.56 Aligned_cols=327 Identities=17% Similarity=0.132 Sum_probs=198.1
Q ss_pred CCCCCCEEecCCC-cCccc-CCccccCCCCCCEEeccCccccccCchhhc----CCCCCCEEecccccCCCcccchhhcc
Q 005278 4 MLPNLKYLTLFDN-KLSGT-IPNSITNASKLIMLDLSSNSFSGLIPNTFG----NLGSLQVLSLAYNYLMTESSAAKWNF 77 (704)
Q Consensus 4 ~l~~l~~L~l~~~-~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~----~l~~L~~L~L~~n~i~~~~~~~~~~~ 77 (704)
.+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|++|++++|. ..+.... +
T Consensus 128 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~---l 203 (594)
T 2p1m_B 128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSA---L 203 (594)
T ss_dssp HCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHH---H
T ss_pred hCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHH---H
Confidence 4789999999999 66643 444455899999999999998876655554 66789999999987 2222221 2
Q ss_pred cccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCc--------------------------cc----ccCC
Q 005278 78 LSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCK--------------------------LR----GNIP 127 (704)
Q Consensus 78 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~--------------------------l~----~~~~ 127 (704)
...+.++++|++|+|++|.-....+..+..+ ++|++|.+..+. +. ..++
T Consensus 204 ~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~-~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~ 282 (594)
T 2p1m_B 204 ERLVTRCPNLKSLKLNRAVPLEKLATLLQRA-PQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP 282 (594)
T ss_dssp HHHHHHCTTCCEEECCTTSCHHHHHHHHHHC-TTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGG
T ss_pred HHHHHhCCCCcEEecCCCCcHHHHHHHHhcC-CcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHH
Confidence 2224557899999999883222344444444 367777755442 11 1233
Q ss_pred hhhhcCCCCCEEEccCCcCccccC-hhhcCCCCcCeeeccCcccCCCCCcc-ccCCCCCCEEEcC---------CCcCCc
Q 005278 128 QEIGNLSGMIVFDLNGCDLNGTIP-TAVGRLRRLQGLYLHGNKLQGSIPYD-LCHLEGLSELNLN---------GNKLCG 196 (704)
Q Consensus 128 ~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~-l~~l~~L~~L~L~---------~n~l~~ 196 (704)
..+..+++|++|+|++|.++.... ..+..+++|++|++++| +++..... ...+++|++|+++ .+.+++
T Consensus 283 ~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~ 361 (594)
T 2p1m_B 283 AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTE 361 (594)
T ss_dssp GGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCH
T ss_pred HHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCH
Confidence 344467888888888888664322 23567788888888877 44222122 2246778888773 344543
Q ss_pred cCCcccc-CcCCCCEEEecCccCCCCCCCccc-CCccccEEEec--C----cccCCCCC-----cccccCcCCcEEEeec
Q 005278 197 HVPPCLA-SLTSLRRLHLGSNKLTSTMPSSFG-SLEYVLYINLS--A----NSLNGSLP-----SNIQNLKVLTNLDLSR 263 (704)
Q Consensus 197 ~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~--~----N~l~~~~~-----~~~~~l~~L~~L~l~~ 263 (704)
.....+. .+++|+.|.+.+|.+++.....+. .+++|+.|+++ + |.+++... ..+..+++|+.|++++
T Consensus 362 ~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~ 441 (594)
T 2p1m_B 362 QGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG 441 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS
T ss_pred HHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC
Confidence 3222222 367777777777777654444443 46777777777 3 34442111 1245567777777765
Q ss_pred CccCCCCCCCcCC-CCCcceeeccCceeeccCCccc-ccccccceEEecccCCCCCCCC-CcccccccCcccccCCC
Q 005278 264 NQLSGDIPTTIGG-LENLETLSLADNQFQGPVPKSF-GSLISLESLDLSRNNLSGEIPK-NFSAQSFLSNYALCGPA 337 (704)
Q Consensus 264 n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~l~~~~l~g~~ 337 (704)
.+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|++++..+. .....+.+....+.+++
T Consensus 442 -~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 442 -LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp -SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred -cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 555444444443 6777777777777765544444 5567777777777777433222 22334455555555543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.6e-21 Score=210.50 Aligned_cols=189 Identities=24% Similarity=0.302 Sum_probs=114.3
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeec
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL 165 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 165 (704)
+|+.|+|++|++++ +|..+. ++|++|+|++|+++ .+| ..+++|++|+|++|.|++ +|. +.. +|+.|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence 45555555555553 332221 24555555555554 333 335666667777666664 444 443 6777777
Q ss_pred cCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCC
Q 005278 166 HGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245 (704)
Q Consensus 166 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 245 (704)
++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|.|++ +|. |. ++|+.|+|++|.|+ .
T Consensus 128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~ 194 (571)
T 3cvr_A 128 DNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-S 194 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-S
T ss_pred CCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-c
Confidence 7777664 444 45667777777777764 443 45667777777777765 444 44 66777777777766 4
Q ss_pred CCcccccCcCC-------cEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccc
Q 005278 246 LPSNIQNLKVL-------TNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303 (704)
Q Consensus 246 ~~~~~~~l~~L-------~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 303 (704)
+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+..
T Consensus 195 lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 195 LPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 444 443 45 77777777777 56766667777777777777777777777665544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.7e-21 Score=209.74 Aligned_cols=188 Identities=23% Similarity=0.333 Sum_probs=161.7
Q ss_pred ccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcC
Q 005278 111 SLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLN 190 (704)
Q Consensus 111 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 190 (704)
+|+.|++++|++++ +|..+ +++|++|+|++|.|+ .+| ..+++|+.|+|++|+|++ +|. +.. +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 79999999999997 66655 388999999999999 566 567999999999999996 776 665 99999999
Q ss_pred CCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCC
Q 005278 191 GNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDI 270 (704)
Q Consensus 191 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 270 (704)
+|+|++ +|. .+++|+.|++++|.|++ +|. .+++|+.|+|++|.+++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 999996 665 68999999999999996 554 57899999999999996 666 66 89999999999999 77
Q ss_pred CCCcCCCCCc-------ceeeccCceeeccCCcccccccccceEEecccCCCCCCCCCccccc
Q 005278 271 PTTIGGLENL-------ETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQS 326 (704)
Q Consensus 271 ~~~~~~l~~L-------~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 326 (704)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 77 665 77 99999999999 6898888999999999999999998887665543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6e-21 Score=212.07 Aligned_cols=189 Identities=23% Similarity=0.313 Sum_probs=91.0
Q ss_pred CCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccc
Q 005278 32 LIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSAS 111 (704)
Q Consensus 32 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~ 111 (704)
+..+.+..+.+.++.+ +..|++|+.|++++|.+..++ .+..+++|++|+|++|++.+..+ +..+ ++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~---------~l~~l~~L~~L~Ls~N~l~~~~~--l~~l-~~ 88 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ---------GIQYLPNVTKLFLNGNKLTDIKP--LTNL-KN 88 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT---------TGGGCTTCCEEECTTSCCCCCGG--GGGC-TT
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh---------HHccCCCCCEEEeeCCCCCCChh--hccC-CC
Confidence 3334444444443322 334444444455444444332 13444444444444444443222 2222 13
Q ss_pred cceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCC
Q 005278 112 LQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG 191 (704)
Q Consensus 112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 191 (704)
|+.|+|++|.+.+. ..+..+++|++|+|++|.+.+. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++
T Consensus 89 L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~ 162 (605)
T 1m9s_A 89 LGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLED 162 (605)
T ss_dssp CCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCS
T ss_pred CCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcC
Confidence 33333333333321 1355555566666666655532 2355555666666666655532 3455555566666666
Q ss_pred CcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCC
Q 005278 192 NKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244 (704)
Q Consensus 192 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 244 (704)
|+|++..| +..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.+..
T Consensus 163 N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 163 NQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 65554333 55555566666665555532 235555555555555555543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4e-20 Score=205.41 Aligned_cols=198 Identities=20% Similarity=0.218 Sum_probs=155.0
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCC
Q 005278 8 LKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNL 87 (704)
Q Consensus 8 l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L 87 (704)
+..+.+..+.+++..+ +..+++|+.|+|++|.+..+. .|..+++|+.|+|++|.++.++. +..+++|
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~---------l~~l~~L 89 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP---------LTNLKNL 89 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG---------GGGCTTC
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh---------hccCCCC
Confidence 3445667777775544 577888888888888888652 57888888888888888876542 6778888
Q ss_pred cEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccC
Q 005278 88 TVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHG 167 (704)
Q Consensus 88 ~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 167 (704)
++|+|++|++.+. + .+..+ ++|++|+|++|.+.+. ..+..+++|+.|+|++|.+.+. ..+..+++|+.|+|++
T Consensus 90 ~~L~Ls~N~l~~l-~-~l~~l-~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~ 162 (605)
T 1m9s_A 90 GWLFLDENKIKDL-S-SLKDL-KKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLED 162 (605)
T ss_dssp CEEECCSSCCCCC-T-TSTTC-TTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCS
T ss_pred CEEECcCCCCCCC-h-hhccC-CCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcC
Confidence 8888888888753 2 45555 4688888888888753 4688999999999999999865 6789999999999999
Q ss_pred cccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCC
Q 005278 168 NKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSL 229 (704)
Q Consensus 168 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 229 (704)
|+|++..| +..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.+.+.....+..+
T Consensus 163 N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l 220 (605)
T 1m9s_A 163 NQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNL 220 (605)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred CcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccE
Confidence 99996655 88999999999999999854 468899999999999999986544444433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.6e-20 Score=187.83 Aligned_cols=172 Identities=26% Similarity=0.405 Sum_probs=100.9
Q ss_pred hcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCE
Q 005278 131 GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRR 210 (704)
Q Consensus 131 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 210 (704)
..+++|++|++++|.+... + .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++ ++ .+..+++|+.
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 3455566666666655532 2 35555666666666666653322 5556666666666666653 22 2556666666
Q ss_pred EEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCcee
Q 005278 211 LHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQF 290 (704)
Q Consensus 211 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 290 (704)
|++++|.+++. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..+ +..+++|+.|++++|.+
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 66666666542 3455566666666666666543 456666666666666666664333 66666666666666666
Q ss_pred eccCCcccccccccceEEecccCCCC
Q 005278 291 QGPVPKSFGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 291 ~~~~p~~~~~l~~L~~L~l~~N~l~~ 316 (704)
++ +| .+..+++|+.|++++|+++.
T Consensus 191 ~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 191 SD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred CC-Ch-hhccCCCCCEEECcCCcccC
Confidence 63 33 36666667777777766654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-19 Score=184.47 Aligned_cols=168 Identities=29% Similarity=0.442 Sum_probs=129.0
Q ss_pred ccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcC
Q 005278 111 SLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLN 190 (704)
Q Consensus 111 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 190 (704)
+|++|++++|.+... + .+..+++|++|+|++|.+++..+ +..+++|+.|+|++|++++ ++ .+..+++|++|+|+
T Consensus 47 ~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (291)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred cccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECC
Confidence 344555555544433 2 36777888888888888885544 7888888888888888874 33 47888888888888
Q ss_pred CCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCC
Q 005278 191 GNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDI 270 (704)
Q Consensus 191 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 270 (704)
+|++++. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|++++ +
T Consensus 121 ~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l 193 (291)
T 1h6t_A 121 HNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L 193 (291)
T ss_dssp TSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C
T ss_pred CCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-C
Confidence 8888853 4577888888888888888854 578888888999999888886544 8888899999999999984 4
Q ss_pred CCCcCCCCCcceeeccCceeec
Q 005278 271 PTTIGGLENLETLSLADNQFQG 292 (704)
Q Consensus 271 ~~~~~~l~~L~~L~L~~n~l~~ 292 (704)
+ .+..+++|+.|++++|+++.
T Consensus 194 ~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 194 R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp G-GGTTCTTCSEEEEEEEEEEC
T ss_pred h-hhccCCCCCEEECcCCcccC
Confidence 4 48889999999999999885
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=8.2e-20 Score=177.04 Aligned_cols=152 Identities=28% Similarity=0.337 Sum_probs=96.2
Q ss_pred CEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCc
Q 005278 137 IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSN 216 (704)
Q Consensus 137 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 216 (704)
+.+++++++++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46677777776 4444333 56677777777776555556666677777777777776665666666666777777666
Q ss_pred cCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 217 KLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 217 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
.|+...+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 666555555666666666666666666555566666666666666666666555555555666666666666555
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.8e-20 Score=177.60 Aligned_cols=134 Identities=28% Similarity=0.351 Sum_probs=68.4
Q ss_pred CCEEEcCCCcCCccCC-ccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEee
Q 005278 184 LSELNLNGNKLCGHVP-PCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLS 262 (704)
Q Consensus 184 L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 262 (704)
+++|+|++|+|++..+ ..|..+++|+.|+|++|.|++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|+
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 3444444444443322 234444444444444444444444444445555555555555544444445555555555555
Q ss_pred cCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCC
Q 005278 263 RNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 263 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
+|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|++.+.
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 5555555555555555555555555555555555555555555555555555543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=3e-20 Score=194.80 Aligned_cols=157 Identities=25% Similarity=0.180 Sum_probs=73.2
Q ss_pred cCeeeccCcccCCCCCcccc-CCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEec
Q 005278 160 LQGLYLHGNKLQGSIPYDLC-HLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238 (704)
Q Consensus 160 L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 238 (704)
++.|+|++|+|++..+..+. .+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+...+..|..+++|++|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 44444444444433333333 44444444444444443333444444444444444444444444444444444445555
Q ss_pred CcccCCCCCcccccCcCCcEEEeecCccCCCCCCCc---CCCCCcceeeccCceeeccCCcccccccc--cceEEecccC
Q 005278 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTI---GGLENLETLSLADNQFQGPVPKSFGSLIS--LESLDLSRNN 313 (704)
Q Consensus 239 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~~~~p~~~~~l~~--L~~L~l~~N~ 313 (704)
+|.+....+..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++..+..+..++. |+.|+|++|+
T Consensus 121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~ 200 (361)
T 2xot_A 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence 444444444444555555555555555543222222 34555555555555555433344444444 2555555555
Q ss_pred CCC
Q 005278 314 LSG 316 (704)
Q Consensus 314 l~~ 316 (704)
+.+
T Consensus 201 ~~C 203 (361)
T 2xot_A 201 LEC 203 (361)
T ss_dssp EEC
T ss_pred ccC
Confidence 543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2e-19 Score=174.23 Aligned_cols=154 Identities=25% Similarity=0.345 Sum_probs=115.0
Q ss_pred CeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCc
Q 005278 161 QGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240 (704)
Q Consensus 161 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 240 (704)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46777777777 5565554 57777888888777666667777777888888888777777777777777888888888
Q ss_pred ccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCC
Q 005278 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 241 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
.++...+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 77765556667777788888888887777777777777788888888877766666677777777888888777653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.4e-19 Score=174.95 Aligned_cols=151 Identities=30% Similarity=0.352 Sum_probs=71.7
Q ss_pred CEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCc
Q 005278 137 IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSN 216 (704)
Q Consensus 137 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 216 (704)
+.++.+++.++ .+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 44555555555 3333222 45555555555555444555555555555555555554333344455555555555555
Q ss_pred cCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 217 KLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 217 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
.|++..+..|..+++|++|+|++|.++ .+|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 555444444444444444444444444 33444444444444444444444333333444444444444444443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.1e-19 Score=172.94 Aligned_cols=155 Identities=23% Similarity=0.266 Sum_probs=115.7
Q ss_pred CEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCC-ccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecC
Q 005278 137 IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIP-YDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGS 215 (704)
Q Consensus 137 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 215 (704)
+++++++|.++ .+|..+. +.++.|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 46777777776 3454432 345677777777775533 3467777777777777777766666777777888888888
Q ss_pred ccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccC
Q 005278 216 NKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294 (704)
Q Consensus 216 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 294 (704)
|.+++..+..|..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+.+..
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 8887776677777888888888888888777778888888888888888888777888888888888888888887543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=190.02 Aligned_cols=152 Identities=18% Similarity=0.178 Sum_probs=75.8
Q ss_pred cEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhh-cCCCCCEEEccCCcCccccChhhcCCCCcCeeecc
Q 005278 88 TVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIG-NLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLH 166 (704)
Q Consensus 88 ~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 166 (704)
+.+++++|+++. +|..+. ..++.|+|++|++++..+..+. ++++|++|+|++|.|+...+..|.++++|++|+|+
T Consensus 21 ~~l~c~~~~l~~-iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcCc-cCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 455555555552 232221 2344444444444444444444 55555555555555555444555555555555555
Q ss_pred CcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcc---cCCccccEEEecCcccC
Q 005278 167 GNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSF---GSLEYVLYINLSANSLN 243 (704)
Q Consensus 167 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~l~~N~l~ 243 (704)
+|+|+...+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.|++..+..| ..+++|+.|+|++|.|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 555554444445555555555555555554445555555555555555555553332223 23444444444444444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-18 Score=170.13 Aligned_cols=156 Identities=26% Similarity=0.304 Sum_probs=132.3
Q ss_pred cCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecC
Q 005278 160 LQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239 (704)
Q Consensus 160 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 239 (704)
-+.+++++++++ .+|..+. ++|++|+|++|.+++..|..|..+++|+.|+|++|.|+...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 567888888888 6676554 7899999999999887788888889999999999999877777788899999999999
Q ss_pred cccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCC
Q 005278 240 NSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 240 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 319 (704)
|.+++..+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++.+..+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9998777777888899999999999998 788888889999999999999987666778888999999999999887655
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-22 Score=218.99 Aligned_cols=204 Identities=20% Similarity=0.210 Sum_probs=147.7
Q ss_pred cCCCCCCEEeccCccccccCchhhcCCCCCCEEeccccc-------------CCCcccchhhcccccCCCCCCCcEEE-c
Q 005278 27 TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY-------------LMTESSAAKWNFLSSLTNCRNLTVLG-L 92 (704)
Q Consensus 27 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-------------i~~~~~~~~~~~~~~~~~l~~L~~L~-L 92 (704)
..+++|+.|+|++|.++ .+|..++++++|+.|++++|. +... .+..+.++++|+.|+ +
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~-------~~~~l~~l~~L~~L~~l 417 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY-------EKETLQYFSTLKAVDPM 417 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGG-------HHHHHHHHHHHHHHCGG
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccC-------CHHHHHHHHhcccCcch
Confidence 45677777777777776 457777777777777776553 1111 233356666666666 5
Q ss_pred cCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCC
Q 005278 93 ASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQG 172 (704)
Q Consensus 93 ~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 172 (704)
+.|.+. +|+.+.+.+|.++...+ ..|+.|+|++|.|++ +|. |+.+++|+.|+|++|+|+
T Consensus 418 ~~n~~~------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~- 476 (567)
T 1dce_A 418 RAAYLD------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR- 476 (567)
T ss_dssp GHHHHH------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-
T ss_pred hhcccc------------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-
Confidence 555432 35555555666553322 248889999998885 565 888889999999999988
Q ss_pred CCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCC-CCcccCCccccEEEecCcccCCCCCcc--
Q 005278 173 SIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTM-PSSFGSLEYVLYINLSANSLNGSLPSN-- 249 (704)
Q Consensus 173 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~~-- 249 (704)
.+|..++.+++|+.|+|++|+|++ +| .+..+++|+.|+|++|.|++.. |..++.+++|+.|+|++|.+++..+..
T Consensus 477 ~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 554 (567)
T 1dce_A 477 ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 554 (567)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHH
Confidence 778888888999999999999885 56 7888899999999999998776 888888999999999999988654432
Q ss_pred -cccCcCCcEEEe
Q 005278 250 -IQNLKVLTNLDL 261 (704)
Q Consensus 250 -~~~l~~L~~L~l 261 (704)
+..+++|+.|++
T Consensus 555 l~~~lp~L~~L~l 567 (567)
T 1dce_A 555 LAEMLPSVSSILT 567 (567)
T ss_dssp HHHHCTTCSEEEC
T ss_pred HHHHCcccCccCC
Confidence 334788888864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-19 Score=168.04 Aligned_cols=107 Identities=18% Similarity=0.275 Sum_probs=50.2
Q ss_pred hcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCE
Q 005278 131 GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRR 210 (704)
Q Consensus 131 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 210 (704)
+.+++|++|++++|.+. .++ .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..+..+++|+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44455555555555555 233 3455555555555555443 1224444455555555555554434444444444444
Q ss_pred EEecCccCCCCCCCcccCCccccEEEecCcc
Q 005278 211 LHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241 (704)
Q Consensus 211 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 241 (704)
|++++|.+++..+..+..+++|++|++++|.
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 4444444443333344444444444444443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.9e-21 Score=214.82 Aligned_cols=204 Identities=19% Similarity=0.148 Sum_probs=157.2
Q ss_pred cCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhh
Q 005278 51 GNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEI 130 (704)
Q Consensus 51 ~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 130 (704)
...++|+.|+|++|+++.+ |+.+.++++|+.|++++|......|.. + ..+...+..|..+
T Consensus 346 ~~~~~L~~L~Ls~n~L~~L--------p~~i~~l~~L~~L~l~~n~~l~~l~~l-------l-----~~~~~~~~~~~~l 405 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTVL--------QSELESCKELQELEPENKWCLLTIILL-------M-----RALDPLLYEKETL 405 (567)
T ss_dssp STTTTSSSCCCCHHHHHHH--------HHHHHHHHHHHHHCTTCHHHHHHHHHH-------H-----HHHCTGGGHHHHH
T ss_pred ccCccceeccCChhhHHhh--------HHHHHHHHHHHHhccccchhhhhHHHH-------H-----HhcccccCCHHHH
Confidence 6788999999999999764 445889999999999776521111100 0 1122334455555
Q ss_pred hcCCCCCEEE-ccC-------------CcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCc
Q 005278 131 GNLSGMIVFD-LNG-------------CDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCG 196 (704)
Q Consensus 131 ~~l~~L~~L~-L~~-------------n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 196 (704)
+++++|+.|+ ++. |.+....+ ..|+.|+|++|+|++ +|. +..+++|+.|+|++|+|+
T Consensus 406 ~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~- 476 (567)
T 1dce_A 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR- 476 (567)
T ss_dssp HHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-
T ss_pred HHHHhcccCcchhhcccchhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-
Confidence 5555555555 343 44442211 358999999999995 676 999999999999999999
Q ss_pred cCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCC-CcccccCcCCcEEEeecCccCCCCCCC--
Q 005278 197 HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSL-PSNIQNLKVLTNLDLSRNQLSGDIPTT-- 273 (704)
Q Consensus 197 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~-- 273 (704)
.+|..++.+++|+.|+|++|.|++ +| .++.+++|+.|+|++|.+++.. |..++.+++|+.|+|++|++++..|..
T Consensus 477 ~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 554 (567)
T 1dce_A 477 ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 554 (567)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHH
Confidence 789999999999999999999996 56 8999999999999999999776 999999999999999999999655532
Q ss_pred -cCCCCCcceeec
Q 005278 274 -IGGLENLETLSL 285 (704)
Q Consensus 274 -~~~l~~L~~L~L 285 (704)
+..+++|+.|++
T Consensus 555 l~~~lp~L~~L~l 567 (567)
T 1dce_A 555 LAEMLPSVSSILT 567 (567)
T ss_dssp HHHHCTTCSEEEC
T ss_pred HHHHCcccCccCC
Confidence 234889999875
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.2e-19 Score=169.07 Aligned_cols=155 Identities=17% Similarity=0.283 Sum_probs=136.8
Q ss_pred hcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCcccc
Q 005278 154 VGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVL 233 (704)
Q Consensus 154 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 233 (704)
...+++|+.|++++|.++ .+| .+..+++|++|++++|.++ . +..+..+++|+.|++++|.+++..+..++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 366789999999999999 556 7999999999999999876 3 34789999999999999999987889999999999
Q ss_pred EEEecCcccCCCCCcccccCcCCcEEEeecCc-cCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEeccc
Q 005278 234 YINLSANSLNGSLPSNIQNLKVLTNLDLSRNQ-LSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312 (704)
Q Consensus 234 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N 312 (704)
+|++++|.+++..+..+..+++|+.|++++|+ ++ .++ .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 99999999998888999999999999999998 65 666 68999999999999999995 44 7889999999999999
Q ss_pred CCCC
Q 005278 313 NLSG 316 (704)
Q Consensus 313 ~l~~ 316 (704)
++.+
T Consensus 192 ~i~~ 195 (197)
T 4ezg_A 192 TIGG 195 (197)
T ss_dssp ----
T ss_pred ccCC
Confidence 9864
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-19 Score=179.80 Aligned_cols=167 Identities=22% Similarity=0.295 Sum_probs=110.6
Q ss_pred ccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcC
Q 005278 111 SLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLN 190 (704)
Q Consensus 111 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 190 (704)
.+..+++.+|.+++.. .+..+++|++|++++|.++. ++ .+..+++|++|+|++|+|++..+ +..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 4666777777776443 56777777888888777773 34 57777777777777777774433 7777777777777
Q ss_pred CCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCC
Q 005278 191 GNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDI 270 (704)
Q Consensus 191 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 270 (704)
+|++++ ++. +.. ++|+.|++++|.+++. ..+..+++|+.|++++|.+++. + .+..+++|+.|++++|++++.
T Consensus 94 ~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 94 RNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp SSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred CCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence 777774 333 222 6777777777777643 3466667777777777776643 2 566666666666666666643
Q ss_pred CCCcCCCCCcceeeccCceeec
Q 005278 271 PTTIGGLENLETLSLADNQFQG 292 (704)
Q Consensus 271 ~~~~~~l~~L~~L~L~~n~l~~ 292 (704)
..+..+++|+.|++++|++++
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEEC
T ss_pred -HHhccCCCCCEEeCCCCcccC
Confidence 456666666666666666664
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.3e-19 Score=175.31 Aligned_cols=170 Identities=24% Similarity=0.354 Sum_probs=89.1
Q ss_pred CCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEE
Q 005278 133 LSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLH 212 (704)
Q Consensus 133 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 212 (704)
+.++..+++++|.++... .+..+++|+.|++++|+++ .++ .+..+++|++|+|++|++++..+ +..+++|+.|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 334445555555555322 3455555555555555555 233 45555555555555555553322 55555555555
Q ss_pred ecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeec
Q 005278 213 LGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292 (704)
Q Consensus 213 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 292 (704)
+++|++++. +. +.. ++|++|++++|.+++. ..+..+++|+.|++++|++++ ++ .+..+++|+.|++++|++++
T Consensus 92 L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcc
Confidence 555555532 21 111 5555555555555532 235555555555555555553 22 45555555555555555554
Q ss_pred cCCcccccccccceEEecccCCCCC
Q 005278 293 PVPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 293 ~~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
. ..+..+++|+.|++++|++++.
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h--HHhccCCCCCEEeCCCCcccCC
Confidence 3 4455555555555555555544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-19 Score=205.58 Aligned_cols=188 Identities=21% Similarity=0.254 Sum_probs=120.1
Q ss_pred ecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCc
Q 005278 117 AYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCG 196 (704)
Q Consensus 117 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 196 (704)
+..|.+. ..+..+..++.|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3344444 56778888999999999999988 66777778999999999999998 78888999999999999999999
Q ss_pred cCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcC-CcEEEeecCccCCCCCCCcC
Q 005278 197 HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKV-LTNLDLSRNQLSGDIPTTIG 275 (704)
Q Consensus 197 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~ 275 (704)
.+|..|..+++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|.+++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~-- 360 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE-- 360 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc--
Confidence 77888999999999999999997 67778999999999999999999888887765432 234789999999888764
Q ss_pred CCCCcceeeccCc--------eeeccCCcccccccccceEEecccCCC
Q 005278 276 GLENLETLSLADN--------QFQGPVPKSFGSLISLESLDLSRNNLS 315 (704)
Q Consensus 276 ~l~~L~~L~L~~n--------~l~~~~p~~~~~l~~L~~L~l~~N~l~ 315 (704)
|+.|+++.| .+.+..+..+..+.++....+++|-+.
T Consensus 361 ----l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 361 ----RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ---------------------------------------------CCC
T ss_pred ----cceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 445666666 333344444455666666667777654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=7.2e-19 Score=174.80 Aligned_cols=138 Identities=21% Similarity=0.250 Sum_probs=106.5
Q ss_pred CCCccccccccCceEEEEEEE-CCCCE--EEEEEeeccchh------------------------hhHHHHHHHHHHHhc
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTN--VAIKVFNLQLER------------------------ASRSFDSECEILRSI 468 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 468 (704)
-|+..+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++.++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999997 68989 999987543111 113688999999999
Q ss_pred CCCCC--ceEEeeeeeCCeEEEEEeccCC-C----CHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 005278 469 RHRNL--IKIISNCCNIDFKALVLEFMPN-G----SLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDL 541 (704)
Q Consensus 469 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dl 541 (704)
+|+++ ...+++ +..++||||+.+ | +|.++... .++.....++.|++.|+.|||. +.+|+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 88754 444442 345899999942 4 67665432 2244567899999999999951 578999999
Q ss_pred CCCCeeeCCCCcEEEeeeccceec
Q 005278 542 KPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 542 k~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999865
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5e-17 Score=171.63 Aligned_cols=264 Identities=10% Similarity=0.095 Sum_probs=137.6
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
..++.+.+.++ ++.+-..+|.+. +|+.+.|..+ ++.+...+|.+. +|+.+.+.. .+..++..+ |.+|+
T Consensus 113 ~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~a-------F~~c~ 180 (401)
T 4fdw_A 113 KGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDI-------FYYCY 180 (401)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSST-------TTTCT
T ss_pred CCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHH-------hhCcc
Confidence 44555555543 333445566653 5666666554 555666666663 566666654 555555444 66666
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeec
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL 165 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 165 (704)
+|+.++|+.|++.......|.. .+|+.+.+.++ +......+|.++++|+.+++..| ++.+...+|.+ .+
T Consensus 181 ~L~~l~l~~n~l~~I~~~aF~~--~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~------ 249 (401)
T 4fdw_A 181 NLKKADLSKTKITKLPASTFVY--AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SG------ 249 (401)
T ss_dssp TCCEEECTTSCCSEECTTTTTT--CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CC------
T ss_pred cCCeeecCCCcceEechhhEee--cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CC------
Confidence 6666666666666444444442 34555555422 44444444555555555555432 33333334444 44
Q ss_pred cCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCC-----CCCCCcccCCccccEEEecCc
Q 005278 166 HGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLT-----STMPSSFGSLEYVLYINLSAN 240 (704)
Q Consensus 166 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-----~~~~~~~~~l~~L~~L~l~~N 240 (704)
|+.+.|. +.++.....+|.++++|+.+.+.+|.+. .+....|.++++|+.++|. +
T Consensus 250 ------------------L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~ 309 (401)
T 4fdw_A 250 ------------------ITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-E 309 (401)
T ss_dssp ------------------CSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-T
T ss_pred ------------------ccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-C
Confidence 4444442 2233233344445555555555444432 2344455555555555555 2
Q ss_pred ccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCccccccc-ccceEEecccCC
Q 005278 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI-SLESLDLSRNNL 314 (704)
Q Consensus 241 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l 314 (704)
.++.....+|.++++|+.++|..| ++.....+|.++ +|+.+++.+|.+....+..|..++ +++.|.+..+.+
T Consensus 310 ~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 310 SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 344444555556666666666433 443445556666 666666666665544445555553 456666655543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-18 Score=179.13 Aligned_cols=265 Identities=14% Similarity=0.113 Sum_probs=166.1
Q ss_pred CCCCCCEEeccCccccccCchhhcC-CCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhh
Q 005278 28 NASKLIMLDLSSNSFSGLIPNTFGN-LGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIG 106 (704)
Q Consensus 28 ~l~~L~~L~L~~n~i~~~~~~~~~~-l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 106 (704)
.+.+|++|.++++ +.......+.. +++|++|||++|+|...... -..++.+..+.+..|.| ....|.
T Consensus 23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~--------~~~~~~~~~~~~~~~~I---~~~aF~ 90 (329)
T 3sb4_A 23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGK--------AGTYPNGKFYIYMANFV---PAYAFS 90 (329)
T ss_dssp HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEES--------SSSSGGGCCEEECTTEE---CTTTTE
T ss_pred hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCc--------ccccccccccccccccc---CHHHhc
Confidence 3677888888865 33233334444 78899999999988721111 11122245555555532 223333
Q ss_pred h-------cccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCccc----CCCCC
Q 005278 107 N-------FSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKL----QGSIP 175 (704)
Q Consensus 107 ~-------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l----~~~~~ 175 (704)
. -+.+|++|.|.+ .++...+.+|.+|++|+.|++++|.+..+.+.+|.+..++..+.+..+.. .....
T Consensus 91 ~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~ 169 (329)
T 3sb4_A 91 NVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEH 169 (329)
T ss_dssp EEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTT
T ss_pred ccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccc
Confidence 3 034677777777 77777777788888888888888877766677777777777666655322 21223
Q ss_pred ccccCCCCCC-EEEcC-------------------------CCcCCccCCccc-cCcCCCCEEEecCccCCCCCCCcccC
Q 005278 176 YDLCHLEGLS-ELNLN-------------------------GNKLCGHVPPCL-ASLTSLRRLHLGSNKLTSTMPSSFGS 228 (704)
Q Consensus 176 ~~l~~l~~L~-~L~L~-------------------------~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~ 228 (704)
..|.++.+|+ .+.+. ++-.. .....+ ..+++|+.|+|++|+++.+....|.+
T Consensus 170 ~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~ 248 (329)
T 3sb4_A 170 FAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQ 248 (329)
T ss_dssp SCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTT
T ss_pred cccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhC
Confidence 3344444444 23332 21110 000011 12577888888887777666677777
Q ss_pred CccccEEEecCcccCCCCCcccccCcCCc-EEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceE
Q 005278 229 LEYVLYINLSANSLNGSLPSNIQNLKVLT-NLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESL 307 (704)
Q Consensus 229 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 307 (704)
+++|+.|+|.+| ++.....+|.++++|+ .+++.+ .++...+.+|.++++|+.|++++|+++...+..|.++++|+.+
T Consensus 249 ~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 249 KKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred CCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 888888888777 6666677777787787 888877 6665566777888888888887787776666777777777776
Q ss_pred E
Q 005278 308 D 308 (704)
Q Consensus 308 ~ 308 (704)
+
T Consensus 327 y 327 (329)
T 3sb4_A 327 Y 327 (329)
T ss_dssp E
T ss_pred c
Confidence 5
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=172.12 Aligned_cols=242 Identities=13% Similarity=0.073 Sum_probs=152.3
Q ss_pred CCCCCEEecCCCcCc--------------------ccCCccccC--------CCCCCEEeccCccccccCchhhcCCCCC
Q 005278 5 LPNLKYLTLFDNKLS--------------------GTIPNSITN--------ASKLIMLDLSSNSFSGLIPNTFGNLGSL 56 (704)
Q Consensus 5 l~~l~~L~l~~~~i~--------------------~~~~~~~~~--------l~~L~~L~L~~n~i~~~~~~~~~~l~~L 56 (704)
+++|+.|||++|+|. .+-..+|.+ +++|++|+|.+ .++.+...+|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 789999999999988 222334444 55555555554 4444555555555555
Q ss_pred CEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCC----CcccCChhhhhcccccc-eEEecCCcccccCChhh-
Q 005278 57 QVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNP----LRGILPPLIGNFSASLQ-EFYAYGCKLRGNIPQEI- 130 (704)
Q Consensus 57 ~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~----i~~~~~~~~~~~~~~L~-~L~l~~n~l~~~~~~~~- 130 (704)
+.|++++|.+..++..+ |..+.++.++.+..+. ........|.... .|+ .+.+.... .++..+
T Consensus 127 ~~l~l~~n~i~~i~~~a-------F~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~-~L~~~i~~~~~~---~l~~~~~ 195 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEA-------LADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE-PLETTIQVGAMG---KLEDEIM 195 (329)
T ss_dssp CEEEBCCSSCCEECTTS-------SCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC-CCEEEEEECTTC---CHHHHHH
T ss_pred ceEEcCCCCccccchhh-------hcCCCceEEecCcchhhhhcccccccccccccc-ccceeEEecCCC---cHHHHHh
Confidence 55555555554444433 4444444444443311 1111111121111 122 22222111 111111
Q ss_pred ---hcCCCCCEEEccCCcCccccChhh-cCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcC
Q 005278 131 ---GNLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLT 206 (704)
Q Consensus 131 ---~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 206 (704)
....++..+.+.++-.. .....+ ..+++|+.|+|++|+++...+.+|.++++|++|+|.+| ++...+.+|.+++
T Consensus 196 ~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~ 273 (329)
T 3sb4_A 196 KAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCG 273 (329)
T ss_dssp HTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred hcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCCh
Confidence 13456677777766333 222222 24789999999999998666678999999999999988 7766677899999
Q ss_pred CCC-EEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEe
Q 005278 207 SLR-RLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDL 261 (704)
Q Consensus 207 ~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 261 (704)
+|+ .+++.+ .++.+.+..|.++++|+.|+++.|.++...+.+|.++++|+.++.
T Consensus 274 ~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 274 RLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred hccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 999 999988 777777889999999999999999998888889999999998863
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-18 Score=198.28 Aligned_cols=184 Identities=21% Similarity=0.264 Sum_probs=79.3
Q ss_pred CCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCccc--chhhcccccCCCCCCCcEEEccCCCCcccCChhhhh
Q 005278 30 SKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESS--AAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGN 107 (704)
Q Consensus 30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~--~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 107 (704)
+.++.|+|.+|.+..+ +..+ |+.++|++|.|..... ...+..+..+..+++|+.|+|++|.+. .+|..+..
T Consensus 173 ~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~ 245 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQAL-----LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFK 245 (727)
T ss_dssp -------------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGG
T ss_pred CccceEEeeCCCCCcc-hhhH-----hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcC
Confidence 5567777777777753 2222 3344444444333210 000112334666777777777777776 44444444
Q ss_pred cccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEE
Q 005278 108 FSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSEL 187 (704)
Q Consensus 108 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 187 (704)
+ .+|++|+|++|.++ .+|..|+++++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|+ .+|..|..+++|++|
T Consensus 246 l-~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L 321 (727)
T 4b8c_D 246 Y-DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFL 321 (727)
T ss_dssp C-CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCE
T ss_pred C-CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEE
Confidence 3 24566666666555 55555666666666666666666 45666666666666666666665 455556666666666
Q ss_pred EcCCCcCCccCCccccCcC-CCCEEEecCccCCCCCCC
Q 005278 188 NLNGNKLCGHVPPCLASLT-SLRRLHLGSNKLTSTMPS 224 (704)
Q Consensus 188 ~L~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~ 224 (704)
+|++|.|++.+|..+..+. .+..|+|++|.+++.+|.
T Consensus 322 ~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 322 GVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp ECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred eCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 6666666655555443321 112245555555554443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=3.9e-17 Score=154.54 Aligned_cols=129 Identities=29% Similarity=0.371 Sum_probs=78.1
Q ss_pred CeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCc-cccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecC
Q 005278 161 QGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239 (704)
Q Consensus 161 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 239 (704)
+.+++++|+++ .+|..+.. +|++|++++|++++..+. .+..+++|+.|+|++|.|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56667777665 45554432 666666666666644443 356666666666666666666566666666666666666
Q ss_pred cccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeec
Q 005278 240 NSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQG 292 (704)
Q Consensus 240 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 292 (704)
|.+++..+..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|.+.+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 66665555555556666666666666655555555555556666666665554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5.5e-16 Score=163.67 Aligned_cols=254 Identities=12% Similarity=0.092 Sum_probs=204.0
Q ss_pred cCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhh
Q 005278 51 GNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEI 130 (704)
Q Consensus 51 ~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 130 (704)
.....++.+.+.. .++.++..+ |.++ +|+.+.|..+ +..+....|... +|+.+.+.+ .+......+|
T Consensus 110 ~~~~~l~~i~ip~-~i~~I~~~a-------F~~~-~L~~i~l~~~-i~~I~~~aF~~~--~L~~i~lp~-~l~~I~~~aF 176 (401)
T 4fdw_A 110 EILKGYNEIILPN-SVKSIPKDA-------FRNS-QIAKVVLNEG-LKSIGDMAFFNS--TVQEIVFPS-TLEQLKEDIF 176 (401)
T ss_dssp EECSSCSEEECCT-TCCEECTTT-------TTTC-CCSEEECCTT-CCEECTTTTTTC--CCCEEECCT-TCCEECSSTT
T ss_pred EecCCccEEEECC-ccCEehHhh-------cccC-CccEEEeCCC-ccEECHHhcCCC--CceEEEeCC-CccEehHHHh
Confidence 4456677777764 466666655 6665 6888888766 666666677663 588888875 6777778899
Q ss_pred hcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCE
Q 005278 131 GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRR 210 (704)
Q Consensus 131 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 210 (704)
.+|++|+.++|++|.++.+...+|. .++|+.+.|..+ ++.....+|.++++|+.+++.+| ++.....+|.+ .+|+.
T Consensus 177 ~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~ 252 (401)
T 4fdw_A 177 YYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITT 252 (401)
T ss_dssp TTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSE
T ss_pred hCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccE
Confidence 9999999999999999977677777 589999999855 77677788999999999999976 56466677877 89999
Q ss_pred EEecCccCCCCCCCcccCCccccEEEecCcccC-----CCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeec
Q 005278 211 LHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN-----GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSL 285 (704)
Q Consensus 211 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-----~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 285 (704)
+.+. |.++.+....|.++++|+.+++.+|.+. ......|.++++|+.+++. +.++.....+|.++.+|+.++|
T Consensus 253 i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~l 330 (401)
T 4fdw_A 253 VKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTI 330 (401)
T ss_dssp EEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEE
T ss_pred EEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEE
Confidence 9994 5677677889999999999999998875 4667889999999999999 4587677789999999999999
Q ss_pred cCceeeccCCcccccccccceEEecccCCCCCCCCCcccc
Q 005278 286 ADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQ 325 (704)
Q Consensus 286 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 325 (704)
..| ++......|.++ +|+.+++++|.+....+..|...
T Consensus 331 p~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~ 368 (401)
T 4fdw_A 331 PAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGF 368 (401)
T ss_dssp CTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCS
T ss_pred Ccc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCC
Confidence 666 766777889999 99999999998876555555443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=3.2e-17 Score=155.14 Aligned_cols=130 Identities=26% Similarity=0.391 Sum_probs=80.9
Q ss_pred CEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCc-cccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecC
Q 005278 137 IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPY-DLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGS 215 (704)
Q Consensus 137 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 215 (704)
+++++++|+++ .+|..+. .+|++|+|++|+|++..+. .+..+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56666666665 4444333 2666666666666644433 356666666666666666655566666666666666666
Q ss_pred ccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCC
Q 005278 216 NKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGD 269 (704)
Q Consensus 216 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 269 (704)
|+|++..+..|..+++|++|+|++|.+++..|..|..+++|+.|++++|++.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 666666666666666666666666666666666666666666666666666643
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=9.3e-17 Score=148.56 Aligned_cols=132 Identities=24% Similarity=0.260 Sum_probs=73.5
Q ss_pred CCCCEEEccCCcCc-cccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEE
Q 005278 134 SGMIVFDLNGCDLN-GTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLH 212 (704)
Q Consensus 134 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 212 (704)
++|++|++++|.+. +.+|..+..+++|+.|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 44555556666666666666666533 4555666666666666666644555555566666666
Q ss_pred ecCccCCCCCC-CcccCCccccEEEecCcccCCCCC---cccccCcCCcEEEeecCccC
Q 005278 213 LGSNKLTSTMP-SSFGSLEYVLYINLSANSLNGSLP---SNIQNLKVLTNLDLSRNQLS 267 (704)
Q Consensus 213 l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~l~~n~l~ 267 (704)
+++|.+++... ..+..+++|++|++++|.+.+..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 66666654211 445555555555555555553332 24445555555555555554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-16 Score=147.24 Aligned_cols=132 Identities=27% Similarity=0.250 Sum_probs=98.8
Q ss_pred CCCCEEEcCCCcCC-ccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEE
Q 005278 182 EGLSELNLNGNKLC-GHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLD 260 (704)
Q Consensus 182 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 260 (704)
++|++|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|++++|.+.+.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 55666677777777777777777754 6677777788888888887766777777788888888
Q ss_pred eecCccCCCC-CCCcCCCCCcceeeccCceeeccCC---cccccccccceEEecccCCC
Q 005278 261 LSRNQLSGDI-PTTIGGLENLETLSLADNQFQGPVP---KSFGSLISLESLDLSRNNLS 315 (704)
Q Consensus 261 l~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~l~~N~l~ 315 (704)
+++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 8888887432 2677788888888888888875444 36778888888888888775
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.7e-16 Score=146.44 Aligned_cols=127 Identities=25% Similarity=0.355 Sum_probs=74.5
Q ss_pred CeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCc
Q 005278 161 QGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240 (704)
Q Consensus 161 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 240 (704)
+.+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|+.|+|++|.|++..+..|..+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666677666 4554443 46666666666666 45566666666666666666666555555666666666666666
Q ss_pred ccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 241 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
.+++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 665555555555555555555555555333334555555555555555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=9.3e-16 Score=144.97 Aligned_cols=128 Identities=26% Similarity=0.335 Sum_probs=83.0
Q ss_pred CEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecC
Q 005278 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRN 264 (704)
Q Consensus 185 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n 264 (704)
+.+++++|.++ .+|..+. ++|+.|++++|.++ .+|..|..+++|+.|+|++|.+++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666666666 4454332 46666777777666 45566666666777777777766666666666666777777777
Q ss_pred ccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCC
Q 005278 265 QLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 265 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 316 (704)
++++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|++.+
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 7665555666666677777777776665444556666667777777776664
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=9.7e-16 Score=142.97 Aligned_cols=113 Identities=30% Similarity=0.313 Sum_probs=56.5
Q ss_pred CCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeecc
Q 005278 207 SLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLA 286 (704)
Q Consensus 207 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 286 (704)
+|+.|++++|.+++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|++++..+..+..+++|+.|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 108 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence 44444444444443333344444444444444444443333444455555555555555554444445555555555555
Q ss_pred CceeeccCCcccccccccceEEecccCCCCCCC
Q 005278 287 DNQFQGPVPKSFGSLISLESLDLSRNNLSGEIP 319 (704)
Q Consensus 287 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 319 (704)
+|++++..+..+..+++|+.|++++|++.+..|
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 555554333344555556666666665555443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-16 Score=144.03 Aligned_cols=127 Identities=25% Similarity=0.263 Sum_probs=69.8
Q ss_pred CCCCEEEcCCCcCC-ccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEE
Q 005278 182 EGLSELNLNGNKLC-GHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLD 260 (704)
Q Consensus 182 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 260 (704)
++|++|++++|.++ +.+|..+..+++|+.|++++|.+++. ..++.+++|++|++++|.+++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34455555555544 34444445555555555555555433 4455555555555555555544555555566666666
Q ss_pred eecCccCCC-CCCCcCCCCCcceeeccCceeeccCC---cccccccccceEEec
Q 005278 261 LSRNQLSGD-IPTTIGGLENLETLSLADNQFQGPVP---KSFGSLISLESLDLS 310 (704)
Q Consensus 261 l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~l~ 310 (704)
+++|++++. .+..++.+++|+.|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666532 23556666666666666666664443 356666666666654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-15 Score=140.82 Aligned_cols=131 Identities=24% Similarity=0.294 Sum_probs=86.5
Q ss_pred CeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCc
Q 005278 161 QGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240 (704)
Q Consensus 161 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 240 (704)
+.+++++|+++ .+|..+. ++|++|++++|++++..+..+..+++|+.|++++|.+++..+..|..+++|++|++++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 45555555555 3343332 46666666666666544455666666666666666666555555666777777777777
Q ss_pred ccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccC
Q 005278 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294 (704)
Q Consensus 241 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 294 (704)
.+++..+..+..+++|+.|++++|++++..+..+..+++|+.|+|++|++.+..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 777666666677777888888888887555555677888888888888877543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=136.98 Aligned_cols=128 Identities=21% Similarity=0.214 Sum_probs=73.0
Q ss_pred CCCCEEeccCcccc-ccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhc
Q 005278 30 SKLIMLDLSSNSFS-GLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNF 108 (704)
Q Consensus 30 ~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~ 108 (704)
++|++|++++|.++ +.+|..|..+++|++|++++|.++.. . .+..+++|++|+|++|++.+.+|..+..+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~-------~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l 87 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--A-------NLPKLNKLKKLELSDNRVSGGLEVLAEKC 87 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--T-------TCCCCTTCCEEECCSSCCCSCTHHHHHHC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--h-------hhhcCCCCCEEECCCCcccchHHHHhhhC
Confidence 44555555555554 33444445555555555555555443 1 14455555555555555554444444333
Q ss_pred ccccceEEecCCccccc-CChhhhcCCCCCEEEccCCcCccccC---hhhcCCCCcCeeeccC
Q 005278 109 SASLQEFYAYGCKLRGN-IPQEIGNLSGMIVFDLNGCDLNGTIP---TAVGRLRRLQGLYLHG 167 (704)
Q Consensus 109 ~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~ 167 (704)
++|++|++++|.+++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|++++
T Consensus 88 -~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 88 -PNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp -TTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred -CCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 2455555555555542 23567778888888888888876655 5678888888888763
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3.6e-16 Score=160.77 Aligned_cols=137 Identities=14% Similarity=0.176 Sum_probs=100.5
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccch--------------hh--------hHHHHHHHHHHHhcCCCC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE--------------RA--------SRSFDSECEILRSIRHRN 472 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~--------~~~~~~e~~~l~~l~h~n 472 (704)
.-|++.++||+|+||.||+|...+|+.||||+++.... .. ......|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999988999999998753210 00 011345777777775544
Q ss_pred Cc--eEEeeeeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 005278 473 LI--KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE 550 (704)
Q Consensus 473 iv--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~ 550 (704)
+. ..+++ ...++||||++++++.++.... ....++.|++.++.|||. .+||||||||.|||+++
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~~-------~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSVP-------DPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCCS-------CHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhcccH-------HHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence 32 22222 1236999999998887654321 235678999999999964 68999999999999987
Q ss_pred CC----------cEEEeeeccceec
Q 005278 551 NM----------TAHVSDFGISKLL 565 (704)
Q Consensus 551 ~~----------~~kl~Dfgla~~~ 565 (704)
++ .+.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999977654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=2.2e-15 Score=140.32 Aligned_cols=131 Identities=19% Similarity=0.224 Sum_probs=71.4
Q ss_pred cCCCCCCEEEcCCCcCCccCCccccCc-CCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCc
Q 005278 179 CHLEGLSELNLNGNKLCGHVPPCLASL-TSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLT 257 (704)
Q Consensus 179 ~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 257 (704)
.++++|++|++++|+++ .++. +..+ ++|+.|++++|.+++. ..+..+++|++|++++|.+++..+..+..+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 33445555555555554 2232 2222 2555555555555533 3455555555555555555543333345566666
Q ss_pred EEEeecCccCCCCCC--CcCCCCCcceeeccCceeeccCCcc----cccccccceEEecccCCC
Q 005278 258 NLDLSRNQLSGDIPT--TIGGLENLETLSLADNQFQGPVPKS----FGSLISLESLDLSRNNLS 315 (704)
Q Consensus 258 ~L~l~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~p~~----~~~l~~L~~L~l~~N~l~ 315 (704)
.|++++|+++ .+|. .+..+++|+.|++++|+++ .+|.. +..+++|+.||+++|...
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 6666666664 3443 5666666666666666665 34443 666677777777776654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-17 Score=156.05 Aligned_cols=155 Identities=23% Similarity=0.284 Sum_probs=104.7
Q ss_pred cCCCCcCeeeccCcccCCCCCc------cccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccC
Q 005278 155 GRLRRLQGLYLHGNKLQGSIPY------DLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGS 228 (704)
Q Consensus 155 ~~l~~L~~L~L~~n~l~~~~~~------~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 228 (704)
.....++.++++.+.+++..|. .+..+++|++|+|++|.+++ +| .+..+++|+.|++++|.++ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3344555555555555554444 56666667777777766664 44 5666677777777777776 45555666
Q ss_pred CccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCC-CCcCCCCCcceeeccCceeeccCCcc----------
Q 005278 229 LEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIP-TTIGGLENLETLSLADNQFQGPVPKS---------- 297 (704)
Q Consensus 229 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p~~---------- 297 (704)
+++|++|++++|.+++ +| .+..+++|+.|++++|++++..+ ..+..+++|+.|++++|++++..|..
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 169 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence 6777777777777764 33 56777788888888888874222 36778888888888888887765543
Q ss_pred cccccccceEEecccCCCC
Q 005278 298 FGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 298 ~~~l~~L~~L~l~~N~l~~ 316 (704)
+..+++|+.|| +|+++.
T Consensus 170 ~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 170 VKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HHHCSSCSEEC--CGGGTT
T ss_pred HHhCCCcEEEC--CcccCH
Confidence 77888898886 777763
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=2.8e-15 Score=139.63 Aligned_cols=132 Identities=18% Similarity=0.127 Sum_probs=65.9
Q ss_pred CCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCc
Q 005278 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRL 160 (704)
Q Consensus 81 ~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 160 (704)
+.++.+|++|+|++|++... + .+..+.++|++|++++|.+++. ..+..+++|++|+|++|.+++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-E-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-C-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-H-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 34455555555555555522 2 1222222344444444444432 345555566666666666654444444556666
Q ss_pred CeeeccCcccCCCCCc--cccCCCCCCEEEcCCCcCCccCCc----cccCcCCCCEEEecCccC
Q 005278 161 QGLYLHGNKLQGSIPY--DLCHLEGLSELNLNGNKLCGHVPP----CLASLTSLRRLHLGSNKL 218 (704)
Q Consensus 161 ~~L~L~~n~l~~~~~~--~l~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~l~~n~l 218 (704)
++|+|++|+|+ .+|. .+..+++|+.|++++|.++ ..|. .+..+++|+.|++++|.+
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 66666666654 3333 4555555555555555555 3333 244555555555555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.2e-13 Score=144.44 Aligned_cols=199 Identities=12% Similarity=0.060 Sum_probs=101.0
Q ss_pred hhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCC
Q 005278 103 PLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLE 182 (704)
Q Consensus 103 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 182 (704)
..|... .+|+.+.+.++. ......+|.++.+|+.+++..+ +..+...+|.+...|+.+.+..+... +........
T Consensus 156 ~aF~~c-~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~ 230 (394)
T 4fs7_A 156 EAFATC-ESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKT 230 (394)
T ss_dssp TTTTTC-TTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTC
T ss_pred hhhccc-CCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccC
Confidence 334433 357777775443 3355666777777777777655 44345556666666666666554332 122222334
Q ss_pred CCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCC---------------------cccCCccccEEEecCcc
Q 005278 183 GLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPS---------------------SFGSLEYVLYINLSANS 241 (704)
Q Consensus 183 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~---------------------~~~~l~~L~~L~l~~N~ 241 (704)
+|+.+.+..+. +......+..+.+|+.+.+..+... .... .|..+.+|+.+.+.++
T Consensus 231 ~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~- 307 (394)
T 4fs7_A 231 GVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS- 307 (394)
T ss_dssp CCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-
T ss_pred CCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccccccccccccccccc-
Confidence 45555444322 2122334444444555444443322 2233 4445555555555443
Q ss_pred cCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecc
Q 005278 242 LNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSR 311 (704)
Q Consensus 242 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~ 311 (704)
++.....+|.++.+|+.+++..+ ++.....+|.++.+|+.+++..| ++.....+|.++.+|+.+++..
T Consensus 308 i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 308 VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 33344455555555666655433 44333455555666666665554 4434445555556666655543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=3.6e-17 Score=155.78 Aligned_cols=155 Identities=22% Similarity=0.313 Sum_probs=99.1
Q ss_pred hhcCCCCCEEEccCCcCccccCh------hhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCcccc
Q 005278 130 IGNLSGMIVFDLNGCDLNGTIPT------AVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLA 203 (704)
Q Consensus 130 ~~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~ 203 (704)
+.....++.++++++.+.+..|. .|..+++|++|+|++|++++ +| .+..+++|++|++++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 33444555555555555544444 66667777777777777764 45 6666677777777777776 4555566
Q ss_pred CcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCC-cccccCcCCcEEEeecCccCCCCCCC---------
Q 005278 204 SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLP-SNIQNLKVLTNLDLSRNQLSGDIPTT--------- 273 (704)
Q Consensus 204 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~--------- 273 (704)
.+++|+.|++++|.+++ ++ .+..+++|++|++++|.+.+..+ ..+..+++|+.|++++|++++.+|..
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 66777777777777764 23 46667777777777777764322 35667777777777777776554442
Q ss_pred -cCCCCCcceeeccCceee
Q 005278 274 -IGGLENLETLSLADNQFQ 291 (704)
Q Consensus 274 -~~~l~~L~~L~L~~n~l~ 291 (704)
+..+++|+.|| +|.++
T Consensus 169 ~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHCSSCSEEC--CGGGT
T ss_pred HHHhCCCcEEEC--CcccC
Confidence 66777777776 55554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-12 Score=138.61 Aligned_cols=271 Identities=15% Similarity=0.114 Sum_probs=184.1
Q ss_pred cCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCC
Q 005278 17 KLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNP 96 (704)
Q Consensus 17 ~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~ 96 (704)
.++.+-..+|.++.+|+++.|.. .++.+...+|.++++|+.++|..+ ++.++..+ |.++.+|+.+.+..+
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~a-------F~~c~~L~~i~~p~~- 127 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCT-------FSGCYALKSILLPLM- 127 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTT-------TTTCTTCCCCCCCTT-
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchh-------hcccccchhhcccCc-
Confidence 35556667899999999999974 588899999999999999999765 77777666 999999999887754
Q ss_pred CcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCc
Q 005278 97 LRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPY 176 (704)
Q Consensus 97 i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 176 (704)
+.......|.... +..... ...+......+|.++++|+.+.+.++. ..+...+|.++++|+.+.+..| ++.....
T Consensus 128 l~~i~~~aF~~~~--~~~~~~-~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~ 202 (394)
T 4fs7_A 128 LKSIGVEAFKGCD--FKEITI-PEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDY 202 (394)
T ss_dssp CCEECTTTTTTCC--CSEEEC-CTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTT
T ss_pred eeeecceeeeccc--cccccc-CccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCch
Confidence 4445556665542 333332 233344566789999999999998664 4466789999999999999877 5545667
Q ss_pred cccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCC
Q 005278 177 DLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVL 256 (704)
Q Consensus 177 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 256 (704)
.|.++..|+.+.+..+... +........+|+.+.+..+ ++......|..+..|+.+.+..+... .....|..+..+
T Consensus 203 ~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l 278 (394)
T 4fs7_A 203 CFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGL 278 (394)
T ss_dssp TTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTC
T ss_pred hhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eecccccccccc
Confidence 8999999999998877644 2333445678999998754 34456678888999999999877543 444445555555
Q ss_pred cEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEec
Q 005278 257 TNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLS 310 (704)
Q Consensus 257 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~ 310 (704)
+.+....+.+. ...|.++.+|+.+.+.++ ++......|.++.+|+.+++.
T Consensus 279 ~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 279 KKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp CEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred ceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence 55544443322 123444444444444433 332333444444444444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.6e-13 Score=126.59 Aligned_cols=105 Identities=26% Similarity=0.345 Sum_probs=61.3
Q ss_pred CCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeec
Q 005278 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSR 263 (704)
Q Consensus 184 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 263 (704)
.+.+++++|.++ .+|..+. ++|+.|+|++|.|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456677777666 3454442 5666666666666665566666666666666666666554444555555555555555
Q ss_pred CccCCCCCCCcCCCCCcceeeccCceee
Q 005278 264 NQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 264 n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
|+|++..+..|..+++|+.|+|++|+++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 5555444444555555555555555554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=3.7e-13 Score=124.25 Aligned_cols=106 Identities=27% Similarity=0.303 Sum_probs=55.1
Q ss_pred CEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCc
Q 005278 209 RRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADN 288 (704)
Q Consensus 209 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 288 (704)
+.+++++|.++. +|..+. ++|++|+|++|.|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 455555555552 333332 45555555555555554555555555555555555555444444555555555555555
Q ss_pred eeeccCCcccccccccceEEecccCCCCC
Q 005278 289 QFQGPVPKSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 289 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
+|++..+..|..+++|+.|+|++|++.+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 55544444455555555555555555544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=3e-15 Score=156.50 Aligned_cols=188 Identities=18% Similarity=0.087 Sum_probs=117.7
Q ss_pred CCCCCEEecccccCCCcccchhhcccccCC-CCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhh-
Q 005278 53 LGSLQVLSLAYNYLMTESSAAKWNFLSSLT-NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEI- 130 (704)
Q Consensus 53 l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~- 130 (704)
+++|++|+|++|.++...... +...+. ..++|++|+|++|.++......+....++|++|+|++|.++......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~---l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~ 147 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTV---VAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLR 147 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHH---HHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHH---HHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHH
Confidence 456777777777776544333 222222 235777777777777765555555544567777777777765444443
Q ss_pred ----hcCCCCCEEEccCCcCccc----cChhhcCCCCcCeeeccCcccCCCC----CccccCCCCCCEEEcCCCcCCcc-
Q 005278 131 ----GNLSGMIVFDLNGCDLNGT----IPTAVGRLRRLQGLYLHGNKLQGSI----PYDLCHLEGLSELNLNGNKLCGH- 197 (704)
Q Consensus 131 ----~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~- 197 (704)
...++|++|+|++|.|+.. ++..+...++|++|+|++|+|++.. +..+...++|++|+|++|.|++.
T Consensus 148 ~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g 227 (372)
T 3un9_A 148 DLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTA 227 (372)
T ss_dssp HHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHH
T ss_pred HHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHH
Confidence 2457788888888887642 3444567788888888888887432 45566677888888888888743
Q ss_pred ---CCccccCcCCCCEEEecCccCCCCCCCcccCC---c--cccEEE--ecCcccC
Q 005278 198 ---VPPCLASLTSLRRLHLGSNKLTSTMPSSFGSL---E--YVLYIN--LSANSLN 243 (704)
Q Consensus 198 ---~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l---~--~L~~L~--l~~N~l~ 243 (704)
++..+...++|+.|+|++|.|+......+..+ . .|+.+. +..|.+.
T Consensus 228 ~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 228 ALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 23344556888888888888875433333322 1 155565 5555544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.6e-13 Score=124.68 Aligned_cols=104 Identities=26% Similarity=0.376 Sum_probs=48.9
Q ss_pred CEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecC
Q 005278 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRN 264 (704)
Q Consensus 185 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n 264 (704)
+.+++++|+++ .+|..+. ++|+.|+|++|.|++..+..|..+++|++|+|++|.|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34444444444 3333332 34444455555444444444444444444444444444333333444555555555555
Q ss_pred ccCCCCCCCcCCCCCcceeeccCceee
Q 005278 265 QLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 265 ~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
+|++..+..|..+++|+.|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555333333555555555555555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=6.4e-13 Score=123.03 Aligned_cols=104 Identities=27% Similarity=0.335 Sum_probs=56.7
Q ss_pred CeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCc
Q 005278 161 QGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240 (704)
Q Consensus 161 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 240 (704)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34455555554 3344332 45555555555555444555555555555555555555444444555555666666666
Q ss_pred ccCCCCCcccccCcCCcEEEeecCccC
Q 005278 241 SLNGSLPSNIQNLKVLTNLDLSRNQLS 267 (704)
Q Consensus 241 ~l~~~~~~~~~~l~~L~~L~l~~n~l~ 267 (704)
.|++..+..|..+++|+.|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 655444444666666666666666665
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.43 E-value=6.1e-12 Score=133.25 Aligned_cols=110 Identities=14% Similarity=0.217 Sum_probs=69.0
Q ss_pred ccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCC
Q 005278 200 PCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLEN 279 (704)
Q Consensus 200 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 279 (704)
.+|.++.+|+.+.+.++... .....|.++++|+.+.+. +.++.....+|.++.+|+.+++..+ ++.....+|.++.+
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~ 335 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ 335 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence 45666677777777655433 455566677777777775 3344455566667777777777654 44344566777777
Q ss_pred cceeeccCceeeccCCcccccccccceEEecccC
Q 005278 280 LETLSLADNQFQGPVPKSFGSLISLESLDLSRNN 313 (704)
Q Consensus 280 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~ 313 (704)
|+.+.+..+ ++......|.++.+|+.+++.+|.
T Consensus 336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 777777544 554445667777777777776654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.7e-14 Score=149.23 Aligned_cols=167 Identities=16% Similarity=0.121 Sum_probs=128.9
Q ss_pred CCCCcEEEccCCCCcccCChhhhhc----ccccceEEecCCcccccCChhh-hcCCCCCEEEccCCcCccccChhh----
Q 005278 84 CRNLTVLGLASNPLRGILPPLIGNF----SASLQEFYAYGCKLRGNIPQEI-GNLSGMIVFDLNGCDLNGTIPTAV---- 154 (704)
Q Consensus 84 l~~L~~L~L~~n~i~~~~~~~~~~~----~~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~---- 154 (704)
+++|++|+|++|.++......++.. ..+|++|+|++|.++......+ ..+++|++|+|++|.++......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 5689999999999987766666655 2479999999999976443333 356789999999999986544444
Q ss_pred -cCCCCcCeeeccCcccCCC----CCccccCCCCCCEEEcCCCcCCcc----CCccccCcCCCCEEEecCccCCCCC---
Q 005278 155 -GRLRRLQGLYLHGNKLQGS----IPYDLCHLEGLSELNLNGNKLCGH----VPPCLASLTSLRRLHLGSNKLTSTM--- 222 (704)
Q Consensus 155 -~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~--- 222 (704)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++. ++..+...++|+.|+|++|.|+...
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 3468899999999999743 344557789999999999999853 2456777889999999999998532
Q ss_pred -CCcccCCccccEEEecCcccCCCCCccc
Q 005278 223 -PSSFGSLEYVLYINLSANSLNGSLPSNI 250 (704)
Q Consensus 223 -~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 250 (704)
+..+...++|++|+|++|.|++.....+
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 3345567899999999999885444333
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.1e-11 Score=129.08 Aligned_cols=297 Identities=12% Similarity=0.145 Sum_probs=158.8
Q ss_pred cccCCccccCCC-CCCEEeccCccccccCchhhcCCCCCCEEeccccc---CCCcccchhhcccccCCCCCCCcEEEccC
Q 005278 19 SGTIPNSITNAS-KLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY---LMTESSAAKWNFLSSLTNCRNLTVLGLAS 94 (704)
Q Consensus 19 ~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~---i~~~~~~~~~~~~~~~~~l~~L~~L~L~~ 94 (704)
+.+-..+|.+.. .|+++.+..+ ++.+...+|.++++|+.+.+..|. ++.++..+ |..+.+|+.+.+..
T Consensus 52 t~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~a-------F~~c~~L~~i~~~~ 123 (394)
T 4gt6_A 52 SKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQA-------FMFCSELTDIPILD 123 (394)
T ss_dssp EEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTT-------TTTCTTCCBCGGGT
T ss_pred eEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhh-------chhcccceeeccCC
Confidence 333344566663 4777777543 566777777777777777776653 55555544 66677777666654
Q ss_pred CCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCC
Q 005278 95 NPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSI 174 (704)
Q Consensus 95 n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 174 (704)
+ +.......|... .+|+.+.+..+ +......+|.++..|+.+.+.++ +..+...+|.. .+|+.+.+..+-.. ..
T Consensus 124 ~-~~~I~~~aF~~c-~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~ 197 (394)
T 4gt6_A 124 S-VTEIDSEAFHHC-EELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IG 197 (394)
T ss_dssp T-CSEECTTTTTTC-TTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-EC
T ss_pred c-cceehhhhhhhh-cccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cc
Confidence 3 333333344433 35666666533 33355556666677777766644 33344444543 45666666544332 34
Q ss_pred CccccCCCCCCEEEcCCCcCCccCCcc--------------ccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCc
Q 005278 175 PYDLCHLEGLSELNLNGNKLCGHVPPC--------------LASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSAN 240 (704)
Q Consensus 175 ~~~l~~l~~L~~L~L~~n~l~~~~~~~--------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 240 (704)
..++.++.++.......+.... .... +.....+..+.+.+ .++......|..+.+|+.+.+.++
T Consensus 198 ~~af~~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~ 275 (394)
T 4gt6_A 198 TNAFSECFALSTITSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDS 275 (394)
T ss_dssp TTTTTTCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTT
T ss_pred cchhhhccccceeccccccccc-ccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccc
Confidence 4455556666665555444331 1111 11112233333322 222234455666667777776655
Q ss_pred ccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCCCC
Q 005278 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPK 320 (704)
Q Consensus 241 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 320 (704)
... ....+|.++++|+.+.+. +.++.....+|.++.+|+.++|..+ ++......|.++.+|+.+.+..+ ++..-..
T Consensus 276 ~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~ 351 (394)
T 4gt6_A 276 VVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPES 351 (394)
T ss_dssp CCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGG
T ss_pred cce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHh
Confidence 433 455566666777777664 3444344556667777777777654 44344566667777777776433 4333333
Q ss_pred CcccccccCcccccC
Q 005278 321 NFSAQSFLSNYALCG 335 (704)
Q Consensus 321 ~~~~~~~l~~~~l~g 335 (704)
.|.....|....+.+
T Consensus 352 aF~~C~~L~~i~~~~ 366 (394)
T 4gt6_A 352 AFSNCTALNNIEYSG 366 (394)
T ss_dssp GGTTCTTCCEEEESS
T ss_pred HhhCCCCCCEEEECC
Confidence 455544444444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=7.9e-12 Score=130.05 Aligned_cols=103 Identities=30% Similarity=0.294 Sum_probs=60.5
Q ss_pred eeeccCc-ccCCCCCccccCCCCCCEEEcCC-CcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecC
Q 005278 162 GLYLHGN-KLQGSIPYDLCHLEGLSELNLNG-NKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239 (704)
Q Consensus 162 ~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 239 (704)
.++++++ +|+ .+|. +..+++|++|+|++ |+|++..+..|..+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3566665 666 4555 66666666666664 666655555666666666666666666665555666666666666666
Q ss_pred cccCCCCCcccccCcCCcEEEeecCccC
Q 005278 240 NSLNGSLPSNIQNLKVLTNLDLSRNQLS 267 (704)
Q Consensus 240 N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 267 (704)
|.|++..+..|..++ |+.|+|++|++.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 666544444444433 555555555554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=3.8e-11 Score=119.55 Aligned_cols=147 Identities=13% Similarity=0.091 Sum_probs=115.7
Q ss_pred HHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEE
Q 005278 410 IQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 410 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 488 (704)
+.....+|......+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445568888888999999999999744 7899999986533233456899999999994 6778899999998889999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG------------------------------------- 531 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------------------------------------- 531 (704)
||||++|.++.+.... ......++.++++++..||..
T Consensus 88 v~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999876321 122346888999999999871
Q ss_pred -------------------CCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 532 -------------------HSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 532 -------------------h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11458999999999999876666799998765
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.23 E-value=1e-09 Score=115.55 Aligned_cols=285 Identities=9% Similarity=0.057 Sum_probs=173.5
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCC
Q 005278 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86 (704)
Q Consensus 7 ~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~ 86 (704)
+|+.+.+.. .++.+-..+|.++.+|++++|..+ ++.+...+|.+. +|+.+.+..+ +..++..+ |..+ +
T Consensus 47 ~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~a-------F~~~-~ 114 (379)
T 4h09_A 47 RISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYV-------FQGT-D 114 (379)
T ss_dssp GCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTT-------TTTC-C
T ss_pred CCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccce-------eccC-C
Confidence 455555543 244444556666666666666433 555666666655 4555555432 44444433 4443 5
Q ss_pred CcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccc------------cChhh
Q 005278 87 LTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGT------------IPTAV 154 (704)
Q Consensus 87 L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------------~~~~~ 154 (704)
|+.+.+..+ +.......|... +|+...+..+ ++......+.++..++.+.+..+..... ....+
T Consensus 115 L~~i~lp~~-~~~i~~~~F~~~--~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (379)
T 4h09_A 115 LDDFEFPGA-TTEIGNYIFYNS--SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESY 190 (379)
T ss_dssp CSEEECCTT-CCEECTTTTTTC--CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEEC
T ss_pred cccccCCCc-cccccccccccc--eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccc
Confidence 666666544 222333333332 3444444432 3334555566667777666665443211 11122
Q ss_pred cCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccE
Q 005278 155 GRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLY 234 (704)
Q Consensus 155 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 234 (704)
.....+..+.+..+... .....+....+|+.+.+..+ ++......+.++..|+.+.+..+ ++......|.++.+|+.
T Consensus 191 ~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~ 267 (379)
T 4h09_A 191 PAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKT 267 (379)
T ss_dssp CTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCE
T ss_pred cccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcc
Confidence 33334444444333222 34456666778888888655 34355567788888999888776 55566778888888998
Q ss_pred EEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEeccc
Q 005278 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRN 312 (704)
Q Consensus 235 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N 312 (704)
+.+..+ +.......|.++++|+.+.+.++.++.....+|.++.+|+.+.|..+ ++.....+|.++.+|+.+.+..+
T Consensus 268 i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 268 LNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp EEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred cccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 888754 55466677888889999999888888666778889999999998765 55455678888888888877543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.20 E-value=3.7e-11 Score=124.93 Aligned_cols=103 Identities=24% Similarity=0.224 Sum_probs=70.4
Q ss_pred EEEccCC-cCccccChhhcCCCCcCeeeccC-cccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecC
Q 005278 138 VFDLNGC-DLNGTIPTAVGRLRRLQGLYLHG-NKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGS 215 (704)
Q Consensus 138 ~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 215 (704)
.++++++ +|+ .+|. +..+++|+.|+|++ |+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 666 4555 77777777777774 777755556677777777777777777766666677777777777777
Q ss_pred ccCCCCCCCcccCCccccEEEecCcccC
Q 005278 216 NKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 216 n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
|+|++..+..|..++ |+.|+|.+|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 777755555555554 777777777766
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=2.2e-10 Score=113.88 Aligned_cols=139 Identities=15% Similarity=0.072 Sum_probs=101.3
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCC--CceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRN--LIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e 491 (704)
..++......+.|..+.||++...+|+.+++|+.... ....+..|+++++.+.+.+ +.+++++....+..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3455543333456669999998777888999997543 2356788999999996544 4568888888788899999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH--------------------------------------- 532 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h--------------------------------------- 532 (704)
|++|.++. ... .. ...++.++++.+..||...
T Consensus 96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 99998884 211 11 2356777778888886521
Q ss_pred ----------------CCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 533 ----------------STPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 533 ----------------~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
...++|+|++|.||++++++.+.|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998763
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.07 E-value=4.4e-11 Score=123.74 Aligned_cols=180 Identities=14% Similarity=0.189 Sum_probs=93.0
Q ss_pred hhhcCCCCCEEEccCCcCc---------cccChhhcCCCCcCeeeccCcc-cCCCCCccccCCCCCCEEEcCCCcCCccC
Q 005278 129 EIGNLSGMIVFDLNGCDLN---------GTIPTAVGRLRRLQGLYLHGNK-LQGSIPYDLCHLEGLSELNLNGNKLCGHV 198 (704)
Q Consensus 129 ~~~~l~~L~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 198 (704)
++..+++|+.|.+.++... +.+...+..+|+|+.|+|++|. +. ++. +. +++|+.|+|..|.++...
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHH
T ss_pred hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHH
Confidence 3455667777776554321 1233455667777777777763 22 222 33 677888888777776433
Q ss_pred Ccccc--CcCCCCEEEecC--ccCCCC-----CCCcc--cCCccccEEEecCcccCCCCCcccc---cCcCCcEEEeecC
Q 005278 199 PPCLA--SLTSLRRLHLGS--NKLTST-----MPSSF--GSLEYVLYINLSANSLNGSLPSNIQ---NLKVLTNLDLSRN 264 (704)
Q Consensus 199 ~~~~~--~l~~L~~L~l~~--n~l~~~-----~~~~~--~~l~~L~~L~l~~N~l~~~~~~~~~---~l~~L~~L~l~~n 264 (704)
...+. .+|+|+.|+|+. |...+. +...+ ..+++|++|+|.+|.+.+..+..+. .+++|+.|+|+.|
T Consensus 210 l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n 289 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAG 289 (362)
T ss_dssp HHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSS
T ss_pred HHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCC
Confidence 33333 567777777753 221111 00111 2356666666666665532222221 3556666666666
Q ss_pred ccCCC----CCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccC
Q 005278 265 QLSGD----IPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNN 313 (704)
Q Consensus 265 ~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~ 313 (704)
.+++. ++..+..+++|+.|+|++|.+++..-..+...- ...+++++|+
T Consensus 290 ~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 290 VLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp CCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred CCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc-CCEEEecCCc
Confidence 66542 223334456666666666665543333333210 2345555554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.5e-08 Score=106.49 Aligned_cols=280 Identities=10% Similarity=0.032 Sum_probs=197.6
Q ss_pred CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccC
Q 005278 2 GYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSL 81 (704)
Q Consensus 2 ~~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~ 81 (704)
++...+|+.++|..+ ++.+-..+|.+. +|+.+.+..+ ++.+...+|.+. +|+.+.+..+ +..++..+ |
T Consensus 65 F~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~i~lp~~-~~~i~~~~-------F 132 (379)
T 4h09_A 65 FNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDDFEFPGA-TTEIGNYI-------F 132 (379)
T ss_dssp TTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTT-------T
T ss_pred hhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-CcccccCCCc-cccccccc-------c
Confidence 456789999999865 676777889887 6888888654 666888888875 8999999765 44444443 5
Q ss_pred CCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccc------------cCChhhhcCCCCCEEEccCCcCccc
Q 005278 82 TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG------------NIPQEIGNLSGMIVFDLNGCDLNGT 149 (704)
Q Consensus 82 ~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~------------~~~~~~~~l~~L~~L~L~~n~l~~~ 149 (704)
.++ +|+.+.+-.+ +.......+... ..++...+..+.... .....+.....+..+.+..+.-. .
T Consensus 133 ~~~-~l~~~~~~~~-v~~i~~~~f~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i 208 (379)
T 4h09_A 133 YNS-SVKRIVIPKS-VTTIKDGIGYKA-ENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-V 208 (379)
T ss_dssp TTC-CCCEEEECTT-CCEECSCTTTTC-TTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-E
T ss_pred ccc-eeeeeeccce-eeccccchhccc-ccccccccccccceeecccceecccccceeccccccccccccccccceeE-E
Confidence 554 5666665543 333334444433 346666555433221 12223445566677666644333 5
Q ss_pred cChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCC
Q 005278 150 IPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSL 229 (704)
Q Consensus 150 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 229 (704)
....+....+|+.+.+..+ ++......+.++.+|+.+.+..+ ++......|.++.+|+.+.+..+ +.......|.++
T Consensus 209 ~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c 285 (379)
T 4h09_A 209 TAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGC 285 (379)
T ss_dssp CTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTC
T ss_pred eecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccc
Confidence 5667788889999988765 44355677888999999999876 55455678888999999999764 555666788999
Q ss_pred ccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCccccccc
Q 005278 230 EYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302 (704)
Q Consensus 230 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 302 (704)
++|+.+.+.++.++.....+|.++.+|+.+.|..+ ++.....+|.++.+|+.+.+..+ ++.....+|.++.
T Consensus 286 ~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 286 SNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred cccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 99999999999888777888999999999999765 66566678999999999998765 5545556666553
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.1e-10 Score=120.78 Aligned_cols=129 Identities=16% Similarity=0.177 Sum_probs=63.8
Q ss_pred ccceEEecCCcccccCChhhh--cCCCCCEEEccC--CcCcc-----ccChhh--cCCCCcCeeeccCcccCCCCCcccc
Q 005278 111 SLQEFYAYGCKLRGNIPQEIG--NLSGMIVFDLNG--CDLNG-----TIPTAV--GRLRRLQGLYLHGNKLQGSIPYDLC 179 (704)
Q Consensus 111 ~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~L~~--n~l~~-----~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~l~ 179 (704)
+|++|++..|.+.......+. .+++|++|+|+. |...+ .+...+ ..+++|+.|+|++|.+++..+..+.
T Consensus 194 ~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la 273 (362)
T 2ra8_A 194 NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273 (362)
T ss_dssp TCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHH
T ss_pred CCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHH
Confidence 455555555554433333333 456666666642 11110 001112 2356677777766666532222222
Q ss_pred ---CCCCCCEEEcCCCcCCcc----CCccccCcCCCCEEEecCccCCCCCCCcccC-CccccEEEecCcc
Q 005278 180 ---HLEGLSELNLNGNKLCGH----VPPCLASLTSLRRLHLGSNKLTSTMPSSFGS-LEYVLYINLSANS 241 (704)
Q Consensus 180 ---~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~N~ 241 (704)
.+++|++|+|+.|.+++. ++..+.++++|+.|+|++|.|+......+.. + ...++++.+.
T Consensus 274 ~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred hCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 356677777777776643 2223345567777777777665332222221 1 2446666665
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=6.7e-09 Score=108.29 Aligned_cols=142 Identities=15% Similarity=0.203 Sum_probs=106.6
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEee--ccc-hhhhHHHHHHHHHHHhcC--CCCCceEEeeeeeC---CeEEEEE
Q 005278 419 ECNLLGTGSFGSVYKGTLFDGTNVAIKVFN--LQL-ERASRSFDSECEILRSIR--HRNLIKIISNCCNI---DFKALVL 490 (704)
Q Consensus 419 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 490 (704)
..+.++.|.++.||+.... +..+++|+.. ... ......+.+|.++++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999999865 4678888875 322 123456889999999997 45678899988776 4578999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH-------------------------------------- 532 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h-------------------------------------- 532 (704)
||++|..+.+.. ...++...+..++.+++..|..||...
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999997774421 122567788889999999999999621
Q ss_pred -----------------CCCcEecCCCCCCeeeCCCCc--EEEeeecccee
Q 005278 533 -----------------STPMVHCDLKPNNILLDENMT--AHVSDFGISKL 564 (704)
Q Consensus 533 -----------------~~~ivH~dlk~~Nil~~~~~~--~kl~Dfgla~~ 564 (704)
...++|||+++.||+++.++. +.|.||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.84 E-value=5e-10 Score=104.54 Aligned_cols=52 Identities=10% Similarity=0.034 Sum_probs=27.5
Q ss_pred chhhcCCCCCCEEecccc-cCCCcccchhhcccccCCCCCCCcEEEccCCCCcccC
Q 005278 47 PNTFGNLGSLQVLSLAYN-YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGIL 101 (704)
Q Consensus 47 ~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 101 (704)
...+...++|++|+|++| .|....... +...+...++|++|+|++|+|....
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~---l~~~L~~~~~L~~L~Ls~n~i~~~g 81 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKA---CAEALKTNTYVKKFSIVGTRSNDPV 81 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHH---HHHHHTTCCSCCEEECTTSCCCHHH
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHH---HHHHHHhCCCcCEEECcCCCCChHH
Confidence 344555555666666665 555443322 3344555556666666666655433
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.83 E-value=9.3e-10 Score=102.69 Aligned_cols=124 Identities=15% Similarity=0.081 Sum_probs=84.4
Q ss_pred cCCccccCCCCCCEEeccCc-ccccc----CchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCC
Q 005278 21 TIPNSITNASKLIMLDLSSN-SFSGL----IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASN 95 (704)
Q Consensus 21 ~~~~~~~~l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n 95 (704)
.+...+...++|++|+|++| .+.+. +...+...++|++|+|++|.|...+... +...+...++|++|+|++|
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~---l~~~L~~n~~L~~L~L~~N 103 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA---LAEMLKVNNTLKSLNVESN 103 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH---HHHHHHHCSSCCEEECCSS
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHH---HHHHHHhCCCcCEEECcCC
Confidence 34455666778888888887 77743 3344566677888888888877655433 4455666677888888888
Q ss_pred CCcccCChhhhhcc---cccceEEe--cCCccccc----CChhhhcCCCCCEEEccCCcCc
Q 005278 96 PLRGILPPLIGNFS---ASLQEFYA--YGCKLRGN----IPQEIGNLSGMIVFDLNGCDLN 147 (704)
Q Consensus 96 ~i~~~~~~~~~~~~---~~L~~L~l--~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~ 147 (704)
.|+......++... ++|++|+| ++|.++.. +...+...++|++|+|++|.+.
T Consensus 104 ~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 104 FISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred cCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 88766544444322 25788888 77777653 4455666788999999998876
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=1.9e-09 Score=109.56 Aligned_cols=187 Identities=16% Similarity=0.153 Sum_probs=120.8
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCC--CceEEeeeeeCC---eEEEEEecc
Q 005278 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRN--LIKIISNCCNID---FKALVLEFM 493 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 493 (704)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 56889986432 34567899999999984 332 445555543333 347899999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG------------------------------------------ 531 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------------------------------------------ 531 (704)
+|.++.+.... .++...+..++.+++..+..||..
T Consensus 99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99888653322 256667777888888888888751
Q ss_pred -------------CCCCcEecCCCCCCeeeCC--CCcEEEeeeccceecCCCCCcceecc------------cccccccc
Q 005278 532 -------------HSTPMVHCDLKPNNILLDE--NMTAHVSDFGISKLLGEGDDSVIQTM------------TIATIGYM 584 (704)
Q Consensus 532 -------------h~~~ivH~dlk~~Nil~~~--~~~~kl~Dfgla~~~~~~~~~~~~~~------------~~gt~~y~ 584 (704)
....++|+|++|.||++++ ...+.++||+.+..-....+-..... .....++.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 1245799999999999998 45678999999876432110000000 00000111
Q ss_pred C-CcccCCCCCCcccceeeHHHHHHHHhhCCCCC
Q 005278 585 A-PEYGSEGIISPKSDVYSYGILLMETFTRKKPT 617 (704)
Q Consensus 585 a-PE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~ 617 (704)
. |+.... .....+.|++|.++|++.+|..+|
T Consensus 256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 111110 111258999999999999998775
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.36 E-value=8.1e-08 Score=86.97 Aligned_cols=92 Identities=10% Similarity=0.122 Sum_probs=65.4
Q ss_pred CCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEeccccc-CCCcccchhhcccccCCCC----CCCcEEEccCCC
Q 005278 22 IPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY-LMTESSAAKWNFLSSLTNC----RNLTVLGLASNP 96 (704)
Q Consensus 22 ~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~~~~~~~l----~~L~~L~L~~n~ 96 (704)
+|.....-..|++|||++|.|++..-..+.++++|++|+|++|. |++..... +..+ ++|++|+|++|.
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~-------L~~~~~~~~~L~~L~Ls~C~ 125 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLER-------LSQLENLQKSMLEMEIISCG 125 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHH-------HHTCHHHHHHCCEEEEESCT
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHH-------HHhcccccCCCCEEEcCCCC
Confidence 34433344568888888888887777778888888888888885 66544333 4443 468888888874
Q ss_pred -CcccCChhhhhcccccceEEecCCc
Q 005278 97 -LRGILPPLIGNFSASLQEFYAYGCK 121 (704)
Q Consensus 97 -i~~~~~~~~~~~~~~L~~L~l~~n~ 121 (704)
|++..-..+..+ ++|++|++++|.
T Consensus 126 ~ITD~Gl~~L~~~-~~L~~L~L~~c~ 150 (176)
T 3e4g_A 126 NVTDKGIIALHHF-RNLKYLFLSDLP 150 (176)
T ss_dssp TCCHHHHHHGGGC-TTCCEEEEESCT
T ss_pred cCCHHHHHHHhcC-CCCCEEECCCCC
Confidence 777666677765 578888888875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.36 E-value=8e-08 Score=93.99 Aligned_cols=65 Identities=29% Similarity=0.495 Sum_probs=33.2
Q ss_pred hcCCCCCEEEccCCcCcc--ccChhhcCCCCcCeeeccCcccCCCCCccccCCC--CCCEEEcCCCcCCcc
Q 005278 131 GNLSGMIVFDLNGCDLNG--TIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLE--GLSELNLNGNKLCGH 197 (704)
Q Consensus 131 ~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~--~L~~L~L~~n~l~~~ 197 (704)
.++++|+.|+|++|.|++ .++..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|.+.+.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~ 235 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDT 235 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGG
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccc
Confidence 445556666666666554 2234455555566666666655532 1222222 555555555555543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.33 E-value=4.8e-08 Score=95.58 Aligned_cols=39 Identities=28% Similarity=0.448 Sum_probs=17.5
Q ss_pred CCCCCEEEcCCCcCCc--cCCccccCcCCCCEEEecCccCC
Q 005278 181 LEGLSELNLNGNKLCG--HVPPCLASLTSLRRLHLGSNKLT 219 (704)
Q Consensus 181 l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~ 219 (704)
+++|+.|+|++|+|++ .++..+..+++|+.|+|++|+|+
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~ 209 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 209 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence 3445555555555443 22233334444444444444444
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=5.4e-06 Score=83.84 Aligned_cols=136 Identities=13% Similarity=0.100 Sum_probs=92.9
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCC---CCceEEeeee-eCCeEEEEEeccCC
Q 005278 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHR---NLIKIISNCC-NIDFKALVLEFMPN 495 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 495 (704)
.+.++.|....||+. |..+++|+... ......+..|.++++.+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 67788998532 23456789999999999753 3556666664 34567899999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG-------------------------------------------- 531 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-------------------------------------------- 531 (704)
.++.+.... .++......++.+++..+..||..
T Consensus 98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 887653211 123334444444444444444431
Q ss_pred -------------CCCCcEecCCCCCCeeeCC---CCc-EEEeeecccee
Q 005278 532 -------------HSTPMVHCDLKPNNILLDE---NMT-AHVSDFGISKL 564 (704)
Q Consensus 532 -------------h~~~ivH~dlk~~Nil~~~---~~~-~kl~Dfgla~~ 564 (704)
....++|+|+.+.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3345799999999999997 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=6.5e-06 Score=81.73 Aligned_cols=135 Identities=18% Similarity=0.112 Sum_probs=98.0
Q ss_pred cccccCce-EEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 422 LLGTGSFG-SVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 422 ~ig~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
.+..|..+ .||+.... ++..+++|+-... ....+..|...++.+. +-.+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556655 68987754 5678999986432 3456888999999884 33467889999999999999999999888
Q ss_pred HHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 005278 499 EKWLYSHNYFLGILERLNIMIDVGLALEYLHHG----------------------------------------------- 531 (704)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----------------------------------------------- 531 (704)
.+...... .....++.+++..+..||..
T Consensus 108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 77654321 12334566677777777631
Q ss_pred --------CCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 532 --------HSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 532 --------h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
+...++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999877777999987763
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.27 E-value=5.3e-07 Score=81.58 Aligned_cols=86 Identities=8% Similarity=0.076 Sum_probs=61.6
Q ss_pred CCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCC-CcccCChhhhhc---ccccceEEecCCc-ccccCC
Q 005278 53 LGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNP-LRGILPPLIGNF---SASLQEFYAYGCK-LRGNIP 127 (704)
Q Consensus 53 l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~---~~~L~~L~l~~n~-l~~~~~ 127 (704)
-.+|++|||++|.|+..+... +..+++|++|+|++|. |++..-..++.+ .++|++|+|++|. ++..--
T Consensus 60 ~~~L~~LDLs~~~Itd~GL~~-------L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 60 KYKIQAIDATDSCIMSIGFDH-------MEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp CCCEEEEEEESCCCCGGGGGG-------GTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CceEeEEeCcCCCccHHHHHH-------hcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 346899999999988766544 7889999999999985 776665666653 2457777777764 665444
Q ss_pred hhhhcCCCCCEEEccCCc
Q 005278 128 QEIGNLSGMIVFDLNGCD 145 (704)
Q Consensus 128 ~~~~~l~~L~~L~L~~n~ 145 (704)
..+..+++|++|+|++|.
T Consensus 133 ~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHGGGCTTCCEEEEESCT
T ss_pred HHHhcCCCCCEEECCCCC
Confidence 556667777777777764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.14 E-value=8.9e-07 Score=81.73 Aligned_cols=47 Identities=11% Similarity=0.196 Sum_probs=20.1
Q ss_pred cCCCCCCEEecccc-cCCCcccchhhcccccCCCCCCCcEEEccCCCCccc
Q 005278 51 GNLGSLQVLSLAYN-YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGI 100 (704)
Q Consensus 51 ~~l~~L~~L~L~~n-~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~ 100 (704)
.+-+.|++|+|++| .|...+..+ +.+.+...+.|+.|+|++|+|.+.
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~---la~aL~~N~~L~~L~L~~n~igd~ 85 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRS---LIEAACNSKHIEKFSLANTAISDS 85 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHH---HHHHHTTCSCCCEEECTTSCCBHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHH---HHHHHhhCCCcCEEEccCCCCChH
Confidence 33344444444443 443332222 333344444455555555554433
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.14 E-value=9.9e-07 Score=81.43 Aligned_cols=123 Identities=16% Similarity=0.158 Sum_probs=84.8
Q ss_pred CCccccCCCCCCEEeccCc-ccccc----CchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCC
Q 005278 22 IPNSITNASKLIMLDLSSN-SFSGL----IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNP 96 (704)
Q Consensus 22 ~~~~~~~l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~ 96 (704)
+...+.+-+.|++|+|++| .|.+. +..++..-+.|+.|+|++|+|......+ +.+.+...+.|++|+|++|.
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~a---lA~aL~~N~tL~~L~L~~N~ 109 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARG---LIELIETSPSLRVLNVESNF 109 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTT---HHHHHHHCSSCCEEECCSSB
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHH---HHHHHhcCCccCeEecCCCc
Confidence 3444556677888888875 77643 3445666677888888888887766554 56667777888888888888
Q ss_pred CcccCChhhhhcc---cccceEEecCC---cccc----cCChhhhcCCCCCEEEccCCcCc
Q 005278 97 LRGILPPLIGNFS---ASLQEFYAYGC---KLRG----NIPQEIGNLSGMIVFDLNGCDLN 147 (704)
Q Consensus 97 i~~~~~~~~~~~~---~~L~~L~l~~n---~l~~----~~~~~~~~l~~L~~L~L~~n~l~ 147 (704)
|+..+...++... .+|++|+|.+| .+.. .+...+..-+.|+.|+++.|.+.
T Consensus 110 Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 110 LTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp CCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred CCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 8876665555432 25888888765 3332 34556777788999999877654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=4.7e-06 Score=86.50 Aligned_cols=80 Identities=9% Similarity=-0.020 Sum_probs=56.5
Q ss_pred cccc-cccCceEEEEEEEC-------CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCC---CCCceEEeeeeeC--
Q 005278 420 CNLL-GTGSFGSVYKGTLF-------DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRH---RNLIKIISNCCNI-- 483 (704)
Q Consensus 420 ~~~i-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~-- 483 (704)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998754 26778899865432 0013567889999998842 3577888887655
Q ss_pred -CeEEEEEeccCCCCHH
Q 005278 484 -DFKALVLEFMPNGSLE 499 (704)
Q Consensus 484 -~~~~lv~e~~~~gsL~ 499 (704)
+..++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=5.7e-05 Score=77.69 Aligned_cols=138 Identities=17% Similarity=0.140 Sum_probs=79.9
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCC--CCCceEEe------eeeeCCeEEEEEec
Q 005278 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRH--RNLIKIIS------NCCNIDFKALVLEF 492 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 492 (704)
+.|+.|..+.||+....+| .+++|+.... ...+..|..+++.+.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987655 4889988642 2334455666665531 12333332 12345677899999
Q ss_pred cCCCCHH--------------HHHhh--CCC-----------ccCHHHHH------------------------------
Q 005278 493 MPNGSLE--------------KWLYS--HNY-----------FLGILERL------------------------------ 515 (704)
Q Consensus 493 ~~~gsL~--------------~~l~~--~~~-----------~~~~~~~~------------------------------ 515 (704)
++|.++. ..++. ... ...|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11121 000 01222110
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 516 -NIMIDVGLALEYLHH----------GHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 516 -~i~~~i~~~l~~Lh~----------~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
.+...+..++++|+. .....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223345666653 135789999999999999888899999998775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=6.7e-05 Score=78.92 Aligned_cols=75 Identities=13% Similarity=0.115 Sum_probs=50.0
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeeccch-------hhhHHHHHHHHHHHhcCC--C-CCceEEeeeeeCCeEEE
Q 005278 420 CNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLE-------RASRSFDSECEILRSIRH--R-NLIKIISNCCNIDFKAL 488 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l 488 (704)
.+.+|.|.++.||++... +++.++||....... .....+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 578899998643211 123456789999988742 3 34456544 3445689
Q ss_pred EEeccCCC
Q 005278 489 VLEFMPNG 496 (704)
Q Consensus 489 v~e~~~~g 496 (704)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00038 Score=69.98 Aligned_cols=137 Identities=13% Similarity=0.068 Sum_probs=92.0
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC---CCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 419 ECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIR---HRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 419 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
..+.|+.|....+|+... ++..++||+.... ....+..|.+.++.+. ...+.+++++....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456799999999999875 4678889986532 3567889999999884 36688899988888889999999998
Q ss_pred CCHH--------H---HHhhCCC---------------------ccCHHHHHH---HHH----------------HHHHH
Q 005278 496 GSLE--------K---WLYSHNY---------------------FLGILERLN---IMI----------------DVGLA 524 (704)
Q Consensus 496 gsL~--------~---~l~~~~~---------------------~~~~~~~~~---i~~----------------~i~~~ 524 (704)
..+. + .++.... .-+|...+. +.. .+...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 1222110 113443221 111 11111
Q ss_pred -HHHHHh-cCCCCcEecCCCCCCeeeCCCCcEEEeeec
Q 005278 525 -LEYLHH-GHSTPMVHCDLKPNNILLDENMTAHVSDFG 560 (704)
Q Consensus 525 -l~~Lh~-~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 560 (704)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 1256799999999999999887 8888973
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00014 Score=72.64 Aligned_cols=79 Identities=15% Similarity=0.135 Sum_probs=58.5
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCC---CCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRH---RNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e 491 (704)
.....++.+|.|..+.||+.+..||+.+.||+...........|..|.+.|+.+.. -.+.+++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34455678999999999999999999999998754433334568899999999842 2345555542 2378999
Q ss_pred ccCCCC
Q 005278 492 FMPNGS 497 (704)
Q Consensus 492 ~~~~gs 497 (704)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00077 Score=71.29 Aligned_cols=80 Identities=14% Similarity=0.121 Sum_probs=48.5
Q ss_pred CCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCC---CCCcccceeeHHHHHH
Q 005278 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG---IISPKSDVYSYGILLM 608 (704)
Q Consensus 532 h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~ 608 (704)
+...++|+|++|.||+++.++ ++++||+.+..-....+ .......-...|++|+..... ......++......+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 567899999999999999876 99999998875322110 000000012346666654321 1122345557777777
Q ss_pred HHhhC
Q 005278 609 ETFTR 613 (704)
Q Consensus 609 el~tg 613 (704)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0036 Score=63.37 Aligned_cols=156 Identities=10% Similarity=0.087 Sum_probs=87.2
Q ss_pred cchHHHHHHhCCCCc-----cccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCC--CceEE
Q 005278 405 TSYLDIQRATNGFNE-----CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRN--LIKII 477 (704)
Q Consensus 405 ~~~~~~~~~~~~~~~-----~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~ 477 (704)
.+..++......|.. .+.|+.|....+|+....+| .+++|+.... .....+..|..+++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344455555555543 34577788889999987655 6889987642 12345667888887774222 23333
Q ss_pred ee------eeeCCeEEEEEeccCCCCHHH--------------HHhhC--C--Cc-------cCHHHHHH----------
Q 005278 478 SN------CCNIDFKALVLEFMPNGSLEK--------------WLYSH--N--YF-------LGILERLN---------- 516 (704)
Q Consensus 478 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~--~--~~-------~~~~~~~~---------- 516 (704)
.. ....+..+++++|++|..+.. .++.. . .. ..|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 122356789999998765311 11110 0 00 11222110
Q ss_pred --HHHHHHHHHHHHHhc----CCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 517 --IMIDVGLALEYLHHG----HSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 517 --i~~~i~~~l~~Lh~~----h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
+...+...++.++.. ...+++|+|+.+.||+++.+..+.++||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001234455555432 23568999999999999987666899998775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0022 Score=65.37 Aligned_cols=139 Identities=12% Similarity=0.062 Sum_probs=74.1
Q ss_pred ccccccCceE-EEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCC--CCCceEEeeeeeCCeEEEEEeccCCCC
Q 005278 421 NLLGTGSFGS-VYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRH--RNLIKIISNCCNIDFKALVLEFMPNGS 497 (704)
Q Consensus 421 ~~ig~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 497 (704)
+.++.|+... +|+....+|+.+++|...... ...+..|+.+++.+.. -.+.+++.+..+.+ +++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566665554 667765446777787643321 1345567777777742 23556676643333 68999998766
Q ss_pred HHHHHhhCC-------------------------CccCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 005278 498 LEKWLYSHN-------------------------YFLGILERL-------N-I------------MIDVGLALEYLH--- 529 (704)
Q Consensus 498 L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~l~~Lh--- 529 (704)
+.+++.... ..++..... . . ...+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655443110 001111100 0 0 001111222221
Q ss_pred hcCCCCcEecCCCCCCeeeCCC----CcEEEeeecccee
Q 005278 530 HGHSTPMVHCDLKPNNILLDEN----MTAHVSDFGISKL 564 (704)
Q Consensus 530 ~~h~~~ivH~dlk~~Nil~~~~----~~~kl~Dfgla~~ 564 (704)
..+...++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1235679999999999999875 6799999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0047 Score=62.71 Aligned_cols=140 Identities=12% Similarity=0.116 Sum_probs=81.3
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCC--CceEEee-----eeeCCeEEEEEecc
Q 005278 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRN--LIKIISN-----CCNIDFKALVLEFM 493 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~ 493 (704)
..++ |....||+....+|+.+++|...... .....+..|..+++.+.... +.+++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877678789999986321 13456777888888774222 3334432 12245567899999
Q ss_pred CCCCHH-----H------H---Hhh--C------CCccCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 005278 494 PNGSLE-----K------W---LYS--H------NYFLGILER----LNI---------------MIDVGLALEYLHHG- 531 (704)
Q Consensus 494 ~~gsL~-----~------~---l~~--~------~~~~~~~~~----~~i---------------~~~i~~~l~~Lh~~- 531 (704)
+|.++. . . ++. . ....++... ..+ ...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 1 0 111 0 011222111 000 11111223333221
Q ss_pred ---CCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 532 ---HSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 532 ---h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
....++|+|+.+.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 345689999999999999 4 899999987754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0027 Score=63.64 Aligned_cols=71 Identities=8% Similarity=0.053 Sum_probs=45.0
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCC-ceEEeeeeeCCeEEEEEecc-CCCC
Q 005278 420 CNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNL-IKIISNCCNIDFKALVLEFM-PNGS 497 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 497 (704)
.+.|+.|....+|+. +.+++|+....... ......|..+++.+....+ .+++++. .+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678999999999998 56888987543211 1223568888877743333 4555543 33346899999 5544
Q ss_pred H
Q 005278 498 L 498 (704)
Q Consensus 498 L 498 (704)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0013 Score=69.64 Aligned_cols=72 Identities=15% Similarity=0.240 Sum_probs=49.5
Q ss_pred cccccccCceEEEEEEECC--------CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCC-ceEEeeeeeCCeEEEEE
Q 005278 420 CNLLGTGSFGSVYKGTLFD--------GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNL-IKIISNCCNIDFKALVL 490 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 490 (704)
.+.|+.|....||+....+ ++.+++|+.... ...+.+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3578888889999998653 578999987432 111455679999988853333 567766543 3899
Q ss_pred eccCCCC
Q 005278 491 EFMPNGS 497 (704)
Q Consensus 491 e~~~~gs 497 (704)
||+++.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0044 Score=57.29 Aligned_cols=104 Identities=13% Similarity=0.040 Sum_probs=69.6
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcceec
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 575 (704)
-+|.+.|...+.++++.++|.++.|.+.+|.-+-.. ..+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc------------
Confidence 389999998888899999999999999998766221 111 1333457889999999888764 1110
Q ss_pred cccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCC
Q 005278 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPT 617 (704)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~ 617 (704)
.....+.|||... ...+.+.=|||+|+++|.-+--..|-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 1122456888753 34567889999999999998855553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0018 Score=66.81 Aligned_cols=139 Identities=12% Similarity=0.119 Sum_probs=80.7
Q ss_pred ccccccCceEEEEEEEC--------CCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEEe
Q 005278 421 NLLGTGSFGSVYKGTLF--------DGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 491 (704)
+.+..|-...+|+.... +++.+++|+.... ......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 56777888889998864 2478999986332 223456678999998884 3223566666543 38999
Q ss_pred ccCCCCHHH--------------H---HhhC----CCccC--HHHHHHHHHHHH-------------------HHHHHHH
Q 005278 492 FMPNGSLEK--------------W---LYSH----NYFLG--ILERLNIMIDVG-------------------LALEYLH 529 (704)
Q Consensus 492 ~~~~gsL~~--------------~---l~~~----~~~~~--~~~~~~i~~~i~-------------------~~l~~Lh 529 (704)
|++|.++.. . ++.- ..... +..+.++..++. ..++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999765421 0 1111 11112 233333333221 1223332
Q ss_pred ----h-cCCCCcEecCCCCCCeeeCCC----CcEEEeeecccee
Q 005278 530 ----H-GHSTPMVHCDLKPNNILLDEN----MTAHVSDFGISKL 564 (704)
Q Consensus 530 ----~-~h~~~ivH~dlk~~Nil~~~~----~~~kl~Dfgla~~ 564 (704)
. .....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 133468999999999999876 7899999988763
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0023 Score=54.93 Aligned_cols=36 Identities=28% Similarity=0.254 Sum_probs=18.9
Q ss_pred CCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCc
Q 005278 56 LQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLR 98 (704)
Q Consensus 56 L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~ 98 (704)
|++|+|++|+|+.++... |..+++|++|+|++|++.
T Consensus 33 l~~L~Ls~N~l~~l~~~~-------f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGL-------LDALPALRTAHLGANPWR 68 (130)
T ss_dssp CSEEECTTSCCSSCCTTT-------GGGCTTCCEEECCSSCCB
T ss_pred CCEEECCCCcCCccChhh-------hhhccccCEEEecCCCee
Confidence 555555555555554433 455555555555555554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0018 Score=55.69 Aligned_cols=57 Identities=23% Similarity=0.318 Sum_probs=37.6
Q ss_pred EEEeecCccC-CCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCC
Q 005278 258 NLDLSRNQLS-GDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 258 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 316 (704)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 5666777665 24444332 357777777777775555667777777778888877764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0045 Score=65.71 Aligned_cols=74 Identities=16% Similarity=0.187 Sum_probs=48.3
Q ss_pred cccccccCceEEEEEEECC-CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCC-ceEEeeeeeCCeEEEEEeccCCCC
Q 005278 420 CNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNL-IKIISNCCNIDFKALVLEFMPNGS 497 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 497 (704)
.+.|+.|-...+|+....+ +..+++|+....... .-....|..+++.+...++ .++++++. + .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4578888889999998765 478889987432211 1122689999999965555 46777663 2 35999998754
Q ss_pred H
Q 005278 498 L 498 (704)
Q Consensus 498 L 498 (704)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0068 Score=62.72 Aligned_cols=72 Identities=11% Similarity=0.208 Sum_probs=44.1
Q ss_pred ccccccCceEEEEEEECC---------CCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCC-CceEEeeeeeCCeEEEEE
Q 005278 421 NLLGTGSFGSVYKGTLFD---------GTNVAIKVFNLQLERASRSFDSECEILRSIRHRN-LIKIISNCCNIDFKALVL 490 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 490 (704)
..++.|....+|+....+ ++.+++|+....... ......|.++++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467788888999998654 268889987543211 112467888888885333 34666544 2 26899
Q ss_pred eccCCCC
Q 005278 491 EFMPNGS 497 (704)
Q Consensus 491 e~~~~gs 497 (704)
||++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.13 E-value=0.031 Score=56.89 Aligned_cols=32 Identities=19% Similarity=0.368 Sum_probs=28.0
Q ss_pred CCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 533 ~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35689999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.79 E-value=0.03 Score=58.56 Aligned_cols=74 Identities=11% Similarity=0.210 Sum_probs=48.1
Q ss_pred cccccccCceEEEEEEECC--------CCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEE
Q 005278 420 CNLLGTGSFGSVYKGTLFD--------GTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 490 (704)
.+.+..|-...+|+....+ ++.+++|+..... ...-...+|.++++.+. +.-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567778888999998653 5789999864432 11123467888888884 222445565332 26899
Q ss_pred eccCCCCH
Q 005278 491 EFMPNGSL 498 (704)
Q Consensus 491 e~~~~gsL 498 (704)
||++|.++
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.68 E-value=0.11 Score=34.10 Aligned_cols=25 Identities=20% Similarity=0.400 Sum_probs=12.8
Q ss_pred cchhhHHHHHHHHHhhhhhhccCCC
Q 005278 364 LPPITSIVLIAIVIIFFIRHRNRST 388 (704)
Q Consensus 364 ~~~~~~~~~v~~~~~~~~~~r~~~~ 388 (704)
+++++.+++++..+++|+|+|+...
T Consensus 18 VgGv~~~~ii~~~~~~~~RRr~~~~ 42 (44)
T 2ks1_B 18 VGALLLLLVVALGIGLFMRRRHIVR 42 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred hHHHHHHHHHHHHHHHHhhhhHhhc
Confidence 3334444444555566666665443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.37 E-value=0.51 Score=49.04 Aligned_cols=29 Identities=34% Similarity=0.463 Sum_probs=24.8
Q ss_pred cEecCCCCCCeee------CCCCcEEEeeecccee
Q 005278 536 MVHCDLKPNNILL------DENMTAHVSDFGISKL 564 (704)
Q Consensus 536 ivH~dlk~~Nil~------~~~~~~kl~Dfgla~~ 564 (704)
++|+|+.+.||++ +++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988764
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.72 E-value=0.4 Score=31.39 Aligned_cols=27 Identities=11% Similarity=0.437 Sum_probs=14.2
Q ss_pred ecchhhHHHHHHHHHhhhhhhccCCCC
Q 005278 363 ILPPITSIVLIAIVIIFFIRHRNRSTK 389 (704)
Q Consensus 363 ~~~~~~~~~~v~~~~~~~~~~r~~~~~ 389 (704)
++++++.+++++..+++|+|+|++..+
T Consensus 16 VVgGv~~v~ii~~~~~~~~RRRr~~~k 42 (44)
T 2l2t_A 16 VIGGLFILVIVGLTFAVYVRRKSIKKK 42 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred ehHHHHHHHHHHHHHHHHhhhhhhhhc
Confidence 333444444455555666666655443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 704 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 9e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-64
Identities = 68/279 (24%), Positives = 126/279 (45%), Gaps = 25/279 (8%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIIS 478
+G+GSFG+VYKG +VA+K+ N+ + ++F +E +LR RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
A+V ++ SL L+ +++ ++I ++YLH ++H
Sbjct: 72 -YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY---GSEGIIS 595
DLK NNI L E++T + DFG++ + S +I +MAPE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 596 PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655
+SDVY++GI+L E T + P + I + + + L L++V
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS----------- 236
Query: 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
+C ++ L +C + ++R A ++ +
Sbjct: 237 ---NCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 3e-56
Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 38/306 (12%)
Query: 406 SYLDIQRATNGFNEC---------NLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQL- 451
++ D A F + ++G G FG V G L VAIK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 452 ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGI 511
E+ R F SE I+ H N+I + ++ EFM NGSL+ +L ++ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 512 LERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571
++ + ++ + ++YL + VH DL NIL++ N+ VSDFG+S+ L +
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 572 VIQTMTI---ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK 628
T + I + APE + SDV+SYGI++ E + +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER------------ 232
Query: 629 HWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAK 688
+T N + ++ +DC ++ L LDC + R
Sbjct: 233 ------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 689 LKKIKE 694
L K+
Sbjct: 287 LDKMIR 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 4e-55
Identities = 65/284 (22%), Positives = 109/284 (38%), Gaps = 29/284 (10%)
Query: 423 LGTGSFGSVYKGTLF---DGTNVAIKVFNLQLERASR-SFDSECEILRSIRHRNLIKIIS 478
LG G+FGSV +G +VAIKV E+A E +I+ + + ++++I
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 479 NCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVH 538
C + LV+E G L K+L + + ++ V + ++YL VH
Sbjct: 77 -VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132
Query: 539 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEYGSEGIISPK 597
DL N+LL A +SDFG+SK LG D + + APE + S +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 598 SDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP-DGLTEVVDANLVREEQAFSV 656
SDV+SYG+ + E + + P + + + +
Sbjct: 193 SDVWSYGVTMWEALSYGQK-------------------PYKKMKGPEVMAFIEQGKRMEC 233
Query: 657 KIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDV 700
+C + L DC + E R +++ V
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-54
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 23/278 (8%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
+G+G FG V+ G + VAIK + F E E++ + H L+++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
C LV EFM +G L +L + L + +DV E + + +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV---CEGMAYLEEACV 122
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
+H DL N L+ EN VSDFG+++ + + D T T + + +PE S S
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 597 KSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSV 656
KSDV+S+G+L+ E F+ K E + + + ++
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGFRLYKPRLASTHVY-------- 232
Query: 657 KIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
+ C E PE R + +L +I E
Sbjct: 233 ---------QIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 61/291 (20%), Positives = 118/291 (40%), Gaps = 23/291 (7%)
Query: 423 LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN 482
+G G FG V++G G VA+K+F+ + ER S ++E +RH N++ I+
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 483 IDFKA----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH-----GHS 533
+ LV ++ +GSL +L + Y + + + + + L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPEYGSE 591
+ H DLK NIL+ +N T ++D G++ D++ + T YMAPE +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 592 GI------ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKE--SLPDGLTEVV 643
I ++D+Y+ G++ E R ++ V S+ + V
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
+ L + L + + +C + R++ L ++ +
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-54
Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 28/285 (9%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTN-----VAIKVFNLQL-ERASRSFDSECEILRSIRH 470
++G G FG VYKG L + VAIK E+ F E I+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH 530
N+I++ ++ E+M NG+L+K+L + +L+ + ++ + + +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI---AAGMKY 125
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEYG 589
+ VH DL NIL++ N+ VSDFG+S++L + ++ T I + APE
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 590 SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649
S + SDV+S+GI++ E T + E+S +K +
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGER----PYWELSNHEVMK--------------AIN 227
Query: 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
+ +DC +I L + C + +R D + L K+
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-54
Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 31/279 (11%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
+G G FG V G G VA+K ++ + +++F +E ++ +RH NL+++
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 477 ISNCCNIDFK-ALVLEFMPNGSLEKWLYSHNY-FLGILERLNIMIDVGLALEYLHHGHST 534
+ +V E+M GSL +L S LG L +DV A+EYL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 122
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII 594
VH DL N+L+ E+ A VSDFG++K D+ + + APE E
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKF 177
Query: 595 SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654
S KSDV+S+GILL E ++ + + LK V V +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVP--------------RVEKGYKM 219
Query: 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693
C ++ + +C R S +L+ IK
Sbjct: 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 7e-54
Identities = 62/277 (22%), Positives = 124/277 (44%), Gaps = 25/277 (9%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
LG G FG V+ G T VA+K + +F +E +++ ++H+ L+++
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF-LGILERLNIMIDVGLALEYLHHGHSTP 535
+ + ++ E+M NGSL +L + + L I + L++ + + ++ +
Sbjct: 74 YA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
+H DL+ NIL+ + ++ ++DFG+++L+ E ++ + I + APE + G +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 596 PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655
KSDV+S+GILL E T + +++ + +VR +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----------GYRMVRPD---- 233
Query: 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+C + L C E PE R + + L+
Sbjct: 234 ---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 8e-54
Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 25/277 (9%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
LG G FG V+ GT T VAIK + +F E ++++ +RH L+++
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGIL-ERLNIMIDVGLALEYLHHGHSTP 535
+ + + +V E+M GSL +L L + +++ + + Y+ +
Sbjct: 78 YA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
VH DL+ NIL+ EN+ V+DFG+++L+ + + + + I + APE G +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFT 192
Query: 596 PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655
KSDV+S+GILL E T+ + G+ + V
Sbjct: 193 IKSDVWSFGILLTELTTKGRV------------------PYPGMVNREVLDQVERGYRMP 234
Query: 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+C S+ L C + PE+R + + A L+
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-53
Identities = 58/276 (21%), Positives = 108/276 (39%), Gaps = 23/276 (8%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKI 476
LGTG FG V G +VAIK+ + F E +++ ++ H L+++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
C ++ E+M NG L +L + + L + DV A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
+H DL N L+++ VSDFG+S+ + + D+ + + + PE S
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 597 KSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSV 656
KSD++++G+L+ E ++ K + T A + +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMP------------------YERFTNSETAEHIAQGLRLYR 222
Query: 657 KIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+ + C E ++R + K + + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 8e-53
Identities = 64/301 (21%), Positives = 122/301 (40%), Gaps = 29/301 (9%)
Query: 407 YLDIQRATNGFNECNLLGTGSFGSVYKGTLFDGTN----VAIKVFN-LQLERASRSFDSE 461
++ I ++ + ++G G FG VY GTL D A+K N + F +E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 462 CEILRSIRHRNLIKIISNCCNIDFKA-LVLEFMPNGSLEKWLYSHNYFLGILERLNIMID 520
I++ H N++ ++ C + +VL +M +G L ++ + + + + + +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--I 578
V + S VH DL N +LDE T V+DFG+++ + + + + T
Sbjct: 139 VAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 579 ATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG 638
+ +MA E + KSDV+S+G+LL E TR P +++
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVY----- 246
Query: 639 LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLD 698
+ + + C + + L C E R S + +++ I F+
Sbjct: 247 ---------LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
Query: 699 D 699
+
Sbjct: 298 E 298
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-52
Identities = 62/302 (20%), Positives = 116/302 (38%), Gaps = 33/302 (10%)
Query: 410 IQRATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRS-FDSECEILRS 467
++ + F + + LG G+ G V+K + G +A K+ +L+++ A R+ E ++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 468 IRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
++ + ++ +E M GSL++ L + + I V L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 587
L H ++H D+KP+NIL++ + DFG+S L + + + T YM+PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 173
Query: 588 YGSEGIISPKSDVYSYGILLMETFTRKKP----------TNEIFIGEMSLKHWVKESLPD 637
S +SD++S G+ L+E + P E
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 638 GLTEVVDANLVREEQAFSVKIDCLLSIMHLALD--------------CCMESPEQRVSMK 683
G R A +D +++ L C +++P +R +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 684 DA 685
Sbjct: 294 QL 295
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 3e-51
Identities = 68/319 (21%), Positives = 115/319 (36%), Gaps = 51/319 (15%)
Query: 406 SYLDIQRATNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERASRSF 458
L ++ N +G G+FG V++ T VA+K+ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 459 DSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF---------- 508
E ++ + N++K++ C L+ E+M G L ++L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 509 -------------LGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAH 555
L E+L I V + YL VH DL N L+ ENM
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 556 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKK 615
++DFG+S+ + D I +M PE + +SDV++YG++L E F+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 616 PTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMES 675
G+ VR+ + +C L + +L C +
Sbjct: 241 QPYY------------------GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKL 282
Query: 676 PEQRVSMKDAAAKLKKIKE 694
P R S L+++ E
Sbjct: 283 PADRPSFCSIHRILQRMCE 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-51
Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 31/281 (11%)
Query: 419 ECNLLGTGSFGSVYKGTLFD---GTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNL 473
E LG+G+FG+V KG VA+K+ + +E +++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+++I C + LV+E G L K+L + + + + ++ V + ++YL +
Sbjct: 71 VRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN- 127
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEYGSEG 592
VH DL N+LL A +SDFG+SK L ++ + + APE +
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP-DGLTEVVDANLVREE 651
S KSDV+S+G+L+ E F+ + P G+ ++ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK-------------------PYRGMKGSEVTAMLEKG 226
Query: 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+ C + L C E R +L+
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 3e-50
Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 25/281 (8%)
Query: 417 FNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
+ LG G +G VY+G VA+K F E +++ I+H NL++
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF-LGILERLNIMIDVGLALEYLHHGHST 534
++ C ++ EFM G+L +L N + + L + + A+EYL
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII 594
+H DL N L+ EN V+DFG+S+L+ GD I + APE +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 595 SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654
S KSDV+++G+LL E T + L + L+ ++
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQVYE--------------LLEKDYRM 235
Query: 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695
C + L C +P R S + + + ++
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-49
Identities = 62/284 (21%), Positives = 107/284 (37%), Gaps = 32/284 (11%)
Query: 412 RATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSI 468
RA + + +GTGS+G K DG + K + E + SE +LR +
Sbjct: 2 RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 469 RHRNLIKIISNCCNIDFKAL--VLEFMPNGSLEKWLYSHNYFLGIL---ERLNIMIDVGL 523
+H N+++ + L V+E+ G L + L L +M + L
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 524 ALEYLH--HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI 581
AL+ H ++H DLKP N+ LD + DFG++++L D+ + T
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTP 178
Query: 582 GYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTE 641
YM+PE + + KSD++S G LL E P ++
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-------------------TAFSQ 219
Query: 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
A +RE + + + + R S+++
Sbjct: 220 KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 4e-49
Identities = 63/284 (22%), Positives = 121/284 (42%), Gaps = 28/284 (9%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL-----ERASRSFDSECEILRSIRH 470
F + +LG+G+FG+VYKG + +G V I V +L +A++ E ++ S+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH 530
++ +++ C L+ + MP G L ++ H +G LN + + + YL
Sbjct: 71 PHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
+VH DL N+L+ ++DFG++KLLG + I +MA E
Sbjct: 130 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 591 EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650
I + +SDV+SYG+ + E T DG+ ++++ +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPASEISSILEK 228
Query: 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
+ C + + + + C M + R ++ + K+
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-48
Identities = 67/285 (23%), Positives = 102/285 (35%), Gaps = 29/285 (10%)
Query: 417 FNECNLLGTGSFGSVYKGTLF----DGTNVAIKVFNLQL---ERASRSFDSECEILRSIR 469
LG GSFG V +G +VA+K + A F E + S+
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLH 529
HRNLI++ K +V E P GSL L H + + V + YL
Sbjct: 70 HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEY 588
S +H DL N+LL + DFG+ + L + DD + + APE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 589 GSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648
S SD + +G+ L E FT + W+ + L +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEP------------WIGLNGSQIL-----HKID 228
Query: 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693
+E + DC I ++ + C PE R + L + +
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 8e-48
Identities = 69/301 (22%), Positives = 119/301 (39%), Gaps = 44/301 (14%)
Query: 415 NGFNECNLLGTGSFGSVYKGTLFDG---TNVAIKVFNLQLERAS-RSFDSECEILRSI-R 469
N +++G G+FG V K + + AIK + R F E E+L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF---------------LGILER 514
H N+I ++ C + + L +E+ P+G+L +L L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 515 LNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574
L+ DV ++YL +H DL NIL+ EN A ++DFG+S+ + V +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKK 183
Query: 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES 634
TM + +MA E + + + SDV+SYG+LL E + M+ +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYE-- 237
Query: 635 LPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
+ + ++C + L C E P +R S L ++ E
Sbjct: 238 ------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
Query: 695 K 695
+
Sbjct: 286 E 286
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 1e-47
Identities = 65/276 (23%), Positives = 100/276 (36%), Gaps = 35/276 (12%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNL---QLERASRSFDSECEILRSIRHRN 472
F++ +G GSFG+VY + + VAIK + Q + E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
I+ LV+E+ + + H L +E + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY---G 589
S M+H D+K NILL E + DFG + ++ + T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAM 186
Query: 590 SEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649
EG K DV+S GI +E RK P + L H + P +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYFR- 244
Query: 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
+ C + P+ R + +
Sbjct: 245 ----------------NFVDSCLQKIPQDRPTSEVL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 57/297 (19%), Positives = 104/297 (35%), Gaps = 45/297 (15%)
Query: 421 NLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLERASR-SFDSECEILRSI-RHRN 472
LG G+FG V + T + VA+K+ R + SE ++L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSH-----------------NYFLGILERL 515
++ ++ C ++ E+ G L +L L + + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 516 NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575
+ V + +L + +H DL NILL + DFG+++ + + V++
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635
+ +MAPE + + +SDV+SYGI L E F+ + +KE
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
+ + C P +R + K ++K
Sbjct: 266 R-----------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 50/299 (16%)
Query: 422 LLGTGSFGSVYKGTLFDGTN------VAIKVFNLQLERASR-SFDSECEILRSI-RHRNL 473
+LG+G+FG V T + + VA+K+ + + + R + SE +++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHN----------------------YFLGI 511
+ ++ C L+ E+ G L +L S L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 512 LERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571
+ L V +E+L VH DL N+L+ + DFG+++ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV 631
V++ + +MAPE EGI + KSDV+SYGILL E F+ + G ++
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPVDANFY 277
Query: 632 KESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLK 690
K L++ I + C +R S + + L
Sbjct: 278 K--------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 58/279 (20%), Positives = 102/279 (36%), Gaps = 28/279 (10%)
Query: 422 LLGTGSFGSVYKGTLFDGTN----VAIKVFNLQLERASRS-FDSECEILRSIRHRNLIKI 476
+G G FG V++G N VAIK + R F E +R H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
I + +++E G L +L Y L + + + AL + S
Sbjct: 74 IG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL---AYLESKRF 129
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
VH D+ N+L+ N + DFG+S+ + E + I +MAPE + +
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 597 KSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSV 656
SDV+ +G+ + E G+ + + +
Sbjct: 189 ASDVWMFGVCMWEILMHGVK------------------PFQGVKNNDVIGRIENGERLPM 230
Query: 657 KIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695
+C ++ L C P +R + A+L I E+
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 4e-47
Identities = 53/272 (19%), Positives = 103/272 (37%), Gaps = 24/272 (8%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNL-QLERASRSFDSECEILRSIRHRNLI 474
++ LG G++G V VA+K+ ++ + + E I + + H N++
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
K + + + L LE+ G L + + + + YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY-GSEGI 593
+ H D+KP N+LLDE +SDFG++ + + + T+ Y+APE
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 594 ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653
+ DV+S GI+L + P ++ W ++ + +D+ +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL----- 237
Query: 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
L +E+P R+++ D
Sbjct: 238 ------------ALLHKILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 4e-47
Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 32/271 (11%)
Query: 423 LGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKII-- 477
+G GSF +VYKG VA + + + F E E+L+ ++H N+++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 478 --SNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
S LV E M +G+L+ +L + I + + L++LH + P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHT-RTPP 134
Query: 536 MVHCDLKPNNILL-DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGII 594
++H DLK +NI + + + D G++ L + I T +MAPE E
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYEEKY- 189
Query: 595 SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654
DVY++G+ ++E T + P +E + P +V +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK------ 243
Query: 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
+ C ++ ++R S+KD
Sbjct: 244 -----------EIIEGCIRQNKDERYSIKDL 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 5e-47
Identities = 60/271 (22%), Positives = 101/271 (37%), Gaps = 28/271 (10%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISN 479
LG G+FG VYK A KV + + E + E +IL S H N++K++
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539
+ +++EF G+++ + L + + AL YL H ++H
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---HDNKIIHR 134
Query: 540 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY-----GSEGII 594
DLK NIL + ++DFG+S + I T +MAPE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 595 SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAF 654
K+DV+S GI L+E + P +E+ + L K P
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPPT----------------L 235
Query: 655 SVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
+ + C ++ + R +
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 2e-46
Identities = 63/301 (20%), Positives = 122/301 (40%), Gaps = 37/301 (12%)
Query: 417 FNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNL-QLERASRSFDSECEILRSIR 469
LG GSFG VY+G T VAIK N R F +E +++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 470 HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGIL---------ERLNIMID 520
++++++ +++E M G L+ +L S + + + + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 521 VGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIAT 580
+ + YL+ + VH DL N ++ E+ T + DFG+++ + E D +
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 581 IGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLT 640
+ +M+PE +G+ + SDV+S+G++L E T + + E L+ ++ L D
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD--- 255
Query: 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDV 700
+C + L C +P+ R S + + +K+ E +V
Sbjct: 256 ---------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
Query: 701 A 701
+
Sbjct: 301 S 301
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 9e-46
Identities = 58/270 (21%), Positives = 107/270 (39%), Gaps = 25/270 (9%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
+ +G G+ G+VY + G VAI+ NLQ + +E ++R ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ + D +V+E++ GSL + G + + + ALE+L HS
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFL---HSNQ 136
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
++H D+K +NILL + + ++DFG + ++ + T +MAPE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYG 194
Query: 596 PKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFS 655
PK D++S GI+ +E + P ++ E L +
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP----YLNENPL-------------RALYLIATNGTPELQ 237
Query: 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
C E+R S K+
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (414), Expect = 2e-45
Identities = 58/267 (21%), Positives = 102/267 (38%), Gaps = 25/267 (9%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
LGTG+FG V++ T G N A K E + E + + +RH L+ +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+ + ++ EFM G L + + + + E + M V L ++H + VH D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 149
Query: 541 LKPNNILL--DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
LKP NI+ + + DFG++ L +T T + APE + +
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 599 DVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKI 658
D++S G+L + P + E+ + L V + ++ AFS
Sbjct: 207 DMWSVGVLSYILLSGLSP-------------FGGENDDETLRNVKSCDWNMDDSAFS--- 250
Query: 659 DCLLSIMHLALDCCMESPEQRVSMKDA 685
+ P R+++ A
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-45
Identities = 54/288 (18%), Positives = 104/288 (36%), Gaps = 28/288 (9%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRN 472
F +LG GSF +V L AIK+ + E E +++ + H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
+K+ + + L + NG L K++ F ++ + L + H
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEI---VSALEYLH 125
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG 592
++H DLKP NILL+E+M ++DFG +K+L + T Y++PE +E
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652
SD+++ G ++ + P + + +++ E+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP-------------FRAGNEYLIFQKIIKLEYDFPEK 232
Query: 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDV 700
F D + + +R+ ++ F + V
Sbjct: 233 FFPKARDLVEK-------LLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-45
Identities = 63/270 (23%), Positives = 103/270 (38%), Gaps = 34/270 (12%)
Query: 421 NLLGTGSFGSVYKGTL-FDGTNVAIKVFN---LQLERASRSFDSECEILRSIRHRNLIKI 476
LG G FG+VY +A+KV L+ E EI +RH N++++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ L+LE+ P G++ + L + F + ++ AL Y H S +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH---SKRV 127
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
+H D+KP N+LL ++DFG S +T T+ Y+ PE +
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDE 183
Query: 597 KSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH-WVKESLPDGLTEVVDANLVREEQAFS 655
K D++S G+L E K P E + V+ + PD +TE
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE-------------- 229
Query: 656 VKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
L +P QR +++
Sbjct: 230 -------GARDLISRLLKHNPSQRPMLREV 252
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 159 bits (402), Expect = 8e-44
Identities = 60/267 (22%), Positives = 107/267 (40%), Gaps = 25/267 (9%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
LG+G+FG V++ G K N + +E I+ + H LI +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+ L+LEF+ G L + + +Y + E +N M L+++ H +VH D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLD 152
Query: 541 LKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
+KP NI+ + + V DFG++ L + I +T AT + APE + +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 599 DVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKI 658
D+++ G+L + P + E + L V + +E AFS
Sbjct: 210 DMWAIGVLGYVLLSGLSP-------------FAGEDDLETLQNVKRCDWEFDEDAFS--- 253
Query: 659 DCLLSIMHLALDCCMESPEQRVSMKDA 685
+ + P +R+++ DA
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-43
Identities = 67/297 (22%), Positives = 117/297 (39%), Gaps = 46/297 (15%)
Query: 421 NLLGTGSFGSVYKGTL--------FDGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RH 470
LG G+FG V T VA+K+ E+ SE E+++ I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYF---------------LGILERL 515
+N+I ++ C +++E+ G+L ++L + L + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 516 NIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQT 575
+ V +EYL S +H DL N+L+ E+ ++DFG+++ + D T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 576 MTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESL 635
+ +MAPE + I + +SDV+S+G+LL E FT
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------------P 237
Query: 636 PDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692
G+ L++E +C + + DC P QR + K L +I
Sbjct: 238 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 66/298 (22%), Positives = 111/298 (37%), Gaps = 44/298 (14%)
Query: 421 NLLGTGSFGSVYKGTLF------DGTNVAIKVFNL-QLERASRSFDSECEILRSIRHRNL 473
LG G+FG V + F VA+K+ R+ SE +IL I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 474 IKIISNCCNIDFKAL--VLEFMPNGSLEKWLYSHNY---------------FLGILERLN 516
+ + C L ++EF G+L +L S FL + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 517 IMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTM 576
V +E+L S +H DL NILL E + DFG+++ + + D V +
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 577 TIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLP 636
+ +MAPE + + + +SDV+S+G+LL E F+ + G + + +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCR---- 248
Query: 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694
++E + LDC P QR + + L + +
Sbjct: 249 ----------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 54/285 (18%), Positives = 119/285 (41%), Gaps = 32/285 (11%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
LG G FG V++ K ++ E IL RHRN++ + +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+++ ++ EF+ + + + + + L E ++ + V AL++L HS + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFD 127
Query: 541 LKPNNILLDENMTAHV--SDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKS 598
++P NI+ ++ + +FG ++ L GD+ + Y APE ++S +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 599 DVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKI 658
D++S G L+ + P ++ E+ + +++A +E+AF
Sbjct: 185 DMWSLGTLVYVLLSGINP-------------FLAETNQQIIENIMNAEYTFDEEAFK--- 228
Query: 659 DCLLSIMHLALDCCMESPEQRVSMKDAAA------KLKKIKEKFL 697
+ + M ++ + R++ +A K++++ K +
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (368), Expect = 6e-40
Identities = 56/281 (19%), Positives = 110/281 (39%), Gaps = 30/281 (10%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKII 477
+LG G V+ L +VA+KV L F E + ++ H ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 478 SNCCNIDFKA----LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+V+E++ +L +++ + + ++ D + L+ H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADA---CQALNFSHQ 129
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEYGSEG 592
++H D+KP NI++ V DFGI++ + + +SV QT + T Y++PE
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652
+ +SDVYS G +L E T + P + +S + V + +
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPP-------------FTGDSPVSVAYQHVREDPIPPSA 236
Query: 653 AFSVKIDCLLSIMHLALDCCMESPEQRV-SMKDAAAKLKKI 692
+ + L ++PE R + + A L ++
Sbjct: 237 RHE---GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 2e-39
Identities = 59/286 (20%), Positives = 110/286 (38%), Gaps = 27/286 (9%)
Query: 402 WRRTSYLDIQRATNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQ-LERASRSFD 459
W++ DI+ + ++ ++LGTG+F V VAIK + LE S +
Sbjct: 1 WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55
Query: 460 SECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMI 519
+E +L I+H N++ + + L+++ + G L + F + ++
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIF 114
Query: 520 DVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIA 579
V A++YLH LDE+ +SDFG+SK+ G + +
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACG 171
Query: 580 TIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL 639
T GY+APE ++ S D +S G++ P + E+
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-------------FYDENDAKLF 218
Query: 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
+++ A + + D S + PE+R + + A
Sbjct: 219 EQILKAEYEFDSPYWD---DISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (365), Expect = 1e-38
Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 24/252 (9%)
Query: 415 NGFNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNL------QLERASRSFDSECEILRS 467
N F+ ++G G FG VY D G A+K + Q E + + ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 468 IRHRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
++ + D + +L+ M G L L H F + ++ L LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEH 122
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 587
+H+ +V+ DLKP NILLDE+ +SD G++ + ++ T GYMAPE
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPE 175
Query: 588 YGSEGI-ISPKSDVYSYGILLMETFTRKKP--------TNEIFIGEMSLKHWVKESLPDG 638
+G+ +D +S G +L + P +EI +++ + +S
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 639 LTEVVDANLVRE 650
L +++ L R+
Sbjct: 236 LRSLLEGLLQRD 247
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (358), Expect = 4e-38
Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 22/230 (9%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKI 476
LGTGSFG V+ +G A+KV ++ + + E +L + H +I++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 477 ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPM 536
+ ++++++ G L + +V L + HS +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEV---CLALEYLHSKDI 125
Query: 537 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISP 596
++ DLKP NILLD+N ++DFG +K + + ++ T Y+APE S +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180
Query: 597 KSDVYSYGILLMETFTRKKPTNE---------IFIGEMSLKHWVKESLPD 637
D +S+GIL+ E P + I E+ + E + D
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 140 bits (353), Expect = 6e-38
Identities = 60/286 (20%), Positives = 107/286 (37%), Gaps = 40/286 (13%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNL---------QLERASRSFDSECEILR 466
+ +LG G V + A+K+ ++ +++ + E +ILR
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 467 SIR-HRNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL 525
+ H N+I++ F LV + M G L +L L E IM + +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVI 123
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 585
LH + +VH DLKP NILLD++M ++DFG S L G+ T Y+A
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLA 177
Query: 586 PEY------GSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGL 639
PE + + D++S G+++ P + L
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-------------FWHRKQMLML 224
Query: 640 TEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
++ N + D ++ L + P++R + ++A
Sbjct: 225 RMIMSGNYQFGSPEWD---DYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 61/280 (21%), Positives = 113/280 (40%), Gaps = 21/280 (7%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL-----ERASRSFDSECEILRSIRHRNLI 474
+ LG G F +VYK VAIK L + +R+ E ++L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
++ + +LV +FM + ++ L M+ L+ L + H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMT---LQGLEYLHQH 119
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-YGSEGI 593
++H DLKPNN+LLDEN ++DFG++K G + + T + T Y APE +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARM 177
Query: 594 ISPKSDVYSYGILLMETFTRKKP---TNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650
D+++ G +L E R +++ + + + V
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 651 EQAFSVKIDCLLS-----IMHLALDCCMESPEQRVSMKDA 685
+ + + + S ++ L + +P R++ A
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (348), Expect = 4e-37
Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 18/281 (6%)
Query: 417 FNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLI 474
++ +G G++G VYK G A+K L+ E + E IL+ ++H N++
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
K+ LV E + + L+K L L + + ++ + L + + H
Sbjct: 64 KLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQL---LNGIAYCHDR 119
Query: 535 PMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-YGSEGI 593
++H DLKP N+L++ ++DFG+++ G T I T+ Y AP+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKK 177
Query: 594 ISPKSDVYSYGILLMETFTRKKP-----TNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648
S D++S G + E + + + +TE+ +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 649 REEQAFSVKIDCLLSIMHLALD----CCMESPEQRVSMKDA 685
L + +D P QR++ K A
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 67/309 (21%), Positives = 119/309 (38%), Gaps = 30/309 (9%)
Query: 410 IQRATNGFNECNLLGTGSFGSVYKGT--LFDGTNVAIKVFNLQL--ERASRSFDSECEIL 465
+ RA + +G G++G V+K G VA+K +Q E S E +L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 466 R---SIRHRNLIKIISNCCNIDFKA-----LVLEFMPNGSLEKWLYSHNYFLGILERLNI 517
R + H N++++ C LV E + + ++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 518 MIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT 577
M + L++LH S +VH DLKP NIL+ + ++DFG++++ + T
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175
Query: 578 IATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP---TNEIFIGEMSLKHWVKES 634
+ T+ Y APE + + D++S G + E F RK ++++ L
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 635 LPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALD----CCMESPEQRVSMKDAAA--- 687
D +V ++ + I L D C +P +R+S A +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295
Query: 688 --KLKKIKE 694
L++ KE
Sbjct: 296 FQDLERCKE 304
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 60/252 (23%), Positives = 100/252 (39%), Gaps = 17/252 (6%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFN---LQLERASRSFDSECEIL-RSIRHRNLIK 475
+LG GSFG V+ AIK + ++ E +L + H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 476 IISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTP 535
+ + V+E++ G L + S + F + ++ L L++LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLHSKG--- 123
Query: 536 MVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIIS 595
+V+ DLK +NILLD++ ++DFG+ K GD T Y+APE +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYN 181
Query: 596 PKSDVYSYGILLMETFTRKKP-----TNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650
D +S+G+LL E + P E+F + L +++ VRE
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVRE 241
Query: 651 -EQAFSVKIDCL 661
E+ V+ D
Sbjct: 242 PEKRLGVRGDIR 253
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 1e-35
Identities = 48/291 (16%), Positives = 97/291 (33%), Gaps = 32/291 (10%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
+G+GSFG +Y GT + G VAIK+ ++ + E +I + ++ I I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+++ + SLE + + L + + +EY+H + +H D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128
Query: 541 LKPNNIL---LDENMTAHVSDFGISKLLGEGDDSVIQ-----TMTIATIGYMAPEYGSEG 592
+KP+N L + ++ DFG++K + T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH--WVKESLPDGLTEVVDANLVRE 650
S + D+ S G +LM P + K+ ++ + + +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK------ 242
Query: 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI--KEKFLDD 699
C + + + + ++ F D
Sbjct: 243 --------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-35
Identities = 59/282 (20%), Positives = 106/282 (37%), Gaps = 18/282 (6%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNL 473
F + +G G++G VYK G VA+K L E + E +L+ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+K++ + LV EF+ + S + + + + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-YGSEG 592
++H DLKP N+L++ ++DFG+++ G T + T+ Y APE
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 593 IISPKSDVYSYGILLMETFTRKKP-----TNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647
S D++S G + E TR+ + E + G+T + D
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 648 VREEQAFSVKIDCLLSIMHLALD----CCMESPEQRVSMKDA 685
+ A + + P +R+S K A
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-35
Identities = 57/289 (19%), Positives = 103/289 (35%), Gaps = 20/289 (6%)
Query: 414 TNGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFN-LQLERASRSFDSECEILRSIRHR 471
+ + +G G++G V + VAIK + + + + E +IL RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYS--HNYFLGILERLNIMIDVGLALEYLH 529
N+I I + + ++ + LY L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 530 HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEY 588
S ++H DLKP+N+LL+ + DFG++++ D +AT Y APE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 589 GSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647
+ D++S G +L E + + + P NL
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 648 VREEQAFSVKIDCLLSIMHL-------ALD----CCMESPEQRVSMKDA 685
S+ + L ALD +P +R+ ++ A
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 54/283 (19%), Positives = 113/283 (39%), Gaps = 20/283 (7%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNL 473
+ + +G G++G+V+K VA+K L E S E +L+ ++H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 474 IKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+++ + LV EF + + + + + + L+ L HS
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQL---LKGLGFCHS 119
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-YGSEG 592
++H DLKP N+L++ N +++FG+++ G + + T+ Y P+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAK 177
Query: 593 IISPKSDVYSYGILLMETFTRKKP------TNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646
+ S D++S G + E +P ++ L E +T++ D
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 647 LVREEQAFSVKIDCLLSIMHLALD----CCMESPEQRVSMKDA 685
A + ++ + + D +P QR+S ++A
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (335), Expect = 2e-35
Identities = 46/292 (15%), Positives = 87/292 (29%), Gaps = 32/292 (10%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
+G GSFG +++GT L + VAIK + E + + I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 481 CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCD 540
+++ + SLE L + + ++ +H +V+ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126
Query: 541 LKPNNILLDENMTAH-----VSDFGISKLLGEGDDSVIQ-----TMTIATIGYMAPEYGS 590
+KP+N L+ + + V DFG+ K + T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 591 EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKH-WVKESLPDGLTEVVDANLVR 649
S + D+ + G + M P + K+ + E + A
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246
Query: 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI--KEKFLDD 699
E MH + + K+ + +D
Sbjct: 247 E----------FYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-35
Identities = 55/230 (23%), Positives = 83/230 (36%), Gaps = 21/230 (9%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL------ERASRSFDSECEILRSIR--HRN 472
LLG+G FGSVY G + D VAIK E +L+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 473 LIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
+I+++ D L+LE + L + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127
Query: 533 STPMVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEY-GS 590
+ ++H D+K NIL+D N + DFG LL + T T Y PE+
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRY 183
Query: 591 EGIISPKSDVYSYGILLMETFTRKKP---TNEIFIGEMSLKHWVKESLPD 637
+ V+S GILL + P EI G++ + V
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 233
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-35
Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 34/275 (12%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRS------FDSECEILRSIRHRNLI 474
LG+G F V K G A K + ++SR + E IL+ I+H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 475 KIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHST 534
+ N L+LE + G L +L E + + L +++ HS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEFLKQI---LNGVYYLHSL 132
Query: 535 PMVHCDLKPNNILLDENMTA----HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
+ H DLKP NI+L + + DFG++ + G++ T ++APE +
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 189
Query: 591 EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650
+ ++D++S G++ + P ++ ++ + L V N E
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASP-------------FLGDTKQETLANVSAVNYEFE 236
Query: 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
++ FS + ++ P++R++++D+
Sbjct: 237 DEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 8e-35
Identities = 53/276 (19%), Positives = 101/276 (36%), Gaps = 37/276 (13%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEIL-RSIRHRNLIKIISN 479
+LG G G V + A+K+ + E E+ R+ + ++++I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 480 CCNIDFKA----LVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHST 534
N+ +V+E + G L + + E IM +G A++YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 535 PMVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSE 591
+ H D+KP N+L N ++DFG +K + T T Y+APE
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGP 187
Query: 592 GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651
D++S G+++ P F L ++ + + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLA----------ISPGMKTRIRMGQ 233
Query: 652 QAFSVKIDCLLS--IMHLALDCCMESPEQRVSMKDA 685
F +S + L + P QR+++ +
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-34
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 28/288 (9%)
Query: 417 FNECNLLGTGSFGSVYKGTLFD-GTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIK 475
+ + ++G GSFG VY+ L D G VAIK + + R + E +I+R + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 476 IISNCCNID------FKALVLEFMPNGSLEKWLY--SHNYFLGILERLNIMIDVGLALEY 527
+ + + LVL+++P + L ++ M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 528 LHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 586
+H + H D+KP N+LLD + + DFG +K L G+ + +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPE 192
Query: 587 EYGSEGIISPKSDVYSYGILLMETFTRKKP---------TNEIFIGEMSLKHWVKESLPD 637
+ DV+S G +L E + EI + +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 638 GLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685
TE + + + L +P R++ +A
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 7e-34
Identities = 59/295 (20%), Positives = 109/295 (36%), Gaps = 30/295 (10%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNL 473
+ + +G G+FG V+K G VA+K ++ E + E +IL+ ++H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 474 IKIISNCCNIDFKA--------LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL 525
+ +I C LV +F + F + E +M + L
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQML---L 127
Query: 526 EYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMT--IATIGY 583
L++ H ++H D+K N+L+ + ++DFG+++ +S T + T+ Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 584 MAPE-YGSEGIISPKSDVYSYGILLMETFTRKKP-----TNEIFIGEMSLKHWVKESLPD 637
PE E P D++ G ++ E +TR L + +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 638 GLTEVVDANLVREEQAFSVKIDCLLSIMHL---ALD----CCMESPEQRVSMKDA 685
+ + + K+ L ALD + P QR+ DA
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 46/206 (22%), Positives = 83/206 (40%), Gaps = 10/206 (4%)
Query: 415 NGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRH 470
N F+ LLG G+FG V G A+K+ ++ + +E +L++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH 530
L + D V+E+ G L L F ++ + L +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARFYGAEI---VSALEY 120
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
HS +V+ D+K N++LD++ ++DFG+ K ++ T Y+APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLE 178
Query: 591 EGIISPKSDVYSYGILLMETFTRKKP 616
+ D + G+++ E + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 1e-31
Identities = 55/245 (22%), Positives = 100/245 (40%), Gaps = 18/245 (7%)
Query: 415 NGFNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRH 470
+ F+ LGTGSFG V G + A+K+ + Q + +E IL+++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 471 RNLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHH 530
L+K+ + + +V+E++ G + L F + L EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH- 158
Query: 531 GHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGS 590
S +++ DLKP N+L+D+ V+DFG +K + ++ T +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIIL 211
Query: 591 EGIISPKSDVYSYGILLMETFTRKKP-----TNEIFIGEMSLKHWVKESLPDGLTEVVDA 645
+ D ++ G+L+ E P +I+ +S K L +++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 646 NLVRE 650
L +
Sbjct: 272 LLQVD 276
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-30
Identities = 59/289 (20%), Positives = 108/289 (37%), Gaps = 30/289 (10%)
Query: 417 FNECNLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNL 473
+ + +G+G++G+V G VAIK E ++ E +L+ +RH N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 474 IKIISNCCNIDFKA------LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEY 527
I ++ + LV+ FM G+ L H LG ++ + L Y
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 136
Query: 528 LHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 587
+H ++H DLKP N+ ++E+ + DFG+++ DS + +
Sbjct: 137 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEV 189
Query: 588 YGSEGIISPKSDVYSYGILLMETFTRKKP---------TNEIFIGEMSLKHWVKESLPDG 638
+ + D++S G ++ E T K EI + + L
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 639 LTEVVDANLVREEQAFSVKIDCLLS--IMHLALDCCMESPEQRVSMKDA 685
+ L E+ I S ++L + EQRV+ +A
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 58/250 (23%), Positives = 100/250 (40%), Gaps = 25/250 (10%)
Query: 421 NLLGTGSFGSVYKGTLF----DGTNVAIKVFN----LQLERASRSFDSECEILRSIRHR- 471
+LGTG++G V+ G A+KV +Q + + +E ++L IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 472 NLIKIISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG 531
L+ + L+L+++ G L L F + I VG + L H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF----TEHEVQIYVGEIVLALEHL 145
Query: 532 HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--YG 589
H +++ D+K NILLD N ++DFG+SK + TI YMAP+ G
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRG 204
Query: 590 SEGIISPKSDVYSYGILLMETFTRKKP---------TNEIFIGEMSLKHWVKESLPDGLT 640
+ D +S G+L+ E T P EI + + + +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264
Query: 641 EVVDANLVRE 650
+++ L+++
Sbjct: 265 DLIQRLLMKD 274
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (286), Expect = 2e-28
Identities = 46/226 (20%), Positives = 96/226 (42%), Gaps = 25/226 (11%)
Query: 403 RRTSYLDIQRATNGFNECN------LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERAS 455
R Y D + + + LG G + V++ + + V +K+
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKK 73
Query: 456 RSFDSECEILRSIR-HRNLIKIISNCCNIDFK--ALVLEFMPNGSLEKWLYSHNYFLGIL 512
+ E +IL ++R N+I + + + ALV E + N ++ + L
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDY 129
Query: 513 ERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDS 571
+ M ++ AL+Y H ++H D+KP+N+++D E+ + D+G+++ G +
Sbjct: 130 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185
Query: 572 VIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKP 616
+ +A+ + PE + + D++S G +L RK+P
Sbjct: 186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 46/220 (20%), Positives = 89/220 (40%), Gaps = 23/220 (10%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIIS 478
+G+G+ G V NVAIK + + ++ E +++ + H+N+I +++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 479 NCC------NIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGH 532
LV+E M + ++ ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----RMSYLLYQMLCGIKHLHSAG 139
Query: 533 STPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEG 592
++H DLKP+NI++ + T + DFG+++ G + T + T Y APE
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM 193
Query: 593 IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK 632
D++S G ++ E K F G + W K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNK 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-27
Identities = 44/283 (15%), Positives = 102/283 (36%), Gaps = 26/283 (9%)
Query: 421 NLLGTGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKII 477
+ +G+G++GSV G VA+K + ++ E +L+ ++H N+I ++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 478 SNC----CNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHS 533
+F + L G+ + ++ + L+Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL-TDDHVQFLIYQILRGLKYIHSAD- 141
Query: 534 TPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGI 593
++H DLKP+N+ ++E+ + DFG+++ D + +
Sbjct: 142 --IIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMH 195
Query: 594 ISPKSDVYSYGILLMETFTRKKP-----TNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648
+ D++S G ++ E T + + + L L ++ N +
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 649 REEQAFSVK--IDCLLSIMHLALD----CCMESPEQRVSMKDA 685
+ + + LA+D + ++R++ A
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (266), Expect = 1e-25
Identities = 42/212 (19%), Positives = 83/212 (39%), Gaps = 20/212 (9%)
Query: 422 LLGTGSFGSVYKGT-LFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNC 480
LG G F +V+ + + T+VA+K+ + + + + E ++L+ + + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 481 CNIDFK---------------ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLAL 525
N K +V E + L + + ++ I + L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 526 EYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 584
+Y+H ++H D+KP N+L++ + ++ I+ L T +I T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 585 APEYGSEGIISPKSDVYSYGILLMETFTRKKP 616
+PE +D++S L+ E T
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.3 bits (246), Expect = 6e-23
Identities = 70/340 (20%), Positives = 120/340 (35%), Gaps = 39/340 (11%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLA-Y 63
L + L + +I + + L ++ S+N + + P NL L + +
Sbjct: 43 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
A N +T + N L N + + +
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158
Query: 124 GNIPQEIG---NLSGMIVFDLNGCDLNGTIPTAV-GRLRRLQGLYLHGNKLQGSIPYDLC 179
+ ++ L+ + + N +V +L L+ L N++ P +
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL 218
Query: 180 HLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239
L EL+LNGN+L LASLT+L L L +N++++ P L + + L A
Sbjct: 219 T--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272
Query: 240 NSLNGSLP--------------------SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLEN 279
N ++ P S I NLK LT L L N +S P + L
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330
Query: 280 LETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIP 319
L+ L A+N+ S +L ++ L N +S P
Sbjct: 331 LQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.5 bits (205), Expect = 8e-18
Identities = 45/206 (21%), Positives = 77/206 (37%), Gaps = 17/206 (8%)
Query: 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLN 142
NL L +N + I P +L E G +L+ + +L+ + DL
Sbjct: 195 KLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 143 GCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCL 202
++ P + L +L L L N++ P ELN N +
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN----QLEDISPI 303
Query: 203 ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLS 262
++L +L L L N ++ P SL + + + N ++ S++ NL + L
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 263 RNQLSGDIPTTIGGLENLETLSLADN 288
NQ+S P + L + L L D
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 79.3 bits (194), Expect = 3e-16
Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 24/216 (11%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+ L NL+ L +N++S P I + L L L+ N T +L +L L
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC 120
LA N + L+ L+ LT L L +N + I P +
Sbjct: 248 LANNQISN---------LAPLSGLTKLTELKLGANQISNISP-----LAGLTALTNLELN 293
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
+ + I NL + L +++ P V L +LQ L+ NK+ L +
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSN 216
L ++ L+ N++ P LA+LT + +L L
Sbjct: 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 2e-04
Identities = 18/81 (22%), Positives = 34/81 (41%), Gaps = 6/81 (7%)
Query: 203 ASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLS 262
+L + LG +T T+ + L+ V + + S+ ++ L LT ++ S
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 74
Query: 263 RNQLSGDIPTTIGGLENLETL 283
NQL+ P + L L +
Sbjct: 75 NNQLTDITP--LKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 11/68 (16%), Positives = 23/68 (33%), Gaps = 4/68 (5%)
Query: 252 NLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSR 311
L L + ++ + + L+ + TL + L +L ++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 312 NNLSGEIP 319
N L+ P
Sbjct: 76 NQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 42/225 (18%), Positives = 73/225 (32%), Gaps = 45/225 (20%)
Query: 132 NLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG 191
+L + + + V L L + N+L P L +L L ++ +N
Sbjct: 42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97
Query: 192 NKLCGHVPPC------------------------------------LASLTSLRRLHLGS 215
N++ P ++ +++L L
Sbjct: 98 NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157
Query: 216 NKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQ-NLKVLTNLDLSRNQLSGDIPTTI 274
+ L + + S N ++ L L +L + NQ+S P I
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI 217
Query: 275 GGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIP 319
NL+ LSL NQ + + SL +L LDL+ N +S P
Sbjct: 218 L--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 258
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.5 bits (236), Expect = 4e-22
Identities = 61/289 (21%), Positives = 102/289 (35%), Gaps = 23/289 (7%)
Query: 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNY 65
P+ L L +NK++ N L L L +N S + P F L L+ L L+ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 66 LMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFS-ASLQEFYAYGCKLRG 124
L L + N + + + + + E K G
Sbjct: 91 LKELPEKMPKTL----------QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
+ + + ++ TIP G L L+L GNK+ L L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
++L L+ N + LA+ LR LHL +NKL +P +Y+ + L N+++
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
Query: 245 ------SLPSNIQNLKVLTNLDLSRNQLS-GDI-PTTIGGLENLETLSL 285
P + + L N + +I P+T + + L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.6 bits (213), Expect = 4e-19
Identities = 57/301 (18%), Positives = 104/301 (34%), Gaps = 45/301 (14%)
Query: 21 TIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSS 80
+P + +LDL +N + + F NL +L L L N + S +
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP-------GA 74
Query: 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFD 140
L L L+ N L+ + P + L+ K+R ++ + N ++
Sbjct: 75 FAPLVKLERLYLSKNQLKEL-PEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELG 132
Query: 141 LNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPP 200
N +G A +++L + + + +IP L
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---------------------- 169
Query: 201 CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLD 260
SL LHL NK+T +S L + + LS NS++ ++ N L L
Sbjct: 170 ----PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225
Query: 261 LSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSF------GSLISLESLDLSRNNL 314
L+ N+L +P + + ++ + L +N F S + L N +
Sbjct: 226 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
Query: 315 S 315
Sbjct: 285 Q 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.1 bits (209), Expect = 1e-18
Identities = 45/246 (18%), Positives = 85/246 (34%), Gaps = 6/246 (2%)
Query: 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGC 144
+ +L L +N + I N +L K+ P L + L+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 145 DLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLAS 204
L L+ L+ K++ S+ L + + EL N K G
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQG 148
Query: 205 LTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRN 264
+ L + + +T+ SL ++L N + ++++ L L L LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 265 QLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSA 324
+S ++ +L L L +N+ VP ++ + L NN+S +F
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 325 QSFLSN 330
+ +
Sbjct: 265 PGYNTK 270
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.5 bits (179), Expect = 9e-15
Identities = 48/212 (22%), Positives = 78/212 (36%), Gaps = 10/212 (4%)
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185
+P+++ + DL + L+ L L L NK+ P L L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLN-- 243
L L+ N+L +L LR N++T S F L ++ + L N L
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHE---NEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303
G Q +K L+ + ++ ++ IP G +L L L N+ S L +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 304 LESLDLSRNNLSGEIPKNFSAQSFLSNYALCG 335
L L LS N++S + + L L
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.0 bits (162), Expect = 1e-12
Identities = 43/241 (17%), Positives = 83/241 (34%), Gaps = 21/241 (8%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L+ L L N+L +L + N + + + F L + V+ L N
Sbjct: 78 LVKLERLYLSKNQLKELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTN 134
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L + + + L+ + +A + I SL E + G K+
Sbjct: 135 PLKSS-----GIENGAFQGMKKLSYIRIADTNITTIPQ----GLPPSLTELHLDGNKITK 185
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
+ L+ + L+ ++ ++ L+ L+L+ NKL +P L + +
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 244
Query: 185 SELNLNGNKLCG------HVPPCLASLTSLRRLHLGSNKLTST--MPSSFGSLEYVLYIN 236
+ L+ N + P S + L SN + PS+F + +
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
Query: 237 L 237
L
Sbjct: 305 L 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.8 bits (133), Expect = 6e-09
Identities = 26/94 (27%), Positives = 39/94 (41%), Gaps = 3/94 (3%)
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
+ S L +P ++ LDL N+++ L+NL TL L +N+
Sbjct: 15 VQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 295 PKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFL 328
P +F L+ LE L LS+N L K L
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL 105
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.2 bits (121), Expect = 2e-07
Identities = 25/125 (20%), Positives = 42/125 (33%), Gaps = 3/125 (2%)
Query: 207 SLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQL 266
LR + L +P ++L N + + +NLK L L L N++
Sbjct: 11 HLRVVQCSDLGLEK-VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 267 SGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQS 326
S P L LE L L+ NQ + K +L L + + + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 327 FLSNY 331
+
Sbjct: 128 VVELG 132
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 19/95 (20%), Positives = 33/95 (34%), Gaps = 3/95 (3%)
Query: 256 LTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
L + S L +P + + L L +N+ F +L +L +L L N +S
Sbjct: 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 316 GEIPKNFSAQSFLSNYALCGPARLQVPSCRKYNSR 350
P F+ L L ++P +
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQ 103
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 30/195 (15%), Positives = 61/195 (31%), Gaps = 44/195 (22%)
Query: 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLA 62
+ L Y+ + D ++ TIP + L L L N + + + L +L L L+
Sbjct: 147 QGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 63 YNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKL 122
+N + + + N L+E + KL
Sbjct: 204 FNSISAVDNGSLANT--------------------------------PHLRELHLNNNKL 231
Query: 123 RGNIPQEIGNLSGMIVFDLNGCDLNG------TIPTAVGRLRRLQGLYLHGNKLQGS--I 174
+P + + + V L+ +++ P + G+ L N +Q
Sbjct: 232 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290
Query: 175 PYDLCHLEGLSELNL 189
P + + + L
Sbjct: 291 PSTFRCVYVRAAVQL 305
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (218), Expect = 6e-20
Identities = 65/296 (21%), Positives = 101/296 (34%), Gaps = 37/296 (12%)
Query: 21 TIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSS 80
+P I AS+ + L N S + +F +L +L L N L +AA
Sbjct: 25 AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 81 LTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFD 140
+ +LR P L +
Sbjct: 83 EQLDLS-------------------------------DNAQLRSVDPATFHGLGRLHTLH 111
Query: 141 LNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPP 200
L+ C L P L LQ LYL N LQ L L+ L L+GN++
Sbjct: 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 201 CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLD 260
L SL RL L N++ P +F L ++ + L AN+L+ + L+ L L
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231
Query: 261 LSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSG 316
L+ N D L+ + ++ +P+ L + L+ N+L G
Sbjct: 232 LNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (208), Expect = 1e-18
Identities = 49/246 (19%), Positives = 83/246 (33%), Gaps = 3/246 (1%)
Query: 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGC 144
+ L N + + +L + + L L+ + DL+
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 145 DLNGTI-PTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLA 203
++ P L RL L+L LQ P L L L L N L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 204 SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSR 263
L +L L L N+++S +F L + + L N + P ++L L L L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 264 NQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323
N LS + L L+ L L DN + ++ L+ S + + +P+ +
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 324 AQSFLS 329
+
Sbjct: 270 GRDLKR 275
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (140), Expect = 5e-10
Identities = 56/211 (26%), Positives = 81/211 (38%), Gaps = 3/211 (1%)
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185
+P I + L+G ++ + R L L+LH N L L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 186 ELNLNGNKLCGHVPP-CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
+L+L+ N V P L L LHL L P F L + Y+ L N+L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 245 SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
++L LT+L L N++S GL +L+ L L N+ P +F L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 305 ESLDLSRNNLSGEIPKNFSAQSFLSNYALCG 335
+L L NNLS + + L L
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLND 234
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (115), Expect = 8e-07
Identities = 45/181 (24%), Positives = 67/181 (37%), Gaps = 4/181 (2%)
Query: 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTM 222
LQ ++P + + L+GN++ + +L L L SN L
Sbjct: 16 TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 223 PSSFGSLEYVLYINLSANSLNGSL-PSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLE 281
++F L + ++LS N+ S+ P+ L L L L R L P GL L+
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 282 TLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQV 341
L L DN Q +F L +L L L N +S + F L L V
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 342 P 342
Sbjct: 193 H 193
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 88.3 bits (217), Expect = 1e-19
Identities = 55/278 (19%), Positives = 103/278 (37%), Gaps = 15/278 (5%)
Query: 24 NSITNASKLIMLDLSSNSFSGL--IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSL 81
++ T ++ LDLS + IP++ NL L L + + L+ L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 82 TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDL 141
++ P + +L L G +P I +L ++
Sbjct: 104 HYLYI-------THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 142 NGCDLNGTIPTAVGRLRRLQG-LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPP 200
+G ++G IP + G +L + + N+L G IP +L +
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN--LAFVDLSRNMLEGDAS 214
Query: 201 CLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLD 260
L + + + G + + ++L N + G+LP + LK L +L+
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 261 LSRNQLSGDIPTTIGGLENLETLSLADNQFQ--GPVPK 296
+S N L G+IP G L+ + + A+N+ P+P
Sbjct: 275 VSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.5 bits (189), Expect = 4e-16
Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 13/274 (4%)
Query: 79 SSLTNCRNLTVLGLASNPLRGI--LPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGM 136
+ T + L L+ L +P + N + L G IP I L+ +
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 137 IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCG 196
+ +++G IP + +++ L L N L G++P + L L + +GN++ G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 197 HVPPCLASLTSLRR-LHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKV 255
+P S + L + + N+LT +P +F L + ++ S +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA--NLNLAFVDLSRNMLEGDASVLFGSDK 221
Query: 256 LTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
T +G +NL L L +N+ G +P+ L L SL++S NNL
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 316 GEIP-----KNFSAQSFLSNYALCGPARLQVPSC 344
GEIP + F ++ +N LCG +P+C
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKCLCGS---PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 1/64 (1%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+ NL L L +N++ GT+P +T L L++S N+ G IP GNL V +
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSA 297
Query: 61 LAYN 64
A N
Sbjct: 298 YANN 301
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 4e-19
Identities = 30/202 (14%), Positives = 62/202 (30%), Gaps = 29/202 (14%)
Query: 421 NLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL----------ERASRSFDSECEILRSIRH 470
L+G G +V+ +K + + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 471 RNLIKI--ISNCCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYL 528
R L K+ ++ ++ + +E Y + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAV------LMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 529 HHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATI-GYMAPE 587
+H +VH DL N+L+ E + DF S +GE I + I Y +
Sbjct: 120 YHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175
Query: 588 YGSEGIISPKSDVYSYGILLME 609
Y + D+ S +++
Sbjct: 176 YR------TEKDINSAIDRILQ 191
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 5e-10
Identities = 40/214 (18%), Positives = 60/214 (28%), Gaps = 15/214 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
+ + + L+ +P + +L LS N T L L+L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
L L L + + PL+G +L +L
Sbjct: 66 ELTKLQ---VDGTLPVLGTLDL--------SHNQLQSLPLLGQTLPALTVLDVSFNRLTS 114
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
+ L + L G +L P + +L+ L L N L L LE L
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKL 218
L L N L +P L L N
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 1e-08
Identities = 50/207 (24%), Positives = 79/207 (38%), Gaps = 7/207 (3%)
Query: 129 EIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELN 188
E+ ++ + + + +L +P + + L+L N L L L++LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 189 LNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPS 248
L+ +L +L L L L N+L S +++S N L
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALT-VLDVSFNRLTSLPLG 118
Query: 249 NIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLD 308
++ L L L L N+L P + LE LSLA+N L +L++L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 309 LSRNNLSGEIPKNFSAQSFLSNYALCG 335
L N+L IPK F L L G
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHG 204
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 41/185 (22%), Positives = 62/185 (33%), Gaps = 5/185 (2%)
Query: 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGC 144
++ T+L L+ N L + ++ L + Q G L + DL+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYT-RLTQLNLDRA--ELTKLQVDGTLPVLGTLDLSHN 87
Query: 145 DLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLAS 204
L + N+L L L L EL L GN+L P L
Sbjct: 88 QLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 205 LTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRN 264
L +L L +N LT LE + + L NSL ++P +L L N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
Query: 265 QLSGD 269
+
Sbjct: 206 PWLCN 210
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 24/93 (25%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 188 NLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLP 247
N + SL L++ +NKL +P+ LE + S N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVP 320
Query: 248 SNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENL 280
QNLK L + N L P +E+L
Sbjct: 321 ELPQNLKQ---LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 52/322 (16%), Positives = 98/322 (30%), Gaps = 18/322 (5%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYL 66
L L + LS ++P + L L S NS + L P +L SL V + L
Sbjct: 39 QAHELELNNLGLS-SLPELPPH---LESLVASCNSLTEL-PELPQSLKSLLVDNNNLKAL 93
Query: 67 MTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGIL-PPLIGNFSASLQEFYAYGCKLRGN 125
++ +S+ + + + + + L + +
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 126 IPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLS 185
E+ NL + + L + + G + + L + +
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 186 ELNLNGNKLCGHVPPCLASLTSLRRLH--LGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243
L L + L L S + F L + N+ +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 244 GSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLIS 303
+ S L L++S N+L ++P LE L + N VP+ +
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VPELPQ---N 325
Query: 304 LESLDLSRNNLSG--EIPKNFS 323
L+ L + N L +IP++
Sbjct: 326 LKQLHVEYNPLREFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 4e-08
Identities = 22/94 (23%), Positives = 39/94 (41%), Gaps = 10/94 (10%)
Query: 164 YLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMP 223
+ N I L ELN++ NKL +P A L RL N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAE-VP 320
Query: 224 SSFGSLEYVLYINLSANSLNG--SLPSNIQNLKV 255
+L+ +++ N L +P ++++L++
Sbjct: 321 ELPQNLK---QLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 1e-07
Identities = 24/101 (23%), Positives = 37/101 (36%), Gaps = 10/101 (9%)
Query: 136 MIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLC 195
+ + I + L+ L + NKL +P LE L + N L
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHL- 316
Query: 196 GHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYIN 236
VP +L++LH+ N L P S+E L +N
Sbjct: 317 AEVPE---LPQNLKQLHVEYNPLRE-FPDIPESVED-LRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 3e-06
Identities = 47/308 (15%), Positives = 90/308 (29%), Gaps = 23/308 (7%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
P+L+ L N L+ +P + L L + +N+ L + L +S
Sbjct: 57 PPHLESLVASCNSLT-ELPELPQS---LKSLLVDNNNLKAL--SDLPPLLEYLGVSNNQL 110
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRG 124
+ E + + + + N + L + LQ
Sbjct: 111 EKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYAD 170
Query: 125 NIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL 184
N + + + + + + L L +Y N L+
Sbjct: 171 NNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALN 230
Query: 185 SELNLNGN--------KLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYIN 236
N + + L+ L N ++ + S + +N
Sbjct: 231 VRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELN 290
Query: 237 LSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPK 296
+S N L LP+ L+ L S N L+ ++P NL+ L + N + P
Sbjct: 291 VSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQ---NLKQLHVEYNPLRE-FPD 341
Query: 297 SFGSLISL 304
S+ L
Sbjct: 342 IPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 6e-05
Identities = 18/85 (21%), Positives = 33/85 (38%), Gaps = 13/85 (15%)
Query: 1 MGYMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
+ + P+L+ L + +NKL +P L L S N + + +L+ L
Sbjct: 279 LCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAEVPE----LPQNLKQLH 330
Query: 61 LAYNYLMTESSAAKWNFLSSLTNCR 85
+ YN L + S+ + R
Sbjct: 331 VEYNPLREFP-----DIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 1e-04
Identities = 12/54 (22%), Positives = 21/54 (38%), Gaps = 5/54 (9%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQV 58
P L+ L N L+ +P N L L + N P+ ++ L++
Sbjct: 303 PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREF-PDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 19/70 (27%), Positives = 26/70 (37%), Gaps = 5/70 (7%)
Query: 179 CHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238
C EL LN L +P L L N LT +P SL+ +L N +
Sbjct: 35 CLDRQAHELELNNLGL-SSLPE---LPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNN 89
Query: 239 ANSLNGSLPS 248
+L+ P
Sbjct: 90 LKALSDLPPL 99
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 37/281 (13%), Positives = 72/281 (25%), Gaps = 22/281 (7%)
Query: 11 LTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTES 70
L L L + + + +I + + F +Q + L+ + + +
Sbjct: 5 LDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62
Query: 71 SAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEI 130
L+ C L L L L + + S +L GC +
Sbjct: 63 ------LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS-NLVRLNLSGCSGFSEFALQT 115
Query: 131 GNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLN 190
S + +LN V + L G
Sbjct: 116 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP 175
Query: 191 GNKLC---------GHVPPCLASLTSLRRLHL-GSNKLTSTMPSSFGSLEYVLYINLSAN 240
L L+ L L + G + + + +
Sbjct: 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235
Query: 241 SLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLE 281
+G+L + L +L ++ + + TIG +N E
Sbjct: 236 VPDGTLQLLKEALP---HLQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 12/69 (17%), Positives = 25/69 (36%), Gaps = 2/69 (2%)
Query: 257 TNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSG 316
LDL+ L D+ + + + P+ + F S ++ +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 317 EIPKNFSAQ 325
+Q
Sbjct: 61 STLHGILSQ 69
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 5e-04
Identities = 41/287 (14%), Positives = 84/287 (29%), Gaps = 49/287 (17%)
Query: 35 LDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLAS 94
LDL+ + P+ G L S V++ + L+ + + + L++
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQP------LAEHFSPFRVQHMDLSN 55
Query: 95 NPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAV 154
+ + I + + LQ G +L I + S ++ +L+GC
Sbjct: 56 SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC---------- 105
Query: 155 GRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLG 214
G + S L L + + V ++T L
Sbjct: 106 ------SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 159
Query: 215 SNKLTSTMPSSFGSLEYVLYINLSANSL-NGSLPSNIQNLKVLTNLDLSRNQLSGDIPTT 273
N S + + +++++LS + + L L +L LSR
Sbjct: 160 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC--------- 210
Query: 274 IGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPK 320
G + +L++L + G +
Sbjct: 211 --------------YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 5e-08
Identities = 12/83 (14%), Positives = 26/83 (31%), Gaps = 5/83 (6%)
Query: 256 LTNLDLSRNQLS-GDIPTTIGGLENLETLSLADNQFQG----PVPKSFGSLISLESLDLS 310
+ +LD+ +LS + L+ + + L D + + +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 311 RNNLSGEIPKNFSAQSFLSNYAL 333
N L + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 5e-07
Identities = 13/120 (10%), Positives = 31/120 (25%), Gaps = 5/120 (4%)
Query: 234 YINLSANSLNGS-LPSNIQNLKVLTNLDLSRNQLSGD----IPTTIGGLENLETLSLADN 288
+++ L+ + + L+ + L L+ I + + L L+L N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 289 QFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQVPSCRKYN 348
+ + S + + +L S + S
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 17/83 (20%), Positives = 26/83 (31%), Gaps = 9/83 (10%)
Query: 247 PSNIQNLKVLTNLDLSRNQLSGD----IPTTIGGLENLETLSLADNQFQGPVPKSFGSLI 302
Q VL L L+ +S + T+ +L L L++N +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 303 -----SLESLDLSRNNLSGEIPK 320
LE L L S E+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 4e-06
Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 160 LQGLYLHGNKLQGSIPYDLC-HLEGLSELNLNGNKL----CGHVPPCLASLTSLRRLHLG 214
+Q L + +L + +L L+ + L+ L C + L +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 215 SNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
SN+L + SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 6e-05
Identities = 22/109 (20%), Positives = 34/109 (31%), Gaps = 27/109 (24%)
Query: 184 LSELNLNGNKL----CGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239
L L L + C + L + SLR L L +N L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG----------------DAGI 414
Query: 240 NSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLE----NLETLS 284
L S+ L+ L L S ++ + LE +L +S
Sbjct: 415 LQLVESVRQPGCLLEQ---LVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 7e-05
Identities = 18/91 (19%), Positives = 32/91 (35%), Gaps = 15/91 (16%)
Query: 234 YINLSANSLNG----SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGG-----LENLETLS 284
+ L+ ++ SL + + L LDLS N L + LE L
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 285 LADNQFQGPVPKSFGSLISLESLDLSRNNLS 315
L D + + L++L+ + +L
Sbjct: 433 LYDIYWSEEMED------RLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 16/74 (21%), Positives = 21/74 (28%), Gaps = 4/74 (5%)
Query: 35 LDLSSNSFSGL-IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLA 93
LD+ S L QV+ L L S+L L L L
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD---ISSALRVNPALAELNLR 63
Query: 94 SNPLRGILPPLIGN 107
SN L + +
Sbjct: 64 SNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 10/88 (11%)
Query: 139 FDLNGCDLNGT-IPTAVGRLRRLQGLYLHGNKLQG----SIPYDLCHLEGLSELNLNGNK 193
D+ +L+ + L++ Q + L L I L L+ELNL N+
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 194 LCGHVPPCLASL-----TSLRRLHLGSN 216
L C+ +++L L +
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 13/90 (14%), Positives = 28/90 (31%), Gaps = 5/90 (5%)
Query: 184 LSELNLNGNKLC-GHVPPCLASLTSLRRLHLGSNKLT----STMPSSFGSLEYVLYINLS 238
+ L++ +L L L + + L LT + S+ + +NL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSG 268
+N L + + + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.001
Identities = 19/99 (19%), Positives = 32/99 (32%), Gaps = 12/99 (12%)
Query: 1 MGYMLPNLKYLTLFDNKLSGT----IPNSITNASKLIMLDLSSNSFSGLIPNTFG----- 51
+G L+ L L D +S + + ++ L LDLS+N
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 52 NLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVL 90
L+ L L Y E + + +L V+
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDR---LQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 11/67 (16%), Positives = 21/67 (31%), Gaps = 4/67 (5%)
Query: 5 LPNLKYLTLFDNKLSG----TIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLS 60
L + + L D L+ I +++ L L+L SN + +
Sbjct: 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 85
Query: 61 LAYNYLM 67
+ L
Sbjct: 86 IQKLSLQ 92
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 9e-08
Identities = 27/119 (22%), Positives = 41/119 (34%), Gaps = 7/119 (5%)
Query: 187 LNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSL 246
L+L L V L L + L L N+L + P + +L + + S N+L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN-- 57
Query: 247 PSNIQNLKVLTNLDLSRNQL-SGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISL 304
+ NL L L L N+L + L L+L N L +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 2e-07
Identities = 31/110 (28%), Positives = 43/110 (39%), Gaps = 6/110 (5%)
Query: 209 RRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSG 268
R LHL LT L V +++LS N L P+ + L+ L L S N L
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 269 DIPTTIGGLENLETLSLADNQFQG-PVPKSFGSLISLESLDLSRNNLSGE 317
L+ L L +N+ Q + S L L+L N+L E
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.002
Identities = 26/120 (21%), Positives = 37/120 (30%), Gaps = 20/120 (16%)
Query: 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMT 68
+ L L L T+ + + LDLS N L P L L+VL + N L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 69 ESSAAKWNF----------------LSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASL 112
A + L +C L +L L N L + + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE-EGIQERLAEML 116
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (116), Expect = 2e-07
Identities = 26/134 (19%), Positives = 53/134 (39%), Gaps = 5/134 (3%)
Query: 197 HVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVL 256
+ ++ + L L S + + +N ++ +L +N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 257 TNLDLSRNQLSG--DIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNL 314
+L+LS N+L D+ + + NL+ L+L+ N+ + + LE L L N+L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 315 SGEIPKNFSAQSFL 328
S + S +
Sbjct: 128 SDTFRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.3 bits (83), Expect = 0.004
Identities = 21/101 (20%), Positives = 33/101 (32%), Gaps = 2/101 (1%)
Query: 146 LNGTIPTAVGRLRRLQGLYLHGNKLQG--SIPYDLCHLEGLSELNLNGNKLCGHVPPCLA 203
+ T+ + L L L N+L + + L LNL+GN+L
Sbjct: 53 MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKI 112
Query: 204 SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNG 244
L L L N L+ T + + L+G
Sbjct: 113 KGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.9 bits (117), Expect = 3e-07
Identities = 34/246 (13%), Positives = 71/246 (28%), Gaps = 20/246 (8%)
Query: 15 DNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAK 74
++K++ IP+ + I L + F G L+ + ++ N ++ A
Sbjct: 17 ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 73
Query: 75 WNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLS 134
++ L L R +N L + G K ++ +
Sbjct: 74 FSNLPKLHEIRIEKA----NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 135 GMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKL 194
++ N + VG L+L+ N +Q + + N L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 195 CGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLK 254
+ L + ++ S +L+ + + NLK
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY-------------NLK 236
Query: 255 VLTNLD 260
L L+
Sbjct: 237 KLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 24/214 (11%), Positives = 52/214 (24%), Gaps = 4/214 (1%)
Query: 4 MLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAY 63
+ N L KL + + L +++S N +I +
Sbjct: 27 LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86
Query: 64 NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR 123
+ ++ G+ P + L +
Sbjct: 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL----LDIQDNINIHT 142
Query: 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEG 183
+G ++ LN + A + + N L+ G
Sbjct: 143 IERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASG 202
Query: 184 LSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNK 217
L+++ ++ L +L LR + K
Sbjct: 203 PVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 5e-04
Identities = 24/217 (11%), Positives = 53/217 (24%), Gaps = 7/217 (3%)
Query: 107 NFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLH 166
+ + E KLR + +++ D+ I V
Sbjct: 26 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85
Query: 167 GNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSF 226
+ L + P + + SL+++ L +
Sbjct: 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 145
Query: 227 GSLEYVLY----INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLET 282
S + + + L+ N + ++ N L G
Sbjct: 146 NSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 205
Query: 283 LSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIP 319
L ++ + +L L + NL ++P
Sbjct: 206 LDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 0.004
Identities = 29/204 (14%), Positives = 49/204 (24%), Gaps = 3/204 (1%)
Query: 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGC 144
RN L LR I F + + L NL + +
Sbjct: 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88
Query: 145 DLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLAS 204
+ I + L N +P L + + H +
Sbjct: 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148
Query: 205 LTSLRR---LHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDL 261
+ L L N + +F + N+L LD+
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208
Query: 262 SRNQLSGDIPTTIGGLENLETLSL 285
SR ++ + L+ L S
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARST 232
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.3 bits (116), Expect = 4e-07
Identities = 31/215 (14%), Positives = 63/215 (29%), Gaps = 14/215 (6%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L N + + ++ T+ + + + L + + L +L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 65 YLMTESSAAK-WNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGC--- 120
+ + + L + + L +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 121 --KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL 178
I + L+ + + T + L +L L NK+ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 179 CHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHL 213
L L E++L N++ P LA+ ++L + L
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 37/238 (15%), Positives = 70/238 (29%), Gaps = 27/238 (11%)
Query: 28 NASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNL 87
+ I + ++ + + T +L + LS + T + + NL
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT---------IEGVQYLNNL 65
Query: 88 TVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLN 147
L L N + + PL + E K I + +
Sbjct: 66 IGLELKDNQITDL-APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 148 GTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTS 207
+ + L + + L G LA+L+
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSK 174
Query: 208 LRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQ 265
L L NK++ S SL ++ ++L N ++ P + N L + L+ NQ
Sbjct: 175 LTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 1e-05
Identities = 37/217 (17%), Positives = 63/217 (29%), Gaps = 46/217 (21%)
Query: 132 NLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG 191
L+ I ++ T+ A L + L G + +I + +L L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 192 NKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINL-------------- 237
N++ P + + L K S + L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 238 ------------------------SANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTT 273
S + S + + NL LT L N++S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 274 IGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLS 310
+ L NL + L +NQ P + +L + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 34/192 (17%), Positives = 65/192 (33%), Gaps = 12/192 (6%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L + L+ F ++ TI + + LI L+L N + L P + LS
Sbjct: 40 LDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPL 97
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGIL------PPLIGNFSASLQEFYAY 118
++ + + LT+ + V LA +L I + Y
Sbjct: 98 KNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLS 157
Query: 119 GCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL 178
+ + + NLS + + ++ P + L L ++L N++ P L
Sbjct: 158 IGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--L 213
Query: 179 CHLEGLSELNLN 190
+ L + L
Sbjct: 214 ANTSNLFIVTLT 225
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.7 bits (114), Expect = 1e-06
Identities = 39/328 (11%), Positives = 86/328 (26%), Gaps = 28/328 (8%)
Query: 7 NLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSG----LIPNTFGNLGSLQVLSLA 62
+LK + ++ + + + LS N+ + + L++ +
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 63 YNYLM---TESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYG 119
+ E A L +L C L + L+ N + +F +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 120 CKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
G PQ ++ + P + L K
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKN-APPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 180 HLEGLSELNLNGNKLCGHVPPCLASLT------SLRRLHLGSNKLTSTMPSSFGSLEYVL 233
L + + + + ++ +S + + S +
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 234 YINLSANSLNGSLPSNI------QNLKVLTNLDLSRNQLSGDIPTTI-----GGLENLET 282
+ L+ L+ + + L L L N++ D T+ + +L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 283 LSLADNQF--QGPVPKSFGSLISLESLD 308
L L N+F + V + S
Sbjct: 307 LELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.6 bits (106), Expect = 1e-05
Identities = 41/326 (12%), Positives = 91/326 (27%), Gaps = 24/326 (7%)
Query: 31 KLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVL 90
L + +++ + S++ + L+ N + TE++ ++S +
Sbjct: 9 SLKLDAITTEDEKSVFAV-LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 91 GLASNPLRGILPPLIGNFS------ASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGC 144
+ + ++ +P + L + + + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 145 DLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLAS 204
N + G L NK + P + G + L K
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 205 LTSLRRLHLGSNKLTSTMPSSFG------SLEYVLYINLSANSLNGSLPSNIQNLKVLTN 258
L +++ + G G L N + + +L +++ L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 259 LDLSRNQLSGDIPTTIG------GLENLETLSLADNQFQGPVPKS-----FGSLISLESL 307
L L+ LS + L+TL L N+ + ++ + L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 308 DLSRNNLSGEIPKNFSAQSFLSNYAL 333
+L+ N S E + S
Sbjct: 308 ELNGNRFSEEDDVVDEIREVFSTRGR 333
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 37/215 (17%), Positives = 61/215 (28%), Gaps = 34/215 (15%)
Query: 21 TIPNSI------TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAK 74
T+P I ++ I +L S + + L S+ + + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS------ 60
Query: 75 WNFLSSLTNCRNLTVLGLASNPLRGILP--------------PLIGNFSASLQEFYAYGC 120
+ + N+T L L N L I P + + S+
Sbjct: 61 ---VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117
Query: 121 KLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCH 180
L N +I L + + N V + I L
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAG 176
Query: 181 LEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGS 215
L L L L+ N + LA L +L L L S
Sbjct: 177 LTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 8e-06
Identities = 36/208 (17%), Positives = 70/208 (33%), Gaps = 32/208 (15%)
Query: 126 IPQEIG------NLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLC 179
+P I + I +L + + L + + + + ++ +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQ 65
Query: 180 HLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLT-----------------STM 222
+L +++L LNGNKL LA+L +L L L NK+
Sbjct: 66 YLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123
Query: 223 PSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLET 282
S L ++ + N + + + + DI + GL L+
Sbjct: 124 ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQN 182
Query: 283 LSLADNQFQGPVPKSFGSLISLESLDLS 310
L L+ N ++ L +L+ L+L
Sbjct: 183 LYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 9e-06
Identities = 32/200 (16%), Positives = 63/200 (31%), Gaps = 30/200 (15%)
Query: 27 TNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86
T ++ + L + + + + +L + L + + + + N
Sbjct: 15 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS---------IDGVEYLNN 63
Query: 87 LTVLGLASNPLRGILP---------------PLIGNFSASLQEFYAYGCKLRGNIPQEIG 131
LT + ++N L I P + + I
Sbjct: 64 LTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 132 NLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNG 191
+ + L + +A+ L LQ L N++ P L +L L L+++
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 192 NKLCGHVPPCLASLTSLRRL 211
NK+ LA LT+L L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 28/189 (14%), Positives = 51/189 (26%), Gaps = 12/189 (6%)
Query: 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYN 64
L L ++ T+ S T+ ++ L + + L +L ++ + N
Sbjct: 17 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 65 YLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR- 123
L + L + N L + + N + + L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 124 -----GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDL 178
I + LN T + L L+ L + NK+ L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 179 CHLEGLSEL 187
L L L
Sbjct: 191 AKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 1e-05
Identities = 19/142 (13%), Positives = 39/142 (27%), Gaps = 13/142 (9%)
Query: 25 SITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84
TNA + LDL I N L + + N + L
Sbjct: 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR---------KLDGFPLL 62
Query: 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNG- 143
R L L + +N + I L + + + +L + +
Sbjct: 63 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
Query: 144 --CDLNGTIPTAVGRLRRLQGL 163
+ + ++ +++ L
Sbjct: 123 PVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 2e-04
Identities = 24/131 (18%), Positives = 46/131 (35%), Gaps = 7/131 (5%)
Query: 157 LRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSN 216
R + L L G K+ I L+ ++ + N++ L L+ L + +N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNN 73
Query: 217 KLTSTMPSSFGSLEYVLYINLSANSLNG-SLPSNIQNLKVLTNLDLS---RNQLSGDIPT 272
++ +L + + L+ NSL + +LK LT L +
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 273 TIGGLENLETL 283
I + + L
Sbjct: 134 VIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 3e-04
Identities = 18/100 (18%), Positives = 37/100 (37%), Gaps = 5/100 (5%)
Query: 235 INLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV 294
+ L+A + + + N LDL ++ I L+ + + +DN+ +
Sbjct: 1 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--K 55
Query: 295 PKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALC 334
F L L++L ++ N + A L+ L
Sbjct: 56 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.002
Identities = 23/155 (14%), Positives = 43/155 (27%), Gaps = 4/155 (2%)
Query: 177 DLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPS-SFGSLEYVLYI 235
D C G S L + L +L L++ + + + L + +
Sbjct: 3 DACCPHGSSGLRCTRDGA-LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 236 NLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPV- 294
+ + L P L+ L+LS N L + +L+ L L+ N
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 295 PKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLS 329
+ + L + S
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 704 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.72 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.64 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.63 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.61 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.6 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.38 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.56 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.38 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.36 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 98.03 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.53 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.82 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=417.12 Aligned_cols=263 Identities=26% Similarity=0.412 Sum_probs=207.6
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|...+.||+|+||+||+|+++ ..||||+++... ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467899999999999999999864 469999986543 3455789999999999999999999998755 45799999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++|+|.+++...+..+++..+..++.|+++||+||| +++||||||||+|||++.++.+||+|||+|+........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877777999999999999999999995 478999999999999999999999999999877554443
Q ss_pred ceeccccccccccCCcccCC---CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 572 VIQTMTIATIGYMAPEYGSE---GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.......||+.|||||++.+ ..++.++|||||||++|||+||+.||.+................+...
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~--------- 231 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL--------- 231 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG---------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc---------
Confidence 34455679999999998854 458899999999999999999999997643221111111111111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
...+.++++++.+++.+||+.||++||||+||++.|+.+++..
T Consensus 232 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 -----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 1122345678899999999999999999999999999988754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-52 Score=411.83 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=203.5
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
++|+..+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++||||++++|++...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 478888999999999999999988899999998754 3345679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|+|.+++......+++..+..++.|+|.||+||| +.+|+||||||+||++++++.+||+|||+++........ ..
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCce-ee
Confidence 99999999887777999999999999999999995 477999999999999999999999999999877543322 23
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCC-CCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKK-PTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....||+.|+|||++.+..++.++|||||||++|||+|++. ||.... .......+.... .
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~~-----------------~ 220 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGF-----------------R 220 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHHTC-----------------C
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHhcC-----------------C
Confidence 34578999999999999999999999999999999999654 444311 111111111110 1
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+..++.++.+++..||+.||++||||+||++.|+++++.
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 111224456788999999999999999999999999998763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=407.91 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=204.9
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999964 79999999987553 23345689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.........
T Consensus 85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999997543 5899999999999999999995 5789999999999999999999999999999875444333
Q ss_pred eeccccccccccCCcccCCCCC-CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
......||+.|||||++.+..+ +.++||||+||++|||+||+.||.........+..+.....
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~---------------- 224 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------- 224 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT----------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Confidence 3455689999999999887775 67899999999999999999999764333222222211100
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......++.++.+++.+||+.||++|||++|+++
T Consensus 225 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111234566788999999999999999999953
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-51 Score=414.56 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=201.5
Q ss_pred CCCCccccccccCceEEEEEEEC-CC---CEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DG---TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
++|+..+.||+|+||+||+|+.. ++ ..||||.+.... ....+.|.+|++++++++|||||+++|++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 35566789999999999999865 23 358899886543 34556799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++......+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999887777999999999999999999996 4789999999999999999999999999998775432
Q ss_pred Ccc---eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 570 DSV---IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 570 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
... ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+.... .....+...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~----------- 249 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQD----------- 249 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTT-----------
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC-----------
Confidence 221 1223457999999999999999999999999999999998 89999764221 111111111
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+.+.+++.++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 250 ------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 ------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11122335667889999999999999999999999999988653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=405.22 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=208.1
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
++|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999985 579999999998665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++|+|.+++.+. .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence 999999988764 3899999999999999999995 57899999999999999999999999999998754322 2
Q ss_pred eccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 574 QTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.+..... .+........+ .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~----------------~ 235 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP----------------E 235 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC----------------C
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCC----------------C
Confidence 345579999999999999999999999999999999999999997532211 11111111100 1
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122345667889999999999999999999964
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=398.98 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=213.5
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMP 494 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 494 (704)
++|+..++||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++||||++++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5889999999999999999999889999999997643 345689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCccee
Q 005278 495 NGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQ 574 (704)
Q Consensus 495 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~ 574 (704)
+|++.+++......+++..++.++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++........ ..
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-ee
Confidence 999999988777779999999999999999999964 78999999999999999999999999999877544322 23
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ ...-+.. + ..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~----~-------------~~ 219 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQ----G-------------LR 219 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHT----T-------------CC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHh----C-------------CC
Confidence 34568999999999999999999999999999999998 899997643221 1111111 0 01
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
...+..++.++.+++..||+.||++|||++|+++.|.+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11222445678999999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=405.00 Aligned_cols=264 Identities=24% Similarity=0.412 Sum_probs=214.5
Q ss_pred CCCCccc-cccccCceEEEEEEEC---CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECN-LLGTGSFGSVYKGTLF---DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
++|...+ .||+|+||+||+|.+. ++..||||+++... ....+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455555 4999999999999764 35579999997554 3445789999999999999999999999865 457899
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999999877777999999999999999999995 4789999999999999999999999999999876543
Q ss_pred Cc-ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 570 DS-VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 570 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.... .....+...
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~------------- 228 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQG------------- 228 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTT-------------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC-------------
Confidence 22 22334468999999999999999999999999999999998 89999764321 111211110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhhc
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDVA 701 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~~ 701 (704)
.....+..++.++.+++.+||+.||++||||.+|++.|+.+.....+.+.
T Consensus 229 ----~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~ 278 (285)
T d1u59a_ 229 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278 (285)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence 11122335667889999999999999999999999999988766655543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=404.24 Aligned_cols=256 Identities=23% Similarity=0.405 Sum_probs=207.7
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|+..+.||+|+||+||+|++++++.||||+++.. ....+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 4578888999999999999999988899999999754 3345679999999999999999999998765 4568999999
Q ss_pred CCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++... ...+++..+..++.||++||+||| +.+|+||||||+||++++++.+||+|||+|+.+.... ..
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence 999999988643 335899999999999999999996 4789999999999999999999999999999875432 22
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......||+.|+|||++.++.++.++|||||||++|||+||+.|+....... .....+... .
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i~~~-----------------~ 227 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERG-----------------Y 227 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTT-----------------C
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhc-----------------C
Confidence 3344578999999999999999999999999999999999766654321111 111111110 0
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
....+..++.++.+++.+||+.||++||||+||++.|+.+-
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11122345667899999999999999999999999998763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-51 Score=408.70 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=212.5
Q ss_pred HhCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 413 ATNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 413 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
..++|+..+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++|||||++++++.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3467888899999999999999975 58899999987543 345679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhh-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 492 FMPNGSLEKWLYS-HNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 492 ~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
|+++|+|.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~- 169 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 169 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC-
Confidence 9999999999975 45568999999999999999999964 689999999999999999999999999998765432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ....+.+....
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~i~~~~--------------- 233 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDY--------------- 233 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTC---------------
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHHHHHHhcCC---------------
Confidence 23344456899999999999999999999999999999999987776432111 11111111110
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
....+..++.++.+++.+||+.||++||||+||++.|+.+.
T Consensus 234 --~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11122345677899999999999999999999999998874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=405.37 Aligned_cols=251 Identities=24% Similarity=0.280 Sum_probs=207.5
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
+.|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999964 68999999998765566678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcce
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVI 573 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~ 573 (704)
++|+|.+++.+....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence 999999998876667999999999999999999995 468999999999999999999999999999865321 112
Q ss_pred eccccccccccCCcccC-----CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 574 QTMTIATIGYMAPEYGS-----EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 574 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
.....||+.|+|||++. +..++.++|||||||++|||+||+.||.+....+ .+........
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~------------- 232 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEP------------- 232 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCC-------------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCC-------------
Confidence 23457999999999873 4568999999999999999999999997643221 1112111110
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+....+..++.++.+++.+||+.||++|||++|+++
T Consensus 233 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 ---PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122345667889999999999999999999965
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=397.21 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=204.6
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57889999999999999999975 68999999987543 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|.......
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999998654 3899999999999999999995 5789999999999999999999999999998654322
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...........
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~------------ 220 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISRVE------------ 220 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTC------------
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC------------
Confidence 2345799999999999999999999999999999999999999975321 11111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..+++++.+++.+||+.||++|||++|+++
T Consensus 221 ---~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0111234567889999999999999999999965
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=400.71 Aligned_cols=260 Identities=26% Similarity=0.441 Sum_probs=204.3
Q ss_pred CCCCccccccccCceEEEEEEECCC-----CEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDG-----TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
+.|+..++||+|+||+||+|.+.++ ..||||++.... ......|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999986532 469999986543 3345578999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+.+|++.+++......+++..+..++.|++.|++||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999999887777999999999999999999995 478999999999999999999999999999877543
Q ss_pred CC-cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DD-SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.. ........||+.|+|||++.++.++.++|||||||++|||+||+.|+...... ......+...
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~------------- 229 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG------------- 229 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTT-------------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhcc-------------
Confidence 22 22233456899999999999999999999999999999999976665432111 1111111111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+.+.+++.++.+++.+||+.||++||+|.||++.|+++.+.
T Consensus 230 ----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 01122234567789999999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=402.69 Aligned_cols=261 Identities=20% Similarity=0.282 Sum_probs=207.5
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999996 479999999997543 234467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999988654 4899999999999999999995 57899999999999999999999999999998765444
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
........||+.|+|||++.+..++.++||||+||++|||+||+.||.+... ...........
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i~~~~------------ 226 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIKLE------------ 226 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHTTC------------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHHHHHcCC------------
Confidence 4344456799999999999999999999999999999999999999975311 11111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhh
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDD 699 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 699 (704)
...+..++.++.+++.+||+.||++|||++|+.+.-.-....|.+.
T Consensus 227 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 227 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp ---CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 0111234567889999999999999999999865433233344433
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=399.32 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=193.7
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee--CCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN--IDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 489 (704)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999864 78999999987543 3345678999999999999999999999865 4568999
Q ss_pred EeccCCCCHHHHHhh---CCCccCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 490 LEFMPNGSLEKWLYS---HNYFLGILERLNIMIDVGLALEYLHHGH--STPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~h--~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
|||+++|+|.+++.+ .+..+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999874 3456999999999999999999998743 34699999999999999999999999999988
Q ss_pred cCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
+..... ......||+.|||||++.+..++.++|||||||++|||+||+.||.+.... .+...+.....
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~~~~-------- 231 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGKF-------- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTCC--------
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHHHHcCCC--------
Confidence 754322 233467999999999999999999999999999999999999999763221 11111111000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..+++++.+++.+||+.||++|||++|+++
T Consensus 232 ---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0112234567889999999999999999999964
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=407.30 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=209.4
Q ss_pred hCCCCccccccccCceEEEEEEECC-C-----CEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD-G-----TNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
.++|+..+.||+|+||+||+|+... + ..||||++.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999998642 2 369999886543 34456789999999998 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC----------------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 005278 486 KALVLEFMPNGSLEKWLYSHN----------------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKP 543 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~ 543 (704)
.++||||+++|+|.++++... ..+++..+..++.|+++||+||| +++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence 999999999999999997543 24788999999999999999995 47899999999
Q ss_pred CCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCcccc
Q 005278 544 NNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFI 622 (704)
Q Consensus 544 ~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~ 622 (704)
+||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999988765554444556678999999999999999999999999999999998 8999976432
Q ss_pred ccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 005278 623 GEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKK 691 (704)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~ 691 (704)
.. .+...+.... ..+.+..++.++.+++.+||+.||++||||+||+++|..
T Consensus 273 ~~-~~~~~~~~~~-----------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DA-NFYKLIQNGF-----------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SH-HHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH-HHHHHHhcCC-----------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 21 2222222111 112233456788999999999999999999999999853
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=395.76 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=200.7
Q ss_pred ccccccCceEEEEEEEC---CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEeccCC
Q 005278 421 NLLGTGSFGSVYKGTLF---DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFMPN 495 (704)
Q Consensus 421 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 495 (704)
+.||+|+||+||+|.+. .++.||||+++... ....+.+.+|++++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 35689999986543 2345679999999999999999999999865 456899999999
Q ss_pred CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc-ee
Q 005278 496 GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-IQ 574 (704)
Q Consensus 496 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~-~~ 574 (704)
|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|+.+....... ..
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999998654 4899999999999999999996 4689999999999999999999999999999875543322 22
Q ss_pred ccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhhh
Q 005278 575 TMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQA 653 (704)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (704)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.... .....+... ..
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~-----------------~~ 228 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKG-----------------ER 228 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT-----------------CC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcC-----------------CC
Confidence 34578999999999999999999999999999999998 89999764221 111111110 11
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 654 FSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 654 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
.+.+..++.++.+++.+||+.||++|||++||++.|+.+-.
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 12233556788999999999999999999999999887643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=387.45 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=194.6
Q ss_pred CccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee----CCeEEEEE
Q 005278 418 NECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN----IDFKALVL 490 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 490 (704)
+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999965 68899999987543 3345678999999999999999999999865 34678999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEeeeccceecCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~-~~~~~kl~Dfgla~~~~~~~ 569 (704)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||+ +..+|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999998654 48999999999999999999965 334599999999999996 5789999999999864322
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
......||+.|||||++.+ .++.++|||||||++|||++|+.||.+.... ....... ..+..
T Consensus 169 ---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~~~~~i-~~~~~--------- 230 (270)
T d1t4ha_ 169 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRV-TSGVK--------- 230 (270)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHH-TTTCC---------
T ss_pred ---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HHHHHHH-HcCCC---------
Confidence 2234579999999998865 5899999999999999999999999753221 1111111 11100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....+..+++++.+++.+||+.||++|||++|+++
T Consensus 231 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 00111233456889999999999999999999965
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-49 Score=399.34 Aligned_cols=262 Identities=25% Similarity=0.401 Sum_probs=213.0
Q ss_pred HHHHhCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccch-hhhHHHHHHHHHHHhcCCCCCceEEeeeee
Q 005278 410 IQRATNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQLE-RASRSFDSECEILRSIRHRNLIKIISNCCN 482 (704)
Q Consensus 410 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 482 (704)
++...++|+..+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3345678999999999999999999863 357899999976543 345679999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC-----------------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 005278 483 IDFKALVLEFMPNGSLEKWLYSHN-----------------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHC 539 (704)
Q Consensus 483 ~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~ 539 (704)
....++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence 999999999999999999997422 24789999999999999999995 5789999
Q ss_pred CCCCCCeeeCCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCC-CCCC
Q 005278 540 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRK-KPTN 618 (704)
Q Consensus 540 dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~-~p~~ 618 (704)
||||+||++|.++.+||+|||+|+.+.........+...||+.|+|||++.+..++.++|||||||++|||++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998775544444445567899999999999999999999999999999999986 5676
Q ss_pred ccccccccHHHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 619 EIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
+.... .....+... .....+..++.++.+++..||+.+|++||||.||+++|+++.
T Consensus 245 ~~~~~--e~~~~v~~~-----------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHE--EVIYYVRDG-----------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHH--HHHHHHHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHH--HHHHHHHcC-----------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 53221 111111110 011123345667899999999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=403.69 Aligned_cols=266 Identities=23% Similarity=0.301 Sum_probs=204.7
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999964 78999999997653 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++|+|.+++.+.+ .+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 999999999998654 389999999999999999999752 37999999999999999999999999999876332
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHH--hhc--------------
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK--ESL-------------- 635 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~-------------- 635 (704)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+............. ...
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 123457999999999999999999999999999999999999999753221110000000 000
Q ss_pred --------C-CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 636 --------P-DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 636 --------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
+ ....+..+.. ....+........+.++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------CCCCHHHHHHHH-HTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccchhHHHHHhhh-hccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 0000000000 0000000000123467889999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=398.15 Aligned_cols=258 Identities=25% Similarity=0.461 Sum_probs=207.2
Q ss_pred CCCCccccccccCceEEEEEEEC-CCC----EEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGT----NVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.+|+..+.||+|+||+||+|++. +|+ .||+|+++... ....+.+.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 444 58888886443 34567899999999999999999999999875 4578
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
++||+.+|+|.+++......+++..+..++.||+.||+|||. ++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 899999999999999888889999999999999999999964 68999999999999999999999999999987655
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
..........||+.|+|||++.++.++.++|||||||++|||+| |..||++....+ +...+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~------------- 229 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKG------------- 229 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHT-------------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcC-------------
Confidence 44444445578999999999999999999999999999999999 788887643221 22222111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+.+..++..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 230 ----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11122335567789999999999999999999999999887643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=393.01 Aligned_cols=269 Identities=22% Similarity=0.314 Sum_probs=204.2
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC----eEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNID----FKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 490 (704)
.+|...+.||+|+||.||+|++ +|+.||||+++... ......+.|+..+.+++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3566678899999999999986 58999999986442 22223345666667789999999999997643 578999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG-----HSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
||+++|+|.+++++.. ++|..++.++.|+|.|++|+|.. |+++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999998754 89999999999999999999863 5789999999999999999999999999999987
Q ss_pred CCCCCcc--eeccccccccccCCcccCCCC------CCcccceeeHHHHHHHHhhCCCCCCccccccc----------cH
Q 005278 566 GEGDDSV--IQTMTIATIGYMAPEYGSEGI------ISPKSDVYSYGILLMETFTRKKPTNEIFIGEM----------SL 627 (704)
Q Consensus 566 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~----------~~ 627 (704)
....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||........ ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 5543322 233457999999999876543 67789999999999999999988754322211 11
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
............ ++.+ +......+++..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 239 ~~~~~~~~~~~~----~p~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQKL----RPNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCC----CCCC----CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccc----CCCC----CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 111111111111 1111 11122334567789999999999999999999999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=390.71 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=202.5
Q ss_pred hCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEecc
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEFM 493 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 493 (704)
.++|++.+.||+|+||+||+|+.++++.||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 3578899999999999999999988889999999654 3345779999999999999999999999865 4578999999
Q ss_pred CCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|++..++... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++++||+|||+|+....... .
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 999999998743 345899999999999999999996 46899999999999999999999999999987654322 2
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREEQ 652 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (704)
......||+.|+|||++.++.++.++|||||||++|||+||+.|+....... ....++....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i~~~~----------------- 231 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGY----------------- 231 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTC-----------------
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcC-----------------
Confidence 2344578999999999999999999999999999999999776654422211 1112111111
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 005278 653 AFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIK 693 (704)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~ 693 (704)
..+.+..++.++.+++.+||+.||++||+|++|+++|+++.
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 11122345667889999999999999999999999888754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.9e-48 Score=396.33 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=208.8
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999986 47999999999776666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--CCCcEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD--ENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~--~~~~~kl~Dfgla~~~~~~~~ 570 (704)
+++|+|.+++......+++..+..++.||+.||+||| +.+||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 9999999999766667999999999999999999995 57899999999999996 46789999999999875432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......||+.|||||++.+..++.++||||+||++|||+||+.||.+.... ..+........ . .
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~-~-~----------- 244 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDW-N-M----------- 244 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC-C-S-----------
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC-C-C-----------
Confidence 233457999999999999999999999999999999999999999753211 11111111000 0 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......++.++.+++.+||+.||++|||++|+++
T Consensus 245 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 --DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111234567889999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-48 Score=392.47 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=190.0
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.+.|+..+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999964 68999999997554 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEeeeccceecCCC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~---~~~~~kl~Dfgla~~~~~~ 568 (704)
|+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||++. +++.+||+|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999997654 4899999999999999999995 57899999999999995 5789999999999876433
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
. ......||+.|||||++.+..++.++||||+||++|||++|+.||.+.... .....+......
T Consensus 164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~~~~----------- 227 (307)
T d1a06a_ 164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQILKAEYE----------- 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHTTCCC-----------
T ss_pred C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCC-----------
Confidence 2 233457999999999999999999999999999999999999999763211 111111110000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+...++++++.+++.+||+.||++|||++|+++
T Consensus 228 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 ---FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 001112234567889999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-47 Score=395.09 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=209.7
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|++.+.||+|+||+||+|+. .+|+.||||++..........+.+|++++++++|||||++++++.+.+..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999986 47999999999876555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--CCCcEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD--ENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~--~~~~~kl~Dfgla~~~~~~~~ 570 (704)
+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999988877777999999999999999999995 57899999999999998 67899999999999875432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... .....+...... +
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~-~----------- 247 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCDWE-F----------- 247 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCCCC-C-----------
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC-C-----------
Confidence 234457999999999999999999999999999999999999999763211 111111110000 0
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.......++.++.+++.+||+.||++|||+.|+++
T Consensus 248 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 --DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111234567889999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=387.48 Aligned_cols=258 Identities=22% Similarity=0.370 Sum_probs=201.1
Q ss_pred hCCCCccccccccCceEEEEEEECC----CCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 488 (704)
.++|+..+.||+|+||.||+|+... +..||||.++... ....+.+.+|++++++++||||++++|++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 3578889999999999999998642 3568899886443 3345679999999999999999999999864 56799
Q ss_pred EEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCC
Q 005278 489 VLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 489 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~ 568 (704)
||||+++|++.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999998877777999999999999999999995 578999999999999999999999999999876543
Q ss_pred CCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccc
Q 005278 569 DDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANL 647 (704)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (704)
.. .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+....+ ....+....
T Consensus 162 ~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~~------------ 226 (273)
T d1mp8a_ 162 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGE------------ 226 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC------------
T ss_pred cc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCC------------
Confidence 22 22344568999999999999999999999999999999998 888987643321 222111110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 648 VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
..+.+..++.++.+++.+||+.||++|||+.||++.|+++.++
T Consensus 227 -----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1112334567889999999999999999999999999998765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-48 Score=392.40 Aligned_cols=244 Identities=25% Similarity=0.286 Sum_probs=198.6
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
.|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 588899999999999999985 478999999987543 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
|+++|++..++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 99999997766544 45899999999999999999995 478999999999999999999999999999865432
Q ss_pred ceeccccccccccCCcccCC---CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccch
Q 005278 572 VIQTMTIATIGYMAPEYGSE---GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLV 648 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (704)
....||+.|||||++.+ +.++.++|||||||++|||++|+.||.+....+ .+........+
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~------------ 232 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP------------ 232 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC------------
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCC------------
Confidence 23469999999998753 468999999999999999999999997532111 01111110000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 649 REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......++..+.+++.+||+.||++|||++|+++
T Consensus 233 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0011134567889999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=388.55 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=209.1
Q ss_pred cccccccCceEEEEEEECCC----CEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeee-CCeEEEEEecc
Q 005278 420 CNLLGTGSFGSVYKGTLFDG----TNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCN-IDFKALVLEFM 493 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 493 (704)
.++||+|+||+||+|++.++ ..||||+++... ....++|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36899999999999986532 358999987433 4455789999999999999999999999876 45789999999
Q ss_pred CCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc--
Q 005278 494 PNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-- 571 (704)
Q Consensus 494 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~-- 571 (704)
++|+|.+++.......++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999988777899999999999999999995 578999999999999999999999999999887543321
Q ss_pred ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 572 VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
.......||+.|+|||++.+..++.++||||||+++|||+||+.||...... .....++....
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~---------------- 251 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGR---------------- 251 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTC----------------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCC----------------
Confidence 2233456899999999999999999999999999999999988887653221 11122221111
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhh
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDD 699 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~ 699 (704)
....+..++..+.+++.+||+.||++||+|.||++.|+++.+++..+
T Consensus 252 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 252 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 11122244567889999999999999999999999999998876654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=383.29 Aligned_cols=250 Identities=29% Similarity=0.441 Sum_probs=198.9
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeee-CCeEEEEEecc
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCN-IDFKALVLEFM 493 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 493 (704)
++|+..+.||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++||||++++|++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46778889999999999999984 788999999654 345779999999999999999999999865 45679999999
Q ss_pred CCCCHHHHHhhCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 494 PNGSLEKWLYSHN-YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 494 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
++|+|.+++.... ..+++..++.++.||+.|++||| +.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999999997543 45899999999999999999995 478999999999999999999999999999865432
Q ss_pred eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccccchhhh
Q 005278 573 IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVREE 651 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (704)
.....+|+.|+|||++.++.++.++|||||||++|||+| |+.||..... .....++....
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~~---------------- 217 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGY---------------- 217 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTC----------------
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCC----------------
Confidence 223467899999999999999999999999999999998 6777765322 22333322111
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 652 QAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
..+.+..++.++.+++.+||+.||++||||.|++++|++++.
T Consensus 218 -~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 218 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 111222345678899999999999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=386.06 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=199.2
Q ss_pred CCCCccccccccCceEEEEEEEC--CC--CEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF--DG--TNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
++|+..+.||+|+||.||+|+.. ++ ..||||++.... ....+.|.+|++++++++||||++++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 56888999999999999999853 22 368999986543 23446799999999999999999999999764 568
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++|++.+++..+...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999999877777999999999999999999996 47899999999999999999999999999998755
Q ss_pred CCCcc-eeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 568 GDDSV-IQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 568 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
..... ......||..|+|||++.+..++.++|||||||++|||+| |+.||.+.... ....++. ..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~---~~~------- 231 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKID---KEG------- 231 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH---TSC-------
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHH---hCC-------
Confidence 44332 2233467889999999999999999999999999999998 89999763221 1112211 110
Q ss_pred cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 005278 646 NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKI 692 (704)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~ 692 (704)
...+.+..++..+.+++.+||+.||++||||.||.+.|++.
T Consensus 232 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01112234566788999999999999999999999998875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=381.66 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=205.2
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch------hhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE------RASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999996 4799999999875431 2346799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeeeccc
Q 005278 487 ALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM----TAHVSDFGIS 562 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~----~~kl~Dfgla 562 (704)
++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+|++|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999998654 4899999999999999999995 57899999999999998776 4999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
........ .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... +.........
T Consensus 165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~~~~---- 232 (293)
T d1jksa_ 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANVSAVN---- 232 (293)
T ss_dssp EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHTTC----
T ss_pred hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-----HHHHHHHhcC----
Confidence 88754322 33457899999999999999999999999999999999999999763211 1111100000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... ....+..++..+.+++.+||+.||++|||++|+++
T Consensus 233 --~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 --YEF-----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCC-----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCC-----CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 01112244567889999999999999999999965
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=386.49 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=201.9
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC-C
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNI-D 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 484 (704)
.++|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 367999999999999999999853 34689999987543 33456678888888877 689999999998664 4
Q ss_pred eEEEEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 005278 485 FKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD 549 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~ 549 (704)
..++||||+++|+|.++++... ..+++..+..++.||+.||+||| +++|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence 6899999999999999997432 34889999999999999999995 57899999999999999
Q ss_pred CCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCC-CCCCccccccccHH
Q 005278 550 ENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRK-KPTNEIFIGEMSLK 628 (704)
Q Consensus 550 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~-~p~~~~~~~~~~~~ 628 (704)
+++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||......+ .+.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HHH
Confidence 99999999999998775544444445567999999999999999999999999999999999975 5776532221 111
Q ss_pred HHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 629 HWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
..+.... ....+..+++++.+++.+||+.||++||||+||+++|+++.+..
T Consensus 248 ~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 248 RRLKEGT-----------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCC-----------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 2111111 11122245667889999999999999999999999999987653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=386.10 Aligned_cols=248 Identities=22% Similarity=0.255 Sum_probs=205.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 489 (704)
.++|+..+.||+|+||.||+|+. .+|+.||||++++.. ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35799999999999999999996 479999999997543 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++...+. +++..+..++.|++.||+||| +++|+||||||+|||++++|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999986554 788999999999999999995 5789999999999999999999999999998764322
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .+...+...
T Consensus 160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~i~~~--------------- 220 (337)
T d1o6la_ 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILME--------------- 220 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC---------------
T ss_pred c--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HHHHHHhcC---------------
Confidence 2 234467999999999999999999999999999999999999999763211 111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
....+..++.++.+++.+||+.||++||+ +.|+++
T Consensus 221 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 ---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 01112234567889999999999999995 777754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=384.40 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=214.4
Q ss_pred hCCCCccccccccCceEEEEEEE------CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 485 (704)
.++|+..+.||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 36788889999999999999985 246789999997543 33456789999999999 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCC-----------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 486 KALVLEFMPNGSLEKWLYSHN-----------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
.++||||+++|+|.++++... ..+++..+..++.||+.|++||| +++|+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence 999999999999999997532 35889999999999999999995 5789999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCC-CCccccccccH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKP-TNEIFIGEMSL 627 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p-~~~~~~~~~~~ 627 (704)
+.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|++.| |... .....+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-CHHHHH
Confidence 99999999999999988665555555667899999999999999999999999999999999995554 4442 222222
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHH
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEK 695 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~ 695 (704)
...+....+. ..+..++..+.+++.+||+.||++||||.||+++|+++..+
T Consensus 258 ~~~i~~~~~~-----------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGFRM-----------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTCCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCC-----------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 3333221111 11223456788999999999999999999999999887554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=385.91 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=208.7
Q ss_pred hCCCCccccccccCceEEEEEEECC--------CCEEEEEEeeccch-hhhHHHHHHHHHHHhc-CCCCCceEEeeeeeC
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLFD--------GTNVAIKVFNLQLE-RASRSFDSECEILRSI-RHRNLIKIISNCCNI 483 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 483 (704)
.++|+..+.||+|+||.||+|+... +..||||+++.... .....+.+|...+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3678888999999999999998532 34799999976553 3456788899999888 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC---------------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHN---------------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILL 548 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~ 548 (704)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 99999999999999999997543 34899999999999999999995 5789999999999999
Q ss_pred CCCCcEEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhh-CCCCCCccccccccH
Q 005278 549 DENMTAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFT-RKKPTNEIFIGEMSL 627 (704)
Q Consensus 549 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~ 627 (704)
+.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |..||.+.... ..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence 9999999999999998766555445556679999999999999999999999999999999998 68888653221 11
Q ss_pred HHHHHhhcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 628 KHWVKESLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
...+... .....+..++.++.+++.+||+.||++||||.||++.|+++.+
T Consensus 247 ~~~i~~~-----------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 FKLLKEG-----------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHTT-----------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcC-----------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111111 0111222455678999999999999999999999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-46 Score=381.93 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=202.8
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5789999999999999999996 469999999997543 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+++|++.+++..... +++..+..++.|++.|++|| |+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccccccc-ccccHHHHHHHHHHHhhhhh---ccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99999999998876543 78888889999999999999 5688999999999999999999999999999986532
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....||+.|||||++.+..++.++||||+||++|||+||+.||.+... ..........
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~~------------- 216 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKILNA------------- 216 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHC-------------
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHHHHHcC-------------
Confidence 2345799999999999999999999999999999999999999976321 1111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
....+..++.++.+++.+|++.||++|| +++|+++
T Consensus 217 --~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 --ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 0011123456688999999999999996 8888865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=383.87 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=206.6
Q ss_pred CCCCccccccccCceEEEEEEEC-CCC--EEEEEEeeccc-hhhhHHHHHHHHHHHhc-CCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGT--NVAIKVFNLQL-ERASRSFDSECEILRSI-RHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 489 (704)
++|+..++||+|+||+||+|++. +|. .||||++.... ....+.+.+|+++++++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888899999999999999865 444 47788875433 33456799999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhhC---------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 005278 490 LEFMPNGSLEKWLYSH---------------NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTA 554 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~ 554 (704)
|||+++|+|.++++.. ...+++..+..++.||+.|++||| +.+|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999999743 356899999999999999999995 5789999999999999999999
Q ss_pred EEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCC-CCCccccccccHHHHHHh
Q 005278 555 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKK-PTNEIFIGEMSLKHWVKE 633 (704)
Q Consensus 555 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~-p~~~~~~~~~~~~~~~~~ 633 (704)
||+|||+|+...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.+.. ..+....
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~~~~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEK 238 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHH
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Confidence 999999998653322 2234468999999999999999999999999999999999765 665421 1111111
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhh
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDV 700 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 700 (704)
. ..+ .....+..++.++.+++.+||+.||++||||+||++.|+++.++....+
T Consensus 239 i-~~~-------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~ 291 (309)
T d1fvra_ 239 L-PQG-------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291 (309)
T ss_dssp G-GGT-------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred H-Hhc-------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCC
Confidence 1 000 1112223456788999999999999999999999999999886654433
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-46 Score=376.64 Aligned_cols=260 Identities=20% Similarity=0.313 Sum_probs=201.7
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC----e
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNID----F 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 485 (704)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999985 579999999997543 233457899999999999999999999987644 4
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..+++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence 789999999999999887654 4899999999999999999995 578999999999999999999999999999876
Q ss_pred CCCCC-cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcc
Q 005278 566 GEGDD-SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVD 644 (704)
Q Consensus 566 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (704)
..... ........||+.|+|||++.+..+++++||||+||++|||+||+.||.+.... ............
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~~~~~~~~---- 232 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPI---- 232 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCC----
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHHHHHhcCCC----
Confidence 44322 22334457999999999999999999999999999999999999999763211 111111111000
Q ss_pred ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHhH
Q 005278 645 ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRV-SMKDAAAKLKKIK 693 (704)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-t~~ev~~~L~~~~ 693 (704)
.......+++.++.+++.+|++.||++|| +++++.+.|.+++
T Consensus 233 -------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 -------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00011123456788999999999999999 8999998888764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=386.73 Aligned_cols=265 Identities=23% Similarity=0.375 Sum_probs=215.7
Q ss_pred hCCCCccccccccCceEEEEEEEC------CCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFK 486 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 486 (704)
.++|+..+.||+|+||+||+|++. +++.||||+++... ......+.+|++++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888899999999999999863 35789999997543 33445789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCC---------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEe
Q 005278 487 ALVLEFMPNGSLEKWLYSHN---------YFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVS 557 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~ 557 (704)
++||||+++|+|.+++.... ..+++..+..++.|+++||.|||. .+|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 99999999999999987421 346889999999999999999964 689999999999999999999999
Q ss_pred eeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCC-CCCCccccccccHHHHHHhhcC
Q 005278 558 DFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRK-KPTNEIFIGEMSLKHWVKESLP 636 (704)
Q Consensus 558 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~ 636 (704)
|||+|+...............||+.|+|||.+.++.++.++||||||+++|||+||+ .||.+. ...++.....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~~~i~- 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLRFVM- 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHHHHH-
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHH-
Confidence 999998775544444445557899999999999999999999999999999999985 666553 2222221111
Q ss_pred CCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhh
Q 005278 637 DGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDV 700 (704)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~ 700 (704)
+. ...+.+..++..+.+++..||+.+|++||||.||+++|++..+...+++
T Consensus 250 -------~~------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 250 -------EG------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp -------TT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred -------hC------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 10 0111223456779999999999999999999999999998866655543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=377.78 Aligned_cols=251 Identities=19% Similarity=0.285 Sum_probs=206.3
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999865 68999999997653 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC--CCcEEEeeeccceecCCCCC
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE--NMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~--~~~~kl~Dfgla~~~~~~~~ 570 (704)
+++|+|.+++...+..+++..+..++.||+.||+||| +.+|+||||||+||+++. ...+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 9999999999877767999999999999999999995 578999999999999985 4589999999998764332
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
......+|+.|+|||...+..++.++||||+||++|||++|..||......+ .+...... ....
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~------------~~~~- 222 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNA------------EYTF- 222 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHT------------CCCC-
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC------------CCCC-
Confidence 2334578999999999999999999999999999999999999997632111 01111110 0000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
......+++.++.+++.+|++.||++|||+.|+++
T Consensus 223 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 --DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111234567889999999999999999999976
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.5e-46 Score=369.15 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=203.1
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc---------hhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeC
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL---------ERASRSFDSECEILRSIR-HRNLIKIISNCCNI 483 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 483 (704)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999986 579999999987542 112346889999999997 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 484 DFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 484 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
+..++||||+++|+|.+++..++ .+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999998654 4899999999999999999995 4689999999999999999999999999999
Q ss_pred ecCCCCCcceeccccccccccCCcccC------CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGS------EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD 637 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (704)
....... .....||+.|+|||++. ...++.++||||+||++|||+||+.||.+....+ ...........
T Consensus 159 ~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~- 233 (277)
T d1phka_ 159 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQ- 233 (277)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC-
T ss_pred EccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCC-
Confidence 8754322 33457999999999864 3457889999999999999999999997632211 11111111000
Q ss_pred CcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 638 GLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+....+++++.+++.+||+.||++||++.||++
T Consensus 234 --------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 234 --------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 001122245677899999999999999999999843
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-46 Score=382.88 Aligned_cols=244 Identities=21% Similarity=0.237 Sum_probs=203.5
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 490 (704)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999864 79999999987543 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
||+.+|+|.+++.+.+ .+++..+..++.||+.||+||| +.+||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 9999999999998654 4899999999999999999995 578999999999999999999999999999987432
Q ss_pred cceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchhh
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVRE 650 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (704)
.....||+.|||||++.+..++.++||||+||++|||+||+.||.+... ..........
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~~------------- 253 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYEKIVSG------------- 253 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC-------------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----HHHHHHHhcC-------------
Confidence 2345799999999999999999999999999999999999999975311 1111110000
Q ss_pred hhhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005278 651 EQAFSVKIDCLLSIMHLALDCCMESPEQRV-----SMKDAAA 687 (704)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~ev~~ 687 (704)
....+..++.++.+++.+||+.||++|+ +++|+++
T Consensus 254 --~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 254 --KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0011223456788999999999999994 8899865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.5e-46 Score=384.31 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=197.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHH---HHHHHhcCCCCCceEEeeeeeCCeEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSE---CEILRSIRHRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~ 487 (704)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+| +++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999964 69999999986542 1222334444 66667778999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
+||||+++|+|.+++.+.. .+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999998654 3788999999999999999995 57899999999999999999999999999997754
Q ss_pred CCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhcccc
Q 005278 568 GDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDAN 646 (704)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (704)
.. .....||+.|+|||++.. ..++.++||||+||++|||+||+.||.+..... ............
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~~~-------- 225 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMA-------- 225 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHSSSCC--------
T ss_pred Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcccCC--------
Confidence 32 234579999999999864 568999999999999999999999997633221 111111111110
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 647 LVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 647 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
...+..+++++.+++.+||+.||++||| ++|+++
T Consensus 226 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 -------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0111234567889999999999999999 577754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=376.63 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=198.5
Q ss_pred hCCCCccc-cccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhc-CCCCCceEEeeeee----CCeE
Q 005278 414 TNGFNECN-LLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSI-RHRNLIKIISNCCN----IDFK 486 (704)
Q Consensus 414 ~~~~~~~~-~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~ 486 (704)
.++|.+.. .||+|+||+||+|+. .+++.||||+++. ...+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788775 599999999999986 5799999999864 34577899987655 89999999999865 4568
Q ss_pred EEEEeccCCCCHHHHHhhC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEeeeccc
Q 005278 487 ALVLEFMPNGSLEKWLYSH-NYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE---NMTAHVSDFGIS 562 (704)
Q Consensus 487 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~---~~~~kl~Dfgla 562 (704)
++|||||++|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||+++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence 9999999999999999865 356999999999999999999995 578999999999999985 567999999999
Q ss_pred eecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 563 KLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 563 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
+....... .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+..... ............
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~i~~~---- 232 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRMG---- 232 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC----
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHHHHhcC----
Confidence 87754332 334579999999999999999999999999999999999999997632211 111111111000
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
... ........+++++.+++.+||+.||++|||+.|+++
T Consensus 233 ---~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 ---QYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---SSS---CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCC---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 001122355678899999999999999999999976
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=378.70 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=200.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc---hhhhHHHHHHHHHHH-hcCCCCCceEEeeeeeCCeEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERASRSFDSECEILR-SIRHRNLIKIISNCCNIDFKALV 489 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 489 (704)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999864 79999999997543 223445666777665 68999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCC
Q 005278 490 LEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 569 (704)
Q Consensus 490 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~ 569 (704)
|||+++|+|.+++..... +++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999999986543 789999999999999999995 4689999999999999999999999999998764332
Q ss_pred CcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccccchh
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDANLVR 649 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (704)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... .+..-+...
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~--------------- 218 (320)
T d1xjda_ 158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMD--------------- 218 (320)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC---------------
T ss_pred --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHcC---------------
Confidence 2234457999999999999999999999999999999999999999763211 111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 005278 650 EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMK-DAAA 687 (704)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~-ev~~ 687 (704)
....+..++.++.+++.+||+.||++||++. |+++
T Consensus 219 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 ---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0111223456788999999999999999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=371.98 Aligned_cols=266 Identities=24% Similarity=0.304 Sum_probs=200.0
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999996 579999999996543 2235678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHH-hhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCC
Q 005278 492 FMPNGSLEKWL-YSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 570 (704)
Q Consensus 492 ~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~ 570 (704)
|+.++ +.+++ ......+++..+..++.|++.||+||| +.+||||||||+||+++.++.+||+|||.|+......
T Consensus 82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 99764 44444 455566999999999999999999995 5789999999999999999999999999998765432
Q ss_pred cceeccccccccccCCcccCCCC-CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhh-cCCC--cchhc-cc
Q 005278 571 SVIQTMTIATIGYMAPEYGSEGI-ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKES-LPDG--LTEVV-DA 645 (704)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~-~~ 645 (704)
.......||+.|+|||+..... ++.++||||+||++|||++|+.||.+....+. +....... .+.. +.... .+
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhcCCCchhhcccccccc
Confidence 2234457999999999866554 68899999999999999999999976322111 11111110 1111 00000 00
Q ss_pred cchhh------hhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 NLVRE------EQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..... ..........+.++.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 0001111234567889999999999999999999954
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=368.03 Aligned_cols=262 Identities=24% Similarity=0.274 Sum_probs=193.6
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeeccchh-----hhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 419 ECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLER-----ASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 419 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
.+++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 457899999999999995 46999999998654321 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+.++++..+. .....+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence 9887666554 44555888999999999999999995 57899999999999999999999999999987654322
Q ss_pred eeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC---Ccchhcc----
Q 005278 573 IQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD---GLTEVVD---- 644 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---- 644 (704)
......||+.|+|||++.. ..++.++||||+||++|||+||..||.+....+ .+....+..... .+.....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchh
Confidence 2234579999999998765 467999999999999999999999997632211 111111111000 0000000
Q ss_pred ccchh--hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 ANLVR--EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..... ...........+.++.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 00001111233567889999999999999999999954
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=365.07 Aligned_cols=239 Identities=23% Similarity=0.265 Sum_probs=194.8
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccch------hhhHHHHHHHHHHHhcC--CCCCceEEeeeeeCCe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLE------RASRSFDSECEILRSIR--HRNLIKIISNCCNIDF 485 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 485 (704)
++|++.+.||+|+||+||+|+. .+|+.||||++..... .....+.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999996 4799999999875421 12234678999999996 8999999999999999
Q ss_pred EEEEEeccCC-CCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeeeccce
Q 005278 486 KALVLEFMPN-GSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-NMTAHVSDFGISK 563 (704)
Q Consensus 486 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-~~~~kl~Dfgla~ 563 (704)
.++||||+.+ +++.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 67888876543 4899999999999999999995 578999999999999985 4799999999998
Q ss_pred ecCCCCCcceeccccccccccCCcccCCCCC-CcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchh
Q 005278 564 LLGEGDDSVIQTMTIATIGYMAPEYGSEGII-SPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEV 642 (704)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (704)
..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ...+..
T Consensus 160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~-------- 220 (273)
T d1xwsa_ 160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQ-------- 220 (273)
T ss_dssp ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCC--------
T ss_pred ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhcc--------
Confidence 75432 2334579999999999887665 567999999999999999999997521 111100
Q ss_pred ccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
...+..++.++.+++.+||+.||++|||++|+++
T Consensus 221 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 -----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0011123466889999999999999999999965
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=366.17 Aligned_cols=275 Identities=23% Similarity=0.277 Sum_probs=203.6
Q ss_pred hCCCCccccccccCceEEEEEEE-CC-CCEEEEEEeeccch--hhhHHHHHHHHHHHhc---CCCCCceEEeeeee----
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FD-GTNVAIKVFNLQLE--RASRSFDSECEILRSI---RHRNLIKIISNCCN---- 482 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 482 (704)
.++|++.+.||+|+||+||+|+. .+ ++.||||+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999986 34 66799999875432 2234566788877766 79999999999853
Q ss_pred -CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecc
Q 005278 483 -IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGI 561 (704)
Q Consensus 483 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgl 561 (704)
....+++|||+++|++..........+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 34678999999988777666666677899999999999999999995 57899999999999999999999999999
Q ss_pred ceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC---
Q 005278 562 SKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG--- 638 (704)
Q Consensus 562 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 638 (704)
++.... ........||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... ..+...........
T Consensus 163 ~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 163 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred hhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchhc
Confidence 886532 22334567999999999999999999999999999999999999999763221 11111111111100
Q ss_pred cchhc---cccch--hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHhhhhhc
Q 005278 639 LTEVV---DANLV--REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKFLDDVA 701 (704)
Q Consensus 639 ~~~~~---~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~~~~~~ 701 (704)
+.... ..... ............+..+.+++.+||+.||++|||++|++ ...|.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L------~Hpff~~i~ 300 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL------SHPYFQDLE 300 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH------TSGGGTTCC
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh------cChhhcCch
Confidence 00000 00000 00001111223456788999999999999999999984 445555543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-44 Score=363.24 Aligned_cols=266 Identities=21% Similarity=0.251 Sum_probs=200.1
Q ss_pred CCCCccccccccCceEEEEEEECCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEec
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLEF 492 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 492 (704)
++|+..+.||+|+||+||+|+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999899999999996543 22356899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCcc
Q 005278 493 MPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 572 (704)
Q Consensus 493 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~~ 572 (704)
+.++.+..+. .....+++..+..++.|++.||+||| +.+||||||||+||+++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence 9876555554 44456999999999999999999996 46899999999999999999999999999987654322
Q ss_pred eeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC---Ccchhcc----
Q 005278 573 IQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD---GLTEVVD---- 644 (704)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---- 644 (704)
......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+. +.......... .+.....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhc
Confidence 2334468999999998765 4579999999999999999999999976432211 11111111100 0100000
Q ss_pred -ccchh--hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 -ANLVR--EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 -~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..... ..+........+..+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00011112234567889999999999999999999964
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-42 Score=350.81 Aligned_cols=264 Identities=16% Similarity=0.160 Sum_probs=211.5
Q ss_pred hCCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCC-CCCceEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRH-RNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 491 (704)
.++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999954 6899999988654 234567889999999975 899999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-----CCcEEEeeeccceecC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDE-----NMTAHVSDFGISKLLG 566 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~-----~~~~kl~Dfgla~~~~ 566 (704)
|+ +|+|.+++...+..+++..+..++.|++.|++|| |+.+|+||||||+||+++. ++.+||+|||+|+...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHH---HHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 6899999988777799999999999999999999 5688999999999999974 5789999999999875
Q ss_pred CCCCc-----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHH-HHHHhhcCCCcc
Q 005278 567 EGDDS-----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLK-HWVKESLPDGLT 640 (704)
Q Consensus 567 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 640 (704)
..... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.+......... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~------ 231 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK------ 231 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH------
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc------
Confidence 43221 123345799999999999999999999999999999999999999976432211110 000000
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHHHh
Q 005278 641 EVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKEKF 696 (704)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~~~ 696 (704)
. ...........+++++.+++..|++.+|++||+++.+.+.|+++.++.
T Consensus 232 -----~--~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 232 -----K--QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -----H--HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----c--CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0 000011112245677899999999999999999999999998876654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-42 Score=353.37 Aligned_cols=261 Identities=19% Similarity=0.208 Sum_probs=203.1
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCc-eEEeeeeeCCeEEEEEe
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLI-KIISNCCNIDFKALVLE 491 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e 491 (704)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+..|+++++.++|+|++ .+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 35799999999999999999986 468999999986542 234588899999999877655 55556677888899999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEeeeccceecCCC
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEG 568 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~---~~~~~kl~Dfgla~~~~~~ 568 (704)
|+ +|++.+.+......+++..+..++.|++.||+||| +++|+||||||+||+++ .+..+|++|||+|+.+...
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99 56787877776677999999999999999999995 57899999999999986 4557999999999987553
Q ss_pred CCc-----ceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccccc--HHHHHHhhcCCCcch
Q 005278 569 DDS-----VIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMS--LKHWVKESLPDGLTE 641 (704)
Q Consensus 569 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 641 (704)
... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......... ...+......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~----- 234 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----- 234 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-----
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-----
Confidence 321 1233457999999999999999999999999999999999999999764332211 1111110000
Q ss_pred hccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHH
Q 005278 642 VVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAAKLKKIKE 694 (704)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~~L~~~~~ 694 (704)
.+.......++.++.+++..||+.+|++||+++++.+.|+.+..
T Consensus 235 ---------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 ---------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ---------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00111122456788999999999999999999999999888643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=359.36 Aligned_cols=268 Identities=20% Similarity=0.217 Sum_probs=195.7
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc-hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC----eEE
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERASRSFDSECEILRSIRHRNLIKIISNCCNID----FKA 487 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 487 (704)
+++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999985 579999999997543 344567899999999999999999999986643 234
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCC
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGE 567 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~ 567 (704)
++++|+.+|+|.+++... .+++..+..++.|++.||+||| +.+||||||||+|||++.++.+||+|||+|.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 555667799999999765 3899999999999999999995 47899999999999999999999999999987644
Q ss_pred CCCc-ceeccccccccccCCcccC-CCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhccc
Q 005278 568 GDDS-VIQTMTIATIGYMAPEYGS-EGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVVDA 645 (704)
Q Consensus 568 ~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (704)
.... .......||+.|+|||++. +..++.++||||+||++|||++|+.||......+.. ..................
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHTC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-HHHhhhccCCChhhhhhh
Confidence 3221 1233457999999999874 456789999999999999999999999763221111 111110001100000000
Q ss_pred c---c---------hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 646 N---L---------VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 646 ~---~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. . .............+.++.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 0000000111123456889999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=358.11 Aligned_cols=260 Identities=25% Similarity=0.298 Sum_probs=191.6
Q ss_pred CCCccccccccCceEEEEEEEC-CCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC------CeEEE
Q 005278 416 GFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNLIKIISNCCNI------DFKAL 488 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 488 (704)
+|+..++||+|+||+||+|+.. +|+.||||++.... ....+|++++++++||||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778889999999999999964 69999999986542 2234799999999999999999998543 35789
Q ss_pred EEeccCCCCHHHHHh--hCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeeeccceec
Q 005278 489 VLEFMPNGSLEKWLY--SHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-TAHVSDFGISKLL 565 (704)
Q Consensus 489 v~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-~~kl~Dfgla~~~ 565 (704)
||||+++|.+..... .....+++..+..++.|++.||+|| |+.+|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH---HhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998764444332 3455699999999999999999999 568999999999999999775 8999999999877
Q ss_pred CCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHH-----------h
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK-----------E 633 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-----------~ 633 (704)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+....+ .
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhh
Confidence 54332 234579999999998764 578999999999999999999999997532211 1111111 1
Q ss_pred hcCCCcchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 634 SLPDGLTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
..+.. ....-+...............++++.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNY-TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccch-hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11100 000000000000000111234567889999999999999999999965
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-42 Score=350.39 Aligned_cols=269 Identities=22% Similarity=0.269 Sum_probs=194.9
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee--------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN-------- 482 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 482 (704)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999996 479999999986543 2345678899999999999999999998855
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccc
Q 005278 483 IDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGIS 562 (704)
Q Consensus 483 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla 562 (704)
.+..++||||+.++.+.. .......++...+..++.|++.|++||| +.+|+||||||+||+++.++.+|++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 345789999998766554 4444556889999999999999999995 578999999999999999999999999999
Q ss_pred eecCCCCCc--ceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHH--hhcCC
Q 005278 563 KLLGEGDDS--VIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVK--ESLPD 637 (704)
Q Consensus 563 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~ 637 (704)
+........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..... ....... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCCCCh
Confidence 877543321 122334699999999987654 68999999999999999999999997532111 1111111 11111
Q ss_pred C-cchhccccc----------hhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 638 G-LTEVVDANL----------VREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 638 ~-~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
. ......... ................+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1 111000000 0000001111223456788999999999999999999953
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-42 Score=346.41 Aligned_cols=267 Identities=20% Similarity=0.223 Sum_probs=202.9
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCCeEEEEEe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNIDFKALVLE 491 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 491 (704)
++|++++.||+|+||+||+|+. .+++.||||+++... ......+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 478999999986543 2345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceecCCCCCc
Q 005278 492 FMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 571 (704)
Q Consensus 492 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~~~~~~~ 571 (704)
++.++++..++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||.|+.......
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 99998888877654 45789999999999999999995 47899999999999999999999999999998754332
Q ss_pred ceeccccccccccCCcccCCCC-CCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCC--C-cc---hhcc
Q 005278 572 VIQTMTIATIGYMAPEYGSEGI-ISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPD--G-LT---EVVD 644 (704)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~-~~---~~~~ 644 (704)
......+++.|+|||++.+.. ++.++||||+||++|||++|+.||.........+.......... . +. ...+
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 233345788999999877654 68999999999999999999999743221111111111111110 0 00 0000
Q ss_pred ----ccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 645 ----ANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 645 ----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
................+..+.+++.+|++.||++||||+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001111122234567889999999999999999999943
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=355.68 Aligned_cols=261 Identities=23% Similarity=0.286 Sum_probs=192.5
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeCC------
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNID------ 484 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 484 (704)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999996 469999999997543 234567889999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 485 FKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 485 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
..++||||+ ++++..+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence 569999999 56787777654 3899999999999999999995 57899999999999999999999999999987
Q ss_pred cCCCCCcceeccccccccccCCcccCC-CCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC--cch
Q 005278 565 LGEGDDSVIQTMTIATIGYMAPEYGSE-GIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG--LTE 641 (704)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 641 (704)
.... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+........... ...
T Consensus 171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHHh
Confidence 6432 234579999999998765 45789999999999999999999999763211 11111111110000 000
Q ss_pred hccc-----------cchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 642 VVDA-----------NLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 642 ~~~~-----------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.... ..... .........++.+.+++.+|++.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKK-DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCC-CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhcchhhhhhhccCCccccc-chHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00000 000111233566789999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=351.09 Aligned_cols=252 Identities=24% Similarity=0.277 Sum_probs=200.2
Q ss_pred CCCCccccccccCceEEEEEEE----CCCCEEEEEEeeccc----hhhhHHHHHHHHHHHhcCC-CCCceEEeeeeeCCe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERASRSFDSECEILRSIRH-RNLIKIISNCCNIDF 485 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 485 (704)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999974 248899999986532 2345678899999999976 899999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||+.+|+|.+++...+. ++......++.|++.|++|+| +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999986654 678888999999999999995 578999999999999999999999999999876
Q ss_pred CCCCCcceeccccccccccCCcccCCC--CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCCcchhc
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEG--IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDGLTEVV 643 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (704)
...... ......|++.|+|||.+.+. .++.++||||+||++|||+||+.||.+...... ..........
T Consensus 180 ~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~------- 250 (322)
T d1vzoa_ 180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILK------- 250 (322)
T ss_dssp CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHH-------
T ss_pred cccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhccc-------
Confidence 443222 23345799999999987654 478899999999999999999999977433222 1111111100
Q ss_pred cccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005278 644 DANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVS-----MKDAAA 687 (704)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~ev~~ 687 (704)
.....+..++.++.+++.+||++||++||+ ++|+++
T Consensus 251 --------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 --------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011122345678899999999999999994 788854
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-41 Score=348.72 Aligned_cols=260 Identities=18% Similarity=0.269 Sum_probs=196.2
Q ss_pred CCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeee--CCeEEEEE
Q 005278 415 NGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCN--IDFKALVL 490 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 490 (704)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 57999999998643 3467889999999995 9999999999875 35689999
Q ss_pred eccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeeeccceecCCCC
Q 005278 491 EFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM-TAHVSDFGISKLLGEGD 569 (704)
Q Consensus 491 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~-~~kl~Dfgla~~~~~~~ 569 (704)
||+++|+|.++. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999997764 24899999999999999999995 57899999999999998655 69999999998875433
Q ss_pred CcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCcccccccc------------HHHHHHhhcC
Q 005278 570 DSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMS------------LKHWVKESLP 636 (704)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~------------~~~~~~~~~~ 636 (704)
. .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ...|......
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 3445789999999987664 4799999999999999999999998653221110 1111111100
Q ss_pred CC---cchhccccch---hhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 637 DG---LTEVVDANLV---REEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 637 ~~---~~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.. .......... ...........+++++.+++.+|++.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 1111100000 000111122334567889999999999999999999954
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=346.77 Aligned_cols=260 Identities=20% Similarity=0.224 Sum_probs=188.8
Q ss_pred CCCCccccccccCceEEEEEEEC-CCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeee------CCe
Q 005278 415 NGFNECNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCN------IDF 485 (704)
Q Consensus 415 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 485 (704)
++|++.++||+|+||+||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999965 69999999997543 2344578899999999999999999999854 367
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.++||||+.++ +.+.+. ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence 89999999765 444443 23789999999999999999995 578999999999999999999999999998865
Q ss_pred CCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHH--------------
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWV-------------- 631 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~-------------- 631 (704)
.... ......+|+.|+|||++.+..+++++||||+||++|||++|+.||.+.... .......
T Consensus 170 ~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 170 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTTS
T ss_pred cccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHHh
Confidence 4322 234457899999999999999999999999999999999999999653211 0011110
Q ss_pred --------HhhcCCC---cchhccccchhhhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 632 --------KESLPDG---LTEVVDANLVREEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 632 --------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
....... .......... ..........+..+.+++.+|++.||++||||+|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLF--PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGS--CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhHHHHhhcCccccccccccccccccc--cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 0000000000 0111223355778899999999999999999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=345.51 Aligned_cols=263 Identities=20% Similarity=0.260 Sum_probs=193.2
Q ss_pred hCCCCccccccccCceEEEEEEE-CCCCEEEEEEeeccc--hhhhHHHHHHHHHHHhcCCCCCceEEeeeeeC-----Ce
Q 005278 414 TNGFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERASRSFDSECEILRSIRHRNLIKIISNCCNI-----DF 485 (704)
Q Consensus 414 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 485 (704)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999985 579999999997543 23445788999999999999999999998643 23
Q ss_pred EEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeeeccceec
Q 005278 486 KALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDFGISKLL 565 (704)
Q Consensus 486 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~~ 565 (704)
.+++++|+.+|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence 46677888899999999654 4899999999999999999995 578999999999999999999999999999764
Q ss_pred CCCCCcceeccccccccccCCcccCCC-CCCcccceeeHHHHHHHHhhCCCCCCccccccccHHHHHHhhcCCC--cchh
Q 005278 566 GEGDDSVIQTMTIATIGYMAPEYGSEG-IISPKSDVYSYGILLMETFTRKKPTNEIFIGEMSLKHWVKESLPDG--LTEV 642 (704)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 642 (704)
.. ......||+.|+|||...+. .++.++||||+||++|+|++|+.||.+..... ............. ....
T Consensus 172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHTT
T ss_pred Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChHHhhh
Confidence 32 23345789999999986654 56889999999999999999999997532111 0111111100000 0000
Q ss_pred cccc--------chh--hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005278 643 VDAN--------LVR--EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDAAA 687 (704)
Q Consensus 643 ~~~~--------~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev~~ 687 (704)
.... ... ...........+..+.+++.+|++.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 000 00000111234567889999999999999999999965
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-36 Score=314.50 Aligned_cols=264 Identities=17% Similarity=0.182 Sum_probs=188.9
Q ss_pred CCCccccccccCceEEEEEEE-CCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-----------CCCCceEEeeeee-
Q 005278 416 GFNECNLLGTGSFGSVYKGTL-FDGTNVAIKVFNLQLERASRSFDSECEILRSIR-----------HRNLIKIISNCCN- 482 (704)
Q Consensus 416 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~- 482 (704)
+|++.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 599999999999999999996 579999999997543 23457788999988875 5789999988754
Q ss_pred -CCeEEEEEeccCCCCHHHH-H-hhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC------c
Q 005278 483 -IDFKALVLEFMPNGSLEKW-L-YSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENM------T 553 (704)
Q Consensus 483 -~~~~~lv~e~~~~gsL~~~-l-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~------~ 553 (704)
....+++++++..+..... . ......+++..+..++.|++.|++|||+ ..+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 4456667776655443222 2 2344568889999999999999999974 47899999999999998655 3
Q ss_pred EEEeeeccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHHHHHhhCCCCCCcccccc-----ccHH
Q 005278 554 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILLMETFTRKKPTNEIFIGE-----MSLK 628 (704)
Q Consensus 554 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~-----~~~~ 628 (704)
++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||....... ..+.
T Consensus 171 ~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 999999999865332 234579999999999999999999999999999999999999997532210 0111
Q ss_pred HHHHhhcC----------------------CCcchhccccchh-hhhhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 005278 629 HWVKESLP----------------------DGLTEVVDANLVR-EEQAFSVKIDCLLSIMHLALDCCMESPEQRVSMKDA 685 (704)
Q Consensus 629 ~~~~~~~~----------------------~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev 685 (704)
..+..... ..+.......... ...........+..+.+++.+|+..||++||||+|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 11110000 0000000000000 001122334667889999999999999999999999
Q ss_pred HH
Q 005278 686 AA 687 (704)
Q Consensus 686 ~~ 687 (704)
++
T Consensus 326 L~ 327 (362)
T d1q8ya_ 326 VN 327 (362)
T ss_dssp HT
T ss_pred hc
Confidence 54
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.5e-30 Score=265.76 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=183.9
Q ss_pred CCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccC-CCCcccCChhhhhcccccceEEecCCcccccCChhhh
Q 005278 53 LGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLAS-NPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIG 131 (704)
Q Consensus 53 l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 131 (704)
-.+++.|+|++|.+.... .+|+.+.++++|++|+|++ |++.+.+|..|.++. +|++|+|++|++.+..+..+.
T Consensus 49 ~~~v~~L~L~~~~l~g~~-----~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~-~L~~L~Ls~N~l~~~~~~~~~ 122 (313)
T d1ogqa_ 49 TYRVNNLDLSGLNLPKPY-----PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT-QLHYLYITHTNVSGAIPDFLS 122 (313)
T ss_dssp CCCEEEEEEECCCCSSCE-----ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCT-TCSEEEEEEECCEEECCGGGG
T ss_pred cEEEEEEECCCCCCCCCC-----CCChHHhcCcccccccccccccccccccccccccc-ccchhhhcccccccccccccc
Confidence 345667777776665431 1344566777777777765 666666677676664 577777777777777777777
Q ss_pred cCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCC-CEEEcCCCcCCccCCccccCcCCCCE
Q 005278 132 NLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGL-SELNLNGNKLCGHVPPCLASLTSLRR 210 (704)
Q Consensus 132 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~ 210 (704)
.+..|+++++++|.+.+.+|..+++++.++.+++++|.+++.+|..+..+.++ +.+++++|++++..|..+..+.. ..
T Consensus 123 ~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~ 201 (313)
T d1ogqa_ 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AF 201 (313)
T ss_dssp GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SE
T ss_pred chhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccc-cc
Confidence 77777778877777777777777777778888888777777777777776665 77777888877777776666544 36
Q ss_pred EEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCcee
Q 005278 211 LHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQF 290 (704)
Q Consensus 211 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 290 (704)
+++.+|...+..|..+..+++|+.+++++|.+.+.++ .+..+++|+.|+|++|+++|.+|..++.+++|++|+|++|+|
T Consensus 202 l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l 280 (313)
T d1ogqa_ 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280 (313)
T ss_dssp EECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcc
Confidence 7777777777777777777788888888887775443 567777888888888888888888888888888888888888
Q ss_pred eccCCcccccccccceEEecccC
Q 005278 291 QGPVPKSFGSLISLESLDLSRNN 313 (704)
Q Consensus 291 ~~~~p~~~~~l~~L~~L~l~~N~ 313 (704)
+|.+|. ++++.+|+.+++++|+
T Consensus 281 ~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 281 CGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp EEECCC-STTGGGSCGGGTCSSS
T ss_pred cccCCC-cccCCCCCHHHhCCCc
Confidence 887774 5677788888777776
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=5.6e-30 Score=261.50 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=214.4
Q ss_pred CCCCCEEeccCccccc--cCchhhcCCCCCCEEeccc-ccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhh
Q 005278 29 ASKLIMLDLSSNSFSG--LIPNTFGNLGSLQVLSLAY-NYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLI 105 (704)
Q Consensus 29 l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 105 (704)
-.++++|+|++|.+++ .+|..|.+|++|++|+|++ |.++.. +|+.+.++++|++|+|++|++.+..+..+
T Consensus 49 ~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~-------iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~ 121 (313)
T d1ogqa_ 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP-------IPPAIAKLTQLHYLYITHTNVSGAIPDFL 121 (313)
T ss_dssp CCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESC-------CCGGGGGCTTCSEEEEEEECCEEECCGGG
T ss_pred cEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccc-------cccccccccccchhhhccccccccccccc
Confidence 3467888888888876 3677888888888888876 666532 34447888888888888888887777777
Q ss_pred hhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCc-CeeeccCcccCCCCCccccCCCCC
Q 005278 106 GNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRL-QGLYLHGNKLQGSIPYDLCHLEGL 184 (704)
Q Consensus 106 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~l~~l~~L 184 (704)
..+. .|+.+++..|.+.+.+|..+++++.|+++++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+..+
T Consensus 122 ~~~~-~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~ 200 (313)
T d1ogqa_ 122 SQIK-TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA 200 (313)
T ss_dssp GGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS
T ss_pred cchh-hhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc
Confidence 6653 68888888888888889999999999999999999999999999888776 889999999998888888876554
Q ss_pred CEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecC
Q 005278 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRN 264 (704)
Q Consensus 185 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n 264 (704)
.+++++|.+.+.+|..+..+++|+.+++++|.+.+.+ ..++.+++|+.|+|++|++++.+|..++++++|+.|+|++|
T Consensus 201 -~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N 278 (313)
T d1ogqa_ 201 -FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp -EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred -ccccccccccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCC
Confidence 7999999999899999999999999999999998654 46888999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcCCCCCcceeeccCce-eec
Q 005278 265 QLSGDIPTTIGGLENLETLSLADNQ-FQG 292 (704)
Q Consensus 265 ~l~~~~~~~~~~l~~L~~L~L~~n~-l~~ 292 (704)
+++|.+|. ++.+++|+.+++++|+ +.|
T Consensus 279 ~l~g~iP~-~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 279 NLCGEIPQ-GGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp EEEEECCC-STTGGGSCGGGTCSSSEEES
T ss_pred cccccCCC-cccCCCCCHHHhCCCccccC
Confidence 99998885 6889999999999997 454
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1e-27 Score=252.30 Aligned_cols=299 Identities=25% Similarity=0.335 Sum_probs=225.5
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
+.+|++|++++|.|+. + +.++.+++|++|+|++|+|+++. .|+++++|++|++++|++..+.. +.++
T Consensus 43 l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~~---------l~~l 109 (384)
T d2omza2 43 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITP---------LANL 109 (384)
T ss_dssp HTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG---------GTTC
T ss_pred hCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccccccc---------cccc
Confidence 5789999999999995 3 46899999999999999999764 39999999999999999987542 7889
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCccc-----------------------------------------
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR----------------------------------------- 123 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~----------------------------------------- 123 (704)
++|+.|++++|.+.+..+.... ..+..+....|.+.
T Consensus 110 ~~L~~L~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (384)
T d2omza2 110 TNLTGLTLFNNQITDIDPLKNL---TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186 (384)
T ss_dssp TTCCEEECCSSCCCCCGGGTTC---TTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccc
Confidence 9999999999998765432221 12333333332221
Q ss_pred ccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCcccc
Q 005278 124 GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLA 203 (704)
Q Consensus 124 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~ 203 (704)
......+..+++++.+++++|.+++..+ +...++|++|++++|+++. + ..+..+++|+.|++++|++++.. .+.
T Consensus 187 ~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~ 260 (384)
T d2omza2 187 VSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLS 260 (384)
T ss_dssp CCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGT
T ss_pred cccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--ccc
Confidence 1233456778888899999988886544 4667888999999998874 2 46778888999999999888543 377
Q ss_pred CcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCccee
Q 005278 204 SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETL 283 (704)
Q Consensus 204 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 283 (704)
.+++|+.|++++|.+++.. .+..++.++.+.++.|.+.+ ...+..+++++.|++++|++++.. .+..+++|+.|
T Consensus 261 ~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L 334 (384)
T d2omza2 261 GLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRL 334 (384)
T ss_dssp TCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEE
T ss_pred ccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEE
Confidence 7888999999988887543 47778888888888888874 345777888888888888888543 37788888888
Q ss_pred eccCceeeccCCcccccccccceEEecccCCCCCCCCCcccccccCcccccC
Q 005278 284 SLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCG 335 (704)
Q Consensus 284 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g 335 (704)
++++|++++ ++ .+..+++|++|++++|++++..| +..++.+..+.+.+
T Consensus 335 ~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~ 382 (384)
T d2omza2 335 FFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382 (384)
T ss_dssp ECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCC
T ss_pred ECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCC
Confidence 888888874 43 57888888888888888886554 55555555554443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=4e-27 Score=239.24 Aligned_cols=243 Identities=25% Similarity=0.351 Sum_probs=180.3
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCC
Q 005278 8 LKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNL 87 (704)
Q Consensus 8 l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L 87 (704)
.+.++-++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+...+ |.++++|
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~-------f~~l~~L 81 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA-------FAPLVKL 81 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT-------TTTCTTC
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh-------hhCCCcc
Confidence 577888999999 6787774 68999999999999888889999999999999999999876554 8999999
Q ss_pred cEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCc--cccChhhcCCCCcCeeec
Q 005278 88 TVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLN--GTIPTAVGRLRRLQGLYL 165 (704)
Q Consensus 88 ~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L 165 (704)
++|++++|+++.. |..+. ..+..|.+.+|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++
T Consensus 82 ~~L~l~~n~l~~l-~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l 157 (305)
T d1xkua_ 82 ERLYLSKNQLKEL-PEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 157 (305)
T ss_dssp CEEECCSSCCSBC-CSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred CEecccCCccCcC-ccchh---hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCcccc
Confidence 9999999999854 43322 35778888888887777767777777777777776543 333456677777777777
Q ss_pred cCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCC
Q 005278 166 HGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGS 245 (704)
Q Consensus 166 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 245 (704)
++|.++ .+|..+ +++|++|++++|.++...+..+..++.++.|++++|.+++..+..+.++++|++|+|++|.++ .
T Consensus 158 ~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~ 233 (305)
T d1xkua_ 158 ADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K 233 (305)
T ss_dssp CSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-S
T ss_pred ccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-c
Confidence 777776 444433 467777777777777666666777777777777777777666666666666666666666666 4
Q ss_pred CCcccccCcCCcEEEeecCccCC
Q 005278 246 LPSNIQNLKVLTNLDLSRNQLSG 268 (704)
Q Consensus 246 ~~~~~~~l~~L~~L~l~~n~l~~ 268 (704)
+|..+..+++|+.|+|++|+|+.
T Consensus 234 lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 234 VPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp CCTTTTTCSSCCEEECCSSCCCC
T ss_pred cccccccccCCCEEECCCCccCc
Confidence 45566666666666666666663
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=4.2e-26 Score=239.82 Aligned_cols=297 Identities=24% Similarity=0.348 Sum_probs=235.3
Q ss_pred ecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEE
Q 005278 12 TLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLG 91 (704)
Q Consensus 12 ~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~ 91 (704)
.+.++.+++.+. ...+.+|++|++++|.|+++ ..+..+++|++|+|++|+|+.++. +.++++|++|+
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~---------l~~L~~L~~L~ 94 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP---------LKNLTKLVDIL 94 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG---------GTTCTTCCEEE
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc---------ccCCccccccc
Confidence 566777776654 46789999999999999975 458899999999999999988642 88999999999
Q ss_pred ccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCcc-----------------------
Q 005278 92 LASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNG----------------------- 148 (704)
Q Consensus 92 L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~----------------------- 148 (704)
+++|++.+..+ +..+ ++|+.|++.++.+++..+. .....+..+....|.+..
T Consensus 95 L~~n~i~~i~~--l~~l-~~L~~L~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (384)
T d2omza2 95 MNNNQIADITP--LANL-TNLTGLTLFNNQITDIDPL--KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK 169 (384)
T ss_dssp CCSSCCCCCGG--GTTC-TTCCEEECCSSCCCCCGGG--TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG
T ss_pred ccccccccccc--cccc-ccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccchhh
Confidence 99999986543 5555 4799999999998864432 333444555444433211
Q ss_pred ------------------ccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCE
Q 005278 149 ------------------TIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRR 210 (704)
Q Consensus 149 ------------------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 210 (704)
.....+..+++++.+++++|.+++..| +...++|++|++++|++++ + +.+..+++|+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~ 245 (384)
T d2omza2 170 PLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTD 245 (384)
T ss_dssp GGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSE
T ss_pred hhccccccccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccch
Confidence 123456778999999999999996544 5567899999999999984 3 46888999999
Q ss_pred EEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCcee
Q 005278 211 LHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQF 290 (704)
Q Consensus 211 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 290 (704)
|++++|.+++.. .+..+++|+.|++++|.+.+.. .+..++.++.++++.|++++ + ..+..+++++.|++++|++
T Consensus 246 L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l 319 (384)
T d2omza2 246 LDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNI 319 (384)
T ss_dssp EECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCC
T ss_pred hccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccc-c-cccchhcccCeEECCCCCC
Confidence 999999998643 4888999999999999998543 47788999999999999985 3 3588899999999999999
Q ss_pred eccCCcccccccccceEEecccCCCCCCCCCcccccccCcccccCCCccC
Q 005278 291 QGPVPKSFGSLISLESLDLSRNNLSGEIPKNFSAQSFLSNYALCGPARLQ 340 (704)
Q Consensus 291 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~l~g~~~~~ 340 (704)
++.. .+..+++|+.|++++|++++ +| .+...+.+....+.++....
T Consensus 320 ~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~ 365 (384)
T d2omza2 320 SDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISD 365 (384)
T ss_dssp SCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCB
T ss_pred CCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCC
Confidence 9643 38899999999999999985 33 46667777777777665443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=2.1e-25 Score=226.34 Aligned_cols=248 Identities=22% Similarity=0.288 Sum_probs=208.2
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
.+++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.+.+|.++++|++|++++|+++.++. ...
T Consensus 30 ~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~----------~~~ 99 (305)
T d1xkua_ 30 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPE----------KMP 99 (305)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCS----------SCC
T ss_pred CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCcc----------chh
Confidence 4789999999999996655689999999999999999999999999999999999999999988663 234
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCccc--ccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCe
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLR--GNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQG 162 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 162 (704)
+.|..|++++|.+....+..+... ..+..+....|... ...+..+..+++|+.+++++|.+. .++..+ .++|+.
T Consensus 100 ~~l~~L~~~~n~l~~l~~~~~~~~-~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~ 175 (305)
T d1xkua_ 100 KTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTE 175 (305)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSE
T ss_pred hhhhhhhccccchhhhhhhhhhcc-ccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCE
Confidence 689999999999996655555443 46778888877544 456778999999999999999998 445433 589999
Q ss_pred eeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCccc
Q 005278 163 LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSL 242 (704)
Q Consensus 163 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 242 (704)
|++++|.++...+..+..++.++.|++++|.+++..+..+.++++|+.|+|++|+|+ .+|..|..+++|++|+|++|+|
T Consensus 176 L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i 254 (305)
T d1xkua_ 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254 (305)
T ss_dssp EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred EECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCcc
Confidence 999999999888899999999999999999999888889999999999999999998 5688999999999999999999
Q ss_pred CCCCCccc------ccCcCCcEEEeecCccC
Q 005278 243 NGSLPSNI------QNLKVLTNLDLSRNQLS 267 (704)
Q Consensus 243 ~~~~~~~~------~~l~~L~~L~l~~n~l~ 267 (704)
+......| ...++|+.|+|++|++.
T Consensus 255 ~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 85443333 23455666666666553
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.7e-26 Score=231.76 Aligned_cols=268 Identities=25% Similarity=0.302 Sum_probs=176.8
Q ss_pred EEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcE
Q 005278 10 YLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTV 89 (704)
Q Consensus 10 ~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~ 89 (704)
.++.+++.++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.... +..+..+..
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~-------~~~~~~~~~ 84 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA-------FTGLALLEQ 84 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT-------TTTCTTCCE
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccc-------ccccccccc
Confidence 4566666666 5565543 45677777777777666667777777777777777776655443 555556666
Q ss_pred EEccC-CCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCc
Q 005278 90 LGLAS-NPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGN 168 (704)
Q Consensus 90 L~L~~-n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 168 (704)
++... |.++ ...+..+.++++|++|++++|.+....+..+...++|+.+++++|
T Consensus 85 l~~~~~~~~~-------------------------~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N 139 (284)
T d1ozna_ 85 LDLSDNAQLR-------------------------SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN 139 (284)
T ss_dssp EECCSCTTCC-------------------------CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cccccccccc-------------------------cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccc
Confidence 55442 3333 344556677777788888877777666667777777888888888
Q ss_pred ccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCc
Q 005278 169 KLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPS 248 (704)
Q Consensus 169 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 248 (704)
+|++..+..|..+++|++|++++|++++..+..|.++++|+.+++++|++++..|..|..+++|++|++++|.+.+..+.
T Consensus 140 ~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~ 219 (284)
T d1ozna_ 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219 (284)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHH
T ss_pred cccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccc
Confidence 87765566777777788888888877766667777777788888777777777777777777777777777777766666
Q ss_pred ccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCC
Q 005278 249 NIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 249 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 316 (704)
.|.++++|+.|++++|++...-+ ...-...++.+....+++....|..+.+ +...+++.+.|+|
T Consensus 220 ~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 220 ALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp HHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred ccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 77777777777777777764221 1111123555555666666666665543 2333455555544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.6e-25 Score=221.99 Aligned_cols=198 Identities=23% Similarity=0.229 Sum_probs=124.6
Q ss_pred cCChhhhcCCCCCEEEcc-CCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCcccc
Q 005278 125 NIPQEIGNLSGMIVFDLN-GCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLA 203 (704)
Q Consensus 125 ~~~~~~~~l~~L~~L~L~-~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~ 203 (704)
..+..+.++..++.++.. .|.++...+..|.++++|++|++++|.+....+..+..+++|+.+++++|.+++..+..|.
T Consensus 71 i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~ 150 (284)
T d1ozna_ 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhc
Confidence 344445555666666554 4455555566677777777777777776655555666667777777777777655556666
Q ss_pred CcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCccee
Q 005278 204 SLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETL 283 (704)
Q Consensus 204 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 283 (704)
.+++|+.|++++|++++..+..|.++++|+.+++++|.+.+..|..|..+++|+.|++++|++.+..+..|+.+++|+.|
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L 230 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEE
Confidence 66777777777777766666666677777777777777766666667777777777777777766666666667777777
Q ss_pred eccCceeeccCCcccccccccceEEecccCCCCCCCCCcc
Q 005278 284 SLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEIPKNFS 323 (704)
Q Consensus 284 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 323 (704)
++++|++.+.-+ ...-...++.+....+++.+..|..+.
T Consensus 231 ~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 231 RLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp ECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred EecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHc
Confidence 777776664322 111122344555555666555555443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.1e-23 Score=208.49 Aligned_cols=198 Identities=25% Similarity=0.257 Sum_probs=114.0
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNC 84 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l 84 (704)
...+.+.+.++++++ .+|..+. ++|++|+|++|.|+++.+.+|.++++|++|+|++|+|+.++. +..+
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~---------~~~l 76 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV---------DGTL 76 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC---------CSCC
T ss_pred cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc---------cccc
Confidence 445566677777777 5666553 467778888887777777777777777777777777765432 4556
Q ss_pred CCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeee
Q 005278 85 RNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLY 164 (704)
Q Consensus 85 ~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 164 (704)
++|++|+|++|++... +..+.++++|++|++++|.+....+..+..+.+++.|+
T Consensus 77 ~~L~~L~Ls~N~l~~~--------------------------~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~ 130 (266)
T d1p9ag_ 77 PVLGTLDLSHNQLQSL--------------------------PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (266)
T ss_dssp TTCCEEECCSSCCSSC--------------------------CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred cccccccccccccccc--------------------------ccccccccccccccccccccceeecccccccccccccc
Confidence 6777777777766521 22344455555555555555544444555555555555
Q ss_pred ccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcc
Q 005278 165 LHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241 (704)
Q Consensus 165 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 241 (704)
+++|.++...+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.
T Consensus 131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np 206 (266)
T d1p9ag_ 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (266)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred ccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCC
Confidence 5555555444444444555555555555555444444455555555555555554 334444444444444444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=8.3e-24 Score=209.54 Aligned_cols=203 Identities=23% Similarity=0.219 Sum_probs=110.0
Q ss_pred CCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcC
Q 005278 82 TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQ 161 (704)
Q Consensus 82 ~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 161 (704)
.+...+.+++.++++++. +|..+ ++++++|+|++|++++..+..|.++++|++|+|++|.|+.
T Consensus 7 ~~~~~~~~v~C~~~~L~~-iP~~l---p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~------------- 69 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLTA-LPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK------------- 69 (266)
T ss_dssp ECSTTCCEEECTTSCCSS-CCSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-------------
T ss_pred cccCCCeEEEccCCCCCe-eCcCc---CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-------------
Confidence 344566667777777773 44332 2345555555555554444445555555555555555442
Q ss_pred eeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecCcc
Q 005278 162 GLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSANS 241 (704)
Q Consensus 162 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 241 (704)
++ .++.+++|++|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.
T Consensus 70 ------------l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~ 135 (266)
T d1p9ag_ 70 ------------LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (266)
T ss_dssp ------------EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred ------------cc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccc
Confidence 21 2334445555555555544 233344455555555555555554444455555555555555555
Q ss_pred cCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCC
Q 005278 242 LNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 242 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 316 (704)
+....+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.+
T Consensus 136 l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 55444455555555666666666666555555666666666666666666 556555566666666666666653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=8e-23 Score=191.30 Aligned_cols=169 Identities=18% Similarity=0.155 Sum_probs=119.5
Q ss_pred CccccccccCceEEEEEEECCCCEEEEEEeeccch------------------hhhHHHHHHHHHHHhcCCCCCceEEee
Q 005278 418 NECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLE------------------RASRSFDSECEILRSIRHRNLIKIISN 479 (704)
Q Consensus 418 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~ 479 (704)
.+.++||+|+||+||+|+..+|+.||||+++.... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35679999999999999988999999998753210 112345678899999999999998876
Q ss_pred eeeCCeEEEEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeee
Q 005278 480 CCNIDFKALVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHGHSTPMVHCDLKPNNILLDENMTAHVSDF 559 (704)
Q Consensus 480 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~h~~~ivH~dlk~~Nil~~~~~~~kl~Df 559 (704)
.. .+++|||++++.+.+ ++......++.|++.+++||| +.+|+||||||+||+++++ .++++||
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence 32 379999998865543 333445679999999999995 4789999999999999965 5899999
Q ss_pred ccceecCCCCCcceeccccccccccCCcccCCCCCCcccceeeHHHHH
Q 005278 560 GISKLLGEGDDSVIQTMTIATIGYMAPEYGSEGIISPKSDVYSYGILL 607 (704)
Q Consensus 560 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l 607 (704)
|.|.............. .... -.+. ..+.|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHHHHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 99987643221100000 0000 0011 135677889999975443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=3.8e-18 Score=175.89 Aligned_cols=270 Identities=26% Similarity=0.286 Sum_probs=173.3
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
.+++.|||++|.++ .+|+. .++|++|+|++|+|+.+ |.. +.+|+.|++++|+++.++. + .+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~---~~~L~~L~l~~n~l~~l~~---------l--p~ 98 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PEL---PQSLKSLLVDNNNLKALSD---------L--PP 98 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCC---CTTCCEEECCSSCCSCCCS---------C--CT
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccc-ccc---hhhhhhhhhhhcccchhhh---------h--cc
Confidence 36889999999998 67864 57899999999999954 554 4678999999999887542 1 14
Q ss_pred CCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeec
Q 005278 86 NLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYL 165 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 165 (704)
.|++|++++|.+... |. +..+ .+|++|++.+|.+..... ....+..+.+.++... ....+..++.++.+++
T Consensus 99 ~L~~L~L~~n~l~~l-p~-~~~l-~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l 169 (353)
T d1jl5a_ 99 LLEYLGVSNNQLEKL-PE-LQNS-SFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYA 169 (353)
T ss_dssp TCCEEECCSSCCSSC-CC-CTTC-TTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEEC
T ss_pred ccccccccccccccc-cc-hhhh-ccceeecccccccccccc----ccccccchhhcccccc--ccccccccccceeccc
Confidence 699999999999844 43 4444 479999999998874322 2344555555544433 2234455556666666
Q ss_pred cCcccCCC------------------CCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCccc
Q 005278 166 HGNKLQGS------------------IPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFG 227 (704)
Q Consensus 166 ~~n~l~~~------------------~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 227 (704)
+.|.+... ....+..++.|+.+++++|... ..+. ...++..+.+.+|.+... +..
T Consensus 170 ~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~~-~~~-- 242 (353)
T d1jl5a_ 170 DNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDL-PEL-- 242 (353)
T ss_dssp CSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSCC-CCC--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc-cccc---cccccccccccccccccc-ccc--
Confidence 65554421 1123445667777777777665 2332 234566666666665521 111
Q ss_pred CCccccEEEecCcccCC----------------CCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 228 SLEYVLYINLSANSLNG----------------SLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 228 ~l~~L~~L~l~~N~l~~----------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
...+...++..|.+.+ .++.....+++|++|++++|+++ .+|.. +++|+.|+|++|+|+
T Consensus 243 -~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~ 317 (353)
T d1jl5a_ 243 -PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA 317 (353)
T ss_dssp -CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred -cccccccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC
Confidence 1223333333322220 11112233578999999999998 66643 678899999999998
Q ss_pred ccCCcccccccccceEEecccCCCCCCCC
Q 005278 292 GPVPKSFGSLISLESLDLSRNNLSGEIPK 320 (704)
Q Consensus 292 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 320 (704)
.+|.. +++|+.|++++|+++ .+|.
T Consensus 318 -~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 318 -EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp -CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred -ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 56653 457899999999987 4554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=1.8e-19 Score=173.44 Aligned_cols=84 Identities=27% Similarity=0.399 Sum_probs=35.0
Q ss_pred hhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCC
Q 005278 130 IGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLR 209 (704)
Q Consensus 130 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 209 (704)
+.++++|+.+++++|...+. ..+...+.++.+.++++.+... ..+..+++|++|++++|.+++. ..+.++++|+
T Consensus 103 l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~ 176 (227)
T d1h6ua2 103 IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLT 176 (227)
T ss_dssp GTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCC
T ss_pred cccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccce
Confidence 33444455555544444321 1233344444444444444321 1233444444444444444321 1134444444
Q ss_pred EEEecCccCC
Q 005278 210 RLHLGSNKLT 219 (704)
Q Consensus 210 ~L~l~~n~l~ 219 (704)
.|++++|+++
T Consensus 177 ~L~Ls~n~l~ 186 (227)
T d1h6ua2 177 TLKADDNKIS 186 (227)
T ss_dssp EEECCSSCCC
T ss_pred ecccCCCccC
Confidence 4444444443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=6.6e-19 Score=169.48 Aligned_cols=205 Identities=20% Similarity=0.296 Sum_probs=163.6
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCc
Q 005278 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLT 88 (704)
Q Consensus 9 ~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~ 88 (704)
..++++++++++.+ .+..+.+|++|++.+|.|+++ ..|.++++|++|++++|.++.... +..+++|+
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~---------l~~l~~l~ 88 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP---------LKNLTKIT 88 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG---------GTTCCSCC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc---------cccccccc
Confidence 34567778888654 467889999999999999865 358899999999999998876542 78889999
Q ss_pred EEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCc
Q 005278 89 VLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGN 168 (704)
Q Consensus 89 ~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 168 (704)
++++++|.++.. ..+..+ ++|+.+.+++|...+. ..+...+.+..+.++++.+... ..+..+++|+.|++++|
T Consensus 89 ~l~~~~n~~~~i--~~l~~l-~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n 161 (227)
T d1h6ua2 89 ELELSGNPLKNV--SAIAGL-QSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNA 161 (227)
T ss_dssp EEECCSCCCSCC--GGGTTC-TTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSS
T ss_pred cccccccccccc--cccccc-cccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccccc
Confidence 999999988743 345555 4799999998887643 3467788999999999888743 34778899999999999
Q ss_pred ccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEecC
Q 005278 169 KLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLSA 239 (704)
Q Consensus 169 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 239 (704)
.+++. ..+.++++|++|+|++|++++ ++ .+.++++|+.|++++|++++.. .+.++++|+.|++++
T Consensus 162 ~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 162 QVSDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp CCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred ccccc--hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 98743 348889999999999999985 33 3888999999999999998543 488999999999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=6e-19 Score=171.74 Aligned_cols=218 Identities=15% Similarity=0.157 Sum_probs=132.6
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCc-ccchhhcccccCCCCCCC
Q 005278 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTE-SSAAKWNFLSSLTNCRNL 87 (704)
Q Consensus 9 ~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~~~~~~~~l~~L 87 (704)
+.++.++++++ .+|..+. +++++|+|++|.|+.+.+.+|.++++|++|+|++|.+... +.. .|.+++++
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~-------~f~~l~~l 80 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD-------VFSNLPKL 80 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSS-------SEESCTTC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecc-------cccccccc
Confidence 56777777777 5665543 4678888888888777777778888888888888776552 222 26667777
Q ss_pred cEEEccC-CCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccC-hhhcCCCCcCeeec
Q 005278 88 TVLGLAS-NPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIP-TAVGRLRRLQGLYL 165 (704)
Q Consensus 88 ~~L~L~~-n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L 165 (704)
++|++.. |++.. ..+..|.++++|++|++++|.+....+ ..+..+..+..+..
T Consensus 81 ~~l~~~~~n~l~~-------------------------~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~ 135 (242)
T d1xwdc1 81 HEIRIEKANNLLY-------------------------INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135 (242)
T ss_dssp CEEEEECCTTCCE-------------------------ECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEE
T ss_pred ccccccccccccc-------------------------cccccccccccccccccchhhhcccccccccccccccccccc
Confidence 7776653 44443 344455666666666666666653322 22334455555555
Q ss_pred cCcccCCCCCccccCCC-CCCEEEcCCCcCCccCCccccCcCCCCEE-EecCccCCCCCCCcccCCccccEEEecCcccC
Q 005278 166 HGNKLQGSIPYDLCHLE-GLSELNLNGNKLCGHVPPCLASLTSLRRL-HLGSNKLTSTMPSSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 166 ~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 243 (704)
+++.+....+..+.+++ .++.|++++|+++...+. ..+.++++.+ ++++|.++...+..|.++++|++|++++|+++
T Consensus 136 ~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~-~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNC-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp SCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTT-TTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred cccccccccccccccccccceeeecccccccccccc-cccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC
Confidence 66666644445555543 566677777777633333 3334454444 34566676555556677777777777777777
Q ss_pred CCCCcccccCcCCcEEEee
Q 005278 244 GSLPSNIQNLKVLTNLDLS 262 (704)
Q Consensus 244 ~~~~~~~~~l~~L~~L~l~ 262 (704)
...+..|.++++|+.|++.
T Consensus 215 ~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 215 SLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CCCSSSCTTCCEEESSSEE
T ss_pred ccCHHHHcCCcccccCcCC
Confidence 5545556666666655553
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=8.6e-19 Score=170.62 Aligned_cols=183 Identities=15% Similarity=0.097 Sum_probs=117.0
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccc-cCchhhcCCCCCCEEeccc-ccCCCcccchhhcccccCC
Q 005278 5 LPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSG-LIPNTFGNLGSLQVLSLAY-NYLMTESSAAKWNFLSSLT 82 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~~~~~~~ 82 (704)
++++++|+|++|.|+.+.+.+|.++++|++|+|++|.+.. +.+.+|.+++++++|++.+ |.+....... |.
T Consensus 28 ~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~-------~~ 100 (242)
T d1xwdc1 28 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEA-------FQ 100 (242)
T ss_dssp CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTS-------EE
T ss_pred CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccc-------cc
Confidence 3589999999999997666789999999999999999875 5567899999999999865 6676665544 89
Q ss_pred CCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCC-CCCEEEccCCcCccccChhhcCCCCcC
Q 005278 83 NCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLS-GMIVFDLNGCDLNGTIPTAVGRLRRLQ 161 (704)
Q Consensus 83 ~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~ 161 (704)
++++|++|++++|++....+..+....+.+..+...++.+....+..+.+++ .++.|++++|+++.+.+..|. .++++
T Consensus 101 ~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~ 179 (242)
T d1xwdc1 101 NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLD 179 (242)
T ss_dssp CCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEE
T ss_pred ccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccccc-chhhh
Confidence 9999999999999998554433333223444445555555544444444443 455555555555533332222 22322
Q ss_pred e-eeccCcccCCCCCccccCCCCCCEEEcCCCcCC
Q 005278 162 G-LYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLC 195 (704)
Q Consensus 162 ~-L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 195 (704)
+ +++++|+++...+..|.++++|++|+|++|+|+
T Consensus 180 ~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 180 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp EEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred ccccccccccccccHHHhcCCCCCCEEECCCCcCC
Confidence 2 234444454322333444455555555555544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=2e-18 Score=163.58 Aligned_cols=53 Identities=19% Similarity=0.209 Sum_probs=25.3
Q ss_pred EeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCc
Q 005278 35 LDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLR 98 (704)
Q Consensus 35 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~ 98 (704)
.++..+.+++.++. ..+.+|++|++++|.+..+. .+..+++|++|+|++|+|+
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~---------~l~~l~~L~~L~L~~n~i~ 81 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ---------GIQYLPNVTKLFLNGNKLT 81 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT---------TGGGCTTCCEEECCSSCCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch---------hHhhCCCCCEEeCCCcccc
Confidence 34444444443322 23445555555555554432 1444555555555555554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.77 E-value=4.3e-17 Score=167.83 Aligned_cols=262 Identities=25% Similarity=0.286 Sum_probs=182.7
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCC-CCCCEEecccccCCCcccchhhcccccC
Q 005278 3 YMLPNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNL-GSLQVLSLAYNYLMTESSAAKWNFLSSL 81 (704)
Q Consensus 3 ~~l~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~~~~~~ 81 (704)
.-+++|++|+|++|+|+ .+|.. ..+|++|++++|.++.+. .+ +.|++|++++|.+..++. +
T Consensus 55 ~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~-----~lp~~L~~L~L~~n~l~~lp~---------~ 116 (353)
T d1jl5a_ 55 ELPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALS-----DLPPLLEYLGVSNNQLEKLPE---------L 116 (353)
T ss_dssp SCCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC-----SCCTTCCEEECCSSCCSSCCC---------C
T ss_pred CCCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhh-----hhccccccccccccccccccc---------h
Confidence 34689999999999999 67865 468999999999999542 23 469999999999987642 6
Q ss_pred CCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccc------------
Q 005278 82 TNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGT------------ 149 (704)
Q Consensus 82 ~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------------ 149 (704)
..+++|++|++++|.+..... . ...+..+.+..+... ....+..++.++.|++++|.+...
T Consensus 117 ~~l~~L~~L~l~~~~~~~~~~-~----~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~ 189 (353)
T d1jl5a_ 117 QNSSFLKIIDVDNNSLKKLPD-L----PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVA 189 (353)
T ss_dssp TTCTTCCEEECCSSCCSCCCC-C----CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEEC
T ss_pred hhhccceeecccccccccccc-c----cccccchhhcccccc--ccccccccccceeccccccccccccccccccccccc
Confidence 789999999999999874432 2 234666766665543 334566777788888877765421
Q ss_pred ------cChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCC---
Q 005278 150 ------IPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTS--- 220 (704)
Q Consensus 150 ------~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--- 220 (704)
....+..++.|+.+++++|... ..+. ...++..+.+.+|.+... +.. ..++...++..|.+.+
T Consensus 190 ~~~~~~~~~~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~~-~~~---~~~l~~~~~~~~~~~~l~~ 261 (353)
T d1jl5a_ 190 GNNILEELPELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDL-PEL---PQSLTFLDVSENIFSGLSE 261 (353)
T ss_dssp CSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSEESC
T ss_pred cccccccccccccccccccccccccccc-cccc---cccccccccccccccccc-ccc---ccccccccccccccccccc
Confidence 1123456788999999999877 3443 345688888888887632 221 1233333333332221
Q ss_pred -------------CCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccC
Q 005278 221 -------------TMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLAD 287 (704)
Q Consensus 221 -------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 287 (704)
.+......+++|++|++++|+++ .+|.. +++|+.|++++|+|+ .+|.. +++|+.|++++
T Consensus 262 l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~ 333 (353)
T d1jl5a_ 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEY 333 (353)
T ss_dssp CCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCS
T ss_pred ccchhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcC
Confidence 01112234578999999999998 56643 578999999999998 67753 56899999999
Q ss_pred ceeeccCCcccccccccceEEe
Q 005278 288 NQFQGPVPKSFGSLISLESLDL 309 (704)
Q Consensus 288 n~l~~~~p~~~~~l~~L~~L~l 309 (704)
|+++ .+|.... +|+.|.+
T Consensus 334 N~L~-~lp~~~~---~L~~L~~ 351 (353)
T d1jl5a_ 334 NPLR-EFPDIPE---SVEDLRM 351 (353)
T ss_dssp SCCS-SCCCCCT---TCCEEEC
T ss_pred CcCC-CCCcccc---ccCeeEC
Confidence 9998 6776433 4555554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=4.5e-19 Score=165.61 Aligned_cols=174 Identities=24% Similarity=0.302 Sum_probs=95.6
Q ss_pred CEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCC-CccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecC
Q 005278 137 IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSI-PYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGS 215 (704)
Q Consensus 137 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 215 (704)
++++.++++++ .+|..+. +++++|+|++|+|+..+ +..|.++++|++|+|++|.+....+..+..+++|+.|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 34555555555 3443332 45566666666665322 33455566666666666666655555566666666666666
Q ss_pred ccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCC
Q 005278 216 NKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVP 295 (704)
Q Consensus 216 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 295 (704)
|+|+++.+..|.++++|++|+|++|.|++..+..|..+++|++|+|++|++..... ...-...++.+.+..|.++...|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCC
Confidence 66665555556666666666666666665555556666666666666666653221 11111234555566666665555
Q ss_pred cccccccccceEEecccCCCCC
Q 005278 296 KSFGSLISLESLDLSRNNLSGE 317 (704)
Q Consensus 296 ~~~~~l~~L~~L~l~~N~l~~~ 317 (704)
..+ ..++.++|+.|.|.+.
T Consensus 167 ~~l---~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 167 SKV---RDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTT---TTSBGGGSCTTTCCCC
T ss_pred hhh---cCCEeeecCHhhCcCC
Confidence 443 3345566666666543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=3.2e-18 Score=162.15 Aligned_cols=166 Identities=27% Similarity=0.393 Sum_probs=113.6
Q ss_pred cCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEE
Q 005278 132 NLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRL 211 (704)
Q Consensus 132 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 211 (704)
.+.+|++|++++|.+... + .+..+++|++|+|++|+|++. + .++.+++|++|++++|++++ ++ .+..+++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccccccc
Confidence 455667777777776633 2 366677777777777777643 2 35667777777777777763 33 46667777777
Q ss_pred EecCccCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceee
Q 005278 212 HLGSNKLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 212 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
++++|.+.. ...+..+++++.+++++|.+++ +..+..+++|+.+++++|++++ ++ .++++++|+.|+|++|+++
T Consensus 118 ~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 118 SLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp ECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred ccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC
Confidence 777777653 2356677777777777777763 3356677778888888888874 33 3777888888888888887
Q ss_pred ccCCcccccccccceEEecc
Q 005278 292 GPVPKSFGSLISLESLDLSR 311 (704)
Q Consensus 292 ~~~p~~~~~l~~L~~L~l~~ 311 (704)
+ +| .+..+++|++|+|++
T Consensus 192 ~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 D-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp B-CG-GGTTCTTCSEEEEEE
T ss_pred C-Ch-hhcCCCCCCEEEccC
Confidence 3 44 577888888888764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=9.4e-18 Score=157.44 Aligned_cols=58 Identities=14% Similarity=0.169 Sum_probs=30.0
Q ss_pred CCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCc
Q 005278 30 SKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLR 98 (704)
Q Consensus 30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~ 98 (704)
.++..+.++.+.+++..+ ...+.+|++|++++|.|.++. .+..+++|++|+|++|+++
T Consensus 18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l~---------~l~~l~nL~~L~Ls~N~l~ 75 (199)
T d2omxa2 18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSID---------GVEYLNNLTQINFSNNQLT 75 (199)
T ss_dssp HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCCT---------TGGGCTTCCEEECCSSCCC
T ss_pred HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCcc---------ccccCCCcCcCcccccccc
Confidence 333444555555554332 234555666666666655432 1445556666666666555
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=1.8e-17 Score=155.44 Aligned_cols=178 Identities=22% Similarity=0.315 Sum_probs=118.2
Q ss_pred EEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcE
Q 005278 10 YLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTV 89 (704)
Q Consensus 10 ~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~ 89 (704)
.+.++++.+++.++ ...++++++|++++|.++.+ ..++.+++|++|++++|+++.... +.++++|++
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~---------l~~l~~L~~ 88 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP---------LKNLTKLVD 88 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG---------GTTCTTCCE
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc---------ccCCccccc
Confidence 34677788876554 46789999999999999965 358899999999999999987542 788999999
Q ss_pred EEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhhcCCCCcCeeeccCcc
Q 005278 90 LGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNK 169 (704)
Q Consensus 90 L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 169 (704)
|++++|.+.... .++++++|++|++++|.+... ..+..+++|+.|++++|+
T Consensus 89 L~l~~n~~~~~~---------------------------~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~ 139 (199)
T d2omxa2 89 ILMNNNQIADIT---------------------------PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNT 139 (199)
T ss_dssp EECCSSCCCCCG---------------------------GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSC
T ss_pred cccccccccccc---------------------------ccccccccccccccccccccc--cccchhhhhHHhhhhhhh
Confidence 999999887331 244555566666665555432 235556666666666666
Q ss_pred cCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEE
Q 005278 170 LQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYI 235 (704)
Q Consensus 170 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 235 (704)
++. + ..+..+++|++|++++|++++. + .+.++++|+.|++++|++++. +.++.+++|+.|
T Consensus 140 l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 140 ISD-I-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp CCC-C-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred hcc-c-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 652 2 2455566666666666666532 2 355666666666666666532 245556666554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=2e-20 Score=200.70 Aligned_cols=163 Identities=24% Similarity=0.199 Sum_probs=107.8
Q ss_pred hcCCCCcCeeeccCcccCCC-----CCccccCCCCCCEEEcCCCcCCccC----CccccCcCCCCEEEecCccCCCCCCC
Q 005278 154 VGRLRRLQGLYLHGNKLQGS-----IPYDLCHLEGLSELNLNGNKLCGHV----PPCLASLTSLRRLHLGSNKLTSTMPS 224 (704)
Q Consensus 154 ~~~l~~L~~L~L~~n~l~~~-----~~~~l~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~ 224 (704)
+...+.++.+++++|.+... .........+++.|++++|.+.... ...+...+.++.+++++|.++.....
T Consensus 222 l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~ 301 (460)
T d1z7xw1 222 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 301 (460)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred ccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 44567888888888876421 2233445678888999988876332 23345667888888888887632211
Q ss_pred cc-----cCCccccEEEecCcccCCCCCccc----ccCcCCcEEEeecCccCCC----CCCCcC-CCCCcceeeccCcee
Q 005278 225 SF-----GSLEYVLYINLSANSLNGSLPSNI----QNLKVLTNLDLSRNQLSGD----IPTTIG-GLENLETLSLADNQF 290 (704)
Q Consensus 225 ~~-----~~l~~L~~L~l~~N~l~~~~~~~~----~~l~~L~~L~l~~n~l~~~----~~~~~~-~l~~L~~L~L~~n~l 290 (704)
.+ .....|+.+++++|.+.......+ ...++|++|+|++|+++.. ++..+. ..+.|+.|+|++|.|
T Consensus 302 ~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i 381 (460)
T d1z7xw1 302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 381 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred hhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence 11 234578888888888775433333 3456788888888888642 222332 356788888888888
Q ss_pred ecc----CCcccccccccceEEecccCCCC
Q 005278 291 QGP----VPKSFGSLISLESLDLSRNNLSG 316 (704)
Q Consensus 291 ~~~----~p~~~~~l~~L~~L~l~~N~l~~ 316 (704)
++. +++.+..+++|++|++++|+++.
T Consensus 382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 382 SDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 753 34455667888888888888864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=4.6e-18 Score=158.60 Aligned_cols=163 Identities=25% Similarity=0.255 Sum_probs=136.9
Q ss_pred cCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccC-CccccCcCCCCEEEecCccCCCCCCCcccCCccccEEEec
Q 005278 160 LQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHV-PPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYINLS 238 (704)
Q Consensus 160 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 238 (704)
.+.++.++++++ .+|..+. +++++|+|++|+|++.+ +..|..+++|+.|++++|.+....+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 357899999999 6787764 68999999999998644 5678899999999999999999999999999999999999
Q ss_pred CcccCCCCCcccccCcCCcEEEeecCccCCCCCCCcCCCCCcceeeccCceeeccCCcccccccccceEEecccCCCCCC
Q 005278 239 ANSLNGSLPSNIQNLKVLTNLDLSRNQLSGDIPTTIGGLENLETLSLADNQFQGPVPKSFGSLISLESLDLSRNNLSGEI 318 (704)
Q Consensus 239 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 318 (704)
+|++....+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+..... ...-...++.+.+..|.+.+..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCC
Confidence 999998888899999999999999999998888889999999999999999985332 2222334677778888888888
Q ss_pred CCCccccc
Q 005278 319 PKNFSAQS 326 (704)
Q Consensus 319 p~~~~~~~ 326 (704)
|..+....
T Consensus 166 p~~l~~~~ 173 (192)
T d1w8aa_ 166 PSKVRDVQ 173 (192)
T ss_dssp STTTTTSB
T ss_pred ChhhcCCE
Confidence 87665544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=4.8e-20 Score=197.65 Aligned_cols=328 Identities=17% Similarity=0.129 Sum_probs=168.3
Q ss_pred CCCEEecCCCcCcccC-CccccCCCCCCEEeccCcccccc----CchhhcCCCCCCEEecccccCCCcccchhhcccccC
Q 005278 7 NLKYLTLFDNKLSGTI-PNSITNASKLIMLDLSSNSFSGL----IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSL 81 (704)
Q Consensus 7 ~l~~L~l~~~~i~~~~-~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~ 81 (704)
+|+.|||++|++++.. ..-+..+++++.|+|++|.+++. ++.++..+++|++|||++|.|+..+... +...+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~---l~~~l 79 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHC---VLQGL 79 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHH---HHHTT
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHH---HHHHH
Confidence 4566666666666321 22344566666666666666632 2334556666666666666665432221 22222
Q ss_pred C-CCCCCcEEEccCCCCcccCChhhhh---cccccceEEecCCcccccCC------------------------------
Q 005278 82 T-NCRNLTVLGLASNPLRGILPPLIGN---FSASLQEFYAYGCKLRGNIP------------------------------ 127 (704)
Q Consensus 82 ~-~l~~L~~L~L~~n~i~~~~~~~~~~---~~~~L~~L~l~~n~l~~~~~------------------------------ 127 (704)
. ...+|++|+|++|++++.....++. -.++|++|++++|.+.....
T Consensus 80 ~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 159 (460)
T d1z7xw1 80 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 159 (460)
T ss_dssp CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred hcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhc
Confidence 2 2335666666666665443322222 12356666666666542111
Q ss_pred ---hhhhcCCCCCEEEccCCcCcccc----Chhh-cCCCCcCeeeccCcccCCCC----CccccCCCCCCEEEcCCCcCC
Q 005278 128 ---QEIGNLSGMIVFDLNGCDLNGTI----PTAV-GRLRRLQGLYLHGNKLQGSI----PYDLCHLEGLSELNLNGNKLC 195 (704)
Q Consensus 128 ---~~~~~l~~L~~L~L~~n~l~~~~----~~~~-~~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~ 195 (704)
..+.....++.++++++...... ...+ ..-.....+++..+.+.... ...+...+.++.+++++|.+.
T Consensus 160 ~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~ 239 (460)
T d1z7xw1 160 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 239 (460)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccc
Confidence 11223345555665555543111 0111 11233445555555544211 122334567777888777764
Q ss_pred c-----cCCccccCcCCCCEEEecCccCCCCC----CCcccCCccccEEEecCcccCCCCCccc-----ccCcCCcEEEe
Q 005278 196 G-----HVPPCLASLTSLRRLHLGSNKLTSTM----PSSFGSLEYVLYINLSANSLNGSLPSNI-----QNLKVLTNLDL 261 (704)
Q Consensus 196 ~-----~~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~l 261 (704)
. ...........|+.+++++|.+.... ...+...+.++.+++++|.+.......+ .....|+.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l 319 (460)
T d1z7xw1 240 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 319 (460)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred ccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccc
Confidence 2 12233444567777888877765321 1223456677777887777653222211 12346777888
Q ss_pred ecCccCCCCCCC----cCCCCCcceeeccCceeeccC----Ccccc-cccccceEEecccCCCCC----CCCCccccccc
Q 005278 262 SRNQLSGDIPTT----IGGLENLETLSLADNQFQGPV----PKSFG-SLISLESLDLSRNNLSGE----IPKNFSAQSFL 328 (704)
Q Consensus 262 ~~n~l~~~~~~~----~~~l~~L~~L~L~~n~l~~~~----p~~~~-~l~~L~~L~l~~N~l~~~----~p~~~~~~~~l 328 (704)
++|.++...... +...++|+.|+|++|++++.. +..+. ..+.|++|+|++|+++.. ++..+...+.+
T Consensus 320 ~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L 399 (460)
T d1z7xw1 320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 399 (460)
T ss_dssp TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred cccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCC
Confidence 877776433222 234557788888888776432 22232 345677888888877632 11222333445
Q ss_pred CcccccCCC
Q 005278 329 SNYALCGPA 337 (704)
Q Consensus 329 ~~~~l~g~~ 337 (704)
....+.+++
T Consensus 400 ~~L~Ls~N~ 408 (460)
T d1z7xw1 400 RELDLSNNC 408 (460)
T ss_dssp CEEECCSSS
T ss_pred CEEECCCCc
Confidence 555555543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.64 E-value=5.5e-18 Score=174.11 Aligned_cols=256 Identities=14% Similarity=0.136 Sum_probs=133.0
Q ss_pred cCCccccCCCCCCEEeccCccccccC----chhhcCCCCCCEEecccccCCCccc---chhhcccccCCCCCCCcEEEcc
Q 005278 21 TIPNSITNASKLIMLDLSSNSFSGLI----PNTFGNLGSLQVLSLAYNYLMTESS---AAKWNFLSSLTNCRNLTVLGLA 93 (704)
Q Consensus 21 ~~~~~~~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~n~i~~~~~---~~~~~~~~~~~~l~~L~~L~L~ 93 (704)
.+...+.+...|++|+|++|.|.... ...+...++|+.|+++++....... .....+.+.+..+++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 34556677777888888887776432 3345566777777777665443221 1111234445566777777777
Q ss_pred CCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccccChhh-------------cCCCCc
Q 005278 94 SNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGTIPTAV-------------GRLRRL 160 (704)
Q Consensus 94 ~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------~~l~~L 160 (704)
+|.+.......+. ..+..+++|++|++++|.+.......+ ...+.|
T Consensus 102 ~n~i~~~~~~~l~---------------------~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L 160 (344)
T d2ca6a1 102 DNAFGPTAQEPLI---------------------DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL 160 (344)
T ss_dssp SCCCCTTTHHHHH---------------------HHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred ccccccccccchh---------------------hhhcccccchheecccccccccccccccccccccccccccccCccc
Confidence 7766643222222 245566778888888887653211111 223445
Q ss_pred CeeeccCcccCCCC----CccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCCccccEEE
Q 005278 161 QGLYLHGNKLQGSI----PYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSLEYVLYIN 236 (704)
Q Consensus 161 ~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 236 (704)
+.+++++|+++... ...+...++|++|+|++|.++..... ..+...+..+++|+.|+
T Consensus 161 ~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~-------------------~~l~~~l~~~~~L~~L~ 221 (344)
T d2ca6a1 161 RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE-------------------HLLLEGLAYCQELKVLD 221 (344)
T ss_dssp CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHH-------------------HHHHTTGGGCTTCCEEE
T ss_pred ceeecccccccccccccccchhhhhhhhcccccccccccccccc-------------------cchhhhhcchhhhcccc
Confidence 55555555544211 11222334455555555544421000 00122334445555555
Q ss_pred ecCcccCCC----CCcccccCcCCcEEEeecCccCCCCCCC----cC--CCCCcceeeccCceeeccC----Ccccc-cc
Q 005278 237 LSANSLNGS----LPSNIQNLKVLTNLDLSRNQLSGDIPTT----IG--GLENLETLSLADNQFQGPV----PKSFG-SL 301 (704)
Q Consensus 237 l~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~----~~--~l~~L~~L~L~~n~l~~~~----p~~~~-~l 301 (704)
+++|.++.. +...+..+++|+.|+|++|.|++..... +. ..+.|++|++++|+++... ...+. ++
T Consensus 222 Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~ 301 (344)
T d2ca6a1 222 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301 (344)
T ss_dssp CCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHC
T ss_pred cccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccC
Confidence 555554321 2233445556666666666665322221 21 2356777777777776422 22232 45
Q ss_pred cccceEEecccCCCC
Q 005278 302 ISLESLDLSRNNLSG 316 (704)
Q Consensus 302 ~~L~~L~l~~N~l~~ 316 (704)
++|+.|++++|++..
T Consensus 302 ~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 302 PDLLFLELNGNRFSE 316 (344)
T ss_dssp TTCCEEECTTSBSCT
T ss_pred CCCCEEECCCCcCCC
Confidence 678888888888753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.63 E-value=1.8e-17 Score=170.09 Aligned_cols=201 Identities=18% Similarity=0.165 Sum_probs=137.0
Q ss_pred CCCCCEEecCCCcCcc----cCCccccCCCCCCEEeccCcccccc----------CchhhcCCCCCCEEecccccCCCcc
Q 005278 5 LPNLKYLTLFDNKLSG----TIPNSITNASKLIMLDLSSNSFSGL----------IPNTFGNLGSLQVLSLAYNYLMTES 70 (704)
Q Consensus 5 l~~l~~L~l~~~~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~----------~~~~~~~l~~L~~L~L~~n~i~~~~ 70 (704)
.+.++.|+|++|.|+. .+...+...++|+.|+++++.+... ....+...++|++|+|++|.+....
T Consensus 30 ~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 109 (344)
T d2ca6a1 30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109 (344)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccc
Confidence 5789999999999864 3455678899999999998765522 2234667899999999999998765
Q ss_pred cchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccc-
Q 005278 71 SAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGT- 149 (704)
Q Consensus 71 ~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~- 149 (704)
... +...+..+++|++|++++|.+.......++.. +..+. ........+.|+.|++++|.+...
T Consensus 110 ~~~---l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~---l~~~~---------~~~~~~~~~~L~~l~l~~n~i~~~~ 174 (344)
T d2ca6a1 110 QEP---LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA---LQELA---------VNKKAKNAPPLRSIICGRNRLENGS 174 (344)
T ss_dssp HHH---HHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH---HHHHH---------HHHHHHTCCCCCEEECCSSCCTGGG
T ss_pred ccc---hhhhhcccccchheeccccccccccccccccc---ccccc---------cccccccCcccceeecccccccccc
Confidence 444 45556788999999999999875444333331 11110 111234556777788887777532
Q ss_pred ---cChhhcCCCCcCeeeccCcccCCC-----CCccccCCCCCCEEEcCCCcCCcc----CCccccCcCCCCEEEecCcc
Q 005278 150 ---IPTAVGRLRRLQGLYLHGNKLQGS-----IPYDLCHLEGLSELNLNGNKLCGH----VPPCLASLTSLRRLHLGSNK 217 (704)
Q Consensus 150 ---~~~~~~~l~~L~~L~L~~n~l~~~-----~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~ 217 (704)
+...+...++|++|+|++|+|+.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|.
T Consensus 175 ~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~ 254 (344)
T d2ca6a1 175 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 254 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCC
T ss_pred cccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCc
Confidence 233455667788888888877632 234466677888888888877632 33455667777777777777
Q ss_pred CCC
Q 005278 218 LTS 220 (704)
Q Consensus 218 l~~ 220 (704)
|++
T Consensus 255 i~~ 257 (344)
T d2ca6a1 255 LSA 257 (344)
T ss_dssp CCH
T ss_pred cCc
Confidence 764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=2.8e-16 Score=156.03 Aligned_cols=233 Identities=16% Similarity=0.153 Sum_probs=149.0
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeccCcccccc-CchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCC
Q 005278 8 LKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGL-IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRN 86 (704)
Q Consensus 8 l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~ 86 (704)
+..+.+.++.+...+ .......+|++|||++|.+++. ....+.++++|++|+|++|.+....... +..+++
T Consensus 25 ~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~-------l~~~~~ 96 (284)
T d2astb2 25 VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT-------LAKNSN 96 (284)
T ss_dssp CSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHH-------HTTCTT
T ss_pred ceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHH-------HhcCCC
Confidence 456666666655333 3344556788888888887743 3445677888888888888776544333 667788
Q ss_pred CcEEEccCC-CCcccCChhhhhcccccceEEecCCc-ccc-cCChhhhc-CCCCCEEEccCCc--Cccc-cChhhcCCCC
Q 005278 87 LTVLGLASN-PLRGILPPLIGNFSASLQEFYAYGCK-LRG-NIPQEIGN-LSGMIVFDLNGCD--LNGT-IPTAVGRLRR 159 (704)
Q Consensus 87 L~~L~L~~n-~i~~~~~~~~~~~~~~L~~L~l~~n~-l~~-~~~~~~~~-l~~L~~L~L~~n~--l~~~-~~~~~~~l~~ 159 (704)
|++|+|++| .+++..-..+....++|++|++++|. ++. .+...+.. .++|+.|+++++. ++.. +...+.++++
T Consensus 97 L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~ 176 (284)
T d2astb2 97 LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176 (284)
T ss_dssp CSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTT
T ss_pred CcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccc
Confidence 888888885 56544334444444678888888764 332 12233333 4678888888753 4322 2334456788
Q ss_pred cCeeeccCc-ccCCCCCccccCCCCCCEEEcCCC-cCCccCCccccCcCCCCEEEecCccCCCCC-CCcccCCccccEEE
Q 005278 160 LQGLYLHGN-KLQGSIPYDLCHLEGLSELNLNGN-KLCGHVPPCLASLTSLRRLHLGSNKLTSTM-PSSFGSLEYVLYIN 236 (704)
Q Consensus 160 L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~ 236 (704)
|++|++++| .+++.....+..+++|++|+|++| .+++.....++++++|+.|+++++ ++... ......+|+| .
T Consensus 177 L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~ 252 (284)
T d2astb2 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---Q 252 (284)
T ss_dssp CSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---E
T ss_pred ccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---c
Confidence 888888876 467666677888888888888885 577665666788888888888877 33211 1112234444 4
Q ss_pred ecCcccCCCCCccccc
Q 005278 237 LSANSLNGSLPSNIQN 252 (704)
Q Consensus 237 l~~N~l~~~~~~~~~~ 252 (704)
+..+.++...+..+++
T Consensus 253 i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 253 INCSHFTTIARPTIGN 268 (284)
T ss_dssp ESCCCSCCTTCSSCSS
T ss_pred ccCccCCCCCCCccCc
Confidence 5666776555555543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=7.3e-16 Score=152.91 Aligned_cols=256 Identities=16% Similarity=0.187 Sum_probs=181.0
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCc
Q 005278 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLT 88 (704)
Q Consensus 9 ~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~ 88 (704)
+.|||+++.+.......+.. ..+..+.+..+.+...... .....+|++||+++|.+..... ...+.++++|+
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l------~~l~~~c~~L~ 74 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL------HGILSQCSKLQ 74 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHH------HHHHTTBCCCS
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHH------HHHHHhCCCcc
Confidence 57899998886322222211 2456788887777644333 3456789999999998865432 23478899999
Q ss_pred EEEccCCCCcccCChhhhhcccccceEEecCC-ccccc-CChhhhcCCCCCEEEccCCc-Cccc-cChhhcC-CCCcCee
Q 005278 89 VLGLASNPLRGILPPLIGNFSASLQEFYAYGC-KLRGN-IPQEIGNLSGMIVFDLNGCD-LNGT-IPTAVGR-LRRLQGL 163 (704)
Q Consensus 89 ~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n-~l~~~-~~~~~~~l~~L~~L~L~~n~-l~~~-~~~~~~~-l~~L~~L 163 (704)
+|+|++|++.+..+..++.+ ++|++|++++| .++.. +...+.++++|++|++++|. ++.. ....+.. .++|+.|
T Consensus 75 ~L~L~~~~l~~~~~~~l~~~-~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L 153 (284)
T d2astb2 75 NLSLEGLRLSDPIVNTLAKN-SNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL 153 (284)
T ss_dssp EEECTTCBCCHHHHHHHTTC-TTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEE
T ss_pred cccccccCCCcHHHHHHhcC-CCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchh
Confidence 99999999998888888876 47999999996 45532 23335679999999999974 4422 2233433 4789999
Q ss_pred eccCcc--cCCC-CCccccCCCCCCEEEcCCC-cCCccCCccccCcCCCCEEEecCc-cCCCCCCCcccCCccccEEEec
Q 005278 164 YLHGNK--LQGS-IPYDLCHLEGLSELNLNGN-KLCGHVPPCLASLTSLRRLHLGSN-KLTSTMPSSFGSLEYVLYINLS 238 (704)
Q Consensus 164 ~L~~n~--l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~ 238 (704)
+++++. +++. +.....++++|++|++++| .+++.....+..+++|+.|++++| .+++.....++++++|+.|+++
T Consensus 154 ~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~ 233 (284)
T d2astb2 154 NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233 (284)
T ss_dssp ECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred hhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeee
Confidence 999763 4422 2223456899999999986 477777788899999999999995 6776666778899999999999
Q ss_pred CcccCCCCCcc-cccCcCCcEEEeecCccCCCCCCCcCCC
Q 005278 239 ANSLNGSLPSN-IQNLKVLTNLDLSRNQLSGDIPTTIGGL 277 (704)
Q Consensus 239 ~N~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l 277 (704)
++ +....-.. ...+|+| .+..++++...+..++..
T Consensus 234 ~~-~~d~~l~~l~~~lp~L---~i~~~~ls~~~~~~~~~~ 269 (284)
T d2astb2 234 GI-VPDGTLQLLKEALPHL---QINCSHFTTIARPTIGNK 269 (284)
T ss_dssp TS-SCTTCHHHHHHHSTTS---EESCCCSCCTTCSSCSST
T ss_pred CC-CCHHHHHHHHHhCccc---cccCccCCCCCCCccCcc
Confidence 98 44222222 2345554 567888887666666543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=7.6e-15 Score=131.66 Aligned_cols=112 Identities=17% Similarity=0.117 Sum_probs=74.6
Q ss_pred cccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChh
Q 005278 25 SITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPL 104 (704)
Q Consensus 25 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 104 (704)
.|.+...|++|+|++|+|+.+ +..+..+++|++|+|++|.|+.++ .|..+++|++|++++|+++...+..
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l~---------~~~~l~~L~~L~ls~N~i~~l~~~~ 82 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLD---------GFPLLRRLKTLLVNNNRICRIGEGL 82 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEEC---------CCCCCSSCCEEECCSSCCCEECSCH
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCccC---------CcccCcchhhhhcccccccCCCccc
Confidence 367788899999999999865 566788899999999999988753 2778888999999988888544433
Q ss_pred hhhcccccceEEecCCcccccCC-hhhhcCCCCCEEEccCCcCc
Q 005278 105 IGNFSASLQEFYAYGCKLRGNIP-QEIGNLSGMIVFDLNGCDLN 147 (704)
Q Consensus 105 ~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~ 147 (704)
+..+ ++|++|++++|++..... ..+..+++|++|++++|.+.
T Consensus 83 ~~~l-~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 83 DQAL-PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp HHHC-TTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccc-cccccceeccccccccccccccccccccchhhcCCCccc
Confidence 3333 245555555555543211 23444555555555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.6e-15 Score=134.70 Aligned_cols=14 Identities=21% Similarity=0.245 Sum_probs=5.6
Q ss_pred CCCCEEEccCCcCc
Q 005278 134 SGMIVFDLNGCDLN 147 (704)
Q Consensus 134 ~~L~~L~L~~n~l~ 147 (704)
..|++|+|++|+|+
T Consensus 18 ~~lr~L~L~~n~I~ 31 (162)
T d1a9na_ 18 VRDRELDLRGYKIP 31 (162)
T ss_dssp TSCEEEECTTSCCC
T ss_pred CcCcEEECCCCCCC
Confidence 33344444444433
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=1.3e-14 Score=123.52 Aligned_cols=101 Identities=30% Similarity=0.366 Sum_probs=47.9
Q ss_pred EEEccCCcCccccChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCcc
Q 005278 138 VFDLNGCDLNGTIPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNK 217 (704)
Q Consensus 138 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 217 (704)
+|+|++|+++ .++ .+..+++|++|++++|+|+ .+|..++.+++|+.|++++|+|++ +| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4555555554 222 2445555555555555554 344445555555555555555552 22 24455555555555555
Q ss_pred CCCCCC-CcccCCccccEEEecCcccC
Q 005278 218 LTSTMP-SSFGSLEYVLYINLSANSLN 243 (704)
Q Consensus 218 l~~~~~-~~~~~l~~L~~L~l~~N~l~ 243 (704)
|++... ..+..+++|+.|++++|.+.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 543221 23444444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=9.7e-14 Score=118.06 Aligned_cols=119 Identities=22% Similarity=0.281 Sum_probs=88.9
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCc
Q 005278 9 KYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLT 88 (704)
Q Consensus 9 ~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~ 88 (704)
++|+|++|+++ .++ .++.+++|++|++++|.|++ +|..|..+++|++|++++|.|+.++ .+..+++|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l~---------~~~~l~~L~ 68 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVD---------GVANLPRLQ 68 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCCG---------GGTTCSSCC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccccC---------ccccccccC
Confidence 58999999999 445 48999999999999999995 4667999999999999999998754 278899999
Q ss_pred EEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcCccc---cChhhcCCCCcCee
Q 005278 89 VLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDLNGT---IPTAVGRLRRLQGL 163 (704)
Q Consensus 89 ~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~---~~~~~~~l~~L~~L 163 (704)
+|++++|+|+.... ...+..+++|++|++++|.+... ....+..+|+|+.|
T Consensus 69 ~L~l~~N~i~~~~~------------------------~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 69 ELLLCNNRLQQSAA------------------------IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp EEECCSSCCCSSST------------------------TGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred eEECCCCccCCCCC------------------------chhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 99999999984421 12345566666667766666522 22234445666554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=2.5e-15 Score=139.82 Aligned_cols=89 Identities=22% Similarity=0.303 Sum_probs=42.3
Q ss_pred cChhhcCCCCcCeeeccCcccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecCccCCCCCCCcccCC
Q 005278 150 IPTAVGRLRRLQGLYLHGNKLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGSNKLTSTMPSSFGSL 229 (704)
Q Consensus 150 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 229 (704)
++..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+ .++..+..+++|+.|++++|.++.. ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence 34455555555555555555552 22 3555555555555555555 3333333334455555555555421 123334
Q ss_pred ccccEEEecCcccC
Q 005278 230 EYVLYINLSANSLN 243 (704)
Q Consensus 230 ~~L~~L~l~~N~l~ 243 (704)
++|+.|++++|.++
T Consensus 115 ~~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 115 VNLRVLYMSNNKIT 128 (198)
T ss_dssp HHSSEEEESEEECC
T ss_pred ccccccccccchhc
Confidence 44444444444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.38 E-value=2e-14 Score=133.70 Aligned_cols=134 Identities=22% Similarity=0.294 Sum_probs=72.5
Q ss_pred chhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccC
Q 005278 47 PNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNI 126 (704)
Q Consensus 47 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 126 (704)
+..|..+++|++|+|++|+|+.++ .+..+++|++|+|++|+|+. ++..+.. .++|++|++++|+++..
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i~---------~l~~l~~L~~L~Ls~N~i~~-i~~~~~~-~~~L~~L~l~~N~i~~l- 108 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKIS---------SLSGMENLRILSLGRNLIKK-IENLDAV-ADTLEELWISYNQIASL- 108 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCCC---------CHHHHTTCCEEECCEEEECS-CSSHHHH-HHHCCEEECSEEECCCH-
T ss_pred hhHHhcccccceeECcccCCCCcc---------cccCCccccChhhccccccc-ccccccc-ccccccccccccccccc-
Confidence 344555555555555555555432 14455555555555555552 2222222 23466666666665532
Q ss_pred ChhhhcCCCCCEEEccCCcCccccC-hhhcCCCCcCeeeccCcccCCCCCcc----------ccCCCCCCEEEcCCCcCC
Q 005278 127 PQEIGNLSGMIVFDLNGCDLNGTIP-TAVGRLRRLQGLYLHGNKLQGSIPYD----------LCHLEGLSELNLNGNKLC 195 (704)
Q Consensus 127 ~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~----------l~~l~~L~~L~L~~n~l~ 195 (704)
+.+..+++|++|++++|.++.... ..+..+++|+.|+|++|+++...+.. +..+++|+.|| +..++
T Consensus 109 -~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 109 -SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp -HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred -ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 335666667777777776663321 35666777777777777665332221 44567777765 44443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=1.4e-12 Score=115.87 Aligned_cols=82 Identities=22% Similarity=0.143 Sum_probs=36.6
Q ss_pred CEEEccCCcCccccChhhcCCCCcCeeeccCc-ccCCCCCccccCCCCCCEEEcCCCcCCccCCccccCcCCCCEEEecC
Q 005278 137 IVFDLNGCDLNGTIPTAVGRLRRLQGLYLHGN-KLQGSIPYDLCHLEGLSELNLNGNKLCGHVPPCLASLTSLRRLHLGS 215 (704)
Q Consensus 137 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 215 (704)
+.++.+++++. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 33444444444 23334444444444444333 24433333444444444444444444433344444444444444444
Q ss_pred ccCC
Q 005278 216 NKLT 219 (704)
Q Consensus 216 n~l~ 219 (704)
|+|+
T Consensus 90 N~l~ 93 (156)
T d2ifga3 90 NALE 93 (156)
T ss_dssp SCCS
T ss_pred CCCc
Confidence 4444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=2e-12 Score=114.81 Aligned_cols=105 Identities=19% Similarity=0.152 Sum_probs=48.3
Q ss_pred CEEEcCCCcCCccCCccccCcCCCCEEEecCc-cCCCCCCCcccCCccccEEEecCcccCCCCCcccccCcCCcEEEeec
Q 005278 185 SELNLNGNKLCGHVPPCLASLTSLRRLHLGSN-KLTSTMPSSFGSLEYVLYINLSANSLNGSLPSNIQNLKVLTNLDLSR 263 (704)
Q Consensus 185 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 263 (704)
+.++++++.+. ..|..+..+++|+.|++.+| .|+.+.+..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 33444444444 33334444444555555433 24433344444445555555555554444444455555555555555
Q ss_pred CccCCCCCCCcCCCCCcceeeccCceee
Q 005278 264 NQLSGDIPTTIGGLENLETLSLADNQFQ 291 (704)
Q Consensus 264 n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 291 (704)
|+|+...+..|. ..+|+.|+|++|.+.
T Consensus 90 N~l~~l~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTC-SCCCCEEECCSSCCC
T ss_pred CCCcccChhhhc-cccccccccCCCccc
Confidence 555522222222 224555555555553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=3.7e-09 Score=93.87 Aligned_cols=85 Identities=20% Similarity=0.189 Sum_probs=55.3
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeccCccccccCchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCC
Q 005278 6 PNLKYLTLFDNKLSGTIPNSITNASKLIMLDLSSNSFSGLIPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCR 85 (704)
Q Consensus 6 ~~l~~L~l~~~~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~ 85 (704)
.+.+.|++++.... ..+..+..+..|+...+.+. ..+..+.++++|++|+|++|+|+.+.. ++..+..++
T Consensus 22 ~~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~-----~~~~~~~l~ 91 (162)
T d1koha1 22 GSQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDD-----MSSIVQKAP 91 (162)
T ss_dssp SSSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSG-----GGTHHHHST
T ss_pred hhhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCch-----hHHHHhhCC
Confidence 35566777665433 22455555666666555554 445566778888888888888887642 223356778
Q ss_pred CCcEEEccCCCCccc
Q 005278 86 NLTVLGLASNPLRGI 100 (704)
Q Consensus 86 ~L~~L~L~~n~i~~~ 100 (704)
+|+.|+|++|.|+..
T Consensus 92 ~L~~L~Ls~N~i~~l 106 (162)
T d1koha1 92 NLKILNLSGNELKSE 106 (162)
T ss_dssp TCCCCCCTTSCCCCG
T ss_pred cccccccccCccccc
Confidence 888888888888754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=3.4e-09 Score=94.13 Aligned_cols=15 Identities=33% Similarity=0.530 Sum_probs=6.6
Q ss_pred cCCCCEEEecCccCC
Q 005278 205 LTSLRRLHLGSNKLT 219 (704)
Q Consensus 205 l~~L~~L~l~~n~l~ 219 (704)
+++|+.|+|++|+|+
T Consensus 64 ~~~L~~L~Ls~N~i~ 78 (162)
T d1koha1 64 IPELLSLNLSNNRLY 78 (162)
T ss_dssp CTTCCCCCCCSSCCC
T ss_pred CCCCCEeeCCCcccc
Confidence 344444444444444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=9.6e-07 Score=84.95 Aligned_cols=149 Identities=13% Similarity=0.118 Sum_probs=103.2
Q ss_pred HHHHHhCCCCccccccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEE
Q 005278 409 DIQRATNGFNECNLLGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKA 487 (704)
Q Consensus 409 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 487 (704)
++......|+..+..+-++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+....+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555566777655544444568998864 56667888876554444556788999988884 434678888888888899
Q ss_pred EEEeccCCCCHHHHHhhCCCccCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 005278 488 LVLEFMPNGSLEKWLYSHNYFLGILERLNIMIDVGLALEYLHHG------------------------------------ 531 (704)
Q Consensus 488 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------------------------------------ 531 (704)
+||+++++.++.+...... ....++.+++..+..||..
T Consensus 87 lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999999988865443211 1233455566666666631
Q ss_pred --------------------CCCCcEecCCCCCCeeeCCCCcEEEeeecccee
Q 005278 532 --------------------HSTPMVHCDLKPNNILLDENMTAHVSDFGISKL 564 (704)
Q Consensus 532 --------------------h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~~ 564 (704)
....++|+|+.|.||++++++.+-|.||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012379999999999999877677999987763
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.38 E-value=1.1e-07 Score=84.48 Aligned_cols=121 Identities=14% Similarity=0.141 Sum_probs=70.0
Q ss_pred CCCCCEEecCCC-cCccc----CCccccCCCCCCEEeccCccccccC----chhhcCCCCCCEEecccccCCCcccchhh
Q 005278 5 LPNLKYLTLFDN-KLSGT----IPNSITNASKLIMLDLSSNSFSGLI----PNTFGNLGSLQVLSLAYNYLMTESSAAKW 75 (704)
Q Consensus 5 l~~l~~L~l~~~-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 75 (704)
-++|+.|+|+++ .++.. +...+...++|++|+|++|.+++.. ...+...+.|++|+|++|.|...+...
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~-- 91 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR-- 91 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH--
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH--
Confidence 466777777653 45422 3334555666777777777666322 233445566777777777666554333
Q ss_pred cccccCCCCCCCcEEEccCCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcC
Q 005278 76 NFLSSLTNCRNLTVLGLASNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDL 146 (704)
Q Consensus 76 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 146 (704)
+...+...++|++|+|++|.+......... .+...+...++|+.|+++.+..
T Consensus 92 -l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~------------------~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 -LLRSTLVTQSIVEFKADNQRQSVLGNQVEM------------------DMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp -HHHHTTTTCCCSEEECCCCSSCCCCHHHHH------------------HHHHHHHHCSSCCEEECCCCCH
T ss_pred -HHHHHHhCCcCCEEECCCCcCCCccHHHHH------------------HHHHHHHhCCCccEeeCcCCCc
Confidence 455566666677777766655433222211 1334566677888888876654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.36 E-value=1.1e-07 Score=84.54 Aligned_cols=68 Identities=18% Similarity=0.203 Sum_probs=32.0
Q ss_pred CCCCCEEeccCc-ccccc----CchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcc
Q 005278 29 ASKLIMLDLSSN-SFSGL----IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRG 99 (704)
Q Consensus 29 l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~ 99 (704)
.++|++|+|+++ .++.. ...++...++|++|+|++|.+....... +...+...++|++|+|++|.++.
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~---la~~L~~n~~L~~L~L~~n~i~~ 86 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARG---LIELIETSPSLRVLNVESNFLTP 86 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTT---HHHHHHHCSSCCEEECCSSBCCH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHH---Hhhhhhhcccccceeeehhhcch
Confidence 455666666542 34421 2223444555555555555554333222 33334444555555555555543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.03 E-value=3.9e-07 Score=80.91 Aligned_cols=71 Identities=15% Similarity=0.109 Sum_probs=33.3
Q ss_pred ccCCCCCCEEeccC-cccccc----CchhhcCCCCCCEEecccccCCCcccchhhcccccCCCCCCCcEEEccCCCCcc
Q 005278 26 ITNASKLIMLDLSS-NSFSGL----IPNTFGNLGSLQVLSLAYNYLMTESSAAKWNFLSSLTNCRNLTVLGLASNPLRG 99 (704)
Q Consensus 26 ~~~l~~L~~L~L~~-n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~ 99 (704)
..+.+.|++|+|++ +.++.. ...++...++|++|+|++|.+....... +...+...++|+.|++++|.+..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~---L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA---LAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH---HHHHHHHCSSCCEEECCSSCCCH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHH---HHHHHhhcccchhhhhccccccc
Confidence 33445555555554 334421 2223344555555555555554433222 33334444555555555555543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=8.3e-06 Score=77.70 Aligned_cols=130 Identities=16% Similarity=0.102 Sum_probs=85.9
Q ss_pred cccccCc-eEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCC--CCCceEEeeeeeCCeEEEEEeccCCCCH
Q 005278 422 LLGTGSF-GSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRH--RNLIKIISNCCNIDFKALVLEFMPNGSL 498 (704)
Q Consensus 422 ~ig~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 498 (704)
.+..|.. +.||+....++..+++|..... ....+..|...++.+.. -.+.+++++..+++..++||+|+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 6799998878888999986533 23457788888887743 3356778888888888999999987655
Q ss_pred HHHHhhCCCccCHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 005278 499 EKWLYSHNYFLGILERLNIMIDVGLALEYLH------------------------------------------------- 529 (704)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh------------------------------------------------- 529 (704)
.+.- .. ....+.++++.+.-||
T Consensus 94 ~~~~------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3210 00 0111222222333332
Q ss_pred --h----cCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 530 --H----GHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 530 --~----~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
. .....++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 012337999999999999987767899998765
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.93 E-value=1.5e-06 Score=76.97 Aligned_cols=119 Identities=13% Similarity=0.185 Sum_probs=87.8
Q ss_pred CCCCCCEEecCC-CcCcc----cCCccccCCCCCCEEeccCcccccc----CchhhcCCCCCCEEecccccCCCcccchh
Q 005278 4 MLPNLKYLTLFD-NKLSG----TIPNSITNASKLIMLDLSSNSFSGL----IPNTFGNLGSLQVLSLAYNYLMTESSAAK 74 (704)
Q Consensus 4 ~l~~l~~L~l~~-~~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 74 (704)
.-|.|++|+|++ +.++. .+..++...++|++|+|++|.++.. +...+...++|+.|++++|.+...+...
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~- 93 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA- 93 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH-
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH-
Confidence 458999999998 46763 2455667899999999999999854 3345677899999999999998776544
Q ss_pred hcccccCCCCCCCcEEEcc--CCCCcccCChhhhhcccccceEEecCCcccccCChhhhcCCCCCEEEccCCcC
Q 005278 75 WNFLSSLTNCRNLTVLGLA--SNPLRGILPPLIGNFSASLQEFYAYGCKLRGNIPQEIGNLSGMIVFDLNGCDL 146 (704)
Q Consensus 75 ~~~~~~~~~l~~L~~L~L~--~n~i~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 146 (704)
+...+...++|+.++|+ +|++.......++ ..+...++|++|+++.+..
T Consensus 94 --l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La---------------------~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 --LVEALQSNTSLIELRIDNQSQPLGNNVEMEIA---------------------NMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp --HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH---------------------HHHHHCSSCCEEECCCSSH
T ss_pred --HHHHHHhCccccEEeeccCCCcCcHHHHHHHH---------------------HHHHhCCCcCEEeCcCCCC
Confidence 67778899999986665 5667644333333 3455667788888776654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.20 E-value=0.00052 Score=69.19 Aligned_cols=76 Identities=14% Similarity=0.138 Sum_probs=49.4
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeeccc-------hhhhHHHHHHHHHHHhcC-C--CCCceEEeeeeeCCeEEE
Q 005278 420 CNLLGTGSFGSVYKGTLF-DGTNVAIKVFNLQL-------ERASRSFDSECEILRSIR-H--RNLIKIISNCCNIDFKAL 488 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l 488 (704)
++.||.|....||+.... +++.++||.-.... .....+...|.+.++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999865 46789999754321 112234567888887763 2 345566654 4455679
Q ss_pred EEeccCCCC
Q 005278 489 VLEFMPNGS 497 (704)
Q Consensus 489 v~e~~~~gs 497 (704)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.53 E-value=0.0044 Score=60.36 Aligned_cols=67 Identities=10% Similarity=0.080 Sum_probs=45.4
Q ss_pred eEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCC--ceEE-----eeeeeCCeEEEEEeccCCC
Q 005278 429 GSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNL--IKII-----SNCCNIDFKALVLEFMPNG 496 (704)
Q Consensus 429 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g 496 (704)
-.||+++..+|+.+++|+.+.. ....+++..|.+.+..+....+ +..+ ..+...+..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4799999999999999997643 2245678889998888842222 1111 1223455678899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.13 E-value=0.011 Score=57.09 Aligned_cols=156 Identities=10% Similarity=0.026 Sum_probs=82.9
Q ss_pred cchHHHHHHhCCCCcccc-----ccccCceEEEEEEECCCCEEEEEEeeccchhhhHHHHHHHHHHHhcCCCCC--ceEE
Q 005278 405 TSYLDIQRATNGFNECNL-----LGTGSFGSVYKGTLFDGTNVAIKVFNLQLERASRSFDSECEILRSIRHRNL--IKII 477 (704)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~-----ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~ 477 (704)
.+..+++....+|...+. |..|---+.|+.+..+|+ +++|++... ...+.+..|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 345677777778876443 345555778998877665 889987543 234556677777777742221 1111
Q ss_pred e------eeeeCCeEEEEEeccCCCCHHH--------------HHhh--C-------C-C----------------ccCH
Q 005278 478 S------NCCNIDFKALVLEFMPNGSLEK--------------WLYS--H-------N-Y----------------FLGI 511 (704)
Q Consensus 478 ~------~~~~~~~~~lv~e~~~~gsL~~--------------~l~~--~-------~-~----------------~~~~ 511 (704)
. +.........++.+..+..... .++. . . . ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1122345566677766543210 0000 0 0 0 0000
Q ss_pred HHHHHHHHHHHHHHHHHH-hcCCCCcEecCCCCCCeeeCCCCcEEEeeeccce
Q 005278 512 LERLNIMIDVGLALEYLH-HGHSTPMVHCDLKPNNILLDENMTAHVSDFGISK 563 (704)
Q Consensus 512 ~~~~~i~~~i~~~l~~Lh-~~h~~~ivH~dlk~~Nil~~~~~~~kl~Dfgla~ 563 (704)
......+......+...+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111111222222222221 1234679999999999999988877899999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.82 E-value=0.0075 Score=60.48 Aligned_cols=73 Identities=14% Similarity=0.180 Sum_probs=48.8
Q ss_pred cccccccCceEEEEEEECC--------CCEEEEEEeeccchhhhHHHHHHHHHHHhcC-CCCCceEEeeeeeCCeEEEEE
Q 005278 420 CNLLGTGSFGSVYKGTLFD--------GTNVAIKVFNLQLERASRSFDSECEILRSIR-HRNLIKIISNCCNIDFKALVL 490 (704)
Q Consensus 420 ~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 490 (704)
++.|+-|-.-.+|+....+ .+.|.+++.... .......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3578888888999998654 245777776422 22334567888888884 4334477777653 5889
Q ss_pred eccCCCCH
Q 005278 491 EFMPNGSL 498 (704)
Q Consensus 491 e~~~~gsL 498 (704)
||+++.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99986543
|